PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Akhondi, SA; Klenner, AG; Tyrchan, C; Manchala, AK; Boppana, K; Lowe, D; Zimmermann, M; Jagarlapudi, SARP; Sayle, R; Kors, JA; Muresan, S				Akhondi, Saber A.; Klenner, Alexander G.; Tyrchan, Christian; Manchala, Anil K.; Boppana, Kiran; Lowe, Daniel; Zimmermann, Marc; Jagarlapudi, Sarma A. R. P.; Sayle, Roger; Kors, Jan A.; Muresan, Sorel			Annotated Chemical Patent Corpus: A Gold Standard for Text Mining	PLOS ONE			English	Article							INFORMATION; ENTITIES; IDENTIFICATION; CHEMISTRY	Exploring the chemical and biological space covered by patent applications is crucial in early-stage medicinal chemistry activities. Patent analysis can provide understanding of compound prior art, novelty checking, validation of biological assays, and identification of new starting points for chemical exploration. Extracting chemical and biological entities from patents through manual extraction by expert curators can take substantial amount of time and resources. Text mining methods can help to ease this process. To validate the performance of such methods, a manually annotated patent corpus is essential. In this study we have produced a large gold standard chemical patent corpus. We developed annotation guidelines and selected 200 full patents from the World Intellectual Property Organization, United States Patent and Trademark Office, and European Patent Office. The patents were pre-annotated automatically and made available to four independent annotator groups each consisting of two to ten annotators. The annotators marked chemicals in different subclasses, diseases, targets, and modes of action. Spelling mistakes and spurious line break due to optical character recognition errors were also annotated. A subset of 47 patents was annotated by at least three annotator groups, from which harmonized annotations and inter-annotator agreement scores were derived. One group annotated the full set. The patent corpus includes 400,125 annotations for the full set and 36,537 annotations for the harmonized set. All patents and annotated entities are publicly available at www.biosemantics.org.	[Akhondi, Saber A.; Kors, Jan A.] Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands; [Klenner, Alexander G.; Zimmermann, Marc] Fraunhofer Gesell, Fraunhofer Inst Algorithms & Sci Comp SCAI, St Augustin, Germany; [Tyrchan, Christian] AstraZeneca R&D, RIA Med Chem, Molndal, Sweden; [Manchala, Anil K.; Boppana, Kiran; Jagarlapudi, Sarma A. R. P.] GVK Biosci Private Ltd, Hyderabad, Andhra Pradesh, India; [Lowe, Daniel; Sayle, Roger] NextMove Software Ltd, Cambridge, England; [Muresan, Sorel] AstraZeneca R&D, Chem Innovat Ctr, Molndal, Sweden	Erasmus University Rotterdam; Erasmus MC; Fraunhofer Gesellschaft; Fraunhofer Institute Center Schloss Birlinghoven; AstraZeneca; AstraZeneca	Kors, JA (corresponding author), Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands.	j.kors@erasmusmc.nl; sorel.muresan@gmail.com	Muresan, Sorel/C-1961-2009	Muresan, Sorel/0000-0003-2386-0436; A. Akhondi, Saber/0000-0003-2855-5633; Tyrchan, Christian/0000-0002-6470-984X	AstraZeneca	AstraZeneca(AstraZeneca)	This study was made possible by a studentship grant provided by AstraZeneca for SAA. The funder provided support in the form of salaries for SAA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhondi SA, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-35; CAS REGISTRY, GOLD STAND CHEM SUBS; Corbett P, 2007, P WORKSH BIONLP 2007, P57; de Matos P, 2010, NUCLEIC ACIDS RES, V38, pD249, DOI 10.1093/nar/gkp886; Degtyarenko K, 2008, NUCLEIC ACIDS RES, V36, pD344, DOI 10.1093/nar/gkm791; Grego T, 2009, LECT NOTES COMPUT SC, V5518, P942, DOI 10.1007/978-3-642-02481-8_144; Heller S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-7; Jessop DM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-40; Kim JD, 2003, BIOINFORMATICS, V19, pi180, DOI 10.1093/bioinformatics/btg1023; Kiss M, 2012, MANUALLY ANNOTATED C, P135; Klinger R, 2008, BIOINFORMATICS, V24, pI268, DOI 10.1093/bioinformatics/btn181; Kolarik C., 2008, WORKSH BUILD EV RES; Kolarik C, 2007, BIOINFORMATICS, V23, pI264, DOI 10.1093/bioinformatics/btm196; Krallinger M, 2013, BIOCREATIVE CHALL EV, V2, P2; Kulick S, 2004, HLT NAACL 2004 WORKS, P61; Lewin I, 2012, LREC 2012 - EIGHTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P3894; Lowe DM, 2013, BIOCREATIVE CHALL EV, V2, P47; Muresan S, 2011, DRUG DISCOV TODAY, V16, P1019, DOI 10.1016/j.drudis.2011.10.005; Robertson D. W., 1991, Washington, DC: U.S. Patent and Trademark Office, Patent No. [5,023,269. U.S. 1991, 5023269]; Sayle R, 2012, J CHEM INF MODEL, V52, P51, DOI 10.1021/ci200463r; Southan C, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-14; Stenetorp Pontus, 2012, P DEM 13 C EUR CHAPT, P102; Tiago G, 2012, ISRN BIOINFORMATICS, V2012; Tseng YH, 2007, INFORM PROCESS MANAG, V43, P1216, DOI 10.1016/j.ipm.2006.11.011; Tyrchan C, 2012, J CHEM INF MODEL, V52, P1480, DOI 10.1021/ci3001293; Undefined, 1978, J CHEM INF COMP SCI, V18, P58, DOI DOI 10.1021/CI60013A609; Vazquez M, 2011, MOL INFORM, V30, P506, DOI 10.1002/minf.201100005; Villani F. J., 1987, Patent No. [US4659716, 4659716, US4659716 A]; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Zimmermann M, 2005, CURR TOP MED CHEM, V5, P785, DOI 10.2174/1568026054637692	30	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107477	10.1371/journal.pone.0107477	http://dx.doi.org/10.1371/journal.pone.0107477			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268232	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700039
J	Wada, T; Kunihiro, A; Tominaga-Wada, R				Wada, Takuji; Kunihiro, Asuka; Tominaga-Wada, Rumi			Arabidopsis CAPRICE (MYB) and GLABRA3 (bHLH) Control Tomato (Solanum lycopersicum) Anthocyanin Biosynthesis	PLOS ONE			English	Article							EPIDERMAL-CELL FATE; REPEAT R3 MYB; TRICHOME DEVELOPMENT; FLAVONOID BIOSYNTHESIS; TRANSCRIPTION FACTOR; SPECIALIZED METABOLITES; EXPRESSION ANALYSIS; NEGATIVE REGULATOR; ROOT EPIDERMIS; GENE	In Arabidopsis thaliana the MYB transcription factor CAPRICE (CPC) and the bHLH transcription factor GLABRA3 (GL3) are central regulators of root-hair differentiation and trichome initiation. By transforming the orthologous tomato genes SlTRY (CPC) and SlGL3 (GL3) into Arabidopsis, we demonstrated that these genes influence epidermal cell differentiation in Arabidopsis, suggesting that tomato and Arabidopsis partially use similar transcription factors for epidermal cell differentiation. CPC and GL3 are also known to be involved in anthocyanin biosynthesis. After transformation into tomato, 35S::CPC inhibited anthocyanin accumulation, whereas GL3::GL3 enhanced anthocyanin accumulation. Real-time reverse transcription PCR analyses showed that the expression of anthocyanin biosynthetic genes including Phe-ammonia lyase (PAL), the flavonoid pathway genes chalcone synthase (CHS), dihydroflavonol reductase (DFR), and anthocyanidin synthase (ANS) were repressed in 35S::CPC tomato. In contrast, the expression levels of PAL, CHS, DFR, and ANS were significantly higher in GL3::GL3 tomato compared with control plants. These results suggest that CPC and GL3 also influence anthocyanin pigment synthesis in tomato.	[Wada, Takuji; Tominaga-Wada, Rumi] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 724, Japan; [Kunihiro, Asuka] Hiroshima Univ, Fac Appl Biol Sci, Higashihiroshima, Hiroshima 724, Japan	Hiroshima University; Hiroshima University	Tominaga-Wada, R (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 724, Japan.	rtomi@hiroshima-u.ac.jp			Cooperative Research Grant of the Gene Research Center; University of Tsukuba; JSPS KAKENHI [24658032, 23570057, 25114513]	Cooperative Research Grant of the Gene Research Center; University of Tsukuba; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Cooperative Research Grant of the Gene Research Center, the University of Tsukuba, and JSPS KAKENHI (Grant numbers 24658032, 23570057 and 25114513). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGGS CJ, 1987, PLANTA, V172, P121, DOI 10.1007/BF00403037; Bernhardt C, 2005, DEVELOPMENT, V132, P291, DOI 10.1242/dev.01565; Bernhardt C, 2003, DEVELOPMENT, V130, P6431, DOI 10.1242/dev.00880; Bloor SJ, 2002, PHYTOCHEMISTRY, V59, P343, DOI 10.1016/S0031-9422(01)00460-5; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Bovy A, 2002, PLANT CELL, V14, P2509, DOI 10.1105/tpc.004218; Carey CC, 2004, PLANT CELL, V16, P450, DOI 10.1105/tpc.018796; Cominelli E, 2008, J PLANT PHYSIOL, V165, P886, DOI 10.1016/j.jplph.2007.06.010; Dolan L, 1996, ANN BOT-LONDON, V77, P547, DOI 10.1006/anbo.1996.0069; Dubos C, 2008, PLANT J, V55, P940, DOI 10.1111/j.1365-313X.2008.03564.x; Esch JJ, 2004, PLANT J, V40, P860, DOI 10.1111/j.1365-313X.2004.02259.x; Esch JJ, 2003, DEVELOPMENT, V130, P5885, DOI 10.1242/dev.00812; Feyissa DN, 2009, PLANTA, V230, P747, DOI 10.1007/s00425-009-0978-3; GALWAY ME, 1994, DEV BIOL, V166, P740, DOI 10.1006/dbio.1994.1352; Gan LJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-176; Girardi CL, 2006, POSTHARVEST BIOL TEC, V42, P1, DOI 10.1016/j.postharvbio.2006.06.002; Glover BJ, 2000, ADV BOT RES, V31, P193, DOI 10.1016/S0065-2296(00)31011-4; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Gould KS, 2004, J BIOMED BIOTECHNOL, P314, DOI 10.1155/S1110724304406147; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; HULSKAMP M, 1994, CELL, V76, P555, DOI 10.1016/0092-8674(94)90118-X; Kang JH, 2010, PLANT PHYSIOL, V154, P262, DOI 10.1104/pp.110.160192; Kang JH, 2010, J EXP BOT, V61, P1053, DOI 10.1093/jxb/erp370; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Koshino-Kimura Y, 2005, PLANT CELL PHYSIOL, V46, P817, DOI 10.1093/pcp/pci096; Larkin JC, 1999, GENETICS, V151, P1591; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Li ST, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27522; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LLOYD AM, 1992, SCIENCE, V258, P1773, DOI 10.1126/science.1465611; Luckwill L.C., 1943, ABERD U STUD, V120, P1; MARTIN C, 1993, PLANT CELL, V5, P1253, DOI 10.1105/tpc.5.10.1253; Matsui K, 2008, PLANT J, V55, P954, DOI 10.1111/j.1365-313X.2008.03565.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mustilli AC, 1999, PLANT CELL, V11, P145, DOI 10.1105/tpc.11.2.145; Payne CT, 2000, GENETICS, V156, P1349; Pemberton LMS, 2001, ANN BOT-LONDON, V87, P649, DOI 10.1006/anbo.2001.1385; Peng MS, 2008, J EXP BOT, V59, P2933, DOI 10.1093/jxb/ern148; Povero G, 2011, J PLANT PHYSIOL, V168, P270, DOI 10.1016/j.jplph.2010.07.022; Quattrocchio F, 1998, PLANT J, V13, P475, DOI 10.1046/j.1365-313X.1998.00046.x; RABINO I, 1986, PLANT PHYSIOL, V81, P922, DOI 10.1104/pp.81.3.922; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; Rowan DD, 2009, NEW PHYTOL, V182, P102, DOI 10.1111/j.1469-8137.2008.02737.x; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; Schilmiller A, 2010, PLANT J, V62, P391, DOI 10.1111/j.1365-313X.2010.04154.x; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Shi MZ, 2010, PLANTA, V231, P1385, DOI 10.1007/s00425-010-1142-9; Simon M, 2007, DEV BIOL, V311, P566, DOI 10.1016/j.ydbio.2007.09.001; Sun HJ, 2006, PLANT CELL PHYSIOL, V47, P426, DOI 10.1093/pcp/pci251; Tominaga R, 2008, DEVELOPMENT, V135, P1335, DOI 10.1242/dev.017947; Tominaga-Wada R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00091; Tominaga-Wada R, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24575; Tominaga-Wada R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054019; Tominaga-Wada R, 2012, INT J MOL SCI, V13, P3478, DOI 10.3390/ijms13033478; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Walker AR, 1999, PLANT CELL, V11, P1337, DOI 10.1105/tpc.11.7.1337; Wang SC, 2007, DEVELOPMENT, V134, P3873, DOI 10.1242/dev.009597; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Yoshida Y, 2009, DEVELOPMENT, V136, P1039, DOI 10.1242/dev.030585; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhou LL, 2012, PLANTA, V236, P825, DOI 10.1007/s00425-012-1674-2; Zhu HF, 2009, MOL PLANT, V2, P790, DOI 10.1093/mp/ssp030	64	31	37	6	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e109093	10.1371/journal.pone.0109093	http://dx.doi.org/10.1371/journal.pone.0109093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268379	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700220
J	Barros, MPS; Franca, CT; Lins, RHFB; Santos, MDV; Silva, EJ; Oliveira, MBM; Silveira, VM; Rezende, AM; Balbino, VQ; Leal-Balbino, TC				Barros, Maria Paloma S.; Franca, Camila T.; Lins, Rosanny Holanda F. B.; Santos, Milena Danda V.; Silva, Ednaldo J.; Oliveira, Maria Betania M.; Silveira-Filho, Vladimir M.; Rezende, Antonio M.; Balbino, Valdir Q.; Leal-Balbino, Tereza Cristina			Dynamics of CRISPR Loci in Microevolutionary Process of Yersinia pestis Strains	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; SEQUENCE; PHYLOGENIES; GENETICS; REVEALS; REPEATS; EBURST	The potential use of CRISPR loci genotyping to elucidate population dynamics and microevolution of 146 Yersinia pestis strains from different biovars and locations was investigated in this work. The majority of strains from the Orientalis biovar presented specific spacer arrays, allowing for the establishment of a CRISPR signature for their respective isolates. Twentyone new spacers were found in the Y. pestis strains from plague foci in Brazil. Ninety-three (64%) strains were grouped in the G1 genotype, whereas the others were distributed in 35 genotypes. This study allowed observing a microevolutionary process in a group of Y. pestis isolated from Brazil. We also identified specific genotypes of Y. pestis that were important for the establishment of the bacteria in plague foci in Brazil. The data have provided supporting evidence for the diversity and dynamics of CRISPR loci present in the genome of Y. pestis strains from plague foci in Brazil.	[Barros, Maria Paloma S.; Franca, Camila T.; Lins, Rosanny Holanda F. B.; Silva, Ednaldo J.; Rezende, Antonio M.; Leal-Balbino, Tereza Cristina] Ctr Pesquisas Aggeu Magalhaes CPqAM Fiocruz, Dept Microbiol, Recife, PE, Brazil; [Lins, Rosanny Holanda F. B.; Balbino, Valdir Q.] Univ Fed Pernambuco UFPE, Dept Genet, Recife, PE, Brazil; [Santos, Milena Danda V.; Oliveira, Maria Betania M.] Univ Fed Pernambuco UFPE, Dept Bioquim, Recife, PE, Brazil; [Silveira-Filho, Vladimir M.] Univ Pernambuco UPE, Dept Biol, Garanhuns, PE, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade de Pernambuco (UPE)	Barros, MPS (corresponding author), Ctr Pesquisas Aggeu Magalhaes CPqAM Fiocruz, Dept Microbiol, Recife, PE, Brazil.	mariapalomabarros@gmail.com	Rezende, Antonio M/S-2126-2018; Franca, Camila/I-4877-2019; Balbino, Valdir de Queiroz/H-6877-2014	Rezende, Antonio M/0000-0003-4775-1779; Franca, Camila/0000-0001-5885-4410; Balbino, Valdir de Queiroz/0000-0002-4319-3952	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco; Centro de Pesquisas Aggeu Magalhaes by the Technique Cooperation Scholarship (BCT)	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Centro de Pesquisas Aggeu Magalhaes by the Technique Cooperation Scholarship (BCT)	Support was provided by Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco and Centro de Pesquisas Aggeu Magalhaes by the Technique Cooperation Scholarship (BCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrangou R., 2009, MICROBE, V4, P224, DOI [10.1128/microbe.4.224.1, DOI 10.1128/microbe.4.224.1, DOI 10.1128/MICROBE.4.224.1]; Barrangou R, 2012, ANNU REV FOOD SCI T, V3, P143, DOI 10.1146/annurev-food-022811-101134; Barros MPS, 2013, GENET MOL RES, V12, P1294, DOI 10.4238/2013.January.4.23; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Cui YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002652; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Eppinger M, 2010, J BACTERIOL, V192, P1685, DOI 10.1128/JB.01518-09; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Le Fleche P, 2001, BMC Microbiol, V1, P2; Li YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002166; Oliveira MBM, 2012, GENET MOL RES, V11, P3414, DOI 10.4238/2012.September.25.10; Platonov M E, 2013, Mol Gen Mikrobiol Virusol, P3; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Riehm JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030624; Spratt BG, 2004, FEMS MICROBIOL LETT, V241, P129, DOI 10.1016/j.femsle.2004.11.015; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Vogler AJ, 2013, MBIO, V4, DOI 10.1128/mBio.00623-12; Zhou DS, 2004, J BACTERIOL, V186, P5147, DOI 10.1128/jb.186.15.5147-5152.2004	26	19	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108353	10.1371/journal.pone.0108353	http://dx.doi.org/10.1371/journal.pone.0108353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265542	Green Published, gold			2022-12-27	WOS:000345745400069
J	Hill, H; Windmann, S				Hill, Holger; Windmann, Sabine			Examining Event-Related Potential (ERP) Correlates of Decision Bias in Recognition Memory Judgments	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL EVIDENCE; PROCESS DISSOCIATION; EPISODIC MEMORY; EMOTIONAL WORDS; CRITERION-SHIFT; RESPONSE BIAS; MODELS; FAMILIARITY; MECHANISMS; FRAMEWORK	Memory judgments can be based on accurate memory information or on decision bias (the tendency to report that an event is part of episodic memory when one is in fact unsure). Event related potentials (ERP) correlates are important research tools for elucidating the dynamics underlying memory judgments but so far have been established only for investigations of accurate old/new discrimination. To identify the ERP correlates of bias, and observe how these interact with ERP correlates of memory, we conducted three experiments that manipulated decision bias within participants via instructions during recognition memory tests while their ERPs were recorded. In Experiment 1, the bias manipulation was performed between blocks of trials (automatized bias) and compared to trial-by-trial shifts of bias in accord with an external cue (flexibly controlled bias). In Experiment 2, the bias manipulation was performed at two different levels of accurate old/new discrimination as the memory strength of old (studied) items was varied. In Experiment 3, the bias manipulation was added to another, bottom-up driven manipulation of bias induced via familiarity. In the first two Experiments, and in the low familiarity condition of Experiment 3, we found evidence of an early frontocentral ERP component at 320 ms poststimulus (the FN320) that was sensitive to the manipulation of bias via instruction, with more negative amplitudes indexing more liberal bias. By contrast, later during the trial (500-700 ms poststimulus), bias effects interacted with old/new effects across all three experiments. Results suggest that the decision criterion is typically activated early during recognition memory trials, and is integrated with retrieved memory signals and task-specific processing demands later during the trial. More generally, the findings demonstrate how ERPs can help to specify the dynamics of recognition memory processes under top-down and bottom-up controlled retrieval conditions.	[Hill, Holger; Windmann, Sabine] Goethe Univ Frankfurt, Inst Psychol, D-60054 Frankfurt, Germany; [Hill, Holger] Karlsruhe Inst Technol, Inst Sports & Sports Sci, Dept Appl Psychol, D-76021 Karlsruhe, Germany	Goethe University Frankfurt; Helmholtz Association; Karlsruhe Institute of Technology	Hill, H (corresponding author), Goethe Univ Frankfurt, Inst Psychol, D-60054 Frankfurt, Germany.	holger.hill@kit.edu			German Research Foundation (DFG) [WI-1582/3-1]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Karlsruhe Institute of Technology	German Research Foundation (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Karlsruhe Institute of Technology	Research reported in this article was supported by a grant to SW of the German Research Foundation (DFG, funding no. WI-1582/3-1) www.dfg.de. The authors acknowledge support for publishing this article by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan K, 1998, ACTA PSYCHOL, V98, P231, DOI 10.1016/S0001-6918(97)00044-9; Armbruster DJN, 2012, J COGNITIVE NEUROSCI, V24, P2385, DOI 10.1162/jocn_a_00286; Azimian-Faridani N, 2006, J COGNITIVE NEUROSCI, V18, P1075, DOI 10.1162/jocn.2006.18.7.1075; Batchelder WH, 2013, PSYCHOL BULL, V139, P1204, DOI 10.1037/a0033894; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; Broder A, 2013, MEMORY, V21, P916, DOI 10.1080/09658211.2013.767348; Curran T, 2007, J EXP PSYCHOL LEARN, V33, P2, DOI 10.1037/0278-7393.33.1.2; De Baene W, 2013, NEUROIMAGE, V77, P207, DOI 10.1016/j.neuroimage.2013.03.057; de Jonge P, 2005, EUR J PSYCHIAT, V19, P209, DOI 10.4321/s0213-61632005000400002; DeCarlo LT, 2008, J EXP PSYCHOL LEARN, V34, P1565, DOI 10.1037/a0013081; Dougal S, 2007, PSYCHON B REV, V14, P423, DOI 10.3758/BF03194083; Dube C, 2013, PSYCHOL BULL, V139, P1213, DOI 10.1037/a0034453; Dube C, 2012, J MEM LANG, V67, P389, DOI 10.1016/j.jml.2012.06.002; Erdfelder E, 2007, EXPERIENCING NEW WOR, P201; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Green DM, 1966, SIGNAL DETECTION THE; Guillaume F, 2013, BRAIN COGNITION, V81, P73, DOI 10.1016/j.bandc.2012.10.007; Hager W, 1994, HDB DEUTSCHSPRACHIGE; Hakuri JG, 2012, BRAIN RES, V1451, P53, DOI 10.1016/j.brainres.2012.02.046; Hawkins J, 2004, INTELLIGENCE; Hedden T, 2010, NEUROIMAGE, V51, P421, DOI 10.1016/j.neuroimage.2010.01.089; Higham PA, 2007, J EXP PSYCHOL GEN, V136, P1, DOI 10.1037/0096-3445.136.1.1; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Jang Y, 2009, J EXP PSYCHOL GEN, V138, P291, DOI 10.1037/a0015525; Johansson M, 2003, BIOL PSYCHOL, V64, P91, DOI 10.1016/S0301-0511(03)00104-2; Kantner J, 2012, MEM COGNITION, V40, P1163, DOI 10.3758/s13421-012-0226-0; Kellen D, 2014, J EXP PSYCH IN PRESS; Lang PJ, 2008, HDB DEUTSCHSPRACHIGE; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042233; Macmillan NA, 2005, MEMORY, V13, P607, DOI 10.1080/09658210444000269; Macmillan NA, 2005, DETECTION THEORY USE; Malmberg KJ, 2008, COGNITIVE PSYCHOL, V57, P335, DOI 10.1016/j.cogpsych.2008.02.004; Mecklinger A, 2000, PSYCHOPHYSIOLOGY, V37, P565, DOI 10.1111/1469-8986.3750565; Mecklinger A, 2006, CLIN EEG NEUROSCI, V37, P292, DOI 10.1177/155005940603700406; Miller MB, 1999, PSYCHOL REV, V106, P398, DOI 10.1037/0033-295X.106.2.398; Mollison MV, 2012, NEUROPSYCHOLOGIA, V50, P2546, DOI 10.1016/j.neuropsychologia.2012.06.027; Nessler D, 2005, COGNITIVE BRAIN RES, V22, P265, DOI 10.1016/j.cogbrainres.2004.03.023; Norman KA, 2008, PSYCHON B REV, V15, P36, DOI 10.3758/PBR.15.1.36; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pazzaglia AM, 2013, PSYCHOL BULL, V139, P1173, DOI 10.1037/a0033044; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Prime DJ, 2009, J COGNITIVE NEUROSCI, V21, P991, DOI 10.1162/jocn.2009.21105; Reckless GE, 2013, NEUROSCIENCE, V238, P135, DOI 10.1016/j.neuroscience.2013.02.015; Reggev N, 2012, COGNITION, V124, P256, DOI 10.1016/j.cognition.2012.04.001; Rugg M.D., 1995, OX PSYCH S, P133; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Thapar A, 2009, PSYCHON B REV, V16, P699, DOI 10.3758/PBR.16.4.699; Turner MS, 2008, NEUROPSYCHOLOGIA, V46, P1442, DOI 10.1016/j.neuropsychologia.2007.12.029; Verde MF, 2004, PSYCHON B REV, V11, P560, DOI 10.3758/BF03196611; Verde MF, 2007, MEM COGNITION, V35, P254, DOI 10.3758/BF03193446; Verde MF, 2006, PERCEPT PSYCHOPHYS, V68, P643, DOI 10.3758/BF03208765; Windmann S, 1998, CONSCIOUS COGN, V7, P603, DOI 10.1006/ccog.1998.0337; Windmann S, 2002, CEREB CORTEX, V12, P808, DOI 10.1093/cercor/12.8.808; Windmann S, 2002, J ABNORM PSYCHOL, V111, P357, DOI 10.1037//0021-843X.111.2.357; Windmann S, 2001, J COGNITIVE NEUROSCI, V13, P577, DOI 10.1162/089892901750363172; Windmann S, 2008, COGNITION EMOTION, V22, P761, DOI 10.1080/02699930701507899; Wixted JT, 2000, PSYCHOL REV, V107, P368, DOI 10.1037//0033-295X.107.2.368; Wolf DH, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00081; Yonelinas AP, 2001, PHILOS T R SOC B, V356, P1363, DOI 10.1098/rstb.2001.0939; Zhang J, 2005, PSYCHOMETRIKA, V70, P203, DOI 10.1007/s11336-003-1119-8; Zhu B, 2013, MEM COGNITION, V41, P832, DOI 10.3758/s13421-013-0300-2	64	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e106411	10.1371/journal.pone.0106411	http://dx.doi.org/10.1371/journal.pone.0106411			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6XR	25264982	gold, Green Published			2022-12-27	WOS:000345745400010
J	Liu, JT; Wang, LL; Guo, X; Pang, QJ; Wu, SX; Wu, CY; Xu, P; Bai, YD				Liu, Jiangtao; Wang, Linlin; Guo, Xiong; Pang, Qingjiang; Wu, Shixun; Wu, Cuiyan; Xu, Peng; Bai, Yidong			The Role of Mitochondria in T-2 Toxin-Induced Human Chondrocytes Apoptosis	PLOS ONE			English	Article							KASHIN-BECK-DISEASE; ARTICULAR CHONDROCYTES; ENDEMIC OSTEOARTHRITIS; DYSFUNCTION; METABOLISM; CARTILAGE; BCL-2; PATHOPHYSIOLOGY; EXPRESSION; PATHWAYS	T-2 toxin, a mycotoxin produced by Fusarium species, has been shown to cause diverse toxic effects in animals and is also a possible pathogenic factor of Kashin-Beck disease (KBD). The role of mitochondria in KBD is recognized in our recent research. The aim of this study was to evaluate the role of mitochondria in T-2 toxin-induced human chondrocytes apoptosis to understand the pathogenesis of KBD. T-2 toxin decreased chondrocytes viabilities in concentration-and timedependent manners. Exposure to T-2 toxin can reduce activities of mitochondrial complexes III, IV and V, Delta Psi m and the cellular ATP, while intracellular ROS increased following treatment with T-2 toxin. Furthermore, mitochondrial cytochrome c release, caspase-9 and 3 activation and chondrocytes apoptosis were also obviously observed. Interestingly, Selenium (Se) can partly block T-2 toxin -induced mitochondria dysfunction, oxidative damage and chondrocytes apoptosis. These results suggest that the effect of T-2 toxin on human chondrocytes apoptosis may be mediated by a mitochondrial pathway, which is highly consistent with the chondrocytes changes in KBD.	[Liu, Jiangtao; Guo, Xiong; Wu, Shixun; Wu, Cuiyan] Xi An Jiao Tong Univ, Sch Publ Hlth, Hlth Sci Ctr, Key Lab Environm & Genes Related Dis,Minist Educ, Xian 710049, Shaanxi, Peoples R China; [Liu, Jiangtao; Pang, Qingjiang] Ningbo 2 Hosp, Dept Orthoped Surg, Ningbo, Zhejiang, Peoples R China; [Wang, Linlin] Ningbo First Hosp, Dept Obstet & Gynecol, Ningbo, Zhejiang, Peoples R China; [Xu, Peng] Xian Red Cross Hosp, Dept Orthopaed Surg, Xian, Shaanxi, Peoples R China; [Bai, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	Xi'an Jiaotong University; University of Texas System; University of Texas Health San Antonio	Guo, X (corresponding author), Xi An Jiao Tong Univ, Sch Publ Hlth, Hlth Sci Ctr, Key Lab Environm & Genes Related Dis,Minist Educ, Xian 710049, Shaanxi, Peoples R China.	guox@mail.xjtu.edu.cn; pqjey@sina.com	Bai, Yidong/A-4959-2012		National Natural Scientific Foundation of China [30972556]; Zhejiang Medical and Health Science Research Fund [2013KYB235, 2014KYB234]; Natural Scientific Foundation of Ningbo [2014A610244]; Ningbo No. 2 Hospital Research Fund [2013006]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Medical and Health Science Research Fund; Natural Scientific Foundation of Ningbo; Ningbo No. 2 Hospital Research Fund	This work was supported by the National Natural Scientific Foundation of China (30972556) (http://isis.nsfc.gov.cn/); the Zhejiang Medical and Health Science Research Fund (2013KYB235, 2014KYB234) (http://www.zjmed.org.cn/); the Natural Scientific Foundation of Ningbo (2014A610244) (http://xmsb.nbsti.gov.cn/); and the Ningbo No. 2 Hospital Research Fund (2013006) (http://www.nbdeyy.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrientos A, 2009, CURRENT PROTOCOLS HU; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Blanco FJ, 2004, MITOCHONDRION, V4, P715, DOI 10.1016/j.mito.2004.07.022; Brown SV, 2006, EUKARYOT CELL, V5, P45, DOI 10.1128/EC.5.1.45-53.2006; Chen JH, 2006, FOOD CHEM TOXICOL, V44, P567, DOI 10.1016/j.fct.2005.09.004; Dimroth P, 2000, J EXP BIOL, V203, P51; Eisenbrand G, 2002, FOOD CHEM TOXICOL, V40, P193, DOI 10.1016/S0278-6915(01)00118-1; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; GE KY, 1993, AM J CLIN NUTR, V57, P259; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Guo X, 2006, J BONE MINER METAB, V24, P319, DOI 10.1007/s00774-006-0690-3; Konigs M, 2009, TOXICOLOGY, V258, P106, DOI 10.1016/j.tox.2009.01.012; Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055; Lattanzio VMT, 2012, J MASS SPECTROM, V47, P466, DOI 10.1002/jms.2980; Li CY, 2012, SCI CHINA LIFE SCI, V55, P1057, DOI 10.1007/s11427-012-4418-4; Li YS, 2011, J AGR FOOD CHEM, V59, P3441, DOI 10.1021/jf200767q; Liu JT, 2010, OSTEOARTHR CARTILAGE, V18, P1218, DOI 10.1016/j.joca.2010.07.003; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P1011, DOI 10.1016/j.joca.2006.03.008; Ma YS, 2009, BBA-GEN SUBJECTS, V1790, P1021, DOI 10.1016/j.bbagen.2009.04.012; Maneiro E, 2005, ANN RHEUM DIS, V64, P388, DOI 10.1136/ard.2004.022152; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Mazat JP, 2013, IUBMB LIFE, V65, P171, DOI 10.1002/iub.1138; National Kashin-Beck Disease Surveillance Group, 2006, CHIN J ENDEMIOL, V25, P670; Ning YJ, 2013, BIOL TRACE ELEM RES, V153, P58, DOI 10.1007/s12011-013-9651-6; Pasteels JL, 2001, INT ORTHOP, V25, P151, DOI 10.1007/s002640000190; Pfander D, 2007, CURR OPIN RHEUMATOL, V19, P457, DOI 10.1097/BOR.0b013e3282ba5693; Renault TT, 2013, INT J BIOCHEM CELL B, V45, P64, DOI 10.1016/j.biocel.2012.09.022; Reynafarje Baltazar D, 2008, Int J Med Sci, V5, P143; Schollenberger M, 2007, MYCOPATHOLOGIA, V164, P101, DOI 10.1007/s11046-007-9036-5; Statistical Center of Ministry of Health PR China, 2007, STAT B DEV CIRC CHIN; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Sun LY, 2012, BIOL TRACE ELEM RES, V150, P371, DOI 10.1007/s12011-012-9469-7; Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069; Wang SH, 2006, J RHEUMATOL, V33, P615; XIA Y, 2004, CHINESE NUTR ENCY, P975; Yamamuro T, 2001, INT ORTHOP, V25, P134, DOI 10.1007/s002640000178; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022983; Zhuang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083105	38	41	47	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108394	10.1371/journal.pone.0108394	http://dx.doi.org/10.1371/journal.pone.0108394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264878	gold, Green Submitted, Green Published			2022-12-27	WOS:000345745400072
J	Millot, S; Cerqueira, M; Castanheira, MF; Overli, O; Oliveira, RF; Martins, CIM				Millot, Sandie; Cerqueira, Marco; Castanheira, Maria-Filipa; Overli, Oyvind; Oliveira, Rui F.; Martins, Catarina I. M.			Behavioural Stress Responses Predict Environmental Perception in European Sea Bass (Dicentrarchus labrax)	PLOS ONE			English	Article							RAINBOW-TROUT; COPING STYLES; GASTEROSTEUS-ACULEATUS; INDIVIDUAL-DIFFERENCES; ANIMAL-WELFARE; CORTISOL; PREFERENCE; EXPOSURE; FISH; RESPONSIVENESS	Individual variation in the response to environmental challenges depends partly on innate reaction norms, partly on experience-based cognitive/emotional evaluations that individuals make of the situation. The goal of this study was to investigate whether pre-existing differences in behaviour predict the outcome of such assessment of environmental cues, using a conditioned place preference/avoidance (CPP/CPA) paradigm. A comparative vertebrate model (European sea bass, Dicentrarchus labrax) was used, and ninety juvenile individuals were initially screened for behavioural reactivity using a net restraining test. Thereafter each individual was tested in a choice tank using net chasing as aversive stimulus or exposure to familiar conspecifics as appetitive stimulus in the preferred or non preferred side respectively (called hereafter stimulation side). Locomotor behaviour (i.e. time spent, distance travelled and swimming speed in each tank side) of each individual was recorded and analysed with video software. The results showed that fish which were previously exposed to appetitive stimulus increased significantly the time spent on the stimulation side, while aversive stimulus led to a strong decrease in time spent on the stimulation side. Moreover, this study showed clearly that proactive fish were characterised by a stronger preference for the social stimulus and when placed in a putative aversive environment showed a lower physiological stress responses than reactive fish. In conclusion, this study showed for the first time in sea bass, that the CPP/CPA paradigm can be used to assess the valence (positive vs. negative) that fish attribute to different stimuli and that individual behavioural traits is predictive of how stimuli are perceived and thus of the magnitude of preference or avoidance behaviour.	[Millot, Sandie; Cerqueira, Marco; Castanheira, Maria-Filipa; Martins, Catarina I. M.] Univ Algarve, CCMAR CIMAR LA, Faro, Portugal; [Overli, Oyvind] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway; [Oliveira, Rui F.] ISPA Unidade Invest Ecoetol Integrat Behav Biol G, Lisbon, Portugal; [Oliveira, Rui F.] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, Oeiras, Portugal	Universidade do Algarve; Norwegian University of Life Sciences; Fundacao Champalimaud; Instituto Gulbenkian de Ciencia	Millot, S (corresponding author), Univ Algarve, CCMAR CIMAR LA, Campus Gambelas, Faro, Portugal.	sandiemillot@yahoo.fr	Cerqueira, Marco/GSI-4368-2022; Oliveira, Rui/A-3581-2013	Oliveira, Rui/0000-0003-1528-618X; Cerqueira, Marco/0000-0001-7237-5053	European Commission [265957]; Portuguese Fundacao para a Ciencia e Tecnologia (FCT) [FRH/BPD/72952/2010]; FCT [SFRH/BD/80029/2011]	European Commission(European CommissionEuropean Commission Joint Research Centre); Portuguese Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research project has been support by the European Commission under the 7th Framework Programme FP7-KBBE-2010-4 Contract nu: 265957 Copewell. The work of Sandie Millot is supported by the Portuguese Fundacao para a Ciencia e Tecnologia (FCT) grant nu: FRH/BPD/72952/2010. The PhD of Marco Cerqueira is supported by the FCT grant nu: SFRH/BD/80029/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby MC, 2002, ANIM WELFARE, V11, P283; Arends RJ, 1999, J ENDOCRINOL, V163, P149, DOI 10.1677/joe.0.1630149; Backstrom T, 2014, J FISH BIOL, V84, P1, DOI 10.1111/jfb.12240; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Broglio C., 2011, FISH COGNITION BEHAV, P325, DOI DOI 10.1002/9781444342536.CH15; Brown C., 2011, FISH COGNITION BEHAV, V2nd; Brown C, 2015, ANIM COGN, V18, P1, DOI 10.1007/s10071-014-0761-0; Bshary R, 2002, ANIM COGN, V5, P1, DOI 10.1007/s10071-001-0116-5; Budaev S., 2011, FISH COGNITION BEHAV, P135, DOI DOI 10.1002/9781444342536.CH7; Castanheira MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062037; Castanheira MF, 2013, APPL ANIM BEHAV SCI, V143, P75, DOI 10.1016/j.applanim.2012.11.008; Chandroo KP, 2004, APPL ANIM BEHAV SCI, V86, P225, DOI 10.1016/j.applanim.2004.02.004; CHATAIN B, 1994, AQUACULTURE, V119, P371, DOI 10.1016/0044-8486(94)90301-8; Dawkins MS, 1998, Q REV BIOL, V73, P305, DOI 10.1086/420307; Demski LS, 2013, BRAIN BEHAV EVOLUT, V82, P31, DOI 10.1159/000351994; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Endo M, 2002, FISHERIES SCI, V68, P253, DOI 10.1046/j.1444-2906.2002.00419.x; Fanouraki E, 2008, BEHAVIOUR, V145, P1267, DOI 10.1163/156853908785765818; Herrero MJ, 2007, J COMP PHYSIOL B, V177, P319, DOI 10.1007/s00360-006-0131-6; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P245, DOI 10.1016/S0003-3472(76)80034-6; Kirkden RD, 2006, APPL ANIM BEHAV SCI, V100, P29, DOI 10.1016/j.applanim.2006.04.009; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Korzan WJ, 2006, ACTA ETHOL, V9, P48, DOI 10.1007/s10211-006-0015-5; Laland KN, 2003, FISH FISH, V4, P199, DOI 10.1046/j.1467-2979.2003.00124.x; Martins CIM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028084; Martins CIM, 2011, APPL ANIM BEHAV SCI, V130, P135, DOI 10.1016/j.applanim.2010.12.007; Mathur P, 2011, BEHAV BRAIN RES, V217, P128, DOI 10.1016/j.bbr.2010.10.015; Silva PIM, 2010, APPL ANIM BEHAV SCI, V124, P75, DOI 10.1016/j.applanim.2010.01.008; Overli O, 2006, PHYSIOL BEHAV, V87, P506, DOI 10.1016/j.physbeh.2005.11.012; Overli O, 2005, INTEGR COMP BIOL, V45, P463, DOI 10.1093/icb/45.3.463; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Pike TW, 2008, P ROY SOC B-BIOL SCI, V275, P2515, DOI 10.1098/rspb.2008.0744; Prus A. J., 2009, METHODS BEHAV ANAL N; Rink E, 2004, BRAIN RES, V1011, P206, DOI 10.1016/j.brainres.2004.03.027; Scherer KR., 1987, GENEVA STUDIES EMOTI, V1, P1, DOI DOI 10.1080/02699930902928969; Scherrer B, 1984, BIOSTATISTIQUE; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sinn DL, 2008, ANIM BEHAV, V75, P433, DOI 10.1016/j.anbehav.2007.05.008; Sneddon LU, 2003, J FISH BIOL, V62, P971, DOI 10.1046/j.1095-8649.2003.00084.x; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Winberg S, 2007, COMP BIOCHEM PHYS A, V146, pS77, DOI 10.1016/j.cbpa.2007.01.719; Yue S, 2008, J APPL ANIM WELF SCI, V11, P14, DOI 10.1080/10888700701729106	45	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108800	10.1371/journal.pone.0108800	http://dx.doi.org/10.1371/journal.pone.0108800			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264870	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000345745400126
J	Sandholm, K; Henningsson, AJ; Save, S; Bergstrom, S; Forsberg, P; Jonsson, N; Ernerudh, J; Ekdahl, KN				Sandholm, Kerstin; Henningsson, Anna J.; Save, Susanne; Bergstrom, Sven; Forsberg, Pia; Jonsson, Nina; Ernerudh, Jan; Ekdahl, Kristina N.			Early Cytokine Release in Response to Live Borrelia burgdorferi Sensu Lato Spirochetes Is Largely Complement Independent	PLOS ONE			English	Article							INNATE IMMUNE ACTIVATION; LYME-DISEASE SPIROCHETE; HUMAN-FACTOR-H; CEREBROSPINAL-FLUID; SURFACE PROTEIN; HUMAN MONOCYTES; SERUM RESISTANCE; CLINICAL-MANIFESTATIONS; PERIPHERAL-BLOOD; DENDRITIC CELLS	Aim: Here we investigated the role of complement activation in phagocytosis and the release of cytokines and chemokines in response to two clinical isolates: Borrelia afzelii K78, which is resistant to complement-mediated lysis, and Borrelia garinii LU59, which is complement-sensitive. Methods: Borrelia spirochetes were incubated in hirudin plasma, or hirudin-anticoagulated whole blood. Complement activation was measured as the generation of C3a and sC5b-9. Binding of the complement components C3, factor H, C4, and C4BP to the bacterial surfaces was analyzed. The importance of complement activation on phagocytosis, and on the release of cytokines and chemokines, was investigated using inhibitors acting at different levels of the complement cascade. Results: 1) Borrelia garinii LU59 induced significantly higher complement activation than did Borrelia afzelii K78. 2) Borrelia afzelii K78 recruited higher amounts of factor H resulting in significantly lower C3 binding. 3) Both Borrelia strains were efficiently phagocytized by granulocytes and monocytes, with substantial inhibition by complement blockade at the levels of C3 and C5. 4) The release of the pro-inflammatory cytokines and chemokines IL-1 beta, IL-6, TNF, CCL20, and CXCL8, together with the anti-inflammatory IL-10, were increased the most (by>10-fold after exposure to Borrelia). 5) Both strains induced a similar release of cytokines and chemokines, which in contrast to the phagocytosis, was almost totally unaffected by complement blockade. Conclusions: Our results show that complement activation plays an important role in the process of phagocytosis but not in the subsequent cytokine release in response to live Borrelia spirochetes.	[Sandholm, Kerstin; Save, Susanne; Jonsson, Nina; Ekdahl, Kristina N.] Linnaeus Univ, Ctr Biomat Chem, Kalmar, Sweden; [Henningsson, Anna J.] Ryhov Cty Hosp, Dept Clin Microbiol, Jonkoping, Sweden; [Henningsson, Anna J.; Forsberg, Pia] Linkoping Univ, Dept Infect Med, Linkoping, Sweden; [Henningsson, Anna J.; Forsberg, Pia; Ernerudh, Jan] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Bergstrom, Sven] Umea Univ, Dept Mol Biol, Umea, Sweden; [Jonsson, Nina; Ekdahl, Kristina N.] Uppsala Univ, Div Clin Immunol, Rudbeck Lab C5, Uppsala, Sweden; [Ernerudh, Jan] Linkoping Univ, Dept Clin Immunol & Transfus Med, Linkoping, Sweden	Linnaeus University; Linkoping University; Linkoping University; Umea University; Uppsala University; Linkoping University	Ekdahl, KN (corresponding author), Linnaeus Univ, Ctr Biomat Chem, Kalmar, Sweden.	Kristina.nilsson_ekdahl@igp.uu.se	Ekdahl, Kristina Nilsson/B-5301-2012	, nina/0000-0001-8771-1523	Futurum Academy for Health and Care; Jonkoping County Council, Sweden; Family Olinder-Nielsen's Foundation; FORSS - Medical Research Council of Southeast Sweden; Linnaeus University	Futurum Academy for Health and Care; Jonkoping County Council, Sweden; Family Olinder-Nielsen's Foundation; FORSS - Medical Research Council of Southeast Sweden; Linnaeus University	AJH was supported by Futurum Academy for Health and Care, Jonkoping County Council, Sweden, and Family Olinder-Nielsen's Foundation. AJH, JE, and KNE were supported by FORSS - Medical Research Council of Southeast Sweden. KNE was also supported by Linnaeus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Alitalo A, 2004, J IMMUNOL, V172, P6195, DOI 10.4049/jimmunol.172.10.6195; Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; BARANTON G, 1992, INT J SYST BACTERIOL, V42, P378, DOI 10.1099/00207713-42-3-378; BERGLUND J, 1995, NEW ENGL J MED, V333, P1319, DOI 10.1056/NEJM199511163332004; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; BRADE V, 1992, IMMUNOBIOLOGY, V185, P453, DOI 10.1016/S0171-2985(11)80087-2; BreitnerRuddock S, 1997, MED MICROBIOL IMMUN, V185, P253, DOI 10.1007/s004300050038; Buffen K, 2013, J BIOL CHEM, V288, P8658, DOI 10.1074/jbc.M112.412841; Bykowski T, 2008, INT J MED MICROBIOL, V298, P249, DOI 10.1016/j.ijmm.2007.10.002; Cervantes JL, 2011, P NATL ACAD SCI USA, V108, P3683, DOI 10.1073/pnas.1013776108; Cimmino MA, 1998, INFECTION, V26, P298, DOI 10.1007/BF02962251; Codolo G, 2008, ARTHRITIS RHEUM, V58, P3609, DOI 10.1002/art.23972; Cruz AR, 2008, INFECT IMMUN, V76, P56, DOI 10.1128/IAI.01039-07; Dennis VA, 2009, INFECT IMMUN, V77, P1238, DOI 10.1128/IAI.01078-08; EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x; Ekerfelt C, 1997, J NEUROIMMUNOL, V79, P155, DOI 10.1016/S0165-5728(97)00118-5; Fijen CAP, 2000, CLIN EXP IMMUNOL, V120, P338, DOI 10.1046/j.1365-2249.2000.01208.x; Giambartolomei GH, 1998, INFECT IMMUN, V66, P2691, DOI 10.1128/IAI.66.6.2691-2697.1998; HAMMER CH, 1981, J BIOL CHEM, V256, P3995; HAZENBOS WLW, 1994, INFECT IMMUN, V62, P4818, DOI 10.1128/IAI.62.11.4818-4824.1994; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; Henningsson AJ, 2007, J NEUROIMMUNOL, V183, P200, DOI 10.1016/j.jneuroim.2006.10.022; Henningsson AJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-36; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Janulczyk R, 2000, J BIOL CHEM, V275, P37257, DOI 10.1074/jbc.M004572200; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Katragadda M, 2006, J MED CHEM, V49, P4616, DOI 10.1021/jm0603419; Klippel N, 2010, MICROBIOL-SGM, V156, P3432, DOI 10.1099/mic.0.040006-0; Ko YP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003816; KOCHI SK, 1991, J IMMUNOL, V146, P3964; Kraiczy P, 2004, J BIOL CHEM, V279, P2421, DOI 10.1074/jbc.M308343200; Kraiczy P, 2001, INT IMMUNOPHARMACOL, V1, P393, DOI 10.1016/S1567-5769(00)00041-2; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kraiczy P, 2000, IMMUNOBIOLOGY, V201, P406, DOI 10.1016/S0171-2985(00)80094-7; KUHN S, 1995, J IMMUNOL, V155, P5663; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Lazarus JJ, 2006, J IMMUNOL, V177, P7076, DOI 10.4049/jimmunol.177.10.7076; Liba Z, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-30; McKisic MD, 2000, INFECT IMMUN, V68, P5190, DOI 10.1128/IAI.68.9.5190-5197.2000; Meri T, 2006, INFECT IMMUN, V74, P4157, DOI 10.1128/IAI.00007-06; MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P197, DOI 10.1111/j.1365-3083.1985.tb01871.x; Moore MW, 2007, INFECT IMMUN, V75, P2046, DOI 10.1128/IAI.01666-06; NILSSON UR, 1993, MOL IMMUNOL, V30, P211, DOI 10.1016/0161-5890(93)90050-L; Nordberg M, 2011, J NEUROIMMUNOL, V232, P186, DOI 10.1016/j.jneuroim.2010.09.028; Nuutila J, 2005, CYTOM PART A, V65A, P93, DOI 10.1002/cyto.a.20139; PETERSON PK, 1976, INFECT IMMUN, V14, P496, DOI 10.1128/IAI.14.2.496-501.1976; Petzke MM, 2009, J IMMUNOL, V183, P5279, DOI 10.4049/jimmunol.0901390; Pietikainen J, 2010, MOL IMMUNOL, V47, P1299, DOI 10.1016/j.molimm.2009.11.028; Ram S, 1998, J EXP MED, V188, P671, DOI 10.1084/jem.188.4.671; Salazar JC, 2003, J IMMUNOL, V171, P2660, DOI 10.4049/jimmunol.171.5.2660; Schwab J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053659; Shamaei-Tousi A, 2000, CELL MICROBIOL, V2, P591, DOI 10.1046/j.1462-5822.2000.00083.x; Sjowall J, 2005, CLIN EXP IMMUNOL, V141, P89, DOI 10.1111/j.1365-2249.2005.02820.x; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Steere AC, 2006, ARTHRITIS RHEUM-US, V54, P3079, DOI 10.1002/art.22131; Suhonen J, 2003, SCAND J IMMUNOL, V58, P67, DOI 10.1046/j.1365-3083.2003.01284.x; Suhonen J, 2000, J INFECT DIS, V181, P195, DOI 10.1086/315195; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; van Burgel ND, 2011, TICKS TICK-BORNE DIS, V2, P20, DOI 10.1016/j.ttbdis.2010.10.003; van Burgel ND, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-43; VanDam AP, 1997, INFECT IMMUN, V65, P1228, DOI 10.1128/IAI.65.4.1228-1236.1997; VANDAM AP, 1993, CLIN INFECT DIS, V17, P708, DOI 10.1093/clinids/17.4.708; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; WHALEY K, 1976, SCIENCE, V193, P1011, DOI 10.1126/science.948757; Widhe M, 2004, J INFECT DIS, V189, P1881, DOI 10.1086/382893; Wilske B, 1996, MED MICROBIOL IMMUN, V184, P195, DOI 10.1007/BF02456135; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	70	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108013	10.1371/journal.pone.0108013	http://dx.doi.org/10.1371/journal.pone.0108013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265036	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400038
J	Cheng, QJ; Li, H; Silenzio, V; Caine, ED				Cheng, Qijin; Li, Hong; Silenzio, Vincent; Caine, Eric D.			Suicide Contagion: A Systematic Review of Definitions and Research Utility	PLOS ONE			English	Review							TELEVISION-NEWS STORIES; TEENAGE SUICIDES; SELF-INJURY; MASS-MEDIA; EPIDEMIC; PREVENTION; CLUSTERS; STRESS; IMPACT; PEER	Objectives: Despite the common use of contagion to analogize the spread of suicide, there is a lack of rigorous assessment of the underlying concept or theory supporting the use of this term. The present study aims to examine the varied definitions and potential utility of the term contagion in suicide-related research. Methods: 100 initial records and 240 reference records in English were identified as relevant with our research objectives, through systematic literature screening. We then conducted narrative syntheses of various definitions and assessed their potential value for generating new research. Results: 20.3% of the 340 records used contagion as equivalent to clustering (contagion-as-cluster); 68.5% used it to refer to various, often related mechanisms underlying the clustering phenomenon (contagion-as-mechanism); and 11.2% without clear definition. Under the category of contagion-as-mechanism, four mechanisms have been proposed to explain how suicide clusters occurred: transmission (contagion-as-transmission), imitation (contagion-as-imitation), contextual influence (contagion-as-context), and affiliation (contagion-as-affiliation). Contagion-as-cluster both confounds and constrains inquiry into suicide clustering by blending proposed mechanism with the phenomenon to be studied. Contagion-as-transmission is, in essence, a double or internally redundant metaphor. Contagion-as-affiliation and contagion-as-context involve mechanisms that are common mechanisms that often occur independently of apparent contagion, or may serve as a facilitating background. When used indiscriminately, these terms may create research blind spots. Contagion-as-imitation combines perspectives from psychology, sociology, and public health research and provides the greatest heuristic utility for examining whether and how suicide and suicidal behaviors may spread among persons at both individual and population levels. Conclusion: Clarifying the concept of "suicide contagion'' is an essential step for more thoroughly investigating its mechanisms. Developing a clearer understanding of the apparent spread of suicide-promoting influences can, in turn, offer insights necessary to build the scientific foundation for prevention and intervention strategies that can be applied at both individual and community levels.	[Cheng, Qijin] Univ Hong Kong, HKJC Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China; [Cheng, Qijin; Li, Hong; Silenzio, Vincent; Caine, Eric D.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA; [Li, Hong] Univ Chinese Acad Sci, Sch Management, Beijing, Peoples R China; [Silenzio, Vincent; Caine, Eric D.] Univ Rochester, Med Ctr, Injury Control Res Ctr Suicide Prevent, Rochester, NY 14642 USA; [Caine, Eric D.] VA Ctr Excellence Suicide Prevent, Canandaigua, NY USA	University of Hong Kong; University of Rochester; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Rochester	Cheng, QJ (corresponding author), Univ Hong Kong, HKJC Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China.	chengq@hku.hk	Silenzio, Vincent Michael Bernard/AAC-1466-2020	Silenzio, Vincent Michael Bernard/0000-0003-1408-7955; Cheng, Qijin/0000-0002-6223-5345	US National Institutes of Health Fogarty International Center [D43 TW009101]; US Centers for Disease Control and Prevention [R49 CE002093]; University of Hong Kong; University of the Chinese Academy of Sciences; University of Rochester Medical Center; FOGARTY INTERNATIONAL CENTER [D43TW009101] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE002093] Funding Source: NIH RePORTER	US National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University of Hong Kong(University of Hong Kong); University of the Chinese Academy of Sciences; University of Rochester Medical Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	QC, HL, and EDC were supported, in part, by a grant from the US National Institutes of Health Fogarty International Center, D43 TW009101. VS and EDC were supported, in part, by the US Centers for Disease Control and Prevention grant R49 CE002093. In addition, QC was supported by The University of Hong Kong; HL was supported by the University of the Chinese Academy of Sciences; and VS and EDC also were supported by funds from the University of Rochester Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbound L, 2009, FRANCE TELECOM CEO V; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; ASHTON JR, 1981, PSYCHOL MED, V11, P735, DOI 10.1017/S0033291700041234; Booth H, 2010, SUICIDE LIFE-THREAT, V40, P1, DOI 10.1521/suli.2010.40.1.1; Brechwald WA, 2011, J RES ADOLESCENCE, V21, P166, DOI 10.1111/j.1532-7795.2010.00721.x; BRENT DA, 1993, J AM ACAD CHILD PSY, V32, P509, DOI 10.1097/00004583-199305000-00004; Bryant J, 2009, COMMUN SER, pXI; Bursztein C, 2009, CURR OPIN PSYCHIATR, V22, P1, DOI 10.1097/YCO.0b013e3283155508; Caine ED, 2013, AM J PUBLIC HEALTH, V103, P822, DOI 10.2105/AJPH.2012.301078; Chotai J, 2005, NORD J PSYCHIAT, V59, P325, DOI 10.1080/08039480500319621; COX B, 1993, J EPIDEMIOL COMMUN H, V47, P69, DOI 10.1136/jech.47.1.69; Daine K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077555; de Leo D, 2008, CRISIS, V29, P11, DOI 10.1027/0227-5910.29.1.11; Durkheim E., 1979, SUICIDE STUDY SOCIOL; English HB, 1958, COMPREHENSIVE DICTIO; GOULD MS, 1986, NEW ENGL J MED, V315, P690, DOI 10.1056/NEJM198609113151107; GOULD MS, 1989, SUICIDE LIFE-THREAT, V19, P17; Gould MS, 2001, ANN NY ACAD SCI, V932, P200; Gould MS, 2012, CONT VIOL WORKSH SUM; Haw C, 2013, SUICIDE LIFE-THREAT, V43, P97, DOI 10.1111/j.1943-278X.2012.00130.x; Hawton K, 2002, BRIT MED J, V325, P1374, DOI 10.1136/bmj.325.7377.1374; Hawton K, 2010, EUR CHILD ADOLES PSY, V19, P513, DOI 10.1007/s00787-009-0065-0; Higgins LJ, 1999, J SOC CLIN PSYCHOL, V18, P436, DOI 10.1521/jscp.1999.18.4.436; Hooghe M, 2011, SUICIDE LIFE-THREAT, V41, P453, DOI 10.1111/j.1943-278X.2011.00047.x; HORTON H, 1984, J SOC PSYCHOL, V123, P141, DOI 10.1080/00224545.1984.9924526; Howard S, 1976, ANN REV SOCIOLOGY; Hsiung RC, 2007, CYBERPSYCHOL BEHAV, V10, P495, DOI 10.1089/cpb.2007.9999; Jarvi S, 2013, ARCH SUICIDE RES, V17, P1, DOI 10.1080/13811118.2013.748404; Johansson Lars, 2006, BMC Fam Pract, V7, P32, DOI 10.1186/1471-2296-7-32; Joiner TE, 2003, J ADOLESCENCE, V26, P495, DOI 10.1016/S0140-1971(02)00133-1; Joiner TE, 1999, CURR DIR PSYCHOL SCI, V8, P89, DOI 10.1111/1467-8721.00021; KAMINER Y, 1986, NEW ENGL J MED, V315, P1030; KESSLER RC, 1988, AM J PSYCHIAT, V145, P1379; KESSLER RC, 1989, J NERV MENT DIS, V177, P551, DOI 10.1097/00005053-198909000-00006; Khan U, 2009, TELEGRAPH; KING CA, 1995, PSYCHIATR SERV, V46, P915; MARZUK PM, 1993, NEW ENGL J MED, V329, P1508, DOI 10.1056/NEJM199311113292022; MATTHEWS PC, 1968, INT J SOC PSYCHIATR, V14, P125, DOI 10.1177/002076406801400206; Merton R., 1967, SOCIAL THEORY SOCIAL; Mesoudi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007252; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; National Center for Injury Prevention and Control (U.S.) Centers for Disease Control and Prevention (U.S.), 2008, PROM IND FAM COMM CO; Nelson K.E., 2013, INFECT DIS EPIDEMIOL; Niederkrotenthaler T, 2012, J EPIDEMIOLOGY COMMU; Niedzwiedz C, 2014, SUICIDE LIFE THREAT; Pfefferbaum B, 1998, CHILD ADOL PSYCH CL, V7, P183, DOI 10.1016/S1056-4993(18)30267-0; PHILLIPS DP, 1985, SCIENCES, V25, P32, DOI 10.1002/j.2326-1951.1985.tb02929.x; PHILLIPS DP, 1979, AM J SOCIOL, V84, P1150, DOI 10.1086/226904; PHILLIPS DP, 1980, SOC FORCES, V58, P1001, DOI 10.2307/2577310; PHILLIPS DP, 1974, AM SOCIOL REV, V39, P340, DOI 10.2307/2094294; PHILLIPS DP, 1986, NEW ENGL J MED, V315, P685, DOI 10.1056/NEJM198609113151106; Pirkis J, 2009, PSYCHIATRY, V8, P269, DOI DOI 10.1016/J.MPPSY.2009.04.009; Prinstein MJ, 2010, J ABNORM CHILD PSYCH, V38, P669, DOI 10.1007/s10802-010-9423-0; ROBBINS D, 1983, J ADOLESCENT HEALTH, V3, P253, DOI 10.1016/S0197-0070(83)80247-2; ROSENBERG ML, 1987, ANNU REV PUBL HEALTH, V8, P417, DOI 10.1146/annurev.publhealth.8.1.417; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Sisask M, 2012, INT J ENV RES PUB HE, V9, P123, DOI 10.3390/ijerph9010123; Sloan PA, 2006, J SOC CLIN PSYCHOL, V25, P1107, DOI 10.1521/jscp.2006.25.10.1107; Sloan PA, 2009, J SOC CLIN PSYCHOL, V28, P535, DOI 10.1521/jscp.2009.28.5.535; Slovic P, 1977, ANN REV PSYCHOL; STACK S, 1987, AM SOCIOL REV, V52, P401, DOI 10.2307/2095359; Stack S, 2000, SOC SCI QUART, V81, P957; TAIMINEN TJ, 1992, ACTA PSYCHIAT SCAND, V85, P449, DOI 10.1111/j.1600-0447.1992.tb03210.x; TAIMINEN TJ, 1994, AM J PSYCHIAT, V151, P1087; Taiminen TJ, 1998, J AM ACAD CHILD PSY, V37, P211, DOI 10.1097/00004583-199802000-00014; Tarde G., 1903, LAWS IMITATION; Tsai CW, 2011, J AFFECT DISORDERS, V131, P402, DOI 10.1016/j.jad.2010.12.013; WHEELER L, 1966, PSYCHOL REV, V73, P179, DOI 10.1037/h0023023; Whitlock JL, 2006, DEV PSYCHOL, V42, P407, DOI 10.1037/0012-1649.42.3.407; Wray M, 2011, ANNU REV SOCIOL, V37, P505, DOI 10.1146/annurev-soc-081309-150058; Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2; ZEMISHLANY Z, 1987, BRIT J PSYCHIAT, V150, P704, DOI 10.1192/bjp.150.5.704	72	57	57	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108724	10.1371/journal.pone.0108724	http://dx.doi.org/10.1371/journal.pone.0108724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IP	25259604	Green Published, gold			2022-12-27	WOS:000342685600095
J	Maneva-Radicheva, L; Amatya, C; Parker, C; Ellefson, J; Radichev, I; Raghavan, A; Charles, ML; Williams, MS; Robbins, MS; Savinov, AY				Maneva-Radicheva, Lilia; Amatya, Christina; Parker, Camille; Ellefson, Jacob; Radichev, Ilian; Raghavan, Arvind; Charles, Matthew L.; Williams, Mark S.; Robbins, Mark S.; Savinov, Alexei Y.			Autoimmune Diabetes Is Suppressed by Treatment with Recombinant Human Tissue Kallikrein-1	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; KININ SYSTEM; SIGNALING PATHWAYS; ENZYME-INHIBITORS; SERINE PROTEASES; RENAL INJURY; LYMPH-NODES; T-CELLS; THERAPY; MICE	The kallikrein-kinin system (KKS) comprises a cascade of proteolytic enzymes and biogenic peptides that regulate several physiological processes. Over-expression of tissue kallikrein-1 and modulation of the KKS shows beneficial effects on insulin sensitivity and other parameters relevant to type 2 diabetes mellitus. However, much less is known about the role of kallikreins, in particular tissue kallikrein-1, in type 1 diabetes mellitus (T1D). We report that chronic administration of recombinant human tissue kallikrein-1 protein (DM199) to non-obese diabetic mice delayed the onset of T1D, attenuated the degree of insulitis, and improved pancreatic beta cell mass in a dose-and treatment frequency-dependent manner. Suppression of the autoimmune reaction against pancreatic beta cells was evidenced by a reduction in the relative numbers of infiltrating cytotoxic lymphocytes and an increase in the relative numbers of regulatory T cells in the pancreas and pancreatic lymph nodes. These effects may be due in part to a DM199 treatment-dependent increase in active TGF-beta1. Treatment with DM199 also resulted in elevated C-peptide levels, elevated glucagon like peptide-1 levels and a reduction in dipeptidyl peptidase-4 activity. Overall, the data suggest that DM199 may have a beneficial effect on T1D by attenuating the autoimmune reaction and improving beta cell health.	[Maneva-Radicheva, Lilia; Amatya, Christina; Parker, Camille; Ellefson, Jacob; Radichev, Ilian; Savinov, Alexei Y.] Sanford Res, Childrens Hlth Res Ctr, Sanford Project, Sioux Falls, SD USA; [Raghavan, Arvind; Charles, Matthew L.; Williams, Mark S.; Robbins, Mark S.] DiaMedica USA Inc, Minneapolis, MN 55447 USA	Sanford Health	Raghavan, A (corresponding author), DiaMedica USA Inc, Minneapolis, MN 55447 USA.	araghavan@diamedica.com; alexei.savinov@sanfordhealth.org		Raghavan, Arvind/0000-0002-2959-3626	NCRR NIH HHS [1P20RR024219, P20 RR024219] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024219] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Agata J, 2002, HYPERTENSION, V40, P653, DOI 10.1161/01.HYP.0000036035.41122.99; Barros CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040573; Biyashev D, 2006, AM J PHYSIOL-HEART C, V290, pH1244, DOI 10.1152/ajpheart.00934.2005; Bledsoe G, 2008, TOXICOL SCI, V102, P433, DOI 10.1093/toxsci/kfn008; Cassim B, 2009, RHEUMATOLOGY, V48, P490, DOI 10.1093/rheumatology/kep016; Chao J, 2005, EXP PHYSIOL, V90, P291, DOI 10.1113/expphysiol.2004.028464; Chao JL, 2008, HYPERTENSION, V52, P715, DOI 10.1161/HYPERTENSIONAHA.108.114587; Chao J, 2010, BIOL CHEM, V391, P345, DOI 10.1515/BC.2010.042; Couture R, 2004, EUR J PHARMACOL, V500, P467, DOI 10.1016/j.ejphar.2004.07.045; Damas J, 2004, DIABETES-METAB RES, V20, P288, DOI 10.1002/dmrr.489; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Egilmez NK, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19369; Emami N, 2010, BIOL CHEM, V391, P85, DOI 10.1515/BC.2010.007; Grewal IS, 2002, J AUTOIMMUN, V19, P9, DOI 10.1006/jaut.2002.0599; Hecquet C, 2000, MOL PHARMACOL, V58, P828, DOI 10.1124/mol.58.4.828; Hillmeister P, 2012, ACTA PHYSIOL, V206, P215, DOI 10.1111/apha.12007; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Jeker LT, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007807; Kayashima Y, 2012, CURR OPIN NEPHROL HY, V21, P92, DOI 10.1097/MNH.0b013e32834d54b1; KIKUTANI H, 1992, ADV IMMUNOL, V51, P285, DOI 10.1016/S0065-2776(08)60490-3; Leiter Edward H, 2001, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1509s24; Li QZ, 2009, GENES IMMUN, V10, P503, DOI 10.1038/gene.2009.7; Lu HS, 1996, PROTEIN EXPRES PURIF, V8, P227, DOI 10.1006/prep.1996.0095; Luo ZR, 2005, TRANSPLANTATION, V79, P1091, DOI 10.1097/01.TP.0000161223.54452.A2; Maahs DM, 2010, ENDOCRIN METAB CLIN, V39, P481, DOI 10.1016/j.ecl.2010.05.011; Maki T, 2005, TRANSPLANTATION, V79, P1051, DOI 10.1097/01.TP.0000161220.87548.EE; Marek-Trzonkowska N, 2013, PEDIATR DIABETES, V14, P322, DOI 10.1111/pedi.12029; MICHEL C, 1989, CLIN EXP IMMUNOL, V75, P457; Montanari D, 2005, DIABETES, V54, P1573, DOI 10.2337/diabetes.54.5.1573; Moreau ME, 2005, J PHARMACOL SCI, V99, P6, DOI 10.1254/jphs.SRJ05001X; Nagy E, 1997, NEUROIMMUNOMODULAT, V4, P107, DOI 10.1159/000097328; Nti BK, 2012, CELL MOL IMMUNOL, V9, P455, DOI 10.1038/cmi.2012.36; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Ranall MV, 2010, BIOTECHNIQUES, V48, P379, DOI 10.2144/000113410; Roth J, 2012, DIABETOLOGIA, V55, P865, DOI 10.1007/s00125-011-2421-0; Savinov AY, 2010, DRUG DISCOV TODAY, V15, P531, DOI 10.1016/j.drudis.2010.05.013; Schmaier AH, 2002, J CLIN INVEST, V109, P1007, DOI 10.1172/JCI200215490; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Suarez-Pinzon WL, 2008, DIABETES, V57, P3281, DOI 10.2337/db08-0688; Tisch R, 2008, ADV IMMUNOL, V100, P125, DOI 10.1016/S0065-2776(08)00805-5; Tomita H, 2012, KIDNEY INT, V81, P733, DOI 10.1038/ki.2011.499; Uehara Y, 1997, AM J HYPERTENS, V10, pS83; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Vasu S, 2013, GENE THER, V20, P1077, DOI 10.1038/gt.2013.33; Wang T, 2004, GENE THER, V11, P1342, DOI 10.1038/sj.gt.3302294; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Yin H, 2005, J BIOL CHEM, V280, P8022, DOI 10.1074/jbc.M407179200; Yuan G, 2007, ENDOCRINOLOGY, V148, P2016, DOI 10.1210/en.2006-0602	49	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107213	10.1371/journal.pone.0107213	http://dx.doi.org/10.1371/journal.pone.0107213			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259810	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600017
J	Sharma, S; Sarkar, J; Haldar, C; Sinha, S				Sharma, Shweta; Sarkar, Jayanta; Haldar, Chandana; Sinha, Sudhir			Melatonin Reverses Fas, E2F-1 and Endoplasmic Reticulum Stress Mediated Apoptosis and Dysregulation of Autophagy Induced by the Herbicide Atrazine in Murine Splenocytes	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; XBP1 MESSENGER-RNA; MALE C57BL/6 MICE; ER STRESS; CELL APOPTOSIS; DRINKING-WATER; ORAL-EXPOSURE; UP-REGULATION; BALB/C MICE; BECLIN 1	Exposure to the herbicide Atrazine (ATR) can cause immunotoxicity, apart from other adverse consequences for animal and human health. We aimed at elucidating the apoptotic mechanisms involved in immunotoxicity of ATR and their attenuation by Melatonin (MEL). Young Swiss mice were divided into control, ATR and MEL+ATR groups based on daily (x14) intraperitoneal administration of the vehicle (normal saline), ATR (100 mg/kg body weight) and MEL (20 mg/kg body weight) with ATR. Isolated splenocytes were processed for detection of apoptosis by Annexin V-FITC and TUNEL assays, and endoplasmic reticulum (ER) stress by immunostaining. Key proteins involved in apoptosis, ER stress and autophagy were quantified by immunoblotting. ATR treatment resulted in Fas-mediated activation of caspases 8 and 3 and inactivation of PARP1 which were inhibited significantly by co-treatment with MEL. MEL also attenuated the ATR-induced, p53 independent mitochondrial apoptosis through upregulation of E2F-1 and PUMA and suppression of their downstream target Bax. An excessive ER stress triggered by ATR through overexpression of ATF-6 alpha, spliced XBP-1, CREB-2 and GADD153 signals was reversed by MEL. MEL also reversed the ATR-induced impairment of autophagy which was indicated by a decline in BECN-1, along with significant enhancement in LC3B-II and p62 expressions. Induction of mitochondrial apoptosis, ER stress and autophagy dysregulation provide a new insight into the mechanism of ATR immunotoxicity. The cytoprotective role of MEL, on the other hand, was defined by attenuation of ER stress, Fas-mediated and p53 independent mitochondria-mediated apoptosis as well as autophagy signals.	[Sharma, Shweta; Sarkar, Jayanta; Sinha, Sudhir] CSIR Cent Drug Res Inst, Div Biochem, Lucknow, Uttar Pradesh, India; [Haldar, Chandana] Banaras Hindu Univ, Dept Zool, Varanasi 221005, Uttar Pradesh, India; [Sarkar, Jayanta; Sinha, Sudhir] Acad Sci & Innovat Res, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Banaras Hindu University (BHU); Academy of Scientific & Innovative Research (AcSIR)	Sharma, S (corresponding author), CSIR Cent Drug Res Inst, Div Biochem, Lucknow, Uttar Pradesh, India.	shwetadr8@gmail.com	Sarkar, Jayanta/C-3250-2009; Sharma, Shweta/V-9349-2018; Sinha, Sudhir/C-7268-2009	Sharma, Shweta/0000-0002-6160-1331; Sinha, Sudhir/0000-0003-3149-1116; Sarkar, Jayanta/0000-0002-9905-7722	Science and Engineering Research Board, Department of Science and Technology, Government of India [SR/FT/LS-115/2009]	Science and Engineering Research Board, Department of Science and Technology, Government of India	The work was supported by the grant funded by Science and Engineering Research Board, Department of Science and Technology, Government of India under Young Scientist Scheme (Grant no SR/FT/LS-115/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Benot S, 1998, J PINEAL RES, V25, P1, DOI 10.1111/j.1600-079X.1998.tb00378.x; Cao XF, 2003, BLOOD, V102, P2605, DOI 10.1182/blood-2003-01-0211; Carrillo-Vico A, 2005, J PINEAL RES, V39, P400, DOI 10.1111/j.1600-079X.2005.00265.x; Chang CF, 2012, J PINEAL RES, V52, P312, DOI 10.1111/j.1600-079X.2011.00945.x; Chen DD, 2012, MOL CELL, V45, P629, DOI 10.1016/j.molcel.2011.12.036; Chen JY, 2013, J ENVIRON SCI HEAL B, V48, P637, DOI 10.1080/03601234.2013.777308; Chen YW, 2012, ARCH TOXICOL, V86, P1547, DOI 10.1007/s00204-012-0873-8; Clayton EMR, 2011, ENVIRON HEALTH PERSP, V119, P390, DOI 10.1289/ehp.1002883; Coban A, 2007, J NEUROCHEM, V100, P1177, DOI 10.1111/j.1471-4159.2006.04294.x; Cragin LA, 2011, ENVIRON RES, V111, P1293, DOI 10.1016/j.envres.2011.09.009; Deegan S, 2013, CELL MOL LIFE SCI, V70, P2425, DOI 10.1007/s00018-012-1173-4; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Filipov NM, 2005, TOXICOL SCI, V86, P324, DOI 10.1093/toxsci/kfi188; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; de la Cadena SC, 2014, APOPTOSIS, V19, P414, DOI 10.1007/s10495-013-0930-7; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; Hao HY, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-24; Hardeland R, 2012, J PINEAL RES, V52, P139, DOI 10.1111/j.1600-079X.2011.00934.x; Hayes TB, 2011, J STEROID BIOCHEM, V127, P64, DOI 10.1016/j.jsbmb.2011.03.015; Herzog C, 2012, AM J PHYSIOL-RENAL, V303, pF1239, DOI 10.1152/ajprenal.00659.2011; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Jang SS, 2009, J PINEAL RES, V47, P147, DOI 10.1111/j.1600-079X.2009.00694.x; John K, 2011, CELL DEATH DIFFER, V18, P874, DOI 10.1038/cdd.2010.153; Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Karrow NA, 2005, TOXICOLOGY, V209, P15, DOI 10.1016/j.tox.2004.12.002; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klucinski P, 2001, Med Sci Monit, V7, P1270; Kucka M, 2012, TOXICOL APPL PHARM, V265, P19, DOI 10.1016/j.taap.2012.09.019; Kuribayashi K, 2011, CELL CYCLE, V10, P2380, DOI 10.4161/cc.10.14.16588; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Lin AMY, 2007, J PINEAL RES, V43, P163, DOI 10.1111/j.1600-079X.2007.00456.x; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Logue SE, 2013, APOPTOSIS, V18, P537, DOI 10.1007/s10495-013-0818-6; Matsumura Y, 2001, J MOL CELL CARDIOL, V33, P1133, DOI 10.1006/jmcc.2001.1373; Mostafalou S, 2013, TOXICOL APPL PHARM, V268, P157, DOI 10.1016/j.taap.2013.01.025; Pandi-Perumal SR, 2006, FEBS J, V273, P2813, DOI 10.1111/j.1742-4658.2006.05322.x; Rajkovic V, 2010, ARCH ENVIRON CON TOX, V59, P334, DOI 10.1007/s00244-010-9477-6; Rehman H, 2011, SCAND J IMMUNOL, V73, P459, DOI 10.1111/j.1365-3083.2011.02521.x; Reiter RJ, 2013, MINI-REV MED CHEM, V13, P373; Rinsky JL, 2012, PUBLIC HEALTH REP, V127, P72, DOI 10.1177/003335491212700108; Rowe AM, 2008, BASIC CLIN PHARMACOL, V102, P139, DOI 10.1111/j.1742-7843.2007.00175.x; Samantaray S, 2008, J PINEAL RES, V44, P348, DOI 10.1111/j.1600-079X.2007.00534.x; Schult C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-560; Seko LMD, 2014, FERTIL STERIL, V101, P154, DOI 10.1016/j.fertnstert.2013.09.036; Toyota H, 2003, CANCER LETT, V189, P221, DOI 10.1016/S0304-3835(02)00552-9; Tunon MJ, 2011, J PINEAL RES, V50, P38, DOI 10.1111/j.1600-079X.2010.00807.x; Uemura A, 2009, J CELL SCI, V122, P2877, DOI 10.1242/jcs.040584; van der Kallen CJH, 2009, APOPTOSIS, V14, P1424, DOI 10.1007/s10495-009-0400-4; Venegas C, 2012, J PINEAL RES, V52, P217, DOI 10.1111/j.1600-079X.2011.00931.x; Xu JM, 2007, J PINEAL RES, V42, P166, DOI 10.1111/j.1600-079X.2006.00401.x; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Zaouali MA, 2013, J PINEAL RES, V55, P65, DOI 10.1111/jpi.12051; Zhang XF, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-117; Zhao H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097266	57	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108602	10.1371/journal.pone.0108602	http://dx.doi.org/10.1371/journal.pone.0108602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259610	Green Submitted, Green Published, gold			2022-12-27	WOS:000342685600087
J	Tang, XQ; Xiao, YH; Lv, TT; Wang, FQ; Zhu, QH; Zheng, TQ; Yang, J				Tang, Xiaoqing; Xiao, Yunhua; Lv, Tingting; Wang, Fangquan; Zhu, QianHao; Zheng, Tianqing; Yang, Jie			High-Throughput Sequencing and De Novo Assembly of the Isatis indigotica Transcriptome	PLOS ONE			English	Article							GENE; ANNOTATION; EXPRESSION; INFECTION; TINCTORIA; CLONING; TOOL	Background: Isatis indigotica, the source of the traditional Chinese medicine Radix isatidis (Ban-Lan-Gen), is an extremely important economical crop in China. To facilitate biological, biochemical and molecular research on the medicinal chemicals in I. indigotica, here we report the first I. indigotica transcriptome generated by RNA sequencing (RNA-seq). Results: RNA-seq library was created using RNA extracted from a mixed sample including leaf and root. A total of 33,238 unigenes were assembled from more than 28 million of high quality short reads. The quality of the assembly was experimentally examined by cDNA sequencing of seven randomly selected unigenes. Based on blast search 28,184 unigenes had a hit in at least one of the protein and nucleotide databases used in this study, and 8 unigenes were found to be associated with biosynthesis of indole and its derivatives. According to Gene Ontology classification, 22,365 unigenes were categorized into 48 functional groups. Furthermore, Clusters of Orthologous Group and Swiss-Port annotation were assigned for 7,707 and 18,679 unigenes, respectively. Analysis of repeat motifs identified 6,400 simple sequence repeat markers in 4,509 unigenes. Conclusion: Our data provide a comprehensive sequence resource for molecular study of I. indigotica. Our results will facilitate studies on the functions of genes involved in the indole alkaloid biosynthesis pathway and on metabolism of nitrogen and indole alkaloids in I. indigotica and its related species.	[Tang, Xiaoqing; Xiao, Yunhua; Lv, Tingting] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Wang, Fangquan; Yang, Jie] Jiangsu Acad Agr Sci, Inst Food Crops, Nanjing, Jiangsu, Peoples R China; [Zhu, QianHao] CSIRO Plant Ind, Canberra, ACT, Australia; [Zheng, Tianqing] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Tang, XQ (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	xqtang@njau.edu.cn	Zhu, Qian-Hao/A-1298-2010	Zhu, Qian-Hao/0000-0002-6505-7417	National Natural Science Foundation of China [31171486]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant no. 31171486). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen L, 2005, INTERVIROLOGY, V48, P207, DOI 10.1159/000084596; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Fortune R., 1846, J R HORTIC SOC, V1, P269; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Ho YL, 2002, PHYTOMEDICINE, V9, P419, DOI 10.1078/09447110260571661; Hsuan SL, 2009, J ETHNOPHARMACOL, V123, P61, DOI 10.1016/j.jep.2009.02.028; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kunikata T, 2000, EUR J PHARMACOL, V410, P93, DOI 10.1016/S0014-2999(00)00879-7; Lin CW, 2005, ANTIVIR RES, V68, P36, DOI 10.1016/j.antiviral.2005.07.002; [刘海利 Liu Haili], 2002, [波谱学杂志, Chinese Journal of Microwave & Radio-frequency Spectroscopy], V19, P315; Liu JJ, 2005, ONCOL REP, V13, P653; [刘云海 Liu Yunhai], 2003, [中草药, Chinese Traditional and Herbal Drugs], V34, P926; [刘云海 Liu Yunhai], 2002, [中草药, Chinese Traditional and Herbal Drugs], V33, P97; Lu Sha-sha, 2011, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V31, P511; National Pharmacopoeia Committee, 2010, PHARMACOPOEIA PEOPLE, V20, P191; Salvini M, 2008, PLANT PHYSIOL BIOCH, V46, P715, DOI 10.1016/j.plaphy.2008.04.002; Spataro G, 2007, GENET RESOUR CROP EV, V54, P573, DOI 10.1007/s10722-006-0014-4; Stoker KG, 1997, THESIS U BRISTOL UK; Sun DD, 2010, CHEM NAT COMPD+, V46, P763, DOI 10.1007/s10600-010-9735-x; [孙晓东 Sun Xiaodong], 2012, [广西植物, Guihaia], V32, P367; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Voets GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052102; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wilhelm BT, 2010, NAT PROTOC, V5, P255, DOI 10.1038/nprot.2009.229; Wu XY, 1997, PLANTA MED, V63, P55, DOI 10.1055/s-2006-957604; Wu XY, 1997, TETRAHEDRON, V53, P13323, DOI 10.1016/S0040-4020(97)00846-6; Wu YX, 2011, FITOTERAPIA, V82, P288, DOI 10.1016/j.fitote.2010.10.016; Xia Xinzhong, 2007, Wuhan Daxue Xuebao (Yixue Ban), V28, P348; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; [徐晗 Xu Han], 2003, [中国药学杂志, Chinese Pharmaceutical Journal], V38, P418; Y-h Liu, 2003, HERBAL MED, V9, P591; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhu QH, 2014, NEW PHYTOL, V201, P574, DOI 10.1111/nph.12537; Zou D, 2013, GENOMICS, V102, P57, DOI 10.1016/j.ygeno.2013.02.014	37	38	40	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e102963	10.1371/journal.pone.0102963	http://dx.doi.org/10.1371/journal.pone.0102963			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259890	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600003
J	Vidal-Dupiol, J; Dheilly, NM; Rondon, R; Grunau, C; Cosseau, C; Smith, KM; Freitag, M; Adjeroud, M; Mitta, G				Vidal-Dupiol, Jeremie; Dheilly, Nolwenn M.; Rondon, Rodolfo; Grunau, Christoph; Cosseau, Celine; Smith, Kristina M.; Freitag, Michael; Adjeroud, Mehdi; Mitta, Guillaume			Thermal Stress Triggers Broad Pocillopora damicornis Transcriptomic Remodeling, while Vibrio coralliilyticus Infection Induces a More Targeted Immuno-Suppression Response	PLOS ONE			English	Article							CORAL ACROPORA-MILLEPORA; SCLERACTINIAN CORAL; CLIMATE-CHANGE; SEA-ANEMONE; CARIBBEAN CORALS; BINDING-PROTEIN; INNATE IMMUNITY; PATHOGEN; TEMPERATURE; DISEASE	Global change and its associated temperature increase has directly or indirectly changed the distributions of hosts and pathogens, and has affected host immunity, pathogen virulence and growth rates. This has resulted in increased disease in natural plant and animal populations worldwide, including scleractinian corals. While the effects of temperature increase on immunity and pathogen virulence have been clearly identified, their interaction, synergy and relative weight during pathogenesis remain poorly documented. We investigated these phenomena in the interaction between the coral Pocillopora damicornis and the bacterium Vibrio coralliilyticus, for which the infection process is temperature-dependent. We developed an experimental model that enabled unraveling the effects of thermal stress, and virulence vs. non-virulence of the bacterium. The physiological impacts of various treatments were quantified at the transcriptome level using a combination of RNA sequencing and targeted approaches. The results showed that thermal stress triggered a general weakening of the coral, making it more prone to infection, non-virulent bacterium induced an 'efficient' immune response, whereas virulent bacterium caused immuno-suppression in its host.	[Vidal-Dupiol, Jeremie; Dheilly, Nolwenn M.; Rondon, Rodolfo; Grunau, Christoph; Cosseau, Celine; Mitta, Guillaume] CNRS, UMR 5244, Perpignan, France; [Vidal-Dupiol, Jeremie; Dheilly, Nolwenn M.; Rondon, Rodolfo; Grunau, Christoph; Cosseau, Celine; Mitta, Guillaume] Univ Perpignan, UMR 5244, F-66025 Perpignan, France; [Rondon, Rodolfo] IFREMER, UMR 5119,UM2, CNRS, F-34095 Montpellier, France; [Smith, Kristina M.; Freitag, Michael] Oregon State Univ, Dept Biochem & Biophys, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Adjeroud, Mehdi] Inst Rech DEv, Biocomplex Ecosyst Coralliens Indo Pacifique U227, Lab Excellence CORAIL, Banyuls Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Ifremer; Universite de Montpellier; Oregon State University; Institut de Recherche pour le Developpement (IRD)	Vidal-Dupiol, J (corresponding author), CNRS, UMR 5244, Perpignan, France.	jeremie.vidal-dupiol@univ-perp.fr	Vidal-Dupiol, Jeremie/ABG-8874-2020; Adjeroud, Mehdi/J-6411-2016; Grunau, Christoph/A-6989-2010; Dheilly, Nolwenn Marie M/A-7213-2011; Cosseau, Celine/G-8240-2011; MITTA, Guillaume/A-6489-2010; Rondon, Rodolfo/ABF-1403-2020	Vidal-Dupiol, Jeremie/0000-0002-0577-2953; Adjeroud, Mehdi/0000-0002-6825-8759; Grunau, Christoph/0000-0002-2161-412X; Dheilly, Nolwenn Marie M/0000-0002-3675-5013; mitta, guillaume/0000-0003-1188-1467; Rondon, Rodolfo/0000-0002-0292-7438	Agence Nationale de la Recherche through the Program BIOADAPT [ADACNI ANR-12-ADAP-0016-03]; French-Israeli High Council for Science and Technology (P2R) [29702YG]; start-up funds from the OSU Computational and Genome Biology Initiative; Oregon State University	Agence Nationale de la Recherche through the Program BIOADAPT(French National Research Agency (ANR)); French-Israeli High Council for Science and Technology (P2R); start-up funds from the OSU Computational and Genome Biology Initiative; Oregon State University	This study was supported by the Agence Nationale de la Recherche through the Program BIOADAPT (ADACNI ANR-12-ADAP-0016-03) and the French-Israeli High Council for Science and Technology (P2R n o29702YG). Work in the Freitag laboratory was supported by start-up funds from the OSU Computational and Genome Biology Initiative and Oregon State University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Bluthgen N, 2004, QBIO0407034 ARXIV; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Brower DL, 1997, P NATL ACAD SCI USA, V94, P9182, DOI 10.1073/pnas.94.17.9182; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Burge CA, 2013, FRONT INVERT PHYSL, V4, P1, DOI DOI 10.3389/FPHYS.2013; Burreson EM, 1996, J SHELLFISH RES, V15, P17; Campbell AH, 2011, GLOBAL CHANGE BIOL, V17, P2958, DOI 10.1111/j.1365-2486.2011.02456.x; Case RJ, 2011, ENVIRON MICROBIOL, V13, P529, DOI 10.1111/j.1462-2920.2010.02356.x; Cook T, 1998, ESTUAR COAST SHELF S, V46, P587, DOI 10.1006/ecss.1997.0283; Decostere A, 1999, J FISH DIS, V22, P1, DOI 10.1046/j.1365-2761.1999.00132.x; Devaux Christian A, 2012, World J Virol, V1, P11, DOI 10.5501/wjv.v1.i1.11; Dinsdale EA, 2002, ABUNDANCE BLACK BAND, P1239; Dishaw LJ, 2005, IMMUNOGENETICS, V57, P535, DOI 10.1007/s00251-005-0005-1; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; Ellner SP, 2007, AM NAT, V170, pE143, DOI 10.1086/522841; Flot JF, 2007, GENE, V401, P80, DOI 10.1016/j.gene.2007.07.006; Fox S, 2010, PLANT SYSTEMS BIOL, P79; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; HANAI K, 1983, COMP BIOCHEM PHYS A, V76, P283; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Hashimoto K, 2004, CORAL REEFS, V23, P485, DOI 10.1007/s00338-004-0410-1; Hayes ML, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-150; Hemmrich G, 2007, TRENDS IMMUNOL, V28, P449, DOI 10.1016/j.it.2007.08.003; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; Jung S, 2009, J BIOL CHEM, V284, P1896, DOI 10.1074/jbc.M804713200; Kaniewska P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034659; Kimes NE, 2012, ISME J, V6, P835, DOI 10.1038/ismej.2011.154; Kimura A, 2009, IMMUNOBIOLOGY, V214, P165, DOI 10.1016/j.imbio.2009.01.003; Knack BA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-136; Kushmaro A, 1997, MAR ECOL PROG SER, V147, P159, DOI 10.3354/meps147159; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Kvennefors ECE, 2010, DEV COMP IMMUNOL, V34, P1219, DOI 10.1016/j.dci.2010.06.016; Le QH, 1997, MOL GEN GENET, V255, P595, DOI 10.1007/s004380050533; LEE DH, 1993, J BIOL CHEM, V268, P8842; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Luna GM, 2007, ENVIRON MICROBIOL, V9, P1851, DOI 10.1111/j.1462-2920.2007.01287.x; Luna GM, 2010, ENV MICROBIOL REP, V2, P120, DOI 10.1111/j.1758-2229.2009.00114.x; Marti-Puig P, 2013, B MAR SCI, V90, P1; Meyer E, 2011, MOL ECOL, V20, P3599, DOI 10.1111/j.1365-294X.2011.05205.x; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Moya A, 2012, MOL ECOL, V21, P1158, DOI 10.1111/j.1365-294X.2012.05458.x; Muller EM, 2012, GLOBAL CHANGE BIOL, V18, P3529, DOI 10.1111/gcb.12019; Mydlarz LD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001811; Mydlarz LD, 2011, COMP BIOCHEM PHYS A, V159, P372, DOI 10.1016/j.cbpa.2011.03.029; Mydlarz LD, 2010, J EXP BIOL, V213, P934, DOI 10.1242/jeb.037580; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; Ovchinnikova TV, 2006, BIOCHEM BIOPH RES CO, V348, P514, DOI 10.1016/j.bbrc.2006.07.078; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Palmer CV, 2012, P ROY SOC B-BIOL SCI, V279, P4106, DOI 10.1098/rspb.2012.1477; Palmer CV, 2012, P ROY SOC B-BIOL SCI, V279, P3879, DOI 10.1098/rspb.2011.2487; Palmer CV, 2011, DEV COMP IMMUNOL, V35, P1096, DOI 10.1016/j.dci.2011.04.001; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; Palmer CV, 2011, J EXP BIOL, V214, P4240, DOI 10.1242/jeb.061267; Palmer CV, 2010, FASEB J, V24, P1935, DOI 10.1096/fj.09-152447; Pinzon JH, 2013, J BIOGEOGR, V40, P1595, DOI 10.1111/jbi.12110; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Pollock FJ, 2010, ENV MICROBIOL REP, V2, P172, DOI 10.1111/j.1758-2229.2009.00131.x; Pomraning KR, 2012, FUNGAL SECONDARY MET; Pomraning KR, 2009, METHODS, V47, P142, DOI 10.1016/j.ymeth.2008.09.022; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reitzel AM, 2008, BIOL BULL-US, V214, P233, DOI 10.2307/25470666; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rozenblat YBH, 2004, CORAL HEALTH AND DISEASE, P301; Rudd S, 2003, TRENDS PLANT SCI, V8, P321, DOI 10.1016/S1360-1385(03)00131-6; Santos ED, 2011, ISME J, V5, P1471, DOI 10.1038/ismej.2011.19; Scheibling RE, 1997, MAR ECOL PROG SER, V152, P155, DOI 10.3354/meps152155; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Shoguchi E, 2013, CURR BIOL, V23, P1399, DOI 10.1016/j.cub.2013.05.062; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Souter P, 2011, MOL ECOL RESOUR, V11, P328, DOI 10.1111/j.1755-0998.2010.02923.x; Stimson J, 2002, CORAL REEFS, V21, P409, DOI 10.1007/s00338-002-0264-3; Vargas-Albores F, 1998, AQUAC RES, V29, P549, DOI 10.1111/j.1365-2109.1998.tb01166.x; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vidal-Dupiol J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058652; Vidal-Dupiol J, 2011, J BIOL CHEM, V286, P22688, DOI 10.1074/jbc.M110.216358; Vidal-Dupiol J, 2011, J EXP BIOL, V214, P1533, DOI 10.1242/jeb.053165; Vidal-Dupiol Jeremie, 2009, BMC Physiology, V9, P14, DOI 10.1186/1472-6793-9-14; Vilaprinyo E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000674; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Weiss Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-400; Wood-Charlson EM, 2009, DEV COMP IMMUNOL, V33, P881, DOI 10.1016/j.dci.2009.01.008; Zhang H, 2006, J EUKARYOT MICROBIOL, V53, P142, DOI 10.1111/j.1550-7408.2005.00085.x; Zhao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046244	102	46	46	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107672	10.1371/journal.pone.0107672	http://dx.doi.org/10.1371/journal.pone.0107672			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259845	Green Published, gold			2022-12-27	WOS:000342685600026
J	Cowling, BJ; Ip, DKM; Fang, VJ; Suntarattiwong, P; Olsen, SJ; Levy, J; Uyeki, TM; Leung, GM; Peiris, JSM; Chotpitayasunondh, T; Nishiura, H; Simmerman, JM				Cowling, Benjamin J.; Ip, Dennis K. M.; Fang, Vicky J.; Suntarattiwong, Piyarat; Olsen, Sonja J.; Levy, Jens; Uyeki, Timothy M.; Leung, Gabriel M.; Peiris, J. S. Malik; Chotpitayasunondh, Tawee; Nishiura, Hiroshi; Simmerman, J. Mark			Modes of Transmission of Influenza B Virus in Households	PLOS ONE			English	Article							AEROSOL TRANSMISSION; HEALTH-CARE; HONG-KONG; MORTALITY; COMMUNITY; THAILAND; BANGKOK; CONTAMINATION; VENTILATION; INFECTION	Introduction:While influenza A and B viruses can be transmitted via respiratory droplets, the importance of small droplet nuclei "aerosols'' in transmission is controversial. Methods and Findings: In Hong Kong and Bangkok, in 2008-11, subjects were recruited from outpatient clinics if they had recent onset of acute respiratory illness and none of their household contacts were ill. Following a positive rapid influenza diagnostic test result, subjects were randomly allocated to one of three household-based interventions: hand hygiene, hand hygiene plus face masks, and a control group. Index cases plus their household contacts were followed for 7-10 days to identify secondary infections by reverse transcription polymerase chain reaction (RT-PCR) testing of respiratory specimens. Index cases with RT-PCR-confirmed influenza B were included in the present analyses. We used a mathematical model to make inferences on the modes of transmission, facilitated by apparent differences in clinical presentation of secondary infections resulting from aerosol transmission. We estimated that approximately 37% and 26% of influenza B virus transmission was via the aerosol mode in households in Hong Kong and Bangkok, respectively. In the fitted model, influenza B virus infections were associated with a 56%-72% risk of fever plus cough if infected via aerosol route, and a 23%-31% risk of fever plus cough if infected via the other two modes of transmission. Conclusions: Aerosol transmission may be an important mode of spread of influenza B virus. The point estimates of aerosol transmission were slightly lower for influenza B virus compared to previously published estimates for influenza A virus in both Hong Kong and Bangkok. Caution should be taken in interpreting these findings because of the multiple assumptions inherent in the model, including that there is limited biological evidence to date supporting a difference in the clinical features of influenza B virus infection by different modes.	[Cowling, Benjamin J.; Ip, Dennis K. M.; Fang, Vicky J.; Leung, Gabriel M.; Peiris, J. S. Malik] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Suntarattiwong, Piyarat; Chotpitayasunondh, Tawee] Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand; [Olsen, Sonja J.; Levy, Jens] Thailand MOPH US CDC Collaborat, Influenza Program, Nonthaburi, Thailand; [Olsen, Sonja J.; Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Peiris, J. S. Malik] Univ Hong Kong, Li Ka Shing Fac Med, Influenza Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Nishiura, Hiroshi] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Simmerman, J. Mark] Sanofi Pasteur, Epidemiol & Med Affairs, Bangkok, Thailand	University of Hong Kong; Centers for Disease Control & Prevention - USA; University of Hong Kong; University of Tokyo; Sanofi-Aventis	Cowling, BJ (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	bcowling@hku.hk	Cowling, Benjamin John/C-4263-2009; Ip, Dennis Kai Ming/C-4283-2009	Cowling, Benjamin John/0000-0002-6297-7154; Nishiura, Hiroshi/0000-0003-0941-8537; Leung, Gabriel/0000-0002-2503-6283; Ip, Dennis Kai Ming/0000-0003-3592-8709	National Institute of Allergy and Infectious Diseases [HHSN266200700005C]; ADB [N01-AI-70005]; National Institute of General Medical Sciences [U54 GM08855]; Area of Excellence Scheme of the Hong Kong University Grants Committee [AoE/M-12/06]; United States Centers for Disease Control and Prevention [1 U01 CI000439, 5 U51 IP000345]; JST PRESTO; National Center for Immunization and Respiratory Diseases (NCIRD) [U51IP000345] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ADB; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Area of Excellence Scheme of the Hong Kong University Grants Committee; United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); JST PRESTO(Japan Science & Technology Agency (JST)); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the National Institute of Allergy and Infectious Diseases under contract no.HHSN266200700005C, ADB No. N01-AI-70005 (NIAID Centers for Excellence in Influenza Research and Surveillance), the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant no. U54 GM088558), and the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant no. AoE/M-12/06). The household trials in Hong Kong and Bangkok were supported by the United States Centers for Disease Control and Prevention (cooperative nos. 1 U01 CI000439 and 5 U51 IP000345). HN received funding support from JST PRESTO. The funding bodies had no role in study design and analysis or the decision to publish, but the CDC was involved in the design of the original studies and the preparation of this manuscript. This work represents the views of the authors and does not reflect the official policy of their institutions, including the Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	AALEN O, 1978, ANN STAT, V6, P701, DOI 10.1214/aos/1176344247; AIR GM, 1990, P NATL ACAD SCI USA, V87, P3884, DOI 10.1073/pnas.87.10.3884; ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Chan PKS, 2013, CLIN INFECT DIS, V56, P677, DOI 10.1093/cid/cis885; Cowling BJ, 2012, CLIN INFECT DIS, V54, P1578, DOI 10.1093/cid/cis240; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Gilks WR, 1996, MARKOV CHAIN MONTE C; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Gralton J, 2011, J INFECTION, V62, P1, DOI 10.1016/j.jinf.2010.11.010; Hobday RA, 2013, J HOSP INFECT, V84, P271, DOI 10.1016/j.jhin.2013.04.011; Levy JW, 2014, INFLUENZA OTHER RESP, V8, P13, DOI 10.1111/irv.12204; LITTLE JW, 1979, J MED VIROL, V3, P177, DOI 10.1002/jmv.1890030303; Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205; Milton DK, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00150; MONTO AS, 1993, EPIDEMIOL INFECT, V110, P145, DOI 10.1017/S0950268800050779; Noti JD, 2012, CLIN INFECT DIS, V54, P1569, DOI 10.1093/cid/cis237; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Poon LLM, 2011, J CLIN VIROL, V52, P146, DOI 10.1016/j.jcv.2011.06.022; Simmerman JM, 2011, INFLUENZA OTHER RESP, V5, P256, DOI 10.1111/j.1750-2659.2011.00205.x; Simmerman JM, 2010, CLIN INFECT DIS, V51, P1053, DOI 10.1086/656581; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Wu P, 2012, J INFECT DIS, V206, P1862, DOI 10.1093/infdis/jis628; Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x	30	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108850	10.1371/journal.pone.0108850	http://dx.doi.org/10.1371/journal.pone.0108850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268241	Green Submitted, gold, Green Published			2022-12-27	WOS:000343671700179
J	Han, RX; Liu, X; Pan, P; Jia, YJ; Yu, JC				Han, Rui-xian; Liu, Xu; Pan, Pan; Jia, Ying-jie; Yu, Jian-chun			Effectiveness and Safety of Chemotherapy Combined with Dendritic Cells Co-Cultured with Cytokine-Induced Killer Cells in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ACTIVE SPECIFIC IMMUNOTHERAPY; THERAPY; EFFICACY; COMBINATION	Background: Lung cancer, particularly non-small-cell lung cancer (NSCLC) is the leading cause of cancer mortality. Chemotherapy combined dendritic cells co-cultured with cytokine-induced killer cells (DC-CIK) immunotherapy has been applied in advanced NSCLC patients' treatment, but couldn't provide consistent beneficial results. Therefore, it is necessary to evaluate the efficiency and safety of combination therapy to promote the application. Methods: A literature search for randomized controlled trials of NSCLC was conducted in PubMed database. Before meta-analysis was performed, studies were evaluated heterogeneity. Pooled risk ratios (RRs) were estimated and 95% confidence intervals (CIs) were calculated using a fixed-effect model. Sensitivity analysis was also performed. Results: Six eligible trials were enrolled. Efficiency and safety of chemotherapy followed by DC-CIK immunotherapy experimental group) and chemotherapy alone control group) were compared. 1-year overall survival (OS) (P = 0.02) and progression free survival (PFS) (P = 0.005) in the experimental group were significantly increased compared with the control. Disease control rate (DCR) (P = 0.006) rose significantly in experimental group. However, no significant differences between the two groups were observed in 2-year OS (P = 0.21), 2-year PFS (P = 0.10), overall response rate (ORR) (P = 0.76) and partial response (PR) (P = 0.22). Temporary fever, anemia, leukopenia and nausea were the four major adverse events (AEs) treated by chemotherapy. The incidence of anemia, leukopenia and nausea in the experimental group was obviously lower than the control group. Temporary fever rate was higher in experimental group than that in the control, but could be alleviated by taking sufficient rest. Conclusions: Chemotherapy combined with DC-CIK immunotherapy showed superiority in DCR, 1-year OS and PFS, and no more AEs appeared, however, there was no significant improvement in ORR, PR, 2-year OS and PFS. As a whole, the combination therapy is safer but modest in efficacy for advanced NSCLC patients.	[Han, Rui-xian; Liu, Xu; Pan, Pan; Jia, Ying-jie; Yu, Jian-chun] Tianjin Univ Tradit Chinese Med, Teaching Hosp 1, Tianjin, Peoples R China; [Han, Rui-xian; Pan, Pan] Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine	Jia, YJ (corresponding author), Tianjin Univ Tradit Chinese Med, Teaching Hosp 1, Tianjin, Peoples R China.	yujianchun2000@hotmail.com; jiayingjie1616@sina.com			National Natural Science Foundation of China [81273937]; Key Project of Anti-Cancer of Tianjin [12ZCDZSY15800]; Science and Technology Developing and Supporting Program from Tianjin [12CDZSY17000]; Specialized Research Fund for the Doctoral Program of Higher Education [20121210110010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Anti-Cancer of Tianjin; Science and Technology Developing and Supporting Program from Tianjin; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China (No. 81273937), Key Project of Anti-Cancer of Tianjin (12ZCDZSY15800), Science and Technology Developing and Supporting Program from Tianjin (12CDZSY17000), Specialized Research Fund for the Doctoral Program of Higher Education (20121210110010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JG, 2013, CANCER RES, V73, P2381, DOI 10.1158/0008-5472.CAN-12-3932; Chrischilles EA, 2010, J CLIN ONCOL, V28, P620, DOI 10.1200/JCO.2009.23.8485; DeVita VT, 2012, NEW ENGL J MED, V366, P2207, DOI 10.1056/NEJMra1204479; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hiret S, 2010, REV MAL RESPIR, V27, P954, DOI 10.1016/j.rmr.2010.08.002; Holt Gregory E, 2011, Therapy, V8, P43, DOI 10.2217/thy.10.84; Huang X, 2011, WORLD J GASTROENTERO, V17, P3002, DOI 10.3748/wjg.v17.i25.3002; Jackson D, 2012, STAT MED, V31, P3805, DOI 10.1002/sim.5453; Jakel CE, 2014, EXPERT OPIN BIOL THE; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kakimi K, 2009, LUNG CANCER, V65, P1, DOI 10.1016/j.lungcan.2008.10.018; Kautio AL, 2011, ANTICANCER RES, V31, P3493; Kelly RJ, 2010, CLIN LUNG CANCER, V11, P228, DOI 10.3816/CLC.2010.n.029; Liu L, 2012, CLIN CANCER RES, V18, P1751, DOI 10.1158/1078-0432.CCR-11-2442; Ma Y, 2012, CYTOTHERAPY, V14, P483, DOI 10.3109/14653249.2011.649185; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Olioso P, 2009, HEMATOL ONCOL, V27, P130, DOI 10.1002/hon.886; Rao BQ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-17; Shi SB, 2012, TUMORI, V98, P314, DOI 10.1700/1125.12398; Tao LL, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0777-3; Thanendrarajan S, 2011, LEUKEMIA RES, V35, P1136, DOI 10.1016/j.leukres.2011.05.005; Wang JK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037647, 10.1371/journal.pone.0030209, 10.1371/journal.pone.0047127, 10.1371/journal.pone.0051808]; Wang Qi-Jing, 2010, Chin J Cancer, V29, P641; Wang XM, 2014, CELL IMMUNOL, V287, P18, DOI 10.1016/j.cellimm.2013.11.009; Wongkajornsilp A, 2013, PLOS ONE, V8; Wu CP, 2008, ANTICANCER RES, V28, P3997; Wu SW, 2011, CANCER INVEST, V29, P460, DOI 10.3109/07357907.2011.597815; Yang LL, 2013, CANCER IMMUNOL IMMUN, V62, P65, DOI 10.1007/s00262-012-1311-8; Zhao Guangqiang, 2009, Zhongguo Fei Ai Za Zhi, V12, P1000, DOI 10.3779/j.issn.1009-3419.2009.09.011; Zheng YW, 2013, CANCER INVEST, V31, P197, DOI 10.3109/07357907.2013.775294; Zhong RB, 2014, TUMOR BIOL, V35, P987, DOI 10.1007/s13277-013-1132-1; Zhong RB, 2011, CANCER IMMUNOL IMMUN, V60, P1497, DOI 10.1007/s00262-011-1060-0	32	36	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108958	10.1371/journal.pone.0108958	http://dx.doi.org/10.1371/journal.pone.0108958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268709	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700203
J	Muthukrishnan, AB; Martikainen, A; Neeli-Venkata, R; Ribeiro, AS				Muthukrishnan, Anantha-Barathi; Martikainen, Antti; Neeli-Venkata, Ramakanth; Ribeiro, Andre S.			In Vivo Transcription Kinetics of a Synthetic Gene Uninvolved in Stress-Response Pathways in Stressed Escherichia coli Cells	PLOS ONE			English	Article							RNA-POLYMERASE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; ACID RESISTANCE; B-R; EXPRESSION; PROMOTER; BACTERIA; INITIATION; ADAPTATION	The fast adaptation of Escherichia coli to stressful environments includes the regulation of gene expression rates, mainly of transcription, by specific and global stress-response mechanisms. To study the effects of mechanisms acting on a global level, we observed with single molecule sensitivity the effects of mild acidic shift and oxidative stress on the in vivo transcription dynamics of a probe gene encoding an RNA target for MS2d-GFP, under the control of a synthetic promoter. After showing that this promoter is uninvolved in fast stress-response pathways, we compared its kinetics of transcript production under stress and in optimal conditions. We find that, following the application of either stress, the mean rates of transcription activation and of subsequent RNA production of the probe gene are reduced, particularly under oxidative stress. Meanwhile, the noise in RNA production decreases under oxidative stress, but not under acidic shift. From distributions of intervals between consecutive RNA productions, we infer that the number and duration of the rate-limiting steps in transcription initiation change, following the application of stress. These changes differ in the two stress conditions and are consistent with the changes in noise in RNA production. Overall, our measurements of the transcription initiation kinetics of the probe gene indicate that, following sub-lethal stresses, there are stress-specific changes in the dynamics of transcription initiation of the probe gene that affect its mean rate and noise of transcript production. Given the non-involvement of the probe gene in stress-response pathways, we suggest that these changes are caused by global response mechanisms of E. coli to stress.	[Muthukrishnan, Anantha-Barathi; Martikainen, Antti; Neeli-Venkata, Ramakanth; Ribeiro, Andre S.] Tampere Univ Technol, Lab Biosyst Dynam, Dept Signal Proc, FIN-33101 Tampere, Finland	Tampere University	Ribeiro, AS (corresponding author), Tampere Univ Technol, Lab Biosyst Dynam, Dept Signal Proc, FIN-33101 Tampere, Finland.	andre.ribeiro@tut.fi	Neeli-Venkata, Ramakanth/P-3276-2019; Ribeiro, Andre S/G-4294-2014	Neeli-Venkata, Ramakanth/0000-0003-0844-8320; Ribeiro, Andre S/0000-0002-7255-5211	Academy of Finland [126803]; Finnish Funding Agency for Technology and Innovation (TEKES) [40284/08]; Fundacao para a Ciencia e a Tecnologia [PTDC/BBB-MET/1084/2012]; TUT President's Doctoral Programme; TEKES [40284/08]	Academy of Finland(Academy of Finland); Finnish Funding Agency for Technology and Innovation (TEKES)(Finnish Funding Agency for Technology & Innovation (TEKES)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); TUT President's Doctoral Programme; TEKES(Finnish Funding Agency for Technology & Innovation (TEKES))	This work was supported by Academy of Finland (126803 to ASR), Finnish Funding Agency for Technology and Innovation (TEKES, 40284/08 to ASR), Fundacao para a Ciencia e a Tecnologia (PTDC/BBB-MET/1084/2012 to ASR), and TUT President's Doctoral Programme (ABM), as well as funding for open access charge from TEKES (40284/08 to ASR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J BACTERIOL, V187, P1591; ARNDT KM, 1988, J MOL BIOL, V202, P271, DOI 10.1016/0022-2836(88)90457-3; Audia JP, 2001, INT J MED MICROBIOL, V291, P97, DOI 10.1078/1438-4221-00106; Baez A, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-23; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Bearson S, 1997, FEMS MICROBIOL LETT, V147, P173, DOI 10.1016/S0378-1097(96)00503-4; BERTRANDBURGGRAF E, 1984, NUCLEIC ACIDS RES, V12, P1697, DOI 10.1093/nar/12.3.1697; Blanchard JL, 2007, PLOS ONE, V2, DOI [10.1371/journal.-pone.0001186, DOI 10.1371/JOURNAL.-PONE.0001186]; BUC H, 1985, BIOCHEMISTRY-US, V24, P2712, DOI 10.1021/bi00332a018; Burgess RR, 2001, CURR OPIN MICROBIOL, V4, P126, DOI 10.1016/S1369-5274(00)00177-6; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Chowdhury S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S10-S8; Chung HJ, 2006, COMPR REV FOOD SCI F, V5, P52, DOI 10.1111/j.1541-4337.2006.00002.x; DENNIS PP, 1974, J MOL BIOL, V84, P407, DOI 10.1016/0022-2836(74)90449-5; Desnues B, 2003, EMBO REP, V4, P400, DOI 10.1038/sj.embor.embor799; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; FARR SB, 1988, J BACTERIOL, V170, P1837, DOI 10.1128/jb.170.4.1837-1842.1988; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; Greive SJ, 2005, NAT REV MOL CELL BIO, V6, P221, DOI 10.1038/nrm1588; GROAT RG, 1986, J BACTERIOL, V168, P486, DOI 10.1128/jb.168.2.486-493.1986; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Hakkinen A, 2014, BIOINFORMATICS, V30, P1146, DOI 10.1093/bioinformatics/btt766; Hengge-Aronis R, 1999, CURR OPIN MICROBIOL, V2, P148, DOI 10.1016/S1369-5274(99)80026-5; Hengge-Aronis R, 2002, J MOL MICROB BIOTECH, V4, P341; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; IMLAY JA, 1987, J BACTERIOL, V169, P2967, DOI 10.1128/jb.169.7.2967-2976.1987; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; JENSEN PR, 1993, EUR J BIOCHEM, V211, P181, DOI 10.1111/j.1432-1033.1993.tb19885.x; Jones TH, 2012, STRESS RESPONSE FOOD, P293; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kandhavelu M, 2012, FEBS LETT, V586, P3870, DOI 10.1016/j.febslet.2012.09.014; Kandhavelu M, 2012, BIOSYSTEMS, V107, P129, DOI 10.1016/j.biosystems.2011.11.001; Kandhavelu M, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-149; Kanjee U, 2013, ANNU REV MICROBIOL, V67, P65, DOI 10.1146/annurev-micro-092412-155708; Kannan G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-37; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; LEMAUX PG, 1978, CELL, V13, P427, DOI 10.1016/0092-8674(78)90317-3; LEYER GJ, 1995, APPL ENVIRON MICROB, V61, P3752, DOI 10.1128/AEM.61.10.3752-3755.1995; Lloyd-Price J, 2012, MOL BIOSYST, V8, P565, DOI 10.1039/c1mb05100h; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lutz R, 2001, NUCLEIC ACIDS RES, V29, P3873, DOI 10.1093/nar/29.18.3873; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Makela J, 2013, NUCLEIC ACIDS RES, V41, P6544, DOI 10.1093/nar/gkt350; Mannerstrom H, 2011, EURASIP J BIOINFORM, DOI 10.1155/2011/572876; MCCLURE WR, 1980, P NATL ACAD SCI-BIOL, V77, P5634, DOI 10.1073/pnas.77.10.5634; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; Muthukrishnan AB, 2012, NUCLEIC ACIDS RES, V40, P8472, DOI 10.1093/nar/gks583; NUNOSHIBA T, 1992, J BACTERIOL, V174, P6054, DOI 10.1128/JB.174.19.6054-6060.1992; Pfaffl M W, 2004, A Z QUANTITATIVE PCR; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Ramos JL, 2001, CURR OPIN MICROBIOL, V4, P166, DOI 10.1016/S1369-5274(00)00183-1; Ribeiro AS, 2013, CAN J CHEM, V91, P487, DOI 10.1139/cjc-2012-0409; Ross W, 2013, MOL CELL, V50, P420, DOI 10.1016/j.molcel.2013.03.021; Semchyshyn H, 2009, CENT EUR J BIOL, V4, P142, DOI 10.2478/s11535-009-0005-5; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; Toulokhonov I, 2003, MOL CELL, V12, P1125, DOI 10.1016/S1097-2765(03)00439-8; Tucker DL, 2002, J BACTERIOL, V184, P6551, DOI 10.1128/JB.184.23.6551-6558.2002; Wang SY, 2009, APPL ENVIRON MICROB, V75, P6110, DOI 10.1128/AEM.00914-09; Ye YF, 2012, J PROTEOME RES, V11, P2559, DOI 10.1021/pr3000128; YOUNG R, 1976, BIOCHEM J, V160, P185, DOI 10.1042/bj1600185; Yuk HG, 2004, APPL ENVIRON MICROB, V70, P3500, DOI 10.1128/AEM.70.6.3500-3505.2004; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	72	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e109005	10.1371/journal.pone.0109005	http://dx.doi.org/10.1371/journal.pone.0109005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268540	gold, Green Submitted, Green Published			2022-12-27	WOS:000343671700211
J	Taiana, MM; Lombardi, R; Porretta-Serapiglia, C; Ciusani, E; Oggioni, N; Sassone, J; Bianchi, R; Lauria, G				Taiana, Michela M.; Lombardi, Raffaella; Porretta-Serapiglia, Carla; Ciusani, Emilio; Oggioni, Norberto; Sassone, Jenny; Bianchi, Roberto; Lauria, Giuseppe			Neutralization of Schwann Cell-Secreted VEGF Is Protective to In Vitro and In Vivo Experimental Diabetic Neuropathy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PERIPHERAL-NERVE REGENERATION; GANGLION NEURONS; HYPERGLYCEMIA; EXPRESSION; NEUROTOXICITY; PATHOGENESIS; MECHANISMS; INHIBITION; APOPTOSIS	The pathogenetic role of vascular endothelial growth factor (VEGF) in long-term retinal and kidney complications of diabetes has been demonstrated. Conversely, little is known in diabetic neuropathy. We examined the modulation of VEGF pathway at mRNA and protein level on dorsal root ganglion (DRG) neurons and Schwann cells (SC) induced by hyperglycaemia. Moreover, we studied the effects of VEGF neutralization on hyperglycemic DRG neurons and streptozotocin-induced diabetic neuropathy. Our findings demonstrated that DRG neurons were not affected by the direct exposition to hyperglycaemia, whereas showed an impairment of neurite outgrowth ability when exposed to the medium of SC cultured in hyperglycaemia. This was mediated by an altered regulation of VEGF and FLT-1 receptors. Hyperglycaemia increased VEGF and FLT-1 mRNA without changing their intracellular protein levels in DRG neurons, decreased intracellular and secreted protein levels without changing mRNA level in SC, while reduced the expression of the soluble receptor sFLT-1 both in DRG neurons and SC. Bevacizumab, a molecule that inhibits VEGF activity preventing the interaction with its receptors, restored neurite outgrowth and normalized FLT-1 mRNA and protein levels in co-cultures. In diabetic rats, it both prevented and restored nerve conduction velocity and nociceptive thresholds. We demonstrated that hyperglycaemia early affected neurite outgrowth through the impairment of SC-derived VEGF/FLT-1 signaling and that the neutralization of SC-secreted VEGF was protective both in vitro and in vivo models of diabetic neuropathy.	[Taiana, Michela M.; Lombardi, Raffaella; Porretta-Serapiglia, Carla; Sassone, Jenny; Bianchi, Roberto; Lauria, Giuseppe] IRCCS Fdn Carlo Besta Neurol Inst, Neuroalgol & Headache Unit, Milan, Italy; [Ciusani, Emilio] IRCCS Fdn Carlo Besta Neurol Inst, Clin Pathol & Genet Unit, Milan, Italy; [Oggioni, Norberto] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, Monza, Italy	IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; University of Milano-Bicocca	Lauria, G (corresponding author), IRCCS Fdn Carlo Besta Neurol Inst, Neuroalgol & Headache Unit, Milan, Italy.	glauria@istituto-besta.it	Ciusani, Emilio/J-9822-2016; lauria, giuseppe/AAN-5371-2020; Lauria, Giuseppe/T-1378-2017; Taiana, Michela/AAB-8846-2019; Lombardi, Raffaella/K-7951-2016	Ciusani, Emilio/0000-0002-7285-123X; lauria, giuseppe/0000-0001-9773-020X; Lauria, Giuseppe/0000-0001-9773-020X; Lombardi, Raffaella/0000-0003-0080-6699	"Ricerca Corrente" of the Italian Ministry of Heath; "Carlo Besta" Neurological Institute, Milan, Italy	"Ricerca Corrente" of the Italian Ministry of Heath; "Carlo Besta" Neurological Institute, Milan, Italy	The study has been funded by the "Ricerca Corrente" of the Italian Ministry of Heath to the IRCCS Foundation, "Carlo Besta" Neurological Institute, Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi F, 2013, OPHTHALMOLOGY, V120, P1641, DOI 10.1016/j.ophtha.2013.01.014; Abu El-Asrar AM, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/539658; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Akude E, 2010, NEUROTOX RES, V17, P28, DOI 10.1007/s12640-009-9074-5; [Anonymous], 1995, ANN INTERN MED, V122, P561, DOI 10.7326/0003-4819-122-8-199504150-00001; Badros A, 2005, BLOOD, V106, P1135, DOI 10.1182/blood-2005-03-0910; Bianchi R, 2012, J PHARMACOL EXP THER, V340, P64, DOI 10.1124/jpet.111.181529; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Cha JJ, 2013, LIFE SCI, V92, P1118, DOI 10.1016/j.lfs.2013.04.008; Chattopadhyay M, 2009, BRAIN, V132, P879, DOI 10.1093/brain/awp014; Deguchi T, 2009, DIABETIC MED, V26, P247, DOI 10.1111/j.1464-5491.2009.02680.x; Delaney CL, 2001, J NEUROPATH EXP NEUR, V60, P147, DOI 10.1093/jnen/60.2.147; Gumy LF, 2008, MOL CELL NEUROSCI, V37, P298, DOI 10.1016/j.mcn.2007.10.004; Hoke A, 2006, NAT CLIN PRACT NEURO, V2, P448, DOI 10.1038/ncpneuro0262; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Katavetin P, 2006, J AM SOC NEPHROL, V17, P1405, DOI 10.1681/ASN.2005090918; Kennedy JM, 2005, J PERIPHER NERV SYST, V10, P144, DOI 10.1111/j.1085-9489.2005.0010205.x; Kulkarni GV, 1998, EXP CELL RES, V245, P170, DOI 10.1006/excr.1998.4245; Leinninger GM, 2006, NEUROBIOL DIS, V23, P11, DOI 10.1016/j.nbd.2006.01.017; Leinninger GM, 2004, J PERIPHER NERV SYST, V9, P26, DOI 10.1111/j.1085-9489.2004.09105.x; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Liu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060558; Luthra S, 2006, RETINA-J RET VIT DIS, V26, P512, DOI 10.1097/01.iae.0000222547.35820.52; Melli G, 2006, BRAIN, V129, P1330, DOI 10.1093/brain/awl058; Melli G, 2009, EXPERT OPIN DRUG DIS, V4, P1035, DOI 10.1517/17460440903266829; Melli G, 2008, EXP NEUROL, V214, P276, DOI 10.1016/j.expneurol.2008.08.013; Mironidou-Tzouveleki M, 2011, CURR DRUG TARGETS, V12, P107, DOI 10.2174/138945011793591581; Mitry D, 2013, COCHRANE DB SYST REV, V1; Nicholson BP, 2010, GRAEF ARCH CLIN EXP, V248, P915, DOI 10.1007/s00417-010-1315-z; Pawson EJ, 2010, DIABETES, V59, P509, DOI 10.2337/db08-1526; Said G, 2007, NAT CLIN PRACT NEURO, V3, P331, DOI 10.1038/ncpneuro0504; Samii A, 1999, NEUROSCI LETT, V262, P159, DOI 10.1016/S0304-3940(99)00064-6; Scarlato M, 2011, CURR OPIN NEUROL, V24, P491, DOI 10.1097/WCO.0b013e328348e107; Schratzberger P, 2001, J CLIN INVEST, V107, P1083, DOI 10.1172/JCI12188; Schrufer TL, 2010, DIABETES, V59, P2107, DOI 10.2337/db10-0148; Sghirlanzoni A, 2005, LANCET NEUROL, V4, P349, DOI 10.1016/S1474-4422(05)70096-X; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Sulaiman OAR, 2000, GLIA, V32, P234, DOI 10.1002/1098-1136(200012)32:3<234::AID-GLIA40>3.0.CO;2-3; Svenningsen AF, 2003, J NEUROSCI RES, V72, P565, DOI 10.1002/jnr.10610; Ta LE, 2006, NEUROTOXICOLOGY, V27, P992, DOI 10.1016/j.neuro.2006.04.010; Tosaki T, 2008, EXP NEUROL, V213, P381, DOI 10.1016/j.expneurol.2008.06.017; Tufro A, 2012, SEMIN NEPHROL, V32, P385, DOI 10.1016/j.semnephrol.2012.06.010; Wang MS, 2004, BRAIN, V127, P671, DOI 10.1093/brain/awh078; Yu C, 2008, GLIA, V56, P877, DOI 10.1002/glia.20662; Zhang G, 2011, J NEUROSCI, V31, P1664, DOI 10.1523/JNEUROSCI.3829-10.2011; Zherebitskaya E, 2009, DIABETES, V58, P1356, DOI 10.2337/db09-0034; Zochodne DW, 2007, MUSCLE NERVE, V36, P144, DOI 10.1002/mus.20785; Zochodne DW, 2001, BRAIN, V124, P2319, DOI 10.1093/brain/124.11.2319	50	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108403	10.1371/journal.pone.0108403	http://dx.doi.org/10.1371/journal.pone.0108403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268360	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700090
J	Watson, JL; Hala, TJ; Putatunda, R; Sannie, D; Lepore, AC				Watson, Jaime L.; Hala, Tamara J.; Putatunda, Rajarshi; Sannie, Daniel; Lepore, Angelo C.			Persistent At-Level Thermal Hyperalgesia and Tactile Allodynia Accompany Chronic Neuronal and Astrocyte Activation in Superficial Dorsal Horn following Mouse Cervical Contusion Spinal Cord Injury	PLOS ONE			English	Article							C-FOS EXPRESSION; NEUROPATHIC PAIN; GLUTAMATE TRANSPORTERS; NOXIOUS-STIMULATION; RAT MODEL; CENTRAL SENSITIZATION; PROMOTER ACTIVITY; DELTA-FOSB; DISEASE; DEGENERATION	In humans, sensory abnormalities, including neuropathic pain, often result from traumatic spinal cord injury (SCI). SCI can induce cellular changes in the CNS, termed central sensitization, that alter excitability of spinal cord neurons, including those in the dorsal horn involved in pain transmission. Persistently elevated levels of neuronal activity, glial activation, and glutamatergic transmission are thought to contribute to the hyperexcitability of these dorsal horn neurons, which can lead to maladaptive circuitry, aberrant pain processing and, ultimately, chronic neuropathic pain. Here we present a mouse model of SCI-induced neuropathic pain that exhibits a persistent pain phenotype accompanied by chronic neuronal hyperexcitability and glial activation in the spinal cord dorsal horn. We generated a unilateral cervical contusion injury at the C5 or C6 level of the adult mouse spinal cord. Following injury, an increase in the number of neurons expressing Delta FosB (a marker of chronic neuronal activation), persistent astrocyte activation and proliferation (as measured by GFAP and Ki67 expression), and a decrease in the expression of the astrocyte glutamate transporter GLT1 are observed in the ipsilateral superficial dorsal horn of cervical spinal cord. These changes have previously been associated with neuronal hyperexcitability and may contribute to altered pain transmission and chronic neuropathic pain. In our model, they are accompanied by robust at-level hyperaglesia in the ipsilateral forepaw and allodynia in both forepaws that are evident within two weeks following injury and persist for at least six weeks. Furthermore, the pain phenotype occurs in the absence of alterations in forelimb grip strength, suggesting that it represents sensory and not motor abnormalities. Given the importance of transgenic mouse technology, this clinically-relevant model provides a resource that can be used to study the molecular mechanisms contributing to neuropathic pain following SCI and to identify potential therapeutic targets for the treatment of chronic pathological pain.	[Watson, Jaime L.; Hala, Tamara J.; Putatunda, Rajarshi; Sannie, Daniel; Lepore, Angelo C.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Farber Inst Neurosci, Dept Neurosci, Philadelphia, PA 19107 USA	Jefferson University	Lepore, AC (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Farber Inst Neurosci, Dept Neurosci, Philadelphia, PA 19107 USA.	Angelo.Lepore@jefferson.edu			NIH [1R01NS079702]; Craig H. Neilsen Foundation [190140]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079702] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Craig H. Neilsen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the NIH (1R01NS079702 to A.C.L.) and the Craig H. Neilsen Foundation (#190140 to A.C.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBADIE C, 1994, NEUROSCIENCE, V59, P457, DOI 10.1016/0306-4522(94)90609-2; Bester H, 2000, J COMP NEUROL, V428, P45, DOI 10.1002/1096-9861(20001204)428:1<45::AID-CNE5>3.0.CO;2-A; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; Busic Z, 2012, SPINE, V37, P1874, DOI 10.1097/BRS.0b013e31825a2c2b; Chen CJ, 2000, J NEUROCHEM, V75, P1557, DOI 10.1046/j.1471-4159.2000.0751557.x; Cho DC, 2011, J KOREAN NEUROSURG S, V49, P83, DOI 10.3340/jkns.2011.49.2.83; Christensen MD, 1996, PAIN, V68, P97, DOI 10.1016/S0304-3959(96)03224-1; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Miguel Marcia de, 2009, Rev. Bras. Anestesiol., V59, P350, DOI 10.1590/S0034-70942009000300011; Detloff MR, 2013, J NEUROTRAUM, V30, P884, DOI 10.1089/neu.2012.2632; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Galan A, 2004, PAIN, V112, P315, DOI 10.1016/j.pain.2004.09.011; Grossman SD, 2000, J NEUROCHEM, V75, P174, DOI 10.1046/j.1471-4159.2000.0750174.x; Gwak YS, 2011, CURR PAIN HEADACHE R, V15, P215, DOI 10.1007/s11916-011-0186-2; Hoschouer EL, 2010, PAIN, V148, P328, DOI 10.1016/j.pain.2009.11.023; Hoschouer EL, 2009, EXP NEUROL, V216, P22, DOI 10.1016/j.expneurol.2008.10.025; Hulsebosch CE, 2009, BRAIN RES REV, V60, P202, DOI 10.1016/j.brainresrev.2008.12.010; Iwasaki R, 2013, J HAND SURG-AM, V38A, P841, DOI 10.1016/j.jhsa.2013.01.034; Jinks SL, 2002, EXP BRAIN RES, V145, P261, DOI 10.1007/s00221-002-1128-3; Jorum E, 2003, PAIN, V101, P229, DOI 10.1016/S0304-3959(02)00122-7; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Katano T, 2008, EUR J NEUROSCI, V27, P3161, DOI 10.1111/j.1460-9568.2008.06293.x; Kosta V, 2009, EUR J PAIN, V13, P243, DOI 10.1016/j.ejpain.2008.04.012; Kundi S., 2013, NEUROSCIENCE, V4, P1, DOI DOI 10.3844/AMJNSP.2013.1.12; Larsson M, 2008, J NEUROSCI, V28, P7084, DOI 10.1523/JNEUROSCI.5749-07.2008; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lepore AC, 2005, EXP NEUROL, V194, P230, DOI 10.1016/j.expneurol.2005.02.020; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Lepore AC, 2008, EXP NEUROL, V211, P423, DOI 10.1016/j.expneurol.2008.02.020; Lepore AC, 2011, GLIA, V59, P1996, DOI 10.1002/glia.21241; Lepore AC, 2011, J NEUROSCI RES, V89, P1001, DOI 10.1002/jnr.22624; Luis-Delgado OE, 2006, J NEUROCHEM, V98, P1423, DOI 10.1111/j.1471-4159.2006.03970.x; Maragakis NJ, 2001, ARCH NEUROL-CHICAGO, V58, P365, DOI 10.1001/archneur.58.3.365; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; McDonald JW, 2003, AM J PHYS MED REHAB, V82, pS38, DOI 10.1097/01.PHM.0000086994.53716.17; Meisner JG, 2010, J NEUROTRAUM, V27, P729, DOI 10.1089/neu.2009.1166; Menendez L, 2002, J NEUROSCI METH, V113, P91, DOI 10.1016/S0165-0270(01)00483-6; Nakae A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939023; Nakagawa T, 2010, J PHARM SCI; National Spinal Cord Injury Statistical Center University of Birmingham Alabama, 2013, SPIN CORD INJ FACTS; Nicaise C, 2013, J NEUROTRAUM, V30, P1092, DOI 10.1089/neu.2012.2728; Nicaise C, 2012, J NEUROTRAUM, V29, P2748, DOI 10.1089/neu.2012.2467; Nicaise C, 2012, EXP NEUROL, V235, P539, DOI 10.1016/j.expneurol.2012.03.007; Olsen ML, 2010, BRAIN, V133, P1013, DOI 10.1093/brain/awq049; Pareek TK, 2006, CELL CYCLE, V5, P585, DOI 10.4161/cc.5.6.2578; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Putatunda R, 2014, BRAIN RES IN PRESS; Ravenscroft A, 2000, SPINAL CORD, V38, P611, DOI 10.1038/sj.sc.3101073; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; Streijger F, 2013, J NEUROTRAUM, V30, P869, DOI 10.1089/neu.2012.2405; Vera-Portocarrero LP, 2002, BRAIN RES, V927, P104, DOI 10.1016/S0006-8993(01)03329-7; YI DK, 1995, PAIN, V60, P257, DOI 10.1016/0304-3959(94)00119-Y	58	31	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e109099	10.1371/journal.pone.0109099	http://dx.doi.org/10.1371/journal.pone.0109099			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268642	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700222
J	Bilancio, G; Lombardi, C; Pisot, R; De Santo, NG; Cavallo, P; Cirillo, M				Bilancio, Giancarlo; Lombardi, Cinzia; Pisot, Rado; De Santo, Natale G.; Cavallo, Pierpaolo; Cirillo, Massimo			Effects of Bed-Rest on Urea and Creatinine: Correlation with Changes in Fat-Free Mass	PLOS ONE			English	Article							WATER METABOLISM; BODY-COMPOSITION; ENERGY; INACTIVITY; RESPONSES; TURNOVER; NITROGEN; PLASMA; VOLUME; BLOOD	Background: Bed-rest experiments are designed for investigation on catabolic effects of hypokinetic conditions and/or for microgravity simulation in on-ground aerospace research. Bed-rest effects include a reduction in fat-free mass and muscle mass. Urea and creatinine are catabolites of endogenous protein and of muscular energetic metabolism which are excreted mainly by the kidney. The study investigated on urea, creatinine, and kidney function during bed-rest. Methods: Twenty healthy young men underwent a 7-day adaptation period (day-6 to day-0) and a 35-day bed-rest experiment (day1 to day35) during normocaloric diet. Urine were collected from day-3 to day0 (baseline) and from day1 to day35. Blood samples and anthropometrical data were collected at day0 (baseline) and bed-rest days 7, 14, 21, 28, and 35. Results: Bed-rest reduced plasma volume, weight, fat-free mass, and muscle mass (P<0.001). During bed-rest there was a transient increase in plasma and urinary urea, a decrease in plasma creatinine, and no change in urinary creatinine. The overall integral of changes from day0 to day35 was on average +101.7 mg/dL for plasma urea (95% CI = +43.4/+159.9), +82.2 g/24 h for urinary urea (95% CI = +55.8/+108.7), 22.5 mg/dL for plasma creatinine (95% CI = -3.1/-1.9). Bed-rest reduced plasma cistatyn C also, which was used as mass-independent marker of glomerular filtration rate (-13.1%, P<0.05). Correlations with final reduction in fat-free mass and muscle mass were significant for the overall integral of changes in urinary urea from day0 to day35 (R = 0.706, P<0.001) and for early changes in urinary urea and plasma urea from day0 to day7 (R = 0.566, P = 0.009 and R = 0.715, P<0.001, respectively). Conclusions: Study results shows that urea is a marker of catabolic conditions secondary to hypokinetic conditions.	[Bilancio, Giancarlo; Cirillo, Massimo] Univ Salerno, Dept Med & Surg, I-84081 Baronissi, Italy; [Lombardi, Cinzia] Hosp Benevento, Dept Matern & Pediat, Benevento, Italy; [Pisot, Rado] Univ Primorska, Inst Kinesiol Res, Koper, Slovenia; [De Santo, Natale G.] Univ Naples 2, Dept Med, Naples, Italy; [Cavallo, Pierpaolo] Univ Salerno, Dept Phys, Fisciano, Italy	University of Salerno; University of Primorska; Universita della Campania Vanvitelli; University of Salerno	Cirillo, M (corresponding author), Univ Salerno, Dept Med & Surg, I-84081 Baronissi, Italy.	mcirillo@unisa.it	Cavallo, Pierpaolo/G-6802-2012; Cirillo, Massimo/G-5480-2018	Cavallo, Pierpaolo/0000-0003-3111-5241; Cirillo, Massimo/0000-0002-6409-3504; Bilancio, Giancarlo/0000-0002-0845-1194	Italian Space Agency	Italian Space Agency(Agenzia Spaziale Italiana (ASI))	The study was part of the OSMA project (OSteoporosis and Muscular Atrophy) sponsored by the Italian Space Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankir L, 1996, KIDNEY, P571; Bettany GEA, 1996, CLIN SCI, V90, P73, DOI 10.1042/cs0900073; Bilancio G, 2013, AM J KIDNEY DIS, V61, P845, DOI 10.1053/j.ajkd.2012.10.015; Bingham SA, 2003, J NUTR, V133, p921S, DOI 10.1093/jn/133.3.921S; Biolo G, 2008, AM J CLIN NUTR, V88, P950, DOI 10.1093/ajcn/88.4.950; Blanc S, 1998, J CLIN ENDOCR METAB, V83, P4289, DOI 10.1210/jc.83.12.4289; Brower Roy G, 2009, Crit Care Med, V37, pS422, DOI 10.1097/CCM.0b013e3181b6e30a; Coker RH, 2012, CURR OPIN CLIN NUTR, V15, P7, DOI 10.1097/MCO.0b013e32834da629; CONVERTINO VA, 1992, ACTA ASTRONAUT, V27, P123, DOI 10.1016/0094-5765(92)90188-O; Cooper C, 2013, CALCIFIED TISSUE INT, V93, P201, DOI 10.1007/s00223-013-9757-z; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Fortney SM, 1996, PHYSL BED REST COMPR, DOI [10.1002/cphy.cp040239, DOI 10.1002/CPHY.CP040239]; Iovino P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072608; Jaffrin MY, 2009, CURR OPIN CLIN NUTR, V12, P482, DOI 10.1097/MCO.0b013e32832da22c; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Johansen LB, 1998, AM J PHYSIOL-REG I, V274, pR126, DOI 10.1152/ajpregu.1998.274.1.R126; LeBlanc A. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P33; Mazzucco S, 2010, J CLIN ENDOCR METAB, V95, P2508, DOI 10.1210/jc.2009-2561; Millet C, 2001, CLIN PHYSIOL, V21, P172, DOI 10.1046/j.1365-2281.2001.00315.x; Muller MJ, 2004, AM J CLIN NUTR, V80, P1379; Nygren J, 1997, NUTRITION, V13, P945, DOI 10.1016/S0899-9007(97)00335-3; Rittweger J, 2009, BONE, V44, P612, DOI 10.1016/j.bone.2009.01.001; Scheld K, 2001, CLIN CHEM, V47, P1688; SCRIMSHAW NS, 1977, AM J CLIN NUTR, V30, P1536, DOI 10.1093/ajcn/30.9.1536; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; WEITZMAN RE, 1980, WESTERN J MED, V132, P16; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; ZORBAS YG, 1986, BIOCHEM MED METAB B, V36, P267, DOI 10.1016/0885-4505(86)90135-0	28	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108805	10.1371/journal.pone.0108805	http://dx.doi.org/10.1371/journal.pone.0108805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265226	Green Submitted, Green Published, gold			2022-12-27	WOS:000345745400129
J	De Angelis, V; Koekman, AC; Weeterings, C; Roest, M; de Groot, PG; Herczenik, E; Maas, C				De Angelis, Valentina; Koekman, Arnold C.; Weeterings, Cees; Roest, Mark; de Groot, Philip G.; Herczenik, Eszter; Maas, Coen			Endocannabinoids Control Platelet Activation and Limit Aggregate Formation under Flow	PLOS ONE			English	Article							CANNABINOID RECEPTOR; CB2 RECEPTORS; ANANDAMIDE; SYSTEM; BRAIN; MODULATION	Background: The endocannabinoid system has previously been implicated in the regulation of neurons and inflammatory cells. Additionally, it has been reported that endocannabinoid receptors are present on circulating platelets, but there has been conflicting evidence on their contribution to platelet function. Objectives: Our aim was to examine the role of endocannabinoids in platelet function in vitro and in vivo. Methods and Results: We studied the effects of the well-characterized endogenous endocannabinoid anandamide on platelet aggregation in suspension, alpha-granule release, calcium mobilization, Syk phosphorylation, as well as platelet spreading and aggregate formation under flow. Anandamide inhibits platelet aggregation and alpha-granule release by collagen, collagen-derived peptide CRP-XL, ADP, arachidonic acid and thromboxane A2 analogue U46619. However, activation via thrombin receptor PAR-1 stays largely unaffected. Calcium mobilization is significantly impaired when platelets are stimulated with collagen or CRP-XL, but remains normal in the presence of the other agonists. In line with this finding, we found that anandamide prevents collagen-induced Syk phosphorylation. Furthermore, anandamide-treated platelets exhibit reduced spreading on immobilized fibrinogen, have a decreased capacity for binding fibrinogen in solution and show perturbed platelet aggregate formation under flow over collagen. Finally, we investigated the influence of Cannabis sativa consumption by human volunteers on platelet activation. Similar to our in vitro findings with anandamide, ex vivo collagen-induced platelet aggregation and aggregate formation on immobilized collagen under flow were impaired in whole blood of donors that had consumed Cannabis sativa. Conclusions: Endocannabinoid receptor agonists reduce platelet activation and aggregate formation both in vitro and ex vivo after Cannabis sativa consumption. Further elucidation of this novel regulatory mechanism for platelet function may prove beneficial in the search for new antithrombotic therapies.	[De Angelis, Valentina; Koekman, Arnold C.; Weeterings, Cees; Roest, Mark; de Groot, Philip G.; Herczenik, Eszter; Maas, Coen] Utrecht Univ Med Ctr, Dept Clin Chem & Haematol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Maas, C (corresponding author), Utrecht Univ Med Ctr, Dept Clin Chem & Haematol, Utrecht, Netherlands.	cmaas4@umcutrecht.nl		Koekman, Arnold/0000-0002-7374-847X; Maas, Coen/0000-0003-4593-0976	Netherlands Organization for Scientific Research (NWO) [016-126-159]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The work of CM was supported by a Veni Fellowship (016-126-159), provided by the Netherlands Organization for Scientific Research (NWO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchan BJ, 2002, ADDICTION, V97, P98, DOI 10.1046/j.1360-0443.97.s01.1.x; Catani MV, 2010, CURR NEUROVASC RES, V7, P311; Catani MV, 2010, CELL MOL LIFE SCI, V67, P601, DOI 10.1007/s00018-009-0198-9; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; De Laurentiis A, 2010, NEUROIMMUNOMODULAT, V17, P153, DOI 10.1159/000258711; Deusch E, 2004, ANESTH ANALG, V99, P1127, DOI 10.1213/01.ANE.0000131505.03006.74; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; FORMUKONG EA, 1989, J PHARM PHARMACOL, V41, P705, DOI 10.1111/j.2042-7158.1989.tb06345.x; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Habayeb OMH, 2004, J CLIN ENDOCR METAB, V89, P5482, DOI 10.1210/jc.2004-0681; Huestis MA, 2007, CHEM BIODIVERS, V4, P1770, DOI 10.1002/cbdv.200790152; Jackson AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093954; Jiang SX, 2011, TRANSFUSION, V51, p65S, DOI 10.1111/j.1537-2995.2011.03368.x; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; KLEIMAN NS, 1995, J AM COLL CARDIOL, V26, P1665, DOI 10.1016/0735-1097(95)00391-6; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Klinkhardt U, 2000, THROMB RES, V97, P201, DOI 10.1016/S0049-3848(99)00155-3; Korporaal SJA, 2007, ARTERIOSCL THROM VAS, V27, P2476, DOI 10.1161/ATVBAHA.107.150698; LEVY R, 1976, THROMB HAEMOSTASIS, V36, P634, DOI 10.1055/s-0038-1648084; Maccarrone M, 1999, FEBS LETT, V447, P277, DOI 10.1016/S0014-5793(99)00308-7; Natarajan A, 2008, DIABETES VASC DIS RE, V5, P138, DOI 10.3132/dvdr.2008.023; Sixma JJ, 1998, THROMB RES, V92, pS43, DOI 10.1016/S0049-3848(98)00159-5; Valk P, 1997, BLOOD, V90, P1448, DOI 10.1182/blood.V90.4.1448.1448_1448_1457; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Wagner JA, 1998, J MOL MED-JMM, V76, P824, DOI 10.1007/s001090050287	27	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108282	10.1371/journal.pone.0108282	http://dx.doi.org/10.1371/journal.pone.0108282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264625	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400061
J	Ho, JN; Du, YA; Wong, OGW; Siu, MKY; Chan, KKL; Cheung, ANY				Ho, Joanna; Du, Yanan; Wong, Oscar Gee-Wan; Siu, Michelle K. Y.; Chan, Karen K. L.; Cheung, Annie N. Y.			Downregulation of the Gli Transcription Factors Regulator Kif7 Facilitates Cell Survival and Migration of Choriocarcinoma Cells	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; ABERRANT ACTIVATION; PROTEIN; GENE; EXPRESSION; MUTATIONS; INVASION; NANOG	The kinesin protein Kif7 has been recognized as an integral component of hedgehog signalling. Aberrant activation of hedgehog signalling has been implicated in many human solid tumours. Gestational trophoblastic disease includes frankly malignant choriocarcinoma and potentially malignant hydatidiform mole. Here we investigated the hedgehog signalling components expression profiles in gestational trophoblastic disease. Downregulation of Gli1, Gli2, Gli3 and Kif7 was demonstrated in clinical samples of choriocarcinoma and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas. Ectopic expression of Kif7 in two choriocarcinoma cell lines JAR and JEG-3 led to a decrease in cell growth and increase in apoptosis demonstrated by MTT and TUNEL assays, respectively. Overexpression of Kif7 also led to suppressed cell migration through transwell assay. In contrast, knocking down Kif7 in HTR-8/SVneo, an immortalized trophoblast cell line, increased cell number over time and increased the migratory ability of the cells. Taken together, Kif7 may contribute to pathogenesis of gestational trophoblastic disease through enhancing survival and promoting dissemination of trophoblasts.	[Ho, Joanna; Du, Yanan; Wong, Oscar Gee-Wan; Cheung, Annie N. Y.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Siu, Michelle K. Y.; Chan, Karen K. L.] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Cheung, Annie N. Y.] Univ Hong Kong, Shenzhen Hosp, Dept Pathol, Shenzhen, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Cheung, ANY (corresponding author), Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	anycheun@pathology.hku.hk	Wong, Gee Wan/C-4661-2009; Cheung, Annie Nga Yin/C-4231-2009	Cheung, Annie Nga Yin/0000-0002-1584-7568	Research Grants Council of the Hong Kong Special Administrative Region [HKU 763211M]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council)	This study was supported by funding from the Research Grants Council of the Hong Kong Special Administrative Region (HKU 763211M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Altieri A, 2003, LANCET ONCOL, V4, P670, DOI 10.1016/S1470-2045(03)01245-2; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Chan HY, 2008, HISTOPATHOLOGY, V53, P139, DOI 10.1111/j.1365-2559.2008.03089.x; Cheung AN, 2009, ROBBOYS PATHOLOGY FE, P881; Cheung ANY, 2003, BEST PRACT RES CL OB, V17, P849, DOI 10.1016/S1521-6934(03)00094-4; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Choksi SP, 2014, DEVELOPMENT, V141, P1427, DOI 10.1242/dev.074666; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Feng Hui Chen, 2005, J Soc Gynecol Investig, V12, pe21, DOI 10.1016/j.jsgi.2005.02.008; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; LEWIS JL, 1993, CANCER-AM CANCER SOC, V71, P1639, DOI 10.1002/cncr.2820710430; Li ASM, 2008, REPROD SCI, V15, P735, DOI 10.1177/1933719108322433; Li ZJ, 2012, DEVELOPMENT, V139, P4152, DOI 10.1242/dev.081190; Liao XY, 2009, MODERN PATHOL, V22, P839, DOI 10.1038/modpathol.2009.45; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; PARADINAS FJ, 2003, HAINES TAYLOR OBSTET, P1359; Putoux A, 2011, NAT GENET, V43, P601, DOI 10.1038/ng.826; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Shih IM, 2008, AM J PATHOL, V173, P911, DOI 10.2353/ajpath.2008.080624; Siu MKY, 2008, AM J PATHOL, V173, P1165, DOI 10.2353/ajpath.2008.080288; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1; Zhang HJ, 2008, PLACENTA, V29, P549, DOI 10.1016/j.placenta.2008.03.003	35	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108248	10.1371/journal.pone.0108248	http://dx.doi.org/10.1371/journal.pone.0108248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265279	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400057
J	Vannini, C; Bracale, M; Crinelli, R; Marconi, V; Campomenosi, P; Marsoni, M; Scoccianti, V				Vannini, Candida; Bracale, Marcella; Crinelli, Rita; Marconi, Valerio; Campomenosi, Paola; Marsoni, Milena; Scoccianti, Valeria			Proteomic Analysis of MG132-Treated Germinating Pollen Reveals Expression Signatures Associated with Proteasome Inhibition	PLOS ONE			English	Article							UDP-GLUCOSE DEHYDROGENASE; PROTEIN DISULFIDE-ISOMERASE; UBIQUITIN/PROTEASOME PATHWAY; 26S PROTEASOME; TUBE GROWTH; PHOSPHATIDIC-ACID; CELL-WALLS; UBIQUITIN; DEGRADATION; ROLES	Chemical inhibition of the proteasome has been previously found to effectively impair pollen germination and tube growth in vitro. However, the mediators of these effects at the molecular level are unknown. By performing 2DE proteomic analysis, 24 differentially expressed protein spots, representing 14 unique candidate proteins, were identified in the pollen of kiwifruit (Actinidia deliciosa) germinated in the presence of the MG132 proteasome inhibitor. qPCR analysis revealed that 11 of these proteins are not up-regulated at the mRNA level, but are most likely stabilized by proteasome inhibition. These differentially expressed proteins are predicted to function in various pathways including energy and lipid metabolism, cell wall synthesis, protein synthesis/degradation and stress responses. In line with this evidence, the MG132-induced changes in the proteome were accompanied by an increase in ATP and ROS content and by an alteration in fatty acid composition.	[Vannini, Candida; Bracale, Marcella; Campomenosi, Paola; Marsoni, Milena] Univ Insubria, Dipartimento Biotecnol & Sci Vita, Varese, Italy; [Crinelli, Rita; Marconi, Valerio] Univ Urbino Carlo Bo, Dipartimento Sci Biomol, Urbino, Italy; [Scoccianti, Valeria] Univ Urbino Carlo Bo, Sez Biol Vegetale, Dipartimento Sci Terra Vita & Ambiente, Urbino, Italy	University of Insubria; University of Urbino; University of Urbino	Vannini, C (corresponding author), Univ Insubria, Dipartimento Biotecnol & Sci Vita, Varese, Italy.	candida.vannini@uninsubria.it	Campomenosi, Paola/C-9729-2011; vannini, candida/B-3705-2010	Campomenosi, Paola/0000-0002-8853-1134; vannini, candida/0000-0002-5196-6142; Scoccianti, Valeria/0000-0001-6710-2659; Crinelli, Rita/0000-0002-1235-8910; Marsoni, Milena/0000-0003-0613-1581	University of Insubria RFO funds; University of Urbino RFO funds	University of Insubria RFO funds; University of Urbino RFO funds	This work was funded by the University of Insubria RFO funds to MB and by University of Urbino RFO funds to VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler E., 1984, GLUTATHIONE RED CELL; Bieler S, 2009, PROTEOMICS, V9, P3257, DOI 10.1002/pmic.200800927; CALZONI GL, 1979, SCI HORTIC-AMSTERDAM, V10, P49, DOI 10.1016/0304-4238(79)90068-2; Chebli Y., 2007, FUNCT PLANT SCI BIOT, V1, P232; Dai SJ, 2007, MOL CELL PROTEOMICS, V6, P207, DOI 10.1074/mcp.M600146-MCP200; Doelling JH, 2007, PLANT PHYSIOL, V145, P801, DOI 10.1104/pp.106.095323; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Gallois JL, 2009, PLANT CELL, V21, P442, DOI 10.1105/tpc.108.062372; Gibeaut DM, 2001, J PLANT PHYSIOL, V158, P569, DOI 10.1078/0176-1617-00229; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Grune T, 2002, ARCH BIOCHEM BIOPHYS, V397, P407, DOI 10.1006/abbi.2001.2719; HEMPEL J, 1994, PROTEIN SCI, V3, P1074, DOI 10.1002/pro.5560030710; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Izard J, 2003, J MICROBIOL METH, V55, P411, DOI 10.1016/S0167-7012(03)00193-3; Jang IC, 2005, GENE DEV, V19, P593, DOI 10.1101/gad.1247205; Kim DY, 2013, PLANT CELL, V25, P1523, DOI 10.1105/tpc.112.108613; Kim M, 2003, J BIOL CHEM, V278, P19406, DOI 10.1074/jbc.M210539200; Kim SG, 2010, PHYSIOL PLANTARUM, V138, P1, DOI 10.1111/j.1399-3054.2009.01290.x; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee KH, 2011, PLANT CELL, V23, P4298, DOI 10.1105/tpc.111.089482; Madoka Y, 2002, PLANT CELL PHYSIOL, V43, P1518, DOI 10.1093/pcp/pcf172; Marsoni M, 2008, PLANT CELL REP, V27, P347, DOI 10.1007/s00299-007-0438-0; Marsoni M, 2010, PLANT CELL ENVIRON, V33, P1161, DOI 10.1111/j.1365-3040.2010.02137.x; Monte E, 2007, J EXP BOT, V58, P3125, DOI 10.1093/jxb/erm186; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Moscatelli A., 2001, CURRENT TRENDS EMBRY, P33, DOI 10.1007/978-94-017-1203-3_3; Nishizawa-Yokoi A, 2010, PLANT CELL PHYSIOL, V51, P486, DOI 10.1093/pcp/pcq015; Obermeyer G, 2013, PLANT PHYSIOL, V162, P1822, DOI 10.1104/pp.113.219857; Petrucco S, 1996, PLANT CELL, V8, P69, DOI 10.1105/tpc.8.1.69; Pleskot R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00054; Potocky M, 2003, PLANTA, V217, P122, DOI 10.1007/s00425-002-0965-4; Qiao H, 2004, PLANT CELL, V16, P582, DOI 10.1105/tpc.017673; Reboul R, 2012, PLANT SIGNAL BEHAV, V7, P298, DOI 10.4161/psb.18894; Reboul R, 2011, J BIOL CHEM, V286, P39982, DOI 10.1074/jbc.M111.255695; Roman E, 2003, BIOCHEM J, V374, P767, DOI 10.1042/BJ20030365; Samac DA, 2004, APPL BIOCHEM BIOTECH, V113, P1167, DOI 10.1385/ABAB:116:1-3:1167; Santner A, 2010, PLANT J, V61, P1029, DOI 10.1111/j.1365-313X.2010.04112.x; Scoccianti V, 2003, SEX PLANT REPROD, V16, P123, DOI 10.1007/s00497-003-0182-8; Sheng XY, 2010, CELL BIOCHEM FUNCT, V28, P420, DOI 10.1002/cbf.1672; Sheng XY, 2006, PLANT PHYSIOL, V141, P1578, DOI 10.1104/pp.106.081703; Smirnova AV, 2009, RUSS J DEV BIOL+, V40, P345, DOI 10.1134/S1062360409060034; Speranza A, 2012, PLANT BIOLOGY, V14, P64, DOI 10.1111/j.1438-8677.2011.00479.x; Speranza A, 2001, PLANT PHYSIOL, V126, P1150, DOI 10.1104/pp.126.3.1150; Speranza A, 2012, PLANT SIGNAL BEHAV, V7, P994, DOI 10.4161/psb.20674; Sullivan JA, 2003, NAT REV GENET, V4, P948, DOI 10.1038/nrg1228; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; THOMPSON TE, 1993, HORTSCIENCE, V28, P1191, DOI 10.21273/HORTSCI.28.12.1191; Wang CL, 2009, PLANT J, V57, P220, DOI 10.1111/j.1365-313X.2008.03681.x; Wang F, 2011, CELL RES, V21, P1286, DOI 10.1038/cr.2011.118; Wang HZ, 2008, PLANT CELL, V20, P3300, DOI 10.1105/tpc.108.062919; Wu GZ, 2010, PLANT CELL, V22, P3726, DOI 10.1105/tpc.110.075564; Zonia L, 2004, PLANT PHYSIOL, V134, P813, DOI 10.1104/pp.103.029454	53	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108811	10.1371/journal.pone.0108811	http://dx.doi.org/10.1371/journal.pone.0108811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265451	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400131
J	Xu, TS; Gu, LH; Schachtschneider, KM; Liu, XL; Huang, W; Xie, M; Hou, SS				Xu, Tieshan; Gu, Lihong; Schachtschneider, Kyle Michael; Liu, Xiaolin; Huang, Wei; Xie, Ming; Hou, Shuisheng			Identification of Differentially Expressed Genes in Breast Muscle and Skin Fat of Postnatal Pekin Duck	PLOS ONE			English	Article							GROWTH-FACTOR-I; SKELETAL-MUSCLE; RNA-SEQ; TRANSCRIPTOME ANALYSIS; SIGNALING PATHWAY; HYPERTROPHY; ADIPOGENESIS; ADIPOCYTE; ATROPHY; CELLS	Lean-type Pekin duck is a commercial breed that has been obtained through long-term selection. Investigation of the differentially expressed genes in breast muscle and skin fat at different developmental stages will contribute to a comprehensive understanding of the potential mechanisms underlying the lean-type Pekin duck phenotype. In the present study, RNA-seq was performed on breast muscle and skin fat at 2-, 4-and 6-weeks of age. More than 89% of the annotated duck genes were covered by our RNA-seq dataset. Thousands of differentially expressed genes, including many important genes involved in the regulation of muscle development and fat deposition, were detected through comparison of the expression levels in the muscle and skin fat of the same time point, or the same tissue at different time points. KEGG pathway analysis showed that the differentially expressed genes clustered significantly in many muscle development and fat deposition related pathways such as MAPK signaling pathway, PPAR signaling pathway, Calcium signaling pathway, Fat digestion and absorption, and TGF-beta signaling pathway. The results presented here could provide a basis for further investigation of the mechanisms involved in muscle development and fat deposition in Pekin duck.	[Xu, Tieshan; Gu, Lihong; Huang, Wei; Xie, Ming; Hou, Shuisheng] CAAS, IAS, Beijing, Peoples R China; [Xu, Tieshan] Chinese Acad Trop Agr Sci, Trop Crops Genet Resources Inst, Danzhuo, Hainan, Peoples R China; [Schachtschneider, Kyle Michael] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Gu, Lihong; Liu, Xiaolin] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Chinese Academy of Tropical Agricultural Sciences; University of Illinois System; University of Illinois Urbana-Champaign; Northwest A&F University - China	Hou, SS (corresponding author), CAAS, IAS, Beijing, Peoples R China.	houss2010@126.com		Schachtschneider, Kyle/0000-0002-7293-8642	earmarked fund for China Agriculture Research System [CARS-43]; Chinese National Key Technology R&D Program during the 11th Five-Years Plan period [2006BAD14B06]	earmarked fund for China Agriculture Research System; Chinese National Key Technology R&D Program during the 11th Five-Years Plan period	This work was funded by the earmarked fund for China Agriculture Research System (CARS-43) and Chinese National Key Technology R&D Program during the 11th Five-Years Plan period (No. 2006BAD14B06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RE, 1987, J CELL PHYSIOL, V133, P567, DOI 10.1002/jcp.1041330319; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Balakrishnan CN, 2012, GENOMICS, V100, P363, DOI 10.1016/j.ygeno.2012.08.002; Bays H, 2004, J CLIN ENDOCR METAB, V89, P463, DOI 10.1210/jc.2003-030723; Bellinge RHS, 2005, ANIM GENET, V36, P1, DOI 10.1111/j.1365-2052.2004.01229.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Chakravarthy MV, 2001, MECH AGEING DEV, V122, P1303, DOI 10.1016/S0047-6374(01)00263-9; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Ekblom R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-219; FOWLER SP, 1980, GROWTH, V44, P235; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Guerci A, 2012, CELL METAB, V15, P25, DOI 10.1016/j.cmet.2011.12.001; GULLER S, 1991, ENDOCRINOLOGY, V129, P527, DOI 10.1210/endo-129-1-527; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hausman GJ, 2009, J ANIM SCI, V87, P1218, DOI 10.2527/jas.2008-1427; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Kamei Y, 2005, FASEB J, V19, pA467; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Li QH, 2012, GENOMICS, V100, P314, DOI 10.1016/j.ygeno.2012.07.008; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu JL, 1999, ENDOCRINOLOGY, V140, P5178, DOI 10.1210/en.140.11.5178; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mlih M, 2011, INFLAMM RES, V60, P116; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mosca B, 2013, NATURE COMMUN, V4, P1451; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Reed SA, 2011, BIOCHEM BIOPH RES CO, V405, P491, DOI 10.1016/j.bbrc.2011.01.059; Roh SG, 2006, ANIM SCI J, V77, P472, DOI 10.1111/j.1740-0929.2006.00374.x; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Senf SM, 2010, AM J PHYSIOL-CELL PH, V298, pC38, DOI 10.1152/ajpcell.00315.2009; SMITH JH, 1963, POULTRY SCI, V42, P283, DOI 10.3382/ps.0420283; Sporer KRB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-143; Vatner SF, 2005, CIRC RES, V96, P705, DOI 10.1161/01.RES.0000164184.63158.6c; Wang BA, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120054; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055496; Xu TS, 2012, MOL BIOL REP, V39, P7647, DOI 10.1007/s11033-012-1599-7; YAMADA S, 1989, MED SCI SPORT EXER, V21, pS173	51	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107574	10.1371/journal.pone.0107574	http://dx.doi.org/10.1371/journal.pone.0107574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264787	gold, Green Submitted, Green Published			2022-12-27	WOS:000345745400026
J	Yang, FJ; Xie, JM; Wang, WM; Xie, YY; Sun, HW; Jin, YP; Xu, D; Chen, BC; Andersson, R; Zhou, MT				Yang, Fajing; Xie, Jianming; Wang, Weiming; Xie, Yangyun; Sun, Hongwei; Jin, Yuepeng; Xu, Dan; Chen, Bicheng; Andersson, Roland; Zhou, Mengtao			Regional Arterial Infusion with Lipoxin A(4) Attenuates Experimental Severe Acute Pancreatitis	PLOS ONE			English	Article							ACUTE LUNG INJURY; NF-KAPPA-B; INFLAMMATORY RESPONSE SYNDROME; HEME OXYGENASE-1; PROTEASE INHIBITOR; ENDOTHELIAL-CELLS; ADHESION MOLECULES; PHOSPHOLIPASE-A; ORGAN INJURY; RAT MODEL	Objective: Investigate the therapeutic effect of regional arterial infusion (RAI) with Aspirin-Triggered Lipoxin A(4) (ATL) in experimental severe acute pancreatitis (SAP) in rats. Materials and Methods: SAP was induced by injection of 5% sodium taurocholate into the pancreatic duct. Rats with SAP were treated with ATL (the ATL group) or physiological saline (the SAP group) infused via the left gastric artery 30 min after injection of sodium taurocholate. The sham group was subjected to the same surgical procedure, though without induction of SAP. Serum levels of amylase, phospholipase A2 (PLA2), interleukin-1 beta (IL-1 beta), IL-6 and tumor necrosis factor-alpha (TNF-alpha) were measured at 12 and 24 h after induction of SAP. Ascitic fluid, the pancreatic index (wet weight ratio) and myeloperoxidase (MPO) levels in the pancreas were determined and histopathological findings were evaluated. The expression of intercellular adhesion molecule-1 (ICAM-1), platelet endothelial cell adhesion molecule-1 (PECAM-1), NF-kappa B p65, and heme oxygenase-1 (HO-1) in the pancreas were estimated by immunofluorescence and western blot, respectively. Results: ATL rats had lower serum levels of TNF-alpha, IL-1 beta, and IL-6 (P<0.01), PLA2 (P<0.05), and amylase levels (P<0.05) studied as compared with the SAP group. The pancreatic index in the ATL group decreased only at 24 h as compared with the SAP group (P<0.05). The histopathological findings and MPO levels in the pancreas significantly decreased in the ATL group as compared to the SAP group (P<0.05 and P<0.01, respectively). Immunofluorescence and western blot showed that ATL attenuated the expression of NF-kappa B p65, ICAM-1 and PECAM-1 in the pancreas, and increased the expression of HO-1 in SAP animals. Conclusions: We demonstrated that RAI with ATL attenuated the severity of experimental SAP, maybe achieved by improving the expression of HO-1, and down-regulating the NF-kappa B signaling pathway, with decreased expression of ICAM-1 and PECAM-1 and reduced generation of pro-inflammatory cytokines.	[Yang, Fajing; Xie, Jianming; Wang, Weiming; Xie, Yangyun; Sun, Hongwei; Jin, Yuepeng; Zhou, Mengtao] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou, Zhejiang, Peoples R China; [Xu, Dan] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China; [Chen, Bicheng] Wenzhou Med Univ, Affiliated Hosp 1, Zhejiang Prov Top Key Discipline Surg, Wenzhou Key Lab Surg,Dept Surg, Wenzhou, Zhejiang, Peoples R China; [Andersson, Roland] Lund Univ, Dept Surg, Clin Sci Lund, Lund, Sweden; [Andersson, Roland] Univ Lund Hosp, S-22185 Lund, Sweden	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Lund University; Lund University; Skane University Hospital	Zhou, MT (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou, Zhejiang, Peoples R China.	zmt0417@hotmail.com		Zhou, Mengtao/0000-0002-2455-250X	National Natural Science Foundation of China [81070372, 81370563]; Provincial Department of Construction Project [WKJ2012-2-033]; Science and Technology Department Commonwealth Technology Applied Research Project of Zhejiang Province [2012C 23108]; Natural Science Foundation of Zhejiang Province [LY12H03005, LY12H03007]; Excellent Youth Foundation of Zhejiang Provincial Natural Science [LR14H030001]; Zhejaing Provincial Program for the Cultivation of High-level Innovative Health talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Department of Construction Project; Science and Technology Department Commonwealth Technology Applied Research Project of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Excellent Youth Foundation of Zhejiang Provincial Natural Science; Zhejaing Provincial Program for the Cultivation of High-level Innovative Health talents	This study was supported by grants of the National Natural Science Foundation of China (Grant No. 81070372, No. 81370563), the Provincial Department of Construction Project (Grant No. WKJ2012-2-033), the Science and Technology Department Commonwealth Technology Applied Research Project of Zhejiang Province (Grant No. 2012C 23108), the Natural Science Foundation of Zhejiang Province (Grant No. LY12H03005, No. LY12H03007), the Excellent Youth Foundation of Zhejiang Provincial Natural Science (Grant No. LR14H030001), the Zhejaing Provincial Program for the Cultivation of High-level Innovative Health talents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO HJ, 1980, SCAND J GASTROENTERO, V15, P1027, DOI 10.3109/00365528009181808; Al Mofleh IA, 2008, WORLD J GASTROENTERO, V14, P675, DOI 10.3748/wjg.14.675; Ben-Ari Z, 2013, APOPTOSIS, V18, P547, DOI 10.1007/s10495-013-0814-x; BIRD NC, 1989, BRIT J SURG, V76, P731, DOI 10.1002/bjs.1800760728; BUCHLER M, 1989, KLIN WOCHENSCHR, V67, P186, DOI 10.1007/BF01711351; BUCHLER M, 1989, GASTROENTEROLOGY, V97, P1521; Buter A, 2002, BRIT J SURG, V89, P298, DOI 10.1046/j.0007-1323.2001.02025.x; Chen QH, 2009, EUR J OBSTET GYN R B, V145, P200, DOI 10.1016/j.ejogrb.2009.05.015; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; Claria J, 1996, MOL MED, V2, P583, DOI 10.1007/BF03401642; El Kebir D, 2008, J LEUKOCYTE BIOL, V84, P600, DOI 10.1189/jlb.1107765; Elfar M, 2007, SURG CLIN N AM, V87, P1325, DOI 10.1016/j.suc.2007.09.002; Fierro IM, 2003, J IMMUNOL, V170, P2688, DOI 10.4049/jimmunol.170.5.2688; GUICE KS, 1991, J SURG RES, V51, P495, DOI 10.1016/0022-4804(91)90171-H; Hughes CB, 1996, PANCREAS, V13, P22, DOI 10.1097/00006676-199607000-00003; Hukkanen RR, 2009, TOXICOL PATHOL, V37, P799, DOI 10.1177/0192623309343778; Imaizumi H, 2004, PANCREAS, V28, P369, DOI 10.1097/00006676-200405000-00003; Jin SW, 2007, ANESTH ANALG, V104, P369, DOI 10.1213/01.ane.0000252414.00363.c4; Kahl S, 2010, DIGEST DIS, V28, P373, DOI 10.1159/000319417; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Li XH, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/354087; Lundberg AH, 2000, ANN SURG, V231, P213, DOI 10.1097/00000658-200002000-00010; Lundberg AH, 2000, J GASTROINTEST SURG, V4, P248, DOI 10.1016/S1091-255X(00)80073-6; Matsuda N, 2006, J PHARMACOL SCI, V101, P189, DOI 10.1254/jphs.CRJ06010X; Mikami Y, 2005, PANCREAS, V30, P248, DOI 10.1097/01.mpa.0000153328.54569.28; Morse D, 2002, AM J RESP CELL MOL, V27, P8, DOI 10.1165/ajrcmb.27.1.4862; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Nascimento-Silva V, 2005, AM J PHYSIOL-CELL PH, V289, pC557, DOI 10.1152/ajpcell.00045.2005; O'Sullivan TP, 2007, J MED CHEM, V50, P5894, DOI 10.1021/jm060270d; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Panek J, 2006, CAN J GASTROENTEROL, V20, P645, DOI 10.1155/2006/372892; Pastor CM, 2001, FASEB J, V15, P893, DOI 10.1096/fj.00-0672rev; RINDERKNECHT H, 1988, INT J PANCREATOL, V3, P105; Satoh Hirohiko, 2004, J Med Invest, V51, P186, DOI 10.2152/jmi.51.186; Scalia R, 1997, P NATL ACAD SCI USA, V94, P9967, DOI 10.1073/pnas.94.18.9967; Schlereth T, 2005, AUTON NEUROSCI-BASIC, V117, P120, DOI 10.1016/j.autneu.2004.11.005; SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007; Seo SW, 2008, PANCREAS, V36, pE22, DOI 10.1097/MPA.0b013e31815a396b; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; Simon R, 2007, BIOCHEM BIOPH RES CO, V355, P280, DOI 10.1016/j.bbrc.2007.01.148; Sircar M, 2007, J IMMUNOL, V178, P5879, DOI 10.4049/jimmunol.178.9.5879; Soares MP, 2004, J IMMUNOL, V172, P3553, DOI 10.4049/jimmunol.172.6.3553; Takeda K, 2001, J Hepatobiliary Pancreat Surg, V8, P216, DOI 10.1007/s005340170019; Uhl W, 1997, GUT, V40, P386, DOI 10.1136/gut.40.3.386; Wang YP, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-95; Xie YY, 2013, LAT AM J PHARM, V32, P477; Yamauchi J, 2001, PANCREATOLOGY, V1, P662, DOI 10.1159/000055878; Zhang XP, 2010, HEPATOB PANCREAT DIS, V9, P83; Zhao Yong-Fu, 2005, Hepatobiliary Pancreat Dis Int, V4, P604; Zhou MT, 2010, WORLD J GASTROENTERO, V16, P2094, DOI 10.3748/wjg.v16.i17.2094; Zhou MT, 2013, PANCREATOLOGY, V13, P212, DOI 10.1016/j.pan.2013.02.004; Zhou MT, 2011, SCAND J GASTROENTERO, V46, P211, DOI 10.3109/00365521.2010.525715; Zhou XY, 2007, INFLAMM RES, V56, P324, DOI 10.1007/s00011-007-7012-7; Zyromski N, 2003, SURGERY, V133, P235, DOI 10.1067/msy.2003.87	58	16	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108525	10.1371/journal.pone.0108525	http://dx.doi.org/10.1371/journal.pone.0108525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265022	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400082
J	Jones, RA; Watson, KL; Campbell, CI; Moorehead, RA				Jones, Robert A.; Watson, Katrina L.; Campbell, Craig I.; Moorehead, Roger A.			IGF-IR Mediated Mammary Tumorigenesis Is Enhanced during Pubertal Development	PLOS ONE			English	Article							DIETHYLSTILBESTROL IN-UTERO; ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; HODGKINS-DISEASE; ENDOCRINE DISRUPTORS; GLAND; RISK; MORPHOGENESIS; WOMEN; CARCINOGENESIS	Although breast cancer typically develops in women over the age of 40, it remains unclear when breast cancer initiating events occur or whether the mammary gland is particularly susceptible to oncogenic transformation at a particular developmental stage. Using MTB-IGFIR transgenic mice that overexpress type I insulin-like growth factor receptor (IGF-IR) in a doxycycline-inducible manner, mammary tumorigenesis was initiated at different developmental stages. Tumor multiplicity was significantly increased while tumor latency was significantly decreased when the IGF-IR transgene was expressed during pubertal development compared to post-pubertal transgene expression. Moreover, metastatic spread of mammary tumors to the lungs was approximately twice as likely when IGF-IR was overexpressed in pubertal mice compared to post-pubertal mice. In addition, engraftment of pubertal MTB-IGFIR mammary tissue into cleared mammary fat pads of pubertal hosts produced tumors more frequently and faster than engraftment into adult hosts. These experiments show that the mammary microenvironment created during puberty renders mammary epithelial cells particularly susceptible to transformation.	[Jones, Robert A.; Watson, Katrina L.; Moorehead, Roger A.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Campbell, Craig I.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada	University of Guelph; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Moorehead, RA (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	rmoorehe@uoguelph.ca		, Roger/0000-0001-9539-6295; Jones, Robert/0000-0001-7665-9301	Canadian Institutes of Health Research [MOP-106579]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by a Canadian Institutes of Health Research Operating grant (MOP-106579) awarded to RAM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aisenberg AC, 1997, CANCER, V79, P1203, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1203::AID-CNCR20>3.0.CO;2-2; Aisenberg AC, 2000, J CLIN ONCOL, V18, P2186, DOI 10.1200/JCO.2000.18.10.2186; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Birnbaum LS, 2003, ENVIRON HEALTH PERSP, V111, P389, DOI 10.1289/ehp.5686; Britt K, 2007, ENDOCR-RELAT CANCER, V14, P907, DOI 10.1677/ERC-07-0137; Bussard KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049221; Campbell CI, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-235; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P986; DECOSSE JJ, 1975, J NATL CANCER I, V54, P913; DECOSSE JJ, 1973, SCIENCE, V181, P1057, DOI 10.1126/science.181.4104.1057; DEOME KB, 1959, CANCER RES, V19, P515; El-Din MAA, 2009, INT J RADIAT ONCOL, V73, P69, DOI 10.1016/j.ijrobp.2008.03.066; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Fenton SE, 2006, ENDOCRINOLOGY, V147, pS18, DOI 10.1210/en.2005-1131; Hassiotou F, 2013, CLIN ANAT, V26, P29, DOI 10.1002/ca.22165; Hatch EE, 1998, JAMA-J AM MED ASSOC, V280, P630, DOI 10.1001/jama.280.7.630; Hoover RN, 2011, NEW ENGL J MED, V365, P1304, DOI 10.1056/NEJMoa1013961; Horwich A, 2004, BRIT J CANCER, V90, P294, DOI 10.1038/sj.bjc.6601499; Huebner RJ, 2014, SEMIN CELL DEV BIOL, V31, P124, DOI 10.1016/j.semcdb.2014.04.019; Jones RA, 2007, ONCOGENE, V26, P1636, DOI 10.1038/sj.onc.1209955; Jones RA, 2009, ONCOGENE, V13, P407; KRATOCHWIL K, 1969, DEV BIOL, V20, P46, DOI 10.1016/0012-1606(69)90004-9; LaMarca HL, 2008, ENDOCRINOLOGY, V149, P4317, DOI 10.1210/en.2008-0450; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; MACMAHON B, 1970, B WORLD HEALTH ORGAN, V43, P209; Macon MB, 2013, J MAMMARY GLAND BIOL, V18, P43, DOI 10.1007/s10911-013-9275-7; Maffini MV, 2004, J CELL SCI, V117, P1495, DOI 10.1242/jcs.01000; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Medina D, 1999, J NATL CANCER I, V91, P967, DOI 10.1093/jnci/91.11.967; Meier-Abt F, 2014, TRENDS MOL MED, V20, P143, DOI 10.1016/j.molmed.2013.11.002; ORR JOHN W., 1963, NATL CANCER INST MONOGR, V10, P531; Palmer JR, 2002, CANCER CAUSE CONTROL, V13, P753, DOI 10.1023/A:1020254711222; Palmer JR, 2006, CANCER EPIDEM BIOMAR, V15, P1509, DOI 10.1158/1055-9965.EPI-06-0109; RUSSO J, 1994, CANCER EPIDEM BIOMAR, V3, P219; Russo J, 2005, CLIN CANCER RES, V11, p931S; RUSSO J, 1990, LAB INVEST, V62, P244; RUSSO J, 1983, ENVIRON HEALTH PERSP, V49, P185, DOI 10.1289/ehp.8349185; Russo J, 2005, BREAST CANCER RES, V7, P131, DOI 10.1186/bcr1029; Russo J, 2001, MICROSC RES TECHNIQ, V52, P204, DOI 10.1002/1097-0029(20010115)52:2<204::AID-JEMT1006>3.0.CO;2-F; Russo J, 1982, Breast Cancer Res Treat, V2, P5, DOI 10.1007/BF01805718; RUSSO J, 1978, J NATL CANCER I, V61, P1451; Russo J, 2008, ADV EXP MED BIOL, V630, P52; SAKAKURA T, 1976, SCIENCE, V194, P1439, DOI 10.1126/science.827022; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Sivaraman L, 1998, CARCINOGENESIS, V19, P1573, DOI 10.1093/carcin/19.9.1573; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Troisi R, 2007, INT J CANCER, V121, P356, DOI 10.1002/ijc.22631; Vaux DL, 2011, BIOESSAYS, V33, P341, DOI 10.1002/bies.201100022; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Weinberg R A, 1998, ONE RENEGADE CELL CA; Weinberg RA, 2007, BIOL CANC; Yang JH, 1999, CARCINOGENESIS, V20, P623, DOI 10.1093/carcin/20.4.623	52	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108781	10.1371/journal.pone.0108781	http://dx.doi.org/10.1371/journal.pone.0108781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259518	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600101
J	Medenwald, D; Girndt, M; Loppnow, H; Kluttig, A; Nuding, S; Tiller, D; Thiery, JJ; Greiser, KH; Haerting, J; Werdan, K				Medenwald, Daniel; Girndt, Matthias; Loppnow, Harald; Kluttig, Alexander; Nuding, Sebastian; Tiller, Daniel; Thiery, Joachim J.; Greiser, Karin H.; Haerting, Johannes; Werdan, Karl			Inflammation and Renal Function after a Four-Year Follow-Up in Subjects with Unimpaired Glomerular Filtration Rate: Results from the Observational, Population-Based CARLA Cohort	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CHRONIC KIDNEY-DISEASE; TNF-ALPHA; MARKERS; CREATININE; RISK; ASSOCIATION; PROGRESSION; EQUATION; INJURY	Background: There is evidence that chronic inflammation is associated with the progression/development of chronic renal failure; however, relations in subjects with preserved renal function remain insufficiently understood. Objective: To examine the association of inflammation with the development of renal failure in a cohort of the elderly general population. Methods: After excluding subjects with reduced estimated glomerular filtration rate (eGFR<60 mL/min/1.73 m(2)) and missing data, the cohort incorporated 785 men and 659 women (aged 45-83 years). Follow-up was performed four years after baseline. Covariate adjusted linear and logistic regression models were used to assess the association of plasma/serum concentrations of soluble tumour necrosis factor receptor 1 (sTNF-R1), C-reactive protein (CRP), and interleukin 6 (IL-6) with change in eGFR/creatinine. The areas under the curve (AUCs) from receiver operating characteristics (ROCs) were estimated. Results: In adjusted models sTNF-R1 was distinctively associated with a decline in eGFR in men (0.6 mL/min/1.73 m(2) per 100 pg/mL sTNF-R1; 95% CI: 0.4-0.8), but not in women. A similar association could not be found for CRP or IL-6. Estimates of sTNF-R1 in the cross-sectional analyses were similar between sexes, while CRP and IL-6 were not relevantly associated with eGFR/creatinine. Conclusion: In the elderly male general population with preserved renal function sTNF-R1 predicts the development of renal failure.	[Medenwald, Daniel; Kluttig, Alexander; Tiller, Daniel; Haerting, Johannes] Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, D-06108 Halle, Germany; [Girndt, Matthias] Univ Halle Wittenberg, Dept Internal Med 2, D-06108 Halle, Germany; [Loppnow, Harald; Nuding, Sebastian; Werdan, Karl] Univ Halle Wittenberg, Dept Internal Med 3, D-06108 Halle, Germany; [Thiery, Joachim J.] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04109 Leipzig, Germany; [Greiser, Karin H.] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Leipzig University; Helmholtz Association; German Cancer Research Center (DKFZ)	Medenwald, D (corresponding author), Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, D-06108 Halle, Germany.	daniel.medenwald@uk-halle.de	Girndt, Matthias/M-1436-2019	Girndt, Matthias/0000-0003-2823-0847	Deutsche Forschungsgemeinschaft as part of the Collaborative Research Centre at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg [598]; Wilhelm-Roux Programme of the Martin-Luther-University Halle-Wittenberg; Ministry of Education and Cultural Affairs of Saxony-Anhalt; Federal Employment Office	Deutsche Forschungsgemeinschaft as part of the Collaborative Research Centre at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg(German Research Foundation (DFG)); Wilhelm-Roux Programme of the Martin-Luther-University Halle-Wittenberg; Ministry of Education and Cultural Affairs of Saxony-Anhalt; Federal Employment Office	The CARLA study was supported by a grant from the Deutsche Forschungsgemeinschaft as part of the Collaborative Research Centre 598 'Heart failure in the elderly - cellular mechanisms and therapy' at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg, by a grant from the Wilhelm-Roux Programme of the Martin-Luther-University Halle-Wittenberg, by the Ministry of Education and Cultural Affairs of Saxony-Anhalt, and by the Federal Employment Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibalini G, 2014, J ENDOCRINOL INVEST; Aomatsu M, 2013, BIOCHEM BIOPH RES CO, V441, P220, DOI 10.1016/j.bbrc.2013.10.042; Carpena N, 2012, ISRN CARDIOL, V2012; Cheuiche AV, 2013, CLIN BIOCHEM, V46, P1423, DOI 10.1016/j.clinbiochem.2013.05.067; Clendenen TV, 2011, CYTOKINE, V56, P769, DOI 10.1016/j.cyto.2011.09.013; Cooker LA, 2007, AM J PHYSIOL-RENAL, V293, pF157, DOI 10.1152/ajprenal.00508.2006; Elmarakby AA, 2006, HYPERTENSION, V47, P557, DOI 10.1161/01.HYP.0000198545.01860.90; Elmarakby AA, 2012, CARDIOVASC THER, V30, P49, DOI 10.1111/j.1755-5922.2010.00218.x; Glymour MM, 2005, AM J EPIDEMIOL, V162, P267, DOI 10.1093/aje/kwi187; Greiser Karin H, 2005, BMC Cardiovasc Disord, V5, P33, DOI 10.1186/1471-2261-5-33; Greiser KH, 2009, EUR J EPIDEMIOL, V24, P123, DOI 10.1007/s10654-009-9317-z; Gupta J, 2012, CLIN J AM SOC NEPHRO, V7, P1938, DOI 10.2215/CJN.03500412; Keller CR, 2007, KIDNEY INT, V71, P239, DOI 10.1038/sj.ki.5002042; Keller C, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-9; Kleinbongard P, 2011, HEART FAIL REV, V16, P49, DOI 10.1007/s10741-010-9180-8; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lin J, 2010, DIABETOLOGIA, V53, P263, DOI 10.1007/s00125-009-1597-z; Lorz C, 2008, J AM SOC NEPHROL, V19, P904, DOI 10.1681/ASN.2007050581; Madero M, 2011, CURR OPIN NEPHROL HY, V20, P622, DOI 10.1097/MNH.0b013e32834ba210; Metcalfe PD, 2008, AM J PHYSIOL-ENDOC M, V294, pE435, DOI 10.1152/ajpendo.00704.2006; Metcalfe PD, 2006, J UROLOGY, V176, P15, DOI 10.1016/S0022-5347(06)00490-3; Miyazawa I, 2011, DIABETES RES CLIN PR, V92, P174, DOI 10.1016/j.diabres.2011.01.008; Navarro JF, 2006, NEPHROL DIAL TRANSPL, V21, P3428, DOI 10.1093/ndt/gfl469; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pruijm M, 2012, AM J NEPHROL, V35, P288, DOI 10.1159/000335934; Ramseyer VD, 2013, AM J PHYSIOL-RENAL, V304, pF1231, DOI 10.1152/ajprenal.00557.2012; RICKHAM PP, 1964, BRIT MED J, V2, P173; Sanchez-Nino MD, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/182958; Shankar A, 2011, KIDNEY INT, V80, P1231, DOI 10.1038/ki.2011.283; Therrien FJ, 2012, AM J NEPHROL, V36, P151, DOI 10.1159/000340033; TorreAmione G, 1996, CIRCULATION, V93, P704, DOI 10.1161/01.CIR.93.4.704	32	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108427	10.1371/journal.pone.0108427	http://dx.doi.org/10.1371/journal.pone.0108427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259714	gold, Green Published, Green Submitted			2022-12-27	WOS:000342685600072
J	Miyake, M; Yamashiro, K; Akagi-Kurashige, Y; Oishi, A; Tsujikawa, A; Hangai, M; Yoshimura, N				Miyake, Masahiro; Yamashiro, Kenji; Akagi-Kurashige, Yumiko; Oishi, Akio; Tsujikawa, Akitaka; Hangai, Masanori; Yoshimura, Nagahisa			Analysis of Fundus Shape in Highly Myopic Eyes by Using Curvature Maps Constructed from Optical Coherence Tomography	PLOS ONE			English	Article							CHOROIDAL NEOVASCULARIZATION; HIGH-RESOLUTION; RETINAL-DETACHMENT; REFRACTIVE ERRORS; OUTER RETINA; ATROPHY; ASSOCIATION; POPULATION; ADULTS; HOLE	Purpose: To evaluate fundus shape in highly myopic eyes using color maps created through optical coherence tomography (OCT) image analysis. Methods: We retrospectively evaluated 182 highly myopic eyes from 113 patients. After obtaining 12 lines of 9-mm radial OCT scans with the fovea at the center, the Bruch's membrane line was plotted and its curvature was measured at 1-mu m intervals in each image, which was reflected as a color topography map. For the quantitative analysis of the eye shape, mean absolute curvature and variance of curvature were calculated. Results: The color maps allowed staphyloma visualization as a ring of green color at the edge and as that of orange-red color at the bottom. Analyses of mean and variance of curvature revealed that eyes with myopic choroidal neovascularization tended to have relatively flat posterior poles with smooth surfaces, while eyes with chorioretinal atrophy exhibited a steep, curved shape with an undulated surface (P < 0.001). Furthermore, eyes with staphylomas and those without clearly differed in terms of mean curvature and the variance of curvature: 98.4% of eyes with staphylomas had mean curvature >= 7.8x10(-5) [1/mu m] and variance of curvature >= 0.26x10(-8) [1/mu m]. Conclusions: We established a novel method to analyze posterior pole shape by using OCT images to construct curvature maps. Our quantitative analysis revealed that fundus shape is associated with myopic complications. These values were also effective in distinguishing eyes with staphylomas from those without. This tool for the quantitative evaluation of eye shape should facilitate future research of myopic complications.	[Miyake, Masahiro; Yamashiro, Kenji; Akagi-Kurashige, Yumiko; Oishi, Akio; Tsujikawa, Akitaka; Hangai, Masanori; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan	Kyoto University	Yamashiro, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	yamashro@kuhp.kyoto-u.ac.jp	Miyake, Masahiro/V-1261-2019; Oishi, Akio/AAE-9996-2020	Miyake, Masahiro/0000-0001-7410-3764; Oishi, Akio/0000-0002-0977-9458; Yamashiro, Kenji/0000-0001-9354-8558; Tsujikawa, Akitaka/0000-0003-0779-7799	Japan Society for the Promotion of Science, Tokyo, Japan [21249084, 200791294]; Japan National Society for the Prevention of Blindness, Tokyo, Japan; Canon; Topcon	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan National Society for the Prevention of Blindness, Tokyo, Japan(Japan National Society for the Prevention of Blindness); Canon; Topcon	This study was supported in part by grants-in-aid for scientific research (Nos. 21249084 and 200791294) from the Japan Society for the Promotion of Science, Tokyo, Japan, and the Japan National Society for the Prevention of Blindness, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Financial Disclosures: Nagahisa Yoshimura: Canon (Financial support), Topcon (Financial support); Masanori Hangai: Canon (Financial support), Topcon (Financial support).	Atchison DA, 2005, INVEST OPHTH VIS SCI, V46, P2698, DOI 10.1167/iovs.04-1506; Chae Ju Byung, 2011, Korean J Ophthalmol, V25, P243, DOI 10.3341/kjo.2011.25.4.243; Chang L, 2013, AM J OPHTHALMOL, V155, P991, DOI 10.1016/j.ajo.2013.01.016; CHENG HM, 1992, OPTOMETRY VISION SCI, V69, P698, DOI 10.1097/00006324-199209000-00005; Chiu SJ, 2012, INVEST OPHTH VIS SCI, V53, P53, DOI 10.1167/iovs.11-7640; Curtin B J, 1977, Trans Am Ophthalmol Soc, V75, P67; CURTIN BJ, 1971, AM J OPHTHALMOL, V71, P42, DOI 10.1016/0002-9394(71)91092-0; Farsiu S, 2013, OPHTHALMOLOGY; Hayashi K, 2010, OPHTHALMOLOGY, V117, P1595, DOI 10.1016/j.ophtha.2009.11.003; Hsiang HW, 2008, AM J OPHTHALMOL, V146, P102, DOI 10.1016/j.ajo.2008.03.010; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P3721, DOI 10.1167/iovs.09-3493; Jacobi FK, 2005, CELL MOL LIFE SCI, V62, P800, DOI 10.1007/s00018-004-4353-z; Kaluzny JJ, 2009, OPHTHAL SURG LAS IM, V40, P102, DOI 10.3928/15428877-20090301-10; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Khor CC, 2013, HUM MOL GENET, V22, P5288, DOI 10.1093/hmg/ddt385; Kojima A, 2004, GRAEF ARCH CLIN EXP, V242, P114, DOI 10.1007/s00417-003-0803-9; Kuo AN, 2013, AM J OPHTHALMOL, V156, P304, DOI 10.1016/j.ajo.2013.03.012; Miyake M, 2013, OPHTHALMOLOGY; Miyake M, 2013, INVEST OPHTH VIS SCI, V54, P4208, DOI 10.1167/iovs.13-12280; MORITA H, 1991, RETINA-J RET VIT DIS, V11, P281, DOI 10.1097/00006982-199111030-00002; Moriyama M, 2011, OPHTHALMOLOGY, V118, P1626, DOI 10.1016/j.ophtha.2011.01.018; Ohno-Matsui K, 2003, BRIT J OPHTHALMOL, V87, P570, DOI 10.1136/bjo.87.5.570; Ohno-Matsui K, 2012, INVEST OPHTH VIS SCI, V53, P6046, DOI 10.1167/iovs.12-10161; Pan CW, 2013, INVEST OPHTH VIS SCI, V54, P2590, DOI 10.1167/iovs.13-11725; Saw Seang-Mei, 2003, Clin Exp Optom, V86, P289; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; Shimada N, 2008, BRIT J OPHTHALMOL, V92, P762, DOI 10.1136/bjo.2007.131359; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Steidl SM, 1997, AM J OPHTHALMOL, V123, P181, DOI 10.1016/S0002-9394(14)71034-7; Szkulmowski M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2771569; Teramura Tamaki, 1993, Nippon Ganka Gakkai Zasshi, V97, P873; van Velthoven MEJ, 2007, PROG RETIN EYE RES, V26, P57, DOI 10.1016/j.preteyeres.2006.10.002; Wong TY, 2002, BRIT J OPHTHALMOL, V86, P963, DOI 10.1136/bjo.86.9.963; Wu PC, 2009, EYE, V23, P356, DOI 10.1038/sj.eye.6703038; Yoshida T, 2003, OPHTHALMOLOGY, V110, P1297, DOI 10.1016/S0161-6420(03)00461-5	36	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107923	10.1371/journal.pone.0107923	http://dx.doi.org/10.1371/journal.pone.0107923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259853	Green Submitted, gold, Green Published			2022-12-27	WOS:000342685600034
J	Mweya, CN; Holst, N; Mboera, LEG; Kimera, SI				Mweya, Clement N.; Holst, Niels; Mboera, Leonard E. G.; Kimera, Sharadhuli I.			Simulation Modelling of Population Dynamics of Mosquito Vectors for Rift Valley Fever Virus in a Disease Epidemic Setting	PLOS ONE			English	Article							WATER-BALANCE MODEL; DIPTERA-CULICIDAE; CULEX-PIPIENS; VERTICAL TRANSMISSION; DISTRIBUTED DELAYS; AEDES-VEXANS; KENYA; CLIMATE; AFRICA; TEMPERATURE	Background: Rift Valley Fever (RVF) is weather dependent arboviral infection of livestock and humans. Population dynamics of mosquito vectors is associated with disease epidemics. In our study, we use daily temperature and rainfall as model inputs to simulate dynamics of mosquito vectors population in relation to disease epidemics. Methods/Findings: Time-varying distributed delays (TVDD) and multi-way functional response equations were implemented to simulate mosquito vectors and hosts developmental stages and to establish interactions between stages and phases of mosquito vectors in relation to vertebrate hosts for infection introduction in compartmental phases. An open-source modelling platforms, Universal Simulator and Qt integrated development environment were used to develop models in C++ programming language. Developed models include source codes for mosquito fecundity, host fecundity, water level, mosquito infection, host infection, interactions, and egg time. Extensible Markup Language (XML) files were used as recipes to integrate source codes in Qt creator with Universal Simulator plug-in. We observed that Floodwater Aedines and Culicine population continued to fluctuate with temperature and water level over simulation period while controlled by availability of host for blood feeding. Infection in the system was introduced by floodwater Aedines. Culicines pick infection from infected host once to amplify disease epidemic. Simulated mosquito population show sudden unusual increase between December 1997 and January 1998 a similar period when RVF outbreak occurred in Ngorongoro district. Conclusion/Significance: Findings presented here provide new opportunities for weather-driven RVF epidemic simulation modelling. This is an ideal approach for understanding disease transmission dynamics towards epidemics prediction, prevention and control. This approach can be used as an alternative source for generation of calibrated RVF epidemics data in different settings.	[Mweya, Clement N.] Natl Inst Med Res, Tukuyu, Tanzania; [Holst, Niels] Aarhus Univ, Dept Agroecol, Slagelse, Denmark; [Mboera, Leonard E. G.] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Mweya, Clement N.; Kimera, Sharadhuli I.] Sokoine Univ Agr, Dept Vet Med & Publ Hlth, Morogoro, Tanzania	Aarhus University; National Institute of Medical Research; Sokoine University of Agriculture	Mweya, CN (corresponding author), Natl Inst Med Res, Tukuyu, Tanzania.	cmweya@nimr.or.tz	sharma, Vijay/T-5286-2019; Mweya, Clement/ABC-4703-2020; sharma, Vijay K/A-6733-2009	sharma, Vijay/0000-0002-8976-5696; Mweya, Clement/0000-0002-7227-3564; sharma, Vijay K/0000-0002-8976-5696; Holst, Niels/0000-0002-8414-6773	National Institute for Medical Research (NIMR)	National Institute for Medical Research (NIMR)	This project was supported by Health Research Users Trust Fund of the National Institute for Medical Research (NIMR) under human capacity development strategy for training of CNM. The funders had no role in study design, decision to publish, or preparation of the manuscript.	Aida H. Nur, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P472, DOI 10.1016/S2221-1691(11)60103-2; Anyamba Assaf, 2006, Int J Health Geogr, V5, P60, DOI 10.1186/1476-072X-5-60; Anyamba A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001465; Anyamba A, 2010, AM J TROP MED HYG, V83, P43, DOI 10.4269/ajtmh.2010.09-0289; Arnell NW, 1999, J HYDROL, V217, P314, DOI 10.1016/S0022-1694(99)00023-2; Aytekin S, 2009, J VECTOR ECOL, V34, P32, DOI [10.1111/j.1948-7134.2009.00005.x, 10.3376/038.034.0105]; Barker CM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002515; BISHOP DHL, 1988, PHILOS T ROY SOC B, V321, P463, DOI 10.1098/rstb.1988.0103; Chevalier V, 2013, CLIN MICROBIOL INFEC, V19, P705, DOI 10.1111/1469-0691.12163; Chitnis N, 2013, J BIOL DYNAM, V7, P11, DOI 10.1080/17513758.2012.733427; Clements ACA, 2007, PREV VET MED, V82, P72, DOI 10.1016/j.prevetmed.2007.05.006; Dar O, 2013, EMERG INFECT DIS, V19, P189, DOI 10.3201/eid1902.120941; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; DAVIES FG, 1975, J HYG-CAMBRIDGE, V75, P219, DOI 10.1017/S0022172400047252; Diallo M, 2000, AM J TROP MED HYG, V62, P702, DOI 10.4269/ajtmh.2000.62.702; Elfadil AA, 2006, REV SCI TECH OIE, V25, P1137, DOI 10.20506/rst.25.3.1722; FAO, 2012, RIFT VALL FEV VIG NE, V27; Fouque F, 1996, J MED ENTOMOL, V33, P32, DOI 10.1093/jmedent/33.1.32; FREIER JE, 1987, AM J TROP MED HYG, V37, P640, DOI 10.4269/ajtmh.1987.37.640; GAFF H, 2011, INT J ARTIFICIAL LIF, V2, P1, DOI DOI 10.4018/JALR.2011040101; Gaff HD, 2007, ELECTRON J DIFFER EQ, P1, DOI DOI 10.1089/VBZ.2010.0084; Gaff H, 2009, MATH BIOSCI ENG, V6, P469, DOI 10.3934/mbe.2009.6.469; Gao DZ, 2013, B MATH BIOL, V75, P523, DOI 10.1007/s11538-013-9818-5; Gerdes GH, 2004, REV SCI TECH OIE, V23, P613, DOI 10.20506/rst.23.2.1500; Gerdes GH, 2002, VET CLIN N AM-FOOD A, V18, P549, DOI 10.1016/S0749-0720(02)00029-4; GOMEZ C, 1977, J MED ENTOMOL, V13, P453, DOI 10.1093/jmedent/13.4-5.453; GUTIERREZ AP, 1992, ECOLOGY, V73, P1552, DOI 10.2307/1940008; Hall RA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/512969; Holst N, 2013, ECOL INFORM, V13, P70, DOI 10.1016/j.ecoinf.2012.11.001; Ikegami T, 2009, VACCINE, V27, pD69, DOI 10.1016/j.vaccine.2009.07.046; Jost CC, 2010, AM J TROP MED HYG, V83, P65, DOI 10.4269/ajtmh.2010.09-0290; Kebede Senait, 2010, East Afr J Public Health, V7, P20; Kokkinn MJ, 2009, MED VET ENTOMOL, V23, P85, DOI 10.1111/j.1365-2915.2008.00787.x; Larkin TS, 2000, T SOC COMPUT SIMUL I, V17, P25; Liang Yunmei, 2000, Acta Theriologica Sinica, V20, P258; Linthicum Kenneth J, 2007, Vet Ital, V43, P663; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; LOGAN TM, 1991, J AM MOSQUITO CONTR, V7, P109; Loncaric Z, 2013, THEOR POPUL BIOL, V83, P82, DOI 10.1016/j.tpb.2012.08.002; MANETSCH TJ, 1976, IEEE T SYST MAN CYB, V6, P547, DOI 10.1109/TSMC.1976.4309549; Manore CA, 2015, TRANSBOUND EMERG DIS, V62, P13, DOI 10.1111/tbed.12082; Meegan J M, 1978, J Egypt Public Health Assoc, V53, P173; Mohamed M, 2010, AM J TROP MED HYG, V83, P22, DOI 10.4269/ajtmh.2010.09-0318; Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004; Mpeshe SC, 2011, ACTA BIOTHEOR, V59, P231, DOI 10.1007/s10441-011-9132-2; Muller A, 2001, ANN I STAT MATH, V53, P567, DOI 10.1023/A:1014629416504; Mweya C. N., 2013, INFECT ECOL EPIDEMIO, V3, DOI [DOI 10.3402/IEE.V3I0.21748, 10.3402/iee.v3i0.21748]; Mweya CN, 2013, TANZAN J HLTH RES, V15, P89438, DOI [10.4314/thrb.v15i3.89438, DOI 10.4314/THRB.V15I3.89438]; Nguku PM, 2010, AM J TROP MED HYG, V83, P5, DOI 10.4269/ajtmh.2010.09-0288; Niu TC, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/138757; OBP, 2013, IMM SCH; Pin-Diop Raphaelle, 2007, Vet Ital, V43, P675; Romoser WS, 2011, RES REP TROP MED, V2, P121, DOI 10.2147/RRTM.S13947; Schaake JC, 1996, J GEOPHYS RES-ATMOS, V101, P7461, DOI 10.1029/95JD02892; Soti V, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-10; Soti V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001795; Suman DS, 2011, MED VET ENTOMOL, V25, P276, DOI 10.1111/j.1365-2915.2010.00939.x; Tabachnick WJ, 2010, J EXP BIOL, V213, P946, DOI 10.1242/jeb.037564; TAUTHONG P, 1977, CAN J ZOOL, V55, P135, DOI 10.1139/z77-016; Tourre YM, 2009, GLOBAL HEALTH ACTION, V2, P133, DOI 10.3402/gha.v2i0.2053; Tsuda Yoshio, 1994, Tropical Medicine, V36, P15; TURELL MJ, 1985, AM J TROP MED HYG, V34, P1211, DOI 10.4269/ajtmh.1985.34.1211; VANSICKLE J, 1977, IEEE T SYST MAN CYB, V7, P635, DOI 10.1109/TSMC.1977.4309800; Witt CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S2-S10; Xue L, 2012, J THEOR BIOL, V306, P129, DOI 10.1016/j.jtbi.2012.04.029; Yao C Q, 1988, J Tongji Med Univ, V8, P249; YEDLOUTSCHNIG RJ, 1981, VET REC, V109, P383, DOI 10.1136/vr.109.17.383; Yusoff N, 2012, INT J MED BIOL SCI, V6, P97	68	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108430	10.1371/journal.pone.0108430	http://dx.doi.org/10.1371/journal.pone.0108430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259792	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600073
J	Yin, Y; Zhang, WJ; Hu, ZY; Jia, FJ; Li, YF; Xu, HW; Zhao, SL; Guo, J; Tian, DH; Qu, ZY				Yin, Yi; Zhang, Weijun; Hu, Zhenyu; Jia, Fujun; Li, Yafang; Xu, Huiwen; Zhao, Shuliang; Guo, Jing; Tian, Donghua; Qu, Zhiyong			Experiences of Stigma and Discrimination among Caregivers of Persons with Schizophrenia in China: A Field Survey	PLOS ONE			English	Article							MENTAL-ILLNESS; FAMILY-MEMBERS; PERCEIVED STIGMATIZATION; SOCIAL SUPPORT; SELF-STIGMA; PEOPLE; DISORDERS; RELATIVES; CULTURE; ADULTS	In China, caregivers for family members with schizophrenia play an important role in treatment and recovery but may experience stigma and discrimination simply because of their family relationship. The object of this study was to measure the degrees and correlates of stigma and discrimination experiences among this group. Four hundred twenty-seven caregivers participated in this hospital-based and cross-sectional study in Ningbo and Guangzhou, China. Data were collected by trained interviewers using fixed questionnaires. Stigma and discrimination experiences were measured by the Modified Consumer Experiences of Stigma Questionnaire (MCESQ). Caregivers' social support was measured by the Social Support Rating Scale. Parametric analysis, nonparametric analysis and multivariate linear regression were used. The mean (SD) score of MCESQ was 2.44(0.45), 2.91(0.71) for stigma experiences and 1.97(0.37) for discrimination experiences on a five-point score ("1 = never'' and "5 = very often''). Approximately 65% of caregivers reported that they tried to conceal their family members' illness, and 71% lacked the support of friends. The experience of stigma was significantly negatively associated with the perceived social support of caregivers (standard beta = -0.2, p < 0.001). Caregivers who were children of the patients experienced fewer stigmas than other (standard beta = -0.18, p < 0.001). Urban residence (standard beta = -0.12, p < 0.01) and patients did not complete primary school education (standard beta = -0.13, p < 0.01) were negatively related with stigmas. In addition, stigma and discrimination was more experienced in Zhejiang than in Guangdong (p < 0.05). In conclusion, this study performed that caregivers of people with schizophrenia in China experienced general stigmas and rare discrimination and found the relations with social support, kinship, patient's educational level and regional differences. More interventions and supports should been given to caregivers who are lack of social support, who live in rural area and who are the patients' parents, spouses or siblings.	[Yin, Yi; Zhang, Weijun; Tian, Donghua; Qu, Zhiyong] Beijing Normal Univ, Sch Social Dev & Publ Policy, Beijing 100875, Peoples R China; [Hu, Zhenyu] Ningbo Kangning Hosp, Off Director, Ningbo, Zhejiang, Peoples R China; [Jia, Fujun] Guangdong Gen Hosp, Guangdong Mental Hlth Ctr, Guangzhou, Guangdong, Peoples R China; [Li, Yafang] Peking Union Med Coll Hosp, Dept Med Affairs, Beijing, Peoples R China; [Xu, Huiwen] Univ Rochester, Sch Med & Dent, Dept Publ Hlth Sci, Rochester, NY USA; [Zhao, Shuliang] Yunnan Univ Finance & Econ, Sch Publ Management, Kunming, Yunnan, Peoples R China; [Guo, Jing] Huazhong Univ Sci & Technol, Dept Sociol, Wuhan 430074, Hubei, Peoples R China	Beijing Normal University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Rochester; Yunnan University of Finance & Economics; Huazhong University of Science & Technology	Qu, ZY (corresponding author), Beijing Normal Univ, Sch Social Dev & Publ Policy, Beijing 100875, Peoples R China.	qzy@bnu.edu.cn	Xu, Huiwen/AAP-8744-2020; guo, jing/A-6416-2018; Xu, Huiwen/HHN-2986-2022; zhang, weijun/AFU-6997-2022; QU, Zhiyong/E-9677-2014	Xu, Huiwen/0000-0002-4033-0659; zhang, weijun/0000-0003-3436-3371; 	Education Foundation of Beijing Normal University	Education Foundation of Beijing Normal University	The study was sponsored by the Education Foundation of Beijing Normal University (http://www.bnuef.org/). DT received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gonzalez-Torres MA, 2007, SOC PSYCH PSYCH EPID, V42, P14, DOI 10.1007/s00127-006-0126-3; Brohan E, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-80; Chafetz L, 1989, Arch Psychiatr Nurs, V3, P61; Chang KH, 2006, J ADV NURS, V53, P435, DOI 10.1111/j.1365-2648.2006.03732.x; Charles H, 2007, INT J SOC PSYCHIATR, V53, P325, DOI 10.1177/0020764006074538; Chen FP, 2004, COMMUNITY MENT HLT J, V40, P423, DOI 10.1023/B:COMH.0000040656.89143.82; Chou YC, 2009, J INTELL DISABIL RES, V53, P654, DOI 10.1111/j.1365-2788.2009.01173.x; Corrigan P, 2003, PSYCHIAT SERV, V54, P1105, DOI 10.1176/appi.ps.54.8.1105; Corrigan P.W., 2004, J MENT HEALTH, V13, P537, DOI DOI 10.1080/09638230400017004; Dickerson FB, 2002, SCHIZOPHRENIA BULL, V28, P143, DOI 10.1093/oxfordjournals.schbul.a006917; Fei H.T., 1992, SOIL FDN CHINESE SOC; [高士元 Gao Shiyuan], 2005, [中国心理卫生杂志, Chinese Mental Health Journal], V19, P82; Girma E, 2014, J MULTIDISCIP HEALTH, V7, P37, DOI 10.2147/JMDH.S57259; Goffman E, 1963, STIGMA NOTES MANAGEM, P141; Karamlou S, 2013, EUR PSYCHIAT, V28, P1; Karnieli-Miller O, 2013, J MENT HEALTH, V22, P254, DOI 10.3109/09638237.2013.779368; KELLY TB, 1995, J GERONTOL SOC WORK, V24, P3, DOI 10.1300/J083V24N01_02; KIRMAYER LJ, 1989, SOC SCI MED, V29, P327, DOI 10.1016/0277-9536(89)90281-5; Kleinman Joan, 1993, CHINESE J MENTAL HLT, V6, P37; Kung WW, 2003, FAM SOC-J CONTEMP H, V84, P547, DOI 10.1606/1044-3894.140; Larson JE, 2008, ACAD PSYCHIATR, V32, P87, DOI 10.1176/appi.ap.32.2.87; Lee S, 2005, BRIT J PSYCHIAT, V186, P153, DOI 10.1192/bjp.186.2.153; LIN KM, 1988, SCHIZOPHRENIA BULL, V14, P555, DOI 10.1093/schbul/14.4.555; Livingston JD, 2010, SOC SCI MED, V71, P2150, DOI 10.1016/j.socscimed.2010.09.030; Lv Y, 2013, GEN HOSP PSYCHIAT, V35, P83, DOI 10.1016/j.genhosppsych.2012.07.007; Magana SM, 2007, PSYCHIAT SERV, V58, P378, DOI 10.1176/appi.ps.58.3.378; Mak WWS, 2012, COMMUNITY MENT HLT J, V48, P270, DOI 10.1007/s10597-011-9422-9; Miao C, 2003, CHINESE J CLIN REHAB, V7, P3384; Mueller B, 2006, SOC SCI MED, V62, P39, DOI 10.1016/j.socscimed.2005.05.014; Muhlbauer S., 2002, J AM PSYCHIAT NURSES, V8, P76, DOI DOI 10.1067/MPN.2002.125222; PEARSON V, 1993, J FAM THER, V15, P163, DOI 10.1111/j.1467-6427.1993.00752.x; Phelan JC, 1998, SCHIZOPHRENIA BULL, V24, P115, DOI 10.1093/oxfordjournals.schbul.a033304; Phillips MR, 2002, BRIT J PSYCHIAT, V181, P488, DOI 10.1192/bjp.181.6.488; Phillips MR, 2000, BRIT J PSYCHIAT, V177, P20, DOI 10.1192/bjp.177.1.20; Saunders P, 2001, SOC POLICY ADMIN, V35, P274, DOI 10.1111/1467-9515.00233; Shibre T, 2001, SOC PSYCH PSYCH EPID, V36, P299, DOI 10.1007/s001270170048; Snowden LR, 2005, ANNU REV CLIN PSYCHO, V1, P143, DOI 10.1146/annurev.clinpsy.1.102803.143846; Struening FL, 2001, PSYCHIATR SERV, V52, P1633; Sue DW, 1994, J COUNS PSYCHOL, V21, P167; Wahl OF, 1999, SCHIZOPHRENIA BULL, V25, P467, DOI 10.1093/oxfordjournals.schbul.a033394; Wu, 2010, SUICIDE JUSTICE CHIN; Xiang B, 2000, TRANSCENDING BOUNDAR, P454; Xiao S., 1994, J CLIN PSYCHIAT, V4, P98, DOI DOI 10.1186/S12913-016-1423-5; Yang LH, 2013, SOC SCI MED, V88, P56, DOI 10.1016/j.socscimed.2013.03.036	44	32	35	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108527	10.1371/journal.pone.0108527	http://dx.doi.org/10.1371/journal.pone.0108527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IP	25259732	Green Submitted, Green Published, gold			2022-12-27	WOS:000342685600080
J	Wang, YJ; He, HW; Liu, LN; Gao, CY; Xu, S; Zhao, P; Xia, QY				Wang, Yejing; He, Huawei; Liu, Lina; Gao, Chunyan; Xu, Shui; Zhao, Ping; Xia, Qingyou			Inactivation and Unfolding of Protein Tyrosine Phosphatase from Thermus thermophilus HB27 during Urea and Guanidine Hydrochloride Denaturation	PLOS ONE			English	Article							MUSCLE CREATINE-KINASE; C-TERMINAL DOMAIN; MOLTEN GLOBULE; STABILITY; STATE; STABILIZATION; THERMODYNAMICS; PURIFICATION; FLUORESCENCE; DEPENDENCE	The effects of urea and guanidine hydrochloride (GdnHCl) on the activity, conformation and unfolding process of protein tyrosine phosphatase (PTPase), a thermostable low molecular weight protein from Thermus thermophilus HB27, have been studied. Enzymatic activity assays showed both urea and GdnHCl resulted in the inactivation of PTPase in a concentration and time-dependent manner. Inactivation kinetics analysis suggested that the inactivation of PTPase induced by urea and GdnHCl were both monophasic and reversible processes, and the effects of urea and GdnHCl on PTPase were similar to that of mixed-type reversible inhibitors. Far-ultraviolet (UV) circular dichroism (CD), Tryptophan and 1-anilinonaphthalene -8-sulfonic acid (ANS) fluorescence spectral analyses indicated the existence of a partially active and an inactive molten globule-like intermediate during the unfolding processes induced by urea and GdnHCl, respectively. Based on the sequence alignment and the homolog Tt1001 protein structure, we discussed the possible conformational transitions of PTPase induced by urea and GdnHCl and compared the conformations of these unfolding intermediates with the transient states in bovine PTPase and its complex structures in detail. Our results may be able to provide some valuable clues to reveal the relationship between the structure and enzymatic activity, and the unfolding pathway and mechanism of PTPase.	[Wang, Yejing; He, Huawei; Liu, Lina; Gao, Chunyan; Zhao, Ping; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Wang, Yejing; He, Huawei; Xu, Shui] Southwest Univ, Coll Biotechnol, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	He, HW (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	hehuawei@swu.edu.cn; xiaqy@swu.edu.cn	liu, li/HGC-0900-2022		National Basic Research Program of China [2012CB114602]; Fundamental Research Funds for the Central Universities [SWU112111, XDJK2013A019, SWU112086, XDJK2013C049]	National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	HH was supported by the National Basic Research Program of China (2012CB114602) and the Fundamental Research Funds for the Central Universities (SWU112111, XDJK2013A019). YW was supported by the Fundamental Research Funds for the Central Universities (SWU112086, XDJK2013C049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUNE KC, 1969, BIOCHEMISTRY-US, V8, P4586, DOI 10.1021/bi00839a053; Bhuyan AK, 2002, BIOCHEMISTRY-US, V41, P13386, DOI 10.1021/bi020371n; Bonincontro A, 2004, BIOPHYS J, V86, P1118, DOI 10.1016/S0006-3495(04)74186-7; BREMS DN, 1990, J BIOL CHEM, V265, P5504; Burke TR, 1998, BIOPOLYMERS, V47, P225, DOI 10.1002/(SICI)1097-0282(1998)47:3<225::AID-BIP3>3.0.CO;2-O; Chen Z, 2012, BIOPHYS J, V103, P558, DOI 10.1016/j.bpj.2012.07.002; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Deshpande RA, 2003, BBA-PROTEINS PROTEOM, V1648, P184, DOI 10.1016/S1570-9639(03)00133-X; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; Easty D, 2006, CURR CANCER DRUG TAR, V6, P519, DOI 10.2174/156800906778194603; Ferreon ACM, 2004, BIOCHEMISTRY-US, V43, P13357, DOI 10.1021/bi048666j; Halim Adyani Azizah Abd, 2013, Biosci Biotechnol Biochem, V77, P87; He HW, 2007, INT J BIOCHEM CELL B, V39, P1816, DOI 10.1016/j.biocel.2007.04.028; He HW, 2005, BIOPHYS J, V89, P2650, DOI 10.1529/biophysj.105.066142; Hendriks WJAJ, 2008, FEBS J, V275, P816, DOI 10.1111/j.1742-4658.2008.06249.x; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Inouye K, 2000, J BIOCHEM-TOKYO, V128, P363, DOI 10.1093/oxfordjournals.jbchem.a022762; Inui T, 2003, J BIOL CHEM, V278, P2845, DOI 10.1074/jbc.M209934200; Jana S, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1230, DOI 10.1134/S0006297906110083; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kuby SA, 1991, STUDY ENZYMES, V1, P20; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MAYR LM, 1993, BIOCHEMISTRY-US, V32, P7994, DOI 10.1021/bi00082a021; MITCHINSON C, 1985, J MOL BIOL, V184, P331, DOI 10.1016/0022-2836(85)90384-5; Mok YK, 1999, J MOL BIOL, V289, P619, DOI 10.1006/jmbi.1999.2769; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; Mustelin T, 2006, ADV EXP MED BIOL, V584, P53; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551; Povarova OI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015035; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shortle DR, 1996, CURR OPIN STRUC BIOL, V6, P24, DOI 10.1016/S0959-440X(96)80091-1; Smith JS, 1996, BIOCHEMISTRY-US, V35, P7292, DOI 10.1021/bi960341i; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Tabernero L, 1999, BIOCHEMISTRY-US, V38, P11651, DOI 10.1021/bi990381x; TONKS NK, 1988, J BIOL CHEM, V263, P6722; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Vassilenko KS, 2002, BBA-PROTEIN STRUCT M, V1594, P168, DOI 10.1016/S0167-4838(01)00303-X; Wang GF, 2000, INT J BIOCHEM CELL B, V32, P873, DOI 10.1016/S1357-2725(00)00027-3; Wang WQ, 2003, CURR TOP MED CHEM, V3, P739, DOI 10.2174/1568026033452302; Wang YJ, 2009, ACTA BIOCH BIOPH SIN, V41, P689, DOI 10.1093/abbs/gmp057; WONG KP, 1973, J BIOL CHEM, V248, P8518; Xie J, 2007, BIOORGAN MED CHEM, V15, P458, DOI 10.1016/j.bmc.2006.09.036; YAO M, 1995, BIOCHEMISTRY-US, V34, P3771, DOI 10.1021/bi00011a035; Zhang M, 1997, BIOCHEMISTRY-US, V36, P15, DOI 10.1021/bi961804n; ZHANG ZY, 1991, J BIOL CHEM, V266, P1516	51	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107932	10.1371/journal.pone.0107932	http://dx.doi.org/10.1371/journal.pone.0107932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255086	Green Submitted, Green Published, gold			2022-12-27	WOS:000344862300044
J	Antonissen, G; Van Immerseel, F; Pasmans, F; Ducatelle, R; Haesebrouck, F; Timbermont, L; Verlinden, M; Janssens, GPJ; Eeckhaut, V; Eeckhout, M; De Saeger, S; Hessenberger, S; Martel, A; Croubels, S				Antonissen, Gunther; Van Immerseel, Filip; Pasmans, Frank; Ducatelle, Richard; Haesebrouck, Freddy; Timbermont, Leen; Verlinden, Marc; Janssens, Geert Paul Jules; Eeckhaut, Venessa; Eeckhout, Mia; De Saeger, Sarah; Hessenberger, Sabine; Martel, An; Croubels, Siska			The Mycotoxin Deoxynivalenol Predisposes for the Development of Clostridium perfringens-Induced Necrotic Enteritis in Broiler Chickens	PLOS ONE			English	Article							TOXIN; GUT; PERFORMANCE; ABSORPTION; PARAMETERS; EPITHELIUM; POULTRY; MODEL; NETB	Both mycotoxin contamination of feed and Clostridium perfringens-induced necrotic enteritis have an increasing global economic impact on poultry production. Especially the Fusarium mycotoxin deoxynivalenol (DON) is a common feed contaminant. This study aimed at examining the predisposing effect of DON on the development of necrotic enteritis in broiler chickens. An experimental Clostridium perfringens infection study revealed that DON, at a contamination level of 3,000 to 4,000 mu g/kg feed, increased the percentage of birds with subclinical necrotic enteritis from 20 +/- 2.6% to 47 +/- 3.0% (P<0.001). DON significantly reduced the transepithelial electrical resistance in duodenal segments (P<0.001) and decreased duodenal villus height (P = 0.014) indicating intestinal barrier disruption and intestinal epithelial damage, respectively. This may lead to an increased permeability of the intestinal epithelium and decreased absorption of dietary proteins. Protein analysis of duodenal content indeed showed that DON contamination resulted in a significant increase in total protein concentration (P = 0.023). Furthermore, DON had no effect on in vitro growth, alpha toxin production and netB toxin transcription of Clostridium perfringens. In conclusion, feed contamination with DON at concentrations below the European maximum guidance level of 5,000 mu g/kg feed, is a predisposing factor for the development of necrotic enteritis in broilers. These results are associated with a negative effect of DON on the intestinal barrier function and increased intestinal protein availability, which may stimulate growth and toxin production of Clostridium perfringens.	[Antonissen, Gunther; Van Immerseel, Filip; Pasmans, Frank; Ducatelle, Richard; Haesebrouck, Freddy; Timbermont, Leen; Verlinden, Marc; Eeckhaut, Venessa; Martel, An] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Antonissen, Gunther; Croubels, Siska] Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium; [Janssens, Geert Paul Jules] Univ Ghent, Fac Vet Med, Dept Nutr Genet & Ethol, Merelbeke, Belgium; [Eeckhout, Mia] Univ Ghent, Fac Biosci Engn, Dept Appl Biosci, B-9000 Ghent, Belgium; [De Saeger, Sarah] Univ Ghent, Fac Pharmaceut Sci, Dept Bioanal, B-9000 Ghent, Belgium; [Hessenberger, Sabine] Biomin Res Ctr, Tulln, Austria	Ghent University; Ghent University; Ghent University; Ghent University; Ghent University	Antonissen, G (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	Gunther.Antonissen@UGent.be	Janssens, Geert/C-2264-2008; Van Immerseel, Filip/K-3701-2014; Haesebrouck, Freddy/M-3857-2014; Pasmans, Frank/D-3667-2014	Van Immerseel, Filip/0000-0003-0455-3350; Haesebrouck, Freddy/0000-0002-1709-933X; Croubels, Siska/0000-0001-6357-3517; Antonissen, Gunther/0000-0001-8832-1498	Biomin GmbH, Herzogenburg, Austria	Biomin GmbH, Herzogenburg, Austria	This work received the financial support from Biomin GmbH, Herzogenburg, Austria. Co-author Sabine Hessenberger is employed by Biomin GmbH. The funder provided support in the form of salary for author Sabine Hessenberger and provided the deoxynivalenol for in vivo experiments for free, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ALTPETER F, 1994, APPL MICROBIOL BIOT, V41, P384, DOI [10.1007/s002530050161, 10.1007/BF00212246]; Applegate TJ, 2009, POULTRY SCI, V88, P1235, DOI 10.3382/ps.2008-00494; Avantaggiato G, 2004, FOOD CHEM TOXICOL, V42, P817, DOI 10.1016/j.fct.2004.01.004; Awad WA, 2008, J ANIM PHYSIOL AN N, V92, P225, DOI 10.1111/j.1439-0396.2007.00709.x; Awad W. A., 2008, International Journal of Poultry Science, V7, P827; Awad WA, 2006, J ANIM PHYSIOL AN N, V90, P32, DOI 10.1111/j.1439-0396.2005.00616.x; Awad WA, 2005, POULTRY SCI, V84, P928, DOI 10.1093/ps/84.6.928; Barbara AJ, 2008, VET MICROBIOL, V126, P377, DOI 10.1016/j.vetmic.2007.07.019; Bouhet S, 2005, VET IMMUNOL IMMUNOP, V108, P199, DOI 10.1016/j.vetimm.2005.08.010; BOYD MJ, 1948, J BIOL CHEM, V174, P1013; Cheung JK, 2010, INFECT IMMUN, V78, P3064, DOI 10.1128/IAI.00123-10; Collier CT, 2008, VET IMMUNOL IMMUNOP, V122, P104, DOI 10.1016/j.vetimm.2007.10.014; Cooper KK, 2009, ANAEROBE, V15, P55, DOI 10.1016/j.anaerobe.2009.01.006; Craven SE, 2000, POULTRY SCI, V79, P843, DOI 10.1093/ps/79.6.843; Craven SE, 2001, AVIAN DIS, V45, P887, DOI 10.2307/1592868; Danicke S., 2001, Proceedings of the Society of Nutrition Physiology, V10, P171; Dietrich B, 2012, ANIMAL, V6, P278, DOI 10.1017/S1751731111001601; European Commission, 2006, OFF J EUR UNION L, VL229, P7; FUCHS AR, 1957, J GEN MICROBIOL, V16, P317, DOI 10.1099/00221287-16-2-317; Gholamiandehkordi AR, 2007, AVIAN PATHOL, V36, P375, DOI 10.1080/03079450701589118; Gholamiandekhordi AR, 2006, VET MICROBIOL, V113, P143, DOI 10.1016/j.vetmic.2005.10.023; Girish CK, 2008, POULTRY SCI, V87, P421, DOI 10.3382/ps.2007-00181; Grenier B, 2013, TOXINS, V5, P396, DOI 10.3390/toxins5020396; JOHNSON J, 1970, EXP PARASITOL, V28, P30, DOI 10.1016/0014-4894(70)90063-9; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Keyburn AL, 2006, INFECT IMMUN, V74, P6496, DOI 10.1128/IAI.00806-06; Lee KW, 2011, POULTRY SCI, V90, P1381, DOI 10.3382/ps.2010-01319; Maresca M, 2002, J NUTR, V132, P2723, DOI 10.1093/jn/132.9.2723; McReynolds JL, 2004, POULTRY SCI, V83, P1948, DOI 10.1093/ps/83.12.1948; Monbaliu S, 2010, J AGR FOOD CHEM, V58, P66, DOI 10.1021/jf903859z; Neirinckx E, 2011, J VET PHARMACOL THER, V34, P290, DOI 10.1111/j.1365-2885.2010.01218.x; Osselaere A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069014; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; Pinton P, 2009, TOXICOL APPL PHARM, V237, P41, DOI 10.1016/j.taap.2009.03.003; Rodrigues I, 2012, TOXINS, V4, P663, DOI 10.3390/toxins4090663; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Sluis W. van der, 2000, World Poultry, V16, P42; Timbermont L, 2011, AVIAN PATHOL, V40, P341, DOI 10.1080/03079457.2011.590967; Timbermont L, 2009, COMP IMMUNOL MICROB, V32, P503, DOI 10.1016/j.cimid.2008.07.001; Uni Z, 1998, J COMP PHYSIOL B, V168, P241, DOI 10.1007/s003600050142; Van der Sluis W., 2000, WORLD POULTRY SCI J, V16, P56; Van Immerseel F, 2004, AVIAN PATHOL, V33, P537, DOI 10.1080/03079450400013162; Vandenbroucke V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023871; Williams RB, 2005, AVIAN PATHOL, V34, P159, DOI 10.1080/03079450500112195	44	53	54	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108775	10.1371/journal.pone.0108775	http://dx.doi.org/10.1371/journal.pone.0108775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268498	gold, Green Submitted, Green Published			2022-12-27	WOS:000343671700161
J	Archetti, M				Archetti, Marco			Stable Heterogeneity for the Production of Diffusible Factors in Cell Populations	PLOS ONE			English	Article							PUBLIC-GOODS; COOPERATION; EVOLUTION; DYNAMICS; GAME	The production of diffusible molecules that promote survival and growth is common in bacterial and eukaryotic cell populations, and can be considered a form of cooperation between cells. While evolutionary game theory shows that producers and non-producers can coexist in well-mixed populations, there is no consensus on the possibility of a stable polymorphism in spatially structured populations where the effect of the diffusible molecule extends beyond one-step neighbours. I study the dynamics of biological public goods using an evolutionary game on a lattice, taking into account two assumptions that have not been considered simultaneously in existing models: that the benefit of the diffusible molecule is a non-linear function of its concentration, and that the molecule diffuses according to a decreasing gradient. Stable coexistence of producers and non-producers is observed when the benefit of the molecule is a sigmoid function of its concentration, while strictly diminishing returns lead to coexistence only for very specific parameters and linear benefits never lead to coexistence. The shape of the diffusion gradient is largely irrelevant and can be approximated by a step function. Since the effect of a biological molecule is generally a sigmoid function of its concentration (as described by the Hill equation), linear benefits or strictly diminishing returns are not an appropriate approximations for the study of biological public goods. A stable polymorphism of producers and non-producers is in line with the predictions of evolutionary game theory and likely to be common in cell populations.	Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Archetti, M (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	m.archetti@uea.ac.uk			Natural Environment Research Council [NE/H015701/1]; Natural Environment Research Council [NE/H015701/2] Funding Source: researchfish; NERC [NE/H015701/1, NE/H015701/2] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council grant NE/H015701/1 (www.nerc.ac.uk). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2013, ELIFE, V2, DOI 10.7554/eLife.01169; Antal T, 2006, B MATH BIOL, V68, P1923, DOI 10.1007/s11538-006-9061-4; Archetti M, 2013, EVOL APPL, V6, P1146, DOI 10.1111/eva.12092; Archetti M, 2012, J THEOR BIOL, V299, P9, DOI 10.1016/j.jtbi.2011.06.018; Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Borenstein DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063304; Chuang JS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.57; Cornish-Bowden A., 2012, FUNDAMENTALS ENZYME; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Frank SA, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-31; Grafen A, 2008, J THEOR BIOL, V252, P694, DOI 10.1016/j.jtbi.2008.01.021; Greig D, 2004, P ROY SOC B-BIOL SCI, V271, pS25, DOI 10.1098/rsbl.2003.0083; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hill AV, 1910, P PHYSL SOC; Ifti M, 2004, J THEOR BIOL, V231, P97, DOI 10.1016/j.jtbi.2004.06.003; Jourdan M, 2005, EUR CYTOKINE NETW, V16, P57; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; Ohtsuki H, 2007, J THEOR BIOL, V246, P681, DOI 10.1016/j.jtbi.2007.01.024; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Scheuring I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100769; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wang Y, 2010, J BACTERIOL, V192, P365, DOI 10.1128/JB.01188-09; Zhang Q, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130031	26	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108526	10.1371/journal.pone.0108526	http://dx.doi.org/10.1371/journal.pone.0108526			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268125	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700108
J	Michaelis, M; Selt, F; Rothweiler, F; Loschmann, N; Nusse, B; Dirks, WG; Zehner, R; Cinatl, J				Michaelis, Martin; Selt, Florian; Rothweiler, Florian; Loeschmann, Nadine; Nuesse, Benedikt; Dirks, Wilhelm G.; Zehner, Richard; Cinatl, Jindrich, Jr.			Aurora Kinases as Targets in Drug-Resistant Neuroblastoma Cells	PLOS ONE			English	Article							INHIBITOR MLN8237; MULTIDRUG-RESISTANCE; RADIATION RESPONSE; CANCER-CELLS; TUMOR-GROWTH; APOPTOSIS; DEATH; PROLIFERATION; COMBINATION; ENHANCEMENT	Aurora kinase inhibitors displayed activity in pre-clinical neuroblastoma models. Here, we studied the effects of the panaurora kinase inhibitor tozasertib (VX680, MK-0457) and the aurora kinase inhibitor alisertib (MLN8237) that shows some specificity for aurora kinase A over aurora kinase B in a panel of neuroblastoma cell lines with acquired drug resistance. Both compounds displayed anti-neuroblastoma activity in the nanomolar range. The anti-neuroblastoma mechanism included inhibition of aurora kinase signalling as indicated by decreased phosphorylation of the aurora kinase substrate histone H3, cell cycle inhibition in G2/M phase, and induction of apoptosis. The activity of alisertib but not of tozasertib was affected by ABCB1 expression. Aurora kinase inhibitors induced a p53 response and their activity was enhanced in combination with the MDM2 inhibitor and p53 activator nutlin-3 in p53 wild-type cells. In conclusion, aurora kinases are potential drug targets in therapy-refractory neuroblastoma, in particular for the vast majority of p53 wild-type cases.	[Michaelis, Martin; Selt, Florian; Rothweiler, Florian; Loeschmann, Nadine; Nuesse, Benedikt; Cinatl, Jindrich, Jr.] Klinikum Goethe Univ, Inst Med Virol, Frankfurt, Germany; [Michaelis, Martin] Univ Kent, Ctr Mol Proc, Canterbury, Kent, England; [Michaelis, Martin] Univ Kent, Sch Biosci, Canterbury, Kent, England; [Dirks, Wilhelm G.] Leibniz Inst Deutsch Sammlung Mikroorganisme & Ze, Braunschweig, Germany; [Zehner, Richard] Klinikum Goethe Univ, Inst Rechtsmed, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Kent; University of Kent; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Cinatl, J (corresponding author), Klinikum Goethe Univ, Inst Med Virol, Frankfurt, Germany.	Cinatl@em.uni-frankfurt.de	z, r/ABA-2962-2021	Dirks, Wilhelm/0000-0001-9781-0998; Michaelis, Martin/0000-0002-5710-5888	Frankfurter Stiftung fur krebskranke Kinder; Kent Cancer Trust	Frankfurter Stiftung fur krebskranke Kinder; Kent Cancer Trust	MM and JC were supported by Frankfurter Stiftung fur krebskranke Kinder (www.kinderkrebs-frankfurt.de) and Frankfurter Stiftung fur krebskranke Kinder (www.kinderkrebsstiftung-frankfurt.de). MM was also supported by Kent Cancer Trust (www.kentcancertrust.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Brockmann M, 2013, CANCER CELL, V24, P75, DOI 10.1016/j.ccr.2013.05.005; Carol H, 2011, CANCER CHEMOTH PHARM, V68, P1291, DOI 10.1007/s00280-011-1618-8; Carr-Wilkinson J, 2010, CLIN CANCER RES, V16, P1108, DOI 10.1158/1078-0432.CCR-09-1865; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Chen LD, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00173; Cheok CF, 2010, CELL DEATH DIFFER, V17, P1486, DOI 10.1038/cdd.2010.18; Cinatl Jr J, BIOCH SOC T IN PRESS; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Dar AA, 2008, CANCER RES, V68, P8998, DOI 10.1158/0008-5472.CAN-08-2658; Donato NJ, 2010, BIOCHEM PHARMACOL, V79, P688, DOI 10.1016/j.bcp.2009.10.009; Faisal A, 2011, MOL CANCER THER, V10, P2115, DOI 10.1158/1535-7163.MCT-11-0333; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Guo J, 2009, PHARMACOGENOMICS J, V9, P90, DOI 10.1038/tpj.2008.20; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Horwacik I, 2013, CANCER LETT, V341, P248, DOI 10.1016/j.canlet.2013.08.018; Ikezoe T, 2010, INT J HEMATOL, V91, P69, DOI 10.1007/s12185-009-0462-7; Inandiklioglu N, 2012, ASIAN PAC J CANCER P, V13, P5391, DOI 10.7314/APJCP.2012.13.11.5391; Kaestner P, 2009, MOL CANCER THER, V8, P2046, DOI 10.1158/1535-7163.MCT-09-0323; Kalous O, 2013, BREAST CANCER RES TR, V141, P397, DOI 10.1007/s10549-013-2702-z; Kojima K, 2008, BLOOD, V112, P2886, DOI 10.1182/blood-2008-01-128611; Kollareddy M, 2012, INVEST NEW DRUG, V30, P2411, DOI 10.1007/s10637-012-9798-6; Kotchetkov R, 2005, INT J ONCOL, V27, P1029; Kotchetkov R, 2003, INT J CANCER, V104, P36, DOI 10.1002/ijc.10917; Loschmann N, 2013, TRANSL ONCOL, V6, P685, DOI 10.1593/tlo.13544; Maris JM, 2010, PEDIATR BLOOD CANCER, V55, P26, DOI 10.1002/pbc.22430; Michaelis M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.129; Michaelis M, 2014, J PHARM PHARM SCI, V17, P92, DOI 10.18433/J3BW2S; Michaelis M, 2011, CELL MOL LIFE SCI, V68, P1079, DOI 10.1007/s00018-010-0510-8; Michaelis M, 2010, BIOCHEM PHARMACOL, V79, P130, DOI 10.1016/j.bcp.2009.08.013; Michaelis M, 2009, CANCER RES, V69, P416, DOI 10.1158/0008-5472.CAN-08-1856; Morgenstern DA, 2013, J PEDIAT HEMATOL ONC, V35, P337, DOI 10.1097/MPH.0b013e318299d637; Morozova O, 2010, CLIN CANCER RES, V16, P4572, DOI 10.1158/1078-0432.CCR-10-0627; Muscal JA, 2013, INVEST NEW DRUG, V31, P39, DOI 10.1007/s10637-012-9831-9; Park JR, 2013, PEDIATR BLOOD CANCER, V60, P985, DOI 10.1002/pbc.24433; Qi WQ, 2011, BIOCHEM PHARMACOL, V81, P881, DOI 10.1016/j.bcp.2011.01.017; Romain C, 2014, J PEDIATR SURG, V49, P159, DOI 10.1016/j.jpedsurg.2013.09.051; Romain CV, 2014, ANTICANCER RES, V34, P2269; Rothweiler F, 2010, NEOPLASIA, V12, P1023, DOI 10.1593/neo.10856; Sehdev V, 2013, CANCER-AM CANCER SOC, V119, P904, DOI 10.1002/cncr.27801; Sehdev V, 2012, MOL CANCER THER, V11, P763, DOI 10.1158/1535-7163.MCT-11-0623; Shang XY, 2009, MOL CANCER THER, V8, P2461, DOI 10.1158/1535-7163.MCT-08-0857; Tao Y, 2008, ONCOGENE, V27, P3244, DOI 10.1038/sj.onc.1210990; Tao Y, 2007, BRIT J CANCER, V97, P1664, DOI 10.1038/sj.bjc.6604083; Tavanti E, 2013, BRIT J CANCER, V109, P2607, DOI 10.1038/bjc.2013.643; Weber K, 2010, GENE THER, V17, P511, DOI 10.1038/gt.2009.149; Weber K, 2012, NAT PROTOC, V7, P839, DOI 10.1038/nprot.2012.026	48	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108758	10.1371/journal.pone.0108758	http://dx.doi.org/10.1371/journal.pone.0108758			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268132	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700158
J	Mo, PKH; Mak, WWS; Chong, ESK; Shen, HY; Cheung, RYM				Mo, Phoenix Kit Han; Mak, Winnie Wing Sze; Chong, Eddie Siu Kwan; Shen, Hanyang; Cheung, Rebecca Yuen Man			The Prevalence and Factors for Cancer Screening Behavior among People with Severe Mental Illness in Hong Kong	PLOS ONE			English	Article							BREAST-CANCER; CERVICAL-CANCER; COLORECTAL-CANCER; PHYSICAL HEALTH; CHINESE WOMEN; PRIMARY-CARE; COST-EFFECTIVENESS; MORTALITY; KNOWLEDGE; MAMMOGRAPHY	Objectives: Screening is useful in reducing cancer incidence and mortality. People with severe mental illness (PSMI) are vulnerable to cancer as they are exposed to higher levels of cancer risks. Little is known about PSMI's cancer screening behavior and associated factors. The present study examined the utilization of breast, cervical, prostate, and colorectal cancer screening among PSMI in Hong Kong and to identify factors associated with their screening behaviors. Method: 591 PSMI from community mental health services completed a cross-sectional survey. Results: The percentage of cancer screening behavior among those who met the criteria for particular screening recommendation was as follows: 20.8% for mammography; 36.5% for clinical breast examination (CBE); 40.5% for pap-smear test; 12.8% for prostate examination; and 21.6% for colorectal cancer screening. Results from logistic regression analyses showed that marital status was a significant factor for mammography, CBE, and pap-smear test; belief that cancer can be healed if found early was a significant factor for pap-smear test and colorectal screening; belief that one can have cancer without having symptoms was a significant factor for CBE and pap-smear test; belief that one will have a higher risk if a family member has had cancer was a significant factor for CBE; and self-efficacy was a significant factor for CBE and pap-smear test behavior. Conclusions: Cancer screening utilization among PSMI in Hong Kong is low. Beliefs about cancer and self-efficacy are associated with cancer screening behavior. Health care professionals should improve the knowledge and remove the misconceptions about cancer among PSMI; self-efficacy should also be promoted.	[Mo, Phoenix Kit Han] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Shatin, Hong Kong, Peoples R China; [Mak, Winnie Wing Sze] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China; [Chong, Eddie Siu Kwan] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Shen, Hanyang] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Cheung, Rebecca Yuen Man] Hong Kong Inst Educ, Dept Special Educ & Counselling, Tai Po, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; University System of Maryland; University of Maryland College Park; Drexel University; Education University of Hong Kong (EdUHK)	Mak, WWS (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China.	wwsmak@psy.cuhk.edu.hk	Mak, Winnie/GNM-9841-2022; Mo, Phoenix K.H./K-2853-2013	Mak, Winnie/0000-0002-9714-7847; Mo, Phoenix K.H./0000-0001-9822-5424; CHEUNG, Rebecca Y. M./0000-0003-0998-7991; Shen, Hanyang/0000-0003-3273-9777; Chong, Eddie/0000-0002-9601-4372	Hong Kong Health and Health Services Research Fund [07080161]	Hong Kong Health and Health Services Research Fund	This work was supported by the Hong Kong Health and Health Services Research Fund (grant number: 07080161). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah ASM, 2001, PUBLIC HEALTH, V115, P212, DOI 10.1016/S0033-3506(01)00446-2; Adab P., 1997, Hong Kong Medical Journal, V3, P427; American Cancer Society, 2012, AM CANC SOC GUID EAR; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Bartsch G, 2001, UROLOGY, V58, P417, DOI 10.1016/S0090-4295(01)01264-X; Bengtsson-Tops A, 1999, SOC PSYCH PSYCH EPID, V34, P513, DOI 10.1007/s001270050169; Blanks RG, 2000, BRIT MED J, V321, P665, DOI 10.1136/bmj.321.7262.665; Breen N, 2001, J NATL CANCER I, V93, P1704, DOI 10.1093/jnci/93.22.1704; Brown S, 1999, PSYCHOL MED, V29, P697, DOI 10.1017/S0033291798008186; Bushe CJ, 2009, SCHIZOPHR RES, V114, P6, DOI 10.1016/j.schres.2009.07.012; Cappell MS, 2008, GASTROENTEROL CLIN N, V37, P129, DOI 10.1016/j.gtc.2007.12.003; Chua MST, 2005, BREAST J, V11, P52, DOI 10.1111/j.1075-122X.2005.21480.x; Gor BJ, 2008, J IMMIGR MINOR HEALT, V10, P373, DOI 10.1007/s10903-007-9090-6; Halbreich U, 2003, PSYCHONEUROENDOCRINO, V28, P53, DOI 10.1016/S0306-4530(02)00112-9; Happell B, 2012, ARCH PSYCHIAT NURS, V26, P192, DOI 10.1016/j.apnu.2011.09.002; Hardy S, 2010, INT J MENT HEALTH NU, V19, P350, DOI 10.1111/j.1447-0349.2010.00686.x; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Hippisley-Cox J, 2007, ARCH GEN PSYCHIAT, V64, P1368, DOI 10.1001/archpsyc.64.12.1368; Hogenmiller JR, 2007, NURS RES, V56, P369, DOI 10.1097/01.NNR.0000299848.21935.8d; Hong Kong Cancer Registry, 2011, SUMM CANC STAT HONG; Kahn LS, 2005, WOMEN HEALTH, V42, P111, DOI 10.1300/J013v42n03_07; Kim JJ, 2004, J PUBLIC HEALTH-UK, V26, P130, DOI 10.1093/pubmed/fdh138; Kwok C, 2012, EUR J ONCOL NURS, V16, P247, DOI 10.1016/j.ejon.2011.06.003; Kwok C, 2014, CANCER NURS, V37, P59, DOI 10.1097/NCC.0b013e31827f0a9d; Leung GM, 2002, BRIT J CANCER, V87, P982, DOI 10.1038/sj.bjc.6600583; Lev E L, 1997, Sch Inq Nurs Pract, V11, P21; Liang WC, 2004, ETHNIC HEALTH, V9, P283, DOI 10.1080/1355785042000250111; Libby G, 2012, BRIT J CANCER, V107, P255, DOI 10.1038/bjc.2012.277; Ma GX, 2012, AM J HEALTH BEHAV, V36, P495, DOI 10.5993/AJHB.36.4.6; Ma GX, 2009, AM J HEALTH BEHAV, V33, P650; McGinty EE, 2012, PSYCHIAT SERV, V63, P714, DOI 10.1176/appi.ps.201100169; McKinley JM, 2007, HERED CANCER CLIN PR, V5, P161, DOI 10.1186/1897-4287-5-3-161; Miller E, 2007, ARCH WOMEN MENT HLTH, V10, P189, DOI 10.1007/s00737-007-0198-4; Osborn DPJ, 2007, SOC PSYCH PSYCH EPID, V42, P787, DOI 10.1007/s00127-007-0247-3; Pandiani JA, 2006, PSYCHIAT SERV, V57, P1032, DOI 10.1176/appi.ps.57.7.1032; Phelan M, 2001, BRIT MED J, V322, P443, DOI 10.1136/bmj.322.7284.443; Robson D, 2007, INT J NURS STUD, V44, P457, DOI 10.1016/j.ijnurstu.2006.07.013; Scott David, 2011, Issues Ment Health Nurs, V32, P589, DOI 10.3109/01612840.2011.569846; Sigurdsson K, 1999, ACTA OBSTET GYN SCAN, V78, P478, DOI 10.1034/j.1600-0412.1999.780602.x; Sung JJY, 2008, AM J GASTROENTEROL, V103, P974, DOI 10.1111/j.1572-0241.2007.01649.x; Tam Tammy K. W., 2011, Hong Kong Medical Journal, V17, P350; Tang TS, 2000, PREV MED, V31, P575, DOI 10.1006/pmed.2000.0753; Thakkar PB, 2011, PSYCHIATR BULL, V35, P30, DOI 10.1192/pb.35.1.30a; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Tilbrook D, 2010, CAN FAM PHYSICIAN, V56, P358; Tu SP, 2003, CANCER, V97, P1293, DOI 10.1002/cncr.11169; Twinn S, 2002, CANCER NURS, V25, P377, DOI 10.1097/00002820-200210000-00007; Wong BCY, 2006, J GASTROEN HEPATOL, V21, P41, DOI 10.1111/j.1440-1746.2005.04000.x; Wong IOL, 2007, CANCER-AM CANCER SOC, V110, P885, DOI 10.1002/cncr.22848; Xiong GL, 2008, PSYCHIAT SERV, V59, P929, DOI 10.1176/ps.2008.59.8.929; Yee EFT, 2011, WOMEN HEALTH ISS, V21, pS195, DOI 10.1016/j.whi.2011.04.027	52	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107237	10.1371/journal.pone.0107237	http://dx.doi.org/10.1371/journal.pone.0107237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268752	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700033
J	Tejedor, MT; Garcia-Sobreviela, MP; Ledesma, M; Arbones-Mainar, JM				Teresa Tejedor, M.; Pilar Garcia-Sobreviela, Maria; Ledesma, Marta; Arbones-Mainar, Jose M.			The Apolipoprotein E Polymorphism rs7412 Associates with Body Fatness Independently of Plasma Lipids in Middle Aged Men	PLOS ONE			English	Article							DIET-INDUCED OBESITY; GENE POLYMORPHISM; POPULATION; EXPRESSION; ADIPOCYTES; MODULATION; ADIPOSITY; DISEASE; HEALTH; FAMILY	Background: The apolipoprotein E (APOE) gene is polymorphic, encoding one of 3 common alleles (epsilon 2, epsilon 3, epsilon 4) produced from combinations of 2 non-synonymous SNPs (rs429358 and rs7412). APOE plays an important role controlling plasma lipids but its association with adipocyte functionality and body fatness remains to be determined. Methods: We analyzed fasting plasma lipids and genotyped the two main APOE-SNPs (rs429358 and rs7412), both located in the fourth exon of the APOE, in 4660 Caucasian middle-aged men free of cardiovascular disease. Results: The rs7412 SNP, which determines the APOE2 isoform, was significantly associated with Body Mass Index (BMI) and Waist Girth (WG) in a multivariate model accounting for age, smoking status and plasma lipids. BMI and WG were highest in TT homozygotes and lowest in CC homozygotes. This effect was independent of the rs429358 SNP, which failed to show any association with the BMI and WG variables. The odds ratio of being obese (BMI. 30) for individuals carrying the APO epsilon 2 allele, present in 14% of the cohort and defined by the rs7412 SNP, was also significant in this multivariate model, with an OR of 1.27 (95% CI: 1.01-1.59). Conclusions: This study provides an evidence of a lipid-independent association between the APOE SNP rs7412 and body fatness surrogates, BMI and WG, in a large cohort of middle-aged males.	[Teresa Tejedor, M.] Univ Zaragoza, Dept Anat Embriol & Genet, Zaragoza, Spain; [Pilar Garcia-Sobreviela, Maria; Arbones-Mainar, Jose M.] Hosp Univ Miguel Servet, Inst Aragones Ciencias Salud, Unidad Invest Traslac, Adipocyte & Fat Biol Lab AdipoFat, Zaragoza, Spain; [Ledesma, Marta] Inst Aragones Ciencias Salud, Unidad Prevenc Cardiovasc, Zaragoza, Spain; [Arbones-Mainar, Jose M.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROb, Madrid, Spain	University of Zaragoza; Miguel Servet University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Arbones-Mainar, JM (corresponding author), Hosp Univ Miguel Servet, Inst Aragones Ciencias Salud, Unidad Invest Traslac, Adipocyte & Fat Biol Lab AdipoFat, Zaragoza, Spain.	jmarbones.iacs@aragon.es	Hernández, M. Teresa Tejedor/H-6582-2019; Arbones-Mainar, Jose M/AGL-8624-2022; Garcia-Sobreviela, Maria Pilar/AHD-2939-2022	Hernández, M. Teresa Tejedor/0000-0001-5026-5144; Arbones-Mainar, Jose M/0000-0002-8982-3737; Garcia-Sobreviela, Maria Pilar/0000-0001-5485-8983	Miguel Servet program from the Instituto de Salud Carlos III (Spain); Marie-Curie Action APOMET; European Commission	Miguel Servet program from the Instituto de Salud Carlos III (Spain); Marie-Curie Action APOMET; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Miguel Servet program from the Instituto de Salud Carlos III (Spain) and by the Marie-Curie Action APOMET from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvim RO, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-128; Arbones-Mainar JM, 2008, INT J OBESITY, V32, P1595, DOI 10.1038/ijo.2008.143; Casasnovas JA, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-45; DALLONGEVILLE J, 1992, J LIPID RES, V33, P447; DONAHUE RP, 1985, AM J EPIDEMIOL, V122, P458, DOI 10.1093/oxfordjournals.aje.a114127; Duman BS, 2004, DIABETES NUTR METAB, V17, P267; Ellis JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026679; Feitosa MF, 2006, ATHEROSCLEROSIS, V185, P426, DOI 10.1016/j.atherosclerosis.2005.06.023; Gottlieb DJ, 2004, NEUROLOGY, V63, P664, DOI 10.1212/01.WNL.0000134671.99649.32; Guerra A, 2003, ANN NUTR METAB, V47, P49, DOI 10.1159/000069275; Guo YF, 2006, J CLIN ENDOCR METAB, V91, P4001, DOI 10.1210/jc.2006-0549; Huang ZH, 2011, J LIPID RES, V52, P1733, DOI 10.1194/jlr.M017160; Huang ZH, 2006, DIABETES, V55, P3394, DOI 10.2337/db06-0354; Izaks GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027415; Kuhel DG, 2013, DIABETES, V62, P382, DOI 10.2337/db12-0390; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; Mannila MN, 2013, ARTERIOSCL THROM VAS, V33, P1063, DOI 10.1161/ATVBAHA.112.300353; Oh JY, 2001, CLIN GENET, V60, P132, DOI 10.1034/j.1399-0004.2001.600207.x; Petkeviciene J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041525; Saar K, 2003, PEDIATRICS, V111, P321, DOI 10.1542/peds.111.2.321; UTERMANN G, 1979, CLIN GENET, V15, P63; Volcik KA, 2006, AM J EPIDEMIOL, V164, P342, DOI 10.1093/aje/kwj202; Vucinic N, 2014, MOL BIOL REP, V41, P5221, DOI 10.1007/s11033-014-3390-4; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; ZECHNER R, 1991, J BIOL CHEM, V266, P10583; Zeljko HM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-9	26	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108605	10.1371/journal.pone.0108605	http://dx.doi.org/10.1371/journal.pone.0108605			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268647	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700122
J	Bourdel-Marchasson, I; Blanc-Bisson, C; Doussau, A; Germain, C; Blanc, JF; Dauba, J; Lahmar, C; Terrebonne, E; Lecaille, C; Ceccaldi, J; Cany, L; Lavau-Denes, S; Houede, N; Chomy, F; Durrieu, J; Soubeyran, P; Senesse, P; Chene, G; Fonck, M				Bourdel-Marchasson, Isabelle; Blanc-Bisson, Christelle; Doussau, Adelaide; Germain, Christine; Blanc, Jean-Frederic; Dauba, Jerome; Lahmar, Cyril; Terrebonne, Eric; Lecaille, Cedric; Ceccaldi, Joel; Cany, Laurent; Lavau-Denes, Sandrine; Houede, Nadine; Chomy, Francois; Durrieu, Jessica; Soubeyran, Pierre; Senesse, Pierre; Chene, Genevieve; Fonck, Mariane			Nutritional Advice in Older Patients at Risk of Malnutrition during Treatment for Chemotherapy: A Two-Year Randomized Controlled Trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; CANCER-PATIENTS; WEIGHT-LOSS; COLORECTAL-CANCER; DIETARY-INTAKE; SUPPORT; INTERVENTION; CACHEXIA; THERAPY; IMPACT	Objective: We tested the effect of dietary advice dedicated to increase intake in older patients at risk for malnutrition during chemotherapy, versus usual care, on one-year mortality. Method: We conducted a multicentre, open-label interventional, stratified (centre), parallel randomised controlled trial, with a 1: 1 ratio, with two-year follow-up. Patients were aged 70 years or older treated with chemotherapy for solid tumour and at risk of malnutrition (MNA, Mini Nutritional Assessment 17-23.5). Intervention consisted of diet counselling with the aim of achieving an energy intake of 30 kCal/kg body weight/d and 1.2 g protein/kg/d, by face-to-face discussion targeting the main nutritional symptoms, compared to usual care. Interviews were performed 6 times during the chemotherapy sessions for 3 to 6 months. The primary endpoint was 1-year mortality and secondary endpoints were 2-year mortality, toxicities and chemotherapy outcomes. Results: Between April 2007 and March 2010 we randomised 341 patients and 336 were analysed: mean (standard deviation) age of 78.0 y (4.9), 51.2% male, mean MNA 20.2 (2.1). Distribution of cancer types was similar in the two groups; the most frequent were colon (22.4%), lymphoma (14.9%), lung (10.4%), and pancreas (17.0%). Both groups increased their dietary intake, but to a larger extent with intervention (p<0.01). At the second visit, the energy target was achieved in 57 (40.4%) patients and the protein target in 66 (46.8%) with the intervention compared respectively to 13 (13.5%) and 20 (20.8%) in the controls. Death occurred during the first year in 143 patients (42.56%), without difference according to the intervention (p = 0.79). No difference in nutritional status changes was found. Response to chemotherapy was also similar between the groups. Conclusion: Early dietary counselling was efficient in increasing intake but had no beneficial effect on mortality or secondary outcomes. Cancer cachexia antianabolism may explain this lack of effect.	[Bourdel-Marchasson, Isabelle; Blanc-Bisson, Christelle; Durrieu, Jessica] CHU Bordeaux, Bordeaux, France; [Bourdel-Marchasson, Isabelle] CNRS, RMSB, UMR 5536, Bordeaux, France; [Bourdel-Marchasson, Isabelle] Univ Bordeaux, RMSB, UMR 5536, Bordeaux, France; [Doussau, Adelaide; Germain, Christine; Chene, Genevieve] CHU Bordeaux, Unite Epidemiol Clin, Bordeaux, France; [Doussau, Adelaide; Chene, Genevieve] INSERM, CIC EC7, Bordeaux, France; [Blanc, Jean-Frederic] CHU Bordeaux, Bordeaux, France; [Blanc, Jean-Frederic; Soubeyran, Pierre] Univ Bordeaux, Bordeaux, France; [Dauba, Jerome; Lahmar, Cyril] Ctr Hosp Layne Mt de Marsan, Mt De Marsan, France; [Terrebonne, Eric] CHU Bordeaux, Serv Hepatoastro & Oncol Digest, Bordeaux, France; [Lecaille, Cedric] Polyclin Bordeaux Nord, Serv Hepato Gastroenterol, Bordeaux, France; [Ceccaldi, Joel] Ctr Hosp Libourne, Libourne, France; [Cany, Laurent] Clin Francheville, Perigueux, France; [Lavau-Denes, Sandrine] CHU Limoges, Unite Rech Clin Oncol Med, Limoges, France; [Houede, Nadine; Chomy, Francois; Soubeyran, Pierre; Fonck, Mariane] Inst Bergonie, Dept Oncol Med, Bordeaux, France; [Senesse, Pierre] Univ Montpellier I, Montpellier, France; [Senesse, Pierre] Univ Montpellier 3, Lab Epsylon EA 4556, F-34032 Montpellier, France; [Senesse, Pierre] CLCC Val dAurelle, Unite Nutr Clin & Gastroenterol, Montpellier, France	CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Limoges; UNICANCER; Institut Bergonie; Universite de Montpellier; Universite de Montpellier; Universite Paul-Valery; Universite de Montpellier	Bourdel-Marchasson, I (corresponding author), CHU Bordeaux, Bordeaux, France.	isabelle.bourdel-marchasson@chu-bordeaux.fr	Soubeyran, Pierre-Louis/F-4523-2012; chene, genevieve/H-8665-2014	Soubeyran, Pierre-Louis/0000-0003-3244-7299; chene, genevieve/0000-0002-8368-6460; doussau, adelaide/0000-0003-2622-5948; Lavau-Denes, Sandrine/0000-0003-4760-1981; blanc-bisson, christelle/0000-0001-7982-8801; Senesse, Pierre/0000-0003-3542-2898	National Hospital Program of Clinical Research (Programme Hospitalier de Recherche Clinique); La Ligue contre le cancer; AMGEN; university hospital of Bordeaux (CHU Bordeaux)	National Hospital Program of Clinical Research (Programme Hospitalier de Recherche Clinique); La Ligue contre le cancer(Ligue nationale contre le cancer); AMGEN(Amgen); university hospital of Bordeaux (CHU Bordeaux)	This work was supported by the National Hospital Program of Clinical Research (Programme Hospitalier de Recherche Clinique 2006) (46%), La Ligue contre le cancer (52%) and AMGEN (2%) and sponsored by the university hospital of Bordeaux (CHU Bordeaux). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaldriks AA, 2011, CRIT REV ONCOL HEMAT, V79, P205, DOI 10.1016/j.critrevonc.2010.05.009; Andreyev HJN, 1998, EUR J CANCER, V34, P503, DOI 10.1016/S0959-8049(97)10090-9; Arends J, 2006, CLIN NUTR, V25, P245, DOI 10.1016/j.clnu.2006.01.020; Argiles J M, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS39, DOI 10.1016/j.ejon.2005.09.006; Baldwin C, 2011, J HUM NUTR DIET, V24, P431, DOI 10.1111/j.1365-277X.2011.01189.x; Baldwin C, 2012, JNCI-J NATL CANCER I, V104, P371, DOI 10.1093/jnci/djr556; Blanc-Bisson C, 2008, CRIT REV ONCOL HEMAT, V67, P243, DOI 10.1016/j.critrevonc.2008.04.005; Bourdel-Marchasson I, 2000, NUTRITION, V16, P1, DOI 10.1016/S0899-9007(99)00227-0; Bozzetti F, 1998, TUMORI, V84, P681, DOI 10.1177/030089169808400614; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Dobrila-Dintinjana R, 2013, HEPATO-GASTROENTEROL, V60, P475, DOI 10.5754/hge12710; Durrieu J, 2011, ONCOLOGIE, V13, P83, DOI 10.1007/s10269-011-1985-4; EVANS WK, 1987, J CLIN ONCOL, V5, P113, DOI 10.1200/JCO.1987.5.1.113; Extermann M, 2007, J CLIN ONCOL, V25, P1824, DOI 10.1200/JCO.2007.10.6559; Extermann M, 2012, CANCER-AM CANCER SOC, V118, P3377, DOI 10.1002/cncr.26646; Gioulbasanis I, 2011, LUNG CANCER, V74, P516, DOI 10.1016/j.lungcan.2011.05.009; Guigoz Y, 2002, CLIN GERIATR MED, V18, P737, DOI 10.1016/S0749-0690(02)00059-9; Isenring E, 2004, J HUM NUTR DIET, V17, P145, DOI 10.1111/j.1365-277X.2004.00502.x; Isenring EA, 2007, J AM DIET ASSOC, V107, P404, DOI 10.1016/j.jada.2006.12.007; Lenk K, 2010, J CACHEXIA SARCOPENI, V1, P9, DOI 10.1007/s13539-010-0007-1; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; OVESEN L, 1993, J CLIN ONCOL, V11, P2043, DOI 10.1200/JCO.1993.11.10.2043; Prado CM, 2013, AM J CLIN NUTR, V98, P1012, DOI 10.3945/ajcn.113.060228; Raffaghello L, 2010, CELL CYCLE, V9, P4474, DOI 10.4161/cc.9.22.13954; Ravasco P, 2005, J CLIN ONCOL, V23, P1431, DOI 10.1200/JCO.2005.02.054; Senesse P, 2008, CANCER TREAT REV, V34, P568, DOI 10.1016/j.ctrv.2008.03.003; Senesse P, 2014, DIGEST LIVER DIS, V46, P667, DOI 10.1016/j.dld.2014.01.160; Soubeyran P, 2012, J CLIN ONCOL, V30, P1829, DOI 10.1200/JCO.2011.35.7442; Uster A, 2013, NUTRITION, V29, P1342, DOI 10.1016/j.nut.2013.05.004; van den Berg MGA, 2010, BRIT J NUTR, V104, P872, DOI 10.1017/S0007114510001315; Yancik R, 2005, CANCER J, V11, P437, DOI 10.1097/00130404-200511000-00002	31	59	60	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108687	10.1371/journal.pone.0108687	http://dx.doi.org/10.1371/journal.pone.0108687			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265392	Green Submitted, Green Published, gold			2022-12-27	WOS:000345745400103
J	Chang, M; Anttonen, KP; Cirillo, SLG; Francis, KP; Cirillo, JD				Chang, MiHee; Anttonen, Katri P.; Cirillo, Suat L. G.; Francis, Kevin P.; Cirillo, Jeffrey D.			Real-Time Bioluminescence Imaging of Mixed Mycobacterial Infections	PLOS ONE			English	Article							IN-VIVO; BACTERIAL PATHOGENS; BOVIS BCG; TUBERCULOSIS; IDENTIFICATION; EXPRESSION; REPORTER; MACROPHAGE; CONSTRUCTION; REPLICATION	Molecular analysis of infectious processes in bacteria normally involves construction of isogenic mutants that can then be compared to wild type in an animal model. Pathogenesis and antimicrobial studies are complicated by variability between animals and the need to sacrifice individual animals at specific time points. Live animal imaging allows real-time analysis of infections without the need to sacrifice animals, allowing quantitative data to be collected at multiple time points in all organs simultaneously. However, imaging has not previously allowed simultaneous imaging of both mutant and wild type strains of mycobacteria in the same animal. We address this problem by using both firefly (Photinus pyralis) and click beetle (Pyrophorus plagiophthalamus) red luciferases, which emit distinct bioluminescent spectra, allowing simultaneous imaging of two different mycobacterial strains during infection. We also demonstrate that these same bioluminescence reporters can be used to evaluate therapeutic efficacy in real-time, greatly facilitating our ability to screen novel antibiotics as they are developed. Due to the slow growth rate of mycobacteria, novel imaging technologies are a pressing need, since they can they can impact the rate of development of new therapeutics as well as improving our understanding of virulence mechanisms and the evaluation of novel vaccine candidates.	[Chang, MiHee; Anttonen, Katri P.; Cirillo, Suat L. G.; Cirillo, Jeffrey D.] Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, Bryan, TX 77807 USA; [Francis, Kevin P.] PerkinElmer, Alameda, CA USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Cirillo, JD (corresponding author), Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, Bryan, TX 77807 USA.	jdcirillo@medicine.tamhsc.edu	Hamblin, Mike/AAB-2511-2022; Hamblin, Michael R/H-2758-2019; Cirillo, Jeffrey D./L-4286-2019	Hamblin, Michael R/0000-0001-6431-4605; Cirillo, Jeffrey D./0000-0003-3058-2702	Bill and Melinda Gates Foundation [48523]; National Institutes of Health [AI104960]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104960] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant 48523 from the Bill and Melinda Gates Foundation and grant AI104960 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu N, 2013, J ANTIMICROB CHEMOTH, V68, P2118, DOI 10.1093/jac/dkt155; Andreu N, 2012, J ANTIMICROB CHEMOTH, V67, P404, DOI 10.1093/jac/dkr472; Andreu N, 2011, FEMS MICROBIOL REV, V35, P360, DOI 10.1111/j.1574-6976.2010.00252.x; Andreu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010777; ANDREW PW, 1993, J CLIN MICROBIOL, V31, P2251, DOI 10.1128/JCM.31.9.2251-2254.1993; Arain TM, 1996, ANTIMICROB AGENTS CH, V40, P1536, DOI 10.1128/AAC.40.6.1536; BARLETTA RG, 1992, J GEN MICROBIOL, V138, P23, DOI 10.1099/00221287-138-1-23; Bartzatt R, 2014, BRIT J PHARM RES, V4, P1535, DOI 10.9734/BJPR/2014/10353; Branchini BR, 2010, ANAL BIOCHEM, V396, P290, DOI 10.1016/j.ab.2009.09.009; Campbell-Valois FX, 2014, FEBS LETT, V588, P2428, DOI 10.1016/j.febslet.2014.05.022; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Chang MH, 2011, JOVE-J VIS EXP, DOI 10.3791/2547; Cirillo SLG, 2000, MICROBIOL-SGM, V146, P1345, DOI 10.1099/00221287-146-6-1345; Cole ST, 2002, MICROBIOL-SGM, V148, P2919, DOI 10.1099/00221287-148-10-2919; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; COOKSEY RC, 1993, ANTIMICROB AGENTS CH, V37, P1348, DOI 10.1128/AAC.37.6.1348; Danelishvili L, 2007, P NATL ACAD SCI USA, V104, P11038, DOI 10.1073/pnas.0610746104; DIFICO MANUAL, 1984, DEHYDRATED CULTURE M, V214; Dothager RS, 2009, CURR OPIN BIOTECH, V20, P45, DOI 10.1016/j.copbio.2009.01.007; Evans TG, 2013, VACCINE, V31, pB223, DOI 10.1016/j.vaccine.2012.11.081; Foucault ML, 2010, APPL ENVIRON MICROB, V76, P264, DOI 10.1128/AEM.01686-09; FRACKMAN S, 1990, J BACTERIOL, V172, P5767, DOI 10.1128/jb.172.10.5767-5773.1990; Francis KP, 2001, INFECT IMMUN, V69, P3350, DOI 10.1128/IAI.69.5.3350-3358.2001; Hardy J, 2004, SCIENCE, V303, P851, DOI 10.1126/science.1092712; Heuts F, 2009, MICROBES INFECT, V11, P1114, DOI 10.1016/j.micinf.2009.08.005; Hickey MJ, 1996, ANTIMICROB AGENTS CH, V40, P400, DOI 10.1128/AAC.40.2.400; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; IMAEDA T, 1985, INT J SYST BACTERIOL, V35, P147, DOI 10.1099/00207713-35-2-147; Janagama HK, 2011, TUBERCULOSIS, V91, pS66, DOI 10.1016/j.tube.2011.10.013; Kapoor R, 2011, ANTIMICROB AGENTS CH, V55, P3058, DOI 10.1128/AAC.01667-10; Kong Y, 2010, P NATL ACAD SCI US; Kong Ying, 2011, Curr Protoc Microbiol, VChapter 2, DOI [10.1002/9780471729259.mc02c04s21, 10.1002/9780471729259.mc02c03s21]; Kong Y, 2010, VIRULENCE, V1, P558, DOI 10.4161/viru.1.6.13901; Kong Y, 2009, TUBERCULOSIS, V89, pS15, DOI 10.1016/S1472-9792(09)70006-X; Lee J, 2009, MICROB BIOTECHNOL, V2, P75, DOI 10.1111/j.1751-7915.2008.00061.x; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; Luker KE, 2010, ANTIVIR RES, V86, P93, DOI 10.1016/j.antiviral.2010.02.002; Mehta PK, 2006, MICROB PATHOGENESIS, V40, P139, DOI 10.1016/j.micpath.2005.12.002; MEIGHEN EA, 1994, ANNU REV GENET, V28, P117, DOI 10.1146/annurev.ge.28.120194.001001; Mezzanotte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019277; Miltner E, 2005, INFECT IMMUN, V73, P4214, DOI 10.1128/IAI.73.7.4214-4221.2005; Mufti N, 2011, BIOMED OPT EXPRESS, V2, P1121, DOI 10.1364/BOE.2.001121; Park B, 2008, INFECT IMMUN, V76, P3100, DOI 10.1128/IAI.00015-08; RANES MG, 1990, J BACTERIOL, V172, P2793, DOI 10.1128/jb.172.5.2793-2797.1990; Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210; Sharma S, 2014, ANTIMICROB AGENTS CH; Singh V, 2014, ANTIMICROB AGENTS CH, V58, P1389, DOI 10.1128/AAC.01301-13; Stolt P, 1996, MICROBIOL-SGM, V142, P2795, DOI 10.1099/13500872-142-10-2795; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Subbian S, 2007, INFECT IMMUN, V75, P127, DOI 10.1128/IAI.01000-06; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Waidmann Mark S, 2011, Bioeng Bugs, V2, P8, DOI 10.4161/bbug.2.1.13566; WAYNE LG, 1968, J BACTERIOL, V96, P1915, DOI 10.1128/JB.96.6.1915-1919.1968; Wayne LG, 1986, BERGEYS MANUAL SYSTE, V2, P1436; WHO, 2013, GLOB TURB REP 2013, P1; Xie HX, 2012, NAT CHEM, V4, P802, DOI [10.1038/NCHEM.1435, 10.1038/nchem.1435]; Zelmer A, 2012, J ANTIMICROB CHEMOTH, V67, P1948, DOI 10.1093/jac/dks161; Zhang TY, 2011, ANTIMICROB AGENTS CH, V55, P56, DOI 10.1128/AAC.01260-10; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388	63	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108341	10.1371/journal.pone.0108341	http://dx.doi.org/10.1371/journal.pone.0108341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265287	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400066
J	Go, YM; Son, DJ; Park, H; Orr, M; Hao, L; Takabe, W; Kumar, S; Kang, DW; Kim, CW; Jo, H; Jones, DP				Go, Young-Mi; Son, Dong Ju; Park, Heonyong; Orr, Michael; Hao, Li; Takabe, Wakako; Kumar, Sandeep; Kang, Dong Won; Kim, Chan Woo; Jo, Hanjoong; Jones, Dean P.			Disturbed Flow Enhances Inflammatory Signaling and Atherogenesis by Increasing Thioredoxin-1 Level in Endothelial Cell Nuclei	PLOS ONE			English	Article							BONE MORPHOGENIC PROTEIN-4; DEPENDENT REDOX REGULATION; NF-KAPPA-B; DNA-BINDING; OXIDATIVE STRESS; GENE-EXPRESSION; GLUTATHIONE; ACTIVATION; DYSFUNCTION; INHIBITION	Background: Oxidative stress occurs with disturbed blood flow, inflammation and cardiovascular disease (CVD), yet freeradical scavenging antioxidants have shown limited benefit in human CVD. Thioredoxin-1 (Trx1) is a thiol antioxidant protecting against non-radical oxidants by controlling protein thiol/disulfide status; Trx1 translocates from cytoplasm to cell nuclei due to stress signaling, facilitates DNA binding of transcription factors, e.g., NF-kB, and potentiates inflammatory signaling. Whether increased nuclear Trx1 contributes to proatherogenic signaling is unknown. Methodology/Principal Findings: In vitro and in vivo atherogenic models were used to test for nuclear translocation of Trx1 and associated proinflammatory signaling. Disturbed flow by oscillatory shear stress stimulated Trx1 nuclear translocation in endothelial cells. Elevation of nuclear Trx1 in endothelial cells and transgenic (Tg) mice potentiated disturbed flow-stimulated proinflammatory signaling including NF-kappa B activation and increased expression of cell adhesion molecules and cytokines. Tg mice with increased nuclear Trx1 had increased carotid wall thickening due to disturbed flow but no significant differences in serum lipids or weight gain compared to wild type mice. Redox proteomics data of carotid arteries showed that disturbed flow stimulated protein thiol oxidation, and oxidation was higher in Tg mice than wild type mice. Conclusions/Significance: Translocation of Trx1 from cytoplasm to cell nuclei plays an important role in disturbed flowstimulated proatherogenesis with greater cytoplasmic protein oxidation and an enhanced nuclear transcription factor activity. The results suggest that pharmacologic interventions to inhibit nuclear translocation of Trx1 may provide a new approach to prevent inflammatory diseases or progression.	[Go, Young-Mi; Orr, Michael; Hao, Li; Jones, Dean P.] Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; [Son, Dong Ju; Takabe, Wakako; Kumar, Sandeep; Kang, Dong Won; Kim, Chan Woo; Jo, Hanjoong] Emory Univ, Dept Med, Div Cardiol, Atlanta, GA 30322 USA; [Park, Heonyong] Dankook Univ, Dept Mol Biol, Yongin, South Korea; [Jo, Hanjoong] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Jo, Hanjoong] Emory Univ, Atlanta, GA 30322 USA	Emory University; Emory University; Dankook University; University System of Georgia; Georgia Institute of Technology; Emory University	Go, YM (corresponding author), Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA.	ygo@emory.edu; dpjones@emory.edu	Jo, Hanjoong/L-6216-2019; Kumar, Sandeep/AAX-4612-2021	Jo, Hanjoong/0000-0003-1833-372X; Kumar, Sandeep/0000-0003-3440-3628	National Institutes of Health (NIH) [HL113451, AG038746, ES009047, ES023485]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113451, R01HL119798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009047, R01ES023485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038746] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants HL113451, AG038746, ES009047 and ES023485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE C, 1990, MOL CELL BIOL, V10, P5532, DOI 10.1128/MCB.10.10.5532; Ando J, 2011, ANTIOXID REDOX SIGN, V15, P1389, DOI 10.1089/ars.2010.3361; Arai RJ, 2006, BIOCHEM BIOPH RES CO, V348, P1254, DOI 10.1016/j.bbrc.2006.07.178; Ashfaq S, 2008, HYPERTENSION, V52, P80, DOI 10.1161/HYPERTENSIONAHA.107.097386; Brooks AR, 2002, PHYSIOL GENOMICS, V9, P27, DOI 10.1152/physiolgenomics.00075.2001; Chang K, 2007, CIRCULATION, V116, P1258, DOI 10.1161/CIRCULATIONAHA.106.683227; Chen Y, 2006, FEBS LETT, V580, P6596, DOI 10.1016/j.febslet.2006.11.007; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Davies PF, 2001, ANN NY ACAD SCI, V947, P7; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; Dhawan SS, 2011, ATHEROSCLEROSIS, V219, P266, DOI 10.1016/j.atherosclerosis.2011.05.020; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; GLEASON FK, 1981, J BIOL CHEM, V256, P8306; Go YM, 2013, AM J PHYSL LUNG CELL; Go YM, 2007, AM J PATHOL, V171, P1670, DOI 10.2353/ajpath.2007.070218; Go YM, 2007, FREE RADICAL BIO MED, V42, P363, DOI 10.1016/j.freeradbiomed.2006.11.005; Go YM, 2013, MOL CELL PROTEOMICS, V12, P3285, DOI 10.1074/mcp.M113.030437; Go YM, 2013, J BIOL CHEM, V288, P26512, DOI 10.1074/jbc.R113.464131; Go Young-Mi, 2011, J Proteomics Bioinform, V4, P196; Go YM, 2013, TOXICOL SCI, V131, P84, DOI 10.1093/toxsci/kfs271; Go YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018918; Go YM, 2011, FREE RADICAL BIO MED, V50, P495, DOI 10.1016/j.freeradbiomed.2010.11.029; Go YM, 2010, ANTIOXID REDOX SIGN, V13, P489, DOI 10.1089/ars.2009.3021; Go YM, 2010, FREE RADICAL BIO MED, V48, P275, DOI 10.1016/j.freeradbiomed.2009.10.050; Go Young-Mi, 2008, V464, P303; Halvey PJ, 2005, BIOCHEM J, V386, P215, DOI 10.1042/BJ20041829; Hansen JM, 2006, FREE RADICAL BIO MED, V40, P138, DOI 10.1016/j.freeradbiomed.2005.09.023; Hansen JM, 2004, TOXICOL SCI, V82, P308, DOI 10.1093/toxsci/kfh231; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Hosoya T, 2005, J BIOL CHEM, V280, P27244, DOI 10.1074/jbc.M502551200; Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0; Kim YC, 2003, ONCOGENE, V22, P1860, DOI 10.1038/sj.onc.1206369; MATTHEWS JR, 1993, NUCLEIC ACIDS RES, V21, P4516, DOI 10.1093/nar/21.19.4516; Mueller CFH, 2005, CIRC RES, V97, P637, DOI 10.1161/01.RES.0000183734.21112.b7; Nam D, 2010, J VISUALIZED EXPT JO; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Ni CW, 2011, AM J PHYSIOL-HEART C, V300, pH1762, DOI 10.1152/ajpheart.00829.2010; Ni CW, 2010, BLOOD, V116, pE66, DOI 10.1182/blood-2010-04-278192; Osborn EA, 2006, AM J PHYSIOL-CELL PH, V290, pC444, DOI 10.1152/ajpcell.00218.2005; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Patel RS, 2011, ATHEROSCLEROSIS, V218, P90, DOI 10.1016/j.atherosclerosis.2011.04.033; Powis G, 2000, FREE RADICAL BIO MED, V29, P312, DOI 10.1016/S0891-5849(00)00313-0; Rezvan A, 2011, ANTIOXID REDOX SIGN, V15, P1433, DOI 10.1089/ars.2010.3365; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroeder P, 2007, ARTERIOSCL THROM VAS, V27, P2325, DOI 10.1161/ATVBAHA.107.149419; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Son DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4000; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Sorescu GP, 2003, J BIOL CHEM, V278, P31128, DOI 10.1074/jbc.M300703200; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; Ueno M, 1999, J BIOL CHEM, V274, P35809, DOI 10.1074/jbc.274.50.35809; Usatyuk PV, 2006, J BIOL CHEM, V281, P35554, DOI 10.1074/jbc.M607305200; Van Hoecke M, 2007, MOL CELL NEUROSCI, V34, P40, DOI 10.1016/j.mcn.2006.09.009; Zschauer TC, 2011, ARTERIOSCL THROM VAS, V31, P650, DOI 10.1161/ATVBAHA.110.218982	59	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108346	10.1371/journal.pone.0108346	http://dx.doi.org/10.1371/journal.pone.0108346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265386	Green Submitted, Green Published, gold			2022-12-27	WOS:000345745400067
J	Kuzaj, P; Kuhn, J; Michalek, RD; Karoly, ED; Faust, I; Dabisch-Ruthe, M; Knabbe, C; Hendig, D				Kuzaj, Patricia; Kuhn, Joachim; Michalek, Ryan D.; Karoly, Edward D.; Faust, Isabel; Dabisch-Ruthe, Mareike; Knabbe, Cornelius; Hendig, Doris			Large-Scaled Metabolic Profiling of Human Dermal Fibroblasts Derived from Pseudoxanthoma Elasticum Patients and Healthy Controls	PLOS ONE			English	Article							XYLOSYLTRANSFERASE-I; PROTEIN MATURATION; TRANSPORT ACTIVITY; ABC TRANSPORTERS; SERUM WITHDRAWAL; THYMOSIN BETA-4; GENE-EXPRESSION; PXE PATIENTS; RESISTANCE; MUTATION	Mutations in the ABC transporter ABCC6 were recently identified as cause of Pseudoxanthoma elasticum ( PXE), a rare genetic disorder characterized by progressive mineralization of elastic fibers. We used an untargeted metabolic approach to identify biochemical differences between human dermal fibroblasts from healthy controls and PXE patients in an attempt to find a link between ABCC6 deficiency, cellular metabolic alterations and disease pathogenesis. 358 compounds were identified by mass spectrometry covering lipids, amino acids, peptides, carbohydrates, nucleotides, vitamins and cofactors, xenobiotics and energy metabolites. We found substantial differences in glycerophospholipid composition, leucine dipeptides, and polypeptides as well as alterations in pantothenate and guanine metabolism to be significantly associated with PXE pathogenesis. These findings can be linked to extracellular matrix remodeling and increased oxidative stress, which reflect characteristic hallmarks of PXE. Our study could facilitate a better understanding of biochemical pathways involved in soft tissue mineralization.	[Kuzaj, Patricia; Kuhn, Joachim; Faust, Isabel; Dabisch-Ruthe, Mareike; Knabbe, Cornelius; Hendig, Doris] Ruhr Univ Bochum, Univ Klin, Inst Labs & Transfus Med, Herz & Diabet Zentrum Nordrhein Westfalen, Bad Oeynhausen, Germany; [Michalek, Ryan D.; Karoly, Edward D.] Metabolon Inc, Durham, NC USA	Ruhr University Bochum; Metabolon	Hendig, D (corresponding author), Ruhr Univ Bochum, Univ Klin, Inst Labs & Transfus Med, Herz & Diabet Zentrum Nordrhein Westfalen, Bad Oeynhausen, Germany.	dhendig@hdz-nrw.de	Hendig, Doris/F-1112-2013	Hendig, Doris/0000-0002-3660-6923; Faust-Hinse, Isabel/0000-0002-2234-9196	German Research Foundation (DFG) [He 5900/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	Parts of this work were funded by the German Research Foundation (DFG, He 5900/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso-Pecchio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049509; Annovazzi L, 2004, EUR J CLIN INVEST, V34, P156, DOI 10.1111/j.1365-2362.2004.01306.x; Barsotti C, 2005, J BIOL CHEM, V280, P13465, DOI 10.1074/jbc.M413347200; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Belinsky MG, 2002, CANCER RES, V62, P6172; Boraldi F, 2008, PROTEOMICS, V8, P66, DOI 10.1002/pmic.200700833; Boraldi F, 2013, J INVEST DERMATOL, V133, P946, DOI 10.1038/jid.2012.460; Boraldi F, 2009, PROTEOM CLIN APPL, V3, P1084, DOI 10.1002/prca.200900007; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Chen ZS, 2011, FEBS J, V278, P3226, DOI 10.1111/j.1742-4658.2011.08235.x; COSTA RT, 1988, COLLAGEN REL RES, V8, P49; Dabisch-Ruthe M, 2014, CLIN BIOCHEM, DOI [10.1016/j.clin-biochem.2014.07.003, DOI 10.1016/J.CLIN-BIOCHEM.2014.07.003]; Dabisch-Ruthe M, 2014, J DERMATOL SCI, V75, P109, DOI 10.1016/j.jdermsci.2014.04.015; Depeint F, 2006, CHEM-BIOL INTERACT, V163, P94, DOI 10.1016/j.cbi.2006.04.014; Diekmann U, 2009, J MOL MED, V87, P965, DOI 10.1007/s00109-009-0497-5; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Faust I, 2013, BIOCHEM BIOPH RES CO, V436, P449, DOI 10.1016/j.bbrc.2013.05.125; Fernandez JR, 2010, BIOORGAN MED CHEM, V18, P6748, DOI 10.1016/j.bmc.2010.07.054; Finger RP, 2009, SURV OPHTHALMOL, V54, P272, DOI 10.1016/j.survophthal.2008.12.006; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Gonzalez Mercedes E, 2009, Dermatol Online J, V15, P17; Gotting C, 2005, J MOL MED, V83, P984, DOI 10.1007/s00109-005-0693-x; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Harris RA, 2004, BIOCHEM BIOPH RES CO, V313, P391, DOI 10.1016/j.bbrc.2003.11.007; Heise R, 2012, SKIN PHARMACOL PHYS, V25, P241, DOI 10.1159/000341144; Hendig D, 2008, LAB INVEST, V88, P1303, DOI 10.1038/labinvest.2008.96; Hu XF, 2003, INVEST OPHTH VIS SCI, V44, P1824, DOI 10.1167/iovs.02-0981; Ilias A, 2002, J BIOL CHEM, V277, P16860, DOI 10.1074/jbc.M110918200; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; Jansen RS, 2014, ARTERIOSCLEROSIS THR, V114; Jo JO, 2010, BBA-MOL CELL RES, V1803, P1244, DOI 10.1016/j.bbamcr.2010.07.005; Keitel V, 2000, HEPATOLOGY, V32, P1317, DOI 10.1053/jhep.2000.19791; Keitel V, 2003, AM J PHYSIOL-GASTR L, V284, pG165, DOI 10.1152/ajpgi.00362.2002; Kobayashi D, 2011, J PHARMACOL SCI, V115, P230, DOI 10.1254/jphs.10224SC; Kristal BS, 1999, ARCH BIOCHEM BIOPHYS, V370, P22, DOI 10.1006/abbi.1999.1387; Krumpochova P, 2012, FASEB J, V26, P738, DOI 10.1096/fj.11-195743; Kuzaj P, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-118; Le Saux O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024738; Lee SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061960; Lee S, 2012, CIRC RES, V111, P778, DOI 10.1161/CIRCRESAHA.111.256859; Li QL, 2009, EXP DERMATOL, V18, P1, DOI 10.1111/j.1600-0625.2008.00795.x; Li QY, 2002, J HEART VALVE DIS, V11, P726; Liu JM, 2003, BLOOD, V101, P3014, DOI 10.1182/blood-2002-07-2315; Matsuzaki Y, 2005, J INVEST DERMATOL, V125, P900, DOI 10.1111/j.0022-202X.2005.23897.x; Nitto T, 2013, J PHARMACOL SCI, V123, P1, DOI 10.1254/jphs.13R01CP; Nonaka I, 1997, BIOSCI BIOTECH BIOCH, V61, P772, DOI 10.1271/bbb.61.772; Pandhare J, 2006, J BIOL CHEM, V281, P2044, DOI 10.1074/jbc.M507867200; Parekh A, 2009, WOUND REPAIR REGEN, V17, P88, DOI 10.1111/j.1524-475X.2008.00445.x; Park JG, 2011, BMB REP, V44, P497, DOI 10.5483/BMBRep.2011.44.8.497; Peng HM, 2010, AM J PHYSIOL-HEART C, V298, pH1357, DOI 10.1152/ajpheart.00464.2009; Phang JM, 2010, ANNU REV NUTR, V30, P441, DOI 10.1146/annurev.nutr.012809.104638; Plomp AS, 2010, AM J MED GENET A, V152A, P1049, DOI 10.1002/ajmg.a.33329; Pomozi V, 2013, J INVEST DERMATOL, V134, P946; Pritsos CA, 2000, CHEM-BIOL INTERACT, V129, P195, DOI 10.1016/S0009-2797(00)00203-9; Quaglino D., 2011, ADV STUDY GENET DISO, DOI [10.5772/22161, DOI 10.5772/22161]; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Ronchetti Ivonne, 2013, Frontiers in Genetics, V4, P22, DOI 10.3389/fgene.2013.00022; Solakivi T., 2005, LIPIDS HEALTH DIS, V4, P1; Solakivi T, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-11; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Szabo Z, 2011, MOL GENET METAB, V104, P421, DOI 10.1016/j.ymgme.2011.07.013; Uitto J, 2001, TRENDS MOL MED, V7, P13, DOI 10.1016/S1471-4914(00)01869-4; Uitto J, 2013, J INVEST DERMATOL, V133, P1444, DOI 10.1038/jid.2013.20; Uitto J, 2010, J INVEST DERMATOL, V130, P661, DOI 10.1038/jid.2009.411; Valerio A, 2011, AGING-US, V3, P464, DOI 10.18632/aging.100322; van de Wetering K, 2012, FASEB J, V26, P4014, DOI 10.1096/fj.12-210039; Van De Wetering K, 2009, GASTROENTEROLOGY, V137, P1725, DOI 10.1053/j.gastro.2009.06.052; Van QN, 2008, J PROTEOME RES, V7, P630, DOI 10.1021/pr700594s; Varadi A, 2011, CURR DRUG TARGETS, V12, P671, DOI 10.2174/138945011795378612; VOELTER W, 1995, NEUROCHEM RES, V20, P55; Wang JY, 2011, ACTA OPHTHALMOL, V89, pE396, DOI 10.1111/j.1755-3768.2011.02114.x; Wiederholt T, 2009, EXP DERMATOL, V18, P969, DOI 10.1111/j.1600-0625.2009.00884.x; Yang J, 2011, CURR OPIN LIPIDOL, V22, P197, DOI 10.1097/MOL.0b013e3283468c10; Zarbock R, 2009, HUM MOL GENET, V18, P3344, DOI 10.1093/hmg/ddp259; Zdanov S, 2007, EXP CELL RES, V313, P3046, DOI 10.1016/j.yexcr.2007.04.033	75	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108336	10.1371/journal.pone.0108336	http://dx.doi.org/10.1371/journal.pone.0108336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265166	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400065
J	Ling, BL; Chiu, CT; Lu, HC; Lin, JJ; Kuo, CY; Chou, FP				Ling, Bey-Leei; Chiu, Chun-Tang; Lu, Hsiu-Chin; Lin, Jin-Jin; Kuo, Chiung-Yin; Chou, Fen-Pi			Short and Long-Term Impact of Lipectomy on Expression Profile of Hepatic Anabolic Genes in Rats: A High Fat and High Cholesterol Diet-Induced Obese Model	PLOS ONE			English	Article							ADIPONECTIN-LEPTIN RATIO; NUCLEAR FACTOR 4-ALPHA; TRANSCRIPTION FACTORS; INSULIN-RESISTANCE; METABOLIC SYNDROME; HOMEOSTASIS; ACTIVATION; PARAMETERS; REGULATORS; PHYSIOLOGY	Objective: To understand the molecular basis of the short and long-term effects of an immediate shortage of energy storage caused by lipectomy on expression profile of genes involved in lipid and carbohydrate metabolism in high fat and high cholesterol diet-induced obese rats. Methods: The hepatic mRNA levels of enzymes, regulator and transcription factors involved in glucose and lipid metabolism were analyzed by quantitative real time polymerase chain reaction (RT-qPCR) ten days and eight weeks after lipectomy in obese rats. Body and liver weights and serum biochemical parameters, adiponectin, leptin and insulin were determined. Results: No significant difference was observed on the food intake between the lipectomized and sham-operated groups during the experimental period. Ten days after the operation, the lipectomized animals showed significant higher triacylglycerol, glucose and insulin levels, a lower adiponectin concentration than the sham-operated rats, along with significant higher hepatic mRNA levels of hepatocyte nuclear factor 4 alpha (HNF4 alpha) and the enzymes involved in lipogenesis, sterol biosynthesis and gluconeogenesis. The results of immunohistochemical (IHC) analysis also confirmed increased levels of lipogenic enzymes in the liver of lipectomized versus sham-operated animals. The lipectomized group had a significantly lower adiponectin/leptin ratio that was positively correlated to the level of LDL (r = 0.823, P < 0.05) and negatively to glucose and insulin (r = -0.821 and -0.892 respectively, P < 0.05). Eight weeks after the operation, the lipectomized animals revealed significant higher body and liver weights, weight gain, liver to body weight ratio, hepatic triacylglycerol and serum insulin level. Conclusions: In response to lipectomy a short term enhancement of the expression of hepatic anabolic genes involved in lipid and carbohydrate metabolism was triggered that might eventually lead to the final extra weight gain. These metabolic changes could be the results of reduced circulating adiponectin that further influences the functions of insulin and hepatic HNF4 alpha.	[Ling, Bey-Leei; Chiu, Chun-Tang; Kuo, Chiung-Yin; Chou, Fen-Pi] Chung Shan Med Univ, Inst Biochem & Biotechnol, Coll Med, Taichung, Taiwan; [Lu, Hsiu-Chin] China Med Univ Hosp, Dept Lab Med, Taichung, Taiwan; [Lu, Hsiu-Chin] HungKuang Univ, Inst Biotechnol, Taichung, Taiwan; [Lin, Jin-Jin] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chou, Fen-Pi] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan	Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Hungkuang University; Academia Sinica - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital	Chou, FP (corresponding author), Chung Shan Med Univ, Inst Biochem & Biotechnol, Coll Med, Taichung, Taiwan.	fpchou@csmu.edu.tw			National Science Council, Taiwan [NSC 99-2632-B-040-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the grant from National Science Council (NSC 99-2632-B-040-001-MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AW, 2006, BIOCHEM J, V399, P285, DOI 10.1042/BJ20060659; Bartoov-Shifman R, 2002, J BIOL CHEM, V277, P25914, DOI 10.1074/jbc.M201582200; Benatti F, 2012, J CLIN ENDOCR METAB, V97, P2388, DOI 10.1210/jc.2012-1012; Brennan AM, 2006, NAT CLIN PRACT ENDOC, V2, P318, DOI 10.1038/ncpendmet0196; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; FOLCH J, 1957, BIOL CHEM, V226, P497; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hara Kazuo, 2005, Curr Diab Rep, V5, P136, DOI 10.1007/s11892-005-0041-0; Hausman DB, 2004, EXP BIOL MED, V229, P512, DOI 10.1177/153537020422900609; Hernandez TL, 2011, OBESITY, V19, P1388, DOI 10.1038/oby.2011.64; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Inoue M, 2005, METABOLISM, V54, P281, DOI 10.1016/j.metabol.2004.09.006; Inoue M, 2006, METABOLISM, V55, P1248, DOI 10.1016/j.metabol.2006.05.010; Kral JG, 1975, RECENT ADV OBES RES, V1, P327; Kral JG, 1988, ACTA MED SCAND, V723, P225; Liszka TG, 1998, PLAST RECONSTR SURG, V102, P1122, DOI 10.1097/00006534-199809040-00031; Liu QQ, 2012, P NATL ACAD SCI USA, V109, P14568, DOI 10.1073/pnas.1211611109; Mars M, 2006, INT J OBESITY, V30, P122, DOI 10.1038/sj.ijo.0803070; Martinez-Jimenez CP, 2010, MOL CELL BIOL, V30, P565, DOI 10.1128/MCB.00927-09; Mauer MM, 1997, AM J PHYSIOL-REG I, V273, pR2117, DOI 10.1152/ajpregu.1997.273.6.R2117; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Qiao LP, 2008, DIABETES, V57, P1824, DOI 10.2337/db07-0435; Renaldi Olly, 2009, Acta Med Indones, V41, P20; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Savary S, 2012, CURR DRUG METAB, V13, P1358, DOI 10.2174/138920012803762729; Thomas H, 2001, HUM MOL GENET, V10, P2089, DOI 10.1093/hmg/10.19.2089; Vega GL, 2013, J OBES, V2013, DOI 10.1155/2013/409679; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Weber RV, 2000, AM J PHYSIOL-REG I, V279, pR936, DOI 10.1152/ajpregu.2000.279.3.R936; Yin LY, 2011, ARTERIOSCL THROM VAS, V31, P328, DOI 10.1161/ATVBAHA.110.217828; Zaletel J, 2010, J ENDOCRINOL INVEST, V33, P514, DOI [10.1007/BF03346639, 10.3275/6811]	33	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108717	10.1371/journal.pone.0108717	http://dx.doi.org/10.1371/journal.pone.0108717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264921	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400109
J	Moorhead, D; Lashermes, G; Recous, S; Bertrand, I				Moorhead, Daryl; Lashermes, Gwenaelle; Recous, Sylvie; Bertrand, Isabelle			Interacting Microbe and Litter Quality Controls on Litter Decomposition: A Modeling Analysis	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; PLANT-CELL WALL; LEAF-LITTER; SOIL; LIGNIN; CARBON; NITROGEN; EFFICIENCY; IMPACT; ROOTS	The decomposition of plant litter in soil is a dynamic process during which substrate chemistry and microbial controls interact. We more clearly quantify these controls with a revised version of the Guild-based Decomposition Model (GDM) in which we used a reverse Michaelis-Menten approach to simulate short-term (112 days) decomposition of roots from four genotypes of Zea mays that differed primarily in lignin chemistry. A co-metabolic relationship between the degradation of lignin and holocellulose (cellulose+hemicellulose) fractions of litter showed that the reduction in decay rate with increasing lignin concentration (LCI) was related to the level of arabinan substitutions in arabinoxylan chains (i.e., arabinan to xylan or A:X ratio) and the extent to which hemicellulose chains are cross-linked with lignin in plant cell walls. This pattern was consistent between genotypes and during progressive decomposition within each genotype. Moreover, decay rates were controlled by these cross-linkages from the start of decomposition. We also discovered it necessary to divide the Van Soest soluble (labile) fraction of litter C into two pools: one that rapidly decomposed and a second that was more persistent. Simulated microbial production was consistent with recent studies suggesting that more rapidly decomposing materials can generate greater amounts of potentially recalcitrant microbial products despite the rapid loss of litter mass. Sensitivity analyses failed to identify any model parameter that consistently explained a large proportion of model variation, suggesting that feedback controls between litter quality and microbial activity in the reverse Michaelis-Menten approach resulted in stable model behavior. Model extrapolations to an independent set of data, derived from the decomposition of 12 different genotypes of maize roots, averaged within <3% of observed respiration rates and total CO2 efflux over 112 days.	[Moorhead, Daryl] Univ Toledo, Dept Environm Sci, Toledo, OH 43606 USA; [Moorhead, Daryl; Lashermes, Gwenaelle; Recous, Sylvie; Bertrand, Isabelle] INRA, Fractionnement AgroRessources & Environm UMR614, Reims, France; [Moorhead, Daryl; Lashermes, Gwenaelle; Recous, Sylvie; Bertrand, Isabelle] Univ Reims, Fractionnement AgroRessources & Environm UMR614, Reims, France	University System of Ohio; University of Toledo; INRAE; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne	Moorhead, D (corresponding author), Univ Toledo, Dept Environm Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	daryl.moorhead@utoledo.edu	Recous, Sylvie/A-8780-2012; Lashermes, Gwenaelle/Q-6353-2016; BERTRAND, ISABELLE/AAC-1982-2021	Recous, Sylvie/0000-0003-4845-7811; Lashermes, Gwenaelle/0000-0002-8269-3562; BERTRAND, ISABELLE/0000-0002-2233-631X	United States National Science Foundation [DEB-0946257, DEB-0918718]; Institut National de la Recherche Agronomique	United States National Science Foundation(National Science Foundation (NSF)); Institut National de la Recherche Agronomique	This study was supported by United States National Science Foundation grants DEB-0946257 and DEB-0918718, and Institut National de la Recherche Agronomique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin BAZ, 2014, BIOGEOCHEMISTRY, V117, P169, DOI 10.1007/s10533-013-9856-y; ANDERSON TH, 1989, SOIL BIOL BIOCHEM, V21, P471, DOI 10.1016/0038-0717(89)90117-X; Bengtson P, 2007, ECOL LETT, V10, P783, DOI 10.1111/j.1461-0248.2007.01072.x; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; Bertrand I, 2009, BIORESOURCE TECHNOL, V100, P155, DOI 10.1016/j.biortech.2008.06.019; Blagodatskaya EV, 2009, EUR J SOIL SCI, V60, P186, DOI 10.1111/j.1365-2389.2008.01103.x; CHESSON A, 1988, ANIM FEED SCI TECH, V21, P219, DOI 10.1016/0377-8401(88)90104-6; Cleveland CC, 2004, ECOSYSTEMS, V7, P275, DOI 10.1007/s10021-003-0236-7; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; Grabber JH, 2009, J SCI FOOD AGR, V89, P122, DOI 10.1002/jsfa.3418; Gunnarsson S, 2008, BIOL FERT SOILS, V45, P27, DOI 10.1007/s00374-008-0303-5; Herman J, 2008, SOIL BIOL BIOCHEM, V40, P2620, DOI 10.1016/j.soilbio.2008.07.003; Hernandez DL, 2010, PLANT SOIL, V335, P397, DOI 10.1007/s11104-010-0428-9; JACQUET G, 1995, J AGR FOOD CHEM, V43, P2746, DOI 10.1021/jf00058a037; JUNG HG, 1993, FORAGE CELL WALL STRUCTURE AND DIGESTIBILITY, P315; Kalbitz K, 2003, GEODERMA, V113, P273, DOI 10.1016/S0016-7061(02)00365-8; Lagomarsino A, 2006, SCI TOTAL ENVIRON, V372, P256, DOI 10.1016/j.scitotenv.2006.08.031; Machinet GE, 2009, EUR J SOIL SCI, V60, P176, DOI 10.1111/j.1365-2389.2008.01109.x; Machinet GE, 2011, SOIL BIOL BIOCHEM, V43, P1544, DOI 10.1016/j.soilbio.2011.04.002; Machinet GE, 2009, SOIL BIOL BIOCHEM, V41, P1253, DOI 10.1016/j.soilbio.2009.03.009; Manzoni S, 2009, SOIL BIOL BIOCHEM, V41, P1355, DOI 10.1016/j.soilbio.2009.02.031; McMahon SK, 2005, SOIL SCI SOC AM J, V69, P1238, DOI 10.2136/sssaj2004.0289; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Merila P, 2010, APPL SOIL ECOL, V46, P259, DOI 10.1016/j.apsoil.2010.08.003; Moorhead DL, 2013, SOIL BIOL BIOCHEM, V66, P17, DOI 10.1016/j.soilbio.2013.06.016; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; Nishimura S, 2012, J ENVIRON QUAL, V41, P823, DOI 10.2134/jeq2011.0342; OADES JM, 1984, PLANT SOIL, V76, P319, DOI 10.1007/BF02205590; Preston CM, 2009, ECOSYSTEMS, V12, P1078, DOI 10.1007/s10021-009-9267-z; Recous S, 1995, SOIL BIOL BIOCHEM, V27, P1529, DOI 10.1016/0038-0717(95)00096-W; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; SINSABAUGH RL, 1994, BIOL FERT SOILS, V17, P69, DOI 10.1007/BF00418675; Sinsabaugh RL, 2013, ECOL LETT, V16, P930, DOI 10.1111/ele.12113; Smith JL, 2007, BIOL FERT SOILS, V44, P315, DOI 10.1007/s00374-007-0206-x; Vailhe MAB, 2000, J AGR FOOD CHEM, V48, P618, DOI 10.1021/jf9906329; Wardle DA, 1998, SOIL BIOL BIOCHEM, V30, P1627, DOI 10.1016/S0038-0717(97)00201-0; Wickings K, 2012, ECOL LETT, V15, P1180, DOI 10.1111/j.1461-0248.2012.01837.x	37	24	24	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108769	10.1371/journal.pone.0108769	http://dx.doi.org/10.1371/journal.pone.0108769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264895	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400117
J	Pupacdi, B; Javed, A; Zaki, MJ; Ruchirawat, M				Pupacdi, Benjarath; Javed, Asif; Zaki, Mohammed J.; Ruchirawat, Mathuros			NSIT: Novel Sequence Identification Tool	PLOS ONE			English	Article							DNA-SEQUENCE; CHROMOSOME; ALIGNMENT; MAP; GENOMES	Novel sequences are DNA sequences present in an individual's genome but absent in the human reference assembly. They are predicted to be biologically important, both individual and population specific, and consistent with the known human migration paths. Recent works have shown that an average person harbors 2-5 Mb of such sequences and estimated that the human pan-genome contains as high as 19-40 Mb of novel sequences. To identify them in a de novo genome assembly, some existing sequence aligners have been used but no computational method has been specifically proposed for this task. In this work, we developed NSIT (Novel Sequence Identification Tool), a software that can accurately and efficiently identify novel sequences in an individual's de novo whole genome assembly. We identified and characterized 1.1 Mb, 1.2 Mb, and 1.0 Mb of novel sequences in NA18507 (African), YH (Asian), and NA12878 (European) de novo genome assemblies, respectively. Our results show very high concordance with the previous work using the respective reference assembly. In addition, our results using the latest human reference assembly suggest that the amount of novel sequences per individual may not be as high as previously reported. We additionally developed a graphical viewer for comparisons of novel sequence contents. The viewer also helped in identifying sequence contamination; we found 130 kb of Epstein-Barr virus sequence in the previously published NA18507 novel sequences as well as 287 kb of zebrafish repeats in NA12878 de novo assembly. NSIT requires <2GB of RAM and 1.5-2 hrs on a commodity desktop. The program is applicable to input assemblies with varying contig/scaffold sizes, ranging from 100 bp to as high as 50 Mb. It works in both 32-bit and 64-bit systems and outperforms, by large margins, other fast sequence aligners previously applied to this task. To our knowledge, NSIT is the first software designed specifically for novel sequence identification in a de novo human genome assembly.	[Pupacdi, Benjarath; Ruchirawat, Mathuros] Chulabhorn Res Inst, Translat Res Unit, Bangkok, Thailand; [Javed, Asif] Agcy Sci Technol & Res, Genome Inst Singapore, Computat & Syst Biol Grp, Singapore, Singapore; [Zaki, Mohammed J.] Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA; [Zaki, Mohammed J.] Qatar Comp Res Inst, Doha, Qatar	Chulabhorn Research Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Rensselaer Polytechnic Institute; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Computing Research Institute	Pupacdi, B (corresponding author), Chulabhorn Res Inst, Translat Res Unit, Bangkok, Thailand.	benjarath@cri.or.th	Javed, Asif/Q-5904-2019	Javed, Asif/0000-0002-6945-9624; Zaki, Mohammed/0000-0003-4711-0234	Thailand Research Fund [TRG5280016]; Coordinating Center for Thai Government Science and Technology Scholarship Students, National Science and Technology Development Agency [SCH-NR2009-51-01]	Thailand Research Fund(Thailand Research Fund (TRF)); Coordinating Center for Thai Government Science and Technology Scholarship Students, National Science and Technology Development Agency	This project was supported by the Thailand Research Fund (Grant Number: TRG5280016, www.trf.or.th) and partially supported by the Coordinating Center for Thai Government Science and Technology Scholarship Students, National Science and Technology Development Agency (Grant Number: SCH-NR2009-51-01, http://stscholar.nstda.or.th). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Gnerre S., 2010, P NATL ACAD SCI; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Hajirasouliha I, 2010, BIOINFORMATICS, V26, P1277, DOI 10.1093/bioinformatics/btq152; Harris R. S., 2007, THESIS PENNSYLVANIA; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Li H., 2013, ARXIV13033997V1QBIOG; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smit A, 1996, REPEATMASKER OPEN 30; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	20	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108011	10.1371/journal.pone.0108011	http://dx.doi.org/10.1371/journal.pone.0108011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264906	Green Submitted, Green Published, gold			2022-12-27	WOS:000345745400037
J	Aparicio-Siegmund, S; Moll, JM; Lokau, J; Grusdat, M; Schroder, J; Plohn, S; Rose-John, S; Grotzinger, J; Lang, PA; Scheller, J; Garbers, C				Aparicio-Siegmund, Samadhi; Moll, Jens M.; Lokau, Juliane; Grusdat, Melanie; Schroeder, Jutta; Ploehn, Svenja; Rose-John, Stefan; Groetzinger, Joachim; Lang, Philipp A.; Scheller, Juergen; Garbers, Christoph			Recombinant p35 from Bacteria Can Form Interleukin (IL-)12, but Not IL-35	PLOS ONE			English	Article							IL-12 P40 HOMODIMER; INFECTIOUS-DISEASES; T-CELLS; CYTOKINE; RECEPTOR; SUBUNIT; PROTEIN; IL-23; DIFFERENTIATION; PROLIFERATION	The Interleukin (IL)-12 family contains several heterodimeric composite cytokines which share subunits among each other. IL-12 consists of the subunits p40 (shared with IL-23) and p35. p35 is shared with the composite cytokine IL-35 which comprises of the p35/EBI3 heterodimer (EBI3 shared with IL-27). IL-35 signals via homo-or heterodimers of IL-12R beta 2, gp130 and WSX-1, which are shared with IL-12 and IL-27 receptor complexes, respectively. p35 was efficiently secreted in complex with p40 as IL-12 but not with EBI3 as IL-35 in several transfected cell lines tested which complicates the analysis of IL-35 signal transduction. p35 and p40 but not p35 and EBI3 form an inter-chain disulfide bridge. Mutation of the responsible cysteine residue (p40(C197A)) reduced IL-12 formation and activity only slightly. Importantly, the p40(C197A) mutation prevented the formation of antagonistic p40 homodimers which enabled the in vitro reconstitution of biologically active IL-12 with p35 produced in bacteria (p35bac). Reconstitution of IL-35 with p35bac and EBI3 did, however, fail to induce signal transduction in Ba/F3 cells expressing IL-12R beta 2 and gp130. In summary, we describe the in vitro reconstitution of IL-12, but fail to produce recombinant IL-35 by this novel approach.	[Aparicio-Siegmund, Samadhi; Moll, Jens M.; Schroeder, Jutta; Ploehn, Svenja; Scheller, Juergen; Garbers, Christoph] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Lokau, Juliane; Rose-John, Stefan; Groetzinger, Joachim] Univ Kiel, Inst Biochem, Kiel, Germany; [Grusdat, Melanie; Lang, Philipp A.] Univ Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany; [Lang, Philipp A.] Univ Dusseldorf, Dept Mol Med 2, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; University of Kiel; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Scheller, J (corresponding author), Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany.	jscheller@uni-duesseldorf.de; cgarbers@biochem.uni-kiel.de	Scheller, Jürgen/K-5290-2015; Rose-John, Stefan/A-7998-2010; Garbers, Christoph/D-9932-2015	Rose-John, Stefan/0000-0002-7519-3279; Garbers, Christoph/0000-0003-4939-6950; Grusdat, Melanie/0000-0003-0708-0077; Lokau, Juliane/0000-0002-2573-7282; Philipp, Svenja/0000-0002-8077-3227	Research Commission of the Medical Faculty of the Heinrich-Heine-University Dusseldorf; Deutsche Forschungsgemeinschaft [SFB841, SFB877]; Cluster of Excellence "Inflammation at Interfaces"	Research Commission of the Medical Faculty of the Heinrich-Heine-University Dusseldorf; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	This work was funded by a grant from the Research Commission of the Medical Faculty of the Heinrich-Heine-University Dusseldorf (to C.G. and J.S.). S.R.-J. is funded by the Deutsche Forschungsgemeinschaft (SFB841, project C1) and the Cluster of Excellence "Inflammation at Interfaces". J.G. is funded by the Deutsche Forschungsgemeinschaft (SFB877, project A6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Crabe S, 2009, J IMMUNOL, V183, P7692, DOI 10.4049/jimmunol.0901464; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Garbers C, 2013, BIOL CHEM, V394, P1145, DOI 10.1515/hsz-2013-0166; Garbers C, 2013, J BIOL CHEM, V288, P4346, DOI 10.1074/jbc.M112.432955; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Heinzel FP, 1997, J IMMUNOL, V158, P4381; Holscher C, 2004, MED MICROBIOL IMMUN, V193, P1, DOI 10.1007/s00430-003-0186-x; Jones LL, 2012, MOL IMMUNOL, V51, P234, DOI 10.1016/j.molimm.2012.03.025; Koch M, 2007, BIOCHEM BIOPH RES CO, V364, P483, DOI 10.1016/j.bbrc.2007.10.053; Lieschke GJ, 1997, NAT BIOTECHNOL, V15, P35, DOI 10.1038/nbt0197-35; LING P, 1995, J IMMUNOL, V154, P116; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; Schuster B, 2003, J BIOL CHEM, V278, P9528, DOI 10.1074/jbc.M210044200; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Shimozato O, 2006, IMMUNOLOGY, V117, P22, DOI 10.1111/j.1365-2567.2005.02257.x; Suthaus J, 2011, EUR J CELL BIOL, V90, P495, DOI 10.1016/j.ejcb.2010.10.016; Tormo AJ, 2013, J IMMUNOL, V191, P1657, DOI 10.4049/jimmunol.1201595; Wang R- XX, 2014, NATURE MED; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530	34	23	23	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107990	10.1371/journal.pone.0107990	http://dx.doi.org/10.1371/journal.pone.0107990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259790	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600041
J	Crawford, LE; Cohn, SM; Kim, AB				Crawford, L. Elizabeth; Cohn, Stephanie M.; Kim, Arnold B.			"Good Is Up'' Is Not Always Better: A Memory Advantage for Words in Metaphor-Incompatible Locations	PLOS ONE			English	Article							ASSOCIATIONS	Four experiments examined whether memory for positive and negative words depended on word location and vertical hand movements. Cognitive processing is known to be facilitated when valenced stimuli are presented in locations that are congruent with the GOOD is UP conceptual metaphor, relative to when they are presented in incongruent locations. In both free recall and recognition tasks, we find a memory advantage for words that had been studied in metaphor incongruent locations (positive down, negative up). This incongruity advantage depends on the location of words during encoding, but no evidence was found to suggest that other spatial associations, such as the vertical position of the hand at encoding or word location during retrieval, affect memory. The results indicate that metaphors, like schemas, categories, and stereotypes, can influence cognition in complex ways, producing variable outcomes across different tasks.	[Crawford, L. Elizabeth; Cohn, Stephanie M.; Kim, Arnold B.] Univ Richmond, Dept Psychol, Richmond, VA 23173 USA	University of Richmond	Crawford, LE (corresponding author), Univ Richmond, Dept Psychol, Richmond, VA 23173 USA.	lcrawfor@richmond.edu			University of Richmond Arts & Sciences Faculty Research grant	University of Richmond Arts & Sciences Faculty Research grant	Support for this work was provided by a University of Richmond Arts & Sciences Faculty Research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; Broookshire G, 2010, COGNITION IN FLUX, P1940; Casasanto D, 2010, COGNITION, V115, P179, DOI 10.1016/j.cognition.2009.11.002; Christianson SA., 1992, HDB EMOTION MEMORY R; Crawford LE, 2006, COGNITION EMOTION, V20, P1153, DOI 10.1080/02699930500347794; Crawford LE, 2009, EMOT REV, V1, P129, DOI 10.1177/1754073908100438; Diemand-Yauman C, 2011, COGNITION, V118, P111, DOI 10.1016/j.cognition.2010.09.012; DONALD M, 1993, SOC RES, V60, P143; Ebbinghaus H., 1885, MEMORY CONTRIBUTION; Gray JR, 2001, J EXP PSYCHOL GEN, V130, P436, DOI 10.1037//0096-3445.130.3.436; Lakoff George, 2003, METAPHOR WE LIVE BY; Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; MATLIN MW, 2004, HDB FALLACIES BIASES, P255; Meier BP, 2006, J RES PERS, V40, P451, DOI 10.1016/j.jrp.2005.03.001; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Meier BP, 2004, PSYCHOL SCI, V15, P82, DOI 10.1111/j.0963-7214.2004.01502002.x; Meier BP, 2008, BASIC APPL SOC PSYCH, V30, P46, DOI 10.1080/01973530701866516; Mulligan NW, 1996, J EXP PSYCHOL LEARN, V22, P1067, DOI 10.1037/0278-7393.22.5.1067; NAIRNE JS, 1988, J EXP PSYCHOL LEARN, V14, P248, DOI 10.1037/0278-7393.14.2.248; Palma TA, 2011, EUR J SOC PSYCHOL, V41, P275, DOI 10.1002/ejsp.795; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; RUNDUS D, 1971, J EXP PSYCHOL, V89, P63, DOI 10.1037/h0031185; Sakamoto Y, 2004, J EXP PSYCHOL GEN, V133, P534, DOI 10.1037/0096-3445.133.4.534; STANGOR C, 1992, PSYCHOL BULL, V111, P42, DOI 10.1037/0033-2909.111.1.42; Weger UW, 2007, PSYCHON B REV, V14, P517, DOI 10.3758/BF03194100; Zwaan RA, 2003, PSYCHON B REV, V10, P954, DOI 10.3758/BF03196557	28	5	5	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108269	10.1371/journal.pone.0108269	http://dx.doi.org/10.1371/journal.pone.0108269			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IP	25259846	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600058
J	Fors, L; Markus, R; Theopold, U; Hamback, PA				Fors, Lisa; Markus, Robert; Theopold, Ulrich; Hamback, Peter A.			Differences in Cellular Immune Competence Explain Parasitoid Resistance for Two Coleopteran Species	PLOS ONE			English	Article							DROSOPHILA; DEFENSE; LARVAE; CHRYSOMELIDAE; PHENOLOXIDASE; PHAGOCYTOSIS; COAGULATION; PLASTICITY; HEMOCYTES; PATTERNS	The immune defence of an organism is evolving continuously, causing counteradaptations in interacting species, which in turn affect other ecological and evolutionary processes. Until recently comparative studies of species interactions and immunity, combining information from both ecological and immunological fields, have been rare. The cellular immune defense in insects, mainly mediated by circulating hemocytes, has been studied primarily in Lepidoptera and Diptera, whereas corresponding information about coleopteran species is still scarce. In the study presented here, we used two closely related chrysomelids, Galerucella pusilla and G. calmariensis (Coleoptera), both attacked by the same parasitoid, Asecodes parviclava (Hymenoptera). In order to investigate the structure of the immune system in Galerucella and to detect possible differences between the two species, we combined ecological studies with controlled parasitism experiments, followed by an investigation of the cell composition in the larval hemolymph. We found a striking difference in parasitism rate between the species, as well as in the level of successful immune response (i.e. encapsulation and melanisation of parasitoid eggs), with G. pusilla showing a much more potent immune defense than G. calmariensis. These differences were linked to differences in the larval cell composition, where hemocyte subsets in both naive and parasitised individuals differed significantly between the species. In particular, the hemocytes shown to be active in the encapsulation process; phagocytes, lamellocytes and granulocytes, differ between the species, indicating that the cell composition reflects the ability to defend against the parasitoid.	[Fors, Lisa; Hamback, Peter A.] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Markus, Robert] Stockholm Univ, Dept Neurosci, S-10691 Stockholm, Sweden; [Theopold, Ulrich] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University; Stockholm University	Fors, L (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	Lisa.Fors@su.se	Hambäck, Peter A/A-8194-2008; Theopold, Ulrich/P-7205-2015	Hambäck, Peter A/0000-0001-6362-6199; Theopold, Ulrich/0000-0002-1009-8254; Markus, Robert/0000-0003-4535-303X	Swedish Research Council Vetenskapsradet [621-2009-4943]	Swedish Research Council Vetenskapsradet(Swedish Research Council)	This paper was supported by grant #621-2009-4943 from the Swedish Research Council Vetenskapsradet (to PAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidla G, 2005, DEV COMP IMMUNOL, V29, P669, DOI 10.1016/j.dci.2004.11.007; Bidla G, 2007, J CELL SCI, V120, P1209, DOI 10.1242/jcs.03420; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Chapman R. F., 1969, INSECTS STRUCTURE FU; Cosse AA, 2004, J ENTOMOL SCI, V39, P281, DOI 10.18474/0749-8004-39.2.281; Dushay MS, 2009, CELL MOL LIFE SCI, V66, P2643, DOI 10.1007/s00018-009-0036-0; Giglio A, 2008, MICRON, V39, P552, DOI 10.1016/j.micron.2007.07.004; Gwynn DM, 2005, P ROY SOC B-BIOL SCI, V272, P1803, DOI 10.1098/rspb.2005.3089; Hamback PA, 2006, OECOLOGIA, V148, P475, DOI 10.1007/s00442-006-0387-2; Hamback Peter, 2004, Entomologisk Tidskrift, V125, P93; Hamback PA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-92; Hansson C, 2013, J HYMENOPT RES, V30, P51, DOI 10.3897/JHR.30.4279; Honti V, 2010, MOL IMMUNOL, V47, P1997, DOI 10.1016/j.molimm.2010.04.017; Jiang H, 2010, ADV EXP MED BIOL, V708, P181; Kounatidis I, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120075; Kraaijeveld AR, 1998, PARASITOLOGY, V116, pS29, DOI 10.1017/S0031182000084924; Kraaijeveld AR, 1999, AM NAT, V153, pS61, DOI 10.1086/303212; Kurucz E, 2007, ACTA BIOL HUNG, V58, P95, DOI 10.1556/ABiol.58.2007.Suppl.8; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Manachini B, 2011, J INVERTEBR PATHOL, V106, P360, DOI 10.1016/j.jip.2010.12.006; Mikkola K, 2010, BIOL J LINN SOC, V99, P831, DOI 10.1111/j.1095-8312.2010.01398.x; Ojala K, 2005, EVOL ECOL RES, V7, P1153; Pham LN, 2008, INSECT IMMUNOLOGY, P97, DOI 10.1016/B978-012373976-6.50007-0; Ratcliffe N.A., 1979, P331, DOI 10.1017/CBO9780511759987.014; RIZKI RM, 1990, J INSECT PHYSIOL, V36, P523, DOI 10.1016/0022-1910(90)90104-N; RIZKI TM, 1992, DEV COMP IMMUNOL, V16, P103, DOI 10.1016/0145-305X(92)90011-Z; SALT G, 1967, FED PROC, V26, P1671; Schulenburg H, 2009, PHILOS T R SOC B, V364, P3, DOI 10.1098/rstb.2008.0249; Shrestha S, 2008, INSECT BIOCHEM MOLEC, V38, P99, DOI 10.1016/j.ibmb.2007.09.013; Stenberg JA, 2007, OIKOS, V116, P482, DOI [10.1111/j.2006.0030-1299.15357.x, 10.1111/j.0030-1299.2007.15357.x]; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Vilcinskas A, 2013, J INSECT PHYSIOL, V59, P123, DOI 10.1016/j.jinsphys.2012.08.018; Wertheim B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r94	36	17	18	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108795	10.1371/journal.pone.0108795	http://dx.doi.org/10.1371/journal.pone.0108795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259576	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600102
J	Menai, M; Fezeu, L; Charreire, H; Kesse-Guyot, E; Touvier, M; Simon, C; Weber, C; Andreeva, VA; Hercberg, S; Oppert, JM				Menai, Mehdi; Fezeu, Leopold; Charreire, Helene; Kesse-Guyot, Emmanuelle; Touvier, Mathilde; Simon, Chantal; Weber, Christiane; Andreeva, Valentina A.; Hercberg, Serge; Oppert, Jean-Michel			Changes in Sedentary Behaviours and Associations with Physical Activity through Retirement: A 6-Year Longitudinal Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; ANTIOXIDANT VITAMINS; WHITEHALL-II; PREVENTION; TIME; QUESTIONNAIRE; METAANALYSIS; POPULATION; SU.VI.MAX	Changes in sedentary behaviours and physical activity according to retirement status need to be better defined. Retirement is a critical life period that may influence a number of health behaviours. We assessed past-year sedentary behaviours (television, computer and reading time during leisure, occupational and domestic sitting time, in h/week) and physical activity (leisure, occupational and domestic, in h/week) over 6 years (2000-2001 and 2007) using the Modifiable Activity Questionnaire in 2,841 participants (mean age: 57.3 +/- 5.0 y) of the SU.VI.MAX (Supplementation with Antioxidants and Minerals) cohort. Analyses were performed according to retirement status. Subjects retired in 2001 and 2007 (40%) were those who spent most time in sedentary behaviour and in physical activity during and outside leisure (p<0.001). Leisure-time sedentary behaviours increased in all subjects during follow-up (p<0.001), but subjects who retired between 2001 and 2007 (31%) were those who reported the greatest changes (+8.4 +/- 0.42 h/week for a combined indicator of leisure-time sedentary behaviour). They also had the greatest increase in time spent in leisure-time physical activity (+2.5 +/- 0.2 h/week). In subjects not retired 2001 and 2007 (29%), changes in time spent watching television were found positively associated with an increase in occupational physical activity (p = 0.04) and negatively associated with changes in leisure-time physical activity (p = 0.02). No consistent association between changes in sedentary behaviours and changes in physical activity was observed in subjects retired in 2001 and 2007. Public health interventions should target retiring age populations not only to encourage physical activity but also to limit sedentary behaviours.	[Menai, Mehdi; Fezeu, Leopold; Charreire, Helene; Kesse-Guyot, Emmanuelle; Touvier, Mathilde; Andreeva, Valentina A.; Hercberg, Serge; Oppert, Jean-Michel] Univ Paris 13, Sorbonne Paris Cite, EREN,Inserm U1153, Inra,Cnam,Ctr Rech Epidemiol & Biostat,CRNH IdF, Bobigny, France; [Charreire, Helene] Paris Est Creteil Univ, Dept Geog, Lab Urba, Urbanism Inst Paris, Paris, France; [Simon, Chantal] Univ Lyon 1, CARMEN, INSERM U1060, INRA Lyon U1235, F-69622 Villeurbanne, France; [Weber, Christiane] Univ Strasbourg, Lab Image Ville & Environm, Strasbourg, France; [Hercberg, Serge] Hop Avicenne, AP HP, Dept Publ Hlth, F-93009 Bobigny, France; [Oppert, Jean-Michel] Univ Paris 06, Pitie Salpetriere Hosp, AP HP, Dept Nutr,CRNH IdF,ICAN, Paris, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Oppert, JM (corresponding author), Univ Paris 13, Sorbonne Paris Cite, EREN,Inserm U1153, Inra,Cnam,Ctr Rech Epidemiol & Biostat,CRNH IdF, Bobigny, France.	jean-michel.oppert@psl.aphp.fr	Oppert, Jean-Michel/F-2810-2017; HERCBERG, Serge/B-4429-2008; Touvier, Mathilde/E-8817-2017; Charreire, Helene/F-3037-2017; , simon/B-2895-2011; Kesse-Guyot, Emmanuelle/F-2692-2017; Kesse-Guyot, Emmanuelle/K-4689-2012; Carmen, Team1/Y-7382-2019; Kesse-Guyot, Emmanuelle/ABH-7347-2020; Fezeu, Leopold/F-2804-2017; Serge, Hercberg/F-3038-2017; Andreeva, Valentina/F-2680-2017	HERCBERG, Serge/0000-0002-3168-1350; Touvier, Mathilde/0000-0002-8322-8857; Charreire, Helene/0000-0002-1260-9812; , simon/0000-0002-7820-3233; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Carmen, Team1/0000-0003-4234-1746; Fezeu, Leopold/0000-0002-7589-3179; Serge, Hercberg/0000-0002-3168-1350; Andreeva, Valentina/0000-0001-9480-5210; Lab, Carmen/0000-0002-5935-3236	French National Research Agency [ANR-05-PNRA-010]; French National Cancer Institute [INCa 2011-1-PL-SHS-10]; French Ministry of Health, Mederic, Sodexo, Ipsen, MGEN; Pierre Fabre	French National Research Agency(French National Research Agency (ANR)); French National Cancer Institute(Institut National du Cancer (INCA) France); French Ministry of Health, Mederic, Sodexo, Ipsen, MGEN; Pierre Fabre	This work was funded by the French National Research Agency (ANR-05-PNRA-010), the French National Cancer Institute (INCa 2011-1-PL-SHS-10), the French Ministry of Health, Mederic, Sodexo, Ipsen, MGEN and Pierre Fabre. Mederic and MGEN are French health insurance organizations, which are complementary to the National Health Insurance System. Ipsen and Pierre Fabre are private pharmaceutical companies. Sodexo, a food catering company, supported the study by organizing meetings between researchers and study participants. They financially supported the overall implementation of the research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Barnes DE, 2007, EXERC SPORT SCI REV, V35, P24, DOI 10.1097/JES.0b013e31802d6bc2; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Barnett I, 2014, J EPIDEMIOL COMMUN H, V68, P747, DOI 10.1136/jech-2013-203225; Barnett I, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-97; Berger U, 2005, AGEING SOC, V25, P181, DOI 10.1017/S0144686X04002739; Bigot R., 2013, DIFFUSION TECHNOLOGI; Brown WJ, 2009, ANN BEHAV MED, V37, P294, DOI 10.1007/s12160-009-9099-2; Da Silva MA, 2012, EUR J EPIDEMIOL, V27, P537, DOI 10.1007/s10654-012-9692-8; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ekerdt DJ, 2010, J GERONTOL B-PSYCHOL, V65, P69, DOI 10.1093/geronb/gbp109; Evenson KR, 2002, AM J EPIDEMIOL, V155, P692, DOI 10.1093/aje/155.8.692; Glamser F. D., 1985, Therapeutic Recreation Journal, V19, P28; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hercberg S, 1998, CONTROL CLIN TRIALS, V19, P336, DOI 10.1016/S0197-2456(98)00015-4; Kaleta Dorota, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P175, DOI 10.2478/v10001-007-0019-z; Koster A., 2012, PLOS ONE, V7, DOI [10.1371/journal.-pone.0037696, DOI 10.1371/journal.pone.0037696]; KRISKA AM, 1990, DIABETES CARE, V13, P401, DOI 10.2337/diacare.13.4.401; Lemanne D, 2013, ONCOLOGY-NY, V27, P580; Mein GK, 2005, EUR J PUBLIC HEALTH, V15, P317, DOI 10.1093/eurpub/cki087; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Pereira M A, 1997, Med Sci Sports Exerc, V29, pS1; Pereira SMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031132; Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Slingerland AS, 2007, AM J EPIDEMIOL, V165, P1356, DOI 10.1093/aje/kwm053; Sugiyama T, 2007, AM J PREV MED, V33, P444, DOI 10.1016/j.amepre.2007.07.035; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Touvier M, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-14; Vuillemin A, 2000, MED SCI SPORT EXER, V32, P1119, DOI 10.1097/00005768-200006000-00013	33	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e106850	10.1371/journal.pone.0106850	http://dx.doi.org/10.1371/journal.pone.0106850			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259801	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600009
J	Turek, D; Klimes, P; Mazura, P; Brzobohaty, B				Turek, Dusan; Klimes, Pavel; Mazura, Pavel; Brzobohaty, Bretislav			Combining Rational and Random Strategies in beta-Glucosidase Zm-p60.1 Protein Library Construction	PLOS ONE			English	Article							SUBSTRATE AGLYCONE SPECIFICITY; CRYSTAL-STRUCTURES; MAIZE; EXPRESSION; CYTOKININ; MUTAGENESIS; EVOLUTION; INSIGHTS; COMPLEX; SITE	Saturation mutagenesis is a cornerstone technique in protein engineering because of its utility (in conjunction with appropriate analytical techniques) for assessing effects of varying residues at selected positions on proteins' structures and functions. Site-directed mutagenesis with degenerate primers is the simplest and most rapid saturation mutagenesis technique. Thus, it is highly appropriate for assessing whether or not variation at certain sites is permissible, but not necessarily the most time-and cost-effective technique for detailed assessment of variations' effects. Thus, in the presented study we applied the technique to randomize position W373 in beta-glucosidase Zm-p60.1, which is highly conserved among beta-glucosidases. Unexpectedly, beta-glucosidase activity screening of the generated variants showed that most variants were active, although they generally had significantly lower activity than the wild type enzyme. Further characterization of the library led us to conclude that a carefully selected combination of randomized codon-based saturation mutagenesis and site-directed mutagenesis may be most efficient, particularly when constructing and investigating randomized libraries with high fractions of positive hits.	[Turek, Dusan; Klimes, Pavel; Mazura, Pavel; Brzobohaty, Bretislav] Mendel Univ Brno, Inst Biophys AS CR, Vvi CEITEC Cent European Inst Technol, Plant Mol Biol Lab, Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Mendel University in Brno	Mazura, P (corresponding author), Mendel Univ Brno, Inst Biophys AS CR, Vvi CEITEC Cent European Inst Technol, Plant Mol Biol Lab, Brno, Czech Republic.	mazura@sci.muni.cz	Mazura, Pavel/D-7959-2012; Brzobohaty, Bretislav/D-7212-2012	Brzobohaty, Bretislav/0000-0002-1552-1314; Mazura, Pavel/0000-0003-2797-9338	Ministry of Education, Youth, and Sports of the Czech Republic [LM2010005]; Ministry of Education, Youth and Sports of the Czech Republic [LC06034]; Czech Science Foundation [P305/11/P768]; project CEITEC - Central European Institute of Technology from the European Regional Development Fund [CZ.1.05/1.1.00/02.0068]	Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); project CEITEC - Central European Institute of Technology from the European Regional Development Fund	Access to the MetaCentrum computing facilities provided under the program "Projects of Large Infrastructure for Research, Development, and Innovations" LM2010005, funded by the Ministry of Education, Youth, and Sports of the Czech Republic, is highly appreciated. This project was supported by grant nos. LC06034 (Ministry of Education, Youth and Sports of the Czech Republic), P305/11/P768 (to PM) from the Czech Science Foundation (http://www.gacr.cz/en/). This work was supported by the project CEITEC - Central European Institute of Technology (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund (http://europa.eu/legislation_summaries/regional_policy/provisions_and_instruments/g24234_en.htm). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRZOBOHATY B, 1993, SCIENCE, V262, P1051, DOI 10.1126/science.8235622; Czjzek M, 2000, P NATL ACAD SCI USA, V97, P13555, DOI 10.1073/pnas.97.25.13555; Dopitova R, 2008, FEBS J, V275, P6123, DOI 10.1111/j.1742-4658.2008.06735.x; FALK A, 1995, PLANT PHYSIOL, V108, P1369, DOI 10.1104/pp.108.4.1369; Filipi T, 2012, PHYTOCHEMISTRY, V74, P40, DOI 10.1016/j.phytochem.2011.10.008; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Kiran NS, 2006, J EXP BOT, V57, P985, DOI 10.1093/jxb/erj084; Madan R, 2005, J BACTERIOL, V187, P7912, DOI 10.1128/JB.187.23.7912-7917.2005; Mazura P, 2011, CARBOHYD RES, V346, P238, DOI 10.1016/j.carres.2010.08.016; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Patrick WM, 2003, PROTEIN ENG, V16, P451, DOI 10.1093/protein/gzg057; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Saino H, 2014, J BIOL CHEM, V289, P16826, DOI 10.1074/jbc.M114.553271; Tang LX, 2012, BIOTECHNIQUES, V52, P149, DOI 10.2144/000113820; Tribolo S, 2007, J MOL BIOL, V370, P964, DOI 10.1016/j.jmb.2007.05.034; Verdoucq L, 2004, J BIOL CHEM, V279, P31796, DOI 10.1074/jbc.M402918200; Verdoucq L, 2003, J BIOL CHEM, V278, P25055, DOI 10.1074/jbc.M301978200; Zhao L, 2012, GENES GENOM, V34, P179, DOI 10.1007/s13258-011-0156-4; Zouhar J, 2001, PLANT PHYSIOL, V127, P973, DOI 10.1104/pp.010712	19	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108292	10.1371/journal.pone.0108292	http://dx.doi.org/10.1371/journal.pone.0108292			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25260034	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600060
J	Zhang, H; Liang, X; Duan, C; Liu, CG; Zhao, ZW				Zhang, Hao; Liang, Xi; Duan, Chao; Liu, Caigang; Zhao, Zuowei			Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; ARSENIC TRIOXIDE; CARCINOMA CELLS; PROGESTERONE-RECEPTOR; EXPRESSION; TUMORIGENICITY	Galectin-3 has a relatively high level of expression in triple-negative breast cancers and is a potential marker for this disease. However, the clinical and prognostic implications of galectin-3 expression in breast cancer remain unclear. We examined mastectomy specimens from 1086 breast cancer cases and matching, adjacent non-cancerous tissues using immunohistochemistry. Overall, triple-negative breast cancers expressed galectin-3 more strongly than did other breast cancers types (63.59% vs 21.36%, P = 0.001). Galectin-3 expression was not found to be an independent prognostic factor for breast cancer by Cox regression analysis, but was associated with chemotherapeutic resistance. Apoptosis was only weakly induced by arsenic trioxide (ATO) treatment in galectin-3-positive breast cancer cells (MDA-MB-231 and MCF-7), although ATO treatment up-regulated galectin-3 expression. Knockdown of galectin-3 in MDA-MB-231 cells sensitized them to killing by ATO. These findings support a possible role for galectin-3 as a marker for triple-negative breast cancer progression and as a therapeutic target in combination with ATO treatment, although the mechanisms that underlie this synergy require further investigation.	[Zhang, Hao; Liang, Xi; Liu, Caigang; Zhao, Zuowei] Dalian Med Univ, Hosp 2, Dept Breast Surg, Dalian, Peoples R China; [Duan, Chao] Benxi Cent Hosp, Dept Cardiothorac, Benxi, Peoples R China	Dalian Medical University	Liu, CG (corresponding author), Dalian Med Univ, Hosp 2, Dept Breast Surg, Dalian, Peoples R China.	angel-s205@163.com	Liu, Caigang/C-7179-2018	Liu, Caigang/0000-0003-2083-235X; Zhang, Hao/0000-0002-0049-1220	China National Natural Science Foundation [81102029, 81172047]; Liaoning National Natural Science Foundation [2013021006]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Liaoning National Natural Science Foundation	This study was funded by the China National Natural Science Foundation (No. 81102029 and 81172047) and Liaoning National Natural Science Foundation (No. 2013021006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baj G, 2002, BREAST CANCER RES TR, V73, P61, DOI 10.1023/A:1015272401822; BAO Q, 1995, J CELL SCI, V108, P2791; Berenson JR, 2006, CLIN LYMPHOMA MYELOM, V7, P192, DOI 10.3816/CLM.2006.n.058; Chen Z, 2002, SEMIN HEMATOL, V39, P22, DOI 10.1053/shem.2002.33611; Chow SKY, 2004, J ENDOCRINOL, V182, P325, DOI 10.1677/joe.0.1820325; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; Dilda PJ, 2007, CANCER TREAT REV, V33, P542, DOI 10.1016/j.ctrv.2007.05.001; Evens AM, 2004, LEUKEMIA RES, V28, P891, DOI 10.1016/j.leukres.2004.01.011; Gaffan J, 2006, J CLIN ONCOL, V24, P1932, DOI 10.1200/JCO.2005.02.6617; Honjo Y, 2001, CLIN CANCER RES, V7, P661; Kasami M, 2008, BREAST, V17, P523, DOI 10.1016/j.breast.2008.04.002; Koo JS, 2011, YONSEI MED J, V52, P89, DOI 10.3349/ymj.2011.52.1.89; LeMarer N, 1996, J CELL PHYSIOL, V168, P51, DOI 10.1002/(SICI)1097-4652(199607)168:1<51::AID-JCP7>3.0.CO;2-7; Ma CX, 2009, ONCOLOGY-NY, V23, P133; Moon BK, 2001, AM J PATHOL, V159, P1055, DOI 10.1016/S0002-9440(10)61780-4; Murgo AJ, 2001, ONCOLOGIST, V6, P22, DOI 10.1634/theoncologist.6-suppl_2-22; NANGIAMAKKER P, 1995, INT J ONCOL, V7, P1079; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Rody A, 2004, ONCOL REP, V12, P695; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; SATO S, 1992, J BIOL CHEM, V267, P6983; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tallman MS, 2008, BEST PRACT RES CL HA, V21, P659, DOI 10.1016/j.beha.2008.09.002; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Verstovsek S, 2006, HEMATOL ONCOL, V24, P181, DOI 10.1002/hon.787	26	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e103482	10.1371/journal.pone.0103482	http://dx.doi.org/10.1371/journal.pone.0103482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254965	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300003
J	Zhou, HQ; Ning, LW; Zhang, HX; Guo, FB				Zhou, Hui-Qi; Ning, Lu-Wen; Zhang, Hui-Xiong; Guo, Feng-Biao			Analysis of the Relationship between Genomic GC Content and Patterns of Base Usage, Codon Usage and Amino Acid Usage in Prokaryotes: Similar GC Content Adopts Similar Compositional Frequencies Regardless of the Phylogenetic Lineages	PLOS ONE			English	Article							HIGHLY EXPRESSED GENES; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE BIAS; MUTATIONAL BIAS; SELECTION; PROTEINS; DNA; INFLUENZAE; ORGANISMS; PRESSURE	The GC contents of 2670 prokaryotic genomes that belong to diverse phylogenetic lineages were analyzed in this paper. These genomes had GC contents that ranged from 13.5% to 74.9%. We analyzed the distance of base frequencies at the three codon positions, codon frequencies, and amino acid compositions across genomes with respect to the differences in the GC content of these prokaryotic species. We found that although the phylogenetic lineages were remote among some species, a similar genomic GC content forced them to adopt similar base usage patterns at the three codon positions, codon usage patterns, and amino acid usage patterns. Our work demonstrates that in prokaryotic genomes: a) base usage, codon usage, and amino acid usage change with GC content with a linear correlation; b) the distance of each usage has a linear correlation with the GC content difference; and c) GC content is more essential than phylogenetic lineage in determining base usage, codon usage, and amino acid usage. This work is exceptional in that we adopted intuitively graphic methods for all analyses, and we used these analyses to examine as many as 2670 prokaryotes. We hope that this work is helpful for understanding common features in the organization of microbial genomes.	[Ning, Lu-Wen] Univ Elect Sci & Technol China, Ctr Bioinformat, Chengdu 610054, Peoples R China; Univ Elect Sci & Technol China, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Guo, FB (corresponding author), Univ Elect Sci & Technol China, Ctr Bioinformat, Chengdu 610054, Peoples R China.	fbguo@uestc.edu.cn	Guo, Feng-Biao/C-2761-2015	Guo, Feng-Biao/0000-0002-1129-5233	National Natural Science Foundation of China [31470068]; Program for New Century Excellent Talents in University [NCET-11-0059]; Sichuan Youth Science and Technology Foundation of China [2014JQ0051]; Fundamental Research Funds for the Central Universities of China [ZYGX2013J100, ZYGX2013J101]; China Postdoctoral Science Foundation [2013M540705]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Sichuan Youth Science and Technology Foundation of China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This study was supported by the National Natural Science Foundation of China (grant number 31470068); the Program for New Century Excellent Talents in University (grant number NCET-11-0059); Sichuan Youth Science and Technology Foundation of China (grant number 2014JQ0051); the Fundamental Research Funds for the Central Universities of China (grant numbers ZYGX2013J100 and ZYGX2013J101); and the China Postdoctoral Science Foundation (grant number 2013M540705). The project was also sponsored by Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee T, 2005, BIOSYSTEMS, V81, P11, DOI 10.1016/j.biosystems.2005.01.002; Chen LL, 2003, BIOCHEM BIOPH RES CO, V306, P310, DOI 10.1016/S0006-291X(03)00973-2; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Goodfellow M, 1993, ROOTS BACTERIAL SYST, P3; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, P1893, DOI 10.1093/nar/8.9.1893; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, P197, DOI DOI 10.1093/NAR/8.1.197-C; Gu X, 1998, GENETICA, V102-3, P383, DOI 10.1023/A:1017028102013; Gupta RS, 2000, FEMS MICROBIOL REV, V24, P367, DOI 10.1111/j.1574-6976.2000.tb00547.x; Gupta SK, 2001, GENE, V273, P63, DOI 10.1016/S0378-1119(01)00576-5; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Lightfield J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017677; Lobry JR, 1997, GENE, V205, P309, DOI 10.1016/S0378-1119(97)00403-4; MUTO A, 1987, P NATL ACAD SCI USA, V84, P166, DOI 10.1073/pnas.84.1.166; OHAMA T, 1990, NUCLEIC ACIDS RES, V18, P1565, DOI 10.1093/nar/18.6.1565; Pan A, 1998, GENE, V215, P405, DOI 10.1016/S0378-1119(98)00257-1; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; SHARP PM, 1989, NUCLEIC ACIDS RES, V17, P5029, DOI 10.1093/nar/17.13.5029; SHIELDS DC, 1988, MOL BIOL EVOL, V5, P704; Singer GAC, 2000, MOL BIOL EVOL, V17, P1581, DOI 10.1093/oxfordjournals.molbev.a026257; SUEOKA N, 1962, P NATL ACAD SCI USA, V48, P582, DOI 10.1073/pnas.48.4.582; SUEOKA N, 1961, P NATL ACAD SCI USA, V47, P1141, DOI 10.1073/pnas.47.8.1141; Tan HD, 2008, YEAST, V25, P29, DOI 10.1002/yea.1547; Wan XF, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-19; Wilquet V, 1999, RES MICROBIOL, V150, P21, DOI 10.1016/S0923-2508(99)80043-6; Zhang CT, 2004, COMPUT BIOL CHEM, V28, P149, DOI 10.1016/j.compbiolchem.2004.02.002	26	18	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107319	10.1371/journal.pone.0107319	http://dx.doi.org/10.1371/journal.pone.0107319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255224	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300021
J	Doskaya, M; Caner, A; Can, H; Iz, SG; Gedik, Y; Doskaya, AD; Kalantari-Dehaghi, M; Guruz, Y				Doskaya, Mert; Caner, Ayse; Can, Huseyin; Iz, Sultan Gulce; Gedik, Yaprak; Doskaya, Aysu Degirmenci; Kalantari-Dehaghi, Mina; Guruz, Yuksel			Diagnostic Value of a Rec-ELISA Using Toxoplasma gondii Recombinant SporoSAG, BAG1, and GRA1 Proteins in Murine Models Infected Orally with Tissue Cysts and Oocysts	PLOS ONE			English	Article							IMMUNOGLOBULIN-G ANTIBODIES; LINKED-IMMUNOSORBENT-ASSAY; DENSE GRANULE ANTIGENS; STAGE CONVERSION; PREGNANT-WOMEN; SERODIAGNOSIS; AVIDITY; MICE; IDENTIFICATION; RESPONSES	Toxoplasma gondii causes congenital toxoplasmosis in newborns resulting with fetal anomalies. Determining the initiation time of infection is very important for pregnant women and current serological assays have drawbacks in distinguishing the recently acute toxoplasmosis. Diagnosis of recently acute infection may be improved by using stage specific antigens in serological assays. In the present study, the diagnostic value of sporozoite specific SporoSAG, bradyzoite specific BAG1 proteins and GRA1 protein expressed by all forms of the parasite have been evaluated ELISA using sera systematically collected from mice administered orally with tissue cyst and oocysts. The anti-SporoSAG IgM antibodies in sera obtained from mice infected with oocysts peaked significantly at days 1, 10, and 15 (P<0.01). The anti-BAG1 IgM antibodies in sera obtained from mice infected with tissue cysts peaked significantly at days 15, 40, and 120 (P<0.05). The anti-GRA1 IgM antibodies in sera obtained from mice infected with oocysts peaked significantly at days 2, 10, and 40 (P<0.01). The anti-GRA1 IgM antibodies in sera obtained from mice infected with tissue cysts peaked significantly only at day 40 (P<0.05). The anti-SporoSAG, anti-BAG1, and anti-GRA1 IgG titers of mice showed significant increases at day 40 (P<0.05) and decrement started for only anti-GRA1 IgG at day 120. The presence of anti-SporoSAG IgM and IgG antibodies can be interpreted as recently acute infection between days 10-40 because IgM decreases at day 40. Similarly, presence of anti-BAG1 IgM and absence of IgG can be evaluated as a recently acute infection that occurred 40 days before because IgG peaks at day 40. A peak in anti-GRA1 antibody level at first testing and reduction in consecutive sample can be considered as an infection approximately around day 40 or prior. Overall, recombinant SporoSAG, BAG1 and GRA1 proteins can be accepted as valuable diagnostic markers of recently acute toxoplasmosis.	[Doskaya, Mert; Caner, Ayse; Can, Huseyin; Gedik, Yaprak; Doskaya, Aysu Degirmenci; Guruz, Yuksel] Ege Univ, Sch Med, Dept Parasitol, Bornova, Turkey; [Can, Huseyin] Ege Univ, Fac Sci, Dept Mol Biol, Bornova, Turkey; [Iz, Sultan Gulce; Gedik, Yaprak] Ege Univ, Fac Engn, Dept Bioengn, Bornova, Turkey; [Kalantari-Dehaghi, Mina] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA	Ege University; Ege University; Ege University; University of California System; University of California Irvine	Doskaya, M (corresponding author), Ege Univ, Sch Med, Dept Parasitol, Bornova, Turkey.	mert.doskaya@ege.edu.tr	Iz, Gulce/C-4174-2013; Degirmenci, Aysu/DET-8805-2022; Can, Hüseyin/AAG-3152-2020; Doskaya, Mert/W-4682-2017; Can, Hüseyin/J-2987-2019; Caner, Ayse/AAG-8982-2019	Can, Hüseyin/0000-0001-9633-9786; Doskaya, Mert/0000-0001-6868-008X; Caner, Ayse/0000-0003-3058-9971; Gulce Iz, Sultan/0000-0002-9275-6272	Scientific and Technological Research Council of Turkey [107S359]; Scientific Research Projects Branch Directorate of Ege University [2007TIP015]	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Scientific Research Projects Branch Directorate of Ege University(Ege University)	This study was supported partly by the grants given by The Scientific and Technological Research Council of Turkey (107S359) and the Scientific Research Projects Branch Directorate of Ege University (2007TIP015) to Yuksel Guruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert D, 2000, J CLIN MICROBIOL, V38, P1144, DOI 10.1128/JCM.38.3.1144-1150.2000; Beghetto E, 2006, J CLIN MICROBIOL, V44, P2133, DOI 10.1128/JCM.00237-06; Bela SR, 2008, DIAGN MICR INFEC DIS, V62, P245, DOI 10.1016/j.diagmicrobio.2008.05.017; BOHNE W, 1995, MOL MICROBIOL, V16, P1221, DOI 10.1111/j.1365-2958.1995.tb02344.x; Buffolano W, 2005, J CLIN MICROBIOL, V43, P5916, DOI 10.1128/JCM.43.12.5916-5924.2005; CESBRONDELAUW MF, 1994, PARASITOL TODAY, V10, P293, DOI 10.1016/0169-4758(94)90078-7; CESBRONDELAUW MF, 1989, P NATL ACAD SCI USA, V86, P7537, DOI 10.1073/pnas.86.19.7537; CHARDES T, 1990, INFECT IMMUN, V58, P1240; Cleary MD, 2002, EUKARYOT CELL, V1, P329, DOI 10.1128/EC.1.3.329-340.2002; Coceres VM, 2010, EXP PARASITOL, V126, P263, DOI 10.1016/j.exppara.2010.04.013; Crawford J, 2010, J BIOL CHEM, V285, P12063, DOI 10.1074/jbc.M109.054866; Dai JF, 2012, CLIN VACCINE IMMUNOL, V19, P338, DOI 10.1128/CVI.05553-11; Di Cristina M, 2004, MICROBES INFECT, V6, P164, DOI 10.1016/j.micinf.2003.11.009; Doskaya M, 2007, VACCINE, V25, P1824, DOI 10.1016/j.vaccine.2006.10.060; Dubey J.P., 1988, TOXOPLASMOSIS ANIMAL; Dubey JP, 1997, J EUKARYOT MICROBIOL, V44, P592, DOI 10.1111/j.1550-7408.1997.tb05965.x; Dubey JP, 1997, J PARASITOL, V83, P870, DOI 10.2307/3284282; Dumetre A, 2004, J MICROBIOL METH, V56, P427, DOI 10.1016/j.mimet.2003.11.020; Ferrandiz J, 2004, CLIN DIAGN LAB IMMUN, V11, P1016, DOI 10.1128/CDLI.11.6.1016-1021.2004; Fritz HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029998; Gatkowska J, 2006, EXP PARASITOL, V114, P220, DOI 10.1016/j.exppara.2006.03.011; Gatkowska J, 2010, POL J MICROBIOL, V59, P137, DOI 10.33073/pjm-2010-022; Harning D, 1996, CLIN DIAGN LAB IMMUN, V3, P355, DOI 10.1128/CDLI.3.3.355-357.1996; Holec L, 2008, EXP PARASITOL, V119, P1, DOI 10.1016/j.exppara.2007.12.002; Holec-Gasior L, 2012, CLIN VACCINE IMMUNOL, V19, P57, DOI 10.1128/CVI.05433-11; Holec-Gasior L, 2010, EXP PARASITOL, V124, P272, DOI 10.1016/j.exppara.2009.10.010; Holec-Gasior L, 2009, CLIN VACCINE IMMUNOL, V16, P510, DOI 10.1128/CVI.00341-08; Jacobs D, 1999, CLIN DIAGN LAB IMMUN, V6, P24, DOI 10.1128/CDLI.6.1.24-29.1999; Joynson D.H., 2005, TOXOPLASMOSIS COMPRE; Lecordier L, 2000, CLIN DIAGN LAB IMMUN, V7, P607, DOI 10.1128/CDLI.7.4.607-611.2000; Martin V, 1998, CLIN DIAGN LAB IMMUN, V5, P627, DOI 10.1128/CDLI.5.5.627-631.1998; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nakajima-Nakano Kyoko, 2000, Parasitology International, V48, P215, DOI 10.1016/S1383-5769(99)00019-7; Nigro M, 2003, DIAGN MICR INFEC DIS, V47, P609, DOI 10.1016/S0732-8893(03)00156-1; Pfrepper KI, 2005, CLIN DIAGN LAB IMMUN, V12, P977, DOI 10.1128/CDLI.12.8.977-982.2005; Pietkiewicz H, 2007, PARASITOL RES, V100, P333, DOI 10.1007/s00436-006-0265-1; Pietkiewicz H, 2004, J CLIN MICROBIOL, V42, P1779, DOI 10.1128/JCM.42.4.1779-1781.2004; Possenti A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-183; Radke JR, 2004, MOL MICROBIOL, V52, P93, DOI 10.1111/j.1365-2958.2003.03967.x; Redlich A, 1998, PARASITOL RES, V84, P700, DOI 10.1007/s004360050473; Staggs SE, 2009, J VIS EXP, V3, P33; Suzuki Y, 2000, J CLIN MICROBIOL, V38, P3967, DOI 10.1128/JCM.38.11.3967-3970.2000; Tilley M, 1997, INFECT IMMUN, V65, P4598, DOI 10.1128/IAI.65.11.4598-4605.1997; Weiss L.M, 2007, TOXOPLASMA GONDII MO, DOI DOI 10.1016/B978-012369542-0/50015-5	44	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108329	10.1371/journal.pone.0108329	http://dx.doi.org/10.1371/journal.pone.0108329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268351	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700080
J	Hedil, M; Hassani-Mehraban, A; Lohuis, D; Kormelink, R				Hedil, Marcio; Hassani-Mehraban, Afshin; Lohuis, Dick; Kormelink, Richard			Analysis of the A-U Rich Hairpin from the Intergenic Region of Tospovirus S RNA as Target and Inducer of RNA Silencing	PLOS ONE			English	Article							SPOTTED-WILT-VIRUS; SHORT INTERFERING RNAS; DOUBLE-STRANDED-RNA; SUPPRESSOR; GENE; PROTEIN; SEQUENCE; ARABIDOPSIS; EXPRESSION; RESISTANCE	Earlier work indicated that Tomato spotted wilt virus (TSWV) messenger transcripts, and not the (anti) genomic RNAs, are targeted by the RNA silencing machinery. Here, the predicted AU-rich hairpin (HP) structure encoded by the intergenic region (IGR) of the TSWV S RNA, and present at the 3' end of viral mRNAs, was analyzed as a target and inducer for RNA silencing. Virus-derived siRNAs (vsiRNAs) purified from virus infected plants were found to derive from all three genomic RNA segments but predominantly the ambisense M and S RNAs. Further profiling on the S RNA sequence revealed that vsiRNAs were found from almost the entire S RNA sequence, except the IGR from where hardly any vsiRNAs were found. Similar profiles were observed with the distantly related Tomato yellow ring tospovirus (TYRV). Dicer cleavage assays using Drosophila melanogaster (Dm) embryo extracts showed that synthetic transcripts of the IGR-HP region were recognized as substrate for Dicer. Transient agroinfiltration assays of a GFP-sensor construct containing the IGR-HP sequence at its 3' UTR (GFP-HP) did not show more rapid/strong silencing and profiling of the corresponding siRNAs, generated outside the context of a viral infection, still revealed relatively low levels of IGR-HP-derived siRNAs. These data support the idea that the IGR-HP is a weak inducer of RNA silencing and only plays a minor role in the amplification of a strong antiviral RNAi response.	[Hedil, Marcio; Hassani-Mehraban, Afshin; Lohuis, Dick; Kormelink, Richard] Wageningen Univ, Dept Plant Sci, Virol Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Kormelink, R (corresponding author), Wageningen Univ, Dept Plant Sci, Virol Lab, NL-6700 AP Wageningen, Netherlands.	Richard.kormelink@wur.nl	Kormelink, Richard/F-7437-2010	Kormelink, Richard/0000-0001-7360-1884; Hedil, Marcio/0000-0001-8018-6850	Brazilian National Council for Scientific and Technological Development (CNPq); Dutch Ministry of Agriculture, Nature and Food Quality	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Dutch Ministry of Agriculture, Nature and Food Quality	The present research was partially supported by the Brazilian National Council for Scientific and Technological Development (CNPq; MH) and the Dutch Ministry of Agriculture, Nature and Food Quality (AHM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Bucher E, 2003, J VIROL, V77, P1329, DOI 10.1128/JVI.77.2.1329-1336.2003; Bucher E, 2004, J GEN VIROL, V85, P983, DOI 10.1099/vir.0.19734-0; Carbonell A, 2008, VIROLOGY, V371, P44, DOI 10.1016/j.virol.2007.09.031; De Ronde D, 2013, MOL PLANT PATHOL, V14, P405, DOI 10.1111/mpp.12016; DEAVILA AC, 1990, J GEN VIROL, V71, P2801, DOI 10.1099/0022-1317-71-12-2801; DEAVILA AC, 1992, J PHYTOPATHOL, V134, P133, DOI 10.1111/j.1439-0434.1992.tb01222.x; DEHAAN P, 1990, J GEN VIROL, V71, P1001, DOI 10.1099/0022-1317-71-5-1001; DEHAAN P, 1991, J GEN VIROL, V72, P2207, DOI 10.1099/0022-1317-72-9-2207; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Geerts-Dimitriadou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031013; Giner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000996; Goto K, 2007, PLANT CELL PHYSIOL, V48, P1050, DOI 10.1093/pcp/pcm074; Groenenboom MAC, 2012, J R SOC INTERFACE, V9, P436, DOI 10.1098/rsif.2011.0361; Hagen C, 2011, ARCH VIROL, V156, P1209, DOI 10.1007/s00705-011-0979-y; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hassani-Mehraban A, 2005, PHYTOPATHOLOGY, V95, P852, DOI 10.1094/PHYTO-95-0852; Incarbone M, 2013, TRENDS PLANT SCI, V18, P382, DOI 10.1016/j.tplants.2013.04.001; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; King AMQ, 2012, 9 INT COMM TAX VIR; KORMELINK R, 1992, J GEN VIROL, V73, P2795, DOI 10.1099/0022-1317-73-11-2795; KORMELINK R, 1994, VIROLOGY, V200, P56, DOI 10.1006/viro.1994.1162; KORMELINK R, 1992, J GEN VIROL, V73, P687, DOI 10.1099/0022-1317-73-3-687; Lakatos L, 2004, EMBO J, V23, P876, DOI 10.1038/sj.emboj.7600096; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Llave C, 2000, P NATL ACAD SCI USA, V97, P13401, DOI 10.1073/pnas.230334397; Mallory AC, 2002, P NATL ACAD SCI USA, V99, P15228, DOI 10.1073/pnas.232434999; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mitter N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076276; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Nguyen M, 2003, VIRUS RES, V93, P141, DOI 10.1016/S0168-1702(03)00094-7; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Prins M, 1997, PLANT MOL BIOL, V33, P235, DOI 10.1023/A:1005729808191; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Ribeiro SG, 2007, J VIROL, V81, P1563, DOI 10.1128/JVI.01238-06; SAMBROOK J, 1992, MOL CLONING LAB MANU; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schnettler E, 2010, J VIROL, V84, P11542, DOI 10.1128/JVI.00595-10; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Szittya G, 2002, PLANT CELL, V14, P359, DOI 10.1105/tpc.010366; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; van Knippenberg I, 2005, VIRUS RES, V110, P125, DOI 10.1016/j.virusres.2005.01.012; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106027	10.1371/journal.pone.0106027	http://dx.doi.org/10.1371/journal.pone.0106027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268120	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700008
J	Murakami, S; Sakurai-Yageta, M; Maruyama, T; Murakami, Y				Murakami, S.; Sakurai-Yageta, M.; Maruyama, T.; Murakami, Y.			Trans-Homophilic Interaction of CADM1 Activates PI3K by Forming a Complex with MAGuK-Family Proteins MPP3 and Dlg (vol 9, e82894, 2014)	PLOS ONE			English	Correction																		Murakami S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082894	1	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e110062	10.1371/journal.pone.0110062	http://dx.doi.org/10.1371/journal.pone.0110062			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268382	Green Published, gold			2022-12-27	WOS:000343671700230
J	Tsiliki, G; Karacapilidis, N; Christodoulou, S; Tzagarakis, M				Tsiliki, Georgia; Karacapilidis, Nikos; Christodoulou, Spyros; Tzagarakis, Manolis			Collaborative Mining and Interpretation of Large-Scale Data for Biomedical Research Insights	PLOS ONE			English	Article							REPOSITORY; EXPRESSION	Biomedical research becomes increasingly interdisciplinary and collaborative in nature. Researchers need to efficiently and effectively collaborate and make decisions by meaningfully assembling, mining and analyzing available large-scale volumes of complex multi-faceted data residing in different sources. In line with related research directives revealing that, in spite of the recent advances in data mining and computational analysis, humans can easily detect patterns which computer algorithms may have difficulty in finding, this paper reports on the practical use of an innovative web-based collaboration support platform in a biomedical research context. Arguing that dealing with data-intensive and cognitively complex settings is not a technical problem alone, the proposed platform adopts a hybrid approach that builds on the synergy between machine and human intelligence to facilitate the underlying sense-making and decision making processes. User experience shows that the platform enables more informed and quicker decisions, by displaying the aggregated information according to their needs, while also exploiting the associated human intelligence.	[Tsiliki, Georgia] Natl Tech Univ Athens, Sch Chem Engn, Athens, Greece; [Karacapilidis, Nikos; Christodoulou, Spyros; Tzagarakis, Manolis] Univ Patras, Patras, Greece; [Karacapilidis, Nikos; Christodoulou, Spyros; Tzagarakis, Manolis] Comp Technol Inst & Press Diophantus, Patras, Greece	National Technical University of Athens; University of Patras	Karacapilidis, N (corresponding author), Univ Patras, Patras, Greece.	nikos@mech.upatras.gr		Tsiliki, Georgia/0000-0001-7209-3670; Karacapilidis, Nikos/0000-0002-6581-6831	EU; European Commission [FP7-ICT-257184]	EU(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This publication has been produced in the context of the EU Collaborative Project ''DICODE - Mastering Data-Intensive Collaboration and Decision'' which is co-funded by the European Commission under the contract FP7-ICT-257184. SC GT MT and NK received funcing from the above project. This publication reflects only the author's views and the Community is not liable for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2008, CANCER RES, V68, P415, DOI 10.1158/0008-5472.CAN-07-2120; [Anonymous], 2011, TECHNICAL REPORT; [Anonymous], 2012, TECHNICAL REPORT; [Anonymous], 2007, GWT ACTION EASY AJAX; Atzmueller M, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P647; Birkland A, 2006, NUCLEIC ACIDS RES, V34, pD235, DOI 10.1093/nar/gkj153; Brazas MD, 2009, NUCLEIC ACIDS RES, V37, pW3, DOI 10.1093/nar/gkp531; Costa FF, 2014, DRUG DISCOV TODAY, V19, P433, DOI 10.1016/j.drudis.2013.10.012; de la Calle G, 2014, INTEGRATING DICODE S; Foreman J. W., 2013, DATA SMART USING DAT; Friesen N, 2014, DICODE DATA MINING S; Goble CA, 2010, NUCLEIC ACIDS RES, V38, pW677, DOI 10.1093/nar/gkq429; Guberman JM, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar041; Haendel MA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001339; Hall M., 2001, MORE SERVLETS JAVASE; Hoshida Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001195; Huber-Keener KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041333; Jacobs MR, 2014, WHITE PAPER; Kaever A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089297; Kahn SD, 2011, SCIENCE, V331, P728, DOI 10.1126/science.1197891; Karacapilidis N, 2014, STUD BIG DATA, V5, P1, DOI 10.1007/978-3-319-02612-1; Karacapilidis N., 2011, P IDT 2011 PIR GREEC, P113, DOI DOI 10.1007/978-3-642-22194-1_12; Karacapilidis N., 2012, P 14 INT C INF INT W, P16; Karacapilidis N, 2012, P 16 IFIP WG8 3 INT, P223; Lee ES, 2007, TECHNICAL REPORT; Marshall C. C., 1997, Eighth ACM Conference on Hypertext, Hypertext '97, P124, DOI 10.1145/267437.267451; Nielsen J., 1999, DESIGNING WEB USABIL; Norman DA., 1998, DESIGN EVERYDAY THIN; Pautasso C., P 17 INT C WORLD WID, V805, P814, DOI [DOI 10.1145/1367497.1367606, 10.1145/1367497.1367606]; Quail A, 2012, BMC GENOMICS, V13, P431; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sass S, 2013, NUCLEIC ACIDS RES, V41, P9622, DOI 10.1093/nar/gkt752; SHIPMAN FM, 1994, HUMAN FACTORS IN COMPUTING SYSTEMS, CHI '94 CONFERENCE PROCEEDINGS - CELEBRATING INTERDEPENDENCE, P285, DOI 10.1145/191666.191768; SNIR M, 1995, MPI COMPLETE REFEREN; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan DE, 2010, CHEM BIODIVERS, V7, P1124, DOI 10.1002/cbdv.200900317; Sun Y, 2012, ACM SIGKDD EXPLORATI; Swick R. R., 1988, USENIX Association Winter Conference Dallas 1988. Proceedings, P221; Thakker D., 2011, WORKSH ONT COM AG SE, V809, P60, DOI DOI 10.1016/J.INTC0M.2010.07.003; Tsiliki G, 2014, CLIN GENOMIC RES ASS; Tsiliki G, 2014, INT J ARTIF INTELL T, V23, DOI 10.1142/S0218213014600100; Tzagarakis M., 2014, FRONTIERS ARTIFICIAL, V262, P172	43	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108600	10.1371/journal.pone.0108600	http://dx.doi.org/10.1371/journal.pone.0108600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268270	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700119
J	Aiamkitsumrit, B; Dampier, W; Martin-Garcia, J; Nonnemacher, MR; Pirrone, V; Ivanova, T; Zhong, W; Kilareski, E; Aldigun, H; Frantz, B; Rimbey, M; Wojno, A; Passic, S; Williams, JW; Shah, S; Blakey, B; Parikh, N; Jacobson, JM; Moldover, B; Wigdahl, B				Aiamkitsumrit, Benjamas; Dampier, Will; Martin-Garcia, Julio; Nonnemacher, Michael R.; Pirrone, Vanessa; Ivanova, Tatyana; Zhong, Wen; Kilareski, Evelyn; Aldigun, Hazeez; Frantz, Brian; Rimbey, Matthew; Wojno, Adam; Passic, Shendra; Williams, Jean W.; Shah, Sonia; Blakey, Brandon; Parikh, Nirzari; Jacobson, Jeffrey M.; Moldover, Brian; Wigdahl, Brian			Defining Differential Genetic Signatures in CXCR4-and the CCR5-Utilizing HIV-1 Co-Linear Sequences	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LONG TERMINAL REPEAT; VIRAL PROTEIN R; CORECEPTOR USAGE; DISEASE PROGRESSION; ENVELOPE GLYCOPROTEIN; REPLICATION CAPACITY; PERIPHERAL-BLOOD; FACTOR-BINDING; SUBTYPE-B	The adaptation of human immunodeficiency virus type-1 (HIV-1) to an array of physiologic niches is advantaged by the plasticity of the viral genome, encoded proteins, and promoter. CXCR4-utilizing (X4) viruses preferentially, but not universally, infect CD4(+) T cells, generating high levels of virus within activated HIV-1-infected T cells that can be detected in regional lymph nodes and peripheral blood. By comparison, the CCR5-utilizing (R5) viruses have a greater preference for cells of the monocyte-macrophage lineage; however, while R5 viruses also display a propensity to enter and replicate in T cells, they infect a smaller percentage of CD4(+) T cells in comparison to X4 viruses. Additionally, R5 viruses have been associated with viral transmission and CNS disease and are also more prevalent during HIV-1 disease. Specific adaptive changes associated with X4 and R5 viruses were identified in co-linear viral sequences beyond the Env-V3. The in silico position-specific scoring matrix (PSSM) algorithm was used to define distinct groups of X4 and R5 sequences based solely on sequences in Env-V3. Bioinformatic tools were used to identify genetic signatures involving specific protein domains or long terminal repeat (LTR) transcription factor sites within co-linear viral protein R (Vpr), trans-activator of transcription (Tat), or LTR sequences that were preferentially associated with X4 or R5 Env-V3 sequences. A number of differential amino acid and nucleotide changes were identified across the co-linear Vpr, Tat, and LTR sequences, suggesting the presence of specific genetic signatures that preferentially associate with X4 or R5 viruses. Investigation of the genetic relatedness between X4 and R5 viruses utilizing phylogenetic analyses of complete sequences could not be used to definitively and uniquely identify groups of R5 or X4 sequences; in contrast, differences in the genetic diversities between X4 and R5 were readily identified within these co-linear sequences in HIV-1-infected patients.	[Aiamkitsumrit, Benjamas; Dampier, Will; Martin-Garcia, Julio; Nonnemacher, Michael R.; Pirrone, Vanessa; Ivanova, Tatyana; Zhong, Wen; Kilareski, Evelyn; Aldigun, Hazeez; Frantz, Brian; Rimbey, Matthew; Wojno, Adam; Passic, Shendra; Williams, Jean W.; Shah, Sonia; Blakey, Brandon; Parikh, Nirzari; Jacobson, Jeffrey M.; Wigdahl, Brian] Drexel Univ, Dept Microbiol & Immunol, Coll Med, Philadelphia, PA 19104 USA; [Jacobson, Jeffrey M.] Drexel Univ, Dept Med, Div Infect Dis & HIV Med, Coll Med, Philadelphia, PA 19104 USA; [Aiamkitsumrit, Benjamas; Dampier, Will; Martin-Garcia, Julio; Nonnemacher, Michael R.; Pirrone, Vanessa; Ivanova, Tatyana; Zhong, Wen; Kilareski, Evelyn; Aldigun, Hazeez; Frantz, Brian; Rimbey, Matthew; Wojno, Adam; Passic, Shendra; Williams, Jean W.; Shah, Sonia; Blakey, Brandon; Parikh, Nirzari; Wigdahl, Brian] Drexel Univ, Ctr Mol Virol & Translat Neurosci, Inst Mol Med & Infect Dis, Coll Med, Philadelphia, PA 19104 USA; [Jacobson, Jeffrey M.] Drexel Univ, Ctr Clin & Translat Med, Inst Mol Med & Infect Dis, Coll Med, Philadelphia, PA 19104 USA; [Moldover, Brian] B Tech Consulting Ltd, Philadelphia, PA USA	Drexel University; Drexel University; Drexel University; Drexel University	Wigdahl, B (corresponding author), Drexel Univ, Dept Microbiol & Immunol, Coll Med, Philadelphia, PA 19104 USA.	bwigdahl@drexelmed.edu	Martin-Garcia, Julio/A-5666-2009	Martin-Garcia, Julio/0000-0001-5450-5029; Nonnemacher, Michael/0000-0003-4299-3779	National Institute of Neurological Disorders and Stroke [R01 NS32092]; National Institute on Drug Abuse [R01 DA19807]; National Institute of Mental Health [P30 MH092177, T32 MH079785]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177, T32MH079785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019807] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research within this manuscript has been supported by the National Institute of Neurological Disorders and Stroke, grant number R01 NS32092, www.ninds.nih.gov; the National Institute on Drug Abuse, grant number R01 DA19807, www.drugabuse.gov; the National Institute of Mental Health, grant number P30 MH092177, www.nimh.nih.gov; and the National Institute of Mental Health, grant number T32 MH079785, www.nimh.nih.gov. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Ambrosino C, 1997, J BIOL CHEM, V272, P14883, DOI 10.1074/jbc.272.23.14883; Azad AA, 2000, BIOCHEM BIOPH RES CO, V267, P677, DOI 10.1006/bbrc.1999.1708; Bano AS, 2007, OLIGONUCLEOTIDES, V17, P465, DOI 10.1089/oli.2007.0091; Bano AS, 2007, AIDS, V21, P1832, DOI 10.1097/QAD.0b013e328277f16b; Bano AS, 2009, J GEN VIROL, V90, P2768, DOI 10.1099/vir.0.011080-0; Bruland T, 2003, J GEN VIROL, V84, P907, DOI 10.1099/vir.0.18625-0; Bukrinsky M, 1999, REV MED VIROL, V9, P39, DOI 10.1002/(SICI)1099-1654(199901/03)9:1<39::AID-RMV235>3.0.CO;2-3; Burdo TH, 2004, J NEUROVIROL, V10, P7, DOI [10.1080/753312746, 10.1080/13550280490270789]; Butto S, 2003, J INFECT DIS, V188, P1171, DOI 10.1086/378412; CANONNEHERGAUX F, 1995, J VIROL, V69, P6634, DOI 10.1128/JVI.69.11.6634-6642.1995; Carrillo A, 1996, J VIROL, V70, P1301, DOI 10.1128/JVI.70.2.1301-1309.1996; Chohan B, 2005, J VIROL, V79, P6528, DOI 10.1128/JVI.79.10.6528-6531.2005; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; COONEY AJ, 1991, J VIROL, V65, P2853, DOI 10.1128/JVI.65.6.2853-2860.1991; Cowley D, 2011, J NEUROVIROL, V17, P70, DOI 10.1007/s13365-010-0002-5; CULLEN BR, 1991, FASEB J, V5, P2361, DOI 10.1096/fasebj.5.10.1712325; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dimonte S, 2012, VIRUS RES, V168, P73, DOI 10.1016/j.virusres.2012.06.019; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Duncan CJA, 2011, VIRUSES-BASEL, V3, P2255, DOI 10.3390/v3112255; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Emerman M, 1996, CURR BIOL, V6, P1096, DOI 10.1016/S0960-9822(02)00676-0; Emerman M, 1998, SCIENCE, V280, P1880, DOI 10.1126/science.280.5371.1880; Eugenin EA, 2007, P NATL ACAD SCI USA, V104, P3438, DOI 10.1073/pnas.0611699104; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Ferrucci A, 2011, ADV VIRUS RES, V81, P165, DOI 10.1016/B978-0-12-385885-6.00010-9; Fields BN, 2007, FIELDS VIROLOGY, P2664; Fu YX, 2001, MOL BIOL EVOL, V18, P620, DOI 10.1093/oxfordjournals.molbev.a003842; GALLO RC, 1986, PROG ALLERGY, V37, P1; GARCIABLANCO MA, 1991, SCIENCE, V254, P815, DOI 10.1126/science.1658933; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; HAHN BH, 1986, SCIENCE, V232, P1548, DOI 10.1126/science.3012778; Henderson AJ, 1997, P NATL ACAD SCI USA, V94, P8714, DOI 10.1073/pnas.94.16.8714; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; Henderson AJ, 1996, IMMUNITY, V5, P91, DOI 10.1016/S1074-7613(00)80313-1; Hogan TH, 2003, J NEUROVIROL, V9, P55, DOI 10.1080/13550280390173292; Hogan TH, 2002, J NEUROVIROL, V8, P21, DOI 10.1080/13550280290167911; HOLZMEISTER J, 1993, BIOCHEM BIOPH RES CO, V197, P1229, DOI 10.1006/bbrc.1993.2608; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Hutto C, 1996, J VIROL, V70, P3589, DOI 10.1128/JVI.70.6.3589-3598.1996; Jensen M, 2007, PSSM; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Jensen Mark A., 2003, AIDS Reviews, V5, P104; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones E., 2001, SCIPY OPEN SOURCE SC; Joos B, 2005, J VIROL, V79, P9026, DOI 10.1128/JVI.79.14.9026-9037.2005; Kalantari P, 2008, J BIOL CHEM, V283, P33183, DOI 10.1074/jbc.M807403200; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kilareski EM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-118; King JE, 2006, MICROBES INFECT, V8, P1347, DOI 10.1016/j.micinf.2005.11.014; Kitayama H, 2008, J VIROL, V82, P2528, DOI 10.1128/JVI.02094-07; Kogan M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-25; Li L, 2012, ADV VIROL, V2012, DOI 10.1155/2012/123605; Li LN, 2011, J NEUROVIROL, V17, P92, DOI 10.1007/s13365-010-0014-1; Liu Y, 2008, VIROLOGY, V374, P229, DOI 10.1016/j.virol.2008.01.029; LU YC, 1989, J VIROL, V63, P4115, DOI 10.1128/JVI.63.9.4115-4119.1989; Macian F, 1999, MOL CELL BIOL, V19, P3645, DOI 10.1128/mcb.19.5.3645; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Markham RB, 1998, P NATL ACAD SCI USA, V95, P12568, DOI 10.1073/pnas.95.21.12568; Markham RB, 1996, J VIROL, V70, P6947, DOI 10.1128/JVI.70.10.6947-6954.1996; Masciotra S, 2002, AIDS, V16, P1887, DOI 10.1097/00002030-200209270-00005; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Max Planck Institut fur Informatik, 2011, GENO2PHENO; Mayne M, 1998, NEUROIMMUNOMODULAT, V5, P184, DOI 10.1159/000026336; Mbonye U, 2011, CURR HIV RES, V9, P554, DOI 10.2174/157016211798998736; McAllister JJ, 2000, VIROLOGY, V274, P262, DOI 10.1006/viro.2000.0476; Mefford ME, 2008, AIDS RES HUM RETROV, V24, P1215, DOI 10.1089/aid.2008.0009; MELTZER MS, 1990, IMMUNOL TODAY, V11, P217, DOI 10.1016/0167-5699(90)90086-O; Mologni D, 2006, AIDS, V20, P567, DOI 10.1097/01.aids.0000210611.60459.0e; Monno L, 2011, ANTIMICROB AGENTS CH, V55, P5078, DOI 10.1128/AAC.00743-11; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Nei M., 2000, MOL EVOLUTION PHYLOG; Neogi U, 2012, AIDS RES HUM RETROV, V28, P952, DOI [10.1089/aid.2011.0380, 10.1089/AID.2011.0380]; Nonnemacher MR, 2004, J NEUROIMMUNOL, V157, P39, DOI 10.1016/j.jneuroim.2004.08.021; Nora T, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-23; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Parker ZF, 2013, J VIROL, V87, P2401, DOI 10.1128/JVI.02964-12; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; POSS M, 1995, J VIROL, V69, P8118, DOI 10.1128/JVI.69.12.8118-8122.1995; Prosperi MCF, 2009, AIDS RES HUM RETROV, V25, P305, DOI 10.1089/aid.2008.0039; Rao VR, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-61; Roebuck KA, 1999, GENE EXPRESSION, V8, P67; Ross HL, 2001, J NEUROVIROL, V7, P235; Rossi F, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-89; Sagar M, 2006, AIDS RES HUM RETROV, V22, P430, DOI 10.1089/aid.2006.22.430; Salzwedel K, 2000, J VIROL, V74, P326, DOI 10.1128/JVI.74.1.326-333.2000; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; SATTENTAU QJ, 1993, J VIROL, V67, P7383, DOI 10.1128/JVI.67.12.7383-7393.1993; Sawaya BE, 2000, J BIOL CHEM, V275, P35209, DOI 10.1074/jbc.M005197200; Schmidtmayerova H, 1998, J VIROL, V72, P4633, DOI 10.1128/JVI.72.6.4633-4642.1998; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; SCHUITEMAKER H, 1995, SCIENCE, V268, P115, DOI 10.1126/science.7755774; Schweighardt B, 2004, J VIROL, V78, P9164, DOI 10.1128/JVI.78.17.9164-9173.2004; Sharon M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X; Sierra S, 2007, EUR J MED RES, V12, P453; Sing T, 2007, ANTIVIR THER, V12, P1097; Soulie C, 2008, HIV MED, V9, P1, DOI 10.1111/j.1468-1293.2008.00518.x; Srinivasan A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-99; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Trouplin V, 2001, J VIROL, V75, P251, DOI 10.1128/JVI.75.1.251-259.2001; Tungaturthi PK, 2004, DNA CELL BIOL, V23, P207, DOI 10.1089/104454904773819798; Tyor W, 2013, J NEUROVIROL, V19, P515, DOI 10.1007/s13365-013-0206-6; Verhofstede C, 2011, HIV MED, V12, P544, DOI 10.1111/j.1468-1293.2011.00922.x; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; Wilen CB, 2011, J VIROL, V85, P8514, DOI 10.1128/JVI.00736-11; Yedavalli VRK, 2001, AIDS RES HUM RETROV, V17, P911, DOI 10.1089/088922201750290032; Zhou Y, 2001, VIROLOGY, V287, P133, DOI 10.1006/viro.2001.1031; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	114	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107389	10.1371/journal.pone.0107389	http://dx.doi.org/10.1371/journal.pone.0107389			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265194	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400021
J	Blankers, M; Frijns, T; Belackova, V; Rossi, C; Svensson, B; Trautmann, F; van Laar, M				Blankers, Matthijs; Frijns, Tom; Belackova, Vendula; Rossi, Carla; Svensson, Bengt; Trautmann, Franz; van Laar, Margriet			Predicting Cannabis Abuse Screening Test (CAST) Scores: A Recursive Partitioning Analysis Using Survey Data from Czech Republic, Italy, the Netherlands and Sweden	PLOS ONE			English	Article							IDENTIFICATION-TEST CUDIT; DEPENDENCE SCALE SDS; USE-DISORDERS; SUBSTANCE-USE; PSYCHOMETRIC PROPERTIES; DSM-IV; POPULATION; USERS; SEVERITY; COCAINE	Introduction: Cannabis is Europe's most commonly used illicit drug. Some users do not develop dependence or other problems, whereas others do. Many factors are associated with the occurrence of cannabis-related disorders. This makes it difficult to identify key risk factors and markers to profile at-risk cannabis users using traditional hypothesis-driven approaches. Therefore, the use of a data-mining technique called binary recursive partitioning is demonstrated in this study by creating a classification tree to profile at-risk users. Methods: 59 variables on cannabis use and drug market experiences were extracted from an internet-based survey dataset collected in four European countries (Czech Republic, Italy, Netherlands and Sweden), n = 2617. These 59 potential predictors of problematic cannabis use were used to partition individual respondents into subgroups with low and high risk of having a cannabis use disorder, based on their responses on the Cannabis Abuse Screening Test. Both a generic model for the four countries combined and four country-specific models were constructed. Results: Of the 59 variables included in the first analysis step, only three variables were required to construct a generic partitioning model to classify high risk cannabis users with 65-73% accuracy. Based on the generic model for the four countries combined, the highest risk for cannabis use disorder is seen in participants reporting a cannabis use on more than 200 days in the last 12 months. In comparison to the generic model, the country-specific models led to modest, nonsignificant improvements in classification accuracy, with an exception for Italy (p = 0.01). Conclusion: Using recursive partitioning, it is feasible to construct classification trees based on only a few variables with acceptable performance to classify cannabis users into groups with low or high risk of meeting criteria for cannabis use disorder. The number of cannabis use days in the last 12 months is the most relevant variable. The identified variables may be considered for use in future screeners for cannabis use disorders.	[Blankers, Matthijs; Frijns, Tom; Trautmann, Franz; van Laar, Margriet] Trimbos Inst, Dept Drug Monitoring, Utrecht, Netherlands; [Blankers, Matthijs] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Blankers, Matthijs] Arkin, Dept Res, Amsterdam, Netherlands; [Belackova, Vendula] Charles Univ Prague, Fac Med 1, Dept Addictol, Prague, Czech Republic; [Belackova, Vendula] Gen Univ Hosp, Prague, Czech Republic; [Rossi, Carla] Univ Roma Tor Vergata, Ctr Biostat & Bioinformat, Rome, Italy; [Svensson, Bengt] Malmo Univ, Dept Social Work, Malmo, Sweden	Trimbos Institute; University of Amsterdam; Academic Medical Center Amsterdam; Charles University Prague; General University Hospital Prague; University of Rome Tor Vergata; Malmo University	Blankers, M (corresponding author), Trimbos Inst, Dept Drug Monitoring, Utrecht, Netherlands.	mblankers@trimbos.nl	Belackova, Vendula/D-1347-2017	Belackova, Vendula/0000-0002-1334-5425	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	Survey development and execution, and preparation of the full report were funded by the European Commission, project "Further insights into aspects of the illicit EU drugs market". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson SJ, 2003, DRUG ALCOHOL REV, V22, P309, DOI 10.1080/0959523031000154454; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Annaheim B, 2008, EUR ADDICT RES, V14, P190, DOI 10.1159/000141643; Annaheim B, 2013, ADDICT RES THEORY, V21, P410, DOI 10.3109/16066359.2012.735295; Bastiani L, 2013, ADDICT BEHAV, V38, P2060, DOI 10.1016/j.addbeh.2012.12.016; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; Blankers M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-455; Breiman L., 2017, CLASSIFICATION REGRE; Chen CY, 2009, ADDICT BEHAV, V34, P319, DOI 10.1016/j.addbeh.2008.10.021; Coffey C, 2003, BRIT J PSYCHIAT, V182, P330, DOI 10.1192/bjp.182.4.330; Cuenca-Royo AM, 2012, ADDICT BEHAV, V37, P709, DOI 10.1016/j.addbeh.2012.02.012; Daniel JZ, 2009, DRUG ALCOHOL REV, V28, P142, DOI 10.1111/j.1465-3362.2008.00042.x; EMCDDA, 2008, MONOGRAPH SERIES, V8, P44; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2013, PERSP DRUGS CHAR FRE; Fernandez-Espejo E, 2009, PSYCHOPHARMACOLOGY, V206, P531, DOI 10.1007/s00213-009-1612-6; GOSSOP M, 1995, ADDICTION, V90, P607, DOI 10.1111/j.1360-0443.1995.tb02199.x; Hammersley R, 2006, ADDICT RES THEORY, V14, P189, DOI 10.1080/16066350500453309; Hawkins DM., 1997, 546 U MINN SCH STAT; Hellemann G, 2009, J SUBST ABUSE TREAT, V36, P59, DOI 10.1016/j.jsat.2008.03.005; Hibell B., 2012, 2011 ESPAD REPORT SU; Hothorn T., 2013, PARTY LAB RECURSIVE; Huang Y, 2013, TOB CONTROL, V22, P274, DOI 10.1136/tobaccocontrol-2011-050124; Hyman SM, 2009, J SUBST ABUSE TREAT, V36, P400, DOI 10.1016/j.jsat.2008.08.005; Kerr Wesley T., 2012, Yale Journal of Biology and Medicine, V85, P363; Large M, 2011, ARCH GEN PSYCHIAT, V68, P555, DOI 10.1001/archgenpsychiatry.2011.5; Legleye S., 2007, Journal of Substance Use, V12, P233, DOI 10.1080/14659890701476532; Legleye S, 2013, INT J METH PSYCH RES, V22, P16, DOI 10.1002/mpr.1378; Legleye S, 2011, DRUG ALCOHOL DEPEN, V113, P229, DOI 10.1016/j.drugalcdep.2010.08.011; Looby A, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-3; Martin G, 2006, DRUG ALCOHOL DEPEN, V83, P90, DOI 10.1016/j.drugalcdep.2005.10.014; Martin-Santos R, 2010, PSYCHOL MED, V40, P383, DOI 10.1017/S0033291709990729; Mello MM, 2011, NEW ENGL J MED, V365, P1248, DOI 10.1056/NEJMhle1107678; Moss HB, 2012, J STUD ALCOHOL DRUGS, V73, P820, DOI 10.15288/jsad.2012.73.820; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; R Core Team, 2021, R LANGUAGE ENV STAT; Rehm J, 2014, ALCOHOL ALCOHOLISM, V49, P118, DOI 10.1093/alcalc/agt171; Rehm J, 2013, ALCOHOL ALCOHOLISM, V48, P633, DOI 10.1093/alcalc/agt127; Rey JM, 2004, J AM ACAD CHILD PSY, V43, P1194, DOI 10.1097/01.chi.0000135623.12843.60; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Swan GE, 2004, ADDICTION, V99, P237, DOI 10.1111/j.1360-0443.2003.00629.x; Thanki D, 2013, ISRN ADDICT, V2013; Therneau T. M., 1997, INTRO RECURSIVE PART; Trautmann F., 2013, FURTHER INSIGHTS ASP; Tziraki S, 2012, REV NEUROLOGIA, V54, P750, DOI 10.33588/rn.5412.2011427; UNODC, 2007, SDED SUCC DURG POL R; van den Bree MBM, 2005, ARCH GEN PSYCHIAT, V62, P311, DOI 10.1001/archpsyc.62.3.311; van der Pol P, 2013, DRUG ALCOHOL DEPEN, V133, P352, DOI 10.1016/j.drugalcdep.2013.06.009; van der Pol P, 2013, ADDICTION, V108, P1459, DOI 10.1111/add.12196; Verdejo-Garcia A, 2007, REV NEUROLOGIA, V44, P432, DOI 10.33588/rn.4407.2006356; Verweij KJH, 2010, ADDICTION, V105, P417, DOI 10.1111/j.1360-0443.2009.02831.x; Walden N, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-20; Yonkers KA, 2010, OBSTET GYNECOL, V116, P827, DOI 10.1097/AOG.0b013e3181ed8290; Zeisser C, 2012, ADDICT RES THEORY, V20, P82, DOI 10.3109/16066359.2011.569101; Zhang HP, 1999, RECURSIVE PARTITIONI	54	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108298	10.1371/journal.pone.0108298	http://dx.doi.org/10.1371/journal.pone.0108298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6XR	25264894	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400063
J	Jacobs, JH; Viboud, C; Tchetgen, ET; Schwartz, J; Steiner, C; Simonsen, L; Lipsitch, M				Jacobs, Jessica Hartman; Viboud, Cecile; Tchetgen, Eric Tchetgen; Schwartz, Joel; Steiner, Claudia; Simonsen, Lone; Lipsitch, Marc			The Association of Meningococcal Disease with Influenza in the United States, 1989-2009	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MENINGITIS; INFECTION; BOOTSTRAP; ENGLAND; SCHOOL; CELLS; WALES	Importance and Objective: Prior influenza infection is a risk factor for invasive meningococcal disease. Quantifying the fraction of meningococcal disease attributable to influenza could improve understanding of viral-bacterial interaction and indicate additional health benefits to influenza immunization. Design, Setting and Participants: A time series analysis of the association of influenza and meningococcal disease using hospitalizations in 9 states from 1989-2009 included in the State Inpatient Databases from the Agency for Healthcare Research and Quality and the proportion of positive influenza tests by subtype reported to the Centers for Disease Control. The model accounts for the autocorrelation of meningococcal disease and influenza between weeks, temporal trends, co-circulating respiratory syncytial virus, and seasonality. The influenza-subtype-attributable fraction was estimated using the model coefficients. We analyzed the synchrony of seasonal peaks in hospitalizations for influenza, respiratory syncytial virus, and meningococcal disease. Results and Conclusions: In 19 of 20 seasons, influenza peaked <= 2 weeks before meningococcal disease, and peaks were highly correlated in time (rho = 0.95; P<.001). H3N2 and H1N1 peaks were highly synchronized with meningococcal disease while pandemic H1N1, B, and respiratory syncytial virus were not. Over 20 years, 12.8% (95% CI, 9.1-15.0) of meningococcal disease can be attributable to influenza in the preceding weeks with H3N2 accounting for 5.2% (95% CI, 3.0-6.5), H1N1 4.3% (95% CI, 2.6-5.6), B 3.0% (95% CI, 0.8-4.9) and pH1N1 0.2% (95% CI, 0-0.4). During the height of influenza season, weekly attributable fractions reach 59%. While vaccination against meningococcal disease is the most important prevention strategy, influenza vaccination could provide further protection, particularly in young children where the meningococcal disease vaccine is not recommended or protective against the most common serogroup.	[Jacobs, Jessica Hartman; Tchetgen, Eric Tchetgen; Schwartz, Joel; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Viboud, Cecile; Simonsen, Lone] NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Tchetgen, Eric Tchetgen] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Schwartz, Joel] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Steiner, Claudia] Agcy Healthcare Res & Qual, Ctr Delivery Org & Markets, Rockville, MD USA; [Simonsen, Lone] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Global Hlth, Washington, DC USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Agency for Healthcare Research & Quality; George Washington University; Harvard University; Harvard T.H. Chan School of Public Health	Lipsitch, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA.	mlipsitc@hsph.harvard.edu	Tchetgen, Eric Tchetgen/AAF-6160-2021; Simonsen, Lone/K-4531-2014	Simonsen, Lone/0000-0003-1535-8526	National Institute Of General Medical Sciences [U54GM088558]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute Of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project described was supported by the National Institute Of General Medical Sciences [Award Number U54GM088558]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of General Medical Sciences, the National Institutes of Health, or the Agency for Healthcare Research and Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1965, HDB MATH FUNCTIONS F; Alonso JM, 2003, FEMS MICROBIOL LETT, V222, P99, DOI 10.1016/S0378-1097(03)00252-0; [Anonymous], [No title captured]; BALTIMORE RS, 1998, BACTERIAL INFECT HUM, P459; Beadling C, 2004, CURR OPIN INFECT DIS, V17, P185, DOI 10.1097/00001432-200406000-00003; Bilukha Oleg O., 2005, Morbidity and Mortality Weekly Report, V54, P1; Brundage JF, 2006, LANCET INFECT DIS, V6, P303, DOI 10.1016/S1473-3099(06)70466-2; CARTWRIGHT KAV, 1991, LANCET, V338, P554, DOI 10.1016/0140-6736(91)91112-8; *CDCP, 2010, OV INFL SURV US; Centers for Disease Control and Prevention, 2013, ACT BACT COR SURV RE; Centers for Disease Control and Prevention, 1999, 1999 2000 INFL SEAS; Centers for Disease Control and Prevention, 2003, 2003 4 INFL SEAS SUM; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; COUGHLIN SS, 1991, AM J EPIDEMIOL, V133, P305, DOI 10.1093/oxfordjournals.aje.a115875; Davison AC, 1997, BOOTSTRAP METHODS TH; Dominguez A, 2007, ANN EPIDEMIOL, V17, P654, DOI 10.1016/j.annepidem.2007.03.006; El Ahmer OR, 1999, FEMS IMMUNOL MED MIC, V23, P331, DOI 10.1016/S0928-8244(98)00153-9; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1111/j.1574-695X.1999.tb01389.x; HARRISON LH, 1991, ARCH INTERN MED, V151, P1005, DOI 10.1001/archinte.151.5.1005; HUBERT B, 1992, J INFECT DIS, V166, P542, DOI 10.1093/infdis/166.3.542; Jansen AGSC, 2008, EPIDEMIOL INFECT, V136, P1448, DOI 10.1017/S0950268807000271; LIU RY, 1988, ANN STAT, V16, P1696, DOI 10.1214/aos/1176351062; MACKOWIAK PA, 1976, SOUTHERN MED J, V69, P222, DOI 10.1097/00007611-197602000-00027; MAMMEN E, 1993, ANN STAT, V21, P255, DOI 10.1214/aos/1176349025; Nicholson KG, 1996, EPIDEMIOL INFECT, V116, P51, DOI 10.1017/S0950268800058957; R Core Team, 2018, R LANG ENV STAT COMP; Racloz VN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-175; Rameix-Welti MA, 2009, INFECT IMMUN, V77, P3588, DOI 10.1128/IAI.00155-09; Read RC, 1999, INFECT IMMUN, V67, P3082, DOI 10.1128/IAI.67.6.3082-3086.1999; Robins JM, 1997, LECT NOTES STAT, V120, P69, DOI DOI 10.1007/978-1-4612-1842-5_4; Sato M, 2005, PEDIATR INFECT DIS J, V24, P931, DOI 10.1097/01.inf.0000180976.81055.ce; SCHUBIGER G, 1986, SCHWEIZ MED WSCHR, V116, P1172; Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347; Steiner Claudia, 2002, Eff Clin Pract, V5, P143; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Stuart JM, 1996, EPIDEMIOL INFECT, V117, P107, DOI 10.1017/S0950268800001199; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; TILLETT HE, 1982, J HYG-CAMBRIDGE, V88, P83, DOI 10.1017/S0022172400069928; TILLETT HE, 1983, INT J EPIDEMIOL, V12, P344, DOI 10.1093/ije/12.3.344; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Tuite AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015493; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wasserman L., 2004, ALL STAT CONCISE COU, V26; World Health Organization, 2011, MEN MEN FACT SHEET 1; YOUNG LS, 1972, NEW ENGL J MED, V287, P5, DOI 10.1056/NEJM197207062870102	46	28	28	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107486	10.1371/journal.pone.0107486	http://dx.doi.org/10.1371/journal.pone.0107486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265409	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400023
J	Ji, W; Zhang, GR; Ran, W; Gardner, JPA; Wei, KJ; Wang, WM; Zou, GW				Ji, Wei; Zhang, Gui-Rong; Ran, Wei; Gardner, Jonathan P. A.; Wei, Kai-Jian; Wang, Wei-Min; Zou, Gui-Wei			Genetic Diversity of and Differentiation among Five Populations of Blunt Snout Bream (Megalobrama amblycephala) Revealed by SRAP Markers: Implications for Conservation and Management	PLOS ONE			English	Article							WATER-FISH CONSERVATION; BIODIVERSITY; AQUARIUM; THREATS; CHINA	The blunt snout bream (Megalobrama amblycephala) is an important freshwater aquaculture fish throughout China. Because of widespread introductions of this species to many regions, the genetic diversity of wild and natural populations is now threatened. In the present study, SRAP (sequence-related amplified polymorphism) markers were used to assess genetic diversity of blunt snout bream. Three natural populations (Liangzi Lake, Poyang Lake and Yuni Lake, one cultured population (Nanxian) and one genetic strain ('Pujiang No. 1') of blunt snout bream were screened with 88 SRAP primer combinations, of which 13 primer pairs produced stable and reproducible amplification patterns. In total, 172 bands were produced, of which 132 bands were polymorphic. Nei's gene diversity (h) and Shannon's information index (I) values provided evidence of differences in genetic diversity among the five populations (Poyang Lake>Liangzi Lake>Nanxian>'Pujiang No. 1'>Yuni Lake). Based on cluster analysis conducted on genetic distance values, the five blunt snout bream populations were divided into three groups, Poyang Lake and Liangzi Lake (natural populations), Nanxian and 'Pujiang No. 1' (cultured population and genetically selected strain), and Yuni Lake (natural population). Significant genetic differentiation was found among the five populations using analysis of molecular variance (AMOVA), with more genetic divergence existing among populations (55.49%), than within populations (44.51%). This molecular marker technique is a simple and efficient method to quantify genetic diversity within and among fish populations, and is employed here to help manage and conserve germplasm variability of blunt snout bream and to support the ongoing selective breeding programme for this fish.	[Ji, Wei; Zhang, Gui-Rong; Ran, Wei; Gardner, Jonathan P. A.; Wei, Kai-Jian; Wang, Wei-Min] Huazhong Agr Univ, Coll Fisheries, Minist Agr, Key Lab Freshwater Anim Breeding, Wuhan, Peoples R China; [Ji, Wei; Zhang, Gui-Rong; Gardner, Jonathan P. A.; Wei, Kai-Jian] Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan, Peoples R China; [Gardner, Jonathan P. A.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Zou, Gui-Wei] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Minist Agr, Key Lab Freshwater Biodivers Conservat, Wuhan, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Victoria University Wellington; Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs	Wei, KJ (corresponding author), Huazhong Agr Univ, Coll Fisheries, Minist Agr, Key Lab Freshwater Anim Breeding, Wuhan, Peoples R China.	kjwei@mail.hzau.edu.cn	Gardner, Jonathan/M-3224-2016	Gardner, Jonathan/0000-0002-6943-2413	Modern Agriculture Industry Technology System Construction Projects of China entitled "Staple Freshwater Fishes Industry Technology System" [CARS-46-05]; National R&D Infrastructure and Facility Development Program of China [2006DKA30470-002-03]; Major Science and Technology Program for Water Pollution Control and Treatment [2012ZX07202-004-02]	Modern Agriculture Industry Technology System Construction Projects of China entitled "Staple Freshwater Fishes Industry Technology System"; National R&D Infrastructure and Facility Development Program of China; Major Science and Technology Program for Water Pollution Control and Treatment	This work was supported by the Modern Agriculture Industry Technology System Construction Projects of China entitled "Staple Freshwater Fishes Industry Technology System" (Grant No. CARS-46-05), the National R&D Infrastructure and Facility Development Program of China (Grant No. 2006DKA30470-002-03), and the Major Science and Technology Program for Water Pollution Control and Treatment (Grant No. 2012ZX07202-004-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, POPGENE VERSION 1 3; Araki H, 2010, AQUACULTURE, V308, pS2, DOI 10.1016/j.aquaculture.2010.05.036; Bian Chun-yuan, 2007, Dalian Shuichan Xueyuan Xuebao, V22, P175; Bondad-Reantaso MG, 2007, FAO FISHERIES TECHNI, V501, P1; Budak H, 2004, THEOR APPL GENET, V109, P280, DOI 10.1007/s00122-004-1630-z; Budak H, 2004, THEOR APPL GENET, V108, P328, DOI 10.1007/s00122-003-1428-4; Cooke SJ, 2013, J FISH BIOL, V83, P997, DOI 10.1111/jfb.12222; Ding WD, 2010, AQUACULT INT, V18, P575, DOI 10.1007/s10499-009-9277-z; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fang Zhan-qiang, 2005, Dalian Shuichan Xueyuan Xuebao, V20, P16; Ferriol M, 2003, THEOR APPL GENET, V107, P271, DOI 10.1007/s00122-003-1242-z; Fisheries Bureau of the Agriculture Ministry of China, 2013, CHIN FISH STAT YB; Freitas CEC, 2014, ECOL FRESHW FISH, V23, P470, DOI 10.1111/eff.12099; Fu CZ, 2003, BIODIVERS CONSERV, V12, P1649, DOI 10.1023/A:1023697714517; Hold N, 2013, CAN J FISH AQUAT SCI, V70, P330, DOI 10.1139/cjfas-2012-0378; Holsinger Kent E, 2009, Nat Rev Genet, V10, P639, DOI 10.1038/nrg2611; Hu Ze-hui, 2010, Shanghai Haiyang Daxue Xuebao, V19, P734; Jones N, 2009, NEW PHYTOL, V183, P935, DOI 10.1111/j.1469-8137.2009.02933.x; Kang B, 2014, FISH FISH, V15, P209, DOI 10.1111/faf.12011; Ko H., 1975, ACTA HYDROBIOL SIN, V5, P293; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Li HH, 2008, FRESHW FISHERIES, V38, P63; Li S. F., 2003, Naga, V26, P20; Li Shao-wu, 2006, Journal of Fishery Sciences of China, V13, P187; Li Si-fa, 2005, Journal of Fisheries of China, V29, P161; Li SiFa, 2000, Journal of Fisheries of China, V24, P201; Li Sifa, 1991, Journal of Fisheries of China, V15, P204; Liang Su-Xian, 2008, Acta Hydrobiologica Sinica, V32, P694, DOI [10.3724/SP.J.0000.2008.50694, 10.3724/SP.J.1035.2008.00694]; Lintermans M, 2013, MAR FRESHW RES SPEIC, V64, P1; Pearce-Kelly P., 2013, International Zoo Yearbook, V47, P81, DOI 10.1111/izy.12016; Qiao LX, 2007, AQUAT BOT, V87, P203, DOI 10.1016/j.aquabot.2007.06.006; Reid G. McG, 2013, International Zoo Yearbook, V47, P6, DOI 10.1111/izy.12020; Reis R. E., 2013, International Zoo Yearbook, V47, P65, DOI 10.1111/izy.12000; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sun SJ, 2006, APPL MICROBIOL BIOT, V72, P537, DOI 10.1007/s00253-005-0299-9; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tang Shou-jie, 2007, Shanghai Shuichan Daxue Xuebao, V16, P97; Tang SJ, 2009, MOL ECOL RESOUR, V9, P971, DOI 10.1111/j.1755-0998.2009.02520.x; [唐首杰 TANG Shoujie], 2008, [中国水产科学, Journal of Fishery Sciences of China], V15, P222; Wang Jun, 2001, Chinese Journal of Oceanology and Limnology, V19, P152, DOI 10.1007/BF02863040; WRIGHT S, 1978, P580; Xin Wenting, 2009, Journal of Northeast Forestry University, V37, P112; Yi PL, 1955, HYDROBIOL ANTHOL, V2, P115; Yue P. Q., 1998, CHINA RED DATA BOOK; Zhang DC, 2001, J CHIN 3 GORGES U NA, V23, P282; Zhang F, 2011, MOL BREEDING, V27, P11, DOI 10.1007/s11032-010-9409-1; Zhang Hongyu, 2009, Marine Science Bulletin (Tianjin), V28, P50; Zhang ZhiWei, 2007, Journal of Fishery Sciences of China, V14, P720; Zhao Yan, 2009, Journal of Fisheries of China, V33, P893; Zou Shu-ming, 2005, Journal of Fisheries of China, V29, P296	52	16	16	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108967	10.1371/journal.pone.0108967	http://dx.doi.org/10.1371/journal.pone.0108967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265288	gold, Green Submitted, Green Published			2022-12-27	WOS:000345745400138
J	Kang, YA; Ling, JH; Suzuki, R; Roife, D; Chopin-Laly, X; Truty, MJ; Chatterjee, D; Wang, HM; Thomas, RM; Katz, MH; Chiao, PJ; Fleming, JB				Kang, Ya'an; Ling, Jianhua; Suzuki, Rei; Roife, David; Chopin-Laly, Xavier; Truty, Mark J.; Chatterjee, Deyali; Wang, Huamin; Thomas, Ryan M.; Katz, Matthew H.; Chiao, Paul J.; Fleming, Jason B.			SMAD4 Regulates Cell Motility through Transcription of N-Cadherin in Human Pancreatic Ductal Epithelium	PLOS ONE			English	Article							TGF-BETA; MESENCHYMAL TRANSITIONS; MIGRATION; CANCER; PROGRESSION; BINDING; GENE; DPC4	Expression of the cellular adhesion protein N-cadherin is a critical event during epithelial-mesenchymal transition (EMT). The SMAD4 protein has been identified as a mediator of transforming growth factor-beta (TGF-beta) superfamily signaling, which regulates EMT, but the mechanisms linking TGF-beta signaling to N-cadherin expression remain unclear. When the TGF-beta pathway is activated, SMAD proteins, including the common mediator SMAD4, are subsequently translocated into the nucleus, where they influence gene transcription via SMAD binding elements (SBEs). Here we describe a mechanism for control of CDH2, the gene encoding N-cadherin, through the canonical TGF beta-SMAD4 pathway. We first identified four previously undescribed SBEs within the CDH2 promoter. Using telomerase immortalized human pancreatic ductal epithelium, we found that TGF-beta stimulation prompted specific SMAD4 binding to all four SBEs. Luciferase reporter and SMAD4-knockdown experiments demonstrated that specific SMAD4 binding to the SBE located at -3790 bp to -3795 bp within the promoter region of CDH2 was necessary for TGF-beta-stimulated transcription. Expression of N-cadherin on the surface of epithelial cells facilitates motility and invasion, and we demonstrated that knockdown of SMAD4 causes decreased N-cadherin expression, which results in diminished migration and invasion of human pancreatic ductal epithelial cells. Similar reduction of cell motility was produced after CDH2 knockdown. Together, these findings suggest that SMAD4 is critical for the TGF-beta-driven upregulation of N-cadherin and the resultant invasive phenotype of human pancreatic ductal epithelial cells during EMT.	[Kang, Ya'an; Roife, David; Katz, Matthew H.; Fleming, Jason B.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Ling, Jianhua; Chiao, Paul J.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Suzuki, Rei] Fukushima Med Univ, Sch Med, Dept Gastroenterol & Rheumatol, Fukushima, Japan; [Chopin-Laly, Xavier] Clin Charcot, Sainte Foy Les Lyon, France; [Truty, Mark J.] Mayo Clin, Dept Surg, Rochester, MN USA; [Chatterjee, Deyali] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Ctr Canc, Dept Pathol, Houston, TX 77030 USA; [Thomas, Ryan M.] Univ Florida, Coll Med, Dept Gen Surg, Gainesville, FL USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Fukushima Medical University; Mayo Clinic; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; State University System of Florida; University of Florida	Fleming, JB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.	jbflemin@mdanderson.org	Suzuki, Rei/S-8531-2017	Suzuki, Rei/0000-0002-4049-0484; Roife, David/0000-0001-9052-2248	Viragh Family Foundation; NIH/NCI of the Core Facilities and Services CCSG of Flow Cytometry and Cellular Imaging Facility, Houston [P30CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Viragh Family Foundation; NIH/NCI of the Core Facilities and Services CCSG of Flow Cytometry and Cellular Imaging Facility, Houston; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by Viragh Family Foundation, and Various Donors in Pancreatic Cancer Research. It was also supported by the NIH/NCI under award number P30CA016672 of the Core Facilities and Services CCSG of Flow Cytometry and Cellular Imaging Facility, Houston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; Cano C, 2010, THESCIENTIFICWORLDJO, V10, P1947, DOI 10.1100/tsw.2010.183; Giroldi LA, 1999, INT J CANCER, V82, P70, DOI 10.1002/(SICI)1097-0215(19990702)82:1<70::AID-IJC13>3.0.CO;2-#; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; Hay ED, 1995, ACTA ANAT, V154, P8; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Hirschtritt ME, 2012, J SUBST ABUSE TREAT, V42, P366, DOI 10.1016/j.jsat.2011.09.010; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Katz MHG, 2009, ANN SURG ONCOL, V16, P836, DOI 10.1245/s10434-008-0295-2; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Lefort CT, 2011, J BIOL CHEM, V286, P3149, DOI 10.1074/jbc.M110.115733; Li ZK, 2009, CANCER RES, V69, P7851, DOI 10.1158/0008-5472.CAN-08-4002; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Perez-Pomares JM, 2002, ANAT RECORD, V268, P343, DOI 10.1002/ar.10165; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rieger-Christ KM, 2001, J CLIN PATHOL-MOL PA, V54, P91, DOI 10.1136/mp.54.2.91; Schutte M, 1996, CANCER RES, V56, P2527; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shih WT, 2012, J CELL SCI, V125, P3661, DOI 10.1242/jcs.103861; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; Sun Z, 2014, MICROCIRCULATION; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomas Rohit Philip, 2007, Biomedical Papers (Olomouc), V151, P85; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	35	16	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107948	10.1371/journal.pone.0107948	http://dx.doi.org/10.1371/journal.pone.0107948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264609	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400034
J	Petitdemange, C; Wauquier, N; Jacquet, JM; Theodorou, I; Leroy, E; Vieillard, V				Petitdemange, Caroline; Wauquier, Nadia; Jacquet, Jean-Michel; Theodorou, Ioannis; Leroy, Eric; Vieillard, Vincent			Association of HLA Class-I and Inhibitory KIR Genotypes in Gabonese Patients Infected by Chikungunya or Dengue Type-2 Viruses	PLOS ONE			English	Article							RECEPTOR; MOLECULES; INNATE; DIVERSITY; AFRICAN; HEALTH; GENES; CELLS	Background: Natural killer (NK) cells provide defense in the early stages of the immune response against viral infections. Killer cell immunoglobulin-like receptors (KIR) expressed on the surface of NK cells play an important role in regulating NK cell response through recognition of human leukocyte antigen (HLA) class I molecules on target cells. Previous studies have shown that specific KIR/ligand combinations are associated with the outcome of several viral infectious diseases. Methods: We investigated the impact of inhibitory and activating KIR and their HLA-class I ligand genotype on the susceptibility to Chikungunya virus (CHIKV) and Dengue virus (DENV2) infections. From April to July 2010 in Gabon, a large outbreak of CHIKV and DENV2 concomitantly occurred in two provinces of Gabon (Ogooue-Lolo and Haut-Ogooue). We performed the genotypic analysis of KIR in the combination with their cognate HLA-class I ligands in 73 CHIKV and 55 DENV2 adult cases, compared with 54 healthy individuals. Results: We found in CHIV-infected patients that KIR2DL1 and KIR2DS5 are significantly increased and decreased respectively, as compared to DENV2(+) patients and healthy donors. The combination of KIR2DL1 and its cognate HLA-C2 ligand was significantly associated with the susceptibility to CHIKV infection. In contrast, no other inhibitory KIR-HLA pairs showed an association with the two mosquito-borne arboviruses. Conclusion: These observations are strongly suggestive that the NK cell repertoire shaped by the KIR2DL1: HLA-C2 interaction facilitate specific infection by CHIKV.	[Petitdemange, Caroline; Theodorou, Ioannis; Vieillard, Vincent] Univ Paris 06, Sorbonne Univ, CR7, CIMI Paris, Paris, France; [Petitdemange, Caroline; Theodorou, Ioannis; Vieillard, Vincent] INSERM, U1135, CIMI Paris, Paris, France; [Petitdemange, Caroline; Leroy, Eric] Ctr Int Rech Med Franceville, Unite Malad Emergentes, Franceville, Gabon; [Wauquier, Nadia] Metabiota Inc, San Francisco, CA USA; [Jacquet, Jean-Michel; Theodorou, Ioannis] Hop La Pitie Salpetriere, AP HP, Dept Immunol, Paris, France; [Leroy, Eric] IRD, Montpellier, France; [Vieillard, Vincent] CNRS, ERL8255, CIMI Paris, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Vieillard, V (corresponding author), Univ Paris 06, Sorbonne Univ, CR7, CIMI Paris, Paris, France.	vincent.vieillard@upmc.fr	Vieillard, Vincent/P-3001-2017; LEROY, Eric M/I-4347-2016	LEROY, Eric M/0000-0003-0022-0890; Wauquier, Nadia/0000-0002-2874-7574	Institut National de la Recherche Medicale (INSERM); Universite Pierre et Marie Curie, Paris, France	Institut National de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie, Paris, France	This study was funded in part by the Institut National de la Recherche Medicale (INSERM), and the Universite Pierre et Marie Curie, Paris, France. Vincent Vieillard is a researcher from the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2008, J CLIN INVEST, V118, P1017, DOI 10.1172/JCI32400; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Azeredo EL, 2006, CLIN EXP IMMUNOL, V143, P345, DOI 10.1111/j.1365-2249.2006.02996.x; Beltrame LM, 2013, TISSUE ANTIGENS, V82, P397, DOI 10.1111/tan.12256; Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; Della Chiesa M, 2008, EUR J IMMUNOL, V38, P2284, DOI 10.1002/eji.200838434; Denis L, 2005, TISSUE ANTIGENS, V66, P267, DOI 10.1111/j.1399-0039.2005.00473.x; de Alencar LXE, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/648475; Falco M, 2013, TISSUE ANTIGENS, V82, P363, DOI 10.1111/tan.12262; Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617; Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255; Hollenbach JA, 2012, IMMUNOGENETICS, V64, P719, DOI 10.1007/s00251-012-0629-x; Ivarsson MA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00184; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Martin MP, 2009, IMMUNOGENETICS, V61, P79, DOI 10.1007/s00251-008-0345-8; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; MULLER CA, 1989, IMMUNOGENETICS, V30, P200, DOI 10.1007/BF02421207; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; Norman PJ, 2002, GENES IMMUN, V3, P86, DOI 10.1038/sj.gene.6363836; Nowak I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012381; Omosun YO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038617; Paladino N, 2007, TISSUE ANTIGENS, V69, P109, DOI 10.1111/j.1399-0039.2006.762_7.x; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Paximadis M, 2012, HUM IMMUNOL, V73, P80, DOI 10.1016/j.humimm.2011.10.013; Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; SVEJGAARD A, 1994, TISSUE ANTIGENS, V43, P18, DOI 10.1111/j.1399-0039.1994.tb02291.x; Vilches C, 2007, TISSUE ANTIGENS, V70, P415, DOI 10.1111/j.1399-0039.2007.00923.x; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006; Wauquier N, 2010, IMMUNOGENETICS, V62, P767, DOI 10.1007/s00251-010-0480-x	37	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108798	10.1371/journal.pone.0108798	http://dx.doi.org/10.1371/journal.pone.0108798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264760	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400125
J	Bruton, J; Jeffries, GDM; Westerblad, H				Bruton, Joseph; Jeffries, Gavin D. M.; Westerblad, Hakan			Usage of a Localised Microflow Device to Show that Mitochondrial Networks Are Not Extensive in Skeletal Muscle Fibres	PLOS ONE			English	Article							VACUOLE FORMATION; MOUSE; CA2+; RETICULUM; FROG; FILAMENTS; FUSION; WHITE; RED	In cells, such as neurones and immune cells, mitochondria can form dynamic and extensive networks that change over the minute timescale. In contrast, mitochondria in adult mammalian skeletal muscle fibres show little motility over several hours. Here, we use a novel three channelled microflow device, the multifunctional pipette, to test whether mitochondria in mouse skeletal muscle connect to each other. The central channel in the pipette delivers compounds to a restricted region of the sarcolemma, typically 30 mu m in diameter. Two channels on either side of the central channel use suction to create a hydrodynamically confined flow zone and remove compounds completely from the bulk solution to internal waste compartments. Compounds were delivered locally to the end or side of single adult mouse skeletal muscle fibres to test whether changes in mitochondrial membrane potential were transmitted to more distant located mitochondria. Mitochondrial membrane potential was monitored with tetramethylrhodamine ethyl ester (TMRE). Cytosolic free [Ca2+] was monitored with fluo-3. A pulse of carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP, 100 mu M) applied to a small area of the muscle fibre (30 mu m in diameter) produced a rapid decrease in the mitochondrial TMRE signal (indicative of depolarization) to 38% of its initial value. After washout of FCCP, the TMRE signal partially recovered. At distances greater than 50 mm away from the site of FCCP application, the mitochondrial TMRE signal was unchanged. Similar results were observed when two sites along the fibre were pulsed sequentially with FCCP. After a pulse of FCCP, cytosolic [Ca2+] was unchanged and fibres contracted in response to electrical stimulation. In conclusion, our results indicate that extensive networks of interconnected mitochondria do not exist in skeletal muscle. Furthermore, the limited and reversible effects of targeted FCCP application with the multifunctional pipette highlight its advantages over bulk application of compounds to isolated cells.	[Bruton, Joseph; Westerblad, Hakan] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Jeffries, Gavin D. M.] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden	Karolinska Institutet; Chalmers University of Technology	Bruton, J (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	Joseph.Bruton@ki.se	Jeffries, Gavin D. M./F-5135-2011	Jeffries, Gavin D. M./0000-0001-5533-169X; Westerblad, Hakan/0000-0002-8180-3029; Bruton, Joseph/0000-0002-6985-099X	Vetenskapsradet [621-2012-5094, 521-2013-2833]; Karolinska Institute	Vetenskapsradet(Swedish Research Council); Karolinska Institute(Karolinska Institutet)	This work is supported by Vetenskapsradet 621-2012-5094 (GDMJ), Vetenskapsradet 521-2013-2833 (HW), and Funds at Karolinska Institute (JB, HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainla A, 2012, LAB CHIP, V12, P1255, DOI 10.1039/c2lc20906c; AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481; Arimura S, 2004, P NATL ACAD SCI USA, V101, P7805, DOI 10.1073/pnas.0401077101; Bereiter-Hahn J, 2010, INT REV CEL MOL BIO, V284, P1, DOI 10.1016/S1937-6448(10)84001-8; BEREITERHAHN J, 1978, J CELL SCI, V30, P99; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Bruton J, 2003, J PHYSIOL-LONDON, V551, P179, DOI 10.1113/jphysiol.2003.043927; Bruton JD, 2010, J PHYSIOL-LONDON, V588, P4275, DOI 10.1113/jphysiol.2010.198598; Caputo C, 2008, PFLUG ARCH EUR J PHY, V455, P733, DOI 10.1007/s00424-007-0317-0; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Dahl R, 2014, ACTA PHYSL, DOI [10.1111/apha.1228, DOI 10.1111/APHA.1228]; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; De Vos KJ, 2007, METHOD CELL BIOL, V80, P627, DOI 10.1016/S0091-679X(06)80030-0; KIRKWOOD SP, 1986, AM J PHYSIOL, V251, pC395, DOI 10.1152/ajpcell.1986.251.3.C395; KIRKWOOD SP, 1987, ARCH BIOCHEM BIOPHYS, V255, P80, DOI 10.1016/0003-9861(87)90296-7; Lannergren J, 1999, J MUSCLE RES CELL M, V20, P19, DOI 10.1023/A:1005412216794; Lannergren J, 2000, J PHYSIOL-LONDON, V526, P597, DOI 10.1111/j.1469-7793.2000.00597.x; Lannergren J, 2001, J MUSCLE RES CELL M, V22, P265, DOI 10.1023/A:1012227009544; Nakada K, 2001, BIOCHEM BIOPH RES CO, V288, P901, DOI 10.1006/bbrc.2001.5873; Ogata T, 1997, ANAT REC, V248, P214; OGATA T, 1985, CELL TISSUE RES, V241, P251, DOI 10.1007/BF00217168; Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012; Powers SK, 2011, COMPR PHYSIOL, V1, P941, DOI 10.1002/cphy.c100054; Reipert S, 1999, EXP CELL RES, V252, P479, DOI 10.1006/excr.1999.4626; Rizzuto R, 1995, METHOD ENZYMOL, V260, P417, DOI 10.1016/0076-6879(95)60155-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; STARON RS, 1984, J HISTOCHEM CYTOCHEM, V32, P146, DOI 10.1177/32.2.6229571; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; Twig G, 2006, AM J PHYSIOL-CELL PH, V291, pC176, DOI 10.1152/ajpcell.00348.2005; Zima AV, 2013, AM J PHYSIOL-HEART C, V304, pH983, DOI 10.1152/ajpheart.00932.2012	33	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108601	10.1371/journal.pone.0108601	http://dx.doi.org/10.1371/journal.pone.0108601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259575	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600086
J	Cejudo-Martin, P; Yuen, A; Vlahovich, N; Lock, P; Courtneidge, SA; Diaz, B				Cejudo-Martin, Pilar; Yuen, Angela; Vlahovich, Nicole; Lock, Peter; Courtneidge, Sara A.; Diaz, Begona			Genetic Disruption of the Sh3pxd2a Gene Reveals an Essential Role in Mouse Development and the Existence of a Novel Isoform of Tks5	PLOS ONE			English	Article							CRANIAL NEURAL CREST; CLEFT-LIP; C-SRC; PODOSOME FORMATION; ALTERNATIVE PROMOTERS; KINASE-ACTIVITY; PROTEIN; DEGRADATION; CANCER; PALATE	Tks5 is a scaffold protein and Src substrate involved in cell migration and matrix degradation through its essential role in invadosome formation and function. We have previously described that Tks5 is fundamental for zebrafish neural crest cell migration in vivo. In the present study, we sought to investigate the function of Tks5 in mammalian development by analyzing mice mutant for sh3pxd2a, the gene encoding Tks5. Homozygous disruption of the sh3pxd2a gene by gene-trapping in mouse resulted in neonatal death and the presence of a complete cleft of the secondary palate. Interestingly, embryonic fibroblasts from homozygous gene-trap sh3pxd2a mice lacked only the highest molecular weight band of the characteristic Tks5 triplet observed in protein extracts, leaving the lower molecular weight bands unaffected. This finding, together with the existence of two human Expressed Sequence Tags lacking the first 5 exons of SH3PXD2A, made us hypothesize about the presence of a second alternative transcription start site located in intron V. We performed 5'RACE on mouse fibroblasts and isolated a new transcript of the sh3pxd2a gene encoding a novel Tks5 isoform, that we named Tks5 beta. This novel isoform diverges from the long form of Tks5 in that it lacks the PX-domain, which confers affinity for phosphatidylinositol-3,4-bisphosphate. Instead, Tks5 beta has a short unique amino terminal sequence encoded by the newly discovered exon 6 beta; this exon includes a start codon located 29 bp from the 5'-end of exon 6. Tks5 beta mRNA is expressed in MEFs and all mouse adult tissues analyzed. Tks5 beta is a substrate for the Src tyrosine kinase and its expression is regulated through the proteasome degradation pathway. Together, these findings indicate the essentiality of the larger Tks5 isoform for correct mammalian development and the transcriptional complexity of the sh3pxd2a gene.	[Cejudo-Martin, Pilar; Yuen, Angela; Vlahovich, Nicole; Courtneidge, Sara A.; Diaz, Begona] Sanford Burnham Med Res Inst, Tumor Microenvironm & Metastasis Program, Ctr Canc, La Jolla, CA USA; [Lock, Peter] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic 3086, Australia	Sanford Burnham Prebys Medical Discovery Institute; La Trobe University	Courtneidge, SA (corresponding author), Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA.	courtneidge@ohsu.edu; bdiaz@sbmri.org		Lock, Peter/0000-0003-4421-3609; Diaz, Begona/0000-0002-7892-6319	National Cancer Institute [CA098383, CA129686]; Beatriu de Pinos postdoctoral fellowship from the government of Catalonia, Spain [2007 BPA69 PCM]; NATIONAL CANCER INSTITUTE [R01CA098383, P30CA030199, R01CA129686] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Beatriu de Pinos postdoctoral fellowship from the government of Catalonia, Spain; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute CA098383 SAC, National Cancer Institute CA129686 SAC, and Beatriu de Pinos postdoctoral fellowship from the government of Catalonia, Spain 2007 BPA69 PCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Anderson KV, 2003, NAT GENET, V33, P285, DOI 10.1038/ng1105; Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Buschman MD, 2009, MOL BIOL CELL, V20, P1302, DOI 10.1091/mbc.E08-09-0949; Cejudo-Martin P, 2011, GENESIS, V49, P209, DOI 10.1002/dvg.20732; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chou Mary T-H, 2010, Genes Cancer, V1, P225; Cobourne MT, 2004, EUR J ORTHODONT, V26, P7, DOI 10.1093/ejo/26.1.7; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643; Crews ST, 2009, CURR BIOL, V19, pR241, DOI 10.1016/j.cub.2009.01.015; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; DAVIDPFEUTY T, 1980, P NATL ACAD SCI-BIOL, V77, P6687, DOI 10.1073/pnas.77.11.6687; Davidson LA, 2012, DEVELOPMENT, V139, P3065, DOI 10.1242/dev.080093; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Diaz B, 2012, FREE RADICAL BIO MED, V52, P247, DOI 10.1016/j.freeradbiomed.2011.09.016; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Gatesman A, 2004, MOL CELL BIOL, V24, P7578, DOI 10.1128/MCB.24.17.7578-7597.2004; Gritli-Linde A, 2008, CURR TOP DEV BIOL, V84, P37, DOI 10.1016/S0070-2153(08)00602-9; Guiet R, 2012, J BIOL CHEM, V287, P13051, DOI 10.1074/jbc.M111.307124; Han H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070595; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; Iqbal Z, 2010, AM J HUM GENET, V86, P254, DOI 10.1016/j.ajhg.2010.01.009; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Janas JA, 2011, MOL CELL BIOL, V31, P2552, DOI 10.1128/MCB.05045-11; Jeong YJ, 2005, MOL REPROD DEV, V71, P284, DOI 10.1002/mrd.20269; Jugessur A, 2009, ORAL DIS, V15, P437, DOI 10.1111/j.1601-0825.2009.01577.x; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Laird AD, 2003, MOL CANCER THER, V2, P461; Li CMC, 2013, GENE DEV, V27, P1557, DOI 10.1101/gad.222745.113; Lock P, 1998, EMBO J, V17, P4346, DOI 10.1093/emboj/17.15.4346; Lopez J, 2012, CELL DEATH DIFFER, V19, P1459, DOI 10.1038/cdd.2012.21; Marzia M, 2006, J BIOL CHEM, V281, P9745, DOI 10.1074/jbc.M513516200; Matzuk MM, 2012, ANNU REV PHYSIOL, V74, P503, DOI 10.1146/annurev-physiol-020911-153248; Murphy DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022499; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Ngondo RP, 2013, NUCLEIC ACIDS RES; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Parada C, 2012, FRONT ORAL BIOL, V16, P60, DOI 10.1159/000337617; Patel A, 2012, EUR J CELL BIOL, V91, P171, DOI 10.1016/j.ejcb.2011.11.006; Penela P, 2001, EMBO J, V20, P5129, DOI 10.1093/emboj/20.18.5129; Ple PA, 2004, J MED CHEM, V47, P871, DOI 10.1021/jm030317k; Robin NH, 2006, SOUTH MED J, V99, P1111, DOI 10.1097/01.smj.0000209093.78617.3a; Rosenthal N, 2007, NAT CELL BIOL, V9, P993, DOI 10.1038/ncb437; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Schofield PN, 2012, HUM MUTAT, V33, P826, DOI 10.1002/humu.22077; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Shimizu T, 2012, STEM CELLS, V30, P1394, DOI 10.1002/stem.1119; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Stylli SS, 2009, J CELL SCI, V122, P2727, DOI 10.1242/jcs.046680; Takkunen M, 2010, J CELL MOL MED, V14, P1569, DOI 10.1111/j.1582-4934.2009.00868.x; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787; Thyagarajan T, 2003, CRIT REV ORAL BIOL M, V14, P154, DOI 10.1177/154411130301400302; Trainor PA, 2010, AM J MED GENET A, V152A, P2984, DOI 10.1002/ajmg.a.33454; Wessels MW, 2010, CLIN GENET, V78, P103, DOI 10.1111/j.1399-0004.2010.01435.x; Xin DD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002377; Yoo Y, 2010, ONCOGENE, V29, P263, DOI 10.1038/onc.2009.319; Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303	66	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107674	10.1371/journal.pone.0107674	http://dx.doi.org/10.1371/journal.pone.0107674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259869	gold, Green Published, Green Submitted			2022-12-27	WOS:000342685600027
J	Katshu, MZU; d'Avossa, G				Katshu, Mohammad Zia Ul Haq; d'Avossa, Giovanni			Fine-Grained, Local Maps and Coarse, Global Representations Support Human Spatial Working Memory	PLOS ONE			English	Article							PREDICTS INDIVIDUAL-DIFFERENCES; POSTERIOR PARIETAL CORTEX; SHORT-TERM-MEMORY; FIELD SIZE; CAPACITY; DISSOCIATION; DISTORTIONS; UNIFORMITY; RESOURCES; STRIATE	While sensory processes are tuned to particular features, such as an object's specific location, color or orientation, visual working memory (vWM) is assumed to store information using representations, which generalize over a feature dimension. Additionally, current vWM models presume that different features or objects are stored independently. On the other hand, configurational effects, when observed, are supposed to mainly reflect encoding strategies. We show that the location of the target, relative to the display center and boundaries, and overall memory load influenced recall precision, indicating that, like sensory processes, capacity limited vWM resources are spatially tuned. When recalling one of three memory items the target distance from the display center was overestimated, similar to the error when only one item was memorized, but its distance from the memory items' average position was underestimated, showing that not only individual memory items' position, but also the global configuration of the memory array may be stored. Finally, presenting the non-target items at recall, consequently providing landmarks and configurational information, improved precision and accuracy of target recall. Similarly, when the non-target items were translated at recall, relative to their position in the initial display, a parallel displacement of the recalled target was observed. These findings suggest that fine-grained spatial information in vWM is represented in local maps whose resolution varies with distance from landmarks, such as the display center, while coarse representations are used to store the memory array configuration. Both these representations are updated at the time of recall.	[Katshu, Mohammad Zia Ul Haq; d'Avossa, Giovanni] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Katshu, Mohammad Zia Ul Haq; d'Avossa, Giovanni] Bangor Univ, Wolfson Ctr Clin & Cognit Neurosci, Bangor, Gwynedd, Wales; [Katshu, Mohammad Zia Ul Haq] Univ Nottingham, Div Psychiat & Appl Psychol, Inst Mental Hlth, Nottingham NG7 2RD, England	Bangor University; Bangor University; University of Nottingham	d'Avossa, G (corresponding author), Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales.	g.davossa@bangor.ac.uk						Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Barnes Jonathan, 1984, COMPLETE WORKS ARIST, V1, P714; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Bays PM, 2011, NEUROPSYCHOLOGIA, V49, P1622, DOI 10.1016/j.neuropsychologia.2010.12.023; Brady TF, 2011, J VISION, V11, DOI 10.1167/11.5.4; Brady TF, 2011, PSYCHOL SCI, V22, P384, DOI 10.1177/0956797610397956; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chafee MV, 2007, CEREB CORTEX, V17, P2914, DOI 10.1093/cercor/bhm017; Chafee MV, 2005, CEREB CORTEX, V15, P1393, DOI 10.1093/cercor/bhi021; Cicero, 1954, RHETORICA HERENNIUM, P207; Delvenne JF, 2005, COGNITION, V96, pB79, DOI 10.1016/j.cognition.2004.12.007; Diedrichsen J, 2004, PERCEPT PSYCHOPHYS, V66, P89, DOI 10.3758/BF03194864; Fortenbaugh FC, 2012, J VISION, V12, DOI 10.1167/12.2.19; Franconeri SL, 2013, TRENDS COGN SCI, V17, P134, DOI 10.1016/j.tics.2013.01.010; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Hu Y, 2000, J COGNITIVE NEUROSCI, V12, P856, DOI 10.1162/089892900562462; Huang J, 2010, J VISION, V10, DOI 10.1167/10.2.24; Hubbard TL, 2000, PSYCHOL RES-PSYCH FO, V64, P41, DOI 10.1007/s004260000029; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; Kleiner M, 2007, PERCEPT S; Lee SH, 2013, NAT NEUROSCI, V16, P997, DOI 10.1038/nn.3452; Linden DEJ, 2003, NEUROIMAGE, V20, P1518, DOI 10.1016/j.neuroimage.2003.07.021; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Ma WJ, 2014, NAT NEUROSCI, V17, P347, DOI 10.1038/nn.3655; NELSON TO, 1980, J EXP PSYCHOL-HUM L, V6, P529, DOI 10.1037/0278-7393.6.5.529; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Riggall AC, 2012, J NEUROSCI, V32, P12990, DOI 10.1523/JNEUROSCI.1892-12.2012; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Sheth BR, 2001, VISION RES, V41, P329, DOI 10.1016/S0042-6989(00)00230-3; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48; Xing Y, 2013, J NEUROSCI, V33, P10301, DOI 10.1523/JNEUROSCI.3754-12.2013; Yates FA, 1992, ART MEMORY, p[47, 148]; ZEKI SM, 1978, J PHYSIOL-LONDON, V277, P273, DOI 10.1113/jphysiol.1978.sp012272; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	40	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107969	10.1371/journal.pone.0107969	http://dx.doi.org/10.1371/journal.pone.0107969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IP	25259601	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600039
J	Somekh, J; Haimovich, G; Guterman, A; Dori, D; Choder, M				Somekh, Judith; Haimovich, Gal; Guterman, Adi; Dori, Dov; Choder, Mordechai			Conceptual Modeling of mRNA Decay Provokes New Hypotheses	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; DEGRADATION; TRANSLATION; SUBUNIT; COMPLEX; DEADENYLATION; TRANSCRIPTION; REVEALS; BIOLOGY	Biologists are required to integrate large amounts of data to construct a working model of the system under investigation. This model is often informal and stored mentally or textually, making it prone to contain undetected inconsistencies, inaccuracies, or even contradictions, not much less than a representation in free natural language. Using Object-Process Methodology (OPM), a formal yet visual and humanly accessible conceptual modeling language, we have created an executable working model of the mRNA decay process in Saccharomyces cerevisiae, as well as the import of its components to the nucleus following mRNA decay. We show how our model, which incorporates knowledge from 43 articles, can reproduce outcomes that match the experimental findings, evaluate hypotheses, and predict new possible outcomes. Moreover, we were able to analyze the effects of the mRNA decay model perturbations related to gene and interaction deletions, and predict the nuclear import of certain decay factors, which we then verified experimentally. In particular, we verified experimentally the hypothesis that Rpb4p, Lsm1p, and Pan2p remain bound to the RNA 3'-untralslated region during the entire process of the 5' to 3' degradation of the RNA open reading frame. The model has also highlighted erroneous hypotheses that indeed were not in line with the experimental outcomes. Beyond the scientific value of these specific findings, this work demonstrates the value of the conceptual model as an in silico vehicle for hypotheses generation and testing, which can reinforce, and often even replace, risky, costlier wet lab experiments.	[Somekh, Judith; Dori, Dov] Technion Israel Inst Technol, Fac Ind Engn & Management, IL-32000 Haifa, Israel; [Somekh, Judith; Haimovich, Gal; Guterman, Adi; Choder, Mordechai] Technion Israel Inst Technol, Fac Med, Haifa, Israel; [Dori, Dov] MIT, Engn Syst Div, Cambridge, MA 02139 USA	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Massachusetts Institute of Technology (MIT)	Somekh, J (corresponding author), Technion Israel Inst Technol, Fac Ind Engn & Management, IL-32000 Haifa, Israel.	yuditol@technion.ac.il	Haimovich, Gal/H-3316-2019	Haimovich, Gal/0000-0002-3360-5108	European Union [262044 - VISIONAIR]; Gordon Center for Systems Engineering at the Technion; Israel Science Foundation; Gruss-Lipper family postdoctoral fellowship (EGL charitable foundation)	European Union(European Commission); Gordon Center for Systems Engineering at the Technion; Israel Science Foundation(Israel Science Foundation); Gruss-Lipper family postdoctoral fellowship (EGL charitable foundation)	This work was funded in part by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 262044 - VISIONAIR and from Gordon Center for Systems Engineering at the Technion (to DD). This work was funded, in part, by a grant from the Israel Science Foundation (to MC). GH is a recipient of the Gruss-Lipper family postdoctoral fellowship (EGL charitable foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ENCY KNOWLEDGE MANAG; Badis G, 2004, MOL CELL, V15, P5, DOI 10.1016/j.molcel.2004.06.028; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; Dahan N, 2013, BBA-GENE REGUL MECH, V1829, P169, DOI 10.1016/j.bbagrm.2012.08.004; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dori D., 2003, OPCAT BIMODAL CASE T; Dori D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000872; Fisher J, 2005, P NATL ACAD SCI USA, V102, P1951, DOI 10.1073/pnas.0409433102; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Lotan R, 2007, J CELL BIOL, V178, P1133, DOI 10.1083/jcb.200701165; Nissan T, 2010, MOL CELL, V39, P773, DOI 10.1016/j.molcel.2010.08.025; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Peleg M, 2000, IEEE T SOFTWARE ENG, V26, P742, DOI 10.1109/32.879812; Perelman V, 2011, S THEOR MOD SIM DEVS; Perelman V, 2011, THESIS TECHNION ISRA; Sharif H, 2013, NUCLEIC ACIDS RES, V41, P8377, DOI 10.1093/nar/gkt600; Somekh J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051430; Steiger M, 2003, RNA, V9, P231, DOI 10.1261/rna.2151403; Tharun S, 2001, MOL CELL, V8, P1075, DOI 10.1016/S1097-2765(01)00395-1; Tuck AC, 2013, CELL, V154, P996, DOI 10.1016/j.cell.2013.07.047; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; VREKEN P, 1992, MOL CELL BIOL, V12, P2986, DOI 10.1128/MCB.12.7.2986; Wand Y, 2002, INFORM SYST RES, V13, P363, DOI 10.1287/isre.13.4.363.69; Yaroker Y, 2012, OPM CONCEPTUAL MODEL	30	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107085	10.1371/journal.pone.0107085	http://dx.doi.org/10.1371/journal.pone.0107085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255440	Green Submitted, Green Published, gold			2022-12-27	WOS:000344862300015
J	Banuelos, CA; Lal, A; Tien, AH; Shah, N; Yang, YC; Mawji, NR; Meimetis, LG; Park, J; Kunzhong, J; Andersen, RJ; Sadar, MD				Banuelos, Carmen A.; Lal, Aaron; Tien, Amy H.; Shah, Neel; Yang, Yu Chi; Mawji, Nasrin R.; Meimetis, Labros G.; Park, Jacob; Kunzhong, Jian; Andersen, Raymond J.; Sadar, Marianne D.			Characterization of Niphatenones that Inhibit Androgen Receptor N-Terminal Domain	PLOS ONE			English	Article							LIGAND-BINDING DOMAIN; PROSTATE-CANCER CELLS; TRANSCRIPTIONAL ACTIVATION; TRANSACTIVATION; IDENTIFICATION; ANTIANDROGEN; ANTAGONIST; INDUCTION; BLOCK	Androgen ablation therapy causes a temporary reduction in tumor burden in patients with advanced prostate cancer. Unfortunately the malignancy will return to form lethal castration-recurrent prostate cancer (CRPC). The androgen receptor (AR) remains transcriptionally active in CRPC in spite of castrate levels of androgens in the blood. AR transcriptional activity resides in its N-terminal domain (NTD). Possible mechanisms of continued AR transcriptional activity may include, at least in part, expression of constitutively active splice variants of AR that lack the C-terminal ligand-binding domain (LBD). Current therapies that target the AR LBD, would not be effective against these AR variants. Currently no drugs are clinically available that target the AR NTD which should be effective against these AR variants as well as full-length AR. Niphatenones were originally isolated and identified in active extracts from Niphates digitalis marine sponge. Here we begin to characterize the mechanism of niphatenones in blocking AR transcriptional activity. Both enantiomers had similar IC50 values of 6 mu M for inhibiting the full-length AR in a functional transcriptional assay. However, (S)-niphatenone had significantly better activity against the AR NTD compared to (R)-niphatenone. Consistent with niphatenones binding to and inhibiting transactivation of AR NTD, niphatenones inhibited AR splice variant. Niphatenone did not affect the transcriptional activity of the related progesterone receptor, but slightly decreased glucocorticoid receptor (GR) activity and covalently bound to GR activation function-1 (AF-1) region. Niphatenone blocked N/C interactions of AR without altering either AR protein levels or its intracellular localization in response to androgen. Alkylation with glutathione suggests that niphatenones are not a feasible scaffold for further drug development.	[Banuelos, Carmen A.; Lal, Aaron; Tien, Amy H.; Shah, Neel; Yang, Yu Chi; Mawji, Nasrin R.; Park, Jacob; Sadar, Marianne D.] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Meimetis, Labros G.; Kunzhong, Jian; Andersen, Raymond J.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia	Sadar, MD (corresponding author), British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada.	msadar@bcgsc.ca	Sadar, Marianne/E-9136-2012	Sadar, Marianne/0000-0003-0599-9215; Yang, Yu Chi/0000-0001-8318-1174	National Institutes of Health (NIH) [CA105304]; National Cancer Institute (NCI) [2R01 CA105304]; Prostate Cancer Foundation (United States of America); NATIONAL CANCER INSTITUTE [R01CA105304] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation (United States of America); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grant CA105304, National Cancer Institute (NCI) (2R01 CA105304), and the Prostate Cancer Foundation (United States of America). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Clegg NJ, 2012, CANCER RES, V72, P1494, DOI 10.1158/0008-5472.CAN-11-3948; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; McEwan Iain J, 2007, Nucl Recept Signal, V5, pe001; McEwan IJ, 2012, MOL BIOSYST, V8, P82, DOI 10.1039/c1mb05249g; Meimetis LG, 2012, J MED CHEM, V55, P503, DOI 10.1021/jm2014056; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Myung JK, 2013, J CLIN INVEST, V123, P2948, DOI 10.1172/JCI66398; Quayle SN, 2007, P NATL ACAD SCI USA, V104, P1331, DOI 10.1073/pnas.0606718104; Romanuik TL, 2009, AM J PATHOL, V175, P2264, DOI 10.2353/ajpath.2009.080868; Romanuik TL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-476; RUNDLETT SE, 1990, MOL ENDOCRINOL, V4, P708, DOI 10.1210/mend-4-5-708; Sadar MD, 2008, ORG LETT, V10, P4947, DOI 10.1021/ol802021w; Sadar MD, 2011, CANCER RES, V71, P1208, DOI 10.1158/0008-5472.CAN_10-3398; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Zhang XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027970; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208	28	22	22	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107991	10.1371/journal.pone.0107991	http://dx.doi.org/10.1371/journal.pone.0107991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268119	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700058
J	Libard, S; Popova, SN; Amini, RM; Karja, V; Pietilainen, T; Hamalainen, KM; Sundstrom, C; Hesselager, G; Bergqvist, M; Ekman, S; Zetterling, M; Smits, A; Nilsson, P; Pfeifer, S; de Stahl, TD; Enblad, G; Ponten, F; Alafuzoff, I				Libard, Sylwia; Popova, Svetlana N.; Amini, Rose-Marie; Karja, Vesa; Pietilainen, Timo; Hamalainen, Kirsi M.; Sundstrom, Christer; Hesselager, Goran; Bergqvist, Michael; Ekman, Simon; Zetterling, Maria; Smits, Anja; Nilsson, Pelle; Pfeifer, Susan; de Stahl, Teresita Diaz; Enblad, Gunilla; Ponten, Fredrik; Alafuzoff, Irina			Human Cytomegalovirus Tegument Protein pp65 Is Detected in All Intra- and Extra-Axial Brain Tumours Independent of the Tumour Type or Grade	PLOS ONE			English	Article							ANTIGEN RETRIEVAL; GLIOBLASTOMA-MULTIFORME; TISSUE; INFECTION; IMMUNOHISTOCHEMISTRY; ASSOCIATION; EXPRESSION; SEROPREVALENCE; NEUROBLASTOMA; PROMOTES	Human cytomegalovirus (HCMV) has been indicated being a significant oncomodulator. Recent reports have suggested that an antiviral treatment alters the outcome of a glioblastoma. We analysed the performance of commercial HCMV-antibodies applying the immunohistochemical (IHC) methods on brain sample obtained from a subject with a verified HCMV infection, on samples obtained from 14 control subjects, and on a tissue microarray block containing cores of various brain tumours. Based on these trials, we selected the best performing antibody and analysed a cohort of 417 extra- and intra-axial brain tumours such as gliomas, medulloblastomas, primary diffuse large B-cell lymphomas, and meningiomas. HCMV protein pp65 immunoreactivity was observed in all types of tumours analysed, and the IHC expression did not depend on the patient's age, gender, tumour type, or grade. The labelling pattern observed in the tumours differed from the labelling pattern observed in the tissue with an active HCMV infection. The HCMV protein was expressed in up to 90% of all the tumours investigated. Our results are in accordance with previous reports regarding the HCMV protein expression in glioblastomas and medulloblastomas. In addition, the HCMV protein expression was seen in primary brain lymphomas, lowgrade gliomas, and in meningiomas. Our results indicate that the HCMV protein pp65 expression is common in intra- and extra-axial brain tumours. Thus, the assessment of the HCMV expression in tumours of various origins and pathologically altered tissue in conditions such as inflammation, infection, and even degeneration should certainly be facilitated.	[Libard, Sylwia; Popova, Svetlana N.; Amini, Rose-Marie; Sundstrom, Christer; Alafuzoff, Irina] Univ Uppsala Hosp, Dept Pathol, S-75185 Uppsala, Sweden; [Libard, Sylwia; Popova, Svetlana N.; Amini, Rose-Marie; Sundstrom, Christer; Ponten, Fredrik; Alafuzoff, Irina] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Karja, Vesa; Pietilainen, Timo; Hamalainen, Kirsi M.] Kuopio Univ Hosp, Dept Clin Pathol, SF-70210 Kuopio, Finland; [Hesselager, Goran; Zetterling, Maria; Nilsson, Pelle] Univ Uppsala Hosp, Dept Neurosurg, S-75185 Uppsala, Sweden; [Bergqvist, Michael] Gavle Cent Hosp, Cty Council Gavleborg, Ctr Res & Dev, Dept Oncol, Gavle, Sweden; [Bergqvist, Michael] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Ekman, Simon; Enblad, Gunilla] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Sect Oncol, Uppsala, Sweden; [Smits, Anja] Uppsala Univ, Dept Neurosci Neurol, Uppsala, Sweden; [Pfeifer, Susan] Uppsala Univ, Univ Uppsala Hosp, Dept Womens & Childrens Hlth, Uppsala, Sweden; [de Stahl, Teresita Diaz] Karolinska Univ Hosp, Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, Stockholm, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Kuopio University Hospital; University of Eastern Finland; Uppsala University; Uppsala University Hospital; Umea University; Uppsala University; Uppsala University; Uppsala University; Uppsala University Hospital; Karolinska Institutet; Karolinska University Hospital	Alafuzoff, I (corresponding author), Univ Uppsala Hosp, Dept Pathol, S-75185 Uppsala, Sweden.	irina.alafuzoff@igp.uu.se	Ekman, Simon/AAB-9387-2021	Diaz de Stahl, Teresita/0000-0001-5933-6623; Libard, Sylwia/0000-0003-1043-5385	Local Uppsala University Hospital	Local Uppsala University Hospital	This work was supported by Local Uppsala University Hospital "ALF" grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho L, 2010, J ALZHEIMERS DIS, V20, P1015, DOI 10.3233/JAD-2010-091681; Barami K, 2010, J CLIN NEUROSCI, V17, P819, DOI 10.1016/j.jocn.2009.10.040; Baryawno N, 2011, J CLIN INVEST, V121, P4043, DOI 10.1172/JCI57147; Bresnahan WA, 2000, P NATL ACAD SCI USA, V97, P14506, DOI 10.1073/pnas.97.26.14506; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Cobbs CS, 2007, J NEURO-ONCOL, V85, P271, DOI 10.1007/s11060-007-9423-2; Cobbs CS, 2013, CURR OPIN ONCOL, V25, P682, DOI 10.1097/CCO.0000000000000005; Cobbs Charles S, 2011, Herpesviridae, V2, P10, DOI 10.1186/2042-4280-2-10; Cobbs CS, 2002, CANCER RES, V62, P3347; Colomo L, 2003, BLOOD, V101, P78, DOI 10.1182/blood-2002-04-1286; D'Amico F, 2009, J IMMUNOL METHODS, V341, P1, DOI 10.1016/j.jim.2008.11.007; Ding DL, 2014, J NEURO-ONCOL, V116, P515, DOI 10.1007/s11060-013-1350-9; Dziurzynski K, 2012, NEURO-ONCOLOGY, V14, P246, DOI 10.1093/neuonc/nor227; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Griffiths P. D., 2009, Clinical virology, P475; Hadaczek P, 2013, CLIN CANCER RES, V19, P6473, DOI 10.1158/1078-0432.CCR-13-1121; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Harkins L, 2002, LANCET, V360, P1557, DOI 10.1016/S0140-6736(02)11524-8; Kampf C, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-103; Karja V, 2010, HUM PATHOL, V41, P199, DOI 10.1016/j.humpath.2009.06.020; Karlsson C, 2011, J HISTOCHEM CYTOCHEM, V59, P1113, DOI 10.1369/0022155411423779; Kauppinen T, 2006, APPL IMMUNOHISTO M M, V14, P353, DOI 10.1097/00129039-200609000-00016; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Landolfo S, 2003, PHARMACOL THERAPEUT, V98, P269, DOI 10.1016/S0163-7258(03)00034-2; Lau SK, 2005, MODERN PATHOL, V18, P838, DOI 10.1038/modpathol.3800352; Leong TYM, 2010, ADV ANAT PATHOL, V17, P404, DOI 10.1097/PAP.0b013e3181f8957c; Liu XF, 2013, VIRUSES-BASEL, V5, P1325, DOI 10.3390/v5051325; Lucas KG, 2011, J NEURO-ONCOL, V103, P231, DOI 10.1007/s11060-010-0383-6; Ludwig A, 2009, EUROSURVEILLANCE, V14, P26; McNicol AM, 1998, HISTOPATHOLOGY, V32, P97; Michaelis M, 2004, CELL MOL LIFE SCI, V61, P1307, DOI 10.1007/s00018-004-3417-4; Michaelis M, 2011, MED MICROBIOL IMMUN, V200, P1, DOI 10.1007/s00430-010-0177-7; Michaelis M, 2009, MED MICROBIOL IMMUN, V198, P79, DOI 10.1007/s00430-009-0107-8; Michelson S, 1999, INTERVIROLOGY, V42, P301, DOI 10.1159/000053964; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035; Mustakangas P, 2000, INT J EPIDEMIOL, V29, P587, DOI 10.1093/ije/29.3.587; Nord H, 2012, J NEURO-ONCOL, V107, P37, DOI 10.1007/s11060-011-0716-0; Poltermann S, 2006, J NEUROVIROL, V12, P90, DOI 10.1080/13550280600654573; Popova SN, 2014, HISTOPATHOLOGY, V64, P365, DOI 10.1111/his.12252; Rahbar A, 2013, J CLIN VIROL, V57, P36, DOI 10.1016/j.jcv.2012.12.018; Ramos-Vara JA, 2014, VET PATHOL, V51, P42, DOI 10.1177/0300985813505879; Ranganathan P, 2012, J VIROL, V86, P854, DOI 10.1128/JVI.06097-11; Reeves M, 2013, VIRUSES-BASEL, V5, P1395, DOI 10.3390/v5061395; Sabatier J, 2005, BRIT J CANCER, V92, P747, DOI 10.1038/sj.bjc.6602339; Samanta M, 2003, J UROLOGY, V170, P998, DOI 10.1097/01.ju.0000080263.46164.97; Scheurer ME, 2008, ACTA NEUROPATHOL, V116, P79, DOI 10.1007/s00401-008-0359-1; Sehic D, 2013, PEDIATR BLOOD CANCER, V60, pE91, DOI 10.1002/pbc.24535; Shi SR, 2001, APPL IMMUNOHISTO M M, V9, P107, DOI 10.1097/00022744-200106000-00002; Slinger E, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001180; Soderberg-Naucler C, 2013, NEW ENGL J MED, V369, P985, DOI 10.1056/NEJMc1302145; Soroceanu L, 2011, CANCER RES, V71, P6643, DOI 10.1158/0008-5472.CAN-11-0744; Stein H, 2008, WHO CLASSIFICATION T, V4th, P233; Straat K, 2009, JNCI-J NATL CANCER I, V101, P488, DOI 10.1093/jnci/djp031; Stragliotto G, 2013, INT J CANCER, V133, P1204, DOI 10.1002/ijc.28111; Trgovcich J, 2006, J VIROL, V80, P951, DOI 10.1128/JVI.80.2.951-963.2006; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wolmer-Solberg N, 2013, INT J CANCER, V133, P2351, DOI 10.1002/ijc.28265; Zafiropoulos A, 2003, CANCER LETT, V198, P77, DOI 10.1016/S0304-3835(03)00269-6	58	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108861	10.1371/journal.pone.0108861	http://dx.doi.org/10.1371/journal.pone.0108861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268364	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700180
J	Chander, D; Garcia, PS; MacColl, JN; Illing, S; Sleigh, JW				Chander, Divya; Garcia, Paul S.; MacColl, Jono N.; Illing, Sam; Sleigh, Jamie W.			Electroencephalographic Variation during End Maintenance and Emergence from Surgical Anesthesia	PLOS ONE			English	Article							GENERAL-ANESTHESIA; RIGHTING REFLEX; THALAMOCORTICAL NEURONS; SPINDLE OSCILLATIONS; CONTROLLED INFUSION; SLEEP-DEPRIVATION; BISPECTRAL INDEX; SPECTRAL EDGE; WOMEN EMERGE; EEG CHANGES	The re-establishment of conscious awareness after discontinuing general anesthesia has often been assumed to be the inverse of loss of consciousness. This is despite the obvious asymmetry in the initiation and termination of natural sleep. In order to characterize the restoration of consciousness after surgery, we recorded frontal electroencephalograph (EEG) from 100 patients in the operating room during maintenance and emergence from general anesthesia. We have defined, for the first time, 4 steady-state patterns of anesthetic maintenance based on the relative EEG power in the slow-wave (<14 Hz) frequency bands that dominate sleep and anesthesia. Unlike single-drug experiments performed in healthy volunteers, we found that surgical patients exhibited greater electroencephalographic heterogeneity while re-establishing conscious awareness after drug discontinuation. Moreover, these emergence patterns could be broadly grouped according to the duration and rapidity of transitions amongst these slow-wave dominated brain states that precede awakening. Most patients progressed gradually from a pattern characterized by strong peaks of delta (0.5-4 Hz) and alpha/spindle (8-14 Hz) power ('Slow-Wave Anesthesia') to a state marked by low delta-spindle power ('Non Slow-Wave Anesthesia') before awakening. However, 31% of patients transitioned abruptly from Slow-Wave Anesthesia to waking; they were also more likely to express pain in the post-operative period. Our results, based on sleep-staging classification, provide the first systematized nomenclature for tracking brain states under general anesthesia from maintenance to emergence, and suggest that these transitions may correlate with post-operative outcomes such as pain.	[Chander, Divya] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA; [Garcia, Paul S.] Emory Univ, Atlanta VA Med Ctr, Dept Anesthesiol, Atlanta, GA 30322 USA; [MacColl, Jono N.; Illing, Sam; Sleigh, Jamie W.] Univ Auckland, Waikato Clin Sch, Dept Anaesthesia, Hamilton, New Zealand	Stanford University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; University of Auckland	Chander, D (corresponding author), Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA.	dchander@stanford.edu			James S. McDonnell Foundation; Veterans Affairs [IK2BX001677] Funding Source: NIH RePORTER	James S. McDonnell Foundation; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a collaborative grant from the James S. McDonnell Foundation, and departmental resources of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrete J A, 1998, J Perianesth Nurs, V13, P148, DOI 10.1016/S1089-9472(98)80044-0; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Alkire MT, 2007, ANESTHESIOLOGY, V107, P264, DOI 10.1097/01.anes.0000270741.33766.24; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Bajaj Pramila, 2007, Middle East Journal of Anesthesiology, V19, P173; Basheer R, 1997, J NEUROSCI, V17, P9746; Berridge CW, 1996, J NEUROSCI, V16, P7010; Besset A, 2001, REV NEUROL-FRANCE, V157, pS107; Boly M, 2012, J NEUROSCI, V32, P7082, DOI 10.1523/JNEUROSCI.3769-11.2012; Bonin RP, 2008, PHARMACOL BIOCHEM BE, V90, P105, DOI 10.1016/j.pbb.2007.12.011; Breshears JD, 2010, P NATL ACAD SCI USA, V107, P21170, DOI 10.1073/pnas.1011949107; BRIMACOMBE J, 1995, CAN J ANAESTH, V42, P1017, DOI 10.1007/BF03011075; Chemali JJ, 2012, ANESTHESIOLOGY, V116, P998, DOI 10.1097/ALN.0b013e3182518bfc; Ching SN, 2010, P NATL ACAD SCI USA, V107, P22665, DOI 10.1073/pnas.1017069108; Cimenser A, 2011, P NATL ACAD SCI USA, V108, P8832, DOI 10.1073/pnas.1017041108; CLARK DL, 1973, ANESTHESIOLOGY, V38, P564, DOI 10.1097/00000542-197306000-00011; CONTRERAS D, 1993, J PHYSIOL-LONDON, V470, P273, DOI 10.1113/jphysiol.1993.sp019858; COURTIN RF, 1950, P STAFF M MAYO CLIN, V25, P197; Dang-Vu TT, 2010, SLEEP, V33, P1589, DOI 10.1093/sleep/33.12.1589; De Jonghe B, 2000, INTENS CARE MED, V26, P275, DOI 10.1007/s001340051150; DEMENT W, 1957, ELECTROEN CLIN NEURO, V9, P673, DOI 10.1016/0013-4694(57)90088-3; DOSSI RC, 1992, J PHYSIOL-LONDON, V447, P215, DOI 10.1113/jphysiol.1992.sp018999; Espa F, 2000, CLIN NEUROPHYSIOL, V111, P929, DOI 10.1016/S1388-2457(00)00249-2; Ferenets Rain, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P6356; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Friedman EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011903; Fuentealba P, 2004, P NATL ACAD SCI USA, V101, P9816, DOI 10.1073/pnas.0402761101; Gais S, 2002, J NEUROSCI, V22, P6830; Gan TJ, 1999, ANESTHESIOLOGY, V90, P1283, DOI 10.1097/00000542-199905000-00010; Garcia PS, 2010, CURR NEUROPHARMACOL, V8, P2, DOI 10.2174/157015910790909502; Gottschalk A, 2003, ANESTHESIOLOGY, V98, P548, DOI 10.1097/00000542-200302000-00037; Gugino LA, 2001, BRIT J ANAESTH, V87, P421, DOI 10.1093/bja/87.3.421; Haenggi M, 2004, ANESTH ANALG, V99, P1728, DOI 10.1213/01.ANE.0000135634.46493.0A; Hilborn R. C., 2000, CHAOS NONLINEAR DYNA; Howell MJ, 2012, NEUROTHERAPEUTICS, V9, P753, DOI 10.1007/s13311-012-0143-8; Hoymork SC, 2005, BRIT J ANAESTH, V95, P627, DOI 10.1093/bja/aei245; HUDSON RJ, 1983, ANESTHESIOLOGY, V59, P301, DOI 10.1097/00000542-198310000-00006; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; Illman H, 2010, J CLIN MONIT COMPUT, V24, P371, DOI 10.1007/s10877-010-9257-x; Imas OA, 2005, NEUROSCI LETT, V387, P145, DOI 10.1016/j.neulet.2005.06.018; John ER, 2001, CONSCIOUS COGN, V10, P165, DOI 10.1006/ccog.2001.0507; Joiner WJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003605; JONES BE, 1991, NEUROSCIENCE, V40, P637, DOI 10.1016/0306-4522(91)90002-6; Keifer JC, 1996, ANESTHESIOLOGY, V84, P945, DOI 10.1097/00000542-199604000-00023; Kelz MB, 2008, P NATL ACAD SCI USA, V105, P1309, DOI 10.1073/pnas.0707146105; KIERSEY D K, 1951, Br J Anaesth, V23, P141, DOI 10.1093/bja/23.3.141; Kroeger D, 2007, J NEUROSCI, V27, P10597, DOI 10.1523/JNEUROSCI.3440-07.2007; Ku SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025155; Lee U, 2013, ANESTHESIOLOGY, V118, P1264, DOI 10.1097/ALN.0b013e31829103f5; Leslie K, 2009, ANESTHESIOLOGY, V111, P547, DOI 10.1097/ALN.0b013e3181adf768; LONG CW, 1989, ANESTH ANALG, V69, P169; Lydic R, 2005, ANESTHESIOLOGY, V103, P1268; MacKay EC, 2010, ANAESTH INTENS CARE, V38, P102, DOI 10.1177/0310057X1003800118; Massimini M, 2012, ARCH ITAL BIOL, V150, P44, DOI 10.4449/aib.v150i2.1361; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Mei W, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.03.009; Mhuircheartaigh RN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006007; Mitra P., 2007, OBSERVED BRAIN DYNAM; Molle M, 2009, EUR J NEUROSCI, V29, P1071, DOI 10.1111/j.1460-9568.2009.06654.x; Morgenthaler TI, 2007, SLEEP, V30, P1705, DOI 10.1093/sleep/30.12.1705; Moser D, 2009, SLEEP, V32, P139, DOI 10.1093/sleep/32.2.139; Mulholland CV, J MOL NEURO IN PRESS; Myles PS, 2001, BRIT MED J, V322, P710, DOI 10.1136/bmj.322.7288.710; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Purdon PL, 2013, P NATL ACAD SCI USA, V110, pE1142, DOI 10.1073/pnas.1221180110; RAMPIL IJ, 1987, ANESTHESIOLOGY, V67, P139, DOI 10.1097/00000542-198707000-00033; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rye DB, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004685; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; SHAFER SL, 1990, ANESTHESIOLOGY, V73, P1091, DOI 10.1097/00000542-199012000-00005; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Sleigh JW, 1999, ANESTH ANALG, V88, P659, DOI 10.1097/00000539-199903000-00035; Solt K, 2014, ANESTHESIOLOGY; Solt K, 2011, ANESTHESIOLOGY, V115, P791, DOI 10.1097/ALN.0b013e31822e92e5; Standards and Practice Parameters Committee, 2010, AM SOC AN STAND BAS; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1985, J NEUROPHYSIOL, V54, P1473, DOI 10.1152/jn.1985.54.6.1473; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steyn-Ross ML, 2004, PROG BIOPHYS MOL BIO, V85, P369, DOI 10.1016/j.pbiomolbio.2004.02.001; Taylor NE, 2013, ANESTHESIOLOGY, V118, P30, DOI 10.1097/ALN.0b013e318278c896; Dang-Vu TT, 2011, P NATL ACAD SCI USA, V108, P15438, DOI 10.1073/pnas.1112503108; TINKER JH, 1977, ANESTHESIOLOGY, V46, P252, DOI 10.1097/00000542-197704000-00005; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Tung A, 2005, ANESTHESIOLOGY, V102, P1158, DOI 10.1097/00000542-200506000-00015; Tung A, 2002, ANESTHESIOLOGY, V97, P906, DOI 10.1097/00000542-200210000-00024; Tung Avery, 2002, J Clin Monit Comput, V17, P37, DOI 10.1023/A:1015404803637; Van Dort CJ, 2008, INT ANESTHESIOL CLIN, V46, P75, DOI 10.1097/AIA.0b013e318181a8ca; Vanhaudenhuyse A, 2011, J COGNITIVE NEUROSCI, V23, P570, DOI 10.1162/jocn.2010.21488; Vazey EM, 2014, P NATL ACAD SCI USA, V111, P3859, DOI 10.1073/pnas.1310025111; Vijayan S, 2013, J NEUROSCI, V33, P11070, DOI 10.1523/JNEUROSCI.5670-12.2013; Villesen Hanne H, 2007, Ther Clin Risk Manag, V3, P961; Walters AS, 2007, J CLIN SLEEP MED, V3, P155; Whitlock EL, 2011, ANESTHESIOLOGY, V115, P1209, DOI 10.1097/ALN.0b013e3182395dcb; Zecharia AY, 2009, J NEUROSCI, V29, P2177, DOI 10.1523/JNEUROSCI.4997-08.2009	98	63	64	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e106291	10.1371/journal.pone.0106291	http://dx.doi.org/10.1371/journal.pone.0106291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264892	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400009
J	Ronning, B; Moe, B; Berntsen, HH; Noreen, E; Bech, C				Ronning, Bernt; Moe, Borge; Berntsen, Henrik H.; Noreen, Elin; Bech, Claus			Is the Rate of Metabolic Ageing and Survival Determined by Basal Metabolic Rate in the Zebra Finch?	PLOS ONE			English	Article							FREE-RADICAL THEORY; EXPLAIN LONGEVITY DIFFERENCES; OXIDATIVE STRESS THEORY; AGE-RELATED-CHANGES; BODY-COMPOSITION; AEROBIC PERFORMANCE; ENERGY-EXPENDITURE; BIRDS; LIFE; REPRODUCTION	The relationship between energy metabolism and ageing is of great interest because aerobic metabolism is the primary source of reactive oxygen species which is believed to be of major importance in the ageing process. We conducted a longitudinal study on captive zebra finches where we tested the effect of age on basal metabolic rate (BMR), as well as the effect of BMR on the rate of metabolic ageing (decline in BMR with age) and survival. Basal metabolic rate declined with age in both sexes after controlling for the effect of body mass, indicating a loss of functionality with age. This loss of functionality could be due to accumulated oxidative damage, believed to increase with increasing metabolic rate, c.f. the free radical theory of ageing. If so, we would expect the rate of metabolic ageing to increase and survival to decrease with increasing BMR. However, we found no effect of BMR on the rate of metabolic ageing. Furthermore, survival was not affected by BMR in the males. In female zebra finches there was a tendency for survival to decrease with increasing BMR, but the effect did not reach significance (P<0.1). Thus, the effect of BMR on the rate of functional deterioration with age, if any, was not strong enough to influence neither the rate of metabolic ageing nor survival in the zebra finches.	[Ronning, Bernt] Norwegian Univ Sci & Technol, Dept Biol, Ctr Biodivers Dynam, N-7034 Trondheim, Norway; [Moe, Borge] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Berntsen, Henrik H.; Noreen, Elin; Bech, Claus] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian Institute Nature Research; Norwegian University of Science & Technology (NTNU)	Ronning, B (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, Ctr Biodivers Dynam, N-7034 Trondheim, Norway.	bernt.ronning@ntnu.no	Bech, Claus/N-1077-2019; Moe, Børge/P-2946-2015; Bech, Claus/C-1086-2011	Bech, Claus/0000-0002-0860-0663; Moe, Børge/0000-0002-2306-1899; Bech, Claus/0000-0002-0860-0663	Research Council of Norway [159584/V40, 138698/432]	Research Council of Norway(Research Council of Norway)	This work was supported by grants from the Research Council of Norway, nos. 159584/V40 and 138698/432 (http://www.forskningsradet.no/no/Forsiden/1173185591033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Beamonte-Barrientos R, 2013, J COMP PHYSIOL B, V183, P675, DOI 10.1007/s00360-013-0745-4; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bouwhuis S, 2011, FUNCT ECOL, V25, P829, DOI 10.1111/j.1365-2435.2011.01850.x; Broggi J, 2010, EVOL ECOL, V24, P177, DOI 10.1007/s10682-009-9299-z; Burton T, 2011, P ROY SOC B-BIOL SCI, V278, P3465, DOI 10.1098/rspb.2011.1778; CALDER WILLIAM A., 1964, PHYSIOL ZOOL, V37, P400; Chappell MA, 2003, J EXP BIOL, V206, P1221, DOI 10.1242/jeb.00255; Chappell MA, 1999, J EXP BIOL, V202, P2269; COX DR, 1972, J R STAT SOC B, V34, P187; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; Even PC, 2001, AM J PHYSIOL-REG I, V280, pR1887; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; IUPS Thermal Commission I., 2001, JPN J PHYSIOL, V51, P245, DOI 10.1016/S0306-4565(02)00055-4; Kelly C, 2005, AM NAT, V166, P700, DOI 10.1086/497402; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; Kirkwood TBL, 2012, BIOESSAYS, V34, P692, DOI 10.1002/bies.201200014; Konarzewski M, 2013, J COMP PHYSIOL B, V183, P27, DOI 10.1007/s00360-012-0698-z; McNab BK, 1997, PHYSIOL ZOOL, V70, P718, DOI 10.1086/515881; Moe B, 2007, J EXP BIOL, V210, P3407, DOI 10.1242/jeb.005090; Moe B, 2009, BIOL LETTERS, V5, P86, DOI 10.1098/rsbl.2008.0481; Montgomery MK, 2012, EXP GERONTOL, V47, P211, DOI 10.1016/j.exger.2011.11.014; Montgomery MK, 2012, EXP GERONTOL, V47, P203, DOI 10.1016/j.exger.2011.11.006; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; O'Connor TP, 2002, COMP BIOCHEM PHYS A, V133, P835, DOI 10.1016/S1095-6433(02)00198-8; Pearl R., 1928, RATE LIVING; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V250, P143, DOI 10.1098/rspb.1992.0142; R Development Core Team, 2012, R LANG ENV STAT COMP; Ricklefs RE, 1996, AM NAT, V147, P1047, DOI 10.1086/285892; Ronning B, 2005, J EXP BIOL, V208, P4663, DOI 10.1242/jeb.01941; Sarkar D., 2019, NLME LINEAR NONLINEA; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Speakman JR, 2003, AGING CELL, V2, P265, DOI 10.1046/j.1474-9728.2003.00061.x; Therneau TM, 2013, PACKAGE SURVIVAL ANA; Vezina F, 2006, ECOLOGY, V87, P2447, DOI 10.1890/0012-9658(2006)87[2447:IVEMSI]2.0.CO;2; Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003; White CR, 2013, J COMP PHYSIOL B, V183, P1, DOI 10.1007/s00360-012-0676-5; Wickens AP, 2001, RESP PHYSIOL, V128, P379, DOI 10.1016/S0034-5687(01)00313-9; Wiersma P, 2004, P ROY SOC B-BIOL SCI, V271, pS360, DOI 10.1098/rsbl.2004.0171; Wikelski M, 2003, P ROY SOC B-BIOL SCI, V270, P2383, DOI 10.1098/rspb.2003.2500; Zann RA., 1996, ZEBRA FINCH SYNTHESI	45	7	7	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108675	10.1371/journal.pone.0108675	http://dx.doi.org/10.1371/journal.pone.0108675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265184	Green Published, gold			2022-12-27	WOS:000345745400101
J	Zhang, T; Victor, TR; Rajkumar, SS; Li, XJ; Okoniewski, JC; Hicks, AC; Davis, AD; Broussard, K; LaDeau, SL; Chaturvedi, S; Chaturvedi, V				Zhang, Tao; Victor, Tanya R.; Rajkumar, Sunanda S.; Li, Xiaojiang; Okoniewski, Joseph C.; Hicks, Alan C.; Davis, April D.; Broussard, Kelly; LaDeau, Shannon L.; Chaturvedi, Sudha; Chaturvedi, Vishnu			Mycobiome of the Bat White Nose Syndrome Affected Caves and Mines Reveals Diversity of Fungi and Local Adaptation by the Fungal Pathogen Pseudogymnoascus (Geomyces) destructans	PLOS ONE			English	Article							BIODIVERSITY; COMMUNITIES; HIBERNACULA; MARNEFFEI; EMERGENCE; ALIGNMENT; DISEASE; YEASTS; SPREAD; SOIL	Current investigations of bat White Nose Syndrome (WNS) and the causative fungus Pseudogymnoascus (Geomyces) destructans (Pd) are intensely focused on the reasons for the appearance of the disease in the Northeast and its rapid spread in the US and Canada. Urgent steps are still needed for the mitigation or control of Pd to save bats. We hypothesized that a focus on fungal community would advance the understanding of ecology and ecosystem processes that are crucial in the disease transmission cycle. This study was conducted in 2010-2011 in New York and Vermont using 90 samples from four mines and two caves situated within the epicenter of WNS. We used culture-dependent (CD) and culture-independent (CI) methods to catalogue all fungi ('mycobiome'). CD methods included fungal isolations followed by phenotypic and molecular identifications. CI methods included amplification of DNA extracted from environmental samples with universal fungal primers followed by cloning and sequencing. CD methods yielded 675 fungal isolates and CI method yielded 594 fungal environmental nucleic acid sequences (FENAS). The core mycobiome of WNS comprised of 136 operational taxonomic units (OTUs) recovered in culture and 248 OTUs recovered in clone libraries. The fungal community was diverse across the sites, although a subgroup of dominant cosmopolitan fungi was present. The frequent recovery of Pd (18% of samples positive by culture) even in the presence of dominant, cosmopolitan fungal genera suggests some level of local adaptation in WNS-afflicted habitats, while the extensive distribution of Pd (48% of samples positive by real-time PCR) suggests an active reservoir of the pathogen at these sites. These findings underscore the need for integrated disease control measures that target both bats and Pd in the hibernacula for the control of WNS.	[Zhang, Tao; Victor, Tanya R.; Rajkumar, Sunanda S.; Li, Xiaojiang; Chaturvedi, Sudha; Chaturvedi, Vishnu] New York State Dept Hlth, Wadsworth Ctr, Mycol Lab, Albany, NY 12205 USA; [Okoniewski, Joseph C.; Hicks, Alan C.] New York State Dept Environm Conservat, Bur Wildlife, Albany, NY USA; [Davis, April D.; Broussard, Kelly] New York State Dept Hlth, Wadsworth Ctr, Rabies Lab, Albany, NY USA; [LaDeau, Shannon L.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Chaturvedi, Sudha; Chaturvedi, Vishnu] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; Wadsworth Center; Cary Institute of Ecosystem Studies; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Chaturvedi, S (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Mycol Lab, Albany, NY 12205 USA.	sudha.chaturvedi@health.ny.gov; vishnu.chaturvedi@health.ny.gov		Chaturvedi, Vishnu/0000-0002-3922-9676	US Fish & Wild Life Service [F12AP01167]	US Fish & Wild Life Service(US Fish & Wildlife Service)	This study was funded by the US Fish & Wild Life Service, F12AP01167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJELLO L, 1995, MYCOPATHOLOGIA, V131, P1, DOI 10.1007/BF01103897; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Awad MF, 2011, CAN J MICROBIOL, V57, P693, DOI [10.1139/W11-056, 10.1139/w11-056]; Bass David, 2011, Fungal Biology Reviews, V25, P159, DOI 10.1016/j.fbr.2011.10.003; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; BILLS GF, 1995, CAN J BOT, V73, pS33, DOI 10.1139/b95-222; Blehert DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002779; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; BRUCE J, 1973, A VAN LEEUW J MICROB, V39, P331, DOI 10.1007/BF02578865; Chaturvedi S, 2011, MYCOPATHOLOGIA, V172, P247, DOI 10.1007/s11046-011-9435-5; Chaturvedi V, 2011, MYCOPATHOLOGIA, V171, P231, DOI 10.1007/s11046-010-9385-3; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; Chibucos MC, 2013, GENOME ANNOUNC, V1; Collado J, 2007, FEMS MICROBIOL ECOL, V60, P521, DOI 10.1111/j.1574-6941.2007.00294.x; Cordier T, 2012, FUNGAL ECOL, V5, P509, DOI 10.1016/j.funeco.2011.12.004; Corry JEL, 1999, HDB CULTURE MEDIA FO, P586; Crous PW, 2004, STUD MYCOL, P19; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Dahlberg A, 2001, NEW PHYTOL, V150, P555, DOI 10.1046/j.1469-8137.2001.00142.x; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; De Hoog G. S., 2000, ATLAS CLIN FUNGI; DENG ZL, 1986, J MED VET MYCOL, V24, P383; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Drell T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054379; EMMONS CW, 1955, AM J HYG, V62, P227, DOI 10.1093/oxfordjournals.aje.a119775; EMMONS CW, 1958, PUBLIC HEALTH REP, V73, P590, DOI 10.2307/4590196; Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gao Z, 2008, APPL ENVIRON MICROB, V74, P6091, DOI 10.1128/AEM.01315-08; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Gilichinsky D, 2005, FEMS MICROBIOL ECOL, V53, P117, DOI 10.1016/j.femsec.2005.02.003; Giordano L, 2013, MYCOL PROG, V12, P127, DOI 10.1007/s11557-012-0822-1; Giraud T, 2010, TRENDS ECOL EVOL, V25, P387, DOI 10.1016/j.tree.2010.03.006; Godinho VM, 2013, ISME J, V7, P1434, DOI 10.1038/ismej.2013.77; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hawksworth DL, 2012, BIODIVERS CONSERV, V21, P2425, DOI 10.1007/s10531-012-0335-x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Johnson LJAN, 2013, APPL ENVIRON MICROB, V79, P5465, DOI 10.1128/AEM.01429-13; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kirby BM, 2011, EXTREMOPHILES HDB, P839; Kirk PM, 2008, AINSWORTH BISBYS DIC; Kochkina GA, 2007, MICROBIOLOGY+, V76, P31, DOI 10.1134/s0026261707010055; LITTMAN ML, 1968, MYCOPATH MYCOL APPL, V35, P329, DOI 10.1007/BF02050749; Lorch JM, 2013, APPL ENVIRON MICROB, V79, P1293, DOI 10.1128/AEM.02939-12; Lyon GM, 2004, AM J TROP MED HYG, V70, P438, DOI 10.4269/ajtmh.2004.70.438; Martinkova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013853; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Michel C, 2004, HDB IND MYCOLOGY; Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Muller LK, 2013, MYCOLOGIA, V105, P253, DOI 10.3852/12-242; Nagy GL, 2011, NEW PHYTOL, V191, P789; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Porras-Alfaro A, 2011, MYCOLOGIA, V103, P10, DOI 10.3852/09-297; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Rajkumar SS, 2011, EMERG INFECT DIS, V17, P1273, DOI 10.3201/eid1707.102056; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Ren P, 2012, EMERG INFECT DIS, V18, P883, DOI 10.3201/eid1805.111711; Rosling A, 2011, SCIENCE, V333, P876, DOI 10.1126/science.1206958; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Turner Gregory G., 2011, Bat Research News, V52, P13; Unterseher M, 2009, MYCOL RES, V113, P645, DOI 10.1016/j.mycres.2009.02.002; Vanderwolf KJ, 2013, INT J SPELEOL, V42, P77, DOI 10.5038/1827-806X.42.1.9; Vanderwolf KJ, 2013, NORTHEAST NAT, V20, P115, DOI 10.1656/045.020.0109; Wang SB, 2011, P NATL ACAD SCI USA, V108, P20449, DOI 10.1073/pnas.1113824108; Warnecke L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0177; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]	74	27	28	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108714	10.1371/journal.pone.0108714	http://dx.doi.org/10.1371/journal.pone.0108714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264864	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400108
J	Adhikary, H; Sanghavi, PB; Macwan, SR; Archana, G; Kumar, GN				Adhikary, Hemanta; Sanghavi, Paulomi B.; Macwan, Silviya R.; Archana, Gattupalli; Kumar, G. Naresh			Artificial Citrate Operon Confers Mineral Phosphate Solubilization Ability to Diverse Fluorescent Pseudomonads	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; NADH BINDING-SITE; ESCHERICHIA-COLI; SOIL-MICROORGANISMS; AERUGINOSA; BACTERIA; SYNTHASE; GENETICS; GLUCOSE; PUTIDA	Citric acid is a strong acid with good cation chelating ability and can be very efficient in solubilizing mineral phosphates. Only a few phosphate solubilizing bacteria and fungi are known to secrete citric acids. In this work, we incorporated artificial citrate operon containing NADH insensitive citrate synthase (gltA1) and citrate transporter (citC) genes into the genome of six-plant growth promoting P. fluorescens strains viz., PfO-1, Pf5, CHAO1, P109, ATCC13525 and Fp315 using MiniTn7 transposon gene delivery system. Comprehensive biochemical characterization of the genomic integrants and their comparison with plasmid transformants of the same operon in M9 minimal medium reveals the highest amount of similar to 7.6 +/- 0.41 mM citric and 29.95 +/- 2.8 mM gluconic acid secretion along with similar to 43.2 +/- 3.24 mM intracellular citrate without affecting the growth of these P. fluorescens strains. All genomic integrants showed enhanced citric and gluconic acid secretion on Tris-Cl rock phosphate (TRP) buffered medium, which was sufficient to release 200-1000 mM Pi in TRP medium. This study demonstrates that MPS ability could be achieved in natural fluorescent pseudomonads by incorporation of artificial citrate operon not only as plasmid but also by genomic integration.	[Adhikary, Hemanta; Sanghavi, Paulomi B.; Macwan, Silviya R.; Kumar, G. Naresh] Maharaja Sayajirao Univ Baroda, Dept Biochem, Fac Sci, Vadodara, Gujarat, India; [Archana, Gattupalli] Maharaja Sayajirao Univ Baroda, Dept Microbiol, Vadodara, Gujarat, India; [Archana, Gattupalli] Maharaja Sayajirao Univ Baroda, Ctr Biotechnol, Fac Sci, Vadodara, Gujarat, India	Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda	Kumar, GN (corresponding author), Maharaja Sayajirao Univ Baroda, Dept Biochem, Fac Sci, Vadodara, Gujarat, India.	gnaresh_k@yahoo.co.in	Gattupalli, Naresh Kumar/AAF-5987-2020; Archana, G/AAA-8828-2019	Gattupalli, Nareshkumar/0000-0001-7317-7438; Sanghavi, Paulomi/0000-0003-3305-7540	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This research was funded by Department of Biotechnology, Government of India as a research grant to GNK and GA. The funders had no role in study design, data collection and anlaysis, decision to publish or preparation of the manuscript.	Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Anastassiadis S, 2006, ELECTRON J BIOTECHN, V9, P26, DOI 10.2225/vol9-issue1-fulltext-5; Antoun H, 2012, PROCEDIA ENGINEER, V46, P62, DOI 10.1016/j.proeng.2012.09.446; Aoshima M, 2003, BIOTECHNOL BIOENG, V84, P732, DOI 10.1002/bit.10832; Archana G., 2012, MICROORGANISMS SUSTA, P35, DOI DOI 10.1007/978-94-007-2214-9_3; Bouwman L, 2013, P NATL ACAD SCI USA, V110, P20882, DOI 10.1073/pnas.1012878108; Buch A, 2008, RES MICROBIOL, V159, P635, DOI 10.1016/j.resmic.2008.09.012; Buch A, 2010, BIORESOURCE TECHNOL, V101, P679, DOI 10.1016/j.biortech.2009.08.075; Buch AD, 2010, APPL MICROBIOL BIOT, V88, P209, DOI 10.1007/s00253-010-2717-x; Buch AD, 2009, MICROBIOL-SGM, V155, P2620, DOI 10.1099/mic.0.028878-0; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; COMPEAU G, 1988, APPL ENVIRON MICROB, V54, P2432, DOI 10.1128/AEM.54.10.2432-2438.1988; Diaz-Perez AL, 2007, FEMS MICROBIOL LETT, V269, P309, DOI 10.1111/j.1574-6968.2007.00654.x; DIMROTH P, 1987, MICROBIOL REV, V51, P320, DOI 10.1128/MMBR.51.3.320-340.1987; Elser J, 2011, NATURE, V478, P29, DOI 10.1038/478029a; Forrest LR, 2013, SCIENCE, V339, P399, DOI 10.1126/science.1228465; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Francois JA, 2006, BIOCHEMISTRY-US, V45, P13487, DOI 10.1021/bi061083k; GOLDSTEIN AH, 1995, BIOL AGRIC HORTIC, V12, P185, DOI 10.1080/01448765.1995.9754736; Gyaneshwar P, 2002, PLANT SOIL, V245, P83, DOI 10.1023/A:1020663916259; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Jones KL, 2000, METAB ENG, V2, P328, DOI 10.1006/mben.2000.0161; Krom BP, 2000, J BACTERIOL, V182, P6374, DOI 10.1128/JB.182.22.6374-6381.2000; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Legisa M, 2007, BIOTECHNOL LETT, V29, P181, DOI 10.1007/s10529-006-9235-z; Li H, 2002, J MEMBRANE BIOL, V185, P9, DOI 10.1007/s00232-001-0106-1; Mancusso R, 2012, NATURE, V491, P622, DOI 10.1038/nature11542; Maurus R, 2003, BIOCHEMISTRY-US, V42, P5555, DOI 10.1021/bi020622s; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; PIKOVSKAIA R. I., 1948, Mikrobiologiya, V17, P362; Richardson AE, 2011, PLANT PHYSIOL, V156, P989, DOI 10.1104/pp.111.175448; Rodriguez H, 2006, PLANT SOIL, V287, P15, DOI 10.1007/s11104-006-9056-9; Sambrook JD, 2001, LAB MANUAL; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Sharma V, 2011, MICROBIOL RES, V166, P36, DOI 10.1016/j.micres.2010.01.008; Shimizu K, 2004, ADV BIOCHEM ENG BIOT, V91, P1; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; Sobczak T, 2005, MICROBIOL MOL BIOL R, V69, P665, DOI 10.1128/MMBR.69.4.665-695.2005; Stokell DJ, 2003, J BIOL CHEM, V278, P35435, DOI 10.1074/jbc.M302786200; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; STUTZ EW, 1986, PHYTOPATHOLOGY, V76, P181, DOI 10.1094/Phyto-76-181; Van Vuuren DP, 2010, GLOBAL ENVIRON CHANG, V20, P428, DOI 10.1016/j.gloenvcha.2010.04.004; Wagh J, 2014, PLANT SOIL, V383, P73, DOI 10.1007/s11104-014-2161-2; Wagh J, 2014, APPL MICROBIOL BIOT, V98, P5117, DOI 10.1007/s00253-014-5610-1; Yadav K, 2014, APPL MICROBIOL BIOT, V98, P8327, DOI 10.1007/s00253-014-5912-3; Yadav K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092400	50	8	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107554	10.1371/journal.pone.0107554	http://dx.doi.org/10.1371/journal.pone.0107554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259527	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600021
J	Dias, FD; Vasconcellos, LRD; Romeiro, A; Attias, M; Souto-Padron, TC; Lopes, AH				Dias, Felipe de Almeida; da Costa Vasconcellos, Luiz Ricardo; Romeiro, Alexandre; Attias, Marcia; Souto-Padron, Thais Cristina; Lopes, Angela Hampshire			Transovum Transmission of Trypanosomatid Cysts in the Milkweed Bug, Oncopeltus fasciatus	PLOS ONE			English	Article							NUCLEAR-POLYHEDROSIS-VIRUS; HORIZONTAL GENE-TRANSFER; LEPTOMONAS-WALLACEI; BLASTOCRITHIDIA-TRIATOMAE; INSECT TRYPANOSOMATIDS; VERTICAL TRANSMISSION; POPULATION-DYNAMICS; OVUM TRANSMISSION; LYMANTRIA-DISPAR; INTESTINAL-TRACT	Leptomonas wallacei is a trypanosomatid that develops promastigotes and cystic forms in the gut of the hemipteran insect Oncopeltus fasciatus. Insect trypanosomatids are thought to be solely transmitted from one host to another through the ingestion of parasite- contaminated feces. However, here we show that L. wallacei cysts present on the eggshells of eggs laid by O. fasciatus can also act as infective forms that are transmitted to the insect offspring. Newly hatched O. faciatus nymphs are parasite-free, but some of them become contaminated with L. wallacei after feeding on eggshell remnants. The present study is the first report of transovum transmission of a trypanosomatid, a process that may have a relevant role in parasite's within- host population dynamics.	[Dias, Felipe de Almeida] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Programa Biol Mol & Biotecnol, Rio De Janeiro, RJ, Brazil; [da Costa Vasconcellos, Luiz Ricardo; Souto-Padron, Thais Cristina; Lopes, Angela Hampshire] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, RJ, Brazil; [Romeiro, Alexandre; Attias, Marcia] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Lopes, AH (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, RJ, Brazil.	angela.lopes@micro.ufrj.br	Lopes, Angela/AAX-2501-2021; Attias, Márcia/G-4003-2012; Dias, Felipe/L-7390-2013	Dias, Felipe/0000-0003-2074-1052; /0000-0002-3877-7013; Hampshire Lopes, Angela/0000-0003-0660-4596	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCTEM)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCTEM)	This work was supported by grants from the Brazilian Agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCTEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy S, 2013, TRENDS PARASITOL, V29, P394, DOI 10.1016/j.pt.2013.06.005; Alves JMP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-190; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; ANTIA R, 1994, AM NAT, V144, P457, DOI 10.1086/285686; Bernays EA, 1998, BIOSCIENCE, V48, P35, DOI 10.2307/1313226; Charpentier G, 2003, J APPL ENTOMOL, V127, P405, DOI 10.1046/j.1439-0418.2003.00759.x; d'Avila-Levy CM, 2006, CURR MICROBIOL, V52, P439, DOI 10.1007/s00284-005-0222-8; de Souza W, 1999, FEMS MICROBIOL LETT, V173, P1, DOI 10.1111/j.1574-6968.1999.tb13477.x; Dias FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048170; DOANE CC, 1969, J INVERTEBR PATHOL, V14, P199, DOI 10.1016/0022-2011(69)90107-4; Erler S, 2012, ECOL EVOL, V2, P930, DOI 10.1002/ece3.250; EWALD PW, 1987, ANN NY ACAD SCI, V503, P295, DOI 10.1111/j.1749-6632.1987.tb40616.x; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; FEIR D, 1974, ANNU REV ENTOMOL, V19, P81, DOI 10.1146/annurev.en.19.010174.000501; Fokin SI, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-203; Francischetti IMB, 2007, INSECT BIOCHEM MOLEC, V37, P903, DOI 10.1016/j.ibmb.2007.04.007; Garcia ES, 2007, J INSECT PHYSIOL, V53, P11, DOI 10.1016/j.jinsphys.2006.10.006; Garcia ES, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-105; Goertz D, 2007, J INVERTEBR PATHOL, V95, P9, DOI 10.1016/j.jip.2006.11.003; Hartley MA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00099; Hubalek Z, 1998, PARASITOL RES, V84, P167, DOI 10.1007/s004360050378; Hughes CL, 2000, DEVELOPMENT, V127, P3683; Ienne S, 2012, INFECT GENET EVOL, V12, P539, DOI 10.1016/j.meegid.2012.01.016; JURA WGZO, 1989, CURR MICROBIOL, V18, P1, DOI 10.1007/BF01568821; LAWRENCE PA, 1970, GENET RES, V15, P347, DOI 10.1017/S0016672300001713; LAWRENCE PA, 1966, J EXP BIOL, V44, P507; LOPES AHDS, 1990, MOL BIOCHEM PARASIT, V40, P151, DOI 10.1016/0166-6851(90)90037-M; Lopes RB, 2011, NEOTROP ENTOMOL, V40, P368, DOI [10.1590/S1519-566X2011000300007, 10.1590/S1519-566X2011000300010]; Maslov DA, 2013, TRENDS PARASITOL, V29, P43, DOI 10.1016/j.pt.2012.11.001; MCGHEE RB, 1964, J PROTOZOOL, V11, P555, DOI 10.1111/j.1550-7408.1964.tb01798.x; Nalepa CA, 2001, INSECT SOC, V48, P194, DOI 10.1007/PL00001767; de Melo AC, 2006, INT J PARASITOL, V36, P415, DOI 10.1016/j.ijpara.2005.12.006; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P470, DOI 10.1016/j.pt.2007.08.002; Panfilio KA, 2009, DEV BIOL, V333, P297, DOI 10.1016/j.ydbio.2009.06.036; Podlipaev S, 2001, INT J PARASITOL, V31, P648, DOI 10.1016/S0020-7519(01)00139-4; Porter A, 1909, ARCH PROTISTENKD, V12, P131; REDUTH D, 1988, PARASITOL RES, V74, P301, DOI 10.1007/BF00539449; Richardson ML, 2010, ANNU REV ENTOMOL, V55, P39, DOI 10.1146/annurev-ento-112408-085314; Rodrigues Juliany Cola Fernandes, 2014, Subcell Biochem, V74, P1, DOI 10.1007/978-94-007-7305-9_1; Romeiro A, 2003, J EUKARYOT MICROBIOL, V50, P409, DOI 10.1111/j.1550-7408.2003.tb00262.x; Romeiro A, 2003, J INVERTEBR PATHOL, V82, P41, DOI 10.1016/S0022-2011(02)00176-3; Romeiro A, 2000, J EUKARYOT MICROBIOL, V47, P208, DOI 10.1111/j.1550-7408.2000.tb00040.x; ROSS RH, 1971, CAN ENTOMOL, V103, P1449, DOI 10.4039/Ent1031449-10; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Sacks DL, 2001, CELL MICROBIOL, V3, P189, DOI 10.1046/j.1462-5822.2001.00115.x; SACKS DL, 1994, PARASITOLOGY, V108, pS55, DOI 10.1017/S0031182000075727; Salinas G, 1996, AM J TROP MED HYG, V54, P425, DOI 10.4269/ajtmh.1996.54.425; Schaub G A, 1988, Mem Inst Oswaldo Cruz, V83 Suppl 1, P622, DOI 10.1590/S0074-02761988000500075; SCHAUB GA, 1990, J INVERTEBR PATHOL, V55, P17, DOI 10.1016/0022-2011(90)90027-4; SCHAUB GA, 1989, ANN TROP MED PARASIT, V83, P215, DOI 10.1080/00034983.1989.11812335; Silva TLAE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072076; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Solter LF, 2006, J INVERTEBR PATHOL, V92, P132, DOI 10.1016/j.jip.2006.03.008; Takata CSA, 1996, EUR J PROTISTOL, V32, P90, DOI 10.1016/S0932-4739(96)80043-5; TIESZEN KL, 1989, PARASITOLOGY, V98, P395, DOI 10.1017/S0031182000061473; Vilaplana L, 2010, EVOL ECOL, V24, P147, DOI 10.1007/s10682-009-9296-2	56	11	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108746	10.1371/journal.pone.0108746	http://dx.doi.org/10.1371/journal.pone.0108746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259791	Green Submitted, gold, Green Published			2022-12-27	WOS:000342685600097
J	Gryshkov, O; Pogozhykh, D; Hofmann, N; Pogozhykh, O; Mueller, T; Glasmacher, B				Gryshkov, Oleksandr; Pogozhykh, Denys; Hofmann, Nicola; Pogozhykh, Olena; Mueller, Thomas; Glasmacher, Birgit			Encapsulating Non-Human Primate Multipotent Stromal Cells in Alginate via High Voltage for Cell-Based Therapies and Cryopreservation	PLOS ONE			English	Article							SIZE DISTRIBUTION; STEM-CELLS; MICROCAPSULES; ELECTROPORATION; MICROBEADS; HYDROGELS	Alginate cell-based therapy requires further development focused on clinical application. To assess engraftment, risk of mutations and therapeutic benefit studies should be performed in an appropriate non-human primate model, such as the common marmoset (Callithrix jacchus). In this work we encapsulated amnion derived multipotent stromal cells (MSCs) from Callithrix jacchus in defined size alginate beads using a high voltage technique. Our results indicate that i) alginate-cell mixing procedure and cell concentration do not affect the diameter of alginate beads, ii) encapsulation of high cell numbers (up to 10 x 10(6) cells/ml) can be performed in alginate beads utilizing high voltage and iii) high voltage (15-30 kV) does not alter the viability, proliferation and differentiation capacity of MSCs post-encapsulation compared with alginate encapsulated cells produced by the traditional air-flow method. The consistent results were obtained over the period of 7 days of encapsulated MSCs culture and after cryopreservation utilizing a slow cooling procedure (1 K/min). The results of this work show that high voltage encapsulation can further be maximized to develop cell-based therapies with alginate beads in a non-human primate model towards human application.	[Gryshkov, Oleksandr; Pogozhykh, Denys; Hofmann, Nicola; Glasmacher, Birgit] Leibniz Univ Hannover, Inst Multiphase Proc, D-30167 Hannover, Germany; [Pogozhykh, Olena; Mueller, Thomas] Hannover Med Sch, Inst Transfus Med, Hannover, Germany	Leibniz University Hannover; Hannover Medical School	Gryshkov, O (corresponding author), Leibniz Univ Hannover, Inst Multiphase Proc, D-30167 Hannover, Germany.	gryshkov@imp.uni-hannover.de	Gryshkov, Oleksandr P/A-2093-2014; Pogozhykh, Olena/AAR-5174-2021	Gryshkov, Oleksandr P/0000-0002-3116-8792; Pogozhykh, Olena/0000-0003-1086-5190; Glasmacher, Birgit/0000-0002-2452-1666; Pogozhykh, Denys/0000-0001-7298-5425	Deutsche Forschungsgemeinschaft (DFG - German Research Foundation); Cluster of Excellence REBIRTH [DFG EXC 62/1]; Open Access Publishing Fund of Leibniz Universitaet Hannover	Deutsche Forschungsgemeinschaft (DFG - German Research Foundation)(German Research Foundation (DFG)); Cluster of Excellence REBIRTH; Open Access Publishing Fund of Leibniz Universitaet Hannover	This work was supported by Deutsche Forschungsgemeinschaft (DFG - German Research Foundation, http://www.dfg.de/) by the Cluster of Excellence REBIRTH (DFG EXC 62/1, http://www.rebirth-hannover.de) and Open Access Publishing Fund of Leibniz Universitaet Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernemann I, 2011, BIOCHEM BIOPH RES CO, V411, P317, DOI 10.1016/j.bbrc.2011.06.134; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Chan ES, 2012, J FOOD ENG, V108, P297, DOI 10.1016/j.jfoodeng.2011.08.010; CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524; de Vos P, 2009, BIOMATERIALS, V30, P2559, DOI 10.1016/j.biomaterials.2009.01.014; Figueiredo C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/796046; Gryshkov O, 2013, CRYOLETT, V34, P186; Gryshkov O, 2014, MAT SCI ENG C-MATER, V36, P77, DOI 10.1016/j.msec.2013.11.048; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang SB, 2010, SENSOR ACTUAT B-CHEM, V147, P755, DOI 10.1016/j.snb.2010.04.021; Huang XB, 2012, J BIOSCI BIOENG, V114, P1, DOI 10.1016/j.jbiosc.2012.02.024; Im DJ, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3665222; Klokk TI, 2002, J MICROENCAPSUL, V19, P415, DOI 10.1080/02652040210144234; Koo LY, 2002, J CELL SCI, V115, P1423; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347; Lee MK, 2000, ADV DRUG DELIVER REV, V42, P103, DOI 10.1016/S0169-409X(00)00056-9; Lewinska D, 2004, ARTIF CELL BLOOD SUB, V32, P41, DOI 10.1081/BIO-120028667; Li RH, 1998, ADV DRUG DELIVER REV, V33, P87, DOI 10.1016/S0169-409X(98)00022-2; MA XJ, 1994, ARTIF CELL BLOOD SUB, V22, P43, DOI 10.3109/10731199409117399; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Morch YA, 2006, BIOMACROMOLECULES, V7, P1471, DOI 10.1021/bm060010d; Muller T, 2009, HUM REPROD, V24, P1359, DOI 10.1093/humrep/dep012; Nature Publishing Group, 2009, NATURE, V459, P7246; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; NEUMANN E, 1972, J MEMBRANE BIOL, V10, P279, DOI 10.1007/BF01867861; Ng Tsz Kin, 2014, World J Stem Cells, V6, P111, DOI 10.4252/wjsc.v6.i2.111; Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104; Pawar SN, 2012, BIOMATERIALS, V33, P3279, DOI 10.1016/j.biomaterials.2012.01.007; Portero A, 2010, REV NEUROLOGIA, V50, P409, DOI 10.33588/rn.5007.2009568; Rokstad AM, 2011, ACTA BIOMATER, V7, P2566, DOI 10.1016/j.actbio.2011.03.011; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Rzaev ZMO, 2007, PROG POLYM SCI, V32, P534, DOI 10.1016/j.progpolymsci.2007.01.006; Serra M, 2012, TRENDS BIOTECHNOL, V30, P350, DOI 10.1016/j.tibtech.2012.03.003; Shi PJ, 2011, POWDER TECHNOL, V210, P60, DOI 10.1016/j.powtec.2011.02.023; Stewart DA, 2004, IEEE T PLASMA SCI, V32, P1696, DOI 10.1109/TPS.2004.832639; VANDENBOSSCHE GMR, 1993, J PHARM PHARMACOL, V45, P484, DOI 10.1111/j.2042-7158.1993.tb05582.x; Wiedemann A, 2012, CELL REPROGRAM, V14, P485, DOI 10.1089/cell.2012.0036; Wollert KC, 2006, CURR OPIN CARDIOL, V21, P234, DOI 10.1097/01.hco.0000221586.94490.d2; Xie JW, 2007, J COLLOID INTERF SCI, V312, P247, DOI 10.1016/j.jcis.2007.04.023; Zhang WJ, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3153326; Zimmermann H, 2005, J MATER SCI-MATER M, V16, P491, DOI 10.1007/s10856-005-0523-2	43	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107911	10.1371/journal.pone.0107911	http://dx.doi.org/10.1371/journal.pone.0107911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259731	gold, Green Published			2022-12-27	WOS:000342685600032
J	Liu, WF; Li, Y; Lin, X; Tao, DC; Wang, YJ				Liu, Weifeng; Li, Yang; Lin, Xu; Tao, Dacheng; Wang, Yanjiang			Hessian-Regularized Co-Training for Social Activity Recognition	PLOS ONE			English	Article							IMAGE ANNOTATION; DISCRIMINANT-ANALYSIS	Co-training is a major multi-view learning paradigm that alternately trains two classifiers on two distinct views and maximizes the mutual agreement on the two-view unlabeled data. Traditional co-training algorithms usually train a learner on each view separately and then force the learners to be consistent across views. Although many co-trainings have been developed, it is quite possible that a learner will receive erroneous labels for unlabeled data when the other learner has only mediocre accuracy. This usually happens in the first rounds of co-training, when there are only a few labeled examples. As a result, co-training algorithms often have unstable performance. In this paper, Hessian-regularized co-training is proposed to overcome these limitations. Specifically, each Hessian is obtained from a particular view of examples; Hessian regularization is then integrated into the learner training process of each view by penalizing the regression function along the potential manifold. Hessian can properly exploit the local structure of the underlying data manifold. Hessian regularization significantly boosts the generalizability of a classifier, especially when there are a small number of labeled examples and a large number of unlabeled examples. To evaluate the proposed method, extensive experiments were conducted on the unstructured social activity attribute (USAA) dataset for social activity recognition. Our results demonstrate that the proposed method outperforms baseline methods, including the traditional co-training and LapCo algorithms.	[Liu, Weifeng; Li, Yang; Wang, Yanjiang] China Univ Petr East China, Coll Informat & Control Engn, Qingdao, Shandong, Peoples R China; [Lin, Xu] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China; [Lin, Xu] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Tao, Dacheng] Univ Technol Sydney, Ctr Quantum Computat & Intelligent Syst, Ultimo, NSW, Australia; [Tao, Dacheng] Univ Technol Sydney, Fac Engn & Informat Technol, Ultimo, NSW, Australia	China University of Petroleum; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese University of Hong Kong; University of Technology Sydney; University of Technology Sydney	Tao, DC (corresponding author), Univ Technol Sydney, Ctr Quantum Computat & Intelligent Syst, Ultimo, NSW, Australia.	Dacheng.Tao@uts.edu.au	Yao, Jun/HCI-2731-2022		National Natural Science Foundation of China [61301242, 61271407]; Shandong Provincial Natural Science Foundation, China [ZR2011FQ016]; Fundamental Research Funds for the Central Universities, China University of Petroleum (East China) [13CX02096A]; Australian Research Council [DP-120103730, FT-130101457, LP-140100569]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); Fundamental Research Funds for the Central Universities, China University of Petroleum (East China); Australian Research Council(Australian Research Council)	Weifeng Liu is supported by the National Natural Science Foundation of China (61301242), Shandong Provincial Natural Science Foundation, China (ZR2011FQ016), and the Fundamental Research Funds for the Central Universities, China University of Petroleum (East China) (13CX02096A). Dacheng Tao is supported by Australian Research Council Projects DP-120103730, FT-130101457, and LP-140100569. Yanjiang Wang is supported by the National Natural Science Foundation of China (61271407). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkin M, 2006, J MACH LEARN RES, V7, P2399; Blum A., 1998, Proceedings of the Eleventh Annual Conference on Computational Learning Theory, P92, DOI 10.1145/279943.279962; Brefeld U, 2006, P 23 INT C MACH LEAR, P137; Brefeld U., 2004, ICML, P16; Donoho DL, 2003, P NATL ACAD SCI USA, V100, P5591, DOI 10.1073/pnas.1031596100; Eells J., 1983, CBMS REGIONAL C SERI, DOI 10.1090/cbms/050; Fu Y., 2012, EUR C COMP VIS; Fu YW, 2014, IEEE T PATTERN ANAL, V36, P303, DOI 10.1109/TPAMI.2013.128; Jiang Y, 2011, P 1 ACM INT C MULT R, P19; Kim KI., 2009, P ADV NEUR INF PROC, P979; Kumar A., 2011, ADV NEURAL INFORM PR, P1413; Kumar A., 2011, PROC 28 INT C MACH L, P393, DOI DOI 10.5555/3104482.3104532; Kumar A, 2010, NIPS 2010 WORKSH NEW; Liu L, 2014, PATTERN RECOGN, V47, P3819, DOI 10.1016/j.patcog.2014.07.006; Liu WF, 2014, COMPUT VIS IMAGE UND, V118, P50, DOI 10.1016/j.cviu.2013.03.007; Liu WF, 2013, IEEE T IMAGE PROCESS, V22, P2676, DOI 10.1109/TIP.2013.2255302; Nigam K., 2000, Proceedings of the Ninth International Conference on Information and Knowledge Management. CIKM 2000, P86, DOI 10.1145/354756.354805; Shao L, 2014, IEEE T CIRC SYST VID, V24, P504, DOI 10.1109/TCSVT.2013.2276700; Sindhwani V., 2005, P ICML WORKSH LEARN, P74; Song ML, 2013, IEEE T IMAGE PROCESS, V22, P3283, DOI 10.1109/TIP.2013.2261307; Song ML, 2012, IEEE T IMAGE PROCESS, V21, P2887, DOI 10.1109/TIP.2012.2183882; Song ML, 2012, INFORM SCIENCES, V193, P233, DOI 10.1016/j.ins.2012.01.004; Tao DC, 2007, IEEE T PATTERN ANAL, V29, P1700, DOI 10.1109/TPAMI.2007.1096; Tao DP, 2014, IEEE T IND INFORM, V10, P813, DOI 10.1109/TII.2013.2255061; Tao DP, 2013, IEEE T CIRC SYST VID, V23, P1675, DOI 10.1109/TCSVT.2013.2255413; Tao DP, 2013, IEEE T MULTIMEDIA, V15, P833, DOI 10.1109/TMM.2013.2238909; Xu C., 2013, ARXIV; Xu C, 2014, IEEE T PATTERN ANAL, V36, P1559, DOI 10.1109/TPAMI.2013.2296528; Yan RM, 2013, IEEE T IMAGE PROCESS, V22, P4689, DOI 10.1109/TIP.2013.2277813; Zhang L, 2014, IEEE T IMAGE PROCESS, V23, P3241, DOI 10.1109/TIP.2014.2328894; Zhang ML, 2011, IEEE T SYST MAN CY B, V41, P1612, DOI 10.1109/TSMCB.2011.2157998; Zhang Z, 2012, IEEE T PATTERN ANAL, V34, P436, DOI 10.1109/TPAMI.2011.157; Zhou ZH, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P908; Zhu F, 2014, INT J COMPUT VISION, V109, P42, DOI 10.1007/s11263-014-0703-y	34	126	129	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108474	10.1371/journal.pone.0108474	http://dx.doi.org/10.1371/journal.pone.0108474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259945	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600076
J	Walkey, AJ; Demissie, S; Shah, D; Romero, F; Puklin, L; Summer, RS				Walkey, Allan J.; Demissie, Serkalem; Shah, Dilip; Romero, Freddy; Puklin, Leah; Summer, Ross S.			Plasma Adiponectin, Clinical Factors, and Patient Outcomes during the Acute Respiratory Distress Syndrome	PLOS ONE			English	Article							ACUTE LUNG INJURY; PULMONARY; MORTALITY; SUPPRESSION; DEFICIENCY; ACTIVATION; PROTEIN	Objective: Adiponectin (APN) is an anti-inflammatory hormone derived from adipose tissue that attenuates acute lung injury in rodents. In this study, we investigated the association between circulating APN and outcomes among patients with acute respiratory distress syndrome (ARDS). Methods: We performed a retrospective cohort study using data and plasma samples from participants in the multicenter ARDS Network Fluid and Catheter Treatment Trial. Results: Plasma APN concentrations were measured in 816 (81.6%) trial participants at baseline and in 568 (56.8%) subjects at both baseline and day 7 after enrollment. Clinical factors associated with baseline APN levels in multivariable-adjusted models included sex, body mass index, past medical history of cirrhosis, and central venous pressure (model R-2 = 9.7%). We did not observe an association between baseline APN and either severity of illness (APACHE III) or extent of lung injury (Lung Injury Score). Among patients who received right heart catheterization (n = 384), baseline APN was inversely related to mean pulmonary artery pressure (beta = -0.015, R-2 1.5%, p = 0.02); however, this association did not persist in multivariable models (beta = -0.009, R-2 0.5%, p = 0.20). Neither baseline APN levels [HR per quartile1.04 (95% CI 0.91-1.18), p = 0.61], nor change in APN level from baseline to day 7 [HR 1.04 (95% CI 0.89-1.23), p = 0.62)] were associated with 60 day mortality in Cox proportional hazards regression models. However, subgroup analysis identified an association between APN and mortality among patients who developed ARDS from extra-pulmonary etiologies [HR per quartile 1.31 (95% CI 1.08-1.57)]. APN levels did not correlate with mortality among patients developing ARDS in association with direct pulmonary injury [HR 0.96 (95% CI 0.83-1.13)], rho(interaction) = 0.016. Conclusions: Plasma APN levels did not correlate with disease severity or mortality in a large cohort of patients with ARDS. However, higher APN levels were associated with increased mortality among patients developing ARDS from extra-pulmonary etiologies.	[Walkey, Allan J.] Boston Univ, Sch Med, Ctr Pulm, Div Pulm Allergy & Crit Care Med,Boston Med Ctr, Boston, MA 02118 USA; [Demissie, Serkalem] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Shah, Dilip; Romero, Freddy; Puklin, Leah; Summer, Ross S.] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; [Shah, Dilip; Romero, Freddy; Puklin, Leah; Summer, Ross S.] Thomas Jefferson Univ, Korman Lung Ctr, Philadelphia, PA 19107 USA	Boston Medical Center; Boston University; Boston University; Jefferson University; Jefferson University	Walkey, AJ (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Div Pulm Allergy & Crit Care Med,Boston Med Ctr, Boston, MA 02118 USA.	alwalkey@bu.edu		Walkey, Allan/0000-0003-4685-6894; Shah, Dilip/0000-0002-4248-5611	National Institutes of Health, National Heart Lung and Blood Institute [R21HL112672, R01HL105490]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL112672, R01HL105490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA023571] Funding Source: NIH RePORTER	National Institutes of Health, National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by National Institutes of Health, National Heart Lung and Blood Institute R21HL112672 (AJW) and R01HL105490 (RSS) (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahasic AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089170; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bull TM, 2010, AM J RESP CRIT CARE, V182, P1123, DOI 10.1164/rccm.201002-0250OC; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Koch A, 2011, J CRIT CARE, V26, P166, DOI 10.1016/j.jcrc.2010.07.015; Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426; Langouche L, 2009, CRIT CARE, V13, DOI 10.1186/cc7956; Li S, 2012, J INVEST SURG, V25, P214, DOI 10.3109/08941939.2011.624257; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; Neumeier M, 2006, J LEUKOCYTE BIOL, V79, P803, DOI 10.1189/jlb.0905521; Nigro E, 2013, INT J BIOCHEM CELL B, V45, P1145, DOI 10.1016/j.biocel.2013.03.003; Pelosi P, 2003, EUR RESPIR J, V22, p48S, DOI 10.1183/09031936.03.00420803; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Summer R, 2009, AM J PHYSIOL-LUNG C, V297, pL432, DOI 10.1152/ajplung.90599.2008; Teoh H, 2008, AM J PHYSIOL-ENDOC M, V295, pE658, DOI 10.1152/ajpendo.90384.2008; van Meurs M, 2012, SHOCK, V37, P392, DOI 10.1097/SHK.0b013e318248225e; Walkey AJ, 2010, CRIT CARE MED, V38, P2329, DOI 10.1097/CCM.0b013e3181fa0561; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213; Wiedemann HP, 2008, CLEV CLIN J MED, V75, P42, DOI 10.3949/ccjm.75.1.42; Xu L, 2013, J SURG RES, V183, P752, DOI 10.1016/j.jss.2013.01.055	23	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108561	10.1371/journal.pone.0108561	http://dx.doi.org/10.1371/journal.pone.0108561			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259893	Green Submitted, Green Published, gold			2022-12-27	WOS:000342685600083
J	Iser, BPM; Malta, DC; Duncan, BB; de Moura, L; Vigo, A; Schmidt, MI				Moehlecke Iser, Betine Pinto; Malta, Deborah Carvalho; Duncan, Bruce Bartholow; de Moura, Lenildo; Vigo, Alvaro; Schmidt, Maria Ines			Prevalence, Correlates, and Description of Self-Reported Diabetes in Brazilian Capitals - Results from a Telephone Survey	PLOS ONE			English	Article							HEALTH; HYPERTENSION; POPULATION; AGREEMENT; GLUCOSE; VALIDATION; MELLITUS; PATIENT; WOMEN	Introduction: The prevalence of diabetes is increasing worldwide. The objective of this study is to estimate the prevalence of self-reported diabetes in Brazilian adults and to describe its population correlates as well as the clinical characteristics of the reported cases. Methods: We analyzed basic and supplementary data of 54.144 subjects participating in VIGITEL 2011 (Surveillance System for Risk and Protective Factors for Chronic Diseases), a telephone survey based on a probabilistic sample of subjects >= 18 years old residing in Brazilian state capitals and the Federal District. Estimates reported are weighted so as to represent the surveyed population. Results: The prevalence of self-reported diabetes was 6.3% (95% CI 5.9-6.7), increasing markedly with age and nutritional status, and decreasing with level of education. Prevalence was higher among those self-declaring their race/color as black. Most cases (90%) reported the diagnosis being made at 35 years or older. The vast majority (99.8%) of self-reported cases informed having previously performed at least one glucose test, and 76% of those not reporting diabetes also informed having previously performed glucose testing. Most cases (92.6%) reported following some form of diabetes treatment, 79% taking medication. Conclusion: The estimated prevalence of known diabetes found, 6.3%, is consistent with estimates given by international summaries. The additional data collected in VIGITEL 2011 regarding previous glucose testing and current treatment support the use of telephone-based information to monitor the prevalence of known diabetes in Brazilian capitals.	[Moehlecke Iser, Betine Pinto; Duncan, Bruce Bartholow; Vigo, Alvaro; Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Sch Med, Post Grad Studies Program Epidemiol, Porto Alegre, RS, Brazil; [Moehlecke Iser, Betine Pinto; Malta, Deborah Carvalho] Minist Hlth, Secretariat Hlth Surveillance, Dept Non Communicable Dis Surveillance & Hlth Pro, Brasilia, DF, Brazil; [de Moura, Lenildo] Pan Amer Hlth Org, Unit Noncommunicable Dis & Mental Hlth, Brasilia, DF, Brazil	Universidade Federal do Rio Grande do Sul; Pan American Health Organization	Iser, BPM (corresponding author), Univ Fed Rio Grande do Sul, Sch Med, Post Grad Studies Program Epidemiol, Porto Alegre, RS, Brazil.	betinee@gmail.com	Duncan, Bruce B/L-4140-2016; Malta, Deborah C/H-7880-2012; Schmidt, Maria Inês/AGP-6441-2022; Malta, Deborah Carvalho/GNM-8218-2022; Vigo, Alvaro/S-2243-2019; Schmidt, Maria/V-3196-2019; Schmidt, Maria Inês/AGT-5691-2022; Malta, Deborah Carvalho/L-2491-2019; Moehlecke Iser, Betine/F-7580-2013	Duncan, Bruce B/0000-0002-7491-2630; Malta, Deborah C/0000-0002-8214-5734; Schmidt, Maria Inês/0000-0002-3837-0731; Malta, Deborah Carvalho/0000-0002-8214-5734; Vigo, Alvaro/0000-0002-5797-9470; Malta, Deborah Carvalho/0000-0002-8214-5734; Moehlecke Iser, Betine/0000-0001-6061-2541	Secretariat of Health Surveillance of the Ministry of Health (SVS/MS) of Brazil, Brasilia-DF	Secretariat of Health Surveillance of the Ministry of Health (SVS/MS) of Brazil, Brasilia-DF	Vigitel is a telephone survey funded by the Secretariat of Health Surveillance of the Ministry of Health (SVS/MS) of Brazil, Brasilia-DF. (http://portalsaude.saude.gov.br/index.php/o-ministerio/principal/secretarias/svs). The funding is related to the telephone survey Vigitel, which originate this paper, but not specifically related to this analyses, which used secondary data. Therefore, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Andrade F, 2009, REV PANAM SALUD PUBL, V26, P9, DOI 10.1590/S1020-49892009000700002; Bener A, 2009, DIABETES RES CLIN PR, V84, P99, DOI 10.1016/j.diabres.2009.02.003; Bernal Regina, 2009, Rev. Saúde Pública, V43, P421, DOI 10.1590/S0034-89102009005000024; Bernal Regina Tomie Ivata, 2014, Rev. bras. epidemiol., V17, P163, DOI 10.1590/1415-790X201400010013ENG; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Analise de SituacAo de Saude, 2011, PLAN AC ESTR ENF DOE; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude Departamento de Vigilancia de Doencas e Agravos nao transmissiveis e Promocao de Saude, 2013, VIG FAT RISC PROT DO; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Danaei Goodarz, 2009, Popul Health Metr, V7, P16, DOI 10.1186/1478-7954-7-16; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Englert H, 2010, J PUBLIC HEALTH-UK, V32, P387, DOI 10.1093/pubmed/fdq013; Espelt A, 2011, J EPIDEMIOL COMMUNIT; Francisco Priscila Maria Stolses Bergamo, 2011, Rev. bras. epidemiol., V14, P5, DOI 10.1590/S1415-790X2011000500002; Goldman N, 2003, J CLIN EPIDEMIOL, V56, P148, DOI 10.1016/S0895-4356(02)00580-2; Huerta JM, 2009, REV ESP CARDIOL, V62, P143, DOI 10.1016/S0300-8932(09)70156-3; Instituto Brasileiro de Geografia e Estatisticas - IBGE, 2012, CENS DEM POP RES; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Bernal RTI, 2013, REV SAUDE PUBL, V47, P316, DOI 10.1590/S0034-8910.2013047003798; Lima-Costa MF, 2007, REV SAUDE PUBL, V41, P943; MALERBI DA, 1992, DIABETES CARE, V15, P1509, DOI 10.2337/diacare.15.11.1509; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; McNeely MJ, 2004, DIABETES CARE, V27, P66, DOI 10.2337/diacare.27.1.66; Ministerio do Planejamento Orcamento e Gestao & Instituto Brasileiro de Geografia e Estatistica, 2011, CENS DEM 2010 CAR PO; Mokdad AH, 2010, PREV CHRONIC DIS, V7; Moser EG, 2012, DIABETES RES CLIN PR, V97, P16, DOI 10.1016/j.diabres.2012.01.027; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Organization WH, 2016, GLOBAL STATUS REPORT; Passos Valéria Maria de Azeredo, 2005, Sao Paulo Med. J., V123, P66, DOI 10.1590/S1516-31802005000200007; de Freitas LRS, 2012, EPIDEMIOL SERV SAUDE, V21, P7, DOI 10.5123/S1679-49742012000100002; Schenker N, 2010, STAT MED, V29, P533, DOI 10.1002/sim.3809; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Schmidt MI, 2009, REV SAUDE PUBL, V43, P74, DOI 10.1590/S0034-89102009000900010; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Simpson CF, 2004, J AM GERIATR SOC, V52, P123, DOI 10.1111/j.1532-5415.2004.52021.x; Francisco PMSB, 2010, CAD SAUDE PUBLICA, V26, P175, DOI 10.1590/S0102-311X2010000100018; Wu SC, 2000, PUBLIC HEALTH, V114, P137, DOI 10.1016/S0033-3506(00)00323-1; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang XP, 2008, DIABETES CARE, V31, P1748, DOI 10.2337/dc08-0572; Zindah Meyasser, 2008, Prev Chronic Dis, V5, pA17	39	19	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108044	10.1371/journal.pone.0108044	http://dx.doi.org/10.1371/journal.pone.0108044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3UZ	25255096	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300052
J	Stival, A; Chiappini, E; Montagnani, C; Orlandini, E; Buzzoni, C; Galli, L; de Martino, M				Stival, Alessia; Chiappini, Elena; Montagnani, Carlotta; Orlandini, Elisa; Buzzoni, Carlotta; Galli, Luisa; de Martino, Maurizio			Sexual Dimorphism in Tuberculosis Incidence: Children Cases Compared to Adult Cases in Tuscany from 1997 to 2011	PLOS ONE			English	Article							CHILDHOOD TUBERCULOSIS; RISK-FACTORS; EPIDEMIOLOGY; CELLS; INFLAMMATION; MACROPHAGES; POPULATION; CHICKENPOX; EXPRESSION; MORTALITY	Background: In most countries, men seem to be more susceptible to tuberculosis (TB) than women, but only few studies have investigated the reasons of this gender incidence difference. The effect of sexual hormones on immunity is possible. Methods: Data from children and adults, living in Tuscany, hospitalized for TB in all the thirty-one regional hospitals from January 1st 1997 to December 31st 2011, were analyzed using the International Classification of Disease, 9th Revision, Clinical Modification. Results: During the study period, 10,744 patients were hospitalized with TB diagnosis, precisely 279 (2.6%) children [0-14 years], 205 (1.9%) adolescents [15-18 years] and 10,260 (95.5%) adults [>= 18 years]. The male population ranged from 249 patients (51.4%) in children and adolescents, to 6,253 (60.9%) in adults. Pulmonary TB was the most common form both in children and adults. Men were more likely than women to have pulmonary TB after puberty, while no significant differences were found between males and females in the hospitalized children. The male gender also resulted the most affected for the extra-pulmonary disease sites, excluding the lymphatic system, during the reproductive age. Conclusions: Our findings suggest a possible role of sexual hormones in the development of TB. No significant male-female difference was found in TB incidence among children, while a sex ratio significantly different from 1: 1 emerged among reproductive age classes. An increased incidence difference also persisted in older men, suggesting that male-biased risk factors could influence TB progression. Some limitations of the study are the sample size, the method of discharge diagnosis which could be deficient in accuracy in some cases, the increasing number of immigrants and the lack of possible individual risk factors (smoke and alcohol). Further studies are needed to investigate the possible hormone-driven immune mechanisms determining the sexual dimorphism in TB.	[Stival, Alessia; Chiappini, Elena; Montagnani, Carlotta; Galli, Luisa; de Martino, Maurizio] Univ Florence, Anna Meyer Childrens Univ Hosp, Dept Hlth Sci, Florence, Italy; [Orlandini, Elisa] Tuscany Reg Govt Dept Right Hlth & Solidar Polici, Informat Technol Sect, Florence, Italy; [Buzzoni, Carlotta] Inst Canc Study & Prevent ISPO, Msc Clin & Descript Epidemiol Unit, Florence, Italy	University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	de Martino, M (corresponding author), Univ Florence, Anna Meyer Childrens Univ Hosp, Dept Hlth Sci, Florence, Italy.	maurizio.demartino@unifi.it	montagnani, carlotta/AAB-7849-2019; Chiappini, Elena/D-1118-2012; chiappini, elena/AAC-3121-2020	Chiappini, Elena/0000-0002-1476-4752; PIRO, SARA/0000-0003-4198-7035; Montagnani, Carlotta/0000-0001-5950-4965				Abubakar I, 2008, ARCH DIS CHILD, V93, P1017, DOI 10.1136/adc.2008.139543; Ackerman LS, 2006, ARCH DERMATOL, V142, P371, DOI 10.1001/archderm.142.3.371; ARS Toscana, 2013, FUM TOSC IT; Bonsignori F, 2007, INFECTION, V35, P444, DOI 10.1007/s15010-007-6248-z; Bonsignori F, 2013, INT J IMMUNOPATH PH, V26, P995, DOI 10.1177/039463201302600421; Burt MA, 2013, INT J NEUROPSYCHOPH, V16, P1835, DOI 10.1017/S1461145713000229; Chiappini E, 2013, PEDIATR INFECT DIS J, V32, P1289, DOI 10.1097/INF.0b013e31829e7d81; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Eritja N, 2013, AM J PATHOL, V183, P277, DOI 10.1016/j.ajpath.2013.03.008; Espinal MA, 1996, J INFECT DIS, V173, P488, DOI 10.1093/infdis/173.2.488; Farchi S, 2008, INT J TUBERC LUNG D, V12, P193; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; FOX HS, 1991, J IMMUNOL, V146, P4362; Friedl R, 2000, LIFE SCI, V68, P417, DOI 10.1016/S0024-3205(00)00953-X; Garcia-Gomez E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/928290; Ghazeeri G, 2011, AM J REPROD IMMUNOL, V66, P163, DOI 10.1111/j.1600-0897.2011.01052.x; Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390; Hamano N, 1998, ALLERGY ASTHMA PROC, V19, P263, DOI 10.2500/108854198778557773; Handa U, 2012, J INFECT DEV COUNTR, V6, P6, DOI 10.3855/jidc.2090; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Klein SL, 2012, ENDOCRINOLOGY, V153, P2544, DOI 10.1210/en.2011-2120; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lin CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063936; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Liu LM, 2006, PARASITOL RES, V99, P189, DOI 10.1007/s00436-006-0168-1; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lotter H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055694; Manenschijn L, 2013, J CLIN ENDOCR METAB, V98, P2078, DOI 10.1210/jc.2012-3663; Marchetto S, 2007, ACTA PAEDIATR, V96, P1490, DOI 10.1111/j.1651-2227.2007.00465.x; Marriott I, 2006, IMMUNOL RES, V34, P177, DOI 10.1385/IR:34:3:177; Martinez AN, 2000, INT J TUBERC LUNG D, V4, P26; McClelland EE, 2011, ARCH IMMUNOL THER EX, V59, P203, DOI 10.1007/s00005-011-0124-3; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388; Valin ER, 2012, REV ESP SALUD PUBLIC, V86, P49, DOI [10.1590/S1135-57272012000100005, 10.1590/s1135-57272012000100005]; Ruwende JET, 2011, J PUBLIC HEALTH-UK, V33, P175, DOI 10.1093/pubmed/fdq046; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Syridou G, 2012, INT J TUBERC LUNG D, V16, P749, DOI 10.5588/ijtld.10.0717; Torres-Garcia D, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-220; Weiss MG, 2008, INT J TUBERC LUNG D, V12, P829; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644	44	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e105277	10.1371/journal.pone.0105277	http://dx.doi.org/10.1371/journal.pone.0105277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255233	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300005
J	Zebala, JA; Mundell, A; Messinger, L; Griffin, CE; Schuler, AD; Kahn, SJ				Zebala, John A.; Mundell, Alan; Messinger, Linda; Griffin, Craig E.; Schuler, Aaron D.; Kahn, Stuart J.			LD-Aminopterin in the Canine Homologue of Human Atopic Dermatitis: A Randomized, Controlled Trial Reveals Dosing Factors Affecting Optimal Therapy	PLOS ONE			English	Article							5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOTIDE TRANSFORMYLASE; L1210 LEUKEMIA-CELLS; RHEUMATOID-ARTHRITIS; INTRATHECAL METHOTREXATE; CEREBROSPINAL-FLUID; COGNITIVE DEFICITS; ADENOSINE RELEASE; SEVERITY SCALE; CLINICAL-TRIAL; T-LYMPHOCYTES	Background: Options are limited for patients with atopic dermatitis (AD) who do not respond to topical treatments. Antifolate therapy with systemic methotrexate improves the disease, but is associated with adverse effects. The investigational antifolate LD-aminopterin may offer improved safety. It is not known how antifolate dose and dosing frequency affect efficacy in AD, but a primary mechanism is thought to involve the antifolate-mediated accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR). However, recent in vitro studies indicate that AICAR increases then decreases as a function of antifolate concentration. To address this issue and understand how dosing affects antifolate efficacy in AD, we examined the efficacy and safety of different oral doses and schedules of LD-aminopterin in the canine model of AD. Methods and Findings: This was a multi-center, double-blind trial involving 75 subjects with canine AD randomized to receive up to 12 weeks of placebo, once-weekly (0.007, 0.014, 0.021 mg/kg) or twice-weekly (0.007 mg/kg) LD-aminopterin. The primary efficacy outcome was the Global Score (GS), a composite of validated measures of disease severity and itch. GS improved in all once-weekly cohorts, with 0.014 mg/kg being optimal and significant (43%, P<0.01). The majority of improvement was seen by 8 weeks. In contrast, GS in the twice-weekly cohort was similar to placebo and worse than all once-weekly cohorts. Adverse events were similar across all treated cohorts and placebo. Conclusions: Once-weekly LD-aminopterin was safe and efficacious in canine AD. Twice-weekly dosing negated efficacy despite having the same daily and weekly dose as effective once-weekly regimens. Optimal dosing in this homologue of human AD correlated with the concentration-selective accumulation of AICAR in vitro, consistent with AICAR mediating LD-aminopterin efficacy in AD.	[Zebala, John A.; Schuler, Aaron D.; Kahn, Stuart J.] Syntrix Biosyst Inc, Auburn, WA 98001 USA; [Mundell, Alan] Anim Dermatol Serv, Edmonds, WA USA; [Messinger, Linda] Vet Referral Ctr Colorado, Englewood, CO USA; [Griffin, Craig E.] Anim Dermatol Clin, San Diego, CA USA		Zebala, JA (corresponding author), Syntrix Biosyst Inc, Auburn, WA 98001 USA.	jzebala@syntrixbio.com			National Institutes of Health [AR 056547]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR056547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institutes of Health (no. AR 056547 to SK and JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEGRA CJ, 1985, P NATL ACAD SCI USA, V82, P4881, DOI 10.1073/pnas.82.15.4881; ALLEGRA CJ, 1986, J BIOL CHEM, V261, P6478; Baggott JE, 1999, ARCH DERMATOL, V135, P813, DOI 10.1001/archderm.135.7.813; BAGGOTT JE, 1986, BIOCHEM J, V236, P193, DOI 10.1042/bj2360193; BAGGOTT JE, 1993, CLIN EXP RHEUMATOL, V11, pS101; Baggott JE, 2010, EXP BIOL MED, V235, P271, DOI 10.1258/ebm.2009.009151; Barker J, 2011, J EUR ACAD DERMATOL, V25, P758, DOI 10.1111/j.1468-3083.2010.03932.x; Behnam Shahrad M, 2005, J Drugs Dermatol, V4, P189; Brown S, 2006, BMJ-BRIT MED J, V332, P584, DOI 10.1136/bmj.332.7541.584; BUESAPEREZ JM, 1980, CANCER RES, V40, P139; Chakravarty K, 2008, RHEUMATOLOGY, V47, P924, DOI 10.1093/rheumatology/kel216a; Chan ESL, 2010, NAT REV RHEUMATOL, V6, P175, DOI 10.1038/nrrheum.2010.5; Cole PD, 2006, CANCER CHEMOTH PHARM, V57, P826, DOI 10.1007/s00280-005-0115-3; Cole PD, 2005, CLIN CANCER RES, V11, P8089, DOI 10.1158/1078-0432.CCR-05-0355; Cole PD, 2009, PEDIATR NEUROL, V40, P34, DOI 10.1016/j.pediatrneurol.2008.09.005; CRONSTEIN BN, 1993, J CLIN INVEST, V92, P2675, DOI 10.1172/JCI116884; CRONSTEIN BN, 1991, P NATL ACAD SCI USA, V88, P2441, DOI 10.1073/pnas.88.6.2441; Cutolo M, 2001, ANN RHEUM DIS, V60, P729, DOI 10.1136/ard.60.8.729; DeBoer DJ, 2001, VET IMMUNOL IMMUNOP, V81, P271, DOI 10.1016/S0165-2427(01)00312-9; Denby KS, 2012, CURR OPIN ALLERGY CL, V12, P421, DOI 10.1097/ACI.0b013e3283551da5; DIXON R, 1993, J CLIN PHARMACOL, V33, P955, DOI 10.1002/j.1552-4604.1993.tb01929.x; El-Khalawany MA, 2013, EUR J PEDIATR, V172, P351, DOI 10.1007/s00431-012-1893-3; Fairbanks LD, 1999, BIOCHEM J, V342, P143, DOI 10.1042/0264-6021:3420143; Funk RS, 2013, J PHARMACOL EXP THER, V347, P154, DOI 10.1124/jpet.113.206672; Genestier L, 1998, J CLIN INVEST, V102, P322, DOI 10.1172/JCI2676; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; HA TS, 1994, J NUTR BIOCHEM, V5, P522, DOI 10.1016/0955-2863(94)90049-3; Heijden JV, 2013, SCAND J RHEUMATOL; Herman S, 2003, CELL STRUCT FUNCT, V28, P113; Hsu J., 1996, MULTIPLE COMP THEORY; Kamal MA, 2004, INT J BIOCHEM CELL B, V36, P545, DOI 10.1016/j.biocel.2003.08.014; Katerelos M, 2010, IMMUNOL CELL BIOL, V88, P754, DOI 10.1038/icb.2010.44; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Li Y, 2010, PHARMACOL BIOCHEM BE, V95, P428, DOI 10.1016/j.pbb.2010.03.003; Li Y, 2010, PHARMACOL BIOCHEM BE, V94, P454, DOI 10.1016/j.pbb.2009.10.008; LYONS SD, 1991, BIOCHEM INT, V24, P187; Marsella R, 2009, J INVEST DERMATOL, V129, P2351, DOI 10.1038/jid.2009.98; Menter A, 2012, J PHARMACOL EXP THER, V342, P696, DOI 10.1124/jpet.112.195479; Morgan SL, 2004, ARTHRITIS RHEUM, V50, P3104, DOI 10.1002/art.20516; Olivry T, 2007, BRIT J DERMATOL, V157, P1040, DOI 10.1111/j.1365-2133.2007.08133.x; Olivry T, 2008, VET DERMATOL, V19, P115, DOI 10.1111/j.1365-3164.2008.00668.x; Olivry T, 2007, VET DERMATOL, V18, P78, DOI 10.1111/j.1365-3164.2007.00569.x; Paillot R, 1998, TRANSPLANT P, V30, P2348, DOI 10.1016/S0041-1345(98)00648-4; Parakkal D, 2011, EUR J GASTROEN HEPAT, V23, P1150, DOI 10.1097/MEG.0b013e32834bb90a; POND EC, 1982, J SMALL ANIM PRACT, V23, P659, DOI 10.1111/j.1748-5827.1982.tb02059.x; Proudfoot LE, 2013, BRIT J DERMATOL, V169, P901, DOI 10.1111/bjd.12505; Quemeneur L, 2003, J IMMUNOL, V170, P4986, DOI 10.4049/jimmunol.170.10.4986; Radmanesh M, 2011, INT J DERMATOL, V50, P1291, DOI 10.1111/j.1365-4632.2011.04967.x; Ratliff AF, 1998, J CLIN ONCOL, V16, P1458, DOI 10.1200/JCO.1998.16.4.1458; Ruperto N, 2004, ARTHRITIS RHEUM-US, V50, P2191, DOI 10.1002/art.20288; Ryan C, 2010, J AM ACAD DERMATOL, V63, P949, DOI 10.1016/j.jaad.2010.02.062; Rybnicek J, 2009, VET DERMATOL, V20, P115, DOI 10.1111/j.1365-3164.2008.00728.x; SANT ME, 1992, J BIOL CHEM, V267, P11038; Schmitt J, 2007, J EUR ACAD DERMATOL, V21, P606, DOI 10.1111/j.1468-3083.2006.02023.x; Schram ME, 2011, J ALLERGY CLIN IMMUN, V128, P353, DOI 10.1016/j.jaci.2011.03.024; SEITHER RL, 1989, J BIOL CHEM, V264, P17016; SKIPPER HE, 1950, CANCER RES, V10, P510; Smith A, 1996, CLIN CANCER RES, V2, P69; Smolenska Z, 1999, RHEUMATOLOGY, V38, P997, DOI 10.1093/rheumatology/38.10.997; Sohn A, 2011, MT SINAI J MED, V78, P730, DOI 10.1002/msj.20289; Spurlock CF, 2011, ARTHRITIS RHEUM-US, V63, P2606, DOI 10.1002/art.30457; Steffan J, 2005, JAVMA-J AM VET MED A, V226, P1855, DOI 10.2460/javma.2005.226.1855; Steffan J, 2004, VET REC, V154, P681, DOI 10.1136/vr.154.22.681; Swierkot J, 2004, ANN RHEUM DIS, V63, P599, DOI 10.1136/ard.2003.015370; Vijayanathan V, 2011, BEHAV BRAIN RES, V225, P491, DOI 10.1016/j.bbr.2011.08.006; Wall M, 2000, BIOCHEMISTRY-US, V39, P11303, DOI 10.1021/bi0007268; Weatherhead SC, 2007, BRIT J DERMATOL, V156, P346, DOI 10.1111/j.1365-2133.2006.07686.x; WILLEMSE T, 1986, J SMALL ANIM PRACT, V27, P771, DOI 10.1111/j.1748-5827.1986.tb02119.x; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Zebala J, 2013, U.S. Patent, Patent No. [No. 8,349,837, 8349837]	70	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108303	10.1371/journal.pone.0108303	http://dx.doi.org/10.1371/journal.pone.0108303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255447	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300071
J	Mitsunami, T; Nishihara, M; Galis, I; Alamgir, KM; Hojo, Y; Fujita, K; Sasaki, N; Nemoto, K; Sawasaki, T; Arimura, G				Mitsunami, Tomoko; Nishihara, Masahiro; Galis, Ivan; Alamgir, Kabir Md; Hojo, Yuko; Fujita, Kohei; Sasaki, Nobuhiro; Nemoto, Keichiro; Sawasaki, Tatsuya; Arimura, Gen-ichiro			Overexpression of the PAP1 Transcription Factor Reveals a Complex Regulation of Flavonoid and Phenylpropanoid Metabolism in Nicotiana tabacum Plants Attacked by Spodoptera litura	PLOS ONE			English	Article							TRANSGENIC TOBACCO; HIGH-TEMPERATURE; MYB; ARABIDOPSIS; ANTHOCYANINS; BIOSYNTHESIS; ACCUMULATION; DEFENSE; EXPRESSION; ATTENUATA	Anthocyanin pigments and associated flavonoids have demonstrated antioxidant properties and benefits for human health. Consequently, current plant bioengineers have focused on how to modify flavonoid metabolism in plants. Most of that research, however, does not consider the role of natural biotic stresses (e.g., herbivore attack). To understand the influence of herbivore attack on the metabolic engineering of flavonoids, we examined tobacco plants overexpressing the Arabidopsis PAP1 gene (encoding an MYB transcription factor), which accumulated anthocyanin pigments and other flavonoids/phenylpropanoids. In comparison to wild-type and control plants, transgenic plants exhibited greater resistance to Spodoptera litura. Moreover, herbivory suppressed the PAP1-induced increase of transcripts of flavonoid/phenylpropanoid biosynthetic genes (e.g., F3H) and the subsequent accumulation of these genes' metabolites, despite the unaltered PAP1 mRNA levels after herbivory. The instances of down-regulation were independent of the signaling pathways mediated by defense-related jasmonates but were relevant to the levels of PAP1-induced and herbivory-suppressed transcription factors, An1a and An1b. Although initially F3H transcripts were suppressed by herbivory, after the S. litura feeding was interrupted, F3H transcripts increased. We hypothesize that in transgenic plants responding to herbivory, there is a complex mechanism regulating enriched flavonoid/phenylpropanoid compounds, via biotic stress signals.	[Mitsunami, Tomoko; Arimura, Gen-ichiro] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Tokyo 162, Japan; [Nishihara, Masahiro; Fujita, Kohei; Sasaki, Nobuhiro] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan; [Galis, Ivan; Alamgir, Kabir Md; Hojo, Yuko] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan; [Nemoto, Keichiro; Sawasaki, Tatsuya] Ehime Univ, Proteosci Ctr, Matsuyama, Ehime, Japan	Tokyo University of Science; Iwate Biotechnology Research Center; Okayama University; Ehime University	Arimura, G (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Tokyo 162, Japan.	garimura@rs.tus.ac.jp	Galis, Ivan/F-5734-2011; Nemoto, Keiichirou/P-2085-2015	Nemoto, Keiichirou/0000-0002-0344-004X; Galis, Ivan/0000-0001-9840-8845; Sawasaki, Tatsuya/0000-0002-7952-0556; Nishihara, Masahiro/0000-0002-1454-8785	MEXT Grants for Excellent Graduate Schools program of Kyoto University; Research Fund of Tokyo University of Science; Japan Society for the Promotion of Science [24770019]; Japan Advanced Plant Science Network	MEXT Grants for Excellent Graduate Schools program of Kyoto University; Research Fund of Tokyo University of Science; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Advanced Plant Science Network	This work was financially supported in part by the MEXT Grants for Excellent Graduate Schools program of Kyoto University; the Research Fund of Tokyo University of Science; and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to G. A. ( No. 24770019). The LC-MS/MS analyses were supported by the Japan Advanced Plant Science Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YH, 2011, PLANTA, V234, P363, DOI 10.1007/s00425-011-1407-y; Bassard JE, 2010, PHYTOCHEMISTRY, V71, P1808, DOI 10.1016/j.phytochem.2010.08.003; Baudry A, 2006, PLANT J, V46, P768, DOI 10.1111/j.1365-313X.2006.02733.x; Ben Zvi MM, 2008, PLANT BIOTECHNOL J, V6, P403, DOI 10.1111/j.1467-7652.2008.00329.x; Boatwright JL, 2013, MOL PLANT PATHOL, V14, P623, DOI 10.1111/mpp.12035; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Chung SH, 2013, P NATL ACAD SCI USA, V110, P15728, DOI 10.1073/pnas.1308867110; Dela G, 2003, PLANT SCI, V164, P333, DOI 10.1016/S0168-9452(02)00417-X; Dixon RA, 2013, CURR OPIN BIOTECH, V24, P329, DOI 10.1016/j.copbio.2012.07.004; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Fukumoto K, 2013, J INTEGR PLANT BIOL, V55, P775, DOI 10.1111/jipb.12057; Galis I, 2006, PLANT J, V46, P573, DOI 10.1111/j.1365-313X.2006.02719.x; Galis I, 2013, METHODS MOL BIOL VIR, P109; Gaquerel E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062336; Glenn WS, 2013, CURR OPIN BIOTECH, V24, P354, DOI 10.1016/j.copbio.2012.08.003; Gulati J, 2014, PLANT J, V77, P880, DOI 10.1111/tpj.12439; Hettenhausen C, 2013, NEW PHYTOL, V199, P787, DOI 10.1111/nph.12312; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Korkina LG, 2007, CELL MOL BIOL, V53, P15, DOI 10.1170/T772; Kumar V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065535; Lulai EC, 2008, J EXP BOT, V59, P1175, DOI 10.1093/jxb/ern019; Maier A, 2013, PLANT J, V74, P638, DOI 10.1111/tpj.12153; Matsuba Y, 2010, PLANT CELL, V22, P3374, DOI 10.1105/tpc.110.077487; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Mishiba K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009670; Misra P, 2010, PLANT PHYSIOL, V152, P2258, DOI 10.1104/pp.109.150979; Mori K, 2007, J EXP BOT, V58, P1935, DOI 10.1093/jxb/erm055; Onkokesung N, 2012, PLANT PHYSIOL, V158, P389, DOI 10.1104/pp.111.187229; Pandey A, 2012, PLANT CELL REP, V31, P1867, DOI 10.1007/s00299-012-1300-6; Pattanaik S, 2010, PLANTA, V231, P1061, DOI 10.1007/s00425-010-1108-y; Rowan DD, 2009, NEW PHYTOL, V182, P102, DOI 10.1111/j.1469-8137.2008.02737.x; Srinivasan T, 2009, PLANT CELL PHYSIOL, V50, P541, DOI 10.1093/pcp/pcp014; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Tzin V, 2012, NEW PHYTOL, V194, P430, DOI 10.1111/j.1469-8137.2012.04052.x; Vaknin H, 2005, PLANTA, V222, P19, DOI 10.1007/s00425-005-1509-5; Wang YC, 2011, APPL MICROBIOL BIOT, V91, P949, DOI 10.1007/s00253-011-3449-2; Xie DY, 2006, PLANT J, V45, P895, DOI 10.1111/j.1365-313X.2006.02655.x; Zhang PJ, 2009, P NATL ACAD SCI USA, V106, P21202, DOI 10.1073/pnas.0907890106; Zhang YA, 2010, J AGR FOOD CHEM, V58, P12168, DOI 10.1021/jf103203e	42	27	32	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108849	10.1371/journal.pone.0108849	http://dx.doi.org/10.1371/journal.pone.0108849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268129	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700178
J	Schievink, B; Heerspink, HL; Leufkens, H; De Zeeuw, D; Hoekman, J				Schievink, Bauke; Heerspink, Hiddo Lambers; Leufkens, Hubert; De Zeeuw, Dick; Hoekman, Jarno			The Use of Surrogate Endpoints in Regulating Medicines for Cardio-Renal Disease: Opinions of Stakeholders	PLOS ONE			English	Article							CLINICAL-TRIALS; CARDIOVASCULAR OUTCOMES; RESPONSE RATES; BIOMARKERS; RISK; ROSIGLITAZONE; APPROVAL; CRITERIA	Aim: There is discussion whether medicines can be authorized on the market based on evidence from surrogate endpoints. We assessed opinions of different stakeholders on this topic. Methods: We conducted an online questionnaire that targeted various stakeholder groups (regulatory agencies, pharmaceutical industry, academia, relevant public sector organisations) and medical specialties (cardiology or nephrology vs. other). Participants were enrolled through purposeful sampling. We inquired for conditions under which surrogate endpoints can be used, the validity of various cardio-renal biomarkers and new approaches for biomarker use. Results: Participants agreed that surrogate endpoints can be used when the surrogate is scientifically valid (5-point Likert response format, mean score: 4.3, SD: 0.9) or when there is an unmet clinical need (mean score: 3.8, SD: 1.2). Industry participants agreed to a greater extent than regulators and academics. However, out of four proposed surrogates (blood pressure (BP), HbA1c, albuminuria, CRP) for cardiovascular outcomes or end-stage renal disease, only use of BP for cardiovascular outcomes was deemed moderately accurate (mean: 3.6, SD: 1.1). Specialists in cardiology or nephrology tended to be more positive about the use of surrogate endpoints. Conclusion: Stakeholders in drug development do not oppose to the use of surrogate endpoints in drug marketing authorization, but most surrogates are not considered valid. To solve this impasse, increased efforts are required to validate surrogate endpoints and to explore alternative ways to use them.	[Schievink, Bauke; Heerspink, Hiddo Lambers; De Zeeuw, Dick] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Leufkens, Hubert; Hoekman, Jarno] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Leufkens, Hubert] Med Evaluat Board, Utrecht, Netherlands	University of Groningen; Utrecht University	Heerspink, HL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.	h.j.lambers.heerspink@umcg.nl	Heerspink, Hiddo J Lambers/K-3358-2014; de Zeeuw, Dick/E-9080-2014; Hoekman, Jarno/C-3287-2017	Heerspink, Hiddo J Lambers/0000-0002-3126-3730; de Zeeuw, Dick/0000-0003-3434-7777; Hoekman, Jarno/0000-0002-2817-1229	TI Pharma [T6-503]; VENI-Grant from the Netherlands Organization for Scientific Research	TI Pharma; VENI-Grant from the Netherlands Organization for Scientific Research	The research was funded by TI Pharma (project number T6-503) http://www.tipharma.com/. Hiddo Lambers Heerspink is supported by a VENI-Grant from the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amgen, 2013, FURTH CARD OUTC RES; Aronson JK, 2012, BRIT J CLIN PHARMACO, V73, P900, DOI 10.1111/j.1365-2125.2012.04234.x; Aronson JK, 2005, BRIT J CLIN PHARMACO, V59, P491, DOI 10.1111/j.1365-2125.2005.02435.x; Boessen R, 2012, THESIS UTRECHT U, VUtrecht University; D'Agostino Ralph B Jr, 2000, Curr Control Trials Cardiovasc Med, V1, P76, DOI 10.1186/CVM-1-2-076; Dieterle F, 2010, NAT BIOTECHNOL, V28, P455, DOI 10.1038/nbt.1625; Domanski M, 2011, FUND CLIN PHARMACOL, V25, P411, DOI 10.1111/j.1472-8206.2010.00865.x; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; Eichler HG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001202; European Medicines Agency, 2008, EMACHMPSAWP728942008; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Food and Drug Administration, 2013, BIOM QUAL PROGR; Goldman M, 2012, CLIN PHARMACOL THER, V91, P418, DOI 10.1038/clpt.2011.321; Goldman M, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-2; Halimi JM, 2012, FUND CLIN PHARMACOL, V26, P771, DOI 10.1111/j.1472-8206.2011.00965.x; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Joffe HV, 2010, REV ENDOCR METAB DIS, V11, P21, DOI 10.1007/s11154-010-9130-8; Krishna R, 2009, CLIN PHARMACOL THER, V85, P239, DOI 10.1038/clpt.2008.240; Kroth PJ, 2009, ANN FAM MED, V7, P245, DOI 10.1370/afm.944; Leece P, 2004, J MED INTERNET RES, V6, P26, DOI 10.2196/jmir.6.3.e30; Lesko LJ, 2001, ANNU REV PHARMACOL, V41, P347, DOI 10.1146/annurev.pharmtox.41.1.347; Lonn E, 2001, PHARMACOEPIDEM DR S, V10, P497, DOI 10.1002/pds.654; Mattes WB, 2009, CLIN PHARMACOL THER, V85, P327, DOI 10.1038/clpt.2008.270; Messerli FH, 2013, AM J MED, V126, pE1, DOI 10.1016/j.amjmed.2012.07.006; Messerli FH, 2010, EUR HEART J, V31, P2205, DOI 10.1093/eurheartj/ehq255; Moynihan R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5160; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P817, DOI 10.1038/nrd3879; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; O'Quigley J, 2006, BIOMETRICS, V62, P297, DOI 10.1111/j.1541-0420.2006.00538.x; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Pfizer, 2013, RED OCC MAJ CARD EV; Pfizer, 2013, EV PF 04950615 RN316; PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407; Psaty BM, 1999, JAMA-J AM MED ASSOC, V282, P786, DOI 10.1001/jama.282.8.786; Psaty BM, 2007, NEW ENGL J MED, V357, P67, DOI 10.1056/NEJMe078116; Sistare FD, 2010, NAT BIOTECHNOL, V28, P446, DOI 10.1038/nbt.1634; Smink PA, 2014, EUR J PREV CARDIOL, V21, P434, DOI 10.1177/2047487313481754; Smink PA, 2014, CLIN PHARMACOL THER, V95, P208, DOI 10.1038/clpt.2013.191; Svensson S, 2013, JAMA INTERN MED, V173, P611, DOI 10.1001/jamainternmed.2013.3037; Temple R, 1999, JAMA-J AM MED ASSOC, V282, P790, DOI 10.1001/jama.282.8.790; Tzoulaki I, 2013, JAMA INTERN MED, V173, P664, DOI 10.1001/jamainternmed.2013.3018; Yarger JB, 2013, SURGERY, V154, P38, DOI 10.1016/j.surg.2013.04.060	42	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108722	10.1371/journal.pone.0108722	http://dx.doi.org/10.1371/journal.pone.0108722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268242	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700149
J	Coventry, PA; Hudson, JL; Kontopantelis, E; Archer, J; Richards, DA; Gilbody, S; Lovell, K; Dickens, C; Gask, L; Waheed, W; Bower, P				Coventry, Peter A.; Hudson, Joanna L.; Kontopantelis, Evangelos; Archer, Janine; Richards, David A.; Gilbody, Simon; Lovell, Karina; Dickens, Chris; Gask, Linda; Waheed, Waquas; Bower, Peter			Characteristics of Effective Collaborative Care for Treatment of Depression: A Systematic Review and Meta-Regression of 74 Randomised Controlled Trials	PLOS ONE			English	Review							STATISTICAL-METHODS; METAANALYSIS; INTERVENTIONS; MANAGEMENT; SEVERITY; HEALTH; MULTIMORBIDITY; IMPROVE	Background: Collaborative care is a complex intervention based on chronic disease management models and is effective in the management of depression. However, there is still uncertainty about which components of collaborative care are effective. We used meta-regression to identify factors in collaborative care associated with improvement in patient outcomes (depressive symptoms) and the process of care (use of anti-depressant medication). Methods and Findings: Systematic review with meta-regression. The Cochrane Collaboration Depression, Anxiety and Neurosis Group trials registers were searched from inception to 9th February 2012. An update was run in the CENTRAL trials database on 29th December 2013. Inclusion criteria were: randomised controlled trials of collaborative care for adults >= 18 years with a primary diagnosis of depression or mixed anxiety and depressive disorder. Random effects meta-regression was used to estimate regression coefficients with 95% confidence intervals (CIs) between study level covariates and depressive symptoms and relative risk (95% CI) and anti-depressant use. The association between anti-depressant use and improvement in depression was also explored. Seventy four trials were identified (85 comparisons, across 21,345 participants). Collaborative care that included psychological interventions predicted improvement in depression (beta coefficient -0.11, 95% CI -0.20 to -0.01, p = 0.03). Systematic identification of patients (relative risk 1.43, 95% CI 1.12 to 1.81, p = 0.004) and the presence of a chronic physical condition (relative risk 1.32, 95% CI 1.05 to 1.65, p = 0.02) predicted use of anti-depressant medication. Conclusion: Trials of collaborative care that included psychological treatment, with or without anti-depressant medication, appeared to improve depression more than those without psychological treatment. Trials that used systematic methods to identify patients with depression and also trials that included patients with a chronic physical condition reported improved use of anti-depressant medication. However, these findings are limited by the observational nature of meta-regression, incomplete data reporting, and the use of study aggregates.	[Coventry, Peter A.; Gask, Linda] Univ Manchester, Collaborat Leadership Appl Hlth Res & Care, Ctr Primary Care, Manchester, Lancs, England; [Coventry, Peter A.; Kontopantelis, Evangelos; Gask, Linda; Bower, Peter] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Hudson, Joanna L.] Kings Coll London, Inst Psychiat, Dept Psychol, Hlth Psychol Sect, London, England; [Kontopantelis, Evangelos; Bower, Peter] Univ Manchester, NIHR Sch Primary Care Res, Ctr Primary Care, Manchester, Lancs, England; [Archer, Janine; Lovell, Karina] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Richards, David A.; Dickens, Chris] Univ Exeter, Sch Med, Inst Hlth Serv Res, Exeter, Devon, England; [Gilbody, Simon] Univ York, Dept Hlth Sci, Mental Hlth Res Grp, York YO10 5DD, N Yorkshire, England; [Gilbody, Simon] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Waheed, Waquas] Lancashire Care NHS Fdn Trust, Preston, Lancs, England	University of Manchester; University of Manchester; University of London; King's College London; University of Manchester; University of Manchester; University of Exeter; University of York - UK; University of Hull; University of York - UK	Coventry, PA (corresponding author), Univ Manchester, Collaborat Leadership Appl Hlth Res & Care, Ctr Primary Care, Manchester, Lancs, England.	peter.a.coventry@manchester.ac.uk	Kontopantelis, Evangelos/H-2966-2019; Lovell, Karina S E/E-6410-2012; Bower, Peter/A-1508-2011; Archer, Janine/D-1876-2010; Coventry, Peter/AAA-9344-2019; Gilbody, Simon/AAY-3720-2021; Coventry, Peter/H-6714-2014; Richards, David/B-4807-2009	Kontopantelis, Evangelos/0000-0001-6450-5815; Lovell, Karina S E/0000-0001-8821-895X; Bower, Peter/0000-0001-9558-3349; Archer, Janine/0000-0002-9999-082X; Coventry, Peter/0000-0003-0625-3829; Gilbody, Simon/0000-0002-8236-6983; Coventry, Peter/0000-0003-0625-3829; Dickens, Chris/0000-0001-6326-7544; Hudson, Joanna/0000-0003-0672-2621; Richards, David/0000-0002-8821-5027	NIHR [RCF_R10_PC]; Medical Research Council [G0401181, MC_PC_13042, MR/K006665/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10203, 10/57/43, 08/19/04] Funding Source: researchfish; MRC [MR/K006665/1, G0401181] Funding Source: UKRI	NIHR(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by a Research and Capability Funding grant awarded by the NIHR Collaboration for Leadership in Applied Health Research and Care for Greater Manchester (ref:RCF_R10_PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams G, 2004, J CLIN EPIDEMIOL, V57, P785, DOI 10.1016/j.jclinepi.2003.12.013; [Anonymous], 2011, COCHRANE HANDB SYST; Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Bambling M, 2006, PSYCHOTHER RES, V16, P317, DOI 10.1080/10503300500268524; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Boerma WGW, 1999, PSYCHOL MED, V29, P689, DOI 10.1017/S003329179900851X; Bower P, 2011, FAM PRACT, V28, P579, DOI 10.1093/fampra/cmr018; Bower P, 2006, BRIT J PSYCHIAT, V189, P484, DOI 10.1192/bjp.bp.106.023655; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deshauer D, 2008, CAN MED ASSOC J, V178, P1293, DOI 10.1503/cmaj.071068; Dickens C, 2012, J PSYCHOSOM RES, V73, P334, DOI 10.1016/j.jpsychores.2012.08.018; Donner A, 2002, STAT MED, V21, P2971, DOI 10.1002/sim.1301; Driessen E, 2010, J CONSULT CLIN PSYCH, V78, P668, DOI 10.1037/a0020570; Ekers D, 2013, J AFFECT DISORDERS, V149, P14, DOI 10.1016/j.jad.2013.02.032; El-Mallakh RS, 2012, CNS DRUGS, V26, P97, DOI 10.2165/11599450-000000000-00000; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Furukawa TA, 2009, ACTA PSYCHIAT SCAND, V119, P290, DOI 10.1111/j.1600-0447.2008.01288.x; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Gilbody S, 2006, BRIT J PSYCHIAT, V189, P297, DOI 10.1192/bjp.bp.105.016006; Gunn J, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-88; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Hewitt C, 2005, BMJ-BRIT MED J, V330, P1057, DOI 10.1136/bmj.38413.576713.AE; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Katon W, 2006, ARCH INTERN MED, V166, P2304, DOI 10.1001/archinte.166.21.2304; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Kendrick T, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b750; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kontopantelis E, 2009, J STAT SOFTWARE, V30; Kontopantelis E., 2009, METAEFF STATA MODULE; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Kontopantelis E, 2012, STAT METHODS MED RES, V21, P409, DOI 10.1177/0962280210392008; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lipsey M. W., 2001, PRACTICAL METAANALYS, V49; Mathur R, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572454; May C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2803; McHugh RK, 2013, J CLIN PSYCHIAT, V74, P595, DOI 10.4088/JCP.12r07757; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Milne D, 2000, BRIT J CLIN PSYCHOL, V39, P111, DOI 10.1348/014466500163149; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Negassa A, 2007, CONTEMP CLIN TRIALS, V28, P242, DOI 10.1016/j.cct.2006.08.007; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Royle Pamela, 2005, BMC Med Res Methodol, V5, P23, DOI 10.1186/1471-2288-5-23; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tsai AC, 2005, AM J MANAG CARE, V11, P478; Von Korff M, 2001, BRIT MED J, V323, P948, DOI 10.1136/bmj.323.7319.948; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925	54	113	114	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108114	10.1371/journal.pone.0108114	http://dx.doi.org/10.1371/journal.pone.0108114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6XR	25264616	Green Published, gold			2022-12-27	WOS:000345745400043
J	Davies, HS; Pudney, PDA; Georgiades, P; Waigh, TA; Hodson, NW; Ridley, CE; Blanch, EW; Thornton, DJ				Davies, Heather S.; Pudney, Paul D. A.; Georgiades, Pantelis; Waigh, Thomas A.; Hodson, Nigel W.; Ridley, Caroline E.; Blanch, Ewan W.; Thornton, David J.			Reorganisation of the Salivary Mucin Network by Dietary Components: Insights from Green Tea Polyphenols	PLOS ONE			English	Article							PROLINE-RICH PROTEIN; PARTICLE-TRACKING MICRORHEOLOGY; BACTERIAL AGGREGATING ACTIVITY; CERVICAL-MUCUS GLYCOPROTEINS; HUMAN WHOLE SALIVA; EPIGALLOCATECHIN GALLATE; CONDENSED TANNINS; ASTRINGENCY; BINDING; MUC5B	The salivary mucins that include MUC5B (gel-forming) and MUC7 (non-gel-forming) are major contributors to the protective mucus barrier in the oral cavity, and it is possible that dietary components may influence barrier properties. We show how one dietary compound, the green tea polyphenol epigallocatechin gallate (EGCG), can substantially alter the properties of both the polymeric MUC5B network and monomeric MUC7. Using rate-zonal centrifugation, MUC5B in human whole saliva and MUC5B purified from saliva sedimented faster in the presence of EGCG. The faster sedimentation by EGCG was shown to be greater with increasing MUC5B concentration. Particle tracking microrheology was employed to determine the viscosity of purified MUC5B solutions and showed that for MUC5B solutions of 200-1600 mu g/mL, EGCG caused a significant increase in mucin viscosity, which was greater at higher MUC5B concentrations. Visualisation of the changes to the MUC5B network by EGCG was performed using atomic force microscopy, which demonstrated increased aggregation of MUC5B in a heterogeneous manner by EGCG. Using trypsin-resistant, high-molecular weight oligosaccharide-rich regions of MUC5B and recombinant N-terminal and C-terminal MUC5B proteins, we showed that EGCG causes aggregation at the protein domains of MUC5B, but not at the oligosaccharide-rich regions of the mucin. We also demonstrated that EGCG caused the majority of MUC7 in human whole saliva to aggregate. Furthermore, purified MUC7 also underwent a large increase in sedimentation rate in the presence of EGCG. In contrast, the green tea polyphenol epicatechin caused no change in the sedimentation rate of either MUC5B or MUC7 in human whole saliva. These findings have demonstrated how the properties of the mucin barrier can be influenced by dietary components. In the case of EGCG, these interactions may alter the function of MUC5B as a lubricant, contributing to the astringency (dry puckering sensation) of green tea.	[Davies, Heather S.; Georgiades, Pantelis; Ridley, Caroline E.; Thornton, David J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Davies, Heather S.; Blanch, Ewan W.] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester, Lancs, England; [Pudney, Paul D. A.] Unilever Discover, Sharnbrook, Beds, England; [Georgiades, Pantelis; Waigh, Thomas A.] Univ Manchester, Dept Phys & Astron, Manchester, Lancs, England; [Hodson, Nigel W.] Univ Manchester, Fac Med & Human Sci, BioAFM Facil Ctr Tissue Injury & Repair, Manchester, Lancs, England	University of Manchester; University of Manchester; Unilever; University of Manchester; University of Manchester	Thornton, DJ (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England.	dave.thornton@manchester.ac.uk	pudney, paul/R-6733-2019; Georgiades, Pantelis/AAJ-5588-2021	Ridley, Caroline/0000-0002-5483-0320; Hodson, Nigel/0000-0002-7486-1976; Blanch, Ewan/0000-0002-0781-4926; Thornton, David/0000-0001-7148-1970	Unilever Discover; Wellcome Trust [088785/Z/09/Z]	Unilever Discover(Unilever); Wellcome Trust(Wellcome TrustEuropean Commission)	The work was partly funded by Unilever Discover who also provided polyphenol samples free of charge to perform the experiments presented. The funders provided support in the form of salary for one of the authors (PDAP), but did not have any additional role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of author PDAP are articulated in the "author contributions" section. Facilities funded through the Wellcome Trust (grant number 088785/Z/09/Z) were used.	ALHASHIMI I, 1989, ARCH ORAL BIOL, V34, P289, DOI 10.1016/0003-9969(89)90070-8; ASQUITH TN, 1987, J AGR FOOD CHEM, V35, P331, DOI 10.1021/jf00075a012; Avivi I, 2009, BONE MARROW TRANSPL, V43, P801, DOI 10.1038/bmt.2008.387; Baxter NJ, 1997, BIOCHEMISTRY-US, V36, P5566, DOI 10.1021/bi9700328; Bennick A, 2002, CRIT REV ORAL BIOL M, V13, P184, DOI 10.1177/154411130201300208; BIESBROCK AR, 1991, INFECT IMMUN, V59, P3492, DOI 10.1128/IAI.59.10.3492-3497.1991; BLIXTJOHANSEN G, 1992, ARCH GERONTOL GERIAT, V14, P193, DOI 10.1016/0167-4943(92)90054-8; Cala O, 2012, LANGMUIR, V28, P17410, DOI 10.1021/la303964m; Canon F, 2013, LANGMUIR, V29, P1926, DOI 10.1021/la3041715; CARLSTEDT I, 1983, BIOCHEM J, V213, P427, DOI 10.1042/bj2130427; CARLSTEDT I, 1983, BIOCHEM J, V211, P13, DOI 10.1042/bj2110013; Carpenter GH, 2013, ANNU REV FOOD SCI T, V4, P267, DOI 10.1146/annurev-food-030212-182700; Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z; Charlton AJ, 2002, J AM CHEM SOC, V124, P9899, DOI 10.1021/ja0126374; Condelli N, 2006, FOOD QUAL PREFER, V17, P96, DOI 10.1016/j.foodqual.2005.04.009; Crouzier T, 2012, BIOMACROMOLECULES, V13, P3401, DOI 10.1021/bm301222f; DAWES C, 1972, J PHYSIOL-LONDON, V220, P529, DOI 10.1113/jphysiol.1972.sp009721; DUXBURY AJ, 1989, BRIT DENT J, V166, P115, DOI 10.1038/sj.bdj.4806731; FOX PC, 1987, J AM DENT ASSOC, V115, P581, DOI 10.1016/S0002-8177(87)54012-0; Gambuti A, 2006, FOOD CHEM, V97, P614, DOI 10.1016/j.foodchem.2005.05.038; Georgiades P, 2014, BIOPOLYMERS, V101, P366, DOI 10.1002/bip.22372; Gibbins HL, 2014, ORAL DIS, V20, P707, DOI 10.1111/odi.12194; Hara K, 2012, EUR J ORAL SCI, V120, P132, DOI 10.1111/j.1600-0722.2012.00947.x; Henning SM, 2003, NUTR CANCER, V45, P226, DOI 10.1207/S15327914NC4502_13; HOFFMAN MP, 1993, INFECT IMMUN, V61, P1940, DOI 10.1128/IAI.61.5.1940-1949.1993; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Hsu SD, 2007, AUTOIMMUNITY, V40, P138, DOI 10.1080/08916930601167343; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Iontcheva I, 1997, J DENT RES, V76, P734, DOI 10.1177/00220345970760030501; Jobstl E, 2004, BIOMACROMOLECULES, V5, P942, DOI 10.1021/bm0345110; Kanwar Jyoti, 2012, Front Biosci (Elite Ed), V4, P111; LANGLEY JN, 1889, P R SOC LOND, V46, P423; Lee CA, 2012, J FOOD SCI, V77, pC381, DOI 10.1111/j.1750-3841.2012.02644.x; Lee JY, 2007, ORAL DIS, V13, P550, DOI 10.1111/j.1601-0825.2006.01332.x; Liu B, 1999, ARCH BIOCHEM BIOPHYS, V364, P286, DOI 10.1006/abbi.1999.1141; Llena-Puy Carmen, 2006, Med Oral Patol Oral Cir Bucal, V11, pE449; Martinez-Maqueda D, 2012, J AGR FOOD CHEM, V60, P8600, DOI 10.1021/jf301279k; McColl J, 2009, J BIOMAT SCI-POLYM E, V20, P841, DOI 10.1163/156856209X427023; MEHANSHO H, 1985, J BIOL CHEM, V260, P4418; Mehrotra R, 1998, BIOCHEM J, V334, P415, DOI 10.1042/bj3340415; MOLE S, 1990, BIOCHEM SYST ECOL, V18, P287, DOI 10.1016/0305-1978(90)90073-O; Monteleone E, 2004, FOOD QUAL PREFER, V15, P761, DOI 10.1016/j.foodqual.2004.06.002; Mukhtar H, 2000, AM J CLIN NUTR, V71, p1698S, DOI 10.1093/ajcn/71.6.1698S; Nayak A, 2008, PHYSIOL BEHAV, V95, P290, DOI 10.1016/j.physbeh.2008.05.023; Osailan SM, 2012, OR SURG OR MED OR PA, V114, P597, DOI 10.1016/j.oooo.2012.05.009; Pascal C, 2008, J AGR FOOD CHEM, V56, P6724, DOI 10.1021/jf800790d; PIOTROWSKI J, 1992, BIOCHEM INT, V28, P1021; Rayment SA, 2000, J DENT RES, V79, P1765; REDDY MS, 1985, J DENT RES, V64, P33, DOI 10.1177/00220345850640010601; RIDLEY C, 2014, J BIOL CHEM; Rogers SS, 2007, PHYS BIOL, V4, P220, DOI 10.1088/1478-3975/4/3/008; Rossetti D, 2008, FOOD HYDROCOLLOID, V22, P1068, DOI 10.1016/j.foodhyd.2007.05.014; Rossetti D, 2009, FOOD HYDROCOLLOID, V23, P1984, DOI 10.1016/j.foodhyd.2009.03.001; Rossetti D, 2013, COLLOID SURFACE B, V110, P474, DOI 10.1016/j.colsurfb.2013.03.004; Rousseau K, 2003, HYBRIDOMA HYBRIDOM, V22, P293, DOI 10.1089/153685903322538818; Rousseau K, 2007, AM J PHYSIOL-LUNG C, V292, pL1396, DOI 10.1152/ajplung.00444.2006; Scalbert A, 2005, AM J CLIN NUTR, V81, p215S, DOI 10.1093/ajcn/81.1.215S; SELLERS LA, 1988, CARBOHYD RES, V178, P93, DOI 10.1016/0008-6215(88)80104-6; SHEEHAN JK, 1987, BIOCHEM J, V245, P757, DOI 10.1042/bj2450757; Shi L, 2000, J COLLOID INTERF SCI, V224, P372, DOI 10.1006/jcis.2000.6724; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; SLOMIANY BL, 1993, INT J BIOCHEM, V25, P935, DOI 10.1016/0020-711X(93)90250-I; Soares RV, 2004, ARCH ORAL BIOL, V49, P337, DOI 10.1016/j.archoralbio.2003.11.007; Stevenson DE, 2007, CELL MOL LIFE SCI, V64, P2900, DOI 10.1007/s00018-007-7237-1; TABAK LA, 1982, J ORAL PATHOL MED, V11, P1, DOI 10.1111/j.1600-0714.1982.tb00138.x; TABAK LA, 1995, ANNU REV PHYSIOL, V57, P547, DOI 10.1146/annurev.ph.57.030195.002555; Thomsson KA, 2002, GLYCOBIOLOGY, V12, P1, DOI 10.1093/glycob/12.1.1; Thornton DJ, 1999, GLYCOBIOLOGY, V9, P293, DOI 10.1093/glycob/9.3.293; Thornton DJ, 1996, BIOCHEM J, V316, P967, DOI 10.1042/bj3160967; THORNTON DJ, 1989, ANAL BIOCHEM, V182, P160, DOI 10.1016/0003-2697(89)90735-5; THORNTON DJ, 1995, ANAL BIOCHEM, V227, P162, DOI 10.1006/abio.1995.1266; Thornton DJ, 2000, AM J PHYSIOL-LUNG C, V278, pL1118, DOI 10.1152/ajplung.2000.278.6.L1118; TURCK D, 1993, PEDIATR RES, V33, P564, DOI 10.1203/00006450-199306000-00005; Wroblewski K, 2001, EUR J BIOCHEM, V268, P4384, DOI 10.1046/j.1432-1327.2001.02350.x; Xu JY, 1998, RHEOL ACTA, V37, P387, DOI 10.1007/s003970050125; Yakubov GE, 2007, BIOMACROMOLECULES, V8, P3467, DOI 10.1021/bm700607w; Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309; Zhao YY, 2012, J PHYS CHEM B, V116, P13010, DOI 10.1021/jp212059x	78	37	37	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108372	10.1371/journal.pone.0108372	http://dx.doi.org/10.1371/journal.pone.0108372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264771	gold, Green Submitted, Green Published			2022-12-27	WOS:000345745400071
J	Jansen, C; Leeming, DJ; Mandorfer, M; Byrjalsen, I; Schierwagen, R; Schwabl, P; Karsdal, MA; Anadol, E; Strassburg, CP; Rockstroh, J; Peck-Radosavljevic, M; Moller, S; Bendtsen, F; Krag, A; Reiberger, T; Trebicka, J				Jansen, Christian; Leeming, Diana J.; Mandorfer, Mattias; Byrjalsen, Inger; Schierwagen, Robert; Schwabl, Philipp; Karsdal, Morten A.; Anadol, Evrim; Strassburg, Christian P.; Rockstroh, Juergen; Peck-Radosavljevic, Markus; Moller, Soren; Bendtsen, Flemming; Krag, Aleksander; Reiberger, Thomas; Trebicka, Jonel			PRO-C3-Levels in Patients with HIV/HCV-Co-Infection Reflect Fibrosis Stage and Degree of Portal Hypertension	PLOS ONE			English	Article							HEPATITIS-C; LIVER FIBROSIS; VIRUS; COLLAGEN; DISEASE; DEGRADATION; COINFECTION; THERAPY; MARKER; PREVENTION	Background: Liver-related deaths represent the leading cause of mortality among patients with HIV/HCV-co-infection, and are mainly related to complications of fibrosis and portal hypertension. In this study, we aimed to evaluate the structural changes by the assessment of extracellular matrix (ECM) derived degradation fragments in peripheral blood as biomarkers for fibrosis and portal hypertension in patients with HIV/HCV co-infection. Methods: Fifty-eight patients (67% male, mean age: 36.5 years) with HIV/HCV-co-infection were included in the study. Hepatic venous pressure gradient (HVPG) was measured in forty-three patients. The fibrosis stage was determined using FIB4 -Score. ECM degraded products in peripheral blood were measured using specific ELISAs (C4M, MMP-2/9 degraded type IV collagen; C5M, MMP-2/9 degraded type V collagen; PRO-C3, MMP degraded n-terminal propeptide of type III collagen). Results: As expected, HVPG showed strong and significant correlations with FIB4-index (r(s) = 0.628; p = 7*10(-7)). Interestingly, PRO-C3 significantly correlated with HVPG (r(s) = 0.354; p = 0.02), alanine aminotransferase (r(s) = 0.30; p = 0.038), as well as with FIB4-index (r(s) = 0.3230; p = 0.035). C4M and C5M levels were higher in patients with portal hypertension (HVPG > 5 mmHg). Conclusion: PRO-C3 levels reflect liver injury, stage of liver fibrosis and degree of portal hypertension in HIV/HCV-coinfected patients. Furthermore, C4M and C5M were associated with increased portal pressure. Circulating markers of hepatic ECM remodeling might be helpful in the diagnosis and management of liver disease and portal hypertension in patients with HIV/HCV co-infection.	[Jansen, Christian; Schierwagen, Robert; Anadol, Evrim; Strassburg, Christian P.; Rockstroh, Juergen; Trebicka, Jonel] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Leeming, Diana J.; Byrjalsen, Inger; Karsdal, Morten A.] Nord Biosci Fibrosis Biol & Biomarkers, Herlev, Denmark; [Mandorfer, Mattias; Schwabl, Philipp; Peck-Radosavljevic, Markus; Reiberger, Thomas] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Rockstroh, Juergen] German Ctr Infect Res DZIF, Bonn, Germany; [Moller, Soren] Univ Copenhagen, Hvidovre Hosp, Dept Clin Physiol, Ctr Funct & Diagnost Imaging & Res, Copenhagen, Denmark; [Bendtsen, Flemming] Univ Copenhagen, Hvidovre Hosp, Fac Hlth Sci, Gastro Unit,Med Div, Copenhagen, Denmark; [Krag, Aleksander] Odense Univ Hosp, Dept Med Gastroenterol, DK-5000 Odense, Denmark	University of Bonn; Nordic Bioscience; Medical University of Vienna; German Center for Infection Research; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Trebicka, J (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	jonel.trebicka@ukb.uni-bonn.de	Krag, Aleksander/ABH-9649-2020; Mandorfer, Mattias/H-7603-2019; Reiberger, Thomas/H-7613-2019; Schierwagen, Robert/AAE-6305-2019	Krag, Aleksander/0000-0002-9598-4932; Mandorfer, Mattias/0000-0003-2330-0017; Reiberger, Thomas/0000-0002-4590-3583; Schierwagen, Robert/0000-0002-2195-3666; Moller, Soren/0000-0001-9684-7764; Schwabl, Philipp/0000-0002-7183-8076; Karsdal, Morten/0000-0001-5026-8740; Trebicka, Jonel/0000-0002-7028-3881	Deutsche Forschungsgemeinschaft [SFB TRR57 P18]; J. & W. Hector-Foundation; Roche Austria; MSD Austria; DZIF TTU HIV Project [05.803]; German Center for Infection Research (DZIF); Danish Science Foundation; Danish Ministry of Science and Technology; Novo Nordisk Fonden [NNF11OC1015075, NNF13OC0006329, NNF11OC1014467] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); J. & W. Hector-Foundation; Roche Austria(Roche Holding); MSD Austria; DZIF TTU HIV Project; German Center for Infection Research (DZIF); Danish Science Foundation(Danmarks Grundforskningsfond); Danish Ministry of Science and Technology; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by: 1. Deutsche Forschungsgemeinschaft (SFB TRR57 P18 to Jonel Trebicka); 2. J. & W. Hector-Foundation (to Jonel Trebicka); 3. unrestricted research grants from Roche Austria (to Markus Peck-Radosavljevic); 4. MSD Austria (to Markus Peck-Radosavljevic); 5. DZIF TTU HIV Project 05.803; 6. German Center for Infection Research (DZIF); 7. Danish Science Foundation; and 8. Danish Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESIANI M, 1990, Pharmacological Research, V22, P15, DOI 10.1016/1043-6618(90)90785-C; Bosch J, 2000, HEPATOLOGY, V32, P660, DOI 10.1053/jhep.2000.16663; Bosch J, 2009, NAT REV GASTRO HEPAT, V6, P573, DOI 10.1038/nrgastro.2009.149; Bosch J, 2009, HEPATOLOGY, V50, P674, DOI 10.1002/hep.23164; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Buck M, 2014, HEPATOLOGY, V59, P1052, DOI 10.1002/hep.26755; Garcia-Pagan JC, 2013, J HEPATOL, V58, P45, DOI 10.1016/j.jhep.2012.08.020; Garcia-Pagan JC, 2012, SEMIN RESP CRIT CARE, V33, P46, DOI 10.1055/s-0032-1301734; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Deng A, 2014, VIRUS RES, V184, P93, DOI 10.1016/j.virusres.2014.02.017; Estes JD, 2013, IMMUNOL REV, V254, P65, DOI 10.1111/imr.12070; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Karsdal MA, 2013, ASSAY DRUG DEV TECHN, V11, P70, DOI 10.1089/adt.2012.474; Larrousse M, 2007, JAIDS-J ACQ IMM DEF, V46, P304, DOI 10.1097/QAI.0b013e3181520502; Lee LM, 2001, JAMA-J AM MED ASSOC, V285, P1308, DOI 10.1001/jama.285.10.1308; Leeming DJ, 2013, ALIMENT PHARM THER, V38, P1086, DOI 10.1111/apt.12484; Leeming DJ, 2011, BIOMARKERS, V16, P616, DOI 10.3109/1354750X.2011.620628; Leeming DJ, 2012, BIOMARK INSIGHTS, V7, P119, DOI 10.4137/BMI.S9415; Liedtke C, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-19; Liu W, 2014, EUR J GASTROEN HEPAT, V26, P95, DOI 10.1097/MEG.0b013e3283632189; M'Kada H, 2011, REGUL TOXICOL PHARM, V60, P290, DOI 10.1016/j.yrtph.2011.04.002; Mandorfer M, 2014, LIVER INT, DOI DOI 10.1111/LIV.12615.PMID:24905495; Mocroft A, 2005, AIDS, V19, P2117, DOI 10.1097/01.aids.0000194799.43799.ea; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Nielsen MJ, 2013, AM J TRANSL RES, V5, P303; Pineda JA, 2005, HEPATOLOGY, V41, P779, DOI 10.1002/hep.20626; Reiberger T, 2013, GUT, V62, P1634, DOI 10.1136/gutjnl-2012-304038; Reiberger T, 2012, ANTIVIR THER, V17, P1327, DOI 10.3851/IMP2349; Reiberger T, 2012, WIEN KLIN WOCHENSCHR, V124, P395, DOI 10.1007/s00508-012-0190-5; Reiberger T, 2011, CLIN GASTROENTEROL H, V9, P602, DOI 10.1016/j.cgh.2011.03.002; Rosenthal E, 2007, J VIRAL HEPATITIS, V14, P183, DOI 10.1111/j.1365-2893.2006.00791.x; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Sanchez-Conde M, 2011, J VIRAL HEPATITIS, V18, P685, DOI 10.1111/j.1365-2893.2010.01371.x; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schierwagen R, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00195; Schwabl P, 2014, LIVER INT; Trebicka J, 2013, J HEPATOL, V58, P234, DOI 10.1016/j.jhep.2012.10.015; Tsochatzis EA, 2014, LANCET; Vali B, 2010, EUR J IMMUNOL, V40, P2493, DOI 10.1002/eji.201040340; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; van Beek JHDA, 2013, BEHAV GENET, V43, P329, DOI 10.1007/s10519-013-9593-y; Veidal SS, 2012, CLIN BIOCHEM, V45, P541, DOI 10.1016/j.clinbiochem.2012.02.007; Veidal SS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-22	44	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108544	10.1371/journal.pone.0108544	http://dx.doi.org/10.1371/journal.pone.0108544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265505	Green Submitted, Green Published, gold			2022-12-27	WOS:000345745400086
J	Reiche, K; Kasack, K; Schreiber, S; Luders, T; Due, EU; Naume, B; Riis, M; Kristensen, VN; Horn, F; Borresen-Dale, AL; Hackermuller, J; Baumbusch, LO				Reiche, Kristin; Kasack, Katharina; Schreiber, Stephan; Luders, Torben; Due, Eldri U.; Naume, Bjorn; Riis, Margit; Kristensen, Vessela N.; Horn, Friedemann; Borresen-Dale, Anne-Lise; Hackermueller, Joerg; Baumbusch, Lars O.			Long Non-Coding RNAs Differentially Expressed between Normal versus Primary Breast Tumor Tissues Disclose Converse Changes to Breast Cancer-Related Protein-Coding Genes	PLOS ONE			English	Article							COPY NUMBER ALTERATION; HUMAN GENOME; MOLECULAR PORTRAITS; BONE-MARROW; HUMAN-CELLS; CHROMATIN; TRANSCRIPTION; REVEALS; ARCHITECTURE; SUPPRESSOR	Breast cancer, the second leading cause of cancer death in women, is a highly heterogeneous disease, characterized by distinct genomic and transcriptomic profiles. Transcriptome analyses prevalently assessed protein-coding genes; however, the majority of the mammalian genome is expressed in numerous non-coding transcripts. Emerging evidence supports that many of these non-coding RNAs are specifically expressed during development, tumorigenesis, and metastasis. The focus of this study was to investigate the expression features and molecular characteristics of long non-coding RNAs (lncRNAs) in breast cancer. We investigated 26 breast tumor and 5 normal tissue samples utilizing a custom expression microarray enclosing probes for mRNAs as well as novel and previously identified lncRNAs. We identified more than 19,000 unique regions significantly differentially expressed between normal versus breast tumor tissue, half of these regions were non-coding without any evidence for functional open reading frames or sequence similarity to known proteins. The identified non-coding regions were primarily located in introns (53%) or in the intergenic space (33%), frequently orientated in antisense-direction of protein-coding genes (14%), and commonly distributed at promoter-, transcription factor binding-, or enhancer-sites. Analyzing the most diverse mRNA breast cancer subtypes Basal-like versus Luminal A and B resulted in 3,025 significantly differentially expressed unique loci, including 682 (23%) for non-coding transcripts. A notable number of differentially expressed protein-coding genes displayed non-synonymous expression changes compared to their nearest differentially expressed lncRNA, including an antisense lncRNA strongly anticorrelated to the mRNA coding for histone deacetylase 3 (HDAC3), which was investigated in more detail. Previously identified chromatin-associated lncRNAs (CARs) were predominantly downregulated in breast tumor samples, including CARs located in the protein-coding genes for CALD1, FTX, and HNRNPH1. In conclusion, a number of differentially expressed lncRNAs have been identified with relation to cancer-related protein-coding genes.	[Reiche, Kristin; Schreiber, Stephan; Hackermueller, Joerg] UFZ Helmholtz Ctr Environm Res, Dept Prote, Young Investigators Grp Bioinformat & Transcript, Leipzig, Germany; [Reiche, Kristin; Schreiber, Stephan; Hackermueller, Joerg] Univ Leipzig, Dept Comp Sci, D-04109 Leipzig, Germany; [Reiche, Kristin; Kasack, Katharina; Schreiber, Stephan; Horn, Friedemann; Hackermueller, Joerg] Fraunhofer Inst Cell Therapy & Immunol IZI, Dept Diagnost, RN Grp, Leipzig, Germany; [Kasack, Katharina] Univ Leipzig, Life Interdisciplinary Res Cluster, D-04109 Leipzig, Germany; [Luders, Torben; Kristensen, Vessela N.] Akershus Univ Hosp, Clin Mol Biol EpiGen, Lorenskog, Norway; [Luders, Torben; Due, Eldri U.; Naume, Bjorn; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, Oslo, Norway; [Due, Eldri U.; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise; Baumbusch, Lars O.] Radiumhosp, Oslo Univ Hosp, Inst Canc Res, Dept Genet, Oslo, Norway; [Naume, Bjorn] Radiumhosp, Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Riis, Margit] Oslo Univ Hosp, Dept Breast & Endocrine Surg, Ulleval, Norway; [Horn, Friedemann] Univ Leipzig, Inst Clin Immunol, D-04109 Leipzig, Germany; [Baumbusch, Lars O.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pediat Res,Women & Childrens Div, N-0027 Oslo, Norway	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Fraunhofer Gesellschaft; Leipzig University; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Leipzig University; University of Oslo; National Hospital Norway	Reiche, K (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Prote, Young Investigators Grp Bioinformat & Transcript, Leipzig, Germany.	kristin.reiche@ufz.de; joerg.hackermueller@ufz.de; lars.o.baumbusch@rr-research.no	Hackermüller, Jörg/F-2494-2016	Hackermüller, Jörg/0000-0003-4920-7072; Baumbusch, Lars O./0000-0003-1290-312X; Reiche, Kristin/0000-0002-4452-4872; Schreiber, Stephan/0000-0001-5219-7974; Luders, Torben/0000-0001-5176-7808	Medical Faculty of the University of Oslo, Norway; Norway of the Norwegian Research Council (NFR); Germany of the Norwegian Research Council (NFR); German Academic Exchange Service (DAAD); NFR [207835]; DAAD [50980950]; Initiative and Networking Fund of the Helmholtz Association [VH-NG738]; Bundesministerium fur Bildung und Forschung (BMBF) through Interdisciplinary Center for Clinical Research (IZKF) at the University of Leipzig; Deutsche Forschungsgemeinschaft (DFG) through the Sonderforschungsbereich 610 [C2]; formel.1 junior research grant; LIFE Leipzig Research Center for Civilization Diseases, University of Leipzig; European Union; European Regional Development Fund (ERDF); Free State of Saxony	Medical Faculty of the University of Oslo, Norway; Norway of the Norwegian Research Council (NFR); Germany of the Norwegian Research Council (NFR); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NFR(Research Council of Norway); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Initiative and Networking Fund of the Helmholtz Association; Bundesministerium fur Bildung und Forschung (BMBF) through Interdisciplinary Center for Clinical Research (IZKF) at the University of Leipzig(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG) through the Sonderforschungsbereich 610(German Research Foundation (DFG)); formel.1 junior research grant; LIFE Leipzig Research Center for Civilization Diseases, University of Leipzig; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony	The work was supported by an extra allowance of the Medical Faculty of the University of Oslo, Norway to A-LB-D and LOB. The work was further supported by a personal mobility grant for the research exchange between Norway and Germany of the Norwegian Research Council (NFR) and the German Academic Exchange Service (DAAD) to KR, KK, JH, and LOB (Grant numbers: NFR 207835 and DAAD 50980950). This work was supported in part by the Initiative and Networking Fund of the Helmholtz Association (VH-NG738), by the Bundesministerium fur Bildung und Forschung (BMBF) through grants by the Interdisciplinary Center for Clinical Research (IZKF) at the University of Leipzig, and by the Deutsche Forschungsgemeinschaft (DFG) through the Sonderforschungsbereich 610, subproject C2 to FH. KK was supported by a formel.1 junior research grant and by LIFE Leipzig Research Center for Civilization Diseases, University of Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF), and by means of the Free State of Saxony within the framework of 42 the excellence initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anko ML, 2010, MOL CELL, V39, P833, DOI 10.1016/j.molcel.2010.09.003; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Aure MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053014; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit MH, 2007, INT J ONCOL, V30, P5; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Berteaux N, 2005, J BIOL CHEM, V280, P29625, DOI 10.1074/jbc.M504033200; Berteaux N, 2008, MOL CELL BIOL, V28, P6731, DOI 10.1128/MCB.02103-07; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; Clark MB, 2011, SEMIN CELL DEV BIOL, V22, P366, DOI 10.1016/j.semcdb.2011.01.001; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Cui WJ, 2010, ACTA PHARMACOL SIN, V31, P725, DOI 10.1038/aps.2010.56; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Gagneur J, 2012, GENOMEINTERVALS OPER; Gesell T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-248; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gruber AR, 2010, BIOCOMPUT-PAC SYM, P69; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hackermuller J, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r48; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jiang Zhengyu, 2012, Frontiers in Genetics, V3, P299, DOI 10.3389/fgene.2012.00299; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kawakami T, 2004, ONCOGENE, V23, P6163, DOI 10.1038/sj.onc.1207808; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim HC, 2010, CELL MOL LIFE SCI, V67, P3499, DOI 10.1007/s00018-010-0388-5; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Li P, 2011, BIOCHEM BIOPH RES CO, V409, P344, DOI 10.1016/j.bbrc.2011.05.021; Lingjaerde OC, 2005, BIOINFORMATICS, V21, P821, DOI 10.1093/bioinformatics/bti113; Lu LG, 2012, BREAST CANCER RES TR, V136, P875, DOI 10.1007/s10549-012-2314-z; Maamar H, 2013, GENE DEV, V27, P1260, DOI 10.1101/gad.217018.113; Magistri M, 2012, TRENDS GENET, V28, P389, DOI 10.1016/j.tig.2012.03.013; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Maruyama R, 2012, P NATL ACAD SCI USA, V109, P2820, DOI 10.1073/pnas.1010559107; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mondal T, 2010, GENOME RES, V20, P899, DOI 10.1101/gr.103473.109; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Nagano T, 2009, MAMM GENOME, V20, P557, DOI 10.1007/s00335-009-9218-1; Nakagawa M, 2007, ONCOL REP, V18, P769; Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43; Naume B, 2007, MOL ONCOL, V1, P160, DOI 10.1016/j.molonc.2007.03.004; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Nordgard SH, 2008, GENE CHROMOSOME CANC, V47, P680, DOI 10.1002/gcc.20569; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Piao HL, 2012, J MAMMARY GLAND BIOL, V17, P33, DOI 10.1007/s10911-012-9245-5; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qiu MT, 2013, TUMOR BIOL, V34, P613, DOI 10.1007/s13277-013-0658-6; R Core Team, 2012, R LANG ENV STAT COMP; Redis RS, 2013, ONCOTARGET IN PRESS; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; Santa FD, 2010, PLOS BIOL, V8, DOI e1000384; Shi YG, 2014, BIOCHEM BIOPH RES CO, V446, P448, DOI 10.1016/j.bbrc.2014.02.144; Shore AN, 2012, J MAMMARY GLAND BIOL, V17, P43, DOI 10.1007/s10911-012-9247-3; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smith MA, 2013, NUCLEIC ACIDS RES, V41, P8220, DOI 10.1093/nar/gkt596; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tierney L, 2012, SNOW SIMPLE NETWORK; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Washietl S, 2007, GENOME RES, V17, P852, DOI 10.1101/gr.5650707; Washietl S, 2011, RNA, V17, P578, DOI 10.1261/rna.2536111; Wiedswang G, 2003, J CLIN ONCOL, V21, P3469, DOI 10.1200/JCO.2003.02.009; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937; Zhao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017845; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	97	38	44	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e106076	10.1371/journal.pone.0106076	http://dx.doi.org/10.1371/journal.pone.0106076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264628	gold, Green Submitted, Green Published			2022-12-27	WOS:000345745400007
J	Cruz-Martinez, P; Martinez-Ferre, A; Jaramillo-Merchan, J; Estirado, A; Martinez, S; Jones, J				Cruz-Martinez, Pablo; Martinez-Ferre, Almudena; Jaramillo-Merchan, Jesus; Estirado, Alicia; Martinez, Salvador; Jones, Jonathan			FGF8 Activates Proliferation and Migration in Mouse Post-Natal Oligodendrocyte Progenitor Cells	PLOS ONE			English	Article							REMYELINATION; DIFFERENTIATION; MYELIN; MIDBRAIN; REPAIR; REGENERATION; EXPRESSION; GENERATION; FAMILY	Fibroblast growth factor 8 (FGF8) is a key molecular signal that is necessary for early embryonic development of the central nervous system, quickly disappearing past this point. It is known to be one of the primary morphogenetic signals required for cell fate and survival processes in structures such as the cerebellum, telencephalic and isthmic organizers, while its absence causes severe abnormalities in the nervous system and the embryo usually dies in early stages of development. In this work, we have observed a new possible therapeutic role for this factor in demyelinating disorders, such as leukodystrophy or multiple sclerosis. In vitro, oligodendrocyte progenitor cells were cultured with differentiating medium and in the presence of FGF8. Differentiation and proliferation studies were performed by immunocytochemistry and PCR. Also, migration studies were performed in matrigel cultures, where oligodendrocyte progenitor cells were placed at a certain distance of a FGF8-soaked heparin bead. The results showed that both migration and proliferation was induced by FGF8. Furthermore, a similar effect was observed in an in vivo demyelinating mouse model, where oligodendrocyte progenitor cells were observed migrating towards the FGF8-soaked heparin beads where they were grafted. In conclusion, the results shown here demonstrate that FGF8 is a novel factor to induce oligodendrocyte progenitor cell activation, migration and proliferation in vitro, which can be extrapolated in vivo in demyelinated animal models.	[Cruz-Martinez, Pablo; Martinez-Ferre, Almudena; Jaramillo-Merchan, Jesus; Estirado, Alicia; Martinez, Salvador; Jones, Jonathan] Univ Miguel Hernandez UMH CSIC, Neurosci Inst, Alicante, Spain; [Martinez, Salvador] Univ Murcia, IMIB Hosp Univ Virgen de la Arrixaca, Murcia, Spain	Universidad Miguel Hernandez de Elche; University of Murcia	Jones, J (corresponding author), Univ Miguel Hernandez UMH CSIC, Neurosci Inst, Alicante, Spain.	jon@umh.es	Mratinez, Salvador/L-4896-2014	Mratinez, Salvador/0000-0002-9320-4103; Jaramillo Merchan, Jesus Alfonso/0000-0001-6886-8453; Martinez, Salvador/0000-0002-2910-8926	MAPFRE Foundation; FARA/FARA Ireland (Friedreich's Ataxia Research Alliance); ASOGAF (Friedreich's Ataxia association of Granada); Science and Innovation Ministry [MICINN BFU2010-27326]; GVA [2009/028]; Prometeoll grant [2014/014]; Tercel [RD06/0010/0023, RD06/0010/24]; MEC-CONSOLIDER [CSD2007-00023]; Cinco P menos Foundation; EUCOMM; Fundacion Diogenes-Elche city government; Walk on Project	MAPFRE Foundation; FARA/FARA Ireland (Friedreich's Ataxia Research Alliance); ASOGAF (Friedreich's Ataxia association of Granada); Science and Innovation Ministry; GVA; Prometeoll grant; Tercel; MEC-CONSOLIDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cinco P menos Foundation; EUCOMM; Fundacion Diogenes-Elche city government; Walk on Project	This work has been funded by MAPFRE Foundation, FARA/FARA Ireland (Friedreich's Ataxia Research Alliance), ASOGAF (Friedreich's Ataxia association of Granada), Science and Innovation Ministry (MICINN BFU2010-27326), GVA Prometeo grant 2009/028 and Prometeoll grant 2014/014, Tercel (RD06/0010/0023 & RD06/0010/24), MEC-CONSOLIDER CSD2007-00023, Cinco P menos Foundation, EUCOMM, Fundacion Diogenes-Elche city government, and Walk on Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Aktas O, 2010, TRENDS NEUROSCI, V33, P140, DOI 10.1016/j.tins.2009.12.002; Armstrong RC, 2006, J NEUROPATH EXP NEUR, V65, P245, DOI 10.1097/01.jnen.0000205142.08716.7e; Bansal R, 1996, MOL CELL NEUROSCI, V7, P263, DOI 10.1006/mcne.1996.0020; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Chari DM, 2007, INT REV NEUROBIOL, V79, P589, DOI 10.1016/S0074-7742(07)79026-8; Chari DM, 2003, J NEUROPATH EXP NEUR, V62, P908, DOI 10.1093/jnen/62.9.908; Chari DM, 2003, J NEUROSCI RES, V73, P787, DOI 10.1002/jnr.10700; Christen B, 1999, DEVELOPMENT, V126, P119; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; Fortin D, 2005, J NEUROSCI, V25, P7470, DOI 10.1523/JNEUROSCI.2120-05.2005; FRESSINAUD C, 1995, J NEUROSCI RES, V40, P285, DOI 10.1002/jnr.490400302; Furusho M, 2011, J NEUROSCI, V31, P5055, DOI 10.1523/JNEUROSCI.4800-10.2011; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; GRINSPAN JB, 1993, J NEUROSCI RES, V36, P672, DOI 10.1002/jnr.490360608; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jaramillo-Merchan J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.304; Jones J, 2012, STEM CELLS DEV, V21, P2817, DOI 10.1089/scd.2012.0029; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Kohler W, 2010, CURR OPIN NEUROL, V23, P234, DOI 10.1097/WCO.0b013e328338313a; KOUHARA H, 1994, ONCOGENE, V9, P455; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Lee X, 2007, J NEUROSCI, V27, P220, DOI 10.1523/JNEUROSCI.4175-06.2007; Lunn JS, 2007, DEV BIOL, V302, P536, DOI 10.1016/j.ydbio.2006.10.014; Martinez-Ferre A, 2009, J NEUROSCI, V29, P13389, DOI 10.1523/JNEUROSCI.2625-09.2009; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Mitew S, 2013, NEUROSCIENCE; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Morello N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020173; Nakamura H, 2008, DEV GROWTH DIFFER, V50, pS113, DOI 10.1111/j.1440-169X.2008.00995.x; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Partanen J, 2007, J NEUROCHEM, V101, P1185, DOI 10.1111/j.1471-4159.2007.04463.x; Reifers F, 1998, DEVELOPMENT, V125, P2381; Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Tsang Michael, 2004, Sci STKE, V2004, ppe17, DOI 10.1126/stke.2282004pe17; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Vernerey J, 2013, J NEUROSCI, V33, P3240, DOI 10.1523/JNEUROSCI.2579-12.2013; Williams A, 2007, BRAIN, V130, P2554, DOI 10.1093/brain/awm202; Yang ZS, 2005, J NEUROSCI METH, V149, P50, DOI 10.1016/j.jneumeth.2005.05.003	53	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108241	10.1371/journal.pone.0108241	http://dx.doi.org/10.1371/journal.pone.0108241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259688	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600056
J	Mogul, HR; Freeman, R; Nguyen, K; Frey, M; Klein, LA; Jozak, S; Tanenbaum, K				Mogul, Harriette R.; Freeman, Ruth; Khoa Nguyen; Frey, Michael; Klein, Lee-Ann; Jozak, Sheila; Tanenbaum, Karen			Carbohydrate Modified Diet & Insulin Sensitizers Reduce Body Weight & Modulate Metabolic Syndrome Measures in EMPOWIR (Enhance the Metabolic Profile of Women with Insulin Resistance): A Randomized Trial of Normoglycemic Women with Midlife Weight Gain	PLOS ONE			English	Article							BETA-CELL FUNCTION; DOUBLE-BLIND; HIGH-PROTEIN; DIABETES-MELLITUS; GLYCEMIC LOAD; RISK-FACTOR; OBESE; HYPERINSULINEMIA; METFORMIN; ROSIGLITAZONE	Rationale: Progressive midlife weight gain is associated with multiple adverse health outcomes and may represent an early manifestation of insulin resistance in a distinct subset of women. Emerging data implicate hyperinsulinema as a proximate cause of weight gain and support strategies that attenuate insulin secretion. Objective: To assess a previously reported novel hypocaloric carbohydrate modified diet alone (D), and in combination with metformin (M) and metformin plus low-dose rosiglitazone (MR), in diverse women with midlife weight gain (defined as > 20lbs since the twenties), normal glucose tolerance, and hyperinsulinemia. Participants: 46 women, mean age 46.6 +/- 1.0, BMI 30.5 +/- 0.04 kg/m(2), 54.5% white, 22.7% black, 15.9% Hispanic, at 2 university medical centers. Methods: A dietary intervention designed to reduce insulin excursions was implemented in 4 weekly nutritional group workshops prior to randomization. Main Outcome Measure: Change in 6-month fasting insulin. Pre-specified secondary outcomes were changes in body weight, HOMA-IR, metabolic syndrome (MS) measures, leptin, and adiponectin. Results: Six-month fasting insulin declined significantly in the M group: 12.5 to 8.0 mu U/ml, p =.026. Mean 6-month weight decreased significantly and comparably in D, M, and MR groups: 4.7, 5.4, and 5.5% (p's. 049,.002, and. 032). HOMA-IR decreased in M and MR groups (2.5 to 1.6 and 1.9 to 1.3, p's =.054,.013). Additional improvement in MS measures included reduced waist circumference in D and MR groups and increased HDL in the D and M groups. Notably, mean fasting leptin did not decline in a subset of subjects with weight loss (26.15 +/- 2.01 ng/ml to 25.99 +/- 2.61 ng/ml, p =.907. Adiponectin increased significantly in the MR group (11.1 +/- 1.0 to 18.5 +/- 7.4, p<.001) Study medications were well tolerated. Conclusions: These findings suggest that EMPOWIR's easily implemented dietary interventions, alone and in combination with pharmacotherapies that target hyperinsulinemia, merit additional investigation in larger, long-term studies.	[Mogul, Harriette R.; Khoa Nguyen; Frey, Michael; Klein, Lee-Ann; Tanenbaum, Karen] New York Med Coll, Dept Med, Div Endocrinol, Valhalla, NY 10595 USA; [Freeman, Ruth; Jozak, Sheila] Albert Einstein Coll Med, Dept Med & Obstet & Gynecol, Bronx, NY 10467 USA	New York Medical College; Yeshiva University; Albert Einstein College of Medicine	Mogul, HR (corresponding author), New York Med Coll, Dept Med, Div Endocrinol, Valhalla, NY 10595 USA.	hrmogul@NYMC.edu			Glaxo Smith Kline; National Center for Advancing Translational Sciences (NCATS) a component of the National Institutes of Health (NIH) through CTSA [UL1TR000086]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000086] Funding Source: NIH RePORTER	Glaxo Smith Kline(GlaxoSmithKline); National Center for Advancing Translational Sciences (NCATS) a component of the National Institutes of Health (NIH) through CTSA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	EMPOWIR (NCT00618072) is an unsolicited, investigator-initiated study supported by Glaxo Smith Kline, with additional support from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), through CTSA grant number UL1TR000086. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemzadeh R, 1996, METABOLISM, V45, P334, DOI 10.1016/S0026-0495(96)90287-5; ALEMZADEH R, 1993, ENDOCRINOLOGY, V133, P705, DOI 10.1210/en.133.2.705; Alemzadeh R, 1998, J CLIN ENDOCR METAB, V83, P1911, DOI 10.1210/jc.83.6.1911; Aubert G, 2011, METABOLISM, V60, P327, DOI 10.1016/j.metabol.2010.02.007; Bray GA, 2012, DIABETES CARE, V35, P731, DOI 10.2337/dc11-1299; Bray GA, 2012, JAMA-J AM MED ASSOC, V307, P47, DOI 10.1001/jama.2011.1918; Brownell KD, 1990, LEARN PROGRAM WEIGHT; Buettner C, 2012, CELL METAB, V16, P691, DOI 10.1016/j.cmet.2012.11.009; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; Cordido F, 2012, NEW ENGL J MED, V366, P380, DOI 10.1056/NEJMc1113675; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; DUNAIF A, 1989, DIABETES, V38, P1165, DOI 10.2337/diabetes.38.9.1165; Ebbeling CB, 2007, JAMA-J AM MED ASSOC, V297, P2092, DOI 10.1001/jama.297.19.2092; Ebbeling CB, 2003, ARCH PEDIAT ADOL MED, V157, P773, DOI 10.1001/archpedi.157.8.773; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Foster-Schubert KE, 2008, J CLIN ENDOCR METAB, V93, P1971, DOI 10.1210/jc.2007-2289; HAFFNER SM, 1986, NEW ENGL J MED, V315, P220, DOI 10.1056/NEJM198607243150403; Helvaci MR, 2008, INTERNAL MED, V47, P697, DOI 10.2169/internalmedicine.47.0787; Ibanez L, 1998, J CLIN ENDOCR METAB, V83, P3558, DOI 10.1210/jc.83.10.3558; Kannel William B., 1996, American Journal of Clinical Nutrition, V63, p419S, DOI 10.1093/ajcn/87.6.1602; Kendall D, 2012, J CLIN ENDOCRINOL ME; Kitabchi AE, 2013, DIABETES CARE, V36, P1919, DOI 10.2337/dc12-1912; Krebs NF, 2010, J PEDIATR-US, V157, P252, DOI 10.1016/j.jpeds.2010.02.010; KUCZMARSKI R J, 1992, American Journal of Clinical Nutrition, V55, p495S, DOI 10.1093/ajcn/55.2.495s; Leibel RL, 2008, INT J OBESITY, V32, pS98, DOI 10.1038/ijo.2008.245; Levri KM, 2005, ANN FAM MED, V3, P457, DOI 10.1370/afm.343; Li X, 2011, J INT MED RES, V39, P358, DOI 10.1177/147323001103900203; Li ZP, 2012, JAMA-J AM MED ASSOC, V307, P86, DOI 10.1001/jama.2011.1959; Liebman M, 2013, NUTRITION; Ludwig DS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e26; Lustig RH, 2004, INT J OBESITY, V28, P1344, DOI 10.1038/sj.ijo.0802753; Lustig RH, 2008, J PEDIATR, V152, P601, DOI 10.1016/j.jpeds.2008.01.021; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Mogul H R, 2001, Heart Dis, V3, P285; Mogul Harriette R, 2003, Heart Dis, V5, P384, DOI 10.1097/01.hdx.0000098361.84908.9c; Mogul Harriette R, 2002, Heart Dis, V4, P78; Mogul HR, 1996, J CLIN ENDOCR METAB, V81, P4492, DOI 10.1210/jc.81.12.4492; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Odeleye OE, 1997, DIABETES, V46, P1341, DOI 10.2337/diabetes.46.8.1341; Ogden Cynthia L, 2013, NCHS Data Brief, P1; Saenger P, 2001, J ENDOCRINOL INVEST, V24, P724, DOI 10.1007/BF03343917; Salpeter SR, 2008, AM J MED, V121, P149, DOI 10.1016/j.amjmed.2007.09.016; SEIDELL JC, 1988, EUR J CLIN NUTR, V42, P805; Skov AR, 1999, INT J OBESITY, V23, P528, DOI 10.1038/sj.ijo.0800867; Soenen S, 2012, PHYSIOL BEHAV, V107, P374, DOI 10.1016/j.physbeh.2012.08.004; Sofer S, 2011, OBESITY, V19, P2006, DOI 10.1038/oby.2011.48; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Westerterp-Plantenga MS, 2009, ANNU REV NUTR, V29, P21, DOI 10.1146/annurev-nutr-080508-141056; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; Wilson DM, 2010, ARCH PEDIAT ADOL MED, V164, P116, DOI 10.1001/archpediatrics.2009.264; Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67; Zinman B, 2010, LANCET, V376, P103, DOI 10.1016/S0140-6736(10)60746-5	56	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108264	10.1371/journal.pone.0108264	http://dx.doi.org/10.1371/journal.pone.0108264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259787	Green Submitted, Green Published, gold			2022-12-27	WOS:000342685600057
J	Braun, TP; Szumowski, M; Levasseur, PR; Grossberg, AJ; Zhu, XX; Agarwal, A; Marks, DL				Braun, Theodore P.; Szumowski, Marek; Levasseur, Peter R.; Grossberg, Aaron J.; Zhu, XinXia; Agarwal, Anupriya; Marks, Daniel L.			Muscle Atrophy in Response to Cytotoxic Chemotherapy Is Dependent on Intact Glucocorticoid Signaling in Skeletal Muscle	PLOS ONE			English	Article							FACTOR-KAPPA-B; CARDIAC-HYPERTROPHY; CANCER CACHEXIA; NLRP3 INFLAMMASOME; IMMUNE-SYSTEM; ADRENAL AXIS; IN-VIVO; ACTIVATION; AUTOPHAGY; ATROGIN-1	Cancer cachexia is a syndrome of weight loss that results from the selective depletion of skeletal muscle mass and contributes significantly to cancer morbidity and mortality. The driver of skeletal muscle atrophy in cancer cachexia is systemic inflammation arising from both the cancer and cancer treatment. While the importance of tumor derived inflammation is well described, the mechanism by which cytotoxic chemotherapy contributes to cancer cachexia is relatively unexplored. We found that the administration of chemotherapy to mice produces a rapid inflammatory response. This drives activation of the hypothalamic-pituitary-adrenal axis, which increases the circulating level of corticosterone, the predominant endogenous glucocorticoid in rodents. Additionally, chemotherapy administration results in a significant loss of skeletal muscle mass 18 hours after administration with a concurrent induction of genes involved with the ubiquitin proteasome and autophagy lysosome systems. However, in mice lacking glucocorticoid receptor expression in skeletal muscle, chemotherapy-induced muscle atrophy is completely blocked. This demonstrates that cytotoxic chemotherapy elicits significant muscle atrophy driven by the production of endogenous glucocorticoids. Further, it argues that pharmacotherapy targeting the glucocorticoid receptor, given in concert with chemotherapy, is a viable therapeutic strategy in the treatment of cancer cachexia.	[Braun, Theodore P.; Szumowski, Marek; Levasseur, Peter R.; Zhu, XinXia; Marks, Daniel L.] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97201 USA; [Braun, Theodore P.] Oregon Hlth & Sci Univ, MD PhD Program, Portland, OR 97201 USA; [Agarwal, Anupriya] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Agarwal, Anupriya] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Grossberg, Aaron J.] Providence St Vincent Med Ctr, Dept Internal Med, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Marks, DL (corresponding author), Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97201 USA.	marksd@ohsu.edu	Marks, Daniel/C-3712-2009; Grossberg, Aaron/AAD-6686-2021	Grossberg, Aaron/0000-0003-4690-4948; Braun, Theodore/0000-0002-6248-2143	National Institutes of Health (NIH) [DK 70333]; Canadian Institutes of Health Research [200948]; NIH [DK 084646]; Rubenstein Radiation Research Scholarship; AMA Foundation; Portland ARCS Chapter; NATIONAL CANCER INSTITUTE [R00CA151670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK084646, R01DK070333] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rubenstein Radiation Research Scholarship; AMA Foundation; Portland ARCS Chapter; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institutes of Health (NIH) DK 70333 and Canadian Institutes of Health Research 200948 to DLM; NIH DK 084646, Rubenstein Radiation Research Scholarship, the AMA Foundation and the Portland ARCS Chapter to TPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bethin KE, 2000, P NATL ACAD SCI USA, V97, P9317, DOI 10.1073/pnas.97.16.9317; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Braun TP, 2013, FASEB J, V27, P3572, DOI 10.1096/fj.13-230375; Braun TP, 2011, J EXP MED, V208, P2449, DOI 10.1084/jem.20111020; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Damrauer J.S., 2008, BASIC APPL MYOL, V18, P139, DOI [10.4081/ejtm.2018.7590, DOI 10.4081/EJTM.2018.7590, DOI 10.4081/ejtm.2018.7590]; DEWYS WD, 1986, CLINICS ONCOL, V5, P251; Dhabhar FS, 1999, P NATL ACAD SCI USA, V96, P1059, DOI 10.1073/pnas.96.3.1059; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Dulger H, 2004, INT J CLIN PRACT, V58, P545, DOI 10.1111/j.1368-5031.2004.00149.x; Gilson H, 2007, ENDOCRINOLOGY, V148, P452, DOI 10.1210/en.2006-0539; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Janelsins MC, 2012, SUPPORT CARE CANCER, V20, P831, DOI 10.1007/s00520-011-1158-0; Kobayashi S, 2010, J BIOL CHEM, V285, P793, DOI 10.1074/jbc.M109.070037; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Limberaki E, 2011, HEALTH, V03, P512, DOI [DOI 10.4236/health.2011.38085, DOI 10.4236/HEALTH.2011.38085]; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Morrow GR, 2002, PSYCHOPHYSIOLOGY, V39, P491, DOI 10.1017/S0048577202991195; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; Richey LM, 2007, CLIN CANCER RES, V13, P6561, DOI 10.1158/1078-0432.CCR-07-0116; Robert F, 2012, CANCER RES, V72, P747, DOI 10.1158/0008-5472.CAN-11-2739; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sauter KAD, 2011, CANCER BIOL THER, V11, P1008, DOI 10.4161/cbt.11.12.15540; Schakman O, 2012, AM J PHYSIOL-ENDOC M, V303, pE729, DOI 10.1152/ajpendo.00060.2012; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Usui S, 2011, CIRC RES, V109, P161, DOI 10.1161/CIRCRESAHA.110.238717; Weymann KB, 2014, BRAIN BEHAV IMMUN, V37, P84, DOI 10.1016/j.bbi.2013.11.003; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	37	57	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e106489	10.1371/journal.pone.0106489	http://dx.doi.org/10.1371/journal.pone.0106489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254959	gold, Green Published, Green Submitted			2022-12-27	WOS:000344862300011
J	Lee, SY; Slagle-Webb, B; Rizk, E; Patel, A; Miller, PA; Sung, SS; Connor, JR				Lee, Sang Y.; Slagle-Webb, Becky; Rizk, Elias; Patel, Akshal; Miller, Patti A.; Sung, Shen-Shu; Connor, James R.			Characterization of a Novel Anti-Cancer Compound for Astrocytomas	PLOS ONE			English	Article							CELL-CYCLE ARREST; TOPOISOMERASE-II INHIBITOR; MALIGNANT GLIOMA; PHASE-II; ANTITUMOR AGENT; ACCURATE DOCKING; MISMATCH REPAIR; BRAIN-TUMORS; IN-VITRO; TEMOZOLOMIDE	The standard chemotherapy for brain tumors is temozolomide (TMZ), however, as many as 50% of brain tumors are reportedly TMZ resistant leaving patients without a chemotherapeutic option. We performed serial screening of TMZ resistant astrocytoma cell lines, and identified compounds that are cytotoxic to these cells. The most cytotoxic compound was an analog of thiobarbituric acid that we refer to as CC-I. There is a dose-dependent cytotoxic effect of CC-I in TMZ resistant astrocytoma cells. Cell death appears to occur via apoptosis. Following CC-I exposure, there was an increase in astrocytoma cells in the S and G2/M phases. In in vivo athymic (nu/nu) nude mice subcutaneous and intracranial tumor models, CC-I completely inhibited tumor growth without liver or kidney toxicity. Molecular modeling and enzyme activity assays indicate that CC-I selectively inhibits topoisomerase II alpha similar to other drugs in its class, but its cytotoxic effects on astrocytoma cells are stronger than these compounds. The cytotoxic effect of CC-I is stronger in cells expressing unmethylated O-6-methylguanine methyltransferase (MGMT) but is still toxic to cells with methylated MGMT. CC-I can also enhance the toxic effect of TMZ on astrocytoma when the two compounds are combined. In conclusion, we have identified a compound that is effective against astrocytomas including TMZ resistant astrocytomas in both cell culture and in vivo brain tumor models. The enhanced cytotoxicity of CC-I and the safety profile of this family of drugs could provide an interesting tool for broader evaluation against brain tumors.	[Lee, Sang Y.; Slagle-Webb, Becky; Rizk, Elias; Patel, Akshal; Connor, James R.] Penn State Univ, Penn State MS Hershey Med Ctr, Coll Med, Dept Neurosurg, Hershey, PA 17033 USA; [Miller, Patti A.] Penn State Univ, Penn State MS Hershey Med Ctr, Coll Med, Dept Radiol, Hershey, PA USA; [Sung, Shen-Shu] Penn State Univ, Penn State MS Hershey Med Ctr, Coll Med, Dept Pharmacol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Lee, SY (corresponding author), Penn State Univ, Penn State MS Hershey Med Ctr, Coll Med, Dept Neurosurg, Hershey, PA 17033 USA.	SYL3@psu.edu		Lee, Sang/0000-0003-3911-8316	National Cancer Institute of the National Institutes of Health [R21CA167406]; Elsa U. Pardee Foundation; Tara Leah Witmer Endowment; NATIONAL CANCER INSTITUTE [R21CA167406] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Elsa U. Pardee Foundation; Tara Leah Witmer Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project is funded, in part, by a grant with the National Cancer Institute of the National Institutes of Health under Award Number R21CA167406 to SL. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This study also supported in part by the Elsa U. Pardee Foundation and the Tara Leah Witmer Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	American Cancer Society, 2012, CANC FACTS FIG 2012; Atallah Ehab, 2005, Curr Treat Options Oncol, V6, P185; Balas VI, 2011, EUR J MED CHEM, V46, P2835, DOI 10.1016/j.ejmech.2011.04.005; Balas VI, 2008, BIOINORG CHEM APPL, V2008, DOI 10.1155/2008/654137; BECK WT, 1996, PRINCIPLES CANC DRUG, P487; Bhonde MR, 2006, ONCOGENE, V25, P165, DOI 10.1038/sj.onc.1209017; BREWER AD, 1985, BIOCHEM PHARMACOL, V34, P2047, DOI 10.1016/0006-2952(85)90335-1; Bruce JN, 2011, NEUROSURGERY, V69, P1272, DOI 10.1227/NEU.0b013e3182233e24; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; CEBO B, 1980, FARMACO-ED SCI, V35, P248; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen Y, 2005, ANTICANCER RES, V25, P4203; de Almeida SF, 2007, J BIOL CHEM, V282, P27905, DOI 10.1074/jbc.M702672200; DRAKE FH, 1989, CANCER RES, V49, P2578; Falaschi A, 2007, CELL CYCLE, V6, P1705, DOI 10.4161/cc.6.14.4495; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Friedman HS, 1998, J CLIN ONCOL, V16, P3851, DOI 10.1200/JCO.1998.16.12.3851; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GLOVER A, 1987, INVEST NEW DRUG, V5, P137; Gong YX, 2006, MOL PHARMACOL, V69, P1320, DOI 10.1124/mol.105.018978; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Jakob J, 2009, INT J RADIAT ONCOL, V75, P810, DOI 10.1016/j.ijrobp.2008.11.032; Kanzawa T, 2003, BRIT J CANCER, V89, P922, DOI 10.1038/sj.bjc.6601193; Kolb RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050281; Lee JH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-18; Lee SY, 2007, FASEB J, V21, P564, DOI 10.1096/fj.06-6397com; Lee SY, 2011, INT J CANCER, V129, P2104, DOI 10.1002/ijc.25888; Marchesia F, 2007, PHARMACOL RES, V56, P275, DOI 10.1016/j.phrs.2007.08.003; Matsumoto Y, 2005, J MED INVESTIG, V52, P41, DOI 10.2152/jmi.52.41; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; Melguizo C, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-250; Mellai M, 2012, J NEURO-ONCOL, V107, P617, DOI 10.1007/s11060-011-0787-y; Minturn JE, 2011, PEDIATR BLOOD CANCER, V56, P39, DOI 10.1002/pbc.22690; Moore MJ, 1998, INVEST NEW DRUG, V16, P77, DOI 10.1023/A:1006043332368; Nishikawa R, 2010, NEUROL MED-CHIR, V50, P713, DOI 10.2176/nmc.50.713; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Park DK, 2007, CANCER CHEMOTH PHARM, V50, P160; Peignan L, 2011, NEUROCHEM RES, V36, P1397, DOI 10.1007/s11064-011-0464-8; Rajamaki S, 2009, BIOORG MED CHEM LETT, V19, P3615, DOI 10.1016/j.bmcl.2009.04.132; Schmidt F, 2008, ONCOL REP, V19, P1061; Singh P, 2009, BIOORG MED CHEM LETT, V19, P3054, DOI 10.1016/j.bmcl.2009.04.014; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Theeler BJ, 2011, CURR TREAT OPTION NE, V13, P386, DOI 10.1007/s11940-011-0130-0; Uzzaman M, 2007, J NEUROSURG, V106, P646, DOI 10.3171/jns.2007.106.4.646; van Brussel JP, 2000, CANCER CHEMOTH PHARM, V45, P509, DOI 10.1007/s002800051027; Vlachostergios PJ, 2013, INVEST NEW DRUG, V31, P1169, DOI 10.1007/s10637-013-9968-1; Wang HY, 2013, FOOD CHEM TOXICOL, V55, P396, DOI 10.1016/j.fct.2012.12.059; WARRELL RP, 1989, METABOLISM, V38, P550, DOI 10.1016/0026-0495(89)90215-1; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012	51	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108166	10.1371/journal.pone.0108166	http://dx.doi.org/10.1371/journal.pone.0108166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255031	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300059
J	Zhuang, YX; Chan, DK; Haugrud, AB; Miskimins, WK				Zhuang, Yongxian; Chan, Daniel K.; Haugrud, Allison B.; Miskimins, W. Keith			Mechanisms by Which Low Glucose Enhances the Cytotoxicity of Metformin to Cancer Cells Both In Vitro and In Vivo	PLOS ONE			English	Article							ANTIDIABETIC DRUG METFORMIN; ACTIVATED PROTEIN-KINASE; RESPIRATORY-CHAIN; DIABETIC-PATIENTS; KETOGENIC DIET; BRAIN CANCER; INHIBITION; TUMOR; AMPK; METABOLISM	Different cancer cells exhibit altered sensitivity to metformin treatment. Recent studies suggest these findings may be due in part to the common cell culture practice of utilizing high glucose, and when glucose is lowered, metformin becomes increasingly cytotoxic to cancer cells. In low glucose conditions ranging from 0 to 5 mM, metformin was cytotoxic to breast cancer cell lines MCF7, MDAMB231 and SKBR3, and ovarian cancer cell lines OVCAR3, and PA-1. MDAMB231 and SKBR3 were previously shown to be resistant to metformin in normal high glucose medium. When glucose was increased to 10 mM or above, all of these cell lines become less responsive to metformin treatment. Metformin treatment significantly reduced ATP levels in cells incubated in media with low glucose (2.5 mM), high fructose (25 mM) or galactose (25 mM). Reductions in ATP levels were not observed with high glucose (25 mM). This was compensated by enhanced glycolysis through activation of AMPK when oxidative phosphorylation was inhibited by metformin. However, enhanced glycolysis was either diminished or abolished by replacing 25 mM glucose with 2.5 mM glucose, 25 mM fructose or 25 mM galactose. These findings suggest that lowering glucose potentiates metformin induced cell death by reducing metformin stimulated glycolysis. Additionally, under low glucose conditions metformin significantly decreased phosphorylation of AKT and various targets of mTOR, while phospho-AMPK was not significantly altered. Thus inhibition of mTOR signaling appears to be independent of AMPK activation. Further in vivo studies using the 4T1 breast cancer mouse model confirmed that metformin inhibition of tumor growth was enhanced when serum glucose levels were reduced via low carbohydrate ketogenic diets. The data support a model in which metformin treatment of cancer cells in low glucose medium leads to cell death by decreasing ATP production and inhibition of survival signaling pathways. The enhanced cytotoxicity of metformin against cancer cells was observed both in vitro and in vivo.	[Zhuang, Yongxian; Haugrud, Allison B.; Miskimins, W. Keith] Sanford Res USD, Canc Biol Res Ctr, Sioux Falls, SD 57104 USA; [Chan, Daniel K.] Univ S Dakota, Sanford Sch Med, Vermillion, SD 57069 USA	Sanford Health; University of South Dakota	Zhuang, YX (corresponding author), Sanford Res USD, Canc Biol Res Ctr, Sioux Falls, SD 57104 USA.	Yongxian.Zhuang@sanfordhealth.org			Susan G. Komen for the Cure [KG100497]; COBRE from National Institute of General Medical Sciences at the National Institutes of Health [5P20GM10358]; COBRE from National Cancer Institute; PHS from National Cancer Institute [1R01CA180033-01]; NATIONAL CANCER INSTITUTE [R01CA180033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103548] Funding Source: NIH RePORTER	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); COBRE from National Institute of General Medical Sciences at the National Institutes of Health; COBRE from National Cancer Institute; PHS from National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported through grant KG100497 (W. K. Miskimins) from Susan G. Komen for the Cure. Seahorse XF24 experiments were supported by COBRE award 5P20GM10358 (W. K Miskimins) from the National Institute of General Medical Sciences at the National Institutes of Health. The project was also supported in part by a COBRE pilot award (Y. Zhuang) and PHS grant 1R01CA180033-01 (W. K. Miskimins) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade BM, 2012, THYROID, V22, P1063, DOI 10.1089/thy.2012.0041; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Batandier C, 2006, J BIOENERG BIOMEMBR, V38, P33, DOI 10.1007/s10863-006-9003-8; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Bonini MG, 2013, IUBMB LIFE, V65, P889, DOI 10.1002/iub.1213; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; De Lorenzo MS, 2011, CARCINOGENESIS, V32, P1381, DOI 10.1093/carcin/bgr107; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Gotlieb WH, 2008, GYNECOL ONCOL, V110, P246, DOI 10.1016/j.ygyno.2008.04.008; Habibollahi P, 2013, J NUCL MED, V54, P252, DOI 10.2967/jnumed.112.107011; Han L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027074; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Javeshghani S, 2012, CANCER RES, V72, P6257, DOI 10.1158/0008-5472.CAN-12-2907; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lea MA, 2011, ANTICANCER RES, V31, P421; Lee C, 2011, ONCOGENE, V30, P3305, DOI 10.1038/onc.2011.91; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Matsuo J, 2012, MOL CANCER THER, V11, P1082, DOI 10.1158/1535-7163.MCT-11-0871; Menendez JA, 2012, CELL CYCLE, V11, P2782, DOI 10.4161/cc.20948; Oleksyszyn J, 2011, MED HYPOTHESES, V77, P171, DOI 10.1016/j.mehy.2011.04.001; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; RIZKALLA SW, 1986, DIABETES METAB, V12, P219; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Salpeter SR, 2010, COCHRANE DATABASE SY; Sandulache VC, 2011, CANCER; Sandulache VC, 2011, CANCER-AM CANCER SOC, V117, P2926, DOI 10.1002/cncr.25868; Seyfried TN, 2011, BBA-BIOENERGETICS, V1807, P577, DOI 10.1016/j.bbabio.2010.08.009; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Sinnett-Smith J, 2013, BIOCHEM BIOPH RES CO, V430, P352, DOI 10.1016/j.bbrc.2012.11.010; Smith TAD, 2013, NUCL MED BIOL, V40, P858, DOI 10.1016/j.nucmedbio.2013.05.006; Vazquez-Martin A, 2009, CELL CYCLE, V8, P88, DOI 10.4161/cc.8.1.7499; Wu H, 2011, J PATHOL; Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5; Zhu Zongjian, 2011, J Carcinog, V10, P17; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18; Zhuang YX, 2011, MOL CANCER RES, V9, P603, DOI 10.1158/1541-7786.MCR-10-0343	41	81	85	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108444	10.1371/journal.pone.0108444	http://dx.doi.org/10.1371/journal.pone.0108444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254953	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300083
J	Hsu, LA; Yeh, YH; Kuo, CT; Chen, YH; Chang, GJ; Tsai, FC; Chen, WJ				Hsu, Lung-An; Yeh, Yung-Hsin; Kuo, Chi-Tai; Chen, Ying-Hwa; Chang, Gwo-Jyh; Tsai, Feng-Chun; Chen, Wei-Jan			Microsatellite Polymorphism in the Heme Oxygenase-1 Gene Promoter and the Risk of Atrial Fibrillation in Taiwanese	PLOS ONE			English	Article							OXIDATIVE STRESS; SUSCEPTIBILITY; ACTIVATION; EXPRESSION; RESTENOSIS; DISEASE	Background: Atrial fibrillation (AF) is associated with increased oxidative stress. Emerging evidence suggests that heme oxygenase-1 (HO-1) is a potent antioxidant system against various oxidative stress-related diseases. The human HO-1 promoter has a GT-repeat length polymorphism that can determine the level of gene transcription. Objective: The aim of this study is to assess the role of the GT-repeat polymorphism in the promoter region of the HO-1 gene in Chinese-Taiwanese patients with AF. Methods and Results: This study enrolled 200 AF patients and 240 controls, comparable for age and gender. In each subject, the length of GT-repeat polymorphism in the HO-1 promoter region was examined by polymerase chain reactions. The frequencies of long GT-repeat alleles (>= 32) were significantly higher in AF patients than in controls. Multivariate analysis showed that the presence of long allele was significantly and independently associated with AF (odds ratio: 1.91, 95% CI 1.07-3.72; P = 0.028). Right atrial tissues from patients with chronic AF were investigated with immunoconfocal microscopy. Patients homozygous for shorter GT-repeat alleles exhibited greater HO-1 expression in their atria than those homozygous for longer alleles, which was reflected by less oxidative stress, myofibril degradation, and fibrosis in the atria of patients with shorter GT-repeat. In vitro, transient transfection assay in HL-1 atrial myocytes showed that the responsiveness of HO-1 transcriptional activity to tachypacing was inversely correlated with the length of the GT-repeats. Conclusion: Our results suggest that the HO-1 microsatellite polymorphism may contribute to the genetic background of AF in Chinese-Taiwanese patients.	[Hsu, Lung-An; Yeh, Yung-Hsin; Kuo, Chi-Tai; Chen, Wei-Jan] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Div Cardiovasc, Taoyuan, Taiwan; [Chen, Ying-Hwa] Natl Yang Ming Univ, Coll Med, Taipei Vet Gen Hosp, Div Cardiol,Dept Internal Med, Taipei 112, Taiwan; [Chang, Gwo-Jyh] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Tsai, Feng-Chun] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Div Cardiac Surg, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chen, YH (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Div Cardiovasc, Taoyuan, Taiwan.	yhchen@vghtpe.gov.tw; wjchen@adm.cgmh.org.tw	Yeh, Yung-Hsin/ABD-9351-2021	Chang, Gwo-Jyh/0000-0001-6967-8758; Hsu, Lung-An/0000-0002-0012-2804	Chang Gung Research Grant Foundation [CMRPG] [3A0571-3, 3A0641-3, 3D1371, 3B0991-3, 3C0621]; National Science Council Grant [NSC 99-2314-B-182A-050-MY2, NSC 102-2314-B-182A-053-MY3, NSC 100-2314-B-182-049-MY2]	Chang Gung Research Grant Foundation [CMRPG]; National Science Council Grant	This work was supported by Chang Gung Research Grant Foundation [CMRPG 3A0571-3, 3A0641-3, 3D1371, 3B0991-3, and 3C0621]; and National Science Council Grant [NSC 99-2314-B-182A-050-MY2, NSC 102-2314-B-182A-053-MY3 and NSC 100-2314-B-182-049-MY2]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam O, 2007, J AM COLL CARDIOL, V50, P359, DOI 10.1016/j.jacc.2007.03.041; Andalib A, 2008, CURR OPIN CARDIOL, V23, P176, DOI 10.1097/HCO.0b013e3282fa7142; Burstein B, 2007, CARDIOVASC RES, V76, P442, DOI 10.1016/j.cardiores.2007.07.013; Chen WJ, 2011, BASIC RES CARDIOL, V106, P163, DOI 10.1007/s00395-010-0149-5; Chen YH, 2004, EUR HEART J, V25, P39, DOI 10.1016/j.ehj.2003.10.009; Chen YH, 2002, HUM GENET, V111, P1, DOI 10.1007/s00439-002-0769-4; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Corradi D, 2008, HUM PATHOL, V39, P1162, DOI 10.1016/j.humpath.2007.12.007; Dudley SC, 2005, CIRCULATION, V112, P1266, DOI 10.1161/CIRCULATIONAHA.105.538108; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Hirai H, 2003, BLOOD, V102, P1619, DOI 10.1182/blood-2002-12-3733; Hu YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057593, 10.1371/journal.pone.0056362, 10.1371/journal.pone.0073264, 10.1371/journal.pone.0056440]; Kim YM, 2005, CIRC RES, V97, P629, DOI 10.1161/01.RES.0000183735.09871.61; Kim YM, 2008, J AM COLL CARDIOL, V51, P68, DOI 10.1016/j.jacc.2007.07.085; Kronke G, 2003, J BIOL CHEM, V278, P51006, DOI 10.1074/jbc.M304103200; Mace LC, 2009, J MOL CELL CARDIOL, V47, P485, DOI 10.1016/j.yjmcc.2009.07.006; Reilly SN, 2011, CIRCULATION, V124, P1107, DOI 10.1161/CIRCULATIONAHA.111.029223; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schillinger M, 2004, J AM COLL CARDIOL, V43, P950, DOI 10.1016/j.jacc.2003.09.058; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Tsai CT, 2008, J AM COLL CARDIOL, V52, P241, DOI 10.1016/j.jacc.2008.02.072; Tung YC, 2013, ACTA CARDIOL SIN, V29, P208; Tyrrell R, 1999, FREE RADICAL RES, V31, P335, DOI 10.1080/10715769900300901; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729; Yang Zhenjiang, 2005, J Mol Cell Cardiol, V38, P299, DOI 10.1016/j.yjmcc.2004.11.015; Yeh YH, 2013, HEART RHYTHM, V10, P383, DOI 10.1016/j.hrthm.2012.11.013; Yeh YH, 2011, CARDIOVASC RES, V91, P62, DOI 10.1093/cvr/cvr041	27	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108773	10.1371/journal.pone.0108773	http://dx.doi.org/10.1371/journal.pone.0108773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268359	gold, Green Submitted, Green Published			2022-12-27	WOS:000343671700160
J	Jaiswal, AK; Khare, P; Joshi, S; Kushawaha, PK; Sundar, S; Dube, A				Jaiswal, Anil Kumar; Khare, Prashant; Joshi, Sumit; Kushawaha, Pramod Kumar; Sundar, Shyam; Dube, Anuradha			Th1 Stimulatory Proteins of Leishmania donovani: Comparative Cellular and Protective Responses of rTriose Phosphate Isomerase, rProtein Disulfide Isomerase and rElongation Factor-2 in Combination with rHSP70 against Visceral Leishmaniasis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; TRYPANOSOMA-CRUZI INFECTION; ADAPTIVE IMMUNE-RESPONSES; NITRIC-OXIDE; BALB/C MICE; IN-VIVO; CUTANEOUS LEISHMANIASIS; T-CELL; IMMUNOSTIMULATORY PROPERTIES; INTERLEUKIN-10 PRODUCTION	In visceral leishmaniasis, the recovery from the disease is always associated with the generation of Th1-type of cellular responses. Based on this, we have previously identified several Th1-stimulatory proteins of Leishmania donovani -triose phosphate isomerase (TPI), protein disulfide isomerase (PDI) and elongation factor-2 (EL-2) etc. including heat shock protein 70 (HSP70) which induced Th1-type of cellular responses in both cured Leishmania patients/hamsters. Since, HSPs, being the logical targets for vaccines aimed at augmenting cellular immunity and can be early targets in the immune response against intracellular pathogens; they could be exploited as vaccine/adjuvant to induce long-term immunity more effectively. Therefore, in this study, we checked whether HSP70 can further enhance the immunogenicity and protective responses of the above said Th1-stimulatory proteins. Since, in most of the studies, immunogenicity of HSP70 of L. donovani was assessed in native condition, herein we generated recombinant HSP70 and tested its potential to stimulate immune responses in lymphocytes of cured Leishmania infected hamsters as well as in the peripheral blood mononuclear cells (PBMCs) of cured patients of VL either individually or in combination with above mentioned recombinant proteins. rLdHSP70 alone elicited strong cellular responses along with remarkable up-regulation of IFN-gamma and IL-12 cytokines and extremely lower level of IL-4 and IL-10. Among the various combinations, rLdHSP70 + rLdPDI emerged as superior one augmenting improved cellular responses followed by rLdHSP70 + rLdEL-2. These combinations were further evaluated for its protective potential wherein rLdHSP70 + rLdPDI again conferred utmost protection (similar to 80%) followed by rLdHSP70 + rLdEL-2 (similar to 75%) and generated a strong cellular immune response with significant increase in the levels of iNOS transcript as well as IFN-gamma and IL-12 cytokines which was further supported by the high level of IgG2 antibody in vaccinated animals. These observations indicated that vaccine(s) based on combination of HSP70 with Th1-stimulatory protein(s) may be a viable proposition against intracellular pathogens.	[Jaiswal, Anil Kumar; Khare, Prashant; Joshi, Sumit; Kushawaha, Pramod Kumar; Dube, Anuradha] CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Banaras Hindu University (BHU)	Dube, A (corresponding author), CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India.	anuradha_dube@hotmail.com	Khare, Prashant/O-8447-2017; Jaiswal, Anil Kumar/I-1369-2019	Khare, Prashant/0000-0001-5792-3082; Jaiswal, Anil Kumar/0000-0002-8169-0335; Dube, Anuradha/0000-0002-5122-400X	Department of Biotechnology, New Delhi; CSIR-CDRI's Supra-institutional network project [SIP-0026]	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); CSIR-CDRI's Supra-institutional network project	This work was supported by the Department of Biotechnology, New Delhi and CSIR-CDRI's Supra-institutional network project (SIP-0026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrin F, 2002, INFECT IMMUN, V70, P6697, DOI 10.1128/IAI.70.12.6697-6706.2002; Ali N, 1997, J PARASITOL, V83, P70, DOI 10.2307/3284319; Anderson KM, 2000, IMMUNOL LETT, V74, P35, DOI 10.1016/S0165-2478(00)00246-7; Armijos RX, 2004, VACCINE, V22, P1320, DOI 10.1016/j.vaccine.2003.06.002; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; BARRIOS C, 1992, EUR J IMMUNOL, V22, P1365, DOI 10.1002/eji.1830220606; Basu MK, 2005, CRIT REV MICROBIOL, V31, P145, DOI 10.1080/10408410591005101; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Bhowmick S, 2007, VACCINE, V25, P6544, DOI 10.1016/j.vaccine.2007.05.042; Bhowmick S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005820; Carrillo E, 2008, VACCINE, V26, P1902, DOI 10.1016/j.vaccine.2008.01.042; CHOMARAT P, 1993, J EXP MED, V177, P523, DOI 10.1084/jem.177.2.523; Coler RN, 2002, INFECT IMMUN, V70, P4215, DOI 10.1128/IAI.70.8.4215-4225.2002; Desjeux P., 1992, World Health Statistics Quarterly, V45, P267; DING AH, 1988, J IMMUNOL, V141, P2407; Dominguez-Bernal G, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-59; Dube A, 2005, PARASITOL RES, V96, P216, DOI 10.1007/s00436-005-1339-1; Echeverria P, 2001, IMMUNOL LETT, V76, P107, DOI 10.1016/S0165-2478(01)00179-1; ENGMAN DM, 1990, J IMMUNOL, V144, P3987; FarautGambarelli F, 1997, ANTIMICROB AGENTS CH, V41, P827, DOI 10.1128/AAC.41.4.827; Garg R, 2006, VACCINE, V24, P2900, DOI 10.1016/j.vaccine.2005.12.053; Garg R, 2005, CLIN EXP IMMUNOL, V140, P149, DOI 10.1111/j.1365-2249.2005.02745.x; Garg R, 2006, INDIAN J MED RES, V123, P439; GHALIB HW, 1993, J CLIN INVEST, V92, P324, DOI 10.1172/JCI116570; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; GUNTHER E, 1991, CURR TOP MICROBIOL, V167, P57; Gupta SK, 2007, PROTEOMICS, V7, P816, DOI 10.1002/pmic.200600725; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hadighi R, 2007, PARASITOL RES, V185, P867; Hadighi R, 2006, PLOS MED, V3, P659, DOI 10.1371/journal.pmed.0030162; Hailu A, 2001, J INFECT DIS, V184, P112, DOI 10.1086/320994; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HOWARD JG, 1984, PHILOS T R SOC B, V307, P87, DOI 10.1098/rstb.1984.0111; Huang Q, 2000, J EXP MED, V191, P403, DOI 10.1084/jem.191.2.403; JAMES SL, 1995, MICROBIOL REV, V59, P533, DOI 10.1128/MMBR.59.4.533-547.1995; Javid B, 2004, BIOCHEM SOC T, V32, P622, DOI 10.1042/BST0320622; KAUFMANN SHE, 1990, IMMUNOL TODAY, V11, P129, DOI 10.1016/0167-5699(90)90050-J; Kaul P, 2000, T ROY SOC TROP MED H, V94, P173, DOI 10.1016/S0035-9203(00)90264-5; Kaur J, 2011, ACTA TROP, V119, P50, DOI 10.1016/j.actatropica.2011.04.007; Kaur T, 2011, PARASITE IMMUNOL, V33, P95, DOI 10.1111/j.1365-3024.2010.01253.x; Kumar D., 2013, MOL BIOMARK DIAGN, V4, DOI [10.4172/2155-9929.1000141, DOI 10.4172/2155-9929.1000141]; KUMAR N, 1990, INFECT IMMUN, V58, P1408, DOI 10.1128/IAI.58.5.1408-1414.1990; Kumar S, 2004, INFECT IMMUN, V72, P949, DOI 10.1128/IAI.72.2.949-957.2004; Kumar S, 2012, AM J TROP MED HYG, V86, P601, DOI 10.4269/ajtmh.2012.11-0261; Kumari S, 2008, VACCINE, V26, P5700, DOI 10.1016/j.vaccine.2008.08.021; Kumari S, 2008, VACCINE, V26, P4813, DOI 10.1016/j.vaccine.2008.06.102; Kushawaha PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045766; Kushawaha PK, 2011, J IMMUNOL, V187, P6417, DOI 10.4049/jimmunol.1102081; Kushawaha PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035670; Lehner T, 2004, BIOCHEM SOC T, V32, P629, DOI 10.1042/BST0320629; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; LIEW FY, 1990, J IMMUNOL, V144, P4794; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACFARLANE J, 1990, EUR J BIOCHEM, V190, P377, DOI 10.1111/j.1432-1033.1990.tb15586.x; MARESCA B, 1992, PARASITOL TODAY, V8, P260, DOI 10.1016/0169-4758(92)90137-Q; Melby PC, 1998, INFECT IMMUN, V66, P2135, DOI 10.1128/IAI.66.5.2135-2142.1998; Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912; Morell M, 2006, VACCINE, V24, P7046, DOI 10.1016/j.vaccine.2006.07.006; Multhoff G, 1999, EXP HEMATOL, V27, P1627, DOI 10.1016/S0301-472X(99)00104-6; Murray HW, 1997, J EXP MED, V185, P867, DOI 10.1084/jem.185.5.867; Oladiran A, 2009, DEV COMP IMMUNOL, V33, P1128, DOI 10.1016/j.dci.2009.06.003; PIRMEZ C, 1993, J CLIN INVEST, V91, P1390, DOI 10.1172/JCI116341; Planelles L, 2001, INFECT IMMUN, V69, P6558, DOI 10.1128/IAI.69.10.6558-6563.2001; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Przepiorka D, 1998, MOL MED TODAY, V4, P478, DOI 10.1016/S1357-4310(98)01345-8; Ravindran R, 2004, CURR MOL MED, V4, P697, DOI 10.2174/1566524043360212; REED SG, 1993, CURR OPIN IMMUNOL, V5, P524, DOI 10.1016/0952-7915(93)90033-O; Rico AI, 2002, CELL STRESS CHAPERON, V7, P339, DOI 10.1379/1466-1268(2002)007<0339:THSPHA>2.0.CO;2; Rico AI, 1998, INFECT IMMUN, V66, P347, DOI 10.1128/IAI.66.1.347-352.1998; Rico AI, 1999, MOL IMMUNOL, V36, P1131, DOI 10.1016/S0161-5890(99)00136-4; Sachdeva R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007880; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Samant M, 2009, J IMMUNOL, V183, P470, DOI 10.4049/jimmunol.0900265; Schild H, 1999, CURR OPIN IMMUNOL, V11, P109, DOI 10.1016/S0952-7915(99)80019-3; Segal BH, 2006, DRUG DISCOV TODAY, V11, P534, DOI 10.1016/j.drudis.2006.04.016; SKEIKY YAW, 1995, INFECT IMMUN, V63, P4105, DOI 10.1128/IAI.63.10.4105-4114.1995; Skeiky YAW, 1998, J IMMUNOL, V161, P6171; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; Srivastava PK, 2001, VACCINE, V19, P2590, DOI 10.1016/S0264-410X(00)00492-8; Sukumaran B, 2004, CURR MOL MED, V4, P667, DOI 10.2174/1566524043360203; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Suzue K, 1997, P NATL ACAD SCI USA, V94, P13146, DOI 10.1073/pnas.94.24.13146; Suzue K, 1996, J IMMUNOL, V156, P873; Suzue K, 1996, EXS, V77, P451; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; YOUNG RA, 1990, ANNU REV IMMUNOL, V8, P401, DOI 10.1146/annurev.immunol.8.1.401; Zugel U, 1999, IMMUNOBIOLOGY, V201, P22; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	94	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108556	10.1371/journal.pone.0108556	http://dx.doi.org/10.1371/journal.pone.0108556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268700	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700113
J	Murabito, E; Verma, M; Bekker, M; Bellomo, D; Westerhoff, HV; Teusink, B; Steuer, R				Murabito, Ettore; Verma, Malkhey; Bekker, Martijn; Bellomo, Domenico; Westerhoff, Hans V.; Teusink, Bas; Steuer, Ralf			Monte-Carlo Modeling of the Central Carbon Metabolism of Lactococcus lactis: Insights into Metabolic Regulation	PLOS ONE			English	Article							GLYCOLYTIC FLUX; SYSTEMS BIOLOGY; ACID BACTERIA; IN-VIVO; ESCHERICHIA-COLI; RATE LAWS; DEHYDROGENASE; UNCERTAINTY; NETWORK; RECONSTRUCTION	Metabolic pathways are complex dynamic systems whose response to perturbations and environmental challenges are governed by multiple interdependencies between enzyme properties, reactions rates, and substrate levels. Understanding the dynamics arising from such a network can be greatly enhanced by the construction of a computational model that embodies the properties of the respective system. Such models aim to incorporate mechanistic details of cellular interactions to mimic the temporal behavior of the biochemical reaction system and usually require substantial knowledge of kinetic parameters to allow meaningful conclusions. Several approaches have been suggested to overcome the severe data requirements of kinetic modeling, including the use of approximative kinetics and Monte-Carlo sampling of reaction parameters. In this work, we employ a probabilistic approach to study the response of a complex metabolic system, the central metabolism of the lactic acid bacterium Lactococcus lactis, subject to perturbations and brief periods of starvation. Supplementing existing methodologies, we show that it is possible to acquire a detailed understanding of the control properties of a corresponding metabolic pathway model that is directly based on experimental observations. In particular, we delineate the role of enzymatic regulation to maintain metabolic stability and metabolic recovery after periods of starvation. It is shown that the feedforward activation of the pyruvate kinase by fructose-1,6-bisphosphate qualitatively alters the bifurcation structure of the corresponding pathway model, indicating a crucial role of enzymatic regulation to prevent metabolic collapse for low external concentrations of glucose. We argue that similar probabilistic methodologies will help our understanding of dynamic properties of small-, medium- and large-scale metabolic networks models.	[Murabito, Ettore; Verma, Malkhey; Westerhoff, Hans V.] Univ Manchester, Manchester Inst Biotechnol, Sch Chem Engn & Analyt Sci CEAS, Manchester Ctr Integrat Syst Biol, Manchester, Lancs, England; [Bekker, Martijn; Westerhoff, Hans V.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Bellomo, Domenico; Teusink, Bas] Vrije Univ Amsterdam, Syst Bioinformat IBIVU, Amsterdam, Netherlands; [Bellomo, Domenico; Teusink, Bas] Vrije Univ Amsterdam, Netherlands Inst Syst Biol, Amsterdam, Netherlands; [Westerhoff, Hans V.] Vrije Univ Amsterdam, FALW, Amsterdam, Netherlands; [Steuer, Ralf] Acad Sci Czech Republ, CzechGlobe Global Change Res Ctr, Brno, Czech Republic; [Steuer, Ralf] Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany	University of Manchester; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; Humboldt University of Berlin	Murabito, E (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Sch Chem Engn & Analyt Sci CEAS, Manchester Ctr Integrat Syst Biol, Manchester, Lancs, England.	ettore.murabito@manchester.ac.uk; ralf.steuer@hu-berlin.de	Westerhoff, Hans V/I-5762-2012; Steuer, Ralf/E-7482-2017	Westerhoff, Hans V/0000-0002-0443-6114; Steuer, Ralf/0000-0003-2217-1655; Teusink, Bas/0000-0003-3929-0423	Systems Biology of MicroOrganisms (SysMO); ERASysBio program; EPSRC/BBSRC [R111828]; MOSES project; ERASysBio [BB/F003528/1, BB/C008219/1, BB/F003544/1, BB/I004696/1, BB/I00470X/1, BB/I017186/1, EP/D508053/1]; OPVK project "Local Team and International Consortium for Computational Modelling of a Cyanobacterial Cell" [CZ.1.07/2.3.00/20.0256]; e:Bio of the BMBF (Forderkennzeichen) [0316192]; BBSRC [BB/F003536/1, BB/F003528/1, BB/I00470X/1, BB/I004696/1, BB/I017186/1, BB/F003544/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I00470X/1, BB/C008219/1, BB/F003536/1, BB/F003544/1, BB/I004696/1, BB/F003528/1, BB/I017186/1] Funding Source: researchfish	Systems Biology of MicroOrganisms (SysMO); ERASysBio program; EPSRC/BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Engineering & Physical Sciences Research Council (EPSRC)); MOSES project; ERASysBio; OPVK project "Local Team and International Consortium for Computational Modelling of a Cyanobacterial Cell"; e:Bio of the BMBF (Forderkennzeichen)(Federal Ministry of Education & Research (BMBF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	HVW acknowledges support by the transnational program Systems Biology of MicroOrganisms (SysMO) and ERASysBio program and its funders EPSRC/BBSRC for the following projects: R111828, MOSES project, ERASysBio, BB/F003528/1, BB/C008219/1, BB/F003544/1, BB/I004696/1, BB/I00470X/1, BB/I017186/1, EP/D508053/1, BB/I017186/1. RS acknowledges funding by the OPVK project "Local Team and International Consortium for Computational Modelling of a Cyanobacterial Cell, Reg. No. CZ.1.07/2.3.00/20.0256". As of 1.1.2013, RS is supported by the framework e:Bio of the BMBF (Forderkennzeichen 0316192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeva S, 2000, J BACTERIOL, V182, P4934, DOI 10.1128/JB.182.17.4934-4940.2000; Andersen AZ, 2009, COMPUT BIOL CHEM, V33, P71, DOI 10.1016/j.compbiolchem.2008.08.001; Bluthgen N, 2010, MOL BIOSYST, V6, P1277, DOI 10.1039/c002598d; Bulik S, 2009, FEBS J, V276, P410, DOI 10.1111/j.1742-4658.2008.06784.x; BURNS JA, 1985, TRENDS BIOCHEM SCI, V10, P16, DOI 10.1016/0968-0004(85)90008-8; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Garrigues C, 1997, J BACTERIOL, V179, P5282, DOI 10.1128/jb.179.17.5282-5287.1997; Girbig D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034686; Grimbs S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100186; Gross T, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016205; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Heijnen JJ, 2005, BIOTECHNOL BIOENG, V91, P534, DOI 10.1002/bit.20558; Heinrich R., 1996, REGULATION CELLULAR; Hoefnagel MHN, 2002, MICROBIOL-SGM, V148, P1003, DOI 10.1099/00221287-148-4-1003; Hoefnagel MHN, 2002, MOL BIOL REP, V29, P157, DOI 10.1023/A:1020313409954; Jonsson M, 2009, APPL ENVIRON MICROB, V75, P4901, DOI 10.1128/AEM.00344-09; Koebmann B, 2005, FEBS J, V272, P2292, DOI 10.1111/j.1742-4658.2005.04656.x; Koebmann BJ, 2002, ANTON LEEUW INT J G, V82, P237, DOI 10.1023/A:1020643918089; Koebmann BJ, 2002, J BACTERIOL, V184, P3909, DOI 10.1128/JB.184.14.3909-3916.2002; Lall R, 2011, MATH COMPUT MODEL, V53; Levering J, 2012, FEBS J, V279, P1274, DOI 10.1111/j.1742-4658.2012.08523.x; Liebermeister W, 2010, BIOINFORMATICS, V26, P1528, DOI 10.1093/bioinformatics/btq141; MAVROVOUNIOTIS ML, 1990, BIOTECHNOL BIOENG, V36, P1119, DOI 10.1002/bit.260361107; MAVROVOUNIOTIS ML, 1991, J BIOL CHEM, V266, P14440; Murabito E., 2013, CURR SYNTH SYS BIOL, V1, P104, DOI [10.4172/2332-0737.1000104, DOI 10.4172/2332-0737.1000104]; Murabito E, 2011, J R SOC INTERFACE, V8, P880, DOI 10.1098/rsif.2010.0540; Neves AR, 2000, EUR J BIOCHEM, V267, P3859, DOI 10.1046/j.1432-1327.2000.01424.x; Neves AR, 2002, J BIOL CHEM, V277, P28088, DOI 10.1074/jbc.M202573200; Neves AR, 2005, FEMS MICROBIOL REV, V29, P531, DOI 10.1016/j.femsre.2005.04.005; Notebaart RA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-296; Novak L, 2000, J BACTERIOL, V182, P1136, DOI 10.1128/JB.182.4.1136-1143.2000; Oddone GM, 2009, METAB ENG, V11, P367, DOI 10.1016/j.ymben.2009.07.007; Oh E, 2011, J MICROBIOL BIOTECHN, V21, P162, DOI 10.4014/jmb.1007.07066; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Papagianni M, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-16; Rohwer JM, 2006, IEE P SYST BIOL, V153, P338, DOI 10.1049/ip-syb:20060026; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Soh KC, 2012, FEMS YEAST RES, V12, P129, DOI 10.1111/j.1567-1364.2011.00771.x; Solem C, 2003, J BACTERIOL, V185, P1564, DOI 10.1128/JB.185.5.1564-1571.2003; Solem C, 2007, J BACTERIOL, V189, P6727, DOI 10.1128/JB.00902-07; Steuer R, 2009, ADV CHEM PHYS, P142; Steuer R, 2007, BIOINFORMATICS, V23, P1378, DOI 10.1093/bioinformatics/btm065; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Tan Y, 2011, METAB ENG, V13, P60, DOI 10.1016/j.ymben.2010.11.001; Teusink B, 2006, NAT REV MICROBIOL, V4, P46, DOI 10.1038/nrmicro1319; Teusink B, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S11; Tran LM, 2008, BIOPHYS J, V95, P5606, DOI 10.1529/biophysj.108.135442; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; Voit E, 2006, P NATL ACAD SCI USA, V103, P9452, DOI 10.1073/pnas.0603337103; Voit EO, 2006, IEE P SYST BIOL, V153, P286, DOI 10.1049/ip-syb:20050087; Wang LQ, 2006, METAB ENG, V8, P142, DOI 10.1016/j.ymben.2005.11.002; Wang LQ, 2006, METAB ENG, V8, P133, DOI 10.1016/j.ymben.2005.11.003; Wang LQ, 2004, BIOPHYS J, V87, P3750, DOI 10.1529/biophysj.104.048090; Wouters JA, 2011, APPL ENVIRON MICROB, V67, P5171; Xu YF, 2012, NAT CHEM BIOL, V8, P562, DOI [10.1038/NCHEMBIO.941, 10.1038/nchembio.941]	57	18	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106453	10.1371/journal.pone.0106453	http://dx.doi.org/10.1371/journal.pone.0106453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268481	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700011
J	Muraro, D; Lauffenburger, DA; Simmons, A				Muraro, Daniele; Lauffenburger, Douglas A.; Simmons, Alison			Prioritisation and Network Analysis of Crohn's Disease Susceptibility Genes	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; TOOL	Recent Genome-Wide Association Studies (GWAS) have revealed numerous Crohn's disease susceptibility genes and a key challenge now is in understanding how risk polymorphisms in associated genes might contribute to development of this disease. For a gene to contribute to disease phenotype, its risk variant will likely adversely communicate with a variety of other gene products to result in dysregulation of common signaling pathways. A vital challenge is to elucidate pathways of potentially greatest influence on pathological behaviour, in a manner recognizing how multiple relevant genes may yield integrative effect. In this work we apply mathematical analysis of networks involving the list of recently described Crohn's susceptibility genes, to prioritise pathways in relation to their potential development of this disease. Prioritisation was performed by applying a text mining and a diffusion based method (GRAIL, GPEC). Prospective biological significance of the resulting prioritised list of proteins is highlighted by changes in their gene expression levels in Crohn's patients intestinal tissue in comparison with healthy donors.	[Muraro, Daniele; Simmons, Alison] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Lauffenburger, Douglas A.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	University of Oxford; Massachusetts Institute of Technology (MIT)	Muraro, D (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford, England.	Daniele.Muraro@ndm.ox.ac.uk		Simmons, Alison/0000-0003-3454-0710	Sir Jules Thorn Charitable Trust [HBRWGDO]; Institute for Collaborative Biotechnologies from the United States Army Research Office [W911NF-09-0001]; Medical Research Council [MC_UU_12010/7] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-R3-12-026] Funding Source: researchfish; MRC [MC_UU_12010/7] Funding Source: UKRI	Sir Jules Thorn Charitable Trust; Institute for Collaborative Biotechnologies from the United States Army Research Office; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DM and AS gratefully acknowledge the Sir Jules Thorn Charitable Trust for financial support through grant HBRWGDO. DL gratefully acknowledges the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the United States Army Research Office; the content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Cho RJ, 2000, TRENDS GENET, V16, P409, DOI 10.1016/S0168-9525(00)02065-5; Le DH, 2012, COMPUT BIOL CHEM, V37, P17, DOI 10.1016/j.compbiolchem.2012.02.004; Fritz T, 2011, GUT, V60, P1580, DOI 10.1136/gut.2009.206466; Hindorff L, 2012, CATALOG PUBLISHED GE; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaser A, 2010, MUCOSAL IMMUNOL, V3, P11, DOI 10.1038/mi.2009.122; Kaser A, 2009, SEMIN IMMUNOL, V21, P156, DOI 10.1016/j.smim.2009.01.001; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mirzasoleiman B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020512; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Noble CL, 2010, INFLAMM BOWEL DIS, V16, P1717, DOI 10.1002/ibd.21263; Nussinov R, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/030301; Pawson T, 2008, FEBS LETT, V582, P1266, DOI 10.1016/j.febslet.2008.02.011; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Schreiber F, 2005, BIOINFORMATICS, V21, P3572, DOI 10.1093/bioinformatics/bti556; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Simmons JD, 2000, GUT, V47, P211, DOI 10.1136/gut.47.2.211; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Valentini G, 2014, ARTIF INTELL MED, V61, P63, DOI 10.1016/j.artmed.2014.03.003; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Yadav G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041827; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Zhang SW, 2014, MOL BIOSYST, V10, P1400, DOI 10.1039/c3mb70588a; Zhu J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S5; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	35	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108624	10.1371/journal.pone.0108624	http://dx.doi.org/10.1371/journal.pone.0108624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268122	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700128
J	Gad, PN; Roy, RR; Zhong, H; Lu, DC; Gerasimenko, YP; Edgerton, VR				Gad, Parag N.; Roy, Roland R.; Zhong, Hui; Lu, Daniel C.; Gerasimenko, Yury P.; Edgerton, V. Reggie			Initiation of Bladder Voiding with Epidural Stimulation in Paralyzed, Step Trained Rats	PLOS ONE			English	Article							SPINAL-CORD; URINARY-BLADDER; MICTURITION; PLASTICITY; LOCOMOTION; CIRCUITRY; REFLEXES; INJURY	The inability to control timely bladder emptying is one of the most serious challenges among the several functional deficits that occur after a complete spinal cord injury. Having demonstrated that electrodes placed epidurally on the dorsum of the spinal cord can be used in animals and humans to recover postural and locomotor function after complete paralysis, we hypothesized that a similar approach could be used to recover bladder function after paralysis. Also knowing that posture and locomotion can be initiated immediately with a specific frequency-dependent stimulation pattern and that with repeated stimulation-training sessions these functions can improve even further, we reasoned that the same two strategies could be used to regain bladder function. Recent evidence suggests that rats with severe paralysis can be rehabilitated with a multisystem neuroprosthetic training regime that counteracts the development of neurogenic bladder dysfunction. No data regarding the acute effects of locomotion on bladder function, however, were reported. In this study we show that enabling of locomotor-related spinal neuronal circuits by epidural stimulation also influences neural networks controlling bladder function and can play a vital role in recovering bladder function after complete paralysis. We have identified specific spinal cord stimulation parameters that initiate bladder emptying within seconds of the initiation of epidural stimulation. The clinical implications of these results are substantial in that this strategy could have a major impact in improving the quality of life and longevity of patients while simultaneously dramatically reducing ongoing health maintenance after a spinal cord injury.	[Gad, Parag N.; Roy, Roland R.; Zhong, Hui; Gerasimenko, Yury P.; Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90045 USA; [Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA; [Lu, Daniel C.; Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Roy, Roland R.; Edgerton, V. Reggie] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Gerasimenko, Yury P.] IP Pavlov Physiol Inst, St Petersburg 199034, Russia	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Pavlov Institute of Physiology Russian Academy of Sciences	Edgerton, VR (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90045 USA.	vre@ucla.edu	Gerasimenko, Yury/A-3655-2017		National Institute of Biomedical Imaging and Bioengineering (NIBIB) [R01EB007615]; National Institute of Health (NIH) [R01NS062009]; Christopher & Dana Reeve Foundation; Walkabout Foundation; Presidium of RAN; Russian Foundation of Basic Research [13-04-01091, 13-04-12030-ofi-m]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB007615, R01EB007615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062009] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Christopher & Dana Reeve Foundation; Walkabout Foundation; Presidium of RAN; Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) R01EB007615, the National Institute of Health (NIH) R01NS062009, Christopher & Dana Reeve Foundation, the Walkabout Foundation, the Program No. 5 and No. 7 of the Presidium of RAN; and the Russian Foundation of Basic Research Grants: 13-04-01091 and 13-04-12030-ofi-m. The work is performed according to the Russian Government Program of Competitive Growth of Kazan Federal University. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; BARBEAU H, 1987, BRAIN RES, V412, P84, DOI 10.1016/0006-8993(87)91442-9; Barrington FJF, 1941, BRAIN, V64, P239, DOI 10.1093/brain/64.4.239; Chew DJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007186; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; D'Amico SC, 2012, J NEUROPHYSIOL, V108, P2554, DOI 10.1152/jn.00927.2011; de Groat WC, 1998, BEHAV BRAIN RES, V92, P127, DOI 10.1016/S0166-4328(97)00185-X; de Groat WC, 2010, NEUROUROL URODYNAM, V29, P63, DOI 10.1002/nau.20761; de Leon RD, 2002, BRAIN RES REV, V40, P267, DOI 10.1016/S0165-0173(02)00209-6; DEGROAT WC, 1990, J AUTONOM NERV SYST, V30, pS71, DOI 10.1016/0165-1838(90)90105-R; Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308; Edgerton VR, 2001, J PHYSIOL-LONDON, V533, P15, DOI 10.1111/j.1469-7793.2001.0015b.x; Gad P, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-108; Gad P, 2013, J NEUROPHYSIOL, V110, P1311, DOI 10.1152/jn.00169.2013; Gad P, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-38; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Holmquist B, 1968, Scand J Urol Nephrol, V2, P129, DOI 10.3109/00365596809136982; Horst M, 2013, J UROLOGY, V189, P747, DOI 10.1016/j.juro.2012.08.200; Ichiyama RM, 2008, J NEUROSCI, V28, P7370, DOI 10.1523/JNEUROSCI.1881-08.2008; Isaev G G, 2004, J Physiol Pharmacol, V55 Suppl 3, P77; KRUSE MN, 1993, AM J PHYSIOL, V264, pR1157, DOI 10.1152/ajpregu.1993.264.6.R1157; Kunstman K, 1921, RUSS FIZIOL ZH, V4, P192; Lavrov I, 2008, J NEUROSCI, V28, P6022, DOI 10.1523/JNEUROSCI.0080-08.2008; Lavrov I, 2006, J NEUROPHYSIOL, V96, P1699, DOI 10.1152/jn.00325.2006; MAGGI CA, 1986, J PHARMACOL METHOD, V15, P157, DOI 10.1016/0160-5402(86)90064-1; Potter P, PROGR BRAIN RES, V152, P51; Rijkhoff NJM, 1997, J UROLOGY, V157, P1504, DOI 10.1016/S0022-5347(01)65032-8; ROSASARELLANO MP, 1988, PHYSIOL BEHAV, V43, P127, DOI 10.1016/0031-9384(88)90109-6; Roy R, 1992, LAB ANIMAL SCI, V42; Shefchyk SJ, 2002, PROG BRAIN RES, V137, P71	31	37	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108184	10.1371/journal.pone.0108184	http://dx.doi.org/10.1371/journal.pone.0108184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264607	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400052
J	Hua, KK; Wang, DZ; Guo, XS; Guo, ZB				Hua, Keke; Wang, Daozhong; Guo, Xisheng; Guo, Zibin			Carbon Sequestration Efficiency of Organic Amendments in a Long-Term Experiment on a Vertisol in Huang-Huai-Hai Plain, China	PLOS ONE			English	Article							SOIL CARBON; FERTILIZER APPLICATIONS; MICROBIAL BIOMASS; CROPPING SYSTEMS; POOL DYNAMICS; MATTER; SATURATION; NITROGEN; TROPICS; STABILIZATION	Soil organic carbon (SOC) sequestration is important for improving soil fertility of cropland and for the mitigation of greenhouse gas emissions to the atmosphere. The efficiency of SOC sequestration depends on the quantity and quality of the organic matter, soil type, and climate. Little is known about the SOC sequestration efficiency of organic amendments in Vertisols. Thus, we conducted the research based on 29 years (1982-2011) of long-term fertilization experiment with a no fertilizer control and five fertilization regimes: CK (control, no fertilizer), NPK (mineral NPK fertilizers alone), NPK+1/2W (mineral NPK fertilizers combined with half the amount of wheat straw), NPK+W (mineral NPK fertilizers combined with full the amount of wheat straw), NPK+PM (mineral NPK fertilizers combined with pig manure) and NPK+CM (mineral NPK fertilizers combined cattle manure). Total mean annual C inputs were 0.45, 1.55, 2.66, 3.71, 4.68 and 6.56 ton/ha/yr for CK, NPK, NPKW1/2, NPKW, NPKPM and NPKCM, respectively. Mean SOC sequestration rate was 0.20 ton/ha/yr in the NPK treatment, and 0.39, 0.50, 0.51 and 0.97 ton/ha/yr in the NPKW1/2, NPKW, NPKPM, and NPKCM treatments, respectively. A linear relationship was observed between annual C input and SOC sequestration rate (SOCsequestration rate = 0.16 Cinput -0.10, R = 0.95, P < 0.01), suggesting a C sequestration efficiency of 16%. The Vertisol required an annual C input of 0.63 ton/ha/yr to maintain the initial SOC level. Moreover, the C sequestration efficiencies of wheat straw, pig manure and cattle manure were 17%, 11% and 17%, respectively. The results indicate that the Vertisol has a large potential to sequester SOC with a high efficiency, and applying cattle manure or wheat straw is a recommendable SOC sequestration practice in Vertisols.	[Hua, Keke; Wang, Daozhong; Guo, Xisheng; Guo, Zibin] Anhui Acad Agr Sci, Soil & Fertilizer Res Inst, Hefei, Peoples R China	Anhui Academy of Agricultural Sciences	Wang, DZ (corresponding author), Anhui Acad Agr Sci, Soil & Fertilizer Res Inst, Hefei, Peoples R China.	wdzhong-3@163.com; 1078681598@qq.com			Natural Science Foundation of China [41401331]; Special Fund for Agro-scientific Research in the Public Interest of China [201203030]; Anhui Academic of Agricultural Science [14B1008, 14B1007]; Anhui Province Science and Technology Program [1206c0805033]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of China; Anhui Academic of Agricultural Science; Anhui Province Science and Technology Program	This work was supported by the Natural Science Foundation of China (Grant No. 41401331), Special Fund for Agro-scientific Research in the Public Interest of China (Grant No. 201203030), the President Distinguished Youth Innovation Fund of Anhui Academic of Agricultural Science (Grants No. 14B1008 and 14B1007), and by the Anhui Province Science and Technology Program (Grant No. 1206c0805033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black CA, 1962, METHODS SOIL ANAL 2; Cai ZC, 2006, GEODERMA, V136, P708, DOI 10.1016/j.geoderma.2006.05.008; Chander K, 1997, BIOL FERT SOILS, V24, P306, DOI 10.1007/s003740050248; Chung H, 2010, SOIL SCI SOC AM J, V74, P130, DOI 10.2136/sssaj2009.0097; Eggleston H.S., 2006, 2019 REF 2006 IPCC G; Elliott E. T., 1988, Ecological Bulletins, V39, P23; Feller C, 1997, GEODERMA, V79, P69, DOI 10.1016/S0016-7061(97)00039-6; Follett RF, 2007, SOIL SCI, V172, P189, DOI 10.1097/ss.0b013e31803403de; Franzluebbers AJ, 1996, SOIL BIOL BIOCHEM, V28, P1367, DOI 10.1016/S0038-0717(96)00143-5; Freibauer A, 2004, GEODERMA, V122, P1, DOI 10.1016/j.geoderma.2004.01.021; GALANTINI JA, 1992, SCI TOTAL ENVIRON, V118, P263, DOI 10.1016/0048-9697(92)90093-8; Ghosh PK, 2004, BIORESOURCE TECHNOL, V95, P77, DOI 10.1016/j.biortech.2004.02.011; Gong W, 2009, PLANT SOIL, V314, P67, DOI 10.1007/s11104-008-9705-2; GUGGENBERGER G, 1994, EUR J SOIL SCI, V45, P449, DOI 10.1111/j.1365-2389.1994.tb00530.x; Gulde S, 2008, SOIL SCI SOC AM J, V72, P605, DOI 10.2136/sssaj2007.0251; Guo ZB, 2014, SPAN J AGRIC RES, V12, P801, DOI 10.5424/sjar/2014123-4859; Hassink J, 1997, PLANT SOIL, V191, P77, DOI 10.1023/A:1004213929699; HIGUCHI T, 1971, ADV ENZYMOL RAMB, V34, P207; Houghton J. T., 1996, REV 1996 IPCC GUID N, V1; Kong AYY, 2005, SOIL SCI SOC AM J, V69, P1078, DOI 10.2136/sssaj2004.0215; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; [李德成 LI Decheng], 2011, [土壤, Soils], V43, P623; Li ZhongPei, 2002, Acta Pedologica Sinica, V39, P351; [林蔚刚 Lin Weigang], 2012, [大豆科学, Soybean Science], V31, P584; LIN XX, 1987, RESOUR CONSERV, V13, P109; Lu R.K, 2000, ANAL METHOD SOIL AGR; Maillard E, 2014, GLOBAL CHANGE BIOL, V20, P666, DOI 10.1111/gcb.12438; McLauchlan KK, 2006, GEODERMA, V136, P289, DOI 10.1016/j.geoderma.2006.03.053; MIAO G, 1989, Acta Agronomica Sinica, V15, P104; NCATS, 1994, CHIN ORG FERT HDB; Rui WY, 2010, AGR ECOSYST ENVIRON, V135, P199, DOI 10.1016/j.agee.2009.09.010; Shi XZ, 2009, SOIL TILL RES, V105, P322, DOI 10.1016/j.still.2008.12.016; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Stewart CE, 2008, SOIL BIOL BIOCHEM, V40, P1741, DOI 10.1016/j.soilbio.2008.02.014; Stewart CE, 2009, SOIL BIOL BIOCHEM, V41, P357, DOI 10.1016/j.soilbio.2008.11.011; Thevenot M, 2010, SOIL BIOL BIOCHEM, V42, P1200, DOI 10.1016/j.soilbio.2010.03.017; Tong CL, 2009, SOIL TILL RES, V106, P8, DOI 10.1016/j.still.2009.09.003; Torres IF, 2014, SOIL BIOL BIOCHEM, V75, P152, DOI 10.1016/j.soilbio.2014.04.007; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; West TO, 2007, CLIMATIC CHANGE, V80, P25, DOI [10.1007/s10584-006-9173-8, 10.1007/s105S4-006-9173-8]; Yan X, 2013, SOIL TILL RES, V130, P42, DOI 10.1016/j.still.2013.01.013; Yang XM, 2003, ENVIRON MANAGE, V32, P459, DOI [10.1007/s00267-003-0016-3, 10.1007/s00267-003-0082-6]; Zhang JB, 2012, EUR J SOIL SCI, V63, P75, DOI 10.1111/j.1365-2389.2011.01410.x; Zhang WJ, 2010, BIOGEOSCIENCES, V7, P409, DOI 10.5194/bg-7-409-2010; Zhang WJ, 2012, J SOIL SEDIMENT, V12, P457, DOI 10.1007/s11368-011-0467-8; Zhou Ping, 2009, Scientia Agricultura Sinica, V42, P4260; Zhou ZC, 2013, EUR J AGRON, V45, P20, DOI 10.1016/j.eja.2012.11.002	49	36	44	9	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108594	10.1371/journal.pone.0108594	http://dx.doi.org/10.1371/journal.pone.0108594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265095	Green Submitted, gold, Green Published			2022-12-27	WOS:000345745400092
J	Wang, CF; Chen, K; Xia, YJ; Dai, WQ; Wang, F; Shen, M; Cheng, P; Wang, JS; Lu, J; Zhang, Y; Yang, J; Zhu, R; Zhang, HW; Li, JJ; Zheng, YY; Zhou, YQ; Guo, CY				Wang, Chengfen; Chen, Kan; Xia, Yujing; Dai, Weiqi; Wang, Fan; Shen, Miao; Cheng, Ping; Wang, Junshan; Lu, Jie; Zhang, Yan; Yang, Jing; Zhu, Rong; Zhang, Huawei; Li, Jingjing; Zheng, Yuanyuan; Zhou, Yingqun; Guo, Chuanyong			N-Acetylcysteine Attenuates Ischemia-Reperfusion-Induced Apoptosis and Autophagy in Mouse Liver via Regulation of the ROS/JNK/Bcl-2 Pathway	PLOS ONE			English	Article							HEME OXYGENASE 1; ISCHEMIA/REPERFUSION INJURY; HEPATIC ISCHEMIA/REPERFUSION; PATHOGENIC MECHANISMS; PROTECTION; BCL-2; JNK; STRESS; HYPOXIA; KINASE	Background: Hepatic ischemia-reperfusion injury (HIRI) remains a pivotal clinical problem after hemorrhagic shock, transplantation, and some types of toxic hepatic injury. Apoptosis and autophagy play important roles in cell death during HIRI. It is also known that N-acetylcysteine (NAC) has significant pharmacologic effects on HIRI including elimination of reactive oxygen species (ROS) and attenuation of hepatic apoptosis. However, the effects of NAC on HIRI-induced autophagy have not been reported. In this study, we evaluated the effects of NAC on autophagy and apoptosis in HIRI, and explored the possible mechanism involved. Methods: A mouse model of segmental (70%) hepatic warm ischemia was adopted to determine hepatic injury. NAC (150 mg/kg), a hepatoprotection agent, was administered before surgery. We hypothesized that the mechanism of NAC may involve the ROS/JNK/Bcl-2 pathway. We evaluated the expression of JNK, P-JNK, Bcl-2, Beclin 1 and LC3 by western blotting and immunohistochemical staining. Autophagosomes were evaluated by transmission electron microscopy (TEM). Results: We found that ALT, AST and pathological changes were significantly improved in the NAC group. Western blotting analysis showed that the expression levels of Beclin 1 and LC3 were significantly decreased in NAC-treated mice. In addition, JNK, p-JNK, Bax, TNF-alpha, NF-kappa B, IL2, IL6 and levels were also decreased in NAC-treated mice. Conclusion: NAC can prevent HIRI-induced autophagy and apoptosis by influencing the JNK signal pathway. The mechanism is likely to involve attenuation of JNK and p-JNK via scavenged ROS, an indirect increase in Bcl-2 level, and finally an alteration in the balance of Beclin 1 and Bcl-2.	[Wang, Chengfen; Chen, Kan; Xia, Yujing; Dai, Weiqi; Wang, Fan; Shen, Miao; Cheng, Ping; Wang, Junshan; Lu, Jie; Zhang, Yan; Yang, Jing; Zhu, Rong; Zhang, Huawei; Li, Jingjing; Zheng, Yuanyuan; Zhou, Yingqun; Guo, Chuanyong] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai 200092, Peoples R China	Tongji University	Zhou, YQ (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai 200092, Peoples R China.	yqzh02@163.com; guochuanyong@hotmail.com		Guo, Chuanyong/0000-0002-6527-4673	National Natural Science Foundation of China [+81101579, 81270515]; Shanghai Science and Technology Innovation Plan of Action for international cooperation projects [11430702400]; China Foundation for Hepatitis Prevention and Control WBN Liver Disease Research Fund [20100021, 20120005]; Shanghai Health Bureau [2011287, 2012107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Innovation Plan of Action for international cooperation projects; China Foundation for Hepatitis Prevention and Control WBN Liver Disease Research Fund; Shanghai Health Bureau	This work was supported by the National Natural Science Foundation of China (Nos. +81101579 and 81270515), the Shanghai Science and Technology Innovation Plan of Action for international cooperation projects (No. 11430702400), the China Foundation for Hepatitis Prevention and Control WBN Liver Disease Research Fund (Nos. 20100021 and 20120005), and the Shanghai Health Bureau issues (Nos. 2011287 and 2012107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amara M, 2010, LIVER TRANSPLANT, V16, P1016, DOI 10.1002/lt.22117; Cheng P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/935251; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; CURRIN RT, 1991, FASEB J, V5, P207, DOI 10.1096/fasebj.5.2.2004664; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Eskelinen Eeva-Liisa, 2007, Autophagy, V3, P166; Georgiev P, 2006, CURR PHARM DESIGN, V12, P2911, DOI 10.2174/138161206777947588; Gillissen A, 1998, RESP MED, V92, P609, DOI 10.1016/S0954-6111(98)90506-6; GORES GJ, 1989, J CLIN INVEST, V83, P386, DOI 10.1172/JCI113896; JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355, DOI 10.1152/ajpgi.1991.260.3.G355; Jaeschke H, 2003, GASTROENTEROLOGY, V125, P1246, DOI 10.1016/S0016-5085(03)01209-5; Kelly G S, 1998, Altern Med Rev, V3, P114; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim SJ, 2013, SHOCK, V39, P380, DOI 10.1097/SHK.0b013e31828aab7f; Li CC, 2010, EUR J PHARMACOL, V635, P96, DOI 10.1016/j.ejphar.2010.03.013; Lin HC, 2013, SHOCK, V39, P543, DOI 10.1097/01.shk.0000430660.63077.7f; Liu L, 2012, EUR J PHARMACOL, V680, P34, DOI 10.1016/j.ejphar.2012.01.016; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Neuman MG, 2001, CRIT REV CL LAB SCI, V38, P109, DOI 10.1080/20014091084182; Ohshima H, 2002, IARC Sci Publ, V156, P393; Ozaki M, 2012, THERANOSTICS, V2, P207, DOI 10.7150/thno.3806; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Rizzardini M, 1998, HEPATOLOGY, V27, P703, DOI 10.1002/hep.510270311; Sakoda H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1239, DOI 10.1152/ajpendo.00455.2001; Samarasinghe DA, 2000, HEPATOLOGY, V31, P160, DOI 10.1002/hep.510310124; Shen M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/954502; Shen M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/461536; Shiratori Y, 1998, DIGEST DIS SCI, V43, P1737, DOI 10.1023/A:1018879502520; Teoh NC, 2011, J GASTROEN HEPATOL, V26, P180, DOI 10.1111/j.1440-1746.2010.06584.x; Teoh NC, 2003, J GASTROEN HEPATOL, V18, P891, DOI 10.1046/j.1440-1746.2003.03056.x; Theodoraki K, 2011, SURG TODAY, V41, P620, DOI 10.1007/s00595-010-4444-4; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; TOLEDOPEREYRA LH, 1975, AM J SURG, V129, P513, DOI 10.1016/0002-9610(75)90308-6; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Verma G, 2012, J CELL PHYSIOL, V227, P1791, DOI 10.1002/jcp.22903; Wanner GA, 1996, SHOCK, V5, P34, DOI 10.1097/00024382-199601000-00008; Weigand K, 2012, HPB SURG, V2012, DOI [10.1155/2012/176723, DOI 10.1155/2012/176723]; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhang Shao, 2003, Zhonghua Gan Zang Bing Za Zhi, V11, P767; Zhou Y, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/706156	43	62	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108855	10.1371/journal.pone.0108855	http://dx.doi.org/10.1371/journal.pone.0108855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264893	gold, Green Submitted, Green Published			2022-12-27	WOS:000345745400135
J	Catalano, KJ; Maddux, BA; Szary, J; Youngren, JF; Goldfine, ID; Schaufele, F				Catalano, Karyn J.; Maddux, Betty A.; Szary, Jaroslaw; Youngren, Jack F.; Goldfine, Ira D.; Schaufele, Fred			Insulin Resistance Induced by Hyperinsulinemia Coincides with a Persistent Alteration at the Insulin Receptor Tyrosine Kinase Domain	PLOS ONE			English	Article							MEMBRANE GLYCOPROTEIN PC-1; DEPENDENT DIABETES-MELLITUS; PULSATILE INSULIN; NEGATIVE COOPERATIVITY; MONOCLONAL-ANTIBODIES; CONTINUOUS DELIVERY; GLUCOSE; AUTOPHOSPHORYLATION; HUMANS; RATS	Insulin resistance, the diminished response of target tissues to insulin, is associated with the metabolic syndrome and a predisposition towards diabetes in a growing proportion of the worldwide population. Under insulin resistant states, the cellular response of the insulin signaling pathway is diminished and the body typically responds by increasing serum insulin concentrations to maintain insulin signaling. Some evidence indicates that the increased insulin concentration may itself further dampen insulin response. If so, insulin resistance would worsen as the level of circulating insulin increases during compensation, which could contribute to the transition of insulin resistance to more severe disease. Here, we investigated the consequences of excess insulin exposure to insulin receptor (IR) activity. Cells chronically exposed to insulin show a diminished the level of IR tyrosine and serine autophosphorylation below that observed after short-term insulin exposure. The diminished IR response did not originate with IR internalization since IR amounts at the cell membrane were similar after short-and long-term insulin incubation. Forster resonance energy transfer between fluorophores attached to the IR tyrosine kinase (TK) domain showed that a change in the TK domain occurred upon prolonged, but not short-term, insulin exposure. Even though the altered 'insulin refractory' IR TK FRET and IR autophosphorylation levels returned to baseline (non-stimulated) levels after wash-out of the original insulin stimulus, subsequent short-term exposure to insulin caused immediate re-establishment of the insulin-refractory levels. This suggests that some cell-based 'memory' of chronic hyperinsulinemic exposure acts directly at the IR. An improved understanding of that memory may help define interventions to reset the IR to full insulin responsiveness and impede the progression of insulin resistance to more severe disease states.	[Catalano, Karyn J.; Maddux, Betty A.; Szary, Jaroslaw; Schaufele, Fred] Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA; [Catalano, Karyn J.; Maddux, Betty A.; Szary, Jaroslaw; Schaufele, Fred] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Maddux, Betty A.; Youngren, Jack F.; Goldfine, Ira D.] Univ Calif San Francisco, Div Endocrinol & Metab, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schaufele, F (corresponding author), Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA.	freds@diabetes.ucsf.edu			NovoNordisk Diabetes Innovation Award Program, a Pilot and Feasibility award; NIH; UCSF Diabetes and Endocrine Research Center [P30 DK063270]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER	NovoNordisk Diabetes Innovation Award Program, a Pilot and Feasibility award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Diabetes and Endocrine Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by an Early Exploration award from the NovoNordisk Diabetes Innovation Award Program, a Pilot and Feasibility award and support for the Diabetes Center Microscopy Core from the NIH-funded, UCSF Diabetes and Endocrine Research Center (P30 DK063270) and a Strategic Opportunities Support award from the NIH-funded UCSF Clinical and Translational Science Institute (UL1 RR024131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avignon A, 1996, DIABETES, V45, P1396, DOI 10.2337/diabetes.45.10.1396; BACKER JM, 1992, J CELL BIOL, V118, P831, DOI 10.1083/jcb.118.4.831; BAR RS, 1977, J CLIN ENDOCR METAB, V44, P1210, DOI 10.1210/jcem-44-6-1210; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; BRATUSCHMARRAIN PR, 1986, DIABETES, V35, P922, DOI 10.2337/diabetes.35.8.922; CARON M, 1994, METABOLISM, V43, P757, DOI 10.1016/0026-0495(94)90127-9; CHERQUI G, 1990, J BIOL CHEM, V265, P21254; Combettes-Souverain M, 1998, DIABETES METAB, V24, P477; CONSIDINE RV, 1995, J CLIN INVEST, V95, P2938, DOI 10.1172/JCI118001; Costanzo BV, 2001, DIABETES, V50, P831, DOI 10.2337/diabetes.50.4.831; Day RN, 2001, METHODS, V25, P4, DOI 10.1006/meth.2001.1211; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; DELPRATO S, 1993, METABOLISM, V42, P24, DOI 10.1016/0026-0495(93)90167-M; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; DICKENS M, 1992, BIOCHEM BIOPH RES CO, V186, P244, DOI 10.1016/S0006-291X(05)80799-5; Dong HJ, 2005, DIABETES, V54, P367, DOI 10.2337/diabetes.54.2.367; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FORSAYETH JR, 1987, J BIOL CHEM, V262, P4134; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; GAVIN JR, 1974, P NATL ACAD SCI USA, V71, P84, DOI 10.1073/pnas.71.1.84; Goldfine ID, 2008, ENDOCR REV, V29, P62, DOI 10.1210/er.2007-0004; HANSEN BC, 1982, J CLIN ENDOCR METAB, V54, P785, DOI 10.1210/jcem-54-4-785; HAWLEY DM, 1989, J BIOL CHEM, V264, P2438; Ishizuka T, 1998, J ENDOCRINOL, V156, P1, DOI 10.1677/joe.0.1560001; Kofoed EM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940366; Koopmans SJ, 1996, DIABETOLOGIA, V39, P391, DOI 10.1007/s001250050458; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; Li M, 2001, DIABETES, V50, P2323, DOI 10.2337/diabetes.50.10.2323; Luo RZT, 1999, SCIENCE, V285, P1077, DOI 10.1126/science.285.5430.1077; Maddux BA, 2006, AM J PHYSIOL-ENDOC M, V290, pE746, DOI 10.1152/ajpendo.00298.2005; MADDUX BA, 1995, NATURE, V373, P448, DOI 10.1038/373448a0; Maddux BA, 2000, DIABETES, V49, P13, DOI 10.2337/diabetes.49.1.13; Marban SL, 1996, TRANSGENIC HYPERINSU, P201; MATTHEWS DR, 1983, DIABETES, V32, P617, DOI 10.2337/diabetes.32.7.617; NANKERVIS A, 1985, DIABETOLOGIA, V28, P427, DOI 10.1007/BF00280885; PAOLISSO G, 1987, DIABETES, V36, P566, DOI 10.2337/diabetes.36.5.566; PAOLISSO G, 1988, J CLIN ENDOCR METAB, V66, P1220, DOI 10.1210/jcem-66-6-1220; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; Schlein M, 2000, J MOL BIOL, V303, P161, DOI 10.1006/jmbi.2000.4134; SCHMITZ O, 1986, ACTA ENDOCRINOL-COP, V113, P559, DOI 10.1530/acta.0.1130559; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Skrha J, 1996, HORM METAB RES, V28, P595, DOI 10.1055/s-2007-979860; WHITE MF, 1988, J BIOL CHEM, V263, P2969; Yip CC, 2003, J BIOL CHEM, V278, P27329, DOI 10.1074/jbc.R300021200; Youngren JF, 2007, CELL MOL LIFE SCI, V64, P873, DOI 10.1007/s00018-007-6359-9; Youngren JF, 1999, AM J PHYSIOL-ENDOC M, V276, pE990, DOI 10.1152/ajpendo.1999.276.5.E990	50	43	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108693	10.1371/journal.pone.0108693	http://dx.doi.org/10.1371/journal.pone.0108693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259572	gold, Green Published, Green Submitted			2022-12-27	WOS:000342685600094
J	Marubayashi, JM; Kliot, A; Yuki, VA; Rezende, JAM; Krause-Sakate, R; Pavan, MA; Ghanim, M				Marubayashi, Julio Massaharu; Kliot, Adi; Yuki, Valdir Atsushi; Marques Rezende, Jorge Alberto; Krause-Sakate, Renate; Pavan, Marcelo Agenor; Ghanim, Murad			Diversity and Localization of Bacterial Endosymbionts from Whitefly Species Collected in Brazil	PLOS ONE			English	Article							BEMISIA-TABACI HOMOPTERA; PEA APHID; HEMIPTERA ALEYRODIDAE; SECONDARY SYMBIONTS; HORIZONTAL TRANSMISSION; ACYRTHOSIPHON-PISUM; NATURAL-POPULATIONS; RICKETTSIA; WOLBACHIA; FITNESS	Whiteflies (Hemiptera: Aleyrodidae) are sap-sucking insect pests, and some cause serious damage in agricultural crops by direct feeding and by transmitting plant viruses. Whiteflies maintain close associations with bacterial endosymbionts that can significantly influence their biology. All whitefly species harbor a primary endosymbiont, and a diverse array of secondary endosymbionts. In this study, we surveyed 34 whitefly populations collected from the states of Sao Paulo, Bahia, Minas Gerais and Parana in Brazil, for species identification and for infection with secondary endosymbionts. Sequencing the mitochondrial Cytochrome Oxidase I gene revealed the existence of five whitefly species: The sweetpotato whitefly Bemisia tabaci B biotype (recently termed Middle East-Asia Minor 1 or MEAM1), the greenhouse whitefly Trialeurodes vaporariorum, B. tabaci A biotype (recently termed New World 2 or NW2) collected only from Euphorbia, the Acacia whitefly Tetraleurodes acaciae and Bemisia tuberculata both were detected only on cassava. Sequencing rRNA genes showed that Hamiltonella and Rickettsia were highly prevalent in all MEAM1 populations, while Cardinium was close to fixation in only three populations. Surprisingly, some MEAM1 individuals and one NW2 population were infected with Fritschea. Arsenopnohus was the only endosymbiont detected in T. vaporariorum. In T. acaciae and B. tuberculata populations collected from cassava, Wolbachia was fixed in B. tuberculata and was highly prevalent in T. acaciae. Interestingly, while B. tuberculata was additionally infected with Arsenophonus, T. acaciae was infected with Cardinium and Fritschea. Fluorescence in situ hybridization analysis on representative individuals showed that Hamiltonella, Arsenopnohus and Fritschea were localized inside the bacteriome, Cardinium and Wolbachia exhibited dual localization patterns inside and outside the bacteriome, and Rickettsia showed strict localization outside the bacteriome. This study is the first survey of whitely populations collected in Brazil, and provides further insights into the complexity of infection with secondary endosymionts in whiteflies.	[Marubayashi, Julio Massaharu; Kliot, Adi; Ghanim, Murad] Agr Res Org, Volcani Ctr, Dept Entomol, IL-50250 Bet Dagan, Israel; [Marubayashi, Julio Massaharu; Krause-Sakate, Renate; Pavan, Marcelo Agenor] UNESP, Fac Ciencias, Dept Fitossanidade, Botucatu, Sao Paolo, Brazil; [Yuki, Valdir Atsushi] Inst Agron Campinas, Campinas, Sao Paolo, Brazil; [Marques Rezende, Jorge Alberto] Escola Super Agr, Dept Fitopato & Nematol, Piracicaba, Sao Paolo, Brazil	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Universidade Estadual Paulista; Instituto Agronomico de Campinas (IAC)	Marubayashi, JM (corresponding author), Agr Res Org, Volcani Ctr, Dept Entomol, IL-50250 Bet Dagan, Israel.	julio@fca.unesp.br; ghanim@volcani.agri.gov.il	Rezende, Jorge A M/C-2726-2012; SAKATE, Renate/N-7292-2014; Kliot, Adi/ABF-1412-2020	Rezende, Jorge A M/0000-0002-4425-2758; SAKATE, Renate/0000-0001-7526-640X; Kliot, Adi/0000-0002-0370-0817; Marubayashi, Julio Massaharu/0000-0002-0793-344X; Agenor Pavan, Marcelo/0000-0003-3317-5096	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [9521/11-9]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	JMM received a fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) scholarship number 9521/11-9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemandri V, 2012, J ECON ENTOMOL, V105, P48, DOI 10.1603/EC11161; Alonso R. da S., 2012, EntomoBrasilis, V5, P78; Balas MT, 1996, EVOL ECOL, V10, P593, DOI 10.1007/BF01237709; Bigliardi E, 2006, TISSUE CELL, V38, P257, DOI 10.1016/j.tice.2006.06.001; Bing XL, 2013, APPL ENVIRON MICROB, V79, P569, DOI 10.1128/AEM.03030-12; Bouchery T, 2013, CLIN MICROBIOL INFEC, V19, P131, DOI 10.1111/1469-0691.12069; Brumin M, 2012, APPL ENVIRON MICROB, V78, P5565, DOI 10.1128/AEM.01184-12; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Caspi-Fluger A, 2012, P ROY SOC B-BIOL SCI, V279, P1791, DOI 10.1098/rspb.2011.2095; Chen DQ, 2000, ENTOMOL EXP APPL, V95, P315, DOI 10.1023/A:1004083324807; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Darby AC, 2003, ECOL ENTOMOL, V28, P145, DOI 10.1046/j.1365-2311.2003.00492.x; Darby AC, 2001, FEMS MICROBIOL ECOL, V36, P43, DOI 10.1111/j.1574-6941.2001.tb00824.x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Barro PJ, 2003, MOL ECOL NOTES, V3, P40, DOI 10.1046/j.1471-8286.2003.00344.x; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Ferrari J, 2004, ECOL ENTOMOL, V29, P60, DOI 10.1111/j.1365-2311.2004.00574.x; Firdaus S, 2013, INSECT SCI, V20, P723, DOI 10.1111/1744-7917.12001; Frohlich D., 1999, MOL ECOL, V8, P1593, DOI DOI 10.1046/J.1365-294X.1999.00754.X; Giorgini M, 2010, APPL ENVIRON MICROB, V76, P2589, DOI 10.1128/AEM.03154-09; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gray SM, 1999, MICROBIOL MOL BIOL R, V63, P128, DOI 10.1128/MMBR.63.1.128-148.1999; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0; Haynes S, 2003, APPL ENVIRON MICROB, V69, P7216, DOI 10.1128/AEM.69.12.7216-7223.2003; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hunter MS, 2003, P ROY SOC B-BIOL SCI, V270, P2185, DOI 10.1098/rspb.2003.2475; Jones CM, 2008, PEST MANAG SCI, V64, P12, DOI 10.1002/ps.1482; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Lawson ET, 2001, HEREDITY, V86, P497, DOI 10.1046/j.1365-2540.2001.00848.x; Lourencao AL, 2008, NEOTROP ENTOMOL, V37, P89, DOI 10.1590/S1519-566X2008000100014; Marubayashi JM, 2013, J APPL ENTOMOL, V137, P113, DOI 10.1111/j.1439-0418.2012.01714.x; Marubayashi JM, 2010, REV RAIZES AMIDOS TR, V6, P92; Matalon Y, 2007, J INVERTEBR PATHOL, V96, P106, DOI 10.1016/j.jip.2007.02.010; Mitsuhashi W, 2002, INSECT MOL BIOL, V11, P577, DOI 10.1046/j.1365-2583.2002.00368.x; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Muyzer G, 1996, MOL MICROBIAL ECOLOG, P1; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; Nirgianaki A, 2003, CURR MICROBIOL, V47, P93, DOI 10.1007/s00284-002-3969-1; Perotti MA, 2006, FASEB J, V20, P2372, DOI 10.1096/fj.06-5870fje; Rabello AR, 2008, GENET MOL BIOL, V31, P585, DOI 10.1590/S1415-47572008000300029; Ricci I, 2012, CURR OPIN MICROBIOL, V15, P278, DOI 10.1016/j.mib.2012.03.004; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Schulenburg JHGV, 2001, APPL ENVIRON MICROB, V67, P270, DOI 10.1128/AEM.67.1.270-277.2001; Scott I. A. W., 2007, New Zealand Plant Protection, V60, P264; Sintupachee S, 2006, MICROB ECOL, V51, P294, DOI 10.1007/s00248-006-9036-x; Skaljac M, 2013, B ENTOMOL RES, V103, P48, DOI 10.1017/S0007485312000399; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Sloan DB, 2012, BIOL LETTERS, V8, P986, DOI 10.1098/rsbl.2012.0664; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Thao ML, 2003, CURR MICROBIOL, V47, P46, DOI 10.1007/s00284-002-3953-9; Thao MLL, 2004, CURR MICROBIOL, V48, P140, DOI 10.1007/s00284-003-4157-7; Tsuchida T, 2002, MOL ECOL, V11, P2123, DOI 10.1046/j.1365-294X.2002.01606.x; Ueda S, 2006, PHYTOPARASITICA, V34, P405, DOI 10.1007/BF02981027; Vautrin E, 2008, J EVOLUTION BIOL, V21, P145, DOI 10.1111/j.1420-9101.2007.01460.x; Vautrin E, 2009, TRENDS MICROBIOL, V17, P95, DOI 10.1016/j.tim.2008.12.002; Weeks AR, 2003, P ROY SOC B-BIOL SCI, V270, P1857, DOI 10.1098/rspb.2003.2425; Wernegreen JJ, 2004, PLOS BIOL, V2, P307, DOI 10.1371/journal.pbio.0020068; WERREN JH, 1994, J BACTERIOL, V176, P388, DOI 10.1128/JB.176.2.388-394.1994; Yusuf M, 2004, J STORED PROD RES, V40, P207, DOI 10.1016/S0022-474X(02)00098-X; Zchori-Fein E, 2001, P NATL ACAD SCI USA, V98, P12555, DOI 10.1073/pnas.221467498; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2	69	46	47	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108363	10.1371/journal.pone.0108363	http://dx.doi.org/10.1371/journal.pone.0108363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259930	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600067
J	Nuruzzaman, M; Kanno, T; Amada, R; Habu, Y; Kasajima, I; Ishikawa, T; Kawai-Yamada, M; Uchimiya, H				Nuruzzaman, Mohammed; Kanno, Tatsuo; Amada, Rika; Habu, Yoshiki; Kasajima, Ichiro; Ishikawa, Toshiki; Kawai-Yamada, Maki; Uchimiya, Hirofumi			Does the Upstream Region Possessing MULE-Like Sequence in Rice Upregulate PsbS1 Gene Expression?	PLOS ONE			English	Article							MUTATOR TRANSPOSABLE ELEMENT; ORIGIN; FLUORESCENCE; GROWTH; DOMESTICATION; DUPLICATIONS; DISPERSAL; DIVERSITY; EVOLUTION; HISTORY	The genomic nucleotide sequences of japonica rice (Sasanishiki and Nipponbare) contained about 2.7-kb unique region at the point of 0.4-kb upstream of the OsPsbS1 gene. In this study, we found that japonica rice with a few exceptions possessing such DNA sequences [denoted to OsMULE-japonica specific sequence (JSS)] is distinct by the presence of Mutator-like-element (MULE). Such sequence was absent in most of indica cultivars and Oryza glaberrima. In OsMULE-JSS1, we noted the presence of possible target site duplication (TSD; CTTTTCCAG) and about 80-bp terminal inverted repeat (TIR) near TSD. We also found the enhancement ofOsPsbS1 mRNA accumulation by intensified light, which was not associated with the DNA methylation status in OsMULE/JSS. In addition, O. rufipogon, possible ancestor of modern rice cultivars was found to compose PsbS gene of either japonica (minor) or indica (major) type. Transient gene expression assay showed that the japonica type promoter elevated a reporter gene activity than indica type.	[Nuruzzaman, Mohammed; Amada, Rika; Kawai-Yamada, Maki; Uchimiya, Hirofumi] Saitama Univ, Inst Environm Sci & Technol, Saitama 3388570, Japan; [Kanno, Tatsuo] Japanese Sci & Technol Agcy, PRESTO, Saitama, Japan; [Kanno, Tatsuo; Habu, Yoshiki] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Plant Genome Engn Res Unit, Ibaraki, Japan; [Kasajima, Ichiro] Natl Agr & Food Res Org, Inst Floricultural Sci, Tsukuba, Ibaraki, Japan; [Nuruzzaman, Mohammed; Ishikawa, Toshiki; Kawai-Yamada, Maki] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan	Saitama University; Japan Science & Technology Agency (JST); National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan; Saitama University	Uchimiya, H (corresponding author), Saitama Univ, Inst Environm Sci & Technol, Saitama 3388570, Japan.	cuchimiya@hotmail.com	Kawai-Yamada, Maki/B-2739-2012; Ishikawa, Toshiki/F-6970-2018	Kawai-Yamada, Maki/0000-0002-8732-052X; Ishikawa, Toshiki/0000-0001-8083-6542; KANNO, Tatsuo/0000-0001-5958-4686	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [24580016] Funding Source: KAKEN	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a grant from the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN), grants from Ministry of Education, Culture, Sports, Science and Technology (MEXT; (http://www.mext.go.jp/english/)), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benito MI, 1997, MOL CELL BIOL, V17, P5165, DOI 10.1128/MCB.17.9.5165; Bennetzen JL, 1996, CURR TOP MICROBIOL, V204, P195; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; CHANDLER VL, 1992, ADV GENET, V30, P77, DOI 10.1016/S0065-2660(08)60319-3; CHANG TT, 1976, EUPHYTICA, V25, P425, DOI 10.1007/BF00041576; Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; CRESSE AD, 1995, GENETICS, V140, P315; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dietrich CR, 2002, GENETICS, V160, P697; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Hiei Y, 1997, PLANT MOL BIOL, V35, P205, DOI 10.1023/A:1005847615493; Higham C, 1998, ANTIQUITY, V72, P867, DOI 10.1017/S0003598X00087500; HUANG CJ, 1986, GENE, V41, P23; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Juretic N, 2005, GENOME RES, V15, P1292, DOI 10.1101/gr.4064205; Kasajima I, 2011, P NATL ACAD SCI USA, V108, P13835, DOI 10.1073/pnas.1104809108; Kasajima I, 2009, PLANT CELL PHYSIOL, V50, P1600, DOI 10.1093/pcp/pcp102; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; Kovach MJ, 2009, P NATL ACAD SCI USA, V106, P14444, DOI 10.1073/pnas.0904077106; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Lisch Damon, 2009, P277, DOI 10.1007/978-0-387-77863-1_14; Liu L, 2007, HOLOCENE, V17, P1059, DOI 10.1177/0959683607085121; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; MORISHIMA H, 1979, AGRO-ECOSYSTEMS, V5, P263, DOI 10.1016/0304-3746(79)90006-4; Numa H, 2010, EMBO J, V29, P352, DOI 10.1038/emboj.2009.374; ROBERTSON DS, 1978, MUTAT RES, V51, P21, DOI 10.1016/0027-5107(78)90004-0; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Tan BC, 2011, G3-GENES GENOM GENET, V1, P293, DOI 10.1534/g3.111.000398; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; WALBOT V, 2002, MOBILE DNA, V533; Yoshizumi T, 1999, PLANT CELL, V11, P1883, DOI 10.1105/tpc.11.10.1883; Zhang LB, 2009, NEW PHYTOL, V184, P708, DOI 10.1111/j.1469-8137.2009.02984.x; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	40	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e102742	10.1371/journal.pone.0102742	http://dx.doi.org/10.1371/journal.pone.0102742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259844	Green Submitted, gold, Green Published			2022-12-27	WOS:000342685600002
J	Xu, HM; Sun, XW; Qi, T; Lin, WY; Liu, NJ; Lou, XY				Xu, Hai-Ming; Sun, Xi-Wei; Qi, Ting; Lin, Wan-Yu; Liu, Nianjun; Lou, Xiang-Yang			Multivariate Dimensionality Reduction Approaches to Identify Gene-Gene and Gene-Environment Interactions Underlying Multiple Complex Traits	PLOS ONE			English	Article							GENERALIZED LINEAR-MODELS; QUANTITATIVE TRAITS; ESTIMATING EQUATIONS; NICOTINE DEPENDENCE; COMBINATORIAL APPROACH; LINKAGE ANALYSES; HUMAN-DISEASES; SUBUNIT GENE; ASSOCIATION; FAMILY	The elusive but ubiquitous multifactor interactions represent a stumbling block that urgently needs to be removed in searching for determinants involved in human complex diseases. The dimensionality reduction approaches are a promising tool for this task. Many complex diseases exhibit composite syndromes required to be measured in a cluster of clinical traits with varying correlations and/or are inherently longitudinal in nature (changing over time and measured dynamically at multiple time points). A multivariate approach for detecting interactions is thus greatly needed on the purposes of handling a multifaceted phenotype and longitudinal data, as well as improving statistical power for multiple significance testing via a two-stage testing procedure that involves a multivariate analysis for grouped phenotypes followed by univariate analysis for the phenotypes in the significant group(s). In this article, we propose a multivariate extension of generalized multifactor dimensionality reduction (GMDR) based on multivariate generalized linear, multivariate quasi-likelihood and generalized estimating equations models. Simulations and real data analysis for the cohort from the Study of Addiction: Genetics and Environment are performed to investigate the properties and performance of the proposed method, as compared with the univariate method. The results suggest that the proposed multivariate GMDR substantially boosts statistical power.	[Xu, Hai-Ming; Sun, Xi-Wei; Qi, Ting] Zhejiang Univ, Inst Bioinformat, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Hai-Ming] Zhejiang Univ, Res Ctr Air Pollut & Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Wan-Yu] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Liu, Nianjun; Lou, Xiang-Yang] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA	Zhejiang University; Zhejiang University; National Taiwan University; University of Alabama System; University of Alabama Birmingham	Lou, XY (corresponding author), Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA.	xylou@uab.edu	Xu, Haiming/AAF-8067-2019; Qi, Ting/D-2705-2017; Sun, Xiwei/HGD-7726-2022	Qi, Ting/0000-0001-5868-0799; LIN, WAN-YU/0000-0002-3385-4702	NIH Grants [DA025095, GM081488]; National Basic Research Program of China (973 Program) [2011CB109306, 2010CB126006]; National Natural Science Foundation [31271608]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025095] Funding Source: NIH RePORTER	NIH Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported in part by NIH Grants DA025095 (XYL) and GM081488 (NL), the National Basic Research Program of China (973 Program 2011CB109306 and 2010CB126006) and the National Natural Science Foundation 31271608 (HMX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1998, AM J HUM GENET, V63, P1190, DOI 10.1086/302038; Allison DB, 1998, GENET EPIDEMIOL, V15, P87, DOI 10.1002/(SICI)1098-2272(1998)15:1<87::AID-GEPI7>3.0.CO;2-1; AMOS CI, 1990, AM J HUM GENET, V47, P247; Beuten J, 2005, AM J MED GENET B, V139B, P73, DOI 10.1002/ajmg.b.30231; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chen GB, 2013, HUM GENET; Choi J, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S6-S15; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Culverhouse R, 2004, GENET EPIDEMIOL, V27, P141, DOI 10.1002/gepi.20006; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Evans DM, 2004, BEHAV GENET, V34, P135, DOI 10.1023/B:BEGE.0000013727.15845.f8; Feng Y, 2004, AM J HUM GENET, V75, P112, DOI 10.1086/422194; Ferreira MAR, 2006, EUR J HUM GENET, V14, P953, DOI 10.1038/sj.ejhg.5201646; Ferreira MAR, 2009, BIOINFORMATICS, V25, P132, DOI 10.1093/bioinformatics/btn563; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Heidema AG, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-23; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2002, STAT MODEL, V2, P163, DOI 10.1191/1471082x02st031oa; Li MD, 2005, HUM MOL GENET, V14, P1211, DOI 10.1093/hmg/ddi132; Li MD, 2008, BIOL PSYCHIAT, V64, P951, DOI 10.1016/j.biopsych.2008.04.026; Li RH, 2006, PLOS GENET, V2, P1046, DOI 10.1371/journal.pgen.0020114; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Liu JF, 2007, AM J HUM GENET, V81, P304, DOI 10.1086/519495; Lou XY, 2008, AM J HUM GENET, V83, P457, DOI 10.1016/j.ajhg.2008.09.001; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Macgregor S, 2005, GENETICS, V171, P1365, DOI 10.1534/genetics.105.043828; Mariani E, 2007, J ALZHEIMERS DIS, V12, P23; Mei H, 2007, AM J HUM GENET, V81, P1251, DOI 10.1086/522307; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; Piper ME, 2006, NICOTINE TOB RES, V8, P339, DOI 10.1080/14622200600672765; PRENTICE RL, 1991, BIOMETRICS, V47, P825, DOI 10.2307/2532642; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Schork NJ, 1997, AM J RESP CRIT CARE, V156, pS103, DOI 10.1164/ajrccm.156.4.12-tac-5; Sing CF, 2003, ARTERIOSCL THROM VAS, V23, P1190, DOI 10.1161/01.ATV.0000075081.51227.86; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; WEDDERBURN RWM, 1974, BIOMETRIKA, V61, P439, DOI 10.2307/2334725; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhu ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061943; Zorn CJW, 2001, AM J POLIT SCI, V45, P470, DOI 10.2307/2669353	47	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108103	10.1371/journal.pone.0108103	http://dx.doi.org/10.1371/journal.pone.0108103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259584	gold, Green Published			2022-12-27	WOS:000342685600046
J	Rakshambikai, R; Gnanavel, M; Srinivasan, N				Rakshambikai, Ramaswamy; Gnanavel, Mutharasu; Srinivasan, Narayanaswamy			Hybrid and Rogue Kinases Encoded in the Genomes of Model Eukaryotes	PLOS ONE			English	Article							PROTEIN-KINASES; SAM DOMAIN; EVOLUTION; YEAST; STIMULATION; COMBINATION; ACTIVATION; EXPRESSION; PARASITE; CHANNELS	The highly modular nature of protein kinases generates diverse functional roles mediated by evolutionary events such as domain recombination, insertion and deletion of domains. Usually domain architecture of a kinase is related to the subfamily to which the kinase catalytic domain belongs. However outlier kinases with unusual domain architectures serve in the expansion of the functional space of the protein kinase family. For example, Src kinases are made-up of SH2 and SH3 domains in addition to the kinase catalytic domain. A kinase which lacks these two domains but retains sequence characteristics within the kinase catalytic domain is an outlier that is likely to have modes of regulation different from classical src kinases. This study defines two types of outlier kinases: hybrids and rogues depending on the nature of domain recombination. Hybrid kinases are those where the catalytic kinase domain belongs to a kinase subfamily but the domain architecture is typical of another kinase subfamily. Rogue kinases are those with kinase catalytic domain characteristic of a kinase subfamily but the domain architecture is typical of neither that subfamily nor any other kinase subfamily. This report provides a consolidated set of such hybrid and rogue kinases gleaned from six eukaryotic genomes-S. cerevisiae, D. melanogaster, C. elegans, M. musculus, T. rubripes and H. sapiens-and discusses their functions. The presence of such kinases necessitates a revisiting of the classification scheme of the protein kinase family using full length sequences apart from classical classification using solely the sequences of kinase catalytic domains. The study of these kinases provides a good insight in engineering signalling pathways for a desired output. Lastly, identification of hybrids and rogues in pathogenic protozoa such as P. falciparum sheds light on possible strategies in host-pathogen interactions.	[Rakshambikai, Ramaswamy; Gnanavel, Mutharasu; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Srinivasan, N (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	ns@mbu.iisc.ernet.in			Department of Biotechnology part of the Ministry of Science and Technology, Government of India	Department of Biotechnology part of the Ministry of Science and Technology, Government of India	The work embodied in the manuscript is supported by the Department of Biotechnology which is a part of the Ministry of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Apic G, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139pe30; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Bashton M, 2007, STRUCTURE, V15, P85, DOI 10.1016/j.str.2006.11.009; Basu MK, 2008, GENOME RES, V18, P449, DOI 10.1101/gr.6943508; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bhaskara RM, 2014, MOL BIOSYSTEMS; Bhattacharjya S, 2005, PROTEIN SCI, V14, P828, DOI 10.1110/ps.041122105; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; da Silva Xavier G, 2004, P NATL ACAD SCI USA, V101, P8319, DOI 10.1073/pnas.0307737101; Daram P, 1997, EMBO J, V16, P3455, DOI 10.1093/emboj/16.12.3455; Doerig C, 2010, CELL HOST MICROBE, V8, P305, DOI 10.1016/j.chom.2010.10.002; Doerig C, 2010, BBA-PROTEINS PROTEOM, V1804, P604, DOI 10.1016/j.bbapap.2009.10.009; Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Eddy Sean R, 2009, Genome Inform, V23, P205; Ehrhardt T, 1997, FEBS LETT, V409, P166, DOI 10.1016/S0014-5793(97)00502-4; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Forslund K, 2008, BIOINFORMATICS, V24, P1681, DOI 10.1093/bioinformatics/btn312; FUJII M, 1995, FEBS LETT, V375, P263, DOI 10.1016/0014-5793(95)01223-2; Furukawa K, 2013, MOL MICROBIOL, V88, P5, DOI 10.1111/mmi.12174; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Grassot J, 2006, MOL BIOL EVOL, V23, P1232, DOI 10.1093/molbev/msk007; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Harris BZ, 2001, J CELL SCI, V114, P3219; Honeyman JN, 2014, SCIENCE, V343, P1010, DOI 10.1126/science.1249484; Karginov AV, 2010, NAT BIOTECHNOL, V28, P743, DOI 10.1038/nbt.1639; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Krupa A, 2002, GENOME BIOL, V3; Krupa A, 2004, NUCLEIC ACIDS RES, V32, pD153, DOI 10.1093/nar/gkh019; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee S, 2002, MOL CELL BIOL, V22, P1778, DOI 10.1128/MCB.22.6.1778-1791.2002; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Marsh JA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-126; Martin J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012460; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Miranda-Saavedra D, 2012, MICROBES INFECT, V14, P796, DOI 10.1016/j.micinf.2012.04.007; NORLING LL, 1994, CELL CALCIUM, V16, P137, DOI 10.1016/0143-4160(94)90008-6; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; PAWSON T, 1994, MOLECULAR AND CELLULAR BASIS FOR CELL TO CELL INTERACTION: ITS SIGNIFICANCE IN CANCER, P303; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Rakshambikai R, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/258284; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Shoval Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017344; Slaughter BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001931; Soliz J, 2008, AM J PHYSIOL-REG I, V295, pR649, DOI 10.1152/ajpregu.00876.2007; Sondermann H, 2005, CELL, V121, P158, DOI 10.1016/j.cell.2005.04.001; Stewart M, 1990, CURR OPIN CELL BIOL, V2, P91, DOI 10.1016/S0955-0674(05)80037-7; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Talevich E, 2012, PHILOS T R SOC B, V367, P2607, DOI 10.1098/rstb.2012.0014; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voets E, 2010, CELL CYCLE, V9, P3591, DOI 10.4161/cc.9.17.12832; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Wang ML, 2006, MOL BIOL EVOL, V23, P2444, DOI 10.1093/molbev/msl117; Williams JC, 1998, TRENDS BIOCHEM SCI, V23, P179, DOI 10.1016/S0968-0004(98)01202-X; Xavier GD, 2011, DIABETOLOGIA, V54, P819, DOI 10.1007/s00125-010-2010-7; Yadav SS, 2009, BIOCHEMISTRY-US, V48, P10956, DOI 10.1021/bi900978f; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; Zimmermann S, 2001, PLANT J, V28, P517, DOI 10.1046/j.1365-313X.2001.01177.x	70	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107956	10.1371/journal.pone.0107956	http://dx.doi.org/10.1371/journal.pone.0107956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255313	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000344862300046
J	De Simone, M; Spagnuolo, L; Lore, NI; Rossi, G; Cigana, C; De Fino, I; Iraqi, FA; Bragonzi, A				De Simone, Maura; Spagnuolo, Lorenza; Lore, Nicola Ivan; Rossi, Giacomo; Cigana, Cristina; De Fino, Ida; Iraqi, Fuad A.; Bragonzi, Alessandra			Host Genetic Background Influences the Response to the Opportunistic Pseudomonas aeruginosa Infection Altering Cell-Mediated Immunity and Bacterial Replication	PLOS ONE			English	Article							FIBROSIS LUNG INFECTION; INBRED MOUSE STRAINS; CYSTIC-FIBROSIS; NATURAL-RESISTANCE; BALB/C MICE; DISEASE; SUSCEPTIBILITY; DISSECTION; MODELS; A/J	Pseudomonas aeruginosa is a common cause of healthcare-associated infections including pneumonia, bloodstream, urinary tract, and surgical site infections. The clinical outcome of P. aeruginosa infections may be extremely variable among individuals at risk and patients affected by cystic fibrosis. However, risk factors for P. aeruginosa infection remain largely unknown. To identify and track the host factors influencing P. aeruginosa lung infections, inbred immunocompetent mouse strains were screened in a pneumonia model system. A/J, BALB/cJ, BALB/cAnNCrl, BALB/cByJ, C3H/HeOuJ, C57BL/6J, C57BL/6NCrl, DBA/2J, and 129S2/SvPasCRL mice were infected with P. aeruginosa clinical strain and monitored for body weight and mortality up to seven days. The most deviant survival phenotypes were observed for A/J, 129S2/SvPasCRL and DBA/2J showing high susceptibility while BALB/cAnNCrl and C3H/HeOuJ showing more resistance to P. aeruginosa infection. Next, one of the most susceptible and resistant mouse strains were characterized for their deviant clinical and immunological phenotype by scoring bacterial count, cell-mediated immunity, cytokines and chemokines profile and lung pathology in an early time course. Susceptible A/J mice showed significantly higher bacterial burden, higher cytokines and chemokines levels but lower leukocyte recruitment, particularly neutrophils, when compared to C3H/HeOuJ resistant mice. Pathologic scores showed lower inflammatory severity, reduced intraluminal and interstitial inflammation extent, bronchial and parenchymal involvement and diminished alveolar damage in the lungs of A/J when compared to C3H/HeOuJ. Our findings indicate that during an early phase of infection a prompt inflammatory response in the airways set the conditions for a nonpermissive environment to P. aeruginosa replication and lock the spread to other organs. Host gene(s) may have a role in the reduction of cell-mediated immunity playing a critical role in the control of P. aeruginosa infection. These results now provide a basis for mapping genomic regions underlying host susceptibility to P. aeruginosa infection.	[De Simone, Maura; Spagnuolo, Lorenza; Lore, Nicola Ivan; Cigana, Cristina; De Fino, Ida; Bragonzi, Alessandra] Ist Sci San Raffaele, Infect & Cyst Fibrosis Unit, IRCCS, I-20132 Milan, Italy; [Rossi, Giacomo] Univ Camerino, Sch Biosci & Vet Med, I-62032 Camerino, Italy; [Iraqi, Fuad A.] Tel Aviv Univ, Sackler Fac Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Camerino; Tel Aviv University; Sackler Faculty of Medicine	Bragonzi, A (corresponding author), Ist Sci San Raffaele, Infect & Cyst Fibrosis Unit, IRCCS, I-20132 Milan, Italy.	bragonzi.alessandra@hsr.it	Bragonzi, Alessandra/AAC-6751-2022; De Fino, Ida/AAN-5189-2020; Lorè, Nicola Ivan/K-9285-2016; Cigana, Cristina/D-2883-2016; Rossi, Giacomo/HCI-9726-2022	De Fino, Ida/0000-0002-5747-7155; Lorè, Nicola Ivan/0000-0001-9159-1632; Cigana, Cristina/0000-0003-0436-9721; rossi, giacomo/0000-0001-8617-5984; Bragonzi, Alessandra/0000-0002-5808-7669	Ministero della Salute [GR/2009/1579812]	Ministero della Salute(Ministry of Health, Italy)	This study was supported by Ministero della Salute (project GR/2009/1579812) to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin TM, 2003, INFECT IMMUN, V71, P6830, DOI 10.1128/IAI.71.12.6830-6834.2003; Bianconi I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001270; Bragonzi A, 2010, INT J MED MICROBIOL, V300, P584, DOI 10.1016/j.ijmm.2010.08.012; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Buer J, 2003, NAT REV GENET, V4, P195, DOI 10.1038/nrg1019; Calum H, 2003, APMIS, V111, P891, DOI 10.1034/j.1600-0463.2003.1110907.x; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Cigana C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/852513; Cigana C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008439; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; Facchini M, 2014, JOVE-J VIS EXP, V17, P85; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; GERVAIS F, 1984, J IMMUNOL, V132, P2078; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Gruenheid S, 2010, CLIN EXP IMMUNOL, V162, P393, DOI 10.1111/j.1365-2249.2010.04249.x; Guillot L, 2014, INT J BIOCH CELL BIO; Jagannath C, 2000, SCAND J IMMUNOL, V52, P369, DOI 10.1046/j.1365-3083.2000.00770.x; Lore NI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035648; Morissette C, 1996, INFECT IMMUN, V64, P4984, DOI 10.1128/IAI.64.12.4984-4992.1996; MORISSETTE C, 1995, INFECT IMMUN, V63, P1718, DOI 10.1128/IAI.63.5.1718-1724.1995; Moser C, 1997, APMIS, V105, P838, DOI 10.1111/j.1699-0463.1997.tb05092.x; Nguyen D, 2006, P NATL ACAD SCI USA, V103, P8305, DOI 10.1073/pnas.0602526103; Paroni M, 2013, J INFECT DIS, V208, P130, DOI 10.1093/infdis/jis636; PENNINGTON JE, 1979, J INFECT DIS, V139, P396, DOI 10.1093/infdis/139.4.396; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; PLANT J, 1974, NATURE, V248, P345, DOI 10.1038/248345a0; Sapru K, 1999, CLIN EXP IMMUNOL, V115, P103; Schughart K, 2012, NATURE, V492, P41, DOI 10.1038/492041c; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; Tam M, 1999, AM J RESP CELL MOL, V20, P710, DOI 10.1165/ajrcmb.20.4.3223; Trammell RA, 2008, EXPERT REV MOL DIAGN, V8, P515, DOI 10.1586/14737159.8.4.515; Tuite A, 2005, GENES IMMUN, V6, P672, DOI 10.1038/sj.gene.6364254; Vidal SM, 2008, ANNU REV IMMUNOL, V26, P81, DOI 10.1146/annurev.immunol.26.021607.090304; Weiler CA, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00040; Wilson KR, 2007, MICROBIOL-SGM, V153, P968, DOI 10.1099/mic.0.2006/002261-0	35	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106873	10.1371/journal.pone.0106873	http://dx.doi.org/10.1371/journal.pone.0106873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268734	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700023
J	Katagiri, S; Akahori, M; Sergeev, Y; Yoshitake, K; Ikeo, K; Furuno, M; Hayashi, T; Kondo, M; Ueno, S; Tsunoda, K; Shinoda, K; Kuniyoshi, K; Tsurusaki, Y; Matsumoto, N; Tsuneoka, H; Iwata, T				Katagiri, Satoshi; Akahori, Masakazu; Sergeev, Yuri; Yoshitake, Kazutoshi; Ikeo, Kazuho; Furuno, Masaaki; Hayashi, Takaaki; Kondo, Mineo; Ueno, Shinji; Tsunoda, Kazushige; Shinoda, Kei; Kuniyoshi, Kazuki; Tsurusaki, Yohinori; Matsumoto, Naomichi; Tsuneoka, Hiroshi; Iwata, Takeshi			Whole Exome Analysis Identifies Frequent CNGA1 Mutations in Japanese Population with Autosomal Recessive Retinitis Pigmentosa	PLOS ONE			English	Article							CGMP-GATED CHANNEL; RHODOPSIN GENE; MISSENSE MUTATION; ARRESTIN GENE; ALPHA-SUBUNIT; EYS GENE; ORTHOLOG; DYSTROPHIES	Objective: The purpose of this study was to investigate frequent disease-causing gene mutations in autosomal recessive retinitis pigmentosa (arRP) in the Japanese population. Methods: In total, 99 Japanese patients with non-syndromic and unrelated arRP or sporadic RP (spRP) were recruited in this study and ophthalmic examinations were conducted for the diagnosis of RP. Among these patients, whole exome sequencing analysis of 30 RP patients and direct sequencing screening of all CNGA1 exons of the other 69 RP patients were performed. Results: Whole exome sequencing of 30 arRP/spRP patients identified disease-causing gene mutations of CNGA1 (four patients), EYS (three patients) and SAG (one patient) in eight patients and potential disease-causing gene variants of USH2A (two patients), EYS (one patient), TULP1 (one patient) and C2orf71 (one patient) in five patients. Screening of an additional 69 arRP/spRP patients for the CNGA1 gene mutation revealed one patient with a homozygous mutation. Conclusions: This is the first identification of CNGA1 mutations in arRP Japanese patients. The frequency of CNGA1 gene mutation was 5.1% (5/99 patients). CNGA1 mutations are one of the most frequent arRP-causing mutations in Japanese patients.	[Katagiri, Satoshi; Akahori, Masakazu; Iwata, Takeshi] Natl Hosp Org, Tokyo Med Ctr, Natl Inst Sensory Organs, Div Mol & Cellular Biol, Tokyo, Japan; [Katagiri, Satoshi; Hayashi, Takaaki; Tsuneoka, Hiroshi] Jikei Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Sergeev, Yuri] NEI, NIH, Bethesda, MD 20892 USA; [Yoshitake, Kazutoshi; Ikeo, Kazuho] Natl Inst Genet, Lab DNA Data Anal, Shizuoka, Japan; [Furuno, Masaaki] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Life Sci Accelerator Technol Grp, Yokohama, Kanagawa, Japan; [Kondo, Mineo] Mie Univ, Grad Sch Med, Dept Ophthalmol, Tsu, Mie 514, Japan; [Ueno, Shinji] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan; [Tsunoda, Kazushige] Natl Inst Sensory Organs, Lab Visual Physiol, Tokyo, Japan; [Shinoda, Kei] Teikyo Univ, Sch Med, Dept Ophthalmol, Tokyo 173, Japan; [Kuniyoshi, Kazuki] Kinki Univ, Fac Med, Dept Ophthalmol, Osaka, Japan; [Tsurusaki, Yohinori; Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Yokohama, Kanagawa 232, Japan	Jikei University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; RIKEN; Mie University; Nagoya University; Teikyo University; Kindai University (Kinki University); Yokohama City University	Iwata, T (corresponding author), Natl Hosp Org, Tokyo Med Ctr, Natl Inst Sensory Organs, Div Mol & Cellular Biol, Tokyo, Japan.	iwatatakeshi@kankakuki.go.jp	Ueno, Shinji/M-5063-2014; Shinoda, Kei/ABC-7993-2020	Shinoda, Kei/0000-0002-1543-9345; Tsurusaki, Yoshinori/0000-0002-7240-6355; Katagiri, Satoshi/0000-0001-7787-8194	Ministry of Health, Labor, and Welfare of Japan [13803661]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25462744, 25462738]; Vehicle Racing Commemorative Foundation; RIKEN Omics Science Center MEXT; NATIONAL EYE INSTITUTE [ZIAEY000476] Funding Source: NIH RePORTER	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; RIKEN Omics Science Center MEXT; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the grants to T.I. from the Ministry of Health, Labor, and Welfare of Japan (13803661); to M.A. and T.H. from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant-in-Aid for Scientific Research C, 25462744 and 25462738); to T.H. from the Vehicle Racing Commemorative Foundation; and to M.F. from the Research Grant for RIKEN Omics Science Center MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Aziz MM, 2008, NAT GENET, V40, P1285, DOI 10.1038/ng.241; Abd El-Aziz MM, 2010, INVEST OPHTH VIS SCI, V51, P4266, DOI 10.1167/iovs.09-5109; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Audo I, 2010, HUM MUTAT, V31, pE1406, DOI 10.1002/humu.21249; Bandah-Rozenfeld D, 2010, INVEST OPHTH VIS SCI, V51, P4387, DOI 10.1167/iovs.09-4732; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Chen XJ, 2013, INVEST OPHTH VIS SCI, V54, P2186, DOI 10.1167/iovs.12-10967; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; Collin RWJ, 2010, AM J HUM GENET, V86, P783, DOI 10.1016/j.ajhg.2010.03.016; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; FUJIKI K, 1992, JPN J HUM GENET, V37, P125, DOI 10.1007/BF01899733; FUJIKI K, 1995, JPN J HUM GENET, V40, P271, DOI 10.1007/BF01876186; Gonzalez-del Pozo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027894; Hagstrom SA, 1998, NAT GENET, V18, P174, DOI 10.1038/ng0298-174; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hosono K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031036; Iwanami M, 2012, INVEST OPHTH VIS SCI, V53, P1033, DOI 10.1167/iovs.11-9048; Jin ZB, 2008, J MED GENET, V45, P465, DOI 10.1136/jmg.2007.056416; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Katagiri S, 2013, MOL VIS, V19, P2393; Klevering BJ, 2004, EUR J HUM GENET, V12, P1024, DOI 10.1038/sj.ejhg.5201258; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mansergh FC, 1999, AM J HUM GENET, V64, P971, DOI 10.1086/302344; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nakazawa M, 1998, ARCH OPHTHALMOL-CHIC, V116, P498, DOI 10.1001/archopht.116.4.498; Paloma E, 2002, J MED GENET, V39, DOI 10.1136/jmg.39.10.e66; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; SAGA M, 1994, OPHTHALMIC GENET, V15, P61, DOI 10.3109/13816819409098865; Shanks ME, 2013, EUR J HUM GENET, V21, P274, DOI 10.1038/ejhg.2012.172; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shuart NG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1466; Zhang QJ, 2004, MOL VIS, V10, P884	35	49	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108721	10.1371/journal.pone.0108721	http://dx.doi.org/10.1371/journal.pone.0108721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268133	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700148
J	Lange, C; Seese, A; Schwarzenbock, S; Steinhoff, K; Umland-Seidler, B; Krause, BJ; Brenner, W; Sabri, O; Kurth, J; Hesse, S; Buchert, R				Lange, Catharina; Seese, Anita; Schwarzenboeck, Sarah; Steinhoff, Karen; Umland-Seidler, Bert; Krause, Bernd J.; Brenner, Winfried; Sabri, Osama; Kurth, Jens; Hesse, Swen; Buchert, Ralph			CT-Based Attenuation Correction in I-123-Ioflupane SPECT	PLOS ONE			English	Article							DOPAMINE TRANSPORTER SPECT; PARKINSONS-DISEASE; I-123-FP-CIT SPECT; VISUAL ASSESSMENT; ESSENTIAL TREMOR; HEALTHY CONTROLS; DIFFERENTIATION; TOMOGRAPHY; AGREEMENT; DEMENTIA	Purpose: Attenuation correction (AC) based on low-dose computed tomography (CT) could be more accurate in brain single-photon emission computed tomography (SPECT) than the widely used Chang method, and, therefore, has the potential to improve both semi-quantitative analysis and visual image interpretation. The present study evaluated CT-based AC for dopamine transporter SPECT with I-123-ioflupane. Materials and methods: Sixty-two consecutive patients in whom I-123-ioflupane SPECT including low-dose CT had been performed were recruited retrospectively at 3 centres. For each patient, 3 different SPECT images were reconstructed: without AC, with Chang AC and with CT-based AC. Distribution volume ratio (DVR) images were obtained by scaling voxel intensities using the whole brain without striata as reference. For assessing the impact of AC on semi-quantitative analysis, specific-to-background ratios (SBR) in caudate and putamen were obtained by fully automated SPM8-based region of interest (ROI) analysis and tested for their diagnostic power using receiver-operator-characteristic (ROC) analysis. For assessing the impact of AC on visual image reading, screenshots of stereotactically normalized DVR images presented in randomized order were interpreted independently by two raters at each centre. Results: CT-based AC resulted in intermediate SBRs about half way between no AC and Chang. Maximum area under the ROC curve was achieved by the putamen SBR, with negligible impact of AC (0.924, 0.935 and 0.938 for no, CT-based and Chang AC). Diagnostic accuracy of visual interpretation also did not depend on AC. Conclusions: The impact of CT-based versus Chang AC on the interpretation of I-123-ioflupane SPECT is negligible. Therefore, CT-based AC cannot be recommended for routine use in clinical patient care, not least because of the additional radiation exposure.	[Lange, Catharina; Brenner, Winfried; Buchert, Ralph] Charite, Dept Nucl Med, D-13353 Berlin, Germany; [Seese, Anita; Steinhoff, Karen; Sabri, Osama; Hesse, Swen] Univ Klinikum Leipzig, Dept Nucl Med, Leipzig, Germany; [Schwarzenboeck, Sarah; Krause, Bernd J.; Kurth, Jens] Univ Med Rostock, Dept Nucl Med, Rostock, Germany; [Umland-Seidler, Bert] GE Healthcare Buchler GmbH & Co KG, Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University; University of Rostock; General Electric	Buchert, R (corresponding author), Charite, Dept Nucl Med, D-13353 Berlin, Germany.	ralph.buchert@charite.de	Buchert, Ralph/AAO-9468-2020; Kurth, Jens/AAF-7336-2019; Lange, Catharina/ABE-1563-2020; Steinhoff, Karen Geva/ABG-2272-2020	Buchert, Ralph/0000-0002-0945-0724; Kurth, Jens/0000-0001-6864-4513; Lange, Catharina/0000-0002-6745-8441; Brenner, Winfried/0000-0003-2478-6004; Sabri, Osama/0000-0002-6425-3504				Benamer HTS, 2000, MOVEMENT DISORD, V15, P503, DOI 10.1002/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V; Bienkiewicz M, 2008, NUCL MED REV, V11, P53; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Booij J, 1998, J NUCL MED, V39, P1879; Booij J, 2001, EUR J NUCL MED, V28, P266, DOI 10.1007/s002590000460; Booij J, 2008, EUR J NUCL MED MOL I, V35, P424, DOI 10.1007/s00259-007-0621-0; Borghammer P, 2014, CLIN NUCL MED, V39, pE87, DOI 10.1097/RLU.0b013e3182816500; Buchert R, 2006, EUR J NUCL MED MOL I, V33, P1073, DOI 10.1007/s00259-006-0067-9; CHANG LT, 1978, IEEE T NUCL SCI, V25, P638, DOI 10.1109/TNS.1978.4329385; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cuberas-Borros G, 2011, CLIN NUCL MED, V36, P991, DOI 10.1097/RLU.0b013e3182291a7b; Darcourt J, 2010, EUR J NUCL MED MOL I, V37, P443, DOI 10.1007/s00259-009-1267-x; Dickson JC, 2010, EUR J NUCL MED MOL I, V37, P23, DOI 10.1007/s00259-009-1212-z; Gamez J, 2014, CLIN NUCL MED, V39, pE227, DOI 10.1097/RLU.0b013e31828162cd; Garibotto V, 2013, CLIN NUCL MED, V38, pE112, DOI 10.1097/RLU.0b013e318279b991; Hesse S, 2003, J NUCL MED, V44, p234P; ICHIHARA T, 1993, J NUCL MED, V34, P2216; INNIS RB, 1993, P NATL ACAD SCI USA, V90, P11965, DOI 10.1073/pnas.90.24.11965; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Kahraman D, 2012, NUKLEARMED-NUCL MED, V51, P244, DOI 10.3413/Nukmed-0449-11-12; Koch W, 2005, J NUCL MED, V46, P1804; Koch W, 2005, J NUCL MED, V46, P1109; Oh M, 2012, J NUCL MED, V53, P399, DOI 10.2967/jnumed.111.095224; Rajeevan N, 1998, J NUCL MED, V39, P1719; Sadik M, 2008, EUR J NUCL MED MOL I, V35, P1464, DOI 10.1007/s00259-008-0721-5; Soderlund TA, 2013, J NUCL MED, V54, P714, DOI 10.2967/jnumed.112.110106; Soret M, 2003, J NUCL MED, V44, P1184; Tatsch K, 2012, Q J NUCL MED MOL IM, V56, P27; Tatsch K, 2013, J NUCL MED, V54, P1331, DOI 10.2967/jnumed.112.105379; Tossici-Bolt L, 2011, EUR J NUCL MED MOL I, V38, P1529, DOI 10.1007/s00259-011-1801-5; van de Giessen E, 2013, NEUROIMAGE, V64, P61, DOI 10.1016/j.neuroimage.2012.09.011; Van Laere K, 2008, EUR J NUCL MED MOL I, V35, P1367, DOI 10.1007/s00259-008-0777-2; Varrone A, 2013, EUR J NUCL MED MOL I, V40, P213, DOI 10.1007/s00259-012-2276-8; Varrone A, 2010, J NUCL MED, V51, P1331, DOI 10.2967/jnumed.109.065656; Walker Z, 2002, J NEUROL NEUROSUR PS, V73, P134, DOI 10.1136/jnnp.73.2.134; Warwick J M, 2011, Int J Mol Imaging, V2011, P195037, DOI 10.1155/2011/195037; Winz OH, 2012, CLIN NUCL MED, V37, P866, DOI 10.1097/RLU.0b013e318251e1b3; Zaidi H, 2003, J NUCL MED, V44, P291; Zubal IG, 2007, J NUCL MED, V48, P857, DOI 10.2967/jnumed.106.037432	39	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108328	10.1371/journal.pone.0108328	http://dx.doi.org/10.1371/journal.pone.0108328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268228	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700079
J	Li, MY; Tan, HW; Wang, F; Jiang, Q; Xu, ZS; Tian, C; Xiong, AS				Li, Meng-Yao; Tan, Hua-Wei; Wang, Feng; Jiang, Qian; Xu, Zhi-Sheng; Tian, Chang; Xiong, Ai-Sheng			De Novo Transcriptome Sequence Assembly and Identification of AP2/ERF Transcription Factor Related to Abiotic Stress in Parsley (Petroselinum crispum)	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GENE-EXPRESSION; SSR-MARKERS; RNA-SEQ; FAMILY; TOOL; EVOLUTIONARY; MICROSATELLITES; ARABIDOPSIS; ANNOTATION	Parsley is an important biennial Apiaceae species that is widely cultivated as herb, spice, and vegetable. Previous studies on parsley principally focused on its physiological and biochemical properties, including phenolic compound and volatile oil contents. However, little is known about the molecular and genetic properties of parsley. In this study, 23,686,707 high-quality reads were obtained and assembled into 81,852 transcripts and 50,161 unigenes for the first time. Functional annotation showed that 30,516 unigenes had sequence similarity to known genes. In addition, 3,244 putative simple sequence repeats were detected in curly parsley. Finally, 1,569 of the identified unigenes belonged to 58 transcription factor families. Various abiotic stresses have a strong detrimental effect on the yield and quality of parsley. AP2/ERF transcription factors have important functions in plant development, hormonal regulation, and abiotic response. A total of 88 putative AP2/ERF factors were identified from the transcriptome sequence of parsley. Seven AP2/ERF transcription factors were selected in this study to analyze the expression profiles of parsley under different abiotic stresses. Our data provide a potentially valuable resource that can be used for intensive parsley research.	[Li, Meng-Yao; Tan, Hua-Wei; Wang, Feng; Jiang, Qian; Xu, Zhi-Sheng; Tian, Chang; Xiong, Ai-Sheng] Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Xiong, AS (corresponding author), Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	Xiongaisheng@njau.edu.cn		Xiong, Ai-Sheng/0000-0002-7900-5001	National Natural Science Foundation of China [31272175]; New Century Excellent Talents in University [NCET-11-0670]; Jiangsu Natural Science Foundation [BK20130027]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Shuangchuang Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Shuangchuang Project	The research was supported by National Natural Science Foundation of China (31272175), New Century Excellent Talents in University (NCET-11-0670), Jiangsu Natural Science Foundation (BK20130027), Priority Academic Program Development of Jiangsu Higher Education Institutions, and Jiangsu Shuangchuang Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Boldizsar I, 2013, JOURNAL OF CHROMATOG; Chen WQJ, 2004, TRENDS PLANT SCI, V9, P591, DOI 10.1016/j.tplants.2004.10.007; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cormack RS, 2002, BBA-GENE STRUCT EXPR, V1576, P92, DOI 10.1016/S0167-4781(02)00298-1; Du HW, 2014, EUPHYTICA, V198, P115, DOI 10.1007/s10681-014-1088-2; Eujayl I, 2004, THEOR APPL GENET, V108, P414, DOI 10.1007/s00122-003-1450-6; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Figueiredo DD, 2012, J EXP BOT, V63, P3643, DOI 10.1093/jxb/ers035; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; GHARGHANI A, 2009, GENET RESOUR CROP EV, V56, P829, DOI [10.1007/s10722-008-9404-0, DOI 10.1007/S10722-008-9404-0]; Girardi CL, 2013, SCI HORTIC-AMSTERDAM, V151, P112, DOI 10.1016/j.scienta.2012.12.017; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; Harr B, 2000, GENETICS, V155, P1213; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Holmberg N, 1998, TRENDS PLANT SCI, V3, P61, DOI 10.1016/S1360-1385(97)01163-1; Hsieh TH, 2010, PLANTA, V231, P1459, DOI 10.1007/s00425-010-1147-4; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Joo J, 2013, PLANTA, P1; Jung Sook, 2005, Functional & Integrative Genomics, V5, P136, DOI 10.1007/s10142-005-0139-0; Justesen U, 1998, J CHROMATOGR A, V799, P101, DOI 10.1016/S0021-9673(97)01061-3; Kaiser A, 2012, FOOD CHEMISTRY; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; Kudo K, 2014, PLANT CELL TISS ORG, V116, P97, DOI 10.1007/s11240-013-0386-z; LAGERCRANTZ U, 1993, NUCLEIC ACIDS RES, V21, P1111, DOI 10.1093/nar/21.5.1111; Lee SJ, 2009, MOL CELLS, V27, P409, DOI 10.1007/s10059-009-0058-3; Li MY, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.10; Li MY, 2013, PLANT MOL BIOL REP, V31, P1002, DOI 10.1007/s11105-013-0570-7; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Licausi F, 2013, NEW PHYTOLOGIST; Liu Yu, 2011, Journal of Agricultural Biotechnology, V19, P462; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Paxton RJ, 1996, MOL ECOL, V5, P511, DOI 10.1111/j.1365-294X.1996.tb00343.x; Petropoulos SA, 2008, SCI HORTIC-AMSTERDAM, V115, P393, DOI 10.1016/j.scienta.2007.10.008; Petropoulos Spiridon A., 2005, Journal of Food Agriculture & Environment, V3, P205; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rashid M, 2012, EVOL BIOINFORM, V8, P321, DOI 10.4137/EBO.S9369; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RONGWEN J, 1995, THEOR APPL GENET, V90, P43, DOI 10.1007/BF00220994; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; STALLINGS RL, 1991, GENOMICS, V10, P807, DOI 10.1016/0888-7543(91)90467-S; Suhaj M, 2006, J FOOD COMPOS ANAL, V19, P531, DOI 10.1016/j.jfca.2004.11.005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; USDA ARS Program NGR, 2013, GERMPLASM RESOURCES; Venturini L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-41; Wang H, 2004, PLANT MOL BIOL, V55, P183, DOI 10.1007/s11103-004-0113-6; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080046; WEISSHAAR B, 1991, EMBO J, V10, P1777, DOI 10.1002/j.1460-2075.1991.tb07702.x; Xu W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-785; Xu ZS, 2011, J INTEGR PLANT BIOL, V53, P570, DOI 10.1111/j.1744-7909.2011.01062.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang H, 2006, FOOD RES INT, V39, P833, DOI 10.1016/j.foodres.2006.03.007; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087; Zhuang J, 2011, MOL BIOL REP, V38, P745, DOI 10.1007/s11033-010-0162-7; Zhuang J, 2011, MOL BIOL REP, V38, P3921, DOI 10.1007/s11033-010-0508-1; Zhuang J, 2010, MOL BIOL REP, V37, P2485, DOI 10.1007/s11033-009-9763-4	79	16	21	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108977	10.1371/journal.pone.0108977	http://dx.doi.org/10.1371/journal.pone.0108977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268141	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700208
J	Liang, DC; Zuo, AJ; Shao, H; Chen, MJZ; Kaplan, HJ; Sun, DM				Liang, Dongchun; Zuo, Aijun; Shao, Hui; Chen, Mingjiazi; Kaplan, Henry J.; Sun, Deming			Roles of the Adenosine Receptor and CD73 in the Regulatory Effect of gamma delta T Cells	PLOS ONE			English	Article							INTERNATIONAL UNION; IMMUNE-RESPONSE; A(2A); ACTIVATION; INFLAMMATION; GENERATION; INHIBITION; EXPRESSION; CLASSIFICATION; ACCUMULATION	The adenosine A2A receptor (A2AR), the main functional adenosine receptor on murine T cells, plays a unique role in the attenuation of inflammation and tissue damage in vivo. Here, we showed that, of the immune cell types tested, activated gamma delta T cells expressed the highest levels of A2AR mRNA and that A2AR ligation inhibited alpha beta T cell activation, but enhanced gamma delta T cell activation. We also showed that the inhibitory effect of an adenosine receptor agonist on autoreactive T cells was prevented by addition of a low percentage of activated gamma delta T cells. Furthermore, compared to resting cells, activated gamma delta T cells expressed significantly lower levels of CD73, an enzyme involved in the generation of extracellular adenosine. Exogenous AMP had a significant inhibitory effect on autoreactive T cell responses, but only in the presence of CD73(+) gamma delta T cells, and this effect was abolished by a CD73 inhibitor. Our results show that expression of increased amounts of A2AR allows gamma delta T cells to bind adenosine and thereby attenuate its suppressive effect, while decreased expression of CD73 results in less generation of adenosine in the inflammatory site. Together, these events allow activated gamma delta T cells to acquire increased proinflammatory activity, leading to augmented autoimmune responses.	[Liang, Dongchun; Zuo, Aijun; Chen, Mingjiazi; Sun, Deming] Univ Calif Los Angeles, Doheny Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Shao, Hui; Kaplan, Henry J.] Univ Louisville, Dept Ophthalmol & Visual Sci, Kentucky Lions Eye Ctr, Louisville, KY 40292 USA	Doheny Eye Institute; University of California System; University of California Los Angeles; University of Louisville	Sun, DM (corresponding author), Univ Calif Los Angeles, Doheny Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA.	dsun@doheny.org			NIH [EY 0022403, EY018827, EY003040]; NATIONAL EYE INSTITUTE [P30EY003040, R01EY022403, R01EY018827] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by NIH grants EY 0022403, EY018827, and EY003040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2009, MUCOSAL IMMUNOL, V2, P232, DOI 10.1038/mi.2009.4; Bar-Yehuda S, 2011, INT J MOL MED, V28, P727, DOI 10.3892/ijmm.2011.753; Beavis PA, 2012, TRENDS IMMUNOL, V33, P231, DOI 10.1016/j.it.2012.02.009; Belikoff BG, 2012, J IMMUNOL, V189, P3707, DOI 10.4049/jimmunol.1201207; Ben Addi A, 2008, EUR J IMMUNOL, V38, P1610, DOI 10.1002/eji.200737781; Blackburn Michael R, 2009, Handb Exp Pharmacol, P215, DOI 10.1007/978-3-540-89615-9_8; BORN W, 1990, SCIENCE, V249, P67, DOI 10.1126/science.1695022; Born W, 1999, Adv Immunol, V71, P77; CRONSTEIN BN, 1986, J CLIN INVEST, V78, P760, DOI 10.1172/JCI112638; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Cui Y, 2009, J IMMUNOL, V183, P560, DOI 10.4049/jimmunol.0900241; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DSouza CD, 1997, J IMMUNOL, V158, P1217; Ehrentraut H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032416; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hayday A, 1997, CURR OPIN IMMUNOL, V9, P884, DOI 10.1016/S0952-7915(97)80193-8; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; HIRSCHHORN R, 1970, P SOC EXP BIOL MED, V133, P1361; Hoskin DW, 2008, INT J ONCOL, V32, P527; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Huber SA, 2000, J IMMUNOL, V165, P4174, DOI 10.4049/jimmunol.165.8.4174; Jin DC, 2010, CANCER RES, V70, P2245, DOI 10.1158/0008-5472.CAN-09-3109; Kabelitz D, 2007, CANCER RES, V67, P5, DOI 10.1158/0008-5472.CAN-06-3069; Kolachala VL, 2008, BRIT J PHARMACOL, V155, P127, DOI 10.1038/bjp.2008.227; Koshiba M, 1999, MOL PHARMACOL, V55, P614; KOZBOR D, 1989, J EXP MED, V169, P1847, DOI 10.1084/jem.169.5.1847; Lappas CM, 2005, J IMMUNOL, V174, P1073, DOI 10.4049/jimmunol.174.2.1073; Liang DC, 2013, J IMMUNOL, V191, P1118, DOI 10.4049/jimmunol.1300626; Liang DC, 2013, INVEST OPHTH VIS SCI, V54, P3493, DOI 10.1167/iovs.12-11432; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; McColl SR, 2005, FASEB J, V19, P187, DOI 10.1096/fj.05-4804fje; Naganuma M, 2006, J IMMUNOL, V177, P2765, DOI 10.4049/jimmunol.177.5.2765; Nian H, 2012, INVEST OPHTH VIS SCI, V53, P897, DOI 10.1167/iovs.11-8297; Nian H, 2011, INVEST OPHTH VIS SCI, V52, P5920, DOI 10.1167/iovs.10-6758; Nian H, 2010, INVEST OPHTH VIS SCI, V51, P4661, DOI 10.1167/iovs.09-5045; Novitskiy SV, 2008, BLOOD, V112, P1822, DOI 10.1182/blood-2008-02-136325; Odashima M, 2005, GASTROENTEROLOGY, V129, P26, DOI 10.1053/j.gastro.2005.05.032; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Poccia F, 2005, IMMUNOL LETT, V100, P14, DOI 10.1016/j.imlet.2005.06.025; POLMAR SH, 1976, NEW ENGL J MED, V295, P1337, DOI 10.1056/NEJM197612092952402; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; RUST CJJ, 1990, NATURE, V346, P572, DOI 10.1038/346572a0; Ryzhov S, 2011, J IMMUNOL, V187, P6120, DOI 10.4049/jimmunol.1101225; Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tagawa T, 2004, J IMMUNOL, V173, P5156, DOI 10.4049/jimmunol.173.8.5156; Tsuchiya T, 2003, J IMMUNOL, V171, P5507, DOI 10.4049/jimmunol.171.10.5507; Uezu K, 2004, J IMMUNOL, V172, P7629, DOI 10.4049/jimmunol.172.12.7629; Varani K, 1996, BRIT J PHARMACOL, V117, P1693, DOI 10.1111/j.1476-5381.1996.tb15341.x; Vincenzi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054195; Wang L, 2011, J CLIN INVEST, V121, P2371, DOI 10.1172/JCI45559; Wilson J, 2011, TLS-TIMES LIT SUPPL, P6; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zaynagetdinov R, 2010, AM J RESP CELL MOL, V42, P564, DOI 10.1165/rcmb.2008-0391OC; Zhou Y, 2009, J IMMUNOL, V182, P8037, DOI 10.4049/jimmunol.0900515	64	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108932	10.1371/journal.pone.0108932	http://dx.doi.org/10.1371/journal.pone.0108932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268760	Green Published, gold			2022-12-27	WOS:000343671700194
J	Pawelek, KA; Niehaus, P; Salmeron, C; Hager, EJ; Hunt, GJ				Pawelek, Kasia A.; Niehaus, Patrick; Salmeron, Cristian; Hager, Elizabeth J.; Hunt, Gregg J.			Modeling Dynamics of Culex pipiens Complex Populations and Assessing Abatement Strategies for West Nile Virus	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; TRANSMISSION; PATHOGENS; CULICIDAE; MOSQUITOS; DIPTERA; BIRDS; DELAY	The primary mosquito species associated with underground stormwater systems in the United States are the Culex pipiens complex species. This group represents important vectors of West Nile virus (WNV) throughout regions of the continental U.S. In this study, we designed a mathematical model and compared it with surveillance data for the Cx. pipiens complex collected in Beaufort County, South Carolina. Based on the best fit of the model to the data, we estimated parameters associated with the effectiveness of public health insecticide (adulticide) treatments (primarily pyrethrin products) as well as the birth, maturation, and death rates of immature and adult Cx. pipiens complex mosquitoes. We used these estimates for modeling the spread of WNV to obtain more reliable disease outbreak predictions and performed numerical simulations to test various mosquito abatement strategies. We demonstrated that insecticide treatments produced significant reductions in the Cx. pipiens complex populations. However, abatement efforts were effective for approximately one day and the vector mosquitoes rebounded until the next treatment. These results suggest that frequent insecticide applications are necessary to control these mosquitoes. We derived the basic reproductive number (R-0) to predict the conditions under which disease outbreaks are likely to occur and to evaluate mosquito abatement strategies. We concluded that enhancing the mosquito death rate results in lower values of R-0, and if R-0<1, then an epidemic will not occur. Our modeling results provide insights about control strategies of the vector populations and, consequently, a potential decrease in the risk of a WNV outbreak.	[Pawelek, Kasia A.; Niehaus, Patrick; Salmeron, Cristian] Univ South Carolina Beaufort, Dept Math & Computat Sci, Bluffton, SC 29902 USA; [Hager, Elizabeth J.; Hunt, Gregg J.] Beaufort Cty Mosquito Control, Beaufort, NC USA		Pawelek, KA (corresponding author), Univ South Carolina Beaufort, Dept Math & Computat Sci, Bluffton, SC 29902 USA.	kpawelek@uscb.edu			University of South Carolina Beaufort Sea Islands Institute; University of South Carolina Magellan Scholar Program; SC EPSCoR/IDeA Scientific Advocate Network	University of South Carolina Beaufort Sea Islands Institute; University of South Carolina Magellan Scholar Program; SC EPSCoR/IDeA Scientific Advocate Network	This work is partially supported by the grants from the University of South Carolina Beaufort Sea Islands Institute (KAP), University of South Carolina Magellan Scholar Program (KAP,PN), and the SC EPSCoR/IDeA Scientific Advocate Network (KAP,CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Arydah M, 2011, MATH BIOSCI ENG, V8, P889, DOI 10.3934/mbe.2011.8.889; ANDERSON R M, 1991; Anticona EMF, 2012, CASE REP INFECT DIS, V2012, DOI 10.1155/2012/839458; Apperson CS, 2004, VECTOR-BORNE ZOONOT, V4, P71, DOI 10.1089/153036604773083013; BCMC, 2012, W NIL VIR; Beaufort County South Carolina, 2012, BEAUF COUNT NAT FACT; Bernard KA, 2001, EMERG INFECT DIS, V7, P679; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Bowman C, 2005, B MATH BIOL, V67, P1107, DOI 10.1016/j.bulm.2005.01.002; Brauer F, 2000, TEXTS APPL MATH SERI; Castillo-Chavez C., 2002, MATH APPROACHES EMER, V1; CDC, 2013, W NIL VIR; CDC, 2014, W NIL VIR DIS CAS DE; Chowell G, 2004, EMERG INFECT DIS, V10, P1258, DOI 10.3201/eid1007.030647; Coffield DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067267; Cruz-Pacheco G, 2005, B MATH BIOL, V67, P1157, DOI 10.1016/j.bulm.2004.11.008; Cruz-Pacheco G, 2009, B MATH BIOL, V71, P1378, DOI 10.1007/s11538-009-9406-x; Darensburg T, 2004, PROCEEDINGS OF DYNAMIC SYSTEMS AND APPLICATIONS, VOL 4, P358; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Doheny K, 2012, W NILE VIRUS WHOS RI; Eidson M, 2001, EMERG INFECT DIS, V7, P5; Elizondo-Quiroga A, 2006, J AM MOSQUITO CONTR, V22, P10, DOI 10.2987/8756-971X(2006)22[10:GCASOC]2.0.CO;2; Enserink M, 2004, SCIENCE, V303, P1605, DOI 10.1126/science.303.5664.1605; Environmental Protection Agency, 2012, STORMW MAN; Fan GH, 2010, MATH BIOSCI, V228, P119, DOI 10.1016/j.mbs.2010.08.010; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Gardner AM, 2012, J MED ENTOMOL, V49, P270, DOI 10.1603/ME11073; Gerberg EJ, 1994, AM MOSQUITO CONTROL, P61; GETZ WM, 1983, AM NAT, V121, P892, DOI 10.1086/284112; Ghosh D, 2011, SOC SCI MED, V72, P418, DOI 10.1016/j.socscimed.2010.09.014; Gubler DJ, 2000, VIRAL IMMUNOL, V13, P469, DOI 10.1089/vim.2000.13.469; Harbison JE, 2010, J MED ENTOMOL, V47, P67, DOI 10.1603/033.047.0109; Hartley DM, 2012, AM J TROP MED HYG, V86, P884, DOI 10.4269/ajtmh.2012.11-0342; Henn JB, 2008, J AM MOSQUITO CONTR, V24, P90, DOI 10.2987/5644.1; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Howard Country, 2013, STORMW MAN STRUCT; HURD H, 1995, PARASITOL TODAY, V11, P411, DOI 10.1016/0169-4758(95)80021-2; Jiang JF, 2009, B MATH BIOL, V71, P627, DOI 10.1007/s11538-008-9374-6; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Lewis M, 2006, B MATH BIOL, V68, P3, DOI 10.1007/s11538-005-9018-z; Lewis MA, 2006, B MATH BIOL, V68, P491, DOI 10.1007/s11538-005-9039-7; MedlinePlus, 2013, W NIL VIR; MOLAEI G, 2007, AM J TROP MED HYG, V77, P73; Pawelek KA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002588; Peterson RKD, 2006, ENVIRON HEALTH PERSP, V114, P366, DOI 10.1289/ehp.8667; Reisen WK, 2006, J MED ENTOMOL, V43, P344, DOI 10.1603/0022-2585(2006)043[0344:OOWNVI]2.0.CO;2; Rong L, 2014, ANTIVIR THER; Simpson JE, 2012, P ROY SOC B-BIOL SCI, V279, P925, DOI 10.1098/rspb.2011.1282; South Carolina Department of Health and Environmental Control Bureau of Laboratories, 2012, 2012 W NIL VIR ACT; Spagnuolo AM, 2012, J BIOL DYNAM, V6, P377, DOI 10.1080/17513758.2011.587896; Spagnuolo Anna Maria, 2011, Journal of Biological Dynamics, V5, P299, DOI 10.1080/17513758.2010.505985; Sun City Hilton Head, 2014, WELC; The South Carolina Department of Health and Environmental Control Bureau of Laboratories, 2014, REP SUBM DEAD BIRDS; United States Census, 2012, 2012 US GAZ FIL; United States Census, 2010, INT POP MAP; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wonham MJ, 2008, LECT NOTES MATH, V1945, P365; Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x; Zinser M, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.20	63	18	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108452	10.1371/journal.pone.0108452	http://dx.doi.org/10.1371/journal.pone.0108452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268229	Green Submitted, gold, Green Published			2022-12-27	WOS:000343671700099
J	Gan, LL; Jia, R; Zhou, LL; Guo, JH; Fan, MW				Gan, Lili; Jia, Rong; Zhou, Lili; Guo, Jihua; Fan, Mingwen			Fusion of CTLA-4 with HPV16 E7 and E6 Enhanced the Potency of Therapeutic HPV DNA Vaccine	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; HIGH-GRADE; INTRAEPITHELIAL NEOPLASIA; PARTICLE VACCINE; PHASE-II; EFFICACY; WOMEN; IMMUNOGENICITY; INFECTION; PROTEINS	Preventive anti-HPV vaccines are effective against HPV infection but not against existing HPV-associated diseases, including cervical cancer and other malignant diseases. Therefore, the development of therapeutic vaccines is urgently needed. To improve anti-tumor effects of therapeutic vaccine, we fused cytotoxic T-lymphocyte antigen 4 (CTLA-4) with HPV16 E7 and E6 as a fusion therapeutic DNA vaccine (pCTLA4-E7E6). pCTLA4-E7E6 induced significantly higher anti-E7E6 specific antibodies and relatively stronger specific CTL responses than the nonfusion DNA vaccine pE7E6 in C57BL/6 mice bearing with TC-1 tumors. pCTLA4-E7E6 showed relatively stronger anti-tumor effects than pE7E6 in therapeutic immunization. These results suggest that fusing CTLA-4 with E7E6 is a useful strategy to develop therapeutic HPV DNA vaccines. In addition, fusing the C-terminal of E7 with the N-terminal of E6 impaired the functions of both E7 and E6.	[Gan, Lili; Jia, Rong; Zhou, Lili; Guo, Jihua; Fan, Mingwen] Wuhan Univ, Sch & Hosp Stomatol, Hubei MOST KLOS & KLOBME, Wuhan 430072, Hubei, Peoples R China; [Guo, Jihua] Wuhan Univ, Sch & Hosp Stomatol, Dept Endodont, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University	Guo, JH (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Hubei MOST KLOS & KLOBME, Wuhan 430072, Hubei, Peoples R China.	gjhpp@hotmail.com; fmw@whuss.com	Jia, Rong/AAD-5835-2021	Guo, Jihua/0000-0002-6713-4439	National Science Foundation of China [81271129]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 81271129 from the National Science Foundation of China, http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi M, 2013, BLOOD, V122, P3160, DOI 10.1182/blood-2013-04-497446; Alderson KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/379123; Bosch FX, 2013, VACCINE, V31, pF1, DOI [10.1016/j.vaccine.2013.10.001, 10.1016/j.vaccine.2013.07.026, 10.1016/j.vaccine.2013.10.003]; Boyle JS, 1998, NATURE, V392, P408, DOI 10.1038/32932; Carter P, 2001, NAT REV CANCER, V1, P118, DOI 10.1038/35101072; DYSON N, 1992, J VIROL, V66, P6893, DOI 10.1128/JVI.66.12.6893-6902.1992; Einstein MH, 2007, GYNECOL ONCOL, V106, P453, DOI 10.1016/j.ygyno.2007.04.038; Fiander AN, 2006, INT J GYNECOL CANCER, V16, P1075, DOI 10.1111/j.1525-1438.2006.00598.x; Garcia F, 2004, OBSTET GYNECOL, V103, P317, DOI 10.1097/01.AOG.0000110246.93627.17; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Grosso Joseph F, 2013, Cancer Immun, V13, P5; Jia R, 2006, VACCINE, V24, P5192, DOI 10.1016/j.vaccine.2006.03.090; Jia R, 2012, INT IMMUNOPHARMACOL, V12, P21, DOI 10.1016/j.intimp.2011.08.016; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Kawana Kei, 2012, Open Virol J, V6, P264, DOI 10.2174/1874357901206010264; Kohrt HE, 2012, IMMUNOTHERAPY-UK, V4, P511, DOI [10.2217/IMT.12.38, 10.2217/imt.12.38]; Lehtinen M, 2013, NAT REV CLIN ONCOL, V10, P400, DOI 10.1038/nrclinonc.2013.84; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Monie A, 2009, EXPERT REV VACCINES, V8, P1221, DOI 10.1586/ERV.09.76; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; O'Day SJ, 2007, CANCER-AM CANCER SOC, V110, P2614, DOI 10.1002/cncr.23086; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Psyrri A, 2008, NAT CLIN PRACT ONCOL, V5, P24, DOI 10.1038/ncponc0984; Roman LD, 2007, GYNECOL ONCOL, V106, P558, DOI 10.1016/j.ygyno.2007.05.038; Schwartz SM, 1998, JNCI-J NATL CANCER I, V90, P1626, DOI 10.1093/jnci/90.21.1626; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Smith EM, 2004, JNCI-J NATL CANCER I, V96, P449, DOI 10.1093/jnci/djh074; Trimble CL, 2009, CLIN CANCER RES, V15, P361, DOI 10.1158/1078-0432.CCR-08-1725; Weber J, 2007, ONCOLOGIST, V12, P864, DOI 10.1634/theoncologist.12-7-864; Yin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022524; Zheng Y, 2008, J MICROBIOL, V46, P728, DOI 10.1007/s12275-008-0087-1; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	33	17	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108892	10.1371/journal.pone.0108892	http://dx.doi.org/10.1371/journal.pone.0108892			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265018	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400136
J	Lin, FR; Shen, YH; Fang, CW; Shie, SS; Huang, CG; Yang, S; Yang, SL; Tsao, KC; Huang, YC; Lai, MW; Chen, CJ				Lin, Fang-Ru; Shen, Yu-Hua; Fang, Chun-Wan; Shie, Shian-Sen; Huang, Chung-Guei; Yang, Shuan; Yang, Shu-Li; Tsao, Kuo-Chien; Huang, Yhu-Chering; Lai, Ming-Wei; Chen, Chih-Jung			Incidence of and Factors Associated with False Positives in Laboratory Diagnosis of Norovirus Infection by Amplification of the RNA-Dependent RNA Polymerase Gene	PLOS ONE			English	Article							NORWALK-LIKE VIRUSES; ENTERIC INFECTION; GASTROENTERITIS; PCR; OUTBREAKS; CALICIVIRUSES; PATHOGENESIS	Background: Conventional reverse transcription-polymerase chain reaction (RT-PCR) amplification of the RNA-dependent RNA polymerase (RdRp) gene remains a used method for the rapid detection of norovirus (NV) in clinical laboratories. The incidence of and factors associated with false positives in this assay have not been previously evaluated. Methods/Principal Findings: After an NV outbreak caused by the GII. 4 Sydney strain in 2012, we reanalysed 250 stool samples positive for NV by RdRp gene detection. True positives were confirmed in 154 (61.6%) samples by successful amplification and sequencing confirmation of the viral protein 1 gene. Of the remaining 96 samples that underwent RT-PCR for the RdRp gene, 34 samples yielded PCR products of the expected length. However, the sequences of the amplicons belonged to the human genome, with 91-97% matched nucleotide sequences, indicating false positives. Multivariate analysis of the clinical features of the patients identified a positive stool culture for bacteria (adjusted odds ratio [aOR] 9.07, 95% adjusted confidence interval [aCI] 2.17-37.92, P = .003) and the use of parenteral antibiotics (aOR 5.55, 95% aCI 1.21-24.73, P = .027) as significant and independent factors associated with false positives. Conclusion: Conventional RT-PCR targeting the RdRp gene of NV can lead to false positives in patients with bacterial enterocolitis by incidental amplification of DNA from a human source.	[Lin, Fang-Ru; Shen, Yu-Hua; Huang, Chung-Guei; Tsao, Kuo-Chien; Huang, Yhu-Chering; Chen, Chih-Jung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Fang, Chun-Wan; Huang, Chung-Guei; Yang, Shuan; Yang, Shu-Li; Tsao, Kuo-Chien] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Shie, Shian-Sen] Chang Gung Mem Hosp, Div Infect Dis, Dept Internal Med, Taoyuan, Taiwan; [Huang, Yhu-Chering; Chen, Chih-Jung] Chang Gung Mem & Childrens Hosp, Div Pediat Infect Dis, Dept Pediat, Taoyuan, Taiwan; [Lai, Ming-Wei] Chang Gung Mem & Childrens Hosp, Div Pediat Gastroenterol, Dept Pediat, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, CJ (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	chinjung@adm.cgmh.org.tw			Chang Gung Memorial Hospital [CMRPG4C0051, CMRPG4C0052]; Medical Foundation	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Medical Foundation	The study was supported by grants from Chang Gung Memorial Hospital (CMRPG4C0051, CMRPG4C0052) and partly supported by a grant from Medical Foundation in Memory of Dr. Deh-Lin Cheng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUS SG, 1973, ANN INTERN MED, V79, P18, DOI 10.7326/0003-4819-79-1-18; ANDO T, 1995, J CLIN MICROBIOL, V33, P64, DOI 10.1128/JCM.33.1.64-71.1995; Atmar RL, 1996, APPL ENVIRON MICROB, V62, P254, DOI 10.1128/AEM.62.1.254-258.1996; Atmar RL, 2001, CLIN MICROBIOL REV, V14, P15, DOI 10.1128/CMR.14.1.15-37.2001; Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; Chiu CH, 1999, J PAEDIATR CHILD H, V35, P372, DOI 10.1046/j.1440-1754.1999.00384.x; De Medici D, 2004, APPL ENVIRON MICROB, V70, P6329, DOI 10.1128/AEM.70.10.6329-6332.2004; Desai R, 2012, CLIN INFECT DIS, V55, P189, DOI 10.1093/cid/cis372; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; GREEN J, 1995, J MED VIROL, V47, P392, DOI 10.1002/jmv.1890470416; Hall Aron J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Halle S, 2007, INFECT IMMUN, V75, P1577, DOI 10.1128/IAI.01392-06; Ketley JM, 1997, MICROBIOL-UK, V143, P5, DOI 10.1099/00221287-143-1-5; KOHBATA S, 1986, MICROBIOL IMMUNOL, V30, P1225, DOI 10.1111/j.1348-0421.1986.tb03055.x; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; LeGuyader F, 1996, ARCH VIROL, V141, P2225, DOI 10.1007/BF01718228; Noel JS, 1999, J INFECT DIS, V179, P1334, DOI 10.1086/314783; Pang XLL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011599; Plantenga MS, 2011, EMERG INFECT DIS, V17, P1553, DOI 10.3201/eid1708.101815; Stuart RL, 2010, PEDIATR INFECT DIS J, V29, P644, DOI 10.1097/INF.0b013e3181d824e1; Tang MB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-338; TORREY S, 1986, J PEDIATR-US, V108, P718, DOI 10.1016/S0022-3476(86)81050-2; Tsai MH, 2011, CLIN MICROBIOL INFEC, V17, P300, DOI 10.1111/j.1469-0691.2010.03230.x; Wassenaar TM, 1999, MICROBES INFECT, V1, P1023, DOI 10.1016/S1286-4579(99)80520-6; Widdowson MA, 2011, PUBLIC HEALTH REP, V126, P251, DOI 10.1177/003335491112600216; WISTROM J, 1992, ANN INTERN MED, V117, P202, DOI 10.7326/0003-4819-117-3-202	26	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e109876	10.1371/journal.pone.0109876	http://dx.doi.org/10.1371/journal.pone.0109876			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264621	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400142
J	Salti, M; El Karoui, I; Maillet, M; Naccache, L				Salti, Moti; El Karoui, Imen; Maillet, Mathurin; Naccache, Lionel			Cognitive Dissonance Resolution Is Related to Episodic Memory	PLOS ONE			English	Article							PREFERENCES; ATTENTION	The notion that our past choices affect our future behavior is certainly one of the most influential concepts of social psychology since its first experimental report in the 50 s, and its initial theorization by Festinger within the "cognitive dissonance'' framework. Using the free choice paradigm (FCP), it was shown that choosing between two similarly rated items made subjects reevaluate the chosen items as more attractive and the rejected items as less attractive. However, in 2010 a major work by Chen and Risen revealed a severe statistical flaw casting doubt on most previous studies. Izuma and colleagues (2010) supplemented the traditional FCP with original control conditions and concluded that the effect observed could not be solely attributed to this methodological flaw. In the present work we aimed at establishing the existence of genuine choice-induced preference change and characterizing this effect. To do so, we replicated Izuma et al.' study and added a new important control condition which was absent from the original study. Moreover, we added a memory test in order to measure the possible relation between episodic memory of choices and observed behavioral effects. In two experiments we provide experimental evidence supporting genuine choice-induced preference change obtained with FCP. We also contribute to the understanding of the phenomenon by showing that choice-induced preference change effects are strongly correlated with episodic memory.	[Salti, Moti; El Karoui, Imen; Maillet, Mathurin; Naccache, Lionel] Univ Paris 06, INSERM, U1127, F-75013 Paris, France; [Salti, Moti; El Karoui, Imen; Maillet, Mathurin; Naccache, Lionel] CNRS, UMR 7225, F-75013 Paris, France; [Salti, Moti; El Karoui, Imen; Maillet, Mathurin; Naccache, Lionel] Univ Paris 06, Sorbonne Univ, UMRS 1127, F-75013 Paris, France; [Salti, Moti; El Karoui, Imen; Maillet, Mathurin; Naccache, Lionel] Inst Cerveau & Moelle Epiniere, ICM, PICNIC Lab, F-75013 Paris, France; [Salti, Moti] Ben Gurion Univ Negev, Dept Brain & Cognit Sci, IL-84105 Beer Sheva, Israel; [Naccache, Lionel] CHU Pitie Salpetriere, Grp Hosp Pitie Salpetriere, AP HP, Dept Neurophysiol, Paris, France; [Naccache, Lionel] CHU Pitie Salpetriere, Grp Hosp Pitie Salpetriere, AP HP, Dept Neurol, Paris, France; [Naccache, Lionel] Univ Paris 06, Sorbonne Univ, Fac Med Pitie Salpetriere, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Ben Gurion University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Salti, M (corresponding author), Univ Paris 06, INSERM, U1127, F-75013 Paris, France.	motisalti@gmail.com; lionel.naccache@psl.aphp.fr	Salti, Moti/GQQ-8585-2022	naccache, lionel/0000-0002-2874-1009; Salti, Moti/0000-0002-1645-9751	Fondation pour la Recherche Medicale (FRM) ('Equipe FRM' grant); Fond AXA pour la Recherche; Institut pour le Cerveau et la Moelle epiniere (ICM Institute, Paris, France); INSERM; AP-HP	Fondation pour la Recherche Medicale (FRM) ('Equipe FRM' grant); Fond AXA pour la Recherche(AXA Research Fund); Institut pour le Cerveau et la Moelle epiniere (ICM Institute, Paris, France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); AP-HP	This work has been supported by the Fondation pour la Recherche Medicale (FRM) ('Equipe FRM 2010' grant to Lionel Naccache), by Fond AXA pour la Recherche (PhD Grant for Imen El Karoui), by the Institut pour le Cerveau et la Moelle epiniere (ICM Institute, Paris, France), by INSERM, and by AP-HP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alos-Ferrer C, 2012, DEFENSE FREE CHOICE; ARONSON E, 1959, J ABNORM SOC PSYCH, V59, P177, DOI 10.1037/h0047195; Aronson E., 1968, THEORIES COGNITIVE C, P5; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bem DJ, 1972, ADV EXPT SOCIAL PSYC, V6, P1, DOI DOI 10.1016/S0065-2601(08)60024-6; BREHM JW, 1956, J ABNORM SOC PSYCH, V52, P384, DOI 10.1037/h0041006; Chen MK, 2010, J PERS SOC PSYCHOL, V99, P573, DOI 10.1037/a0020217; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; Cooper J, 2007, GOGNITIVE DISSONANCE; Egan LC, 2007, PSYCHOL SCI, V18, P978, DOI 10.1111/j.1467-9280.2007.02012.x; Egan LC, 2010, J EXP SOC PSYCHOL, V46, P204, DOI 10.1016/j.jesp.2009.08.014; FESTINGER L, 1959, J ABNORM SOC PSYCH, V58, P203, DOI 10.1037/h0041593; Festinger L, 1956, PROPHECY FAILS, DOI 10.1037/10030-000; Festinger L., 1957, THEORY COGNITIVE DIS, V2; FRIES A, 1980, J EXP SOC PSYCHOL, V16, P405, DOI 10.1016/0022-1031(80)90047-5; Holden S, 2013, J APPL SOC PSYCHOL, V43, P83, DOI 10.1111/j.1559-1816.2012.00983.x; Izuma K, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00041; Izuma K, 2010, P NATL ACAD SCI USA, V107, P22014, DOI 10.1073/pnas.1011879108; Johansson P, 2013, J BEHAV DECIS MAK; Kitayama S, 2013, NEUROIMAGE, V69, P206, DOI 10.1016/j.neuroimage.2012.11.034; Lieberman MD, 2001, PSYCHOL SCI, V12, P135, DOI 10.1111/1467-9280.00323; Mengarelli F, 2013, CEREB CORTEX; Nakamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072071; Risen JL, 2010, SOC PERSONAL PSYCHOL, V4, P1151, DOI 10.1111/j.1751-9004.2010.00323.x; Sharot T, 2012, PSYCHOL SCI, V23, P1123, DOI 10.1177/0956797612438733; Sharot T, 2010, PSYCHOL SCI, V21, P1231, DOI 10.1177/0956797610379235; Sharot T, 2009, J NEUROSCI, V29, P3760, DOI 10.1523/JNEUROSCI.4972-08.2009; THIBODEAU R, 1992, PERS SOC PSYCHOL B, V18, P591, DOI 10.1177/0146167292185010; van Veen V, 2009, NAT NEUROSCI, V12, P1469, DOI 10.1038/nn.2413	29	21	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108579	10.1371/journal.pone.0108579	http://dx.doi.org/10.1371/journal.pone.0108579			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6XR	25264950	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400091
J	Tassaneetrithep, B; Tivon, D; Swetnam, J; Karasavvas, N; Michael, NL; Kim, JH; Marovich, M; Cardozo, T				Tassaneetrithep, Boonrat; Tivon, Doreen; Swetnam, James; Karasavvas, Nicos; Michael, Nelson L.; Kim, Jerome H.; Marovich, Mary; Cardozo, Timothy			Cryptic Determinant of alpha 4 beta 7 Binding in the V2 Loop of HIV-1 gp120	PLOS ONE			English	Article							VACCINE EFFICACY; T-CELLS; INFECTION; REGIONS; ANTIBODIES; INTEGRIN; TRIAL	The peptide segment of the second variable loop of HIV-1 spanning positions 166-181 harbors two functionally important sites. The first, spanning positions 179-181, engages the human alpha 4 beta 7 integrin receptor which is involved in T-cell guthoming and may play a role in human immunodeficiency virus (HIV)-host cell interactions. The second, at positions 166-178, is a major target of anti-V2 antibodies elicited by the ALVAC/AIDSVAX vaccine used in the RV144 clinical trial. Notably, these two sites are directly adjacent, but do not overlap. Here, we report the identity of a second determinant of alpha 4 beta 7 binding located at positions 170-172 of the V2 loop. This segment - tripeptide QRV(170-172)-is located within the second site, yet functionally affects the first site. The absence of this segment abrogates alpha 4 beta 7 binding in peptides bearing the same sequence from position 173-185 as the V2 loops of the RV144 vaccines. However, peptides exhibiting V2 loop sequences from heterologous HIV-1 strains that include this QRV(170-172) motif bind the alpha 4 beta 7 receptor on cells. Therefore, the peptide segment at positions 166-178 of the V2 loop of HIV-1 viruses appears to harbor a cryptic determinant of alpha 4 beta 7 binding. Prior studies show that the anti-V2 antibody response elicited by the RV144 vaccine, along with immune pressure inferred from a sieve analysis, is directed to this same region of the V2 loop. Accordingly, the anti-V2 antibodies that apparently reduced the risk of infection in the RV144 trial may have functioned by blocking alpha 4 beta 7-mediated HIV-host cell interactions via this cryptic determinant.	[Tassaneetrithep, Boonrat] Mahidol Univ, Fac Med, Siriraj Hosp, Off Res & Dev, Bangkok 10700, Thailand; [Tassaneetrithep, Boonrat; Michael, Nelson L.; Kim, Jerome H.; Marovich, Mary] Walter Reed Army Inst Res, US Mil Hlth Res Program, Silver Spring, MD USA; [Tivon, Doreen; Swetnam, James; Cardozo, Timothy] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA; [Karasavvas, Nicos] Armed Forces Res Inst Med Sci, US Army Med Component, Dept Retrovirol, Bangkok 10400, Thailand	Mahidol University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); New York University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Cardozo, T (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA.	Timothy.Cardozo@nyumc.org	Tassaneetrithep, Boonrat/ACF-0768-2022; Tassaneetrithep, Boonrat/AAF-5715-2022	Tassaneetrithep, Boonrat/0000-0001-9617-3659	National Institutes of Health [R01A1084119]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-11-2-0174]; U.S. Department of Defense (DOD) [W81XWH-11-2-0174]; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA036478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the National Institutes of Health R01A1084119 to Timothy Cardozo, and a cooperative agreement (W81XWH-11-2-0174) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Almond David, 2010, J Vis Exp, DOI 10.3791/2118; Almond D, 2010, AIDS RES HUM RETROV, V26, P717, DOI 10.1089/aid.2009.0254; [Anonymous], 1998, NUMBERING POSITIONS; Ansari AA, 2011, J IMMUNOL, V186, P1044, DOI 10.4049/jimmunol.1003052; Arnautova YA, 2011, PROTEINS, V79, P477, DOI 10.1002/prot.22896; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Jelicic K, 2013, NAT IMMUNOL, V14, P1256, DOI 10.1038/ni.2746; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Martinelli E, 2013, JAIDS-J ACQ IMM DEF, V64, P325, DOI 10.1097/QAI.0b013e31829f6e1a; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Parrish NF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002686; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	21	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108446	10.1371/journal.pone.0108446	http://dx.doi.org/10.1371/journal.pone.0108446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265384	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400076
J	Xiao, DL; Dasgupta, C; Li, Y; Huang, XH; Zhang, LB				Xiao, DaLiao; Dasgupta, Chiranjib; Li, Yong; Huang, Xiaohui; Zhang, Lubo			Perinatal Nicotine Exposure Increases Angiotensin II Receptor-Mediated Vascular Contractility in Adult Offspring	PLOS ONE			English	Article							PKC-EPSILON GENE; BLOOD-PRESSURE; DNA METHYLATION; SMOOTH-MUSCLE; EPIGENETIC REPRESSION; PROMOTER METHYLATION; SIGNAL-TRANSDUCTION; NEONATAL EXPOSURE; CIGARETTE-SMOKING; PRENATAL EXPOSURE	Previous studies have reported that perinatal nicotine exposure causes development of hypertensive phenotype in adult offspring. Aims: The present study was to determine whether perinatal nicotine exposure causes an epigenetic programming of vascular Angiotensin II receptors (ATRs) and their-mediated signaling pathway leading to heightened vascular contraction in adult offspring. Main methods: Nicotine was administered to pregnant rats via subcutaneous osmotic minipumps from day 4 of gestation to day 10 after birth. The experiments were conducted at 5 months of age of male offspring. Key Findings: Nicotine treatment enhanced Angitension II (Ang II)-induced vasoconstriction and 20-kDa myosin light chain phosphorylation (MLC20-P) levels. In addition, the ratio of Ang II-induced tension/MLC-P was also significantly increased in nicotine-treated group compared with the saline group. Nicotine-mediated enhanced constrictions were not directly dependent on the changes of [Ca2+] i concentrations but dependent on Ca2+ sensitivity. Perinatal nicotine treatment significantly enhanced vascular ATR type 1a (AT(1a)R) but not AT(1b)R mRNA levels in adult rat offspring, which was associated with selective decreases in DNA methylation at AT(1a)R promoter. Contrast to the effect on AT(1a)R, nicotine decreased the mRNA levels of vascular AT(2)R gene, which was associated with selective increases in DNA methylation at AT(2)R promoter. Significance: Our results indicated that perinatal nicotine exposure caused an epigenetic programming of vascular ATRs and their-mediated signaling pathways, and suggested that differential regulation of AT(1)R/AT(2)R gene expression through DNA methylation mechanism may be involved in nicotine-induced heightened vasoconstriction and development of hypertensive phenotype in adulthood.	[Xiao, DaLiao; Dasgupta, Chiranjib; Li, Yong; Huang, Xiaohui; Zhang, Lubo] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol, Loma Linda, CA 92354 USA	Loma Linda University	Xiao, DL (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol, Loma Linda, CA 92354 USA.	Dxiao@llu.edu	Xiao, DaLiao/AAY-1800-2020	Xiao, DaLiao/0000-0003-0147-2758; Zhang, Lubo/0000-0002-9386-8938	Regents of the University of California; Tobacco-Related Diseases Research Program (TRDRP) [22XT-0022]; National Institutes of Health [HL089012, HL110125, DA032510]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118861, R01HL110125, R01HL089012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA032510] Funding Source: NIH RePORTER	Regents of the University of California(University of California System); Tobacco-Related Diseases Research Program (TRDRP); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by funds provided by The Regents of the University of California, Tobacco-Related Diseases Research Program (TRDRP), grant# 22XT-0022 (DX) and by the National Institutes of Health grants HL089012, HL110125 (LZ), and DA032510 (DX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DA, 2014, FASEB J, V28, P2088, DOI 10.1096/fj.13-238402; Beratis NG, 1996, J PEDIATR-US, V128, P806, DOI 10.1016/S0022-3476(96)70333-5; Blake KV, 2000, EARLY HUM DEV, V57, P137, DOI 10.1016/S0378-3782(99)00064-X; Campanero MR, 2000, P NATL ACAD SCI USA, V97, P6481, DOI 10.1073/pnas.100340697; Franco MDP, 2003, CARDIOVASC RES, V59, P767, DOI 10.1016/S0008-6363(03)00461-9; Gao YJ, 2008, EUR J PHARMACOL, V590, P264, DOI 10.1016/j.ejphar.2008.05.044; Gryzinska M, 2013, BIOCHEM GENET, V51, P554, DOI 10.1007/s10528-013-9586-9; Hadoke PWF, 2006, J ENDOCRINOL, V188, P435, DOI 10.1677/joe.1.06506; Horowitz A, 1996, PHYSIOL REV, V76, P967, DOI 10.1152/physrev.1996.76.4.967; Hutchison SJ, 1998, J AM COLL CARDIOL, V32, P1463, DOI 10.1016/S0735-1097(98)00217-4; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059752; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Lambers DS, 1996, SEMIN PERINATOL, V20, P115, DOI 10.1016/S0146-0005(96)80079-6; Langley-Evans SC, 1999, BIOCHEM SOC T, V27, P88, DOI 10.1042/bst0270088; Lawrence J, 2008, J PHARMACOL EXP THER, V324, P331, DOI 10.1124/jpet.107.132175; Lawrence J, 2011, CARDIOVASC RES, V89, P89, DOI 10.1093/cvr/cvq270; Lee Ken W. K., 2013, Frontiers in Genetics, V4, P132, DOI 10.3389/fgene.2013.00132; Li Y, 2013, NEUROBIOL DIS, V60, P32, DOI 10.1016/j.nbd.2013.08.011; Li Y, 2012, STROKE, V43, P2483, DOI 10.1161/STROKEAHA.112.664698; Mao CP, 2009, REPROD TOXICOL, V27, P149, DOI 10.1016/j.reprotox.2009.01.012; McKay JA, 2011, MOL NUTR FOOD RES, V55, P1717, DOI 10.1002/mnfr.201100150; Meyer K, 2009, J MOL CELL CARDIOL, V47, P504, DOI 10.1016/j.yjmcc.2009.06.004; Morgan KG, 2001, J APPL PHYSIOL, V91, P953, DOI 10.1152/jappl.2001.91.2.953; Nickenig G, 2000, CIRCULATION, V102, P1828; Nickenig G, 1998, CIRCULATION, V97, P2197, DOI 10.1161/01.CIR.97.22.2197; Ozaki T, 2001, J PHYSIOL-LONDON, V530, P141, DOI 10.1111/j.1469-7793.2001.0141m.x; Patterson AJ, 2012, CARDIOVASC RES, V93, P302, DOI 10.1093/cvr/cvr322; Pausova Z, 2003, KIDNEY INT, V64, P829, DOI 10.1046/j.1523-1755.2003.00172.x; Pfitzer G, 2001, J APPL PHYSIOL, V91, P497, DOI 10.1152/jappl.2001.91.1.497; Sherman RC, 1998, CLIN SCI, V94, P373, DOI 10.1042/cs0940373; Slotkin TA, 1998, J PHARMACOL EXP THER, V285, P931; Tao HH, 2013, PEPTIDES, V44, P111, DOI 10.1016/j.peptides.2013.02.019; Toledo-Rodriguez M, 2012, TOXICOL LETT, V213, P228, DOI 10.1016/j.toxlet.2012.06.009; Touyz RM, 2000, PHARMACOL REV, V56, P145; WENGER NK, 1993, NEW ENGL J MED, V329, P247, DOI 10.1056/NEJM199307223290406; Woodsome TP, 2001, J PHYSIOL-LONDON, V535, P553, DOI 10.1111/j.1469-7793.2001.t01-1-00553.x; WU JN, 1994, HYPERTENSION, V23, P819, DOI 10.1161/01.HYP.23.6.819; Xiao DL, 2008, HYPERTENSION, V51, P1239, DOI 10.1161/HYPERTENSIONAHA.107.106203; Xiao DL, 2007, J PHARMACOL EXP THER, V320, P654, DOI 10.1124/jpet.106.113332; Xiao DL, 2013, HYPERTENSION, V61, P1246, DOI 10.1161/HYPERTENSIONAHA.113.01152; Xiao DL, 2011, BRIT J PHARMACOL, V164, P1400, DOI 10.1111/j.1476-5381.2011.01437.x; Xiao DL, 2005, AM J PHYSIOL-HEART C, V288, pH142, DOI 10.1152/ajpheart.00655.2004; Xiong FX, 2012, FASEB J, V26, P2753, DOI 10.1096/fj.11-199422	45	37	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108161	10.1371/journal.pone.0108161	http://dx.doi.org/10.1371/journal.pone.0108161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265052	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400047
J	Yao, ZY; Song, XT; Cao, SR; Liang, WZ; Lu, WR; Yang, LJ; Zhang, ZZ; Wei, L				Yao, Zhiyan; Song, Xiaotian; Cao, Shiru; Liang, Wenzhang; Lu, Wenran; Yang, Lijuan; Zhang, Zhengzheng; Wei, Lin			Role of the Exogenous HCV Core Protein in the Interaction of Human Hepatocyte Proliferation and Macrophage Sub-Populations	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; KUPFFER CELLS; TGF-BETA; EXPRESSION; LIVER; ACTIVATION; CHEMOKINES; IMMUNITY; BINDING; GC1QR	Background: The core protein of hepatitis C virus (HCV) is found in the cytoplasm and nuclei of infected cells, including hepatocytes and other cells in the liver. The core protein could be secreted as well. Resident liver macrophages are dependent on the tissue micro-environment and external stimuli to differentiate M1 and M2 hypotypes with distinct functions, and increased expression of the nuclear transcription factor STAT3 was seen in M2-polarized macrophages. In contrast to proinflammatory M1 macrophages, M2 macrophages serve beneficial roles in chronic inflammation, immunosuppression, and tumorigenesis. Methods: Monocyte-derived human macrophage line (mTHP-1) was treated with the exogenous HCV core protein. Next, the mTHP-1 culture supernatant or cell pellets were added to culture media of normal human liver cell line (L02). Results: Only the culture supernatant stimulated L02 cells proliferation, which was associated with phosphorylated ERK expression. Core protein activated mTHP-1 cells showed enhanced pro-and anti-inflammatory cytokines secretion, which was accompanied by high expression of phosphorylated NF-kappa B105 and NF-kappa B65. However, phosphorylated STAT1, and STAT3, which are normally associated with M1 and M2 macrophage polarization, and cell surface expression of CD206, CD14, CD16, and CD86, were unaltered. A transwell co-culture system showed that only in mTHP-1 co-cultured with L02 in the presence of exogenous core protein, were higher levels of phosphorylated STAT3 and CD206 seen. Conclusions: We showed L02 cells proliferation was accelerated by the culture supernatant of mTHP-1 cells treated with the exogenous HCV core protein. The exogenous core protein mediated the interaction between macrophages and hepatocytes in co-culture, which enhanced the expression of phosphorylated STAT3 and CD206 in macrophages.	[Yao, Zhiyan; Song, Xiaotian; Cao, Shiru; Liang, Wenzhang; Lu, Wenran; Yang, Lijuan; Zhang, Zhengzheng; Wei, Lin] Hebei Med Univ, Dept Immunol, Shijiazhuang, Peoples R China; [Yao, Zhiyan; Song, Xiaotian; Cao, Shiru; Liang, Wenzhang; Lu, Wenran; Yang, Lijuan; Zhang, Zhengzheng; Wei, Lin] Key Lab Immune Mech & Intervent Serious Dis Hebei, Shijiazhuang, Peoples R China	Hebei Medical University	Wei, L (corresponding author), Hebei Med Univ, Dept Immunol, Shijiazhuang, Peoples R China.	weilin501@163.com			Key Basic Research Project of Hebei Province [12966117D]; Science and Technology Research Projects of the Colleges and Universities of Hebei Province [z2013002]	Key Basic Research Project of Hebei Province; Science and Technology Research Projects of the Colleges and Universities of Hebei Province	The present study was supported by the Key Basic Research Project of Hebei Province (No. 12966117D) and the Science and Technology Research Projects of the Colleges and Universities of Hebei Province (No. z2013002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2009, J VIROL, V83, P9663, DOI 10.1128/JVI.00872-09; Benzoubir N, 2013, J HEPATOL, V59, P1160, DOI 10.1016/j.jhep.2013.07.036; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Biswas SK, 2010, J LEUKOCYTE BIOL, V88, P877, DOI 10.1189/jlb.0310153; BOUFFARD P, 1992, J INFECT DIS, V166, P1276, DOI 10.1093/infdis/166.6.1276; Buhler S, 2012, DIGEST DIS, V30, P445, DOI 10.1159/000341688; Clement S, 2010, J HEPATOL, V52, P635, DOI 10.1016/j.jhep.2009.10.035; Dolganiuc A, 2003, J IMMUNOL, V170, P5615, DOI 10.4049/jimmunol.170.11.5615; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Giorgio S, 2013, INFLAMM RES, V62, P835, DOI 10.1007/s00011-013-0647-7; Heydtmann M, 2009, HEPATOLOGY, V49, P676, DOI 10.1002/hep.22763; Hosszu KK, 2010, INNATE IMMUN-LONDON, V16, P115, DOI 10.1177/1753425909339815; Hosui A, 2006, BIOCHEM BIOPH RES CO, V346, P1125, DOI 10.1016/j.bbrc.2006.05.114; KANTO T, 1995, J HEPATOL, V22, P440, DOI 10.1016/0168-8278(95)80107-3; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413; Lerat H, 1996, J CLIN INVEST, V97, P845, DOI 10.1172/JCI118485; Ma CQ, 2009, CELL MOL IMMUNOL, V6, P73, DOI 10.1038/cmi.2009.10; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Moorman JP, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-105; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Nakamura H, 2011, HEPATOL RES, V41, P455, DOI 10.1111/j.1872-034X.2011.00792.x; Nattermann J, 2005, AM J PATHOL, V166, P443, DOI 10.1016/S0002-9440(10)62267-5; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sabile A, 1999, HEPATOLOGY, V30, P1064, DOI 10.1002/hep.510300429; Saito K, 2006, J VIROL, V80, P4372, DOI 10.1128/JVI.80.9.4372-4379.2006; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Tacke RS, 2009, J IMMUNOL, V182, P134; Tellinghuisen TL, 2002, CURR OPIN MICROBIOL, V5, P419, DOI 10.1016/S1369-5274(02)00341-7; Thimme R, 2014, VIRAL HEPATITIS, 4TH EDITION, P266; Yang QW, 2002, CHINESE MED J-PEKING, V115, P286; Yao ZQ, 2004, J VIROL, V78, P6409, DOI 10.1128/JVI.78.12.6409-6419.2004; Yue P, 2011, EUR J CANCER, V47, P1115, DOI 10.1016/j.ejca.2011.01.017; Zeremski M, 2007, J VIRAL HEPATITIS, V14, P675, DOI 10.1111/j.1365-2893.2006.00838.x; Zhang Y, 2011, J IMMUNOL, V186, P3093, DOI 10.4049/jimmunol.1002006	42	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108278	10.1371/journal.pone.0108278	http://dx.doi.org/10.1371/journal.pone.0108278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265479	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400059
J	Ye, A; He, HZ; Kim, J				Ye, An; He, Hongzhi; Kim, Joomyeong			Paternally Expressed Peg3 Controls Maternally Expressed Zim1 as a Trans Factor	PLOS ONE			English	Article							IMPRINTED GENE; H19	The expression of two adjacent imprinted genes, Peg3 and Zim1, is inversely correlated: down-regulation of Peg3 coinciding with up-regulation of Zim1. The current study characterized this inverse correlation using a mutant allele targeting Peg3. According to the results, the mutation on the paternal allele of Peg3 resulted in a dramatic increase in the transcription levels of the maternal allele of Zim1, suggesting the involvement of unknown trans factors in this trans-allelic event. Subsequent ChIP experiments revealed that the protein encoded by Peg3 itself binds to the zinc finger exon of Zim1, which is modified with the repression mark H3K9me3. Interestingly, the levels of H3K9me3 on Zim1 are also reduced in the mutant cells lacking the protein PEG3, suggesting potential roles for PEG3 in establishing H3K9me3 on Zim1. Reintroducing PEG3 into the mutant cell restored down-regulation of Zim1, confirming the predicted repressor role for Peg3 on Zim1. Overall, these results demonstrated that paternally expressed Peg3 controls maternally expressed Zim1 as a trans factor. The current study also provides the first case for the trans-allelic interaction of two oppositely imprinted genes through their gene products.	[Ye, An; He, Hongzhi; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu			National Institute of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066225, R01GM097074] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institute of Health (J.K. R01-GM066225 and R01-GM097074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow BP, 2014, COLD SPRING HARBOR P, V6; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2005, ENCY GENETICS GENOMI; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Kim J, 2012, HUM MOL GENET, V21, P2677, DOI 10.1093/hmg/dds092; Kim JY, 1999, HUM MOL GENET, V8, P847, DOI 10.1093/hmg/8.5.847; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Webber AL, 1998, NATURE, V391, P711, DOI 10.1038/35655; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	14	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108596	10.1371/journal.pone.0108596	http://dx.doi.org/10.1371/journal.pone.0108596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265264	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400093
J	Bazargani, YT; de Boer, A; Leufkens, HGM; Mantel-Teeuwisse, AK				Bazargani, Yaser T.; de Boer, Anthonius; Leufkens, Hubert G. M.; Mantel-Teeuwisse, Aukje K.			Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists	PLOS ONE			English	Article							CARE; MANAGEMENT; ACCESS; AVAILABILITY; INSULIN	Aim: Diabetes is a growing burden especially in low and middle income countries (LMICs). Inadequate access to diabetes care is of particular concern and selection of appropriate diabetes medicines on national essential medicines lists (NEMLs) is a first step in achieving adequate access. This selection was studied among LMICs and influences of various factors associated with selection decisions were assessed. Methods: Countries were studied if they employed NEMLs for reimbursement or procurement purposes. Presence and number of essential diabetes medicines from different classes, both insulins and oral blood glucose lowering medicines, were surveyed and calculated. Data were also analyzed by country income level, geographic region, year of last update of the NEML and purpose of NEML employment. The effect of prevalence and burden of disease on the number of essential diabetes medicines was also studied. Non parametric tests and univariate linear regression analysis were used. Results: Nearly all countries (n = 32) had chosen fast (97%) and intermediate acting insulin (93%), glibenclamide and metformin (100% both) as essential medicines. The median number of essential diabetes medicines was 6, equally divided between insulins and oral medicines. 20% of the countries had selected insulin analogues as essential medicines. Among all the studied factors, an increase in burden of diabetes and wealth of countries were associated with selection of higher numbers of essential diabetes medicines (p = 0.02 in both cases). Conclusions: Nearly all the studied LMICs had included the minimum required medicines for diabetes management in their NEMLs. Selection can still be improved (e. g. exclusion of insulin analogues and replacement of glibenclamide by gliclazide). Nevertheless, the known suboptimal and inconsistent availability of essential diabetes medicines in LMICs cannot be explained by inadequate selection of essential medicines. Countries should therefore be encouraged to give precedence to implementation of NEMLs to make essential diabetes medicines more accessible.	[Bazargani, Yaser T.; de Boer, Anthonius; Leufkens, Hubert G. M.; Mantel-Teeuwisse, Aukje K.] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	Utrecht University	Mantel-Teeuwisse, AK (corresponding author), Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands.	A.K.Mantel@uu.nl	Mantel-Teeuwisse, Aukje/I-8902-2016					Abbatecola AM, 2009, DRUG AGING, V26, P53, DOI 10.2165/11534660-000000000-00000; Ali S, 2012, EXPERT OPIN PHARMACO, V13, P1797, DOI 10.1517/14656566.2012.705829; [Anonymous], 2012, JEMDSA, V17, pS1, DOI 10.1080/22201009.2012.10872277; Bazargani YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087576; BERAN D, 2012, HOW TO INVESTIGATE A; Beran D, 2008, B WORLD HEALTH ORGAN, V86, P648, DOI 10.2471/BLT.07.048710; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Beran D, 2013, INT J HEALTH PLAN M, V28, pe121, DOI 10.1002/hpm.2145; Beran D, 2013, ASIA-PAC J PUBLIC HE, V25, P92, DOI 10.1177/1010539511412177; Beran D, 2010, DIABETES RES CLIN PR, V88, P217, DOI 10.1016/j.diabres.2010.03.029; Bhojani U, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.22258; Blonde L, 2010, AM J MED, V123, pS12, DOI 10.1016/j.amjmed.2009.12.005; Bo S, 2013, EUR J ENDOCRINOL, V169, P117, DOI 10.1530/EJE-13-0299; Cameron A, 2011, B WORLD HEALTH ORGAN, V89, P412, DOI 10.2471/BLT.10.084327; Cohen D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5782; COLAGIURI S, 2012, GLOBAL GUIDELINE FOR; Erlich Deborah R, 2013, FP Essent, V408, P20; Gill GV, 2011, DIABETOLOGIA, V54, P19, DOI 10.1007/s00125-010-1897-3; Grant P, 2013, CLIN MED, V13, P27, DOI 10.7861/clinmedicine.13-1-27; *HLTH ACT INT, 2010, LIFE SAVING INSULIN; Holden SE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000258; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; *IHME, 2013, GLOBAL BURDEN OF DIS; Imam K, 2013, ADV EXP MED BIOL, V771, P340; *INT DIAB FED, 2013, GLOBAL GUIDELINE FOR; *INT DIAB FED, 2013, TREATMENT ALGORITHM; International Diabetes Federation, 2009, DIABETES ATLAS; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; *IQWIG, 2005, ANONYMOUS INSTITUTE; Krishna S, 2010, J RURAL HEALTH, V26, P3, DOI 10.1111/j.1748-0361.2009.00259.x; Lamos EM, 2012, EXPERT OPIN PHARMACO, V13, P2545, DOI 10.1517/14656566.2012.738196; *MAN SCI HLTH, 2012, INTERNATIONAL DRUG P; Marks Donald H, 2013, Int J Risk Saf Med, V25, P39, DOI 10.3233/JRS-120581; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Nagpal J, 2006, DIABETES CARE, V29, P2341, DOI 10.2337/dc06-0783; *NICE, 2004, TYPE 1 DIABETES DIAG; *NORW I PUBL HLTH, 2012, ANATOMICAL THERAPEUT; Ramachandran A, 2008, J Assoc Physicians India, V56, P513; RICHTER B, HUMAN INSULIN VERSUS; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; United Nations, POLITICAL DECLARATIO; *WHO, 2013, DIABETES; *WHO, 2013, WHO REGIONS AND THE; *WHO, 2013, DIABETES PROGRAMME; *WHO, 2011, REVIEW OF THE EVIDEN; *WHO, 2013, SELECTION OF ESSENTI; *WHO, 2012, PHARMACEUTICAL COUNT; *WHO, 2013, DEVELOPMENT OF COUNT; *WHO, 2013, DIABETES FACTSHEETS; *WHO, 2013, WHO FRAMEWORK FOR AC; *WHO, 2013, NATIONAL MEDICINES L; *WORLD BANK, 2013, COUNTRY CLASSIFICATI; World Health Organization, 2013, GLOBAL ACTION PLAN F; World Health Organization, 2013, WHO MODEL LIST OF ES	55	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e106072	10.1371/journal.pone.0106072	http://dx.doi.org/10.1371/journal.pone.0106072			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259517	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600005
J	Cieszanowski, A; Maj, E; Kulisiewicz, P; Grudzinski, IP; Jakoniuk-Glodala, K; Chlipala-Nitek, I; Kaczynski, B; Rowinski, O				Cieszanowski, Andrzej; Maj, Edyta; Kulisiewicz, Piotr; Grudzinski, Ireneusz P.; Jakoniuk-Glodala, Karolina; Chlipala-Nitek, Irena; Kaczynski, Bartosz; Rowinski, Olgierd			Non-Contrast-Enhanced Whole-Body Magnetic Resonance Imaging in the General Population: The Incidence of Abnormal Findings in Patients 50 Years Old and Younger Compared to Older Subjects	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; BONE METASTASES; LUNG-CANCER; MULTIPLE-MYELOMA; FDG PET/CT; MRI; CT; FEASIBILITY; EXPERIENCE; DISEASE	Purpose: To assess and compare the incidence of abnormal findings detected during non-contrast-enhanced whole-body magnetic resonance imaging (WB-MRI) in the general population in two age groups: (1) 50 years old and younger; and (2) over 50 years old. Materials and Methods: The analysis included 666 non-contrast-enhanced WB-MRIs performed on a 1.5-T scanner between December 2009 and June 2013 in a private hospital in 451 patients 50 years old and younger and 215 patients over 50 years old. The following images were obtained: T2-STIR (whole body-coronal plane), T2-STIR (whole spine-sagittal), T2-TSE with fat-saturation (neck and trunk-axial), T2-FLAIR (head-axial), 3D T1-GRE (thorax-coronal, axial), T2-TSE (abdomen-axial), chemical shift (abdomen-axial). Detected abnormalities were classified as: insignificant (type I), potentially significant, requiring medical attention (type II), significant, requiring treatment (type III). Results: There were 3375 incidental findings depicted in 659 (98.9%) subjects: 2997 type I lesions (88.8%), 363 type II lesions (10.8%) and 15 type III lesions (0.4%), including malignant or possibly malignant lesions in seven subjects. The most differences in the prevalence of abnormalities on WB-MRI between patients 50 years old and younger and over 50 years old concerned: brain infarction (22.2%, 45.0% respectively), thyroid cysts/nodules (8.7%, 18.8%), pulmonary nodules (5.0%, 16.2%), significant degenerative disease of the spine (23.3%, 44.5%), extra-spinal degenerative disease (22.4%, 61.1%), hepatic steatosis (15.8%, 24.9%), liver cysts/hemangiomas (24%, 34.5%), renal cysts (16.9%, 40.6%), prostate enlargement (5.1% of males, 34.2% of males), uterine fibroids (16.3% of females, 37.9% of females). Conclusions: Incidental findings were detected in almost all of the subjects. WB-MRI demonstrated that the prevalence of the vast majority of abnormalities increases with age.	[Cieszanowski, Andrzej; Maj, Edyta; Kulisiewicz, Piotr; Jakoniuk-Glodala, Karolina; Chlipala-Nitek, Irena; Rowinski, Olgierd] Med Univ Warsaw, Dept Clin Radiol 2, Warsaw, Poland; [Cieszanowski, Andrzej; Maj, Edyta; Kulisiewicz, Piotr] Medicover Hosp, Ctr Diagnost, Warsaw, Poland; [Grudzinski, Ireneusz P.] Med Univ Warsaw, Dept Toxicol, Fac Pharm, Warsaw, Poland; [Kaczynski, Bartosz] Med Univ Warsaw, Dept Med Informat & Telemed, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Medical University of Warsaw	Maj, E (corresponding author), Med Univ Warsaw, Dept Clin Radiol 2, Warsaw, Poland.	jeczene@gmail.com		Grudzinski, Ireneusz/0000-0002-6113-1771; Grudzinski, Ireneusz/0000-0002-1485-7529				Bandettini PA, 2009, ANN NY ACAD SCI, V1156, P260, DOI 10.1111/j.1749-6632.2009.04420.x; Biederer J, 2008, CANCER IMAGING, V8, P125, DOI 10.1102/1470-7330.2008.0018; Brennan DD, 2005, AM J ROENTGENOL, V185, P418, DOI 10.2214/ajr.185.2.01850418; Brunner DO, 2009, NATURE, V457, P994, DOI 10.1038/nature07752; Chang KJ, 2008, RADIOGRAPHICS, V28, P1983, DOI 10.1148/rg.287075154; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Costelloe CM, 2012, J MAGN RESON IMAGING, V35, P399, DOI 10.1002/jmri.22815; Dyer R, 2008, RADIOLOGY, V247, P331, DOI 10.1148/radiol.2472061846; Engelhard K, 2004, EUR RADIOL, V14, P99, DOI 10.1007/s00330-003-1968-7; Fenchel M, 2006, RADIOLOGY, V238, P280, DOI 10.1148/radiol.2381041532; Frericks BB, 2008, J MAGN RESON IMAGING, V27, P538, DOI 10.1002/jmri.21218; Furtado CD, 2005, RADIOLOGY, V237, P385, DOI 10.1148/radiol.2372041741; Ghanem NA, 2007, EUR SPINE J, V16, P1907, DOI 10.1007/s00586-007-0350-x; Goehde SC, 2005, AM J ROENTGENOL, V184, P598, DOI 10.2214/ajr.184.2.01840598; Gohagan J, 2004, CHEST, V126, P114, DOI 10.1378/chest.126.1.114; Gore R M, 2010, Cancer Imaging, V10 Spec no A, pS15, DOI 10.1102/1470-7330.2010.9021; Hanrahan CJ, 2010, RADIOGRAPHICS, V30, P127, DOI 10.1148/rg.301095066; Hegenscheid K, 2009, ROFO-FORTSCHR RONTG, V181, P748, DOI 10.1055/s-0028-1109510; Hegenscheid K, 2013, EUR RADIOL, V23, P816, DOI 10.1007/s00330-012-2636-6; Khan Ali Nawaz, 2011, Avicenna J Med, V1, P39, DOI 10.4103/2231-0770.90915; Kitajima M, 2012, AM J NEURORADIOL, V33, P922, DOI 10.3174/ajnr.A2874; Kramer H, 2009, EUR J RADIOL, V70, P418, DOI 10.1016/j.ejrad.2009.03.025; Kruger DG, 2002, MAGN RESON MED, V47, P224, DOI 10.1002/mrm.10061; Ladd SC, 2009, EUR J RADIOL, V70, P452, DOI 10.1016/j.ejrad.2009.02.011; Laible M, 2012, INSIGHTS IMAGING, V3, P485, DOI 10.1007/s13244-012-0180-1; Ley S, 2009, EUR J RADIOL, V70, P442, DOI 10.1016/j.ejrad.2009.02.012; Lo Gladys G., 2008, Hong Kong Medical Journal, V14, P90; Low RN, 2007, J MAGN RESON IMAGING, V25, P848, DOI 10.1002/jmri.20864; Ludwig UA, 2014, J MAGN RESON IMAGING, V40, P1437, DOI 10.1002/jmri.24509; Morin SHX, 2009, EUR J RADIOL, V72, P529, DOI 10.1016/j.ejrad.2008.08.006; Morris Z, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3016; Ng CS, 2008, AM J ROENTGENOL, V191, P1220, DOI 10.2214/AJR.07.3568; Ohno Y, 2008, RADIOLOGY, V248, P643, DOI 10.1148/radiol.2482072039; Patriquin L, 2001, J MAGN RESON IMAGING, V13, P277, DOI 10.1002/1522-2586(200102)13:2<277::AID-JMRI1040>3.0.CO;2-W; Qu XH, 2012, EUR J RADIOL, V81, P1007, DOI 10.1016/j.ejrad.2011.01.126; Schmidt CO, 2013, EUR RADIOL, V23, P1343, DOI 10.1007/s00330-012-2723-8; Schmidt GP, 2007, SKELETAL RADIOL, V36, P1109, DOI 10.1007/s00256-007-0323-5; Schmidt GP, 2007, EUR RADIOL, V17, P939, DOI 10.1007/s00330-006-0361-8; Shortt CP, 2009, AM J ROENTGENOL, V192, P980, DOI 10.2214/AJR.08.1633; Sohaib SA, 2009, BRIT J RADIOL, V82, P632, DOI 10.1259/bjr/52773262; Swensen SJ, 2003, RADIOLOGY, V226, P756, DOI 10.1148/radiol.2263020036; Takatalo J, 2009, SPINE, V34, P1716, DOI 10.1097/BRS.0b013e3181ac5fec; Tan BB, 2003, CHEST, V123, p89S, DOI 10.1378/chest.123.1_suppl.89S; Tsui KH, 2000, J UROLOGY, V163, P426, DOI 10.1016/S0022-5347(05)67892-5; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Weckbach S, 2009, EUR J RADIOL, V70, P424, DOI 10.1016/j.ejrad.2009.04.013; Woodward CI, 2009, CLIN RADIOL, V64, P951, DOI 10.1016/j.crad.2009.04.010	47	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107840	10.1371/journal.pone.0107840	http://dx.doi.org/10.1371/journal.pone.0107840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259581	Green Submitted, gold, Green Published			2022-12-27	WOS:000342685600030
J	Mirams, L; Poliakoff, E; Zandstra, EH; Hoeksma, M; Thomas, A; El-Deredy, W				Mirams, Laura; Poliakoff, Ellen; Zandstra, Elizabeth H.; Hoeksma, Marco; Thomas, Anna; El-Deredy, Wael			Feeling Bad and Looking Worse: Negative Affect Is Associated with Reduced Perceptions of Face-Healthiness	PLOS ONE			English	Article							IMPLICIT SELF-ESTEEM; BODY DYSMORPHIC DISORDER; PSYCHOMETRIC PROPERTIES; INDIVIDUAL-DIFFERENCES; VALIDITY; ENHANCEMENT; EXPERIENCE; COMPLAINTS; SYMPTOMS; BEHAVIOR	Some people perceive themselves to look more, or less attractive than they are in reality. We investigated the role of emotions in enhancement and derogation effects; specifically, whether the propensity to experience positive and negative emotions affects how healthy we perceive our own face to look and how we judge ourselves against others. A psychophysical method was used to measure healthiness of self-image and social comparisons of healthiness. Participants who self-reported high positive (N = 20) or negative affectivity (N = 20) judged themselves against healthy (red-tinged) and unhealthy looking (green-tinged) versions of their own and stranger's faces. An adaptive staircase procedure was used to measure perceptual thresholds. Participants high in positive affectivity were un-biased in their face health judgement. Participants high in negative affectivity on the other hand, judged themselves as equivalent to less healthy looking versions of their own face and a stranger's face. Affective traits modulated self-image and social comparisons of healthiness. Face health judgement was also related to physical symptom perception and self-esteem; high physical symptom reports were associated a less healthy self-image and high self-reported (but not implicit) self-esteem was associated with more favourable social comparisons of healthiness. Subject to further validation, our novel face health judgement task could have utility as a perceptual measure of well-being. We are currently investigating whether face health judgement is sensitive to laboratory manipulations of mood.	[Mirams, Laura; Poliakoff, Ellen; El-Deredy, Wael] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Zandstra, Elizabeth H.; Hoeksma, Marco] Unilever R&D, Vlaardingen, Netherlands; [Thomas, Anna] Unilever R&D, Port Sunlight, England	University of Manchester; Unilever; Unilever	Mirams, L (corresponding author), Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England.	L.R.Mirams@ljmu.ac.uk	Hoeksma, Marco R/U-4459-2017; Poliakoff, Ellen/N-9910-2015; El-deredy, Wael/H-6521-2015	Poliakoff, Ellen/0000-0003-4975-7787; El-deredy, Wael/0000-0002-9822-1092; Hoeksma, Marco/0000-0002-3777-5198; Mirams, Laura/0000-0002-5176-1200	Unilever Research and Development	Unilever Research and Development(Unilever)	This research was funded by Unilever Research and Development (www.unilever.co.uk). The first, second and sixth authors worked collaboratively with the third, fourth and fifth authors, who have an affiliation with Unilever, during the study design process. Data collection and analysis was carried out by the corresponding author at the University of Manchester. The decision to publish was taken with permission from Unilever R & D. The funders had a role in study design, but did not have a role in data collection, analysis, or preparation of the manuscript.	Back MD, 2009, J RES PERS, V43, P933, DOI 10.1016/j.jrp.2009.04.002; Buckingham JT, 2002, J PERS SOC PSYCHOL, V83, P1117, DOI 10.1037//0022-3514.83.5.1117; Clerkin EM, 2008, COGNITION EMOTION, V22, P1327, DOI 10.1080/02699930701766099; Conner T, 2005, EMOTION, V5, P476, DOI 10.1037/1528-3542.5.4.476; CORNSWEET TN, 1962, AM J PSYCHOL, V75, P485, DOI 10.2307/1419876; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Detweiler-Bedell B, 2006, COGNITION EMOTION, V20, P196, DOI 10.1080/02699930500294996; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Epley N, 2008, PERS SOC PSYCHOL B, V34, P1159, DOI 10.1177/0146167208318601; Espeset EMS, 2012, EUR EAT DISORD REV, V20, P451, DOI 10.1002/erv.2183; Farmer H, 2014, PSYCHOL SCI, V25, P290, DOI 10.1177/0956797613494852; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Gardner RM, 1996, J CLIN PSYCHOL, V52, P3, DOI 10.1002/(SICI)1097-4679(199601)52:1<3::AID-JCLP1>3.0.CO;2-X; Gentile B, 2009, REV GEN PSYCHOL, V13, P34, DOI 10.1037/a0013689; GrayLittle B, 1997, PERS SOC PSYCHOL B, V23, P443, DOI 10.1177/0146167297235001; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2000, J PERS SOC PSYCHOL, V79, P1022, DOI 10.1037//0022-3514.79.6.1022; Grilo CM, 2012, J CONSULT CLIN PSYCH, V80, P897, DOI 10.1037/a0027001; Han C, 2009, PSYCHOSOMATICS, V50, P580, DOI 10.1176/appi.psy.50.6.580; Helmholtz H., 1866, TREATISE PHYSL OPTIC, VVol. III; Hepper EG, 2010, J PERS, V78, P781, DOI 10.1111/j.1467-6494.2010.00633.x; Interian A, 2006, PSYCHOSOMATICS, V47, P392, DOI 10.1176/appi.psy.47.5.392; JEROME L, 1992, AM J PSYCHIAT, V149, P577, DOI 10.1176/ajp.149.4.577; Kolk AM, 2003, SOC SCI MED, V57, P2343, DOI 10.1016/S0277-9536(02)00451-3; Koole SL, 2001, J PERS SOC PSYCHOL, V80, P669, DOI 10.1037//0022-3514.80.4.669; Krause S, 2011, EUR J PERSONALITY, V25, P239, DOI 10.1002/per.792; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Mussweiler T, 2004, J PERS SOC PSYCHOL, V87, P832, DOI 10.1037/0022-3514.87.6.832; Nosek BA, 2005, PERS SOC PSYCHOL B, V31, P166, DOI 10.1177/0146167204271418; Pennebaker J.W., 1982, PSYCHOL PHYS SYMPTOM; Re DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017859; Rosenberg M, 1989, SOC ADOLESCENT SELF; Rudolph A, 2010, Z PSYCHOL, V218, P12, DOI 10.1027/0044-3409/a000003; Sinclair SJ, 2010, EVAL HEALTH PROF, V33, P56, DOI 10.1177/0163278709356187; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Suls J, 2012, CURR DIR PSYCHOL SCI, V21, P129, DOI 10.1177/0963721412439298; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Van Diest I, 2005, SOC SCI MED, V61, P1835, DOI 10.1016/j.socscimed.2005.03.031; Verosky SC, 2010, NEUROIMAGE, V49, P1690, DOI 10.1016/j.neuroimage.2009.10.017; Wald A., 1947, SEQUENTIAL ANAL; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; WHEELER L, 1992, J PERS SOC PSYCHOL, V62, P760, DOI 10.1037/0022-3514.62.5.760; Williams PG, 2002, PERS SOC PSYCHOL B, V28, P1015, DOI 10.1177/01461672022811001; Zell E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036742	48	6	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107912	10.1371/journal.pone.0107912	http://dx.doi.org/10.1371/journal.pone.0107912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IP	25259802	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000342685600033
J	Coggins, LG; Bacheler, NM; Gwinn, DC				Coggins, Lewis G., Jr.; Bacheler, Nathan M.; Gwinn, Daniel C.			Occupancy Models for Monitoring Marine Fish: A Bayesian Hierarchical Approach to Model Imperfect Detection with a Novel Gear Combination	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; GULF-OF-MEXICO; LANDSCAPE CHARACTERISTICS; STOCK ASSESSMENT; RED SNAPPER; REEF; ABUNDANCE; FISHERIES; DESIGN; RATES	Occupancy models using incidence data collected repeatedly at sites across the range of a population are increasingly employed to infer patterns and processes influencing population distribution and dynamics. While such work is common in terrestrial systems, fewer examples exist in marine applications. This disparity likely exists because the replicate samples required by these models to account for imperfect detection are often impractical to obtain when surveying aquatic organisms, particularly fishes. We employ simultaneous sampling using fish traps and novel underwater camera observations to generate the requisite replicate samples for occupancy models of red snapper, a reef fish species. Since the replicate samples are collected simultaneously by multiple sampling devices, many typical problems encountered when obtaining replicate observations are avoided. Our results suggest that augmenting traditional fish trap sampling with camera observations not only doubled the probability of detecting red snapper in reef habitats off the Southeast coast of the United States, but supplied the necessary observations to infer factors influencing population distribution and abundance while accounting for imperfect detection. We found that detection probabilities tended to be higher for camera traps than traditional fish traps. Furthermore, camera trap detections were influenced by the current direction and turbidity of the water, indicating that collecting data on these variables is important for future monitoring. These models indicate that the distribution and abundance of this species is more heavily influenced by latitude and depth than by micro-scale reef characteristics lending credence to previous characterizations of red snapper as a reef habitat generalist. This study demonstrates the utility of simultaneous sampling devices, including camera traps, in aquatic environments to inform occupancy models and account for imperfect detection when describing factors influencing fish population distribution and dynamics.	[Coggins, Lewis G., Jr.; Bacheler, Nathan M.] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Beaufort, NC 28516 USA; [Coggins, Lewis G., Jr.] US Fish & Wildlife Serv, Yukon Delta Natl Wildlife Refuge, Bethel, AK USA; [Gwinn, Daniel C.] Univ Florida, Gainesville, FL USA; [Gwinn, Daniel C.] Univ Florida, Sch Forest Resources & Conservat, Program Fisheries & Aquat Sci, Gainesville, FL 32611 USA	National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; US Fish & Wildlife Service; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Coggins, LG (corresponding author), Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Beaufort, NC 28516 USA.	lewis_coggins@fws.gov	Gwinn, Daniel C./I-7328-2019	Gwinn, Daniel C./0000-0002-3633-0904				[Anonymous], P GULF CARIBBEAN FIS; Archaux F, 2012, METHODS ECOL EVOL, V3, P188, DOI 10.1111/j.2041-210X.2011.00142.x; Bacheler NM, 2013, FISH RES, V143, P81, DOI 10.1016/j.fishres.2013.01.013; Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; Bischof R, 2014, METHODS ECOL EVOL, V5, P44, DOI 10.1111/2041-210X.12115; Conn Paul B., 2011, NOAA TECHNICAL MEMOR, P38; Conroy Michael J., 1996, P41; Cowan JH, 2011, FISHERIES, V36, P319, DOI 10.1080/03632415.2011.589318; Dorazio R, 2011, BIODIVERSITY LOSS CH, P1; Erisman BE, 2011, CAN J FISH AQUAT SCI, V68, P1705, DOI 10.1139/F2011-090; Evans CR, 1996, FISH RES, V26, P149, DOI 10.1016/0165-7836(95)00391-6; Fautin D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011914; Gallaway BJ, 2009, REV FISH SCI, V17, P48, DOI 10.1080/10641260802160717; Gelman A., 2004, BAYESIAN DATA ANAL; Graves TA, 2011, ANIM CONSERV, V14, P652, DOI 10.1111/j.1469-1795.2011.00471.x; Guillera-Arroita G, 2011, METHODS ECOL EVOL, V2, P401, DOI 10.1111/j.2041-210X.2011.00089.x; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; International Workshop on Distributed Statistical Computing. Vienna Austria. R Development Core Team, 2014, INT WORKSH DISTR STA; Issaris Y, 2012, MAR ECOL PROG SER, V453, P95, DOI 10.3354/meps09668; Katsanevakis S, 2012, AQUAT BIOL, V16, P31, DOI 10.3354/ab00426; Kendall MS, 2008, T AM FISH SOC, V137, P1134, DOI 10.1577/T07-210.1; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacNeil MA, 2010, P 11 INT COR REEF S, P785; Martell SJD, 2002, B MAR SCI, V70, P695; Mazerolle MJ, 2005, ECOL APPL, V15, P824, DOI 10.1890/04-0502; McCarthy MA, 2013, OIKOS, V122, P717, DOI 10.1111/j.1600-0706.2012.20781.x; McCullagh P, 1989, GEN LINEAR MODELS; McDonough M, 2007, P GULF CARIBBEAN FIS, V59, P159; MESA MG, 1989, T AM FISH SOC, V118, P644, DOI 10.1577/1548-8659(1989)118<0644:EMADME>2.3.CO;2; Nichols JD, 2008, J APPL ECOL, V45, P1321, DOI 10.1111/j.1365-2664.2008.01509.x; O'Connell AF, 2006, J WILDLIFE MANAGE, V70, P1625, DOI 10.2193/0022-541X(2006)70[1625:ESOADP]2.0.CO;2; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; RECKSIEK CW, 1991, FISH RES, V10, P177, DOI 10.1016/0165-7836(91)90074-P; Rose GA, 1999, CAN J FISH AQUAT SCI, V56, P118, DOI 10.1139/cjfas-56-S1-118; Rota CT, 2013, J APPL ECOL, V46, P1173; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Rudershausen PJ, 2010, FISH RES, V105, P254, DOI 10.1016/j.fishres.2010.05.005; Schobernd CM, 2009, B MAR SCI, V84, P67; Schobernd ZH, 2014, CAN J FISH AQUAT SCI, V71, P464, DOI 10.1139/cjfas-2013-0086; SEDAR, 2009, SEDAR15; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Walters C, 1996, REV FISH BIOL FISHER, V6, P125; Walters C, 1998, CAN J FISH AQUAT SCI, V55, P2691, DOI 10.1139/cjfas-55-12-2691; Walters C, 2003, CAN J FISH AQUAT SCI, V60, P1433, DOI 10.1139/F03-152; Walters C., 1986, ADAPTIVE MANAGEMENT; Wenger SJ, 2008, ECOLOGY, V89, P2953, DOI 10.1890/07-1127.1; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	52	29	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108302	10.1371/journal.pone.0108302	http://dx.doi.org/10.1371/journal.pone.0108302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255325	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300070
J	Garber, MD; Sajuria, M; Lobelo, F				Garber, Michael D.; Sajuria, Marcelo; Lobelo, Felipe			Geographical Variation in Health-Related Physical Fitness and Body Composition among Chilean 8th Graders: A Nationally Representative Cross-Sectional Study	PLOS ONE			English	Article							SHUTTLE RUN TEST; CARDIOVASCULAR RISK-FACTORS; CARDIORESPIRATORY FITNESS; NUTRITION TRANSITION; WAIST CIRCUMFERENCE; MUSCULAR STRENGTH; SPANISH ADOLESCENTS; ABDOMINAL OBESITY; POLICY STATEMENT; URBAN CHILDREN	Purpose: In addition to excess adiposity, low cardiorespiratory fitness (CRF) and low musculoskeletal fitness (MSF) are important independent risk factors for future cardio-metabolic disease in adolescents, yet global fitness surveillance in adolescents is poor. The objective of this study was to describe and investigate geographical variation in levels of health-related physical fitness, including CRF, MSF, body mass index (BMI), and waist circumference (WC) in Chilean 8th graders. Methods: This cross-sectional study was based on a population-based, representative sample of 19,929 8th graders (median age = 14 years) in the 2011 National Physical Education Survey from Chile. CRF was assessed with the 20-meter shuttle run test, MSF with standing broad jump, and body composition with BMI and WC. Data were classified according to health-related standards. Prevalence of levels of health-related physical fitness was mapped for each of the four variables, and geographical variation was explored at the country level by region and in the Santiago Metropolitan Area by municipality. Results: Girls had significantly higher prevalence of unhealthy CRF, MSF, and BMI than boys (p<0.05). Overall, 26% of boys and 55% of girls had unhealthy CRF, 29% of boys and 35% of girls had unhealthy MSF, 29% of boys and 44% of girls had unhealthy BMI, and 31% of adolescents had unhealthy WC. High prevalence of unhealthy fitness levels concentrates in the northern and middle regions of the country and in the North and Southwest sectors for the Santiago Metropolitan Area. Conclusion: Prevalence of unhealthy CRF, MSF, and BMI is relatively high among Chilean 8th graders, especially in girls, when compared with global estimates. Identification of geographical regions and municipalities with high prevalence of unhealthy physical fitness presents opportunity for targeted intervention.	[Garber, Michael D.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Sajuria, Marcelo] Chile Natl Inst Sport, Hlth & Sci Unit, Santiago, Chile; [Lobelo, Felipe] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Lobelo, F (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	rlobelo@emory.edu	Lobelo, R.L Felipe/AAB-2264-2021; Garber, Michael/V-1344-2019; Correa-Bautista, Jorge Enrique/N-2741-2015	Lobelo, R.L Felipe/0000-0003-4185-7193; Garber, Michael/0000-0003-0122-5634; Correa-Bautista, Jorge Enrique/0000-0002-0646-2316				Albala C, 2002, PUBLIC HEALTH NUTR, V5, P123, DOI 10.1079/PHN2001283; Albarwani S, 2009, METAB SYNDR RELAT D, V7, P369, DOI 10.1089/met.2008.0052; [Anonymous], AN COM SANT CHIL; [Anonymous], 2013, SIMCE ED FIS 2012 PR; [Anonymous], 2005, DAT AN THIS PAP WAS; [Anonymous], 2005, TRAYECT DES HUM COM, P1; [Anonymous], 2010, ARCADIS GEOTECNIA RE, P1; [Anonymous], 2010, ALPH HLTH REL FITN T, P1; [Anonymous], 2009, COB ED BAS MED SEG Q; [Anonymous], 2010, MET CONSTR GRUP SOC; [Anonymous], 2013, 2012 2013 CAL PHYS F; Artero EG, 2012, J CARDIOPULM REHABIL, V32, P351, DOI 10.1097/HCR.0b013e3182642688; Artero EG, 2011, PEDIATR DIABETES, V12, P704, DOI 10.1111/j.1399-5448.2011.00769.x; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; Bouchard C, 1992, Exerc Sport Sci Rev, V20, P27; Brewer CA, 2002, ANN ASSOC AM GEOGR, V92, P662, DOI 10.1111/1467-8306.00310; Camacho-Minano MJ, 2011, HEALTH EDUC RES, V26, P1025, DOI 10.1093/her/cyr040; Castro-Pinero J, 2010, BRIT J SPORT MED, V44, P934, DOI 10.1136/bjsm.2009.058321; Castro-Pinero J, 2010, J STRENGTH COND RES, V24, P1810, DOI 10.1519/JSC.0b013e3181ddb03d; Catley MJ, 2013, BRIT J SPORT MED, V47, P98, DOI 10.1136/bjsports-2011-090218; CDC (Centers for Disease Control and Prevention), 2011, SEX TRANSM DIS SURV; Chillon P, 2011, J SCI MED SPORT, V14, P417, DOI 10.1016/j.jsams.2011.04.004; Clemente Ana Paula G., 2011, Rev. paul. pediatr., V29, P171; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cuenca-Garcia M, 2012, BRIT J NUTR, V107, P1850, DOI 10.1017/S0007114511005149; Cuevas A, 2011, CURR OPIN ENDOCRINOL, V18, P134, DOI 10.1097/MED.0b013e3283449167; de Moraes ACF, 2011, OBES REV, V12, P69, DOI 10.1111/j.1467-789X.2010.00753.x; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Cohen DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093150; Ekelund U, 2009, AM J CLIN NUTR, V89, P90, DOI 10.3945/ajcn.2008.26649; Eriksen M, 2013, TOBACCO ATLAS; Espana-Romero V, 2010, INT J SPORTS MED, V31, P490, DOI 10.1055/s-0030-1251990; de Moraes ACF, 2013, ANN HUM BIOL, V40, P1, DOI 10.3109/03014460.2012.745900; Grontved A, 2015, BRIT J SPORT MED, V49, P90, DOI 10.1136/bjsports-2012-091907; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hallal PC, 2010, J PHYS ACT HEALTH, V7, pS129, DOI 10.1123/jpah.7.s2.s129; Haugen T, 2014, SCAND J PUBLIC HEALT, V42, P67, DOI 10.1177/1403494813504502; Jimenez-Pavon D, 2010, INT J PEDIATR OBES, V5, P467, DOI 10.3109/17477160903576093; Jimenez-Pavon D, 2010, INT J PEDIATR OBES, V5, P3, DOI 10.3109/17477160903067601; Kaminsky LA, 2013, CIRCULATION, V127, P652, DOI 10.1161/CIR.0b013e31827ee100; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P190, DOI 10.1016/S0895-4356(00)00315-2; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Kok MO, 2012, EUR ADDICT RES, V18, P70, DOI 10.1159/000333600; Laurson KR, 2011, AM J PREV MED, V41, pS100, DOI 10.1016/j.amepre.2011.07.004; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Lobelo F, 2013, J SCHOOL HEALTH, V83, P668, DOI 10.1111/josh.12080; Lobelo F, 2010, J ADOLESCENT HEALTH, V47, P352, DOI 10.1016/j.jadohealth.2010.04.012; Lobelo F, 2009, MED SCI SPORT EXER, V41, P1222, DOI 10.1249/MSS.0b013e318195d491; Lobstein T, 2007, INT J PEDIATR OBES, V2, P62, DOI 10.1080/17477160601103948; Machado-Rodrigues AM, 2012, J CHILD HEALTH CARE, V16, P166, DOI 10.1177/1367493511430676; McCarthy HD, 2001, EUR J CLIN NUTR, V55, P902, DOI 10.1038/sj.ejcn.1601240; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Meredith MD, 2004, FITNESSGRAM TEST ADM; Messiah SE, 2008, J PEDIATR-US, V153, P845, DOI 10.1016/j.jpeds.2008.06.013; Ministerio de Salud. Gobierno de Chile, 2010, ENC NAC SAL 2009 201; Ministry of Health & Family Welfare, 2012, IND PUBL HLTH STAND, Vsecond, P1; Morrow JR, 2013, AM J PREV MED, V44, P439, DOI 10.1016/j.amepre.2013.01.008; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Olds T, 2006, J SPORT SCI, V24, P1025, DOI 10.1080/02640410500432193; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Ortega FB, 2011, BRIT J SPORT MED, V45, P20, DOI 10.1136/bjsm.2009.062679; Ortega FB, 2005, REV ESP CARDIOL, V58, P898, DOI 10.1016/S1885-5857(06)60372-1; Ortega FB, 2008, REV ESP CARDIOL, V61, P123, DOI 10.1016/S1885-5857(08)60087-0; Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279; Ozdirenc M, 2005, PEDIATR INT, V47, P26, DOI 10.1111/j.1442-200x.2004.02008.x; Pate R, 2012, FITNESS MEASURES HLT, P274; Pate RR, 2006, ARCH PEDIAT ADOL MED, V160, P1005, DOI 10.1001/archpedi.160.10.1005; Pate RR, 2006, CIRCULATION, V114, P1214, DOI 10.1161/CIRCULATIONAHA.106.177052; Pfeiffer KA, 2008, ENDURANCE TRAINABILI, P84; Powell KE, 2009, AM J PREV MED, V36, P304, DOI 10.1016/j.amepre.2008.11.015; Pratt M, 2012, LANCET, V380, P282, DOI 10.1016/S0140-6736(12)60736-3; Reyes MEP, 2003, AM J HUM BIOL, V15, P800, DOI 10.1002/ajhb.10218; Ribeiro IC, 2010, GLOB HEALTH PROMOT, V17, P5, DOI 10.1177/1757975910365231; Rivera JA, 2004, NUTR REV, V62, pS149, DOI 10.1111/j.1753-4887.2004.tb00086.x; Ruiz JR, 2009, BRIT J SPORT MED, V43, P909, DOI 10.1136/bjsm.2008.056499; Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439; Ruiz JR, 2011, BRIT J SPORT MED, V45, P518, DOI 10.1136/bjsm.2010.075341; Ruiz JR, 2009, J SPORT SCI, V27, P899, DOI 10.1080/02640410902902835; Sanchez-Cruz JJ, 2013, REV ESP CARDIOL, V66, P371, DOI [10.1016/j.rec.2012.10.012, 10.1016/j.recesp.2012.10.016]; Schejtman J, 2010, COMUNAS RURALES CHIL; Shields M, 2010, INT J PEDIATR OBES, V5, P265, DOI 10.3109/17477160903268282; Steene-Johannessen J, 2009, MED SCI SPORT EXER, V41, P1361, DOI 10.1249/MSS.0b013e31819aaae5; Suminski RR, 2009, J PHYS ACT HEALTH, V6, P667, DOI 10.1123/jpah.6.5.667; TAYLOR HL, 1955, J APPL PHYSIOL, V8, P73, DOI 10.1152/jappl.1955.8.1.73; Taylor RW, 2000, AM J CLIN NUTR, V72, P490; Terry-McElrath YM, 2011, ADDICTION, V106, P1855, DOI 10.1111/j.1360-0443.2011.03489.x; Tomkinson GR, 2007, SCAND J MED SCI SPOR, V17, P497, DOI 10.1111/j.1600-0838.2006.00569.x; Mojica GT, 2008, ARCH LATINOAM NUTR, V58, P265; Tremblay Mark S, 2010, Health Rep, V21, P7; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; Twisk JWR, 2000, MED SCI SPORT EXER, V32, P1455, DOI 10.1097/00005768-200008000-00014; Vio F, 2008, PUBLIC HEALTH NUTR, V11, P405, DOI 10.1017/S136898000700050X; Vio F, 2000, PUBLIC HEALTH NUTR, V3, P49, DOI 10.1017/S1368980000000070; Voss C, 2013, PEDIATR INT, V55, P498, DOI 10.1111/ped.12092; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Weintraub WS, 2011, CIRCULATION, V124, P967, DOI 10.1161/CIR.0b013e3182285a81; Welk GJ, 2011, AM J PREV MED, V41, pS111, DOI 10.1016/j.amepre.2011.07.007; Welk GJ, 2011, AM J PREV MED, V41, pS131, DOI 10.1016/j.amepre.2011.07.011; World Health Organization, 2013, DRAFT COMPR GLOB MON	100	38	38	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108053	10.1371/journal.pone.0108053	http://dx.doi.org/10.1371/journal.pone.0108053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3UZ	25255442	Green Submitted, gold, Green Published			2022-12-27	WOS:000344862300055
J	Messingham, KN; Holahan, HM; Frydman, AS; Fullenkamp, C; Srikantha, R; Fairley, JA				Messingham, Kelly N.; Holahan, Heather M.; Frydman, Alexandra S.; Fullenkamp, Colleen; Srikantha, Rupasree; Fairley, Janet A.			Human Eosinophils Express the High Affinity IgE Receptor, Fc epsilon RI, in Bullous Pemphigoid	PLOS ONE			English	Article							MEMBRANE ZONE ANTIBODIES; NC16A DOMAIN; BIOLOGICAL-PROPERTIES; BP180 ECTODOMAIN; DISEASE-ACTIVITY; SERUM-LEVELS; SEVERE FORM; MAST-CELLS; HUMAN SKIN; AUTOANTIBODIES	Bullous pemphigoid (BP) is an autoimmune blistering disease mediated by autoantibodies targeting BP180 (type XVII collagen). Patient sera and tissues typically have IgG and IgE autoantibodies and elevated eosinophil numbers. Although the pathogenicity of the IgE autoantibodies is established in BP, their contribution to the disease process is not well understood. Our aims were two-fold: 1) To establish the clinical relationships between total and BP180-specific IgE, eosinophilia and other markers of disease activity; and 2) To determine if eosinophils from BP patients express the high affinity IgE receptor, Fc epsilon RI, as a potential mechanism of action for IgE in BP. Our analysis of 48 untreated BP patients revealed a correlation between BP180 IgG and both BP180 IgE and peripheral eosinophil count. Additionally, we established a correlation between total IgE concentration and both BP180 IgE levels and eosinophil count. When only sera from patients (n = 16) with total IgE >= 400 IU/ml were analyzed, BP180 IgG levels correlated with disease severity, BP230 IgG, total circulating IgE and BP180 IgE. Finally, peripheral eosinophil count correlated more strongly with levels of BP180 IgE then with BP180 IgG. Next, eosinophil FceRI expression was investigated in the blood and skin using several methods. Peripheral eosinophils from BP patients expressed mRNA for all three chains (alpha, beta and gamma) of the Fc epsilon RI. Surface expression of the Fc epsilon RI alpha was confirmed on both peripheral and tissue eosinophils from most BP patients by immunostaining. Furthermore, using a proximity ligation assay, interaction of the alpha- and beta-chains of the Fc epsilon RI was observed in some biopsy specimens, suggesting tissue expression of the trimeric receptor form in some patients. These studies provide clinical support for the relevance of IgE in BP disease and provide one mechanism of action of these antibodies, via binding to the Fc epsilon RI on eosinophils.	[Messingham, Kelly N.; Holahan, Heather M.; Frydman, Alexandra S.; Fullenkamp, Colleen; Srikantha, Rupasree; Fairley, Janet A.] Univ Iowa, Dept Dermatol, Iowa City, IA 52242 USA; [Fairley, Janet A.] Vet Adm Med Ctr, Iowa City, IA USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Messingham, KN (corresponding author), Univ Iowa, Dept Dermatol, Iowa City, IA 52242 USA.	janet-fairley@uiowa.edu	Messingham, Kelly/AAD-8388-2020	Messingham, Kelly/0000-0003-4630-0722; Fairley, Janet/0000-0002-8203-0486	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development [1I01CX000317-01]; Doris Duke Charitable Research Foundation; CTSA award [U54 RR023418-01A1]	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); Doris Duke Charitable Research Foundation(Doris Duke Charitable Foundation (DDCF)); CTSA award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This material is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development 1I01CX000317-01 (JAF) and the Doris Duke Charitable Research Foundation (ASF and HMH). Patient database support was received through the CTSA award to the University of Iowa, U54 RR023418-01A1. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the granting agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo Y, 2001, J DERMATOL SCI, V26, P14, DOI 10.1016/S0923-1811(00)00149-3; ARBESMAN CE, 1974, ARCH DERMATOL, V110, P378, DOI 10.1001/archderm.110.3.378; ASBRINK E, 1984, ACTA DERM-VENEREOL, V64, P243; Barata LT, 1997, EUR J IMMUNOL, V27, P1236, DOI 10.1002/eji.1830270527; Blanchard C, 2009, ADV IMMUNOL, V101, P81, DOI 10.1016/S0065-2776(08)01003-1; Borkowski TA, 2001, J IMMUNOL, V167, P1290, DOI 10.4049/jimmunol.167.3.1290; Borrego B, 1996, AM J PATHOL, V148, P13; CZECH W, 1993, J AM ACAD DERMATOL, V29, P210, DOI 10.1016/0190-9622(93)70170-X; Dehlink E, 2009, IMMUNOL ALLERGY CLIN, V29, P159, DOI 10.1016/j.iac.2008.09.004; Delaporte E, 1996, J IMMUNOL, V157, P3642; Dibbern DA, 2003, J IMMUNOL METHODS, V274, P37, DOI 10.1016/S0022-1759(02)00369-1; Dimson OG, 2003, J INVEST DERMATOL, V120, P784, DOI 10.1046/j.1523-1747.2003.12146.x; Dopp R, 2000, J AM ACAD DERMATOL, V42, P577, DOI 10.1067/mjd.2000.103986; DUBERTRET L, 1980, BRIT J DERMATOL, V103, P615, DOI 10.1111/j.1365-2133.1980.tb01683.x; Dufour C, 2012, BRIT J DERMATOL, V166, P1140, DOI 10.1111/j.1365-2133.2011.10748.x; DVORAK AM, 1982, J INVEST DERMATOL, V78, P91, DOI 10.1111/1523-1747.ep12505711; Fairley JA, 2005, J INVEST DERMATOL, V125, P467, DOI 10.1111/j.0022-202X.2005.23853.x; Fairley JA, 2007, J INVEST DERMATOL, V127, P2605, DOI 10.1038/sj.jid.5700958; Fairley JA, 2013, J AM ACAD DERMATOL, V68, P395, DOI 10.1016/j.jaad.2012.09.012; Fairley JA, 2009, J ALLERGY CLIN IMMUN, V123, P704, DOI 10.1016/j.jaci.2008.11.035; GIUDICE GJ, 1993, J IMMUNOL, V151, P5742; GOUNNI AS, 1994, J ALLERGY CLIN IMMUN, V94, P1214, DOI 10.1016/0091-6749(94)90334-4; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; Hasegawa M, 2003, J IMMUNOL, V170, P3732, DOI 10.4049/jimmunol.170.7.3732; Hofmann S, 2002, J INVEST DERMATOL, V119, P1065, DOI 10.1046/j.1523-1747.2002.19529.x; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Iwata Y, 2008, ARCH DERMATOL, V144, P41, DOI 10.1001/archdermatol.2007.9; Kashahara-Imamura M, 2000, INT J MOL MED, V7, P4; Kayaba H, 2001, J IMMUNOL, V167, P995, DOI 10.4049/jimmunol.167.2.995; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kita H, 1999, J IMMUNOL, V162, P6901; Kita H, 2011, IMMUNOL REV, V242, P161, DOI 10.1111/j.1600-065X.2011.01026.x; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; London VA, 2012, ARCH DERMATOL, V148, P1241, DOI 10.1001/archdermatol.2012.1604; Mawhorter SD, 1996, J IMMUNOL, V156, P4851; Messingham KAN, 2009, J IMMUNOL METHODS, V346, P18, DOI 10.1016/j.jim.2009.04.013; Messingham KN, 2011, J IMMUNOL, V187, P553, DOI 10.4049/jimmunol.1001753; Murrell DF, 2012, J AM ACAD DERMATOL, V66, P479, DOI 10.1016/j.jaad.2011.06.032; Pomponi D, 2013, BRIT J DERMATOL, V168, P1205, DOI 10.1111/bjd.12161; Rajakulasingam K, 1997, J ALLERGY CLIN IMMUN, V100, P78, DOI 10.1016/S0091-6749(97)70198-2; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; SCHAUMBURGLEVER G, 1972, ARCH DERMATOL, V106, P662, DOI 10.1001/archderm.106.5.662; Schmidt E, 2000, ARCH DERMATOL, V136, P174, DOI 10.1001/archderm.136.2.174; Seminario MC, 1999, J IMMUNOL, V162, P6893; Sihra BS, 1997, J ALLERGY CLIN IMMUN, V99, P699, DOI 10.1016/S0091-6749(97)70033-2; Smith SJ, 2000, J ALLERGY CLIN IMMUN, V105, P309, DOI 10.1016/S0091-6749(00)90081-2; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; SUTTON BJ, 1993, NATURE, V366, P421, DOI 10.1038/366421a0; Sutton BJ, 2000, BRIT MED BULL, V56, P1004, DOI 10.1258/0007142001903508; Tsuji-Abe Y, 2005, J DERMATOL SCI, V37, P145, DOI 10.1016/j.jdermsci.2004.10.007; van den Bergh F, 2006, BIOCHEM BIOPH RES CO, V350, P1032, DOI 10.1016/j.bbrc.2006.09.147; Wintroub B U, 1987, Clin Dermatol, V5, P126, DOI 10.1016/0738-081X(87)90057-5; Wong CK, 2009, IMMUNOLOGY, V126, P579, DOI 10.1111/j.1365-2567.2008.02916.x; Yamashita M, 2001, CYTOTECHNOLOGY, V36, P179, DOI 10.1023/A:1014001322272; Ying S, 1998, IMMUNOLOGY, V93, P281, DOI 10.1046/j.1365-2567.1998.00418.x; Yu KK, 2014, JAAD IN PRESS; Zillikens D, 1997, J INVEST DERMATOL, V109, P573, DOI 10.1111/1523-1747.ep12337492; Zone JJ, 2007, J INVEST DERMATOL, V127, P1167, DOI 10.1038/sj.jid.5700681	59	61	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107725	10.1371/journal.pone.0107725	http://dx.doi.org/10.1371/journal.pone.0107725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255430	Green Submitted, gold, Green Published			2022-12-27	WOS:000344862300031
J	Cameron, EK; Cahill, JF; Bayne, EM				Cameron, Erin K.; Cahill, James F., Jr.; Bayne, Erin M.			Root Foraging Influences Plant Growth Responses to Earthworm Foraging	PLOS ONE			English	Article							MORPHOLOGICAL PLASTICITY; RESOURCE ACQUISITION; SOIL; COMMUNITIES; INVASION; PATTERNS; FORESTS; COLONIZATION; EXPLOITATION; RESPIRATION	Interactions among the foraging behaviours of co-occurring animal species can impact population and community dynamics; the consequences of interactions between plant and animal foraging behaviours have received less attention. In North American forests, invasions by European earthworms have led to substantial changes in plant community composition. Changes in leaf litter have been identified as a critical indirect mechanism driving earthworm impacts on plants. However, there has been limited examination of the direct effects of earthworm burrowing on plant growth. Here we show a novel second pathway exists, whereby earthworms (Lumbricus terrestris L.) impact plant root foraging. In a minirhizotron experiment, roots occurred more frequently in burrows and soil cracks than in the soil matrix. The roots of Achillea millefolium L. preferentially occupied earthworm burrows, where nutrient availability was presumably higher than in cracks due to earthworm excreta. In contrast, the roots of Campanula rotundifolia L. were less likely to occur in burrows. This shift in root behaviour was associated with a 30% decline in the overall biomass of C. rotundifolia when earthworms were present. Our results indicate earthworm impacts on plant foraging can occur indirectly via physical and chemical changes to the soil and directly via root consumption or abrasion and thus may be one factor influencing plant growth and community change following earthworm invasion. More generally, this work demonstrates the potential for interactions to occur between the foraging behaviours of plants and soil animals and emphasizes the importance of integrating behavioural understanding in foraging studies involving plants.	[Cameron, Erin K.; Cahill, James F., Jr.; Bayne, Erin M.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Cameron, EK (corresponding author), Univ Helsinki, Dept Biol & Environm Sci, Metapopulat Res Grp, Helsinki, Finland.	ecameron@ualberta.ca	Cahill, James F/B-6147-2015	Cahill, James F/0000-0002-4110-1516; Bayne, Erin/0000-0002-0679-4521	National Sciences and Engineering Research Council of Canada	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by the National Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/), through a Discovery Grant and Discovery Accelerator Supplement to JFC, a Discovery Grant to EMB, and a Vanier Canada Graduate Scholarship to EKC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENGOUGH AG, 1990, J SOIL SCI, V41, P341, DOI 10.1111/j.1365-2389.1990.tb00070.x; Bever JD, 2012, ANNU REV MICROBIOL, V66, P265, DOI 10.1146/annurev-micro-092611-150107; Cahill JF, 2011, ANNU REV ECOL EVOL S, V42, P289, DOI 10.1146/annurev-ecolsys-102710-145006; Cahill JF, 2010, SCIENCE, V328, P1657, DOI 10.1126/science.1189736; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; CORTEZ J, 1992, SOIL BIOL BIOCHEM, V24, P913, DOI 10.1016/0038-0717(92)90014-O; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; Drenovsky RE, 2008, AM J BOT, V95, P681, DOI 10.3732/ajb.2007408; EDWARDS CA, 1980, J APPL ECOL, V17, P533, DOI 10.2307/2402635; EHLERS W, 1983, SOIL TILL RES, V3, P261, DOI 10.1016/0167-1987(83)90027-2; Eisenhauer N, 2009, ECOSYSTEMS, V12, P1008, DOI 10.1007/s10021-009-9275-z; Felten D, 2009, BIOL FERT SOILS, V45, P789, DOI 10.1007/s00374-009-0393-8; Fisk MG, 2004, ECOSYSTEMS, V7, P55, DOI 10.1007/s10021-003-0130-3; Frelich LE, 2006, BIOL INVASIONS, V8, P1235, DOI 10.1007/s10530-006-9019-3; Gates G. E., 1972, T AM PHILOS SOC, V62, P166, DOI [10.2307/1006214, DOI 10.2307/1006214]; GROSS KL, 1993, OECOLOGIA, V95, P61, DOI 10.1007/BF00649507; Gundale MJ, 2002, CONSERV BIOL, V16, P1555, DOI 10.1046/j.1523-1739.2002.01229.x; GUNN A, 1993, PEDOBIOLOGIA, V37, P303; Hale CM, 2006, ECOLOGY, V87, P1637, DOI 10.1890/0012-9658(2006)87[1637:CIHFUP]2.0.CO;2; Hirth JR, 1997, SOIL BIOL BIOCHEM, V29, P529, DOI 10.1016/S0038-0717(96)00176-9; Hodge A, 2010, FUNGAL ECOL, V3, P267, DOI 10.1016/j.funeco.2010.02.002; HUSTON MA, 1994, AM NAT, V144, P954, DOI 10.1086/285720; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; James JJ, 2010, INVAS PLANT SCI MANA, V3, P169, DOI 10.1614/IPSM-D-09-00033.1; Jensen EL, 2011, AM NAT, V177, P377, DOI 10.1086/658343; Johnson HA, 2001, BASIC APPL ECOL, V2, P127, DOI 10.1078/1439-1791-00044; Karst JD, 2012, OECOLOGIA, V170, P925, DOI 10.1007/s00442-012-2358-0; Lawrence B, 2003, NEW PHYTOL, V157, P145, DOI 10.1046/j.1469-8137.2003.00649.x; Lunt HA, 1944, SOIL SCI, V58, P367, DOI 10.1097/00010694-194411000-00003; McNickle GG, 2009, P NATL ACAD SCI USA, V106, P4747, DOI 10.1073/pnas.0807971106; Mommer L, 2012, FUNCT ECOL, V26, P66, DOI 10.1111/j.1365-2435.2011.01916.x; Nuzzo VA, 2009, CONSERV BIOL, V23, P966, DOI 10.1111/j.1523-1739.2009.01168.x; Railsback SF, 2013, TRENDS ECOL EVOL, V28, P119, DOI 10.1016/j.tree.2012.08.023; Regnier E, 2008, J APPL ECOL, V45, P1621, DOI 10.1111/j.1365-2664.2008.01489.x; Scheu S, 2003, PEDOBIOLOGIA, V47, P846, DOI 10.1016/s0031-4056(04)70279-6; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; Springett J, 1997, SOIL BIOL BIOCHEM, V29, P621, DOI 10.1016/S0038-0717(96)00235-0; Stevens GN, 2006, NEW PHYTOL, V171, P127, DOI 10.1111/j.1469-8137.2006.01731.x; Stevens GN, 2006, ECOLOGY, V87, P616, DOI 10.1890/05-0809; Tiunov AV, 1999, SOIL BIOL BIOCHEM, V31, P2039, DOI 10.1016/S0038-0717(99)00127-3; Valentine TA, 2012, ANN BOT-LONDON, V110, P259, DOI 10.1093/aob/mcs118; WANG J, 1986, SOIL SCI, V141, P432, DOI 10.1097/00010694-198606000-00005; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Yeh PJ, 2004, AM NAT, V164, P531, DOI 10.1086/423825	45	23	23	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108873	10.1371/journal.pone.0108873	http://dx.doi.org/10.1371/journal.pone.0108873			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268503	gold, Green Submitted, Green Published			2022-12-27	WOS:000343671700181
J	Gurbuz, N; Ashour, AA; Alpay, SN; Ozpolat, B				Gurbuz, N.; Ashour, A. A.; Alpay, S. N.; Ozpolat, B.			Down-Regulation of 5-HT1B and 5-HT1D Receptors Inhibits Proliferation, Clonogenicity and Invasion of Human Pancreatic Cancer Cells (vol 9, e105245, 2014)	PLOS ONE			English	Correction															NCI NIH HHS [4S4CA151668, U54 CA151668] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA151668] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Gurbuz N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105245	1	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e110067	10.1371/journal.pone.0110067	http://dx.doi.org/10.1371/journal.pone.0110067			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268648	Green Published, gold			2022-12-27	WOS:000343671700232
J	Keane, MG; Horsfall, LJ; Rait, G; Pereira, SP				Keane, Margaret G.; Horsfall, Laura J.; Rait, Greta; Pereira, Stephen P.			Sociodemographic Trends in the Incidence of Pancreatic and Biliary Tract Cancer in UK Primary Care	PLOS ONE			English	Article							CIGARETTE-SMOKING; RISK-FACTORS; MORTALITY-RATES; UNITED-STATES; ENGLAND; CHOLANGIOCARCINOMA; SURVIVAL; MEN; EPIDEMIOLOGY; PREVALENCE	Background: The UK incidence of pancreatic ductal adenocarcinoma (PDAC) is approximately 9/100,000 population compared with 1-2/100,000 for biliary tract cancer (BTC). This study explores the incidence of these cancers over time and the influence of socio-demographic and geographic factors in a UK primary care cohort. Methods: This study uses data from a large UK primary care database, The Health Improvement Network (THIN). All adult patients contributing data to THIN between January 2000 and December 2010 were included. Annual incidence rates were calculated, adjusted for age, gender, time period, deprivation score (Townsend quintile) and strategic health authority. Results: From 2000-2010, the annual incidence of PDAC increased by an average of 3% per year (95% CI 1.00-4.00%) and BTC by 4% (95% CI 2.00-6.00%). Incidence of both cancers increased steeply with age and was higher in men. BTC was associated with increasing deprivation (most deprived versus least deprived quintile (OR: 1.45 [95% CI: 1.17, 1.79.]). Conclusions: The overall incidence of both cancers is low but increasing. Variations in incidence may reflect changes in coding practice or increased exposure to associated risk factors.	[Keane, Margaret G.; Pereira, Stephen P.] UCL, Inst Liver & Digest Hlth, London, England; [Horsfall, Laura J.; Rait, Greta] UCL, Res Dept Primary Care & Populat Hlth, London, England	University of London; University College London; University of London; University College London	Pereira, SP (corresponding author), UCL, Inst Liver & Digest Hlth, London, England.	stephen.pereira@ucl.ac.uk	Keane, Geri/AAX-6245-2021; Pereira, Stephen P/C-5639-2009; Keane, Geri/AAU-3604-2021	Keane, Geri/0000-0001-7477-4541; Pereira, Stephen P/0000-0003-0821-1809; Keane, Geri/0000-0001-7477-4541; Rait, Greta/0000-0002-7216-7294	National Institutes of Health (NIH) [PO1CA84203]; Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme; CRUK research training bursary; NATIONAL CANCER INSTITUTE [P01CA084203] Funding Source: NIH RePORTER; Pancreatic Cancer UK [2011 Grant - Pereira] Funding Source: researchfish	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); CRUK research training bursary; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pancreatic Cancer UK	SPP is supported by National Institutes of Health (NIH) grant PO1CA84203. The work was undertaken at UCLH/UCL, which receives a proportion of funding from the Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme. MGK is supported by a CRUK research training bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2010, SEER CANC STAT; Ariyama J, 1986, Nihon Rinsho, V44, P1729; Baastrup R, 2008, EUR J CANCER, V44, P1962, DOI 10.1016/j.ejca.2008.06.013; Batty GD, 2009, CANCER EPIDEM BIOMAR, V18, P673, DOI 10.1158/1055-9965.EPI-08-1032; Bonelli L, 2003, PANCREAS, V27, P143, DOI 10.1097/00006676-200308000-00007; Booth N, 1994, Health Libr Rev, V11, P177; Brown J, 1998, Popul Trends, P35; Carter R, 2012, CLIN MED, V12, P456, DOI 10.7861/clinmedicine.12-5-456; Chapman RW, 1999, ANN ONCOL, V10, P308, DOI 10.1023/A:1008313809752; Claessen MMH, 2009, J HEPATOL, V50, P158, DOI 10.1016/j.jhep.2008.08.013; Coupland VH, 2012, CANCER EPIDEMIOL, V36, pE207, DOI 10.1016/j.canep.2012.03.010; CRUK, 2011, CANC RES UK CANCERST; Curado MP, 2007, CANC INCIDENCE 5 CON; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807; Ferlay J, 2008, CANC INCIDENCE MORTA, V10; Fuchs CS, 1996, ARCH INTERN MED, V156, P2255, DOI 10.1001/archinte.156.19.2255; Gullo L, 2001, PANCREAS, V22, P210, DOI 10.1097/00006676-200103000-00017; Hariharan D, 2008, HPB, V10, P327, DOI 10.1080/13651820802007464; Hassan MM, 2007, AM J GASTROENTEROL, V102, P2696, DOI 10.1111/j.1572-0241.2007.01510.x; Haynes K, 2009, PHARMACOEPIDEM DR S, V18, P730, DOI 10.1002/pds.1774; Hippisley-Cox J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X616355; Horsfall L, 2013, PHARMACOEPIDEM DR S, V22, P64, DOI 10.1002/pds.3368; Iodice S, 2008, LANGENBECK ARCH SURG, V393, P535, DOI 10.1007/s00423-007-0266-2; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Khan SA, 2012, J HEPATOL, V56, P848, DOI 10.1016/j.jhep.2011.11.015; Klein AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072311; Larsson SC, 2005, BRIT J CANCER, V93, P1310, DOI 10.1038/sj.bjc.6602868; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Ma JM, 2013, JNCI-J NATL CANCER I, V105, P1694, DOI 10.1093/jnci/djt292; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Malvezzi M, 2014, ANN ONCOL, V25, P1650, DOI 10.1093/annonc/mdu138; Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382; Muscat JE, 1997, CANCER EPIDEM BIOMAR, V6, P15; NCIN (National Cancer Intelligence Network), 2008, CANC INC MORT CANC N; Office for National Statistics, 2010, SER MB1; Quinn M, 2001, CANC TRENDS ENGLAND; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; SILVERMAN DT, 1994, JNCI-J NATL CANCER I, V86, P1510, DOI 10.1093/jnci/86.20.1510; Simpson CR, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X514729; Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983; SMITH GD, 1991, INT J EPIDEMIOL, V20, P339, DOI 10.1093/ije/20.2.339; Stapley S, 2012, BRIT J CANCER, V106, P1940, DOI 10.1038/bjc.2012.190; Szatkowski L, 2012, J EPIDEMIOL COMMUN H, V66, P791, DOI 10.1136/jech.2010.120154; Taylor-Robinson SD, 2001, GUT, V48, P816, DOI 10.1136/gut.48.6.816; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; van Boeckel PGA, 2010, CANCER EPIDEMIOL, V34, P696, DOI 10.1016/j.canep.2010.08.004; Weiderpass E, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-41; West J, 2006, BRIT J CANCER, V94, P1751, DOI 10.1038/sj.bjc.6603127; Wood HE, 2006, ALIMENT PHARM THER, V23, P1205, DOI 10.1111/j.1365-2036.2006.02860.x	51	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108498	10.1371/journal.pone.0108498	http://dx.doi.org/10.1371/journal.pone.0108498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268478	Green Published, gold			2022-12-27	WOS:000343671700101
J	Lecarpentier, Y; Claes, V; Lecarpentier, E; Guerin, C; Hebert, JL; Arsalane, A; Moumen, A; Krokidis, X; Michel, F; Timbely, O				Lecarpentier, Yves; Claes, Victor; Lecarpentier, Edouard; Guerin, Catherine; Hebert, Jean-Louis; Arsalane, Abdelilah; Moumen, Abdelouahab; Krokidis, Xenophon; Michel, Francine; Timbely, Oumar			Ultraslow Myosin Molecular Motors of Placental Contractile Stem Villi in Humans	PLOS ONE			English	Article							TRACHEAL SMOOTH-MUSCLE; STATISTICAL-MECHANICS; KINETICS; SHEATH; ACTIN; FORCE; HEART	Human placental stem villi (PSV) present contractile properties. In vitro mechanics were investigated in 40 human PSV. Contraction of PSV was induced by both KCl exposure (n = 20) and electrical tetanic stimulation (n = 20). Isotonic contractions were registered at several load levels ranging from zero-load up to isometric load. The tension-velocity relationship was found to be hyperbolic. This made it possible to apply the A. Huxley formalism for determining the rate constants for myosin cross-bridge (CB) attachment and detachment, CB single force, catalytic constant, myosin content, and maximum myosin ATPase activity. These molecular characteristics of myosin CBs did not differ under either KCl exposure or tetanus. A comparative approach was established from studies previously published in the literature and driven by mean of a similar method. As compared to that described in mammalian striated muscles, we showed that in human PSV, myosin CB rate constants for attachment and detachment were about 10(3) times lower whereas myosin ATPase activity was 10(5) times lower. Up to now, CB kinetics of contractile cells arranged along the long axis of the placental sheath appeared to be the slowest ever observed in any mammalian contractile tissue.	[Lecarpentier, Yves; Lecarpentier, Edouard; Krokidis, Xenophon] Ctr Hosp Reg Meaux, Ctr Rech Clin, Meaux, France; [Guerin, Catherine; Arsalane, Abdelilah; Moumen, Abdelouahab; Michel, Francine; Timbely, Oumar] Ctr Hosp Reg Meaux, Serv Gynecol Obstet, Meaux, France; [Claes, Victor] Univ Antwerp, Dept Pharmaceut Sci, Antwerp, Belgium; [Hebert, Jean-Louis] Hop La Pitie Salpetriere, AP HP, Inst Cardiol, Paris, France; [Lecarpentier, Edouard] Univ Descartes Paris 5, INSERM, U767, Sorbonne Paris Cite, Paris, France	University of Antwerp; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lecarpentier, Y (corresponding author), Ctr Hosp Reg Meaux, Ctr Rech Clin, Meaux, France.	yves.c.lecarpentier@gmail.com	Lecarpentier, Edouard/Q-4557-2018	Claes, Victor/0000-0002-1914-0228; Krokidis, Xenophon/0000-0003-4771-6957; HEBERT, Jean-Louis/0000-0001-6049-0601				Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197; Benirschke K, 2006, PATHOLOGY HUMAN PLAC, V5th; Blanc FX, 2003, EUR RESPIR J, V22, P227, DOI 10.1183/09031936.03.00064203; BRUTSAERT DL, 1973, CIRC RES, V32, P385, DOI 10.1161/01.RES.32.3.385; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Demir R, 1997, MICROSC RES TECHNIQ, V38, P29; Dubreuil G, 1932, CR SOC BIOL, V111, P170; Farley AE, 2004, AM J PHYSIOL-REG I, V287, pR680, DOI 10.1152/ajpregu.00222.2004; Graf R, 1997, CELL TISSUE RES, V290, P601, DOI 10.1007/s004410050965; GRAF R, 1995, PLACENTA, V16, P57, DOI 10.1016/0143-4004(95)90081-0; GRAF R, 1994, ANAT EMBRYOL, V190, P541; Heissler S. M., 2012, CELL MOL LIFE SCI; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; HUSZAR G, 1979, AM J OBSTET GYNECOL, V135, P707, DOI 10.1016/0002-9378(79)90379-X; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Iizuka S., 1916, BEITR GEBURTSH GYNAE, V19, P101; KING TM, 1965, AM J OBSTET GYNECOL, V93, P253, DOI 10.1016/0002-9378(65)90665-4; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Krantz EK, 1963, CLIN OBSTET GYNECOL, V6, P26; Lecarpentier E, 2013, PLACENTA, V34, P1163, DOI 10.1016/j.placenta.2013.10.007; Lecarpentier ER, 2011, J APPL PHYSIOL, V111, P1096, DOI 10.1152/japplphysiol.00414.2011; Lecarpentier Y, 2005, J THEOR BIOL, V235, P381, DOI 10.1016/j.jtbi.2005.01.018; Lecarpentier Y, 2002, AM J PHYSIOL-LUNG C, V282, pL83, DOI 10.1152/ajplung.2002.282.1.L83; Lecarpentier Y, 2011, CR BIOL, V334, P725, DOI 10.1016/j.crvi.2011.08.001; Leguillette Renaud, 2008, Proc Am Thorac Soc, V5, P40, DOI 10.1513/pats.200704-053VS; Matsumura S, 2011, PLACENTA, V32, P347, DOI 10.1016/j.placenta.2011.02.008; MICHAEL C, 1974, J OBSTET GYN BR COMM, V81, P307; Naujoks H, 1922, Z GEBURTSH GYNAEK Z GEBURTSH GYNAEK, V84, P304; Spanner R., 1935, Z ANAT ENTWICKLUNGS, V105, P163, DOI [10.1007/BF02118325, DOI 10.1007/BF02118325]; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Woledge R.C., 1985, ENERGETIC ASPECTS MU, V41, P1	33	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108814	10.1371/journal.pone.0108814	http://dx.doi.org/10.1371/journal.pone.0108814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268142	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700168
J	Lundholm, M; Schroder, M; Nagaeva, O; Baranov, V; Widmark, A; Mincheva-Nilsson, L; Wikstrom, P				Lundholm, Marie; Schroder, Mona; Nagaeva, Olga; Baranov, Vladimir; Widmark, Anders; Mincheva-Nilsson, Lucia; Wikstrom, Pernilla			Prostate Tumor-Derived Exosomes Down-Regulate NKG2D Expression on Natural Killer Cells and CD8(+) T Cells: Mechanism of Immune Evasion	PLOS ONE			English	Article							CANCER-PATIENTS; LIGANDS; MICROVESICLES; IMMUNORECEPTOR; APOPTOSIS; VESICLES; RECEPTOR; RELEASE; IMMUNOSURVEILLANCE; CYTOTOXICITY	Tumor-derived exosomes, which are nanometer-sized extracellular vesicles of endosomal origin, have emerged as promoters of tumor immune evasion but their role in prostate cancer (PC) progression is poorly understood. In this study, we investigated the ability of prostate tumor-derived exosomes to downregulate NKG2D expression on natural killer (NK) and CD8(+) T cells. NKG2D is an activating cytotoxicity receptor whose aberrant loss in cancer plays an important role in immune suppression. Using flow cytometry, we found that exosomes produced by human PC cells express ligands for NKG2D on their surface. The NKG2D ligand-expressing prostate tumor-derived exosomes selectively induced downregulation of NKG2D on NK and CD8(+) T cells in a dose-dependent manner, leading to impaired cytotoxic function in vitro. Consistent with these findings, patients with castration-resistant PC (CRPC) showed a significant decrease in surface NKG2D expression on circulating NK and CD8(+) T cells compared to healthy individuals. Tumor-derived exosomes are likely involved in this NKG2D downregulation, since incubation of healthy lymphocytes with exosomes isolated from serum or plasma of CRPC patients triggered downregulation of NKG2D expression in effector lymphocytes. These data suggest prostate tumor-derived exosomes as down-regulators of the NKG2D-mediated cytotoxic response in PC patients, thus promoting immune suppression and tumor escape.	[Lundholm, Marie; Schroder, Mona; Wikstrom, Pernilla] Umea Univ, Dept Med Biosci, Umea, Sweden; [Nagaeva, Olga; Baranov, Vladimir; Mincheva-Nilsson, Lucia] Umea Univ, Dept Clin Microbiol, Umea, Sweden; [Widmark, Anders] Umea Univ, Dept Radiat Sci, Umea, Sweden	Umea University; Umea University; Umea University	Lundholm, M (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	marie.lundholm@medbio.umu.se			Swedish Research Council [C0217901]; Swedish Cancer Society [CAN2010-788]; Cancer Research Foundation in Northern Sweden [LP 10-1841, LP 12-1940]; Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Cancer Research Foundation in Northern Sweden; Umea University	This work was supported by grants from the Swedish Research Council (Grant no. C0217901, PW)(www.vr.se); the Swedish Cancer Society (Grant no. CAN2010-788, PW)(www.cancerfonden.se); the Cancer Research Foundation in Northern Sweden (Grant no. LP 10-1841 and LP 12-1940, ML) (www.cancerforskningsfonden.se); and Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusamra AJ, 2005, BLOOD CELL MOL DIS, V35, P169, DOI 10.1016/j.bcmd.2005.07.001; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; Ashiru O, 2010, CANCER RES, V70, P481, DOI 10.1158/0008-5472.CAN-09-1688; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Clayton A, 2005, BLOOD CELL MOL DIS, V34, P206, DOI 10.1016/j.bcmd.2005.03.003; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Fernandez-Messina L, 2010, J BIOL CHEM, V285, P8543, DOI 10.1074/jbc.M109.045906; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hayakawa Y, 2006, SEMIN IMMUNOL, V18, P176, DOI 10.1016/j.smim.2006.03.005; Hedlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016899; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; Huber V, 2005, GASTROENTEROLOGY, V128, P1796, DOI 10.1053/j.gastro.2005.03.045; Ichim TE, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-37; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Lanier LL, 2001, NAT MED, V7, P1178, DOI 10.1038/nm1101-1178; Lee JC, 2004, J IMMUNOL, V172, P7335, DOI 10.4049/jimmunol.172.12.7335; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Ljunggren HG, 2008, IMMUNITY, V28, P492, DOI 10.1016/j.immuni.2008.03.007; Michaelsson J, 2002, J EXP MED, V196, P1403, DOI 10.1084/jem.20020797; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Salih HR, 2008, FRONT BIOSCI, V13, P3448; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; Watson NFS, 2006, INT J CANCER, V118, P1445, DOI 10.1002/ijc.21510; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu JD, 2004, J CLIN INVEST, V114, P560, DOI 10.1172/JCI200422206	43	181	196	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108925	10.1371/journal.pone.0108925	http://dx.doi.org/10.1371/journal.pone.0108925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268476	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700191
J	Moon, TC; Campos-Alberto, E; Yoshimura, T; Bredo, G; Rieger, AM; Puttagunta, L; Barreda, DR; Befus, AD; Cameron, L				Moon, Tae Chul; Campos-Alberto, Eduardo; Yoshimura, Tsuyoshi; Bredo, Graeme; Rieger, Aja M.; Puttagunta, Lakshmi; Barreda, Daniel R.; Befus, A. Dean; Cameron, Lisa			Expression of DP2 (CRTh2), a Prostaglandin D-2 Receptor, in Human Mast Cells	PLOS ONE			English	Article							HUMAN EOSINOPHILS; CUTTING EDGE; TH2 CELLS; ALLERGIC INFLAMMATION; PROSTANOID RECEPTOR; IMMUNE-RESPONSES; ADP-RIBOSYLATION; TRANSPORTER PGT; MOUSE CRTH2; BASOPHILS	PGD(2) has long been implicated in allergic diseases. Recent cloning of a second PGD(2) receptor, DP2 (also known as CRTh2), led to a greater understanding of the physiological and pathophysiological implications of PGD(2). PGD(2) signaling through DP1 and DP2 mediates different and often opposite effects in many cell types of the immune system. Although mast cells (MC) are the largest source of PGD(2) in the body, there is little information about their potential expression of DP2 and its functional significance. In this study, we show that tissue MC in human nasal polyps express DP2 protein, and that human MC lines and primary cultured human MC express mRNA as well as protein of DP2. By immunohistochemistry, we detected that 34% of MC in human nasal polyps expressed DP2. In addition, flow cytometry showed that 87% of the LAD2 human MC line and 98% of primary cultured human MC contained intracellular DP2. However, we could not detect surface expression of DP2 on human MC by single cell analysis using imaging flow cytometry. Blocking of endogenous PGD(2) production with aspirin did not induce surface expression of DP2 in human MC. Two DP2 selective agonists, DK-PGD(2) and 15R-15-methyl PGD(2) induced dose-dependent intracellular calcium mobilization that was abrogated by pertussis toxin, but not by three DP2 selective antagonists. MC mediator release including degranulation was not affected by DP2 selective agonists. Thus, human MC express DP2 intracellularly rather than on their surface, and the function of DP2 in human MC is different than in other immune cells such as Th2 cells, eosinophils and basophils where it is expressed on the cell surface and induces Th2 cytokine and/or granule associated mediator release. Further studies to elucidate the role of intracellular DP2 in human MC may expand our understanding of this molecule and provide novel therapeutic opportunities.	[Moon, Tae Chul; Campos-Alberto, Eduardo; Yoshimura, Tsuyoshi; Bredo, Graeme; Befus, A. Dean; Cameron, Lisa] Univ Alberta, Dept Med, Pulm Res Grp, Edmonton, AB, Canada; [Rieger, Aja M.; Barreda, Daniel R.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Puttagunta, Lakshmi] Univ Alberta Hosp, Dept Lab Med & Pathol, Edmonton, AB T6G 2R7, Canada; [Barreda, Daniel R.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Cameron, Lisa] Univ Western Ontario, Schulich Sch Med & Dent, Dept Pathol & Lab Med, London, ON, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; Western University (University of Western Ontario)	Befus, AD (corresponding author), Univ Alberta, Dept Med, Pulm Res Grp, Edmonton, AB, Canada.	dean.befus@ualberta.ca; lisa.cameron@schulich.uwo.ca	Befus, Dean/C-5561-2009; Barreda, Daniel/A-2613-2014	Befus, Dean/0000-0002-1611-2897; Barreda, Daniel/0000-0003-4630-2840	Canadian Institutes of Health Research (CIHR) [7034, 111267]; CIHR-Rx&D/Canadian Lung Association/GlaxoSmithKline (GSK) research program fellowship [XCL-81974]; Alberta Innovates - Health Solutions, AIHS [200501397]; Tokyo Jikei Medical University; AllerGen/Canadian Allergy, Asthma and Immunology Foundation (CAAIF)/Merck International Clinician-Scientist and Post-Doctoral Research Fellowship; AIHS	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR-Rx&D/Canadian Lung Association/GlaxoSmithKline (GSK) research program fellowship; Alberta Innovates - Health Solutions, AIHS; Tokyo Jikei Medical University; AllerGen/Canadian Allergy, Asthma and Immunology Foundation (CAAIF)/Merck International Clinician-Scientist and Post-Doctoral Research Fellowship; AIHS	This study was supported by the Canadian Institutes of Health Research (CIHR, 7034, 111267). TCM received a CIHR-Rx&D/Canadian Lung Association/GlaxoSmithKline (GSK) research program fellowship (XCL-81974) and Alberta Heritage Foundation for Medical Research (now Alberta Innovates - Health Solutions, AIHS) fellowship (200501397). TY received a fellowship from Tokyo Jikei Medical University. EC received an AllerGen/Canadian Allergy, Asthma and Immunology Foundation (CAAIF)/Merck International Clinician-Scientist and Post-Doctoral Research Fellowship. LC received a salary award from AIHS and held a GSK-CIHR Chair in Airway Inflammation, and these were competitive peer reviewed grant competitions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1999, GENE, V227, P71, DOI 10.1016/S0378-1119(98)00599-X; Alberto EC, 2012, ALLERGY, V67, P1357, DOI 10.1111/all.12003; Bao Y, 2002, AM J PHYSIOL-RENAL, V282, pF1103, DOI 10.1152/ajprenal.00152.2001; BEASLEY R, 1988, CLIN ALLERGY, V18, P619, DOI 10.1111/j.1365-2222.1988.tb02914.x; Befus AD, 1999, J IMMUNOL, V163, P947; Binda C, 2014, J CELL BIOL, V204, P377, DOI 10.1083/jcb.201304015; Bochenek G, 2004, THORAX, V59, P459, DOI 10.1136/thx.2003.013573; Boehme SA, 2009, INT IMMUNOL; Bohm E, 2004, J BIOL CHEM, V279, P7663, DOI 10.1074/jbc.M310270200; Boyce JA, 2005, CHEM IMMUNOL ALLERGY, V87, P59, DOI 10.1159/000087571; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Chan BS, 1998, J BIOL CHEM, V273, P6689, DOI 10.1074/jbc.273.12.6689; Chiba T, 2011, ANN ALLERG ASTHMA IM, V106, P511, DOI 10.1016/j.anai.2011.01.027; Clarke DL, 2005, AM J PHYSIOL-LUNG C, V288, pL238, DOI 10.1152/ajplung.00313.2004; COLUMBO M, 1992, J IMMUNOL, V149, P599; Crosignani S, 2008, J MED CHEM, V51, P2227, DOI 10.1021/jm701383e; El-Shazly AE, 2011, INT IMMUNOPHARMACOL, V11, P1864, DOI 10.1016/j.intimp.2011.07.017; FULLER RW, 1986, AM REV RESPIR DIS, V133, P252; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gervais FG, 2001, J ALLERGY CLIN IMMUN, V108, P982, DOI 10.1067/mai.2001.119919; Gosset P, 2003, J IMMUNOL, V170, P4943, DOI 10.4049/jimmunol.170.10.4943; Grigat J, 2007, J IMMUNOL, V179, P3958, DOI 10.4049/jimmunol.179.6.3958; Hamada Kazuyuki, 2004, Allergology International, V53, P179, DOI 10.1111/j.1440-1592.2004.00323.x; Hirai H, 2003, BIOCHEM BIOPH RES CO, V307, P797, DOI 10.1016/S0006-291X(03)01266-X; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Hirai H, 2002, J IMMUNOL, V168, P981, DOI 10.4049/jimmunol.168.3.981; Huber JP, 2010, J IMMUNOL, V185, P813, DOI 10.4049/jimmunol.1000469; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; JOHNSTON SL, 1995, EUR RESPIR J, V8, P411, DOI 10.1183/09031936.95.08030411; Joo M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/503128; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; Katada T, 2012, BIOL PHARM BULL, V35, P2103, DOI 10.1248/bpb.b212024; Kirshenbaum AS, 1999, BLOOD, V94, P2333, DOI 10.1182/blood.V94.7.2333.419k30_2333_2342; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kostenis E, 2006, TRENDS MOL MED, V12, P148, DOI 10.1016/j.molmed.2006.02.005; LEWIS RA, 1982, J IMMUNOL, V129, P1627; Lu R, 1996, J CLIN INVEST, V98, P1142, DOI 10.1172/JCI118897; Mackay GA, 2011, BRIT J PHARMACOL, V162, P1671, DOI 10.1111/j.1476-5381.2011.01236.x; Marcet CW, 2013, IMMUNOL RES, V56, P32, DOI 10.1007/s12026-012-8377-4; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Mesquita-Santos FP, 2011, BRIT J PHARMACOL, V162, P1674, DOI 10.1111/j.1476-5381.2010.01086.x; Mesquita-Santos FP, 2006, J IMMUNOL, V176, P1326, DOI 10.4049/jimmunol.176.3.1326; Monneret G, 2003, J PHARMACOL EXP THER, V304, P349, DOI 10.1124/jpet.102.042937; Moon TC, 2010, MUCOSAL IMMUNOL, V3, P111, DOI 10.1038/mi.2009.136; Moon TC, 2012, J LEUKOCYTE BIOL, V91, P581, DOI 10.1189/jlb.0811436; Moon TC, 2003, MOL CELLS, V16, P154; Nagata K, 2003, PROSTAG LEUKOTR ESS, V69, P169, DOI 10.1016/S0952-3278(03)00078-4; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; Nagata K, 1999, J IMMUNOL, V162, P1278; Obata T, 1996, BIOCHEM BIOPH RES CO, V225, P1015, DOI 10.1006/bbrc.1996.1287; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Roy SJ, 2010, EUR J PHARMACOL, V630, P10, DOI 10.1016/j.ejphar.2009.12.022; Schuligoi R, 2009, J LEUKOCYTE BIOL, V85, P136, DOI 10.1189/jlb.0608387; Schuster VL, 1998, ANNU REV PHYSIOL, V60, P221, DOI 10.1146/annurev.physiol.60.1.221; Sekar Y, 2010, J IMMUNOL, V185, P578, DOI 10.4049/jimmunol.0902720; Shirasaki H, 2009, ANN ALLERG ASTHMA IM, V102, P110, DOI 10.1016/S1081-1206(10)60239-6; Sugimoto H, 2005, EUR J PHARMACOL, V524, P30, DOI 10.1016/j.ejphar.2005.09.005; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Ulanova M, 2005, AM J PHYSIOL-LUNG C, V288, pL497, DOI 10.1152/ajplung.00246.2004; Ulven T, 2005, J MED CHEM, V48, P897, DOI 10.1021/jm049036i; UNDERWOOD DC, 1994, J PHARMACOL EXP THER, V268, P304; URADE Y, 1989, J IMMUNOL, V143, P2982; Xue LZ, 2005, J IMMUNOL, V175, P6531, DOI 10.4049/jimmunol.175.10.6531; Yoshimura T, 2012, ANN ALLERG ASTHMA IM, V108, P172, DOI 10.1016/j.anai.2011.12.013; Yoshimura-Uchiyama C, 2004, CLIN EXP ALLERGY, V34, P1283, DOI 10.1111/j.1365-2222.2004.02027.x; Zuba-Surma EK, 2007, FOLIA HISTOCHEM CYTO, V45, P279	70	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108595	10.1371/journal.pone.0108595	http://dx.doi.org/10.1371/journal.pone.0108595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268140	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700118
J	Spoor, JR; Lehmiller, JJ				Spoor, Jennifer R.; Lehmiller, Justin J.			The Impact of Course Title and Instructor Gender on Student Perceptions and Interest in a Women's and Gender Studies Course	PLOS ONE			English	Article							ATTITUDES; FEMINIST; PROFESSORS; PSYCHOLOGY; EXPERIENCE; PROGRESS; RATINGS; BIAS; MENS; IM	Diversity awareness has enormous benefits, and universities in the United States increasingly require students to complete diversity-related courses. Prior research has demonstrated that students' initial attitudes toward these courses affect their subsequent engagement, as well as the quality of their learning experience; however, very little research has examined how these initial attitudes are formed. We conducted an experiment to examine this issue in the context of a women's and gender studies course in psychology. Participants read one of two identical course descriptions that varied only the course title (i.e., Psychology of Gender versus Psychology of Women) and instructor gender. Participants perceived a women-titled course to be narrowly focused compared to an identical gender-titled course and were more interested in taking the gender-titled course. Instructor gender had no effects on any of the variables. Additionally, female participants had more positive attitudes toward the course than male participants, regardless of title. Exploratory mediation analyses indicated that the main effects of course title and participant gender were mediated by perceptions of course content. Implications for improving student experiences and interest in diversity-related courses are discussed.	[Spoor, Jennifer R.] La Trobe Univ, La Trobe Business Sch, Dept Management, Melbourne, Vic, Australia; [Lehmiller, Justin J.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	La Trobe University; Harvard University	Spoor, JR (corresponding author), La Trobe Univ, La Trobe Business Sch, Dept Management, Melbourne, Vic, Australia.	j.spoor@latrobe.edu.au						Abel MH, 2007, SEX ROLES, V57, P173, DOI 10.1007/s11199-007-9245-x; AMBADY N, 1993, J PERS SOC PSYCHOL, V64, P431, DOI 10.1037/0022-3514.64.3.431; Anderson KJ, 2011, J APPL SOC PSYCHOL, V41, P1538, DOI 10.1111/j.1559-1816.2011.00757.x; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Basow SA, 1995, J EDUC PSYCHOL, V87, P656, DOI 10.1037/0022-0663.87.4.656; Basow SA, 2006, PSYCHOL WOMEN QUART, V30, P25, DOI 10.1111/j.1471-6402.2006.00259.x; Bell MP, 2009, ACAD MANAG LEARN EDU, V8, P597, DOI 10.5465/AMLE.2009.47785478; Bertrand M, 2004, AM ECON REV, V94, P991, DOI 10.1257/0002828042002561; Bowman NA, 2009, J DIVERS HIGH EDUC, V2, P182, DOI 10.1037/a0016639; Breen AB, 2008, SEX ROLES, V58, P299, DOI 10.1007/s11199-007-9317-y; Brown TJ, 2011, PSYCHOL WOMEN QUART, V35, P162, DOI 10.1177/0361684310396065; Burke RJ, 1997, J BUS ETHICS, V16, P933, DOI 10.1023/A:1017991421416; Bush MEL, 2009, DIVERSITY MIND ACTIO, P67; Case KA, 2007, PSYCHOL WOMEN QUART, V31, P426, DOI 10.1111/j.1471-6402.2007.00391.x; Crano WD, 2006, ANNU REV PSYCHOL, V57, P345, DOI 10.1146/annurev.psych.57.102904.190034; Crawford M, 1999, COMING HER OWN ED SU, P155; Denson N, 2009, REV EDUC RES, V79, P805, DOI 10.3102/0034654309331551; Eagly A. H., 1993, PSYCHOL ATTITUDES; Edwards W., 2008, FEMINIST TEACHER, V18, P145, DOI 10.1353/ftr.2008.0010; Eibach RP, 2010, SEX ROLES, V63, P882, DOI 10.1007/s11199-010-9846-7; Ewing VL, 2003, J SOC PSYCHOL, V143, P569, DOI 10.1080/00224540309598464; Flood M, 2011, MEN MASC, V14, P135, DOI 10.1177/1097184X11407042; HADDOCK G, 1994, PSYCHOL WOMEN QUART, V18, P25, DOI 10.1111/j.1471-6402.1994.tb00295.x; Hartung B, 1990, NATIONAL WOMENS STUD, V2, P254; HENDERSONKING DH, 1994, SEX ROLES, V31, P505, DOI 10.1007/BF01544276; Holladay C. L., 2003, HUMAN RESOURCE DEV Q, V14, P245, DOI DOI 10.1002/HRDQ.1065; Holladay CL, 2008, ACAD MANAG LEARN EDU, V7, P343, DOI 10.5465/AMLE.2008.34251672; Humphreys D, 2000, NATL SURVEY FINDS DI; Jenen J, 2009, SEX ROLES, V60, P14, DOI 10.1007/s11199-008-9514-3; JONES GP, 1988, SEX ROLES, V18, P611, DOI 10.1007/BF00287964; Kulik CT, 2008, ACAD MANAG LEARN EDU, V7, P309, DOI 10.5465/AMLE.2008.34251670; Malkin C, 2004, SEX ROLES, V50, P455, DOI 10.1023/B:SERS.0000023066.79915.83; MATLIN MW, 1989, PSYCHOL WOMEN QUART, V13, P245, DOI 10.1111/j.1471-6402.1989.tb01000.x; Moore M, 2007, COLL STUD J, V31, P434; Paludi MA, 2008, PSYCHOL WOMEN HDB IS, P174; Petty R. E., 1998, HDB SOCIAL PSYCHOL, P323; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Rhoades KA, 1999, TEACHING INTRO WOMEN, P225; Schmitt MT., 2009, GLASS CEILING 21 CEN, P49, DOI [10.1037/11863-003, DOI 10.1037/11863-003]; Sevelius JM, 2003, J APPL SOC PSYCHOL, V33, P2341, DOI 10.1111/j.1559-1816.2003.tb01888.x; Smith G, 2005, J LAT EDUC, V4, P115, DOI 10.1207/s1532771xjle0402_4; Spoor JR, 2011, BASIC APPL SOC PSYCH, V33, P24, DOI 10.1080/01973533.2010.539948; Stake JE, 2007, SEX ROLES, V57, P43, DOI 10.1007/s11199-007-9227-z; Stake JE, 2003, PSYCHOL WOMEN QUART, V27, P174, DOI 10.1111/1471-6402.00097; STAKE JE, 1987, PSYCHOL WOMEN QUART, V11, P277, DOI 10.1111/j.1471-6402.1987.tb00903.x; THOMSEN CJ, 1995, PSYCHOL WOMEN QUART, V19, P419, DOI 10.1111/j.1471-6402.1995.tb00084.x; TURKEL KD, 1986, TEACH SOCIOL, V14, P188, DOI 10.2307/1318475; Twenge JM, 1999, PSYCHOL WOMEN QUART, V23, P591, DOI 10.1111/j.1471-6402.1999.tb00383.x; Uleman JS, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P141; Williams R, 1997, SEX ROLES, V37, P885, DOI 10.1007/BF02936345; Yoder JD, 2007, PSYCHOL WOMEN QUART, V31, P415, DOI 10.1111/j.1471-6402.2007.00390.x; YZERBYT VY, 1994, J PERS SOC PSYCHOL, V66, P48, DOI 10.1037/0022-3514.66.1.48; Zucker AN, 2004, PSYCHOL WOMEN QUART, V28, P423, DOI 10.1111/j.1471-6402.2004.00159.x	53	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106286	10.1371/journal.pone.0106286	http://dx.doi.org/10.1371/journal.pone.0106286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268353	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700010
J	Tang, WZ; Shan, BQ; Zhang, WQ; Zhang, H; Wang, LS; Ding, YK				Tang, Wenzhong; Shan, Baoqing; Zhang, Wenqiang; Zhang, Hong; Wang, Lishuo; Ding, Yuekui			Heavy Metal Pollution Characteristics of Surface Sediments in Different Aquatic Ecosystems in Eastern China: A Comprehensive Understanding	PLOS ONE			English	Article							SEQUENTIAL EXTRACTION PROCEDURE; POTENTIAL ECOLOGICAL RISK; AGRICULTURAL INTENSIFICATION; SPATIAL-DISTRIBUTION; RIVER; ACCUMULATION; SPECIATION; LAKES; CONTAMINATION; MALAYSIA	Aquatic ecosystems in eastern China are suffering threats from heavy metal pollution because of rapid economic development and urbanization. Heavy metals in surface sediments were determined in five different aquatic ecosystems (river, reservoir, estuary, lake, and wetland ecosystems). The average Cd, Cr, Cu, Ni, Pb, and Zn concentrations were 0.716, 118, 37.3, 32.7, 56.6, and 204 mg/kg, respectively, and the higher concentrations were mainly found in sediment samples from river ecosystems. Cd was the most anthropogenically enriched pollutant, followed by Zn and Pb, indicated by enrichment factors > 1.5. According to consensus-based sediment quality guidelines, potential ecological risk indices, and risk assessment codes, all five types of aquatic ecosystems were found to be polluted with heavy metals, and the most polluted ecosystems were mainly rivers. Cd was the most serious pollutant in all five aquatic ecosystems, and it was mainly found in the exchangeable fraction (about 30% of the total Cd concentration, on average). The results indicate that heavy metal contamination, especially of Cd, in aquatic ecosystems in eastern China should be taken into account in the development of management strategies for protecting the aquatic environment.	[Tang, Wenzhong; Shan, Baoqing; Zhang, Wenqiang; Zhang, Hong; Wang, Lishuo; Ding, Yuekui] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, Beijing, Peoples R China; [Wang, Lishuo] China Univ Min & Technol Beijing, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); China University of Mining & Technology	Tang, WZ (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, POB 934, Beijing, Peoples R China.	wztang@rcees.ac.cn; bqshan@rcees.ac.cn	Tang, Wenzhong/AAM-6971-2020	Tang, Wenzhong/0000-0001-8347-8592	National Natural Science Foundation of China [21107126]; National Water Pollution Control Program [2012ZX07203-002]; One-Three-Fiver Program of Research Center for Eco-Environmental Sciences [YSW2013B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Water Pollution Control Program; One-Three-Fiver Program of Research Center for Eco-Environmental Sciences	This work was supported by the National Natural Science Foundation of China (No. 21107126), the National Water Pollution Control Program (No. 2012ZX07203-002), and the One-Three-Fiver Program of Research Center for Eco-Environmental Sciences (No. YSW2013B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AllenGil SM, 1997, ENVIRON TOXICOL CHEM, V16, P733, DOI [10.1002/etc.5620160418, 10.1897/1551-5028(1997)016&lt;0733:HMAISA&gt;2.3.CO;2]; Buggy CJ, 2008, ENVIRON POLLUT, V155, P308, DOI 10.1016/j.envpol.2007.11.032; Cheng SP, 2003, ENVIRON SCI POLLUT R, V10, P192, DOI 10.1065/espr2002.11.141.1; China National Environmental Monitoring Center (CNEMC), 1990, BACKGR CANC SOIL EL; Dragovic S, 2008, CHEMOSPHERE, V72, P491, DOI 10.1016/j.chemosphere.2008.02.063; Fu J, 2014, J HAZARD MATER, V270, P102, DOI 10.1016/j.jhazmat.2014.01.044; Gao XL, 2012, WATER RES, V46, P1901, DOI 10.1016/j.watres.2012.01.007; Guo WH, 2010, PROCEDIA ENVIRON SCI, V2, P729, DOI 10.1016/j.proenv.2010.10.084; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; He MC, 1998, WATER RES, V32, P510, DOI 10.1016/S0043-1354(97)00229-7; Iksandar I. K., 1974, ENVIRON SCI TECHNOL, V8, P165; Jiang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071176; Karak T, 2013, ECOTOX ENVIRON SAFE, V92, P161, DOI 10.1016/j.ecoenv.2013.03.019; Kim IS, 2003, ENVIRON POLLUT, V126, P235, DOI 10.1016/S0269-7491(03)00190-8; Lambert R, 2007, SCI TOTAL ENVIRON, V378, P293, DOI 10.1016/j.scitotenv.2007.02.008; Liu YJ, 2012, NEW PHYTOL, V194, P523, DOI 10.1111/j.1469-8137.2012.04050.x; Ma ZW, 2013, J ENVIRON QUAL, V42, P341, DOI 10.2134/jeq2012.0178; MacDonald DD, 2000, ARCH ENVIRON CON TOX, V39, P20, DOI 10.1007/s002440010075; Menge DNL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042045; Nemati K, 2011, J HAZARD MATER, V192, P402, DOI 10.1016/j.jhazmat.2011.05.039; Satarug S, 2010, ENVIRON HEALTH PERSP, V118, P182, DOI 10.1289/ehp.0901234; Singh KP, 2005, J HYDROL, V312, P14, DOI 10.1016/j.jhydrol.2005.01.021; Sondi I, 2008, ESTUAR COAST SHELF S, V80, P12, DOI 10.1016/j.ecss.2008.07.001; Suresh G, 2012, ECOTOX ENVIRON SAFE, V84, P117, DOI 10.1016/j.ecoenv.2012.06.027; Tang WZ, 2013, ECOTOX ENVIRON SAFE, V98, P317, DOI 10.1016/j.ecoenv.2013.09.038; Tang WZ, 2010, J HAZARD MATER, V176, P945, DOI 10.1016/j.jhazmat.2009.11.131; Taweel A, 2013, ECOTOX ENVIRON SAFE, V93, P45, DOI 10.1016/j.ecoenv.2013.03.031; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Weng HX, 2014, J HAZARD MATER, V265, P96, DOI 10.1016/j.jhazmat.2013.11.051; Yang ZF, 2009, J HAZARD MATER, V166, P1186, DOI 10.1016/j.jhazmat.2008.12.034; Zhang H, 2008, SCI TOTAL ENVIRON, V399, P113, DOI 10.1016/j.scitotenv.2008.03.036; Zhang J, 2002, ESTUAR COAST SHELF S, V54, P1051, DOI 10.1006/ecss.2001.0879; Zhang LW, 2013, CLEAN-SOIL AIR WATER, V41, P878, DOI 10.1002/clen.201200565	33	8	9	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108996	10.1371/journal.pone.0108996	http://dx.doi.org/10.1371/journal.pone.0108996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268385	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700210
J	Tremblay, E; Vannasing, P; Roy, MS; Lefebvre, F; Kombate, D; Lassonde, M; Lepore, F; McKerral, M; Gallagher, A				Tremblay, Emmanuel; Vannasing, Phetsamone; Roy, Marie-Sylvie; Lefebvre, Francine; Kombate, Damelan; Lassonde, Maryse; Lepore, Franco; McKerral, Michelle; Gallagher, Anne			Delayed Early Primary Visual Pathway Development in Premature Infants: High Density Electrophysiological Evidence	PLOS ONE			English	Article							PRETERM INFANTS; DORSAL; BRAIN; EXPERIENCE; HEAD; VEP; AGE	In the past decades, multiple studies have been interested in developmental patterns of the visual system in healthy infants. During the first year of life, differential maturational changes have been observed between the Magnocellular (P) and the Parvocellular (P) visual pathways. However, few studies investigated P and M system development in infants born prematurely. The aim of the present study was to characterize P and M system maturational differences between healthy preterm and fullterm infants through a critical period of visual maturation: the first year of life. Using a cross-sectional design, high-density electroencephalogram (EEG) was recorded in 31 healthy preterms and 41 fullterm infants of 3, 6, or 12 months (corrected age for premature babies). Three visual stimulations varying in contrast and spatial frequency were presented to stimulate preferentially the M pathway, the P pathway, or both systems simultaneously during EEG recordings. Results from early visual evoked potentials in response to the stimulation that activates simultaneously both systems revealed longer N1 latencies and smaller P1 amplitudes in preterm infants compared to fullterms. Moreover, preterms showed longer N1 and P1 latencies in response to stimuli assessing the M pathway at 3 months. No differences between preterms and fullterms were found when using the preferential P system stimulation. In order to identify the cerebral generator of each visual response, distributed source analyses were computed in 12-month-old infants using LORETA. Source analysis demonstrated an activation of the parietal dorsal region in fullterm infants, in response to the preferential M pathway, which was not seen in the preterms. Overall, these findings suggest that the Magnocellular pathway development is affected in premature infants. Although our VEP results suggest that premature children overcome, at least partially, the visual developmental delay with time, source analyses reveal abnormal brain activation of the Magnocellular pathway at 12 months of age.	[Tremblay, Emmanuel; Vannasing, Phetsamone; Lefebvre, Francine; Lassonde, Maryse; Lepore, Franco; Gallagher, Anne] Ctr Hosp Univ Ste Justine, Ctr Rech, Montreal, PQ, Canada; [Tremblay, Emmanuel; Kombate, Damelan; Lassonde, Maryse; Lepore, Franco; McKerral, Michelle; Gallagher, Anne] Univ Montreal, Dept Psychol, Ctr Rech Neuropsychol & Cognit, Montreal, PQ H3C 3J7, Canada; [Roy, Marie-Sylvie] Ctr Hosp Univ Ste Justine, Dept Ophthalmol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Gallagher, A (corresponding author), Ctr Hosp Univ Ste Justine, Ctr Rech, Montreal, PQ, Canada.	anne.gallagher@umontreal.ca			Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council (NSERC); Canada Research Chair Program; Canadian Foundation for Innovation (CFI); Fonds de la Recherche du Quebec - Sante (FRQ-S)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Program(Canada Research Chairs); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de la Recherche du Quebec - Sante (FRQ-S)	This study was supported by the Canadian Institutes of Health Research (CIHR) (ML, FL, MMK, AG), the Natural Sciences and Engineering Research Council (NSERC) (ML, MMK), the Canada Research Chair Program (ML, FL), the Canadian Foundation for Innovation (CFI) (ML) and the Fonds de la Recherche du Quebec - Sante (FRQ-S) (AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaye M, 2008, NEUROIMAGE, V43, P721, DOI 10.1016/j.neuroimage.2008.07.060; Atkinson J, 2006, NEUROPSYCHOLOGIA, V44, P828, DOI 10.1016/j.neuropsychologia.2005.08.002; Beauchemin M, 2011, CEREB CORTEX, V21, P1705, DOI 10.1093/cercor/bhq242; Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Bosworth R.G., 2009, J VIS, V9, P11; Bosworth RG, 2013, VISION RES, V82, P31, DOI 10.1016/j.visres.2013.02.009; Braddick O, 2011, PROG BRAIN RES, V189, P95, DOI 10.1016/B978-0-444-53884-0.00020-8; DIPIETRO JA, 1991, CHILD DEV, V62, P1184, DOI 10.2307/1131162; GROSE J, 1989, CLIN VISION SCI, V4, P239; Hammarrenger B, 2003, DOC OPHTHALMOL, V107, P225, DOI 10.1023/B:DOOP.0000005331.66114.05; Hammarrenger B, 2007, DEV MED CHILD NEUROL, V49, P28, DOI 10.1017/S0012162207000084; Jung TP, 1998, ADV NEUR IN, V10, P894; Kiebel SJ, 2005, HUM BRAIN MAPP, V26, P170, DOI 10.1002/hbm.20153; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Michelson Albert A., 1927, STUDIES OPTICS; NUNEZ PL, 1981, IEEE T BIO-MED ENG, V28, P281, DOI 10.1109/TBME.1981.324701; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pizzagalli DA, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P56, DOI 10.1017/CBO9780511546396.003; Plank M, 2013, BRAIN PRODUCT RELEAS, V49, P1; Riera JJ, 1998, IEEE T BIO-MED ENG, V45, P746, DOI 10.1109/10.678609; Spencer J, 2000, NEUROREPORT, V11, P2765, DOI 10.1097/00001756-200008210-00031; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Tsuneishi S, 2000, DEV MED CHILD NEUROL, V42, P663, DOI 10.1017/S0012162200001225; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Wilson-Ching M, 2014, J PAEDIATR CHILD H, V50, P182, DOI 10.1111/jpc.12475; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3	26	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107992	10.1371/journal.pone.0107992	http://dx.doi.org/10.1371/journal.pone.0107992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268226	Green Submitted, gold, Green Published			2022-12-27	WOS:000343671700059
J	Xie, J; Wei, QP; Deng, HC; Li, G; Ma, LL; Zeng, H				Xie, Jing; Wei, Qianping; Deng, Huacong; Li, Gang; Ma, Lingli; Zeng, Hui			Negative Regulation of Grb10 Interacting GYF Protein 2 on Insulin-Like Growth Factor-1 Receptor Signaling Pathway Caused Diabetic Mice Cognitive Impairment	PLOS ONE			English	Article							GIGYF2 GENE; ADAPTER; NEUROGENESIS; KNOCKDOWN; DOMAIN; MEMORY; RATS	Heterozygous Gigyf2(+/-) mice exhibits histopathological evidence of neurodegeneration such as motor dysfunction. Several lines of evidence have demonstrated the important role of insulin-like growth factor-1 receptor (IGF1R) signaling pathway in the neuropathogenic process of cognitive impairment, while decreased Grb10-Interacting GYF Protein 2 (GIGYF2) expression can alter IGF1R trafficking and its downstream signaling pathways. Growth factor receptor-bound protein 10 (Grb10), a suppressor of IGF1R pathway, has been shown to play a critical role in regulating diabetes-associated cognitive impairment. It remains unknown whether endogenous GIGYF2 expression contributes to the development of diabetes-associated cognitive impairment. Using streptozotocin (STZ)-induced diabetic mice model, we first demonstrated that a significantly increased level of GIGYF2 expression was correlated with a significant decrease in the expression of phosphorylated IGF1R as well as the phosphorylation of AKT and ERK1/2, two signaling pathways downstream of IGF1R, in the hippocampus of diabetic mice. On the contrary, in situ knockdown of GIGYF2 expression in hippocampus resulted in increased expression of phosphorylated IGF1R expression and correspondingly reversed the down-regulation of ERK1/2 phsophorylation but had no obvious effect on Grb10 expression. Functionally, knockdown of GIGYF2 expression markedly ameliorated diabetes-associated cognitive dysfunction as well as the ultrastructural pathology and abnormal neurobehavioral changes. These results suggest that increased expression of GIGYF2 might contribute to the development of diabetes-associated cognitive disorder via negatively regulating IGF1R signaling pathway. Therefore, down-regulation of GIGYF2 expression may provide a potential novel approach to treat diabetes-associated cognitive impairment caused by aberrant IGF1R signaling pathway.	[Xie, Jing; Wei, Qianping; Ma, Lingli; Zeng, Hui] Chongqing Med Univ, Affiliated Hosp 1, Dept Geriatr, Chongqing, Peoples R China; [Deng, Huacong] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China; [Li, Gang] Mental Hlth Ctr Jiulongpo Dist, Dept Mental Hlth, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Wei, QP (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Geriatr, Chongqing, Peoples R China.	wqp68894940@163.com			National Key Clinical Specialties Construction Program of China [[2013]544]; Chongqing Health Bureau: The promoter CamKII-alpha mediated Grb10-siRNA intervention of diabetes encephalopathy [2011-1-009]	National Key Clinical Specialties Construction Program of China; Chongqing Health Bureau: The promoter CamKII-alpha mediated Grb10-siRNA intervention of diabetes encephalopathy	This study was supported by grants from National Key Clinical Specialties Construction Program of China (No. [2013]544), the Chongqing Health Bureau: The promoter CamKII-alpha mediated Grb10-siRNA intervention of diabetes encephalopathy (No. 2011-1-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; Aleman A, 2009, PROG NEUROBIOL, V89, P256, DOI 10.1016/j.pneurobio.2009.07.008; Alvarez EO, 2009, BEHAV BRAIN RES, V198, P224, DOI 10.1016/j.bbr.2008.11.001; Ansaloni Sara, 2010, J RNAi Gene Silencing, V6, P411; Barron AM, 2010, ENDOCRINOLOGY, V151, P5380, DOI 10.1210/en.2009-1168; BASERGA R, 1994, CELL PROLIFERAT, V27, P63, DOI 10.1111/j.1365-2184.1994.tb01406.x; Brismar T, 2007, PSYCHONEUROENDOCRINO, V32, P1041, DOI 10.1016/j.psyneuen.2007.08.002; Carson JP, 1999, CANCER RES, V59, P1449; Colley BS, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-8; D'Ercole AJ, 2008, ENDOCRINOLOGY, V149, P5958, DOI 10.1210/en.2008-0920; Duarte JMN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0021899; Dufresne AM, 2005, ENDOCRINOLOGY, V146, P4399, DOI 10.1210/en.2005-0150; Efstratiadis A, 1998, INT J DEV BIOL, V42, P955; Freude S, 2009, FASEB J, V23, P3315, DOI 10.1096/fj.09-132043; Giovannone B, 2003, J BIOL CHEM, V278, P31564, DOI 10.1074/jbc.M211572200; Giovannone B, 2009, HUM MOL GENET, V18, P4629, DOI 10.1093/hmg/ddp430; Gualco E, 2009, FRONT BIOSCI-LANDMRK, V14, P352, DOI 10.2741/3249; Guella I, 2011, NEUROBIOL AGING, V32, P1994, DOI 10.1016/j.neurobiolaging.2009.12.016; Guo J, 2010, NEUROSCI RES, V68, P329, DOI 10.1016/j.neures.2010.08.012; Gupta R, 2012, PHARMACOL REP, V64, P438; Hashizume Kiyoshi, 2013, Nihon Rinsho, V71, P1941; Heiser WC, 2004, METHODS MOL BIOL, V246; Higashi S, 2010, J NEUROCHEM, V115, P423, DOI 10.1111/j.1471-4159.2010.06930.x; Huang MW, 2001, ADHES AGE, V44, P31; Huang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066160; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Kooijman R, 2006, CYTOKINE GROWTH F R, V17, P305, DOI 10.1016/j.cytogfr.2006.02.002; Landau D, 2009, ENDOCRINE, V36, P126, DOI 10.1007/s12020-009-9190-2; Langlais P, 2004, MOL ENDOCRINOL, V18, P350, DOI 10.1210/me.2003-0117; Lautier C, 2008, AM J HUM GENET, V82, P822, DOI 10.1016/j.ajhg.2008.01.015; Luikart BW, 2011, J NEUROSCI, V31, P4345, DOI 10.1523/JNEUROSCI.0061-11.2011; Lupien SB, 2003, J NEUROSCI RES, V74, P512, DOI 10.1002/jnr.10791; Ma L, 2013, J NEUROENDOCRINOL, V25, P626, DOI 10.1111/jne.12040; Maurice T, 1996, BRAIN RES, V706, P181, DOI 10.1016/0006-8993(95)01032-7; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Mori K, 2005, MOL CELL ENDOCRINOL, V230, P39, DOI 10.1016/j.mce.2004.11.004; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Northam EA, 2006, NAT CLIN PRACT NEURO, V2, P78, DOI 10.1038/ncpneuro0097; Orduna V, 2011, BEHAV BRAIN RES, V224, P189, DOI 10.1016/j.bbr.2011.06.005; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pleil KE, 2011, ENDOCRINOLOGY, V152, P946, DOI 10.1210/en.2010-0715; Popovic M, 2001, BEHAV BRAIN RES, V122, P201, DOI 10.1016/S0166-4328(01)00186-3; Saenger S, 2011, GROWTH HORM IGF RES, V21, P292, DOI 10.1016/j.ghir.2011.07.006; Shen L, 2000, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V17, P167; Stein EG, 2001, FEBS LETT, V493, P106, DOI 10.1016/S0014-5793(01)02282-7; Tsukuda S, 2013, BIOORGAN MED CHEM, V21, P311, DOI 10.1016/j.bmc.2012.10.037; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang L, 2011, J CLIN NEUROSCI, V18, P1699, DOI 10.1016/j.jocn.2011.05.014; Werner H, 2014, EUR NEUROPSYCHOPHARM, V24, P1947, DOI 10.1016/j.euroneuro.2014.01.020; Yang SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058100; Zemva J, 2011, CURR DIABETES REV, V7, P356, DOI 10.2174/157339911797415594; Zhou L, 2010, ENDOCRINOLOGY, V151, P1153, DOI 10.1210/en.2009-0254	53	10	12	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108559	10.1371/journal.pone.0108559	http://dx.doi.org/10.1371/journal.pone.0108559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268761	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700114
J	Aissi, D; Dennis, J; Ladouceur, M; Truong, V; Zwingerman, N; Rocanin-Arjo, A; Germain, M; Paton, TA; Morange, PE; Gagnon, F; Tregouet, DA				Aissi, Dylan; Dennis, Jessica; Ladouceur, Martin; Vinh Truong; Zwingerman, Nora; Rocanin-Arjo, Ares; Germain, Marine; Paton, Tara A.; Morange, Pierre-Emmanuel; Gagnon, France; Tregouet, David-Alexandre			Genome-Wide Investigation of DNA Methylation Marks Associated with FV Leiden Mutation	PLOS ONE			English	Article							ACTIVATED PROTEIN-C; INHERITED RESISTANCE; VENOUS THROMBOSIS; RISK-FACTORS; BLOOD; MICROARRAY; DISCOVERY; IDENTIFICATION; EPIGENETICS; VALIDATION	In order to investigate whether DNA methylation marks could contribute to the incomplete penetrance of the FV Leiden mutation, a major genetic risk factor for venous thrombosis (VT), we measured genome-wide DNA methylation levels in peripheral blood samples of 98 VT patients carrying the mutation and 251 VT patients without the mutation using the dedicated Illumina HumanMethylation450 array. The genome-wide analysis of 388,120 CpG probes identified three sites mapping to the SLC19A2 locus whose DNA methylation levels differed significantly (p<3 10-(8)) between carriers and noncarriers. The three sites replicated (p<2 10(-7)) in an independent sample of 214 individuals from five large families ascertained on VT and FV Leiden mutation among which 53 were carriers and 161 were non-carriers of the mutation. In both studies, these three CpG sites were also associated (2.33 10-(11), p<3.02 10-(4)) with biomarkers of the Protein C pathway known to be influenced by the FV Leiden mutation. A comprehensive linkage disequilibrium (LD) analysis of the whole locus revealed that the original associations were due to LD between the FV Leiden mutation and a block of single nucleotide polymorphisms (SNP) located in SLC19A2. After adjusting for this block of SNPs, the FV Leiden mutation was no longer associated with any CpG site (p>0.05). In conclusion, our work clearly illustrates some promises and pitfalls of DNA methylation investigations on peripheral blood DNA in large epidemiological cohorts. DNA methylation levels at SLC19A2 are influenced by SNPs in LD with FV Leiden, but these DNA methylation marks do not explain the incomplete penetrance of the FV Leiden mutation.	[Aissi, Dylan; Rocanin-Arjo, Ares; Germain, Marine; Tregouet, David-Alexandre] Univ Paris 06, Univ Sorbonne, UMR S 1166, Team Genom & Pathophysiol Cardiovasc Dis, Paris, France; [Aissi, Dylan; Rocanin-Arjo, Ares; Germain, Marine; Tregouet, David-Alexandre] INSERM, UMR S 1166, Team Genom & Pathophysiol Cardiovasc Dis, Paris, France; [Aissi, Dylan; Rocanin-Arjo, Ares; Germain, Marine; Tregouet, David-Alexandre] ICAN, Paris, France; [Dennis, Jessica; Ladouceur, Martin; Vinh Truong; Zwingerman, Nora; Gagnon, France] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Ladouceur, Martin] CHUM, Ctr Rech, Montreal, PQ, Canada; [Paton, Tara A.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada; [Paton, Tara A.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Morange, Pierre-Emmanuel] Aix Marseille Univ, UMR S 1062, Marseille, France; [Morange, Pierre-Emmanuel] INSERM, UMR S 1062, Marseille, France; [Morange, Pierre-Emmanuel] La Timone Hosp, Haematol Lab, Marseille, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Toronto; Universite de Montreal; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Tregouet, DA (corresponding author), Univ Paris 06, Univ Sorbonne, UMR S 1166, Team Genom & Pathophysiol Cardiovasc Dis, Paris, France.	david.tregouet@upmc.fr	Tregouet, David-Alexandre/E-3961-2016; Trégouët, David-Alexandre/P-9210-2019; Morange, Pierre/T-9070-2019; Aïssi, Dylan/AAH-1499-2019	Trégouët, David-Alexandre/0000-0001-9084-7800; Morange, Pierre/0000-0002-9065-722X; Aïssi, Dylan/0000-0002-5858-6468; Germain, Marine/0000-0002-8489-8916; Dennis, Jessica/0000-0002-8507-9699	Region Ile de France (CORDDIM); Vanier Canada Graduate Scholarship; Canadian Institutes of Health Research (CIHR) [MOP 86466, MOP86466]; Canada Research Chair; CIHR [GET-101831]; Program Hospitalier de Recherche Clinique; Heart and Stroke Foundation of Canada [T6484]; Region Ile de France, Pierre and Marie Curie University; Institute for Cardiometabolism and Nutrition [ANR-10-IAHU-05]	Region Ile de France (CORDDIM)(Region Ile-de-France); Vanier Canada Graduate Scholarship; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR)); Program Hospitalier de Recherche Clinique; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Region Ile de France, Pierre and Marie Curie University(Region Ile-de-France); Institute for Cardiometabolism and Nutrition	DA and ARA were supported by a PhD grant from the Region Ile de France (CORDDIM). JD holds a Vanier Canada Graduate Scholarship, ML holds a fellowship from the Canadian Institutes of Health Research (CIHR), and FG holds a Canada Research Chair. JD, ML and NZ are fellows of the CIHR Strategic Training for Advanced Genetic Epidemiology Training Grant (STAGE) in Genetic Epidemiology and Statistical Genetics (GET-101831). The MARTHA project was supported by a grant from the Program Hospitalier de Recherche Clinique. The H450M epityping was partially funded by the Canadian Institutes of Health Research (grant MOP 86466) and by the Heart and Stroke Foundation of Canada (grant T6484). Statistical analyses of the MARTHA datasets was performed using the C2BIG computing cluster funded by the Region Ile de France, Pierre and Marie Curie University, and the Institute for Cardiometabolism and Nutrition (ANR-10-IAHU-05). The F5L Thrombophilia French-Canadian Pedigree study was supported by grants from the Canadian Institutes of Health Research (MOP86466) and by the Heart and Stroke Foundation of Canada (T6484). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni G, 2010, J THROMB HAEMOST, V8, P2671, DOI 10.1111/j.1538-7836.2010.04092.x; Antoni G, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-102; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Bezemer ID, 2009, ARCH INTERN MED, V169, P610, DOI 10.1001/archinternmed.2008.589; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bind MA, 2012, EPIDEMIOLOGY, V23, P332, DOI 10.1097/EDE.0b013e31824523f0; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Callaway E, 2014, NATURE, V508, P22, DOI 10.1038/508022a; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Chen YA, 2012, AM J HUM GENET, V91, P762, DOI 10.1016/j.ajhg.2012.06.020; Cohen W, 2014, J THROMB HAEMOST, V12, P138, DOI 10.1111/jth.12461; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; DAHLBACK B, 1995, J INTERN MED, V237, P221, DOI 10.1111/j.1365-2796.1995.tb01170.x; DAHLBACK B, 1994, HAEMOSTASIS, V24, P139; Diaz GA, 1999, NAT GENET, V22, P309, DOI 10.1038/10385; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; Frazier-Wood AC, 2014, J LIPID RES, V55, P1324, DOI 10.1194/jlr.M048504; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Gagnon F, 2014, J LIPID RES, V55, P1189, DOI 10.1194/jlr.E051276; Gaidatzis D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004143; Gao S, 2005, THROMB HAEMOSTASIS, V94, P651, DOI 10.1160/TH05-02-0114; Germain M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038538; Germain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025581; Grundberg E, 2013, AM J HUM GENET, V93, P876, DOI 10.1016/j.ajhg.2013.10.004; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Huang J, 2012, BLOOD, V120, P4873, DOI 10.1182/blood-2012-06-436188; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Johnson EO, 2013, HUM GENET, V132, P509, DOI 10.1007/s00439-013-1266-7; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Koestler DC, 2013, EPIGENETICS-US, V8, P816, DOI 10.4161/epi.25430; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Liu G, 2014, BLOOD CELL MOL DIS, V52, P203, DOI 10.1016/j.bcmd.2013.11.002; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morange PE, 2011, J THROMB HAEMOST, V9, P258, DOI 10.1111/j.1538-7836.2011.04311.x; Murphy TM, 2014, LANCET, V383, P1952, DOI 10.1016/S0140-6736(14)60269-5; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Osorio Joana, 2014, Nat Rev Endocrinol, V10, P249, DOI 10.1038/nrendo.2014.42; Oudot-Mellakh T, 2012, BRIT J HAEMATOL, V157, P230, DOI 10.1111/j.1365-2141.2011.09025.x; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Robert A, 1996, THROMB HAEMOSTASIS, V75, P562; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Schlesinger F, 2013, GENOME RES, V23, P1601, DOI 10.1101/gr.157271.113; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Siegmund KD, 2011, HUM GENET, V129, P585, DOI 10.1007/s00439-011-0993-x; Sorensen HT, 2011, J THROMB HAEMOST, V9, P320, DOI 10.1111/j.1538-7836.2010.04129.x; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Tarantini L, 2013, OCCUP ENVIRON MED, V70, P418, DOI 10.1136/oemed-2012-101079; Terry MB, 2011, EPIGENETICS-US, V6, P828, DOI 10.4161/epi.6.7.16500; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Triche TJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt090; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wierda RJ, 2010, J CELL MOL MED, V14, P1225, DOI 10.1111/j.1582-4934.2010.01022.x; Wilhelm-Benartzi CS, 2013, BRIT J CANCER, V109, P1394, DOI 10.1038/bjc.2013.496; Wood MC, 2014, PSYCHIAT CLIN NEUROS, V68, P487, DOI 10.1111/pcn.12143; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812; Zhuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047193	65	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108087	10.1371/journal.pone.0108087	http://dx.doi.org/10.1371/journal.pone.0108087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265411	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400041
J	Devaud, C; Yong, CSM; John, LB; Westwood, JA; Duong, CPM; House, CM; Denoyer, D; Li, J; Darcy, PK; Kershaw, MH				Devaud, Christel; Yong, Carmen S. M.; John, Liza B.; Westwood, Jennifer A.; Duong, Connie P. M.; House, Colin M.; Denoyer, Delphine; Li, Jason; Darcy, Phillip K.; Kershaw, Michael H.			Foxp3 Expression in Macrophages Associated with RENCA Tumors in Mice	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; RNA-SEQ; CELLS; CANCER	The transcription factor Foxp3 represents the most specific functional marker of CD4(+) regulatory T cells (TRegs). However, previous reports have described Foxp3 expression in other cell types including some subsets of macrophages, although there are conflicting reports and Foxp3 expression in cells other than Treg is not well characterized. We performed detailed investigations into Foxp3 expression in macrophages in the normal tissue and tumor settings. We detected Foxp3 protein in macrophages infiltrating mouse renal cancer tumors injected subcutaneously or in the kidney. Expression was demonstrated using flow cytometry and Western blot with two individual monoclonal antibodies. Further analyses confirmed Foxp3 expression in macrophages by RT PCR, and studies using ribonucleic acid-sequencing (RNAseq) demonstrated a previously unknown Foxp3 messenger (m)RNA transcript in tumor-associated macrophages. In addition, depletion of Foxp3(+) cells using diphtheria toxin in Foxp3(DTR) mice reduced the frequency of type-2 macrophages (M2) in kidney tumors. Collectively, these results indicate that tumor-associated macrophages could express Foxp3.	[Devaud, Christel; Yong, Carmen S. M.; John, Liza B.; Westwood, Jennifer A.; Duong, Connie P. M.; House, Colin M.; Darcy, Phillip K.; Kershaw, Michael H.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Canc Immunol Res Program, Parkville, Vic 3052, Australia; [Denoyer, Delphine] Peter MacCallum Canc Ctr, Dept Oncol, Mol Imaging & Targeted Therapeut Lab, East Melbourne, Vic, Australia; [Li, Jason] Peter MacCallum Canc Ctr, Dept Oncol, Bioinformat Core Facil, East Melbourne, Vic, Australia; [Darcy, Phillip K.; Kershaw, Michael H.] Monash Univ, Dept Immunol, Prahran, Vic, Australia	Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Monash University	Devaud, C (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Canc Immunol Res Program, Parkville, Vic 3052, Australia.	christel.devaud@petermac.org; michael.kershaw@petermac.org	Devaud, Christel'/W-8141-2019	Devaud, Christel'/0000-0003-3511-3219; Duong, Connie/0000-0002-9067-8557; Denoyer, Delphine/0000-0001-8932-5116; Darcy, Phillip/0000-0002-5303-9561; Kershaw, Michael/0000-0002-2697-487X; Li, Jason/0000-0002-1150-3549	National Health and Medical Research Council (NHMRC) of Australia [1013667]; Cancer Council of Victoria [1006209]; NHMRC	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Program Grant #1013667 from the National Health and Medical Research Council (NHMRC) of Australia, and by Project Grant #1006209 from the Cancer Council of Victoria. PD and MK were supported by NHMRC Senior Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, J EXP MED, V208, P2561; Chang X, 2005, J EXP MED, V202, P1141, DOI 10.1084/jem.20050157; Chen GY, 2008, J IMMUNOL, V180, P5163, DOI 10.4049/jimmunol.180.8.5163; Devaud C, 2014, MOL THER, V22, P18, DOI 10.1038/mt.2013.219; Ebert LM, 2008, CANCER RES, V68, P3001, DOI 10.1158/0008-5472.CAN-07-5664; Fontenot JD, 2003, NAT IMMUNOL; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liston A, 2007, J EXP MED, V204, P475, DOI 10.1084/jem.20062465; Manrique SZ, 2011, J EXP MED, V208, P1485, DOI 10.1084/jem.20100730; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Mayer CT, 2012, BLOOD, V119, P1314, DOI 10.1182/blood-2011-11-392266; Mayer CT, 2011, EUR J IMMUNOL, V41, P716, DOI 10.1002/eji.201040913; Put S, 2012, BLOOD, V119, P1316, DOI 10.1182/blood-2011-11-391755; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	21	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108670	10.1371/journal.pone.0108670	http://dx.doi.org/10.1371/journal.pone.0108670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264896	Green Published, gold			2022-12-27	WOS:000345745400099
J	Jalak, J; Valjamae, P				Jalak, Juergen; Vaeljamaee, Priit			Multi-Mode Binding of Cellobiohydrolase Cel7A from Trichoderma reesei to Cellulose	PLOS ONE			English	Article							CRYSTALLINE CELLULOSE; ENZYMATIC-HYDROLYSIS; MICROCRYSTALLINE CELLULOSE; ADSORPTION; KINETICS; SURFACE; DOMAIN; SUBSTRATE; ENZYMES; REVERSIBILITY	Enzymatic hydrolysis of recalcitrant polysaccharides like cellulose takes place on the solid-liquid interface. Therefore the adsorption of enzymes to the solid surface is a pre-requisite for catalysis. Here we used enzymatic activity measurements with fluorescent model-substrate 4-methyl-umbelliferyl-b-D-lactoside for sensitive monitoring of the binding of cellobiohydrolase TrCel7A from Trichoderma reesei to bacterial cellulose (BC). The binding at low nanomolar free TrCel7A concentrations was exclusively active site mediated and was consistent with Langmuir's one binding site model with Kd and Amax values of 2.9 nM and 126 nmol/g BC, respectively. This is the strongest binding observed with non-complexed cellulases and apparently represents the productive binding of TrCel7A to cellulose chain ends on the hydrophobic face of BC microfibril. With increasing free TrCel7A concentrations the isotherm gradually deviated from the Langmuir's one binding site model. This was caused by the increasing contribution of lower affinity binding modes that included both active site mediated binding and non-productive binding with active site free from cellulose chain. The binding of TrCel7A to BC was found to be only partially reversible. Furthermore, the isotherm was dependent on the concentration of BC with more efficient binding observed at lower BC concentrations. The phenomenon can be ascribed to the BC concentration dependent aggregation of BC microfibrils with concomitant reduction of specific surface area.	[Jalak, Juergen; Vaeljamaee, Priit] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	University of Tartu	Valjamae, P (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	priit.valjamae@ut.ee	Väljamäe, Priit/O-6468-2018	Väljamäe, Priit/0000-0002-1035-9493	Estonian Science Foundation [9227]	Estonian Science Foundation	This work was funded by the Estonian Science Foundation (grant no. 9227), www.etag.ee. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; BHIKHABHAI R, 1984, Journal of Applied Biochemistry, V6, P336; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Bommarius AS, 2008, METAB ENG, V10, P370, DOI 10.1016/j.ymben.2008.06.008; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bothwell MK, 1997, ENZYME MICROB TECH, V20, P411, DOI 10.1016/S0141-0229(96)00178-0; Bubner P, 2013, BIOTECHNOL BIOENG, V110, P1529, DOI 10.1002/bit.24884; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; Cruys-Bagger N, 2014, ANAL BIOCHEM, V447, P162, DOI 10.1016/j.ab.2013.11.024; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Ding SY, 2012, SCIENCE, V338, P1055, DOI 10.1126/science.1227491; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gao DH, 2013, P NATL ACAD SCI USA, V110, P10922, DOI 10.1073/pnas.1213426110; GILKES NR, 1992, J BIOL CHEM, V267, P6743; Guo J, 2013, BIOMACROMOLECULES, V14, P1268, DOI 10.1021/bm300810t; Herner ML, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1012; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hong J, 2007, LANGMUIR, V23, P12535, DOI 10.1021/la7025686; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Igarashi K, 2007, FEBS J, V274, P1785, DOI 10.1111/j.1742-4658.2007.05727.x; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Ishizawa CI, 2009, CELLULOSE, V16, P677, DOI 10.1007/s10570-009-9313-1; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jiang F, 2013, LANGMUIR, V29, P3280, DOI 10.1021/la3040193; Kamat RK, 2013, ACS APPL MATER INTER, V5, P8486, DOI 10.1021/am401916k; Kostylev M, 2012, BIOTECHNOL BIOENG, V109, P295, DOI 10.1002/bit.23299; Kristensen JB, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-11; Kuijk A, 2013, LANGMUIR, V29, P14356, DOI 10.1021/la403397d; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; KYRIACOU A, 1989, BIOTECHNOL BIOENG, V33, P631, DOI 10.1002/bit.260330517; Linder M, 1996, P NATL ACAD SCI USA, V93, P12251, DOI 10.1073/pnas.93.22.12251; Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Ma AZ, 2008, ENZYME MICROB TECH, V42, P543, DOI 10.1016/j.enzmictec.2008.02.009; Maurer SA, 2013, J COLLOID INTERF SCI, V394, P498, DOI 10.1016/j.jcis.2012.12.022; Maurer SA, 2012, LANGMUIR, V28, P14598, DOI 10.1021/la3024524; McLean BW, 2002, J BIOL CHEM, V277, P50245, DOI 10.1074/jbc.M204433200; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; Medve J, 1997, APPL BIOCHEM BIOTECH, V66, P39, DOI 10.1007/BF02788806; Modenbach AA, 2013, BIOMASS BIOENERG, V56, P526, DOI 10.1016/j.biombioe.2013.05.031; Moran-Mirabal JM, 2011, BIOPHYS CHEM, V155, P20, DOI 10.1016/j.bpc.2011.02.003; NIDETZKY B, 1994, BIOCHEM J, V303, P817, DOI 10.1042/bj3030817; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Palonen H, 1999, APPL ENVIRON MICROB, V65, P5229; Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110; Roberts KM, 2011, CELLULOSE, V18, P759, DOI 10.1007/s10570-011-9509-z; Shang BZ, 2013, J BIOL CHEM, V288, P29081, DOI 10.1074/jbc.M113.497412; Shibafuji Y, 2014, J BIOL CHEM, V289, P14056, DOI 10.1074/jbc.M113.546085; Sild V, 1996, FEBS LETT, V378, P51, DOI 10.1016/0014-5793(95)01420-9; Sipos B, 2010, APPL BIOCHEM BIOTECH, V161, P347, DOI 10.1007/s12010-009-8824-4; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Sugimoto N, 2012, LANGMUIR, V28, P14323, DOI 10.1021/la302352k; Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-104; Velleste R, 2010, CELLULOSE, V17, P125, DOI 10.1007/s10570-009-9356-3; Wahlstrom R, 2014, BIOTECHNOL BIOENG, V111, P726, DOI 10.1002/bit.25144; Wang W, 2011, APPL BIOCHEM BIOTECH, V164, P1139, DOI 10.1007/s12010-011-9200-8; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Zhu ZG, 2009, ANALYST, V134, P2267, DOI 10.1039/b906065k	63	31	31	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108181	10.1371/journal.pone.0108181	http://dx.doi.org/10.1371/journal.pone.0108181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265511	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400051
J	Montplaisir, J; Petit, D; Quinn, MJ; Ouakki, M; Deceuninck, G; Desautels, A; Mignot, E; De Wals, P				Montplaisir, Jacques; Petit, Dominique; Quinn, Marie-Josee; Ouakki, Manale; Deceuninck, Genevieve; Desautels, Alex; Mignot, Emmanuel; De Wals, Philippe			Risk of Narcolepsy Associated with Inactivated Adjuvanted (AS03) A/H1N1 (2009) Pandemic Influenza Vaccine in Quebec	PLOS ONE			English	Article							EPIDEMIOLOGY	Context: An association between an adjuvanted (AS03) A/H1N1 pandemic vaccine and narcolepsy has been reported in Europe. Objective: To assess narcolepsy risk following administration of a similar vaccine in Quebec. Design: Retrospective population-based study. Setting: Neurologists and lung specialists in the province were invited to report narcolepsy cases to a single reference centre. Population: Patients were interviewed by two sleep experts and standard diagnostic tests were performed. Immunization status was verified in the provincial pandemic influenza vaccination registry. Main Outcome Measures: Confirmed narcolepsy with or without cataplexy with onset of excessive daytime sleepiness between January 1 st, 2009, and December 31 st, 2010. Relative risks (RRs) were calculated using a Poisson model in a cohort analysis, by a self-controlled case series (SCCS) and a case-control method. Results: A total of 24 cases were included and overall incidence rate was 1.5 per million person-years. A cluster of 7 cases was observed among vaccinated persons in the winter 2009-2010. In the primary cohort analysis, 16-week post-vaccination RR was 4.32 (95% CI: 1.50-11.12). RR was 2.07 (0.70-6.17) in the SCCS, and 1.48 (0.37-7.03) using the case-control method. Estimates were lower when observation was restricted to the period of pandemic influenza circulation, and tended to be higher in persons,20 years old and for cataplexy cases. Conclusions: Results are compatible with an excess risk of approximately one case per million vaccine doses, mainly in persons less than 20 years of age. However, a confounding effect of the influenza infection cannot be ruled out.	[Montplaisir, Jacques; Petit, Dominique; Quinn, Marie-Josee; Desautels, Alex] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Montplaisir, Jacques] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Ouakki, Manale] Quebec Natl Publ Hlth Inst, Quebec City, PQ, Canada; [Deceuninck, Genevieve] Quebec Univ Hosp Res Ctr, Quebec City, PQ, Canada; [Desautels, Alex] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Mignot, Emmanuel] Stanford Univ, Stanford Ctr Sleep Sci & Med, Palo Alto, CA USA; [De Wals, Philippe] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada	Universite de Montreal; Universite de Montreal; Institut national de sante publique du Quebec (INSPQ); Universite de Montreal; Stanford University; Laval University	De Wals, P (corresponding author), Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada.	Philippe.De.Wals@ssss.gouv.qc.ca			GlaxoSmithKline Biologicals	GlaxoSmithKline Biologicals(GlaxoSmithKline)	This study was funded by GlaxoSmithKline Biologicals. The sponsor had a role in the design of the study and provided comments on the first draft of the manuscript. It has, however, no role in the conduct of the study, collection, management, analysis of data, and preparation and approval of the final version of the manuscript.	Ahmed SS, 2014, J AUTOIMMUN, V50, P1, DOI 10.1016/j.jaut.2014.01.033; [Anonymous], 2011, OCC NARC CAT CHILDR; Burgess CR, 2012, J NEUROSCI, V32, P12305, DOI 10.1523/JNEUROSCI.2630-12.2012; Choe YJ, 2012, VACCINE, V30, P7439, DOI 10.1016/j.vaccine.2012.10.030; COMSTOCK GW, 1994, EPIDEMIOL REV, V16, P77, DOI 10.1093/oxfordjournals.epirev.a036147; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; Dauvilliers Y, 2010, SLEEP, V33, P1428, DOI 10.1093/sleep/33.11.1428; De Wals P, 2012, JAMA-J AM MED ASSOC, V308, P175, DOI 10.1001/jama.2012.7342; European Centre for Disease Prevention and Control, 2012, NARC ASS PAND INFL V; European Medicine Agency, 2013, PAND EPAR PROD INF A; GlaxoSmithKline Inc, 2009, PROD INF LEAFL AR H1; Han F, 2013, ANN NEUROL, V73, P560, DOI 10.1002/ana.23799; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Heier MS, 2013, SLEEP MED, V14, P867, DOI 10.1016/j.sleep.2013.03.020; Institut national de sante publique du Quebec (INSPQ), 2010, BIL EP PAND INFL AHI; LANKFORD DA, 1994, SLEEP, V17, pS25, DOI 10.1093/sleep/17.suppl_8.S25; Longstreth WT, 2007, SLEEP, V30, P13, DOI 10.1093/sleep/30.1.13; Melen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068402; MIGNOT E, 1995, ADV NEUROIMMUNOL, V5, P23, DOI 10.1016/0960-5428(94)00043-N; Mignot E, 1997, SLEEP, V20, P1012; Mignot E, 1997, TISSUE ANTIGENS, V49, P329, DOI 10.1111/j.1399-0039.1997.tb02761.x; MIGNOT E, 1992, SLEEP, V15, P415, DOI 10.1093/sleep/15.5.415; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; Ministere de la Sante et des Services sociaux du Quebec (MSSS), 2011, BIL DIR GEN SANT PUB; Morrish E, 2004, SLEEP MED, V5, P37, DOI 10.1016/j.sleep.2003.06.002; National Narcolepsy Study Steering Committee, 2012, INV INCR INC NARC CH; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; ORELLANA C, 1994, SLEEP, V17, pS50, DOI 10.1093/sleep/17.suppl_8.S50; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Picchioni D, 2007, NEUROEPIDEMIOLOGY, V29, P185, DOI 10.1159/000111581; POIRIER G, 1986, SLEEP, V9, P153, DOI 10.1093/sleep/9.1.153; Poli F, 2013, VACCINE, V31, P994, DOI 10.1016/j.vaccine.2012.12.014; Silber MH, 2002, SLEEP, V25, P197, DOI 10.1093/sleep/25.2.197; Singh AK, 2013, J AUTOIMMUN, V43, P26, DOI 10.1016/j.jaut.2013.02.003; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; Van Buynder PG, 2010, INFLUENZA OTHER RESP, V4, P171, DOI 10.1111/j.1750-2659.2010.00146.x; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Wijnans L, 2013, VACCINE, V31, P1246, DOI 10.1016/j.vaccine.2012.12.015	38	61	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108489	10.1371/journal.pone.0108489	http://dx.doi.org/10.1371/journal.pone.0108489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264897	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400081
J	Moustardas, P; Kadoglou, NPE; Katsimpoulas, M; Kapelouzou, A; Kostomitsopoulos, N; Karayannacos, PE; Kostakis, A; Liapis, CD				Moustardas, Petros; Kadoglou, Nikolaos P. E.; Katsimpoulas, Michalis; Kapelouzou, Alkistis; Kostomitsopoulos, Nikolaos; Karayannacos, Panayotis E.; Kostakis, Alkiviadis; Liapis, Christos D.			The Complementary Effects of Atorvastatin and Exercise Treatment on the Composition and Stability of the Atherosclerotic Plaques in ApoE Knockout Mice	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; APOLIPOPROTEIN-E; DEFICIENT; EXPRESSION; STATINS; RISK; PATHOGENESIS; INFLAMMATION	Aim: This study aimed to investigate the effects of combined atorvastatin and exercise treatment on the composition and stability of the atherosclerotic plaques in apolipoproteinE (apoE) knockout mice. Methods: Forty male, apoE 2/2 mice were fed a high-fat diet for 16 weeks. Thereafter, while maintained on high-fat diet, they were randomized into four (n = 10) groups for 8 additional weeks: Group CO: Control. Group AT: Atorvastatin treatment (10 mg/Kg/day). Group EX: Exercise-training on treadmill. Group AT+EX: Atorvastatin and simultaneous exercise training. At the study's end, plasma cholesterol levels, lipids and triglycerides were measured, along with the circulating concentrations of matrix-metalloproteinases (MMP-2,3,8,9) and their inhibitors (TIMP-1,2,3). Plaque area and the relative concentrations of collagen, elastin, macrophages, smooth muscle cells, MMP-2,3,8,9 and TIMP-1,2,3 within plaques were determined. Lastly, MMP activity was assessed in the aortic arch. Results: All intervention groups showed a lower degree of lumen stenosis, with atheromatous plaques containing more collagen and elastin. AT+EX group had less stenosis and more elastin compared to single intervention groups. MMP-3,-8 -9 and macrophage intra-plaque levels were reduced in all intervention groups. EX group had increased TIMP-1 levels within the lesions, while TIMP-2 was decreased in all intervention groups. The blood levels of the above molecules increased during atherosclerosis development, but they did not change after the therapeutic interventions in accordance to their intra-plaque levels. Conclusion: The two therapeutic strategies act with synergy regarding the extent of the lesions and lumen stenosis. They stabilize the plaque, increasing its content in elastin and collagen, by influencing the MMP/TIMP equilibrium, which is mainly associated with the macrophage amount. While the increased MMP-2,-3,-8 -9, as well as TIMP-1 and TIMP-2 circulating levels are markers of atherosclerosis, they are not correlated with their corresponding concentrations within the lesions after the therapeutic interventions, and cannot serve as markers for the disease development/amelioration.	[Moustardas, Petros; Kadoglou, Nikolaos P. E.; Katsimpoulas, Michalis; Kapelouzou, Alkistis; Kostomitsopoulos, Nikolaos; Karayannacos, Panayotis E.; Kostakis, Alkiviadis] Acad Athens, Biomed Res Fdn, Ctr Expt Surg, Athens, Greece; [Liapis, Christos D.] Univ Athens, Sch Med, Dept Vasc Surg, Attikon Hosp, GR-11527 Athens, Greece	Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon	Moustardas, P (corresponding author), Acad Athens, Biomed Res Fdn, Ctr Expt Surg, Athens, Greece.	pmoustardas@bioacademy.gr	Kadoglou, Nikolaos/AAA-8639-2021; Kapelouzou, Alkistis/AAB-5087-2021	Kadoglou, Nikolaos/0000-0002-7830-3488; LIAPIS, CHRISTOS/0000-0002-1195-9108; Katsimpoulas, Michalis/0000-0001-8083-3878; Kapelouzou, Alkistis/0000-0002-7637-8152; Kostomitsopoulos, Nikolaos/0000-0003-4787-5106	Operational Program "Competitiveness and Entrepreneurship"; Regional Operational Programmes of the National Strategic Reference Framework (NSRF); Greek State Scholarships Foundation	Operational Program "Competitiveness and Entrepreneurship"; Regional Operational Programmes of the National Strategic Reference Framework (NSRF); Greek State Scholarships Foundation(Greek Ministry of Development-GSRT)	The project was co-funded by the Operational Program "Competitiveness and Entrepreneurship" and Regional Operational Programmes of the National Strategic Reference Framework (NSRF) 2007-2013 (http://www.espa.gr/en/Pages/default.aspx). "SYNERGASIA": "Collaborative projects of small and medium scale". ClinicalTrials.gov Identifier: NCT00636766. NPE Kadoglou was granted by the Greek State Scholarships Foundation (http://www.iky.gr/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalinei C, 2010, ROM J MORPHOL EMBRYO, V51, P215; Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; Bea F, 2002, ARTERIOSCL THROM VAS, V22, P1832, DOI 10.1161/01.ATV.0000036081.01231.16; Bot I, 2011, ATHEROSCLEROSIS, V214, P295, DOI 10.1016/j.atherosclerosis.2010.11.008; Brauer PR, 2006, FRONT BIOSCI-LANDMRK, V11, P447, DOI 10.2741/1810; Cevik C, 2008, J CARDIOVASC MED, V9, P1274, DOI 10.2459/JCM.0b013e328316912f; Corsini A, 2007, VASC HEALTH RISK MAN, V3, P611; Dela F, 2007, APPL PHYSIOL NUTR ME, V32, P602, DOI 10.1139/H07-028; Ding SF, 2008, AM J MED SCI, V336, P27, DOI 10.1097/MAJ.0b013e31815b60a1; ENDO A, 1992, J LIPID RES, V33, P1569; Fiotti N, 2011, ATHEROSCLEROSIS, V215, P153, DOI 10.1016/j.atherosclerosis.2010.12.010; Fujimoto S, 2008, J AM COLL CARDIOL, V52, P1847, DOI 10.1016/j.jacc.2008.08.048; Fukao K, 2010, J ATHEROSCLER THROMB, V17, P1226, DOI 10.5551/jat.4788; Fukumoto Y, 2001, CIRCULATION, V103, P993; Gielen S, 2009, EUR J CARDIOV PREV R, V16, pS29, DOI 10.1097/01.hjr.0000359233.58023.64; Heider P, 2009, VASC ENDOVASC SURG, V43, P551, DOI 10.1177/1538574409334826; Hijova E, 2005, Bratisl Lek Listy, V106, P127; Indolfi C, 2002, CIRC RES, V91, P1190, DOI 10.1161/01.RES.0000046233.94299.D6; Insull W, 2009, AM J MED, V122, pS3, DOI 10.1016/j.amjmed.2008.10.013; Kadoglou NPE, 2008, EUR J VASC ENDOVASC, V35, P264, DOI 10.1016/j.ejvs.2007.08.022; Kadoglou NPE, 2010, DIABETES METAB, V36, P144, DOI 10.1016/j.diabet.2009.11.004; Kadoglou NPE, 2011, J VASC RES, V48, P347, DOI 10.1159/000321174; Kadoglou NP, 2005, ANGIOLOGY, V56, P173, DOI 10.1177/000331970505600208; Kadoglou NP, 2004, CURR MED RES OPIN, V20, P419, DOI 10.1185/030079904125003143; Kajimoto K, 2009, ATHEROSCLEROSIS, V206, P505, DOI 10.1016/j.atherosclerosis.2009.03.028; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Li YY, 2000, CARDIOVASC RES, V46, P214, DOI 10.1016/S0008-6363(00)00003-1; Mikus C.R., 2013, J AM COLL CARDIOL, DOI 10.1016/j.jacc.2013.02.074; Niessner A, 2006, ATHEROSCLEROSIS, V186, P160, DOI 10.1016/j.atherosclerosis.2005.06.047; Ohshima S, 2009, J NUCL MED, V50, P612, DOI 10.2967/jnumed.108.055889; Pellegrin M, 2009, HYPERTENSION, V53, P782, DOI 10.1161/HYPERTENSIONAHA.108.128165; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Roberts CK, 2007, ATHEROSCLEROSIS, V191, P98, DOI 10.1016/j.atherosclerosis.2006.09.011; Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6; Shah PK, 2009, CARDIOVASC DRUG THER, V23, P31, DOI 10.1007/s10557-008-6147-2; Shaposhnik Z, 2009, J LIPID RES, V50, P623, DOI 10.1194/jlr.M800361-JLR200; SILVA JA, 1995, CIRCULATION, V92, P1731, DOI 10.1161/01.CIR.92.7.1731; Toyama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041369; van de Poll SWE, 2003, J MOL CELL CARDIOL, V35, P109; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vongpatanasin Wanpen, 2007, J Clin Hypertens (Greenwich), V9, P11; Wu TC, 2005, EUR J CLIN INVEST, V35, P537, DOI 10.1111/j.1365-2362.2005.01548.x; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	43	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108240	10.1371/journal.pone.0108240	http://dx.doi.org/10.1371/journal.pone.0108240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264981	Green Submitted, gold, Green Published			2022-12-27	WOS:000345745400055
J	Pedersen, ML; Kristensen, KK; Friberg, N				Pedersen, Morten Lauge; Kristensen, Klaus Kevin; Friberg, Nikolai			Re-Meandering of Lowland Streams: Will Disobeying the Laws of Geomorphology Have Ecological Consequences?	PLOS ONE			English	Article							RIVER RESTORATION; HABITAT STRUCTURE; DIVERSITY; MACROPHYTES; SCALE; MACROINVERTEBRATES; HETEROGENEITY; BIODIVERSITY; ECOSYSTEMS; QUALITY	We evaluated the restoration of physical habitats and its influence on macroinvertebrate community structure in 18 Danish lowland streams comprising six restored streams, six streams with little physical alteration and six channelized streams. We hypothesized that physical habitats and macroinvertebrate communities of restored streams would resemble those of natural streams, while those of the channelized streams would differ from both restored and near-natural streams. Physical habitats were surveyed for substrate composition, depth, width and current velocity. Macroinvertebrates were sampled along 100 m reaches in each stream, in edge habitats and in riffle/run habitats located in the center of the stream. Restoration significantly altered the physical conditions and affected the interactions between stream habitat heterogeneity and macroinvertebrate diversity. The substrate in the restored streams was dominated by pebble, whereas the substrate in the channelized and natural streams was dominated by sand. In the natural streams a relationship was identified between slope and pebble/gravel coverage, indicating a coupling of energy and substrate characteristics. Such a relationship did not occur in the channelized or in the restored streams where placement of large amounts of pebble/gravel distorted the natural relationship. The analyses revealed, a direct link between substrate heterogeneity and macroinvertebrate diversity in the natural streams. A similar relationship was not found in either the channelized or the restored streams, which we attribute to a de-coupling of the natural relationship between benthic community diversity and physical habitat diversity. Our study results suggest that restoration schemes should aim at restoring the natural physical structural complexity in the streams and at the same time enhance the possibility of re-generating the natural geomorphological processes sustaining the habitats in streams and rivers. Documentation of restoration efforts should be intensified with continuous monitoring of geomorphological and ecological changes including surveys of reference river systems.	[Pedersen, Morten Lauge] Aalborg Univ, Dept Civil Engn, Aalborg, Denmark; [Kristensen, Klaus Kevin] Ringkjobing Skjern Municipal, Ringkobing, Denmark; [Friberg, Nikolai] Norwegian Inst Water Res, Sect Freshwater Biol, Oslo, Norway	Aalborg University; Norwegian Institute for Water Research (NIVA)	Pedersen, ML (corresponding author), Aalborg Univ, Dept Civil Engn, Aalborg, Denmark.	mlp@civil.aau.dk			Aalborg University	Aalborg University	This work has been funded by the Aalborg University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN JD, 1975, ECOLOGY, V56, P1040, DOI 10.2307/1936145; [Anonymous], 1985, 291 DAN STAND; [Anonymous], 1975, 223 DAN STAND; [Anonymous], 1975, 219 DAN STAND; [Anonymous], 1985, 292 DAN STAND; [Anonymous], 1981, AQUATIC CHEM INTRO E; [Anonymous], 1999, 18991 DAN STAND; [Anonymous], 1975, 221 DAN STAND; Beechie TJ, 2010, BIOSCIENCE, V60, P209, DOI 10.1525/bio.2010.60.3.7; Bernhardt ES, 2011, ECOL APPL, V21, P1926, DOI 10.1890/10-1574.1; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Brookes A., 1988, CHANNELIZED RIVERS P; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Doyle MW, 1999, P ASCE INT C WAT RES; Ernst AG, 2012, RESTOR ECOL, V20, P532, DOI 10.1111/j.1526-100X.2011.00790.x; Feld CK, 2011, ADV ECOL RES, V44, P119, DOI 10.1016/B978-0-12-374794-5.00003-1; Feld CK, 2010, BIODIVERS CONSERV, V19, P2895, DOI 10.1007/s10531-010-9875-0; Feld CK, 2009, OIKOS, V118, P1862, DOI 10.1111/j.1600-0706.2009.17860.x; Friberg N, 2011, ADV ECOL RES, V44, P1, DOI 10.1016/B978-0-12-374794-5.00001-8; Friberg N, 2010, FRESHWATER BIOL, V55, P1367, DOI 10.1111/j.1365-2427.2010.02442.x; FRISSELL CA, 1986, ENVIRON MANAGE, V10, P199, DOI 10.1007/BF01867358; Haury J, 1996, HYDROBIOLOGIA, V340, P43, DOI 10.1007/BF00012733; Hildrew AG, 2009, RIVERS OF EUROPE, 1ST EDITION, P685, DOI 10.1016/B978-0-12-369449-2.00019-9; Hynes H. B. N., 1970, ECOLOGY RUNNING WATE; Jahnig SC, 2011, ECOL APPL, V21, P2007, DOI 10.1890/10-0618.1; Jahnig SC, 2008, AQUAT SCI, V70, P292, DOI 10.1007/s00027-008-8042-0; Jahnig SC, 2009, AQUAT CONSERV, V19, P157, DOI 10.1002/aqc.976; Jahnig SC, 2008, AQUAT CONSERV, V18, P1200, DOI 10.1002/aqc.875; Johnson RK, 2009, J APPL ECOL, V46, P175, DOI 10.1111/j.1365-2664.2008.01583.x; Kondolf GM, 2006, ECOL SOC, V11; Kristensen EA, 2012, ENVIRON SCI POLICY, V23, P1, DOI 10.1016/j.envsci.2012.06.013; KRISTENSEN P, 1994, EEA ENV MONOGRAPHS, V1; Langford TEL, 2009, ECOL INDIC, V9, P1064, DOI 10.1016/j.ecolind.2008.12.012; Lepori F, 2005, ECOL APPL, V15, P2060, DOI 10.1890/04-1372; Lorenz AW, 2012, J APPL ECOL, V49, P202, DOI 10.1111/j.1365-2664.2011.02082.x; Moerke AH, 2003, N AM J FISH MANAGE, V23, P748, DOI 10.1577/M02-012; Muotka T, 2007, FRESHWATER BIOL, V52, P724, DOI 10.1111/j.1365-2427.2007.01727.x; Newson MD, 2006, EARTH SURF PROC LAND, V31, P1606, DOI 10.1002/esp.1430; Niezgoda SL, 2005, ENVIRON MANAGE, V35, P579, DOI 10.1007/s00267-004-0088-8; OCONNOR NA, 1991, OECOLOGIA, V85, P504, DOI 10.1007/BF00323762; Palmer MA, 2005, J APPL ECOL, V42, P208, DOI 10.1111/j.1365-2664.2005.01004.x; Palmer M, 2007, RESTOR ECOL, V15, P472, DOI 10.1111/j.1526-100X.2007.00243.x; Palmer MA, 2010, FRESHWATER BIOL, V55, P205, DOI 10.1111/j.1365-2427.2009.02372.x; Pedersen ML, 2004, RIVER RES APPL, V20, P653, DOI 10.1002/rra.770; Pedersen ML, 2007, ECOL ENG, V30, P145, DOI 10.1016/j.ecoleng.2006.08.009; PETTS G E, 1988, Regulated Rivers Research and Management, V2, P201, DOI 10.1002/rrr.3450020303; Pinder LCV, 1997, REGUL RIVER, V13, P203, DOI 10.1002/(SICI)1099-1646(199705)13:3&lt;203::AID-RRR449&gt;3.0.CO;2-F; Ricklefs Robert E., 1993, P350; Roni P, 2008, N AM J FISH MANAGE, V28, P856, DOI 10.1577/M06-169.1; Rosgen D., 1996, APPL RIVER MORPHOLOG; ROSGEN DL, 1994, CATENA, V22, P169, DOI 10.1016/0341-8162(94)90001-9; Simon Andrew, 2007, J AM WATER RESOUR AS, V43, P1, DOI DOI 10.1111/J.1752-1688.2007.00091.X; Snedecor G.W., 1989, AMES IOWA STATE U PR; Sokal R.R., 2012, BIOMETRY; Tockner K, 2009, RIVERS OF EUROPE, 1ST EDITION, P1, DOI 10.1016/B978-0-12-369449-2.00001-1; Tullos DD, 2006, ECOL ENG, V27, P228, DOI 10.1016/j.ecoleng.2006.03.001; Tullos DD, 2009, J N AM BENTHOL SOC, V28, P80, DOI 10.1899/07-122.1; Vaughan IP, 2009, AQUAT CONSERV, V19, P113, DOI 10.1002/aqc.895; WASHINGTON HG, 1984, WATER RES, V18, P653, DOI 10.1016/0043-1354(84)90164-7; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910	60	18	18	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108558	10.1371/journal.pone.0108558	http://dx.doi.org/10.1371/journal.pone.0108558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264627	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000345745400088
J	Xie, XX; Ma, YF; Chen, ZL; Liao, RR; Zhang, XZ; Wang, QS; Pan, YC				Xie, Xiaoxian; Ma, Yufang; Chen, Zhenliang; Liao, Rongrong; Zhang, Xiangzhe; Wang, Qishan; Pan, Yuchun			Transgenic Mice Expressing Yeast CUP1 Exhibit Increased Copper Utilization from Feeds	PLOS ONE			English	Article							PHOSPHORUS POLLUTION-CONTROL; WEANLING PIGS; BACTERIAL PHYTASE; SALIVARY-GLANDS; LYSINE COMPLEX; YOUNG MEN; METALLOTHIONEIN; GROWTH; ZINC; GENE	Copper is required for structural and catalytic properties of a variety of enzymes participating in many vital biological processes for growth and development. Feeds provide most of the copper as an essential micronutrient consumed by animals, but inorganic copper could not be utilized effectively. In the present study, we aimed to develop transgenic mouse models to test if copper utilization will be increased by providing the animals with an exogenous gene for generation of copper chelatin in saliva. Considering that the S. cerevisiae CUP1 gene encodes a Cys-rich protein that can bind copper as specifically as copper chelatin in yeast, we therefore constructed a transgene plasmid containing the CUP1 gene regulated for specific expression in the salivary glands by a promoter of gene coding pig parotid secretory protein. Transgenic CUP1 was highly expressed in the parotid and submandibular salivary glands and secreted in saliva as a 9-kDa copper-chelating protein. Expression of salivary copper-chelating proteins reduced fecal copper contents by 21.61% and increased body-weight by 12.97%, suggesting that chelating proteins improve the utilization and absorbed efficacy of copper. No negative effects on the health of the transgenic mice were found by blood biochemistry and histology analysis. These results demonstrate that the introduction of the salivary CUP1 transgene into animals offers a possible approach to increase the utilization efficiency of copper and decrease the fecal copper contents.	[Pan, Yuchun] Shanghai Jiao Tong Univ, Dept Anim Sci, Sch Agr & Biol, Shanghai 200030, Peoples R China; Shanghai Key Lab Vet Biotechnol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Pan, YC (corresponding author), Shanghai Jiao Tong Univ, Dept Anim Sci, Sch Agr & Biol, Shanghai 200030, Peoples R China.	panyuchun1963@aliyun.com			National Transgenic Breeding Program [2014ZX08006-004, 2014ZX08009-003-006]	National Transgenic Breeding Program	This work was supported by the National Transgenic Breeding Program (grant no.: 2014ZX08006-004; 2014ZX08009-003-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnink AJA, 2007, LIVEST SCI, V109, P194, DOI 10.1016/j.livsci.2007.01.112; APGAR GA, 1995, J ANIM SCI, V73, P2640; Armstrong TA, 2004, J ANIM SCI, V82, P1234; BREMNER I, 1987, J NUTR, V117, P19, DOI 10.1093/jn/117.1.19; BUNCH RJ, 1965, J ANIM SCI, V24, P995, DOI 10.2527/jas1965.244995x; COFFEY RD, 1994, J ANIM SCI, V72, P2880, DOI 10.2527/1994.72112880x; CROMWELL GL, 1989, J ANIM SCI, V67, P2996, DOI 10.2527/jas1989.67112996x; de Lange K, 1999, ADVANCES IN PORK PRODUCTION, VOL 10, P173; Delahaye R, 2003, EMISSIE ZEVEN ZWARE; ECKER DJ, 1986, J BIOL CHEM, V261, P6895; Elvehjem C, 1929, J BIOL CHEM, V84, P131; Elvehjem CA, 1932, J BIOL CHEM, V95, P363; Elvehjem CA, 1937, AM J DIS CHILD, V53, P785; FOGEL S, 1983, CURR GENET, V7, P347, DOI 10.1007/BF00445874; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Gambling L, 2011, SEMIN CELL DEV BIOL, V22, P637, DOI 10.1016/j.semcdb.2011.08.011; Golovan SP, 2001, NAT BIOTECHNOL, V19, P429, DOI 10.1038/88091; Graber U., 2005, GEOGR TIDSSKR-DEN, V105, P15, DOI [10.1080/00167223.2005.10649536, DOI 10.1080/00167223.2005.10649536]; Harris ED, 2003, CRIT REV CL LAB SCI, V40, P547, DOI 10.1080/10408360390250649; HOGAN B, 1986, MANIPULATING MOUSE E; HU YF, 1992, AM J PHYSIOL, V263, pE607, DOI 10.1152/ajpendo.1992.263.4.E607; Isobe H., 1999, Japanese Journal of Soil Science and Plant Nutrition, V70, P39; JACOB RA, 1987, J NUTR, V117, P2109, DOI 10.1093/jn/117.12.2109; Jensen LT, 1996, J BIOL CHEM, V271, P18514, DOI 10.1074/jbc.271.31.18514; Jondreville C, 2003, LIVEST PROD SCI, V84, P147, DOI 10.1016/j.livprodsci.2003.09.011; KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001; KAGI JHR, 1960, J BIOL CHEM, V235, P3460; KARIN M, 1984, P NATL ACAD SCI-BIOL, V81, P337, DOI 10.1073/pnas.81.2.337; Lv J, 2013, J MED FOOD, V16, P912, DOI 10.1089/jmf.2012.2626; MADSEN HO, 1985, NUCLEIC ACIDS RES, V13, P1, DOI 10.1093/nar/13.1.1; Meyer JL, 2006, BIOL CONTROL, V36, P129, DOI 10.1016/j.biocontrol.2005.08.007; MIKKELSEN TR, 1992, NUCLEIC ACIDS RES, V20, P2249, DOI 10.1093/nar/20.9.2249; Ogiyama S, 2005, SOIL SCI PLANT NUTR, V51, P801, DOI 10.1111/j.1747-0765.2005.tb00114.x; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Potrykus J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003910; Poulsen HD, 1998, J ANIM FEED SCI, V7, P135, DOI 10.22358/jafs/69961/1998; RICHARDS MP, 1989, J NUTR, V119, P1062, DOI 10.1093/jn/119.7.1062; SANDSTEAD HH, 1995, AM J CLIN NUTR, V61, p621S, DOI 10.1093/ajcn/61.3.621S; Shils ME, 2006, MODERN NUTR HLTH DIS, V10th; Spencer RL, 2000, BRAIN RES, V868, P275, DOI 10.1016/S0006-8993(00)02341-6; STANSBURY WF, 1990, J ANIM SCI, V68, P1318; Thomas JC, 2003, BIOTECHNOL PROGR, V19, P273, DOI 10.1021/bp025623q; TSOU RC, 1977, ENDOCRINOLOGY, V101, P534, DOI 10.1210/endo-101-2-534; Turnlund JR, 1997, AM J CLIN NUTR, V65, P72, DOI 10.1093/ajcn/65.1.72; VANRIJS J, 1985, P NATL ACAD SCI USA, V82, P5832; Xiong XO, 2010, RESOUR CONSERV RECY, V54, P985, DOI 10.1016/j.resconrec.2010.02.005; Yin HF, 2006, J ANIM SCI, V84, P513, DOI 10.2527/2006.843513x; ZHOU W, 1994, J ANIM SCI, V72, P2395, DOI 10.2527/1994.7292395x	48	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107810	10.1371/journal.pone.0107810	http://dx.doi.org/10.1371/journal.pone.0107810			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265503	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400032
J	Das, M; Isaakidis, P; Shenoy, R; Anicete, R; Sharma, HK; Ao, I; Osah, K; Mansoor, H; Saranchuk, P; Abraham, S				Das, Mrinalini; Isaakidis, Petros; Shenoy, Rahul; Anicete, Rey; Sharma, Hemant Kumar; Ao, Imyangluba; Osah, Kaikho; Mansoor, Homa; Saranchuk, Peter; Abraham, Sunita			Self-Administered Tuberculosis Treatment Outcomes in a Tribal Population on the Indo-Myanmar Border, Nagaland, India	PLOS ONE			English	Article								Background: Multiple strategies are being adopted by national tuberculosis (TB) programmes to achieve universal coverage of tuberculosis treatment. However, populations living in 'hard-to-reach' areas of north-east India have poor access to health services. Our study aimed to detail treatment outcomes in TB program supported by Medecins Sans Frontieres (MSF) and using an alternative model of TB treatment delivery in Mon district, Nagaland, India. Methods: This was a retrospective cohort study of TB patients, initiated on self-administered therapy (SAT) through Mon District Hospital, Nagaland, India between April 2012 and March 2013. Results: A total of 238 tuberculosis patients had final TB treatment outcomes during the study period, including 82 and 156 from semi-urban and rural areas respectively. The majority of patients (62%, 147/238) were suffering from pulmonary, smear-positive tuberculosis. Overall, 74% of patients (175/238) had successful outcomes, being cured or having completed their treatment. Females (81%), pulmonary TB patients (75%) and those on a Category I regimen (79%) had better treatment success rates than males (67%), extra-pulmonary TB patients (62%) and patients on a Category II regimen (61%). The univariate and bivariate analyses found age, sex and TB treatment regimen significantly associated with unsuccessful TB treatment outcomes (defined as death, loss-to-follow-up and failure). However, only older age showed significance in a multivariate binary logistic regression model. Conclusion: Our study suggests that self-administered TB treatment is feasible for patients living in areas with limited or no access to health services. The relatively low number of patients with adverse outcomes suggests that SAT models are safe; other advantages include the need for fewer resources and less frequent movements by patients. National TB programmes should consider allowing SAT strategies for delivery of TB treatment to 'hard-to-reach' populations, which could in turn help to achieve universal coverage and contribute to global TB elimination by 2050.	[Das, Mrinalini; Isaakidis, Petros; Shenoy, Rahul; Anicete, Rey; Sharma, Hemant Kumar; Osah, Kaikho; Mansoor, Homa; Abraham, Sunita] Med Sans Frontieres, Nagaland, India; [Ao, Imyangluba] Dist TB Control Off RNTCP, Nagaland, India; [Saranchuk, Peter] Med Sans Frontieres, SAMU, Cape Town, South Africa		Das, M (corresponding author), Med Sans Frontieres, Nagaland, India.	msfocb-delhi-epi@brussels.msf.org		Isaakidis, Petros/0000-0002-7881-1554				Albanna AS, 2013, EUR RESPIR J, V42, P721, DOI 10.1183/09031936.00180612; Balasubramanian VN, 2000, INT J TUBERC LUNG D, V4, P409; Central TB Division, 2005, TECHN OP GUID TUB CO, P24; Central TB Division, 2013, TB IND 2013; Deiss RG, 2009, CLIN INFECT DIS, V48, P72, DOI 10.1086/594126; Department of AIDS Control, 2013, ANN REP 2012 13; Department of Planning and Coordination, 2011, DISTR HUM DEV REP MO, P9; Isaakidis P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068869; Khogali M, 2014, INT HEALTH, V6, P112, DOI 10.1093/inthealth/ihu008; Mandal PK, 2013, J CLIN DIAGN RES, V7, P292, DOI [10.7860/JCDR/2013/5122.2750, 10.7860/JCDR/2013/6122.2750]; Murali MS, 2004, INDIAN J COMMU MED, V29, P18; Nackers F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032140; Tayler-Smith K, 2011, INT J TUBERC LUNG D, V15, P1367, DOI 10.5588/ijtld.10.0751; Tripathy JP, 2013, PHA, V3; Verma R, 2009, INTERNET J EPIDEMIOL, V8; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2006, STOP TB STRAT BUILD	18	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108186	10.1371/journal.pone.0108186	http://dx.doi.org/10.1371/journal.pone.0108186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259868	Green Submitted, Green Published, gold			2022-12-27	WOS:000342685600051
J	Plomp, M; Carroll, AM; Setlow, P; Malkin, AJ				Plomp, Marco; Carroll, Alicia Monroe; Setlow, Peter; Malkin, Alexander J.			Architecture and Assembly of the Bacillus subtilis Spore Coat	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; RODLET LAYER; STRUCTURAL DYNAMICS; CROSS-LINKING; PROTEIN; SURFACE; GROWTH; GENE; MORPHOGENESIS; THURINGIENSIS	Bacillus spores are encased in a multilayer, proteinaceous self-assembled coat structure that assists in protecting the bacterial genome from stresses and consists of at least 70 proteins. The elucidation of Bacillus spore coat assembly, architecture, and function is critical to determining mechanisms of spore pathogenesis, environmental resistance, immune response, and physicochemical properties. Recently, genetic, biochemical and microscopy methods have provided new insight into spore coat architecture, assembly, structure and function. However, detailed spore coat architecture and assembly, comprehensive understanding of the proteomic composition of coat layers, and specific roles of coat proteins in coat assembly and their precise localization within the coat remain in question. In this study, atomic force microscopy was used to probe the coat structure of Bacillus subtilis wild type and cotA, cotB, safA, cotH, cotO, cotE, gerE, and cotE gerE spores. This approach provided high-resolution visualization of the various spore coat structures, new insight into the function of specific coat proteins, and enabled the development of a detailed model of spore coat architecture. This model is consistent with a recently reported four-layer coat assembly and further adds several coat layers not reported previously. The coat is organized starting from the outside into an outermost amorphous (crust) layer, a rodlet layer, a honeycomb layer, a fibrous layer, a layer of "nanodot'' particles, a multilayer assembly, and finally the undercoat/basement layer. We propose that the assembly of the previously unreported fibrous layer, which we link to the darkly stained outer coat seen by electron microscopy, and the nanodot layer are cotH-and cotE-dependent and cotE-specific respectively. We further propose that the inner coat multilayer structure is crystalline with its apparent two-dimensional (2D) nuclei being the first example of a non-mineral 2D nucleation crystallization pattern in a biological organism.	[Plomp, Marco; Malkin, Alexander J.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Phys & Life Sci Directorate, Livermore, CA USA; [Carroll, Alicia Monroe; Setlow, Peter] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Connecticut	Setlow, P (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA.	setlow@nso2.uchc.edu; malkin1@llnl.gov			National Institutes of Health [GM-19698]; Department of Defense Multidisciplinary University Research Initiative through United States Army Research Laboratory; United States Army Research Office [W911F-09-1-0286]; Lawrence Livermore National Laboratory through Laboratory Directed Research and Development Grant [04-ERD-002]; United States Department of Energy by the University of California, Lawrence Livermore National Laboratory [W-7405-Eng-48]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019698, R01GM019698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Multidisciplinary University Research Initiative through United States Army Research Laboratory; United States Army Research Office; Lawrence Livermore National Laboratory through Laboratory Directed Research and Development Grant; United States Department of Energy by the University of California, Lawrence Livermore National Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health (http://www.nih.gov/) (GM-19698) (PS), by a Department of Defense Multidisciplinary University Research Initiative (http//www.arl.army.mil/www/default.cfm?page=472) through the United States Army Research Laboratory and the United States Army Research Office under contract number W911F-09-1-0286 (PS), and by the Lawrence Livermore National Laboratory (https://www.lInl.gov/) through Laboratory Directed Research and Development Grant 04-ERD-002 (AJM). Part of this work was performed under the auspices of the United States Department of Energy by the University of California, Lawrence Livermore National Laboratory under Contract W-7405-Eng-48. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. This document was cleared by the Lawrence Livermore National Laboratory for publication.	Abhyankar W, 2011, PROTEOMICS, V11, P4541, DOI 10.1002/pmic.201100003; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; ARONSON AI, 1976, BACTERIOL REV, V40, P360, DOI 10.1128/MMBR.40.2.360-402.1976; BEALL B, 1993, J BACTERIOL, V175, P1705, DOI 10.1128/JB.175.6.1705-1716.1993; BEEVER RE, 1979, J BACTERIOL, V140, P1063, DOI 10.1128/JB.140.3.1063-1070.1979; Butzin XY, 2012, J BACTERIOL, V194, P5749, DOI 10.1128/JB.01276-12; Cabrera N., 1958, GROWTH PERFECTION CR, V393-425; Carroll AM, 2008, APPL ENVIRON MICROB, V74, P5875, DOI 10.1128/AEM.01228-08; Chada VGR, 2003, J BACTERIOL, V185, P6255, DOI 10.1128/JB.185.21.6255-6261.2003; Chernov A.A., 2012, MODERN CRYSTALLOGRAP, V36; Claessen D, 2004, MOL MICROBIOL, V53, P433, DOI 10.1111/j.1365-2958.2004.04143.x; de Francesco M, 2012, J BACTERIOL, V194, P4941, DOI 10.1128/JB.00914-12; de Hoon MJL, 2010, CURR BIOL, V20, pR735, DOI 10.1016/j.cub.2010.06.031; De Yoreo JJ, 2003, REV MINERAL GEOCHEM, V54, P57, DOI 10.2113/0540057; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DONOVAN W, 1987, J MOL BIOL, V196, P1, DOI 10.1016/0022-2836(87)90506-7; Driks A, 2002, TRENDS MICROBIOL, V10, P251, DOI 10.1016/S0966-842X(02)02373-9; Driks A, 2003, P NATL ACAD SCI USA, V100, P3007, DOI 10.1073/pnas.0730807100; Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1; Dufrene YF, 1999, J BACTERIOL, V181, P5350; Dufrene YF, 2004, NAT REV MICROBIOL, V2, P451, DOI 10.1038/nrmicro905; Eichenberger P, 2003, J MOL BIOL, V327, P945, DOI 10.1016/S0022-2836(03)00205-5; Frenkel D, 2006, NATURE, V443, P641, DOI 10.1038/443641a; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; Ghosh S, 2008, J BACTERIOL, V190, P6741, DOI 10.1128/JB.00896-08; HASHIMOTO T, 1976, J BACTERIOL, V127, P1543, DOI 10.1128/JB.127.3.1543-1549.1976; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Henriques AO, 2000, METHODS, V20, P95, DOI 10.1006/meth.1999.0909; Hollander FFA, 2001, SURF SCI, V471, P101, DOI 10.1016/S0039-6028(00)00889-X; HOLT SC, 1969, BACTERIOL REV, V33, P346, DOI 10.1128/MMBR.33.2.346-378.1969; Imamura D, 2011, J BACTERIOL, V193, P4075, DOI 10.1128/JB.05310-11; Imamura D, 2010, J BACTERIOL, V192, P518, DOI 10.1128/JB.01103-09; Isticato R, 2001, J BACTERIOL, V183, P6294, DOI 10.1128/JB.183.21.6294-6301.2001; Isticato R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074949; Kailas L, 2011, P NATL ACAD SCI USA, V108, P16014, DOI 10.1073/pnas.1109419108; Klobutcher LA, 2006, P NATL ACAD SCI USA, V103, P165, DOI 10.1073/pnas.0507121102; Krajcikova D, 2009, J BACTERIOL, V191, P3212, DOI 10.1128/JB.01807-08; Kuznetsov YG, 1997, BIOPHYS J, V72, P2357, DOI 10.1016/S0006-3495(97)78880-5; Kuznetsov YG, 1997, J STRUCT BIOL, V120, P180, DOI 10.1006/jsbi.1997.3936; Laaberki MH, 2008, J BACTERIOL, V190, P6197, DOI 10.1128/JB.00623-08; Land TA, 1999, NATURE, V399, P442, DOI 10.1038/20886; Magonov SN, 1997, SURF SCI, V375, pL385, DOI 10.1016/S0039-6028(96)01591-9; Magonov SN, 1997, SURF SCI, V389, P201, DOI 10.1016/S0039-6028(97)00412-3; Maiwa K, 1998, J CRYST GROWTH, V186, P214, DOI 10.1016/S0022-0248(97)00446-6; MALKIN AJ, 1995, NAT STRUCT BIOL, V2, P956, DOI 10.1038/nsb1195-956; Malkin AJ, 1999, J CRYST GROWTH, V196, P471, DOI 10.1016/S0022-0248(98)00823-9; Malkin AJ, 2004, NAN SCI TEC, P201; Malkin AJ, 2010, SCANNING PROBE MICROSCOPY OF FUNCTIONAL MATERIALS: NANOSCALE IMAGING AND SPECTROSCOPY, P39, DOI 10.1007/978-1-4419-7167-8_2; Maniatis T., 1982, MOL CLONING; McKenney PT, 2013, NAT REV MICROBIOL, V11, P33, DOI 10.1038/nrmicro2921; McKenney PT, 2012, MOL MICROBIOL, V83, P245, DOI 10.1111/j.1365-2958.2011.07936.x; McKenney PT, 2010, CURR BIOL, V20, P934, DOI 10.1016/j.cub.2010.03.060; McPherson DC, 2005, J BACTERIOL, V187, P8278, DOI 10.1128/JB.187.24.8278-8290.2005; MOIR A, 1981, J BACTERIOL, V146, P1106, DOI 10.1128/JB.146.3.1106-1116.1981; Monroe A, 2006, J BACTERIOL, V188, P7609, DOI 10.1128/JB.01116-06; Mullerova D, 2009, FEMS MICROBIOL LETT, V299, P74, DOI 10.1111/j.1574-6968.2009.01737.x; Naclerio G, 1996, J BACTERIOL, V178, P4375, DOI 10.1128/jb.178.15.4375-4380.1996; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Ozin AJ, 2000, J BACTERIOL, V182, P1828, DOI 10.1128/JB.182.7.1828-1833.2000; Plomp M, 2005, LANGMUIR, V21, P10710, DOI 10.1021/la0517437; Plomp M, 2005, LANGMUIR, V21, P7892, DOI 10.1021/la050412r; Plomp M, 2005, BIOPHYS J, V88, P603, DOI 10.1529/biophysj.104.049312; Plomp M, 2003, J CRYST GROWTH, V249, P600, DOI 10.1016/S0022-0248(02)02325-4; Plomp M, 2003, PROTEINS, V50, P486, DOI 10.1002/prot.10288; Plomp M, 2001, J PHYS CHEM B, V105, P542, DOI 10.1021/jp003007b; Plomp M, 2007, J BACTERIOL, V189, P6457, DOI 10.1128/JB.00757-07; Plomp M, 2007, P NATL ACAD SCI USA, V104, P9644, DOI 10.1073/pnas.0610626104; Plomp M, 2009, LANGMUIR, V25, P403, DOI 10.1021/la803129r; Qiao HY, 2013, J STRUCT BIOL, V181, P128, DOI 10.1016/j.jsb.2012.11.002; Qiu XY, 2009, J BACTERIOL, V191, P7620, DOI 10.1128/JB.01200-09; Ragkousi K, 2004, J BACTERIOL, V186, P5567, DOI 10.1128/JB.186.17.5567-5575.2004; Rogilo DI, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.036105; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; SOUSA JCF, 1976, NATURE, V263, P53, DOI 10.1038/263053a0; Takamatsu H, 1999, J BACTERIOL, V181, P4986, DOI 10.1128/JB.181.16.4986-4994.1999; Tang J, 2007, J MOL RECOGNIT, V20, P483, DOI 10.1002/jmr.828; vanEnckevort WJP, 1996, J CRYST GROWTH, V166, P156, DOI 10.1016/0022-0248(96)00136-4; Waller LN, 2004, J MICROBIOL METH, V58, P23, DOI 10.1016/j.mimet.2004.02.012; Wang KH, 2009, MOL MICROBIOL, V74, P634, DOI 10.1111/j.1365-2958.2009.06886.x; WEHRLI E, 1980, EUR J CELL BIOL, V20, P283; Wessels JGH, 1997, ADV MICROB PHYSIOL, V38, P1; Westphal AJ, 2003, P NATL ACAD SCI USA, V100, P3461, DOI 10.1073/pnas.232710999; Wosten HAB, 2000, BBA-REV BIOMEMBRANES, V1469, P79, DOI 10.1016/S0304-4157(00)00002-2; ZHENG LB, 1988, GENE DEV, V2, P1047, DOI 10.1101/gad.2.8.1047; Zilhao R, 2004, J BACTERIOL, V186, P1110, DOI 10.1128/JB.186.4.1110-1119.2004; Zilhao R, 1999, J BACTERIOL, V181, P2631	86	40	42	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108560	10.1371/journal.pone.0108560	http://dx.doi.org/10.1371/journal.pone.0108560			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259857	gold, Green Submitted, Green Published			2022-12-27	WOS:000342685600082
J	Boyd, A; Ribeiro, JMC; Nutman, TB				Boyd, Alexis; Ribeiro, Jose M. C.; Nutman, Thomas B.			Human CD117 (cKit)+ Innate Lymphoid Cells Have a Discrete Transcriptional Profile at Homeostasis and Are Expanded during Filarial Infection	PLOS ONE			English	Article							DENDRITIC CELLS; TYPE-2 IMMUNITY; EXPRESSION; GROWTH; T(H)2; INHIBITION; CARCINOMA; RESPONSES; PARASITES; EPS8	Since innate lymphoid cells (ILCs) have been found to play a role in the immune response to helminth parasites in rodents, we sought to determine their role in human helminth infection. By developing multicolor flow cytometry-based methods to identify and enumerate circulating ILCs and their subsets, we were able to identify a subset of cKit+ ILCs defined as Lineage (Lin)-/CD45+/cKit+/CD127+ that were significantly expanded in the filarial-infected individuals (p = 0.0473) as were those cKit+ ILCs that produced IL-13. Additionally, the frequency of these cKit+ ILCs correlated with the frequency of IL-17 producing CD4+ T cells (Th17 cells; p = 0.025). To investigate the function of cKit+ ILCs, sorted, highly purified human ILCs were subjected to transcriptional profiling by RNAseq and compared to appropriate control cells. These cKit+ ILCs expressed TLRs, a broad range of cytokines/cytokine receptors and MHC Class II molecules suggesting that these ILCs sense pathogens independent of other cell types. Functional analysis revealed expanded cKit+ ILC-specific transcription and ILC-specific microRNA precursors.	[Boyd, Alexis; Nutman, Thomas B.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Ribeiro, Jose M. C.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nutman, TB (corresponding author), NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	tnutman@niaid.nih.gov		Ribeiro, Jose/0000-0002-9107-0818	Division of Intramural Research, NIAID, NIH	Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded entirely by the Division of Intramural Research, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2012, MOL CELL BIOL, V32, P2530, DOI 10.1128/MCB.00510-12; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Chu PY, 2012, ASIA-PAC J CLIN ONCO, V8, pE77, DOI 10.1111/j.1743-7563.2011.01459.x; Di Fiore PP, 2002, INT J BIOCHEM CELL B, V34, P1178, DOI 10.1016/S1357-2725(02)00064-X; Gentek R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00334; Ivaska J, 2010, CELL TISSUE RES, V339, P111, DOI 10.1007/s00441-009-0857-z; Keklikoglou I, 2012, ONCOGENE, V31, P4150, DOI 10.1038/onc.2011.571; Khan AP, 2011, ANAL BIOCHEM, V417, P57, DOI 10.1016/j.ab.2011.05.040; King CL, 2001, PARASITE IMMUNOL, V23, P363, DOI 10.1046/j.1365-3024.2001.00395.x; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Lin J, 2011, CARCINOGENESIS, V32, P1641, DOI 10.1093/carcin/bgr199; Metenou S, 2010, J IMMUNOL, V184, P5375, DOI 10.4049/jimmunol.0904067; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; RADERMECKER M, 1974, INT ARCH ALLER A IMM, V47, P285, DOI 10.1159/000231221; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Semnani RT, 2008, BLOOD, V112, P1290, DOI 10.1182/blood-2008-04-149856; Semnani RT, 2013, ADV EXP MED BIOL, V785, P49, DOI 10.1007/978-1-4614-6217-0_6; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spooner CJ, 2013, NAT IMMUNOL; Xu Z, 2011, J BIOL CHEM, V286, P21401, DOI 10.1074/jbc.M110.198630; Yang TP, 2010, CHEM-BIOL INTERACT, V183, P181, DOI 10.1016/j.cbi.2009.09.018	29	35	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108649	10.1371/journal.pone.0108649	http://dx.doi.org/10.1371/journal.pone.0108649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255226	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300101
J	Conrad, MS; Sutton, BP; Dilger, RN; Johnson, RW				Conrad, Matthew S.; Sutton, Bradley P.; Dilger, Ryan N.; Johnson, Rodney W.			An In Vivo Three-Dimensional Magnetic Resonance Imaging-Based Averaged Brain Collection of the Neonatal Piglet (Sus scrofa)	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; VOXEL-BASED MORPHOMETRY; DOMESTIC PIG; GOTTINGEN MINIPIG; TEMPLATE IMAGES; VOLUMETRIC DATA; ATLAS; MRI; SEGMENTATION; MACAQUE	Due to the fact that morphology and perinatal growth of the piglet brain is similar to humans, use of the piglet as a translational animal model for neurodevelopmental studies is increasing. Magnetic resonance imaging (MRI) can be a powerful tool to study neurodevelopment in piglets, but many of the MRI resources have been produced for adult humans. Here, we present an average in vivo MRI-based atlas specific for the 4-week-old piglet. In addition, we have developed probabilistic tissue classification maps. These tools can be used with brain mapping software packages (e. g. SPM and FSL) to aid in voxel-based morphometry and image analysis techniques. The atlas enables efficient study of neurodevelopment in a highly tractable translational animal with brain growth and development similar to humans.	[Conrad, Matthew S.; Dilger, Ryan N.; Johnson, Rodney W.] Univ Illinois, Dept Anim Sci, Urbana, IL 61820 USA; [Conrad, Matthew S.; Sutton, Bradley P.; Dilger, Ryan N.; Johnson, Rodney W.] Univ Illinois, Neurosci Program, Urbana, IL USA; [Conrad, Matthew S.; Johnson, Rodney W.] Univ Illinois, Integrat Immunol & Behav Program, Urbana, IL USA; [Sutton, Bradley P.; Dilger, Ryan N.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Sutton, Bradley P.] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Dilger, Ryan N.; Johnson, Rodney W.] Univ Illinois, Div Nutr Sci, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Johnson, RW (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL 61820 USA.	rwjohn@illinois.edu	Sutton, Bradley P./A-4801-2008	Sutton, Bradley P./0000-0002-8443-0408; Johnson, Rodney/0000-0002-2376-1852; Dilger, Ryan/0000-0003-2538-2845	National Institute of Health [R01 HD069899]; National Institute of Food and Agriculture, U.S. Department of Agriculture [538-382]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069899] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by a grant from the National Institute of Health (R01 HD069899) and the National Institute of Food and Agriculture, U.S. Department of Agriculture, under Agreement No. 538-382. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaye M, 2008, NEUROIMAGE, V43, P721, DOI 10.1016/j.neuroimage.2008.07.060; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Black KJ, 1997, J COMPUT ASSIST TOMO, V21, P881, DOI 10.1097/00004728-199711000-00006; Black KJ, 2001, NEUROIMAGE, V14, P736, DOI 10.1006/nimg.2001.0752; Black KJ, 2001, NEUROIMAGE, V14, P744, DOI 10.1006/nimg.2001.0871; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; Conrad MS, 2012, PEDIATR RES, V71, P179, DOI 10.1038/pr.2011.21; Cross DJ, 2000, J NUCL MED, V41, P1879; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Dilger RN, 2010, BRAIN BEHAV IMMUN, V24, P1156, DOI 10.1016/j.bbi.2010.05.008; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Elmore MRP, 2012, ANIM COGN, V15, P667, DOI 10.1007/s10071-012-0495-9; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; Fang MR, 2005, NEUROSIGNALS, V14, P222, DOI 10.1159/000088638; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; FOX PT, 1985, J COMPUT ASSIST TOMO, V9, P141, DOI 10.1097/00004728-198501000-00025; Giedd JN, 1996, J COMP NEUROL, V366, P223, DOI 10.1002/(SICI)1096-9861(19960304)366:2<223::AID-CNE3>3.0.CO;2-7; Ishizu K, 2000, SYNAPSE, V38, P87, DOI 10.1002/1098-2396(200010)38:1<87::AID-SYN10>3.0.CO;2-C; Jakobsen S, 2006, J NUCL MED, V47, P2008; Jelsing J, 2006, J EXP BIOL, V209, P1454, DOI 10.1242/jeb.02141; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Knickmeyer RC, 2010, CEREB CORTEX, V20, P1053, DOI 10.1093/cercor/bhp166; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; McLaren DG, 2010, METHODS, V50, P157, DOI 10.1016/j.ymeth.2009.10.003; McLaren DG, 2009, NEUROIMAGE, V45, P52, DOI 10.1016/j.neuroimage.2008.10.058; Pfluger T, 1999, EPILEPSIA, V40, P414, DOI 10.1111/j.1528-1157.1999.tb00735.x; Radlowski EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091951; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P20, DOI 10.1016/j.nbd.2008.09.016; Shi F, 2010, NEUROIMAGE, V49, P391, DOI 10.1016/j.neuroimage.2009.07.066; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Watanabe H, 2001, NEUROIMAGE, V14, P1089, DOI 10.1006/nimg.2001.0910; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	37	27	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107650	10.1371/journal.pone.0107650	http://dx.doi.org/10.1371/journal.pone.0107650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254955	Green Submitted, Green Published, gold			2022-12-27	WOS:000344862300027
J	Li, L; Xing, DX; Li, QR; Xiao, Y; Ye, MQ; Yang, Q				Li, Li; Xing, Dong-Xu; Li, Qing-Rong; Xiao, Yang; Ye, Ming-Qiang; Yang, Qiong			Determination of Albendazole and Metabolites in Silkworm Bombyx mori Hemolymph by Ultrafast Liquid Chromatography Tandem Triple Quadrupole Mass Spectrometry	PLOS ONE			English	Article							HUMAN PLASMA; SULFOXIDE; SULFONE; VALIDATION; RESIDUES; SHEEP	Albendazole is a broad-spectrum parasiticide with high effectiveness and low host toxicity. No method is currently available for measuring albendazole and its metabolites in silkworm hemolymph. This study describes a rapid, selective, sensitive, synchronous and reliable detection method for albendazole and its metabolites in silkworm hemolymph using ultrafast liquid chromatography tandem triple quadrupole mass spectrometry (UFLC-MS/MS). The method is liquid-liquid extraction followed by UFLC separation and quantification in an MS/MS system with positive electrospray ionization in multiple reaction monitoring mode. Precursor-to-product ion transitions were monitored at 266.100 to 234.100 for albendazole (ABZ), 282.200 to 208.100 for albendazole sulfoxide (ABZSO), 298.200 to 159.100 for albendazole sulfone (ABZSO(2)) and 240.200 to 133.100 for albendazole amino sulfone (ABZSO(2)-NH2). Calibration curves had good linearities with R-2 of 0.9905-0.9972. Limits of quantitation (LOQs) were 1.32 ng/mL for ABZ, 16.67 ng/mL for ABZSO, 0.76 ng/mL for ABZSO(2) and 5.94 ng/mL for ABZSO(2)-NH2. Recoveries were 93.12%-103.83% for ABZ, 66.51%-108.51% for ABZSO, 96.85%-105.6% for ABZSO(2) and 96.46%-106.14% for ABZSO(2)-NH2, (RSDs <8%). Accuracy, precision and stability tests showed acceptable variation in quality control (QC) samples. This analytical method successfully determined albendazole and its metabolites in silkworm hemolymph in a pharmacokinetic study. The results of single-dose treatment suggested that the concentrations of ABZ, ABZSO and ABZSO(2) increased and then fell, while ABZSO(2)-NH2 level was low without obvious change. Different trends were observed for multi-dose treatment, with concentrations of ABZSO and ABZSO(2) rising over time.	[Li, Li; Xing, Dong-Xu; Li, Qing-Rong; Xiao, Yang; Ye, Ming-Qiang; Yang, Qiong] Sericulture & Agri Food Res Inst GAAS, Guangzhou, Guangdong, Peoples R China		Yang, Q (corresponding author), Sericulture & Agri Food Res Inst GAAS, Guangzhou, Guangdong, Peoples R China.	serilover@126.com			Ministry of Education and Ministry of Science and Technology for Guangdong province [2012B090600049]; National Natural Science Foundation of China (NSFC) [31201856]; Presidential Foundation of the Guangdong Academy of Agricultural Sciences [201214]	Ministry of Education and Ministry of Science and Technology for Guangdong province; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Presidential Foundation of the Guangdong Academy of Agricultural Sciences	This work was financially supported by the university-industry cooperation projects of Ministry of Education and Ministry of Science and Technology for Guangdong province (No. 2012B090600049), the National Natural Science Foundation of China (NSFC) (No. 31201856) and the Presidential Foundation of the Guangdong Academy of Agricultural Sciences (201214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Luiz MM, 2008, J CHROMATOGR A, V1205, P10, DOI 10.1016/j.chroma.2008.07.066; Alvinerie M, 1984, J Pharm Biomed Anal, V2, P73, DOI 10.1016/0731-7085(84)80091-6; Balizs G, 1999, J CHROMATOGR B, V727, P167, DOI 10.1016/S0378-4347(99)00052-3; Batzias GC, 2004, J CHROMATOGR B, V805, P267, DOI 10.1016/j.jchromb.2004.03.012; BENOIT E, 1992, AM J VET RES, V53, P1663; Bonato PS, 2003, J CHROMATOGR B, V783, P237, DOI 10.1016/S1570-0232(02)00665-7; BUICK AR, 1990, J PHARMACEUT BIOMED, V8, P629, DOI 10.1016/0731-7085(90)80093-5; Chen DR, 2012, THESIS JIANGSU U SCI; D'Avolio A, 2006, J CHROMATOGR B, V835, P127, DOI 10.1016/j.jchromb.2006.03.019; De Ruyck H, 2000, FOOD CONTROL, V11, P165, DOI 10.1016/S0956-7135(99)00089-4; DELATOUR P, 1991, XENOBIOTICA, V21, P217, DOI 10.3109/00498259109039463; DELATOUR P, 1990, J VET PHARMACOL THER, V13, P361, DOI 10.1111/j.1365-2885.1990.tb00790.x; DELATOUR P, 1991, RES VET SCI, V50, P134, DOI 10.1016/0034-5288(91)90095-6; Di Corcia A, 2002, J CHROMATOGR A, V974, P53, DOI 10.1016/S0021-9673(02)00905-6; Ellison SLR, 2009, PRACTICAL STATISTICS FOR THE ANALYTICAL SCIENTIST: A BENCH GUIDE, SECOND EDITION, P92; Fan ShengXian, 2004, Scientia Agricultura Sinica, V37, P1229; Fu WH, 2009, CHINESE PHARM J, V23, P37; Garcia JJ, 1999, J CHROMATOGR B, V723, P265, DOI 10.1016/S0378-4347(98)00497-6; Gonzalez-Hernandez I, 2012, BIOMED CHROMATOGR, V26, P267, DOI 10.1002/bmc.1659; Grabowski T, 2011, BIOMED CHROMATOGR, V25, P1159, DOI 10.1002/bmc.1588; GYURIK RJ, 1981, DRUG METAB DISPOS, V9, P503; Kitzman D, 2002, J PHARMACEUT BIOMED, V30, P801, DOI 10.1016/S0731-7085(02)00382-5; Lanchote VL, 1998, J CHROMATOGR B, V709, P273, DOI 10.1016/S0378-4347(98)00082-6; Li W, 2008, THESIS CHINA MED U; Lu XM, 2000, AGR LIFE SCI, V26, P547; Menon KI, 2002, THESIS MURDOCH U; Mirfazaelian A, 2002, J PHARMACEUT BIOMED, V30, P1249, DOI 10.1016/S0731-7085(02)00482-X; Molina AJ, 2007, EUR J PHARM SCI, V31, P16, DOI 10.1016/j.ejps.2007.01.008; Mottier L, 2003, J CHROMATOGR B, V798, P117, DOI 10.1016/j.jchromb.2003.09.034; O'Mahony J, 2013, J CHROMATOGR A, V1292, P83, DOI 10.1016/j.chroma.2013.01.007; Prochazkova A, 2000, ELECTROPHORESIS, V21, P729, DOI 10.1002/(SICI)1522-2683(20000301)21:4&lt;729::AID-ELPS729&gt;3.0.CO;2-M; Romero-Gonzalez R, 2007, J CHROMATOGR B, V857, P142, DOI 10.1016/j.jchromb.2007.07.011; Rubelt MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048502; [单玲玲 SHAN LING-ling], 2011, [中华中医药杂志, China Journal of Traditional Chinese Medicine and Pharmacy], V26, P2340; Shaw LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043848; Xia X, 2013, J CHROMATOGR A, V1292, P96, DOI 10.1016/j.chroma.2012.09.006; Yang Q, 2010, GUANGDONG CANYE, V44, P35; Zhan J, 2013, FOOD CHEM, V138, P827, DOI 10.1016/j.foodchem.2012.09.130; Zhang XJ, 2011, CHINESE J ANAL CHEM, V39, P815, DOI 10.3724/SP.J.1096.2011.00815	39	5	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e105637	10.1371/journal.pone.0105637	http://dx.doi.org/10.1371/journal.pone.0105637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255321	gold, Green Published, Green Submitted			2022-12-27	WOS:000344862300006
J	van der Heijden, KM; van der Heijden, IM; Galvao, FH; Lopes, CG; Costa, SF; Abdala, E; D'Albuquerque, LA; Levin, AS				van der Heijden, Karin M.; van der Heijden, Inneke M.; Galvao, Flavio H.; Lopes, Camila G.; Costa, Silvia F.; Abdala, Edson; D'Albuquerque, Luiz A.; Levin, Anna S.			Intestinal Translocation of Clinical Isolates of Vancomycin-Resistant Enterococcus faecalis and ESBL-Producing Escherichia coli in a Rat Model of Bacterial Colonization and Liver Ischemia/Reperfusion Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; GUT-ORIGIN; TRANSPLANTATION; PERMEABILITY; BACTEREMIA; CIRRHOSIS; SEPSIS	The objectives of this study were to develop a rat model of gastrointestinal colonization with vancomycin-resistant Enterococcus faecalis (VRE) and extended-spectrum beta-lactamase (ESBL)-producing E. coli and to evaluate intestinal translocation to blood and tissues after total and partial hepatic ischemia. Methods - We developed a model of rat colonization with VRE and ESBL-E coli. Then we studied four groups of colonized rats: Group I (with hepatic pedicle occlusion causing complete liver ischemia and intestinal stasis); Group II (with partial liver ischemia without intestinal stasis); Group III (surgical manipulation without hepatic ischemia or intestinal stasis); Group IV (anesthetized without surgical manipulation). After sacrifice, portal and systemic blood, large intestine, small intestine, spleen, liver, lungs, and cervical and mesenteric lymph nodes were cultured. Endotoxin concentrations in portal and systemic blood were determined. Results - The best inocula were: VRE: 2.4x10(10) cfu and ESBL-E. coli: 1.12x10(10) cfu. The best results occurred 24 hours after inoculation and antibiotic doses of 750 mu mg/mL of water for vancomycin and 2.1 mg/mL for ceftriaxone. There was a significantly higher proportion of positive cultures for ESBL-E. coli in the lungs in Groups I, II and III when compared with Group IV (67%; 60%; 75% and 13%, respectively; p: 0.04). VRE growth was more frequent in mesenteric lymph nodes for Groups I (67%) and III (38%) than for Groups II (13%) and IV (none) (p:0.002). LPS was significantly higher in systemic blood of Group I (9.761x13.804 EU/mL-p:0.01). No differences for endotoxin occurred in portal blood. Conclusion - e developed a model of rats colonized with resistant bacteria useful to study intestinal translocation. Translocation occurred in surgical procedures with and without hepatic ischemia-reperfusion and probably occurred via the bloodstream. Translocation was probably lymphatic in the ischemia-reperfusion groups. Systemic blood endotoxin levels were higher in the group with complete hepatic ischemia.	[van der Heijden, Karin M.; van der Heijden, Inneke M.; Costa, Silvia F.; Abdala, Edson; Levin, Anna S.] Univ Sao Paulo, Dept Infect Dis, Hosp Clin, Sao Paulo, Brazil; [Galvao, Flavio H.; Lopes, Camila G.; Abdala, Edson; D'Albuquerque, Luiz A.] Univ Sao Paulo, Div Transplantat, Dept Gastroenterol, Sao Paulo, Brazil; [Costa, Silvia F.; Levin, Anna S.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Levin, AS (corresponding author), Univ Sao Paulo, Dept Infect Dis, Hosp Clin, LIM 54, Sao Paulo, Brazil.	gcih.adm@hc.fm.usp.br	van der Heijden, Inneke Marie/O-2021-2019; D'Albuquerque, Luiz A Carneiro/I-4011-2012; Costa, Silvia F/K-4768-2012; Abdala, Edson/H-5165-2012; Levin, Anna S/C-8831-2012; Levin, Anna S./AAJ-1712-2021; Galvao, Flavio Henrique Ferreira/D-3487-2017; Figueiredo Costa, silvia/ABC-7704-2021	D'Albuquerque, Luiz A Carneiro/0000-0001-7607-7168; Costa, Silvia F/0000-0003-1087-752X; Abdala, Edson/0000-0003-0765-6654; Levin, Anna S/0000-0003-2427-8368; Levin, Anna S./0000-0003-2427-8368; Galvao, Flavio Henrique Ferreira/0000-0003-1924-3208; Figueiredo Costa, silvia/0000-0003-1087-752X; van der Heijden, Inneke Marie/0000-0002-1392-6000				Abdala E, 2007, LIVER TRANSPLANT, V13, P488, DOI 10.1002/lt.21085; Alencar SSS, 2001, ACTA CIR BRAS S1, V17, P35; Baumgart DC, 2002, CURR OPIN CLIN NUTR, V5, P685, DOI 10.1097/00075197-200211000-00012; Bellot P, 2013, LIVER INT, V33, P31, DOI 10.1111/liv.12021; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V303, pG775, DOI 10.1152/ajpgi.00155.2012; CLSI, 2012, M100S22 CLSI; Condette CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102217; de Rougemont O, 2009, LIVER TRANSPLANT, V15, P1172, DOI 10.1002/lt.21876; Deitch EA, 2012, SURG-J R COLL SURG E, V10, P350, DOI 10.1016/j.surge.2012.03.003; Goyal Ajesh, 2013, Trop Gastroenterol, V34, P136; Grootjans J, 2010, WORLD J GASTRO SURG, V2, P61, DOI 10.4240/wjgs.v2.i3.61; Guarner C, 2006, HEPATOLOGY, V44, P633, DOI 10.1002/hep.21286; Iris NE, 2013, AM J INFECT CONTROL, V41, P261, DOI 10.1016/j.ajic.2012.04.331; Karatzas T, 2014, J SURG RES; Kaufmann ME, 1998, METH MOLEC MED, V15, P33, DOI 10.1385/0-89603-498-4:33; Koh IHJ, 2002, TRANSPLANT P, V34, P1003, DOI 10.1016/S0041-1345(02)02757-4; Liong MT, 2008, NUTR REV, V66, P192, DOI 10.1111/j.1753-4887.2008.00024.x; MacFie J, 1999, GUT, V45, P223, DOI 10.1136/gut.45.2.223; McKinnell JA, 2012, INFECT CONT HOSP EP, V33, P718, DOI 10.1086/666331; Miyazaki S, 2001, J MED MICROBIOL, V50, P695, DOI 10.1099/0022-1317-50-8-695; Murray P.R., 2003, MANUAL CLIN MICROBIO, V8th; O'Boyle CJ, 1998, GUT, V42, P29, DOI 10.1136/gut.42.1.29; Oplustil CP, 2004, PROCEDIMENTOS BASICO, P544; Papadopoulos D, 2013, ARCH TRAUMA RES, V2, P63, DOI 10.5812/atr.12501; Ren ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075950; Ridley AM, 1998, METH MOLEC MED, V15, P103, DOI 10.1385/0-89603-498-4:103; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; TOLEDOPEREYRA LH, 1975, AM J SURG, V129, P513, DOI 10.1016/0002-9610(75)90308-6; Waynforth HB, 1992, EXPT SURG TECHNIQUES, P384; Whitman MS, 1996, ANTIMICROB AGENTS CH, V40, P1526, DOI 10.1128/AAC.40.6.1526; Zacharioudakis IM, 2014, AM J KIDNEY DIS; Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225	33	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108453	10.1371/journal.pone.0108453	http://dx.doi.org/10.1371/journal.pone.0108453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255079	gold, Green Submitted, Green Published			2022-12-27	WOS:000344862300084
J	Wang, XX; Han, X; Guo, XJ; Luo, XL; Wang, DL				Wang, Xingxing; Han, Xu; Guo, Xiaojing; Luo, Xiaolong; Wang, Dalin			The Effect of Periodontal Treatment on Hemoglobin A1c Levels of Diabetic Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							GLYCEMIC CONTROL; METABOLIC-CONTROL; A(1C) LEVELS; THERAPY; DISEASE; MELLITUS; IMPROVES; ADIPONECTIN; OUTCOMES; HEALTH	Background: There is growing evidence that periodontal treatment may affect glycemic control in diabetic patients. And several systematic reviews have been conducted to assess the effect of periodontal treatment on diabetes outcomes. Researches of this aspect are widely concerned, and several new controlled trials have been published. The aim of this study was to update the account for recent findings. Methods: A literature search (until the end of January 2014) was carried out using various databases with language restriction to English. A randomized controlled trial (RCT) was selected if it investigated periodontal therapy for diabetic subjects compared with a control group received no periodontal treatment for at least 3 months of the follow-up period. The primary outcome was hemoglobin A1c (HbA1c), and secondary outcomes were periodontal parameters included probing pocket depth (PPD) and clinical attachment level (CAL). Results: Ten trials of 1135 patients were included in the analysis. After the follow-up of 3 months, treatment substantially lowered HbA1c compared with no treatment after periodontal therapy (-0.36%, 95% CI, -0.52% to -0.19%, P<0.0001). Clinically substantial and statistically significant reduction of PPD and CAL were found between subjects with and without treatment after periodontal therapy (PPD -0.42 mm, 95% CI: -0.60 to -0.23, P<0.00001; CAL -0.34 mm, 95% CI: -0.52 to -0.16, P = 0.0002). And there is no significant change of the level of HbA1c at the 6-month comparing with no treatment (-0.30%, 95% CI, -0.69% to 0.09%, P = 0.13). Conclusions: Periodontal treatment leads to the modest reduction in HbA1c along with the improvement of periodontal status in diabetic patients for 3 months, and this result is consistent with previous systematic reviews. And the effect of periodontal treatment on HbA1c cannot be observed at 6-month after treatment.	[Wang, Xingxing; Han, Xu; Luo, Xiaolong; Wang, Dalin] Second Mil Med Univ, Changhai Hosp, Dept Stomatol, Shanghai, Peoples R China; [Guo, Xiaojing] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Wang, DL (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Stomatol, Shanghai, Peoples R China.	Wang_Dento@163.com						Al-Khabbaz AK, 2014, ORAL HLTH PREV DENT, V12, P77, DOI 10.3290/j.ohpd.a31223; Bharti P, 2013, OBES RES CLIN PRACT, V7, pE129, DOI 10.1016/j.orcp.2011.11.005; Borenstein M, 2009, INTRO METAANALYSIS, P217; Botero JE, 2013, J PERIODONTAL RES, V48, P706, DOI 10.1111/jre.12058; Chen HH, 2013, JCR-J CLIN RHEUMATOL, V19, P432, DOI 10.1097/RHU.0000000000000041; Chen L, 2012, J PERIODONTOL, V83, P435, DOI 10.1902/jop.2011.110327; Choi YH, 2014, J PERIODONTOL; Engebretson S, 2013, J PERIODONTOL, V84, pS153, DOI [10.1902/jop.2013.1340017, 10.1111/jcpe.12084]; Engebretson SP, 2013, JAMA-J AM MED ASSOC, V310, P2523, DOI 10.1001/jama.2013.282431; Gaikwad SP, 2013, J PERIODONTAL IMPLAN, V43, P79, DOI 10.5051/jpis.2013.43.2.79; Goldfine AB, 2011, CLIN CHEM, V57, P162, DOI 10.1373/clinchem.2010.148833; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Higgins JPT, 1996, CONTROL CLIN TRIALS; Holtfreter B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084603; Huang LY, 2014, J CLIN PHARM; Hung HC, 2003, J AM DENT ASSOC, V134, P1185, DOI 10.14219/jada.archive.2003.0353; Iwamoto Y, 2001, J PERIODONTOL, V72, P774, DOI 10.1902/jop.2001.72.6.774; Jones A, 2014, PRIM CARE DIABETES; Jones JA, 2007, J CLIN PERIODONTOL, V34, P46, DOI 10.1111/j.1600-051X.2006.01002.x; Katagiri S, 2009, DIABETES RES CLIN PR, V83, P308, DOI 10.1016/j.diabres.2008.10.016; Kiran M, 2005, J CLIN PERIODONTOL, V32, P266, DOI 10.1111/j.1600-051X.2005.00658.x; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; Koromantzos PA, 2011, J CLIN PERIODONTOL, V38, P142, DOI 10.1111/j.1600-051X.2010.01652.x; Liew AKC, 2013, AUST DENT J, V58, P350, DOI 10.1111/adj.12091; LOE H, 1993, DIABETES CARE, V16, P329, DOI 10.2337/diacare.16.1.329; Lopez NJ, 2013, J PERIODONTOL; Mealey BL, 2006, J PERIODONTOL, V77, P1289, DOI 10.1902/jop.2006.050459; Meenawat Ajita, 2013, J Indian Soc Periodontol, V17, P597, DOI 10.4103/0972-124X.119286; Merchant AT, 2014, JAMA-J AM MED ASSOC, V311, P1919, DOI 10.1001/jama.2014.2228; Mirnic J, 2013, SRP ARK CELOK LEK, V141, P738, DOI 10.2298/SARH1312738M; Moeintaghavi A, 2012, AUST DENT J, V57, P31, DOI 10.1111/j.1834-7819.2011.01652.x; Moodley A, 2013, SADJ, V68, P262; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; NELSON RG, 1990, DIABETES CARE, V13, P836, DOI 10.2337/diacare.13.8.836; Persson GR, 2006, INT DENT J, V56, P240; Pucher Jeffery, 2004, Curr Diab Rep, V4, P46, DOI 10.1007/s11892-004-0011-y; Santacroce Luigi, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P57; Shangase SL, 2013, S AFRICAN DENT J, V68, P10; Singh S, 2008, INT J DIABETES DEV C, V28, P38, DOI 10.4103/0973-3930.43097; Soskolne W A, 2001, Ann Periodontol, V6, P91, DOI 10.1902/annals.2001.6.1.91; Stanko P, 2014, BIOMED PAP MED FAC U; Sun WL, 2011, INTERNAL MED, V50, P1569, DOI 10.2169/internalmedicine.50.5166; Taylor GW, 2008, ORAL DIS, V14, P191, DOI 10.1111/j.1601-0825.2008.01442.x; Teeuw WJ, 2014, J CLIN PERIODONTOL, V41, P70, DOI 10.1111/jcpe.12171; Teeuw WJ, 2010, DIABETES CARE, V33, P421, DOI 10.2337/dc09-1378; Telgi RL, 2013, J PERIODONTAL IMPLAN, V43, P177, DOI 10.5051/jpis.2013.43.4.177; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Tsai C, 2002, COMMUNITY DENT ORAL, V30, P182, DOI 10.1034/j.1600-0528.2002.300304.x; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vergnes JN, 2014, JAMA-J AM MED ASSOC, V311, P1920, DOI 10.1001/jama.2014.2225; Wen BW, 2013, QJM; Yun Fu, 2007, Folia Med (Plovdiv), V49, P32; Zhang YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042551	53	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108412	10.1371/journal.pone.0108412	http://dx.doi.org/10.1371/journal.pone.0108412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255331	gold, Green Published, Green Submitted			2022-12-27	WOS:000344862300078
J	Mahalingam, J; Lin, CY; Chiang, JM; Su, PJ; Chu, YY; Lai, HY; Fang, JH; Huang, CT; Lin, YC				Mahalingam, Jayashri; Lin, Chun-Yen; Chiang, Jy-Ming; Su, Po-Jung; Chu, Yu-Yi; Lai, Hsin-Yi; Fang, Jian-He; Huang, Ching-Tai; Lin, Yung-Chang			CD4(+) T Cells Expressing Latency-Associated Peptide and Foxp3 Are an Activated Subgroup of Regulatory T Cells Enriched in Patients with Colorectal Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; BETA-DEPENDENT MANNER; VERSUS-HOST-DISEASE; TGF-BETA; EFFECTOR/MEMORY; TOLERANCE; ENCEPHALOMYELITIS; IMMUNOTHERAPY; PROGRESSION; INDUCTION	Latency-associated peptide (LAP) - expressing regulatory T cells (Tregs) are important for immunological self-tolerance and immune homeostasis. In order to investigate the role of LAP in human CD4(+)Foxp3(+) Tregs, we designed a cross-sectional study that involved 42 colorectal cancer (CRC) patients. The phenotypes, cytokine-release patterns, and suppressive ability of Tregs isolated from peripheral blood and tumor tissues were analyzed. We found that the population of LAP-positive CD4+Foxp3+ Tregs significantly increased in peripheral blood and cancer tissues of CRC patients as compared to that in the peripheral blood and tissues of healthy subjects. Both LAP(+) and LAP(-) Tregs had a similar effector/memory phenotype. However, LAP+ Tregs expressed more effector molecules, including tumor necrosis factor receptor II, granzyme B, perforin, Ki67, and CCR5, than their LAP 2 negative counterparts. The in vitro immunosuppressive activity of LAP+ Tregs, exerted via a transforming growth factor-beta-mediated mechanism, was more potent than that of LAP(-) Tregs. Furthermore, the enrichment of LAP(+) Treg population in peripheral blood mononuclear cells (PBMCs) of CRC patients correlated with cancer metastases. In conclusion, we found that LAP(+) Foxp3(+) CD4(+) Treg cells represented an activated subgroup of Tregs having more potent regulatory activity in CRC patients. The increased frequency of LAP(+) Tregs in PBMCs of CRC patients suggests their potential role in controlling immune response to cancer and presents LAP as a marker of tumor-specific Tregs in CRC patients.	[Mahalingam, Jayashri; Lin, Chun-Yen; Chiang, Jy-Ming; Lai, Hsin-Yi; Huang, Ching-Tai; Lin, Yung-Chang] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Mahalingam, Jayashri; Lin, Chun-Yen; Fang, Jian-He] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Gastroenterol Hepatol, Taoyuan, Taiwan; [Chiang, Jy-Ming] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Surg, Colorectal Surg Sect, Taoyuan, Taiwan; [Su, Po-Jung; Chu, Yu-Yi; Lin, Yung-Chang] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Hematol Oncol, Taoyuan, Taiwan; [Huang, Ching-Tai] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Infect Dis, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Lin, YC (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	yclinof@adm.cgmh.org		Lin, Chun-Yen/0000-0003-3007-3190	National Science Council, Taiwan (NSC) [NSC 99-3112-B-182-011, 97-2314-B-182A-027]; CMRPG from Chang Gung Memorial Hospital [380362, 380743, 392087]	National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan); CMRPG from Chang Gung Memorial Hospital	This work was supported by the National Science Council, Taiwan (NSC Grant NSC 99-3112-B-182-011, 97-2314-B-182A-027) and CMRPG 380362, 380743, 392087 from Chang Gung Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Chang LY, 2012, J IMMUNOL, V189, P567, DOI 10.4049/jimmunol.1200266; Chen ML, 2008, J IMMUNOL, V180, P7327, DOI 10.4049/jimmunol.180.11.7327; Chen X, 2010, CURR DIR AUTOIMMUN, V11, P119, DOI 10.1159/000289201; Chen ZM, 2003, BLOOD, V101, P5076, DOI 10.1182/blood-2002-09-2798; Duan W, 2011, J IMMUNOL, V187, P6499, DOI 10.4049/jimmunol.1101398; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gandhi R, 2010, J IMMUNOL, V184, P4620, DOI 10.4049/jimmunol.0903329; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Lin YC, 2013, INT J CANCER, V132, P1341, DOI 10.1002/ijc.27784; Lin YC, 2009, J IMMUNOL, V182, P6095, DOI 10.4049/jimmunol.0803829; Mahalingam J, 2012, CLIN CANCER RES, V18, P5224, DOI 10.1158/1078-0432.CCR-12-0211; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; MIYAZONO K, 1993, GROWTH FACTORS, V8, P11, DOI 10.3109/08977199309029130; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Oida T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015523; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shevach EM, 2008, EUR J IMMUNOL, V38, P915, DOI 10.1002/eji.200738111; Shevach EM, 2008, J CLIN IMMUNOL, V28, P640, DOI 10.1007/s10875-008-9240-1; Sun JJ, 2012, CANCER DISCOV, V2, P122, DOI 10.1158/2159-8290.CD-11-0236; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; Tran DQ, 2009, BLOOD, V113, P5125, DOI 10.1182/blood-2009-01-199950; Wang GH, 2010, IMMUNOL LETT, V132, P61, DOI 10.1016/j.imlet.2010.06.001; Wei HX, 2008, J IMMUNOL, V181, P7221, DOI 10.4049/jimmunol.181.10.7221; Wysocki CA, 2005, BLOOD, V106, P3300, DOI 10.1182/blood-2005-04-1632; Xu L, 2010, CLIN IMMUNOL, V135, P466, DOI 10.1016/j.clim.2010.01.014; Zhang XM, 2006, INT IMMUNOL, V18, P495, DOI 10.1093/intimm/dxh390; Zhao DC, 2008, BLOOD, V112, P2129, DOI 10.1182/blood-2008-02-140277; Zhou G, 2007, J IMMUNOL, V178, P2155, DOI 10.4049/jimmunol.178.4.2155	34	29	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108554	10.1371/journal.pone.0108554	http://dx.doi.org/10.1371/journal.pone.0108554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268580	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700112
J	Rout, SP; Radford, J; Laws, AP; Sweeney, F; Elmekawy, A; Gillie, LJ; Humphreys, PN				Rout, Simon P.; Radford, Jessica; Laws, Andrew P.; Sweeney, Francis; Elmekawy, Ahmed; Gillie, Lisa J.; Humphreys, Paul N.			Biodegradation of the Alkaline Cellulose Degradation Products Generated during Radioactive Waste Disposal	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; GLUCOISOSACCHARINIC ACID; MICROBIAL-DEGRADATION; ISOSACCHARINIC ACID; REDUCTION; IRON; COMPLEXATION; PCR	The anoxic, alkaline hydrolysis of cellulosic materials generates a range of cellulose degradation products (CDP) including alpha and beta forms of isosaccharinic acid (ISA) and is expected to occur in radioactive waste disposal sites receiving intermediate level radioactive wastes. The generation of ISA's is of particular relevance to the disposal of these wastes since they are able to form complexes with radioelements such as Pu enhancing their migration. This study demonstrates that microbial communities present in near-surface anoxic sediments are able to degrade CDP including both forms of ISA via iron reduction, sulphate reduction and methanogenesis, without any prior exposure to these substrates. No significant difference (n = 6, p = 0.118) in alpha and beta ISA degradation rates were seen under either iron reducing, sulphate reducing or methanogenic conditions, giving an overall mean degradation rate of 4.7x10(-2) hr (-1) (SE +/- 2.9x10(-3)). These results suggest that a radioactive waste disposal site is likely to be colonised by organisms able to degrade CDP and associated ISA's during the construction and operational phase of the facility.	[Rout, Simon P.; Radford, Jessica; Laws, Andrew P.; Sweeney, Francis; Elmekawy, Ahmed; Gillie, Lisa J.; Humphreys, Paul N.] Univ Huddersfield, Sch Appl Sci, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England	University of Huddersfield	Humphreys, PN (corresponding author), Univ Huddersfield, Sch Appl Sci, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England.	p.n.humphreys@hud.ac.uk	Elmekawy, Ahmed A./I-8303-2014	Elmekawy, Ahmed A./0000-0001-5560-2701; Rout, Simon/0000-0001-5778-6145; Gillie, Lisa/0000-0003-4423-7387; Laws, Andrew/0000-0002-1278-6894; Humphreys, Paul/0000-0003-3431-7930	University of Huddersfield	University of Huddersfield	The research was funded by the University of Huddersfield. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard S, 2006, J SOLUTION CHEM, V35, P1173, DOI 10.1007/s10953-006-9048-7; Askarieh MM, 2000, WASTE MANAGE, V20, P93, DOI 10.1016/S0956-053X(99)00275-5; B.S.I, 2005, 14853 BS ISO BSI; BAILEY MJ, 1986, APPL MICROBIOL BIOT, V24, P493; Chaudhuri SK, 2001, APPL ENVIRON MICROB, V67, P2844, DOI 10.1128/AEM.67.6.2844-2848.2001; Cowper M, 2011, SECRO TECHNOLOGY REP; Daly K, 2000, MICROBIOL-UK, V146, P1693, DOI 10.1099/00221287-146-7-1693; Grant W. D., 2002, AEATERRA0301; Greenfield B, 1997, NSSR375 AEA TECHN; Humphreys P, 2010, SERCO TECHNICAL REPO; Humphreys P, 2010, QUINTESSA CONTRACTOR; Knill CJ, 2003, CARBOHYD POLYM, V51, P281, DOI 10.1016/S0144-8617(02)00183-2; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P1536, DOI 10.1128/AEM.53.7.1536-1540.1987; LOVLEY DR, 1991, MICROBIOL REV, V55, P259, DOI 10.1128/MMBR.55.2.259-287.1991; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; LOVLEY DR, 1993, MAR GEOL, V113, P41, DOI 10.1016/0025-3227(93)90148-O; McDonald JE, 2008, ENVIRON MICROBIOL, V10, P1310, DOI 10.1111/j.1462-2920.2007.01544.x; NDA, 2011, NDASTSTY110004; NDA, 2010, NDARWMD033; Nirex, 1997, S97089 NIR SELL GEOL; Rittmann B. E., 2001, ENV BIOTECHNOLOGY; Shaw PB, 2012, CARBOHYD RES, V349, P6, DOI 10.1016/j.carres.2011.11.022; STRAND SE, 1984, APPL ENVIRON MICROB, V47, P268, DOI 10.1128/AEM.47.2.268-271.1984; WANG SH, 1993, HOLZFORSCHUNG, V47, P141, DOI 10.1515/hfsg.1993.47.2.141; Warwick P, 2003, RADIOCHIM ACTA, V91, P233, DOI 10.1524/ract.91.4.233.19971	25	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107433	10.1371/journal.pone.0107433	http://dx.doi.org/10.1371/journal.pone.0107433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268118	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700038
J	Zhu, K; Jiang, BC; Hu, R; Yang, Y; Miao, M; Li, YC; Liu, ZG				Zhu, Ke; Jiang, Benchun; Hu, Rong; Yang, Ying; Miao, Miao; Li, Yingchun; Liu, Zhuogang			The CXCL12 G801A Polymorphism Is Associated with Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LYMPH-NODE METASTASIS; BREAST-CANCER; FACTOR-I; SUSCEPTIBILITY LOCI; CHEMOKINE RECEPTORS; GENE POLYMORPHISMS; COLORECTAL-CANCER; CELL CARCINOMA; RS1801157 POLYMORPHISM	Background: CXCL12 is a small chemotactic cytokine belonging to the CXC chemokine family expressed in various organs. It contributes to the migration, invasion and angiogenesis of cancer cells. Recently, the CXCL12 G801A polymorphism was shown to be associated with an increased risk of various kinds of cancers, but the results were too inconsistent to be conclusive. Methods: To solve the problem of inadequate statistical power and conflicting results, a meta-analysis of published case-control studies was performed, including 4,435 cancer cases and 6,898 controls. Odds ratios (ORs) and their 95% confidence intervals (CIs) were used to determine the strength of association between CXCL12 G801A polymorphism and cancer risk. Results: A significant association between CXCL12 G801A polymorphism and cancer risk was found under all genetic models. Further, subgroup analysis stratified by ethnicity suggested a significant association between CXCL12 G801A polymorphism and cancer risk in the Asian subgroup under all genetic models. However, in the Caucasian subgroup, a significant association was only found under an additive genetic model and a dominant genetic model. The analysis stratified by cancer type found that CXCL12 G801A polymorphism may increase the risk of breast cancer, lung cancer, and "other" cancers. Based on subgroup stratified by source of controls, a significant association was observed in hospital-based studies under all genetic models. Conclusions: The CXCL12 G801A polymorphism is associated with an increased risk of cancer based on current published data. In the future, large-scale well-designed studies with more information are needed to better estimate possible gene-gene or gene-environment interactions.	[Zhu, Ke; Hu, Rong; Yang, Ying; Miao, Miao; Li, Yingchun; Liu, Zhuogang] China Med Univ, Affiliated Shengjing Hosp, Dept Hematol, Shenyang, Peoples R China; [Jiang, Benchun] China Med Univ, Affiliated Shengjing Hosp, Dept Gen Surg, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Liu, ZG (corresponding author), China Med Univ, Affiliated Shengjing Hosp, Dept Hematol, Shenyang, Peoples R China.	liuzg@sj-hospital.org						Barbieri F, 2006, ANN NY ACAD SCI, V1090, P332, DOI 10.1196/annals.1378.037; Beheshti A, 2013, RADIAT RES, V179, P208, DOI 10.1667/RR3100.1; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Cacina C, 2012, MOL BIOL REP, V39, P1225, DOI 10.1007/s11033-011-0852-9; Cai C, 2013, TISSUE ANTIGENS, V82, P165, DOI 10.1111/tan.12170; Chen YC, 2003, CANCER RES, V63, P4801; de Oliveira CEC, 2007, J CLIN LAB ANAL, V21, P49, DOI 10.1002/jcla.20142; de Oliveira KB, 2013, CLIN EXP MED, V13, P211, DOI 10.1007/s10238-012-0194-5; de Oliveira KB, 2011, CYTOKINE, V55, P260, DOI 10.1016/j.cyto.2011.04.017; de Oliveira KB, 2009, J CLIN LAB ANAL, V23, P387, DOI 10.1002/jcla.20346; Dimberg J, 2007, INT J MOL MED, V19, P11; Gong H, 2012, GENE, V509, P228, DOI 10.1016/j.gene.2012.08.018; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Hidalgo-Pascual M, 2007, ONCOL REP, V18, P1583; Hirata H, 2007, CLIN CANCER RES, V13, P5056, DOI 10.1158/1078-0432.CCR-07-0859; Jin FY, 2012, MOL CANCER RES, V10, P1021, DOI 10.1158/1541-7786.MCR-11-0498; Kato M, 2003, BREAST CANCER RES, V5, pR144, DOI 10.1186/bcr627; Kerdivel G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060567; Khademi B, 2008, PATHOL ONCOL RES, V14, P45, DOI 10.1007/s12253-008-9007-2; Kontogianni P, 2013, MOL BIOL REP, V40, P43, DOI 10.1007/s11033-012-1989-x; Kruszyna A, 2010, PATHOL ONCOL RES, V16, P223, DOI 10.1007/s12253-009-9214-5; Kruszyna L, 2010, DNA CELL BIOL, V29, P423, DOI 10.1089/dna.2010.1030; Kucukgergin C, 2012, GENE, V511, P7, DOI 10.1016/j.gene.2012.09.011; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Lane WJ, 2000, BLOOD, V96, P4152; Lee D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065396; Lee YL, 2011, LUNG CANCER, V73, P147, DOI 10.1016/j.lungcan.2010.12.011; Li N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098251; Liarmakopoulos E, 2013, MOL MED REP, V7, P887, DOI 10.3892/mmr.2012.1247; Lin GT, 2009, OMICS, V13, P165, DOI 10.1089/omi.2008.0050; LOCATI M, 1999, ANNU REV MED, V50, P425; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Ma XY, 2012, CELL MOL BIOL, V58, P1702, DOI 10.1170/198; Mori T, 2004, MOL CANCER THER, V3, P29; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Perim AD, 2013, MOL BIOL REP, V40, P4591, DOI 10.1007/s11033-013-2551-1; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Razmkhah M, 2005, LUNG CANCER, V49, P311, DOI 10.1016/j.lungcan.2005.04.014; Razmkhah M, 2005, CANCER LETT, V225, P261, DOI 10.1016/j.canlet.2004.10.039; Razmkhah M, 2013, INDIAN J GASTROENTER, V32, P28, DOI 10.1007/s12664-012-0283-0; Schimanski CC, 2005, CLIN CANCER RES, V11, P1743, DOI 10.1158/1078-0432.CCR-04-1195; Sei S, 2001, AIDS, V15, P1343, DOI 10.1097/00002030-200107270-00003; Shi MD, 2013, ARCH MED SCI, V9, P999, DOI 10.5114/aoms.2013.39211; Shiraishi K, 2012, NAT GENET, V44, P900, DOI 10.1038/ng.2353; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Singh V, 2014, TUMOR BIOL, V35, P4765, DOI 10.1007/s13277-014-1624-7; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tee YT, 2012, INT J GYNECOL CANCER, V22, P1297, DOI 10.1097/IGC.0b013e318265d334; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; Vairaktaris E, 2008, ANTICANCER RES, V28, P271; Vazquez-Lavista LG, 2009, UROLOGY, V74, P414, DOI 10.1016/j.urology.2009.04.016; Veron A, 2014, BIOMARK MED, V8, P287, DOI 10.2217/bmm.13.121; Watanabe MAE, 2003, MICROB PATHOGENESIS, V35, P31, DOI 10.1016/S0882-4010(03)00088-3; Zafiropoulos A, 2004, J MED GENET, V41, DOI 10.1136/JMG.2003.013649; Zhang YF, 2014, CANCER EPIDEM BIOMAR, V23, P622, DOI 10.1158/1055-9965.EPI-13-1043	57	13	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108953	10.1371/journal.pone.0108953	http://dx.doi.org/10.1371/journal.pone.0108953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268356	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700200
J	Anka, MS; Hassan, L; Khairani-Bejo, S; Zainal, MA; bin Mohamad, R; Salleh, A; Adzhar, A				Anka, Mukhtar Salihu; Hassan, Latiffah; Khairani-Bejo, Siti; Zainal, Mohamed Abidin; bin Mohamad, Ramlan; Salleh, Annas; Adzhar, Azri			A Case-Control Study of Risk Factors for Bovine Brucellosis Seropositivity in Peninsular Malaysia	PLOS ONE			English	Article							BOAR SUS-SCROFA; CROPS-RUMINANTS SYSTEMS; SEROLOGICAL SURVEY; CATTLE; INFECTION; SEROPREVALENCE; LIVESTOCK; WILDLIFE; EPIDEMIOLOGY; DIAGNOSIS	Bovine brucellosis was first reported in Peninsular Malaysia in 1950. A subsequent survey conducted in the country revealed that the disease was widespread. Current knowledge on the potential risk factors for brucellosis occurrence on cattle farms in Malaysia is lacking. Therefore, we conducted a case-control study to identify the potential herd-level risk factors for bovine brucellosis occurrence in four states in the country, namely Kelantan, Pahang, Selangor and Negeri Sembilan. Thirty-five cases and 36 controls of herds were selected where data on farm management, biosecurity, medical history and public health were collected. Multivariable logistic regression identified that Brucella seropositive herds were more likely to; have some interaction with wildlife (OR 8.9, 95% CI = 1.59-50.05); originated from farms where multiple species such as buffalo/others (OR 41.8, 95% CI = 3.94-443.19) and goat/sheep (OR 8.9, 95% Cl = 1.10-71.83) were reared, practice extensive production system (OR 13.6, 95% CI 1.31-140.24) and have had episodes of abortion in the past (OR 51.8, 95% CI = 4.54-590.90) when compared to seronegative herds. Considering the lack of information on the epidemiology of bovine brucellosis in peninsular Malaysia and absence of information on preventing the inception or spread of the disease, this report could contribute to the on-going area-wise national brucellosis eradication program.	[Anka, Mukhtar Salihu; Hassan, Latiffah; Khairani-Bejo, Siti; Salleh, Annas] Univ Putra Malaysia, Fac Vet Med, Dept Vet Pathol & Microbiol, Serdang 43400, Selangor, Malaysia; [Zainal, Mohamed Abidin] Univ Putra Malaysia, Fac Agr, Dept Agribusiness & Informat Syst, Serdang 43400, Selangor, Malaysia; [bin Mohamad, Ramlan] Vet Res Inst, Ipoh, Malaysia; [Adzhar, Azri] Dept Vet Serv, Epidemiol & Surveillance Unit, Putrajaya, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Institute Penyelidikan Haiwan	Hassan, L (corresponding author), Univ Putra Malaysia, Fac Vet Med, Dept Vet Pathol & Microbiol, Serdang 43400, Selangor, Malaysia.	latiffah@upm.edu.my	hassan, latiffah/H-4795-2019	hassan, latiffah/0000-0003-0731-9906; Salleh, Annas/0000-0003-4142-0418	Universiti Putra Malaysia [01-03-10-0956RU]	Universiti Putra Malaysia	This project was funded by the Universiti Putra Malaysia Grant no 01-03-10-0956RU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdussalam M, 1984, DEV BIOL STAND, V56, P9; Abernethy DA, 2011, PREV VET MED, V98, P223, DOI 10.1016/j.prevetmed.2010.11.002; Agricinfo, 2011, FRAM SYST SUST AGR B; Al-Majali AM, 2009, J VET SCI, V10, P61, DOI 10.4142/jvs.2009.10.1.61; Alexander KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032842; Anka MS, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-230; Apan TZ, 2007, TURK J VET ANIM SCI, V31, P75; Bahaman A.R., 2007, J VET MALAYS, V19, P1; Borriello G, 2006, INFECT IMMUN, V74, P2115, DOI 10.1128/IAI.74.4.2115-2120.2006; CFSPH, 2009, BOV BRUC; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; Crawford R. P., 1990, Animal brucellosis., P131; De BK, 2008, J CLIN MICROBIOL, V46, P43, DOI 10.1128/JCM.01494-07; Devendra C, 2004, OUTLOOK AGR, V33, P157, DOI 10.5367/0000000042530231; Devendra C, 2011, ASIAN AUSTRAL J ANIM, V24, P587, DOI 10.5713/ajas.2011.r.07; Dhand NK, 2005, REV SCI TECH OIE, V24, P879, DOI 10.20506/rst.24.3.1614; Donald SD, 1990, ANIMAL BRUCELLOSIS, P321; DVS, 2012, MAL SELF SUFF LIV PR; DVS, 2007, LAP TAH JAB PERK HA; FAO, 2005, CAP BUILD SURV CONTR; Godfroid J, 2002, REV SCI TECH OIE, V21, P277, DOI 10.20506/rst.21.2.1333; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; Godfroid J, 2012, COMP IMMUNOL MICROB; Godfroid J, 2010, CROAT MED J, V51, P296, DOI 10.3325/cmj.2010.51.296; Gregoire F, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-80; Havas KA, 2013, BRUCELLOSIS DIS CONT; Heng N, 1986, ERADICATION BRUCELLO, P255; Hubalek Z, 2002, VET MED-CZECH, V47, P60, DOI 10.17221/5805-VETMED; Ismail D, 1993, MANAGEMENT AGR FORES; Johari J.A., 2009, P 8 MAL C GEN 4 6 AU, P22; John K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009968; Joseph P, 1980, TROPICAL AGR RES SER, V13; Kang SI, 2009, J MICROBIOL METH, V78, P144, DOI 10.1016/j.mimet.2009.05.009; Kaoud HA, 2010, NATURE SCI, V8, P190; Lee BY, 2009, PREV VET MED, V90, P66, DOI 10.1016/j.prevetmed.2009.03.003; Lopes L. B., 2010, Open Veterinary Science Journal, V4, P72, DOI 10.2174/1874318801004010072; Mai HM, 2013, PREV VET MED, V111, P256, DOI 10.1016/j.prevetmed.2013.05.016; Makita K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-60; McDermott JJ, 2002, VET MICROBIOL, V90, P111, DOI 10.1016/S0378-1135(02)00249-3; Megersa B, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-24; Megersa B, 2011, TROP ANIM HEALTH PRO, V43, P651, DOI 10.1007/s11250-010-9748-2; Mekonnen H, 2010, PREV VET MED, V94, P28, DOI 10.1016/j.prevetmed.2009.12.001; Memish ZA, 2004, J TRAVEL MED, V11, P49, DOI 10.2310/7060.2004.13551; Meng XJ, 2009, PHILOS T R SOC B, V364, P2697, DOI 10.1098/rstb.2009.0086; MOA, 2011, MIN AGR AGR IND MAL, P3; Muma JB, 2007, REV SCI TECH OIE, V26, P721, DOI 10.20506/rst.26.3.1782; Nielsen K, 2005, REV SCI TECH OIE, V24, P1027, DOI 10.20506/rst.24.3.1628; Omer MK, 2000, PREV VET MED, V46, P257, DOI 10.1016/S0167-5877(00)00152-5; PRIOR MG, 1976, CAN J COMP MED, V40, P117; ROTA A, 2010, INTEGRATED CROP LIVE; Sanogo M, 2012, PREV VET MED, V107, P51, DOI 10.1016/j.prevetmed.2012.05.010; Sohayati R, 2012, INT C ON HLTH 24 VAM, P139; UZAL FA, 1995, J VET DIAGN INVEST, V7, P473, DOI 10.1177/104063879500700408; Watarai M, 2006, J VET MED SCI, V68, P1139, DOI 10.1292/jvms.68.1139; Zainor M, 2008, 20 C VET ASS MAL 15, P69	55	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108673	10.1371/journal.pone.0108673	http://dx.doi.org/10.1371/journal.pone.0108673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265020	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000345745400100
J	Montarolo, F; Raffaele, C; Perga, S; Martire, S; Finardi, A; Furlan, R; Hintermann, S; Bertolotto, A				Montarolo, Francesca; Raffaele, Chiara; Perga, Simona; Martire, Serena; Finardi, Annamaria; Furlan, Roberto; Hintermann, Samuel; Bertolotto, Antonio			Effects of Isoxazolo-Pyridinone 7e, a Potent Activator of the Nurr1 Signaling Pathway, on Experimental Autoimmune Encephalomyelitis in Mice	PLOS ONE			English	Article							NUCLEAR RECEPTOR NURR1; EXPRESSION; CELLS; GENES; INDUCTION; NEURONS; NR4A2; TH17	Multiple sclerosis (MS) is an autoimmune chronic disease of the central nervous system (CNS) characterized by immune-mediated inflammation, demyelination and subsequent axonal damage. Gene expression profiling showed that Nurr1, an orphan nuclear receptor, is down-regulated in peripheral blood mononuclear cells of MS patients. Nurr1 exerts an anti-inflammatory role repressing the activity of the pro-inflammatory transcription factor NF-kB. Here, we report that the preventive treatment with isoxazolo-pyridinone 7e, an activator of Nurr1 signaling pathway, reduces the incidence and the severity of a MS murine model, i.e. experimental autoimmune encephalomyelitis (EAE). The compound is able to attenuate inflammation and neurodegeneration in spinal cords of EAE mice by an NF-kB pathway-dependent process.	[Montarolo, Francesca; Perga, Simona; Martire, Serena; Bertolotto, Antonio] Univ Turin, NICO, Neurobiol Unit, Neurol CRESM Reg Referring Ctr Multiple Sclerosis, Turin, Italy; [Montarolo, Francesca; Perga, Simona; Martire, Serena; Bertolotto, Antonio] AOU San Luigi, Turin, Italy; [Raffaele, Chiara; Finardi, Annamaria; Furlan, Roberto] Ist Sci San Raffaele, Div Neurosci, Expt Neurol Inst INSPE, I-20132 Milan, Italy; [Hintermann, Samuel] Novartis Inst BioMed Res, Basel, Switzerland	University of Turin; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Novartis	Montarolo, F (corresponding author), Univ Turin, NICO, Neurobiol Unit, Neurol CRESM Reg Referring Ctr Multiple Sclerosis, Turin, Italy.	francesca.montarolo@unito.it	Bertolotto, Antonio/K-8346-2015; Furlan, Roberto/N-5224-2019; Furlan, Roberto/J-9177-2016; Montarolo, F/K-3331-2018; Martire, Serena/AAB-8714-2022	Bertolotto, Antonio/0000-0002-7052-1907; Furlan, Roberto/0000-0001-7376-9425; Furlan, Roberto/0000-0001-7376-9425; Montarolo, F/0000-0002-3633-8746; Martire, Serena/0000-0001-6889-888X	Novartis S.p.a.	Novartis S.p.a.	The funder Novartis S.p.a. provided support in the form of salaries for authors S.H. who was involved in the study design and the preparation of the manuscript, but did not have any role in the data collection and analysis, and decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Achiron A, 2010, NEUROBIOL DIS, V38, P201, DOI 10.1016/j.nbd.2009.12.029; Aherne CM, 2009, MOL IMMUNOL, V46, P3345, DOI 10.1016/j.molimm.2009.07.019; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Castillo SO, 1998, MOL CELL NEUROSCI, V11, P36, DOI 10.1006/mcne.1998.0673; Chu YP, 2002, J COMP NEUROL, V450, P203, DOI 10.1002/cne.10261; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Frohman EM, 2007, ARCH NEUROL-CHICAGO, V64, P452, DOI 10.1001/archneur.64.3.452; Gilli F, 2011, ARCH NEUROL-CHICAGO, V68, P879, DOI 10.1001/archneurol.2011.32; Gilli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008962; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hintermann S, 2007, BIOORG MED CHEM LETT, V17, P193, DOI 10.1016/j.bmcl.2006.09.062; Inamoto T, 2008, MOL CANCER THER, V7, P3825, DOI 10.1158/1535-7163.MCT-08-0730; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Le WD, 2008, J NEUROL SCI, V273, P29, DOI 10.1016/j.jns.2008.06.007; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; McGeachy MJ, 2007, SEMIN IMMUNOL, V19, P372, DOI 10.1016/j.smim.2007.10.012; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Navone ND, 2014, J NEUROIMMUNOL, V272, P99, DOI 10.1016/j.jneuroim.2014.04.017; O'Kane M, 2008, J INVEST DERMATOL, V128, P300, DOI 10.1038/sj.jid.5701023; Ordentlich P, 2003, J BIOL CHEM, V278, P24791, DOI 10.1074/jbc.M302167200; Raveney BJE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056595; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Satoh J, 2005, NEUROBIOL DIS, V18, P537, DOI 10.1016/j.nbd.2004.10.007; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Shin T, 2012, ANAT CELL BIOL, V45, P141, DOI 10.5115/acb.2012.45.3.141; Wallen A, 1999, EXP CELL RES, V253, P737, DOI 10.1006/excr.1999.4691; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	31	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108791	10.1371/journal.pone.0108791	http://dx.doi.org/10.1371/journal.pone.0108791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265488	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400122
J	Rybanska-Spaeder, I; Ghosh, R; Franco, S				Rybanska-Spaeder, Ivana; Ghosh, Rajib; Franco, Sonia			53BP1 Mediates the Fusion of Mammalian Telomeres Rendered Dysfunctional by DNA-PKcs Loss or Inhibition	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; CLASS-SWITCH RECOMBINATION; PROTEIN-KINASE INHIBITOR; END-JOINING PATHWAYS; DAMAGE-RESPONSE; V(D)J RECOMBINATION; CATALYTIC SUBUNIT; HISTONE H2AX; REPAIR; CANCER	Telomere dysfunction promotes genomic instability and carcinogenesis via inappropriate end-to-end chromosomal rearrangements, or telomere fusions. Previous work indicates that the DNA Damage Response (DDR) factor 53BP1 promotes the fusion of telomeres rendered dysfunctional by loss of TRF2, but is dispensable for the fusion of telomeres lacking Pot1 or critically shortened (in telomerase-deficient mice). Here, we examine a role for 53BP1 at telomeres rendered dysfunctional by loss or catalytic inhibition of DNA-PKcs. Using mouse embryonic fibroblasts lacking 53BP1 and/or DNA-PKcs, we show that 53BP1 deficiency suppresses G1-generated telomere fusions that normally accumulate in DNA-PKcs-deficient fibroblasts with passage. Likewise, we find that 53BP1 promotes telomere fusions during the replicative phases of the cell cycle in cells treated with the specific DNA-PKcs inhibitor NU7026. However, telomere fusions are not fully abrogated in DNA-PKcs-inhibited 53BP1-deficient cells, but occur with a frequency approximately 10-fold lower than in control 53BP1-proficient cells. Treatment with PARP inhibitors or PARP1 depletion abrogates residual fusions, while Ligase IV depletion has no measurable effect, suggesting that PARP1-dependent alternative end-joining operates at low efficiency at 53BP1-deficient, DNA-PKcs-inhibited telomeres. Finally, we have also examined the requirement for DDR factors ATM, MDC1 or H2AX in this context. We find that ATM loss or inhibition has no measurable effect on the frequency of NU7026-induced fusions in wild-type MEFs. Moreover, analysis of MEFs lacking both ATM and 53BP1 indicates that ATM is also dispensable for telomere fusions via PARP-dependent end-joining. In contrast, loss of either MDC1 or H2AX abrogates telomere fusions in response to DNA-PKcs inhibition, suggesting that these factors operate upstream of both 53BP1-dependent and independent telomere rejoining. Together, these experiments define a novel requirement for 53BP1 in the fusions of DNA-PKcs- deficient telomeres throughout the cell cycle and uncover a Ligase IV-independent, PARP1-dependent pathway that fuses telomeres at reduced efficiency in the absence of 53BP1.	[Franco, Sonia] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Franco, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21218 USA.	sfranco2@jhmi.edu	GHOSH, RAJIB/C-7007-2019	GHOSH, RAJIB/0000-0002-3389-3533	American Cancer Society [RSG-12-160-01-DMC]	American Cancer Society(American Cancer Society)	The work was funded by Research Scholar Grant RSG-12-160-01-DMC from the American Cancer Society (www.cancer.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Bailey SM, 2004, DNA REPAIR, V3, P349, DOI 10.1016/j.dnarep.2003.11.007; Bailey SM, 2004, DNA REPAIR, V3, P225, DOI 10.1016/j.dnarep.2003.10.013; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Boboila C, 2012, ADV IMMUNOL, V116, P1, DOI 10.1016/B978-0-12-394300-2.00001-6; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; Bothmer A, 2013, J EXP MED, V210, P115, DOI 10.1084/jem.20121975; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Chandra G, 2012, ARCH PHARM RES, V35, P639, DOI 10.1007/s12272-012-0407-1; Davis AJ, 2014, DNA REPAIR, V17, P21, DOI 10.1016/j.dnarep.2014.02.020; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; Dimitrova N, 2009, MOL CELL BIOL, V29, P5552, DOI 10.1128/MCB.00476-09; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dobbs TA, 2010, DNA REPAIR, V9, P1307, DOI 10.1016/j.dnarep.2010.09.019; Espejel S, 2002, EMBO J, V21, P6275, DOI 10.1093/emboj/cdf593; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Franco S, 2008, J EXP MED, V205, P557, DOI 10.1084/jem.20080044; Franco S, 2006, DNA REPAIR, V5, P1030, DOI 10.1016/j.dnarep.2006.05.024; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Godon C, 2008, NUCLEIC ACIDS RES, V36, P4454, DOI 10.1093/nar/gkn403; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Helleday T, 2013, CURR OPIN ONCOL, V25, P609, DOI 10.1097/CCO.0000000000000016; Jankovic M, 2013, MOL CELL, V49, P623, DOI 10.1016/j.molcel.2012.11.029; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Lottersberger F., 2013, P NATL ACAD SCI US; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Luo KT, 2011, J BIOL CHEM, V286, P28192, DOI 10.1074/jbc.M111.258087; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Mansour WY, 2013, DNA REPAIR, V12, P1134, DOI 10.1016/j.dnarep.2013.10.005; Martinez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x; Maser RS, 2007, MOL CELL BIOL, V27, P2253, DOI 10.1128/MCB.01354-06; McClintock B, 1939, P NATL ACAD SCI USA, V25, P405, DOI 10.1073/pnas.25.8.405; Misri S, 2008, CYTOGENET GENOME RES, V122, P297, DOI 10.1159/000167816; Nakamura K, 2006, DNA REPAIR, V5, P741, DOI 10.1016/j.dnarep.2006.03.008; Neboori HJR, 2012, INT J RADIAT ONCOL, V83, pE677, DOI 10.1016/j.ijrobp.2012.01.089; Oh S, 2013, NUCLEIC ACIDS RES, V41, P1734, DOI 10.1093/nar/gks1326; Orsburn B, 2010, MOL CELL BIOL, V30, P2341, DOI 10.1128/MCB.00091-10; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Patel AG, 2012, CLIN CANCER RES, V18, P1655, DOI 10.1158/1078-0432.CCR-11-2890; Rai R, 2010, EMBO J, V29, P2598, DOI 10.1038/emboj.2010.142; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rybanska I, 2013, ONCOGENE, V32, P1761, DOI 10.1038/onc.2012.199; Rybanska-Spaeder I, 2013, MOL CANCER RES, V11, P1223, DOI 10.1158/1541-7786.MCR-13-0252-T; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Squatrito M, 2012, CANCER RES, V72, P5250, DOI 10.1158/0008-5472.CAN-12-0045; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Takeyama K, 2008, ONCOGENE, V27, P318, DOI 10.1038/sj.onc.1210650; Tobin LA, 2012, MOL CANCER RES, V10, P96, DOI 10.1158/1541-7786.MCR-11-0255; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Williams ES, 2009, CANCER RES, V69, P2100, DOI 10.1158/0008-5472.CAN-08-2854; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Yang YG, 2004, ONCOGENE, V23, P3872, DOI 10.1038/sj.onc.1207491; Zhang Y, 2011, NAT STRUCT MOL BIOL, V18, P80, DOI 10.1038/nsmb.1940	72	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108731	10.1371/journal.pone.0108731	http://dx.doi.org/10.1371/journal.pone.0108731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264618	Green Submitted, Green Published, gold			2022-12-27	WOS:000345745400115
J	Shigehiro, T; Kasai, T; Murakami, M; Sekhar, SC; Tominaga, Y; Okada, M; Kudoh, T; Mizutani, A; Murakami, H; Salomon, DS; Mikuni, K; Mandai, T; Hamada, H; Seno, M				Shigehiro, Tsukasa; Kasai, Tomonari; Murakami, Masaharu; Sekhar, Sreeja C.; Tominaga, Yuki; Okada, Masashi; Kudoh, Takayuki; Mizutani, Akifumi; Murakami, Hiroshi; Salomon, David S.; Mikuni, Katsuhiko; Mandai, Tadakatsu; Hamada, Hiroki; Seno, Masaharu			Efficient Drug Delivery of Paclitaxel Glycoside: A Novel Solubility Gradient Encapsulation into Liposomes Coupled with Immunoliposomes Preparation	PLOS ONE			English	Article							BREAST-CANCER CELLS; ANTI-HER2 IMMUNOLIPOSOMES; FORMULATIONS; NANOPARTICLES; EFFICACY; TAXOIDS; TUMORS; EGFR	Although the encapsulation of paclitaxel into liposomes has been extensively studied, its significant hydrophobic and uncharged character has generated substantial difficulties concerning its efficient encapsulation into the inner water core of liposomes. We found that a more hydrophilic paclitaxel molecule, 7-glucosyloxyacetylpaclitaxel, retained tubulin polymerization stabilization activity. The hydrophilic nature of 7-glucosyloxyacetylpaclitaxel allowed its efficient encapsulation into the inner water core of liposomes, which was successfully accomplished using a remote loading method with a solubility gradient between 40% ethylene glycol and Cremophor EL/ethanol in PBS. Trastuzumab was then conjugated onto the surface of liposomes as immunoliposomes to selectively target human epidermal growth factor receptor-2 (HER2)-overexpressing cancer cells. In vitro cytotoxicity assays revealed that the immunoliposomes enhanced the toxicity of 7-glucosyloxyacetylpaclitaxel in HER2-overexpressing cancer cells and showed more rapid suppression of cell growth. The immunoliposomes strongly inhibited the tumor growth of HT-29 cells xenografted in nude mice. Notably, mice survived when treated with the immunoliposomes formulation, even when administered at a lethal dose of 7glucosyloxyacetylpaclitaxel in vivo. This data successfully demonstrates immunoliposomes as a promising candidate for the efficient delivery of paclitaxel glycoside.	[Shigehiro, Tsukasa; Kasai, Tomonari; Murakami, Masaharu; Sekhar, Sreeja C.; Tominaga, Yuki; Okada, Masashi; Kudoh, Takayuki; Mizutani, Akifumi; Murakami, Hiroshi; Seno, Masaharu] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biotechnol, Okayama 7008530, Japan; [Salomon, David S.] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA; [Mikuni, Katsuhiko] Ensuiko Sugar Refining Co Ltd, Tokyo, Japan; [Mandai, Tadakatsu] Kurashiki Univ Sci & Arts, Fac Life Sci, Kurashiki, Okayama, Japan; [Hamada, Hiroki] Okayama Univ Sci, Fac Sci, Okayama, Japan	Okayama University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Okayama University of Science	Hamada, H (corresponding author), Okayama Univ Sci, Fac Sci, Okayama, Japan.	hamada@dls.ous.ac.jp; mseno@okayama-u.ac.jp	Shigehiro, Tsukasa/AHA-5978-2022; Shigehiro, Tsukasa/R-5805-2019; hamada, hiroki/A-4276-2009; SENO, Masaharu/B-2092-2011	Shigehiro, Tsukasa/0000-0002-5286-5108; SENO, Masaharu/0000-0001-8547-6259; sekhar, sreeja/0000-0002-9827-5349	Ministry of Education, Culture, Sports, Science and Technology of Japan [23650598, 25242045, 26640079, 24510151, 24501315]; Japan Society for the Promotion of Science; Ensuiko Sugar Refining Co., Ltd. (Tokyo, Japan); Grants-in-Aid for Scientific Research [24510151] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ensuiko Sugar Refining Co., Ltd. (Tokyo, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by Grant-in-Aid for Challenging Exploratory Research No. 23650598 (MS), 25242045 (MS), and 26640079 (MS); Grant-in-Aid for Scientific Research (C) Nos. 24510151 (T. Kasai) and 24501315 (AM) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp); and from the Japan Society for the Promotion of Science (http://www.jsps.go.jp). This research was funded by a commercial company, Ensuiko Sugar Refining Co., Ltd. (Tokyo, Japan). Ensuiko Sugar Refining Co., Ltd. had a role in the study design. The other funders had no role in study design. All funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript in this study.	Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Crosasso P, 2000, J CONTROL RELEASE, V63, P19, DOI 10.1016/S0168-3659(99)00166-2; Desai N, 2006, CLIN CANCER RES, V12, P1317, DOI 10.1158/1078-0432.CCR-05-1634; Fetterly GJ, 2003, AAPS PHARMSCI, V5; Gao J, 2011, BIOMATERIALS, V32, P3459, DOI 10.1016/j.biomaterials.2011.01.034; Gelderblom H, 2001, EUR J CANCER, V37, P1590, DOI 10.1016/S0959-8049(01)00171-X; Kan P, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/629234; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; Koudelka S, 2012, J CONTROL RELEASE, V163, P322, DOI 10.1016/j.jconrel.2012.09.006; Koudelka S, 2010, J PHARM SCI-US, V99, P2309, DOI 10.1002/jps.21992; Ma P, 2013, J NANOMED NANOTECHNO, V4, DOI DOI 10.4172/2157-7439.1000164; Mandai T, 2001, HETEROCYCLES, V54, P561, DOI 10.3987/COM-00-S(I)34; Maruyama K, 2011, ADV DRUG DELIVER REV, V63, P161, DOI 10.1016/j.addr.2010.09.003; Park JW, 1997, CANCER LETT, V118, P153, DOI 10.1016/S0304-3835(97)00326-1; Park JW, 2002, CLIN CANCER RES, V8, P1172; Park JW, 2001, J CONTROL RELEASE, V74, P95, DOI 10.1016/S0168-3659(01)00315-7; PAZDUR R, 1993, CANCER TREAT REV, V19, P351, DOI 10.1016/0305-7372(93)90010-O; Rusnak DW, 2007, CELL PROLIFERAT, V40, P580, DOI 10.1111/j.1365-2184.2007.00455.x; Sharma A, 1997, INT J CANCER, V71, P103, DOI 10.1002/(SICI)1097-0215(19970328)71:1<103::AID-IJC17>3.0.CO;2-J; Singla AK, 2002, INT J PHARMACEUT, V235, P179, DOI 10.1016/S0378-5173(01)00986-3; Sparreboom A, 1997, P NATL ACAD SCI USA, V94, P2031, DOI 10.1073/pnas.94.5.2031; Spratlin J, 2007, CRIT REV ONCOL HEMAT, V61, P222, DOI 10.1016/j.critrevonc.2006.09.006; Steinhauser I, 2006, BIOMATERIALS, V27, P4975, DOI 10.1016/j.biomaterials.2006.05.016; Tai WY, 2010, J CONTROL RELEASE, V146, P264, DOI 10.1016/j.jconrel.2010.04.009; Vaidyanath A, 2011, J CELL MOL MED, V15, P2525, DOI 10.1111/j.1582-4934.2011.01277.x; Wang HB, 2013, MOL MED REP, V7, P947, DOI 10.3892/mmr.2013.1264; Xu H, 2005, MOL CANCER THER, V4, P435; Yang T, 2007, PHARM RES-DORDR, V24, P2402, DOI 10.1007/s11095-007-9425-y; Yang T, 2007, J CONTROL RELEASE, V120, P169, DOI 10.1016/j.jconrel.2007.05.011; Yang T, 2007, INT J PHARMACEUT, V338, P317, DOI 10.1016/j.ijpharm.2007.02.011; Yoshizawa Y, 2011, INT J PHARMACEUT, V412, P132, DOI 10.1016/j.ijpharm.2011.04.008; Zhigaltsev IV, 2010, J CONTROL RELEASE, V144, P332, DOI 10.1016/j.jconrel.2010.02.029	33	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107976	10.1371/journal.pone.0107976	http://dx.doi.org/10.1371/journal.pone.0107976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264848	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400036
J	Singh, D; Fox, SM; Tal-Singer, R; Bates, S; Riley, JH; Celli, B				Singh, Dave; Fox, Steven M.; Tal-Singer, Ruth; Bates, Stewart; Riley, John H.; Celli, Bartolome		ECLIPSE Investigators	Altered Gene Expression in Blood and Sputum in COPD Frequent Exacerbators in the ECLIPSE Cohort	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; T-LYMPHOCYTES; IDENTIFICATION; INFLAMMATION; APOPTOSIS; CYTOKINE; PROTEIN; REGION	Patients with chronic obstructive pulmonary disease (COPD) who are defined as frequent exacerbators suffer with 2 or more exacerbations every year. The molecular mechanisms responsible for this phenotype are poorly understood. We investigated gene expression profile patterns associated with frequent exacerbations in sputum and blood cells in a well-characterised cohort. Samples from subjects from the ECLIPSE COPD cohort were used; sputum and blood samples from 138 subjects were used for microarray gene expression analysis, while blood samples from 438 subjects were used for polymerase chain reaction (PCR) testing. Using microarray, 150 genes were differentially expressed in blood (>+/- 1.5 fold change, p <= 0.01) between frequent compared to non-exacerbators. In sputum cells, only 6 genes were differentially expressed. The differentially regulated genes in blood included downregulation of those involved in lymphocyte signalling and upregulation of pro-apoptotic signalling genes. Multivariate analysis of the microarray data followed by confirmatory PCR analysis identified 3 genes that predicted frequent exacerbations; B3GNT, LAF4 and ARHGEF10. The sensitivity and specificity of these 3 genes to predict the frequent exacerbator phenotype was 88% and 33% respectively. There are alterations in systemic immune function associated with frequent exacerbations; down-regulation of lymphocyte function and a shift towards pro-apoptosis mechanisms are apparent in patients with frequent exacerbations.	[Singh, Dave] Univ Manchester, Med Evaluat Unit, Manchester, Lancs, England; [Fox, Steven M.; Bates, Stewart] GlaxoSmithKline, Med Res Ctr, Stevenage, Herts, England; [Tal-Singer, Ruth] GlaxoSmithKline, King Of Prussia, PA USA; [Riley, John H.] GlaxoSmithKline, Uxbridge, Middx, England; [Celli, Bartolome] Brigham & Womens Hosp, Boston, MA 02115 USA; [Celli, Bartolome] Harvard Univ, Sch Med, Boston, MA USA	University of Manchester; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Singh, D (corresponding author), Univ Manchester, Med Evaluat Unit, Manchester, Lancs, England.	dsingh@meu.org.uk	Singh, Dave/AAH-4342-2020; Tal-Singer, Ruth/AAQ-2925-2021	Singh, Dave/0000-0001-8918-7075; Tal-Singer, Ruth/0000-0002-5275-8062	GSK; STFC [ST/J001465/1] Funding Source: UKRI	GSK(GlaxoSmithKline); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	GSK funded the study, and were involved in study design, analysis, decision to publish and preparation of the manuscript.	Bahr TM, 2013, AM J RESP CELL MOL, V49, P316, DOI 10.1165/rcmb.2012-0230OC; Bhattacharya Soumyaroop, 2011, J Clin Bioinforma, V1, P12, DOI 10.1186/2043-9113-1-12; Chaya T, 2011, J BIOL CHEM, V286, P29511, DOI 10.1074/jbc.M111.236810; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Erdei A, 2009, MOL IMMUNOL, V46, P2767, DOI 10.1016/j.molimm.2009.05.181; Grundy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071629; Hasler P, 2001, FASEB J, V15, P2085, DOI 10.1096/fj.00-0860rev; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jury EC, 2003, ARTHRITIS RHEUM-US, V48, P1343, DOI 10.1002/art.10978; Kawasaki N, 2011, J INNATE IMMUN, V3, P411, DOI 10.1159/000322375; Lee PL, 2009, GLYCOBIOLOGY, V19, P655, DOI 10.1093/glycob/cwp035; Ma C, 1996, BLOOD, V87, P734, DOI 10.1182/blood.V87.2.734.bloodjournal872734; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Marlow LA, 2012, J CELL SCI, V125, P4253, DOI 10.1242/jcs.097428; Maurice MM, 1997, J IMMUNOL, V159, P2973; Otsuki M, 1999, BIOCHEM BIOPH RES CO, V266, P97, DOI 10.1006/bbrc.1999.1784; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Rygiel TP, 2009, J IMMUNOL, V183, P1990, DOI 10.4049/jimmunol.0900252; Saitou M, 2000, ONCOGENE, V19, P2796, DOI 10.1038/sj.onc.1203604; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Simpson TR, 2010, CURR OPIN IMMUNOL, V22, P326, DOI 10.1016/j.coi.2010.01.001; Singh SD, 2011, THORAX, V65, P764; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Ware CF, 1996, J CELL BIOCHEM, V60, P47, DOI 10.1002/(SICI)1097-4644(19960101)60:1<47::AID-JCB8>3.3.CO;2-H; Weckbach LT, 2014, BLOOD, V123, P1887, DOI 10.1182/blood-2013-06-510875; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Ying HY, 2011, IMMUNOBIOLOGY, V216, P566, DOI 10.1016/j.imbio.2010.09.016; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	31	35	38	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107381	10.1371/journal.pone.0107381	http://dx.doi.org/10.1371/journal.pone.0107381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265030	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400020
J	Sugahara, K; Hirose, Y; Mikuriya, T; Hashimoto, M; Kanagawa, E; Hara, H; Shimogori, H; Yamashita, H				Sugahara, Kazuma; Hirose, Yoshinobu; Mikuriya, Takefumi; Hashimoto, Makoto; Kanagawa, Eiju; Hara, Hirotaka; Shimogori, Hiroaki; Yamashita, Hiroshi			Coenzyme Q10 Protects Hair Cells against Aminoglycoside	PLOS ONE			English	Article							INDUCED HEARING-LOSS; IRON CHELATOR; IN-VIVO; OTOTOXICITY; Q(10); PURESORB-Q(TM)40; PREVENTION; RECOVERY; TRAUMA	It is well known that the production of free radicals is associated with sensory cell death induced by an aminoglycoside. Many researchers have reported that antioxidant reagents protect sensory cells in the inner ear, and coenzyme Q10 (CoQ10) is an antioxidant that is consumed as a health food in many countries. The purpose of this study was to investigate the role of CoQ10 in mammalian vestibular hair cell death induced by aminoglycoside. Cultured utricles of CBA/ CaN mice were divided into three groups (control group, neomycin group, and neomycin + CoQ10 group). In the neomycin group, utricles were cultured with neomycin (1 mu M) to induce hair cell death. In the neomycin + CoQ10 group, utricles were cultured with neomycin and water-soluble CoQ10 (30-0.3 mu M). Twenty-four hours after exposure to neomycin, the cultured tissues were fixed, and vestibular hair cells were labeled using an anti-calmodulin antibody. Significantly more hair cells survived in the neomycin + CoQ10 group than in the neomycin group. These data indicate that CoQ10 protects sensory hair cells against neomycin-induced death in the mammalian vestibular epithelium; therefore, CoQ10 may be useful as a protective drug in the inner ear.	[Sugahara, Kazuma; Hirose, Yoshinobu; Mikuriya, Takefumi; Hashimoto, Makoto; Kanagawa, Eiju; Hara, Hirotaka; Shimogori, Hiroaki; Yamashita, Hiroshi] Yamaguchi Univ, Grad Sch Med, Dept Otolaryngol, Ube, Yamaguchi 755, Japan	Yamaguchi University	Sugahara, K (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Otolaryngol, Ube, Yamaguchi 755, Japan.	kazuma@yamaguchi-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Japanese Ministry of Education, Culture, Sports, Science, and Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DUCKERT LG, 1993, J COMP NEUROL, V331, P75, DOI 10.1002/cne.903310105; Fetoni AR, 2012, ACTA OTORHINOLARYNGO, V32, P103; Hirose Y, 2008, ACTA OTO-LARYNGOL, V128, P1071, DOI 10.1080/00016480801891694; Kopke R, 1999, ANN NY ACAD SCI, V884, P171, DOI 10.1111/j.1749-6632.1999.tb08641.x; Matsui JI, 2003, J NEUROSCI, V23, P6111, DOI 10.1523/JNEUROSCI.23-14-06111.2003; Nukui K, 2007, J NUTR SCI VITAMINOL, V53, P187, DOI 10.3177/jnsv.53.187; Nukui K, 2008, BIOFACTORS, V32, P209, DOI 10.1002/biof.5520320125; Ryals B, 1997, HEARING RES, V112, P44, DOI 10.1016/S0378-5955(97)00094-4; SATO K, 1988, ACTA OTO-LARYNGOL, P95; Sergi B, 2006, NEUROREPORT, V17, P857, DOI 10.1097/01.wnr.0000221834.18470.8c; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950; Wu WJ, 2002, AUDIOL NEURO-OTOL, V7, P171, DOI 10.1159/000058305; Yamasoba T, 1999, BRAIN RES, V815, P317, DOI 10.1016/S0006-8993(98)01100-7	14	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108280	10.1371/journal.pone.0108280	http://dx.doi.org/10.1371/journal.pone.0108280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265538	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400060
J	Habbeddine, M; Verbeke, P; Karaz, S; Bobe, P; Kanellopoulos-Langevin, C				Habbeddine, Mohamed; Verbeke, Philippe; Karaz, Sonia; Bobe, Pierre; Kanellopoulos-Langevin, Colette			Leukocyte Population Dynamics and Detection of IL-9 as a Major Cytokine at the Mouse Fetal-Maternal Interface	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; UTERINE NK CELLS; DENDRITIC CELLS; SUCCESSFUL PREGNANCY; EMBRYO IMPLANTATION; KNOCKOUT MICE; ESTROUS-CYCLE; BONE-MARROW; T-CELLS; GM-CSF	Despite much interest in the mechanisms regulating fetal-maternal interactions, information on leukocyte populations and major cytokines present in uterus and placenta remains fragmentary. This report presents a detailed and quantitative study of leukocyte populations at the mouse fetal-maternal interface, including a comparison between pregnancies from syngeneic and allogeneic crosses. Our results provide evidence for drastic differences not only in the composition of leukocyte populations in the uterus during pregnancy, but also between uterine and placental tissues. Interestingly, we have observed a significant decrease in the number of myeloid Gr1+ cells including monocytes, and myeloid CD11c+ cells including DCs in placenta from an allogeneic pregnancy. In addition, we have compared the expression levels of a panel of cytokines in non-pregnant (NP) or pregnant mouse uterus, in placenta, or in their isolated resident leukocytes. Qualitative and quantitative differences have emerged between NP, pregnant uterus and placenta. Unexpectedly, IL-9 was the major cytokine in NP uterus, and was maintained at high levels during pregnancy both in uterus and placenta. Moreover, we have found that pregnancy is associated with an increase in uterine IL-1 alpha and a significant decrease in uterine G-CSF and GM-CSF. Comparing allogeneic versus syngeneic pregnancy, less allogeneic placental pro-inflammatory cytokines CCL2 (MCP-1), CXCL10 (IP-10) and more IL1-alpha in whole uterus was reproducibly observed. To our knowledge, this is the first report showing a detailed overview of the leukocyte and cytokine repertoire in the uterus of virgin females and at the fetal-maternal interface, including a comparison between syngeneic and allogeneic pregnancy. This is also the first evidence for the presence of IL-9 in NP uterus and at the maternal-fetal interface, suggesting a major role in the regulation of local inflammatory or immune responses potentially detrimental to the conceptus.	[Habbeddine, Mohamed; Verbeke, Philippe; Bobe, Pierre; Kanellopoulos-Langevin, Colette] CNRS, Inst Jacques Monod, Lab Inflammat Gestat & Autoimmun, Paris, France; [Habbeddine, Mohamed; Verbeke, Philippe; Karaz, Sonia; Bobe, Pierre; Kanellopoulos-Langevin, Colette] Univ Paris Diderot, Paris, France; [Karaz, Sonia] CNRS, Inst Jacques Monod, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Kanellopoulos-Langevin, C (corresponding author), Univ Paris 07, Ctr Rech Inflammat, INSERM UMR 1149, Paris, France.	colette.kanellopoulos@inserm.fr		Bobe, Pierre/0000-0002-8835-6786				Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Barrientos G, 2013, ANGIOGENESIS, V16, P417, DOI 10.1007/s10456-012-9325-6; Bennett W A, 1997, Early Pregnancy, V3, P190; Blois SM, 2004, BIOL REPROD, V70, P1018, DOI 10.1095/biolreprod.103.022640; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bulmer JN, 2005, MOL IMMUNOL, V42, P511, DOI 10.1016/j.molimm.2004.07.035; Chen ZL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102293; Chu VT, 2014, IMMUNITY, V40, P582, DOI 10.1016/j.immuni.2014.02.014; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; Croy BA, 2006, IMMUNOL REV, V214, P161; Croy BA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102830; Croy BA, 2000, PLACENTA, V21, pS77, DOI 10.1053/plac.1999.0518; DELASSUS S, 1994, J IMMUNOL, V152, P2411; Dimitriadis E, 2005, HUM REPROD UPDATE, V11, P613, DOI 10.1093/humupd/dmi023; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Erlebacher A, 2013, NAT REV IMMUNOL, V13, P23, DOI 10.1038/nri3361; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; GANSLER H, 1956, VIRCHOWS ARCH A, V329, P235, DOI 10.1007/BF00955143; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Grohmann U, 2000, J IMMUNOL, V164, P4197, DOI 10.4049/jimmunol.164.8.4197; Guimond MJ, 1998, J EXP MED, V187, P217, DOI 10.1084/jem.187.2.217; Habbeddine M, 2013, MICROBES INFECT, V15, P928, DOI 10.1016/j.micinf.2013.08.006; Hancock WW, 2000, CURR OPIN IMMUNOL, V12, P511, DOI 10.1016/S0952-7915(00)00130-8; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hanna N, 2000, J IMMUNOL, V164, P5721, DOI 10.4049/jimmunol.164.11.5721; Hofmann AP, 2014, MOL HUM REPROD, V20, P66, DOI 10.1093/molehr/gat060; Hunt JS, 1996, J REPROD IMMUNOL, V32, P1, DOI 10.1016/S0165-0378(96)88352-5; Ingman WV, 2008, HUM REPROD UPDATE, V14, P179, DOI 10.1093/humupd/dmm042; Ito K, 2000, P NATL ACAD SCI USA, V97, P740, DOI 10.1073/pnas.97.2.740; Jenkins C, 2000, FERTIL STERIL, V73, P1206, DOI 10.1016/S0015-0282(00)00517-3; Kammerer U, 2008, IMMUNOL INVEST, V37, P499, DOI 10.1080/08820130802191334; Kaplan MH, 2013, IMMUNOL REV, V252, P104, DOI 10.1111/imr.12028; Keenihan SNH, 2004, BIOL REPROD, V70, P1562, DOI 10.1095/biolreprod.103.024794; Lavialle C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0507; Licona-Limon P, 2013, IMMUNITY, V39, P744, DOI 10.1016/j.immuni.2013.07.020; Lima PDA, 2012, J LEUKOCYTE BIOL, V92, P195, DOI 10.1189/jlb.0312136; LIN H, 1993, J IMMUNOL, V151, P4562; Lombardelli L, 2013, J IMMUNOL, V191, P3651, DOI 10.4049/jimmunol.1300567; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; MITCHELL MD, 1993, PLACENTA, V14, P249, DOI 10.1016/S0143-4004(05)80426-6; Miyazaki S, 2002, AM J REPROD IMMUNOL, V47, P222, DOI 10.1034/j.1600-0897.2002.01074.x; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Moldenhauer LM, 2010, J IMMUNOL, V185, P7085, DOI 10.4049/jimmunol.1001374; Murphy SP, 2005, J IMMUNOL, V175, P4084, DOI 10.4049/jimmunol.175.6.4084; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Paul W.E, 2008, FUNDAMENTAL IMMUNOLO; PEPPER H, 1960, P SOC EXP BIOL MED, V104, P145; Piccinni MP, 2002, AM J REPROD IMMUNOL, V47, P289, DOI 10.1034/j.1600-0897.2002.01104.x; Piccinni MP, 1998, NAT MED, V4, P1020, DOI 10.1038/2006; Plaks V, 2008, J CLIN INVEST, V118, P3954, DOI 10.1172/JCI36682; Pollard JW, 1998, BIOL REPROD, V58, P1469, DOI 10.1095/biolreprod58.6.1469; Rajagopalan S, 2012, P NATL ACAD SCI USA, V109, P20596, DOI 10.1073/pnas.1208248109; RATHANASWAMI P, 1993, J BIOL CHEM, V268, P5834; Robertson SA, 2007, CYTOKINE GROWTH F R, V18, P287, DOI 10.1016/j.cytogfr.2007.04.008; ROSS R, 1966, J EXP MED, V124, P653, DOI 10.1084/jem.124.4.653; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Salamonsen LA, 1999, J REPROD IMMUNOL, V44, P1; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Seymour JF, 1997, BLOOD, V90, P3037, DOI 10.1182/blood.V90.8.3037; Silver RM, 1997, AM J OBSTET GYNECOL, V176, P544, DOI 10.1016/S0002-9378(97)70545-3; Trautman MS, 1997, J SOC GYNECOL INVEST, V4, P247, DOI 10.1016/S1071-5576(97)00045-2; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; White CA, 2004, BIOL REPROD, V70, P123, DOI 10.1095/biolreprod.103.018754; Yadi H, 2008, J IMMUNOL, V181, P6140, DOI 10.4049/jimmunol.181.9.6140	68	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107267	10.1371/journal.pone.0107267	http://dx.doi.org/10.1371/journal.pone.0107267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259859	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600018
J	Mol, JPS; Costa, EA; Carvalho, AF; Sun, YH; Tsolis, RM; Paixao, TA; Santos, RL				Mol, Juliana P. S.; Costa, Erica A.; Carvalho, Alex F.; Sun, Yao-Hui; Tsolis, Renee M.; Paixao, Tatiane A.; Santos, Renato L.			Early Transcriptional Responses of Bovine Chorioallantoic Membrane Explants to Wild Type, Delta virB2 or Delta btpB Brucella abortus Infection	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; IV SECRETION; PATHOGENESIS; EXPRESSION; REQUIRES; STRAINS; ALPHA; LIFE	The pathogenesis of the Brucella-induced inflammatory response in the bovine placenta is not completely understood. In this study we evaluated the role of the B. abortus Type IV secretion system and the anti-inflammatory factor BtpB in early interactions with bovine placental tissues. Transcription profiles of chorioallantoic membrane (CAM) explants inoculated with wild type (strain 2308), Delta virB2 or Delta btpB Brucella abortus were compared by microarray analysis at 4 hours post infection. Transcripts with significant variation (>2 fold change; P < 0.05) were functionally classified, and transcripts related to defense and inflammation were assessed by quantitative real time RT-PCR. Infection with wild type B. abortus resulted in slightly more genes with decreased than increased transcription levels. Conversely, infection of trophoblastic cells with the Delta virB2 or the Delta btpB mutant strains, that lack a functional T4SS or that has impaired inhibition of TLR signaling, respectively, induced more upregulated than downregulated genes. Wild type Brucella abortus impaired transcription of host genes related to immune response when compared to Delta virB and Delta btpB mutants. Our findings suggest that proinflammatory genes are negatively modulated in bovine trophoblastic cells at early stages of infection. The virB operon and btpB are directly or indirectly related to modulation of these host genes. These results shed light on the early interactions between B. abortus and placental tissue that ultimately culminate in inflammatory pathology and abortion.	[Mol, Juliana P. S.; Costa, Erica A.; Santos, Renato L.] Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Belo Horizonte, MG, Brazil; [Carvalho, Alex F.] Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, Belo Horizonte, MG, Brazil; [Sun, Yao-Hui; Tsolis, Renee M.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Paixao, Tatiane A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of California System; University of California Davis; Universidade Federal de Minas Gerais	Santos, RL (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Belo Horizonte, MG, Brazil.	rsantos@vet.ufmg.br	CARVALHO, ALEX F/K-1947-2015; de Lima Santos, Renato/A-1134-2008; Paixao, Tatiane/A-2871-2013	de Lima Santos, Renato/0000-0002-4830-0470; Mol, Juliana/0000-0002-6946-8213; Paixao, Tatiane/0000-0001-8284-9902; Tsolis, Renee/0000-0001-9131-6657	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil); PRONEX from FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050553] Funding Source: NIH RePORTER	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRONEX from FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work in RLS' lab is supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil), PRONEX grant from FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil), and a PNPD fellowship for JPSM from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha PN, 2003, PAN AM HLTH ORG SCI, V580, p3v; ANDERSON TD, 1986, AM J PATHOL, V124, P226; Baker SJ, 1996, ONCOGENE, V12, P1; Bellaire BH, 2005, INFECT IMMUN, V73, P3702, DOI 10.1128/IAI.73.6.3702-3713.2005; Bitoun E, 2003, HUM MOL GENET, V12, P2417, DOI 10.1093/hmg/ddg247; Boschiroli ML, 2002, VET MICROBIOL, V90, P341, DOI 10.1016/S0378-1135(02)00219-5; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; CAMPBELL GA, 1994, VET IMMUNOL IMMUNOP, V41, P295, DOI 10.1016/0165-2427(94)90103-1; Celli J, 2005, P NATL ACAD SCI USA, V102, P1673, DOI 10.1073/pnas.0406873102; Celli J, 2004, CURR OPIN MICROBIOL, V7, P93, DOI 10.1016/j.mib.2003.11.001; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Cutler SJ, 2005, J APPL MICROBIOL, V98, P1270, DOI 10.1111/j.1365-2672.2005.02622.x; de Almeida LA, 2013, INFECT IMMUN, V81, P1654, DOI 10.1128/IAI.01356-12; de Jong MF, 2012, FUTURE MICROBIOL, V7, P47, DOI [10.2217/fmb.11.136, 10.2217/FMB.11.136]; den Hartigh AB, 2004, INFECT IMMUN, V72, P5143, DOI 10.1128/IAI.72.9.5143-5149.2004; Descargues P, 2006, J INVEST DERMATOL, V126, P1622, DOI 10.1038/sj.jid.5700284; Diaz-Guillen MA, 1999, IMMUNOGENETICS, V49, P549, DOI 10.1007/s002510050534; EVANS H E, 1973, Zentralblatt fuer Veterinaermedizin Reihe C, V2, P11; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; Gui JH, 2013, HUM CELL, V26, P67, DOI 10.1007/s13577-012-0058-z; Hansen TR, 2010, AM J REPROD IMMUNOL, V64, P295, DOI 10.1111/j.1600-0897.2010.00904.x; Hayashi J, 2005, VIROLOGY, V335, P264, DOI 10.1016/j.virol.2005.02.018; Kahl-McDonagh MM, 2006, VACCINE, V24, P5169, DOI 10.1016/j.vaccine.2006.04.005; Kyme P, 2012, J CLIN INVEST, V122, P3316, DOI 10.1172/JCI62070; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Male DA, 2000, MOL IMMUNOL, V37, P41, DOI 10.1016/S0161-5890(00)00024-9; MCGEE DW, 1999, MUCOSAL IMMUNOLOGY, P559; MEADOR VP, 1989, VET PATHOL, V26, P357, DOI 10.1177/030098588902600501; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Neta AVC, 2008, INFECT IMMUN, V76, P1897, DOI 10.1128/IAI.01554-07; Neta AVC, 2010, VET J, V184, P146, DOI 10.1016/j.tvjl.2009.04.010; Nicoletti P., 1990, Laboratory diagnosis of livestock abortion., P22; Nomura S, 2007, TRANSPL IMMUNOL, V18, P115, DOI 10.1016/j.trim.2007.05.012; Roux CM, 2007, CELL MICROBIOL, V9, P1851, DOI 10.1111/j.1462-5822.2007.00922.x; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Salcedo SP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00028; Samartino LE, 1996, COMP IMMUNOL MICROB, V19, P55, DOI 10.1016/0147-9571(95)00018-6; SAMARTINO LE, 1993, COMP IMMUNOL MICROB, V16, P95, DOI 10.1016/0147-9571(93)90001-L; SAMARTINO LE, 1992, AM J VET RES, V53, P359; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Santos RL, 2013, PESQUI VET BRASIL, V33, P759, DOI 10.1590/S0100-736X2013000600012; Seleem MN, 2008, VET MICROBIOL, V129, P1, DOI 10.1016/j.vetmic.2007.11.023; Shi XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075473; Silva TMA, 2011, INFECT IMMUN, V79, P1706, DOI 10.1128/IAI.01109-10; Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Sun YH, 2005, INFECT IMMUN, V73, P6048, DOI 10.1128/IAI.73.9.6048-6054.2005; Watanabe K, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-212; Wende E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062257; Wolf AJ, 2011, J IMMUNOL, V187, P6002, DOI 10.4049/jimmunol.1100232; Xavier MN, 2009, J COMP PATHOL, V140, P149, DOI 10.1016/j.jcpa.2008.10.004	55	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108606	10.1371/journal.pone.0108606	http://dx.doi.org/10.1371/journal.pone.0108606			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259715	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600088
J	Narang, R; Bakewell, K; Peach, J; Clayton, S; Samuels, M; Alexander, J; Lenney, W; Gilchrist, FJ				Narang, Ravi; Bakewell, Kelly; Peach, Jane; Clayton, Sadie; Samuels, Martin; Alexander, John; Lenney, Warren; Gilchrist, Francis J.			Bacterial Distribution in the Lungs of Children with Protracted Bacterial Bronchitis	PLOS ONE			English	Article							CHRONIC WET COUGH; BRONCHOALVEOLAR LAVAGE; CYSTIC-FIBROSIS; PREVALENCE; CHILDHOOD	Objectives: Flexible bronchoscopy with bronchoalveolar lavage (FB-BAL) is increasingly used for the microbiological confirmation of protracted bacterial bronchitis (PBB) in children with a chronic wet cough. At our centre, when performing FB-BAL for microbiological diagnosis we sample 6 lobes (including lingula) as this is known to increase the rate of culture positive procedures in children with cystic fibrosis. We investigated if this is also the case in children with PBB. Methods: We undertook a retrospective case note review of 50 children investigated for suspected PBB between May 2011 and November 2013. Results: The median (IQR) age at bronchoscopy was 2.9 (1.7-4.4) years and the median (IQR) duration of cough was 11 (8.0-14) months. Positive cultures were obtained from 41/50 (82%) and 16 (39%) of these patients isolated >= 2 organisms. The commonest organisms isolated were Haemophilus influenzae (25 patients), Moraxella catarrhalis (14 patients), Staphylococcus aureus (11 patients) and Streptococcus pneumoniae (8 patients). If only one lobe had been sampled (as per the European Respiratory Society guidance) 17 different organisms would have been missed in 15 patients, 8 of whom would have had no organism cultured at all. The FB-BAL culture results led to an antibiotic other than co-amoxiclav being prescribed in 17/41 (41%) patients. Conclusions: Bacterial distribution in the lungs of children with PBB is heterogeneous and organisms may therefore be missed if only one lobe is sampled at FB-BAL. Positive FB-BAL results are useful in children with PBB and can influence treatment.	[Narang, Ravi; Bakewell, Kelly; Peach, Jane; Clayton, Sadie; Samuels, Martin; Lenney, Warren; Gilchrist, Francis J.] Univ Hosp North Staffordshire, Acad Dept Child Hlth, Stoke On Trent, Staffs, England; [Alexander, John] Univ Hosp North Staffordshire, Stoke On Trent, Staffs, England; [Lenney, Warren; Gilchrist, Francis J.] Keele Univ, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England	Keele University	Gilchrist, FJ (corresponding author), Univ Hosp North Staffordshire, Acad Dept Child Hlth, Stoke On Trent, Staffs, England.	francis.gilchrist@uhns.nhs.uk	Gilchrist, Francis J./F-4198-2014; Gilchrist, Francis/AAH-9468-2020; Alexander, John/GVS-7271-2022	Gilchrist, Francis J./0000-0002-1947-7621; 				Arnold SR, 2006, AMBUL PEDIATR, V6, P225, DOI 10.1016/j.ambp.2006.04.005; Brodlie M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1177; Craven V, 2013, ARCH DIS CHILD, V98, P72, DOI 10.1136/archdischild-2012-302760; de Blic J, 2000, EUR RESPIR J, V15, P217; de Blic J, 2002, EUR RESPIR J, V20, P1271, DOI 10.1183/09031936.02.02072001; Donnelly D, 2007, THORAX, V62, P80, DOI 10.1136/thx.2006.058933; Eastham KM, 2004, THORAX, V59, P324, DOI 10.1136/thx.2003.011577; Faniran AO, 1999, CHEST, V115, P434, DOI 10.1378/chest.115.2.434; Gilchrist FJ, 2011, ARCH DIS CHILD, V96, P215, DOI 10.1136/adc.2009.177618; Linehan MF, 2005, ARCH DIS CHILD, V90, P516, DOI 10.1136/adc.2004.061879; Marchant J, 2012, THORAX, V67, P689, DOI 10.1136/thoraxjnl-2011-201506; Marchant JM, 2006, CHEST, V129, P1132, DOI 10.1378/chest.129.5.1132; Shields MD, 2008, THORAX, V63, P1, DOI 10.1136/thx.2007.077370; Zgherea D, 2012, PEDIATRICS, V129, pE364, DOI 10.1542/peds.2011-0805	14	28	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108523	10.1371/journal.pone.0108523	http://dx.doi.org/10.1371/journal.pone.0108523			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259619	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000342685600079
J	Odigie, KO; Flegal, AR				Odigie, Kingsley O.; Flegal, A. Russell			Trace Metal Inventories and Lead Isotopic Composition Chronicle a Forest Fire's Remobilization of Industrial Contaminants Deposited in the Angeles National Forest	PLOS ONE			English	Article							SAN-FRANCISCO BAY; UNITED-STATES; LOS-ANGELES; MERCURY EMISSIONS; CALIFORNIA; POLLUTION; SEDIMENTS; HISTORY; SOILS; PERSISTENCE	The amounts of labile trace metals: [Co] (3 to 11 mu g g(-1)), [Cu] (15 to 69 mu g g(-1)), [Ni] (6 to 15 mu g g(-1)), [Pb] (7 to 42 mu g g(-1)), and [Zn] (65 to 500 mu g g(-1)) in ash collected from the 2012 Williams Fire in Los Angeles, California attest to the role of fires in remobilizing industrial metals deposited in forests. These remobilized trace metals may be dispersed by winds, increasing human exposures, and they may be deposited in water bodies, increasing exposures in aquatic ecosystems. Correlations between the concentrations of these trace metals, normalized to Fe, in ash from the fire suggest that Co, Cu, and Ni in most of those samples were predominantly from natural sources, whereas Pb and Zn were enriched in some ash samples. The predominantly anthropogenic source of excess Pb in the ash was further demonstrated by its isotopic ratios (Pb-208/Pb-207: Pb-206/Pb-207) that fell between those of natural Pb and leaded gasoline sold in California during the previous century. These analyses substantiate current human and environmental health concerns with the pyrogenic remobilization of toxic metals, which are compounded by projections of increases in the intensity and frequency of wildfires associated with climate change.	[Odigie, Kingsley O.; Flegal, A. Russell] Univ Calif Santa Cruz, WIGS Lab, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Odigie, KO (corresponding author), Univ Calif Santa Cruz, WIGS Lab, Santa Cruz, CA 95064 USA.	kodigie@ucsc.edu	Odigie, Kingsley/I-2040-2013		Flegal Research Fund; Department of Energy (DOE) Office of Science Graduate Fellowship Program	Flegal Research Fund; Department of Energy (DOE) Office of Science Graduate Fellowship Program(United States Department of Energy (DOE))	This work was supported by Flegal Research Fund and the Department of Energy (DOE) Office of Science Graduate Fellowship Program. All opinions expressed in this paper are the authors' and do not necessarily reflect the policies and views of DOE Office of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas A, 2008, SCI TOTAL ENVIRON, V404, P129, DOI 10.1016/j.scitotenv.2008.05.043; Biswas A, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002696; BRULAND KW, 1974, ENVIRON SCI TECHNOL, V8, P425, DOI 10.1021/es60090a010; Charles D, 2010, SCIENCE, V329, P738, DOI 10.1126/science.329.5993.738-b; CHOW TJ, 1973, SCIENCE, V181, P551, DOI 10.1126/science.181.4099.551; Cohen AS, 2005, J PALEOLIMNOL, V34, P1, DOI 10.1007/s10933-005-2392-6; Councell TB, 2004, ENVIRON SCI TECHNOL, V38, P4206, DOI 10.1021/es034631f; DASKALAKIS KD, 1995, ENVIRON SCI TECHNOL, V29, P470, DOI 10.1021/es00002a024; Dunlap CE, 2008, GEOCHIM COSMOCHIM AC, V72, P5935, DOI 10.1016/j.gca.2008.10.006; Emmanuel S, 2002, GEOCHIM COSMOCHIM AC, V66, P2517, DOI 10.1016/S0016-7037(02)00863-3; FINNEY B, 1989, MAR POLLUT BULL, V20, P181, DOI 10.1016/0025-326X(89)90490-6; Flannigan MD, 2005, CLIMATIC CHANGE, V72, P1, DOI 10.1007/s10584-005-5935-y; Flegal AR, 2013, CRIT REV ENV SCI TEC, V43, P1869, DOI 10.1080/10643389.2012.671738; FLEGAL AR, 1992, NEW ENGL J MED, V326, P1293; Friedli HR, 2009, ENVIRON SCI TECHNOL, V43, P3507, DOI 10.1021/es802703g; Gabet EJ, 2011, INT J WILDLAND FIRE, V20, P443, DOI 10.1071/WF09105; Gilbert N, 2010, NATURE, DOI [10.1038/news.2010.404, DOI 10.1038/NEWS.2010.404]; Gillett NP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020876; Harris AR, 2005, ENVIRON SCI TECHNOL, V39, P7410, DOI 10.1021/es050642s; HOLMGREN GGS, 1993, J ENVIRON QUAL, V22, P335, DOI 10.2134/jeq1993.00472425002200020015x; Hornberger MI, 1999, MAR CHEM, V64, P39, DOI 10.1016/S0304-4203(98)80083-2; Hu SH, 2009, ATMOS ENVIRON, V43, P2950, DOI 10.1016/j.atmosenv.2009.02.052; InciWeb, 2012, CAMP WILL FIR; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Kober B, 1999, GEOCHIM COSMOCHIM AC, V63, P1293, DOI 10.1016/S0016-7037(99)00064-2; Kristensen LJ, 2014, ENVIRON POLLUT, V190, P159, DOI 10.1016/j.envpol.2014.03.025; McGeer JC, 2000, AQUAT TOXICOL, V50, P231, DOI 10.1016/S0166-445X(99)00105-8; McKenzie D, 2004, CONSERV BIOL, V18, P890, DOI 10.1111/j.1523-1739.2004.00492.x; Mielke HW, 2010, SCI TOTAL ENVIRON, V408, P3965, DOI 10.1016/j.scitotenv.2010.05.017; NG A, 1982, GEOCHIM COSMOCHIM AC, V46, P2307; Nriagu JO, 1996, SCIENCE, V272, P223, DOI 10.1126/science.272.5259.223; Obrist D, 2008, ENVIRON SCI TECHNOL, V42, P721, DOI 10.1021/es071279n; Odigie KO, 2011, ENVIRON SCI TECHNOL, V45, P6290, DOI 10.1021/es200944w; Pakbin P, 2011, AEROSOL SCI TECHNOL, V45; PIRKLE JL, 1994, JAMA-J AM MED ASSOC, V272, P284, DOI 10.1001/jama.272.4.284; Ranali AJ, 2004, 20041296 USGS; Ritson PI, 1999, MAR CHEM, V64, P71, DOI 10.1016/S0304-4203(98)00085-1; Sabin LD, 2005, WATER RES, V39, P3929, DOI 10.1016/j.watres.2005.07.003; Sardar SB, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004627; Schiff KC, 1999, MAR ENVIRON RES, V48, P161, DOI 10.1016/S0141-1136(99)00033-1; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Semlali RM, 2004, ENVIRON SCI TECHNOL, V38, P1513, DOI 10.1021/es0341384; Shacklette H. T., 1984, US GEOLOGICAL SURVEY; SHIRAHATA H, 1980, GEOCHIM COSMOCHIM AC, V44, P149, DOI 10.1016/0016-7037(80)90127-1; Simpson IJ, 2011, ATMOS CHEM PHYS, V11, P6445, DOI 10.5194/acp-11-6445-2011; Singh M, 2002, ATMOS ENVIRON, V36, P1675, DOI 10.1016/S1352-2310(02)00166-8; Smail EA, 2012, ENVIRON SCI TECHNOL, V46, P4304, DOI 10.1021/es2023913; Soto-Jimenez MF, 2006, ENVIRON SCI TECHNOL, V40, P764, DOI 10.1021/es048478g; Steding DJ, 2000, P NATL ACAD SCI USA, V97, P11181, DOI 10.1073/pnas.180125697; Stein ED, 2012, ENVIRON TOXICOL CHEM, V31, P2625, DOI 10.1002/etc.1994; Su JG, 2009, ENVIRON RES, V109, P657, DOI 10.1016/j.envres.2009.06.001; Sutherland RA, 2000, ENVIRON GEOL, V39, P611, DOI 10.1007/s002540050473; US Census, 2013, US CENS BUR 2012 POP; USDA, 2013, ANG NAT FOR; Wang YH, 2010, ECOL MODEL, V221, P122, DOI 10.1016/j.ecolmodel.2008.12.007; Weinhold B, 2011, ENVIRON HEALTH PERSP, V119, pA386, DOI 10.1289/ehp.119-a386; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; Wheeler W, 2013, MMWR-MORBID MORTAL W, V62, P245; Wiedinmyer C, 2007, ENVIRON SCI TECHNOL, V41, P8092, DOI 10.1021/es071289o; Witt EL, 2009, ENVIRON SCI TECHNOL, V43, P1776, DOI 10.1021/es802634y; World Health Organization, 2010, CHILDH LEAD POIS; Wu J, 2010, JAMA-J AM MED ASSOC, V303, P309, DOI 10.1001/jama.2009.1959; YOUNG DR, 1977, MAR POLLUT BULL, V8, P109, DOI 10.1016/0025-326X(77)90133-3	64	35	35	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107835	10.1371/journal.pone.0107835	http://dx.doi.org/10.1371/journal.pone.0107835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259524	Green Published, gold			2022-12-27	WOS:000342685600029
J	Vandini, A; Temmerman, R; Frabetti, A; Caselli, E; Antonioli, P; Balboni, PG; Platano, D; Branchini, A; Mazzacane, S				Vandini, Alberta; Temmerman, Robin; Frabetti, Alessia; Caselli, Elisabetta; Antonioli, Paola; Balboni, Pier Giorgio; Platano, Daniela; Branchini, Alessio; Mazzacane, Sante			Hard Surface Biocontrol in Hospitals Using Microbial-Based Cleaning Products	PLOS ONE			English	Article							BACILLUS-SUBTILIS; TETANUS TOXIN; DISEASE TRANSMISSION; PROBIOTIC BACTERIA; INFECTION-CONTROL; BIOFILM FORMATION; SILICONE-RUBBER; ADHESION; DISINFECTION; BIOSURFACTANTS	Background: Healthcare-Associated Infections (HAIs) are one of the most frequent complications occurring in healthcare facilities. Contaminated environmental surfaces provide an important potential source for transmission of many healthcare-associated pathogens, thus indicating the need for new and sustainable strategies. Aim: This study aims to evaluate the effect of a novel cleaning procedure based on the mechanism of biocontrol, on the presence and survival of several microorganisms responsible for HAIs (i.e. coliforms, Staphyloccus aureus, Clostridium difficile, and Candida albicans) on hard surfaces in a hospital setting. Methods: The effect of microbial cleaning, containing spores of food grade Bacillus subtilis, Bacillus pumilus and Bacillus megaterium, in comparison with conventional cleaning protocols, was evaluated for 24 weeks in three independent hospitals (one in Belgium and two in Italy) and approximately 20000 microbial surface samples were collected. Results: Microbial cleaning, as part of the daily cleaning protocol, resulted in a reduction of HAI-related pathogens by 50 to 89%. This effect was achieved after 3-4 weeks and the reduction in the pathogen load was stable over time. Moreover, by using microbial or conventional cleaning alternatively, we found that this effect was directly related to the new procedure, as indicated by the raise in CFU/m(2) when microbial cleaning was replaced by the conventional procedure. Although many questions remain regarding the actual mechanisms involved, this study demonstrates that microbial cleaning is a more effective and sustainable alternative to chemical cleaning and non-specific disinfection in healthcare facilities. Conclusions: This study indicates microbial cleaning as an effective strategy in continuously lowering the number of HAI-related microorganisms on surfaces. The first indications on the actual level of HAIs in the trial hospitals monitored on a continuous basis are very promising, and may pave the way for a novel and cost-effective strategy to counteract or (bio) control healthcare-associated pathogens.	[Vandini, Alberta; Frabetti, Alessia; Mazzacane, Sante] Univ Ferrara, CIAS Lab, Ctr Study Phys Chem & Microbiol Contaminat Highly, Dept Architecture, I-44100 Ferrara, Italy; [Temmerman, Robin] Univ Ghent, Lab Microbial Ecol & Technol, B-9000 Ghent, Belgium; [Temmerman, Robin] Chrisal R&D Dept, Lommel, Belgium; [Caselli, Elisabetta; Balboni, Pier Giorgio] Univ Ferrara, Dept Med Sci, Microbiol Sect, I-44100 Ferrara, Italy; [Antonioli, Paola] Ferrara Univ Hosp, Dept Infect Prevent Control & Risk Management, Ferrara, Italy; [Platano, Daniela] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Branchini, Alessio] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy	University of Ferrara; Ghent University; University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; University of Bologna; University of Ferrara	Mazzacane, S (corresponding author), Univ Ferrara, CIAS Lab, Ctr Study Phys Chem & Microbiol Contaminat Highly, Dept Architecture, I-44100 Ferrara, Italy.	sante.mazzacane@unife.it	Elisabetta, Caselli/H-1513-2012; antonioli, paola/M-8975-2016; Branchini, Alessio/H-8636-2019	Elisabetta, Caselli/0000-0001-6048-9141; antonioli, paola/0000-0002-1257-3434; Branchini, Alessio/0000-0002-6113-2694	COPMA scrl; Chrisal NV; Flemish Institute for the Promotion of Innovation by Science and Technology (IWT - Vlaanderen, Brussels, Belgium)	COPMA scrl; Chrisal NV; Flemish Institute for the Promotion of Innovation by Science and Technology (IWT - Vlaanderen, Brussels, Belgium)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was financially supported by COPMA scrl, Chrisal NV and the Flemish Institute for the Promotion of Innovation by Science and Technology (IWT - Vlaanderen, Brussels, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090402; Al-Ajlani MM, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-17; Allegranzi B, 2011, REPORT BURDEN ENDEMI; Amuguni H, 2012, MICROBES INFECT, V14, P447, DOI 10.1016/j.micinf.2011.12.001; Amuguni JH, 2011, VACCINE, V29, P4778, DOI 10.1016/j.vaccine.2011.04.083; [Anonymous], 2009, M2A9 CLSI; [Anonymous], 2013, POINT PREVALENCE SUR; Barnes AGC, 2007, EUR J IMMUNOL, V37, P1538, DOI 10.1002/eji.200636875; BAUER AW, 1959, ARCH INTERN MED, V104, P208, DOI 10.1001/archinte.1959.00270080034004; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Beric T, 2013, J APPL MICROBIOL; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Christiaen SEA, 2014, PATHOG DIS, V70, P271, DOI 10.1111/2049-632X.12124; *CLIN LAB STAND I, 2011, M100S21 CLSI; Clinical and Laboratory Standards Institute, 2016, METH ANT DIL DISK SU, V3, pM45; Cohen NR, 2013, CELL HOST MICROBE, V13, P632, DOI 10.1016/j.chom.2013.05.009; Dancer SJ, 2009, J HOSP INFECT, V73, P378, DOI 10.1016/j.jhin.2009.03.030; Davis GS, 2014, J HOSP INFECT, V86, P227, DOI 10.1016/j.jhin.2014.01.010; de Souza RD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087454; DEBOER AS, 1991, APPL MICROBIOL BIOT, V36, P1; Dettenkofer M, 2007, J HOSP INFECT, V65, P55, DOI 10.1016/S0195-6701(07)60016-4; Donskey CJ, 2013, AM J INFECT CONTROL, V41, pS12, DOI 10.1016/j.ajic.2012.12.010; Falagas ME, 2009, J HOSP INFECT, V71, P301, DOI 10.1016/j.jhin.2008.12.008; Frabetti A, 2009, AM J INFECT CONTROL, V37, P658, DOI 10.1016/j.ajic.2009.03.011; Gatesoupe FJ, 1999, AQUACULTURE, V180, P147, DOI 10.1016/S0044-8486(99)00187-8; Gaudart J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076249; Gause GF, 1932, J EXP BIOL, V9, P389; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hinc K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095187; Hota B, 2004, CLIN INFECT DIS, V39, P1182, DOI 10.1086/424667; Huang JM, 2010, VACCINE, V28, P1021, DOI 10.1016/j.vaccine.2009.10.127; Kirby WMM, 1957, ANTIBIOT ANNU, V1956, P892; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Larsen N, 2014, APPL MICROBIOL BIOT, V98, P1105, DOI 10.1007/s00253-013-5343-6; Lee S, 2010, VACCINE, V28, P6658, DOI 10.1016/j.vaccine.2010.08.016; Levkovich T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053867; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Ochoa-Solano JL, 2006, FOOD MICROBIOL, V23, P519, DOI 10.1016/j.fm.2005.10.004; Ohlsson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092368; Otter JA, 2013, AM J INFECT CONTROL, V41, pS6, DOI 10.1016/j.ajic.2012.12.004; Permpoonpattana P, 2011, INFECT IMMUN, V79, P2295, DOI 10.1128/IAI.00130-11; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Porwal S, 2009, PLOS ONE, V4, pe4438, DOI DOI 10.1371/journal.pone.0004438; Ran C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045793; Rodrigues L, 2006, FEMS IMMUNOL MED MIC, V46, P107, DOI 10.1111/j.1574-695X.2005.00006.x; Rodrigues L, 2004, APPL MICROBIOL BIOT, V66, P306, DOI 10.1007/s00253-004-1674-7; Rodrigues L, 2004, APPL ENVIRON MICROB, V70, P4408, DOI 10.1128/AEM.70.7.4408-4410.2004; Rodrigues LR, 2006, J APPL MICROBIOL, V100, P470, DOI 10.1111/j.1365-2672.2005.02826.x; Rutala WA, 2005, AM J INFECT CONTROL, V33, P434, DOI 10.1016/j.ajic.2004.12.007; Rutala WA, 1996, AM J INFECT CONTROL, V24, P313, DOI 10.1016/S0196-6553(96)90066-8; Rutala WA., 2008, GUIDELINES DISINFECT; Scott D., 2009, DIRECT MED COSTS HEA; Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1; Shu MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055380; Temmerman R, 2007, ENG LIFE SCI, V7, P497, DOI 10.1002/elsc.200620212; Ustok FI, 2014, J BACTERIOL, V196, P1045, DOI 10.1128/JB.01298-13; Vary PS, 2007, APPL MICROBIOL BIOT, V76, P957, DOI 10.1007/s00253-007-1089-3; Walencka E, 2008, FOLIA MICROBIOL, V53, P61, DOI 10.1007/s12223-008-0009-y; Weber DJ, 2013, AM J INFECT CONTROL, V41, pS67, DOI 10.1016/j.ajic.2012.10.031; WHO/CDS/CSR/EPH, 2002, PREV HOSP ACQ INF PR, V12; Woo J, 2013, LETT APPL MICROBIOL, V56, P307, DOI 10.1111/lam.12051; Zhao YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092486	66	61	66	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108598	10.1371/journal.pone.0108598	http://dx.doi.org/10.1371/journal.pone.0108598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259528	gold, Green Published			2022-12-27	WOS:000342685600085
J	Zhang, C; Zhao, L; Ma, XH; Zhang, ZQ; Fan, ZM				Zhang, Chen; Zhao, Lei; Ma, Xiaohai; Zhang, Zhaoqi; Fan, Zhanming			A Feasibility Study of an Intravascular Imaging Antenna to Image Atherosclerotic Plaques in Swine Using 3.0 T MRI	PLOS ONE			English	Article								Purpose: To investigate the feasibility of an intravascular imaging antenna to image abdominal aorta atherosclerotic plaque in swine using 3.0T magnetic resonance imaging (MRI). Methods: Atherosclerotic model was established in 6 swine. After 8 months, swine underwent an MR examination, which was performed using an intravascular imaging guide-wire, and images of the common iliac artery and the abdominal aorta were acquired. Intravascular ultrasound (IVUS) was performed in the right femoral artery; images at the same position as for the MR examination were obtained. The luminal border and external elastic membrane of the targeted arteries were individually drawn in the MR and IVUS images. After co-registering these images, the vessel, lumen, and vessel wall areas and the plaque burden in the same lesions imaged using different modalities were calculated and compared. The diagnostic accuracy of intravascular MR examination in delineating the vessel wall and detecting plaques were analyzed and compared using IVUS. Results: Compared with IVUS, good agreement was found between MRI and IVUS for delineating vessel, lumen, and vessel wall areas and plaque burden (r value: 0.98, 0.95, 0.96 and 0.91, respectively; P<0.001). Conclusion: Compared with IVUS, using an intravascular imaging guide-wire to image deep seated arteries allowed determination of the vessel, lumen and vessel wall areas and plaque size and burden. This may provide an alternative method for detecting atherosclerotic plaques in the future.	[Zhang, Chen; Zhao, Lei; Ma, Xiaohai; Zhang, Zhaoqi; Fan, Zhanming] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China	Capital Medical University	Ma, XH (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China.	maxi8238@gmail.com			National Natural Science Foundation of China [81101173]; Project for training high level medical technical personnel in health system in Beijing [2013-3-005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project for training high level medical technical personnel in health system in Beijing	This study is supported by National Natural Science Foundation of China (Grant No.81101173; URL: http://www.nsfc.gov.cn/) and Project for training high level medical technical personnel in health system in Beijing (project number 2013-3-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atalar E, 1996, MAGNET RESON MED, V36, P596, DOI 10.1002/mrm.1910360415; El-Sharkawy AMM, 2008, MED PHYS, V35, P1995, DOI 10.1118/1.2905027; Ganz P, 2000, AM J CARDIOL, V86, p8J; Gu HD, 2011, MAGN RESON IMAGING, V29, P1002, DOI 10.1016/j.mri.2011.04.001; Hiro T, 1997, AM HEART J, V133, P1, DOI 10.1016/S0002-8703(97)70241-2; Kim SH, 2009, AM J CARDIOL, V103, P1221, DOI 10.1016/j.amjcard.2009.01.015; Larose E, 2005, CIRCULATION, V112, P2324, DOI 10.1161/CIRCULATIONAHA.105.538942; Libby P, 2000, AM J CARDIOL, V86, p3J; MacNeill BD, 2003, ARTERIOSCL THROM VAS, V23, P1333, DOI 10.1161/01.ATV.0000080948.08888.BF; Meng YF, 2011, APPL MAGN RESON, V40, P105, DOI 10.1007/s00723-010-0186-0; Ocali O, 1997, MAGNET RESON MED, V37, P112, DOI 10.1002/mrm.1910370116; Qian D, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-20; Qiu BS, 2005, MAGN RESON MED, V53, P986, DOI 10.1002/mrm.20384; Trivedi RA, 2004, EUR J VASC ENDOVASC, V28, P207, DOI 10.1016/j.ejvs.2004.05.001; Yang Xiaoming, 1999, Int J Cardiovasc Intervent, V2, P85; Yuan HY, 2013, MAGN RESON IMAGING, V31, P150, DOI 10.1016/j.mri.2012.06.032; Zimmermann GG, 1997, RADIOLOGY, V204, P769, DOI 10.1148/radiology.204.3.9280257	17	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108301	10.1371/journal.pone.0108301	http://dx.doi.org/10.1371/journal.pone.0108301			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259585	gold, Green Submitted, Green Published			2022-12-27	WOS:000342685600062
J	Kim, MJ; O'Connor, MB				Kim, Myung-Jun; O'Connor, Michael B.			Anterograde Activin Signaling Regulates Postsynaptic Membrane Potential and GluRIIA/B Abundance at the Drosophila Neuromuscular Junction	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; NEURAL STEM-CELLS; TGF-BETA LIGAND; BMP HOMOLOG GBB; GLUTAMATE-RECEPTOR; SYNAPTIC GROWTH; RETROGRADE SIGNAL; QUANTAL SIZE; II RECEPTOR; NERVOUS-SYSTEM	Members of the TGF-beta superfamily play numerous roles in nervous system development and function. In Drosophila, retrograde BMP signaling at the neuromuscular junction (NMJ) is required presynaptically for proper synapse growth and neurotransmitter release. In this study, we analyzed whether the Activin branch of the TGF-beta superfamily also contributes to NMJ development and function. We find that elimination of the Activin/TGF-beta type I receptor babo, or its downstream signal transducer smox, does not affect presynaptic NMJ growth or evoked excitatory junctional potentials (EJPs), but instead results in a number of postsynaptic defects including depolarized membrane potential, small size and frequency of miniature excitatory junction potentials (mEJPs), and decreased synaptic densities of the glutamate receptors GluRIIA and B. The majority of the defective smox synaptic phenotypes were rescued by muscle-specific expression of a smox transgene. Furthermore, a mutation in act beta, an Activin-like ligand that is strongly expressed in motor neurons, phenocopies babo and smox loss-of-function alleles. Our results demonstrate that anterograde Activin/TGF-beta signaling at the Drosophila NMJ is crucial for achieving normal abundance and localization of several important postsynaptic signaling molecules and for regulating postsynaptic membrane physiology. Together with the well-established presynaptic role of the retrograde BMP signaling, our findings indicate that the two branches of the TGF-beta superfamily are differentially deployed on each side of the Drosophila NMJ synapse to regulate distinct aspects of its development and function.	[Kim, Myung-Jun; O'Connor, Michael B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	O'Connor, MB (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	moconnor@umn.edu	O'Connor, Michael B/C-9977-2014	O'Connor, Michael B/0000-0002-3067-5506	NIH [GM95746]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095746] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM95746 to MBO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Ageta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001869; Ai FK, 2012, BIOL OPEN, V1, P362, DOI 10.1242/bio.2012448; Aigner L, 2008, CELL TISSUE RES, V331, P225, DOI 10.1007/s00441-007-0466-7; Albin SD, 2004, J NEUROSCI, V24, P6871, DOI 10.1523/JNEUROSCI.1538-04.2004; ANDREASSON K, 1995, NEUROSCIENCE, V69, P781, DOI 10.1016/0306-4522(95)00245-E; Awasaki T, 2011, NAT NEUROSCI, V14, P821, DOI 10.1038/nn.2833; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Charytoniuk DA, 2000, NEUROSCIENCE, V100, P33, DOI 10.1016/S0306-4522(00)00246-3; Chen HL, 2003, BRAIN RES, V994, P81, DOI 10.1016/j.brainres.2003.09.020; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Clark RI, 2011, CURR BIOL, V21, P1672, DOI 10.1016/j.cub.2011.08.048; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219; Ellis JE, 2010, DEV BIOL, V342, P121, DOI 10.1016/j.ydbio.2010.03.012; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Fuentes-Medel Y, 2012, CURR BIOL, V22, P1831, DOI 10.1016/j.cub.2012.07.063; Fukushima T, 2007, HIPPOCAMPUS, V17, P5, DOI 10.1002/hipo.20243; Gesualdi SC, 2007, FLY, V1, P212, DOI 10.4161/fly.5116; Ghosh AC, 2014, P NATL ACAD SCI USA, V111, P5729, DOI 10.1073/pnas.1319116111; Gibbens YY, 2011, DEVELOPMENT, V138, P2693, DOI 10.1242/dev.063412; Goold CP, 2007, NEURON, V56, P109, DOI 10.1016/j.neuron.2007.08.006; Heckscher ES, 2007, NEURON, V55, P859, DOI 10.1016/j.neuron.2007.08.005; James RE, 2011, DEVELOPMENT, V138, P3273, DOI 10.1242/dev.066142; Jensen PA, 2009, MECH DEVELOP, V126, P950, DOI 10.1016/j.mod.2009.09.003; Jordan-Alvarez S, 2012, J CELL SCI, V125, P3621, DOI 10.1242/jcs.102806; Karunanithi S, 2002, J NEUROSCI, V22, P10267; Kim NC, 2012, DEV NEUROBIOL, V72, P1541, DOI 10.1002/dneu.22021; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Krieglstein K, 2011, TRENDS NEUROSCI, V34, P421, DOI 10.1016/j.tins.2011.06.002; Liu GS, 2003, CURR OPIN NEUROBIOL, V13, P324, DOI 10.1016/S0959-4388(03)00078-3; Liu ZW, 2010, J NEUROSCI, V30, P11624, DOI 10.1523/JNEUROSCI.0410-10.2010; Luo J, 2006, P NATL ACAD SCI USA, V103, P18326, DOI 10.1073/pnas.0605077103; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Nahm M, 2010, J CELL BIOL, V191, P661, DOI 10.1083/jcb.201007086; Pan L, 2007, J NEUROSCI, V27, P12378, DOI 10.1523/JNEUROSCI.2970-07.2007; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Parker L, 2006, DEVELOPMENT, V133, P4981, DOI 10.1242/dev.02673; Penney J, 2012, NEURON, V74, P166, DOI 10.1016/j.neuron.2012.01.030; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Peterson AJ, 2013, DEVELOPMENT, V140, P649, DOI 10.1242/dev.085605; Peterson AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036548; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; RAFTERY LA, 1995, GENETICS, V139, P241; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Schmid A, 2008, NAT NEUROSCI, V11, P659, DOI 10.1038/nn.2122; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; Schuster CM, 2006, CELL TISSUE RES, V326, P287, DOI 10.1007/s00441-006-0290-5; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Serpe M, 2008, DEV CELL, V14, P940, DOI 10.1016/j.devcel.2008.03.023; Serpe M, 2006, DEVELOPMENT, V133, P4969, DOI 10.1242/dev.02711; Smith RB, 2012, J CELL SCI, V125, P3752, DOI 10.1242/jcs.094292; Soderstrom S, 1996, CELL TISSUE RES, V286, P269, DOI 10.1007/s004410050697; Specht H, 2003, MOL CELL NEUROSCI, V22, P75, DOI 10.1016/S1044-7431(02)00023-4; Sun M, 2007, J NEUROSCI, V27, P7740, DOI 10.1523/JNEUROSCI.1604-07.2007; Ting CY, 2007, NEURON, V56, P793, DOI 10.1016/j.neuron.2007.09.033; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Vincze C, 2010, J COMP NEUROL, V518, P3752, DOI 10.1002/cne.22422; Yang Maocheng, 2004, BMC Dev Biol, V4, P14, DOI 10.1186/1471-213X-4-14; Zhang YL, 2007, NEURON, V53, P201, DOI 10.1016/j.neuron.2006.12.016; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zhu CC, 2008, DEVELOPMENT, V135, P513, DOI 10.1242/dev.010876	68	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107443	10.1371/journal.pone.0107443	http://dx.doi.org/10.1371/journal.pone.0107443			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255438	Green Submitted, Green Published, gold			2022-12-27	WOS:000344862300023
J	Diao, LT; Ding, C; Qi, SQ; Zeng, QH; Huang, B; Xu, MS; Fan, LX; Yang, D				Diao, Liuting; Ding, Cody; Qi, Senqing; Zeng, Qinghong; Huang, Bo; Xu, Mengsi; Fan, Lingxia; Yang, Dong			Influence of Supraliminal Reward Information on Unconsciously Triggered Response Inhibition	PLOS ONE			English	Article							PREFRONTAL CORTEX; PERFORMANCE; BEHAVIOR; BRAIN; CUES; CONSCIOUSNESS; ACTIVATION; MOTIVATION	Although executive functions (e.g., response inhibition) are often thought to interact consciously with reward, recent studies have demonstrated that they can also be triggered by unconscious stimuli. Further research has suggested a close relationship between consciously and unconsciously triggered response inhibition. To date, however, the effect of reward on unconsciously triggered response inhibition has not been explored. To address this issue, participants in this study performed runs of a modified Go/No-Go task during which they were exposed to both high and low value monetary rewards presented both supraliminally and subliminally. Participants were informed that they would earn the reward displayed if they responded correctly to each trial of the run. According to the results, when rewards were presented supraliminally, a greater unconsciously triggered response inhibition was observed for high-value rewards than for low-value rewards. In contrast, when rewards were presented subliminally, no enhanced unconsciously triggered response inhibition was observed. Results revealed that supraliminal and subliminal rewards have distinct effects on unconsciously triggered response inhibition. These findings have important implications for extending our understanding of the relationship between reward and response inhibition.	[Diao, Liuting; Ding, Cody; Zeng, Qinghong; Huang, Bo; Xu, Mengsi; Fan, Lingxia; Yang, Dong] Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Diao, Liuting; Ding, Cody; Zeng, Qinghong; Huang, Bo; Xu, Mengsi; Fan, Lingxia; Yang, Dong] Southwest Univ, Mental Hlth Res Ctr, Chongqing, Peoples R China; [Ding, Cody] Univ Missouri, St Louis, MO 63121 USA; [Qi, Senqing] Shaanxi Normal Univ, MOE Key Lab Modern Teaching Technol, Xian, Peoples R China	Southwest University - China; Southwest University - China; University of Missouri System; University of Missouri Saint Louis; Shaanxi Normal University	Yang, D (corresponding author), Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	yangd@swu.edu.cn	Zeng, Ginger Qinghong/AEX-3916-2022; Xu, Mengsi/D-9814-2017; Zeng, Ginger Qinghong/AAH-1066-2022	Xu, Mengsi/0000-0003-1025-9289; 	Humanities and Social Science Research Funds of Chinese Ministry of Education [11XJC190003]; National Natural Science Foundation of China [71472156]	Humanities and Social Science Research Funds of Chinese Ministry of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Humanities and Social Science Research Funds of Chinese Ministry of Education (11XJC190003), and the National Natural Science Foundation of China (71472156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 2008, SCIENCE, V319, P1639, DOI 10.1126/science.1150432; Bijleveld E, 2012, CURR DIR PSYCHOL SCI, V21, P273; Bijleveld E, 2012, J EXP PSYCHOL GEN, V141, P728, DOI 10.1037/a0027615; Bijleveld E, 2010, COGNITION, V115, P330, DOI 10.1016/j.cognition.2009.12.012; Bijleveld E, 2009, PSYCHOL SCI, V20, P1313, DOI 10.1111/j.1467-9280.2009.02443.x; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; Bustin GM, 2012, CONSCIOUS COGN, V21, P947, DOI 10.1016/j.concog.2012.03.005; Capa RL, 2013, CORTEX, V49, P1943, DOI 10.1016/j.cortex.2012.05.018; Capa RL, 2011, INT J PSYCHOPHYSIOL, V81, P22, DOI 10.1016/j.ijpsycho.2011.04.001; Capa RL, 2011, EXP PSYCHOL, V58, P370, DOI 10.1027/1618-3169/a000104; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Houben K, 2011, DRUG ALCOHOL DEPEN, V116, P132, DOI 10.1016/j.drugalcdep.2010.12.011; Jack AI, 2001, COGNITION, V79, P161, DOI 10.1016/S0010-0277(00)00128-1; Jimura K, 2010, P NATL ACAD SCI USA, V107, P8871, DOI 10.1073/pnas.1002007107; Jones A, 2013, EXP CLIN PSYCHOPHARM, V21, P8, DOI 10.1037/a0030683; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Lenartowicz A, 2011, J COGNITIVE NEUROSCI, V23, P3388, DOI 10.1162/jocn_a_00031; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Norman D. A., 1986, CONSCIOUSNESS SELF R, VIV, P1, DOI 10.1007/978-1-4757-0629-1_1; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Van den Bussche E, 2010, CONSCIOUS COGN, V19, P86, DOI 10.1016/j.concog.2009.12.019; van Gaal S, 2008, J NEUROSCI, V28, P8053, DOI 10.1523/JNEUROSCI.1278-08.2008; van Gaal S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00121; van Gaal S, 2011, J COGNITIVE NEUROSCI, V23, P91, DOI 10.1162/jocn.2010.21431; van Gaal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011508; van Gaal S, 2010, J NEUROSCI, V30, P4143, DOI 10.1523/JNEUROSCI.2992-09.2010; Wokke ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025729; Zedelius C. M., 2014, COGN AFFECT BEHAV NE, P1; Zedelius CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042547; Zedelius CM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00219	32	1	1	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108530	10.1371/journal.pone.0108530	http://dx.doi.org/10.1371/journal.pone.0108530			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268227	Green Published, gold			2022-12-27	WOS:000343671700109
J	Han, LH; Su, WR; Huang, JW; Zhou, JW; Qiu, SJ; Liang, D				Han, Longhui; Su, Wenru; Huang, Jingwen; Zhou, Jingwen; Qiu, Sujuan; Liang, Dan			Doxycycline Inhibits Inflammation-Induced Lymphangiogenesis in Mouse Cornea by Multiple Mechanisms	PLOS ONE			English	Article							GROWTH FACTOR-C; LYMPHATIC METASTASIS; MEDIATED INHIBITION; MACROPHAGES; CELLS; NEOVASCULARIZATION; PROMOTES; ANGIOGENESIS; INDUCTION; MELANOMA	Lymphangiogenesis is significantly involved in the pathogenesis of diseases, including graft rejection, cancer metastasis and various inflammatory conditions. The inhibition of lymphangiogenesis has become a new therapeutic target for the treatment of these diseases. Here, we explored the anti-lymphangiogenic effects of doxycycline in inflammation-induced lymphangiogenesis (ILA) in the cornea and the underlying mechanisms. In the present study, mice with ILA of the cornea were treated with topical doxycycline (0.1%) or vehicle control. Lymphangiogenesis was quantified using corneal immunostaining of lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1). Human dermal lymphatic endothelial cells (HDLECs) and a murine macrophage cell line (RAW264.7) were used to further explore the underlying mechanisms of doxycycline-mediated anti-lymphangiogenesis in vitro. Our results showed that doxycycline treatment dramatically inhibited ILA in the mouse cornea (p<0.001), with a significant decrease in vascular endothelial growth factor (VEGF)-C/VEGF receptor 3 signalling, macrophage infiltration and inflammatory cytokine expression. Doxycycline also significantly inhibited VEGF-C-induced HDLEC proliferation in vitro by modulating the PI3K/Akt/endothelial nitric oxide (NO) synthase (eNOS) pathway and significantly suppressed interleukin-1 beta (IL-1 beta), TNF-alpha and VEGF-C production in the RAW264.7 cell line by modulating the PI3K/Akt/nuclear factor-kappaB (NF-kappa B) pathway. Additionally, doxycycline treatment dramatically reduced the phosphorylation of NF-kappa Bp65, Akt and eNOS in ILA and significantly inhibited matrix metalloproteinases (MMPs) activity in vitro and in ILA. In conclusion, doxycycline inhibited ILA, possibly through suppression of VEGF-C signalling, macrophage function and MMPs activity. This observation suggests that doxycycline is a potential therapeutic agent for lymphangiogenesis-related diseases.	[Han, Longhui; Su, Wenru; Huang, Jingwen; Zhou, Jingwen; Qiu, Sujuan; Liang, Dan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Han, Longhui] Hebei Eye Hosp, Hebei Prov Eye Inst, Hebei Prov Key Lab Ophthalmol, Xingtai, Peoples R China	Sun Yat Sen University	Su, WR (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	suwr3@mail.sysu.edu.cn; liangd2@mail.sysu.edu.cn		Su, Wenru/0000-0002-0506-6362	Natural Science Foundation of China [81271051, 81300740]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China: 81271051 and 81300740. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 2008, ANN NY ACAD SCI, V1131, P225, DOI 10.1196/annals.1413.020; Aziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027685; Bahrami F, 2012, MINI-REV MED CHEM, V12, P44, DOI 10.2174/138955712798868977; Bennuru S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000688; Cao RH, 2011, NAT PROTOC, V6, P817, DOI 10.1038/nprot.2011.359; Cazalis J, 2008, J PERIODONTOL, V79, P1762, DOI [10.1902/jop.2008.080051, 10.1902/jop.2008.080051 ]; Chen L, 2004, NAT MED, V10, P813, DOI 10.1038/nm1078; Coso S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039558; Cursiefen C, 2003, CORNEA, V22, P273, DOI 10.1097/00003226-200304000-00021; Cursiefen C, 2011, J EXP MED, V208, P1083, DOI 10.1084/jem.20092277; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; Debrah AY, 2006, PLOS PATHOG, V2, P829, DOI 10.1371/journal.ppat.0020092; Detry B, 2012, BLOOD, V119, P5048, DOI 10.1182/blood-2011-12-400267; Dietrich T, 2010, J IMMUNOL, V184, P535, DOI 10.4049/jimmunol.0903180; Dong M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039695; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Goyal S, 2010, ARCH OPHTHALMOL-CHIC, V128, P819, DOI 10.1001/archophthalmol.2010.124; He LZ, 2014, J BIOL CHEM, V289, P8019, DOI 10.1074/jbc.M113.535765; Ji Rui-Cheng, 2006, Lymphatic Research and Biology, V4, P83, DOI 10.1089/lrb.2006.4.83; Ji RC, 2012, CELL MOL LIFE SCI, V69, P897, DOI 10.1007/s00018-011-0848-6; Jonigk D, 2007, TRANSPLANTATION, V84, P1335, DOI 10.1097/01.tp.0000287458.72440.75; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Kluger MS, 2011, J INVEST DERMATOL, V131, P17, DOI 10.1038/jid.2010.347; Lahdenranta J, 2009, CANCER RES, V69, P2801, DOI 10.1158/0008-5472.CAN-08-4051; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Samtani S, 2009, INVEST OPHTH VIS SCI, V50, P5098, DOI 10.1167/iovs.08-3174; Skobe M, 2001, AM J PATHOL, V159, P893, DOI 10.1016/S0002-9440(10)61765-8; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stuart PM, 2004, INVEST OPHTH VIS SCI, V45, P1169, DOI 10.1167/iovs.03-0932; Su WR, 2013, INVEST OPHTH VIS SCI, V54, P783, DOI 10.1167/iovs.12-10323; Su WR, 2011, INVEST OPHTH VIS SCI, V52, P9108, DOI 10.1167/iovs.11-7255; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Wuest TR, 2010, J EXP MED, V207, P101, DOI 10.1084/jem.20091385; Yan H, 2010, CURR EYE RES, V35, P685, DOI 10.3109/02713681003793136; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Zhang BC, 2011, MED ONCOL, V28, P1447, DOI 10.1007/s12032-010-9638-5; Zhao QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044956	40	24	28	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108931	10.1371/journal.pone.0108931	http://dx.doi.org/10.1371/journal.pone.0108931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268699	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700193
J	Martin, CC; Nezlek, JB				Martin, Chris C.; Nezlek, John B.			The White Ceiling Heuristic and the Underestimation of Asian-American Income	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; RACIAL-DISCRIMINATION; INEQUALITY; HEALTH; RACE; STEREOTYPES; PEOPLE; RELIABILITY; PRIVILEGE; DECISION	The belief that ethnic majorities dominate ethnic minorities informs research on intergroup processes. This belief can lead to the social heuristic that the ethnic majority sets an upper limit that minority groups cannot surpass, but this possibility has not received much attention. In three studies of perceived income, we examined how this heuristic, which we term the White ceiling heuristic leads people to inaccurately estimate the income of a minority group that surpasses the majority. We found that Asian Americans, whose median income has surpassed White median income for nearly three decades, are still perceived as making less than Whites, with the least accurate estimations being made by people who strongly believe that Whites are privileged. In contrast, income estimates for other minorities were fairly accurate. Thus, perceptions of minorities are shaped both by stereotype content and a heuristic.	[Martin, Chris C.] Emory Univ, Atlanta, GA 30322 USA; [Nezlek, John B.] Coll William & Mary, Williamsburg, VA USA; [Nezlek, John B.] Univ Social Sci & Humanities, Poznan, Poland	Emory University; William & Mary; SWPS University of Social Sciences & Humanities	Martin, CC (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	chris.martin.e@gmail.com	Nezlek, John/M-7819-2019	Nezlek, John/0000-0003-4963-3637; Martin, Chris/0000-0002-7806-5838	Graduate Research Grants from the College of William and Mary	Graduate Research Grants from the College of William and Mary	This research was supported by Graduate Research Grants from the College of William and Mary (www.wm.edu/as/graduate/studentresources/researchgrants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NH, 1974, ADV EXPT SOCIAL PSYC, P1, DOI [10.1016/S0065-2601(08)60035-0, DOI 10.1016/S0065-2601(08)60035-0]; Barnes DM, 2013, SOC PSYCH PSYCH EPID, V48, P1941, DOI 10.1007/s00127-013-0718-7; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Beyer S, 1999, SEX ROLES, V40, P787, DOI 10.1023/A:1018864803330; BONACICH E, 1989, SOCIOL SPECTRUM, V9, P77, DOI 10.1080/02732173.1989.9981875; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Breslau J, 2008, J NERV MENT DIS, V196, P297, DOI 10.1097/NMD.0b013e31816a490e; Central Intelligence Agency, 2014, WORLD FACTBOOK; Chen E, 2013, ANNU REV CLIN PSYCHO, V9, P723, DOI 10.1146/annurev-clinpsy-050212-185634; Chorba C, 2001, VA LAW REV, V87, P319, DOI 10.2307/1073890; Chow RM, 2013, PERS SOC PSYCHOL B, V39, P332, DOI 10.1177/0146167212475224; Cohen J.E., 1988, STAT POWER ANAL BEHA; DeNavas-Walt C., 2012, INCOME POVERTY HLTH; Devos T, 2005, J PERS SOC PSYCHOL, V88, P447, DOI 10.1037/0022-3514.88.3.447; Diekman AB, 2000, PERS SOC PSYCHOL B, V26, P1171, DOI 10.1177/0146167200262001; Edwards JR, 2001, ORGAN RES METHODS, V4, P265, DOI 10.1177/109442810143005; Elsass PM, 1997, ACAD MANAGE REV, V22, P946, DOI 10.2307/259250; Evans GW, 2002, ANNU REV PUBL HEALTH, V23, P303, DOI 10.1146/annurev.publhealth.23.112001.112349; Fukuyama MA, 1999, HANDBOOK OF COUNSELING AND PSYCHOTHERAPY WITH LESBIAN, GAY, AND BISEXUAL CLIENTS, P81; Gee GC, 2007, SOC SCI MED, V64, P1984, DOI 10.1016/j.socscimed.2007.02.013; Halualani RT, 2004, INT J INTERCULT REL, V28, P353, DOI 10.1016/j.ijintrel.2004.08.004; Helms J. E., 1995, HDB MULTICULTURAL CO, P181, DOI DOI 10.1177/0011000091191007; Ho AK, 2011, J PERS SOC PSYCHOL, V100, P492, DOI 10.1037/a0021562; Howell D., 2009, STAT METHODS PSYCHOL, V7th; Joshanloo M, 2013, J HAPPINESS STUD, V14, P1857, DOI 10.1007/s10902-012-9406-7; Jussim L., 2012, SOCIAL PERCEPTION SO, DOI 10.1093/acprof:oso/9780195366600.003.0074; Keyes CLM, 2009, J PERS, V77, P1677, DOI 10.1111/j.1467-6494.2009.00597.x; Keyes KM, 2011, SOC SCI MED, V72, P650, DOI 10.1016/j.socscimed.2010.12.005; Kteily NS, 2011, J EXP SOC PSYCHOL, V47, P208, DOI 10.1016/j.jesp.2010.09.009; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; KUO WH, 1995, ETHNIC RACIAL STUD, V18, P109, DOI 10.1080/01419870.1995.9993856; Lai L, 2013, J ORGAN BEHAV, V34, P310, DOI 10.1002/job.1799; Lee YT, 2007, AM BEHAV SCI, V51, P271, DOI 10.1177/0002764207306059; Lee YT, 2013, SOC PERSONAL PSYCHOL, V7, P470, DOI 10.1111/spc3.12039; Lewis MB, 2011, PERS INDIV DIFFER, V50, P159, DOI 10.1016/j.paid.2010.09.018; Lewis MB, 2010, PERCEPTION, V39, P136, DOI 10.1068/p6626; Lewis VA, 2011, SOC FORCES, V89, P1385, DOI 10.1093/sf/89.4.1385; Lowery BS, 2010, J PERS SOC PSYCHOL, V98, P956, DOI 10.1037/a0017926; MACKIE M, 1973, SOC PROBL, V20, P431, DOI 10.1525/sp.1973.20.4.03a00040; Markides KS, 2005, J GERONTOL B-PSYCHOL, V60, P68, DOI 10.1093/geronb/60.Special_Issue_2.S68; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Mays VM, 2007, ANNU REV PSYCHOL, V58, P201, DOI 10.1146/annurev.psych.57.102904.190212; McIntosh P., 1990, INDEPENDENT SCH, V49, P31, DOI DOI 10.1080/23311886.2015.1053183; Min PG, 2006, ASIAN AM CONT TRENDS, P80, DOI DOI 10.4135/9781452233802.N5; Myers Walter Dean, 2014, NEW YORK TIMES, pSR1; Ng WL, 2002, JAPANESE AM INTERNME, VII; Paisano EdnaL, 1993, WE AM ASIANS; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Pew Research Center, 2012, RIS AS AM; Powell AA, 2005, PERS SOC PSYCHOL B, V31, P508, DOI 10.1177/0146167204271713; Quillian L, 2012, AM SOCIOL REV, V77, P354, DOI 10.1177/0003122412447793; Rubenstein WB, 2003, TULANE LAW REV, V78, P1213; Sadler MS, 2012, J SOC ISSUES, V68, P286, DOI 10.1111/j.1540-4560.2012.01749.x; Sakamoto A, 2000, DEMOGRAPHY, V37, P41, DOI 10.2307/2648095; Sakamoto A, 2012, SOCIOL SPECTRUM, V32, P309, DOI 10.1080/02732173.2012.664042; Sakamoto A, 2009, ANNU REV SOCIOL, V35, P255, DOI 10.1146/annurev-soc-070308-115958; Shih M, 2002, J PERS SOC PSYCHOL, V83, P638, DOI 10.1037//0022-3514.83.3.638; Short K., 2012, RES SUPPLEMENTAL POV; Sidanius J, 1996, INT J INTERCULT REL, V20, P385, DOI 10.1016/0147-1767(96)00025-9; Simons DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051876; Sowell T, 2013, INTELLECTUALS RACE; Stewart TL, 2012, J SOC ISSUES, V68, P11, DOI 10.1111/j.1540-4560.2012.01733.x; SUE S, 1990, AM PSYCHOL, V45, P913, DOI 10.1037/0003-066X.45.8.913; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Thomas DR, 2012, EDUC PSYCHOL MEAS, V72, P37, DOI 10.1177/0013164411409929; Walton GM, 2003, J EXP SOC PSYCHOL, V39, P456, DOI 10.1016/S0022-1031(03)00019-2; Wong YJ, 2012, CULT DIVERS ETHN MIN, V18, P258, DOI 10.1037/a0028423; Zimmerman DW, 1997, BRIT J MATH STAT PSY, V50, P73, DOI 10.1111/j.2044-8317.1997.tb01103.x; Zitek EM, 2012, J PERS SOC PSYCHOL, V102, P98, DOI 10.1037/a0025345	69	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108732	10.1371/journal.pone.0108732	http://dx.doi.org/10.1371/journal.pone.0108732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268366	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700150
J	Minchew, CL; Didenko, VV				Minchew, Candace L.; Didenko, Vladimir V.			Nanoblinker: Brownian Motion Powered Bio-Nanomachine for FRET Detection of Phagocytic Phase of Apoptosis	PLOS ONE			English	Article							DNA TOPOISOMERASE-I; RESONANCE ENERGY-TRANSFER; VACCINIA; BREAKS; DEGRADATION; LIGATION; CLEAVAGE; GOVERN	We describe a new type of bio-nanomachine which runs on thermal noise. The machine is solely powered by the random motion of water molecules in its environment and does not ever require re-fuelling. The construct, which is made of DNA and vaccinia virus topoisomerase protein, can detect DNA damage by employing fluorescence. It uses Brownian motion as a cyclic motor to continually separate and bring together two types of fluorescent hairpins participating in FRET. This biomolecular oscillator is a fast and specific sensor of 5'OH double-strand DNA breaks present in phagocytic phase of apoptosis. The detection takes 30 s in solution and 3 min in cell suspensions. The phagocytic phase is critical for the effective execution of apoptosis as it ensures complete degradation of the dying cells' DNA, preventing release of pathological, viral and tumor DNA and self-immunization. The construct can be used as a smart FRET probe in studies of cell death and phagocytosis.	[Minchew, Candace L.; Didenko, Vladimir V.] Baylor Coll Med, Houston, TX 77030 USA; [Minchew, Candace L.; Didenko, Vladimir V.] Michael E DeBakey VA Med Ctr, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine	Didenko, VV (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	vdidenko@bcm.edu		Didenko, Vladimir/0000-0002-8293-5410	National Institute of Neurological Disorders and Stroke, National Institutes of Health [R01 NS062842, R21 NS064403]; National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health [R21 EB006301]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB006301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062842, R21NS064403] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grant R01 NS062842 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health (V.V.D.) and by grants R21 NS064403 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health (V.V.D.) and R21 EB006301, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health (V.V.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; CHAMPOUX JJ, 1990, DNA TOPOLOGY ITS BIO; Didenko Vladimir V, 2002, Methods Mol Biol, V203, P143; Didenko VV, 2011, METHODS MOL BIOL, V682, P77, DOI 10.1007/978-1-60327-409-8_7; Didenko VV, 2003, AM J PATHOL, V162, P1571, DOI 10.1016/S0002-9440(10)64291-5; Dighe NS, 2010, INT J DRUG FORMULATI, V1, P66; Green DR, 2011, MEANS END APOPTOSIS; Hailey DW, 2002, METHOD ENZYMOL, V351, P34; Haugland RP., 2010, HDB FLUORESCENT PROB; Hornsby PJ, 2011, METHODS MOL BIOL, V682, P49, DOI 10.1007/978-1-60327-409-8_5; Kay ER, 2005, TOP CURR CHEM, V262, P133, DOI 10.1007/128_011; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Krieser RJ, 2002, CELL DEATH DIFFER, V9, P956, DOI 10.1038/sj.cdd.4401056; Lambert NA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125re5; Minchew CL, 2011, MOLECULES, V16, P4599, DOI 10.3390/molecules16064599; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Saini DK, 2009, TRENDS PHARMACOL SCI, V30, P278, DOI 10.1016/j.tips.2009.04.001; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; SHUMAN S, 1988, J BIOL CHEM, V263, P16401; SHUMAN S, 1992, J BIOL CHEM, V267, P8620; Shuman S, 1998, BBA-GENE STRUCT EXPR, V1400, P321, DOI 10.1016/S0167-4781(98)00144-4; Singh R, 2006, ENCY DICT BIOPHYSICS; Stahley MR, 2010, BIOCHEMISTRY-US, V49, P2786, DOI 10.1021/bi902204v; STIVERS JT, 1994, BIOCHEMISTRY-US, V33, P15449, DOI 10.1021/bi00255a027; STIVERS JT, 1994, BIOCHEMISTRY-US, V33, P327, DOI 10.1021/bi00167a043; von Delius M, 2011, CHEM SOC REV, V40, P3656, DOI 10.1039/c1cs15005g; Yakovleva L, 2008, J BIOL CHEM, V283, P16093, DOI 10.1074/jbc.M801595200; Yang JS, 2008, ORG LETT, V10, P2279, DOI 10.1021/ol800689a	31	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108734	10.1371/journal.pone.0108734	http://dx.doi.org/10.1371/journal.pone.0108734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268504	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700151
J	Moeckel, S; Meyer, K; Leukel, P; Heudorfer, F; Seliger, C; Stangl, C; Bogdahn, U; Proescholdt, M; Brawanski, A; Vollmann-Zwerenz, A; Riemenschneider, MJ; Bosserhoff, AK; Spang, R; Hau, P				Moeckel, Sylvia; Meyer, Katharina; Leukel, Petra; Heudorfer, Fabian; Seliger, Corinna; Stangl, Christina; Bogdahn, Ulrich; Proescholdt, Martin; Brawanski, Alexander; Vollmann-Zwerenz, Arabel; Riemenschneider, Markus J.; Bosserhoff, Anja-Katrin; Spang, Rainer; Hau, Peter			Response-Predictive Gene Expression Profiling of Glioma Progenitor Cells In Vitro	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; TUMOR-CELLS; SUNITINIB; CANCER; RECEPTORS; MIGRATION; IDENTIFICATION; RESISTANCE; PATTERN	Background: High-grade gliomas are amongst the most deadly human tumors. Treatment results are disappointing. Still, in several trials around 20% of patients respond to therapy. To date, diagnostic strategies to identify patients that will profit from a specific therapy do not exist. Methods: In this study, we used serum-free short-term treated in vitro cell cultures to predict treatment response in vitro. This approach allowed us (a) to enrich specimens for brain tumor initiating cells and (b) to confront cells with a therapeutic agent before expression profiling. Results: As a proof of principle we analyzed gene expression in 18 short-term serum-free cultures of high-grade gliomas enhanced for brain tumor initiating cells (BTIC) before and after in vitro treatment with the tyrosine kinase inhibitor Sunitinib. Profiles from treated progenitor cells allowed to predict therapy-induced impairment of proliferation in vitro. Conclusion: For the tyrosine kinase inhibitor Sunitinib used in this dataset, the approach revealed additional predictive information in comparison to the evaluation of classical signaling analysis.	[Moeckel, Sylvia; Leukel, Petra; Heudorfer, Fabian; Seliger, Corinna; Stangl, Christina; Bogdahn, Ulrich; Vollmann-Zwerenz, Arabel; Hau, Peter] Univ Hosp Regensburg, Dept Neurol, Regensburg, Germany; [Moeckel, Sylvia; Leukel, Petra; Heudorfer, Fabian; Seliger, Corinna; Stangl, Christina; Bogdahn, Ulrich; Vollmann-Zwerenz, Arabel; Hau, Peter] Univ Hosp Regensburg, Wilhelm Sander NeuroOncol Unit, Regensburg, Germany; [Meyer, Katharina; Spang, Rainer] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Proescholdt, Martin; Brawanski, Alexander] Univ Hosp Regensburg, Dept Neurosurg, Regensburg, Germany; [Riemenschneider, Markus J.] Regensburg Univ Hosp, Dept Neuropathol, Regensburg, Germany; [Bosserhoff, Anja-Katrin] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg	Hau, P (corresponding author), Univ Hosp Regensburg, Dept Neurol, Regensburg, Germany.	peter.hau@ukr.de	Bosserhoff, Anja/GNH-4801-2022; Reifenberger, Guido/AAE-3599-2019	Bosserhoff, Anja/0000-0001-8147-394X; Spang, Rainer/0000-0002-1326-4297; Hau, Peter/0000-0003-3894-5053	Wilhelm Sander-Stiftung, Munich, Germany [2009-803-1]; BioSysNet, Germany	Wilhelm Sander-Stiftung, Munich, Germany; BioSysNet, Germany	The work was supported by an unrestricted grant of the Wilhelm Sander-Stiftung, Munich, Germany (http://www.wilhelm-sander-stiftung.de/cms/front_content.php), grant number 2009-803-1, and by BioSysNet, Germany (http://www.biosysnet.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouantoun TJ, 2011, J NEURO-ONCOL, V101, P215, DOI 10.1007/s11060-010-0259-9; Adams VR, 2007, CLIN THER, V29, P1338, DOI 10.1016/j.clinthera.2007.07.022; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chahal M, 2010, NEURO-ONCOLOGY, V12, P822, DOI 10.1093/neuonc/noq017; D'Amico R, 2012, NEUROL RES, V34, P252, DOI 10.1179/1743132812Y.0000000005; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; de Bouard S, 2007, NEURO-ONCOLOGY, V9, P412, DOI 10.1215/15228517-2007-024; Deisboeck TS, 2001, CELL PROLIFERAT, V34, P115, DOI 10.1046/j.1365-2184.2001.00202.x; Deryugina EI, 1996, J CELL SCI, V109, P643; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Giannopoulou E, 2010, INVEST NEW DRUG, V28, P554, DOI 10.1007/s10637-009-9290-0; Gotink KJ, 2011, CLIN CANCER RES, V17, P7337, DOI 10.1158/1078-0432.CCR-11-1667; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Koutras AK, 2007, ANTICANCER RES, V27, P4255; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; McCord AM, 2009, CLIN CANCER RES, V15, P5145, DOI 10.1158/1078-0432.CCR-09-0263; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Mimeault M, 2011, BRAIN PATHOL, V21, P479, DOI 10.1111/j.1750-3639.2011.00505.x; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Nazarenko I, 2012, UPSALA J MED SCI, V117, P99, DOI 10.3109/03009734.2012.665097; Neyns B, 2011, J NEURO-ONCOL, V103, P491, DOI 10.1007/s11060-010-0402-7; Nilsson MB, 2010, ONCOGENE, V29, P2938, DOI 10.1038/onc.2010.60; Pan E, 2012, J NEURO-ONCOL, V110, P111, DOI 10.1007/s11060-012-0943-z; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; PLATE KH, 1993, CANCER RES, V53, P5822; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Reardon DA, 2011, J NEURO-ONCOL, V105, P621, DOI 10.1007/s11060-011-0631-4; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Stupp Roger, 2005, Curr Neurol Neurosci Rep, V5, P198, DOI 10.1007/s11910-005-0047-7; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weller M, 2012, CANCER J, V18, P40, DOI 10.1097/PPO.0b013e318243f6c9; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Yang F, 2010, MOL CANCER RES, V8, P35, DOI 10.1158/1541-7786.MCR-09-0220; Zhou QY, 2012, J PHARMACOL EXP THER, V343, P509, DOI 10.1124/jpet.112.196097	48	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108632	10.1371/journal.pone.0108632	http://dx.doi.org/10.1371/journal.pone.0108632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268354	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700130
J	Sharman, M; Gallea, C; Lehongre, K; Galanaud, D; Nicolas, N; Similowski, T; Cohen, L; Straus, C; Naccache, L				Sharman, Mike; Gallea, Cecile; Lehongre, Katia; Galanaud, Damien; Nicolas, Nathalie; Similowski, Thomas; Cohen, Laurent; Straus, Christian; Naccache, Lionel			The Cerebral Cost of Breathing: An fMRI Case-Study in Congenital Central Hypoventilation Syndrome	PLOS ONE			English	Article							BLOOD-FLOW; RESPONSES; CHILDREN; ACTIVATION; AWARENESS; NETWORK; PHOX2B; GENE; LOAD	Certain motor activities - like walking or breathing - present the interesting property of proceeding either automatically or under voluntary control. In the case of breathing, brainstem structures located in the medulla are in charge of the automatic mode, whereas cortico-subcortical brain networks - including various frontal lobe areas - subtend the voluntary mode. We speculated that the involvement of cortical activity during voluntary breathing could impact both on the "resting state'' pattern of cortical-subcortical connectivity, and on the recruitment of executive functions mediated by the frontal lobe. In order to test this prediction we explored a patient suffering from central congenital hypoventilation syndrome (CCHS), a very rare developmental condition secondary to brainstem dysfunction. Typically, CCHS patients demonstrate efficient cortically-controlled breathing while awake, but require mechanically-assisted ventilation during sleep to overcome the inability of brainstem structures to mediate automatic breathing. We used simultaneous EEG-fMRI recordings to compare patterns of brain activity between these two types of ventilation during wakefulness. As compared with spontaneous breathing (SB), mechanical ventilation (MV) restored the default mode network (DMN) associated with self-consciousness, mind-wandering, creativity and introspection in healthy subjects. SB on the other hand resulted in a specific increase of functional connectivity between brainstem and frontal lobe. Behaviorally, the patient was more efficient in cognitive tasks requiring executive control during MV than during SB, in agreement with her subjective reports in everyday life. Taken together our results provide insight into the cognitive and neural costs of spontaneous breathing in one CCHS patient, and suggest that MV during waking periods may free up frontal lobe resources, and make them available for cognitive recruitment. More generally, this study reveals how the active maintenance of cortical control over a continuous motor activity impacts on brain functioning and cognition.	[Sharman, Mike; Lehongre, Katia; Cohen, Laurent; Naccache, Lionel] INSERM, Inst Cerveau & Moelle Epiniere ICM, Unite Mixte Rech 1127, PICNIC Lab, Paris, France; [Sharman, Mike; Lehongre, Katia; Cohen, Laurent; Naccache, Lionel] CNRS, Inst Cerveau & Moelle Epiniere ICM, Unite 7225, PICNIC Lab, Paris, France; [Gallea, Cecile; Galanaud, Damien] INSERM, Inst Cerveau & Moelle Epiniere ICM, Unite Mixte Rech 1127, CENIR, Paris, France; [Galanaud, Damien] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Dept Neuroradiol, Paris, France; [Galanaud, Damien; Similowski, Thomas; Cohen, Laurent; Straus, Christian] Univ Paris 06, Fac Med Pitie Salpetriere, Paris, France; [Nicolas, Nathalie; Naccache, Lionel] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Ctr Invest Clin 1421, Paris, France; [Similowski, Thomas; Straus, Christian] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Serv Pneumol & Reanimat Med, Dept R3S, Paris, France; [Similowski, Thomas; Straus, Christian] Sorbonne Univ, Univ Paris 06, Unite Mixte Rech Neurophysiol Resp Expt & Clin 11, F-75230 Paris 05, France; [Similowski, Thomas; Straus, Christian] INSERM, Unite Mixte Rech Neurophysiol Resp Expt & Clin 11, Paris, France; [Cohen, Laurent; Naccache, Lionel] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Dept Neurol, Paris, France; [Straus, Christian] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Serv Explorat Fonct Respirat Exercice & Dyspnee, Dept R3S, Paris, France; [Straus, Christian] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Ctr Reference Malad Rares Syndrome Ondine, Paris, France; [Naccache, Lionel] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Dept Neurophysiol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Naccache, L (corresponding author), INSERM, Inst Cerveau & Moelle Epiniere ICM, Unite Mixte Rech 1127, PICNIC Lab, Paris, France.	lionel.naccache@gmail.com		cohen, laurent/0000-0002-5010-9085; naccache, lionel/0000-0002-2874-1009; GALLEA, Cecile/0000-0001-8070-8794	Fondation pour la Recherche Medicale (FRM) ('Equipe FRM' grant); Institut pour le Cerveau et la Moelle epiniere (ICM Institute, Paris, France); INSERM; program "Investissement d'Avenir of the French Government" [ANR-10-AIHU 06]; IHU-A-ICM ('Investissement d'avenir' program) [ANR-10-IAIHU-06]; Assistance Publique-Hopitaux de Paris (AP-HP) Departement de la Recherche Clinique et du Developpement (DRCD) ("RESPIRONDINE'' project); Association Francaise du Syndrome d'Ondine (AFSO); program "Investissements d'avenir" [ANR-10-IAIHU-06]	Fondation pour la Recherche Medicale (FRM) ('Equipe FRM' grant); Institut pour le Cerveau et la Moelle epiniere (ICM Institute, Paris, France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); program "Investissement d'Avenir of the French Government"(French National Research Agency (ANR)); IHU-A-ICM ('Investissement d'avenir' program)(French National Research Agency (ANR)); Assistance Publique-Hopitaux de Paris (AP-HP) Departement de la Recherche Clinique et du Developpement (DRCD) ("RESPIRONDINE'' project); Association Francaise du Syndrome d'Ondine (AFSO); program "Investissements d'avenir"(French National Research Agency (ANR))	This work has been supported by the Fondation pour la Recherche Medicale (FRM) ('Equipe FRM 2010' grant to Lionel Naccache), by the Institut pour le Cerveau et la Moelle epiniere (ICM Institute, Paris, France), by INSERM, by AP-HP, by the program "Investissement d'Avenir ANR-10-AIHU 06 of the French Government'', by the IHU-A-ICM ('Investissement d'avenir' program, ANR-10-IAIHU-06), by Assistance Publique-Hopitaux de Paris (AP-HP) Departement de la Recherche Clinique et du Developpement (DRCD) ("RESPIRONDINE'' project), by Association Francaise du Syndrome d'Ondine (AFSO). The research leading to these results has received funding from the program "Investissements d'avenir'' ANR-10-IAIHU-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Cajochen C, 1995, SLEEP, V18, P890, DOI 10.1093/sleep/18.10.890; COLEBATCH JG, 1991, J PHYSIOL-LONDON, V443, P91, DOI 10.1113/jphysiol.1991.sp018824; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Denot-Ledunois S, 1998, INT J PSYCHOPHYSIOL, V29, P13, DOI 10.1016/S0167-8760(97)00086-X; El Karoui I, 2013, CNS ANN M SAN FRANC; Evans KC, 1999, J PHYSIOL-LONDON, V520, P383, DOI 10.1111/j.1469-7793.1999.00383.x; GALLEGO J, 1991, PSYCHOPHYSIOLOGY, V28, P217, DOI 10.1111/j.1469-8986.1991.tb00413.x; Goldenberg F, 1986, Rev Electroencephalogr Neurophysiol Clin, V16, P39, DOI 10.1016/S0370-4475(86)80017-X; GOLDENBERG F, 1988, Neurophysiologie Clinique, V18, P433, DOI 10.1016/S0987-7053(88)80054-6; Gozal D, 1996, J CLIN INVEST, V97, P47, DOI 10.1172/JCI118405; GOZAL D, 1995, P NATL ACAD SCI USA, V92, P6607, DOI 10.1073/pnas.92.14.6607; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; GUILLEMINAULT C, 1982, PEDIATRICS, V70, P684; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Isaev G, 2002, J PHYSIOL-LONDON, V539, P935, DOI 10.1113/jphysiol.2001.012957; Kunde W, 2003, PSYCHON B REV, V10, P198, DOI 10.3758/BF03196485; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Laufs H, 2008, NEUROIMAGE, V40, P515, DOI 10.1016/j.neuroimage.2007.11.039; Laviolette L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062258; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Macey KE, 2004, J APPL PHYSIOL, V97, P1897, DOI 10.1152/japplphysiol.00359.2004; Macey PM, 2005, PEDIATR RES, V57, P500, DOI 10.1203/01.PDR.0000155757.98389.53; Macey PM, 2005, J APPL PHYSIOL, V98, P958, DOI 10.1152/japplphysiol.00969.2004; MCCARTHY RA, 1990, COGNITIVE NEUROPSYCH; Mckay LC, 2008, NEUROIMAGE, V40, P1824, DOI 10.1016/j.neuroimage.2008.01.058; MELLINS RB, 1970, MEDICINE, V49, P487, DOI 10.1097/00005792-197011000-00003; Merikle PM, 1995, CONSCIOUS COGN, V4, P422, DOI 10.1006/ccog.1995.1049; Naccache L., 2009, REV NEUROPSYCHOL, V1, P42; Naccache L, 2008, CONSCIOUS COGN, V17, P1359, DOI 10.1016/j.concog.2008.01.002; OREN J, 1987, PEDIATRICS, V80, P375; PATON JY, 1993, AM REV RESPIR DIS, V147, P1185, DOI 10.1164/ajrccm/147.5.1185; PATON JY, 1989, AM REV RESPIR DIS, V140, P368, DOI 10.1164/ajrccm/140.2.368; Pattinson KTS, 2009, NEUROIMAGE, V44, P295, DOI 10.1016/j.neuroimage.2008.09.007; Patwari PP, 2010, RESP PHYSIOL NEUROBI, V173, P322, DOI 10.1016/j.resp.2010.06.013; Perlbarg V, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/218519; Pizoli CE, 2011, P NATL ACAD SCI USA, V108, P11638, DOI 10.1073/pnas.1109144108; Poldrack RA, 2005, J NEUROSCI, V25, P5356, DOI 10.1523/JNEUROSCI.3880-04.2005; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAMSAY SC, 1993, J PHYSIOL-LONDON, V461, P85, DOI 10.1113/jphysiol.1993.sp019503; Raux M, 2007, ANESTHESIOLOGY, V107, P746, DOI 10.1097/01.anes.0000287005.58761.e8; Raux M, 2007, J PHYSIOL-LONDON, V578, P569, DOI 10.1113/jphysiol.2006.120246; Raux M, 2013, RESP PHYSIOL NEUROBI, V189, P571, DOI 10.1016/j.resp.2013.08.005; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; SHEA SA, 1993, RESP PHYSIOL, V94, P251, DOI 10.1016/0034-5687(93)90022-3; Smejkal V, 2000, PHYSIOL RES, V49, P659; Smith JC, 2013, TRENDS NEUROSCI, V36, P152, DOI 10.1016/j.tins.2012.11.004; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Tremoureux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084534; Tremoureux L, 2010, J APPL PHYSIOL, V108, P1127, DOI 10.1152/japplphysiol.91449.2008; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Gaal S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00121; van Gaal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011508; Vanhaudenhuyse A, 2011, J COGNITIVE NEUROSCI, V23, P570, DOI 10.1162/jocn.2010.21488; Weese-Mayer DE, 2010, AM J RESP CRIT CARE, V181, P626, DOI 10.1164/rccm.200807-1069ST; Weiskrantz L., 1997, CONSCIOUSNESS LOST F; Woo MA, 2005, PEDIATR RES, V57, P510, DOI 10.1203/01.PDR.0000155763.93819.46; Zelko FA, 2010, PEDIATR PULM, V45, P92, DOI 10.1002/ppul.21170	58	19	19	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107850	10.1371/journal.pone.0107850	http://dx.doi.org/10.1371/journal.pone.0107850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268234	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700049
J	Shitan, N; Minami, S; Morita, M; Hayashida, M; Ito, S; Takanashi, K; Omote, H; Moriyama, Y; Sugiyama, A; Goossens, A; Moriyasu, M; Yazaki, K				Shitan, Nobukazu; Minami, Shota; Morita, Masahiko; Hayashida, Minaho; Ito, Shingo; Takanashi, Kojiro; Omote, Hiroshi; Moriyama, Yoshinori; Sugiyama, Akifumi; Goossens, Alain; Moriyasu, Masataka; Yazaki, Kazufumi			Involvement of the Leaf-Specific Multidrug and Toxic Compound Extrusion (MATE) Transporter Nt-JAT2 in Vacuolar Sequestration of Nicotine in Nicotiana tabacum	PLOS ONE			English	Article							BINDING CASSETTE PROTEIN; MEMBRANE-TRANSPORT; PLANT; EFFLUX; ALKALOIDS; BIOSYNTHESIS; METABOLISM; RESISTANCE; MECHANISM; CITRATE	Alkaloids play a key role in higher plant defense against pathogens and herbivores. Following its biosynthesis in root tissues, nicotine, the major alkaloid of Nicotiana species, is translocated via xylem transport toward the accumulation sites, leaf vacuoles. Our transcriptome analysis of methyl jasmonate-treated tobacco BY-2 cells identified several multidrug and toxic compound extrusion (MATE) transporter genes. In this study, we characterized a MATE gene, Nicotiana tabacum jasmonate-inducible alkaloid transporter 2 (Nt-JAT2), which encodes a protein that has 32% amino acid identity with Nt-JAT1. Nt-JAT2 mRNA is expressed at a very low steady state level in whole plants, but is rapidly upregulated by methyl jasmonate treatment in a leaf-specific manner. To characterize the function of Nt-JAT2, yeast cells were used as the host organism in a cellular transport assay. Nt-JAT2 was localized at the plasma membrane in yeast cells. When incubated in nicotine-containing medium, the nicotine content in Nt-JAT2-expressing cells was significantly lower than in control yeast. Nt-JAT2-expressing cells also showed lower content of other alkaloids like anabasine and anatabine, but not of flavonoids, suggesting that Nt-JAT2 transports various alkaloids including nicotine. Fluorescence assays in BY-2 cells showed that Nt-JAT2-GFP was localized to the tonoplast. These findings indicate that Nt-JAT2 is involved in nicotine sequestration in leaf vacuoles following the translocation of nicotine from root tissues.	[Shitan, Nobukazu; Minami, Shota; Hayashida, Minaho; Moriyasu, Masataka] Kobe Pharmaceut Univ, Dept Nat Med Chem, Kobe, Hyogo 658, Japan; [Shitan, Nobukazu; Morita, Masahiko; Ito, Shingo; Takanashi, Kojiro; Sugiyama, Akifumi; Yazaki, Kazufumi] Kyoto Univ, Res Inst Sustainable Humanosphere, Lab Plant Gene Express, Kyoto, Japan; [Omote, Hiroshi; Moriyama, Yoshinori] Okayama Univ, Dept Membrane Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Goossens, Alain] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Goossens, Alain] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium	Kobe Pharmaceutical University; Kyoto University; Okayama University; Flanders Institute for Biotechnology (VIB); Ghent University	Shitan, N (corresponding author), Kobe Pharmaceut Univ, Dept Nat Med Chem, Kobe, Hyogo 658, Japan.	shitan@kobepharma-u.ac.jp		Goossens, Alain/0000-0002-1599-551X; Shitan, Nobukazu/0000-0001-7760-2745; Sugiyama, Akifumi/0000-0002-9643-6639	JSPS KAKENHI [25712012, 21880048, 19039019]; Takeda Science Foundation; Hyogo Science and Technology Association; Noda Institute for Scientific Research; Nippon Life Insurance Foundation; Exploratory Research on Sustainable Humanosphere Science from Research Institute for Sustainable Humanosphere (RISH), Kyoto University; Grants-in-Aid for Scientific Research [25712012] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Hyogo Science and Technology Association; Noda Institute for Scientific Research(Noda Institute for Scientific Research); Nippon Life Insurance Foundation(Nippon Life Insurance Foundation); Exploratory Research on Sustainable Humanosphere Science from Research Institute for Sustainable Humanosphere (RISH), Kyoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JSPS KAKENHI Grant Numbers 25712012 (Grant-in-Aid for Young Scientists (A) to N.S.), 21880048 (Grant-in-Aid for Young Scientists (Start-up) to N.S.), and 19039019 (Grant-in-Aid for Scientific Research on Priority Areas to K.Y.); by the Takeda Science Foundation, the Hyogo Science and Technology Association, the Noda Institute for Scientific Research, the Nippon Life Insurance Foundation, and by grant for Exploratory Research on Sustainable Humanosphere Science from Research Institute for Sustainable Humanosphere (RISH), Kyoto University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN IT, 1989, J CHEM ECOL, V15, P1661, DOI 10.1007/BF01012392; Carqueijeiro I, 2013, PLANT PHYSIOL, V162, P1486, DOI 10.1104/pp.113.220558; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Diener AC, 2001, PLANT CELL, V13, P1625, DOI 10.1105/tpc.13.7.1625; Durrett TP, 2007, PLANT PHYSIOL, V144, P197, DOI 10.1104/pp.107.097162; Gomez C, 2009, PLANT PHYSIOL, V150, P402, DOI 10.1104/pp.109.135624; Goossens A, 2003, P NATL ACAD SCI USA, V100, P8595, DOI 10.1073/pnas.1032967100; Hakkinen S, 2004, PLANTA MED, V70, P936, DOI 10.1055/s-2004-832620; Hashimoto T, 2003, CURR OPIN BIOTECH, V14, P163, DOI 10.1016/S0958-1669(03)00027-2; Hildreth SB, 2011, P NATL ACAD SCI USA, V108, P18179, DOI 10.1073/pnas.1108620108; Kessler D, 2012, PLANT J, V71, P529, DOI 10.1111/j.1365-313X.2012.05008.x; Krecek P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-249; Kutsuna N, 2002, PLANT CELL PHYSIOL, V43, P965, DOI 10.1093/pcp/pcf138; Li LG, 2002, J BIOL CHEM, V277, P5360, DOI 10.1074/jbc.M108777200; Lochmann H, 2001, J CHROMATOGR A, V917, P311, DOI 10.1016/S0021-9673(01)00627-6; Marinova K, 2007, PLANT CELL, V19, P2023, DOI 10.1105/tpc.106.046029; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; Morita M, 2009, P NATL ACAD SCI USA, V106, P2447, DOI 10.1073/pnas.0812512106; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Naconsie M, 2014, PLANT CELL PHYSIOL, V55, P436, DOI 10.1093/pcp/pct179; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Nour-Eldin HH, 2013, CURR OPIN BIOTECH, V24, P263, DOI 10.1016/j.copbio.2012.09.006; Otani M, 2005, PLANT PHYSIOL, V138, P1939, DOI 10.1104/pp.105.064352; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Shitan N, 2007, CURR PHARM BIOTECHNO, V8, P244; Shitan N, 2003, P NATL ACAD SCI USA, V100, P751, DOI 10.1073/pnas.0134257100; Shitan N, 2011, ANAL PLANT SECONDARY, P51; Shitan N, 2013, INT REV CEL MOL BIO, V305, P383, DOI 10.1016/B978-0-12-407695-2.00009-3; Shitan N, 2013, PHYTOCHEMISTRY, V91, P109, DOI 10.1016/j.phytochem.2012.02.012; Shitan Nobukazu, 2013, Methods Mol Biol, V1011, P241, DOI 10.1007/978-1-62703-414-2_19; Shoji T, 2009, PLANT PHYSIOL, V149, P708, DOI 10.1104/pp.108.132811; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Takanashi K, 2013, PLANT CELL PHYSIOL, V54, P585, DOI 10.1093/pcp/pct019; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson EP, 2010, J EXP BOT, V61, P439, DOI 10.1093/jxb/erp312; Tiwari M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03964; Yazaki Kazufumi, 2008, Phytochemistry Reviews, V7, P513, DOI 10.1007/s11101-007-9079-8; Yu F, 2013, P NATL ACAD SCI USA, V110, P15830, DOI 10.1073/pnas.1307504110; Zhao J, 2011, PLANT CELL, V23, P1536, DOI 10.1105/tpc.110.080804; Zhao J, 2010, TRENDS PLANT SCI, V15, P72, DOI 10.1016/j.tplants.2009.11.006; Zhao J, 2009, PLANT CELL, V21, P2323, DOI 10.1105/tpc.109.067819	43	43	53	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108789	10.1371/journal.pone.0108789	http://dx.doi.org/10.1371/journal.pone.0108789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268729	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700163
J	Wang, WC; Wu, CY; Lai, YC; Lin, NS; Hsu, YH; Hu, CC				Wang, Wei-Chen; Wu, Chia-Ying; Lai, Yi-Chin; Lin, Na-Sheng; Hsu, Yau-Heiu; Hu, Chung-Chi			Characterization of the Cryptic AV3 Promoter of Ageratum Yellow Vein Virus in Prokaryotic and Eukaryotic Systems	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; ABUTILON MOSAIC-VIRUS; BINDING-PROTEIN; RNA-POLYMERASE; TRANSCRIPTIONAL ACTIVATOR; NUCLEOTIDE-SEQUENCE; GENE-EXPRESSION; CORE PROMOTER; REPLICATION; GEMINIVIRUSES	A cryptic prokaryotic promoter, designated AV3 promoter, has been previously identified in certain begomovirus genus, including ageratum yellow vein virus isolate NT(AYVV-NT). In this study, we demonstrated that the core nucleotides in the putative -10 and -35 boxes are necessary but not sufficient for promoter activity in Escherichia coli, and showed that AYVV-NT AV3 promoter could specifically interact with single-stranded DNA-binding protein and sigma 70 of E. coli involved in transcription. Several AYVV-NT-encoded proteins were found to increase the activity of AV3 promoter. The transcription start sites downstream to AV3 promoter were mapped to nucleotide positions 803 or 805 in E. coli, and 856 in Nicotiana benthamiana. The eukaryotic activity of AV3 promoter and the translatability of a short downstream open reading frame were further confirmed by using a green fluorescent protein reporter construct in yeast (Saccharomyces cerevisiae) cells. These results suggested that AV3 promoter might be a remnant of evolution that retained cryptic activity at present.	[Wang, Wei-Chen; Wu, Chia-Ying; Lai, Yi-Chin; Hsu, Yau-Heiu; Hu, Chung-Chi] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Lin, Na-Sheng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan	National Chung Hsing University; Academia Sinica - Taiwan	Hu, CC (corresponding author), Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan.	cchu@dragon.nchu.edu.tw			National Science Council, Executive Yuan, ROC [NSC 97-2313-B-005-038-MY3, NSC 99-2321-B-005-011-MY3]	National Science Council, Executive Yuan, ROC(Ministry of Science and Technology, Taiwan)	Characterization of the Cryptic AV3 Promoter of Ageratum Yellow Vein Virus in Prokaryotic and Eukaryotic Systems'' was supported by grants NSC 97-2313-B-005-038-MY3 and NSC 99-2321-B-005-011-MY3 to CCH from National Science Council, Executive Yuan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSELBERGS FAM, 1983, J MOL BIOL, V163, P177, DOI 10.1016/0022-2836(83)90003-7; Barrios H, 1999, NUCLEIC ACIDS RES, V27, P4305, DOI 10.1093/nar/27.22.4305; BARTLETT MS, 1994, J BACTERIOL, V176, P5560, DOI 10.1128/JB.176.17.5560-5564.1994; Brown JK, 2012, VIRUS TAXONOMY, P351; Butler JEF, 2001, GENE DEV, V15, P2515, DOI 10.1101/gad.924301; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Carlson JM, 2007, NUCLEIC ACIDS RES, V35, pW259, DOI 10.1093/nar/gkm310; CHANNARAYAPPA, 1992, ENVIRON MOL MUTAGEN, V20, P117, DOI 10.1002/em.2850200207; CHO NY, 1995, J MOL BIOL, V246, P461, DOI 10.1006/jmbi.1994.0098; CSORDASTOTH E, 1979, NUCLEIC ACIDS RES, V7, P2189, DOI 10.1093/nar/7.8.2189; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Davydova EK, 2003, P NATL ACAD SCI USA, V100, P9250, DOI 10.1073/pnas.1133325100; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; FRISCHMUTH T, 1990, VIROLOGY, V178, P461, DOI 10.1016/0042-6822(90)90343-P; GlucksmannKuis MA, 1996, CELL, V84, P147, DOI 10.1016/S0092-8674(00)81001-6; Gotz M, 2012, J VIROL, V86, P13241, DOI 10.1128/JVI.00880-12; GRONING BR, 1990, MOL GEN GENET, V220, P485, DOI 10.1007/BF00391759; GRONING BR, 1987, P NATL ACAD SCI USA, V84, P8996, DOI 10.1073/pnas.84.24.8996; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hanley-Bowdoin L, 2013, NAT REV MICROBIOL, V11, P777, DOI 10.1038/nrmicro3117; Harrison BD, 1999, ANNU REV PHYTOPATHOL, V37, P369, DOI 10.1146/annurev.phyto.37.1.369; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; Hu GQ, 2008, NUCLEIC ACIDS RES, V36, pD114, DOI 10.1093/nar/gkm799; KOONIN EV, 1992, J GEN VIROL, V73, P2763, DOI 10.1099/0022-1317-73-10-2763; KOZAK M, 1991, GENE EXPRESSION, V1, P111; Lee SJ, 2001, J BIOL CHEM, V276, P30064, DOI 10.1074/jbc.M102886200; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; MARKIEWICZ P, 1992, GENE DEV, V6, P2010, DOI 10.1101/gad.6.10.2010; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; NAGAWA F, 1985, P NATL ACAD SCI USA, V82, P8557, DOI 10.1073/pnas.82.24.8557; Nawaz-Ul-Rehman MS, 2009, FEBS LETT, V583, P1825, DOI 10.1016/j.febslet.2009.05.045; Nimonkar AV, 2003, J BIOL CHEM, V278, P9678, DOI 10.1074/jbc.M212555200; Novick RP, 1998, TRENDS BIOCHEM SCI, V23, P434, DOI 10.1016/S0968-0004(98)01302-4; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; PRATT D, 1974, J MOL BIOL, V82, P425, DOI 10.1016/0022-2836(74)90239-3; PRIBNOW D, 1975, P NATL ACAD SCI USA, V72, P784, DOI 10.1073/pnas.72.3.784; Rigden JE, 1996, P NATL ACAD SCI USA, V93, P10280, DOI 10.1073/pnas.93.19.10280; Rochester SC, 1998, J VIROL, V72, P2917, DOI 10.1128/JVI.72.4.2917-2926.1998; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Saccardo F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-185; Selth LA, 2002, FEBS LETT, V516, P179, DOI 10.1016/S0014-5793(02)02539-5; Shivaprasad PV, 2005, J VIROL, V79, P8149, DOI 10.1128/JVI.79.13.8149-8163.2005; Shung CY, 2007, VIROLOGY, V364, P112, DOI 10.1016/j.virol.2007.03.006; STENGER DC, 1991, P NATL ACAD SCI USA, V88, P8029, DOI 10.1073/pnas.88.18.8029; SUNTER G, 1993, VIROLOGY, V195, P275, DOI 10.1006/viro.1993.1374; SUNTER G, 1992, PLANT CELL, V4, P1321, DOI 10.1105/tpc.4.10.1321; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Wang WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070037; Wang Y, 2003, J BACTERIOL, V185, P5800, DOI 10.1128/JB.185.19.5800-5806.2003; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu CY, 2008, J VIROL METHODS, V147, P355, DOI 10.1016/j.jviromet.2007.10.002; Wu CY, 2007, VIRUS RES, V125, P14, DOI 10.1016/j.virusres.2006.12.001	55	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108608	10.1371/journal.pone.0108608	http://dx.doi.org/10.1371/journal.pone.0108608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268755	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700123
J	Sarwar, UN; Novik, L; Enama, ME; Plummer, SA; Koup, RA; Nason, MC; Bailer, RT; McDermott, AB; Roederer, M; Mascola, JR; Ledgerwood, JE; Graham, BS				Sarwar, Uzma N.; Novik, Laura; Enama, Mary E.; Plummer, Sarah A.; Koup, Richard A.; Nason, Martha C.; Bailer, Robert T.; McDermott, Adrian B.; Roederer, Mario; Mascola, John R.; Ledgerwood, Julie E.; Graham, Barney S.		VRC 015 Study Team	Homologous Boosting with Adenoviral Serotype 5 HIV Vaccine (rAd5) Vector Can Boost Antibody Responses despite Preexisting Vector-Specific Immunity in a Randomized Phase I Clinical Trial	PLOS ONE			English	Article							T-CELL RESPONSES; DNA VACCINE; HEALTHY-ADULTS; NEUTRALIZING ANTIBODY; IMMUNOGENICITY EVALUATION; CANDIDATE VACCINE; MALARIA VACCINE; NEEDLE; SAFETY; INJECTION	Background: Needle-free delivery improves the immunogenicity of DNA vaccines but is also associated with more local reactogenicity. Here we report the first comparison of Biojector and needle administration of a candidate rAd5 HIV vaccine. Methods: Thirty-one adults, 18-55 years, 20 naive and 11 prior rAd5 vaccine recipients were randomized to receive single rAd5 vaccine via needle or Biojector IM injection at 10(10) PU in a Phase I open label clinical trial. Solicited reactogenicity was collected for 5 days; clinical safety and immunogenicity follow-up was continued for 24 weeks. Results: Overall, injections by either method were well tolerated. There were no serious adverse events. Frequency of any local reactogenicity was 16/16 (100%) for Biojector compared to 11/15 (73%) for needle injections. There was no difference in HIV Env-specific antibody response between Biojector and needle delivery. Env-specific antibody responses were more than 10-fold higher in subjects receiving a booster dose of rAd5 vaccine than after a single dose delivered by either method regardless of interval between prime and boost. Conclusions: Biojector delivery did not improve antibody responses to the rAd5 vaccine compared to needle administration. Homologous boosting with rAd5 gene-based vectors can boost insert-specific antibody responses despite pre-existing vector-specific immunity.	[Sarwar, Uzma N.; Novik, Laura; Enama, Mary E.; Plummer, Sarah A.; Koup, Richard A.; Bailer, Robert T.; McDermott, Adrian B.; Roederer, Mario; Mascola, John R.; Ledgerwood, Julie E.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Nason, Martha C.] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bgraham@mail.nih.gov	Roederer, Mario/G-1887-2011; Mascola, John/AAI-7193-2021; Graham, Barney S./AAC-5898-2019	Graham, Barney S./0000-0001-8112-0853; Richie, Thomas/0000-0002-2946-5456; McDermott, Adrian/0000-0003-0616-9117	U.S. Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005035, ZICAI005123, ZIAAI005073] Funding Source: NIH RePORTER	U.S. Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by U.S. Government funding for the intramural research conducted by the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar JC, 2001, VACCINE, V20, P275, DOI 10.1016/S0264-410X(01)00273-0; Barbosa RPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061795; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Cheng C, 2010, J VIROL, V84, P630, DOI 10.1128/JVI.00866-09; Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225; De Rosa SC, 2011, J IMMUNOL, V187, P3391, DOI 10.4049/jimmunol.1101421; Epstein JE, 2002, HUM GENE THER, V13, P1551, DOI 10.1089/10430340260201644; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Graham BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059340; Graham BSGMEE, 2013, PLOS ONE IN PRESS; Hammer SM, 2013, N ENGL J MED; Jackson LA, 2001, VACCINE, V19, P4703, DOI 10.1016/S0264-410X(01)00225-0; Jaoko W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012873; Kibuuka H, 2010, J INFECT DIS, V201, P600, DOI 10.1086/650299; Koblin BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024517; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Ledgerwood JE, 2010, VACCINE, V29, P304, DOI 10.1016/j.vaccine.2010.10.037; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054; Levine MM, 2003, NAT MED, V9, P99, DOI 10.1038/nm0103-99; Limbach KJ, 2009, PARASITE IMMUNOL, V31, P501, DOI 10.1111/j.1365-3024.2009.01141.x; Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650; Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026; Mathei C, 1997, VACCINE, V15, P402, DOI 10.1016/S0264-410X(96)00196-X; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Moodie Z, 2006, J IMMUNOL METHODS, V315, P121, DOI 10.1016/j.jim.2006.07.015; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Peiperl L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013579; Raviprakash K, 2003, VIROLOGY, V315, P345, DOI 10.1016/S0042-6822(03)00542-7; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Tamminga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025868; Williams J, 2000, VACCINE, V18, P1939, DOI 10.1016/S0264-410X(99)00446-6; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996	35	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e106240	10.1371/journal.pone.0106240	http://dx.doi.org/10.1371/journal.pone.0106240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264782	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400008
J	Xiao, SH; Yang, Z; Lv, RY; Zhao, J; Wu, M; Liao, YW; Liu, Q				Xiao, Songhua; Yang, Zhen; Lv, Ruiyan; Zhao, Jia; Wu, Ming; Liao, Yiwei; Liu, Qing			miR-135b Contributes to the Radioresistance by Targeting GSK3 beta in Human Glioblastoma Multiforme Cells	PLOS ONE			English	Article							HUMAN CANCER-CELLS; MOLECULAR PATHOLOGY; GASTRIC-CANCER; RESISTANCE; MIR-200B; TEMOZOLOMIDE; MICRORNAS; RADIATION; PROFILES; PATHWAY	Radioresistance remains a major challenge in the treatment of glioblastoma multiforme (GBM). Recent data strongly suggests the important role of miRNAs in cancer progression and therapeutic response. Here, we have established a radioresistant human GBM cell line U87R derived from parental U87 and found miR-135b expression was upregulated in U87R cells. miR-135b knockdown reversed radioresistance of U87R cells, and miR-135b overexpression enhanced radioresistance of U87 cells. Mechanically, bioinformatics analysis combined with experimental analysis demonstrated GSK3 beta (Glycogen synthase kinase 3 beta) was a novel direct target of miR-135b. Moreover, GSK3 beta protein expression was downregulated in U87R cells and restored expression of GSK3 beta increased radiosensitivity of U87R cells. In addition, clinical data indicated that the expression of miR-135b or GSK3 beta was significantly association with IR resistance of GBM samples. Our findings suggest miR-135b is involved in the radioresistance of human GBM cells and miR-135b-GSK3 beta axis may be a novel candidate for developing rational therapeutic strategies for human GBM treatment.	[Xiao, Songhua; Lv, Ruiyan; Zhao, Jia] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Yang, Zhen] Sun Yat Sen Univ, Dept Hypertens & Vasc Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Wu, Ming; Liao, Yiwei; Liu, Qing] Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha, Hunan, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Central South University	Liu, Q (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha, Hunan, Peoples R China.	chingliucn@yahoo.com			Nature Scientific Foundation of China [30901539]; Science and Technology Planning Project of Guangdong Province, People's Republic of China [2011B031800138]	Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, People's Republic of China	This study was supported by the Nature Scientific Foundation of China (30901539). Science and Technology Planning Project of Guangdong Province, People's Republic of China, No. 2011B031800138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Chiou GY, 2013, MOL CELL, V52, P693, DOI 10.1016/j.molcel.2013.11.009; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Gupta K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052572; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Liu Q, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0859-x; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Matsuyama H, 2011, BLOOD, V118, P6881, DOI 10.1182/blood-2011-05-354654; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Niemoeller OM, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-29; Noda SE, 2009, SEMIN RADIAT ONCOL, V19, P171, DOI 10.1016/j.semradonc.2009.02.005; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Quesnelle KM, 2011, CLIN CANCER RES, V17, P5935, DOI 10.1158/1078-0432.CCR-11-0370; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; She XL, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0892-9; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sulman EP, 2009, SEMIN RADIAT ONCOL, V19, P142, DOI 10.1016/j.semradonc.2009.02.001; Tang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084146; Tang HL, 2013, CLIN CANCER RES, V19, P5602, DOI 10.1158/1078-0432.CCR-13-1326; Tang HL, 2013, CANCER LETT, V340, P72, DOI 10.1016/j.canlet.2013.06.027; Wang GH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S22; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Xie C, 2014, BIOCHEM BIOPH RES CO, V445, P263, DOI 10.1016/j.bbrc.2014.02.003	26	44	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108810	10.1371/journal.pone.0108810	http://dx.doi.org/10.1371/journal.pone.0108810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265336	gold, Green Submitted, Green Published			2022-12-27	WOS:000345745400130
J	Huang, CQ; Yang, XJ; Yu, Y; Wu, HT; Liu, Y; Yonemura, Y; Li, Y				Huang, Chao-Qun; Yang, Xiao-Jun; Yu, Yang; Wu, Hai-Tao; Liu, Yang; Yonemura, Yutaka; Li, Yan			Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival for Patients with Peritoneal Carcinomatosis from Colorectal Cancer: A Phase II Study from a Chinese Center	PLOS ONE			English	Article							SYSTEMIC CHEMOTHERAPY; MITOMYCIN-C; OXALIPLATIN; MANAGEMENT; HIPEC; TRIAL; CHEMOPERFUSION; MALIGNANCIES; IRINOTECAN; EXPERIENCE	Background: Peritoneal carcinomatosis (PC) is a difficult clinical challenge in colorectal cancer (CRC) because conventional treatment modalities could not produce significant survival benefit, which highlights the acute need for new treatment strategies. Our previous case-control study demonstrated the potential survival advantage of cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) over CRS alone. This phase II study was to further investigate the efficacy and adverse events of CRS + HIPEC for Chinese patients with CRC PC. Methods: A total of 60 consecutive CRC PC patients underwent 63 procedures consisting of CRS + HIPEC and postoperative chemotherapy, all by a designated team focusing on this combined treatment modality. All the clinico-pathological information was systematically integrated into a prospective database. The primary end point was disease-specific overall survival (OS), and the secondary end points were perioperative safety profiles. Results: By the most recent database update, the median follow-up was 29.9 (range 3.5-108.9) months. The peritoneal cancer index (PCI) <= 20 was in 47.0% of patients, complete cytoreductive surgery (CC0-1) was performed in 53.0% of patients. The median OS was 16.0 (95% confidence interval [CI] 12.2-19.8) months, and the 1-, 2-, 3-, and 5-year survival rates were 70.5%, 34.2%, 22.0% and 22.0%, respectively. Mortality and grades 3 to 5 morbidity rates in postoperative 30 days were 0.0% and 30.2%, respectively. Univariate analysis identified 3 parameters with significant effects on OS: PCI <= 20, CC0-1 and adjuvant chemotherapy over 6 cycles. On multivariate analysis, however, only CC0-1 and adjuvant chemotherapy >= 6 cycles were found to be independent factors for OS benefit. Discussion: CRS + HIPEC at a specialized treatment center could improve OS for selected CRC PC patients from China, with acceptable perioperative safety.	[Huang, Chao-Qun; Yang, Xiao-Jun; Yu, Yang; Wu, Hai-Tao; Liu, Yang; Li, Yan] Wuhan Univ, Dept Oncol, Zhongnan Hosp, Hubei Canc Clin Study Ctr, Wuhan 430072, Peoples R China; [Huang, Chao-Qun; Yang, Xiao-Jun; Yu, Yang; Wu, Hai-Tao; Liu, Yang; Li, Yan] Hubei Key Lab Tumor Biol Behav, Wuhan, Peoples R China; [Liu, Yang; Yonemura, Yutaka] NPO Org Support Peritoneal Disseminat Treatment, Osaka, Japan	Wuhan University	Li, Y (corresponding author), Wuhan Univ, Dept Oncol, Zhongnan Hosp, Hubei Canc Clin Study Ctr, Wuhan 430072, Peoples R China.	liyansd2@163.com			Hubei Sciences and Technology Bureau [2008BCC011, 2060402-542]; Science Fund for Doctorate Mentors by China's Ministry of Education [20120141110042]; Fundamental Research Fund for the Central Universities [2012303030212]	Hubei Sciences and Technology Bureau; Science Fund for Doctorate Mentors by China's Ministry of Education; Fundamental Research Fund for the Central Universities	This study was supported by the grants for New Strategies to Treat Peritoneal Carcinomatosis from Hubei Sciences and Technology Bureau (No. 2008BCC011, No. 2060402-542), the Science Fund for Doctorate Mentors by China's Ministry of Education (No. 20120141110042), and the Fundamental Research Fund for the Central Universities (No. 2012303030212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	al-Shammaa HAH, 2008, WORLD J GASTROENTERO, V14, P1159, DOI 10.3748/wjg.14.1159; Brucher BLDM, 2012, CANCER INVEST, V30, P209, DOI 10.3109/07357907.2012.654871; Cao C, 2009, ANN SURG ONCOL, V16, P2152, DOI 10.1245/s10434-009-0487-4; Cavaliere F, 2011, EJSO-EUR J SURG ONC, V37, P148, DOI 10.1016/j.ejso.2010.10.014; Ceelen WP, 2008, ANN SURG ONCOL, V15, P535, DOI 10.1245/s10434-007-9648-5; Chua TC, 2011, ANN SURG ONCOL, V18, P1560, DOI 10.1245/s10434-010-1522-1; Chua TC, 2009, ANN SURG, V249, P900, DOI 10.1097/SLA.0b013e3181a45d86; Cotte E, 2011, ANN SURG ONCOL, V18, P2599, DOI 10.1245/s10434-011-1651-1; da Silva RG, 2006, J AM COLL SURGEONS, V203, P878, DOI 10.1016/j.jamcollsurg.2006.08.024; Dedrick RL, 1997, JNCI-J NATL CANCER I, V89, P480, DOI 10.1093/jnci/89.7.480; Elias D, 2007, ANN SURG ONCOL, V14, P1818, DOI 10.1245/s10434-007-9348-1; Elias D, 2007, ANN SURG ONCOL, V14, P509, DOI 10.1245/s10434-006-9167-9; Elias D, 2010, J CLIN ONCOL, V28, P63, DOI 10.1200/JCO.2009.23.9285; Elias D, 2009, J CLIN ONCOL, V27, P681, DOI 10.1200/JCO.2008.19.7160; Franko J, 2010, CANCER-AM CANCER SOC, V116, P3756, DOI 10.1002/cncr.25116; Fu JF, 2013, WORLD J GASTROENTERO, V19, P8078, DOI 10.3748/wjg.v19.i44.8078; FUJIMOTO S, 1992, CANCER, V70, P2754, DOI 10.1002/1097-0142(19921215)70:12<2754::AID-CNCR2820701205>3.0.CO;2-A; Glehen J, 2004, BRIT J SURG, V91, P747, DOI 10.1002/bjs.4473; Glehen O, 2004, J CLIN ONCOL, V22, P3284, DOI 10.1200/JCO.2004.10.012; Glehen O, 2003, J CLIN ONCOL, V21, P799, DOI 10.1200/JCO.2003.06.139; Glehen O, 2004, LANCET ONCOL, V5, P219, DOI 10.1016/S1470-2045(04)01425-1; Glehen Olivier, 2003, Surg Oncol Clin N Am, V12, P729, DOI 10.1016/S1055-3207(03)00044-9; Glockzin G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-67; Harrison LE, 2008, ANN SURG ONCOL, V15, P1407, DOI 10.1245/s10434-007-9718-8; Ho JWC, 2004, INT J CANCER, V109, P587, DOI 10.1002/ijc.20018; Hompes D, 2012, ANN SURG ONCOL, V19, P2186, DOI 10.1245/s10434-012-2264-z; Huang CQ, 2014, J SURG ONCOL, V109, P730, DOI 10.1002/jso.23545; Jacquet P, 1996, Cancer Treat Res, V82, P359; Jayne DG, 2002, BRIT J SURG, V89, P1545, DOI 10.1046/j.1365-2168.2002.02274.x; Kerscher AG, 2013, BRIT J CANCER, V108, P1432, DOI 10.1038/bjc.2013.82; Kuijpers AMJ, 2013, ANN SURG ONCOL, V20, P4224, DOI 10.1245/s10434-013-3145-9; Li PC, 2008, J CANCER RES CLIN, V134, P37, DOI 10.1007/s00432-007-0242-9; Logan RFA, 2012, GUT, V61, P1439, DOI 10.1136/gutjnl-2011-300843; Maggiori L, 2010, EJSO-EUR J SURG ONC, V36, P599, DOI 10.1016/j.ejso.2010.05.007; Mizumoto A, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/836425; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; Quenet F, 2011, ANN SURG, V254, P294, DOI 10.1097/SLA.0b013e3182263933; Rouers A, 2006, ACTA CHIR BELG, V106, P302; Sadeghi B, 2000, CANCER-AM CANCER SOC, V88, P358, DOI 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O; Saxena A, 2010, ANN SURG ONCOL, V17, P1291, DOI 10.1245/s10434-009-0875-9; Sideris L, 2009, CAN J SURG, V52, P135; Stewart JH, 2008, ANN SURG ONCOL, V15, P2137, DOI 10.1245/s10434-008-9967-1; Sugarbaker PH, 1999, CANCER CHEMOTH PHARM, V43, pS15, DOI 10.1007/s002800051093; Sugarbaker PH, 2001, EUR J SURG ONCOL, V27, P239, DOI 10.1053/ejso.2000.1038; Sugarbaker T A, 1996, Cancer Treat Res, V82, P65; Tang L, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-53; van Leeuwen BL, 2008, ANN SURG ONCOL, V15, P745, DOI 10.1245/s10434-007-9700-5; Verwaal VJ, 2003, J CLIN ONCOL, V21, P3737, DOI 10.1200/JCO.2003.04.187; Wang T, 2009, GASTROINTEST ENDOSC, V69, P609, DOI 10.1016/j.gie.2008.05.017; WHITTEMORE AS, 1990, JNCI-J NATL CANCER I, V82, P915, DOI 10.1093/jnci/82.11.915; Witkamp AJ, 2001, EUR J CANCER, V37, P979, DOI 10.1016/S0959-8049(01)00058-2; Xu AG, 2010, WORLD J GASTROENTERO, V16, P960, DOI 10.3748/wjg.v16.i8.960; Xu J, 2007, ANN SURG, V245, P583, DOI 10.1097/01.sla.0000250453.34507.d3; Yan TD, 2008, ANN SURG, V248, P829, DOI 10.1097/SLA.0b013e31818a15b5; Yang XJ, 2011, ANN SURG ONCOL, V18, P1575, DOI 10.1245/s10434-011-1631-5; Yang XJ, 2009, ANN SURG ONCOL, V16, P345, DOI 10.1245/s10434-008-0226-2; Zhang SH, 2009, INT J COLORECTAL DIS, V24, P943, DOI 10.1007/s00384-009-0726-y; Zheng S, 2003, DIS COLON RECTUM, V46, P51, DOI 10.1007/s10350-004-6496-2	58	27	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108509	10.1371/journal.pone.0108509	http://dx.doi.org/10.1371/journal.pone.0108509			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259574	Green Submitted, gold, Green Published			2022-12-27	WOS:000342685600078
J	Casarejos, MJ; Perucho, J; Lopez-Sendon, JL; de Yebenes, JG; Bettencourt, C; Gomez, A; Ruiz, C; Heutink, P; Rizzu, P; Mena, MA				Jose Casarejos, Maria; Perucho, Juan; Luis Lopez-Sendon, Jose; Garcia de Yebenes, Justo; Bettencourt, Conceicao; Gomez, Ana; Ruiz, Carolina; Heutink, Peter; Rizzu, Patrizia; Angeles Mena, Maria			Trehalose Improves Human Fibroblast Deficits in a New CHIP-Mutation Related Ataxia	PLOS ONE			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; FOLDING IN-VITRO; OXIDATIVE STRESS; HSP70-INTERACTING PROTEIN; UBIQUITIN LIGASE; ALPHA-SYNUCLEIN; DEGRADATION; PARKIN; PATHWAYS; MICE	In this work we investigate the role of CHIP in a new CHIP-mutation related ataxia and the therapeutic potential of trehalose. The patient's fibroblasts with a new form of hereditary ataxia, related to STUB1 gene (CHIP) mutations, and three age and sex-matched controls were treated with epoxomicin and trehalose. The effects on cell death, protein misfolding and proteostasis were evaluated. Recent studies have revealed that mutations in STUB-1 gene lead to a growing list of molecular defects as deregulation of protein quality, inhibition of proteasome, cell death, decreased autophagy and alteration in CHIP and HSP70 levels. In this CHIP-mutant patient fibroblasts the inhibition of proteasome with epoxomicin induced severe pathophysiological age-associated changes, cell death and protein ubiquitination. Additionally, treatment with epoxomicin produced a dose-dependent increase in the number of cleaved caspase-3 positive cells. However, co-treatment with trehalose, a disaccharide of glucose present in a wide variety of organisms and known as a autophagy enhancer, reduced these pathological events. Trehalose application also increased CHIP and HSP70 expression and GSH free radical levels. Furthermore, trehalose augmented macro and chaperone mediated autophagy (CMA), rising the levels of LC3, LAMP2, CD63 and increasing the expression of Beclin-1 and Atg5-Atg12. Trehalose treatment in addition increased the percentage of immunoreactive cells to HSC70 and LAMP2 and reduced the autophagic substrate, p62. Although this is an individual case based on only one patient and the statistical comparisons are not valid between controls and patient, the low variability among controls and the obvious differences with this patient allow us to conclude that trehalose, through its autophagy activation capacity, anti-aggregation properties, anti-oxidative effects and lack of toxicity, could be very promising for the treatment of CHIP-mutation related ataxia, and possibly a wide spectrum of neurodegenerative disorders related to protein disconformation.	[Jose Casarejos, Maria; Perucho, Juan; Gomez, Ana; Angeles Mena, Maria] Hosp Ramon & Cajal, Dept Neurobiol, E-28034 Madrid, Spain; [Luis Lopez-Sendon, Jose; Garcia de Yebenes, Justo; Ruiz, Carolina] Hosp Ramon & Cajal, Dept Neurol, E-28034 Madrid, Spain; [Jose Casarejos, Maria; Perucho, Juan; Luis Lopez-Sendon, Jose; Garcia de Yebenes, Justo; Gomez, Ana; Ruiz, Carolina; Angeles Mena, Maria] Inst Salud Carlos III, CIBERNED, Madrid, Spain; [Bettencourt, Conceicao] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Bettencourt, Conceicao] Univ Porto, Inst Mol & Cell Biol IBMC, P-4100 Oporto, Portugal; [Bettencourt, Conceicao] Univ Azores, Ctr Res Nat Resources CIRN, Ponta Delgada, Portugal; [Bettencourt, Conceicao] Univ Azores, Dept Biol, Ponta Delgada, Portugal; [Heutink, Peter; Rizzu, Patrizia] German Ctr Neurodegenerat Dis, Tubingen, Germany	Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; CIBERNED; Instituto de Salud Carlos III; University of London; University College London; Universidade do Porto; Universidade dos Acores; Universidade dos Acores; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Casarejos, MJ (corresponding author), Hosp Ramon & Cajal, Dept Neurobiol, E-28034 Madrid, Spain.	m.jose.casarejos@hrc.es	Casarejos, María jose/AAA-9629-2019	Casarejos, María jose/0000-0003-1288-1717; Lopez-Sendon Moreno, Jose Luis/0000-0001-9414-3990; Bettencourt, Conceicao/0000-0001-9090-7690; Heutink, Peter/0000-0001-5218-1737	Spanish Ministry of Health [EIS 2010/172, CIBER 2006/05/0059, CIBERNED PI 2010/06, MICINN EC-10-098 2011/0035, CAM 2011/BMD-2308]; "Comunidad Autonoma de Madrid" (CAM); EIS predoctoral fellowship; "Fundacao para a Ciencia e a Tecnologia" - FCT [SFRH / BPD / 63121/2009]; Medical Research Council (UK)	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); "Comunidad Autonoma de Madrid" (CAM)(Comunidad de Madrid); EIS predoctoral fellowship; "Fundacao para a Ciencia e a Tecnologia" - FCT(Portuguese Foundation for Science and Technology); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study has been supported in part by grants from the Spanish Ministry of Health, EIS 2010/172, CIBER 2006/05/0059, CIBERNED PI 2010/06, MICINN EC-10-098 2011/0035 and CAM 2011/BMD-2308. JP and MFS have a "Comunidad Autonoma de Madrid" (CAM) postdoctoral and a EIS predoctoral fellowship, respectively. CB was recipient of a postdoctoral fellowship from the "Fundacao para a Ciencia e a Tecnologia" - FCT [SFRH / BPD / 63121/2009] until January 2013, and, as PH and PR, is presently supported by the Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2004, FEBS LETT, V564, P121, DOI 10.1016/S0014-5793(04)00326-6; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Bettencourt C, 2013, J NEUROL SCI, V326, P120, DOI 10.1016/j.jns.2013.01.022; Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009; Bregere F, 2006, AGEING RES REV, V5, P60, DOI 10.1016/j.arr.2005.09.002; Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957; Casarejos MJ, 2011, NEUROCHEM INT, V58, P512, DOI 10.1016/j.neuint.2011.01.008; Casarejos MJ, 2005, J NEUROCHEM, V94, P1005, DOI 10.1111/j.1471-4159.2005.03249.x; Choi JY, 2007, MOL CELL NEUROSCI, V34, P69, DOI 10.1016/j.mcn.2006.10.002; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Conlin LK, 2007, MOL CELL BIOL, V27, P1505, DOI 10.1128/MCB.01158-06; Cook C, 2012, HUM MOL GENET, V21, P2936, DOI 10.1093/hmg/dds125; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Depondt C, 2014, NEUROLOGY, V82, P1749, DOI 10.1212/WNL.0000000000000416; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Erichsen AK, 2009, BRAIN, V132, P1577, DOI 10.1093/brain/awp056; Ferreira JV, 2013, AUTOPHAGY, V9, P1349, DOI 10.4161/auto.25190; Gelino S, 2012, J CLIN EXP PATHOL S4; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Ibarretxe G, 2006, GLIA, V53, P201, DOI 10.1002/glia.20267; Kaushik S., 2008, V445, P227, DOI 10.1007/978-1-59745-157-4_15; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kumar P, 2012, J NEUROCHEM, V120, P350, DOI 10.1111/j.1471-4159.2011.07588.x; Kweon SM, 2001, BIOSCIENCE REP, V21, P341, DOI 10.1023/A:1013290316939; Lazic SE, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-5; Lee JS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.181; Li HW, 2011, PLANTA, V234, P1007, DOI 10.1007/s00425-011-1458-0; Li JY, 2012, MOL VIS, V18, P317; Liu R, 2005, NEUROBIOL DIS, V20, P74, DOI 10.1016/j.nbd.2005.02.003; Luo C, 2013, J CELL BIOCHEM, V114, P212, DOI 10.1002/jcb.24356; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Mizushima N, 2010, FEBS LETT, V584, P1279, DOI 10.1016/j.febslet.2010.02.053; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Noubhani A, 2009, J BIOL CHEM, V284, P27229, DOI 10.1074/jbc.M109.029454; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Perucho J, 2012, CURR ALZHEIMER RES, V9, P334, DOI 10.2174/156720512800107573; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Richards AB, 2002, FOOD CHEM TOXICOL, V40, P871, DOI 10.1016/S0278-6915(02)00011-X; Rodriguez-Navarro JA, 2010, NEUROBIOL DIS, V39, P423, DOI 10.1016/j.nbd.2010.05.014; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Ruiz C, 2012, PLOS CURR, V4; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Shi C-H, 2013, HUM MOL GENET; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Solano RM, 2008, J NEUROSCI, V28, P598, DOI 10.1523/JNEUROSCI.4609-07.2008; Solano RM, 2012, J ALZHEIMERS DIS, V32, P57, DOI 10.3233/JAD-2012-120406; Sorensen JG, 2002, FUNCT ECOL, V16, P379, DOI 10.1046/j.1365-2435.2002.00639.x; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Xin H, 2005, J BIOL CHEM, V280, P20842, DOI 10.1074/jbc.M412275200; Yamaguchi R, 2007, CELL DEATH DIFFER, V14, P616, DOI 10.1038/sj.cdd.4402035; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	60	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e106931	10.1371/journal.pone.0106931	http://dx.doi.org/10.1371/journal.pone.0106931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259530	Green Submitted, gold, Green Published			2022-12-27	WOS:000342685600013
J	Muhire, BM; Varsani, A; Martin, DP				Muhire, Brejnev Muhizi; Varsani, Arvind; Martin, Darren Patrick			SDT: A Virus Classification Tool Based on Pairwise Sequence Alignment and Identity Calculation	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MOLECULAR VARIABILITY; DIVERSITY; BEGOMOVIRUS; IDENTIFICATION; RECOMBINATION; ACCURACY; SEARCH; POTATO	The perpetually increasing rate at which viral full-genome sequences are being determined is creating a pressing demand for computational tools that will aid the objective classification of these genome sequences. Taxonomic classification approaches that are based on pairwise genetic identity measures are potentially highly automatable and are progressively gaining favour with the International Committee on Taxonomy of Viruses (ICTV). There are, however, various issues with the calculation of such measures that could potentially undermine the accuracy and consistency with which they can be applied to virus classification. Firstly, pairwise sequence identities computed based on multiple sequence alignments rather than on multiple independent pairwise alignments can lead to the deflation of identity scores with increasing dataset sizes. Also, when gap-characters need to be introduced during sequence alignments to account for insertions and deletions, methodological variations in the way that these characters are introduced and handled during pairwise genetic identity calculations can cause high degrees of inconsistency in the way that different methods classify the same sets of sequences. Here we present Sequence Demarcation Tool (SDT), a free user-friendly computer program that aims to provide a robust and highly reproducible means of objectively using pairwise genetic identity calculations to classify any set of nucleotide or amino acid sequences. SDT can produce publication quality pairwise identity plots and colour-coded distance matrices to further aid the classification of sequences according to ICTV approved taxonomic demarcation criteria. Besides a graphical interface version of the program for Windows computers, command-line versions of the program are available for a variety of different operating systems (including a parallel version for cluster computing platforms).	[Muhire, Brejnev Muhizi; Varsani, Arvind; Martin, Darren Patrick] Univ Cape Town, Dept Clin Lab Sci, ZA-7925 Cape Town, South Africa; [Varsani, Arvind] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Varsani, Arvind] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand; [Varsani, Arvind] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Varsani, Arvind] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	University of Cape Town; University of Canterbury; University of Canterbury; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Muhire, BM (corresponding author), Univ Cape Town, Dept Clin Lab Sci, ZA-7925 Cape Town, South Africa.	mubrejnev@gmail.com	Martin, Darren P/C-4599-2008; Martin, Darren/ABE-3614-2021	Varsani, Arvind/0000-0003-4111-2415	University of Cape Town; National Research Foundation, South Africa	University of Cape Town; National Research Foundation, South Africa(National Research Foundation - South Africa)	BMM is funded by the University of Cape Town. AV and DPM are supported by the National Research Foundation, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1995, PHYLIP PHYLOGENY INF; Bao YM, 2012, VIRUSES-BASEL, V4, P1318, DOI 10.3390/v4081318; Bernardo P, 2013, VIRUS RES, V177, P35, DOI 10.1016/j.virusres.2013.07.006; Dayaram A, 2014, INFECT GENET EVOL, V22, P134, DOI 10.1016/j.meegid.2014.01.013; Dayaram A, 2013, J GEN VIROL, V94, P1827, DOI 10.1099/vir.0.052654-0; Du Z, 2014, VIRUS GENES, V80, P246; Du ZG, 2014, ARCH VIROL, V159, P1527, DOI 10.1007/s00705-013-1890-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias I, 2006, J COMPUT BIOL, V13, P1323, DOI 10.1089/cmb.2006.13.1323; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fiallo-Olive E, 2014, ARCH VIROL, V159, P1857, DOI 10.1007/s00705-014-1996-4; Grigoras I, 2014, J GEN VIROL, V95, P1178, DOI 10.1099/vir.0.063115-0; Kanakala S, 2013, APPL MICROBIOL BIOT, V97, P9491, DOI 10.1007/s00253-013-5162-9; Kardani SG, 2013, VIRUS GENES, V46, P571, DOI 10.1007/s11262-013-0875-5; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lauber C, 2012, J VIROL, V86, P3890, DOI 10.1128/JVI.07173-11; Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P1; Liu P, 2014, PHYTOPARASITICA, V42, P445, DOI 10.1007/s12600-013-0381-2; Liu QL, 2014, ARCH VIROL, V159, P1537, DOI 10.1007/s00705-013-1958-2; Manzoor MT, 2014, ARCH VIROL, V159, P1217, DOI 10.1007/s00705-013-1911-4; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Muhire B, 2013, ARCH VIROL, V158, P1411, DOI 10.1007/s00705-012-1601-7; Muhire BM, 2014, J VIROL, V88, P1972, DOI 10.1128/JVI.03031-13; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Oluwafemi S, 2014, ARCH VIROL, V159, P2765, DOI 10.1007/s00705-014-2090-7; Paz-Carrasco LC, 2014, ARCH VIROL, V159, P2127, DOI 10.1007/s00705-014-2046-y; Phelps NBD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087593; Piasecki T, 2013, VIROLOGY, V438, P98, DOI 10.1016/j.virol.2013.01.009; Razavinejad S, 2013, VIRUS GENES, V46, P345, DOI 10.1007/s11262-012-0858-y; Sievers F, 2013, BIOINFORMATICS, V29, P989, DOI 10.1093/bioinformatics/btt093; Sikorski A, 2013, VIRUS RES, V177, P209, DOI 10.1016/j.virusres.2013.08.008; Srivastava A, 2014, ARCH VIROL, V159, P2711, DOI 10.1007/s00705-014-2108-1; Stenzel T, 2014, J GEN VIROL, V95, P1338, DOI 10.1099/vir.0.063917-0; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tabasinejad F, 2014, ARCH VIROL, V159, P2081, DOI 10.1007/s00705-014-2037-z; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; Varsani A, 2014, ARCH VIROL, V159, P1873, DOI 10.1007/s00705-014-1982-x; Varsani A, 2014, J GEN VIROL, V95, P1352, DOI 10.1099/vir.0.064436-0; Wilm A, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-19; Zawar-Reza P, 2014, INFECT GENET EVOL, V26, P132, DOI 10.1016/j.meegid.2014.05.018	45	509	532	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108277	10.1371/journal.pone.0108277	http://dx.doi.org/10.1371/journal.pone.0108277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259891	Green Submitted, Green Published, gold			2022-12-27	WOS:000342685600059
J	Ran, L; Jin, J; Xu, Y; Bu, YQ; Song, FZ				Ran, Longke; Jin, Jing; Xu, Yan; Bu, Youquan; Song, Fangzhou			Comparison of Robotic Surgery with Laparoscopy and Laparotomy for Treatment of Endometrial Cancer: A Meta-Analysis	PLOS ONE			English	Article							ASSISTED VAGINAL HYSTERECTOMY; ABDOMINAL HYSTERECTOMY; SURGICAL OUTCOMES; COST; LYMPHADENECTOMY	Purpose: To compare the relative merits among robotic surgery, laparoscopy, and laparotomy for patients with endometrial cancer by conducting a meta-analysis. Methods: The MEDLINE, Embase, PubMed, Web of Science, and Cochrane Library databases were searched. Studies clearly documenting a comparison between robotic surgery and laparoscopy or between robotic surgery and laparotomy for endometrial cancer were selected. The outcome measures included operating time (OT), number of complications, length of hospital stay (LOHS), estimated blood loss (EBL), number of transfusions, total lymph nodes harvested (TLNH), and number of conversions. Pooled odds ratios and weighted mean differences with 95% confidence intervals were calculated using either a fixed-effects or random-effects model. Results: Twenty-two studies were included in the meta-analysis. These studies involved a total of 4420 patients, 3403 of whom underwent both robotic surgery and laparoscopy and 1017 of whom underwent both robotic surgery and laparotomy. The EBL (p = 0.01) and number of conversions (p = 0.0008) were significantly lower and the number of complications (p<0.0001) was significantly higher in robotic surgery than in laparoscopy. The OT, LOHS, number of transfusions, and TLNH showed no significant differences between robotic surgery and laparoscopy. The number of complications (p<0.00001), LOHS (p<0.00001), EBL (p<0.00001), and number of transfusions (p = 0.03) were significantly lower and the OT (p<0.00001) was significantly longer in robotic surgery than in laparotomy. The TLNH showed no significant difference between robotic surgery and laparotomy. Conclusions: Robotic surgery is generally safer and more reliable than laparoscopy and laparotomy for patients with endometrial cancer. Robotic surgery is associated with significantly lower EBL than both laparoscopy and laparotomy; fewer conversions but more complications than laparoscopy; and shorter LOHS, fewer complications, and fewer transfusions but a longer OT than laparoscopy. Further studies are required.	[Ran, Longke; Jin, Jing] Chongqing Med Univ, Dept Bioinformat, Chongqing, Peoples R China; [Ran, Longke; Bu, Youquan; Song, Fangzhou] Chongqing Med Univ, Mol Med & Canc Res Ctr, Chongqing, Peoples R China; [Xu, Yan] Third Mil Med Univ, Southwest Hosp, Dept Obstet & Gynecol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Army Medical University	Song, FZ (corresponding author), Chongqing Med Univ, Mol Med & Canc Res Ctr, Chongqing, Peoples R China.	fzsongcq@126.com			National Natural Science Foundation of China [81101994, 81072125]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81101994 and 81072125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell MC, 2008, GYNECOL ONCOL, V111, P407, DOI 10.1016/j.ygyno.2008.08.022; Boggess JF, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.058; Cardenas-Goicoechea J, 2010, GYNECOL ONCOL, V117, P224, DOI 10.1016/j.ygyno.2010.01.009; Coronado PJ, 2012, EUR J OBSTET GYN R B, V165, P289, DOI 10.1016/j.ejogrb.2012.07.006; DeNardis SA, 2008, GYNECOL ONCOL, V111, P412, DOI 10.1016/j.ygyno.2008.08.025; ElSahwi KS, 2012, GYNECOL ONCOL, V124, P260, DOI 10.1016/j.ygyno.2011.09.038; Fagotti A, 2013, GYNECOL ONCOL, V130, P219, DOI 10.1016/j.ygyno.2013.04.004; Frigerio L, 2006, INT J GYNECOL OBSTET, V93, P209, DOI 10.1016/j.ijgo.2006.02.011; Gil-Moreno A, 2006, J MINIM INVAS GYN, V13, P26, DOI 10.1016/j.jmig.2005.08.013; Gocmen A, 2010, ARCH GYNECOL OBSTET, V282, P539, DOI 10.1007/s00404-010-1593-z; Goel M, 2011, J ROBOT SURG, V5, P109, DOI 10.1007/s11701-010-0239-2; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Herron DM, 2008, SURG ENDOSC, V22, P313, DOI 10.1007/s00464-007-9727-5; Hoekstra AV, 2009, INT J MED ROBOT COMP, V5, P392, DOI 10.1002/rcs.268; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jung YW, 2010, J SURG ONCOL, V101, P116, DOI 10.1002/jso.21436; Lim PC, 2010, J MINIM INVAS GYN, V17, P739, DOI 10.1016/j.jmig.2010.07.008; Magrina JF, 2008, GYNECOL ONCOL, V109, P86, DOI 10.1016/j.ygyno.2008.01.011; Martino MA, 2011, GYNECOL ONCOL, V123, P528, DOI 10.1016/j.ygyno.2011.08.021; O'Neill M, 2013, ARCH GYNECOL OBSTET, V287, P907, DOI 10.1007/s00404-012-2681-z; Peiretti M, 2009, J MINIM INVAS GYN, V16, P427, DOI 10.1016/j.jmig.2009.03.013; Reza M, 2010, BRIT J SURG, V97, P1772, DOI 10.1002/bjs.7269; Sarlos D, 2010, EUR J OBSTET GYN R B, V150, P92, DOI 10.1016/j.ejogrb.2010.02.012; Seamon LG, 2009, OBSTET GYNECOL, V114, P16, DOI 10.1097/AOG.0b013e3181aa96c7; Seamon LG, 2009, GYNECOL ONCOL, V113, P36, DOI 10.1016/j.ygyno.2008.12.005; Seror J, 2013, J MINIM INVASIVE GYN; Subramaniam A, 2011, GYNECOL ONCOL, V122, P604, DOI 10.1016/j.ygyno.2011.05.024; Veljovich DS, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.032; Venkat P, 2012, GYNECOL ONCOL, V125, P237, DOI 10.1016/j.ygyno.2011.11.036; Wells GA, 2007, P 3 S SYST REV BAS I, V7, P3; Wright JD, 2012, J CLIN ONCOL, V30, P783, DOI 10.1200/JCO.2011.36.7508	32	46	47	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108361	10.1371/journal.pone.0108361	http://dx.doi.org/10.1371/journal.pone.0108361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259856	gold, Green Published, Green Submitted			2022-12-27	WOS:000342685600066
J	Selamat, MH; Loh, SY; Mackenzie, L; Vardy, J				Selamat, Maryam Hafsah; Loh, Siew Yim; Mackenzie, Lynette; Vardy, Janette			Chemobrain Experienced by Breast Cancer Survivors: A Meta-Ethnography Study Investigating Research and Care Implications	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; WOMENS PERCEPTIONS; COGNITIVE FUNCTION	Background: Cognitive impairment, colloquially termed "chemobrain'', occurs in 10-40% of all cancer patients, and is an emerging target of cancer survivorship research. Aim: This study reviews published qualitative studies to explore cognitive impairments or chemobrain among breast cancer survivors, with particular attention given to the impact on quality of life. Method: Using keywords, we searched ten electronic databases (CINAHL, EMBASE, Proquest, OVID SP, MEDLINE, Oxford Journal, Science Direct, PubMED). Findings: Of 457 papers, seven relevant papers were included. Data was extracted and concepts were analysed using a meta ethnography approach. Four second order intepretations were identified, on the basis of which, four third order intrepretations were constructed. Linked together in a line of argument, was a consistent account on their struggles to self-manage the chemobrain impairments that impact their daily lives. Five concepts emerged from the analysis of the primary findings: i) real experiences of cognitive changes, ii) calls for help, iii) impact of cognitive impairments, iv) coping and v) survivorship and meaning. Further synthesis resulted in four new order intepretations: i) The chemobrain struggle, ii) The substantial impact of chemobrain on life domains, iii) The struggle to readjust and to self manage, and iv) 'thankful yet fearful' representation. Discussion: Awareness of cognitive changes were context-dependent on healthcare settings and cultural contexts as strong determinants. Subjects verified the existence of chemobrain but healthcare providers mis-recognised, under-recognised, and sometimes negated it perhaps due to its unknown aetiology. Asian breast cancer survivors appear less vocal than their western counterparts. Conclusion: The current literature on the lived experiences of how women experienced chemobrain provides a consistent report that chemobrain is real, persistent and with detrimental impacts on quality of life -manifested as a constant struggles. A greater awareness of the effects of chemobrain with improved functional assessment and interventions is warranted.	[Selamat, Maryam Hafsah] Univ Malaya, Dept Postgrad Studies, Kuala Lumpur, Malaysia; [Loh, Siew Yim] Univ Malaya, Fac Med, Dept Rehabil Med, Kuala Lumpur, Malaysia; [Loh, Siew Yim; Mackenzie, Lynette] Univ Sydney, Fac Hlth Sci, Discipline Occupat Therapy, Sydney, NSW 2006, Australia; [Vardy, Janette] Concord Repatriat & Gen Hosp, Concord Canc Ctr, Sydney, NSW, Australia; [Vardy, Janette] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Universiti Malaya; Universiti Malaya; University of Sydney; Concord Repatriation General Hospital; University of Sydney	Loh, SY (corresponding author), Univ Malaya, Fac Med, Dept Rehabil Med, Kuala Lumpur, Malaysia.	syloh@um.edu.my	Dr Siew Yim, Loh/B-2796-2010	Dr Siew Yim, Loh/0000-0002-6924-8368; Vardy, Janette/0000-0002-5739-5790	University Malaya Research Grant [UMRG 477/12htm]	University Malaya Research Grant	This study is funded by the University Malaya Research Grant (UMRG 477/12htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahles AT, 2007, NATURE REV CANC, V7, P195; American Cancer Society, 2012, CANC FACTS FIG 2012; Argyriou AA, 2011, J PAIN SYMPTOM MANAG, V41, P126, DOI 10.1016/j.jpainsymman.2010.04.021; Asher Arash, 2011, Am J Phys Med Rehabil, V90, pS16, DOI 10.1097/PHM.0b013e31820be463; Atkins S, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-21; Banning M, 2011, EUR J CANCER CARE, V20, P708, DOI 10.1111/j.1365-2354.2011.01291.x; Baumgartner Karen, 2004, Semin Oncol Nurs, V20, P284, DOI 10.1016/S0749-2081(04)00092-0; Biglia N, 2012, EUR J CANCER CARE, V21, P485, DOI 10.1111/j.1365-2354.2011.01320.x; Boykoff N, 2009, J CANCER SURVIV, V3, P223, DOI 10.1007/s11764-009-0098-x; Breitbart WS, 2009, HARVARD REV PSYCHIAT, V17, P361, DOI 10.3109/10673220903465700; Britten Nicky, 2002, J Health Serv Res Policy, V7, P209, DOI 10.1258/135581902320432732; Burstein HJ, 2007, BREAST, V16, pS166, DOI 10.1016/j.breast.2007.07.027; Campbell R, 2011, HEALTH TECHNOL ASSES, V15, pIII, DOI 10.3310/hta15430; Campbell R, 2003, SOC SCI MED, V56, P671, DOI 10.1016/S0277-9536(02)00064-3; Castellon S, 2009, BREAST CANCER RES TR, V116, P125, DOI 10.1007/s10549-008-0211-2; Cheung YT, 2012, ANN ONCOL, V23, P2547, DOI 10.1093/annonc/mds029; Cheung YT, 2013, J CANCER SURVIV, V7, P146, DOI 10.1007/s11764-012-0256-4; Christie LA, 2012, CLIN CANCER RES, V18, P1954, DOI 10.1158/1078-0432.CCR-11-2000; Creswell J. W., 2007, QUALITATIVE INQUIRY; Critical Appraisal Skill Programme, 2013, 10 QUEST HELP YOU MA; Dixon-Woods Mary, 2006, BMC Med Res Methodol, V6, P35, DOI 10.1186/1471-2288-6-35; Dixon-Woods Mary, 2005, J Health Serv Res Policy, V10, P45, DOI 10.1258/1355819052801804; Furuta M, 2014, MIDWIFERY, V30, P158, DOI 10.1016/j.midw.2013.09.001; Hall BA, 2003, ADV NURS SCI, V26, P53, DOI 10.1097/00012272-200301000-00008; Henwood KL, 1996, HDB QUALITATIVE RES, P25; Hirokawa K, 2004, J PSYCHOSOM RES, V56, P103, DOI 10.1016/S0022-3999(03)00046-1; Jansen CE, 2011, SUPPORT CARE CANCER, V19, P1647, DOI 10.1007/s00520-010-0997-4; Leventhal H, 1984, HDB PSYCHOL; Leventhal H., 1997, PERCEPTIONS HLTH ILL, V2, P19; Matsuda Tomohiro, 2005, Breast Cancer, V12, P279, DOI 10.2325/jbcs.12.279; Meade Elizabeth, 2012, Br J Nurs, V21, pS4; Munir F, 2010, J CLIN NURS, V19, P1362, DOI 10.1111/j.1365-2702.2009.03006.x; Myers Jamie S, 2012, Oncol Nurs Forum, V39, pE31, DOI 10.1188/12.ONF.E31-E40; Nelson Christian J, 2007, Palliat Support Care, V5, P273; Noblit G. W., 1988, METAETHNOGRAPHY SYNT; Petrie KJ, 2007, CURR OPIN PSYCHIATR, V20, P163, DOI 10.1097/YCO.0b013e328014a871; Marin AP, 2009, SOUTH MED J, V102, P929, DOI 10.1097/SMJ.0b013e3181b23bf5; Pirl William F, 2007, J Support Oncol, V5, P499; Raffa RB, 2006, J CLIN PHARM THER, V31, P129, DOI 10.1111/j.1365-2710.2006.00726.x; Schagen SB, 2012, PSYCHO-ONCOLOGY, V21, P1132, DOI 10.1002/pon.2011; Schilder CMT, 2010, CRIT REV ONCOL HEMAT, V76, P133, DOI 10.1016/j.critrevonc.2009.11.001; Schutz A., 1962, COLLECT PAPERS, V1; Sherwood G, 2011, TORCH IWMF NEWSLETTE; Shilling V, 2005, BREAST, V14, P142, DOI 10.1016/j.breast.2004.10.004; Tamsin Mulrooney, 2007, THESIS; Thielen JZ, 2008, THESIS; Toye F, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-46; Vardy J, 2009, CANCER TREAT RES, P387, DOI 10.1007/978-0-387-75115-3_24; Vearncombe KJ, 2009, J INT NEUROPSYCH SOC, V15, P951, DOI 10.1017/S1355617709990567; Von Ah D, 2013, EUR J ONCOL NURS, V17, P236, DOI 10.1016/j.ejon.2012.06.002; Wagner LI, 2009, J SUPPORT ONCOL, V7, pW32, DOI DOI 10.1016/J.JPAINSYMMAN.2014.08.012; Wefel JS, 2008, NEUROPSYCHOL REV, V18, P121, DOI 10.1007/s11065-008-9058-x; Weiss B, 2008, NEUROTOXICOLOGY, V29, P891, DOI 10.1016/j.neuro.2008.03.009	53	67	67	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108002	10.1371/journal.pone.0108002	http://dx.doi.org/10.1371/journal.pone.0108002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IP	25259847	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600042
J	Wanglar, C; Takahashi, J; Yabe, T; Takada, S				Wanglar, Chimwar; Takahashi, Jun; Yabe, Taijiro; Takada, Shinji			Tbx Protein Level Critical for Clock-Mediated Somite Positioning Is Regulated through Interaction between Tbx and Ripply	PLOS ONE			English	Article							BOX TRANSCRIPTION FACTORS; SEGMENTATION CLOCK; PRESOMITIC MESODERM; VERTEBRATE SEGMENTATION; GENE-EXPRESSION; MESP FAMILY; ZEBRAFISH; SOMITOGENESIS; NOTCH; BOUNDARY	Somitogenesis in vertebrates is a complex and dynamic process involving many sequences of events generated from the segmentation clock. Previous studies with mouse embryos revealed that the presumptive somite boundary is periodically created at the anterior border of the expression domain of Tbx6 protein. Ripply1 and Ripply2 are required for the determination of the Tbx6 protein border, but the mechanism by which this Tbx6 domain is regulated remains unclear. Furthermore, since zebrafish and frog Ripplys are known to be able to suppress Tbx6 function at the transcription level, it is also unclear whether Ripply-mediated mechanism of Tbx6 regulation is conserved among different species. Here, we tested the generality of Tbx6 protein-mediated process in somite segmentation by using zebrafish and further examined the mechanism of regulation of Tbx6 protein. By utilizing an antibody against zebrafish Tbx6/Fss, previously referred to as Tbx24, we found that the anterior border of Tbx6 domain coincided with the presumptive intersomitic boundary even in the zebrafish and it shifted dynamically during 1 cycle of segmentation. Consistent with the findings in mice, the tbx6 mRNA domain was located far anterior to its protein domain, indicating the possibility of posttranscriptional regulation. When both ripply1/2 were knockdown, the Tbx6 domain was anteriorly expanded. We further directly demonstrated that Ripply could reduce the expression level of Tbx6 protein depending on physical interaction between Ripply and Tbx6. Moreover, the onset of ripply1 and ripply2 expression occurred after reduction of FGF signaling at the anterior PSM, but this expression initiated much earlier on treatment with SU5402, a chemical inhibitor of FGF signaling. These results strongly suggest that Ripply is a direct regulator of the Tbx6 protein level for the establishment of intersomitic boundaries and mediates a reduction in FGF signaling for the positioning of the presumptive intersomitic boundary in the PSM.	[Wanglar, Chimwar; Takahashi, Jun; Yabe, Taijiro; Takada, Shinji] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Wanglar, Chimwar; Takahashi, Jun; Yabe, Taijiro; Takada, Shinji] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Wanglar, Chimwar; Takahashi, Jun; Yabe, Taijiro; Takada, Shinji] Grad Univ Adv Studies SOKENDAI, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Takada, S (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	stakada@nibb.ac.jp		Takada, Shinji/0000-0003-4125-6056; Yabe, Taijiro/0000-0002-0843-7472	Japan Society for the Promotion of Science [24770218, 18107006, 23657153]; Daiko Foundation [9141]; Grants-in-Aid for Scientific Research [24111002] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Daiko Foundation(Daiko Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html; to T.Y. (#24770218) and S.T. (grant numbers:#18107006, #23657153)) and by a research grant from Daiko Foundation (http://www1.s3.starcatne.jp/daiko-f/; to S. T. (grant number #9141)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama R, 2014, DEVELOPMENT, V141, P1104, DOI 10.1242/dev.098905; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Bajard L, 2014, DEVELOPMENT, V141, P1381, DOI 10.1242/dev.093435; Cha TC, 2007, FEBS LETT, V581, P2691, DOI 10.1016/j.febslet.2007.05.017; Cutty SJ, 2012, INT J DEV BIOL, V56, P285, DOI 10.1387/ijdb.113447sc; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Gibb S, 2009, DEV BIOL, V330, P21, DOI 10.1016/j.ydbio.2009.02.035; Henry CA, 2002, DEVELOPMENT, V129, P3693; Hitachi K, 2009, INT J DEV BIOL, V53, P631, DOI 10.1387/ijdb.082823kh; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Julich D, 2005, DEV BIOL, V286, P391, DOI 10.1016/j.ydbio.2005.06.040; Kageyama R, 2012, WIRES DEV BIOL, V1, P629, DOI 10.1002/wdev.46; Kawamura A, 2005, DEV CELL, V9, P735, DOI 10.1016/j.devcel.2005.09.021; Kawamura A, 2008, MOL CELL BIOL, V28, P3236, DOI 10.1128/MCB.01754-07; Kishimoto Y, 2004, MECH DEVELOP, V121, P79, DOI 10.1016/j.mod.2003.10.001; Kondow A, 2007, BIOCHEM BIOPH RES CO, V359, P959, DOI 10.1016/j.bbrc.2007.05.211; Kondow A, 2006, INT J DEV BIOL, V50, P473, DOI 10.1387/ijdb.052138ak; Maroto M, 2012, DEVELOPMENT, V139, P2453, DOI 10.1242/dev.069310; Matsui T, 2011, P NATL ACAD SCI USA, V108, P9881, DOI 10.1073/pnas.1017248108; Moreno TA, 2008, DEV BIOL, V315, P317, DOI 10.1016/j.ydbio.2007.12.038; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Morimoto M, 2007, DEVELOPMENT, V134, P1561, DOI 10.1242/dev.000836; Muller M, 1996, DEVELOPMENT, V122, P2071; Nikaido M, 1997, MECH DEVELOP, V61, P75, DOI 10.1016/S0925-4773(96)00625-9; Nikaido M, 2002, NAT GENET, V31, P195, DOI 10.1038/ng899; Niwa Y, 2011, GENE DEV, V25, P1115, DOI [10.1101/gad.2035311, 10.1101/gad.2035311.]; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Oginuma M, 2008, DEVELOPMENT, V135, P2555, DOI 10.1242/dev.019877; Ozbudak EM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040015; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Saga Y, 2012, CURR OPIN GENET DEV, V22, P331, DOI 10.1016/j.gde.2012.05.004; Sawada A, 2000, DEVELOPMENT, V127, P1691; Sawada A, 2001, DEVELOPMENT, V128, P4873; Takahashi J, 2010, DEV BIOL, V342, P134, DOI 10.1016/j.ydbio.2010.03.015; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Westerfield M., 2000, ZEBRA FISH BOOK GUID; White PH, 2003, DEVELOPMENT, V130, P1681, DOI 10.1242/dev.00367; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103	41	30	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107928	10.1371/journal.pone.0107928	http://dx.doi.org/10.1371/journal.pone.0107928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259583	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600038
J	Muneer, Z; Wiesinger, C; Voigtlander, T; Werner, HB; Berger, J; Forss-Petter, S				Muneer, Zahid; Wiesinger, Christoph; Voigtlaender, Till; Werner, Hauke B.; Berger, Johannes; Forss-Petter, Sonja			Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice	PLOS ONE			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; CHAIN FATTY-ACID; CULTURED SKIN FIBROBLASTS; CELL GENE-THERAPY; BETA-OXIDATION; NITRIC-OXIDE; MOUSE MODEL; TRANSPORTER; PROTEIN; ALD	The inherited peroxisomal disorder X-linked adrenoleukodystrophy (X-ALD), associated with neurodegeneration and inflammatory cerebral demyelination, is caused by mutations in the ABCD1 gene encoding the peroxisomal ATP-binding cassette (ABC) transporter ABCD1 (ALDP). ABCD1 transports CoA-esters of very long-chain fatty acids (VLCFA) into peroxisomes for degradation by beta-oxidation; thus, ABCD1 deficiency results in VLCFA accumulation. The closest homologue, ABCD2 (ALDRP), when overexpressed, compensates for ABCD1 deficiency in X-ALD fibroblasts and in Abcd1-deficient mice. Microglia/macrophages have emerged as important players in the progression of neuroinflammation. Human monocytes, lacking significant expression of ABCD2, display severely impaired VLCFA metabolism in X-ALD. Here, we used thioglycollate-elicited primary mouse peritoneal macrophages (MPM Phi) from Abcd1 and Abcd2 single-and double-deficient mice to establish how these mutations affect VLCFA metabolism. By quantitative RT-PCR, Abcd2 mRNA was about half as abundant as Abcd1 mRNA in wild-type and similarly abundant in Abcd1-deficient MPM Phi. VLCFA (C26:0) accumulated about twofold in Abcd1-deficient MPM Phi compared with wild-type controls, as measured by gas chromatography-mass spectrometry. In Abcd2-deficient macrophages VLCFA levels were normal. However, upon Abcd1/Abcd2 double-deficiency, VLCFA accumulation was markedly increased (sixfold) compared with Abcd1-deficient MPM Phi.Elovl1 mRNA, encoding the rate-limiting enzyme for elongation of VLCFA, was equally abundant across all genotypes. Peroxisomal beta-oxidation of C26: 0 amounted to 62% of wild-type activity in Abcd1-deficient MPMW and was significantly more impaired (29% residual activity) upon Abcd1/Abcd2 double-deficiency. Single Abcd2 deficiency did not significantly compromise beta-oxidation of C26:0. Thus, the striking accumulation of VLCFA in double-deficient MPM Phi compared with single Abcd1 deficiency was due to the loss of ABCD2-mediated, compensatory transport of VLCFA into peroxisomes. We propose that moderate endogenous expression of Abcd2 in Abcd1-deficient murine macrophages prevents the severe metabolic phenotype observed in human X-ALD monocytes, which lack appreciable expression of ABCD2. This supports upregulation of ABCD2 as a therapeutic concept in X-ALD.	[Muneer, Zahid; Wiesinger, Christoph; Berger, Johannes; Forss-Petter, Sonja] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Voigtlaender, Till] Med Univ Vienna, Inst Neurol, Vienna, Austria; [Werner, Hauke B.] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany	Medical University of Vienna; Medical University of Vienna; Max Planck Society	Forss-Petter, S (corresponding author), Med Univ Vienna, Ctr Brain Res, Vienna, Austria.	sonja.forss-petter@meduniwien.ac.at	Berger, Johannes/A-9122-2014	Berger, Johannes/0000-0003-0182-2658; Wiesinger, Christoph/0000-0003-1257-4522; Werner, Hauke/0000-0002-7710-5738	European Union [241622]; Austrian Science Fund (FWF) project [P26112-B19]; Higher Education Commission of Pakistan; Austrian Science Fund (FWF) [P 26112] Funding Source: researchfish	European Union(European Commission); Austrian Science Fund (FWF) project(Austrian Science Fund (FWF)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the European Union (FP7-HEALTH-2009) project No. 241622, "LEUKOTREAT" (URL:http://cordis.europa.eu/fp7/home_en.html) and from the Austrian Science Fund (FWF) project P26112-B19 (URL: http://www.fwf.ac.at). ZM was supported by a PhD scholarship from the Higher Education Commission of Pakistan (URL: http://www.hec.gov.pk/Pages/HECMain.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBOURG P, 1990, NEW ENGL J MED, V322, P1860, DOI 10.1056/NEJM199006283222607; Berger J, 2014, BIOCHIMIE, V98, P135, DOI 10.1016/j.biochi.2013.11.023; Berger J, 1999, EUR J BIOCHEM, V265, P719, DOI 10.1046/j.1432-1327.1999.00772.x; Berger J, 2006, BBA-MOL CELL RES, V1763, P1721, DOI 10.1016/j.bbamcr.2006.07.010; Berger J, 2010, BRAIN PATHOL, V20, P845, DOI 10.1111/j.1750-3639.2010.00393.x; BIZZOZERO OA, 1991, J NEUROCHEM, V56, P872, DOI 10.1111/j.1471-4159.1991.tb02003.x; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Cartier N, 2010, BRAIN PATHOL, V20, P857, DOI 10.1111/j.1750-3639.2010.00394.x; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COHN ZA, 1978, J IMMUNOL, V121, P813; Eichler FS, 2008, ANN NEUROL, V63, P729, DOI 10.1002/ana.21391; Engelen M, 2014, BRAIN, V137, P693, DOI 10.1093/brain/awt361; Ferrer I, 2005, HUM MOL GENET, V14, P3565, DOI 10.1093/hmg/ddi384; ForssPetter S, 1997, J NEUROSCI RES, V50, P829, DOI 10.1002/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Fourcade S, 2009, AM J PHYSIOL-ENDOC M, V296, pE211, DOI 10.1152/ajpendo.90736.2008; Galino J, 2011, ANTIOXID REDOX SIGN, V15, P2095, DOI 10.1089/ars.2010.3877; Gilg AG, 2000, J NEUROPATH EXP NEUR, V59, P1063, DOI 10.1093/jnen/59.12.1063; HO JK, 1995, J CLIN INVEST, V96, P1455, DOI 10.1172/JCI118182; Holzinger A, 1997, BIOCHEM BIOPH RES CO, V239, P261, DOI 10.1006/bbrc.1997.7391; Hubbard WC, 2006, MOL GENET METAB, V89, P185, DOI 10.1016/j.ymgme.2006.05.001; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Kemp S, 2005, MOL GENET METAB, V84, P144, DOI 10.1016/j.ymgme.2004.09.015; Kemp S, 1998, NAT MED, V4, P1261, DOI 10.1038/3242; Kemp S, 2012, BBA-MOL BASIS DIS, V1822, P1465, DOI 10.1016/j.bbadis.2012.03.012; Kemp S, 2010, BRAIN PATHOL, V20, P831, DOI 10.1111/j.1750-3639.2010.00391.x; KISHIMOTO Y, 1980, BIOCHEM BIOPH RES CO, V96, P69, DOI 10.1016/0006-291X(80)91182-1; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; KNAZEK RA, 1983, J CLIN INVEST, V72, P245, DOI 10.1172/JCI110963; Kobayashi T, 1997, BIOCHEM BIOPH RES CO, V232, P631, DOI 10.1006/bbrc.1997.6340; Langmann T, 2006, CLIN CHEM, V52, P310, DOI 10.1373/clinchem.2005.059774; LEIJH PCJ, 1984, INFECT IMMUN, V46, P448, DOI 10.1128/IAI.46.2.448-452.1984; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; Lopez-Erauskin J, 2013, HUM MOL GENET, V22, P3296, DOI 10.1093/hmg/ddt186; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu JF, 1997, P NATL ACAD SCI USA, V94, P9366, DOI 10.1073/pnas.94.17.9366; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; McGuinness MC, 2003, MOL CELL BIOL, V23, P744, DOI 10.1128/MCB.23.2.744-753.2003; Misharin AV, 2012, J LEUKOCYTE BIOL, V92, P325, DOI 10.1189/jlb.1111560; MOSER HW, 1981, NEUROLOGY, V31, P1241, DOI 10.1212/WNL.31.10.1241; Moser HW, 1997, BRAIN, V120, P1485, DOI 10.1093/brain/120.8.1485; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Netik A, 1999, HUM MOL GENET, V8, P907, DOI 10.1093/hmg/8.5.907; Ofman R, 2010, EMBO MOL MED, V2, P90, DOI 10.1002/emmm.201000061; Peters C, 2004, BLOOD, V104, P881, DOI 10.1182/blood-2003-10-3402; Powers JM, 2005, J NEUROPATH EXP NEUR, V64, P1067, DOI 10.1097/01.jnen.0000190064.28559.a4; Pujol A, 2004, HUM MOL GENET, V13, P2997, DOI 10.1093/hmg/ddh323; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; SINGH I, 1984, PEDIATR RES, V18, P286, DOI 10.1203/00006450-198403000-00016; Singh J, 2013, BBA-MOL CELL BIOL L, V1831, P747, DOI 10.1016/j.bbalip.2013.01.004; Troffer-Charlier N, 1998, EUR J CELL BIOL, V75, P254, DOI 10.1016/S0171-9335(98)80121-0; TSUJI S, 1981, J BIOCHEM-TOKYO, V90, P1233, DOI 10.1093/oxfordjournals.jbchem.a133578; Unterberger U, 2007, CLIN BIOCHEM, V40, P1037, DOI 10.1016/j.clinbiochem.2007.04.015; van Roermund CWT, 2014, BBA-MOL CELL BIOL L, V1841, P563, DOI 10.1016/j.bbalip.2013.12.001; van Roermund CWT, 2011, BBA-MOL CELL BIOL L, V1811, P148, DOI 10.1016/j.bbalip.2010.11.010; Van Roermund CW, 2013, BIOCH BIOPHYS ACTA; WATKINS PA, 1991, ARCH BIOCHEM BIOPHYS, V289, P329, DOI 10.1016/0003-9861(91)90419-J; Weber FD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103742; Weber FD, 2014, HUM MOL GENET, V23, P2542, DOI 10.1093/hmg/ddt645; Weinhofer I, 2005, FEBS LETT, V579, P5512, DOI 10.1016/j.febslet.2005.09.014; Wiesinger C, 2013, J BIOL CHEM, V288, P19269, DOI 10.1074/jbc.M112.445445; Yanagisawa N, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-48; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	65	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108655	10.1371/journal.pone.0108655	http://dx.doi.org/10.1371/journal.pone.0108655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255441	Green Submitted, Green Published, gold			2022-12-27	WOS:000344862300103
J	Wang, K; Bhandari, V; Giuliano, JS; O'Hern, CS; Shattuck, MD; Kirby, M				Wang, Kun; Bhandari, Vineet; Giuliano, John S., Jr.; O'Hern, Corey S.; Shattuck, Mark D.; Kirby, Michael			Angiopoietin-1, Angiopoietin-2 and Bicarbonate as Diagnostic Biomarkers in Children with Severe Sepsis	PLOS ONE			English	Article							MULTIPLE ORGAN DYSFUNCTION; SEPTIC SHOCK; RISK	Severe pediatric sepsis continues to be associated with high mortality rates in children. Thus, an important area of biomedical research is to identify biomarkers that can classify sepsis severity and outcomes. The complex and heterogeneous nature of sepsis makes the prospect of the classification of sepsis severity using a single biomarker less likely. Instead, we employ machine learning techniques to validate the use of a multiple biomarkers scoring system to determine the severity of sepsis in critically ill children. The study was based on clinical data and plasma samples provided by a tertiary care center's Pediatric Intensive Care Unit (PICU) from a group of 45 patients with varying sepsis severity at the time of admission. Canonical Correlation Analysis with the Forward Selection and Random Forests methods identified a particular set of biomarkers that included Angiopoietin-1 (Ang-1), Angiopoietin-2 (Ang-2), and Bicarbonate (HCO3) as having the strongest correlations with sepsis severity. The robustness and effectiveness of these biomarkers for classifying sepsis severity were validated by constructing a linear Support Vector Machine diagnostic classifier. We also show that the concentrations of Ang-1, Ang-2, and HCO3 enable predictions of the time dependence of sepsis severity in children.	[Wang, Kun; Kirby, Michael] Colorado State Univ, Dept Math, Ft Collins, CO 80523 USA; [Wang, Kun; O'Hern, Corey S.] Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT USA; [Bhandari, Vineet; Giuliano, John S., Jr.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [O'Hern, Corey S.] Yale Univ, Dept Appl Phys, Dept Phys, New Haven, CT 06520 USA; [O'Hern, Corey S.] Yale Univ, Grad Program Computat Biol & Bioinformat, New Haven, CT USA; [Shattuck, Mark D.] CUNY, Benjamin Levich Inst, New York, NY 10021 USA; [Shattuck, Mark D.] CUNY, Dept Phys, New York, NY 10021 USA	Colorado State University; Yale University; Yale University; Yale University; Yale University; City University of New York (CUNY) System; City University of New York (CUNY) System	Kirby, M (corresponding author), Colorado State Univ, Dept Math, Ft Collins, CO 80523 USA.	kirby@math.colostate.edu	Shattuck, Mark D/F-5680-2015; Bhandari, Vineet/AAS-3365-2020; O'Hern, Corey/I-3459-2014	Shattuck, Mark D/0000-0001-8473-2505; O'Hern, Corey/0000-0002-8272-5640; Giuliano, John/0000-0003-2753-8460	DARPA (Space and Naval Warfare System Center Pacic) [N66001-11-1-4184]; Infectious Disease Supercluster, Colorado State University	DARPA (Space and Naval Warfare System Center Pacic); Infectious Disease Supercluster, Colorado State University	This work was partially supported by DARPA (Space and Naval Warfare System Center Pacic) under award number N66001-11-1-4184 (http://www.darpa.mil/). Additional support for this work was provided by Infectious Disease Supercluster, Colorado State University, 2012 seed grant (http://infectiousdisease.colostate.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BJORCK A, 1973, MATH COMPUT, V27, P579, DOI 10.2307/2005662; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2002, MANUAL SETTING USING; Breiman L., 2017, CLASSIFICATION REGRE; David S, 2012, CRIT CARE MED, V40, P3034, DOI 10.1097/CCM.0b013e31825fdc31; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Efroymson M. A., 1960, MATH METHODS DIGITAL, P191; Giuliano JS, 2007, SHOCK, V28, P650, DOI 10.1097/shk.0b013e318123867b; Giuliano JS, 2014, PEDIATR CRIT CARE ME, V15, pE1, DOI 10.1097/PCC.0b013e3182a553bb; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Kim HC, 2003, PATTERN RECOGN, V36, P2757, DOI 10.1016/S0031-3203(03)00175-4; Kochanek KD, 2012, PEDIAT PEDS; Fiusa MML, 2013, CRIT CARE, V17, DOI 10.1186/cc12848; Mangasarian OL, 1999, OPER RES LETT, V24, P15, DOI 10.1016/S0167-6377(98)00049-2; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Mladenic D., 2004, Proceedings of Sheffield SIGIR 2004. The Twenty-Seventh Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P234, DOI 10.1145/1008992.1009034; Morik K, 1999, MACHINE LEARNING, PROCEEDINGS, P268; Pang H, 2006, BIOINFORMATICS, V22, P2028, DOI 10.1093/bioinformatics/btl344; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Proulx F, 2009, PEDIATR CRIT CARE ME, V10, P12, DOI 10.1097/PCC.0b013e31819370a9; Ricciuto DR, 2011, CRIT CARE MED, V39, P702, DOI 10.1097/CCM.0b013e318206d285; Samraj RS, 2013, SHOCK, V40, P358, DOI 10.1097/SHK.0b013e3182a66bd6; Sjostrand K, 2012, J STAT SOFT IN PRESS; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Tofallis C, 1999, J ROY STAT SOC D-STA, V48, P371, DOI 10.1111/1467-9884.00195; van der Heijden M, 2009, INTENS CARE MED, V35, P1567, DOI 10.1007/s00134-009-1560-y; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Wang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082700; Watson RS, 2003, AM J RESP CRIT CARE, V167, P695, DOI 10.1164/rccm.200207-682OC; Watson RS, 2005, PEDIATR CRIT CARE ME, V6, pS3, DOI DOI 10.1097/01.PCC.0000161289.22464.C3; Wong HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092121; Wong HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086242; Wong HR, 2012, CRIT CARE, V16, DOI 10.1186/cc11652	34	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108461	10.1371/journal.pone.0108461	http://dx.doi.org/10.1371/journal.pone.0108461			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255212	Green Published, gold			2022-12-27	WOS:000344862300085
J	Gurung, S; Mamidi, S; Bonman, JM; Xiong, M; Brown-Guedira, G; Adhikari, TB				Gurung, Suraj; Mamidi, Sujan; Bonman, J. Michael; Xiong, Mai; Brown-Guedira, Gina; Adhikari, Tika B.			Genome-Wide Association Study Reveals Novel Quantitative Trait Loci Associated with Resistance to Multiple Leaf Spot Diseases of Spring Wheat	PLOS ONE			English	Article							SEPTORIA-TRITICI BLOTCH; STAGONOSPORA-NODORUM BLOTCH; FUSARIUM HEAD BLIGHT; HOST-SELECTIVE TOXIN; PATHOGEN-INDUCED EXPRESSION; IRON-DEFICIENCY CHLOROSIS; TAN SPOT; LINKAGE DISEQUILIBRIUM; ARABIDOPSIS-THALIANA; POPULATION-STRUCTURE	Accelerated wheat development and deployment of high-yielding, climate resilient, and disease resistant cultivars can contribute to enhanced food security and sustainable intensification. To facilitate gene discovery, we assembled an association mapping panel of 528 spring wheat landraces of diverse geographic origin for a genome-wide association study (GWAS). All accessions were genotyped using an Illumina Infinium 9K wheat single nucleotide polymorphism (SNP) chip and 4781 polymorphic SNPs were used for analysis. To identify loci underlying resistance to the major leaf spot diseases and to better understand the genomic patterns, we quantified population structure, allelic diversity, and linkage disequilibrium. Our results showed 32 loci were significantly associated with resistance to the major leaf spot diseases. Further analysis identified QTL effective against major leaf spot diseases of wheat which appeared to be novel and others that were previously identified by association analysis using Diversity Arrays Technology (DArT) and bi-parental mapping. In addition, several identified SNPs co-localized with genes that have been implicated in plant disease resistance. Future work could aim to select the putative novel loci and pyramid them in locally adapted wheat cultivars to develop broad-spectrum resistance to multiple leaf spot diseases of wheat via marker-assisted selection (MAS).	[Gurung, Suraj] Univ Calif Davis, Dept Plant Pathol, USDA ARS, Salinas, CA USA; [Mamidi, Sujan] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Bonman, J. Michael] USDA ARS, Small Grains & Potato Germplasm Res Unit, Aberdeen, ID USA; [Xiong, Mai; Brown-Guedira, Gina] N Carolina State Univ, USDA ARS, Dept Crop Sci, Plant Sci Res Unit, Raleigh, NC 27695 USA; [Adhikari, Tika B.] N Carolina State Univ, Ctr Integrated Pest Management, Raleigh, NC 27695 USA; [Adhikari, Tika B.] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis; North Dakota State University Fargo; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Adhikari, TB (corresponding author), N Carolina State Univ, Ctr Integrated Pest Management, Raleigh, NC 27695 USA.	tika_adhikari@ncsu.edu	mamidi, sujan/P-7009-2018	mamidi, sujan/0000-0002-3837-6121; Brown-Guedira, Gina/0000-0002-1958-2827; Bonman, John/0000-0002-7414-044X	Wheat Research and Promotion Council, Minnesota; North Dakota Wheat Commission; State Board of Agricultural Research and Education, North Dakota; USDA-ARS [58-5366-0-133]; National Research Initiative Competitive Grant (Triticeae-CAP) from the USDA National Institute of Food and Agriculture [2011-68002-30029]; ARS [ARS-0424394] Funding Source: Federal RePORTER	Wheat Research and Promotion Council, Minnesota; North Dakota Wheat Commission; State Board of Agricultural Research and Education, North Dakota; USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Research Initiative Competitive Grant (Triticeae-CAP) from the USDA National Institute of Food and Agriculture; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors gratefully acknowledge financial support for this project from the Wheat Research and Promotion Council, Minnesota, North Dakota Wheat Commission, and State Board of Agricultural Research and Education, North Dakota, and USDA-ARS Specific Cooperative Agreement # 58-5366-0-133. The authors are grateful to the National Research Initiative Competitive Grant 2011-68002-30029 (Triticeae-CAP) from the USDA National Institute of Food and Agriculture for 9K wheat SNP data. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abeysekara NS, 2012, PHYTOPATHOLOGY, V102, P94, DOI 10.1094/PHYTO-02-11-0040; Abeysekara NS, 2009, THEOR APPL GENET, V120, P117, DOI 10.1007/s00122-009-1163-6; Adhikari T., 2009, FUNGAL LEAF SPOT DIS; Adhikari TB, 2003, PHYTOPATHOLOGY, V93, P1158, DOI 10.1094/PHYTO.2003.93.9.1158; Adhikari TB, 2004, THEOR APPL GENET, V109, P944, DOI 10.1007/s00122-004-1709-6; Adhikari TB, 2004, PHYTOPATHOLOGY, V94, P1198, DOI 10.1094/PHYTO.2004.94.11.1198; Adhikari TB, 2012, PLANT GENOME-US, V5, P1, DOI 10.3835/plantgenome2011.12.0032; Adhikari TB, 2011, PHYTOPATHOLOGY, V101, P1301, DOI 10.1094/PHYTO-03-11-0076; Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Arraiano LS, 2007, PLANT PATHOL, V56, P73, DOI 10.1111/j.1365-3059.2006.01499.x; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Bragard C, 1997, PHYTOPATHOLOGY, V87, P1111, DOI 10.1094/PHYTO.1997.87.11.1111; Brown PJ, 2008, GENETICS, V180, P629, DOI 10.1534/genetics.108.092239; Castro AJ, 2003, CROP SCI, V43, P651, DOI 10.2135/cropsci2003.0651; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; CENTURY KS, 1995, P NATL ACAD SCI USA, V92, P6597, DOI 10.1073/pnas.92.14.6597; Chartrain L, 2009, PLANT PATHOL, V58, P547, DOI 10.1111/j.1365-3059.2008.02013.x; Chu CG, 2008, THEOR APPL GENET, V117, P873, DOI 10.1007/s00122-008-0826-z; Chu CG, 2010, MOL BREEDING, V25, P327, DOI 10.1007/s11032-009-9335-2; Coca M, 2010, PLANT J, V63, P526, DOI 10.1111/j.1365-313X.2010.04255.x; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; de Silva K, 2011, J EXP BOT, V62, P2679, DOI 10.1093/jxb/erq468; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Emebiri LC, 2010, MOL BREEDING, V26, P39, DOI 10.1007/s11032-009-9375-7; Eriksen L, 2003, THEOR APPL GENET, V107, P515, DOI 10.1007/s00122-003-1276-2; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Eyal Z., 1987, SEPTORIA DIS WHEAT C; FAO, 2013, FAO STAT YB 2013 WOR; Faris JD, 2005, THEOR APPL GENET, V111, P386, DOI 10.1007/s00122-005-2033-5; Faris JD, 1997, THEOR APPL GENET, V94, P98, DOI 10.1007/s001220050387; Faris JD, 2013, THEOR APPL GENET, V126, P2197, DOI 10.1007/s00122-013-2157-y; Faris JD, 2009, PHYTOPATHOLOGY, V99, P906, DOI 10.1094/PHYTO-99-8-0906; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; FORSTER RL, 1988, PLANT DIS, V72, P935, DOI 10.1094/PD-72-0935; Francki MG, 2011, PHYTOPATHOLOGY, V101, P1278, DOI 10.1094/PHYTO-02-11-0054; Friesen TL, 2008, CROP SCI, V48, P1062, DOI 10.2135/cropsci2007.08.0463; Friesen TL, 2008, PLANT PHYSIOL, V146, P682, DOI 10.1104/pp.107.108761; Friesen TL, 2010, CAN J PLANT PATHOL, V32, P20, DOI 10.1080/07060661003620896; Friesen TL, 2009, THEOR APPL GENET, V118, P1489, DOI 10.1007/s00122-009-0997-2; Friesen TL, 2004, THEOR APPL GENET, V109, P464, DOI 10.1007/s00122-004-1678-9; Garvin DF, 2009, PHYTOPATHOLOGY, V99, P447, DOI 10.1094/PHYTO-99-4-0447; Geisler M, 2000, BBA-BIOMEMBRANES, V1465, P52, DOI 10.1016/S0005-2736(00)00131-0; Ghaffary SMT, 2012, THEOR APPL GENET, V124, P125, DOI 10.1007/s00122-011-1692-7; Gurung S, 2011, THEOR APPL GENET, V123, P1029, DOI 10.1007/s00122-011-1645-1; Gurung S, 2012, CROP SCI, V52, P1640, DOI 10.2135/cropsci2011.08.0408; Gurung S, 2011, PHYTOPATHOLOGY, V101, P1251, DOI 10.1094/PHYTO-08-10-0212; Gurung S, 2009, CROP SCI, V49, P1655, DOI 10.2135/cropsci2008.10.0633; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Iqbal MJ, 2012, THEOR APPL GENET, V125, P517, DOI 10.1007/s00122-012-1850-6; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kim YC, 2002, J EXP BOT, V53, P383, DOI 10.1093/jexbot/53.367.383; Kollers S, 2014, MOL BREEDING, V34, P363, DOI 10.1007/s11032-014-0039-x; Kopka J, 1998, PLANT MOL BIOL, V36, P627, DOI 10.1023/A:1005915020760; Kumar S, 2007, PHYTOPATHOLOGY, V97, P592, DOI 10.1094/PHYTO-97-5-0592; Kumar U, 2010, MOL BREEDING, V26, P477, DOI 10.1007/s11032-009-9388-2; Kumar U, 2009, THEOR APPL GENET, V118, P783, DOI 10.1007/s00122-008-0938-5; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Lehti-Shiu MD, 2012, PHILOS T R SOC B, V367, P2619, DOI 10.1098/rstb.2012.0003; Li HB, 2011, THEOR APPL GENET, V122, P395, DOI 10.1007/s00122-010-1455-x; Lillemo M, 2013, THEOR APPL GENET, V126, P711, DOI 10.1007/s00122-012-2012-6; Liu JZ, 2013, PLANT J, V74, P110, DOI 10.1111/tpj.12108; Liu ZH, 2004, PHYTOPATHOLOGY, V94, P1056, DOI 10.1094/PHYTO.2004.94.10.1056; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Mamidi S, 2013, HEREDITY, V110, P267, DOI 10.1038/hdy.2012.82; Mamidi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107469; Mamidi S, 2011, PLANT GENOME-US, V4, P154, DOI 10.3835/plantgenome2011.04.0011; Matthies IE, 2012, MOL BREEDING, V30, P951, DOI 10.1007/s11032-011-9678-3; Mergoum M, 2007, PLANT DIS, V91, P1310, DOI 10.1094/PDIS-91-10-1310; Meyer KB, 2013, AM J HUM GENET, V93, P1046, DOI 10.1016/j.ajhg.2013.10.026; Miedaner T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-858; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; Oliver RE, 2005, CROP SCI, V45, P1353, DOI 10.2135/cropsci2004.0503; Patel JS, 2013, CROP SCI, V53, P842, DOI 10.2135/cropsci2012.01.0036; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pritchard JK, 2000, GENETICS, V155, P945; Ranc N, 2012, G3-GENES GENOM GENET, V2, P853, DOI 10.1534/g3.112.002667; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Richardson KL, 2006, THEOR APPL GENET, V113, P485, DOI 10.1007/s00122-006-0314-2; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Rosenberg NA, 2001, GENETICS, V159, P699; ROSIELLE AA, 1979, EUPHYTICA, V28, P385, DOI 10.1007/BF00056596; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Sarowar S, 2011, J EXP BOT, V62, P4851, DOI 10.1093/jxb/err147; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sharma RC, 2007, FIELD CROP RES, V103, P109, DOI 10.1016/j.fcr.2007.05.004; Shi AN, 2009, MOL BREEDING, V23, P113, DOI 10.1007/s11032-008-9219-x; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; Suh MC, 2001, FEBS LETT, V488, P211, DOI 10.1016/S0014-5793(00)02419-4; Tommasini L, 2007, THEOR APPL GENET, V115, P697, DOI 10.1007/s00122-007-0601-6; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang J, 2008, THEOR APPL GENET, V116, P777, DOI 10.1007/s00122-008-0710-x; Wilson R, 1985, INHERITANCE RESISTAN; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027565; Zhou H, 2013, GENOME WIDE ASS MAPP, P257; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	101	114	115	0	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108179	10.1371/journal.pone.0108179	http://dx.doi.org/10.1371/journal.pone.0108179			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268502	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700071
J	Kim, SHJ; Jackson, AJ; Hunt, CA				Kim, Sean H. J.; Jackson, Andre J.; Hunt, C. Anthony			In Silico, Experimental, Mechanistic Model for Extended-Release Felodipine Disposition Exhibiting Complex Absorption and a Highly Variable Food Interaction	PLOS ONE			English	Article							VIVO DRUG-RELEASE; GASTROINTESTINAL TRANSIT; MULTISCALE; RESOLUTION; SYSTEMS; IMPACT; VITRO	The objective of this study was to develop and explore new, in silico experimental methods for deciphering complex, highly variable absorption and food interaction pharmacokinetics observed for a modified-release drug product. Toward that aim, we constructed an executable software analog of study participants to whom product was administered orally. The analog is an object- and agent-oriented, discrete event system, which consists of grid spaces and event mechanisms that map abstractly to different physiological features and processes. Analog mechanisms were made sufficiently complicated to achieve prespecified similarity criteria. An equation-based gastrointestinal transit model with nonlinear mixed effects analysis provided a standard for comparison. Subject-specific parameterizations enabled each executed analog's plasma profile to mimic features of the corresponding six individual pairs of subject plasma profiles. All achieved prespecified, quantitative similarity criteria, and outperformed the gastrointestinal transit model estimations. We observed important subject-specific interactions within the simulation and mechanistic differences between the two models. We hypothesize that mechanisms, events, and their causes occurring during simulations had counterparts within the food interaction study: they are working, evolvable, concrete theories of dynamic interactions occurring within individual subjects. The approach presented provides new, experimental strategies for unraveling the mechanistic basis of complex pharmacological interactions and observed variability.	[Kim, Sean H. J.] Univ Pittsburgh, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA; [Jackson, Andre J.] US FDA, Off Clin Pharmacol, Silver Spring, MD USA; [Hunt, C. Anthony] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Food & Drug Administration (FDA); University of California System; University of California San Francisco	Kim, SHJ (corresponding author), Univ Pittsburgh, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA.	skim@pitt.edu		Hunt, C. Anthony/0000-0001-9372-6860	CDH Research Foundation; Alternatives Research and Development Foundation; American Association of Colleges of Pharmacy New Investigator Award	CDH Research Foundation; Alternatives Research and Development Foundation; American Association of Colleges of Pharmacy New Investigator Award	This research was supported in part by the CDH Research Foundation (CAH, SHJK), the Alternatives Research and Development Foundation (CAH), and the American Association of Colleges of Pharmacy New Investigator Award (SHJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSSON B, 1993, PHARMACEUT RES, V10, P709, DOI 10.1023/A:1018959732744; Agoram B, 2001, ADV DRUG DELIVER REV, V50, pS41, DOI 10.1016/S0169-409X(01)00179-X; Amigoni R, 2007, STUD COMPUT INTELL, V64, P179; An G, 2009, WIRES SYST BIOL MED, V1, P159, DOI 10.1002/wsbm.45; Bazzo GC, 2012, J PHARM SCI-US, V101, P1518, DOI 10.1002/jps.23044; Bergstrand M, 2009, CLIN PHARMACOL THER, V86, P77, DOI 10.1038/clpt.2009.43; Bergstrand M, 2012, PHARM RES-DORDR, V29, P695, DOI 10.1007/s11095-011-0594-3; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Clerman NS, 2011, MODERN FORTRAN STYLE; Eker J, 2003, P IEEE, V91, P127, DOI 10.1109/JPROC.2002.805829; Engelberg JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002030; Epstein B, 2012, ROUT STU PHILOS SCI, V9, P115; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Food and Drug Administration, 2003, EXPL RESP REL STUD D; Godfrey KR, 2011, COMPUT METH PROG BIO, V104, P62, DOI 10.1016/j.cmpb.2010.03.007; Henin E, 2012, AAPS J, V14, P155, DOI 10.1208/s12248-012-9324-y; Hunt CA, 2013, WIRES SYST BIOL MED, V5, P461, DOI 10.1002/wsbm.1222; Hunt CA, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-35; Hunt CA, 2009, PHARM RES-DORDR, V26, P2369, DOI 10.1007/s11095-009-9958-3; Hussain N, 2001, ADV DRUG DELIVER REV, V50, P107, DOI 10.1016/S0169-409X(01)00152-1; Ingo B, 2012, STANFORD ENCY PHILOS; Kim EJ, 2006, EUR J PHARM BIOPHARM, V64, P200, DOI 10.1016/j.ejpb.2006.04.001; Kim SHJ, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-39; Kirschner DE, 2014, WIRES SYST BIOL MED, V6, P225, DOI 10.1002/wsbm.1270; Lam TN, 2009, DRUG METAB DISPOS, V37, P237, DOI 10.1124/dmd.108.023820; Lenth R., 2019, Journal of Statistical Software, V60, P1; Lobenberg R, 2000, EUR J PHARM BIOPHARM, V50, P3, DOI 10.1016/S0939-6411(00)00091-6; Luke S, 2005, SIMUL-T SOC MOD SIM, V81, P517, DOI 10.1177/0037549705058073; Macal CM, 2010, J SIMUL, V4, P151, DOI 10.1057/jos.2010.3; MacMillen D, 2000, IEEE T COMPUT AID D, V19, P1428, DOI 10.1109/43.898825; MRSNY RJ, 1992, J CONTROL RELEASE, V22, P15, DOI 10.1016/0168-3659(92)90113-6; Park S, 2010, J PHARMACOL EXP THER, V334, P124, DOI 10.1124/jpet.110.168526; Pooch UW, 1992, DISCRETE EVENT SIMUL; Robertson D.A., 2005, MANAG ORG COMPLEX PH, V24, P417; Schildt Herbert, 2011, JAVA COMPLETE REFERE; Tang J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000681; Travis J., 2006, LABVIEW EVERYONE GRA; Trevaskis NL, 2008, ADV DRUG DELIVER REV, V60, P702, DOI 10.1016/j.addr.2007.09.007; Weitschies W, 1997, J PHARM SCI, V86, P1218, DOI 10.1021/js970185g; Weitschies W, 2005, J CONTROL RELEASE, V108, P375, DOI 10.1016/j.jconrel.2005.08.018; Wirfs-Brock R, 1990, DESIGNING OBJECT ORI; Yasir M., 2010, INT J PHARMTECH RES, V2, P1681; Zeigler B., 2000, THEORY MODELING SIMU; Zhou HH, 2003, J CLIN PHARMACOL, V43, P211, DOI 10.1177/0091270002250613	44	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108392	10.1371/journal.pone.0108392	http://dx.doi.org/10.1371/journal.pone.0108392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268237	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000343671700089
J	Tomita, T; Ieguchi, K; Coin, F; Kato, Y; Kikuchi, H; Oshima, Y; Kurata, S; Maru, Y				Tomita, Takeshi; Ieguchi, Katsuaki; Coin, Fredric; Kato, Yasuhiro; Kikuchi, Haruhisa; Oshima, Yoshiteru; Kurata, Shoichiro; Maru, Yoshiro			ZFC3H1, a Zinc Finger Protein, Modulates IL-8 Transcription by Binding with Celastramycin A, a Potential Immune Suppressor	PLOS ONE			English	Article							TETRATRICOPEPTIDE REPEAT DOMAIN; INTERLEUKIN-8 GENE REPRESSION; BRONCHIAL EPITHELIAL-CELLS; NUCLEOTIDE EXCISION-REPAIR; LUNG METASTASIS; MYELOID CELLS; INFLAMMATION; RECEPTORS; ACTIVATOR; TARGETS	Celastramycin A, a small molecule that inhibits the production of antibacterial peptides in an ex vivo culture system of Drosophila, suppresses the TNFa-mediated induction of IL-8 in mammalian cells. To understand its molecular mechanism, we examined Celastramycin A binding proteins and investigated their biological functions. Our screening and subsequent pull-down assay revealed ZFC3H1 (also known as CCDC131 or CSRC2), an uncharacterized zinc finger protein, as a Celastramycin A binding protein. The knockdown of ZFC3H1 reduced IL-8 expression levels in the TNFa-stimulated lung carcinoma cell line, LU99, and UV-irradiated HeLa cells. Based on reporter assay results, we concluded that ZFC3H1 participates in the transcriptional activation of IL-8. The findings of our UV-irradiation experiments implied that ZFC3H1 may indirectly interact with ERCC1 in an activated DNA repair complex. Thus, we designated ZFC3H1 as a mammalian target of Celastramycin A (mTOC).	[Tomita, Takeshi; Ieguchi, Katsuaki; Maru, Yoshiro] Tokyo Womens Med Univ, Dept Pharmacol, Shinjuku Ku, Tokyo, Japan; [Coin, Fredric] Univ Strasbourg, INSERM, CNRS, IGBMC,Dept Funct Genom & Canc, Strasbourg, France; [Kato, Yasuhiro; Kikuchi, Haruhisa; Oshima, Yoshiteru; Kurata, Shoichiro] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 980, Japan	Tokyo Women's Medical University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Tohoku University	Tomita, T (corresponding author), Tokyo Womens Med Univ, Dept Pharmacol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo, Japan.	tomitat@research.twmu.ac.jp; ymaru@research.twmu.ac.jp	Kikuchi, Haruhisa/AAC-3758-2019; Coin, Frédéric/F-5925-2013	Kikuchi, Haruhisa/0000-0001-6938-0185; Coin, Frédéric/0000-0002-5620-8519; Tomita, Takeshi/0000-0001-6815-2244	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science; Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Strategic International Cooperative program from Japan Science and Technology Agency; Global COE program, Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM); MEXT, Japan;  [21117008];  [25870760];  [25122716];  [23590347];  [21117005];  [23710247];  [21310134]; Grants-in-Aid for Scientific Research [26440063] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Strategic International Cooperative program from Japan Science and Technology Agency; Global COE program, Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; 21117008 (Y.M.); 25870760 (K.I.); 25122716 (K.I.); 23590347 (T.T.); 21117005 (S.K.); 23710247 (H.K.); 21310134 (Y.O.); the Japan Society for the Promotion of Science; the Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) (S.K.); the Strategic International Cooperative program from Japan Science and Technology Agency (S.K.), and the Global COE program, Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM), from MEXT, Japan (K.I.and T.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Competing	Abe S, 2000, AM J RESP CELL MOL, V22, P51, DOI 10.1165/ajrcmb.22.1.3400; ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Araujo SJ, 2000, GENE DEV, V14, P349; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bezzerri V, 2011, J IMMUNOL, V187, P6069, DOI 10.4049/jimmunol.1100821; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Dayer JM, 2005, EXPERT OPIN BIOL TH, V5, pS83, DOI 10.1517/14712598.5.1.S83; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Keogh B, 2011, TRENDS PHARMACOL SCI, V32, P435, DOI 10.1016/j.tips.2011.03.008; Kikuchi H, 2009, ORG LETT, V11, P1693, DOI 10.1021/ol9002306; Kim JK, 2006, CELL METAB, V4, P417, DOI 10.1016/j.cmet.2006.11.008; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Liu X, 2011, INT IMMUNOPHARMACOL, V11, P1451, DOI 10.1016/j.intimp.2011.04.027; McInnes IB, 2010, ANN RHEUM DIS, V69, P1898, DOI 10.1136/ard.2010.134684; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Schweiger R, 2013, J BIOL CHEM, V288, P30614, DOI 10.1074/jbc.M113.493015; SINGH RK, 1995, CANCER RES, V55, P3669; Tomita T, 2011, ONCOGENE, V30, P3429, DOI 10.1038/onc.2011.53; Villarete LH, 1996, AM J PATHOL, V149, P1685; Yajima M, 2003, BIOCHEM J, V371, P205, DOI 10.1042/BJ20021603; Zhu JZ, 2010, J IMMUNOL, V184, P5768, DOI 10.4049/jimmunol.0903559	24	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108957	10.1371/journal.pone.0108957	http://dx.doi.org/10.1371/journal.pone.0108957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268596	gold, Green Submitted, Green Published			2022-12-27	WOS:000343671700202
J	Yong, KJ; Milenic, DE; Baidoo, KE; Brechbiel, MW				Yong, Kwon Joong; Milenic, Diane E.; Baidoo, Kwamena E.; Brechbiel, Martin W.			Impact of alpha-Targeted Radiation Therapy on Gene Expression in a Pre-Clinical Model for Disseminated Peritoneal Disease when Combined with Paclitaxel	PLOS ONE			English	Article							CELL-CYCLE ARREST; CHECKPOINT; RADIOIMMUNOTHERAPY; REPAIR; BRCA1; PB-212-TCMC-TRASTUZUMAB; POTENTIATION; MICROTUBULE; MECHANISMS; APC/C	To better understand the molecular basis of the enhanced cell killing effected by the combined modality of paclitaxel and Pb-212-trastuzumab (Pac/Pb-212-trastuzumab), gene expression in LS-174T i.p. xenografts was investigated 24 h after treatment. Employing a real time quantitative PCR array (qRT-PCR array), 84 DNA damage response genes were quantified. Differentially expressed genes following therapy with Pac/Pb-212-trastuzumab included those involved in apoptosis (BRCA1, CIDEA, GADD45 alpha, GADD45 gamma, GML, IP6K3, PCBP4, PPP1R15A, RAD21, and p73), cell cycle (BRCA1, CHK1, CHK2, GADD45 alpha, GML, GTSE1, NBN, PCBP4, PPP1R15A, RAD9A, and SESN1), and damaged DNA repair (ATRX, BTG2, EXO1, FEN1, IGHMBP2, OGG1, MSH2, MUTYH, NBN, PRKDC, RAD21, and p73). This report demonstrates that the increased stressful growth arrest conditions induced by the Pac/Pb-212-trastuzumab treatment suppresses cell proliferation through the regulation of genes which are involved in apoptosis and damaged DNA repair including single and double strand DNA breaks. Furthermore, the study demonstrates that Pb-212-trastuzumab potentiation of cell killing efficacy results from the perturbation of genes related to the mitotic spindle checkpoint and BASC (BRCA1-associated genome surveillance complex), suggesting cross-talk between DNA damage repair and the spindle damage response.	[Yong, Kwon Joong; Milenic, Diane E.; Baidoo, Kwamena E.; Brechbiel, Martin W.] NCI, Radioimmune & Inorgan Chem Sect, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brechbiel, MW (corresponding author), NCI, Radioimmune & Inorgan Chem Sect, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA.	martinwb@mail.nih.gov			Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; AREVA Med LLC	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AREVA Med LLC	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, and AREVA Med LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abal M, 2003, CURR CANCER DRUG TAR, V3, P193, DOI 10.2174/1568009033481967; Barbet Jacques, 2012, Methods Mol Biol, V907, P681, DOI 10.1007/978-1-61779-974-7_38; Bindra RS, 2005, CANCER RES, V65, P11597, DOI 10.1158/0008-5472.CAN-05-2119; Carrassa L, 2009, J CELL MOL MED, V13, P1565, DOI [10.1111/j.1582-4934.2008.00362.x, 10.1111/j.1582-4934.2009.00362.x]; Chappell LL, 2000, NUCL MED BIOL, V27, P93, DOI 10.1016/S0969-8051(99)00086-4; Chauhan V, 2011, RADIOL RES PRACT, V2011, DOI 10.1155/2011/679806; Chen JG, 2003, CANCER RES, V63, P7891; Choi KS, 2012, DNA REPAIR, V11, P965, DOI 10.1016/j.dnarep.2012.09.009; Dahle J, 2011, CURR RADIOPHARM, V4, P321, DOI 10.2174/1874471011104040321; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Dalton WB, 2009, FUTURE ONCOL, V5, P1363, DOI 10.2217/FON.09.118; Danielsson A, 2013, INT J RADIAT BIOL, V89, P250, DOI 10.3109/09553002.2013.746751; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Hollander MC, 2003, ONCOGENE, V22, P3827, DOI 10.1038/sj.onc.1206567; Jurcic JG, 2013, IMMUNOTHERAPY-UK, V5, P383, DOI [10.2217/IMT.13.11, 10.2217/imt.13.11]; Kagawa K, 1997, BIOCHEM BIOPH RES CO, V241, P481, DOI 10.1006/bbrc.1997.7818; Kim YS, 2012, TUMOR BIOL, V33, P573, DOI 10.1007/s13277-011-0286-y; Kimura Y, 1997, ONCOGENE, V15, P1369, DOI 10.1038/sj.onc.1201255; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Matson DR, 2011, MOL INTERV, V11, P141, DOI 10.1124/mi.11.2.12; Meredith RF, 2014, CANCER BIOTHER RADIO, V29, P12, DOI 10.1089/cbr.2013.1531; Milenic DE, 2005, CANCER BIOTHER RADIO, V20, P557, DOI 10.1089/cbr.2005.20.557; Milenic DE, 2008, CLIN CANCER RES, V14, P5108, DOI 10.1158/1078-0432.CCR-08-0256; Milenic DE, 2007, CLIN CANCER RES, V13, P1926, DOI 10.1158/1078-0432.CCR-06-2300; Navarro-Teulon I, 2013, IMMUNOTHERAPY-UK, V5, P467, DOI [10.2217/IMT.13.34, 10.2217/imt.13.34]; Olive PL, 1998, RADIAT RES, V150, pS42, DOI 10.2307/3579807; Seidl C, 2014, IMMUNOTHERAPY-UK, V6, P431, DOI 10.2217/imt.14.16; Seidl C, 2010, INVEST NEW DRUG, V28, P49, DOI 10.1007/s10637-008-9214-4; Sgouros G, 2010, J NUCL MED, V51, P311, DOI 10.2967/jnumed.108.058651; Sivaprasad U, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-8; Sugimura M, 2004, ONCOLOGY-BASEL, V66, P53, DOI 10.1159/000076335; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; Tomasini R, 2009, P NATL ACAD SCI USA, V106, P797, DOI 10.1073/pnas.0812096106; Tophkhane C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043564; Wang RH, 2004, P NATL ACAD SCI USA, V101, P17108, DOI 10.1073/pnas.0407585101; Wang Y, 2000, GENE DEV, V14, P927; Xu H, 2012, BREAST CANCER RES, V13, pR69; Yong KJ, 2013, BRIT J CANCER, V108, P2013, DOI 10.1038/bjc.2013.189; Yong K, 2011, DALTON T, V40, P6068, DOI 10.1039/c0dt01387k; Yong KJ, 2013, CANCER MED-US, V2, P646, DOI 10.1002/cam4.132; Yong KJ, 2012, MOL CANCER THER, V11, P639, DOI 10.1158/1535-7163.MCT-11-0671; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003	44	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108511	10.1371/journal.pone.0108511	http://dx.doi.org/10.1371/journal.pone.0108511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268703	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700103
J	Jaouadi, NZ; Jaouadi, B; Ben Hlima, H; Rekik, H; Belhoul, M; Hmidi, M; Ben Aicha, HS; Hila, CG; Toumi, A; Aghajari, N; Bejar, S				Jaouadi, Nadia Zarai; Jaouadi, Bassem; Ben Hlima, Hajer; Rekik, Hatem; Belhoul, Mouna; Hmidi, Maher; Ben Aicha, Houda Slimene; Hila, Chiraz Gorgi; Toumi, Abdessatar; Aghajari, Nushin; Bejar, Samir			Probing the Crucial Role of Leu31 and Thr33 of the Bacillus pumilus CBS Alkaline Protease in Substrate Recognition and Enzymatic Depilation of Animal Hide	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; SERINE-PROTEASE; PURIFICATION; SPECIFICITY; SKINS	The sapB gene, encoding Bacillus pumilus CBS protease, and seven mutated genes (sapB-L31I, sapB-T33S, sapB-N99Y, sapB-L31I/T33S, sapB-L31I/N99Y, sapB-T33S/N99Y, and sapB-L31I/T33S/N99Y) were overexpressed in protease-deficient Bacillus subtilis DB430 and purified to homogeneity. SAPB-N99Y and rSAPB displayed the highest levels of keratinolytic activity, hydrolysis efficiency, and enzymatic depilation. Interestingly, and at the semi-industrial scale, rSAPB efficiently removed the hair of goat hides within a short time interval of 8 h, thus offering a promising opportunity for the attainment of a lime and sulphide-free depilation process. The efficacy of the process was supported by submitting depilated pelts and dyed crusts to scanning electron microscopic analysis, and the results showed well opened fibre bundles and no apparent damage to the collagen layer. The findings also revealed better physico-chemical properties and less effluent loads, which further confirmed the potential candidacy of the rSAPB enzyme for application in the leather industry to attain an ecofriendly process of animal hide depilation. More interestingly, the findings on the substrate specificity and kinetic properties of the enzyme using the synthetic peptide para-nitroanilide revealed strong preferences for an aliphatic amino-acid (valine) at position P1 for keratinases and an aromatic amino-acid (phenylalanine) at positions P1/P4 for subtilisins. Molecular modeling suggested the potential involvement of a Leu31 residue in a network of hydrophobic interactions, which could have shaped the S4 substrate binding site. The latter could be enlarged by mutating L31I, fitting more easily in position P4 than a phenylalanine residue. The molecular modeling of SAPB-T33S showed a potential S2 subside widening by a T33S mutation, thus suggesting its importance in substrate specificity.	[Jaouadi, Nadia Zarai; Jaouadi, Bassem; Ben Hlima, Hajer; Rekik, Hatem; Belhoul, Mouna; Hmidi, Maher; Bejar, Samir] Univ Sfax, CBS, Lab Microorganisms & Biomol, Sfax, Tunisia; [Ben Aicha, Houda Slimene; Hila, Chiraz Gorgi; Toumi, Abdessatar] Natl Leather & Shoe Ctr CNCC, Megrine, Ben Arous, Tunisia; [Aghajari, Nushin] UMR 5086 CNRS Univ Lyon 1, IBCP, Lab Biocrystallog & Struct Biol Therapeut Targets, FR3302, Lyon, France	Centre de Biotechnologie de Sfax; Universite de Sfax; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Jaouadi, B (corresponding author), Univ Sfax, CBS, Lab Microorganisms & Biomol, Sfax, Tunisia.	bassem.jaouadi@cbs.rnrt.tn; samir.bejar@cbs.rnrt.tn	Aghajari, Nushin B.H./P-1906-2016; JAOUADI, Bassem/AAN-8106-2021	Aghajari, Nushin B.H./0000-0002-2245-2679; Bassem, JAOUADI/0000-0002-5182-7353	Tunisian Ministry of Higher Education, Scientific Research and Information and Communication Technologies Higher Education and Scientific Research sector under the "Contract Program LMB-CBS" [LR10CBS04 2010-2013]; Tunisian Ministry of Industry, Energy and Mines [PNRI-ENZYMES 2012-2015]	Tunisian Ministry of Higher Education, Scientific Research and Information and Communication Technologies Higher Education and Scientific Research sector under the "Contract Program LMB-CBS"; Tunisian Ministry of Industry, Energy and Mines	This work was funded by the Tunisian Ministry of Higher Education, Scientific Research and Information and Communication Technologies Higher Education and Scientific Research sector under the "Contract Program LMB-CBS, grant no. LR10CBS04 2010-2013" and the Tunisian Ministry of Industry, Energy and Mines under the "National Programme for the Promotion of Technological Innovation, grant no. PNRI-ENZYMES 2012-2015." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association A., 1995, STANDARD METHODS EXA; [Anonymous], 2018, 40482018 ISO; [Anonymous], 53971984 ISO; Benkiar A, 2013, INT BIODETER BIODEGR, V83, P129, DOI 10.1016/j.ibiod.2013.05.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Colmenares JC, 2014, APPL CATAL B-ENVIRON, V150, P432, DOI 10.1016/j.apcatb.2013.12.038; Dayanandan A, 2003, J CLEAN PROD, V11, P533, DOI 10.1016/S0959-6526(02)00056-2; Gamble M, 2012, FEBS OPEN BIO, V2, P209, DOI 10.1016/j.fob.2012.07.001; Gupta R, 2006, APPL MICROBIOL BIOT, V70, P21, DOI 10.1007/s00253-005-0239-8; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Huang Q, 2003, CURR MICROBIOL, V46, P169, DOI 10.1007/s00284-002-3850-2; IUP, 2000, S J SOC LEATHER TECH, V84, P327; IUP 6, 2000, J SOC LEATHER TECHNO, V84, P312; Jain SC, 1998, J MOL BIOL, V284, P137, DOI 10.1006/jmbi.1998.2161; Jaouadi B, 2008, BIOCHIMIE, V90, P1291, DOI 10.1016/j.biochi.2008.03.004; Jaouadi B, 2010, BIORESOURCE TECHNOL, V101, P8361, DOI 10.1016/j.biortech.2010.05.066; Jaouadi B, 2010, BIOCHIMIE, V92, P360, DOI 10.1016/j.biochi.2010.01.008; Jaouadi NZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076722; Jaouadi NZ, 2012, BIORESOURCE TECHNOL, V105, P142, DOI 10.1016/j.biortech.2011.11.115; Kumar AG, 2008, J APPL MICROBIOL, V104, P411, DOI 10.1111/j.1365-2672.2007.03564.x; Kumar EV, 2011, BIOPROC BIOSYST ENG, V34, P403, DOI 10.1007/s00449-010-0483-x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Najafi MF, 2005, ELECTRON J BIOTECHN, V8, P197, DOI 10.2225/vol8-issue2-fulltext-5; Nilegaonkar SS, 2007, BIORESOURCE TECHNOL, V98, P1238, DOI 10.1016/j.biortech.2006.05.003; Pandeeti EVP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016742; Pillai P, 2008, APPL MICROBIOL BIOT, V78, P643, DOI 10.1007/s00253-008-1355-z; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Sambrook J., 1989, MOL CLONING LAB MANU, P23; SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Sivasubramanian S, 2008, CHEMOSPHERE, V70, P1025, DOI 10.1016/j.chemosphere.2007.07.084; Sivasubramanian S, 2008, CHEMOSPHERE, V70, P1015, DOI 10.1016/j.chemosphere.2007.09.036; Sundararajan S, 2011, J BIOSCI BIOENG, V111, P128, DOI 10.1016/j.jbiosc.2010.09.009; Takagi H, 1996, FEBS LETT, V395, P127, DOI 10.1016/0014-5793(96)01014-9; Thanikaivelan P, 2004, TRENDS BIOTECHNOL, V22, P181, DOI 10.1016/j.tibtech.2004.02.008; Thanikaivelan P, 2003, ENVIRON SCI TECHNOL, V37, P2609, DOI 10.1021/es026474a; Thanikaivelan P, 2002, ENVIRON SCI TECHNOL, V36, P4187, DOI 10.1021/es025618i; Wang HY, 2007, LETT APPL MICROBIOL, V44, P1, DOI 10.1111/j.1472-765X.2006.02039.x	38	30	31	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108367	10.1371/journal.pone.0108367	http://dx.doi.org/10.1371/journal.pone.0108367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264614	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400070
J	Lee, YH; Kown, MH; Kim, KJ; Lee, EY; Kim, D; Lee, BW; Kang, ES; Cha, BS; Lee, HC				Lee, Yong-ho; Kown, Mi Hyang; Kim, Kwang Joon; Lee, Eun Young; Kim, Daham; Lee, Byung-Wan; Kang, Eun Seok; Cha, Bong Soo; Lee, Hyun Chul			Inverse Association between Glycated Albumin and Insulin Secretory Function May Explain Higher Levels of Glycated Albumin in Subjects with Longer Duration of Diabetes	PLOS ONE			English	Article							HEMOGLOBIN; GLUCOSE; INFLAMMATION; RESISTANCE; INDICATOR; MELLITUS; HBA1C; RATIO	Background: Glycated albumin (GA) has been increasingly used as a reliable index for short-term glycemic monitoring, and is inversely associated with beta-cell function. Because the pathophysiologic nature of type 2 diabetes (T2D) is characterized by progressive decline in insulin secretion, the aim was to determine whether GA levels were affected by diabetes duration in subjects with T2D. Methods: To minimize the effect of glucose variability on GA, subjects with stably maintained HbA(1c) levels of <0.5% fluctuation across 6 months of measurements were included. Patients with newly diagnosed T2D (n = 1059) and with duration >1 year (n = 781) were recruited and categorized as New-T2D and Old-T2D, respectively. Biochemical, glycemic, and C-peptide parameters were measured. Results: GA levels were significantly elevated in HbA(1c)-matched Old-T2D subjects compared to New-T2D subjects. Duration of diabetes was positively correlated with GA, whereas a negative relationship was found with C-peptide increment (Delta C-peptide). Among insulin secretory indices, dynamic parameters such as Delta C-peptide were inversely related to GA (r = -0.42, p < 0.001). Multiple linear regression analyses showed that duration of diabetes was associated with GA (standardized beta coefficient [STD beta] = 0.05, p < 0.001), but not with HbA(1c) (STD beta = 0.04, p < 0.095). This association disappeared after additional adjustment with Delta C-peptide (STD beta = 0.02, p = 0.372), suggesting that beta-cell function might be a linking factor of close relationship between duration of diabetes and GA values. Conclusions: The present study showed that GA levels were significantly increased in subjects with longer duration T2D and with decreased insulin secretory function. Additional caution should be taken when interpreting GA values to assess glycemic control status in these individuals.	[Lee, Yong-ho; Kim, Kwang Joon; Lee, Eun Young; Lee, Byung-Wan; Kang, Eun Seok; Cha, Bong Soo; Lee, Hyun Chul] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Yong-ho; Kown, Mi Hyang; Kim, Kwang Joon; Lee, Eun Young; Lee, Byung-Wan; Kang, Eun Seok; Cha, Bong Soo; Lee, Hyun Chul] Severance Hosp, Seoul, South Korea; [Kim, Kwang Joon] Yonsei Univ Hlth Syst, Severance Execut Healthcare Clin, Seoul, South Korea; [Kim, Daham] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, BW (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	bwanlee@yuhs.ac	Wan, Lee Byung/K-2649-2019; Lee, Yong-ho/AAT-4106-2020	Lee, Yong-ho/0000-0002-6219-4942; Cha, Bong-Soo/0000-0003-0542-2854; Kim, Daham/0000-0003-1871-686X; Kang, Eun Seok/0000-0002-0364-4675; Lee, Byung-Wan/0000-0002-9899-4992				Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; CRANSTON I, 1994, LANCET, V344, P283, DOI 10.1016/S0140-6736(94)91336-6; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Inaba M, 2007, J AM SOC NEPHROL, V18, P896, DOI 10.1681/ASN.2006070772; Kim D, 2012, CLIN ENDOCRINOL, V77, P679, DOI 10.1111/j.1365-2265.2011.04312.x; Kim KJ, 2012, DIABETES METAB J, V36, P98, DOI 10.4093/dmj.2012.36.2.98; Ko SH, 2012, DIABETES METAB J, V36, P222, DOI 10.4093/dmj.2012.36.3.222; Koga M, 2007, CLIN CHIM ACTA, V378, P48, DOI 10.1016/j.cca.2006.10.013; Koga M, 2013, J DIABETES COMPLICAT, V27, P211, DOI 10.1016/j.jdiacomp.2012.12.001; Koga M, 2011, DIABETES RES CLIN PR, V94, pE12, DOI 10.1016/j.diabres.2011.06.022; Koga M, 2011, CLIN CHIM ACTA, V412, P253, DOI 10.1016/j.cca.2010.10.014; Koga M, 2010, ENDOCR J, V57, P751, DOI 10.1507/endocrj.K10E-138; Koga M, 2010, DIABETES CARE, V33, P270, DOI 10.2337/dc09-1002; Kouzuma T, 2002, CLIN CHIM ACTA, V324, P61, DOI 10.1016/S0009-8981(02)00207-3; Lee EJ, 2013, ENDOCRINOL METAB, V28, P125, DOI 10.3803/EnM.2013.28.2.125; Lee EY, 2011, ACTA DIABETOL, V48, P167, DOI 10.1007/s00592-010-0242-0; Lee YH, 2012, DIABETES TECHNOL THE, V14, P508, DOI 10.1089/dia.2011.0208; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ogawa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046517; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Park KH, 2014, ACTA DIABETOL, V51, P15, DOI 10.1007/s00592-012-0420-3; Shiraki T, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-20; Song YM, 2013, ENDOCRINOLOGY, V154, P2626, DOI 10.1210/en.2013-1031; Suwa T, 2010, ENDOCR J, V57, P135, DOI 10.1507/endocrj.K09E-234; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Zafon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066696	26	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108772	10.1371/journal.pone.0108772	http://dx.doi.org/10.1371/journal.pone.0108772			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265016	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400118
J	Wu, WM; Hong, XF; Tian, R; You, L; Dai, MH; Liao, Q; Zhang, TP; Zhao, YP				Wu, Wenming; Hong, Xiafei; Tian, Rui; You, Lei; Dai, Menghua; Liao, Quan; Zhang, Taiping; Zhao, Yupei			An Increased Total Resected Lymph Node Count Benefits Survival following Pancreas Invasive Intraductal Papillary Mucinous Neoplasms Resection: An Analysis Using the Surveillance, Epidemiology, and End Result Registry Database	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS GUIDELINES; COLON-CANCER; CLINICOPATHOLOGICAL FEATURES; SURGICAL RESECTION; CYSTIC NEOPLASMS; PROPENSITY SCORE; STAGE-I; MANAGEMENT; PREDICTORS; EXPERIENCE	Background: The therapeutic effect of lymph node dissection for pancreas invasive intraductal papillary mucinous neoplasms (IPMN) remains unclear. The study investigated whether cancer-specific survival (CSS) and overall survival (OS) rates among invasive IPMN patients improve when more lymph nodes are harvested during surgery. Study Design: The study cohort was retrieved from the Surveillance, Epidemiology, and End Results (SEER) database. The lymph node count was categorized into quartiles. The relationship between lymph node count and survival was analyzed using Kaplan-Meier curves and a Cox proportional-hazards model. The stage migration was assessed by Chi-square tests. Propensity score matching (PSM) was used to minimize confounding variables between groups. Results: In total, 1,080 patients with resected invasive IPMNs from 1992 to 2011 were included. Univariate and multivariate Cox models indicated that an increased lymph node count independently improves survival. The Kaplan-Meier and log-rank tests identified 16 nodes as an optimal cut-off value that yielded a significant survival benefit for all invasive IPMN patients. The stage migration effect existed in this cohort. After PSM, the 5-year CSS increased from 36% to 47%, and the median survival rate increased from 30 months to 40 months by increasing the lymph node count to over 16, alone. The 5-year OS rate also provided additional support for this result. Conclusion: Increased lymph node counts were associated with improved survival in invasive IPMN patients. One cut-off value of lymph node count was 16 for this improvement.	[Zhao, Yupei] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhao, YP (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China.	zhao8028@263.net	DAI, M/GPS-8291-2022					Azar C, 1996, GUT, V39, P457, DOI 10.1136/gut.39.3.457; Chari ST, 2002, GASTROENTEROLOGY, V123, P1500, DOI 10.1053/gast.2002.36552; Chen SL, 2006, ANN SURG, V244, P602, DOI 10.1097/01.sla.0000237655.11717.50; Crippa S, 2010, CLIN GASTROENTEROL H, V8, P213, DOI 10.1016/j.cgh.2009.10.001; D'Angelica M, 2004, ANN SURG, V239, P400, DOI 10.1097/01.sla.0000114132.47816.dd; Falconi M, 2001, BRIT J SURG, V88, P376, DOI 10.1046/j.1365-2168.2001.01720.x; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; Fritz S, 2009, ONCOLOGIST, V14, P125, DOI 10.1634/theoncologist.2008-0200; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Hwang DW, 2012, LANGENBECK ARCH SURG, V397, P93, DOI 10.1007/s00423-010-0674-6; Jang JY, 2008, ANN SURG ONCOL, V15, P199, DOI 10.1245/s10434-007-9603-5; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kanno A, 2010, J GASTROENTEROL, V45, P952, DOI 10.1007/s00535-010-0238-0; Khan S, 2010, WORLD J GASTRO SURG, V2, P314, DOI 10.4240/wjgs.v2.i10.314; Kidner TB, 2012, AM J SURG, V204, P843, DOI 10.1016/j.amjsurg.2012.05.003; Kloppel GES, 1996, HISTOLOGICAL TYPING; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; Longnecker DS, 2000, WHO CLASSIFICATION T, P237; Lykke J, 2013, COLORECTAL DIS, V15, P559, DOI 10.1111/codi.12059; Maire F, 2002, GUT, V51, P717, DOI 10.1136/gut.51.5.717; Mino-Kenudson M, 2011, GUT, V60, P1712, DOI 10.1136/gut.2010.232272; National Comprehensive Cancer Network, PANCR AD VERS 1 2014; National Comprehensive Cancer Network, GASTR CANC VERS 2 20; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Partelli S, 2010, ANN SURG, V251, P477, DOI 10.1097/SLA.0b013e3181cf9155; Reid-Lombardo KM, 2008, PANCREAS, V37, P139, DOI 10.1097/MPA.0b013e318162a10f; Riall TS, 2007, J AM COLL SURGEONS, V204, P803, DOI 10.1016/j.jamcollsurg.2007.01.015; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Sahani Dushyant V, 2009, J Am Coll Radiol, V6, P376, DOI 10.1016/j.jacr.2008.10.004; Salvia R, 2004, ANN SURG, V239, P678, DOI 10.1097/01.sla.0000124386.54496.15; Schmidt CM, 2007, ANN SURG, V246, P644, DOI 10.1097/SLA.0b013e318155a9e5; Schnelldorfer T, 2008, ARCH SURG-CHICAGO, V143, P639, DOI 10.1001/archsurg.143.7.639; Sohn TA, 2004, ANN SURG, V239, P788, DOI 10.1097/01.sla.0000128306.90650.aa; Sohn TA, 2001, ANN SURG, V234, P313, DOI 10.1097/00000658-200109000-00005; Tamura K, 2014, ANN SURG, V259, P360, DOI 10.1097/SLA.0b013e3182a690ff; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Thoemmes F, 2012, PROPENSITY SCORE MAT	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107962	10.1371/journal.pone.0107962	http://dx.doi.org/10.1371/journal.pone.0107962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264746	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400035
J	Ballester, V; Guo, XQ; Vendrell, R; Haritunians, T; Klomhaus, AM; Li, DL; McGovern, DPB; Rotter, JI; Torres, EA; Taylor, KD				Ballester, Veroushka; Guo, Xiuqing; Vendrell, Roberto; Haritunians, Talin; Klomhaus, Alexandra M.; Li, Dalin; McGovern, Dermot P. B.; Rotter, Jerome I.; Torres, Esther A.; Taylor, Kent D.			Association of NOD2 and IL23R with Inflammatory Bowel Disease in Puerto Rico	PLOS ONE			English	Article							GENOME-WIDE PATTERNS; CROHNS-DISEASE; SUSCEPTIBILITY; HAPLOTYPE; ANCESTRY; INFERENCE; MUTATIONS; ADMIXTURE; GENETICS; NUMBER	The Puerto Rico population may be modeled as an admixed population with contributions from three continents: Sub-Saharan Africa, Ancient America, and Europe. Extending the study of the genetics of inflammatory bowel disease (IBD) to an admixed population such as Puerto Rico has the potential to shed light on IBD genes identified in studies of European populations, find new genes contributing to IBD susceptibility, and provide basic information on IBD for the care of US patients of Puerto Rican and Latino descent. In order to study the association between immune-related genes and Crohn's disease (CD) and ulcerative colitis (UC) in Puerto Rico, we genotyped 1159 Puerto Rican cases, controls, and family members with the ImmunoChip. We also genotyped 832 subjects from the Human Genome Diversity Panel to provide data for estimation of global and local continental ancestry. Association of SNPs was tested by logistic regression corrected for global continental descent and family structure. We observed the association between Crohn's disease and NOD2 (rs17313265, 0.28 in CD, 0.19 in controls, OR 1.5, p = 9x10(-6)) and IL23R (rs11209026, 0.026 in CD, 0.0.071 in controls, OR 0.4, p = 3.8x10(-4)). The haplotype structure of both regions resembled that reported for European populations and "local" continental ancestry of the IL23R gene was almost entirely of European descent. We also observed suggestive evidence for the association of the BAZ1A promoter SNP with CD (rs1200332, 0.45 in CD, 0.35 in controls, OR 1.5, p = 2x10(-6)). Our estimate of continental ancestry surrounding this SNP suggested an origin in Ancient America for this putative susceptibility region. Our observations underscored the great difference between global continental ancestry and local continental ancestry at the level of the individual gene, particularly for immune-related loci.	[Ballester, Veroushka; Vendrell, Roberto; Torres, Esther A.] Univ Puerto Rico Med Sci Campus, Sch Med, Div Gastroenterol, Dept Med, San Juan, PR USA; [Haritunians, Talin; Li, Dalin; McGovern, Dermot P. B.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Haritunians, Talin; Li, Dalin; McGovern, Dermot P. B.] Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90048 USA; [Guo, Xiuqing; Klomhaus, Alexandra M.; Rotter, Jerome I.; Taylor, Kent D.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Taylor, KD (corresponding author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA.	ktaylor@labiomed.org	Rotter, Jerome/AAY-6598-2021	Torres, Esther A/0000-0002-1276-0731	National Center for Research Resources [U54 RR026139]; National Institute on Minority Health and Health Disparities [8U54MD 007587-03]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425, U54RR026139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062413, R21DK084554, P30DK063491] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007587] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was supported by Award Number U54 RR026139 from the National Center for Research Resources, and the Award Number 8U54MD 007587-03 from the National Institute on Minority Health and Health Disparities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Baran Y, 2012, BIOINFORMATICS, V28, P1359, DOI 10.1093/bioinformatics/bts144; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Dassopoulos T, 2007, INFLAMM BOWEL DIS, V13, P975, DOI 10.1002/ibd.20144; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Hugot JP, 2007, AM J GASTROENTEROL, V102, P1259, DOI 10.1111/j.1572-0241.2007.01149.x; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jimenez de Wagenheim O, 1998, PUERTO RICO INTERPRE; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kakuta Y, 2009, HUM MOL GENET, V18, P1089, DOI 10.1093/hmg/ddp005; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Manichaikul A, 2012, PLOS GENET, V8, P285, DOI 10.1371/journal.pgen.1002640; Mann C., 2005, 1491 NEW REVELATIONS; Melendez JD, 2011, P R HEALTH SCI J, V30, P3; Ng SC, 2012, INFLAMM BOWEL DIS, V18, P1164, DOI 10.1002/ibd.21845; Nguyen GC, 2006, AM J GASTROENTEROL, V101, P1012, DOI 10.1111/j.1572-0241.2006.00504.x; Pasaniuc B, 2009, BIOINFORMATICS, V25, pI213, DOI 10.1093/bioinformatics/btp197; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Torres EA, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/574079; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Zaahl MG, 2005, MOL CELL PROBE, V19, P278, DOI 10.1016/j.mcp.2005.03.001	37	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108204	10.1371/journal.pone.0108204	http://dx.doi.org/10.1371/journal.pone.0108204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259511	gold, Green Submitted, Green Published			2022-12-27	WOS:000342685600053
J	Beninson, LA; Brown, PN; Loughridge, AB; Saludes, JP; Maslanik, T; Hills, AK; Woodworth, T; Craig, W; Yin, H; Fleshner, M				Beninson, Lida A.; Brown, Peter N.; Loughridge, Alice B.; Saludes, Jonel P.; Maslanik, Thomas; Hills, Abigail K.; Woodworth, Tyler; Craig, Wendy; Yin, Hang; Fleshner, Monika			Acute Stressor Exposure Modifies Plasma Exosome-Associated Heat Shock Protein 72 (Hsp72) and microRNA ( miR-142-5p and miR-203)	PLOS ONE			English	Article							EXTRACELLULAR HSP72; CELLS; INDUCTION; IMMUNITY; PATHWAY; HEAT-SHOCK-PROTEIN-70; ACTIVATION; RESISTANCE; MEMBRANE; ALPHA	Exosomes, biologically active nanoparticles (40-100 nm) released by hematopoietic and non-hematopoietic cells, contain a variety of proteins and small, non-coding RNA known as microRNA (miRNA). Exposure to various pathogens and disease states modifies the composition and function of exosomes, but there are no studies examining in vivo exosomal changes evoked by the acute stress response. The present study reveals that exposing male Fisher 344 rats to an acute stressor modulates the protein and miRNA profile of circulating plasma exosomes, specifically increasing surface heat shock protein 72 (Hsp72) and decreasing miR-142-5p and -203. The selected miRNAs and Hsp72 are associated with immunomodulatory functions and are likely a critical component of stress-evoked modulation of immunity. Further, we demonstrate that some of these stress-induced modifications in plasma exosomes are mediated by sympathetic nervous system (SNS) activation of alpha-1 adrenergic receptors (ADRs), since drug-mediated blockade of the receptors significantly attenuates the stress-induced modifications of exosomal Hsp72 and miR-142-5p. Together, these findings demonstrate that activation of the acute stress response modifies the proteomic and miRNA profile of exosomes released into the circulation.	[Beninson, Lida A.; Loughridge, Alice B.; Maslanik, Thomas; Hills, Abigail K.; Woodworth, Tyler; Craig, Wendy; Fleshner, Monika] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Beninson, Lida A.; Loughridge, Alice B.; Maslanik, Thomas; Hills, Abigail K.; Woodworth, Tyler; Craig, Wendy; Fleshner, Monika] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA; [Brown, Peter N.; Yin, Hang] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Brown, Peter N.; Yin, Hang] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Saludes, Jonel P.] Washington State Univ, Dept Chem, Pullman, WA 99164 USA; [Yin, Hang] Tsinghua Univ, Dept Chem, Ctr Basic Mol Sci, Beijing 100084, Peoples R China	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Washington State University; Tsinghua University	Fleshner, M (corresponding author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA.	fleshner@colorado.edu	YIN, HANG HUBERT/O-2097-2014	YIN, HANG HUBERT/0000-0002-9762-4818; Saludes, Jonel/0000-0001-9536-5982; Fleshner, Monika/0000-0002-0470-0827	National Science Foundation [IOS 1022451]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (IOS 1022451) (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Almqvist N, 2008, IMMUNOLOGY, V125, P21, DOI 10.1111/j.1365-2567.2008.02812.x; Asea A, 2008, J REPROD IMMUNOL, V79, P12, DOI 10.1016/j.jri.2008.06.001; Bissels U, 2011, STEM CELLS, V29, P847, DOI 10.1002/stem.627; Black PH, 2006, MED HYPOTHESES, V67, P879, DOI 10.1016/j.mehy.2006.04.008; BRUCE DG, 1992, DIABETOLOGIA, V35, P835, DOI 10.1007/BF00399929; Campisi J, 2003, J APPL PHYSIOL, V94, P43, DOI 10.1152/japplphysiol.00681.2002; Campisi J, 2003, CELL STRESS CHAPERON, V8, P272, DOI 10.1379/1466-1268(2003)008<0272:SEHIAF>2.0.CO;2; Campisi J, 2003, AM J PHYSIOL-REG I, V284, pR520, DOI 10.1152/ajpregu.00513.2002; Campisi J, 2012, STRESS, V15, P637, DOI 10.3109/10253890.2011.653596; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen TY, 2009, J IMMUNOL, V182, P1449, DOI 10.4049/jimmunol.182.3.1449; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Cox SS, 2014, BRAIN BEHAV IMMUN, V36, P183, DOI 10.1016/j.bbi.2013.11.018; Dhabhar FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033069; Dhabhar FS, 1996, J IMMUNOL, V156, P2608; Ding XM, 2013, J BIOL CHEM, V288, P10241, DOI 10.1074/jbc.M112.443655; Fleshner M, 1998, AM J PHYSIOL-REG I, V275, pR870, DOI 10.1152/ajpregu.1998.275.3.R870; FLESHNER M, 2007, HEAT SHOCK PROTEINS, P235; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hartman ZC, 2011, VACCINE; Johnson JD, 2005, J APPL PHYSIOL, V99, P1789, DOI 10.1152/japplphysiol.00390.2005; Johnson JD, 2006, J LEUKOCYTE BIOL, V79, P425, DOI 10.1189/jlb.0905523; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Kuwahira I, 1999, J APPL PHYSIOL, V86, P181, DOI 10.1152/jappl.1999.86.1.181; Lagrange B, 2013, BBA-MOL CELL RES, V1833, P1936, DOI 10.1016/j.bbamcr.2013.04.007; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Loughridge AB, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00037; Maslanik T, 2012, BRAIN BEHAV IMMUN, P1; Mollerup S, 2011, CELL COMMUN ADHES, V18, P57, DOI 10.3109/15419061.2011.611920; Padgett DA, 1998, P NATL ACAD SCI USA, V95, P7231, DOI 10.1073/pnas.95.12.7231; Pickering T G, 2001, Curr Hypertens Rep, V3, P249, DOI 10.1007/s11906-001-0047-1; Primo MN, 2012, CYTOKINE, V60, P741, DOI 10.1016/j.cyto.2012.07.031; Ru Peng, 2011, Genes Cancer, V2, P720, DOI 10.1177/1947601911425832; Saunderson SC, 2008, J IMMUNOL, V180, P8146, DOI 10.4049/jimmunol.180.12.8146; Schilders G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2119; Shang F, 1997, J BIOL CHEM, V272, P23086, DOI 10.1074/jbc.272.37.23086; Sharma S, 2012, EMBO MOL MED, V4, P617, DOI 10.1002/emmm.201200234; Singh PP, 2012, J IMMUNOL, V189, P777, DOI 10.4049/jimmunol.1103638; Skokos D, 2001, INT ARCH ALLERGY IMM, V124, P133, DOI 10.1159/000053691; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van den Besselaar AMHP, 2010, BIOLOGICALS, V38, P430, DOI 10.1016/j.biologicals.2010.02.012; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Viaud S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004942; Wei J, 2013, MOL IMMUNOL, V55, P303, DOI 10.1016/j.molimm.2013.03.004; Yu J, 2011, FUNCT INTEGR GENOMIC, V11, P203, DOI 10.1007/s10142-010-0198-8; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	53	42	46	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108748	10.1371/journal.pone.0108748	http://dx.doi.org/10.1371/journal.pone.0108748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259839	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600098
J	Schulkens, IA; Heusschen, R; van den Boogaart, V; van Suylen, RJ; Dingemans, AMC; Griffioen, AW; Thijssen, VL				Schulkens, Iris A.; Heusschen, Roy; van den Boogaart, Vivian; van Suylen, Robert-Jan; Dingemans, Anne-Marie C.; Griffioen, Arjan W.; Thijssen, Victor L.			Galectin Expression Profiling Identifies Galectin-1 and Galectin-9 Delta 5 as Prognostic Factors in Stage I/II Non-Small Cell Lung Cancer	PLOS ONE			English	Article							NASOPHARYNGEAL CARCINOMA-CELLS; SPLICE VARIANT EXPRESSION; BREAST-CANCER; GLYCAN INTERACTIONS; REGULATORY LECTINS; ANGIOGENESIS; ADHESION; PROGRESSION; ENDOTHELIUM; LINES	Approximately 30-40% of the patients with early stage non-small cell lung cancer (NSCLC) will present with recurrent disease within two years of resection. Here, we performed extensive galectin expression profiling in a retrospective study using frozen and paraffin embedded tumor tissues from 87 stage I/II NSCLC patients. Our data show that galectin mRNA expression in NSCLC is confined to galectin-1, -3, -4, -7, -8, and -9. Next to stage, univariable Cox regression analysis identified galectin-1, galectin-9FL and galectin-9 Delta 5 as possible prognostic markers. Kaplan-Meier survival estimates revealed that overall survival was significantly shorter in patients that express galectin-1 above median levels, i.e., 23.0 (2.9-43.1) vs. 59.9 (47.7-72.1) months (p = 0.020) as well as in patients that express galectin-9 Delta 5 or galectin-9FL below the median, resp. 59.9 (41.9-75.9) vs. 32.8 (8.7-56.9) months (p = 0.014) or 23.2 (20.4-46.8) vs. 58.9 (42.9-74.9) months (p = 0.042). All three galectins were also prognostic for disease free survival. Multivariable Cox regression analysis showed that for OS, the most significant prognostic model included stage, age, gal-1 and gal-9 Delta 5 while the model for DFS included stage, age and gal-9 Delta 5. In conclusion, the current study confirms the prognostic value of galectin-1 and identifies galectin-9 Delta 5 as novel potential prognostic markers in early stage NSCLC. These findings could help to identify early stage NSCLC patients that might benefit most from adjuvant chemotherapy.	[Schulkens, Iris A.; Heusschen, Roy; Griffioen, Arjan W.; Thijssen, Victor L.] Vrije Univ Amsterdam Med Ctr, Angiogenesis Lab, Dept Med Oncol, Amsterdam, Netherlands; [van den Boogaart, Vivian; Dingemans, Anne-Marie C.] Maastricht Univ Med Ctr, Dept Pulmonol, Maastricht, Netherlands; [van den Boogaart, Vivian; Dingemans, Anne-Marie C.] Maastricht Univ Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [van Suylen, Robert-Jan] Maastricht Univ Med Ctr, Dept Pathol, Maastricht, Netherlands; [Thijssen, Victor L.] Vrije Univ Amsterdam Med Ctr, Dept Radiotherapy, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Thijssen, VL (corresponding author), Vrije Univ Amsterdam Med Ctr, Angiogenesis Lab, Dept Med Oncol, Amsterdam, Netherlands.	v.thijssen@vumc.nl	Thijssen, Victor LJL/B-2792-2009	Thijssen, Victor LJL/0000-0002-6146-1842	Dutch Cancer Society [UM2008-4101, VU2009-4358]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by grants from the Dutch Cancer Society (www.kwfkankerbestrijding.nl:UM2008-4101; VU2009-4358) to AWG and VLT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Barrow H, 2011, CLIN CANCER RES, V17, P7035, DOI 10.1158/1078-0432.CCR-11-1462; Bonett DG, 2002, PSYCHOL METHODS, V7, P370, DOI 10.1037//1082-989X.7.3.370; Delgado VMC, 2011, FASEB J, V25, P242, DOI 10.1096/fj.09-144907; Chabot S, 2002, GLYCOBIOLOGY, V12, P111, DOI 10.1093/glycob/12.2.111; Chung LY, 2012, CLIN CANCER RES, V18, P4037, DOI 10.1158/1078-0432.CCR-11-3348; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Croci DO, 2012, J EXP MED, V209, P1985, DOI 10.1084/jem.20111665; Dalotto-Moreno T, 2013, CANCER RES, V73, P1107, DOI 10.1158/0008-5472.CAN-12-2418; Dingemans AMC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-152; Earl LA, 2011, GLYCOBIOLOGY, V21, P6, DOI 10.1093/glycob/cwq144; Fritz P, 1999, ACTA HISTOCHEM, V101, P239, DOI 10.1016/S0065-1281(99)80025-7; Hayashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081883; Heusschen R, 2014, BBA-MOL BASIS DIS, V1842, P284, DOI 10.1016/j.bbadis.2013.12.003; Heusschen R, 2013, BBA-REV CANCER, V1836, P177, DOI 10.1016/j.bbcan.2013.04.006; Heusschen R, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105460; Hirashima M, 2000, INT ARCH ALLERGY IMM, V122, P6, DOI 10.1159/000053623; Irie A, 2005, CLIN CANCER RES, V11, P2962, DOI 10.1158/1078-0432.CCR-04-0861; Jeong SH, 2008, JPN J CLIN ONCOL, V38, P661, DOI 10.1093/jjco/hyn089; Jiang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081799; Kageshita T, 2002, INT J CANCER, V99, P809, DOI 10.1002/ijc.10436; Kasamatsu A, 2005, INT J MOL MED, V16, P269; Keryer-Bibens C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-283; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Kosacka M, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-101; Kuo PL, 2011, J IMMUNOL, V186, P1521, DOI 10.4049/jimmunol.1002940; Laderach DJ, 2013, CANCER RES, V73, P86, DOI 10.1158/0008-5472.CAN-12-1260; Lahm H, 2001, J CANCER RES CLIN, V127, P375, DOI 10.1007/s004320000207; Liang M, 2008, J CANCER RES CLIN, V134, P899, DOI 10.1007/s00432-008-0352-z; Mathieu A, 2005, MODERN PATHOL, V18, P1264, DOI 10.1038/modpathol.3800416; Nobumoto A, 2008, GLYCOBIOLOGY, V18, P735, DOI 10.1093/glycob/cwn062; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Rabinovich GA, 2012, IMMUNITY, V36, P322, DOI 10.1016/j.immuni.2012.03.004; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Sanchez-Ruderisch H, 2011, CELL DEATH DIFFER, V18, P806, DOI 10.1038/cdd.2010.148; Spitzenberger F, 2001, BIOCHIMIE, V83, P851, DOI 10.1016/S0300-9084(01)01335-9; Szoke T, 2007, EUR J CARDIO-THORAC, V31, P783, DOI 10.1016/j.ejcts.2007.01.072; Szoke T, 2005, ONCOLOGY-BASEL, V69, P167, DOI 10.1159/000087841; Thijssen VL, 2008, AM J PATHOL, V172, P545, DOI 10.2353/ajpath.2008.070938; Thijssen VL, 2013, CYTOKINE GROWTH F R, V24, P547, DOI 10.1016/j.cytogfr.2013.07.003; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; van den Brule F, 2002, GLYCOCONJUGATE J, V19, P537, DOI 10.1023/B:GLYC.0000014083.48508.6a; Wiersma V. R., 2011, MED RES REV; Yamauchi A, 2006, BREAST J, V12, pS196, DOI 10.1111/j.1075-122X.2006.00334.x; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zhang F, 2009, MOL BIOL REP, V36, P823, DOI 10.1007/s11033-008-9251-2; Zhang ZY, 2012, ASIAN PAC J CANCER P, V13, P2503, DOI 10.7314/APJCP.2012.13.6.2503	49	25	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107988	10.1371/journal.pone.0107988	http://dx.doi.org/10.1371/journal.pone.0107988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259711	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600040
J	Sudo, M; Yamaguchi, Y; Spath, PJ; Matsumoto-Morita, K; Ong, BK; Shahrizaila, N; Yuki, N				Sudo, Makoto; Yamaguchi, Yoshiki; Spaeth, Peter J.; Matsumoto-Morita, Kana; Ong, Benjamin K.; Shahrizaila, Nortina; Yuki, Nobuhiro			Different IVIG Glycoforms Affect In Vitro Inhibition of Anti-Ganglioside Antibody-Mediated Complement Deposition	PLOS ONE			English	Article							MULTIFOCAL MOTOR NEUROPATHY; ANTIINFLAMMATORY ACTIVITY; FC-SIALYLATION; IMMUNOGLOBULINS; GLYCOSYLATION; SERA; IGG	Intravenous immunoglobulin (IVIG) is the first line treatment for Guillain-Barre syndrome and multifocal motor neuropathy, which are caused by anti-ganglioside antibody-mediated complement-dependent cytotoxicity. IVIG has many potential mechanisms of action, and sialylation of the IgG Fc portion reportedly has an anti-inflammatory effect in antibody-dependent cell-mediated cytotoxicity models. We investigated the effects of different IVIG glycoforms on the inhibition of antibody-mediated complement-dependent cytotoxicity. Deglycosylated, degalactosylated, galactosylated and sialylated IgG were prepared from IVIG following treatment with glycosidases and glycosyltransferases. Sera from patients with Guillain-Barre syndrome, Miller Fisher syndrome and multifocal motor neuropathy associated with anti-ganglioside antibodies were used. Inhibition of complement deposition subsequent to IgG or IgM autoantibody binding to ganglioside, GM1 or GQ1b was assessed on microtiter plates. Sialylated and galactosylated IVIGs more effectively inhibited C3 deposition than original IVIG or enzyme-treated IVIGs (agalactosylated and deglycosylated IVIGs). Therefore, sialylated and galactosylated IVIGs may be more effective than conventional IVIG in the treatment of complement-dependent autoimmune diseases.	[Sudo, Makoto; Ong, Benjamin K.; Yuki, Nobuhiro] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Yamaguchi, Yoshiki; Matsumoto-Morita, Kana] RIKEN, Struct Glycobiol Team, Wako, Saitama, Japan; [Spaeth, Peter J.] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Shahrizaila, Nortina] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Yuki, Nobuhiro] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore	National University of Singapore; RIKEN; University of Bern; Universiti Malaya; National University of Singapore	Yuki, N (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore.	mdcyuki@nus.edu.sg	SHAHRIZAILA, NORTINA/B-9402-2010; Yamaguchi, Yoshiki/N-5246-2015	SHAHRIZAILA, NORTINA/0000-0003-0031-7692; Yamaguchi, Yoshiki/0000-0003-0100-5439	Singapore National Medical Research Council [IRG 10nov086]; Start-Up Grant from the Singapore Ministry of Health; Yong Loo Lin School of Medicine; Grants-in-Aid for Scientific Research [25460054] Funding Source: KAKEN	Singapore National Medical Research Council(National Medical Research Council, Singapore); Start-Up Grant from the Singapore Ministry of Health(Ministry of Health-Singapore); Yong Loo Lin School of Medicine(National University of Singapore); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Dr. Yuki receives grant support from the Singapore National Medical Research Council (IRG 10nov086), and Start-Up Grant from the Singapore Ministry of Health and Yong Loo Lin School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Holland M, 2006, BBA-GEN SUBJECTS, V1760, P669, DOI 10.1016/j.bbagen.2005.11.021; Jacobs BC, 2003, BRAIN, V126, P2220, DOI 10.1093/brain/awg235; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kaveri SV, 2008, NEW ENGL J MED, V359, P307, DOI 10.1056/NEJMcibr0803649; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P130, DOI 10.1006/abio.1995.1200; Piepers S, 2010, J NEUROIMMUNOL, V229, P256, DOI 10.1016/j.jneuroim.2010.08.023; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Takahashi N, 2003, TRENDS GLYCOSCI GLYC, V15, P235, DOI 10.4052/tigg.15.235; TAKAHASHI N, 1995, ANAL BIOCHEM, V226, P139, DOI 10.1006/abio.1995.1201; Vlam L, 2012, NAT REV NEUROL, V8, P48, DOI 10.1038/nrneurol.2011.175; von Gunten S, 2014, NAT REV IMMUNOL, V14, P349, DOI 10.1038/nri3401-c1; Yuki N, 2011, J NEUROL NEUROSUR PS, V82, P87, DOI 10.1136/jnnp.2010.205856; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525; Zhang G, 2004, BRAIN, V127, P1085, DOI 10.1093/brain/awh127	15	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107772	10.1371/journal.pone.0107772	http://dx.doi.org/10.1371/journal.pone.0107772			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259950	Green Published, gold			2022-12-27	WOS:000342685600028
J	Aggarwal, P; Turner, A; Matter, A; Kattman, SJ; Stoddard, A; Lorier, R; Swanson, BJ; Arnett, DK; Broeckel, U				Aggarwal, Praful; Turner, Amy; Matter, Andrea; Kattman, Steven J.; Stoddard, Alexander; Lorier, Rachel; Swanson, Bradley J.; Arnett, Donna K.; Broeckel, Ulrich			RNA Expression Profiling of Human iPSC-Derived Cardiomyocytes in a Cardiac Hypertrophy Model	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; NATRIURETIC PEPTIDES; MICRORNAS; WEBGESTALT; PATHWAYS; MIRBASE	Cardiac hypertrophy is an independent risk factor for cardiovascular disease and heart failure. There is increasing evidence that microRNAs (miRNAs) play an important role in the regulation of messenger RNA (mRNA) and the pathogenesis of various cardiovascular diseases. However, the ability to comprehensively study cardiac hypertrophy on a gene regulatory level is impacted by the limited availability of human cardiomyocytes. Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer the opportunity for disease modeling. Here we utilize a previously established in vitro model of cardiac hypertrophy to interrogate the regulatory mechanism associated with the cardiac disease process. We perform miRNA sequencing and mRNA expression analysis on endothelin 1 (ET-1) stimulated hiPSC-CMs to describe associated RNA expression profiles. MicroRNA sequencing revealed over 250 known and 34 predicted novel miRNAs to be differentially expressed between ET-1 stimulated and unstimulated control hiPSC-CMs. Messenger RNA expression analysis identified 731 probe sets with significant differential expression. Computational target prediction on significant differentially expressed miRNAs and mRNAs identified nearly 2000 target pairs. A principal component analysis approach comparing the in vitro data with human myocardial biopsies detected overlapping expression changes between the in vitro samples and myocardial biopsies with Left Ventricular Hypertrophy. These results provide further insights into the complex RNA regulatory mechanism associated with cardiac hypertrophy.	[Aggarwal, Praful; Turner, Amy; Matter, Andrea; Stoddard, Alexander; Lorier, Rachel; Arnett, Donna K.] Med Coll Wisconsin, Dept Pediat, Childrens Res Inst, Milwaukee, WI 53226 USA; [Aggarwal, Praful; Turner, Amy; Matter, Andrea; Stoddard, Alexander; Lorier, Rachel; Broeckel, Ulrich] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Kattman, Steven J.; Swanson, Bradley J.] Cellular Dynam Int Inc, Madison, WI USA; [Arnett, Donna K.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	Medical College of Wisconsin; Medical College of Wisconsin; University of Alabama System; University of Alabama Birmingham	Broeckel, U (corresponding author), Med Coll Wisconsin, Dept Pediat, Childrens Res Inst, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	Broeckel@mcw.edu		Turner, Amy/0000-0003-0867-7545	National Institutes of Health/National Heart, Lung, and Blood Institute - Children's Research Institute [U01 HL107437]; Medical College of Wisconsin; Milwaukee Cullen Run; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107437] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute - Children's Research Institute; Medical College of Wisconsin(General Electric); Milwaukee Cullen Run; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study is supported in part by National Institutes of Health/National Heart, Lung, and Blood Institute grant U01 HL107437, funds by Children's Research Institute, Medical College of Wisconsin, and the Milwaukee Cullen Run. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Bupha-Intr T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043179; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Busk PK, 2002, CARDIOVASC RES, V56, P64, DOI 10.1016/S0008-6363(02)00510-2; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Carlson C, 2013, J BIOMOLECULAR SCREE; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Devereux RB, 2004, JAMA-J AM MED ASSOC, V292, P2350, DOI 10.1001/jama.292.19.2350; Devereux RB, 1999, HYPERTENS RES-CLIN E, V22, P1, DOI 10.1291/hypres.22.1; Dries Daniel L, 2010, Heart Fail Clin, V6, P55, DOI 10.1016/j.hfc.2009.08.007; Fahmi A, 2013, CELL SIGNAL, V25, P898, DOI 10.1016/j.cellsig.2012.12.008; Filtz TM, 2009, FASEB J, V23, P3564, DOI 10.1096/fj.09-133983; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Harper AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055061; Hayek S, 2011, CARDIOVASC THER, V29, P362, DOI 10.1111/j.1755-5922.2010.00152.x; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Kattman SJ, 2011, J CARDIOVASC TRANSL, V4, P66, DOI 10.1007/s12265-010-9235-1; Kolodziejczyk SM, 1999, CURR BIOL, V9, P1203, DOI 10.1016/S0960-9822(00)80027-5; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kroumpouzou E, 2003, HYBRIDOMA HYBRIDOM, V22, P41, DOI 10.1089/153685903321538071; Kuwahara K, 2010, ENDOCR J, V57, P555, DOI 10.1507/endocrj.K10E-150; Latronico MVG, 2011, EXP BIOL MED, V236, P125, DOI 10.1258/ebm.2010.010269; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Miyauchi T, 1999, ANNU REV PHYSIOL, V61, P391, DOI 10.1146/annurev.physiol.61.1.391; Okin PM, 2004, JAMA-J AM MED ASSOC, V292, P2343, DOI 10.1001/jama.292.19.2343; Olson AK, 2013, J MOL CELL CARDIOL, V55, P156, DOI 10.1016/j.yjmcc.2012.07.005; Parman C, GENTLEMAN RC AFFYQC; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Topkara VK, 2010, PERS MED, V7, P531, DOI 10.2217/PME.10.44; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang K, 2012, J BIOL CHEM, V287, P589, DOI 10.1074/jbc.M111.266940; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	54	41	42	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108051	10.1371/journal.pone.0108051	http://dx.doi.org/10.1371/journal.pone.0108051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255322	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300054
J	Hu, F; Pan, LT; Zhang, K; Xing, FL; Wang, XY; Lee, I; Zhang, XZ; Xu, JJ				Hu, Fen; Pan, Leiting; Zhang, Kai; Xing, Fulin; Wang, Xinyu; Lee, Imshik; Zhang, Xinzheng; Xu, Jingjun			Elevation of Extracellular Ca2+ Induces Store-Operated Calcium Entry via Calcium-Sensing Receptors: A Pathway Contributes to the Proliferation of Osteoblasts	PLOS ONE			English	Article							CA2+-SENSING RECEPTOR; MOLECULAR-MECHANISMS; PRIMARY CULTURES; S-NITROSYLATION; EXPRESSION; DIFFERENTIATION; CHANNEL; ACTIVATION; RELEASE; INFLUX	Aims: The local concentration of extracellular Ca2+ ([Ca2+](o)) in bone microenvironment is accumulated during bone remodeling. In the present study we investigated whether elevating [Ca2+](o) induced store-operated calcium entry (SOCE) in primary rat calvarial osteoblasts and further examined the contribution of elevating [Ca2+](o) to osteoblastic proliferation. Methods: Cytosolic Ca2+ concentration ([Ca2+](c)) of primary cultured rat osteoblasts was detected by fluorescence imaging using calcium-sensitive probe fura-2/AM. Osteoblastic proliferation was estimated by cell counting, MTS assay and ATP assay. Agonists and antagonists of calcium-sensing receptors (CaSR) as well as inhibitors of phospholipase C (PLC), SOCE and voltage-gated calcium (Cav) channels were applied to study the mechanism in detail. Results: Our data showed that elevating [Ca2+](o) evoked a sustained increase of [Ca2+](c) in a dose-dependent manner. This [Ca2+](c) increase was blocked by TMB-8 (Ca2+ release inhibitor), 2-APB and BTP-2 (both SOCE blockers), respectively, whereas not affected by Cav channels blockers nifedipine and verapamil. Furthermore, NPS2143 (a CaSR antagonist) or U73122 (a PLC inhibitor) strongly reduced the [Ca2+](o)-induced [Ca2+](c) increase. The similar responses were observed when cells were stimulated with CaSR agonist spermine. These data indicated that elevating [Ca2+](o) resulted in SOCE depending on the activation of CaSR and PLC in osteoblasts. In addition, high [Ca2+](o) significantly promoted osteoblastic proliferation, which was notably reversed by BAPTA-AM (an intracellular calcium chelator), 2-APB, BTP-2, TMB-8, NPS2143 and U73122, respectively, but not affected by Cav channels antagonists. Conclusions: Elevating [Ca2+](o) induced SOCE by triggering the activation of CaSR and PLC. This process was involved in osteoblastic proliferation induced by high level of extracellular Ca2+ concentration.	[Pan, Leiting] Nankai Univ, Key Lab Weak Light Nonlinear Photon, Minist Educ, TEDA Appl Phys Inst, Tianjin 300071, Peoples R China; Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Pan, LT (corresponding author), Nankai Univ, Key Lab Weak Light Nonlinear Photon, Minist Educ, TEDA Appl Phys Inst, Tianjin 300071, Peoples R China.	plt@nankai.edu.cn; jjxu@nankai.edu.cn	Lee, Imshik/G-6129-2010; xu, jing/GRR-8698-2022; Zhang, Xinzheng/C-5703-2009; Jingjun, Xu/A-1282-2010	Lee, Imshik/0000-0002-0098-392X; Zhang, Xinzheng/0000-0001-8128-3273; 	National Natural Science Foundation of China [11204142]; National Basic Research Program of China [2010CB934101, 11074133, 31160370]; International S&T cooperation program of China [2011DFA52870]; 111 Project [B07013]; National Science Fund for Talent Training in Basic Sciences [J1103208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); International S&T cooperation program of China; 111 Project(Ministry of Education, China - 111 Project); National Science Fund for Talent Training in Basic Sciences	This work was supported by the National Natural Science Foundation of China (No. 11204142), the National Basic Research Program of China (No. 2010CB934101), International S&T cooperation program of China (2011DFA52870), the 111 Project (No. B07013), the National Natural Science Foundation of China (No. 11074133, No. 31160370) and the National Science Fund for Talent Training in Basic Sciences (No. J1103208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed E, 2009, MOL MEMBR BIOL, V26, P146, DOI 10.1080/09687680802612721; Baldi C, 2003, J CELL BIOCHEM, V90, P197, DOI 10.1002/jcb.10612; Bergh JJ, 2004, ENDOCRINOLOGY, V145, P426, DOI 10.1210/en.2003-0319; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; Caudarella R, 2011, J Endocrinol Invest, V34, P13; Chattopadhyay N, 2004, ENDOCRINOLOGY, V145, P3451, DOI 10.1210/en.2003-1127; Chaudhari A, 1997, MOL CELL BIOCHEM, V167, P31, DOI 10.1023/A:1006853009828; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101; Dvorak-Ewell MM, 2011, J BONE MINER RES, V26, P2935, DOI 10.1002/jbmr.520; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Feng SL, 2011, BIOCHEM BIOPH RES CO, V406, P278, DOI 10.1016/j.bbrc.2011.02.033; Hattori T, 2001, CELL CALCIUM, V30, P67, DOI 10.1054/ceca.2001.0214; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Hiani YEL, 2009, CELL PHYSIOL BIOCHEM, V23, P335, DOI 10.1159/000218179; Hu F, 2012, BIOCHEM BIOPH RES CO, V424, P196, DOI 10.1016/j.bbrc.2012.06.115; Huang ZM, 2001, J BIOL CHEM, V276, P21351, DOI 10.1074/jbc.M010921200; Ishikawa J, 2003, J IMMUNOL, V170, P4441, DOI 10.4049/jimmunol.170.9.4441; Kanaya S, 2010, BONE, V47, P564, DOI 10.1016/j.bone.2010.05.042; Khoshniat S, 2011, BONE, V48, P894, DOI 10.1016/j.bone.2010.12.002; Koori K, 2014, CELL TISSUE RES, V357, P707, DOI 10.1007/s00441-014-1918-5; Labelle D, 2007, CELL PROLIFERAT, V40, P866, DOI 10.1111/j.1365-2184.2007.00477.x; Lee HL, 2011, BONE, V49, P242, DOI 10.1016/j.bone.2011.04.006; Leung FP, 2008, BRIT J PHARMACOL, V153, P846, DOI 10.1038/sj.bjp.0707455; Mackie EJ, 2003, INT J BIOCHEM CELL B, V35, P1301, DOI 10.1016/S1357-2725(03)00107-9; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Nakahama K, 2010, CELL MOL LIFE SCI, V67, P4001, DOI 10.1007/s00018-010-0479-3; Pan LT, 2013, EUR J PHARMACOL, V715, P280, DOI 10.1016/j.ejphar.2013.05.009; Pan LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025262; Pan LT, 2008, BIOCHEM BIOPH RES CO, V377, P1320, DOI 10.1016/j.bbrc.2008.11.001; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARTRIDGE NC, 1981, ENDOCRINOLOGY, V108, P213, DOI 10.1210/endo-108-1-213; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Rey O, 2005, J BIOL CHEM, V280, P22875, DOI 10.1074/jbc.M503455200; Riccardi D, 2009, PFLUG ARCH EUR J PHY, V458, P1007, DOI 10.1007/s00424-009-0681-z; Santillan G, 2004, J STEROID BIOCHEM, V89-90, P291, DOI 10.1016/j.jsbmb.2004.03.032; Shao Y, 2005, DEV DYNAM, V234, P54, DOI 10.1002/dvdy.20517; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; Suzuki Y, 2011, BIOCHEM BIOPH RES CO, V410, P317, DOI 10.1016/j.bbrc.2011.05.140; Tada H, 2010, BIOCHEM BIOPH RES CO, V394, P1093, DOI 10.1016/j.bbrc.2010.03.135; Takaoka S, 2010, HORM METAB RES, V42, P627, DOI 10.1055/s-0030-1255091; Valenti G, 2010, CELL PHYSIOL BIOCHEM, V26, P901, DOI 10.1159/000323999; Vazquez G, 2002, EMBO J, V21, P4531, DOI 10.1093/emboj/cdf467; Wiemann M, 1999, CALCIFIED TISSUE INT, V65, P479, DOI 10.1007/s002239900736; Wiemann M, 1998, CALCIFIED TISSUE INT, V63, P154, DOI 10.1007/s002239900507; Wong CK, 2012, J CELL PHYSIOL, V227, P2519, DOI 10.1002/jcp.22990; Yamaguchi T, 1998, J BONE MINER RES, V13, P1530, DOI 10.1359/jbmr.1998.13.10.1530; Yamaguchi T, 2001, AM J PHYSIOL-CELL PH, V280, pC382, DOI 10.1152/ajpcell.2001.280.2.C382; Yamauchi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE608, DOI 10.1152/ajpendo.00229.2004; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675	51	38	43	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107217	10.1371/journal.pone.0107217	http://dx.doi.org/10.1371/journal.pone.0107217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254954	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300019
J	Li, W; Tao, W; Jiang, YX; Diao, RN; Yang, JP; Xiao, LH				Li, Wei; Tao, Wei; Jiang, Yanxue; Diao, Ruinan; Yang, Jinping; Xiao, Lihua			Genotypic Distribution and Phylogenetic Characterization of Enterocytozoon bieneusi in Diarrheic Chickens and Pigs in Multiple Cities, China: Potential Zoonotic Transmission	PLOS ONE			English	Article							VIRUS-INFECTED PATIENTS; 1ST DETECTION; ENCEPHALITOZOON-CUNICULI; MICROSPORIDIOSIS; IDENTIFICATION; EPIDEMIOLOGY; SWINE; PREVALENCE; OUTBREAK; PIGEONS	This study investigated diarrheic broiler and layer chickens (<50 days; n = 14) and pigs of three age groups (preweaned <30 days, weaned approximate to 30 to 60 days, and growing >60 days; n = 64) for E. bieneusi genotypes in northeast China and evaluated the potential roles of chickens and pigs in zoonotic transmission of microsporidiosis. Two 45-day-old layer chickens in city Jixi, Heilongjiang province and one 23-day-old broiler chicken in city Songyuan, Jilin province were identified to harbor a human-pathogenic E. bieneusi genotype Henan-IV and a new genotype named CC-1, respectively, by nested PCR and sequence analysis of the ribosomal internal transcribed spacer (ITS). Eleven of 64 (17.2%) duodenal mucosal specimens from pigs in city Tianjin, city Tongliao of Inner Mongolia, cities Jilin and Songyuan of Jilin province, and cities Daqing, Harbin, and Suihua of Heilongjiang province, were positive for E. bieneusi, with the infection rates of weaned pigs (35%, 7/20) significantly higher than preweaned ones (3.6%, 1/28; P<0.05). Nucleotide sequences of the ITS were obtained from 6 pig specimens, belonging to 3 known genotypes CHN7, EbpC, and Henan-IV. That the previous reports have described the occurrence of genotypes EbpC and Henan-IV in humans and EbpC in wastewater in central China and the clustering of genotypes CC-1 and CHN7 into a major phylogenetic group of E. bieneusi genotypes with zoonotic potential indicated that chickens and pigs could be potential sources of human micorsporidiosis. To our knowledge, this is the first report describing the existence of zoonotic E. bieneusi genotypes in diarrheic chickens.	[Li, Wei; Tao, Wei; Jiang, Yanxue; Diao, Ruinan; Yang, Jinping] Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China; [Xiao, Lihua] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA	Northeast Agricultural University - China; Centers for Disease Control & Prevention - USA	Li, W (corresponding author), Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China.	neaulw@gmail.com; lax0@cdc.gov	Xiao, Lihua/B-1704-2013; Li, Wei/H-7214-2013	Xiao, Lihua/0000-0001-8532-2727; Li, Wei/0000-0002-4264-1864	Scientific Research Funds of Heilongjiang Provincial Education Department [1253HQ015]	Scientific Research Funds of Heilongjiang Provincial Education Department	This study was supported by the Scientific Research Funds of Heilongjiang Provincial Education Department (no. 1253HQ015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2010, VECTOR-BORNE ZOONOT, V10, P425, DOI 10.1089/vbz.2009.0039; Akinbo FO, 2012, AM J TROP MED HYG, V86, P441, DOI 10.4269/ajtmh.2012.11-0548; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; Bern C, 2005, J INFECT DIS, V191, P1658, DOI 10.1086/429674; Breitenmoser AC, 1999, PARASITOLOGY, V118, P447, DOI 10.1017/S0031182099004229; Buckholt MA, 2002, APPL ENVIRON MICROB, V68, P2595, DOI 10.1128/AEM.68.5.2595-2599.2002; Cama VA, 2007, J CLIN MICROBIOL, V45, P2708, DOI 10.1128/JCM.00725-07; Dengjel B, 2001, J CLIN MICROBIOL, V39, P4495, DOI 10.1128/JCM.39.12.4495-4499.2001; Deplazes P, 1996, J EUKARYOT MICROBIOL, V43, pS93, DOI 10.1111/j.1550-7408.1996.tb05018.x; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Espern A, 2007, J CLIN MICROBIOL, V45, P2999, DOI 10.1128/JCM.00684-07; Ghosh Kaya, 2009, Interdiscip Perspect Infect Dis, V2009, P926521, DOI 10.1155/2009/926521; Haro M, 2005, APPL ENVIRON MICROB, V71, P3153, DOI 10.1128/AEM.71.6.3153-3157.2005; Jeong DK, 2007, PARASITOL RES, V102, P123, DOI 10.1007/s00436-007-0740-3; Kasickova D, 2009, VET PARASITOL, V165, P125, DOI 10.1016/j.vetpar.2009.06.033; Lallo MA, 2012, VET PARASITOL, V190, P418, DOI 10.1016/j.vetpar.2012.06.030; Leelayoova S, 2006, J CLIN MICROBIOL, V44, P3001, DOI 10.1128/JCM.00945-06; Leelayoova S, 2009, J CLIN MICROBIOL, V47, P1572, DOI 10.1128/JCM.00187-09; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Li W, 2014, PARASITOL RES, V113, P1147, DOI 10.1007/s00436-014-3752-9; Li W, 2011, J CLIN MICROBIOL, V49, P4326, DOI 10.1128/JCM.05051-11; Lobo ML, 2006, APPL ENVIRON MICROB, V72, P7380, DOI 10.1128/AEM.01394-06; Mathis A, 2005, CLIN MICROBIOL REV, V18, P423, DOI 10.1128/CMR.18.3.423-445.2005; Matos Olga, 2012, J Parasitol Res, V2012, P981424, DOI 10.1155/2012/981424; Muller MG, 2008, VET PARASITOL, V152, P67, DOI 10.1016/j.vetpar.2007.11.019; Nemejc K, 2014, PARASITOL RES, V113, P761, DOI 10.1007/s00436-013-3707-6; Reetz J, 2002, INT J PARASITOL, V32, P785, DOI 10.1016/S0020-7519(02)00045-0; Reetz J, 2009, PARASITOL INT, V58, P285, DOI 10.1016/j.parint.2009.03.002; Rinder H, 2000, J PARASITOL, V86, P185, DOI 10.1645/0022-3395(2000)086[0185:CGRBEB]2.0.CO;2; Sak B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001162; Sak B, 2011, J CLIN MICROBIOL, V49, P1064, DOI 10.1128/JCM.01147-10; Sak B, 2008, VET PARASITOL, V153, P220, DOI 10.1016/j.vetpar.2008.01.043; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Sulaiman IM, 2003, J EUKARYOT MICROBIOL, V50, P591, DOI 10.1111/j.1550-7408.2003.tb00642.x; Sulaiman IM, 2003, APPL ENVIRON MICROB, V69, P4495, DOI 10.1128/AEM.69.8.4495-4501.2003; Thellier M, 2008, PARASITE, V15, P349, DOI 10.1051/parasite/2008153349; Wang L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002437; Wang L, 2013, J CLIN MICROBIOL, V51, P557, DOI 10.1128/JCM.02758-12; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653; Zhang X, 2011, J CLIN MICROBIOL, V49, P2006, DOI 10.1128/JCM.00372-11	40	36	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108279	10.1371/journal.pone.0108279	http://dx.doi.org/10.1371/journal.pone.0108279			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255117	gold, Green Published, Green Submitted			2022-12-27	WOS:000344862300068
J	Pentinsaari, M; Hebert, PDN; Mutanen, M				Pentinsaari, Mikko; Hebert, Paul D. N.; Mutanen, Marko			Barcoding Beetles: A Regional Survey of 1872 Species Reveals High Identification Success and Unusually Deep Interspecific Divergences	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; MITOCHONDRIAL-DNA; COLEOPTERA; EPHEMEROPTERA; EVOLUTION; LIFE	With 400 K described species, beetles (Insecta: Coleoptera) represent the most diverse order in the animal kingdom. Although the study of their diversity currently represents a major challenge, DNA barcodes may provide a functional, standardized tool for their identification. To evaluate this possibility, we performed the first comprehensive test of the effectiveness of DNA barcodes as a tool for beetle identification by sequencing the COI barcode region from 1872 North European species. We examined intraspecific divergences, identification success and the effects of sample size on variation observed within and between species. A high proportion (98.3%) of these species possessed distinctive barcode sequence arrays. Moreover, the sequence divergences between nearest neighbor species were considerably higher than those reported for the only other insect order, Lepidoptera, which has seen intensive analysis (11.99% vs up to 5.80% mean NN divergence). Although maximum intraspecific divergence increased and average divergence between nearest neighbors decreased with increasing sampling effort, these trends rarely hampered identification by DNA barcodes due to deep sequence divergences between most species. The Barcode Index Number system in BOLD coincided strongly with known species boundaries with perfect matches between species and BINs in 92.1% of all cases. In addition, DNA barcode analysis revealed the likely occurrence of about 20 overlooked species. The current results indicate that DNA barcodes distinguish species of beetles remarkably well, establishing their potential to provide an effective identification tool for this order and to accelerate the discovery of new beetle species.	[Pentinsaari, Mikko; Mutanen, Marko] Univ Oulu, Dept Biol, Oulu, Finland; [Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	University of Oulu; University of Guelph	Pentinsaari, M (corresponding author), Univ Oulu, Dept Biol, Oulu, Finland.	mikko.pentinsaari@oulu.fi	Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700; Pentinsaari, Mikko/0000-0001-7241-3873	Genome Canada; Ontario Genomics Institute; Ella and Georg Ehrnrooth Foundation; Kone Foundation; Finnish Cultural Foundation	Genome Canada(Genome Canada); Ontario Genomics Institute; Ella and Georg Ehrnrooth Foundation; Kone Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	Funding from the government of Canada through Genome Canada (http://www.genomecanada.ca) and the Ontario Genomics Institute (http://www.ontariogenomics.ca/) to the International Barcode of Life Project enabled the Canadian Centre for DNA Barcoding (University of Guelph) to carry out the sequence analysis on our specimens. The authors also thank the Ontario Ministry of Research and Innovation (https://www.ontario.ca/ministry-research-innovation) for funding the ongoing development of BOLD. This study was funded by personal grants to MP from the Ella and Georg Ehrnrooth Foundation (http://www.ellageorg.fi/) and from the Jenny and Antti Wihuri Foundation (http://www.wihurinrahasto.fi/). The FinBOL project is funded by the Kone Foundation (http://www.koneensaatio.fi/), the Finnish Cultural Foundation (https://www.skr.fi/) and the University of Oulu (http://www.oulu.fi/yliopisto/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SL, 2005, J N AM BENTHOL SOC, V24, P508, DOI 10.1899/04-142.1; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Besuchet C, 1989, KAFER MITTELEUROPAS, V12, P240; Chang CH, 2009, PEDOBIOLOGIA, V52, P171, DOI 10.1016/j.pedobi.2008.08.002; Chapman A, 2009, NUMBERS LIVING SPECI, P1; Crowson RA, 1981, BIOL COLEOPTERA; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fossen EI, 2014, THESIS NORWEGIAN U S; FOX CW, 1993, FUNCT ECOL, V7, P203, DOI 10.2307/2389888; Garcia-Robledo C, 2013, BIOL J LINN SOC, V110, P189, DOI 10.1111/bij.12115; Giangrande A, 2003, AQUAT CONSERV, V13, P451, DOI 10.1002/aqc.584; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; HARE JD, 1990, ANNU REV ENTOMOL, V35, P81, DOI 10.1146/annurev.en.35.010190.000501; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Kubisz D, 2012, CENT EUR J BIOL, V7, P69, DOI 10.2478/s11535-011-0099-4; Lohse GA, 1983, KAFER MITTELEUROPAS, V11, P180; LONGSTAFF BC, 1981, PROT ECOL, V3, P83; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Lyal CHC, 2004, SCIENCE, V305, P1106; MacLeod A, 2002, CROP PROT, V21, P635, DOI 10.1016/S0261-2194(02)00016-9; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; MITCHELL R, 1975, ECOLOGY, V56, P696, DOI 10.2307/1935504; Mutanen M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02901; Mutanen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047214; Nilsson AN., 2012, DNA BARCODES, V1, P1, DOI DOI 10.2478/DNA-2012-0001; Oberprieler Rolf G., 2007, Zootaxa, V1668, P491; Odegaard F, 2000, BIOL J LINN SOC, V71, P583, DOI 10.1006/bijl.2000.0468; Odegaard Frode, 2001, Norwegian Journal of Entomology, V48, P237; Pentinsaari M, 2014, EUR J ENTOM IN PRESS; Pons J, 2010, MOL PHYLOGENET EVOL, V56, P796, DOI 10.1016/j.ympev.2010.02.007; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Silfverberg Hans, 2010, Sahlbergia, V16, P1; Slipinski SA, 2011, ZOOTAXA, V3148, P203, DOI [DOI 10.11646/ZOOTAXA.3148.1.39, 10.11646/zootaxa.3148.1.39]; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wirta HK, 2014, P NATL ACAD SCI USA, V111, P1885, DOI 10.1073/pnas.1316990111; Zahiri R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092797; Zhou X, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-30	54	116	124	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108651	10.1371/journal.pone.0108651	http://dx.doi.org/10.1371/journal.pone.0108651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255319	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300102
J	Alshareef, M; Krishna, V; Ferdous, J; Alshareef, A; Kindy, M; Kolachalama, VB; Shazly, T				Alshareef, Mohammed; Krishna, Vibhor; Ferdous, Jahid; Alshareef, Ahmed; Kindy, Mark; Kolachalama, Vijaya B.; Shazly, Tarek			Effect of Spinal Cord Compression on Local Vascular Blood Flow and Perfusion Capacity	PLOS ONE			English	Article							NO-REFLOW PHENOMENON; CEREBROSPINAL-FLUID; FINITE-ELEMENT; CERVICAL-SPINE; INJURY MODEL; TRAUMA; MECHANISMS; PATHOPHYSIOLOGY; NOREPINEPHRINE; PRESSURE	Spinal cord injury (SCI) can induce prolonged spinal cord compression that may result in a reduction of local tissue perfusion, progressive ischemia, and potentially irreversible tissue necrosis. Due to the combination of risk factors and the varied presentation of symptoms, the appropriate method and time course for clinical intervention following SCI are not always evident. In this study, a three-dimensional finite element fluid-structure interaction model of the cervical spinal cord was developed to examine how traditionally sub-clinical compressive mechanical loads impact spinal arterial blood flow. The spinal cord and surrounding dura mater were modeled as linear elastic, isotropic, and incompressible solids, while blood was modeled as a single-phased, incompressible Newtonian fluid. Simulation results indicate that anterior, posterior, and anteroposterior compressions of the cervical spinal cord have significantly different ischemic potentials, with prediction that the posterior component of loading elevates patient risk due to the concomitant reduction of blood flow in the arterial branches. Conversely, anterior loading compromises flow through the anterior spinal artery but minimally impacts branch flow rates. The findings of this study provide novel insight into how sub-clinical spinal cord compression could give rise to certain disease states, and suggest a need to monitor spinal artery perfusion following even mild compressive loading.	[Alshareef, Mohammed] Med Univ S Carolina, Coll Med, Charleston, SC 29425 USA; [Krishna, Vibhor; Kindy, Mark] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Ferdous, Jahid; Shazly, Tarek] Univ S Carolina, Biomed Engn Program, Columbia, SC 29208 USA; [Alshareef, Ahmed] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Kindy, Mark] Ralph H Johnson VA Med Ctr, Charleston, SC USA; [Kolachalama, Vijaya B.] Charles Stark Draper Lab, Cambridge, MA USA; [Shazly, Tarek] Univ S Carolina, Dept Mech Engn, Columbia, SC 29208 USA	Medical University of South Carolina; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; The Charles Stark Draper Laboratory, Inc.; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Shazly, T (corresponding author), Univ S Carolina, Biomed Engn Program, Columbia, SC 29208 USA.	shazly@mailbox.sc.edu	Krishna, Vibhor/AAG-3809-2019; Kolachalama, Vijaya B./AAH-3528-2020	Kolachalama, Vijaya B./0000-0002-5312-8644; Alshareef, Ahmed/0000-0003-4512-1618	National Science Foundation [EPS-0903795, IIP-917987]; National Institutes of Health [R01 ES016774-01, 5 P20 RR016461, 8P20GM103444-04, P20RR021949-03]; VA Merit Award; Charles Stark Draper Laboratory [CSDL-29414-005]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461, P20RR021949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103444] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); Charles Stark Draper Laboratory; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (EPS-0903795 and IIP-917987), the National Institutes of Health (R01 ES016774-01, 5 P20 RR016461, 8P20GM103444-04 and P20RR021949-03), a VA Merit Award, and a grant (CSDL-29414-005) from the Charles Stark Draper Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES A, 1968, AM J PATHOL, V52, P437; Amiri AR, 2013, SPINE J, V13, P1818, DOI 10.1016/j.spinee.2013.05.054; Brown A, 2014, J NEUROSURG-SPINE, V20, P164, DOI 10.3171/2013.10.SPINE13113; Carlson GD, 2003, J BONE JOINT SURG AM, V85A, P86, DOI 10.2106/00004623-200301000-00014; CROFT TJ, 1972, J NEUROSURG, V36, P402, DOI 10.3171/jns.1972.36.4.0402; Dafny N., 1997, NEUROSCIENCE ONLINE; DOHRMANN GJ, 1971, J NEUROSURG, V35, P263, DOI 10.3171/jns.1971.35.3.0263; DOPPMAN JL, 1973, J NEUROSURG, V38, P438, DOI 10.3171/jns.1973.38.4.0438; DOPPMAN JL, 1979, J NEUROSURG, V51, P201, DOI 10.3171/jns.1979.51.2.0201; DUCKER TB, 1971, J NEUROSURG, V35, P700, DOI 10.3171/jns.1971.35.6.0700; EPSTEIN NE, 1994, J SPINAL DISORD, V7, P259, DOI 10.1097/00002517-199407030-00011; FEHLINGS MG, 1989, J NEUROSURG, V71, P403, DOI 10.3171/jns.1989.71.3.0403; FISCHER EG, 1977, STROKE, V8, P36, DOI 10.1161/01.STR.8.1.36; FORD RWJ, 1983, J NEUROSURG, V59, P268, DOI 10.3171/jns.1983.59.2.0268; Greaves CY, 2008, ANN BIOMED ENG, V36, P396, DOI 10.1007/s10439-008-9440-0; GUHA A, 1989, STROKE, V20, P372, DOI 10.1161/01.STR.20.3.372; Ichihara K, 2001, J NEUROTRAUM, V18, P361, DOI 10.1089/08977150151071053; Kang CE, 2010, J NEUROTRAUM, V27, P2041, DOI 10.1089/neu.2010.1345; Karikari IO, 2009, NEUROSURGERY, V65, P919, DOI 10.1227/01.NEU.0000356972.97356.C5; Luo YH, 2012, P I MECH ENG H, V226, P499, DOI 10.1177/0954411912445729; Martirosyan NL, 2011, J NEUROSURG-SPINE, V15, P238, DOI 10.3171/2011.4.SPINE10543; Masud A, 2006, COMPUT MECH, V38, P293, DOI 10.1007/s00466-006-0063-8; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; Mazuchowski EL, 2003, SUMM BIOENG C; Mizuno Junichi, 2006, Spine J, V6, p282S, DOI 10.1016/j.spinee.2006.05.009; MODIC MT, 1986, AM J ROENTGENOL, V147, P757, DOI 10.2214/ajr.147.4.757; NELSON SR, 1971, J APPL PHYSIOL, V30, P268, DOI 10.1152/jappl.1971.30.2.268; Nemecek S, 1978, Adv Neurol, V20, P395; Newton D, 2011, J BONE JOINT SURG BR, V93B, P1646, DOI 10.1302/0301-620X.93B12.27048; NSCISC, 2010, SPIN CORD INJ FACTS; OSTERHOLM JL, 1972, J NEUROSURG, V36, P386, DOI 10.3171/jns.1972.36.4.0386; Persson C, 2011, J APPL BIOMECH, V27, P330, DOI 10.1123/jab.27.4.330; Persson C, 2011, J NEUROTRAUM, V28, P113, DOI 10.1089/neu.2010.1332; Persson C, 2010, ANN BIOMED ENG, V38, P975, DOI 10.1007/s10439-010-9924-6; Phillips JP, 2010, J PHYS CONF SER, V238, DOI 10.1088/1742-6596/238/1/012060; Purdy PD, 2004, AM J NEURORADIOL, V25, P1435; RAMSEY R, 1973, RADIOLOGY, V107, P99, DOI 10.1148/107.1.99; Selden NR, 1999, NEUROSURGERY, V44, P785, DOI 10.1097/00006123-199904000-00057; Shields CB, 2005, J NEUROSURG-SPINE, V3, P302, DOI 10.3171/spi.2005.3.4.0302; Soubeyrand M, 2014, EUR SPINE J, V23, P658, DOI 10.1007/s00586-013-3086-9; Sparrey CJ, 2009, J NEUROTRAUM, V26, P585, DOI 10.1089/neu.2008.0654; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; THIENPRASIT P, 1975, J NEUROSURG, V42, P150, DOI 10.3171/jns.1975.42.2.0150; Torii R, 2007, J BIOMECH, V40, P2501, DOI 10.1016/j.jbiomech.2006.11.004; Vlajic I, 1978, Adv Neurol, V20, P451; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Wilson JR, 2013, SPINE, V38, P97, DOI 10.1097/BRS.0b013e31826e2b91	48	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108820	10.1371/journal.pone.0108820	http://dx.doi.org/10.1371/journal.pone.0108820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268384	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700170
J	An, R; Liu, XY; Wang, R; Wu, HC; Liang, S; Shao, JX; Qi, YF; An, LJ; Yu, F				An, Rui; Liu, Xiayan; Wang, Rui; Wu, Haicui; Liang, Shuang; Shao, Jingxia; Qi, Yafei; An, Lijun; Yu, Fei			The Over-Expression of Two Transcription Factors, ABS5/bHLH30 and ABS7/MYB101, Leads to Upwardly Curly Leaves	PLOS ONE			English	Article							GAMYB-LIKE GENES; ARABIDOPSIS-THALIANA; ANTHER DEVELOPMENT; AUXIN; FAMILY; GROWTH; MORPHOGENESIS; MICRORNA; MUTATIONS; POLARITY	Proper leaf development is essential for plant growth and development, and leaf morphogenesis is under the control of intricate networks of genetic and environmental cues. We are interested in dissecting these regulatory circuits genetically and report here the isolation of two Arabidopsis dominant mutants, abnormal shoot5-1D (abs5-1D) and abs7-1D identified through activation tagging screens. Both abs5-1D and abs7-1D display an intriguing upwardly curly leaf phenotype. Molecular cloning showed that the elevated expression of a bHLH transcription factor ABS5/T5L1/bHLH30 or a MYB transcription factor ABS7/MYB101 is the cause for the abnormal leaf phenotypes found in abs5-1D or abs7-1D, respectively. Protoplast transient expression assays confirmed that both ABS5/T5L1 and ABS7/MYB101 are targeted to the nucleus. Interestingly, the expression domains of auxin response reporter DR5::GUS were abnormal in leaves of abs5-1D and ABS5/T5L1 over-expression lines. Moreover, cotyledon venation analysis showed that more areoles and free-ending veins are formed in abs5-1D. We found that the epidermis-specific expressions of ABS5/T5L1 or ABS7/MYB101 driven by the Arabidopsis Meristem Layer 1 promoter (P-AtML1) were sufficient to recapitulate the curly leaf phenotype of abs5-1D or abs7-1D. In addition, P-AtML1::ABS5 lines exhibited similar changes in DR5::GUS expression patterns as those found in 35S-driven ABS5/T5L1 over-expression lines. Our work demonstrated that enhanced expressions of two transcription factors, ABS5/T5L1 and ABS7/MYB101, are able to alter leaf lamina development and reinforce the notion that leaf epidermis plays critical roles in regulating plant organ morphogenesis.	[An, Rui; Liu, Xiayan; Wang, Rui; Wu, Haicui; Liang, Shuang; Shao, Jingxia; Qi, Yafei; An, Lijun; Yu, Fei] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [An, Rui; Liu, Xiayan; Wang, Rui; Wu, Haicui; Liang, Shuang; Shao, Jingxia; Qi, Yafei; An, Lijun; Yu, Fei] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Yu, F (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Yu, F (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	flyfeiyu@gmail.com		Wang, Rui/0000-0002-6196-0780	National Natural Science Foundation of China [31071073, 31170219, 31100864, 31300988]; Natural Science Foundation of Shaanxi Province, China [2011JQ3004, 2012JQ3015, 2452013QN086, 2013JQ3014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province, China(Natural Science Foundation of Shaanxi Province)	This work was supported by funding from the National Natural Science Foundation of China (31071073, 31170219 to F.Y., 31100864 to X.L. and 31300988 to Y.Q.) and by grants from the Natural Science Foundation of Shaanxi Province, China (2011JQ3004 to X.L., 2012JQ3015 to Y.Q., 2452013QN086 to J.S. and 2013JQ3014 to L.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Alonso-Peral MM, 2006, DEVELOPMENT, V133, P3755, DOI 10.1242/dev.02554; Barrero JM, 2007, PLANT CELL, V19, P2822, DOI 10.1105/tpc.107.054130; Bennett T, 2010, CURR TOP DEV BIOL, V91, P67, DOI 10.1016/S0070-2153(10)91003-X; Berna G, 1999, GENETICS, V152, P729; Bilsborough GD, 2011, P NATL ACAD SCI USA, V108, P3424, DOI 10.1073/pnas.1015162108; Bollman KM, 2003, DEVELOPMENT, V130, P1493, DOI 10.1242/dev.00362; Breuninger H, 2010, CURR TOP DEV BIOL, V91, P185, DOI 10.1016/S0070-2153(10)91007-7; Byrne ME, 2012, CURR OPIN PLANT BIOL, V15, P24, DOI 10.1016/j.pbi.2011.10.009; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Rybel B, 2013, DEV CELL, V24, P426, DOI 10.1016/j.devcel.2012.12.013; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Esteve-Bruna D, 2013, PLANT PHYSIOL, V161, P1303, DOI 10.1104/pp.112.207779; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Ha CM, 2010, CURR TOP DEV BIOL, V91, P103, DOI 10.1016/S0070-2153(10)91004-1; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Ilegems M, 2010, DEVELOPMENT, V137, P975, DOI 10.1242/dev.047662; Iwakawa H, 2007, PLANT J, V51, P173, DOI 10.1111/j.1365-313X.2007.03132.x; Kawade K, 2013, CURR BIOL, V23, P788, DOI 10.1016/j.cub.2013.03.044; Kerstetter RA, 2001, NATURE, V411, P706, DOI 10.1038/35079629; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Kidner CA, 2010, CURR TOP DEV BIOL, V91, P141, DOI 10.1016/S0070-2153(10)91005-3; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; Lai ZB, 2011, PLANT CELL, V23, P3824, DOI 10.1105/tpc.111.090571; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Leyser O, 2009, MECH PLANT DEV, P224; Liang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003933; Liu XD, 2013, J NEUROSURG-SPINE, V19, P2; Perez-Perez JM, 2010, PLANT CELL PHYSIOL, V51, P1661, DOI 10.1093/pcp/pcq123; McConnell JR, 1998, DEVELOPMENT, V125, P2935; Meadows M G, 1981, Plant Cell Rep, V1, P77, DOI 10.1007/BF00269279; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Murray F, 2003, PLANT J, V33, P481, DOI 10.1046/j.1365-313X.2003.01641.x; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Ochando I, 2006, PLANT PHYSIOL, V141, P607, DOI 10.1104/pp.106.077149; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Qin GJ, 2005, PLANT CELL, V17, P2693, DOI 10.1105/tpc.105.034959; Robles P, 2010, PLANT PHYSIOL, V152, P1357, DOI 10.1104/pp.109.149369; Savaldi-Goldstein S, 2008, CURR OPIN PLANT BIOL, V11, P42, DOI 10.1016/j.pbi.2007.10.009; Savaldi-Goldstein S, 2007, NATURE, V446, P199, DOI 10.1038/nature05618; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Scarpella E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001511; Serrano-Cartagena J, 2000, GENETICS, V156, P1363; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; Shao JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049861; Sieburth LE, 1999, PLANT PHYSIOL, V121, P1179, DOI 10.1104/pp.121.4.1179; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; Tian Q, 1999, DEVELOPMENT, V126, P711; Tissier AF, 1999, PLANT CELL, V11, P1841, DOI 10.1105/tpc.11.10.1841; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Tsuji H, 2006, PLANT J, V47, P427, DOI 10.1111/j.1365-313X.2006.02795.x; Tsukaya H, 2006, ANNU REV PLANT BIOL, V57, P477, DOI 10.1146/annurev.arplant.57.032905.105320; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wang MJ, 2012, J EXP BOT, V63, P5787, DOI 10.1093/jxb/ers227; Woodger FJ, 2003, PLANT J, V33, P707, DOI 10.1046/j.1365-313X.2003.01663.x; Yu F, 2004, PLANT J, V37, P864, DOI 10.1111/j.1365-313X.2003.02014.x; Yu F, 2008, PLANT CELL, V20, P1786, DOI 10.1105/tpc.107.054965	61	20	22	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107637	10.1371/journal.pone.0107637	http://dx.doi.org/10.1371/journal.pone.0107637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268707	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700043
J	Flores, DI; Sotelo-Mundo, RR; Brizuela, CA				Flores, David I.; Sotelo-Mundo, Rogerio R.; Brizuela, Carlos A.			A Simple Extension to the CMASA Method for the Prediction of Catalytic Residues in the Presence of Single Point Mutations	PLOS ONE			English	Article							SECONDARY-STRUCTURE; PROTEIN-STRUCTURE; FUNCTIONAL SITES; ALGORITHM; PATTERNS; MODEL; IDENTIFICATION; MUTAGENESIS; TEMPLATES; ALIGNMENT	The automatic identification of catalytic residues still remains an important challenge in structural bioinformatics. Sequence-based methods are good alternatives when the query shares a high percentage of identity with a well-annotated enzyme. However, when the homology is not apparent, which occurs with many structures from the structural genome initiative, structural information should be exploited. A local structural comparison is preferred to a global structural comparison when predicting functional residues. CMASA is a recently proposed method for predicting catalytic residues based on a local structure comparison. The method achieves high accuracy and a high value for the Matthews correlation coefficient. However, point substitutions or a lack of relevant data strongly affect the performance of the method. In the present study, we propose a simple extension to the CMASA method to overcome this difficulty. Extensive computational experiments are shown as proof of concept instances, as well as for a few real cases. The results show that the extension performs well when the catalytic site contains mutated residues or when some residues are missing. The proposed modification could correctly predict the catalytic residues of a mutant thymidylate synthase, 1EVF. It also successfully predicted the catalytic residues for 3HRC despite the lack of information for a relevant side chain atom in the PDB file.	[Flores, David I.; Brizuela, Carlos A.] Ctr Invest Cient & Educ Super Ensenada, Dept Ciencias Comp, Ensenada, Baja California, Mexico; [Sotelo-Mundo, Rogerio R.] Ctr Invest Alimentac & Desarrollo AC, Hermosillo, Sonora, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; CIAD - Centro de Investigacion en Alimentacion y Desarrollo	Brizuela, CA (corresponding author), Ctr Invest Cient & Educ Super Ensenada, Dept Ciencias Comp, Ensenada, Baja California, Mexico.	cbrizuel@cicese.mx	Brizuela, Carlos/B-1400-2013; Sotelo-Mundo, Rogerio/A-6097-2011	Brizuela, Carlos/0000-0003-4621-0380; Sotelo-Mundo, Rogerio/0000-0001-5543-6889	National Council of Science and Technology of Mexico [SEP-CONACYT-CB-2010-154737]; Center for Scientific Research and Higher Education of Ensenada [FOFO71]	National Council of Science and Technology of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Center for Scientific Research and Higher Education of Ensenada	The work of CB and DF was partially supported by the National Council of Science and Technology of Mexico (www.conacyt.gob.mx) under grant SEP-CONACYT-CB-2010-154737. The remaining funding came from the Center for Scientific Research and Higher Education of Ensenada (www.cicese.edu.mx) under grant FOFO71. RSM received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARTYMIUK PJ, 1994, J MOL BIOL, V243, P327, DOI 10.1006/jmbi.1994.1657; Ausiello G, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S5; Ausiello G, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S2; Barker JA, 2003, BIOINFORMATICS, V19, P1644, DOI 10.1093/bioinformatics/btg226; Bromberg Y, 2008, BIOINFORMATICS, V24, pI207, DOI 10.1093/bioinformatics/btn268; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Copley SD, 2012, BIOESSAYS, V34, P578, DOI 10.1002/bies.201100191; Furnham N, 2014, NUCLEIC ACIDS RES, V42, pD485, DOI 10.1093/nar/gkt1243; GART JJ, 1966, AM J EPIDEMIOL, V83, P593, DOI 10.1093/oxfordjournals.aje.a120610; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Jambon M, 2003, PROTEINS, V52, P137, DOI 10.1002/prot.10339; Kinoshita K, 2003, PROTEIN SCI, V12, P1589, DOI 10.1110/ps.0368703; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Li GH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-439; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Milik M, 2003, PROTEIN ENG, V16, P543, DOI 10.1093/protein/gzg080; Nilmeier JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062535; Ondrechen MJ, 2001, P NATL ACAD SCI USA, V98, P12473, DOI 10.1073/pnas.211436698; Phan J, 2000, BIOCHEMISTRY-US, V39, P6969, DOI 10.1021/bi000367g; Rahimi A, 2013, J THEOR BIOL, V336, P36, DOI 10.1016/j.jtbi.2013.07.003; Rost B, 2003, CELL MOL LIFE SCI, V60, P2637, DOI 10.1007/s00018-003-3114-8; Schmitt S, 2002, J MOL BIOL, V323, P387, DOI 10.1016/S0022-2836(02)00811-2; Shulman-Peleg A, 2004, J MOL BIOL, V339, P607, DOI 10.1016/j.jmb.2004.04.012; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Spriggs RV, 2003, J CHEM INF COMP SCI, V43, P412, DOI 10.1021/ci0255984; Stark A, 2003, NUCLEIC ACIDS RES, V31, P3341, DOI 10.1093/nar/gkg506; Stark A, 2003, J MOL BIOL, V326, P1307, DOI 10.1016/S0022-2836(03)00045-7; Tseng YY, 2009, J MOL BIOL, V387, P451, DOI 10.1016/j.jmb.2008.12.072; ULLMANN JR, 1976, J ACM, V23, P31, DOI 10.1145/321921.321925; Volkamer A, 2013, PROTEINS, V81, P479, DOI 10.1002/prot.24205; VUORI K, 1992, J BIOL CHEM, V267, P7211; Wallace AC, 1997, PROTEIN SCI, V6, P2308; Wangikar PP, 2003, J MOL BIOL, V326, P955, DOI 10.1016/S0022-2836(02)01384-0; Yahalom R, 2011, PROTEINS, V79, P1952, DOI 10.1002/prot.23020	37	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108513	10.1371/journal.pone.0108513	http://dx.doi.org/10.1371/journal.pone.0108513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268770	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700104
J	Frostegard, AG; Sjoberg, BG; Frostegard, J; Norman, M				Frostegard, Anna G.; Sjoberg, Beatrice G.; Frostegard, Johan; Norman, Mikael			IgM-Antibodies against Phosphorylcholine in Mothers and Normal or Low Birth Weight Term Newborn Infants	PLOS ONE			English	Article							OXIDATION-SPECIFIC EPITOPES; NATURAL ANTIBODIES; STREPTOCOCCUS-PNEUMONIAE; ATHEROSCLEROTIC PLAQUES; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; PROTECTIVE FACTORS; APOPTOTIC CELLS; NEW-GUINEA; CHILDREN	Objective: To determine levels of athero-protective IgM antibodies against phosphorylcholine in mothers and term-born normal or low birth weight infants. Approach: Twenty three mother-infant pairs were studied, of whom 16 infants were within the normal weight range for gestational age (NGA; 3652[504] g) and 7 were small for gestational age (SGA; birth weight: 2715[255] g), the latter <2SD below the Swedish reference data mean for normal fetal growth. All infants were born at term (mean +/- SD 40.5 +/- 1.1 weeks). Serum was available from 6 mothers with SGA and 14 with NGA infants. Participating mothers were aged 34.0 +/- 3.9 years (no difference between groups). Fourteen neonates were boys and seven were girls. Levels of anti-PC IgM were determined by ELISA. Results: Neonatal IgM anti-PC levels were low (undetectable in 8 infants out of which 3 were SGA) with a median of 76[range 0-2.51] U/ml. Maternal IgM anti-PC levels were significantly higher (median 7198[range: 25.32-656.0]) U/ml) and the proportion of mothers in highest quartile (>75th percentile) was larger in mothers of NGA-infants (43%) vs. those of SGA-infants (0%, p = 0.032). Conclusions: IgM anti-PC levels are low at birth, which suggests that these antibodies do not play a "housekeeping" role in immune function during fetal life/development, but arise predominately on exposure to external antigens after birth. Furthermore, low maternal IgM anti-PC levels may play a role in placental insufficiency, contributing to poor fetal growth and a small-for-date baby. This preliminary observation may have implications for the future risk of atherosclerosis/cardiovascular disease development in pregnant women and their offspring.	[Frostegard, Anna G.; Frostegard, Johan] Karolinska Inst, Inst Environm Med, Unit Immunol & Chron Dis, S-10401 Stockholm, Sweden; [Sjoberg, Beatrice G.] Karolinska Inst, Dept Med, Huddinge, Sweden; [Sjoberg, Beatrice G.] Karolinska Univ Hosp, Huddinge, Sweden; [Norman, Mikael] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Frostegard, AG (corresponding author), Karolinska Inst, Inst Environm Med, Unit Immunol & Chron Dis, S-10401 Stockholm, Sweden.	anna.frostegard@ki.se		Frostegard, Johan/0000-0002-3569-3367; Norman, Mikael/0000-0003-4191-3781	The Torsten Soderberg Foundation; The Swedish Research Council; The Swedish Heart-Lung Foundation	The Torsten Soderberg Foundation; The Swedish Research Council(Swedish Research Council); The Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	The funders are the following: 1. The Torsten Soderberg Foundation; 2. The Swedish Research Council; and 3. The Swedish Heart-Lung Foundation. The funders had no role in study design, data collections and analysis, decision to publish, or preparation of the manuscript.	Agmon-Levin N, 2009, ANN NY ACAD SCI, V1173, P675, DOI 10.1111/j.1749-6632.2009.04671.x; BRILES DE, 1982, J EXP MED, V156, P1177, DOI 10.1084/jem.156.4.1177; BRUSSOW H, 1992, J CLIN MICROBIOL, V30, P2765; Caidahl K, 2013, INT J CARDIOL, V167, P464, DOI 10.1016/j.ijcard.2012.01.018; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; de Faire U, 2010, J AUTOIMMUN, V34, P73, DOI 10.1016/j.jaut.2009.05.003; Faria-Neto JR, 2006, ATHEROSCLEROSIS, V189, P83, DOI 10.1016/j.atherosclerosis.2005.11.033; Fiskesund R, 2012, RESULTS IMMUNOLOGY; Fiskesund R, 2014, J IMMUNOL, V192, P4551, DOI 10.4049/jimmunol.1303035; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Frostegard J, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-7; Frostegard J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-117; Halvorsen CP, 2006, J INTERN MED, V259, P155, DOI 10.1111/j.1365-2796.2005.01593.x; Leeson CPM, 1997, CIRCULATION, V96, P2233; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; Madi A, 2012, ADV EXP MED BIOL, V750, P198, DOI 10.1007/978-1-4614-3461-0_15; Martin H, 2000, CIRCULATION, V102, P2739, DOI 10.1161/01.CIR.102.22.2739; Martin H, 2000, PEDIATR RES, V47, P457, DOI 10.1203/00006450-200004000-00008; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; Silverman Gregg J, 2009, Discov Med, V8, P151; Su J, 2008, RHEUMATOLOGY, V47, P1144, DOI 10.1093/rheumatology/ken120; Su J, 2006, ATHEROSCLEROSIS, V188, P160, DOI 10.1016/j.atherosclerosis.2005.10.017; Wang CG, 2013, INT IMMUNOL, V25, P575, DOI 10.1093/intimm/dxt022	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106584	10.1371/journal.pone.0106584	http://dx.doi.org/10.1371/journal.pone.0106584			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268587	Green Submitted, gold, Green Published			2022-12-27	WOS:000343671700012
J	Groves, AK; McNaughton-Reyes, HL; Foshee, VA; Moodley, D; Maman, S				Groves, Allison K.; McNaughton-Reyes, H. Luz; Foshee, Vangie A.; Moodley, Dhayendre; Maman, Suzanne			Relationship Factors and Trajectories of Intimate Partner Violence among South African Women during Pregnancy and the Postpartum Period	PLOS ONE			English	Article							HEALTH BEHAVIORS; PHYSICAL ABUSE; RISK; HIV; STRESS	Intimate partner violence (IPV) is a significant public health problem in South Africa. However, there is limited research on whether and how IPV changes during pregnancy and the postpartum period and on the factors that might affect women's risk during this time. In this study, we describe the mean trajectories of physical and psychological IPV during pregnancy and the postpartum period and examine whether relationship power, partner social support, and relationship stress are associated with women's trajectories of IPV. Data come from a longitudinal study with 1,480 women recruited during pregnancy between May 2008 and June 2010 at a public clinic in Durban. Women completed behavioral assessments at their first antenatal visit, at fourteen weeks and at nine months postpartum. Women's experiences of IPV were measured at all three time points and relationship power, partner social support and relationship stress were each measured at the baseline assessment. We used multilevel random coefficients growth modeling to build our models. The mean trajectory for both types of IPV was flat which means that, on average, there was not significant change in levels of IPV over pregnancy and the postpartum period. However, there was significant individual variability in trajectories of IPV over the study period. Women who had higher relationship power had lower levels of physical and psychological IPV over time than women with lower relationship power. Additionally, women with higher relationship stress and lower partner support had higher levels of psychological IPV at pregnancy. Interventions that maximize women's relationship power and partner social support and minimize relationship stress during this transformative time are needed.	[Groves, Allison K.] Amer Univ, Dept Sociol, Ctr Hlth Risk & Soc, Washington, DC 20016 USA; [McNaughton-Reyes, H. Luz; Foshee, Vangie A.; Maman, Suzanne] Univ N Carolina, Dept Hlth Behav, Chapel Hill, NC USA; [Foshee, Vangie A.; Moodley, Dhayendre] Univ KwaZulu Natal, Dept Obstet & Gynaecol, Womens Hlth & HIV Res Ctr, Durban, South Africa	American University; University of North Carolina; University of North Carolina Chapel Hill; University of Kwazulu Natal	Groves, AK (corresponding author), Amer Univ, Dept Sociol, Ctr Hlth Risk & Soc, Washington, DC 20016 USA.	groves@american.edu	Moodley, Dhayendre/U-6802-2019; Maman, Suzanne/A-3802-2016	McNaughton Reyes, Heathe Luz/0000-0002-8696-9140	National Institute of Child Health and Development [R01 1-R01-HD050134001-A1]; Open Society Institute [20020472/20030878]; Elton John AIDS Foundation [20020472/20030878]; Department of Health and Human Services, DHHS/NIH/NIAID [T32 AI007001-34]; University of North Carolina; University of North Carolina Gillings School of Public Health	National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Open Society Institute; Elton John AIDS Foundation; Department of Health and Human Services, DHHS/NIH/NIAID; University of North Carolina; University of North Carolina Gillings School of Public Health	Funding support by National Institute of Child Health and Development, R01 1-R01-HD050134001-A1 (https://www.nichd.nih.gov/Pages/index.aspx), to SM and DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2. Open Society Institute, http://www.opensocietyfoundations.org/ (20020472/20030878) DM "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 3. Elton John AIDS Foundation, http://ejaf.org/, (20020472/20030878) DM "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 4. Department of Health and Human Services, DHHS/NIH/NIAID T32 AI007001-34, AKG "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 5. University of North Carolina, http://gradschool.unc.edu/funding/gradschool/dissertation.html, (Dissertation Completion Fellowship) AKG "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 6. University of North Carolina Gillings School of Public Health, http://sph.unc.edu/ (Gillings Dissertation Award, Winstanly Scholarship, Doris Buffet Scholarship) AKG "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Brennan PA, 1997, CLIN PSYCHOL REV; Cano A, 2001, AGGRESS VIOLENT BEH, V6, P459, DOI 10.1016/S1359-1789(00)00017-3; Capaldi DM, 2005, LIFE SPAN DEV SYSTEM; Cohen S., 1995, MEASURING STRESS GUI, P3; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Dunkle KL, 2004, LANCET; Elder G. H., 1985, PERSPECTIVES LIFE CO; Fisher J, 2010, B WORLD HEALTH ORGAN, V88, P737, DOI 10.2471/BLT.09.067066; Fox GL, 2006, PUBLIC HEALTH REP, V121, P419, DOI 10.1177/003335490612100410; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Gass JD, 2010, SAMJ S AFR MED J, V100, P582, DOI 10.7196/SAMJ.4274; Guo SF, 2004, INT J GYNECOL OBSTET, V84, P281, DOI 10.1016/j.ijgo.2003.08.019; Jasinski Jana L, 2004, Trauma Violence Abuse, V5, P47, DOI 10.1177/1524838003259322; Jasinski JL, 2001, J INTERPERS VIOLENCE, V16, P712, DOI 10.1177/088626001016007006; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Koenig LJ, 2006, AM J PUBLIC HEALTH, V96, P1052, DOI 10.2105/AJPH.2005.067744; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; LAUB JH, 1993, CRIMINOLOGY, V31, P301, DOI 10.1111/j.1745-9125.1993.tb01132.x; Lazarus R.S., 1984, EMOTION ADAPTATION; Lobel M., 1990, ANXIETY RES, V3, P213, DOI [10.1080/08917779008248754, DOI 10.1080/08917779008248754]; Lobel M, 2008, HEALTH PSYCHOL, V27, P604, DOI 10.1037/a0013242; Ludermir AB, 2010, LANCET, V376, P903, DOI 10.1016/S0140-6736(10)60887-2; Macy RJ, 2007, WOMEN HEALTH ISS, V17, P290, DOI 10.1016/j.whi.2007.03.006; Martin SL, 2001, JAMA-J AM MED ASSOC, V285, P1581, DOI 10.1001/jama.285.12.1581; Mullick S, 2005, AGENDA SPECIAL FOCUS, V6, P124; Ngcobo N, 2011, PRINCE MSHIYENE MEMO; Norbeck JS, 1981, DEV INSTRUMENT MEASU; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Raudenbush S. W., 2001, HIERARCHICAL LINEAR, V2nd; Salazar M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-350; Saltzman Linda E, 2003, Matern Child Health J, V7, P31, DOI 10.1023/A:1022589501039; SAS Institute, 2009, SAS VERS 9 2; Sharps PW, 2007, TRAUMA VIOLENCE ABUS, V8, P105, DOI 10.1177/1524838007302594; Shortt JW, 2013, J YOUTH ADOLESCENCE, V42, P619, DOI 10.1007/s10964-013-9911-y; Silverman JG, 2006, AM J OBSTET GYNECOL, V195, P140, DOI 10.1016/j.ajog.2005.12.052; STEWART DE, 1993, CAN MED ASSOC J, V149, P1257; Taillieu TL, 2010, AGGRESS VIOLENT BEH, V15, P14, DOI 10.1016/j.avb.2009.07.013; Wheaton B, 1997, STRESS ADVERSITY LIF, P1, DOI [DOI 10.1017/CBO9780511527623.001, DOI 10.1017/CB09780511527623.001]; Wuest J, 2008, J FAM VIOLENCE, V23, P281, DOI 10.1007/s10896-008-9155-x	41	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106829	10.1371/journal.pone.0106829	http://dx.doi.org/10.1371/journal.pone.0106829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268363	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700020
J	Tannous, E; Kanaya, S				Tannous, Elias; Kanaya, Shigenori			Divalent Metal Ion-Induced Folding Mechanism of RNase H1 from Extreme Halophilic Archaeon Halobacterium sp NRC-1	PLOS ONE			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; R-LOOP FORMATION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TOPOISOMERASE-I; BACILLUS-STEAROTHERMOPHILUS; DIHYDROFOLATE REDUCTASES; SINGLE RIBONUCLEOTIDE; SUBSTRATE-SPECIFICITY; MOLECULAR DIVERSITIES	RNase H1 from Halobacterium sp. NRC-1 (Halo-RNase H1) is characterized by the abundance of acidic residues on the surface, including bi/quad-aspartate site residues. Halo-RNase H1 exists in partially folded (I) and native (N) states in low-salt and high-salt conditions respectively. Its folding is also induced by divalent metal ions. To understand this unique folding mechanism of Halo-RNase H1, the active site mutant (2A-RNase H1), the bi/quad-aspartate site mutant (6A-RNase H1), and the mutant at both sites (8A-RNase H1) were constructed. The far-UV CD spectra of these mutants suggest that 2A-RNase H1 mainly exists in the I state, 6A-RNase H1 exists both in the I and N states, and 8A-RNase H1 mainly exists in the N state in a low salt-condition. These results suggest that folding of Halo-RNase H1 is induced by binding of divalent metal ions to the bi/quad-aspartate site. To examine whether metal-induced folding is unique to Halo-RNase H1, RNase H2 from the same organism (Halo-RNase H2) was overproduced and purified. Halo-RNase H2 exists in the I and N states in low-salt and high-salt conditions respectively, as does Halo-RNase H1. However, this protein exists in the I state even in the presence of divalent metal ions. Halo-RNase H2 exhibits junction ribonuclease activity only in a high-salt condition. A tertiary model of this protein suggests that this protein does not have a quad-aspartate site. We propose that folding of Halo-RNase H1 is induced by binding of divalent metal ion to the quad-aspartate site in a low-salt condition.	[Tannous, Elias; Kanaya, Shigenori] Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Suita, Osaka, Japan	Osaka University	Kanaya, S (corresponding author), Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Suita, Osaka, Japan.	kanaya@mls.eng.osaka-u.ac.jp		Tannous, Elias/0000-0001-8073-1599	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24380055]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant (24380055) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funder had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Arakawa T, 2004, PROTEIN PEPTIDE LETT, V11, P125, DOI 10.2174/0929866043478220; Bandyopadhyay AK, 2007, EXTREMOPHILES, V11, P615, DOI 10.1007/s00792-007-0075-0; Besir H, 2005, FEBS LETT, V579, P6595, DOI 10.1016/j.febslet.2005.10.052; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broccoli S, 2004, MOL MICROBIOL, V52, P1769, DOI 10.1111/j.1365-2958.2004.04092.x; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; Cheng B, 2003, FEMS MICROBIOL LETT, V221, P237, DOI 10.1016/S0378-1097(03)00209-X; Chon H, 2006, J MOL BIOL, V356, P165, DOI 10.1016/j.jmb.2005.11.017; Chon H, 2013, NUCLEIC ACIDS RES, V41, P3130, DOI 10.1093/nar/gkt027; Coquelle N, 2010, J MOL BIOL, V404, P493, DOI 10.1016/j.jmb.2010.09.055; Crouch R. J., 1982, NUCLEASES, P211; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; DROLET M, 1995, P NATL ACAD SCI USA, V92, P3526, DOI 10.1073/pnas.92.8.3526; Elcock AH, 1998, J MOL BIOL, V280, P731, DOI 10.1006/jmbi.1998.1904; Esposito Francesca, 2012, Mol Biol Int, V2012, P586401, DOI 10.1155/2012/586401; Gloss LM, 2008, J MOL BIOL, V376, P1451, DOI 10.1016/j.jmb.2007.12.056; Goedken ER, 2001, J BIOL CHEM, V276, P7266, DOI 10.1074/jbc.M009626200; GOODWIN TW, 1946, BIOCHEM J, V40, pR10; Haruki M, 2002, FEBS LETT, V531, P204, DOI 10.1016/S0014-5793(02)03503-2; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Ishibashi M, 2001, FEBS LETT, V493, P134, DOI 10.1016/S0014-5793(01)02292-X; Itaya M, 1999, J BACTERIOL, V181, P2118, DOI 10.1128/JB.181.7.2118-2123.1999; Kanaya S, 1996, J BIOL CHEM, V271, P32729, DOI 10.1074/jbc.271.51.32729; KATAYANAGI K, 1993, PROTEINS, V17, P337, DOI 10.1002/prot.340170402; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Lu Z, 2012, BBA-PROTEINS PROTEOM, V1824, P859, DOI 10.1016/j.bbapap.2012.04.003; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; McDonald JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003030; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; Mevarech M, 2000, BIOPHYS CHEM, V86, P155, DOI 10.1016/S0301-4622(00)00126-5; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; OGAWA T, 1984, MOL GEN GENET, V193, P231, DOI 10.1007/BF00330673; Ohtani N, 1999, BIOCHEMISTRY-US, V38, P605, DOI 10.1021/bi982207z; Ohtani N, 1999, J BIOSCI BIOENG, V88, P12, DOI 10.1016/S1389-1723(99)80168-6; Ohtani N, 2004, BIOCHEM J, V381, P795, DOI 10.1042/BJ20040153; Ohtani N, 2008, FEBS J, V275, P5444, DOI 10.1111/j.1742-4658.2008.06673.x; Permanasari ED, 2013, FEBS J, V280, P5065, DOI 10.1111/febs.12479; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Rychlik MP, 2010, MOL CELL, V40, P658, DOI 10.1016/j.molcel.2010.11.001; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Tadokoro T, 2009, FEBS J, V276, P1482, DOI 10.1111/j.1742-4658.2009.06907.x; Tannous E, 2012, FEBS OPEN BIO, V2, P345, DOI 10.1016/j.fob.2012.10.003; Tsunaka Y, 2005, J MOL BIOL, V345, P1171, DOI 10.1016/j.jmb.2004.11.007; Wright DB, 2002, J MOL BIOL, V323, P327, DOI 10.1016/S0022-2836(02)00916-6; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	52	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e109016	10.1371/journal.pone.0109016	http://dx.doi.org/10.1371/journal.pone.0109016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268753	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700213
J	Zimmer, BL; May, AL; Bhedi, CD; Dearth, SP; Prevatte, CW; Pratte, Z; Campagna, SR; Richardson, LL				Zimmer, Beth L.; May, Amanda L.; Bhedi, Chinmayee D.; Dearth, Stephen P.; Prevatte, Carson W.; Pratte, Zoe; Campagna, Shawn R.; Richardson, Laurie L.			Quorum Sensing Signal Production and Microbial Interactions in a Polymicrobial Disease of Corals and the Coral Surface Mucopolysaccharide Layer	PLOS ONE			English	Article							BLACK-BAND-DISEASE; ACYL-HOMOSERINE LACTONE; N-ACYLHOMOSERINE LACTONES; MUCUS-ASSOCIATED BACTERIA; TANDEM MASS-SPECTROMETRY; VIBRIO-HARVEYI; GENE-EXPRESSION; PSEUDOMONAS-AERUGINOSA; SALMONELLA-TYPHIMURIUM; ECOLOGICAL PHYSIOLOGY	Black band disease (BBD) of corals is a complex polymicrobial disease considered to be a threat to coral reef health, as it can lead to mortality of massive reef-building corals. The BBD community is dominated by gliding, filamentous cyanobacteria with a highly diverse population of heterotrophic bacteria. Microbial interactions such as quorum sensing (QS) and antimicrobial production may be involved in BBD disease pathogenesis. In this study, BBD (whole community) samples, as well as 199 bacterial isolates from BBD, the surface mucopolysaccharide layer (SML) of apparently healthy corals, and SML of apparently healthy areas of BBD-infected corals were screened for the production of acyl homoserine lactones (AHLs) and for autoinducer-2 (AI-2) activity using three bacterial reporter strains. AHLs were detected in all BBD (intact community) samples tested and in cultures of 5.5% of BBD bacterial isolates. Over half of a subset (153) of the isolates were positive for AI-2 activity. AHL-producing isolates were further analyzed using LC-MS/MS to determine AHL chemical structure and the concentration of (S)-4,5-dihydroxy-2,3-pentanedione (DPD), the biosynthetic precursor of AI-2. C6-HSL was the most common AHL variant detected, followed by 3OC4-HSL. In addition to QS assays, 342 growth challenges were conducted among a subset of the isolates, with 27% of isolates eliciting growth inhibition and 2% growth stimulation. 24% of BBD isolates elicited growth inhibition as compared to 26% and 32% of the bacteria from the two SML sources. With one exception, only isolates that exhibited AI-2 activity or produced DPD inhibited growth of test strains. These findings demonstrate for the first time that AHLs are present in an active coral disease. It is possible that AI-2 production among BBD and coral SML bacteria may structure the microbial communities of both a polymicrobial infection and the healthy coral microbiome.	[Zimmer, Beth L.; Bhedi, Chinmayee D.; Pratte, Zoe; Richardson, Laurie L.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Zimmer, Beth L.] Atkins North Amer, Miami, FL USA; [May, Amanda L.; Dearth, Stephen P.; Prevatte, Carson W.; Campagna, Shawn R.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA	State University System of Florida; Florida International University; University of Tennessee System; University of Tennessee Knoxville	Richardson, LL (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.	Laurie.Richardson@fiu.edu		Dearth, Stephen/0000-0002-9026-8611	NSF [OCE-1208784, OCE-1061352]; Florida International University; Atkins North America; University of Tennessee, Knoxville, Open Access Publishing Funds; Directorate For Geosciences [1061352] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Florida International University; Atkins North America; University of Tennessee, Knoxville, Open Access Publishing Funds; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the NSF (grant no. OCE-1208784 to LLR and SRC and OCE-1061352 to SRC) and by Florida International University. The websites are www.nsf.gov and www.fiu.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. First author Beth Zimmer is employed by the commercial company Atkins North America. Atkins North America provided support in the form of salary for author BZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. Publication of this article was funded in part by Florida International University and in part by the University of Tennessee, Knoxville, Open Access Publishing Funds.	Alagely A, 2011, ISME J, V5, P1609, DOI 10.1038/ismej.2011.45; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antonius A, 1976, P ASS ISL MAR LAB CA, V10, P17; Arotsker L, 2009, FEMS MICROBIOL ECOL, V70, P515, DOI 10.1111/j.1574-6941.2009.00770.x; Bachofen R, 1998, MICROBIOL RES, V153, P61; Bandara HMHN, 2012, CRIT REV MICROBIOL, V38, P217, DOI 10.3109/1040841X.2011.652065; Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Bodor A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-13; Brown BE, 2005, MAR ECOL PROG SER, V296, P291, DOI 10.3354/meps296291; BRUCKNER AW, 1997, P 8 INT COR REEF S, V1, P601; Buch C, 2003, SYST APPL MICROBIOL, V26, P338, DOI 10.1078/072320203322497365; Burgess NA, 2002, MICROBIOL-SGM, V148, P763, DOI 10.1099/00221287-148-3-763; Byers JT, 2002, J BACTERIOL, V184, P1163, DOI 10.1128/jb.184.4.1163-1171.2002; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Campagna SR, 2009, ANAL CHEM, V81, P6374, DOI 10.1021/ac900824j; CARLTON RG, 1995, FEMS MICROBIOL ECOL, V18, P155, DOI 10.1016/0168-6496(95)00052-C; Casamatta D, 2012, PHYCOLOGIA, V51, P489, DOI 10.2216/11-10.1; Case RJ, 2011, ENVIRON MICROBIOL, V13, P529, DOI 10.1111/j.1462-2920.2010.02356.x; Cha C, 1998, MOL PLANT MICROBE IN, V11, P1119, DOI 10.1094/MPMI.1998.11.11.1119; Charlton TS, 2000, ENVIRON MICROBIOL, V2, P530, DOI 10.1046/j.1462-2920.2000.00136.x; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; CHILTON MD, 1974, P NATL ACAD SCI USA, V71, P3672, DOI 10.1073/pnas.71.9.3672; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; De Keersmaecker SCJ, 2006, TRENDS MICROBIOL, V14, P114, DOI 10.1016/j.tim.2006.01.003; Decho AW, 2010, TRENDS MICROBIOL, V18, P73, DOI 10.1016/j.tim.2009.12.008; Decho AW, 2009, ENVIRON MICROBIOL, V11, P409, DOI 10.1111/j.1462-2920.2008.01780.x; DeKeersmaecker SCJ, 2003, MICROBIOL-SGM, V149, P1953, DOI 10.1099/mic.0.C0117-0; DUCKLOW HW, 1979, LIMNOL OCEANOGR, V24, P715, DOI 10.4319/lo.1979.24.4.0715; EDMUNDS PJ, 1991, CORAL REEFS, V10, P161, DOI 10.1007/BF00572175; Farrand SK, 2002, METHOD ENZYMOL, V358, P452; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gantar M, 2011, MAR DRUGS, V9, P2089, DOI 10.3390/md9102089; Gantar M, 2009, MICROB ECOL, V58, P856, DOI 10.1007/s00248-009-9540-x; Garcia-Aljaro C, 2012, J APPL MICROBIOL, V112, P383, DOI 10.1111/j.1365-2672.2011.05199.x; GAUTHIER MJ, 1982, INT J SYST BACTERIOL, V32, P82, DOI 10.1099/00207713-32-1-82; Geffen Y, 2005, MAR BIOL, V146, P931, DOI 10.1007/s00227-004-1505-5; Glas MS, 2012, ISME J, V6, P1526, DOI 10.1038/ismej.2012.2; Golberg K, 2011, MICROB ECOL, V61, P783, DOI 10.1007/s00248-011-9848-1; Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06; Gram L, 2002, APPL ENVIRON MICROB, V68, P4111, DOI 10.1128/AEM.68.8.4111-4116.2002; Guppy R, 2006, MAR ECOL PROG SER, V328, P133, DOI 10.3354/meps328133; Han XG, 2009, CURR MICROBIOL, V58, P146, DOI 10.1007/s00284-008-9291-9; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; Horswill AR, 2007, ANAL BIOANAL CHEM, V387, P371, DOI 10.1007/s00216-006-0720-y; Huang YL, 2008, AQUAT MICROB ECOL, V52, P185, DOI 10.3354/ame01215; Huang YL, 2009, ISME J, V3, P296, DOI 10.1038/ismej.2008.105; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; Joint I, 2007, PHILOS T R SOC B, V362, P1115, DOI 10.1098/rstb.2007.2038; Jones R, 2004, BEE WORLD, V85, P63; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kimes NE, 2012, ISME J, V6, P835, DOI 10.1038/ismej.2011.154; Koh KS, 1997, J CHEM ECOL, V23, P379; Kramarsky-Winter E, 2014, MICROB ECOL, V67, P177, DOI 10.1007/s00248-013-0309-x; Kuta KG, 1996, CORAL REEFS, V15, P219, DOI 10.1007/BF01787455; KUTA KG, 1997, P 8 INT COR REEF S, V1, P575; LICHSTEIN HC, 1946, J BACTERIOL, V52, P145, DOI 10.1128/JB.52.1.145-146.1946; Matz C, 2011, SPRINGER SER BIOFILM, V5, P29, DOI 10.1007/978-3-642-19940-0_2; May AL, 2012, ANAL CHEM, V84, P1243, DOI 10.1021/ac202636d; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; McDougald D, 2003, MICROBIOL-SGM, V149, P1923, DOI 10.1099/mic.0.26321-0; McGowan SJ, 2005, MOL MICROBIOL, V55, P526, DOI 10.1111/j.1365-2958.2004.04397.x; MEIKLE P, 1988, MAR BIOL, V99, P187, DOI 10.1007/BF00391980; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Miller AW, 2011, FEMS MICROBIOL ECOL, V75, P231, DOI 10.1111/j.1574-6941.2010.00991.x; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; Myers JL, 2007, APPL ENVIRON MICROB, V73, P5173, DOI 10.1128/AEM.00900-07; Nissimov J, 2009, FEMS MICROBIOL LETT, V292, P210, DOI 10.1111/j.1574-6968.2009.01490.x; Ransome E, 2013, FEMS MICROB IN PRESS; Richardson L. L., 1997, P 8 INT COR REEF S, V1, P597; Richardson LL, 2007, FEMS MICROBIOL LETT, V272, P182, DOI 10.1111/j.1574-6968.2007.00751.x; Richardson LL, 2009, DIS AQUAT ORGAN, V87, P79, DOI 10.3354/dao02083; Richardson LL, 2003, FEMS MICROBIOL ECOL, V43, P287, DOI 10.1016/S0168-6496(03)00025-4; Richardson LL, 2000, P 9 INT COR REEF S, V2, P1225; Riedel K, 2001, MICROBIOL-SGM, V147, P3249, DOI 10.1099/00221287-147-12-3249; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rosenberg E, 2004, CORAL HLTH DIS; Rutzler K, 1983, PSZNI MAR ECOL, V4, P329, DOI DOI 10.1111/J.1439-0485.1983.TB00118.X; Ryan RP, 2008, MICROBIOL-SGM, V154, P1845, DOI 10.1099/mic.0.2008/017871-0; Rypien KL, 2010, ENVIRON MICROBIOL, V12, P28, DOI 10.1111/j.1462-2920.2009.02027.x; Sato Y, 2010, ISME J, V4, P203, DOI 10.1038/ismej.2009.103; Sato Y, 2009, P R SOC B, V276, P2795, DOI 10.1098/rspb.2009.0481; Schaefer AL, 2000, METHOD ENZYMOL, V305, P288; Sekar R, 2008, MAR ECOL PROG SER, V362, P85, DOI 10.3354/meps07496; Sekar R, 2006, APPL ENVIRON MICROB, V72, P5963, DOI 10.1128/AEM.00843-06; Semmelhack MF, 2005, ORG LETT, V7, P569, DOI 10.1021/ol047695j; Sharif DI, 2008, ISME J, V2, P1171, DOI 10.1038/ismej.2008.68; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; Stanic D, 2011, ENVIRON MICROBIOL, V13, P900, DOI 10.1111/j.1462-2920.2010.02388.x; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Taga Michiko E, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01c01s00; Tait K, 2005, ENVIRON MICROBIOL, V7, P229, DOI 10.1111/j.1462-2920.2004.00706.x; Tait K, 2010, ENV MICROBIOL REP, V2, P145, DOI 10.1111/j.1758-2229.2009.00122.x; Taylor MW, 2004, APPL ENVIRON MICROB, V70, P4387, DOI 10.1128/AEM.70.7.4387-4389.2004; Van Houdt R, 2007, FEMS MICROBIOL REV, V31, P407, DOI 10.1111/j.1574-6976.2007.00071.x; Van Mooy BAS, 2012, ISME J, V6, P422, DOI 10.1038/ismej.2011.115; Vargas-Angel B, 2003, CORAL REEFS, V22, P465, DOI 10.1007/s00338-003-0336-z; VOELKERT E, 1970, ANAL BIOCHEM, V34, P131, DOI 10.1016/0003-2697(70)90093-X; VONBODMAN SB, 1992, P NATL ACAD SCI USA, V89, P643, DOI 10.1073/pnas.89.2.643; Voss JD, 2006, DIS AQUAT ORGAN, V69, P33, DOI 10.3354/dao069033; Wild C, 2005, MAR ECOL PROG SER, V287, P87, DOI 10.3354/meps287087; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Wood DW, 1997, J BACTERIOL, V179, P7663, DOI 10.1128/jb.179.24.7663-7670.1997; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002	117	23	30	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108541	10.1371/journal.pone.0108541	http://dx.doi.org/10.1371/journal.pone.0108541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268348	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700110
J	Bompard, L; Xu, S; Styner, M; Paniagua, B; Ahn, M; Yuan, Y; Jewells, V; Gao, W; Shen, DG; Zhu, HT; Lin, WL				Bompard, Lucile; Xu, Shun; Styner, Martin; Paniagua, Beatriz; Ahn, Mihye; Yuan, Ying; Jewells, Valerie; Gao, Wei; Shen, Dinggang; Zhu, Hongtu; Lin, Weili			Multivariate Longitudinal Shape Analysis of Human Lateral Ventricles during the First Twenty-Four Months of Life	PLOS ONE			English	Article							BRAIN-DEVELOPMENT; PRETERM INFANTS; CHILDREN; MRI; VOLUME; SCHIZOPHRENIA; SEGMENTATION; REGISTRATION; ENLARGEMENT; ASYMMETRY	Background: Little is known about the temporospatial shape characteristics of human lateral ventricles (LVs) during the first two years of life. This study aimed to delineate the morphological growth characteristics of LVs during early infancy using longitudinally acquired MR images in normal healthy infants. Methods: 24 healthy infants were MR imaged starting from 2 weeks old every 3 months during the first and every 6 months during the second year. Bilateral LVs were segmented and longitudinal morphological and shape analysis were conducted using longitudinal mixed effect models. Results: A significant bilateral ventricular volume increase (p<0.0001) is observed in year one (Left: 126 +/- 51% and Right: 145 +/- 62%), followed by a significant reduction (p<0.02) during the second year of life (Left: -24 +/- 27% and Right: -20 +/- 18%) despite the continuing increase of intracranial volume. Morphological analysis reveals that the ventricular growth is spatially non-uniform, and that the most significant growth occurs during the first 6 months. The first 3 months of life exhibit a significant (p<0.01) bilateral lengthening of the anterior lateral ventricle and a significant increase of radius (p<0.01) and area (p<0.01) at the posterior portion of the ventricle. Shape analysis shows that the horns exhibit a faster growth rate than the mid-body. Finally, bilateral significant age effects (p<0.01) are observed for the growth of LVs whereas gender effects are more subtle and significant effects (p<0.01) only present at the left anterior and posterior horns. More importantly, both the age and gender effects are growth directionally dependent. Conclusions: We have demonstrated the temporospatial shape growth characteristics of human LVs during the first two years of life using a unique longitudinal MR data set. A temporally and spatially non-uniform growth pattern was reported. These normative results could provide invaluable information to discern abnormal growth patterns in patients with neurodevelopmental disorders.	[Bompard, Lucile; Gao, Wei; Shen, Dinggang; Zhu, Hongtu; Lin, Weili] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC 27599 USA; [Xu, Shun; Styner, Martin; Paniagua, Beatriz] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC USA; [Styner, Martin; Paniagua, Beatriz] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Ahn, Mihye; Zhu, Hongtu] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Yuan, Ying] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Jewells, Valerie; Gao, Wei; Shen, Dinggang; Lin, Weili] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; St Jude Children's Research Hospital; University of North Carolina; University of North Carolina Chapel Hill	Lin, WL (corresponding author), Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC 27599 USA.	weili_lin@med.unc.edu	Shen, Dinggang/ABF-6812-2020; Styner, Martin/AAS-9949-2020	Shen, Dinggang/0000-0002-7934-5698; Styner, Martin/0000-0002-8747-5118; Jewells, Valerie/0000-0002-2844-3263; Ahn, Mihye/0000-0002-0388-7036	National Institutes of Health (NIH) [R01NS055754, RR025747-01, P01CA142538-01, MH086633, EB005149-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079124] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA142538] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009634, U54EB005149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100217, R01MH086633, P50MH064065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042599] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by grants from the National Institutes of Health (NIH): R01NS055754, RR025747-01, P01CA142538-01, MH086633 and EB005149-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron R, 1997, OBSTET GYNECOL, V89, P233, DOI 10.1016/S0029-7844(96)00506-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bookstein F L, 1997, Med Image Anal, V1, P225; Bouix S, 2005, NEUROIMAGE, V25, P1077, DOI 10.1016/j.neuroimage.2004.12.051; BRECHBUHLER C, 1995, COMPUT VIS IMAGE UND, V61, P154, DOI 10.1006/cviu.1995.1013; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Davies RH, 2002, IEEE T MED IMAGING, V21, P525, DOI 10.1109/TMI.2002.1009388; Davis BC, 2010, INT J COMPUT VISION, V90, P255, DOI 10.1007/s11263-010-0367-1; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Fletcher PT, 2004, IEEE T MED IMAGING, V23, P995, DOI 10.1109/TMI.2004.831793; Frangou S, 1997, AM J PSYCHIAT, V154, P1424; Gao W, 2009, P NATL ACAD SCI USA, V106, P6790, DOI 10.1073/pnas.0811221106; Gilmore JH, 2010, AM J PSYCHIAT, V167, P1083, DOI 10.1176/appi.ajp.2010.09101492; Gilmore JH, 2008, BIOL PSYCHIAT, V64, P1069, DOI 10.1016/j.biopsych.2008.07.031; Hazlett HC, 2005, ARCH GEN PSYCHIAT, V62, P1366, DOI 10.1001/archpsyc.62.12.1366; Hazlett HC, 2012, AM J PSYCHIAT, V169, P601, DOI 10.1176/appi.ajp.2012.11091425; Ichihashi K, 2002, EARLY HUM DEV, V68, P55; Kelemen A, 1998, 3 DIMENSIONAL MODEL, P87; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lawrie SM, 1998, BRIT J PSYCHIAT, V172, P110, DOI 10.1192/bjp.172.2.110; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; LEVENE MI, 1981, ARCH DIS CHILD, V56, P900, DOI 10.1136/adc.56.12.900; Lyall AE, 2012, EARLY HUM DEV, V88, P691, DOI 10.1016/j.earlhumdev.2012.02.003; Munsell BC, 2008, IEEE T PATTERN ANAL, V30, P2023, DOI 10.1109/TPAMI.2007.70841; Paniagua B, 2013, P SOC PHOTO-OPT INST, V8672; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; PIVEN J, 1995, AM J PSYCHIAT, V152, P1145; Pizer SM, 1999, IEEE T MED IMAGING, V18, P851, DOI 10.1109/42.811263; Prassopoulos P, 1996, J CHILD NEUROL, V11, P197, DOI 10.1177/088307389601100306; REISS AL, 1995, NAT GENET, V11, P331, DOI 10.1038/ng1195-331; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Resnick SM, 2000, CEREB CORTEX, V10, P464, DOI 10.1093/cercor/10.5.464; SALIBA E, 1990, ARCH DIS CHILD-FETAL, V65, P1029, DOI 10.1136/adc.65.10_Spec_No.1029; SHAH P S, 1992, Indian Pediatrics, V29, P439; Shattuck DW, 2001, IEEE T MED IMAGING, V20, P1167, DOI 10.1109/42.963819; Shi F, 2010, NEUROIMAGE, V49, P391, DOI 10.1016/j.neuroimage.2009.07.066; Shun Xu, 2008, 2008 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P1, DOI 10.1109/CVPRW.2008.4563011; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Styner M, 2005, P NATL ACAD SCI USA, V102, P4872, DOI 10.1073/pnas.0501117102; Styner Martin, 2006, Insight J, P242; Styner M, 2007, I S BIOMED IMAGING, P1192, DOI 10.1109/ISBI.2007.357071; Team RC, 2013, R LANG ENV STAT COMP; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Wu GR, 2010, LECT NOTES COMPUT SC, V6362, P618; Yuan Ying, 2013, Inf Process Med Imaging, V23, P220, DOI 10.1007/978-3-642-38868-2_19; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; ZIPURSKY RB, 1990, PSYCHIAT RES-NEUROIM, V35, P71, DOI 10.1016/0925-4927(90)90010-4	51	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108306	10.1371/journal.pone.0108306	http://dx.doi.org/10.1371/journal.pone.0108306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265017	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400064
J	Grovenburg, TW; Monteith, KL; Jacques, CN; Klaver, RW; DePerno, CS; Brinkman, TJ; Monteith, KB; Gilbert, SL; Smith, JB; Bleich, VC; Swanson, CC; Jenks, JA				Grovenburg, Troy W.; Monteith, Kevin L.; Jacques, Christopher N.; Klaver, Robert W.; DePerno, Christopher S.; Brinkman, Todd J.; Monteith, Kyle B.; Gilbert, Sophie L.; Smith, Joshua B.; Bleich, Vernon C.; Swanson, Christopher C.; Jenks, Jonathan A.			Re-Evaluating Neonatal-Age Models for Ungulates: Does Model Choice Affect Survival Estimates?	PLOS ONE			English	Article							WHITE-TAILED DEER; CAUSE-SPECIFIC MORTALITY; VAGINAL-IMPLANT TRANSMITTERS; MULE DEER; POPULATION-DYNAMICS; TEMPORAL VARIATION; CALF SURVIVAL; DOE BEHAVIOR; FAWNS; CAPTURE	New-hoof growth is regarded as the most reliable metric for predicting age of newborn ungulates, but variation in estimated age among hoof-growth equations that have been developed may affect estimates of survival in staggered-entry models. We used known-age newborns to evaluate variation in age estimates among existing hoof-growth equations and to determine the consequences of that variation on survival estimates. During 2001-2009, we captured and radiocollared 174 newborn (<= 24-hrs old) ungulates: 76 white-tailed deer (Odocoileus virginianus) in Minnesota and South Dakota, 61 mule deer (O. hemionus) in California, and 37 pronghorn (Antilocapra americana) in South Dakota. Estimated age of known-age newborns differed among hoof-growth models and varied by >15 days for white-tailed deer, >20 days for mule deer, and >10 days for pronghorn. Accuracy (i.e., the proportion of neonates assigned to the correct age) in aging newborns using published equations ranged from 0.0% to 39.4% in white-tailed deer, 0.0% to 3.3% in mule deer, and was 0.0% for pronghorns. Results of survival modeling indicated that variability in estimates of age-at-capture affected short-term estimates of survival (i.e., 30 days) for white-tailed deer and mule deer, and survival estimates over a longer time frame (i.e., 120 days) for mule deer. Conversely, survival estimates for pronghorn were not affected by estimates of age. Our analyses indicate that modeling survival in daily intervals is too fine a temporal scale when age-at-capture is unknown given the potential inaccuracies among equations used to estimate age of neonates. Instead, weekly survival intervals are more appropriate because most models accurately predicted ages within 1 week of the known age. Variation among results of neonatal-age models on short-and long-term estimates of survival for known-age young emphasizes the importance of selecting an appropriate hoof-growth equation and appropriately defining intervals (i.e., weekly versus daily) for estimating survival.	[Grovenburg, Troy W.; Monteith, Kyle B.; Smith, Joshua B.; Jenks, Jonathan A.] S Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA; [Monteith, Kevin L.] Univ Wyoming, Dept Zool & Physiol, Wyoming Cooperat Fish & Wildlife Res Unit, Laramie, WY 82071 USA; [Jacques, Christopher N.] Western Illinois Univ, Dept Biol Sci, Macomb, IL 61455 USA; [Klaver, Robert W.] Iowa State Univ, Dept Nat Resource Ecol & Management, Iowa Cooperat Fish & Wildlife Res Unit, US Geol Survey, Ames, IA USA; [DePerno, Christopher S.] N Carolina State Univ, Dept Forestry & Environm Resources Fisheries Wild, Raleigh, NC 27695 USA; [Brinkman, Todd J.; Gilbert, Sophie L.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Brinkman, Todd J.; Gilbert, Sophie L.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK USA; [Bleich, Vernon C.] Calif Dept Fish & Game, Sierra Nevada Bighorn Sheep Recovery Program, Bishop, CA USA; [Swanson, Christopher C.] US Fish & Wildlife Serv, Kulm, ND USA	South Dakota State University; University of Wyoming; Western Illinois University; Iowa State University; United States Department of the Interior; United States Geological Survey; University of North Carolina; North Carolina State University; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; United States Department of the Interior; US Fish & Wildlife Service	Grovenburg, TW (corresponding author), S Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA.	troy.grovenburg@sdstate.edu	Grovenburg, Troy/K-3346-2012; Jenks, Jonathan A/B-7321-2009	Gilbert, Sophie/0000-0002-9974-5146	Federal Aid [W-75-R-145, 7530, 75103, 7510]; Minnesota Department of Natural Resources; Alaska Department of Fish and Game through the Alaska Cooperative Fish and Wildlife Research Unit; California Department of Fish and Game Deer Herd Management Plan Implementation Program; South Dakota State University; Idaho State University; U.S. Forest Service; National Science Foundation; Bend of the River Chapter of Minnesota Deer Hunters Association; Bluffland Whitetails Association; Cottonwood County Game and Fish League; Des Moines Valley Chapter of Minnesota Deer Hunters Association; Minnesota Bowhunters, Inc.; Minnesota Deer Hunters Association; Minnesota State Archery Association I; North Country Bowhunters Chapter of Safari Club International; Rum River Chapter of Minnesota Deer Hunters Association; South Metro Chapter of Minnesota Deer Hunters Association; Whitetail Institute of North America	Federal Aid; Minnesota Department of Natural Resources; Alaska Department of Fish and Game through the Alaska Cooperative Fish and Wildlife Research Unit; California Department of Fish and Game Deer Herd Management Plan Implementation Program; South Dakota State University; Idaho State University; U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service); National Science Foundation(National Science Foundation (NSF)); Bend of the River Chapter of Minnesota Deer Hunters Association; Bluffland Whitetails Association; Cottonwood County Game and Fish League; Des Moines Valley Chapter of Minnesota Deer Hunters Association; Minnesota Bowhunters, Inc.; Minnesota Deer Hunters Association; Minnesota State Archery Association I; North Country Bowhunters Chapter of Safari Club International; Rum River Chapter of Minnesota Deer Hunters Association; South Metro Chapter of Minnesota Deer Hunters Association; Whitetail Institute of North America	Funding for this study was provided by Federal Aid to Wildlife Restoration (Project W-75-R-145, nos. 7530, 75103, and 7510) administered by South Dakota Department of Game, Fish, and Parks, the Minnesota Department of Natural Resources, the Alaska Department of Fish and Game through the Alaska Cooperative Fish and Wildlife Research Unit, and the California Department of Fish and Game Deer Herd Management Plan Implementation Program. Funding also was provided by South Dakota State University, Idaho State University, the U.S. Forest Service, the National Science Foundation, Bend of the River Chapter of Minnesota Deer Hunters Association, Bluffland Whitetails Association, Cottonwood County Game and Fish League, Des Moines Valley Chapter of Minnesota Deer Hunters Association, Minnesota Bowhunters, Inc., Minnesota Deer Hunters Association, Minnesota State Archery Association I, North Country Bowhunters Chapter of Safari Club International, Rum River Chapter of Minnesota Deer Hunters Association, South Metro Chapter of Minnesota Deer Hunters Association, and Whitetail Institute of North America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert D. A, 1995, NC179 USDA FOR SERV; Barber-Meyer SM, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-004; BERGER J, 1992, ECOLOGY, V73, P323, DOI 10.2307/1938743; Bishop CJ, 2007, J WILDLIFE MANAGE, V71, P945, DOI 10.2193/2006-123; Bleich VC, 2006, CALIF FISH GAME, V92, P24; Brinkman TJ, 2004, WILDLIFE SOC B, V32, P726, DOI 10.2193/0091-7648(2004)032[0726:SOWDIA]2.0.CO;2; Brinkman TJ, 2002, WILDLIFE SOC B, V30, P258; Brinkman Todd J., 2004, Prairie Naturalist, V36, P75; Bryce SA., 1996, ECOREGIONS N DAKOTA; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Byers J.A., 1997, AM PRONGHORN SOCIAL; Carstensen M, 2003, WILDLIFE SOC B, V31, P634; Carstensen M, 2009, J WILDLIFE MANAGE, V73, P175, DOI 10.2193/2006-107; Clements MN, 2011, FUNCT ECOL, V25, P691, DOI 10.1111/j.1365-2435.2010.01812.x; Cooch E. G., 2014, PROGRAM MARK GENTLE; DelGiudice GD, 2002, J WILDLIFE MANAGE, V66, P698, DOI 10.2307/3803136; DelGiudice GD, 2007, J MAMMAL, V88, P427, DOI 10.1644/06-MAMM-A-164R.1; DOWNING RL, 1969, J WILDLIFE MANAGE, V33, P711, DOI 10.2307/3799399; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; GAVIN TA, 1984, WILDLIFE MONOGR, P5; Grovenburg TW, 2014, WILDLIFE SOC B, V38, P89, DOI 10.1002/wsb.366; Grovenburg TW, 2012, J WILDLIFE MANAGE, V76, P944, DOI 10.1002/jwmg.339; Grovenburg TW, 2012, J WILDLIFE MANAGE, V76, P632, DOI 10.1002/jwmg.288; Grovenburg TW, 2011, J WILDLIFE MANAGE, V75, P213, DOI 10.1002/jwmg.20; Grovenburg TW, 2010, J WILDLIFE MANAGE, V74, P1250, DOI 10.2193/2009-399; Harris NC, 2008, J WILDLIFE MANAGE, V72, P1143, DOI 10.2193/2007-277; Haskell SP, 2007, J MAMMAL, V88, P1482, DOI 10.1644/07-MAMM-A-004R.1; HAUGEN AO, 1950, J WILDLIFE MANAGE, V14, P290, DOI 10.2307/3796148; HAUGEN ARNOLD O., 1959, JOUR MAMMAL, V40, P108, DOI 10.2307/1376121; HAUGEN ARNOLD O., 1958, JOUR WILDLIFE MANAGEMENT, V22, P319, DOI 10.2307/3796471; HUEGEL CN, 1985, WILDLIFE SOC B, V13, P287; Hurley MA, 2011, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.4; JACOBSEN NK, 1979, J MAMMAL, V60, P343, DOI 10.2307/1379806; Jacques C. N., 2007, PRAIRIE NATURALIST, V36, P251; Jacques CN, 2007, J WILDLIFE MANAGE, V71, P737, DOI 10.2193/2005-685; Jacques CN, 2009, J WILDLIFE MANAGE, V73, P1282, DOI 10.2193/2009-039; Johnson W. F., 1988, SOIL SURVEY HARDING; Kalvels J., 1982, SOIL SURVEY FALL RIV; Keech MA, 2000, J WILDLIFE MANAGE, V64, P450, DOI 10.2307/3803243; KUNKEL KE, 1994, CAN J ZOOL, V72, P1557, DOI 10.1139/z94-207; Larson G.E., 1999, GRASSLAND PLANTS S D; Lomas LA, 2007, J WILDLIFE MANAGE, V71, P884, DOI 10.2193/2006-203; Long RA, 2009, WILDLIFE BIOL, V15, P288, DOI 10.2981/09-003; MECH LD, 1985, J WILDLIFE DIS, V21, P405, DOI 10.7589/0090-3558-21.4.405; Monteith KL, 2007, J WILDLIFE MANAGE, V71, P1712, DOI 10.2193/2005-763; Monteith KL, 2014, WILDLIFE MONOGR, V186, P1, DOI 10.1002/wmon.1011; Monteith KL, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00096.1; NELSON TA, 1987, J WILDLIFE MANAGE, V51, P326, DOI 10.2307/3801010; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P7, DOI 10.2307/3801296; Porath W. R., 1980, WHITE TAILED DEER PO, P55; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; Raithel JD, 2007, J WILDLIFE MANAGE, V71, P795, DOI 10.2193/2005-608; ROBINETTE WL, 1973, J WILDLIFE MANAGE, V37, P312, DOI 10.2307/3800121; Rohm JH, 2007, J WILDLIFE MANAGE, V71, P851, DOI 10.2193/2006-027; Sams MG, 1996, WILDLIFE SOC B, V24, P53; SAS Institute Inc, 2011, BAS SAS UT REF; SAUER JR, 1989, WILDLIFE SOC B, V17, P549; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smith JB, 2014, WILDLIFE SOC B, V38, P165, DOI 10.1002/wsb.360; Stephenson TR, 1995, ALCES N AM, V31, P167; Swanson CC, 2008, WILDLIFE BIOL, V14, P272, DOI 10.2981/0909-6396(2008)14[272:DTUOVT]2.0.CO;2; Testa JW, 2002, J MAMMAL, V83, P699, DOI 10.1644/1545-1542(2002)083<0699:DPONIS>2.0.CO;2; Tucker RD, 1980, P ANN C W ASS FISH W, V60, P620; Verme LJ, 1962, P NATL DEER DISEASE, P15; Verme LJ, 1984, WHITE TAILED DEER EC; VERME LOUIS J., 1965, J WILDLIFE MANAGE, V29, P74, DOI 10.2307/3798633; Westin F. C., 1959, SOIL SURVEY; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WHITE M, 1972, J WILDLIFE MANAGE, V36, P897, DOI 10.2307/3799446; Whitlaw HA, 1998, J WILDLIFE MANAGE, V62, P1335, DOI 10.2307/3801999; Winterstein SR, 2001, RADIO TRACKING ANIMA, P352	71	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108797	10.1371/journal.pone.0108797	http://dx.doi.org/10.1371/journal.pone.0108797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264612	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400124
J	Haanes, KA; Edvinsson, L				Haanes, Kristian Agmund; Edvinsson, Lars			Expression and Characterization of Purinergic Receptors in Rat Middle Meningeal Artery-Potential Role in Migraine	PLOS ONE			English	Article							GAMMA-S DISCRIMINATE; UDP-BETA-S; P2 RECEPTORS; MOLECULAR-MECHANISMS; CAFFEINE; MEDIATORS; ADENOSINE; RESPONSES; NEURONS; BRAIN	The dura mater and its vasculature have for decades been central in the hypothesis of migraine and headache pathophysiology. Although recent studies have questioned the role of the vasculature as the primary cause, dural vessel physiology is still relevant in understanding the complex pathophysiology of migraine. The aim of the present study was to isolate the middle meningeal artery (MMA) from rodents and characterize their purinergic receptors using a sensitive wire myograph method and RT-PCR. The data presented herein suggest that blood flow through the MMA is, at least in part, regulated by purinergic receptors. P2X1 and P2Y6 receptors are the strongest contractile receptors and, surprisingly, ADP beta S caused contraction most likely via P2Y1 or P2Y13 receptors, which is not observed in other arteries. Adenosine addition, however, caused relaxation of the MMA. The adenosine relaxation could be inhibited by SCH58261 (A2A receptor antagonist) and caffeine (adenosine receptor antagonist). This gives one putative molecular mechanism for the effect of caffeine, often used as an adjuvant remedy of cranial pain. Semi-quantitative RT-PCR expression data for the receptors correlate well with the functional findings. Together these observations could be used as targets for future understanding of the in vivo role of purinergic receptors in the MMA.	[Haanes, Kristian Agmund; Edvinsson, Lars] Copenhagen Univ Hosp, Dept Clin Expt Res, Glostrup, Denmark	University of Copenhagen	Haanes, KA (corresponding author), Copenhagen Univ Hosp, Dept Clin Expt Res, Glostrup, Denmark.	kristian.agmund.haanes@regionh.dk	Haanes, Kristian Agmund/I-5881-2013	Haanes, Kristian Agmund/0000-0001-5182-8957; Edvinsson, Lars/0000-0002-1805-1346	Lundbeck Foundation	Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation, Lundbeck Grant of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Alsaqati M, 2013, BRIT J PHARMACOL, V171, P701; Amin FM, 2013, LANCET NEUROL, V12, P454, DOI 10.1016/S1474-4422(13)70067-X; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; BURNSTOCK G, 1985, GEN PHARMACOL, V16, P433, DOI 10.1016/0306-3623(85)90001-1; Communi D, 2001, J BIOL CHEM, V276, P41479, DOI 10.1074/jbc.M105912200; Compan V, 2012, J NEUROSCI, V32, P4284, DOI 10.1523/JNEUROSCI.6332-11.2012; DENARO CP, 1990, CLIN PHARMACOL THER, V48, P277, DOI 10.1038/clpt.1990.150; Derry CJ, 2012, COCHRANE DB SYST REV, V3; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Fricks IP, 2009, J PHARMACOL EXP THER, V330, P162, DOI 10.1124/jpet.109.150730; Giniatullin R, 2008, MOL NEUROBIOL, V37, P83, DOI 10.1007/s12035-008-8020-5; GRAHAM TE, 1995, J APPL PHYSIOL, V78, P867, DOI 10.1152/jappl.1995.78.3.867; Gupta S, 2011, HEADACHE, V51, P1029, DOI 10.1111/j.1526-4610.2011.01929.x; Haanes KA, 2014, FEBS LETT IN PRESS; Hullugundi SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060677; HUMPHREY PPA, 1990, ANN NY ACAD SCI, V600, P587, DOI 10.1111/j.1749-6632.1990.tb16912.x; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Le KT, 1997, FEBS LETT, V418, P195, DOI 10.1016/S0014-5793(97)01380-X; Maassen VanDenBrink A, 2013, LANCET NEUROL, V12, P847; Malmsjo M, 2000, BRIT J PHARMACOL, V131, P51, DOI 10.1038/sj.bjp.0703536; Malmsjo M, 2003, EUR J PHARMACOL, V458, P305, DOI 10.1016/S0014-2999(02)02787-5; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Rahmann A, 2008, CEPHALALGIA, V28, P226, DOI 10.1111/j.1468-2982.2007.01497.x; Ray BS, 1940, ARCH SURG-CHICAGO, V41, P813, DOI 10.1001/archsurg.1940.01210040002001; Ribeiro JA, 2010, J ALZHEIMERS DIS, V20, pS3, DOI 10.3233/JAD-2010-1379; Schytz HW, 2010, DAN MED BULL, V57; Shapiro RE, 2007, NEUROL SCI, V28, pS179, DOI 10.1007/s10072-007-0773-5; Staikopoulos V, 2007, NEUROSCIENCE, V144, P208, DOI 10.1016/j.neuroscience.2006.09.035; Tawfik HE, 2005, AM J PHYSIOL-HEART C, V288, pH1411, DOI 10.1152/ajpheart.00684.2004; Waldo GL, 2004, MOL PHARMACOL, V65, P426, DOI 10.1124/mol.65.2.426; Wang LW, 2002, J CARDIOVASC PHARM, V40, P841, DOI 10.1097/00005344-200212000-00005; Zocchi C, 1996, J PHARMACOL EXP THER, V276, P398	35	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108782	10.1371/journal.pone.0108782	http://dx.doi.org/10.1371/journal.pone.0108782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265286	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400120
J	Rose, SJ; Neville, ME; Gupta, R; Bermudez, LE				Rose, Sasha J.; Neville, Mary E.; Gupta, Renu; Bermudez, Luiz E.			Delivery of Aerosolized Liposomal Amikacin as a Novel Approach for the Treatment of Nontuberculous Mycobacteria in an Experimental Model of Pulmonary Infection	PLOS ONE			English	Article							AVIUM COMPLEX INFECTION; MOUSE MODEL; GUINEA-PIG; ABSCESSUS; TUBERCULOSIS; MICE; AMINOGLYCOSIDES; CAPREOMYCIN; RESISTANCE; EFFICACY	Pulmonary infections caused by nontuberculous mycobacteria (NTM) are an increasing problem in individuals with chronic lung conditions and current therapies are lacking. We investigated the activity of liposomal amikacin for inhalation (LAI) against NTM in vitro as well as in a murine model of respiratory infection. Macrophage monolayers were infected with three strains of Mycobacterium avium, two strains of Mycobacterium abscessus, and exposed to LAI or free amikacin for 4 days before enumerating bacterial survival. Respiratory infection was established in mice by intranasal inoculation with M. avium and allowing three weeks for the infection to progress. Three different regimens of inhaled LAI were compared to inhaled saline and parenterally administered free amikacin over a 28 day period. Bacteria recovered from the mice were analyzed for acquired resistance to amikacin. In vitro, liposomal amikacin for inhalation was more effective than free amikacin in eliminating both intracellular M. avium and M. abscessus. In vivo, inhaled LAI demonstrated similar effectiveness to a similar to 25% higher total dose of parenterally administered amikacin at reducing M. avium in the lungs when compared to inhaled saline. Additionally, there was no acquired resistance to amikacin observed after the treatment regimen. The data suggest that LAI has the potential to be an effective therapy against NTM respiratory infections in humans.	[Rose, Sasha J.; Bermudez, Luiz E.] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA; [Rose, Sasha J.; Bermudez, Luiz E.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Neville, Mary E.; Gupta, Renu] Insmed Inc, Monmouth Jct, NJ USA	Oregon State University; Oregon State University	Bermudez, LE (corresponding author), Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA.	Luiz.Bermudez@oregonstate.edu			Insmed	Insmed	This study was funded by Insmed. Co-authors MEN and RG are employed by Insmed. The funder provided support in the form of salaries for authors MEN and RG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bermudez LE, 2001, ANTIMICROB AGENTS CH, V45, P2210, DOI 10.1128/AAC.45.8.2210-2214.2001; BERMUDEZ LE, 1990, J INFECT DIS, V161, P1262, DOI 10.1093/infdis/161.6.1262; Bermudez LE, 2008, J INFECT DIS, V197, P1506, DOI 10.1086/587906; Briones E, 2008, J CONTROL RELEASE, V125, P210, DOI 10.1016/j.jconrel.2007.10.027; Carter G, 2003, J MED MICROBIOL, V52, P747, DOI 10.1099/jmm.0.05224-0; Clancy JP, 2013, THORAX, V68, P818, DOI 10.1136/thoraxjnl-2012-202230; Dharmadhikari AS, 2013, ANTIMICROB AGENTS CH, V57, P2613, DOI 10.1128/AAC.02346-12; Garcia-Contreras L, 2007, ANTIMICROB AGENTS CH, V51, P2830, DOI 10.1128/AAC.01164-06; Garcia-Contreras L, 2006, J ANTIMICROB CHEMOTH, V58, P980, DOI 10.1093/jac/dkl369; Gonzalez-Juarrero M, 2012, ANTIMICROB AGENTS CH, V56, P3957, DOI 10.1128/AAC.00464-12; Greendyke R, 2008, ANTIMICROB AGENTS CH, V52, P2019, DOI 10.1128/AAC.00986-07; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Griffith DE, 2011, CLIN INFECT DIS, V52, P572, DOI 10.1093/cid/ciq252; HORSBURGH CR, 1991, NEW ENGL J MED, V324, P1332, DOI 10.1056/NEJM199105093241906; ISEMAN MD, 1989, NEW ENGL J MED, V321, P896, DOI 10.1056/NEJM198909283211310; Johnson MM, 2014, J THORAC DIS, V6, P210, DOI 10.3978/j.issn.2072-1439.2013.12.24; KILBY JM, 1992, CHEST, V102, P70, DOI 10.1378/chest.102.1.70; Laugero KD, 2000, AM J PHYSIOL-ENDOC M, V279, pE33, DOI 10.1152/ajpendo.2000.279.1.E33; Luedtke NW, 2003, J AM CHEM SOC, V125, P12374, DOI 10.1021/ja0360135; Meers P, 2008, J ANTIMICROB CHEMOTH, V61, P859, DOI 10.1093/jac/dkn059; Nash KA, 2009, ANTIMICROB AGENTS CH, V53, P1367, DOI 10.1128/AAC.01275-08; Teng SH, 2013, J CLIN MICROBIOL, V51, P3113, DOI 10.1128/JCM.01239-13; WOLFF RK, 1993, CRIT REV TOXICOL, V23, P343, DOI 10.3109/10408449309104076; Yamazaki Y, 2006, CELL MICROBIOL, V8, P806, DOI 10.1111/j.1462-5822.2005.00667.x	24	56	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108703	10.1371/journal.pone.0108703	http://dx.doi.org/10.1371/journal.pone.0108703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264757	Green Submitted, gold, Green Published			2022-12-27	WOS:000345745400107
J	Sandoval, IM; Price, BA; Gross, AK; Chan, F; Sammons, JD; Wilson, JH; Wensel, TG				Sandoval, Ivette M.; Price, Brandee A.; Gross, Alecia K.; Chan, Fung; Sammons, Joshua D.; Wilson, John H.; Wensel, Theodore G.			Abrupt Onset of Mutations in a Developmentally Regulated Gene during Terminal Differentiation of Post-Mitotic Photoreceptor Neurons in Mice	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; DNA-REPAIR; RHODOPSIN GENE; MOUSE RETINA; RAT RETINA; TRANSCRIPTION; GENOME; EXPRESSION; YEAST; NEURODEGENERATION	For sensitive detection of rare gene repair events in terminally differentiated photoreceptors, we generated a knockin mouse model by replacing one mouse rhodopsin allele with a form of the human rhodopsin gene that causes a severe, early-onset form of retinitis pigmentosa. The human gene contains a premature stop codon at position 344 (Q344X), cDNA encoding the enhanced green fluorescent protein (EGFP) at its 3' end, and a modified 59 untranslated region to reduce translation rate so that the mutant protein does not induce retinal degeneration. Mutations that eliminate the stop codon express a human rhodopsin-EGFP fusion protein (hRho-GFP), which can be readily detected by fluorescence microscopy. Spontaneous mutations were observed at a frequency of about one per retina; in every case, they gave rise to single fluorescent rod cells, indicating that each mutation occurred during or after the last mitotic division. Additionally, the number of fluorescent rods did not increase with age, suggesting that the rhodopsin gene in mature rod cells is less sensitive to mutation than it is in developing rods. Thus, there is a brief developmental window, coinciding with the transcriptional activation of the rhodopsin locus, in which somatic mutations of the rhodopsin gene abruptly begin to appear.	[Sandoval, Ivette M.; Chan, Fung; Wilson, John H.; Wensel, Theodore G.] Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Price, Brandee A.; Wilson, John H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gross, Alecia K.; Sammons, Joshua D.] Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL USA	Baylor College of Medicine; University of Alabama System; University of Alabama Birmingham	Wensel, TG (corresponding author), Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	twensel@bcm.edu	Gross, Alecia K./AAJ-1792-2021	Gross, Alecia K./0000-0003-1857-6633; Wensel, Theodore/0000-0003-3518-9352	National Eye Institute, National Institutes of Health [R01-EY011731, R01-EY007981, R01-EY019311, P30-EY002520, T32-EY007102]; National Institute of General Medical Sciences, National Institutes of Health [R25-GM56929]; Robert A. Welch Foundation [Q0035]; NATIONAL EYE INSTITUTE [R01EY019311, P30EY002520, R01EY007981, T32EY007102, R01EY011731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by the National Eye Institute, National Institutes of Health www.nei.nih.gov Grants R01-EY011731 to JHW, R01-EY007981 to TGW, R01-EY019311 to AKG, P30-EY002520 core grant for vision research, training grant T32-EY007102 to BAP; National Institute of General Medical Sciences, National Institutes of Health www.nigms.nih.gov Training grant R25-GM56929 to IMS; Robert A. Welch Foundation wwww.welch1.org Grant: Q0035 to TGW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Borgesius NZ, 2011, J NEUROSCI, V31, P12543, DOI 10.1523/JNEUROSCI.1589-11.2011; Chan F, 2004, P NATL ACAD SCI USA, V101, P9109, DOI 10.1073/pnas.0403149101; Chan F, 2011, NUCLEIC ACIDS RES, V39, P5955, DOI 10.1093/nar/gkr196; DATTA A, 1995, SCIENCE, V268, P1616, DOI 10.1126/science.7777859; Deretic D, 1998, P NATL ACAD SCI USA, V95, P10620, DOI 10.1073/pnas.95.18.10620; Gilliam JC, 2012, CELL, V151, P1029, DOI 10.1016/j.cell.2012.10.038; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Gross AK, 2006, VISION RES, V46, P4510, DOI 10.1016/j.visres.2006.07.012; Hill KA, 1999, MUTAT RES-REV MUTAT, V436, P11, DOI 10.1016/S1383-5742(98)00024-6; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; HUBBARD R, 1958, P NATL ACAD SCI USA, V44, P130, DOI 10.1073/pnas.44.2.130; JACOBSON SG, 1994, INVEST OPHTH VIS SCI, V35, P2521; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kim N, 2007, DNA REPAIR, V6, P1285, DOI 10.1016/j.dnarep.2007.02.023; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; LEE AT, 1994, FASEB J, V8, P545, DOI 10.1096/fasebj.8.8.8181674; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Majewski J, 2003, AM J HUM GENET, V73, P688, DOI 10.1086/378134; Mollersen L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001242; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; Nouspikel T, 2000, MOL CELL BIOL, V20, P1562, DOI 10.1128/MCB.20.5.1562-1570.2000; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Palpant NJ, 2012, GENE THER; Price BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049889; Price BA, 2011, INVEST OPHTH VIS SCI, V52, P9728, DOI 10.1167/iovs.11-8654; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; Reimers JM, 2004, MICROBIOL-SGM, V150, P1457, DOI 10.1099/mic.0.26954-0; Rossmiller B, 2012, MOL VIS, V18, P2479; Rubin AF, 2009, P NATL ACAD SCI USA, V106, P21766, DOI 10.1073/pnas.0912499106; Sargent RG, 1997, MOL CELL BIOL, V17, P267, DOI 10.1128/MCB.17.1.267; Simonatto M, 2007, J CELL PHYSIOL, V213, P642, DOI 10.1002/jcp.21275; SUNG CH, 1994, J NEUROSCI, V14, P5818; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Wen XH, 2009, BIOPHYS J, V96, P939, DOI 10.1016/j.bpj.2008.10.016; Wensel TG, 2005, VISION RES, V45, P3445, DOI 10.1016/j.visres.2005.07.016; ZHANG LH, 1992, J MOL BIOL, V223, P627, DOI 10.1016/0022-2836(92)90979-T	41	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108135	10.1371/journal.pone.0108135	http://dx.doi.org/10.1371/journal.pone.0108135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264759	Green Submitted, Green Published, gold			2022-12-27	WOS:000345745400044
J	Xue, Q; Patterson, AJ; Xiao, DL; Zhang, LB				Xue, Qin; Patterson, Andrew J.; Xiao, Daliao; Zhang, Lubo			Glucocorticoid Modulates Angiotensin II Receptor Expression Patterns and Protects the Heart from Ischemia and Reperfusion Injury	PLOS ONE			English	Article							EPSILON GENE REPRESSION; ISOLATED RABBIT HEARTS; WORKING RAT HEARTS; KINASE C-EPSILON; NF-KAPPA-B; TYPE-2 RECEPTOR; CELL-DEATH; MECHANICAL FUNCTION; AT(2) RECEPTOR; AT(1)	Glucocorticoid regulates angiotensin II receptor (ATR) expression via activating glucocorticoid receptors and binding to glucocorticoid response elements. The regulation of ATR by glucocorticoids in the context of myocardial injury from ischemia/reperfusion (I/R) is yet to be elucidated. The present study determined the role of ATR in glucocorticoid-induced cardiac protection. Adult male rats were administered once a day i.p. 1 mg/kg/day dexamethasone or dexamethasone plus 10 mg/kg/day RU486 for 5 days. Hearts were then isolated and subjected to I/R injury in a Langendorff preparation. Dexamethasone treatment significantly decreased I/R injury and improved post-ischemic recovery of cardiac function. Dexamethasone increased glucocorticoid receptor binding to glucocorticoid response elements at AT(1a)R and AT(2)R promoters, resulting in a significant increase in expression of AT(1)R protein but a decrease in AT(2)R expression in the heart. In addition, dexamethasone treatment significantly increased PKC epsilon expression and p-PKC epsilon protein abundance. These dexamethasone-mediated effects were blocked by RU486. More importantly, blockade of AT(1)R and AT(2)R with losartan and PD123319 abrogated dexamethasone-induced protection of the heart from I/R injury. The results indicate that glucocorticoid promotes a cardioprotective phenotype associated with the upregulation of AT(1)R and PKC epsilon and downregulation of AT(2)R in the heart.	[Xue, Qin; Patterson, Andrew J.; Xiao, Daliao; Zhang, Lubo] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol,Div Pharmacol, Loma Linda, CA 92354 USA	Loma Linda University	Zhang, LB (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol,Div Pharmacol, Loma Linda, CA 92354 USA.	lzhang@llu.edu	Xiao, DaLiao/AAY-1800-2020	Xiao, DaLiao/0000-0003-0147-2758; Zhang, Lubo/0000-0002-9386-8938	National Institutes of Health [HL118861, HL082779, HL083966]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083966, R01HL118861, R01HL082779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants HL118861, HL082779 and HL083966. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano K, 1997, CIRCULATION, V95, P1193; Baxter GF, 2001, BASIC RES CARDIOL, V96, P329, DOI 10.1007/s003950170041; Billet S, 2008, KIDNEY INT, V74, P1379, DOI 10.1038/ki.2008.358; Bogdarina IG, 2009, J MOL ENDOCRINOL, V43, P73, DOI 10.1677/JME-09-0036; Booz GW, 2004, HYPERTENSION, V43, P1162, DOI 10.1161/01.HYP.0000128531.39964.c0; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chen QM, 2005, MOL PHARMACOL, V67, P1861, DOI 10.1124/mol.104.003814; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; Dasgupta C, 2011, DRUG DISCOV TODAY, V16, P22, DOI 10.1016/j.drudis.2010.11.016; Diaz RJ, 1997, J MOL CELL CARDIOL, V29, P129, DOI 10.1006/jmcc.1996.0258; Duma D, 2006, J STEROID BIOCHEM, V102, P11, DOI 10.1016/j.jsbmb.2006.09.009; Dumont A, 1998, TRENDS BIOCHEM SCI, V23, P233, DOI 10.1016/S0968-0004(98)01212-2; ENGELMAN RM, 1989, CIRCULATION, V80, P36; Fan WJ, 2009, LIFE SCI, V84, P838, DOI 10.1016/j.lfs.2009.03.014; Ford WR, 1998, AM J PHYSIOL-HEART C, V274, pH1524, DOI 10.1152/ajpheart.1998.274.5.H1524; Ford WR, 1996, CIRCULATION, V94, P3087, DOI 10.1161/01.CIR.94.12.3087; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; GUO DF, 1995, CIRC RES, V77, P249, DOI 10.1161/01.RES.77.2.249; Karnik SS, 2012, HYPERTENSION, V59, P542, DOI 10.1161/HYPERTENSIONAHA.111.189423; Kawamura S, 1998, AM J PHYSIOL-HEART C, V275, pH2266; LIU YG, 1995, J MOL CELL CARDIOL, V27, P883, DOI 10.1016/0022-2828(95)90038-1; Maddali KK, 2005, VASC PHARMACOL, V42, P153, DOI 10.1016/j.vph.2004.11.008; Matsubara H, 1998, CIRC RES, V83, P1182, DOI 10.1161/01.RES.83.12.1182; Meyer K, 2009, J MOL CELL CARDIOL, V47, P504, DOI 10.1016/j.yjmcc.2009.06.004; Nussinovitch U, 2010, CURR PHARM DESIGN, V16, P3574, DOI 10.2174/138161210793797870; Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259; Ping PP, 2002, J CLIN INVEST, V109, P499, DOI 10.1172/JCI200213200; Roy SG, 2009, CELL PHYSIOL BIOCHEM, V24, P1, DOI 10.1159/000227803; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Rush JWE, 2008, APPL PHYSIOL NUTR ME, V33, P162, DOI 10.1139/H07-147; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Segar JL, 1997, AM J PHYSIOL-REG I, V273, pR1501, DOI 10.1152/ajpregu.1997.273.4.R1501; Tokudome S, 2009, J CLIN INVEST, V119, P1477, DOI 10.1172/JCI37413; Tsutsumi Y, 1998, CIRC RES, V83, P1035, DOI 10.1161/01.RES.83.10.1035; Valen G, 2000, FREE RADICAL RES, V33, P31, DOI 10.1080/10715760000300591; Valen G, 2000, AM J PHYSIOL-HEART C, V279, pH836, DOI 10.1152/ajpheart.2000.279.2.H836; Varga E, 2004, LIFE SCI, V75, P2411, DOI 10.1016/j.lfs.2004.04.031; Xu Y, 2000, HYPERTENSION, V36, P506, DOI 10.1161/01.HYP.36.4.506; Xue Q, 2011, CARDIOVASC RES, V89, P300, DOI 10.1093/cvr/cvq303; Yamada T, 1996, P NATL ACAD SCI USA, V93, P156, DOI 10.1073/pnas.93.1.156; Yasuda N, 2012, HYPERTENSION, V59, P627, DOI 10.1161/HYPERTENSIONAHA.111.175208; Zhang MZ, 2006, P NATL ACAD SCI USA, V103, P16045, DOI 10.1073/pnas.0602176103; Zhao TC, 2001, CIRC RES, V89, P915, DOI 10.1161/hh2201.099452	44	29	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e106827	10.1371/journal.pone.0106827	http://dx.doi.org/10.1371/journal.pone.0106827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265380	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400013
J	Zhao, JS; Zhu, SM; Sun, LB; Meng, FZ; Zhao, L; Zhao, YS; Tian, H; Li, P; Niu, YJ				Zhao, Jinsheng; Zhu, Shimiao; Sun, Libin; Meng, Fanzheng; Zhao, Lin; Zhao, Yusheng; Tian, Hao; Li, Ping; Niu, Yuanjie			Androgen Deprivation Therapy for Prostate Cancer Is Associated with Cardiovascular Morbidity and Mortality: A Meta-Analysis of Population-Based Observational Studies	PLOS ONE			English	Article							CHOLESTEROL-FED RABBITS; CORONARY-HEART-DISEASE; ENDOGENOUS TESTOSTERONE; EUROPEAN ORGANIZATION; HORMONE AGONISTS; LOCAL TREATMENT; PCBASE SWEDEN; MEN; RISK; TRIAL	Background: There is no consensus regarding whether androgen deprivation therapy (ADT) is associated with cardiovascular disease (CVD) and cardiovascular mortality (CVM). The objective of this study was to determine the role of ADT for prostate cancer (PCa) in development of cardiovascular events (CVD and CVM). Methods and Findings: We performed a meta-analysis from population-based observational studies comparing ADT vs control aimed at treating PCa in patients with PCa, reporting either CVD or CVM as outcome. Publications were searched using Medline, Embase, Cochrane Library Central Register of observational studies database up to May 31th 2014, and supplementary searches in publications from potentially relevant journals. 6 studies were identified with a total of 129,802 ADT users and 165,605 controls investigating the relationship between ADT and CVD. The incidence of CVD was 10% higher in ADT groups, although no significant association was observed (HR = 1.10, 95% CIs: 1.00-1.21; P = 0.06). For different types of ADT, CVD was related with gonadotropin-releasing hormone (GnRH) (HR = 1.19, 95% CIs: 1.04-1.36; P<0.001) and GnRH plus oral antiandrogen (AA) (HR = 1.46, 95% CIs: 1.03-2.08; P = 0.04), but not with AA alone or orchiectomy. For CVM, 119,625 ADT users and 150,974 controls from 6 eligible studies were included, pooled results suggested that ADT was associated with CVM (HR = 1.17, 95% CIs: 1.04-1.32; P = 0.01). Significantly increased CVM was also detected in GnRH and GnRH plus AA groups. When patients received other treatments (e.g. prostatectomy and radiotherapy) were ruled out of consideration, more increased CVD (HR = 1.19, 95% CIs: 1.08-1.30; P<0.001) and CVM (HR = 1.30, 95% CIs: 1.13-1.50; P<0.001) were found in men treated with ADT monotherapy. Conclusions: ADT is associated with both CVD and CVM. Particularly, GnRH alone and GnRH plus AA can significantly increase the incidence of cardiovascular events in patients with PCa.	[Zhao, Jinsheng; Zhu, Shimiao; Sun, Libin; Zhao, Lin; Tian, Hao; Niu, Yuanjie] Tianjin Med Univ, Tianjin, Peoples R China; [Zhao, Jinsheng; Meng, Fanzheng] Tianjin Nankai Hosp, Dept Neurol, Tianjin, Peoples R China; [Zhao, Jinsheng; Zhu, Shimiao; Sun, Libin; Tian, Hao; Niu, Yuanjie] Tianjin Med Unvers, Hosp 2, Tianjin Inst Urol, Dept Urol, Tianjin, Peoples R China; [Zhao, Yusheng] Tianjin Univ, Teaching Hosp 1, TCM, Tianjin, Peoples R China; [Li, Ping] Tianjin Third Cent Hosp, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin University	Niu, YJ (corresponding author), Tianjin Med Univ, Tianjin, Peoples R China.	yuanjieniu68@hotmail.com			National Basic Research Program of China [2012CB518304]; International S&T Cooperation Program of China (ISTCP) [S2012GR0142]	National Basic Research Program of China(National Basic Research Program of China); International S&T Cooperation Program of China (ISTCP)	The work was supported by the National Basic Research Program of China (grant no. 2012CB518304) and the International S&T Cooperation Program of China (ISTCP) (grant no. S2012GR0142). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen P, 1999, CIRC RES, V84, P813; Alibhai SMH, 2009, J CLIN ONCOL, V27, P3452, DOI 10.1200/JCO.2008.20.0923; [Anonymous], 2014, CLIN INFECT DIS, V58, pi; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blankfield RP, 2012, JAMA-J AM MED ASSOC, V307, P1252, DOI 10.1001/jama.2012.352; Conteduca V, 2013, CRIT REV ONCOL HEMAT, V86, P42, DOI 10.1016/j.critrevonc.2012.09.008; Efstathiou JA, 2008, EUR UROL, V54, P816, DOI 10.1016/j.eururo.2008.01.021; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gandaglia G, 2014, BJU INT; GLUECK CJ, 1993, J LAB CLIN MED, V122, P412; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang G, 2014, J ONCOL, V2014, DOI 10.1155/2014/529468; Huggins C, 1972, CA Cancer J Clin, V22, P232, DOI 10.3322/canjclin.22.4.232; HUGGINS C, 1967, SCIENCE, V156, P1050, DOI 10.1126/science.156.3778.1050; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P280, DOI 10.1111/j.1365-2265.2005.02339.x; Jespersen CG, 2013, EUR UROL; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Keating NL, 2012, J NATL CANCER I, V104, P1518, DOI 10.1093/jnci/djs376; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Kim J, 2011, INT J RADIAT ONCOL, V80, P742, DOI 10.1016/j.ijrobp.2010.03.018; Langley RE, 2013, LANCET ONCOL, V14, P306, DOI 10.1016/S1470-2045(13)70025-1; LARSEN BA, 1993, ATHEROSCLEROSIS, V99, P79, DOI 10.1016/0021-9150(93)90053-W; Laughlin GA, 2008, J CLIN ENDOCR METAB, V93, P68, DOI 10.1210/jc.2007-1792; Liu DQ, 2013, WORLD J GASTROENTERO, V19, P4053, DOI 10.3748/wjg.v19.i25.4053; Martin-Merino E, 2011, DRUG SAFETY, V34, P1061, DOI 10.2165/11594540-000000000-00000; Merrick GS, 2006, INT J RADIAT ONCOL, V65, P669, DOI 10.1016/j.ijrobp.2006.01.030; Messing EM, 2006, LANCET ONCOL, V7, P472, DOI 10.1016/S1470-2045(06)70700-8; Nettleship JE, 2007, CIRCULATION, V116, P2427, DOI 10.1161/CIRCULATIONAHA.107.708768; Nguyen PL, 2011, JAMA-J AM MED ASSOC, V306, P2359, DOI 10.1001/jama.2011.1745; Phillips B, 2004, ARCH DIS CHILD, V89, P489, DOI 10.1136/adc.2004.050898; Punnen S, 2011, J CLIN ONCOL, V29, P3510, DOI 10.1200/JCO.2011.35.1494; Robinson D, 2012, INT J CANCER, V130, P478, DOI 10.1002/ijc.26022; Rosmond R, 1996, OBES RES, V4, P245, DOI 10.1002/j.1550-8528.1996.tb00542.x; Saigal CS, 2007, CANCER-AM CANCER SOC, V110, P1493, DOI 10.1002/cncr.22933; Saylor PJ, 2010, J NATL COMPR CANC NE, V8, P211, DOI 10.6004/jnccn.2010.0014; Schroder FH, 2009, EUR UROL, V55, P14, DOI 10.1016/j.eururo.2008.09.008; Schulz KF, 2006, LANCET HDB ESSENTIAL; Smith Matthew R, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P247, DOI 10.1097/MED.0b013e32814db88c; Studer UE, 2006, J CLIN ONCOL, V24, P1868, DOI 10.1200/JCO.2005.04.7423; Svartberg J, 2004, EUR J ENDOCRINOL, V150, P65, DOI 10.1530/eje.0.1500065; Traish AM, 2009, J ANDROL, V30, P477, DOI 10.2164/jandrol.108.007245; Tsai HK, 2007, J NATL CANCER I, V99, P1516, DOI 10.1093/jnci/djm168; Van Hemelrijck M, 2012, EUR UROL, V61, P690, DOI 10.1016/j.eururo.2011.09.010; Van Hemelrijck M, 2010, J CLIN ONCOL, V28, P3448, DOI 10.1200/JCO.2010.29.1567; Wells G.A., 2000, VIS COMMUN Q; Whitsel EA, 2001, AM J MED, V111, P261, DOI 10.1016/S0002-9343(01)00833-6; Zhu SM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-332	48	71	72	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107516	10.1371/journal.pone.0107516	http://dx.doi.org/10.1371/journal.pone.0107516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264674	Green Submitted, Green Published, gold			2022-12-27	WOS:000345745400025
J	Christianson, S; Voth, D; Wolfe, J; Sharma, MK				Christianson, Sara; Voth, Dylan; Wolfe, Joyce; Sharma, Meenu K.			Re-Evaluation of the Critical Concentration for Ethambutol Antimicrobial Sensitivity Testing on the MGIT 960	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SUSCEPTIBILITY; MUTATIONS; RESISTANCE; 1ST-LINE; STRAINS; DRUGS	The critical concentration (CC) for ethambutol testing on the Bactec MGIT 960 M. tuberculosis susceptibility testing has been questioned in recent publications. In this study, we correlate susceptibility results from the Bactec 460, MGIT 960 and embB gene sequencing to determine if the Bactec MGIT 960 adequately detects ethambutol resistance. We discovered discrepancies between the methods that highlight a need to re-evaluate ethambutol susceptibility testing recommendations, namely by considering lowering currently recommended CC on the MGIT 960. Further studies on the clinical significance of low-level ethambutol resistance are also required.	[Christianson, Sara; Wolfe, Joyce; Sharma, Meenu K.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Natl Reference Ctr Mycobacteriol, Winnipeg, MB, Canada; [Voth, Dylan; Sharma, Meenu K.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba	Christianson, S (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Natl Reference Ctr Mycobacteriol, Winnipeg, MB, Canada.	sara.christianson@phac-aspc.gc.ca	Sharma, Meenu/GWM-5030-2022; Sharma, Meenu/AAE-2536-2022	Sharma, Meenu/0000-0002-6020-9995				Banu S, 2014, J CLIN MICROBIOL, V52, P156, DOI 10.1128/JCM.02378-13; Bemer P, 2002, J CLIN MICROBIOL, V40, P150, DOI 10.1128/JCM.40.1.150-154.2002; Clinical and Laboratory Standards Institute, 2011, M24A2 CLSI; Gumbo T, 2010, ANTIMICROB AGENTS CH, V54, P1484, DOI 10.1128/AAC.01474-09; Kruuner A, 2006, J CLIN MICROBIOL, V44, P811, DOI 10.1128/JCM.44.3.811-818.2006; Plinke C, 2010, J ANTIMICROB CHEMOTH, V65, P1359, DOI 10.1093/jac/dkq120; Ramaswamy SV, 2000, ANTIMICROB AGENTS CH, V44, P326, DOI 10.1128/AAC.44.2.326-336.2000; Safi H, 2008, ANTIMICROB AGENTS CH, V52, P2027, DOI 10.1128/AAC.01486-07; Safi H, 2013, NAT GENET, V45, P1190, DOI 10.1038/ng.2743; Safi H, 2010, ANTIMICROB AGENTS CH, V54, P103, DOI 10.1128/AAC.01288-09; Sirgel FA, 2012, CHEMOTHERAPY, V58, P358, DOI 10.1159/000343474; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567	12	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108911	10.1371/journal.pone.0108911	http://dx.doi.org/10.1371/journal.pone.0108911			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259734	Green Submitted, Green Published, gold			2022-12-27	WOS:000342685600104
J	Pedersen, C; Brauner, EV; Rod, NH; Albieri, V; Andersen, CE; Ulbak, K; Hertel, O; Johansen, C; Schuz, J; Raaschou-Nielsen, O				Pedersen, Camilla; Brauner, Elvira V.; Rod, Naja H.; Albieri, Vanna; Andersen, Claus E.; Ulbak, Kaare; Hertel, Ole; Johansen, Christoffer; Schuez, Joachim; Raaschou-Nielsen, Ole			Distance to High-Voltage Power Lines and Risk of Childhood Leukemia - an Analysis of Confounding by and Interaction with Other Potential Risk Factors	PLOS ONE			English	Article							MAGNETIC-FIELDS; AIR-POLLUTION; ELECTROMAGNETIC-FIELDS; INCREASED EXPOSURE; DOMESTIC RADON; CANCER; STREET; ENGLAND; ONTARIO; WALES	We investigated whether there is an interaction between distance from residence at birth to nearest power line and domestic radon and traffic-related air pollution, respectively, in relation to childhood leukemia risk. Further, we investigated whether adjusting for potential confounders alters the association between distance to nearest power line and childhood leukemia. We included 1024 cases aged <15, diagnosed with leukemia during 1968-1991, from the Danish Cancer Registry and 2048 controls randomly selected from the Danish childhood population and individually matched by gender and year of birth. We used geographical information systems to determine the distance between residence at birth and the nearest 132-400 kV overhead power line. Concentrations of domestic radon and traffic-related air pollution (NOx at the front door) were estimated using validated models. We found a statistically significant interaction between distance to nearest power line and domestic radon regarding risk of childhood leukemia (p = 0.01) when using the median radon level as cut-off point but not when using the 75th percentile (p = 0.90). We found no evidence of an interaction between distance to nearest power line and traffic-related air pollution (p = 0.73). We found almost no change in the estimated association between distance to power line and risk of childhood leukemia when adjusting for socioeconomic status of the municipality, urbanization, maternal age, birth order, domestic radon and traffic-related air pollution. The statistically significant interaction between distance to nearest power line and domestic radon was based on few exposed cases and controls and sensitive to the choice of exposure categorization and might, therefore, be due to chance.	[Pedersen, Camilla; Brauner, Elvira V.; Albieri, Vanna; Johansen, Christoffer; Raaschou-Nielsen, Ole] Danish Canc Soc Res Ctr, Copenhagen O, Denmark; [Brauner, Elvira V.] Aalborg Univ, Danish Bldg Res Inst, Copenhagen SV, Denmark; [Rod, Naja H.] Univ Copenhagen, Dept Publ Hlth, Social Med Sect, Copenhagen K, Denmark; [Andersen, Claus E.] Tech Univ Denmark, Div Radiat Res, Riso Natl Lab Sustainable Energy, Roskilde, Denmark; [Ulbak, Kaare] Natl Inst Radiat Protect, Herlev, Denmark; [Hertel, Ole] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Hertel, Ole] Roskilde Univ, Dept Environm Social & Spatial Change ENSPAC, Roskilde, Denmark; [Johansen, Christoffer] Univ Copenhagen, Oncol Clin, Finsen Ctr, Rigshosp 5073, Copenhagen O, Denmark; [Schuez, Joachim] Int Agcy Res Canc, Sect Environm & Radiat, F-69372 Lyon, France	Danish Cancer Society; Aalborg University; University of Copenhagen; Technical University of Denmark; Aarhus University; Roskilde University; Rigshospitalet; University of Copenhagen; World Health Organization; International Agency for Research on Cancer (IARC)	Pedersen, C (corresponding author), Danish Canc Soc Res Ctr, Copenhagen O, Denmark.	camped@cancer.dk	Rod, Naja/B-9411-2015; Hertel, Ole/L-4346-2013; Johansen, Christoffer/AAG-7916-2020; Albieri, Vanna/AAU-6720-2020; Raaschou-Nielsen, Ole/GOK-0338-2022; Brauner, Elvira/C-7455-2018	Rod, Naja/0000-0002-6400-5105; Hertel, Ole/0000-0003-0972-7735; Johansen, Christoffer/0000-0002-4384-206X; Albieri, Vanna/0000-0003-1435-2405; Raaschou-Nielsen, Ole/0000-0002-1223-0909; Brauner, Elvira/0000-0001-9183-4796; Andersen, Claus E./0000-0002-7356-9607; Pedersen, Camilla/0000-0003-2068-0536	foundation Children with Cancer UK	foundation Children with Cancer UK	This work was supported by a grant by the foundation Children with Cancer UK (formerly Children with Leukaemia) http://www.childrenwithcancer.org.uk/, by Danish Energy Association for provision on data on power lines, and by the Danish Cancer Society. The funders had no role in study design and analysis, decision to publish, or preparation of the manuscript. Danish Energy have provided data on power lines.	AGNIR-Advisory Group on Non-Ionising Radiation, 2004, DOC NRPB, V15; Ahlbom A, 2000, BRIT J CANCER, V83, P692, DOI 10.1054/bjoc.2000.1376; Andersen CE, 2007, RADIAT PROT DOSIM, V123, P83, DOI 10.1093/rpd/ncl082; Berkowicz R, 2000, ENVIRON MONIT ASSESS, V65, P323, DOI 10.1023/A:1006448321977; Brauner EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074435; Brauner EV, 2012, ENVIRON RES, V118, P130, DOI 10.1016/j.envres.2012.05.012; Brauner EV, 2010, CANCER CAUSE CONTROL, V21, P1961, DOI 10.1007/s10552-010-9608-4; Cheng KK, 1999, LANCET, V354, P1925, DOI 10.1016/S0140-6736(99)10074-6; Cheng KK, 2000, BRIT J CANCER, V83, P1573, DOI 10.1054/bjoc.2000.1550; Draper G, 2005, BRIT MED J, V330, P1290, DOI 10.1136/bmj.330.7503.1290; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Fews AP, 1999, INT J RADIAT BIOL, V75, P1505, DOI 10.1080/095530099139115; Fews AP, 1999, INT J RADIAT BIOL, V75, P1523, DOI 10.1080/095530099139124; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Green LM, 1999, CANCER CAUSE CONTROL, V10, P233, DOI 10.1023/A:1008919408855; Green LM, 1999, INT J CANCER, V82, P161, DOI 10.1002/(SICI)1097-0215(19990719)82:2<161::AID-IJC2>3.0.CO;2-X; Henshaw DL, 1996, INT J RADIAT BIOL, V69, P25, DOI 10.1080/095530096146156; Hertel O, 2001, PURE APPL CHEM, V73, P137, DOI 10.1351/pac200173010137; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2002, IARC MON EV CARC RIS, V80; Jensen SS, 2001, TRANSPORT RES D-TR E, V6, P229, DOI 10.1016/S1361-9209(00)00026-2; Kakosimos KE, 2010, ENVIRON CHEM, V7, P485, DOI 10.1071/EN10070; Ketzel M, 2003, ATMOS ENVIRON, V37, P2735, DOI 10.1016/S1352-2310(03)00245-0; Ketzel M, 2011, INT J ENVIRON POLLUT, V47, P226, DOI 10.1504/IJEP.2011.047337; Kheifets L, 2005, BIOELECTROMAGNETICS, pS51, DOI 10.1002/bem.20139; Kroll ME, 2010, BRIT J CANCER, V103, P1122, DOI 10.1038/sj.bjc.6605795; Linet MS, 1997, NEW ENGL J MED, V337, P1, DOI 10.1056/NEJM199707033370101; LITTLE J, 1999, IARC SCI PUBLICATION, V149; LONDON SJ, 1991, AM J EPIDEMIOL, V134, P923, DOI 10.1093/oxfordjournals.aje.a116176; McBride ML, 1999, AM J EPIDEMIOL, V149, P831, DOI 10.1093/oxfordjournals.aje.a009899; Michaelis J, 1997, CANCER CAUSE CONTROL, V8, P167, DOI 10.1023/A:1018464012055; Pedersen C, 2014, CANCER CAUSE CONTROL, V25, P171, DOI 10.1007/s10552-013-0319-5; Petridou E, 1997, INT J CANCER, V73, P345, DOI 10.1002/(SICI)1097-0215(19971104)73:3<345::AID-IJC7>3.0.CO;2-#; PRENTICE RL, 1978, BIOMETRICS, V34, P153; Raaschou-Nielsen O, 2004, SCAND J PUBLIC HEALT, V32, P279, DOI 10.1080/14034940310022214; Raaschou-Nielsen O, 2000, J EXPO ANAL ENV EPID, V10, P4, DOI 10.1038/sj.jea.7500070; Raaschou-Nielsen O, 2008, EPIDEMIOLOGY, V19, P536, DOI 10.1097/EDE.0b013e318176bfcd; Rossig C, 2008, RADIAT PROT DOSIM, V132, P114, DOI 10.1093/rpd/ncn269; SAVITZ DA, 1988, AM J EPIDEMIOL, V128, P21, DOI 10.1093/oxfordjournals.aje.a114943; Schuz J, 2008, RADIAT PROT DOSIM, V132, P202, DOI 10.1093/rpd/ncn270; Schuz J, 2001, INT J CANCER, V91, P728, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1097&gt;3.0.CO;2-D; World Health Organization, 2007, EXTR LOW FREQ FIELDS; Wunsch V, 2011, CANCER EPIDEMIOL, V35, P534, DOI 10.1016/j.canep.2011.05.008	42	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107096	10.1371/journal.pone.0107096	http://dx.doi.org/10.1371/journal.pone.0107096			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259740	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600016
J	Canto-Bustos, M; Loeza-Alcocer, E; Gonzalez-Ramirez, R; Gandini, MA; Delgado-Lezama, R; Felix, R				Canto-Bustos, Martha; Loeza-Alcocer, Emanuel; Gonzalez-Ramirez, Ricardo; Gandini, Maria A.; Delgado-Lezama, Rodolfo; Felix, Ricardo			Functional Expression of T-Type Ca2+ Channels in Spinal Motoneurons of the Adult Turtle	PLOS ONE			English	Article							CALCIUM-CHANNELS; ELECTROPHYSIOLOGICAL PROPERTIES; RESPONSE PROPERTIES; IN-VITRO; CURRENTS; NEURONS; EXCITABILITY; INVOLVEMENT; RECEPTORS; OUTPUT	Voltage-gated Ca2+ (Ca-V) channels are transmembrane proteins comprising three subfamilies named Ca(V)1, Ca(V)2 and Ca(V)3. The Ca(V)3 channel subfamily groups the low-voltage activated Ca2+ channels (LVA or T-type) a significant role in regulating neuronal excitability. Ca(V)3 channel activity may lead to the generation of complex patterns of action potential firing such as the postinhibitory rebound (PIR). In the adult spinal cord, these channels have been found in dorsal horn interneurons where they control physiological events near the resting potential and participate in determining excitability. In motoneurons, Ca(V)3 channels have been found during development, but their functional expression has not yet been reported in adult animals. Here, we show evidence for the presence of Ca(V)3 channel-mediated PIR in motoneurons of the adult turtle spinal cord. Our results indicate that Ni2+ and NNC55-0396, two antagonists of Ca(V)3 channel activity, inhibited PIR in the adult turtle spinal cord. Molecular biology and biochemical assays revealed the expression of the Ca(V)3.1 channel isotype and its localization in motoneurons. Together, these results provide evidence for the expression of Ca(V)3.1 channels in the spinal cord of adult animals and show also that these channels may contribute to determine the excitability of motoneurons.	[Canto-Bustos, Martha; Loeza-Alcocer, Emanuel; Delgado-Lezama, Rodolfo] Natl Polytech Inst Cinvestav IPN, Ctr Res & Adv Studies, Dept Physiol Biophys & Neurosci, Mexico City, DF, Mexico; [Gonzalez-Ramirez, Ricardo] Dr Manuel Gea Gonzalez Gen Hosp, Dept Mol Biol & Histocompatibil, Mexico City, DF, Mexico; [Gandini, Maria A.; Felix, Ricardo] Cinvestav IPN, Dept Cell Biol, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Felix, R (corresponding author), Cinvestav IPN, Dept Cell Biol, Mexico City, DF, Mexico.	rfelix@cell.cinvestav.mx	González-Ramírez, Ricardo/O-1792-2014; Felix, Ricardo/A-6989-2008	González-Ramírez, Ricardo/0000-0003-1399-8036; Felix, Ricardo/0000-0002-5383-7176; Gandini, Maria/0000-0003-4399-1679; Canto Bustos, Martha/0000-0001-5859-5500	National Council of Science and Technology (Conacyt) of Mexico [128707-Q, 50864-Q]	National Council of Science and Technology (Conacyt) of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from the National Council of Science and Technology (Conacyt) of Mexico to R. F. and R. D.-L. (128707-Q and 50864-Q, respectively). The URL of the funder is http://www.conacyt.mx/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvina K, 2009, NEUROSCIENCE, V158, P635, DOI 10.1016/j.neuroscience.2008.09.052; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Bru-Mercier G, 2012, J CELL MOL MED, V16, P2990, DOI 10.1111/j.1582-4934.2012.01626.x; Carlin KP, 2000, EUR J NEUROSCI, V12, P1624, DOI 10.1046/j.1460-9568.2000.00050.x; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Cheong E, 2013, PHYSIOL REV, V93, P961, DOI 10.1152/physrev.00010.2012; Deleuze C, 2012, J NEUROSCI, V32, P12228, DOI 10.1523/JNEUROSCI.1362-12.2012; Delgado-Lezama R, 2004, J NEUROPHYSIOL, V91, P40, DOI 10.1152/jn.00569.2003; DURAND J, 1989, EXP BRAIN RES, V76, P141; Engbers JDT, 2011, J PHYSIOL-LONDON, V589, P5391, DOI 10.1113/jphysiol.2011.215632; Felix R, 2003, BIOCHEM BIOPH RES CO, V311, P187, DOI 10.1016/j.bbrc.2003.09.197; Field EC, 1997, J NEUROPHYSIOL, V78, P1404, DOI 10.1152/jn.1997.78.3.1404; GRANTYN R, 1978, EXP BRAIN RES, V31, P249; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V398, P575, DOI 10.1113/jphysiol.1988.sp017058; Huang LP, 2004, J PHARMACOL EXP THER, V309, P193, DOI 10.1124/jpet.103.060814; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Jiang Z, 1999, EUR J NEUROSCI, V11, P3481, DOI 10.1046/j.1460-9568.1999.00765.x; Lambert RC, 2014, PFLUG ARCH EUR J PHY, V466, P415, DOI 10.1007/s00424-013-1353-6; Lee SE, 2009, KOREAN J PHYSIOL PHA, V13, P241, DOI 10.4196/kjpp.2009.13.3.241; Li M, 2005, CARDIOVASC DRUG REV, V23, P173; Liao YF, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-43; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P549, DOI 10.1113/jphysiol.1981.sp013763; Loeza-Alcocer E, 2013, J NEUROPHYSIOL, V110, P2175, DOI 10.1152/jn.00330.2013; Martin-Caraballo M, 2001, J NEUROBIOL, V46, P231, DOI 10.1002/1097-4695(200103)46:4<231::AID-NEU1005>3.0.CO;2-U; Martin-Caraballo M, 1999, J NEUROPHYSIOL, V81, P1365, DOI 10.1152/jn.1999.81.3.1365; MCCOBB DP, 1989, NEURON, V2, P1633, DOI 10.1016/0896-6273(89)90052-4; MYNLIEFF M, 1992, J NEUROPHYSIOL, V68, P85, DOI 10.1152/jn.1992.68.1.85; Oguri A, 2010, AM J PHYSIOL-CELL PH, V298, pC1414, DOI 10.1152/ajpcell.00488.2009; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perrier JF, 2000, BRAIN RES BULL, V53, P529, DOI 10.1016/S0361-9230(00)00386-5; Powers RK, 2001, REV PHYSIOL BIOCH P, V143, P137, DOI 10.1007/BFb0115594; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Russier M, 2003, J PHYSIOL-LONDON, V549, P21, DOI 10.1113/jphysiol.2002.037069; Russo RE, 1996, J PHYSIOL-LONDON, V493, P55, DOI 10.1113/jphysiol.1996.sp021364; Segura-Chama P, 2012, AM J PHYSIOL-HEART C, V302, pH467, DOI 10.1152/ajpheart.00849.2011; Seto SW, 2010, BRIT J PHARMACOL, V159, P1211, DOI 10.1111/j.1476-5381.2009.00600.x; Talley EM, 1999, J NEUROSCI, V19, P1895; Viana F, 1997, CELL CALCIUM, V22, P299, DOI 10.1016/S0143-4160(97)90068-3; Wang F, 2011, CELL CALCIUM, V49, P12, DOI 10.1016/j.ceca.2010.11.002; Wu SW, 2000, J PHARMACOL EXP THER, V292, P939	42	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108187	10.1371/journal.pone.0108187	http://dx.doi.org/10.1371/journal.pone.0108187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255145	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300060
J	Nakamaru, M; Yokoyama, A				Nakamaru, Mayuko; Yokoyama, Akira			The Effect of Ostracism and Optional Participation on the Evolution of Cooperation in the Voluntary Public Goods Game	PLOS ONE			English	Article							RECIPROCITY; DYNAMICS; ASSOCIATION; REPUTATION; REWARD	Not only animals, plants and microbes but also humans cooperate in groups. The evolution of cooperation in a group is an evolutionary puzzle, because defectors always obtain a higher benefit than cooperators. When people participate in a group, they evaluate group member's reputations and then decide whether to participate in it. In some groups, membership is open to all who are willing to participate in the group. In other groups, a candidate is excluded from membership if group members regard the candidate's reputation as bad. We developed an evolutionary game model and investigated how participation in groups and ostracism influence the evolution of cooperation in groups when group members play the voluntary public goods game, by means of computer simulation. When group membership is open to all candidates and those candidates can decide whether to participate in a group, cooperation cannot be sustainable. However, cooperation is sustainable when a candidate cannot be a member unless all group members admit them to membership. Therefore, it is not participation in a group but rather ostracism, which functions as costless punishment on defectors, that is essential to sustain cooperation in the voluntary public goods game.	[Nakamaru, Mayuko; Yokoyama, Akira] Tokyo Inst Technol, Meguro Ku, Tokyo 152, Japan	Tokyo Institute of Technology	Nakamaru, M (corresponding author), Tokyo Inst Technol, Meguro Ku, Tokyo 152, Japan.	nakamaru@valdes.titech.ac.jp	Nakamaru, Mayuko/N-9127-2013	Nakamaru, Mayuko/0000-0003-2116-1711	JSPS KAKENHI [21770016]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by JSPS KAKENHI Grant Number 21770016 (to MN) [http://www.jsps.go.jp/english/index.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktipis CA, 2004, J THEOR BIOL, V231, P249, DOI 10.1016/j.jtbi.2004.06.020; Armendaris B, 2010, EC MICROFINANCE; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Chang C-Y, 2013, INT NETW SOC NETW AN; Chiang YS, 2008, RATION SOC, V20, P173, DOI 10.1177/1043463108089544; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Feinberg M, 2014, PSYCHOL SCI, V25, P656, DOI 10.1177/0956797613510184; Garcia T, 2013, EVOLUTION, V67, P131, DOI 10.1111/j.1558-5646.2012.01739.x; GEERTZ C, 1962, ECON DEV CULT CHANGE, V10, P241, DOI 10.1086/449960; Giraldeau LA, 1999, TRENDS ECOL EVOL, V14, P102, DOI 10.1016/S0169-5347(98)01542-0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hauert C, 2002, J THEOR BIOL, V218, P187, DOI 10.1006/jtbi.2002.3067; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Helbing D, 2012, SOCIAL SELF ORG; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Koike S, 2010, J THEOR BIOL, V264, P143, DOI 10.1016/j.jtbi.2009.12.030; Lade SJ, 2013, THEOR ECOL-NETH, V6, P359, DOI 10.1007/s12080-013-0187-3; LEVIN BR, 1974, EVOLUTION, V28, P527, DOI 10.1111/j.1558-5646.1974.tb00787.x; Levin SA, 2009, SPRINGER SER GAME TH, P1, DOI 10.1007/978-3-540-85436-4; Lyle HF, 2014, P NATL ACAD SCI USA, V111, P4820, DOI 10.1073/pnas.1318372111; Maier-Rigaud FP, 2010, J ECON BEHAV ORGAN, V73, P387, DOI 10.1016/j.jebo.2009.11.001; Matsuda H., 1987, P67; Nakamaru M, 1997, J THEOR BIOL, V184, P65, DOI 10.1006/jtbi.1996.0243; Nakamaru M, 2006, J THEOR BIOL, V240, P475, DOI 10.1016/j.jtbi.2005.10.011; Nakamura M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-213; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Ostrom E., 1990, GOVERNING COMMONS EV; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; Sasaki T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2498; Semmann D, 2003, NATURE, V425, P390, DOI 10.1038/nature01986; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sober E., 1999, OTHERS EVOLUTION PSY; Sugden R, 1986, EC RIGHTS COOPERATIO; Suzuki S, 2005, P ROY SOC B-BIOL SCI, V272, P1373, DOI 10.1098/rspb.2005.3072; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041021; Szolnoki A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/9/093016; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Tavoni A, 2012, J THEOR BIOL, V299, P152, DOI 10.1016/j.jtbi.2011.07.003; Uchida S, 2010, J THEOR BIOL, V263, P13, DOI 10.1016/j.jtbi.2009.11.013; Vasconcelos VV, 2014, P NATL ACAD SCI USA, V111, P2212, DOI 10.1073/pnas.1323479111; VEHRENCAMP SL, 1983, ANIM BEHAV, V31, P667, DOI 10.1016/S0003-3472(83)80222-X; Werner GDA, 2014, P NATL ACAD SCI USA, V111, P1237, DOI 10.1073/pnas.1315980111; Wilson DS, 1997, AM NAT, V149, P336, DOI 10.1086/285993	53	12	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108423	10.1371/journal.pone.0108423	http://dx.doi.org/10.1371/journal.pone.0108423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3UZ	25255458	gold, Green Published, Green Submitted			2022-12-27	WOS:000344862300079
J	Chen, X; Zhang, J; Liu, QZ; Guo, W; Zhao, TT; Ma, QH; Wang, GX				Chen, Xin; Zhang, Jin; Liu, Qingzhong; Guo, Wei; Zhao, Tiantian; Ma, Qinghua; Wang, Guixi			Transcriptome Sequencing and Identification of Cold Tolerance Genes in Hardy Corylus Species (C. heterophylla Fisch) Floral Buds	PLOS ONE			English	Article							OMEGA-3-FATTY-ACID DESATURASE GENES; ACTIN-DEPOLYMERIZING FACTOR; ORYZA-SATIVA L.; FREEZING TOLERANCE; ARABIDOPSIS-THALIANA; LOW-TEMPERATURE; STRESS TOLERANCE; OSMOTIC-STRESS; TRANSGENIC ARABIDOPSIS; FUNCTIONAL GENOMICS	Background: The genus Corylus is an important woody species in Northeast China. Its products, hazelnuts, constitute one of the most important raw materials for the pastry and chocolate industry. However, limited genetic research has focused on Corylus because of the lack of genomic resources. The advent of high-throughput sequencing technologies provides a turning point for Corylus research. In the present study, we performed de novo transcriptome sequencing for the first time to produce a comprehensive database for the Corylus heterophylla Fisch floral buds. Results: The C. heterophylla Fisch floral buds transcriptome was sequenced using the Illumina paired-end sequencing technology. We produced 28,930,890 raw reads and assembled them into 82,684 contigs. A total of 40,941 unigenes were identified, among which 30,549 were annotated in the NCBI Non-redundant (Nr) protein database and 18,581 were annotated in the Swiss-Prot database. Of these annotated unigenes, 25,311 and 10,514 unigenes were assigned to gene ontology (GO) categories and clusters of orthologous groups (COG), respectively. We could map 17,207 unigenes onto 128 pathways using the Kyoto Encyclopedia of Genes and Genomes Pathway (KEGG) database. Additionally, based on the transcriptome, we constructed a candidate cold tolerance gene set of C. heterophylla Fisch floral buds. The expression patterns of selected genes during four stages of cold acclimation suggested that these genes might be involved in different cold responsive stages in C. heterophylla Fisch floral buds. Conclusion: The transcriptome of C. heterophylla Fisch floral buds was deep sequenced, de novo assembled, and annotated, providing abundant data to better understand the C. heterophylla Fisch floral buds transcriptome. Candidate genes potentially involved in cold tolerance were identified, providing a material basis for future molecular mechanism analysis of C. heterophylla Fisch floral buds tolerant to cold stress.	[Chen, Xin; Liu, Qingzhong] Shandong Inst Pomol, Shandong Prov Key Lab Fruit Tree Biotechnol Breed, Tai An, Shandong, Peoples R China; [Zhang, Jin; Zhao, Tiantian; Ma, Qinghua; Wang, Guixi] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Guo, Wei] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; State University System of Florida; University of Florida	Wang, GX (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	wanggx0114@126.com	Zhang, Jin/J-9618-2019	Zhang, Jin/0000-0002-8397-5078	Special Project for Scientific Research of Forestry Commonweal Industry of National Forestry Bureau [201304710]; China Postdoctoral Science Foundation [2014M550104]	Special Project for Scientific Research of Forestry Commonweal Industry of National Forestry Bureau; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the Special Project for Scientific Research of Forestry Commonweal Industry of National Forestry Bureau (201304710) to GW and the China Postdoctoral Science Foundation (2014M550104) to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Alves MS, 2011, PLANT SIGNAL BEHAV, V6, P1993, DOI 10.4161/psb.6.12.18268; Baek K.-H., 2012, JACEN, V1, P43, DOI [10.4236/jacen.2012.11006, DOI 10.4236/JACEN.2012.11006]; BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; Benedict C, 2006, PLANT PHYSIOL, V141, P1219, DOI 10.1104/pp.106.083527; Breton G, 2003, PLANT PHYSIOL, V132, P64, DOI 10.1104/pp.102.015255; Cabello JV, 2012, PLANT J, V69, P141, DOI 10.1111/j.1365-313X.2011.04778.x; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chelysheva VV, 1999, FEBS LETT, V456, P22, DOI 10.1016/S0014-5793(99)00923-0; Chinnusamy V, 2010, METHODS MOL BIOL, V639, P39, DOI 10.1007/978-1-60761-702-0_3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Danyluk J, 1996, FEBS LETT, V389, P324, DOI 10.1016/0014-5793(96)00599-6; Dhanaraj AL, 2007, PLANTA, V225, P735, DOI 10.1007/s00425-006-0382-1; Dong MA, 2011, P NATL ACAD SCI USA, V108, P7241, DOI 10.1073/pnas.1103741108; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Erdogan V, 2000, SYST BOT, V25, P727, DOI 10.2307/2666730; Faccioli P, 2001, PLANT BREEDING, V120, P497, DOI 10.1046/j.1439-0523.2001.00652.x; Fallico B, 2003, FOOD CHEM, V81, P569, DOI 10.1016/S0308-8146(02)00497-1; Fan LF, 2013, J PROTEOMICS, V80, P196, DOI 10.1016/j.jprot.2012.12.017; Garnier M, 2010, APPL ENVIRON MICROB, V76, P8011, DOI 10.1128/AEM.01331-10; Goni O, 2013, PHYTOCHEMISTRY, V95, P94, DOI 10.1016/j.phytochem.2013.07.004; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gradishar WJ, 2012, BREAST CANCER-BASIC, V6, P159, DOI 10.4137/BCBCR.S8205; Guo L, 2013, J EXP BOT, V64, P1755, DOI 10.1093/jxb/ert040; Guy C, 2008, PHYSIOL PLANTARUM, V132, P220, DOI 10.1111/j.1399-3054.2007.00999.x; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; Heidarvand L, 2010, ACTA PHYSIOL PLANT, V32, P419, DOI 10.1007/s11738-009-0451-8; Huang CL, 2011, PLANT SCI, V181, P57, DOI 10.1016/j.plantsci.2011.03.011; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Janska A, 2010, PLANT BIOLOGY, V12, P395, DOI 10.1111/j.1438-8677.2009.00299.x; Jiang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071054; Kalinina EB, 2012, BIOL PLANTARUM, V56, P699, DOI 10.1007/s10535-012-0132-0; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kaplan F, 2005, PLANT J, V44, P730, DOI 10.1111/j.1365-313X.2005.02565.x; Kargiotidou A, 2008, J EXP BOT, V59, P2043, DOI 10.1093/jxb/ern065; Kariola T, 2006, PLANT PHYSIOL, V142, P1559, DOI 10.1104/pp.106.086223; Kasukabe Y, 2004, PLANT CELL PHYSIOL, V45, P712, DOI 10.1093/pcp/pch083; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kumar S, 2010, INT J WOMENS HEALTH, V2, P411, DOI 10.2147/IJWH.S7012; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liao Y, 2008, PLANTA, V228, P225, DOI 10.1007/s00425-008-0731-3; Liu JF, 2013, SCI HORTIC-AMSTERDAM, V150, P348, DOI 10.1016/j.scienta.2012.12.001; Liu L, 2012, PLANT MOL BIOL REP, V30, P679, DOI 10.1007/s11105-011-0380-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lourenco T, 2013, PLANT MOL BIOL, V83, P351, DOI 10.1007/s11103-013-0092-6; Lv DK, 2010, GENE, V459, P39, DOI 10.1016/j.gene.2010.03.011; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; MEHLENBACHER SA, 1991, ACTA HORTIC, V290, P789; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morsy MR, 2005, GENE, V344, P171, DOI 10.1016/j.gene.2004.09.033; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakashima K, 2006, PHYSIOL PLANTARUM, V126, P62, DOI 10.1111/j.1399-3054.2005.00592.x; Ouellet F, 2001, PLANT PHYSIOL, V125, P360, DOI 10.1104/pp.125.1.360; Ozdemir F, 2004, J FOOD ENG, V63, P341, DOI 10.1016/j.jfoodeng.2003.08.006; Ozdemir M, 2001, FOOD CHEM, V73, P191, DOI 10.1016/S0308-8146(00)00273-9; Plosker GL, 2001, PHARMACOECONOMICS, V19, P1111, DOI 10.2165/00019053-200119110-00005; Polashock JJ, 2010, J AM SOC HORTIC SCI, V135, P40, DOI 10.21273/JASHS.135.1.40; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roman A, 2012, J EXP BOT, V63, P4973, DOI 10.1093/jxb/ers174; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; Sui N, 2007, PLANTA, V226, P1097, DOI 10.1007/s00425-007-0554-7; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Tahtiharju S, 2001, PLANT J, V26, P461, DOI 10.1046/j.1365-313X.2001.01048.x; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Teixeira MC, 2010, J AGR FOOD CHEM, V58, P1870, DOI 10.1021/jf902684v; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Vergnolle C, 2005, PLANT PHYSIOL, V139, P1217, DOI 10.1104/pp.105.068171; Wang J, 2011, PHYSIOL PLANTARUM, V142, P339, DOI 10.1111/j.1399-3054.2011.01471.x; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wathugala DL, 2011, NEW PHYTOL, V191, P984, DOI 10.1111/j.1469-8137.2011.03759.x; WEISER CJ, 1970, SCIENCE, V169, P1269, DOI 10.1126/science.169.3952.1269; Xing WB, 2001, ENVIRON EXP BOT, V46, P21, DOI 10.1016/S0098-8472(01)00078-8; Zarka DG, 2003, PLANT PHYSIOL, V133, P910, DOI 10.1104/pp.103.027169; Zhang J, 2012, FOOD MICROBIOL, V31, P285, DOI 10.1016/j.fm.2012.04.006; Zhang YD, 2006, J PLANT PHYSIOL, V163, P968, DOI 10.1016/j.jplph.2005.09.002; Zhao MG, 2009, PLANT PHYSIOL, V151, P755, DOI 10.1104/pp.109.140996; Zhao ZG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-222	80	9	9	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108604	10.1371/journal.pone.0108604	http://dx.doi.org/10.1371/journal.pone.0108604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268521	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700121
J	Punja, S; Shamseer, L; Olson, K; Vohra, S				Punja, Salima; Shamseer, Larissa; Olson, Karin; Vohra, Sunita			Rhodiola Rosea for Mental and Physical Fatigue in Nursing Students: A Randomized Controlled Trial	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; HEALTH; EXTRACT; PLACEBO; SHR-5; SF-36; WORK	Background: Fatigue is one of many unintended consequences of shift work in the nursing profession. Natural products (NHPs) for fatigue are becoming an increasingly popular topic of clinical study; one such NHP is Rhodiola rosea. well-designed, rigorously conducted randomized controlled trial is required before therapeutic claims for this product be made. Objective: To compare the efficacy of R. rosea with placebo for reducing fatigue in nursing students on shift work. Design: A parallel-group randomized, double-blinded, placebo-controlled trial of 18-55 year old students from the of Nursing from the University of Alberta, participating in clinical rotations between January 2011 and September 2011. Interventions: Participants were randomized to take 364 mg of either R. rosea or identical placebo at the start of wakeful period and up to one additional capsule within the following four hours on a daily basis over a 42-day period. Outcomes: The primary outcome was reduction in fatigue over the 42-day trial period measured using the Vitality-subscale of the RAND-36, cross-validated by the visual analogue scale for fatigue (VAS-F). Secondary outcomes included health-related quality of life, individualized outcomes assessment, and adverse events. Results: A total of 48 participants were randomized to R. rosea (n = 24) or placebo (n = 24). The mean change in scores the Vitality-subscale was significantly different between the study groups at day 42 in favor of placebo (-17.3 (95% Cl -30.6, -3.9), p = 0.011), The mean change in scores on the VAS-F was also significantly difference between study groups day 42 in favour of placebo (1.9 (95% Cl 0.4, 3.5), p = 0.015). Total number of adverse events did not differ between R. and placebo groups. Conclusion: This study indicates that among nursing students on shift work, a 42-day course of R. Rosea compared placebo worsened fatigue; however, the results should be interpreted with caution.	[Punja, Salima] Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada; [Shamseer, Larissa] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Shamseer, Larissa] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Olson, Karin] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [Vohra, Sunita] Univ Alberta, Fac Med & Dent, Dept Pediat, Complementary & Alternat Res & Educ CARE Program, Edmonton, AB, Canada; [Vohra, Sunita] Univ Alberta, Fac Med & Dent, Sch Publ Hlth, Edmonton, AB, Canada	University of Alberta; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Alberta; University of Alberta; University of Alberta	Vohra, S (corresponding author), Univ Alberta, Fac Med & Dent, Dept Pediat, Complementary & Alternat Res & Educ CARE Program, Edmonton, AB, Canada.	svohra@ualberta.ca	Shamseer, Larissa/E-9645-2017; Vohra, Sunita/F-5755-2016	Shamseer, Larissa/0000-0003-3690-3378; Vohra, Sunita/0000-0002-6210-7933	Alberta Agriculture and Rural Development, Government of Alberta, through AVAC Ltd.	Alberta Agriculture and Rural Development, Government of Alberta, through AVAC Ltd.	This project was funded by the Alberta Agriculture and Rural Development, Government of Alberta, through AVAC Ltd. The funder developed and prepared the trial intervention, but had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Admi H, 2008, NURS ECON, V26, P250; BREKHMAN II, 1969, ANNU REV PHARMACOLOG, V9, P419, DOI 10.1146/annurev.pa.09.040169.002223; Carrier J, 2000, CHRONOBIOL INT, V17, P719, DOI 10.1081/CBI-100102108; Ellis JM, 2002, ANN PHARMACOTHER, V36, P375, DOI 10.1345/aph.1A245; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Hemingway H, 1997, BMJ-BRIT MED J, V315, P1273, DOI 10.1136/bmj.315.7118.1273; *HLTH CAN, 2005, BAS NAT HLTH PROD SU; Hughes R, 2004, AM J NURS, V104, P60, DOI 10.1097/00000446-200409000-00026; Hung SK, 2011, PHYTOMEDICINE, V18, P235, DOI 10.1016/j.phymed.2010.08.014; Ishaque S, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-70; Jansen NWH, 2003, OCCUP ENVIRON MED, V60, P47; Krueger G.P, 1994, HUMAN ERROR MED, P311; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Obidoa C.A., 2010, J SOCIAL BEHAV HLTH, V4, P30, DOI 10.5590/JSBHS.2010.04.1.02; Olsson EMG, 2009, PLANTA MED, V75, P105, DOI 10.1055/s-0028-1088346; Paterson C, 1996, BRIT MED J, V312, P1016; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Shevtsov VA, 2003, PHYTOMEDICINE, V10, P95, DOI 10.1078/094471103321659780; WINGET CM, 1985, MED SCI SPORT EXER, V17, P498	20	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108416	10.1371/journal.pone.0108416	http://dx.doi.org/10.1371/journal.pone.0108416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268730	Green Submitted, gold, Green Published			2022-12-27	WOS:000343671700093
J	Song, FN; Duan, M; Liu, LZ; Wang, ZC; Shi, JY; Yang, LX; Zhou, J; Fan, J; Gao, Q; Wang, XY				Song, Fang-Nan; Duan, Meng; Liu, Long-Zi; Wang, Zhi-Chao; Shi, Jie-Yi; Yang, Liu-Xiao; Zhou, Jian; Fan, Jia; Gao, Qiang; Wang, Xiao-Ying			RANKL Promotes Migration and Invasion of Hepatocellular Carcinoma Cells via NF-kappa B-Mediated Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							UP-REGULATION; RECEPTOR ACTIVATOR; T-CELLS; METASTASIS; TUMOR; CANCER; EXPRESSION; SNAIL; MICROENVIRONMENT; CROSSROADS	Background: Metastasis accounts for the most deaths in patients with hepatocellular carcinoma (HCC). Receptor activator of nuclear factor kappa B ligand (RANKL) is associated with cancer metastasis, while its role in HCC remains largely unknown. Methods: Immunohistochemistry was performed to determine the expression of RANK in HCC tissue (n = 398). Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot were used to examine the expression of RANK, E-cadherin, N-cadherin, vimentin, Snail, Slug, Twist and MMPs in HCC cells. Wound healing and Transwell assays were used to evaluate cell migration and invasion ability. Results: We found that expression of RANK, the receptor of RANKL, was significantly higher in HCC tumor tissues than in peritumor liver tissues (p<0.001). Constitutive expression of RANK was detected in HCC cell lines, which can be up-regulated when HCC cells were stimulated with RANKL. Notably, in vitro experiments showed that activation of RANKL-RANK axis significantly promoted migration and invasion ability of HCC cells. In addition, RANKL stimulation increased the expression levels of N-cadherin, Snail, and Twist, while decreased the expression of E-cadherin, with concomitant activation of NF-kappa B signaling pathway. Moreover, administration of the NF-kappa B inhibitor attenuated RANKL-induced migration, invasion and epithelial-mesenchymal transition of HCC cells. Conclusions: RANKL could potentiate migration and invasion ability of RANK-positive HCC cells through NF-kappa B pathway-mediated epithelial-mesenchymal transition, which means that RANKL-RANK axis could be a potential target for HCC therapy.	[Song, Fang-Nan; Duan, Meng; Liu, Long-Zi; Wang, Zhi-Chao; Shi, Jie-Yi; Yang, Liu-Xiao; Zhou, Jian; Fan, Jia; Gao, Qiang; Wang, Xiao-Ying] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Minist Educ, Shanghai 200433, Peoples R China; [Song, Fang-Nan; Duan, Meng; Liu, Long-Zi; Wang, Zhi-Chao; Shi, Jie-Yi; Yang, Liu-Xiao; Zhou, Jian; Fan, Jia; Gao, Qiang; Wang, Xiao-Ying] Fudan Univ, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Shanghai 200433, Peoples R China; [Zhou, Jian; Fan, Jia] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Gao, Q (corresponding author), Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Minist Educ, Shanghai 200433, Peoples R China.	gao.qiang@zs-hospital.sh.cn; wang.xiaoying1@zs-hospital.sh.cn	SHI, JIE/GXG-3394-2022; Fan, Jia/C-6689-2017	Zhou, Jian/0000-0002-7650-7540; Gao, Qiang/0000-0002-6695-9906	NSFC [81030038]; National Key Sci-Tech Project [2012ZX10002011]; National Natural Science Foundation of China [81272730, 81272725, 81372648]; FANEDD [201183]; Shanghai ''Promising Youth Medical Worker'' Project [13Y055]; Fok Ying-Tong Education Foundation [132029]	NSFC(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); FANEDD(Foundation for the Author of National Excellent Doctoral Dissertation of China); Shanghai ''Promising Youth Medical Worker'' Project; Fok Ying-Tong Education Foundation(Fok Ying Tung Education Foundation)	This work was supported by the Major Program of NSFC (No. 81030038), National Key Sci-Tech Project (2012ZX10002011), National Natural Science Foundation of China (Nos. 81272730, 81272725, 81372648), FANEDD (No. 201183), Shanghai ''Promising Youth Medical Worker'' Project (No. 13Y055), and the Fok Ying-Tong Education Foundation (No. 132029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adya R, 2008, DIABETES CARE, V31, P758, DOI 10.2337/dc07-1544; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Armstrong AP, 2008, PROSTATE, V68, P92, DOI 10.1002/pros.20678; Beristain AG, 2012, J CELL SCI, V125, P943, DOI 10.1242/jcs.094029; Borghaei RC, 2004, BIOCHEM BIOPH RES CO, V316, P182, DOI 10.1016/j.bbrc.2004.02.030; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Chen LM, 2011, J CELL BIOCHEM, V112, P933, DOI 10.1002/jcb.23009; Cheng ML, 2014, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00329; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Gao Q, 2012, CANCER RES, V72, P3546, DOI 10.1158/0008-5472.CAN-11-4032; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hofmann UB, 2005, BIOCHIMIE, V87, P307, DOI 10.1016/j.biochi.2005.01.013; Hsu CJ, 2010, J CELL BIOCHEM, V111, P138, DOI 10.1002/jcb.22677; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Miyoshi A, 2004, BRIT J CANCER, V90, P1265, DOI 10.1038/sj.bjc.6601685; Palafox M, 2012, CANCER RES, V72, P2879, DOI 10.1158/0008-5472.CAN-12-0044; Sanchez-Tillo E, 2012, CELL MOL LIFE SCI, V69, P3429, DOI 10.1007/s00018-012-1122-2; Santini D, 2011, J CELL PHYSIOL, V226, P780, DOI 10.1002/jcp.22402; Sasaki A, 2007, ANN SURG ONCOL, V14, P1191, DOI 10.1245/s10434-006-9277-4; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Schmitz ML, 2001, TRENDS BIOCHEM SCI, V26, P186, DOI 10.1016/S0968-0004(00)01753-9; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsubaki M, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-62; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	35	31	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108507	10.1371/journal.pone.0108507	http://dx.doi.org/10.1371/journal.pone.0108507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268581	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700102
J	Coronado, RA; Simon, CB; Valencia, C; Parr, JJ; Borsa, PA; George, SZ				Coronado, Rogelio A.; Simon, Corey B.; Valencia, Carolina; Parr, Jeffrey J.; Borsa, Paul A.; George, Steven Z.			Suprathreshold Heat Pain Response Predicts Activity-Related Pain, but Not Rest-Related Pain, in an Exercise-Induced Injury Model	PLOS ONE			English	Article							EXPERIMENTAL MUSCLE PAIN; POSTOPERATIVE PAIN; MUSCULOSKELETAL PAIN; PSYCHOMETRIC PROPERTIES; SEX-DIFFERENCES; TAMPA SCALE; INTENSITY; FEAR; PRESSURE; DISABILITY	Exercise-induced injury models are advantageous for studying pain since the onset of pain is controlled and both pre-injury and post-injury factors can be utilized as explanatory variables or predictors. In these studies, rest-related pain is often considered the primary dependent variable or outcome, as opposed to a measure of activity-related pain. Additionally, few studies include pain sensitivity measures as predictors. In this study, we examined the influence of pre-injury and post-injury factors, including pain sensitivity, for induced rest and activity-related pain following exercise induced muscle injury. The overall goal of this investigation was to determine if there were convergent or divergent predictors of rest and activity-related pain. One hundred forty-three participants provided demographic, psychological, and pain sensitivity information and underwent a standard fatigue trial of resistance exercise to induce injury of the dominant shoulder. Pain at rest and during active and resisted shoulder motion were measured at 48- and 96-hours post-injury. Separate hierarchical models were generated for assessing the influence of pre-injury and post-injury factors on 48- and 96-hour rest-related and activity-related pain. Overall, we did not find a universal predictor of pain across all models. However, pre-injury and post-injury suprathreshold heat pain response (SHPR), a pain sensitivity measure, was a consistent predictor of activity-related pain, even after controlling for known psychological factors. These results suggest there is differential prediction of pain. A measure of pain sensitivity such as SHPR appears more influential for activity-related pain, but not rest-related pain, and may reflect different underlying processes involved during pain appraisal.	[Coronado, Rogelio A.; Simon, Corey B.; George, Steven Z.] Univ Florida, Dept Phys Therapy, Gainesville, FL 32611 USA; [Valencia, Carolina] Indiana State Univ, Dept Appl Med & Rehabil, Terre Haute, IN USA; [Parr, Jeffrey J.] Univ Pittsburgh, Dept Sports Med & Nutr, Pittsburgh, PA USA; [Borsa, Paul A.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA; [George, Steven Z.] Univ Florida, Ctr Pain Res & Behav Hlth, Gainesville, FL USA	State University System of Florida; University of Florida; Indiana State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Coronado, RA (corresponding author), Univ Florida, Dept Phys Therapy, Gainesville, FL 32611 USA.	rogelio.coronado@vanderbilt.edu; szgeorge@phhp.ufl.edu	Valencia, Carolina/L-6401-2019	Coronado, Rogelio/0000-0002-7112-4903; George, Steven/0000-0003-4988-9421	NIAMS/NIH [AR055899]; NIH [5T32HDO43730]; NIH/NCATS [TL1 TR000066, UL1 TR000064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043730] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000066, UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055899] Funding Source: NIH RePORTER	NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for this study was received by a NIAMS/NIH grant AR055899. RAC was supported by NIH T32 Interdisciplinary Training in Rehabilitation and Neuromuscular Plasticity grant (5T32HDO43730). CBS was supported in part by the NIH/NCATS Clinical and Translational Science Awards to the University of Florida (TL1 TR000066 and UL1 TR000064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt-Nielsen L, 2009, J PAIN, V10, P556, DOI 10.1016/j.jpain.2009.02.002; Ayles S, 2011, J PAIN, V12, P884, DOI 10.1016/j.jpain.2011.02.355; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Backonja M, 2013, PAIN, V154, P1807, DOI 10.1016/j.pain.2013.05.047; Bishop MD, 2012, NEUROSCI LETT, V526, P1, DOI 10.1016/j.neulet.2012.07.067; Bishop MD, 2011, CLIN J PAIN, V27, P398, DOI 10.1097/AJP.0b013e31820d9bbf; Bishop MD, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-35; Chesterton LS, 2007, CLIN J PAIN, V23, P760, DOI 10.1097/AJP.0b013e318154b6ae; Coronado RA, 2014, CLIN J PAIN, V30, P143, DOI 10.1097/AJP.0b013e318287a2a4; Coronado RA, 2011, J ORTHOP SPORT PHYS, V41, P165, DOI 10.2519/jospt.2011.3416; Cruz-Almeida Y, 2014, PAIN MED, V15, P61, DOI 10.1111/pme.12230; Dannecker EA, 2005, CLIN J PAIN, V21, P120, DOI 10.1097/00002508-200503000-00002; Dannecker EA, 2003, J SPORT MED PHYS FIT, V43, P78; Dannecker EA, 2011, CLIN J PAIN, V27, P42, DOI 10.1097/AJP.0b013e3181f04818; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; George SZ, 2008, CLIN J PAIN, V24, P793, DOI 10.1097/AJP.0b013e31817bcb65; George SZ, 2007, CLIN J PAIN, V23, P76, DOI 10.1097/01.ajp.0000210949.19429.34; Granot M, 2012, EUR J PAIN, V16, P247, DOI 10.1016/j.ejpain.2011.07.003; Granot M, 2009, CURR OPIN ANESTHESIO, V22, P425, DOI 10.1097/ACO.0b013e32832a40e1; GREEN SB, 1991, MULTIVAR BEHAV RES, V26, P499, DOI 10.1207/s15327906mbr2603_7; Henriksen M, 2007, J APPL PHYSIOL, V103, P132, DOI 10.1152/japplphysiol.01105.2006; Hubscher M, 2013, PAIN, V154, P1497, DOI 10.1016/j.pain.2013.05.031; Kehlet H, 2011, PAIN, V152, P1699, DOI 10.1016/j.pain.2011.03.013; Kong JT, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/187182; Landau R, 2010, J VIS EXP; Law LAF, 2008, J PAIN, V9, P714, DOI 10.1016/j.jpain.2008.03.009; Lentz TA, 2009, J ORTHOP SPORT PHYS, V39, P270, DOI 10.2519/jospt.2009.2879; Litcher-Kelly L, 2007, J PAIN, V8, P906, DOI 10.1016/j.jpain.2007.06.009; Melzack R, 2013, WIRES COGN SCI, V4, P1, DOI 10.1002/wcs.1201; Mintken PE, 2010, ARCH PHYS MED REHAB, V91, P1128, DOI 10.1016/j.apmr.2010.04.009; Parks EL, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2010.12.007; Parr J, 2014, INT J SPORTS MED, V35, P232, DOI 10.1055/s-0033-1345179; Parr JJ, 2012, J PAIN, V13, P370, DOI 10.1016/j.jpain.2011.12.011; Persson AL, 2004, J REHABIL MED, V36, P17, DOI 10.1080/16501970310015218; Pielsticker A, 2005, PAIN, V118, P215, DOI 10.1016/j.pain.2005.08.019; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; PRICE DD, 1994, PAIN, V59, P165, DOI 10.1016/0304-3959(94)90069-8; Price Donald D, 2002, Mol Interv, V2, P392, DOI 10.1124/mi.2.6.392; Rakel BA, 2012, PAIN, V153, P2192, DOI 10.1016/j.pain.2012.06.021; Slater H, 2005, PAIN, V114, P118, DOI 10.1016/j.pain.2004.12.003; Slater H, 2003, EUR J PAIN, V7, P277, DOI 10.1016/S1090-3801(02)00141-6; Srikandarajah S, 2011, PAIN, V152, P1734, DOI 10.1016/j.pain.2011.02.008; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Torisu T, 2010, EUR J PAIN, V14, P719, DOI 10.1016/j.ejpain.2009.12.001; Trost Z, 2012, PAIN, V153, P2161, DOI 10.1016/j.pain.2012.07.019; Valencia C, 2013, CLIN J PAIN; Valencia C, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-182; Valencia C, 2012, J PAIN, V13, P81, DOI 10.1016/j.jpain.2011.10.006; Valencia C, 2011, J PAIN, V12, P133, DOI 10.1016/j.jpain.2010.06.002; Woby SR, 2005, PAIN, V117, P137, DOI 10.1016/j.pain.2005.05.029; Wu CL, 2005, REGION ANESTH PAIN M, V30, P516, DOI 10.1016/j.rapm.2005.07.190; Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033; Yarnitsky D, 2014, PAIN, V155, P663, DOI 10.1016/j.pain.2013.11.005	54	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108699	10.1371/journal.pone.0108699	http://dx.doi.org/10.1371/journal.pone.0108699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265560	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000345745400105
J	Zimmermann, J; Abarca, N; Enk, N; Skibbe, O; Kusber, WH; Jahn, R				Zimmermann, Jonas; Abarca, Nelida; Enk, Neela; Skibbe, Oliver; Kusber, Wolf-Henning; Jahn, Regine			Taxonomic Reference Libraries for Environmental Barcoding: A Best Practice Example from Diatom Research	PLOS ONE			English	Article							DNA BARCODE; PROMISE; BIODIVERSITY; TYPIFICATION; DIVERSITY; FUTURE; ALGAE; COX1; VIEW; RBCL	DNA barcoding uses a short fragment of a DNA sequence to identify a taxon. After obtaining the target sequence it is compared to reference sequences stored in a database to assign an organism name to it. The quality of data in the reference database is the key to the success of the analysis. In the here presented study, multiple types of data have been combined and critically examined in order to create best practice guidelines for taxonomic reference libraries for environmental barcoding. 70 unialgal diatom strains from Berlin waters have been established and cultured to obtain morphological and molecular data. The strains were sequenced for 18S V4 rDNA (the pre-Barcode for protists) as well as rbcL data, and identified by microscopy. LM and for some strains also SEM pictures were taken and physical vouchers deposited at the BGBM. 37 freshwater taxa from 15 naviculoid diatom genera were identified. Four taxa from the genera Amphora, Mayamaea, Planothidium and Stauroneis are described here as new. Names, molecular, morphological and habitat data as well as additional images of living cells are also available electronically in the AlgaTerra Information System. All reference sequences (or reference barcodes) presented here are linked to voucher specimens in order to provide a complete chain of evidence back to the formal taxonomic literature.	[Zimmermann, Jonas; Abarca, Nelida; Enk, Neela; Skibbe, Oliver; Kusber, Wolf-Henning; Jahn, Regine] Free Univ Berlin, Bot Garden & Bot Museum Berlin Dahlem, Berlin, Germany; [Zimmermann, Jonas] Univ Giessen, AG Spezielle Bot, D-35390 Giessen, Hessen, Germany; [Skibbe, Oliver] Larger Life Micro & Nat Photog, Berlin, Germany	Free University of Berlin; Justus Liebig University Giessen	Zimmermann, J (corresponding author), Free Univ Berlin, Bot Garden & Bot Museum Berlin Dahlem, Berlin, Germany.	j.zimmermann@bgbm.org		Skibbe, Oliver/0000-0003-1495-5468; Zimmermann, Jonas/0000-0002-0522-0569	Deutsche Forschungsgemeinschaft [INST 130/839-1 FUGG, GE 12 42/11-1 RJ]; German Federal Ministry of Education and Research [01 LI 1001 A]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Deutsche Forschungsgemeinschaft (http://www.dfg.de/) grant INST 130/839-1 FUGG. Institution was funded. Deutsche Forschungsgemeinschaft (http://www.dfg.de/) grant GE 12 42/11-1 RJ; JZ is employed on this grant. German Federal Ministry of Education and Research (http://www.bmbf.de/) funding for microscopy data within the GBIF-D project 01 LI 1001 A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086885; [Anonymous], 1999, IUOB MUSEUM NH INT C; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Becker S, 2011, MITOCHONDR DNA, V22, P3, DOI 10.3109/19401736.2010.535528; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Bold H, 1978, INTRO ALGAE STRUCTUR, P571; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Bruder K, 2007, NOVA HEDWIGIA, V85, P331, DOI 10.1127/0029-5035/2007/0085-0331; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Cocquyt C, 2013, DIATOM RES, V28, P121, DOI 10.1080/0269249X.2012.752411; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Droege G, 2013, NUCL ACIDS RES; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eiler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053516; Enke N, 2012, ECOL INFORM, V11, P25, DOI 10.1016/j.ecoinf.2012.03.004; Ettl H, 2013, SYLLABUS BODEN LUFT, P773; European-Committee-for-Standardization, 2003, 14407 EN EUR COMM ST; Evans KM, 2008, J PHYCOL, V44, P215, DOI 10.1111/j.1529-8817.2007.00454.x; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Geissler U, 2003, ARTENDIVERSITAT VERA, P777; Gemeinholzer B, 2009, DNA BANK NETWORK WEB; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Hamsher SE, 2011, PROTIST, V162, P405, DOI 10.1016/j.protis.2010.09.005; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hofmann G, 2011, DIATOMEEN SUSSWASSER; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jahn R, 2005, ALGATERRA INFORM SYS; Jahn R., 2007, P 1 CENTR EUR DIAT M, P63; Jahn R, 2009, FOTTEA, V9, P275, DOI 10.5507/fot.2009.027; Kelly MG, 1998, J APPL PHYCOL, V10, P215, DOI 10.1023/A:1008033201227; Kermarrec L, 2013, MOL ECOL RESOUR, V13, P607, DOI 10.1111/1755-0998.12105; Kermarrec L, FRESHWATER SCIENCE, V33, P349; Krammer K, 1997, BACILLARIOPHYCEAE; Kusber WH, 2001, OKOLOGIE UMWELTSIHER, V21, P197; Kvist S, 2013, MOL PHYLOGENET EVOL, V69, P39, DOI 10.1016/j.ympev.2013.05.012; Lange-Bertalot H, 2001, NAVICULA SENSU STRIC; Levkov Z, 2014, DIATOMS EUROPE DIATO, V7, P7; Levkov Z, 2009, DIATOMS EUROPE DIATO, P5; MacGillivary ML, 2011, J EUKARYOT MICROBIOL, V58, P529, DOI 10.1111/j.1550-7408.2011.00585.x; Mann DG, 2010, CRYPTOGAMIE ALGOL, V31, P557; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Mann DG, 1996, HYDROBIOLOGIA, V336, P19, DOI 10.1007/BF00010816; Marakeby H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089142; McNeill J, 2012, REGNUM VEG, V154, P1; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Moniz MBJ, 2010, PROTIST, V161, P7, DOI 10.1016/j.protis.2009.07.001; Moniz MBJ, 2009, MOL ECOL RESOUR, V9, P65, DOI 10.1111/j.1755-0998.2009.02633.x; Muller J, 2010, PHYDE PHYLOGENETIC D; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Poulickova A, 2008, HYDROBIOLOGIA, V614, P373, DOI 10.1007/s10750-008-9521-y; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Ratnasingham S, 2007, MOL ECOLOGY NOTES; Robba L, 2006, AM J BOT, V93, P1101, DOI 10.3732/ajb.93.8.1101; Romero OE, 2013, DIATOM RES, V28, P175, DOI 10.1080/0269249X.2013.770801; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Schaumburg J, 2004, LIMNOLOGICA, V34, P302, DOI 10.1016/S0075-9511(04)80003-3; Schaumburg J, 2005, FLIESSGEWASSERN UMSE; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; Straub F, 1990, OUVRAGE DEDIE MEMOIR; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Van der Vijver B, 2004, BIBLIOTHECA DIATOMOL, P51; Vanelslander B, 2009, J PHYCOL, V45, P1278, DOI 10.1111/j.1529-8817.2009.00762.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Watanabe T, 1988, P 9 INT DIAT S 1986, P123; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x; Zimmermann J, MOL ECOLOGY RESOURCE; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6	73	69	73	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108793	10.1371/journal.pone.0108793	http://dx.doi.org/10.1371/journal.pone.0108793			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265556	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400123
J	Chiang, TC; Lu, RB; Hsieh, S; Chang, YH; Yang, YK				Chiang, Tzu-Ching; Lu, Ru-Band; Hsieh, Shulan; Chang, Yun-Hsuan; Yang, Yen-Kuang			Stimulation in the Dorsolateral Prefrontal Cortex Changes Subjective Evaluation of Percepts	PLOS ONE			English	Article							EXECUTIVE ATTENTION; METAMEMORY; BLINDSIGHT	Nelson and Narens have proposed a metacognition model that dissociates the objective processing of information (object-level) and the subjective evaluation of the performance (i.e., the metalevel). Neurophysiological evidence also indicates that the prefrontal cortices (PFC) are the brain areas which perform the metalevel function [1-3]. A corresponding neural mechanism of Nelson and Narens's model, called dynamic filtering theory [4,5], indicates that object-level processing is distributed in the posterior cortices and regulated by the prefrontal cortices with a filtering or gating mechanism to select appropriate signals and suppress inappropriate signals and noise. Based on this model, a hypothesis can be developed that, in the case of uncertainty or overloading of object-level processing, the prefrontal cortices will become more active in order to modulate signals and noise. This hypothesis is supported by a recent fMRI study [6] showing that the PFC (Brodmann area 9, BA9) was activated when subjects were overloaded in a bimodal attentional task, compared to a unimodal task. Here, we report a study showing that applying repetitive transmagnetic stimulation (rTMS) over the BA9 in order to interfere with its functional activity resulted in significant increas in guessed responses, compared to three other control conditions (i.e., no-TMS, sham TMS on BA9, and rTMS on Cz). The results are compatible with the dynamic filtering theory and suggest that a malfunction of the PFC would weaken the quality of meta-cognitive percepts and increase the number of guessed responses.	[Chiang, Tzu-Ching] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Chiang, Tzu-Ching] Natl Chung Cheng Univ, Dept Psychol, Chiayi, Taiwan; [Lu, Ru-Band; Yang, Yen-Kuang] Natl Cheng Kung Univ & Hosp, Coll Med, Dept Psychiat, Tainan, Taiwan; [Lu, Ru-Band; Yang, Yen-Kuang] Natl Cheng Kung Univ, Coll Med, Inst Behav Med, Tainan 70101, Taiwan; [Lu, Ru-Band; Hsieh, Shulan; Chang, Yun-Hsuan] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan 70101, Taiwan; [Hsieh, Shulan] Natl Cheng Kung Univ, Dept Psychol, Tainan 70101, Taiwan	Western University (University of Western Ontario); National Chung Cheng University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Chiang, TC (corresponding author), Univ Western Ontario, Brain & Mind Inst, London, ON, Canada.	tchiang5@uwo.ca		Hsieh, Shulan/0000-0001-6247-244X	Ministry of Science and Technology [MOST100-2410-H-194-047]; National Cheng Kung University Hospital [NCKUH-9902022]; Headquarters of University Advancement at the National Cheng Kung University; Ministry of Education, Taiwan, R.O.C.	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Cheng Kung University Hospital; Headquarters of University Advancement at the National Cheng Kung University; Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan)	The research was made possible by the following funding from Ministry of Science and Technology (MOST100-2410-H-194-047) and National Cheng Kung University Hospital (NCKUH-9902022). In addition, this research received funding from the Headquarters of University Advancement at the National Cheng Kung University, which is sponsored by the Ministry of Education, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Chiang TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077408; Dienes Z, 2008, PROG BRAIN RES, V168, P49, DOI 10.1016/S0079-6123(07)68005-4; Dienes Z, 2013, CORTEX, V49, P386, DOI 10.1016/j.cortex.2012.07.009; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Fleck MS, 2006, CEREB CORTEX, V16, P1623, DOI 10.1093/cercor/bhj097; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Galvin SJ, 2003, PSYCHON B REV, V10, P843, DOI 10.3758/BF03196546; Gelfand SA, 2010, HEARING INTRO PSYCH; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; Kaiser P., 1991, LIMITS VISION, P171; KOLB FC, 1995, NATURE, V377, P336, DOI 10.1038/377336a0; Macmillan NA, 2005, DETECTION THEORY USE; Maniscalco B, 2012, CONSCIOUS COGN, V21, P422, DOI 10.1016/j.concog.2011.09.021; McGuire JT, 2010, P NATL ACAD SCI USA, V107, P7922, DOI 10.1073/pnas.0910662107; Morgan MJ, 1997, NATURE, V385, P401, DOI 10.1038/385401b0; Naccache L, 2005, NEUROPSYCHOLOGIA, V43, P1318, DOI 10.1016/j.neuropsychologia.2004.11.024; Nelson T. O., 1994, METACOGNITION KNOWIN, P1, DOI [10.7551/mitpress/4561.001.0001, DOI 10.1080/01443410.2013.860217]; Nelson T.O., 1990, PSYCHOL LEARNING MOT, V26, P125, DOI [10.1016/S0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5, 10.1016/s0079-7421(08)60053-5]; Pannu JK, 2005, NEUROPSYCHOL REV, V15, P105, DOI 10.1007/s11065-005-7091-6; Pannu JK, 2005, J INT NEUROPSYCH SOC, V11, P668, DOI 10.1017/S13556177050873; RABBITT P, 1977, Q J EXP PSYCHOL, V29, P727, DOI 10.1080/14640747708400645; Rahnev D, 2011, NAT NEUROSCI, V14, P1513, DOI 10.1038/nn.2948; Rounis E, 2010, COGN NEUROSCI-UK, V1, P165, DOI 10.1080/17588921003632529; Shimamura A. P., 2008, HDB METAMEMORY MEMOR, P373; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Shimamura AP, 1996, METACOGNITION IMPLIC, P210; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Turatto M, 2004, NEUROREPORT, V15, P2549, DOI 10.1097/00001756-200411150-00024	31	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e106943	10.1371/journal.pone.0106943	http://dx.doi.org/10.1371/journal.pone.0106943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259586	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600014
J	Chumbley, J; Fehr, E				Chumbley, Justin; Fehr, Ernst			Does General Motivation Energize Financial Reward-Seeking Behavior? Evidence from an Effort Task	PLOS ONE			English	Article							REINFORCEMENT SENSITIVITY; INDIVIDUAL-DIFFERENCES; RESPONSES; COGNITION; EMOTION	We aimed to predict how hard subjects work for financial rewards from their general trait and state reward-motivation. We specifically asked 1) whether individuals high in general trait "reward responsiveness'' work harder 2) whether task-irrelevant cues can make people work harder, by increasing general motivation. Each trial of our task contained a 1 second earning interval in which male subjects earned money for each button press. This was preceded by one of three predictive cues: an erotic picture of a woman, a man, or a geometric figure. We found that individuals high in trait "reward responsiveness'' worked harder and earned more, irrespective of the predictive cue. Because female predictive cues are more rewarding, we expected them to increase general motivation in our male subjects and invigorate work, but found a more complex pattern.	[Chumbley, Justin; Fehr, Ernst] Univ Zurich, Dept Econ, Zurich, Switzerland	University of Zurich	Chumbley, J (corresponding author), Univ Zurich, Dept Econ, Zurich, Switzerland.	jrchum@gmail.com			UZH; SystemsX, Switzerland; Fonds zur Forderung des Akademischen Nachwuchses (FAN); NCCR Affective Sciences; European Research Council [295642]	UZH; SystemsX, Switzerland; Fonds zur Forderung des Akademischen Nachwuchses (FAN); NCCR Affective Sciences; European Research Council(European Research Council (ERC)European Commission)	JC was funded by a UZH grant (http://www.researchers.uzh.ch/promotion/forschungskredit_en.html), SystemsX, Switzerland (http://www.systemsx.ch/), and a research excellence grant from Fonds zur Forderung des Akademischen Nachwuchses (FAN). EF is funded by NCCR Affective Sciences and European Research Council Grant 295642, Foundations of Economic Preferences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Ariely D, 2009, REV ECON STUD, V76, P451, DOI 10.1111/j.1467-937X.2009.00534.x; BAUMEISTER RF, 1984, J PERS SOC PSYCHOL, V46, P610, DOI 10.1037/0022-3514.46.3.610; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Bolles R.C., 1967, THEORY OF MOTIVATION; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chiew KS, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00015; COHEN RM, 1982, ARCH GEN PSYCHIAT, V39, P593; CORR PJ, 1995, PERS INDIV DIFFER, V19, P47, DOI 10.1016/0191-8869(95)00013-V; Corr PJ, 2004, NEUROSCI BIOBEHAV R, V28, P317, DOI 10.1016/j.neubiorev.2004.01.005; Franken IHA, 2005, APPETITE, V45, P198, DOI 10.1016/j.appet.2005.04.004; Gelman A., 2007, DATA ANAL USING REGR; GRAY JA, 1990, COGNITION EMOTION, V4, P269, DOI 10.1080/02699939008410799; Gray JR, 2002, P NATL ACAD SCI USA, V99, P4115, DOI 10.1073/pnas.062381899; Hartig J., 2003, Z DIFFER DIAGN PSYCH, V24, P293, DOI [DOI 10.1024/0170-1789.24.4.293, 10.1024/0170-1789.24.4.293]; Henriques JB, 2000, COGNITION EMOTION, V14, P711, DOI 10.1080/02699930050117684; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Niv Y, 2006, ADV NEURAL INF PROCE, V18, P1019; Scheres Anouk, 2006, Behav Brain Funct, V2, P35, DOI 10.1186/1744-9081-2-35; Smillie LD, 2006, PERS INDIV DIFFER, V40, P1039, DOI 10.1016/j.paid.2005.10.012; Smillie LD, 2008, EUR J PERSONALITY, V22, P359, DOI 10.1002/per.674; Sorrentino R. M., 1986, HDB MOTIVATION COGNI, V1, P379; Van den Berg I, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00239; Van den Bergh B, 2008, J CONSUM RES, V35, P85, DOI 10.1086/525505; Van den Bergh B, 2006, P R SOC B, V273, P2091, DOI 10.1098/rspb.2006.3550	26	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e101936	10.1371/journal.pone.0101936	http://dx.doi.org/10.1371/journal.pone.0101936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IP	25259798	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600001
J	Qin, SY; Zhou, Y; Li, P; Jiang, HX				Qin, Shan-yu; Zhou, You; Li, Ping; Jiang, Hai-xing			Diagnostic Efficacy of Cell Block Immunohistochemistry, Smear Cytology, and Liquid-Based Cytology in Endoscopic Ultrasound-Guided Fine-Needle Aspiration of Pancreatic Lesions: A Single-Institution Experience	PLOS ONE			English	Article							CONVENTIONAL SMEAR; URINE CYTOLOGY; FNA BIOPSY; BILE-DUCT; CARCINOMA; ACCURACY; MASSES; NEOPLASMS; SPECIMENS; 25-GAUGE	Background: The diagnostic efficiency of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) cytology varies widely depending on the treatment method of the specimens. The present study aimed to evaluate the diagnostic efficacy of cell block (CB) immunohistochemistry, smear cytology (SC), and liquid-based cytology (LBC) in patients with pancreatic lesions without consulting an on-site cytopathologist. Methods: This study prospectively enrolled 72 patients with pancreatic lesions. The EUS-FNA specimens were examined by SC, LBC, and CB immunohistochemistry. The diagnostic efficacy of the 3 methods was then compared. Patients' final diagnosis was confirmed by surgical resection specimens, diagnostic imaging, and clinical follow-up. Results: Our results included 60 malignant and 12 benign pancreatic lesions. The diagnostic sensitivity (90%), negative predictive value (66.7%), and accuracy (91.7%) of CB immunohistochemistry were significantly higher than those of SC (70.0%, 30.0%, and 75.0%, respectively) and LBC (73.3%, 31.6%, and 77.8%, respectively) (all P < 0.05). The combination of CB and SC, or CB and LBC, did not significantly increase the efficacy compared to CB immunohistochemistry alone. Conclusion: Our findings suggest that in the absence of an on-site cytopathologist, CB immunohistochemistry on EUS-FNA specimens offers a higher diagnostic efficacy in patients with pancreatic lesions than does SC and LBC.	[Qin, Shan-yu; Jiang, Hai-xing] Guangxi Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanning, Guangxi, Peoples R China; [Zhou, You] Minerva Fdn, Helsinki, Finland; [Li, Ping] Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Zhou, Y (corresponding author), Minerva Fdn, Helsinki, Finland.	you.zhou@helsinki.fi; gxjianghx@163.com		ZHOU, YOU/0000-0002-1743-1291	Science and Technology Project of Guangxi Higher Education [LX2014076]	Science and Technology Project of Guangxi Higher Education	This study was supported by research funding from the Science and Technology Project of Guangxi Higher Education (LX2014076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B, 2008, GASTROINTEST ENDOSC, V68, P237, DOI 10.1016/j.gie.2008.01.026; Ardengh JC, 2007, WORLD J GASTROENTERO, V13, P3112, DOI 10.3748/wjg.v13.i22.3112; Ardengh Jose Celso, 2008, Acta Gastroenterologica Latinoamericana, V38, P246; Bernstein SJ, 2001, AM J OBSTET GYNECOL, V185, P308, DOI 10.1067/mob.2001.116736; Chhieng DC, 2003, CANCER CYTOPATHOL, V99, P365, DOI 10.1002/cncr.11857; Collins BT, 2013, CANCER CYTOPATHOL, V121, P518, DOI 10.1002/cncy.21340; Eloubeidi MA, 2006, AM J GASTROENTEROL, V101, P2841, DOI 10.1111/j.1572-0241.2006.00852.x; Haba S, 2013, J GASTROENTEROL, V48, P973, DOI 10.1007/s00535-012-0695-8; Hosoda W, 2010, PATHOL INT, V60, P358, DOI 10.1111/j.1440-1827.2010.02527.x; Hutchinson ML, 1999, CANCER CYTOPATHOL, V87, P48, DOI 10.1002/(SICI)1097-0142(19990425)87:2&lt;48::AID-CNCR2&gt;3.0.CO;2-D; Iglesias-Garcia J, 2011, AM J GASTROENTEROL, V106, P1705, DOI 10.1038/ajg.2011.119; Iwashita T, 2013, GASTROINTEST ENDOSC, V77, P909, DOI 10.1016/j.gie.2013.01.001; Klapman JB, 2003, AM J GASTROENTEROL, V98, P1289, DOI 10.1016/S0002-9270(03)00246-6; Kopelman Y, 2011, CYTOPATHOLOGY, V22, P174, DOI 10.1111/j.1365-2303.2010.00766.x; Layfield LJ, 2001, CANCER CYTOPATHOL, V93, P319, DOI 10.1002/cncr.9046; LeBlanc JK, 2010, ENDOSCOPY, V42, P389, DOI 10.1055/s-0029-1243841; Lee JK, 2013, SCAND J GASTROENTERO, V48, P752, DOI 10.3109/00365521.2013.786127; Lee JK, 2011, ACTA CYTOL, V55, P401, DOI 10.1159/000330811; Linder J, 1998, DIAGN CYTOPATHOL, V18, P24, DOI 10.1002/(SICI)1097-0339(199801)18:1<24::AID-DC5>3.0.CO;2-U; Liu K, 1998, DIAGN CYTOPATHOL, V19, P70, DOI 10.1002/(SICI)1097-0339(199807)19:1<70::AID-DC15>3.3.CO;2-L; Mansy SS, 2006, ULTRASTRUCT PATHOL, V30, P379, DOI 10.1080/01913120600854269; Meara RS, 2006, CYTOPATHOLOGY, V17, P42, DOI 10.1111/j.1365-2303.2006.00319.x; Mitsuhashi T, 2006, CYTOPATHOLOGY, V17, P34, DOI 10.1111/j.1365-2303.2006.00277.x; Nathan NA, 2000, AM J CLIN PATHOL, V114, P599, DOI 10.1309/G035-P2MM-D1TM-T5QE; Noda Y, 2010, J GASTROENTEROL, V45, P868, DOI 10.1007/s00535-010-0217-5; Raddaoui E, 2011, ACTA CYTOL, V55, P26, DOI 10.1159/000320908; Sai JK, 2013, GASTROINTEST ENDOSC, V77, P726, DOI 10.1016/j.gie.2012.11.008; Son SM, 2012, KOREAN J PATHOL, V46, P68, DOI 10.4132/KoreanJPathol.2012.46.1.68; Sykes PH, 2008, BJOG-INT J OBSTET GY, V115, P1375, DOI 10.1111/j.1471-0528.2008.01865.x; Varadarajulu S, 2005, GASTROINTEST ENDOSC, V62, P728, DOI 10.1016/j.gie.2005.06.051; Volmar KE, 2005, GASTROINTEST ENDOSC, V61, P854, DOI 10.1016/S0016-5107(05)00364-0; Woolf KM, 2013, CANC CYTOPATHOL	32	43	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108762	10.1371/journal.pone.0108762	http://dx.doi.org/10.1371/journal.pone.0108762			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259861	Green Submitted, Green Published, gold			2022-12-27	WOS:000342685600099
J	Saradjian, AH; Paleressompoulle, D; Louber, D; Coyle, T; Blouin, J; Mouchnino, L				Saradjian, Anahid H.; Paleressompoulle, Dany; Louber, Didier; Coyle, Thelma; Blouin, Jean; Mouchnino, Laurence			Do Gravity-Related Sensory Information Enable the Enhancement of Cortical Proprioceptive Inputs When Planning a Step in Microgravity?	PLOS ONE			English	Article							SOMATOSENSORY-EVOKED-POTENTIALS; PROLONGED WEIGHTLESSNESS; POINTING MOVEMENTS; VOLUNTARY MOVEMENT; POSTURAL RESPONSES; BODY ORIENTATION; EGOCENTRIC SPACE; CEREBRAL-CORTEX; H-REFLEX; STIMULATION	We recently found that the cortical response to proprioceptive stimulation was greater when participants were planning a step than when they stood still, and that this sensory facilitation was suppressed in microgravity. The aim of the present study was to test whether the absence of gravity-related sensory afferents during movement planning in microgravity prevented the proprioceptive cortical processing to be enhanced. We reestablished a reference frame in microgravity by providing and translating a horizontal support on which the participants were standing and verified whether this procedure restored the proprioceptive facilitation. The slight translation of the base of support (lateral direction), which occurred prior to step initiation, stimulated at least cutaneous and vestibular receptors. The sensitivity to proprioceptive stimulation was assessed by measuring the amplitude of the cortical somatosensory-evoked potential (SEP, over the Cz electrode) following the vibration of the leg muscle. The vibration lasted 1 s and the participants were asked to either initiate a step at the vibration offset or to remain still. We found that the early SEP (90-160 ms) was smaller when the platform was translated than when it remained stationary, revealing the existence of an interference phenomenon (i.e., when proprioceptive stimulation is preceded by the stimulation of different sensory modalities evoked by the platform translation). By contrast, the late SEP (550 ms post proprioceptive stimulation onset) was greater when the translation preceded the vibration compared to a condition without pre-stimulation (i.e., no translation). This suggests that restoring a body reference system which is impaired in microgravity allowed a greater proprioceptive cortical processing. Importantly, however, the late SEP was similarly increased when participants either produced a step or remained still. We propose that the absence of step-induced facilitation of proprioceptive cortical processing results from a decreased weight of proprioception in the absence of balance constraints in microgravity.	[Saradjian, Anahid H.; Louber, Didier; Blouin, Jean; Mouchnino, Laurence] Aix Marseille Univ, CNRS, Lab Neurosci Cognit UMR 7291, Marseille, France; [Paleressompoulle, Dany] Aix Marseille Univ, CNRS, Federat Rech Comportement Cerveau Cognit 3C, Marseille, France; [Coyle, Thelma] Aix Marseille Univ, CNRS, Inst Sci Mouvement, UMR 7287, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Mouchnino, L (corresponding author), Aix Marseille Univ, CNRS, Lab Neurosci Cognit UMR 7291, Marseille, France.	laurence.mouchnino@univ-amu.fr		Blouin, Jean/0000-0002-8118-8994	CNES [4800000624]	CNES(Centre National D'etudes Spatiales)	This study was supported by CNES, Grant no. 4800000624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkin AL, 2008, NEUROSCI LETT, V435, P120, DOI 10.1016/j.neulet.2008.02.018; ALTENMULLER E, 1995, EVOKED POTENTIAL, V96, P516, DOI 10.1016/0013-4694(95)00093-E; Asanuma K, 2003, NEUROREPORT, V14, P375, DOI 10.1097/01.wnr.0000059625.96928.89; Bernier PM, 2009, CEREB CORTEX, V19, P2106, DOI 10.1093/cercor/bhn233; Blanke O, 2005, NEUROSCIENTIST, V11, P16, DOI 10.1177/1073858404270885; BLOUIN J, 1995, J NEUROPHYSIOL, V74, P2216, DOI 10.1152/jn.1995.74.5.2216; Blouin J, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-25; Bolton DAE, 2011, EXP BRAIN RES, V212, P279, DOI 10.1007/s00221-011-2728-6; Bottini G, 2001, BRAIN, V124, P1182, DOI 10.1093/brain/124.6.1182; Bringoux L, 2012, J NEUROPHYSIOL, V107, P2541, DOI 10.1152/jn.00364.2011; BRUNT D, 1991, AM J PHYS MED REHAB, V70, P206, DOI 10.1097/00002060-199108000-00009; BURKE D, 1988, ELECTROEN CLIN NEURO, V70, P118, DOI 10.1016/0013-4694(88)90112-5; BURKE D, 1982, ELECTROEN CLIN NEURO, V53, P349, DOI 10.1016/0013-4694(82)90001-3; BURKE D, 1981, ELECTROEN CLIN NEURO, V51, P579, DOI 10.1016/0013-4694(81)90202-9; Carriot J, 2004, AVIAT SPACE ENVIR MD, V75, P795; Chapman CE, 2005, J NEUROPHYSIOL, V94, P4094, DOI 10.1152/jn.00303.2005; CHERON G, 1987, ELECTROEN CLIN NEURO, V67, P537, DOI 10.1016/0013-4694(87)90056-3; CLEMENT G, 1988, EXP BRAIN RES, V72, P381; Cybulska-Klosowicz A, 2011, EXP BRAIN RES, V210, P291, DOI 10.1007/s00221-011-2632-0; Day BL, 2002, BRAIN, V125, P2081, DOI 10.1093/brain/awf212; Dietz V, 2001, NEUROREPORT, V12, P2743, DOI 10.1097/00001756-200108280-00030; Disbrow E, 2003, J COMP NEUROL, V462, P382, DOI 10.1002/cne.10731; DUYSENS J, 1995, EXP BRAIN RES, V105, P423; Eickhoff SB, 2006, HUM BRAIN MAPP, V27, P611, DOI 10.1002/hbm.20205; EKLUND G, 1966, EXP NEUROL, V16, P80, DOI 10.1016/0014-4886(66)90088-4; Ferre ER, 2011, EUR J NEUROSCI, V34, P1337, DOI 10.1111/j.1460-9568.2011.07859.x; Ferre ER, 2012, BRAIN STRUCT FUNCT, V217, P859, DOI 10.1007/s00429-012-0404-7; FISK J, 1993, J NEUROPHYSIOL, V69, P504, DOI 10.1152/jn.1993.69.2.504; Gaveau J, 2011, J NEUROPHYSIOL, V106, P620, DOI 10.1152/jn.00081.2011; Gentili RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005176; Gianna C, 1996, BRAIN RES BULL, V40, P443, DOI 10.1016/0361-9230(96)00140-2; Glasauer S, 1998, BRAIN RES REV, V28, P185, DOI 10.1016/S0165-0173(98)00038-1; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P559; Guldin WO, 1998, TRENDS NEUROSCI, V21, P254, DOI 10.1016/S0166-2236(97)01211-3; Gurfinkel' V. S., 1996, Fiziologiya Cheloveka, V22, P83; Hlavacka F, 2006, PHYSIOL RES, V55, pS121, DOI 10.33549/physiolres.930000.55.S1.121; Hlavacka F, 1996, BRAIN RES BULL, V40, P431, DOI 10.1016/0361-9230(96)00138-4; Horak FB, 2001, J NEUROPHYSIOL, V86, P575, DOI 10.1152/jn.2001.86.2.575; Hultborn H, 1996, EXP BRAIN RES, V108, P450; Jacobs JV, 2008, CLIN NEUROPHYSIOL, V119, P1431, DOI 10.1016/j.clinph.2008.02.015; KARNATH HO, 1994, BRAIN, V117, P1001, DOI 10.1093/brain/117.5.1001; Kennedy PM, 2001, CLIN NEUROPHYSIOL, V112, P2159, DOI 10.1016/S1388-2457(01)00665-4; MacKinnon CD, 2007, J NEUROPHYSIOL, V97, P4368, DOI 10.1152/jn.01136.2006; Mizelle JC, 2010, EXP BRAIN RES, V203, P659, DOI 10.1007/s00221-010-2273-8; Mochizuki G, 2008, CLIN NEUROPHYSIOL, V119, P1626, DOI 10.1016/j.clinph.2008.03.020; Morita H, 1998, EXP BRAIN RES, V120, P143, DOI 10.1007/s002210050388; Mouchnino L, 1996, J NEUROPHYSIOL, V76, P1212, DOI 10.1152/jn.1996.76.2.1212; Nelson AJ, 2004, COGNITIVE BRAIN RES, V19, P174, DOI 10.1016/j.cogbrainres.2003.11.013; Papaxanthis C, 2005, NEUROSCIENCE, V135, P371, DOI 10.1016/j.neuroscience.2005.06.063; PARKER DE, 1985, AVIAT SPACE ENVIR MD, V56, P601; Perennou DA, 2000, BRAIN RES BULL, V53, P359, DOI 10.1016/S0361-9230(00)00360-9; Pfeiffer C, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00031; Popov KE, 1999, EUR J NEUROSCI, V11, P3307, DOI 10.1046/j.1460-9568.1999.00733.x; Quant S, 2005, NEUROSCI LETT, V381, P269, DOI 10.1016/j.neulet.2005.02.015; Quant S, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-18; Robert G, 2004, HUM MOVEMENT SCI, V23, P169, DOI 10.1016/j.humov.2004.08.001; ROLL JP, 1982, EXP BRAIN RES, V47, P177; Roll R, 1998, EXP BRAIN RES, V122, P393, DOI 10.1007/s002210050527; ROSS HE, 1986, EXP BRAIN RES, V64, P358; Saradjian AH, 2013, J NEUROPHYSIOL, V110, P397, DOI 10.1152/jn.00905.2012; Seki K, 2003, NAT NEUROSCI, V6, P1309, DOI 10.1038/nn1154; Shimazu H, 1999, NEUROREPORT, V10, P2457, DOI 10.1097/00001756-199908200-00004; Sibley KM, 2010, EXP BRAIN RES, V203, P533, DOI 10.1007/s00221-010-2257-8; Staines WR, 2000, NEUROREPORT, V11, P1713, DOI 10.1097/00001756-200006050-00024; Staines WR, 2002, NEUROIMAGE, V15, P190, DOI 10.1006/nimg.2001.0953; STARR A, 1985, BRAIN RES, V348, P183, DOI 10.1016/0006-8993(85)90377-4; STEIN JF, 1989, Q J EXP PHYSIOL CMS, V74, P583, DOI 10.1113/expphysiol.1989.sp003314; Teasdale N, 2001, GAIT POSTURE, V14, P203, DOI 10.1016/S0966-6362(01)00134-5; Wasaka T, 2012, EXP BRAIN RES, V219, P227, DOI 10.1007/s00221-012-3082-z; WATT DGD, 1986, EXP BRAIN RES, V64, P308	71	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108636	10.1371/journal.pone.0108636	http://dx.doi.org/10.1371/journal.pone.0108636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259838	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600090
J	Arunrut, N; Suebsing, R; Withyachumnarnkul, B; Kiatpathomchai, W				Arunrut, Narong; Suebsing, Rungkarn; Withyachumnarnkul, Boonsirm; Kiatpathomchai, Wansika			Demonstration of a Very Inexpensive, Turbidimetric, Real-Time, RT-LAMP Detection Platform Using Shrimp Laem-Singh Virus (LSNV) as a Model	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; LATERAL FLOW DIPSTICK; TAURA-SYNDROME VIRUS; DOUBLE-STRANDED-RNA; PENAEUS-MONODON; SENSITIVE DETECTION; TIGER SHRIMP; THAILAND; HYBRIDIZATION; PATHOGENS	Rapid and accurate detection of pathogens under field laboratory conditions is necessary for effective control of veterinary pathogens. Here we describe a prototype, portable, pathogen detection device developed for single tube, real-time, reverse transcription, loop-mediated isothermal amplification (RT-LAMP) using Laem-Singh virus (LSNV) as a model. LSNV is an RNA virus and a component cause of growth retardation in black tiger shrimp. We chose its RNA-dependent RNA polymerase (RdRp) gene as the target for our tests. The basis for detection was measurement of turbidity arising from formation of a white, insoluble magnesium pyrophosphate precipitate byproduct upon amplification of the RdRp target sequence from 100 ng template RNA extracted from shrimp. The measurement device consisted of a heating block to maintain constant temperature in the RT-LAMP reaction for 8 Eppindorf sample tubes, a light-emitting diode (LED) light source providing red light emission at 650 nm wavelength to pass through sample tubes, a light dependent resistance (LDR) photo-detector and a software program to report turbidity events and could potentially be marketed for under US$3000. The device was connected to a computer to display real-time results in a variety of formats. The optimized protocol for LSNV detection consisted of incubation of the sample tubes at 65 degrees C for 1 h during which turbidity was continuously measured, and quantitative results could be obtained by reaction time measurement. The sensitivity of detection was comparable to that of conventional nested RT-PCR and there was no cross reaction with other common shrimp viruses. The device was used for quantitative measurement of relative copy numbers of LSNV RdRp in 8 shrimp tissues and they were found to be highest in the gills followed in order by the lymphoid organ and hemolymph (p <= 0.05). This platform can be easily adapted for detection of other pathogens under field laboratory settings.	[Arunrut, Narong; Suebsing, Rungkarn; Withyachumnarnkul, Boonsirm; Kiatpathomchai, Wansika] Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol CENEX, Bangkok 10400, Thailand; [Arunrut, Narong; Suebsing, Rungkarn; Kiatpathomchai, Wansika] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand; [Withyachumnarnkul, Boonsirm] Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand; [Withyachumnarnkul, Boonsirm] Prince Songkla Univ, Fac Sci & Ind Technol, Aquat Anim Biotechnol Res Ctr, Surat Thani, Thailand	Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Prince of Songkla University	Kiatpathomchai, W (corresponding author), Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol CENEX, Bangkok 10400, Thailand.	wansika@biotec.or.th	Kiatpathomchai, Wansika/F-1625-2011; Suebsing, Rungkarn/AAL-7161-2021		National Science and Technology Development Agency; Mahidol University	National Science and Technology Development Agency; Mahidol University	This work was supported by grants from the National Science and Technology Development Agency and Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunrut N, 2013, J VIROL METHODS, V193, P542, DOI 10.1016/j.jviromet.2013.07.017; Arunrut N, 2011, J VIROL METHODS, V177, P71, DOI 10.1016/j.jviromet.2011.06.020; Arunrut N, 2011, J VIROL METHODS, V171, P21, DOI 10.1016/j.jviromet.2010.09.022; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Chayaburakul K, 2004, DIS AQUAT ORGAN, V60, P89, DOI 10.3354/dao060089; Fauquet C. M., 2000, VIRUS TAXONOMY; Flegel TW, 2006, AQUACULTURE, V258, P1, DOI 10.1016/j.aquaculture.2006.05.013; Flegel TW, 2012, J INVERTEBR PATHOL, V110, P166, DOI 10.1016/j.jip.2012.03.004; Jaroenrama W, 2009, MOL CELL PROBE, V23, P65, DOI 10.1016/j.mcp.2008.12.003; Khunthong S, 2013, J VIROL METHODS, V188, P51, DOI 10.1016/j.jviromet.2012.11.041; Kiatpathomchai W, 2008, J VIROL METHODS, V153, P214, DOI 10.1016/j.jviromet.2008.06.025; Mekata T, 2009, J VIROL METHODS, V162, P81, DOI 10.1016/j.jviromet.2009.07.018; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; Panphut W, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-18; Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005; Poon LLM, 2005, J CLIN MICROBIOL, V43, P427, DOI 10.1128/JCM.43.1.427-430.2005; Prakasha BK, 2007, DIS AQUAT ORGAN, V77, P83, DOI 10.3354/dao01835; Pratoomthai B, 2008, AQUACULTURE, V284, P53, DOI 10.1016/j.aquaculture.2008.07.040; Saksmerprome V, 2013, J BIOTECHNOL, V164, P449, DOI 10.1016/j.jbiotec.2013.01.028; Sappat A, 2011, J VIROL METHODS, V175, P141, DOI 10.1016/j.jviromet.2011.05.013; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Sritunyalucksana K, 2006, VIRUS RES, V118, P31, DOI 10.1016/j.virusres.2005.11.005; Teng PH, 2007, J VIROL METHODS, V146, P317, DOI 10.1016/j.jviromet.2007.07.027; Thammasorn T, 2013, ANTIVIR RES, V100, P202, DOI 10.1016/j.antiviral.2013.08.005	25	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108047	10.1371/journal.pone.0108047	http://dx.doi.org/10.1371/journal.pone.0108047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255231	gold, Green Published, Green Submitted			2022-12-27	WOS:000344862300053
J	Ilie, G; Adlaf, EM; Mann, RE; Boak, A; Hamilton, H; Asbridge, M; Colantonio, A; Turner, NE; Rehm, J; Cusimano, MD				Ilie, Gabriela; Adlaf, Edward M.; Mann, Robert E.; Boak, Angela; Hamilton, Hayley; Asbridge, Mark; Colantonio, Angela; Turner, Nigel E.; Rehm, Juergen; Cusimano, Michael D.			The Moderating Effects of Sex and Age on the Association between Traumatic Brain Injury and Harmful Psychological Correlates among Adolescents	PLOS ONE			English	Article							GENDER-DIFFERENCES; RISK BEHAVIOR; UNITED-STATES; HEAD-INJURY; VALIDITY; HEALTH; WOMEN; PREVALENCE; DISORDERS; CHILDREN	Background: Although it is well established that sex is a risk factor in acquiring a traumatic brain injury (TBI) among adolescents, it has not been established whether it also moderates the influence of other TBI psychological health correlates. Methods and Findings: Data were derived from a 2011 population-based cross-sectional school survey, which included 9,288 Ontario 7th-12th graders who completed anonymous self-administered questionnaires in classrooms. Response rate was 62%. Preliminary analyses found no evidence of nonresponse bias in the reporting of TBI. TBI was defined as a hit or blow to the head that resulted in a 5 minutes loss of consciousness or at least one overnight hospitalization due to symptoms associated with it. Reports of lifetime TBI were more common among males than females (23.1%, 95% CI: 20.5, 25.8 vs. 17.1%, 95% CI: 14.7, 19.8). Thirteen correlates were examined and included cigarette smoking, elevated psychological distress, suicide ideation, bully victimization (at school, as well as cyber bullying), bullying others, cannabis use, cannabis dependence and drug use problems, physical injuries, daily smoking, drinking alcohol, binge drinking, use of cannabis, and poor academic performance. Among the outcomes examined, sex moderated the relationship between lifetime TBI and cigarette smoking. In addition, sex and age jointly moderated the relationship between lifetime TBI and daily smoking, alcohol use and physical injuries. Late adolescent males who reported lifetime TBI, relative to females, displayed elevated daily smoking and injuries, whereas their females counterparts displayed elevated past year drinking. Possible bias related to self-report procedures and the preclusion of causal inferences due to the cross-sectional nature of the data are limitations of this study. Conclusions: TBI differences in outcomes need to be assessed for potential moderating effects of sex and age. Results have important implications for more tailored injury prevention efforts.	[Ilie, Gabriela; Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Ilie, Gabriela; Cusimano, Michael D.] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Adlaf, Edward M.; Mann, Robert E.; Boak, Angela; Hamilton, Hayley; Turner, Nigel E.; Rehm, Juergen] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Adlaf, Edward M.; Mann, Robert E.; Hamilton, Hayley; Colantonio, Angela; Turner, Nigel E.; Rehm, Juergen; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Emergency Med, Halifax, NS, Canada; [Colantonio, Angela] Toronto Rehabil Inst, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Dalhousie University; Dalhousie University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute	Ilie, G (corresponding author), St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	ilieg@smh.ca	Cusimano, Michael/GWR-1025-2022; Cusimano, Michael/X-4059-2019; Ilie, Gabriela/AAM-9122-2021; Turner, Nigel E/ABC-8263-2020	Turner, Nigel E/0000-0002-1035-2064; Chen, Xinguang/0000-0001-8263-643X; Colantonio, Angela/0000-0003-2094-4765	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research [TIR-103946]; Ontario Neurotrauma Foundation; AUTO21, Networks of Centers of Excellence program - Natural Sciences and Engineering Research Council; Social Sciences and Humanities Research Council; Industry Canada; Ontario Ministry of Health and Long-Term Care; CIHR Research Chair in Gender Work and Health [CGW-126580]; Toronto Rehabilitation Institute	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research(Canadian Institutes of Health Research (CIHR)); Ontario Neurotrauma Foundation; AUTO21, Networks of Centers of Excellence program - Natural Sciences and Engineering Research Council; Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Industry Canada; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); CIHR Research Chair in Gender Work and Health(Canadian Institutes of Health Research (CIHR)); Toronto Rehabilitation Institute(University of Toronto)	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research # TIR-103946, and the Ontario Neurotrauma Foundation. Additional funding was obtained from a grant from AUTO21, a member of the Networks of Centers of Excellence program that is administered and funded by the Natural Sciences and Engineering Research Council, the Social Sciences and Humanities Research Council, in partnership with Industry Canada; ongoing funding support from the Ontario Ministry of Health and Long-Term Care; a CIHR Research Chair in Gender Work and Health #?CGW-126580; and the Toronto Rehabilitation Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Arnold C, 2014, LANCET NEUROL, V13, P136, DOI 10.1016/S1474-4422(13)70287-4; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Billette JM, 2013, 82624XWE; Body C, 1996, BRAIN INJURY, V10, P567, DOI 10.1080/026990596124133; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Brown SB, 2012, HEALTH CARE WOMEN IN, V33, P896, DOI 10.1080/07399332.2012.673654; Caro D. H., 2011, GLOBAL J HLTH SCI, V3, P19, DOI DOI 10.5539/GJHS.V3N1P19; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centre for Disease Control and Prevention Traumatic Brain Injury in the United States, 2010, EM DEP VIS HOSP DEAT; Chase S, 2012, HEALTH CARE WOMEN IN, V33, P631, DOI 10.1080/07399332.2012.673652; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; FRANCES ALLEN, 2000, DSM 4 CLASSIFICATION; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Ilie G, J HEAD TRAUMA REHABI; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Knight JR, 2002, ARCH PEDIAT ADOL MED, V156, P607, DOI 10.1001/archpedi.156.6.607; Korn E. L., 1999, ANAL HLTH SURVEYS; Levy DT, 2004, MED SCI MONITOR, V10, pCR17; May A, 2011, ASSESSMENT, V18, P379, DOI 10.1177/1073191110374285; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2013, J HEAD TRAUMA REHABI; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moore DW, 2010, NEUROPSYCHOL REHABIL, V20, P340, DOI 10.1080/09602010903250928; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Paglia-Boak A., 2011, CAMH RES DOCUMENT SE, V32; Paglia-Boak A, 2011, CAMH RES DOCUMENT SE, V34; Pickett W, 2002, ARCH PEDIAT ADOL MED, V156, P786, DOI 10.1001/archpedi.156.8.786; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Schmidt AT, 2012, INT J DEV NEUROSCI, V30, P225, DOI 10.1016/j.ijdevneu.2011.11.003; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Tait RJ, 2003, AUST NZ J PSYCHIAT, V37, P374, DOI 10.1046/j.1440-1614.2003.01133.x; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; West BT, 2008, STATA J, V8, P520, DOI 10.1177/1536867X0800800404; Zernicke R. F., 2009, Journal of Intercollegiate Sport, V2, P42	51	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108167	10.1371/journal.pone.0108167	http://dx.doi.org/10.1371/journal.pone.0108167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268238	Green Published, gold			2022-12-27	WOS:000343671700069
J	Lescat, M; Reibel, F; Pintard, C; Dion, S; Glodt, J; Gateau, C; Launay, A; Ledda, A; Cruvellier, S; Tourret, J; Tenaillon, O				Lescat, Mathilde; Reibel, Florence; Pintard, Coralie; Dion, Sara; Glodt, Jeremy; Gateau, Cecile; Launay, Adrien; Ledda, Alice; Cruvellier, Stephane; Tourret, Jerome; Tenaillon, Olivier			The Conserved nhaAR Operon Is Drastically Divergent between B2 and Non-B2 Escherichia coli and Is Involved in Extra-Intestinal Virulence	PLOS ONE			English	Article							NA+/H+ ANTIPORTER; STRAINS; DIVERSITY; ADHESIN; TRANSCRIPTION; ADAPTATION; RESISTANCE; EVOLUTION; SEQUENCE; ISLANDS	The Escherichia coli species is divided in phylogenetic groups that differ in their virulence and commensal distribution. Strains belonging to the B2 group are involved in extra-intestinal pathologies but also appear to be more prevalent as commensals among human occidental populations. To investigate the genetic specificities of B2 sub-group, we used 128 sequenced genomes and identified genes of the core genome that showed marked difference between B2 and non-B2 genomes. We focused on the gene and its surrounding region with the strongest divergence between B2 and non-B2, the antiporter gene nhaA. This gene is part of the nhaAR operon, which is in the core genome but flanked by mobile regions, and is involved in growth at high pH and high sodium concentrations. Consistently, we found that a panel of non-B2 strains grew faster than B2 at high pH and high sodium concentrations. However, we could not identify differences in expression of the nhaAR operon using fluorescence reporter plasmids. Furthermore, the operon deletion had no differential impact between B2 and non-B2 strains, and did not result in a fitness modification in a murine model of gut colonization. Nevertheless, sequence analysis and experiments in a murine model of septicemia revealed that recombination in nhaA among B2 strains was observed in strains with low virulence. Finally, nhaA and nhaAR operon deletions drastically decreased virulence in one B2 strain. This effect of nhaAR deletion appeared to be stronger than deletion of all pathogenicity islands. Thus, a population genetic approach allowed us to identify an operon in the core genome without strong effect in commensalism but with an important role in extra-intestinal virulence, a landmark of the B2 strains.	[Lescat, Mathilde; Reibel, Florence; Pintard, Coralie; Dion, Sara; Glodt, Jeremy; Gateau, Cecile; Launay, Adrien; Ledda, Alice; Tourret, Jerome; Tenaillon, Olivier] INSERM, Unite Mixte Rech UMR 1137, Paris, France; [Lescat, Mathilde] Hop Jean Verdier, Microbiol Lab, Bondy, France; [Lescat, Mathilde] Univ Paris 13, Sorbonne Paris Cite, Paris, France; [Dion, Sara; Glodt, Jeremy] Univ Paris Diderot, Sorbonne Paris Cite, UMR 1137, Paris, France; [Cruvellier, Stephane] Commissariat Energie Atom & Energies Alternat CEA, Inst Genom, UMR 8030, Lab Genom Comparat,CNRS, Evry, France; [Tourret, Jerome] Hop La Pitie Salpetriere, AP HP, Dept Urol Nephrol & Transplantat, Paris, France; [Tourret, Jerome] Univ Paris 06, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Universite Paris 13; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Lescat, M (corresponding author), INSERM, Unite Mixte Rech UMR 1137, Paris, France.	mathilde.lescat@inserm.fr	Tenaillon, Olivier/L-9857-2017	Tenaillon, Olivier/0000-0002-3796-1601	European Research Council under the European Union (FP7)/ERC [310944]	European Research Council under the European Union (FP7)/ERC	This work was supported by the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC Grant 310944. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingen E, 1998, J INFECT DIS, V177, P642, DOI 10.1086/514217; Bleibtreu A, 2013, INFECT IMMUN, V81, P2733, DOI 10.1128/IAI.01329-12; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clermont O, 2008, ENVIRON MICROBIOL, V10, P1000, DOI 10.1111/j.1462-2920.2007.01520.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diard M, 2010, J BACTERIOL, V192, P4885, DOI 10.1128/JB.00804-10; Dover N, 1996, J BACTERIOL, V178, P6508, DOI 10.1128/jb.178.22.6508-6517.1996; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Goller C, 2006, J BACTERIOL, V188, P8022, DOI 10.1128/JB.01106-06; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hommais F, 2003, INFECT IMMUN, V71, P3619, DOI 10.1128/IAI.71.6.3619-3622.2003; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Lescat M, 2013, ENV MICROBIOL REP, V5, P49, DOI 10.1111/j.1758-2229.2012.00374.x; Lesniak J, 2003, PROTEIN SCI, V12, P2838, DOI 10.1110/ps.03375603; Mackenzie IMJ, 2001, ANAESTHESIA, V56, P130, DOI 10.1046/j.1365-2044.2001.01866.x; Maes M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.391128; Nowrouzian FL, 2012, MICROB PATHOGENESIS, V53, P180, DOI 10.1016/j.micpath.2012.05.011; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; PADAN E, 1989, J BIOL CHEM, V264, P20297; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Pannuri A, 2012, J BACTERIOL, V194, P79, DOI 10.1128/JB.06209-11; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; Secher T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077157; Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922; Sturny R, 2003, J BACTERIOL, V185, P4298, DOI 10.1128/JB.185.15.4298-4304.2003; Subashchandrabose S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003788; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Toh H, 2010, J BACTERIOL, V192, P1165, DOI 10.1128/JB.01543-09; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Tourret J, 2011, MICROBIOL-SGM, V157, P774, DOI 10.1099/mic.0.037416-0; Tourret J, 2010, INT J MED MICROBIOL, V300, P435, DOI 10.1016/j.ijmm.2010.04.013; Vallenet D, 2013, NUCLEIC ACIDS RES, V41, pE636, DOI 10.1093/nar/gks1194; Walk ST, 2009, APPL ENVIRON MICROB, V75, P6534, DOI 10.1128/AEM.01262-09; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	41	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108738	10.1371/journal.pone.0108738	http://dx.doi.org/10.1371/journal.pone.0108738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268639	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700152
J	Cai, WL; Su, N; Liu, XD				Cai, Wenli; Su, Ning; Liu, Xiangdong			Unsteady Convection Flow and Heat Transfer over a Vertical Stretching Surface	PLOS ONE			English	Article							MHD FREE-CONVECTION; POROUS-MEDIUM; VARIABLE VISCOSITY; CHEMICAL-REACTION; VISCOUS DISSIPATION; MASS-TRANSFER; MOVING PLATE; RADIATION; SUCTION; BOUNDARY	This paper investigates the effect of thermal radiation on unsteady convection flow and heat transfer over a vertical permeable stretching surface in porous medium, where the effects of temperature dependent viscosity and thermal conductivity are also considered. By using a similarity transformation, the governing time-dependent boundary layer equations for momentum and thermal energy are first transformed into coupled, non-linear ordinary differential equations with variable coefficients. Numerical solutions to these equations subject to appropriate boundary conditions are obtained by the numerical shooting technique with fourth-fifth order Runge-Kutta scheme. Numerical results show that as viscosity variation parameter increases both the absolute value of the surface friction coefficient and the absolute value of the surface temperature gradient increase whereas the temperature decreases slightly. With the increase of viscosity variation parameter, the velocity decreases near the sheet surface but increases far away from the surface of the sheet in the boundary layer. The increase in permeability parameter leads to the decrease in both the temperature and the absolute value of the surface friction coefficient, and the increase in both the velocity and the absolute value of the surface temperature gradient.	[Cai, Wenli; Su, Ning] Tsinghua Univ, Dept Math Sci, Beijing 100084, Peoples R China; [Liu, Xiangdong] Univ Sci & Technol Beijing, Donlinks Sch Econ & Management, Dept Financial Engn, Beijing 100083, Peoples R China	Tsinghua University; University of Science & Technology Beijing	Liu, XD (corresponding author), Univ Sci & Technol Beijing, Donlinks Sch Econ & Management, Dept Financial Engn, Beijing 100083, Peoples R China.	xdliu@ustb.edu.cn	Liu, Xiang-dong/AAU-3481-2020	Liu, Xiang-dong/0000-0002-4270-647X; Cai, Wenli/0000-0003-3480-8932	National Natural Science Foundation of China [11271218]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work is supported by National Natural Science Foundation of China(11271218). Cai obtained financial support from China Scholarship Council through a joint research program between Tsinghua University and Iowa State University (2013-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Z, 2008, INT J HEAT MASS TRAN, V51, P1024, DOI 10.1016/j.ijheatmasstransfer.2007.05.031; Abd El-Naby MA, 2004, APPL MATH COMPUT, V151, P327, DOI 10.1016/S0096-3003(03)00344-8; Afify AA, 2007, APPL MATH MODEL, V31, P1621, DOI 10.1016/j.apm.2006.05.002; Anbuchezhian N, 2012, MECCANICA, V47, P515, DOI 10.1007/s11012-011-9465-6; Ei-Aziz MA, 2009, INT COMMUN HEAT MASS, V36, P521, DOI 10.1016/j.icheatmasstransfer.2009.01.016; Elbashbeshy EM., 2010, AFRICAN J MATH COMPU, V3, P68; GORLA RSR, 1994, APPL SCI RES, V52, P247, DOI 10.1007/BF00853952; Hayat T, 2010, NONLINEAR ANAL-REAL, V11, P3186, DOI 10.1016/j.nonrwa.2009.11.012; Hayat T, 2010, COMMUN NONLINEAR SCI, V15, P2375, DOI 10.1016/j.cnsns.2009.09.013; Hayat T, 2010, INT J HEAT MASS TRAN, V53, P466, DOI 10.1016/j.ijheatmasstransfer.2009.09.010; Ibrahim FS, 2008, COMMUN NONLINEAR SCI, V13, P1056, DOI 10.1016/j.cnsns.2006.09.007; Ibrahim W, 2013, INT J HEAT MASS TRAN, V56, P1, DOI 10.1016/j.ijheatmasstransfer.2012.08.034; Ishak A, 2009, NONLINEAR ANAL-REAL, V10, P2909, DOI 10.1016/j.nonrwa.2008.09.010; Israel-Cookey C, 2003, INT J HEAT MASS TRAN, V46, P2305, DOI 10.1016/S0017-9310(02)00544-6; Jordan JZ, 2007, APPL MATH MODEL, V31, P2019, DOI 10.1016/j.apm.2006.08.004; Kesavaiah D.C., 2011, INT J APPL MATH MECH, V7, P52; Kim YJ, 2000, INT J ENG SCI, V38, P833, DOI 10.1016/S0020-7225(99)00063-4; Muhaimin I, 2009, THEOR APPL MECH, V36, P101, DOI 10.2298/TAM0902101M; Mukhopadhyay S, 2009, INT J HEAT MASS TRAN, V52, P3261, DOI 10.1016/j.ijheatmasstransfer.2008.12.029; Mukhopadhyay S, 2012, MECCANICA, V47, P863, DOI 10.1007/s11012-011-9457-6; Pal D, 2010, MECCANICA, V45, P415, DOI 10.1007/s11012-009-9254-7; Pal D, 2010, COMMUN NONLINEAR SCI, V15, P2878, DOI 10.1016/j.cnsns.2009.10.029; Pal D, 2010, COMMUN NONLINEAR SCI, V15, P1843, DOI 10.1016/j.cnsns.2009.07.024; Pop SR., 2004, TECH MECH, V25, P100; Raptis A, 1998, INT COMMUN HEAT MASS, V25, P289, DOI 10.1016/S0735-1933(98)00016-5; Samad MA, 2006, J NAV ARCHIT MAR ENG, V3, P7; Seddeek MA, 2002, INT J HEAT MASS TRAN, V45, P931, DOI 10.1016/S0017-9310(01)00189-2; Seddeek MA, 2000, INT COMMUN HEAT MASS, V27, P1037, DOI 10.1016/S0735-1933(00)00183-4; Shateyi S, 2010, MATH PROBLEMS ENG, V2009; Singh P., 2010, INT J INFORM MATH SC, V6, P63; Srinivas S, 2010, COMMUN NONLINEAR SCI, V15, P2098, DOI 10.1016/j.cnsns.2009.09.003; Tsai R, 2008, INT COMMUN HEAT MASS, V35, P1340, DOI 10.1016/j.icheatmasstransfer.2008.07.001; Vajravelu K, 2013, NONLINEAR ANAL-REAL, V14, P455, DOI 10.1016/j.nonrwa.2012.07.008	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107229	10.1371/journal.pone.0107229	http://dx.doi.org/10.1371/journal.pone.0107229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264737	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400017
J	He, JM; Ji, YT; Li, AM; Zhang, QM; Song, WQ; Li, YJ; Huang, HX; Qian, J; Zhai, AX; Yu, X; Zhao, JY; Shang, QL; Wei, LL; Zhang, FM				He, Junming; Ji, Yuting; Li, Aimei; Zhang, Qingmeng; Song, Wuqi; Li, Yujun; Huang, Hongxin; Qian, Jun; Zhai, Aixia; Yu, Xin; Zhao, Jinyun; Shang, Qinglong; Wei, Lanlan; Zhang, Fengmin			MiR-122 Directly Inhibits Human Papillomavirus E6 Gene and Enhances Interferon Signaling through Blocking Suppressor of Cytokine Signaling 1 in SiHa Cells	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; LIVER-SPECIFIC MICRORNA; REPLICATION; EXPRESSION; MODULATION; TARGETS	Human Papillomavirus (HPV) 16 infection is considered as one of the significant causes of human cervical cancer. The expression of the viral oncogenes like E6 and E7 play an important role in the development of the cancer. MiR-122 has been reported to exhibit a strong relationship with hepatitis viruses and take part in several tumor development, while the effects of miR-122 on HPV infection and the HPV viral oncogenes expression still remain unexplored. In this study, using RNAhybrid software, the potential binding sites between miR-122 and HPV16 E6 and E7 mRNAs were identified. Over and loss of miR122 function showed that miR-122 could directly bind with HPV16 E6 mRNA and significantly inhibit its expression in SiHa cells, which was further confirmed by constructing the miR-122-E6-mu to eliminate the miR-122 binding effects with E6. The increase of the expression of type I interferon (IFN) and its classical effective molecules and the phosphorylation of signal transducers and activators of transcription (STAT1) protein indicated that miR-122 might enhance type I interferon in cervical carcinoma cells, which explained the significant reduction of HPV16 E7 and E6*I mRNA expression. This might be due to the binding between miR-122 and suppressor of cytokine signaling 1 (SOCS1) mRNA, which is the suppressor of interferon signaling pathway. Moreover, it was identified that the miR-122 binding position was nt359-nt375 in SOCS1 mRNA. Taken together, this study indicated that HPV16 could be effectively inhibited by miR-122 through both direct binding with E6 mRNA and promoting SOCS1-dependent IFN signaling pathway. Thus, miR-122 may serve as a new therapeutic option for inhibiting HPV infection.	[He, Junming; Ji, Yuting; Li, Aimei; Song, Wuqi; Huang, Hongxin; Yu, Xin; Zhao, Jinyun; Shang, Qinglong; Wei, Lanlan; Zhang, Fengmin] Harbin Med Univ, Dept Microbiol, Harbin, Heilongjiang, Peoples R China; [Zhang, Qingmeng; Song, Wuqi; Zhai, Aixia; Wei, Lanlan; Zhang, Fengmin] Heilongjiang Key Lab Immun & Infect, Harbin, Heilongjiang, Peoples R China; [Li, Yujun; Qian, Jun; Wei, Lanlan; Zhang, Fengmin] Heilongjiang Higher Educ Instruct, Key Lab Pathogen Biol, Harbin, Heilongjiang, Peoples R China; [He, Junming] Chinese Acad Sci, Inst Biophys, CAS Key Lab Infect & Immun, IBP UC Grp Immunotherapy, Beijing 100080, Peoples R China	Harbin Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wei, LL (corresponding author), Harbin Med Univ, Dept Microbiol, Harbin, Heilongjiang, Peoples R China.	weilanlan_1119@163.com; fengminzhang@ems.hrbmu.edu.cn		Song, Wuqi/0000-0001-5900-5154; Huang, Hongxin/0000-0001-5449-1675	National Natural Science Foundation of China (NSFC) [J1103609, J1210062, 81202296, 30070673, 30901706, 81000726, J0730858]; Natural Science Foundation of Heilongjiang Province, China [ZD201020, QC2012C058]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province, China(Natural Science Foundation of Heilongjiang Province)	This work was supported by grants from the National Natural Science Foundation of China (NSFC) (J1103609, J1210062, 81202296, 30070673, 30901706, 81000726 and J0730858) and the Natural Science Foundation of Heilongjiang Province, China (ZD201020 and QC2012C058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Chiantore MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036909; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; HAUSEN HZ, 1991, VIROLOGY, V184, P9, DOI 10.1016/0042-6822(91)90816-T; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Li AM, 2013, INT J BIOCHEM CELL B, V45, P858, DOI 10.1016/j.biocel.2013.01.008; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Park IH, 2014, ANTIVIR RES, V104, P118, DOI 10.1016/j.antiviral.2014.01.021; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Platanias LC, 2005, J INTERF CYTOK RES, V25, P732, DOI 10.1089/jir.2005.25.732; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Qian J, 2010, ANTIVIR RES, V87, P249, DOI 10.1016/j.antiviral.2010.05.011; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tian YJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002159; Wei LL, 2009, CANCER RES, V69, P4878, DOI 10.1158/0008-5472.CAN-08-4695; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008	23	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108410	10.1371/journal.pone.0108410	http://dx.doi.org/10.1371/journal.pone.0108410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265013	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400073
J	Huang, CM; Zhang, JR; Zheng, CH; Li, P; Xie, JW; Wang, JB; Lin, JX; Lu, J; Chen, QY				Huang, Chang-Ming; Zhang, Jun-Rong; Zheng, Chao-Hui; Li, Ping; Xie, Jian-Wei; Wang, Jia-Bin; Lin, Jian-Xian; Lu, Jun; Chen, Qi-Yue			A 346 Case Analysis for Laparoscopic Spleen-Preserving No.10 Lymph Node Dissection for Proximal Gastric Cancer: A Single Center Study	PLOS ONE			English	Article							TOTAL GASTRECTOMY; SPLENIC HILUM; SPLENECTOMY; METASTASIS; PRESERVATION; LYMPHADENECTOMY; FREQUENCY; SURGERY; IMPACT	Purpose: This study was designed to formulate a model that efficiently predicts splenic hilar lymph node metastasis (SHLNM) in patients with proximal gastric cancer and to assess indications for laparoscopic spleen-preserving no.10 lymph node dissection (LSPNo.10LND) based on this model. Methods: Patients (N = 346) with proximal gastric cancer who underwent LSPNo.10LND from January 2010 to October 2013 were prospectively enrolled and retrospectively evaluated. Groups of patients with and without SHLNM were compared, and independent risk factors for SHLNM determined. An optimal predictive model of SHLNM in patients with proximal gastric cancer was well established. Results: Of the 346 patients with proximal gastric cancer, only 35 (10.1%) were diagnosed with SHLNM. Depth of invasion, tumor location and metastases to No.7 and No.11 lymph nodes (LNs) were independent risk factors for SHLNM (p<0.0001 each). A model involving depth of invasion, tumor location and metastasis to No.7 and 11 LNs yielded a lowest Akaike's information criterion (AIC) of -913.535 and a highest area under the ROC curve (AUC) of 0.897(95% CI: 0.851-0.944). Stratification analysis showed no SHLNMs in the absence of serosal invasion of the lesser curvature and metastases at No. 7 and No.11 LNs (T2-3: 0/87, 95% CI: 0.00-4.15). Conclusions: A model including depth of invasion, tumor location and metastases at No.7 and No.11 LNs was found optimal for predicting SHLNM for proximal gastric cancers. LSPNo.10LND may be avoided when tumors on the lesser curvature did not show serosal invasion or metastases at No.7 and No.11 LNs.	[Huang, Chang-Ming; Zhang, Jun-Rong; Zheng, Chao-Hui; Li, Ping; Xie, Jian-Wei; Wang, Jia-Bin; Lin, Jian-Xian; Lu, Jun; Chen, Qi-Yue] Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou, Fujian Province, Peoples R China	Fujian Medical University	Huang, CM (corresponding author), Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou, Fujian Province, Peoples R China.	hcmlr2002@163.com	Li, Ping/GYV-4914-2022; Zheng, Chao-hui/HGE-3348-2022	Zheng, Chao-hui/0000-0001-8680-3127	National Key Clinical Specialty Discipline Construction Program of China [[2012]649]	National Key Clinical Specialty Discipline Construction Program of China	The work was supported by National Key Clinical Specialty Discipline Construction Program of China (No. [2012]649). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi K, 2010, WORLD J HEPATOL, V2, P81, DOI 10.4254/wjh.v2.i2.81; Cheong O, 2008, J SURG ONCOL, V98, P500, DOI 10.1002/jso.21137; Csendes A, 2002, SURGERY, V131, P401, DOI 10.1067/msy.2002.121891; Eom BW, 2010, J LAPAROENDOSC ADV S, V20, P643, DOI 10.1089/lap.2010.0080; Fatouros M, 2005, ANTICANCER RES, V25, P3023; Hur H, 2008, J SURG ONCOL, V97, P169, DOI 10.1002/jso.20927; Hyung WJ, 2008, J AM COLL SURGEONS, V207, pE6, DOI 10.1016/j.jamcollsurg.2008.04.027; Ikeguchi M, 2004, AM SURGEON, V70, P645; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Cancer Association, 2010, JAPN CLASS GASTR CAR, P5; KITANO S, 1994, SURG LAPAROSC ENDOSC, V4, P146; Lu J, 2013, HEPATO-GASTROENTEROL, V60, P296, DOI 10.5754/hge12641; MAEHARA Y, 1991, CANCER, V67, P3006, DOI 10.1002/1097-0142(19910615)67:12<3006::AID-CNCR2820671213>3.0.CO;2-V; MARUYAMA K, 1989, ANN SURG, V210, P596, DOI 10.1097/00000658-198911000-00005; Monig SP, 2001, J SURG ONCOL, V76, P89; Nashimoto A, 2012, INT J SURG ONCOL, V2012, DOI 10.1155/2012/301530; Okabe Hiroshi, 2010, J Am Coll Surg, V211, pe1, DOI 10.1016/j.jamcollsurg.2010.04.006; OKAJIMA K, 1995, WORLD J SURG, V19, P537, DOI 10.1007/BF00294715; Sasada S, 2009, ANTICANCER RES, V29, P3347; Schwarz RE, 2002, J SURG ONCOL, V79, P73, DOI 10.1002/jso.10036; Smeets A, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-480; Sobin LH, 2011, TNM CLASSIFICATION M; Ueno H, 2013, J GASTROENTEROL; Wanebo HJ, 1997, J AM COLL SURGEONS, V185, P177, DOI 10.1016/S1072-7515(01)00901-2; Wang JB, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-241; Yu W, 2006, BRIT J SURG, V93, P559, DOI 10.1002/bjs.5353; Zhang CH, 2007, ANN SURG ONCOL, V14, P1312, DOI 10.1245/s10434-006-9190-x	28	22	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108480	10.1371/journal.pone.0108480	http://dx.doi.org/10.1371/journal.pone.0108480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264673	Green Submitted, gold, Green Published			2022-12-27	WOS:000345745400079
J	Huang, JZ; Lu, X; Zhang, WK; Huang, RF; Chen, SY; Zheng, YZ				Huang, Jianzi; Lu, Xiang; Zhang, Wanke; Huang, Rongfeng; Chen, Shouyi; Zheng, Yizhi			Transcriptome Sequencing and Analysis of Leaf Tissue of Avicennia marina Using the Illumina Platform	PLOS ONE			English	Article							FORSK. VIERH. AVICENNIACEAE; GENETIC-STRUCTURE; FUNCTIONAL-CHARACTERIZATION; MICROSATELLITE MARKERS; ENDOPHYTIC FUNGI; MANGROVE; STRESS; DIVERSITY; SALINITY; TAGS	Avicennia marina is a widely distributed mangrove species that thrives in high-salinity habitats. It plays a significant role in supporting coastal ecosystem and holds unique potential for studying molecular mechanisms underlying ecological adaptation. Despite and sometimes because of its numerous merits, this species is facing increasing pressure of exploitation and deforestation. Both study on adaptation mechanisms and conservation efforts necessitate more genomic resources for A. marina. In this study, we used Illumina sequencing of an A. marina foliar cDNA library to generate a transcriptome dataset for gene and marker discovery. We obtained 40 million high-quality reads and assembled them into 91,125 unigenes with a mean length of 463 bp. These unigenes covered most of the publicly available A. marina Sanger ESTs and greatly extended the repertoire of transcripts for this species. A total of 54,497 and 32,637 unigenes were annotated based on homology to sequences in the NCBI non-redundant and the Swiss-prot protein databases, respectively. Both Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed some transcriptomic signatures of stress adaptation for this halophytic species. We also detected an extraordinary amount of transcripts derived from fungal endophytes and demonstrated the utility of transcriptome sequencing in surveying endophyte diversity without isolating them out of plant tissues. Additionally, we identified 3,423 candidate simple sequence repeats (SSRs) from 3,141 unigenes with a density of one SSR locus every 8.25 kb sequence. Our transcriptomic data will provide valuable resources for ecological, genetic and evolutionary studies in A. marina.	[Huang, Jianzi; Zheng, Yizhi] Shenzhen Univ, Shenzhen Key Lab Microbial Genet Engn, Coll Life Sci, Shenzhen, Peoples R China; [Lu, Xiang; Zhang, Wanke; Chen, Shouyi] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China; [Huang, Rongfeng] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Shenzhen University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Huang, RF (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	rfhuang@caas.net.cn; sychen@genetics.ac.cn; yzzheng@szu.edu.cn	陆, 翔/A-1329-2019; Trilety, Roman/I-8225-2014	陆, 翔/0000-0002-1176-5389; Trilety, Roman/0000-0002-3778-0368	National Natural Science Foundation of China [31300275, 31370289]; National Basic Research Program of China [2012CB114200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (No. 31300275 and No. 31370289) and the National Basic Research Program of China (No. 2012CB114200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud-Haond S, 2006, MOL ECOL, V15, P3515, DOI 10.1111/j.1365-294X.2006.02997.x; Balakrishna P, 1995, CURR SCI INDIA, V69, P926; Basyuni M, 2012, AQUAT BOT, V97, P17, DOI 10.1016/j.aquabot.2011.10.005; Bharathidasan R, 2011, EUR J EXP BIOL, V1, P31; Blasco F., 2001, Wetlands Ecology and Management, V9, P245, DOI 10.1023/A:1011169025815; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chen SF, 2011, MAR GENOM, V4, P129, DOI 10.1016/j.margen.2011.03.005; Ciuffetti LM, 1997, PLANT CELL, V9, P135, DOI 10.1105/tpc.9.2.135; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; Dassanayake M, 2011, NAT GENET, V43, P913, DOI 10.1038/ng.889; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Duke NC, 1998, EVOLUTION, V52, P1612, DOI [10.1111/j.1558-5646.1998.tb02242.x, 10.2307/2411335]; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Ganesan G, 2008, PLANT PHYSIOL BIOCH, V46, P928, DOI 10.1016/j.plaphy.2008.05.002; Geng QF, 2007, MOL ECOL NOTES, V7, P1208, DOI 10.1111/j.1471-8286.2007.01834.x; Giang LH, 2003, GENES GENET SYST, V78, P399, DOI 10.1266/ggs.78.399; Hibino T, 2001, PLANT MOL BIOL, V45, P353, DOI 10.1023/A:1006497113323; Huang JZ, 2012, DNA RES, V19, P195, DOI 10.1093/dnares/dss004; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jithesh MN, 2006, PLANT CELL REP, V25, P865, DOI 10.1007/s00299-006-0127-4; Kavitha K, 2008, PLANT PHYSIOL BIOCH, V46, P794, DOI 10.1016/j.plaphy.2008.05.008; Kavitha K, 2010, BIOCHIMIE, V92, P1321, DOI 10.1016/j.biochi.2010.06.009; Khraiwesh B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060774; Kumaresan V, 2001, MYCOL RES, V105, P1388, DOI 10.1017/S0953756201004841; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Maguire TL, 2000, THEOR APPL GENET, V101, P279, DOI 10.1007/s001220051480; Maguire TL, 2000, MOL ECOL, V9, P1853, DOI 10.1046/j.1365-294x.2000.01089.x; Maguire TL, 2002, THEOR APPL GENET, V104, P388, DOI 10.1007/s001220100724; Mastrangelo AM, 2012, PLANT SCI, V185, P40, DOI 10.1016/j.plantsci.2011.09.006; Mehta PA, 2005, THEOR APPL GENET, V110, P416, DOI 10.1007/s00122-004-1801-y; Mehta PA, 2009, PLANT PHYSIOL BIOCH, V47, P701, DOI 10.1016/j.plaphy.2009.03.008; Miyama M, 2006, PLANT SCI, V171, P234, DOI 10.1016/j.plantsci.2006.03.015; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nair KSS, 2007, TROPICAL FOREST INSECT PESTS: ECOLOGY, IMPACT, AND MANAGEMENT, P1, DOI 10.1017/CBO9780511542695; Oh DH, 2014, PLANT PHYSIOL, V164, P2123, DOI 10.1104/pp.113.233551; Oh DH, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-3-241, 10.1186/gb4003]; Parani M, 1997, GENOME, V40, P487, DOI 10.1139/g97-065; Parida AK, 2010, TREES-STRUCT FUNCT, V24, P199, DOI 10.1007/s00468-010-0417-x; Prashanth SR, 2008, TRANSGENIC RES, V17, P281, DOI 10.1007/s11248-007-9099-6; Ricklefs Robert E., 1993, P215; Saenger P, 2013, MANGROVE ECOLOGY SIL; Schliesky S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00220; Simon SA, 2009, ANNU REV PLANT BIOL, V60, P305, DOI 10.1146/annurev.arplant.043008.092032; Singh LP, 2011, PLANT SIGNAL BEHAV, V6, P175, DOI 10.4161/psb.6.2.14146; Staiger D, 2013, PLANT CELL, V25, P3640, DOI 10.1105/tpc.113.113803; Steinke Trevor D., 1997, Mycoscience, V38, P101, DOI 10.1007/BF02460843; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; SUBRAMANIAN D, 1988, CYTOLOGIA, V53, P87, DOI 10.1508/cytologia.53.87; Taji T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-115; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Waditee R, 2002, J BIOL CHEM, V277, P18373, DOI 10.1074/jbc.M112012200; Costa IPMW, 2012, BRAZ J MICROBIOL, V43, P1165, DOI [10.1590/S1517-83822012000300044, 10.1590/S1517-838220120003000044]; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	57	12	12	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108785	10.1371/journal.pone.0108785	http://dx.doi.org/10.1371/journal.pone.0108785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265387	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400121
J	Liu, ZH; Wei, PM; Huang, MH; Liu, YB; Li, L; Gong, X; Chen, J; Li, XN				Liu, Zhihao; Wei, Pingmin; Huang, Minghao; Liu, Yuan Bao; Li, Lucy; Gong, Xiao; Chen, Juan; Li, Xiaoning			Determinants of Consistent Condom Use among College Students in China: Application of the Information-Motivation-Behavior Skills (IMB) Model	PLOS ONE			English	Article							HIGH-SCHOOL-STUDENTS; SEXUAL RISK BEHAVIOR; DEVELOPING-COUNTRIES; UNITED-STATES; PREDICTORS; PREVENTION; INTERVENTION; ASSOCIATIONS; PERCEPTIONS; INFECTION	Background: Due to the increase incidents of premarital sex and the lack of reproductive health services, college students are at high risk of HIV/AIDS infections in China. This study was designed to examine the predictors of consistency of condom use among college students based on the Information-Motivation-Behavioral Skills (IMB) model and to describe the relationships between the model constructs. Methods: A cross-sectional study was conducted to assess HIV/AIDS related information, motivation, behavioral skills and preventive behavior among college students in five colleges and universities in Nanjing, China. An anonymous questionnaire survey was conducted for data collection, and the structural equation model (SEM) was used to assess the IMB model. Results: A total of 3183 participants completed this study. The average age was 19.90 years (SD = 1.43, range 16 to 25). 342 (10.7%) participants of them reported having had premarital sex, among whom 30.7% reported having had a consistent condom use, 13.7% with the experience of abortion (including the participants whose sex partner has the same experience), 32.7% of participants had experience of multiple sex partners. The final IMB model provided acceptable fit to the data (CFI = 0.992, RMSEA = 0.028). Preventive behavior was significantly predicted by behavioral skills (beta = 0.754, P < 0.001). Information (beta = 0.138, P < 0.001) and motivation (beta = 0.363, P < 0.001) were indirectly affected preventive behavior, and was mediated through behavioral skills. Conclusions: The results of the study demonstrate the utility of the IMB model for consistent condom use among college students in China. The main influencing factor of preventive behavior among college students is behavioral skills. Both information and motivation could affect preventive behavior through behavioral skills. Further research could develop preventive interventions based on the IMB model to promote consistent condom use among college students in China.	[Liu, Zhihao; Huang, Minghao; Liu, Yuan Bao; Li, Xiaoning] Jiangsu Prov Ctr Dis Control & Prevent, Inst Hlth Educ, Nanjing, Jiangsu, Peoples R China; [Wei, Pingmin] Southeast Univ China, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Nanjing, Jiangsu, Peoples R China; [Li, Lucy] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Gong, Xiao] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Juan] Chinese Acad Med Sci, Inst Med Informat & Lib, Beijing 100730, Peoples R China; [Chen, Juan] Peking Union Med Coll, Beijing 100021, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Southeast University - China; State University System of Florida; University of Florida; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Information - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, XN (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Inst Hlth Educ, Nanjing, Jiangsu, Peoples R China.	1604918553@qq.com		Chen, Xinguang/0000-0001-8263-643X	National Health and Family Planning Commission of the People's Republic of China [WA2005-14]	National Health and Family Planning Commission of the People's Republic of China	This study was funded by National Health and Family Planning Commission of the People's Republic of China (Project No. WA2005-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ES, 2006, ANN BEHAV MED, V31, P70, DOI 10.1207/s15324796abm3101_11; Black J.T, 1992, MULTIVARIATE DATA AN; BOLLEN KA, 1989, SOCIOL METHOD RES, V17, P303, DOI 10.1177/0049124189017003004; Cai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062787; Cai Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-262; Cottrell L, 2005, PREV MED, V40, P189, DOI 10.1016/j.ypmed.2004.05.019; Fisher CM, 2011, J HIV-AIDS SOC SERV, V10, P5, DOI 10.1080/15381501.2011.549064; Fisher JD, 1996, HEALTH PSYCHOL, V15, P114, DOI 10.1037/0278-6133.15.2.114; Fisher JD, 2002, HEALTH PSYCHOL, V21, P177, DOI 10.1037//0278-6133.21.2.177; FISHER JD, 1992, PSYCHOL BULL, V111, P455, DOI 10.1037/0033-2909.111.3.455; Fisher WA, 2004, AIDS BEHAV, V3, P13; Fonner VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089692; Gao XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044881; Guo RL, 2014, J COMMUN HEALTH, V39, P712, DOI 10.1007/s10900-013-9816-4; Hau K.-T., 2004, STRUCTURAL EQUATION; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Joreskog K.G., 1996, LISREL 8 USERS REFER; Kalichman S, 2002, Psychol Health Med, V7, P327, DOI 10.1080/13548500220139368; Kalichman SC, 2008, J HEALTH PSYCHOL, V13, P680, DOI 10.1177/1359105307082456; Kennedy CE, 2010, B WORLD HEALTH ORGAN, V88, P615, DOI 10.2471/BLT.09.068213; Khan MR, 2012, AM J PUBLIC HEALTH, V102, P867, DOI 10.2105/AJPH.2011.300373; Kline RB, 2005, PRINCIPLES PRACTICE; Li S, 2009, INT J STD AIDS, V20, P561, DOI 10.1258/ijsa.2008.008433; Li SH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-295; Li XM, 2011, HEALTH EDUC RES, V26, P419, DOI 10.1093/her/cyr001; Long L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051782; Ma QQ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-111; *MIN HLTH CHIN, 2011, EST HIV AIDS EP CHIN; Mittal M, 2012, AIDS BEHAV, V16, P1011, DOI 10.1007/s10461-011-9949-3; Mmari K, 2009, GLOB PUBLIC HEALTH, V4, P350, DOI 10.1080/17441690701664418; Pan Xiao-hong, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P499; Robertson AA, 2006, J ADOLESCENT HEALTH, V38, P18, DOI 10.1016/j.jadohealth.2004.08.013; Scott-Sheldon LAJ, 2010, J HEALTH PSYCHOL, V15, P1093, DOI 10.1177/1359105310364174; Shao YM, 2012, LANCET, V379, P804, DOI 10.1016/S0140-6736(12)60349-3; SOBER E, 1981, BRIT J PHILOS SCI, V32, P145, DOI 10.1093/bjps/32.2.145; Sun XY, 2013, AIDS CARE, V25, P775, DOI 10.1080/09540121.2012.748875; Tang LJ, 2013, AIDS CARE, V25, P515, DOI 10.1080/09540121.2012.720360; Tung WC, 2013, WESTERN J NURS RES, V35, P1171, DOI 10.1177/0193945913486201; Walsh JL, 2011, ANN BEHAV MED, V42, P235, DOI 10.1007/s12160-011-9284-y; Williams SS, 1998, AIDS BEHAV, V2, P177, DOI DOI 10.1023/A:1022155100116; Xiao ZW, 2010, AIDS CARE, V22, P332, DOI 10.1080/09540120903193609; Zhang HS, 2004, AIDS BEHAV, V8, P105, DOI 10.1023/B:AIBE.0000030242.46843.71; Zhang H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-113	43	24	28	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108976	10.1371/journal.pone.0108976	http://dx.doi.org/10.1371/journal.pone.0108976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6XR	25265390	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400139
J	Shishtar, E; Sievenpiper, JL; Djedovic, V; Cozma, AI; Ha, V; Jayalath, VH; Jenkins, DJA; Meija, SB; de Souza, RJ; Jovanovski, E; Vuksan, V				Shishtar, Esra'; Sievenpiper, John L.; Djedovic, Vladimir; Cozma, Adrian I.; Ha, Vanessa; Jayalath, Viranda H.; Jenkins, David J. A.; Meija, Sonia Blanco; de Souza, Russell J.; Jovanovski, Elena; Vuksan, Vladimir			The Effect of Ginseng (The Genus Panax) on Glycemic Control: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials	PLOS ONE			English	Review							TYPE-2 DIABETES-MELLITUS; KOREAN RED GINSENG; GLUCOSE-TOLERANCE; OXIDATIVE STRESS; EFFICACY; SUPPLEMENTATION; SAFETY	Importance: Despite the widespread use of ginseng in the management of diabetes, supporting evidence of its anti-hyperglycemic efficacy is limited, necessitating the need for evidence-based recommendations for the potential inclusion of ginseng in diabetes management. Objective: To elucidate the effect of ginseng on glycemic control in a systematic review and meta-analysis of randomized controlled trials in people with and without diabetes. Data sources: MEDLINE, EMBASE, CINAHL and the Cochrane Library (through July 3, 2013). Study selection: Randomized controlled trials >= 30 days assessing the glycemic effects of ginseng in people with and without diabetes. Data extraction: Relevant data were extracted by 2 independent reviewers. Discrepancies were resolved by consensus. The Heyland Methodological Quality Score and the Cochrane risk of bias tool were used to assess study quality and risk of bias respectively. Data synthesis: Sixteen trials were included, in which 16 fasting blood glucose (n = 770), 10 fasting plasma insulin (n = 349), 9 glycated hemoglobin (n = 264), and 7 homeostasis model assessment of insulin resistance (n = 305) comparisons were reported. Ginseng significantly reduced fasting blood glucose compared to control (MD = -0.31 mmol/L [95% CI: -0.59 to -0.03], P = 0.03). Although there was no significant effect on fasting plasma insulin, glycated hemoglobin, or homeostasis model assessment of insulin resistance, a priori subgroup analyses did show significant reductions in glycated hemoglobin in parallel compared to crossover trials (MD = 0.22% [95% CI: 0.06 to 0.37], P = 0.01). Limitations: Most trials were of short duration (67% trials<12wks), and included participants with a relatively good glycemic control (median HbA1c non-diabetes = 5.4% [2 trials]; median HbA1c diabetes = 7.1% [7 trials]). Conclusions: Ginseng modestly yet significantly improved fasting blood glucose in people with and without diabetes. In order to address the uncertainty in our effect estimates and provide better assessments of ginseng's anti-diabetic efficacy, larger and longer randomized controlled trials using standardized ginseng preparations are warranted.	[Shishtar, Esra'; Sievenpiper, John L.; Djedovic, Vladimir; Cozma, Adrian I.; Ha, Vanessa; Jayalath, Viranda H.; Jenkins, David J. A.; Meija, Sonia Blanco; de Souza, Russell J.; Jovanovski, Elena; Vuksan, Vladimir] St Michaels Hosp, Risk Factor Modificat Ctr, Toronto, ON M5B 1W8, Canada; [Shishtar, Esra'; Djedovic, Vladimir; Cozma, Adrian I.; Ha, Vanessa; Jayalath, Viranda H.; Jenkins, David J. A.; Meija, Sonia Blanco; Jovanovski, Elena; Vuksan, Vladimir] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada; [Sievenpiper, John L.] McMaster Univ, Fac Hlth Sci, Dept Pathol, Hamilton, ON, Canada; [Sievenpiper, John L.] McMaster Univ, Fac Hlth Sci, Dept Mol Med, Hamilton, ON, Canada; [de Souza, Russell J.] McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol, Hamilton, ON, Canada; [Jenkins, David J. A.; Vuksan, Vladimir] Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada; [Jenkins, David J. A.; Vuksan, Vladimir] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; McMaster University; McMaster University; McMaster University; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Vuksan, V (corresponding author), St Michaels Hosp, Risk Factor Modificat Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.	v.vuksan@utoronto.ca	de Souza, Russell J/ABB-7735-2021	de Souza, Russell J/0000-0001-8945-513X	embassy of the state of Kuwait	embassy of the state of Kuwait	This work was part of ES's master's thesis, who was supported by a fellowship from the embassy of the state of Kuwait. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biondo PD, 2008, APPL PHYSIOL NUTR ME, V33, P966, DOI 10.1139/H08-080; Chang HY, 2007, J ADV NURS, V58, P307, DOI 10.1111/j.1365-2648.2007.04291.x; Cheng AYY, 2013, CAN J DIABETES, V37, pS291, DOI 10.1016/j.jcjd.2013.01.048; Choi K.M., 1997, KOREAN J GINSENG SCI, V21, P153; Christensen LP, 2009, ADV FOOD NUTR RES, V55, P1, DOI 10.1016/S1043-4526(08)00401-4; Dickman JR, 2009, J AM COLL NUTR, V28, P219, DOI 10.1080/07315724.2009.10719773; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Franz MJ, 2002, DIABETES CARE, V25, P148, DOI 10.2337/diacare.25.1.148; GOLDSTEIN DE, 1995, DIABETES CARE, V18, P896, DOI 10.2337/diacare.18.6.896; 김혜옥, 2011, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V40, P696; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Kim S, 2011, CHIN J INTEGR MED, V17, P937, DOI 10.1007/s11655-011-0937-2; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Lee NH, 2011, J ACUPUNCT MERIDIAN, V4, P85, DOI 10.1016/S2005-2901(11)60013-7; Levy P, 2009, POSTGRAD MED, V121, P7, DOI 10.3810/pgm.2009.05.suppl53.287; Luo JZ, 2009, EVID-BASED COMPL ALT, V6, P423, DOI 10.1093/ecam/nem178; Ma SW, 2008, DIABETES OBES METAB, V10, P1125, DOI 10.1111/j.1463-1326.2008.00858.x; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mucalo I, 2012, COLLEGIUM ANTROPOL, V36, P1435; Park BJ, 2012, KOREAN J FAM MED, V33, P190, DOI 10.4082/kjfm.2012.33.4.190; Reay JL, 2009, BRIT J NUTR, V101, P1673, DOI 10.1017/S0007114508123418; Reeds DN, 2011, DIABETES CARE, V34, P1071, DOI 10.2337/dc10-2299; Rhee MY, 2011, J ALTERN COMPLEM MED, V17, P45, DOI 10.1089/acm.2010.0065; Scaglione F, 1996, DRUG EXP CLIN RES, V22, P65; Shergis JL, 2013, PHYTOTHER RES, V27, P949, DOI 10.1002/ptr.4832; Shin SK, 2011, J MED FOOD, V14, P108, DOI 10.1089/jmf.2009.1366; Sievenpiper JL, 2004, DIABETES CARE, V27, P839, DOI 10.2337/diacare.27.3.839-a; SIMON D, 1989, DIABETOLOGIA, V32, P864, DOI 10.1007/BF00297451; SOTANIEMI EA, 1995, DIABETES CARE, V18, P1373, DOI 10.2337/diacare.18.10.1373; Tackett K.L, 2009, J PHARM PRACT, V22, P546, DOI [10.1177/0897190009332658, DOI 10.1177/0897190009332658]; Tetsutani T, 2000, GINSENG REV, V28, P44; Vogler BK, 1999, EUR J CLIN PHARMACOL, V55, P567, DOI 10.1007/s002280050674; Vuksan V, 2000, DIABETES S1, P384; Vuksan V, 2008, NUTR METAB CARDIOVAS, V18, P46, DOI 10.1016/j.numecd.2006.04.003; Yeh GY, 2003, DIABETES CARE, V26, P1277, DOI 10.2337/diacare.26.4.1277; Yoon JW, 2012, J DIABETES INVEST, V3, P309, DOI 10.1111/j.2040-1124.2011.00185.x; Zhang Ying, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P1066	38	76	77	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107391	10.1371/journal.pone.0107391	http://dx.doi.org/10.1371/journal.pone.0107391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265315	Green Submitted, gold, Green Published			2022-12-27	WOS:000345745400022
J	Syrjanen, RK; Jokinen, J; Ziegler, T; Sundman, J; Lahdenkari, M; Julkunen, I; Kilpi, TM				Syrjanen, Ritva K.; Jokinen, Jukka; Ziegler, Thedi; Sundman, Jonas; Lahdenkari, Mika; Julkunen, Ilkka; Kilpi, Terhi M.			Effectiveness of Pandemic and Seasonal Influenza Vaccines in Preventing Laboratory-Confirmed Influenza in Adults: A Clinical Cohort Study during Epidemic Seasons 2009-2010 and 2010-2011 in Finland	PLOS ONE			English	Article							A H1N1; A(H1N1)2009 INFECTION; BURDEN; TRIVALENT; ENGLAND; ILLNESS; VIRUS; SPAIN; A(H1N1)PDM09; CIRCULATION	Background: One dose of pandemic influenza vaccine Pandemrix (GlaxoSmithKline) was offered to the entire population of Finland in 2009-10. We conducted a prospective clinical cohort study to determine the vaccine effectiveness in preventing febrile laboratory-confirmed influenza infection during the influenza season 2009-10 and continued the study in 2010-11. Methods: In total, 3,518 community dwelling adults aged 18-75 years living in Tampere city were enrolled. The participants were not assigned to any vaccination regimen, but they could participate in the study regardless of their vaccination status or intention to be vaccinated with the pandemic or seasonal influenza vaccine. They were asked to report if they received Pandemrix in 2009-10 and/or trivalent influenza vaccine in 2010-11. Vaccinations were verified from medical records. The participants were instructed to report all acute symptoms of respiratory tract infection with fever (at least 38 degrees C) and pneumonias to the study staff. Nasal and oral swabs were obtained within 5-7 days after symptom onset and influenza-specific RNA was identified by reverse transcription polymerase chain reaction. Results: In 2009-10, the estimated vaccine effectiveness was 81% (95% CI 30-97). However, the vaccine effectiveness could not be estimated reliably, because only persons in prioritized groups were vaccinated before/during the first pandemic wave and many participants were enrolled when they already had the symptoms of A(H1N1) pdm09 influenza infection. In 2010-11, 2,276 participants continued the follow-up. The vaccine effectiveness, adjusted for potential confounding factors was 81% (95% CI 41-96) for Pandemrix only and 88% (95% CI 63-97) for either Pandemrix or trivalent influenza vaccine 2010-11 or both, respectively. Conclusion: Vaccination with an AS03-adjuvanted pandemic vaccine in 2009-10 was still effective in preventing A(H1N1) pdm09 influenza during the following epidemic season in 2010-11.	[Syrjanen, Ritva K.] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Tampere, Finland; [Jokinen, Jukka; Ziegler, Thedi; Sundman, Jonas; Lahdenkari, Mika; Julkunen, Ilkka; Kilpi, Terhi M.] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Syrjanen, RK (corresponding author), Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Tampere, Finland.	ritva.syrjanen@thl.fi		Julkunen, Ilkka/0000-0003-0165-2564	National Institute for Health and Welfare (THL); Ministry of Social Affairs and Health; FLUSECURE-project - European Commission [2005207]; Identification of Mechanisms Correlating with Susceptibility for Avian Influenza project - European Commission [201169]; Directorate-General Research; Health & Consumer Protection Directorate-General	National Institute for Health and Welfare (THL); Ministry of Social Affairs and Health; FLUSECURE-project - European Commission; Identification of Mechanisms Correlating with Susceptibility for Avian Influenza project - European Commission; Directorate-General Research; Health & Consumer Protection Directorate-General	This work was funded by the National Institute for Health and Welfare (THL, www.thl.fi) and the Ministry of Social Affairs and Health (www.stm.fi). The authors and the study staff for clinical work, laboratory analyses and data management were employed by THL. The preparation of the protocol was partly supported by the FLUSECURE-project [grant no 2005207] funded by the European Commission (ec.europa.eu), Health & Consumer Protection Directorate-General and the participating member states. The laboratory work was supported by the Identification of Mechanisms Correlating with Susceptibility for Avian Influenza project [grant no 201169] supported by the European Commission (ec.europa.eu), Directorate-General Research and the participating member states. The funders outside THL had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Athanasiou M, 2011, EUROSURVEILLANCE, V16, P14; Bateman AC, 2013, J INFECT DIS, V207, P1262, DOI 10.1093/infdis/jit020; Castilla J, 2011, VACCINE, V29, P5919, DOI 10.1016/j.vaccine.2011.06.063; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Costa JT, 2012, INT ARCH OCC ENV HEA, V85, P747, DOI 10.1007/s00420-011-0714-8; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Emborg HD, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7901; Englund H, 2013, EPIDEMIOL INFECT, V141, P1807, DOI 10.1017/S0950268812002282; European Centre for Disease Prevention and Control (ECDC), 2011, SEAS INFL 2010 2011, P10; European Commission, 2009, OFFICIAL J EUROPEA L, V110; Fielding JE, 2011, EMERG INFECT DIS, V17, P1181, DOI 10.3201/eid1707.101959; Gilmour H, 2010, HEALTH REP, V21; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; Hardelid P, 2011, EUROSURVEILLANCE, V16, P12; Herrador BRG, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-63; Hulkko T, 2011, 392011 NAT I HLTH WE, P7; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Jacks A, 2012, EUROSURVEILLANCE, V17, P7; Jimenez-Jorge S, 2012, VACCINE, V30, P3595, DOI 10.1016/j.vaccine.2012.03.048; Kavanagh K, 2013, VACCINE, V31, P4556, DOI 10.1016/j.vaccine.2013.07.056; Kissling E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027622; Lyytikainen O, 2011, EUROSURVEILLANCE, V16, P17; Lyytikainen O, 2011, SUOM LAAKARILEHTI, V66, P2925; Mahmud S, 2011, VACCINE, V29, P7975, DOI 10.1016/j.vaccine.2011.08.068; Manzoli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024384; Molbak K, 2011, VACCINE, V29, pB63, DOI 10.1016/j.vaccine.2011.03.064; Mytton OT, 2012, EUROSURVEILLANCE, V17, P11; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Orsted I, 2013, INFLUENZA OTHER RESP, V7, P776, DOI 10.1111/irv.12093; Ortqvist A, 2011, CLIN INFECT DIS, V52, P1203, DOI 10.1093/cid/cir182; Pebody R, 2011, EUROSURVEILLANCE, V16, P8; Presanis AM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5408; R Core Team, 2021, R LANGUAGE ENV STAT; Ronkko E, 2011, J CLIN MICROBIOL, V49, P2009, DOI 10.1128/JCM.00259-11; Savulescu C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-899; Shubin M, 2014, EPIDEMIOL INFECT, V142, P964, DOI 10.1017/S0950268813002537; Simpson CR, 2010, HEALTH TECHNOL ASSES, V14, P323, DOI 10.3310/hta14340-05; Skowronski DM, 2012, CLIN INFECT DIS, V55, P332, DOI 10.1093/cid/cis431; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; Uphoff H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019932; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P872, DOI 10.1111/irv.12074; Walker WT, 2010, EXPERT REV VACCINES, V9, P1385, DOI [10.1586/erv.10.141, 10.1586/ERV.10.141]; Wichmann O, 2010, EUROSURVEILLANCE, V15, P2; Widgren K, 2013, EUROSURVEILLANCE, V18, P37	46	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108538	10.1371/journal.pone.0108538	http://dx.doi.org/10.1371/journal.pone.0108538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265186	Green Submitted, gold, Green Published			2022-12-27	WOS:000345745400083
J	Wegdam, W; Argmann, CA; Kramer, G; Vissers, JP; Buist, MR; Kenter, GG; Aerts, JMFG; Meijer, D; Moerland, PD				Wegdam, Wouter; Argmann, Carmen A.; Kramer, Gertjan; Vissers, Johannes P.; Buist, Marrije R.; Kenter, Gemma G.; Aerts, Johannes M. F. G.; Meijer, Danielle; Moerland, Perry D.			Label-Free LC-MSe in Tissue and Serum Reveals Protein Networks Underlying Differences between Benign and Malignant Serous Ovarian Tumors	PLOS ONE			English	Article							PROTEOMIC BIOMARKERS; CANCER; STAGE; GENE; EXPRESSION; DISCOVERY; ACTININ-4; QUANTIFICATION; IDENTIFICATION; TRANSCRIPTION	Purpose: To identify proteins and (molecular/biological) pathways associated with differences between benign and malignant epithelial ovarian tumors. Experimental Procedures: Serum of six patients with a serous adenocarcinoma of the ovary was collected before treatment, with a control group consisting of six matched patients with a serous cystadenoma. In addition to the serum, homogeneous regions of cells exhibiting uniform histology were isolated from benign and cancerous tissue by laser microdissection. We subsequently employed label-free liquid chromatography tandem mass spectrometry (LC-MSe) to identify proteins in these serum and tissues samples. Analyses of differential expression between samples were performed using Bioconductor packages and in-house scripts in the statistical software package R. Hierarchical clustering and pathway enrichment analyses were performed, as well as network enrichment and interactome analysis using MetaCore. Results: In total, we identified 20 and 71 proteins that were significantly differentially expressed between benign and malignant serum and tissue samples, respectively. The differentially expressed protein sets in serum and tissue largely differed with only 2 proteins in common. MetaCore network analysis, however inferred GCR-alpha and Sp1 as common transcriptional regulators. Interactome analysis highlighted 14-3-3 zeta/delta, 14-3-3 beta/alpha, Alpha-actinin 4, HSP60, and PCBP1 as critical proteins in the tumor proteome signature based on their relative overconnectivity. The data have been deposited to the ProteomeXchange with identifier PXD001084. Discussion: Our analysis identified proteins with both novel and previously known associations to ovarian cancer biology. Despite the small overlap between differentially expressed protein sets in serum and tissue, APOA1 and Serotransferrin were significantly lower expressed in both serum and cancer tissue samples, suggesting a tissue-derived effect in serum. Pathway and subsequent interactome analysis also highlighted common regulators in serum and tissue samples, suggesting a yet unknown role for PCBP1 in ovarian cancer pathophysiology.	[Wegdam, Wouter; Buist, Marrije R.; Kenter, Gemma G.; Meijer, Danielle] Univ Amsterdam, Acad Med Ctr, Dept Gynecol, NL-1105 AZ Amsterdam, Netherlands; [Argmann, Carmen A.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Kramer, Gertjan; Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Clin Prote Grp, NL-1105 AZ Amsterdam, Netherlands; [Vissers, Johannes P.] Waters Corp MS Technol Ctr, Manchester, Lancs, England; [Moerland, Perry D.] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Icahn School of Medicine at Mount Sinai; University of Amsterdam; Academic Medical Center Amsterdam; Waters Corporation; University of Amsterdam; Academic Medical Center Amsterdam	Wegdam, W (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Gynecol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	W.Wegdam@amc.uva.nl	Aerts, Johannes/A-1028-2009; Moerland, Perry/AAG-1425-2020; Meijer, Danielle/AFL-5078-2022	Aerts, Johannes/0000-0001-8168-2565; Moerland, Perry/0000-0002-2357-3659; Kramer, Gertjan/0000-0002-8541-0337	Academic Medical Center, University of Amsterdam; Waters Corporation; Academic Medical Center	Academic Medical Center, University of Amsterdam; Waters Corporation; Academic Medical Center	The study was funded by the Academic Medical Center, University of Amsterdam. Co-author Johannes P. Vissers is employed by Waters Corporation (MS Technologies Center, Manchester, United Kingdom). Waters Corporation provided support in the form of salary for author Johannes P. Vissers. The specific role of this author is articulated in the 'author contributions' section. Both funders, Academic Medical Center and Waters Corporation, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglesio MS, 2008, MOL CANCER RES, V6, P1678, DOI 10.1158/1541-7786.MCR-08-0193; Barazi HO, 2002, CANCER RES, V62, P1541; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bessarabova M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S13; Bicaku E, 2012, BRIT J CANCER, V106, P1967, DOI 10.1038/bjc.2012.207; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Cappello F, 2014, EXPERT OPIN THER TAR, V18, P185, DOI 10.1517/14728222.2014.856417; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Clarke CH, 2011, GYNECOL ONCOL, V122, P548, DOI 10.1016/j.ygyno.2011.06.002; Cloke B, 2010, ENDOCRINOLOGY, V151, P3954, DOI [10.1210/en.2009-1264, 10.1210//en.2009-1264]; Dickinson RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027792; Dieplinger H, 2009, CANCER EPIDEM BIOMAR, V18, P1127, DOI 10.1158/1055-9965.EPI-08-0653; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Fuzery AK, 2013, CLIN PROTEOM, V10, DOI 10.1186/1559-0275-10-13; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Gubbay O, 2005, BRIT J CANCER, V92, P1927, DOI 10.1038/sj.bjc.6602568; He YF, 2010, J PROTEOME RES, V9, P6180, DOI 10.1021/pr100822v; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lawrie Laura C, 2005, Methods Mol Biol, V293, P245; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Lurie G, 2008, CANCER EPIDEM BIOMAR, V17, P2070, DOI 10.1158/1055-9965.EPI-08-0145; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Martens L, 2005, BIOINFORMATICS, V21, P3584, DOI 10.1093/bioinformatics/bti588; Melvin JC, 2012, CANCER EPIDEM BIOMAR, V21, P1381, DOI 10.1158/1055-9965.EPI-12-0188; Moore LE, 2012, CANCER-AM CANCER SOC, V118, P91, DOI 10.1002/cncr.26241; Moore RG, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.043; O'Malley BW, 2009, CANCER RES, V69, P8217, DOI 10.1158/0008-5472.CAN-09-2223; Previdi S, 2010, GYNECOL ONCOL, V118, P182, DOI 10.1016/j.ygyno.2010.03.020; Rai AJ, 2002, ARCH PATHOL LAB MED, V126, P1518; Runnebaum IB, 2005, CLIN CANCER RES, V11, P6325, DOI 10.1158/1078-0432.CCR-05-0182; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Skates SJ, 2004, J CLIN ONCOL, V22, P4059, DOI 10.1200/JCO.2004.03.091; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Ueland FR, 2011, OBSTET GYNECOL, V117, P1289, DOI 10.1097/AOG.0b013e31821b5118; Vissers JPC, 2007, MOL CELL PROTEOMICS, V6, P755, DOI 10.1074/mcp.M600303-MCP200; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang XH, 2008, J BIOL CHEM, V283, P13934, DOI 10.1074/jbc.M709300200; Warnes GR, 2013, VARIOUS R PROGRAMMIN; Wegdam W, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-45; Woenckhaus J, 2006, ONCOL REP, V15, P1137; Xu BJ, 2010, PROTEOM CLIN APPL, V4, P116, DOI 10.1002/prca.200900138; Yamamoto S, 2007, MODERN PATHOL, V20, P1278, DOI 10.1038/modpathol.3800966; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234; Yano A, 2006, CLIN CANCER RES, V12, P3003, DOI 10.1158/1078-0432.CCR-05-2085; Zhang Z, 2004, CANCER RES, V64, P5882, DOI 10.1158/0008-5472.CAN-04-0746; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012	52	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108046	10.1371/journal.pone.0108046	http://dx.doi.org/10.1371/journal.pone.0108046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265318	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400040
J	Wood, C; Gladwell, V; Barton, J				Wood, Carly; Gladwell, Valerie; Barton, Jo			A Repeated Measures Experiment of School Playing Environment to Increase Physical Activity and Enhance Self-Esteem in UK School Children	PLOS ONE			English	Article							PLAYGROUND MARKINGS; HEALTH; INTERVENTION; EXERCISE; FITNESS; PEOPLE	School playtime provides daily opportunities for children to be active outdoors, but only makes small contributions to physical activity (PA) requirements. Natural environments facilitate unstructured PA and children report a preference for play in nature. Thus, play on the school field might encourage children to be more active during playtime. The primary aim of this study was to examine the impact of the school playing environment on children's PA. Descriptive data and fitness were assessed in 25 children aged 8-9 years from a single primary school. Over two consecutive weeks participants were allocated to either play on the school field or playground during playtime. The order of play in the two areas was randomised and counterbalanced. Moderate to vigorous PA (MVPA) was assessed during playtime on the last two days of each week using accelerometers. There was a significant interaction of environment and sex on MVPA during morning play (F(1,22) = 6.27; P<0.05; n(p)(2) = 0.222), but not during lunch (P>0.05; n(p)(2) = 0.060) or all of playtime combined (P>0.05; n(p)(2) = 0.140). During morning play boys were significantly more active than girls on the playground (t(23) = 1.32; P<0.01; n(2) = 0.291), but not on the field (P>0.05; n(2) = 0.071). For lunch (F(1,22) = 24,11; P<0.001; n(p)(2) = 0.523) and all of playtime combined (F(1,22) = 33.67; P<0.001; n(p)(2) = 0.616) there was a significant effect of environment. There was also a significant main effect of sex during lunch (F(1,22) = 11.56; P<0.01; n(p)(2) = 0.344) and all of playtime combined (F(1,22) = 12.37; P<0.01; n(p)(2) = 0.371). MVPA was higher on the field and boys were more active than girls. Play on the field leads to increases in MVPA, particularly in girls. The promising trend for the effect of the natural environment on MVPA indicates that interventions aimed at increasing MVPA should use the natural environment and that schools should encourage greater use of their natural areas to increase PA.	[Wood, Carly; Gladwell, Valerie; Barton, Jo] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England	University of Essex	Wood, C (corresponding author), Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England.	cjwood@essex.ac.uk	Gladwell, Valerie/AAY-8410-2021	Barton, Jo/0000-0003-3548-9478; Wood, Carly/0000-0003-1723-552X	Economic and Social Research Council [ES/F039158/1] Funding Source: researchfish; ESRC [ES/F039158/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], 2007, NATURAL THINKING INV; Babey SH, 2008, AM J PREV MED, V34, P345, DOI 10.1016/j.amepre.2008.01.020; Barton J., 2014, INT J ENVIRON HEAL R, P1; Barton J, 2010, ENVIRON SCI TECHNOL, V44, P3947, DOI 10.1021/es903183r; Bowler DE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/147-2458-10-456; Bratman GN, 2012, ANN NY ACAD SCI, V1249, P118, DOI 10.1111/j.1749-6632.2011.06400.x; Brockman R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-461; Burdette HL, 2005, ARCH PEDIAT ADOL MED, V159, P46, DOI 10.1001/archpedi.159.1.46; CALFAS KJ, 1994, PEDIATR EXERC SCI, V6, P406, DOI 10.1123/pes.6.4.406; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Corder K, 2007, J SPORT SCI, V25, P1607, DOI 10.1080/02640410701283841; Ekeland E, 2005, BRIT J SPORT MED, V39, P792, DOI 10.1136/bjsm.2004.017707; Faigenbaum AD, 2012, CURR SPORT MED REP, V11, P196, DOI 10.1249/JSR.0b013e31825da961; Health and Social Care Information Centre, 2012, HLTH SURV ENGL 2012; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; Howe CA, 2012, PEDIATR OBES, V7, P82, DOI 10.1111/j.2047-6310.2011.00007.x; Huberty JL, 2011, J SCHOOL HEALTH, V81, P251, DOI 10.1111/j.1746-1561.2011.00591.x; Hyndman BP, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-164; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Janz KF, 2010, MED SCI SPORT EXER, V42, P1072, DOI 10.1249/MSS.0b013e3181c619b2; Kristjansson A, 2007, HEALTH EDUC BEHAV, V37, P51; Meredith MD, 2004, FITNESSGRAM ACTIVITY, P59; Mitchell R, 2008, LANCET, V372, P1655, DOI 10.1016/S0140-6736(08)61689-X; Natural England, 2009, CHILDH NAT SURV CHAN; Parrish AM, 2009, J PHYS ACT HEALTH, V6, pS89, DOI 10.1123/jpah.6.s1.s89; Pretty J, 2007, J ENVIRON PLANN MAN, V50, P211, DOI 10.1080/09640560601156466; Pretty J, 2005, INT J ENVIRON HEAL R, V15, P319, DOI 10.1080/09603120500155963; Pretty J, 2009, NATURE CHILDHOOD LIF; Reed K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069176; Ridgers ND, 2006, SPORTS MED, V36, P359, DOI 10.2165/00007256-200636040-00005; Ridgers ND, 2007, PREV MED, V44, P393, DOI 10.1016/j.ypmed.2007.01.009; Ridgers ND, 2011, HEALTH EDUC RES, V26, P586, DOI 10.1093/her/cyr014; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Sandercock G, 2010, PREV MED, V50, P193, DOI 10.1016/j.ypmed.2010.01.005; Stratton, 1999, J SPORT PEDAGOGY, V2, P71, DOI 10.1177/1356336X17743048; Stratton G, 2005, PREV MED, V41, P828, DOI 10.1016/j.ypmed.2005.07.009; Stratton G, 2000, ERGONOMICS, V43, P1538, DOI 10.1080/001401300750003961; Treuth MS, 2004, MED SCI SPORT EXER, V36, P1259, DOI 10.1249/01.MSS.0000074670.03001.98; Verstraete SJM, 2006, EUR J PUBLIC HEALTH, V16, P415, DOI 10.1093/eurpub/ckl008; Watson AC, 2007, SCHIZOPHRENIA BULL, V33, P1312, DOI 10.1093/schbul/sbl076; Wells NM, 2007, ENVIRON BEHAV, V39, P6, DOI 10.1177/0013916506295570; Wood C, 2014, INT J ENV H IN PRESS; Wood C, 2012, INT J ENVIRON HEAL R, V23, P311; World Health Organisation, 2010, GLOB REC PHYS ACT HL	44	21	21	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108701	10.1371/journal.pone.0108701	http://dx.doi.org/10.1371/journal.pone.0108701			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6XR	25264610	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400106
J	Zhao, LC; Zhang, HY; Yang, YJ; Zheng, YQ; Dong, MJ; Wang, YQ; Bai, GH; Ye, XJ; Yan, ZH; Gao, HC				Zhao, Liangcai; Zhang, Haiyan; Yang, Yunjun; Zheng, Yongquan; Dong, Minjian; Wang, Yaqiang; Bai, Guanghui; Ye, Xinjian; Yan, Zhihan; Gao, Hongchang			Serum Metabonomic Analysis of Protective Effects of Curcuma aromatica Oil on Renal Fibrosis Rats	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; NUCLEAR-MAGNETIC-RESONANCE; GLYCINE; SPECTROSCOPY; METABOLOMICS; PATHOGENESIS; METABOLISM; INJURY; H-1	Background: Curcuma aromatica oil is a traditional herbal medicine demonstrating protective and anti-fibrosis activities in renal fibrosis patients. However, study of its mechanism of action is challenged by its multiple components and multiple targets that its active agent acts on. Methodology/Principal Findings: Nuclear magnetic resonance (NMR)-based metabonomics combined with clinical chemistry and histopathology examination were performed to evaluate intervening effects of Curcuma aromatica oil on renal interstitial fibrosis rats induced by unilateral ureteral obstruction. The metabolite levels were compared based on integral values of serum H-1 NMR spectra from rats on 3, 7, 14, and 28 days after the medicine administration. Time trajectory analysis demonstrated that metabolic profiles of the agent-treated rats were restored to control levels after 7 days of dosage. The results confirmed that the agent would be an effective anti-fibrosis medicine in a time-dependent manner, especially in early renal fibrosis stage. Targeted metabolite analysis showed that the medicine could lower levels of lipid, acetoacetate, glucose, phosphorylcholine/choline, trimethylamine oxide and raise levels of pyruvate, glycine in the serum of the rats. Serum clinical chemistry and kidney histopathology examination dovetailed well with the metabonomics data. Conclusions/Significances: The results substantiated that Curcuma aromatica oil administration can ameliorate renal fibrosis symptoms by inhibiting some metabolic pathways, including lipids metabolism, glycolysis and methylamine metabolism, which are dominating targets of the agent working in vivo. This study further strengthens the novel analytical approach for evaluating the effect of traditional herbal medicine and elucidating its molecular mechanism.	[Zhao, Liangcai; Zhang, Haiyan; Zheng, Yongquan; Dong, Minjian; Wang, Yaqiang; Gao, Hongchang] Wenzhou Med Univ, Sch Pharmaceut Sci, Inst Metabon & Med NMR, Wenzhou, Peoples R China; [Bai, Guanghui; Ye, Xinjian; Yan, Zhihan; Gao, Hongchang] Wenzhou Med Univ, Affiliated Hosp 2, Dept Radiol, Wenzhou, Peoples R China; [Yang, Yunjun] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiol, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Yan, ZH (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Radiol, Wenzhou, Peoples R China.	zhihanyan@hotmail.com; gaohc27@gmail.com			National Natural Science Foundation of China [21175099, 81100598]; Zhejiang Provincial Project of Key Scientific Group [2010R50042]; Zhejiang Provincial Natural Science Foundation of China [Y13H070016]; Scientific Research Foundation for the Talents, Wenzhou Medical University [QTJ13004, QTJ08008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Project of Key Scientific Group; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Scientific Research Foundation for the Talents, Wenzhou Medical University	This work was supported by the National Natural Science Foundation of China (Nos. 21175099 and 81100598), the Zhejiang Provincial Project of Key Scientific Group (2010R50042), the Zhejiang Provincial Natural Science Foundation of China (No. Y13H070016), and the Scientific Research Foundation for the Talents, Wenzhou Medical University (QTJ13004 and QTJ08008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL JD, 1991, BIOCHIM BIOPHYS ACTA, V1096, P101, DOI 10.1016/0925-4439(91)90046-C; BROSNAN JT, 1983, AM J PHYSIOL, V244, pE151, DOI 10.1152/ajpendo.1983.244.2.E151; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Gaedeke J, 2005, KIDNEY INT, V68, P2042, DOI 10.1111/j.1523-1755.2005.00658.x; Gao HC, 2008, ANAL CHIM ACTA, V624, P269, DOI 10.1016/j.aca.2008.06.051; Garrod S, 1999, MAGNET RESON MED, V41, P1108, DOI 10.1002/(SICI)1522-2594(199906)41:6<1108::AID-MRM6>3.0.CO;2-M; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Gu Y, 2010, TALANTA, V81, P766, DOI 10.1016/j.talanta.2010.01.015; Hong JY, 2006, J FOOD SCI, V71, pS626, DOI 10.1111/j.1750-3841.2006.00194.x; Jayaprakasha GK, 2005, TRENDS FOOD SCI TECH, V16, P533, DOI 10.1016/j.tifs.2005.08.006; Kasuya F, 1999, CHEM-BIOL INTERACT, V118, P233, DOI 10.1016/S0009-2797(99)00084-8; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Liang XP, 2011, J PROTEOME RES, V10, P790, DOI 10.1021/pr1009299; Liao S, 2011, J WENZHOU MED COLL, V41, P3; Lindon JC, 2008, ANNU REV ANAL CHEM, V1, P45, DOI 10.1146/annurev.anchem.1.031207.113026; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Lu XM, 2011, TALANTA, V83, P700, DOI 10.1016/j.talanta.2010.09.026; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Pan C, 2005, BIOCHEM J, V390, P447, DOI 10.1042/BJ20050141; Psihogios NG, 2007, J PROTEOME RES, V6, P3760, DOI 10.1021/pr070172w; Qiu J, 2007, NATURE, V448, P126, DOI 10.1038/448126a; Roth GN, 1998, J NAT PROD, V61, P542, DOI 10.1021/np970459f; Shyur LF, 2008, CURR OPIN CHEM BIOL, V12, P66, DOI 10.1016/j.cbpa.2008.01.032; Soetikno V, 2013, MOL NUTR FOOD RES, V57, P1649, DOI 10.1002/mnfr.201200540; Song XF, 2013, J PHARMACEUT BIOMED, V78-79, P202, DOI 10.1016/j.jpba.2013.02.014; Wang M, 2005, PHYTOTHER RES, V19, P173, DOI 10.1002/ptr.1624; Wetmore DR, 2010, J BIOL CHEM, V285, P30516, DOI 10.1074/jbc.M110.140806; Xie BG, 2009, J PHARMACEUT BIOMED, V49, P492, DOI 10.1016/j.jpba.2008.10.022; Yin M, 2002, AM J PHYSIOL-RENAL, V282, pF417, DOI 10.1152/ajprenal.00011.2001; Zhang HY, 2012, MOL BIOSYST, V8, P595, DOI 10.1039/c1mb05311f; Zhao LC, 2012, J ETHNOPHARMACOL, V142, P647, DOI 10.1016/j.jep.2012.05.031	31	17	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108678	10.1371/journal.pone.0108678	http://dx.doi.org/10.1371/journal.pone.0108678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265289	gold, Green Submitted, Green Published			2022-12-27	WOS:000345745400102
J	Zhong, CK; Lv, LY; Liu, CJ; Zhao, L; Zhou, M; Sun, WJ; Xu, T; Tong, WJ				Zhong, Chongke; Lv, Liying; Liu, Changjiang; Zhao, Liang; Zhou, Mo; Sun, Wenjie; Xu, Tan; Tong, Weijun			High Homocysteine and Blood Pressure Related to Poor Outcome of Acute Ischemia Stroke in Chinese Population	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; C-REACTIVE PROTEIN; PLASMA HOMOCYSTEINE; CARDIOVASCULAR-DISEASE; GLOBAL BURDEN; RISK; SEVERITY; METAANALYSIS; ASSOCIATION; PREVENTION	Objectives: To assess the association between plasma homocysteine (Hcy), blood pressure (BP) and poor outcome at hospital discharge among acute ischemic stroke patients, and if high Hcy increases the risk of poor outcome based on high BP status in a northern Chinese population. Methods: Between June 1, 2009 and May 31, 2013, a total of 3695 acute ischemic stroke patients were recruited from three hospitals in northern Chinese cities. Demographic characteristics, lifestyle risk factors, medical history, and other clinical characteristics were recorded for all subjects. Poor outcome was defined as a discharge modified Rankin Scale (mRS) score >= 3 or death. The association between homocysteine concentration, admission blood pressure, and risk of poor outcome following acute ischemic stroke was analyzed by using multivariate non-conditional logistic regression models. Results: Compared with those in the lowest quartile of Hcy concentration in a multivariate-adjusted model, those in the highest quartile of Hcy concentration had increased risk of poor outcome after acute ischemic stroke, (OR = 1.33, P<0.05). The dose-response relationship between Hcy concentration and risk of poor outcome was statistically significant (p-value for trend = 0.027). High BP was significantly associated with poor outcome following acute ischemic stroke (adjusted OR = 1.44, 95% CI, 1.19-1.74). Compared with non-high BP with nhHcy, in a multivariate-adjusted model, the ORs (95% CI) of non-high BP with hHcy, high BP with nhHcy, and high BP with hHcy to poor outcome were 1.14 (0.85-1.53), 1.37 (1.03-1.84) and 1.70 (1.29-2.34), respectively. Conclusion: The present study suggested that high plasma Hcy and blood pressure were independent risk factors for prognosis of acute ischemic stroke, and hHcy may further increase the risk of poor outcome among patients with high blood pressure. Additionally, the results indicate that high Hcy with high BP may cause increased susceptibility to poor outcome among acute ischemic stroke patients in a northern Chinese population.	[Zhong, Chongke; Zhou, Mo; Xu, Tan; Tong, Weijun] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Jiangsu, Peoples R China; [Lv, Liying] Xinganmeng Peoples Hosp, Dept Neurol, Xinganmeng, Inner Mongolia, Peoples R China; [Liu, Changjiang] Fuxin Ctr Hosp, Dept Neurol, Fuxing, Liaoning, Peoples R China; [Zhao, Liang] Chengde Med Univ, Affiliated Hosp, Dept Neurol, Chengde, Hebei, Peoples R China; [Sun, Wenjie] Guangdong Pharmaceut Univ, Sch Food Sci, Zhongshan, Peoples R China; [Sun, Wenjie] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Xu, Tan] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA	Soochow University - China; Chengde Medical University; Guangdong Pharmaceutical University; Tulane University; Tulane University	Xu, T (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Jiangsu, Peoples R China.	xutan@suda.edu.cn; tongweijun@suda.edu.cn	Zhong, Chongke/AAI-6454-2020; Sun, Wenjie/I-7692-2013		National Natural Science Foundation of China [81172760]; FOGARTY INTERNATIONAL CENTER [D43TW009107] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by National Natural Science Foundation of China (Grant No. 81172760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; Alvarez FJ, 2004, J CEREBR BLOOD F MET, V24, P1267, DOI 10.1097/01.WCB.0000139370.93203.4A; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Bonita R, 2004, LANCET NEUROL, V3, P391, DOI 10.1016/S1474-4422(04)00800-2; Eastern S, 1998, LANCET, V352, P1801; Faraci FM, 2004, STROKE, V35, P345, DOI 10.1161/01.STR.0000115161.10646.67; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Iso H, 2004, CIRCULATION, V109, P2766, DOI 10.1161/01.CIR.0000131942.77635.2D; Kalita J, 2009, CLIN NEUROL NEUROSUR, V111, P364, DOI 10.1016/j.clineuro.2008.12.010; Khan U, 2008, STROKE, V39, P2943, DOI 10.1161/STROKEAHA.107.513416; Leonardi-Bee J, 2002, STROKE, V33, P1315, DOI 10.1161/01.STR.0000014509.11540.66; LLOYD B, 1978, CLIN CHEM, V24, P1724; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Meairs S, 2006, CEREBROVASC DIS, V22, P75, DOI 10.1159/000093098; Mizrahi EH, 2005, ARCH PHYS MED REHAB, V86, P60, DOI 10.1016/j.apmr.2004.01.031; Naess H, 2013, J STROKE CEREBROVASC, V22, pE435, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.031; Perini F, 2005, NEUROL SCI, V26, P310, DOI 10.1007/s10072-005-0505-7; Pniewski Ja, 2002, ACTA NEUROBIOLOGIAE, V63, P127; Qizilbash N, 1995, NASLOV CHOLESTEROL D; Refsum H, 1997, J INHERIT METAB DIS, V20, P286, DOI 10.1023/A:1005321225893; Refsum H, 2004, CLIN CHEM, V50, P3, DOI 10.1373/clinchem.2003.021634; Ridker PM, 1999, JAMA-J AM MED ASSOC, V281, P1817, DOI 10.1001/jama.281.19.1817; Song IU, 2009, J NEUROL SCI, V278, P60, DOI 10.1016/j.jns.2008.11.011; Stead LG, 2006, NEUROLOGY, V66, P1878, DOI 10.1212/01.wnl.0000219628.78513.b5; Tofler GH, 2002, THROMB HAEMOSTASIS, V88, P799; Towfighi A, 2010, J NEUROL SCI, V298, P153, DOI 10.1016/j.jns.2010.07.013; Tu WJ, 2013, NEUROL RES, V35, P912, DOI 10.1179/1743132813Y.0000000228; Tuttolomondo A, 2011, INT J CARDIOL, V151, P318, DOI 10.1016/j.ijcard.2010.06.005; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wang H, 1997, J BIOL CHEM, V272, P25380, DOI 10.1074/jbc.272.40.25380; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Wang YZ, 2013, STROKE, V44, P3298, DOI 10.1161/STROKEAHA.113.002604; Wu XQ, 2013, EUR J INTERN MED, V24, P362, DOI 10.1016/j.ejim.2013.01.015; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200	37	35	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107498	10.1371/journal.pone.0107498	http://dx.doi.org/10.1371/journal.pone.0107498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265507	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400024
J	Crowther, LP; Hein, PL; Bourke, AFG				Crowther, Liam P.; Hein, Pierre-Louis; Bourke, Andrew F. G.			Habitat and Forage Associations of a Naturally Colonising Insect Pollinator, the Tree Bumblebee Bombus hypnorum	PLOS ONE			English	Article							LANDSCAPE CONTEXT; NEST DENSITY; CONSERVATION; VULNERABILITY; AVAILABILITY; REPRODUCTION; DECLINES; DISTANCE; BEES	Bumblebees (Bombus species) are major pollinators of commercial crops and wildflowers but factors affecting their abundance, including causes of recent population declines, remain unclear. Investigating the ecology of species with expanding ranges provides a potentially powerful means of elucidating these factors. Such species may also bring novel pollination services to their new ranges. We therefore investigated landscape-scale habitat use and foraging preferences of the Tree Bumblebee, B. hypnorum, a recent natural colonist that has rapidly expanded its range in the UK over the past decade. Counts of B. hypnorum and six other Bombus species were made in March-June 2012 within a mixed landscape in south-eastern Norfolk, UK. The extent of different landscape elements around each transect was quantified at three scales (250 m, 500 m and 1500 m). We then identified the landscape elements that best predicted the density of B. hypnorum and other Bombus species. At the best fitting scale (250 m), B. hypnorum density was significantly positively associated with extent of both urban and woodland cover and significantly negatively associated with extent of oilseed rape cover. This combination of landscape predictors was unique to B. hypnorum. Urban and woodland cover were associated with B. hypnorum density at three and two, respectively, of the three scales studied. Relative to other Bombus species, B. hypnorum exhibited a significantly higher foraging preference for two flowering trees, Crataegus monogyna and Prunus spinosa, and significantly lower preferences for Brassica napus, Glechoma hederacea and Lamium album. Our study provides novel, quantitative support for an association of B. hypnorum with urban and woodland landscape elements. Range expansion in B. hypnorum appears to depend, on exploitation of widespread habitats underutilised by native Bombus species, suggesting B. hypnorum will readily co-exist with these species. These findings suggest that management could target bumblebee species with distinctive habitat requirements to help maintain pollination services.	[Crowther, Liam P.; Hein, Pierre-Louis; Bourke, Andrew F. G.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Hein, Pierre-Louis] IUT Nancy Brabois, Villers Les Nancy, CS, France	University of East Anglia; Universite de Lorraine	Crowther, LP (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	l.crowther@uea.ac.uk	Bourke, Andrew F. G./E-5271-2011; Crowther, Liam/HHM-9432-2022		Natural Environment Research Council; Natural Environment Research Council [1315522] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported in part by a studentship held by LPC funded by a Natural Environment Research Council Doctoral Training Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2011, LANGUAGER DATA SETS; Bates D, 2012, LME4 LINEAR MIXED EF; BENTON T, 2006, BUMBLEBEES; Bommarco R, 2012, P ROY SOC B-BIOL SCI, V279, P309, DOI 10.1098/rspb.2011.0647; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Carvell C, 2011, ECOL APPL, V21, P1760, DOI 10.1890/10-0677.1; Carvell C, 2006, BIOL CONSERV, V132, P481, DOI 10.1016/j.biocon.2006.05.008; Carvell C, 2012, OIKOS, V121, P734, DOI 10.1111/j.1600-0706.2011.19832.x; Chapman RE, 2003, MOL ECOL, V12, P2801, DOI 10.1046/j.1365-294X.2003.01957.x; Charman TG, 2010, MOL ECOL, V19, P2661, DOI 10.1111/j.1365-294X.2010.04697.x; Darvill B, 2004, OIKOS, V107, P471, DOI 10.1111/j.0030-1299.2004.13510.x; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; Edwards M, 2005, FIELD GUIDE BUMBLEBE; Esri Inc., 2011, ARCGIS DESKT REL 10; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Goulson D, 2006, J INSECT CONSERV, V10, P95, DOI 10.1007/s10841-006-6286-3; Goulson Dave, 2001, British Journal of Entomology and Natural History, V14, P129; Gyan KY, 1987, FUNCT ECOL, V1, P261, DOI 10.2307/2389429; Heard MS, 2007, BIOL LETTERS, V3, P638, DOI 10.1098/rsbl.2007.0425; Jha S, 2013, P NATL ACAD SCI USA, V110, P555, DOI 10.1073/pnas.1208682110; Jones CM, 2014, J ANIM ECOL, V83, P1428, DOI 10.1111/1365-2656.12235; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; Loken A, 1973, NORSK ENTOMOLOGISK T, V20; McGarigal K., 2012, TECH REP; OS, 2019, MASTERMAP TOP LAYER; Osborne JL, 2008, J APPL ECOL, V45, P784, DOI 10.1111/j.1365-2664.2007.01359.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; PEKKARINEN A, 1979, Acta Zoologica Fennica, P1; Plowright CMS, 1997, CAN ENTOMOL, V129, P985, DOI 10.4039/Ent129985-6; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pywell RF, 2011, J INSECT CONSERV, V15, P853, DOI 10.1007/s10841-011-9383-x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roberts SPM, 2013, BOMB HYPN UK REC; Roberts SPM, 2013, BOMB HYPN MAPP PROJ; Sepp K, 2004, LANDSCAPE URBAN PLAN, V67, P173, DOI 10.1016/S0169-2046(03)00037-9; Usenik V, 2011, EUR J HORTIC SCI, V76, P1; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Westphal C, 2009, J APPL ECOL, V46, P187, DOI 10.1111/j.1365-2664.2008.01580.x; Williams P, 2005, BIOL CONSERV, V122, P33, DOI 10.1016/j.biocon.2004.06.019; Williams PH, 2007, BIOL CONSERV, V138, P493, DOI 10.1016/j.biocon.2007.06.001; WILLIAMS PH, 1989, BOT J LINN SOC, V101, P31, DOI 10.1111/j.1095-8339.1989.tb00134.x; Zuur AF, 2009, MEDIA	44	27	29	2	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107568	10.1371/journal.pone.0107568	http://dx.doi.org/10.1371/journal.pone.0107568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259579	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000342685600022
J	Davaine, JM; Quillard, T; Brion, R; Laperine, O; Guyomarch, B; Merlini, T; Chatelais, M; Guilbaud, F; Brennan, MA; Charrier, C; Heymann, D; Goueffic, Y; Heymann, MF				Davaine, Jean-Michel; Quillard, Thibaut; Brion, Regis; Laperine, Olivier; Guyomarch, Beatrice; Merlini, Thierry; Chatelais, Mathias; Guilbaud, Florian; Brennan, Meadhbh Aine; Charrier, Celine; Heymann, Dominique; Goueffic, Yann; Heymann, Marie-Francoise			Osteoprotegerin, Pericytes and Bone-Like Vascular Calcification Are Associated with Carotid Plaque Stability	PLOS ONE			English	Article							KAPPA-B LIGAND; ATHEROSCLEROTIC LESIONS; RECEPTOR ACTIVATOR; CELLS; ENDARTERECTOMY; STENOSIS; VULNERABILITY; DIFFERENTIATION; EXPRESSION; CYTOKINE	Background and Purpose: Vascular calcification, recapitulating bone formation, has a profound impact on plaque stability. The aim of the present study was to determine the influence of bone-like vascular calcification (named osteoid metaplasia = OM) and of osteoprotegerin on plaque stability. Methods: Tissue from carotid endarterectomies were analysed for the presence of calcification and signs of vulnerability according to AHA grading system. Osteoprotegerin (OPG), pericytes and endothelial cells were sought using immunohistochemistry. Symptoms and preoperative imaging findings (CT-scan, MRI and Doppler-scan) were analyzed. Human pericytes were cultured to evaluate their ability to secrete OPG and to influence mineralization in the plaque. Results: Seventy-three carotid plaques (49 asymptomatic and 24 symptomatic) were harvested. A significantly higher presence of OM (18.4% vs 0%, p<0.01), OPG (10.2% of ROI vs 3.4% of ROI, p<0.05) and pericytes (19% of ROI vs 3.8% of ROI, p, 0.05) were noted in asymptomatic compared to symptomatic plaques. Consistently, circulating OPG levels were higher in the plasma of asymptomatic patients (3.2 ng/mL vs 2.5 ng/mL, p = 0.05). In vitro, human vascular pericytes secreted considerable amounts of OPG and underwent osteoblastic differentiation. Pericytes also inhibited the osteoclastic differentiation of CD14+ cells through their secretion of OPG. Conclusions: OPG (intraplaque an plasmatic) and OM are associated with carotid plaque stability. Pericytes may be involved in the secretion of intraplaque OPG and in the formation of OM.	[Davaine, Jean-Michel; Quillard, Thibaut; Brion, Regis; Laperine, Olivier; Merlini, Thierry; Chatelais, Mathias; Guilbaud, Florian; Brennan, Meadhbh Aine; Charrier, Celine; Heymann, Dominique; Heymann, Marie-Francoise] INSERM, UMR 957, Nantes, France; [Davaine, Jean-Michel; Brion, Regis; Laperine, Olivier; Merlini, Thierry; Chatelais, Mathias; Guilbaud, Florian; Brennan, Meadhbh Aine; Charrier, Celine; Heymann, Dominique; Heymann, Marie-Francoise] Univ Nantes, Nantes Atlantique Univ, Nantes, France; [Davaine, Jean-Michel; Brion, Regis; Laperine, Olivier; Guyomarch, Beatrice; Merlini, Thierry; Guilbaud, Florian; Heymann, Dominique; Goueffic, Yann; Heymann, Marie-Francoise] CHU Nantes, F-44035 Nantes 01, France; [Guyomarch, Beatrice; Goueffic, Yann] Inst Thorax, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Davaine, JM (corresponding author), INSERM, UMR 957, Nantes, France.	davainej@yahoo.fr	Charrier, Céline/K-9198-2015; Heymann, Dominique/AAC-6014-2019; Goueffic, Yann/L-7438-2015; Quillard, Thibaut/K-8150-2015; Brennan, Meadhbh A/L-2068-2015	Heymann, Dominique/0000-0001-7777-0669; Quillard, Thibaut/0000-0002-8096-2597; CHARRIER, Celine/0000-0002-4487-5066; Brennan, Meadhbh A/0000-0002-1532-9760; Heymann, Marie-Francoise/0000-0002-5585-8261	ANR (Agence Nationale de Recherche) grant; PHRC (Programme Hospitalier de Recherche Clinique) Grand Ouest grant	ANR (Agence Nationale de Recherche) grant(French National Research Agency (ANR)); PHRC (Programme Hospitalier de Recherche Clinique) Grand Ouest grant	This work has been funded by an ANR (Agence Nationale de Recherche) grant and by a PHRC (Programme Hospitalier de Recherche Clinique) Grand Ouest grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2007, AM J CARDIOL, V99, P513, DOI 10.1016/j.amjcard.2006.08.064; Andreeva ER, 1998, TISSUE CELL, V30, P127, DOI 10.1016/S0040-8166(98)80014-1; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Bunting CH, 1906, J EXP MED, V8, P365, DOI 10.1084/jem.8.3.365; Collett GDM, 2005, CIRC RES, V96, P930, DOI 10.1161/01.RES.0000163634.51301.0d; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Duplomb L, 2008, ENDOCRINOLOGY, V149, P3688, DOI 10.1210/en.2007-1719; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Golledge J, 2004, STROKE, V35, P1636, DOI 10.1161/01.STR.0000129790.00318.a3; Herisson F, 2011, ATHEROSCLEROSIS, V216, P348, DOI 10.1016/j.atherosclerosis.2011.02.004; Heymann MF, 2012, CYTOKINE, V58, P300, DOI 10.1016/j.cyto.2012.02.004; Hoshino T, 2009, AM J PHYSIOL-HEART C, V297, pH802, DOI 10.1152/ajpheart.00318.2009; Hunt J, 2002, POETRY WALES, V37, P33; Kaden JJ, 2004, J MOL CELL CARDIOL, V36, P57, DOI 10.1016/j.yjmcc.2003.09.015; Kadoglou NPE, 2008, J VASC SURG, V47, P55, DOI 10.1016/j.jvs.2007.09.058; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Maldonado N, 2012, AM J PHYSIOL-HEART C, V303, pH619, DOI 10.1152/ajpheart.00036.2012; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; Oksala N, 2010, ANN MED, V42, P360, DOI 10.3109/07853890.2010.486408; Omland T, 2008, J AM COLL CARDIOL, V51, P627, DOI 10.1016/j.jacc.2007.09.058; Ozkok A, 2012, CLIN J AM SOC NEPHRO, V7, P965, DOI 10.2215/CJN.11191111; Panizo S, 2009, CIRC RES, V104, P1041, DOI 10.1161/CIRCRESAHA.108.189001; Qiao JH, 2003, HUM PATHOL, V34, P402, DOI 10.1053/hupa.2003.72; Rennenberg RJMW, 2009, VASC HEALTH RISK MAN, V5, P185; Rerkasem K, 2009, STROKE, V40, pE564, DOI 10.1161/STROKEAHA.109.558528; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Straface G, 2011, STROKE, V42, P3022, DOI 10.1161/STROKEAHA.111.619288; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Wong KKL, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-7; Yin TT, 2000, CIRCULATION, V102, P2636, DOI 10.1161/01.cir.102.21.2636; Zannettino ACW, 2005, J CELL PHYSIOL, V204, P714, DOI 10.1002/jcp.20354; Ziegler S, 2005, ATHEROSCLEROSIS, V182, P175, DOI 10.1016/j.atherosclerosis.2005.01.042	40	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107642	10.1371/journal.pone.0107642	http://dx.doi.org/10.1371/journal.pone.0107642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259713	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000342685600024
J	Kim, SH; Huh, SY; Hyun, JW; Jeong, IH; Lee, SH; Joung, A; Kim, HJ				Kim, Su-Hyun; Huh, So-Young; Hyun, Jae-Won; Jeong, In Hye; Lee, Sang Hyun; Joung, Aeran; Kim, Ho Jin			A Longitudinal Brain Magnetic Resonance Imaging Study of Neuromyelitis Optica Spectrum Disorder	PLOS ONE			English	Article							AQUAPORIN-4; ABNORMALITIES; DISTINCTION; LESIONS; MRI	Brain involvement is commonly seen in patients with neuromyelitis optica spectrum disorder (NMOSD). However, little is known about the chronic changes of acute brain lesions on MRI over time. Here, our objective was to evaluate how acute brain MRI lesions in NMOSD changed on follow-up MRI. We reviewed the MRIs of 63 patients with NMOSD who had acute brain lesions and follow-up MRI over an interval of at least 3 months. Of the 211 acute brain lesions, 24% of lesions disappeared completely on T2-weighed images (WI) and a decrease in size >= 50% on T2-WI was observed in 58% of lesions on follow-up MRI. However, 47% of lesions revealed focal T1-hypointensity and, in particular, 18% showed focal cystic changes. Cystic changes were observed most commonly in corticospinal tract and corpus callosal lesions whereas the vast majority of lesions in the cerebellum, basal ganglia and temporal white matter resolved completely. MRI remission on T2-WI occurred in 82% of lesions, while approximately half of the lesions presented foci of T1-hypointensity, which may be considered a severe tissue injury over time. The extent of brain injury following an acute brain lesion in NMOSD may depend on the location of the lesion.	[Kim, Su-Hyun; Hyun, Jae-Won; Jeong, In Hye; Joung, Aeran; Kim, Ho Jin] Res Inst & Hosp Natl Canc Ctr, Dept Neurol, Goyang, South Korea; [Huh, So-Young] Kosin Univ, Sch Med, Dept Neurol, Pusan, South Korea; [Lee, Sang Hyun] Res Inst & Hosp Natl Canc Ctr, Dept Radiol, Goyang, South Korea	National Cancer Center - Korea (NCC); Pusan National University; Pusan National University Hospital; National Cancer Center - Korea (NCC)	Kim, HJ (corresponding author), Res Inst & Hosp Natl Canc Ctr, Dept Neurol, Goyang, South Korea.	hojinkim@ncc.re.kr			National Research Foundation of Korea [2013R1A1A2058612]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (no. 2013R1A1A2058612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bichuetti DB, 2008, ARQ NEURO-PSIQUIAT, V66, P1, DOI 10.1590/S0004-282X2008000100001; Cabrera-Gomez JA, 2012, EUR J NEUROL, V19, P812, DOI 10.1111/j.1468-1331.2011.03565.x; Cabrera-Gomez J, 2008, MULT SCLER J, V14, P248, DOI 10.1177/1352458507082617; Hickman SJ, 2001, J NEUROL SCI, V187, P35, DOI 10.1016/S0022-510X(01)00519-6; Hinson SR, 2008, J EXP MED, V205, P2473, DOI 10.1084/jem.20081241; Hinson SR, 2012, P NATL ACAD SCI USA, V109, P1245, DOI 10.1073/pnas.1109980108; Hinson SR, 2009, ARCH NEUROL-CHICAGO, V66, P1164, DOI 10.1001/archneurol.2009.188; Jarius S, 2010, J NEUROL SCI, V291, P52, DOI 10.1016/j.jns.2010.01.002; Kim SH, 2012, MULT SCLER J, V18, P1340, DOI 10.1177/1352458512441271; Kim W, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/735486; Kim W, 2012, MULT SCLER J, V18, P578, DOI 10.1177/1352458511424590; Kim W, 2011, J CLIN NEUROL, V7, P115, DOI 10.3988/jcn.2011.7.3.115; Kim W, 2011, MULT SCLER J, V17, P1107, DOI 10.1177/1352458511404917; Kim W, 2010, MULT SCLER J, V16, P1229, DOI 10.1177/1352458510376640; Kister I, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/398259; Kister I, 2013, NEUROLOGY, V81, P1966, DOI 10.1212/01.wnl.0000436079.95856.1f; Lassmann H, 2008, NEUROIMAG CLIN N AM, V18, P563, DOI 10.1016/j.nic.2008.06.005; Magana SM, 2009, NEUROLOGY, V72, P712, DOI 10.1212/01.wnl.0000343001.36493.ae; Makino T, 2013, MULT SCLER J, V19, P308, DOI 10.1177/1352458512454772; Matsushita T, 2009, MULT SCLER J, V15, P1113, DOI 10.1177/1352458509106613; Matthews L, 2013, NEUROLOGY, V80, P1330, DOI 10.1212/WNL.0b013e3182887957; MILLER DH, 1988, BRAIN, V111, P927, DOI 10.1093/brain/111.4.927; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Moore GRW, 2000, NEUROLOGY, V55, P1506, DOI 10.1212/WNL.55.10.1506; Nakamura M, 2005, MULT SCLER J, V11, P735, DOI 10.1191/1352458505ms1236cr; Nakamura M, 2009, MULT SCLER, V15, P695, DOI 10.1177/1352458509103301; Pichiecchio A, 2012, MULT SCLER J, V18, P817, DOI 10.1177/1352458511431072; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P390, DOI 10.1001/archneur.63.3.390; Popescu BFG, 2011, NEUROLOGY, V76, P1229, DOI 10.1212/WNL.0b013e318214332c; Raz E, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/986923; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Sahraian MA, 2010, ACTA NEUROL SCAND, V122, P1, DOI 10.1111/j.1600-0404.2009.01221.x; Saiki S, 2009, J NEUROL SCI, V284, P217, DOI 10.1016/j.jns.2009.05.022; Sinnecker T, 2012, NEUROLOGY, V79, P708, DOI 10.1212/WNL.0b013e3182648bc8; Tang H, 2001, J NEUROIMMUNOL, V115, P53, DOI 10.1016/S0165-5728(01)00249-1; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107	38	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108320	10.1371/journal.pone.0108320	http://dx.doi.org/10.1371/journal.pone.0108320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259647	gold, Green Published, Green Submitted			2022-12-27	WOS:000342685600063
J	Sato, H; Suzuki, Y; Ide, M; Katoh, T; Noda, S; Ando, K; Oike, T; Yoshimoto, Y; Okonogi, N; Mimura, K; Asao, T; Kuwano, H; Nakano, T				Sato, Hiro; Suzuki, Yoshiyuki; Ide, Munenori; Katoh, Toshihide; Noda, Shin-ei; Ando, Ken; Oike, Takahiro; Yoshimoto, Yuya; Okonogi, Noriyuki; Mimura, Kousaku; Asao, Takayuki; Kuwano, Hiroyuki; Nakano, Takashi			HLA Class I Expression and Its Alteration by Preoperative Hyperthermo-Chemoradiotherapy in Patients with Rectal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MHC CLASS-I; ANTIGEN DOWN-REGULATION; COLORECTAL-CANCER; TUMOR; RADIATION; SURVIVAL; LESIONS; IMMUNOSURVEILLANCE; ASSOCIATION	Objective: Enhancing immunologic responses, including human leukocyte antigen (HLA) class I expression on tumor cells and recognition and elimination of tumor cells by tumor-specific cytotoxic T lymphocyte (CTL), is considered a novel concept of radiotherapy. The present study examined patients who underwent preoperative hyperthermo-chemoradiotherapy (HCRT) for locally advanced rectal cancer to assess the correlation between HLA class I expression and clinical outcome. Materials and Methods: Seventy-eight patients with locally advanced rectal adenocarcinoma who received preoperative HCRT were enrolled. The median age of the patients was 64 years (range, 33-85 years) and 4, 18, and 56 patients had clinical stage I, II and III disease, respectively. Formalin-fixed and paraffin-embedded tissues excised before and after HCRT were subjected to immunohistochemical analysis with an anti-HLA class I-A, B, C antibody. HLA class I expression was graded according to tumor cell positivity. Results: In pre-HCRT, the number of specimens categorized as Grade 0 and 1 were 19 (24%) and 58 (74%), respectively. Only 1 patient (1%) showed Grade 2 expression. However, 6 (8%), 27 (35%), 7 (9%), and 12 (15%) post-HCRT specimens were graded as Grade 0, 1, 2, and 3, respectively. There was a significant increase in HLA class I expression in post-HCRT specimens (p<0.01). However, neither pre- nor post-HCRT HLA class I expression affected overall survival and distant metastasis-free survival in clinical stage III patients. Univariate analysis revealed that Post-HCRT HLA class I expression showed a significant negative relationship with LC (p<0.05). Nevertheless, multivariate analysis showed that there was no correlation between HLA class I expression and clinical outcome. Conclusion: HCRT increased HLA class I expression in rectal cancer patients. However, multivariate analysis failed to show any correlation between the level of HLA class I expression and prognosis.	[Sato, Hiro; Suzuki, Yoshiyuki; Noda, Shin-ei; Ando, Ken; Oike, Takahiro; Yoshimoto, Yuya; Okonogi, Noriyuki; Nakano, Takashi] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma 371, Japan; [Ide, Munenori] Gunma Univ, Grad Sch Med, Dept Human Pathol, Maebashi, Gunma 371, Japan; [Katoh, Toshihide; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma 371, Japan; [Mimura, Kousaku] Natl Univ Singapore, Dept Surg, Singapore 117548, Singapore; [Asao, Takayuki] Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Maebashi, Gunma 371, Japan	Gunma University; Gunma University; Gunma University; National University of Singapore; Gunma University	Suzuki, Y (corresponding author), Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma 371, Japan.	syoshi@gunma-u.ac.jp	/CAH-2060-2022; Sato, Hiro/GWU-7659-2022	Okonogi, Noriyuki/0000-0002-9486-1922	Grants-in-Aid for Scientific Research [24591834] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		AbdelWahab Z, 1996, CELL IMMUNOL, V171, P246, DOI 10.1006/cimm.1996.0200; Bandoh N, 2010, ONCOL REP, V23, P933, DOI 10.3892/or_00000717; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Gameiro SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070417; Garnett CT, 2004, CANCER RES, V64, P7985, DOI 10.1158/0008-5472.CAN-04-1525; Homma I, 2009, CANCER SCI, V100, P2331, DOI 10.1111/j.1349-7006.2009.01329.x; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Kikuchi E, 2007, CANCER SCI, V98, P1424, DOI 10.1111/j.1349-7006.2007.00558.x; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Mizukami Y, 2008, BRIT J CANCER, V99, P1462, DOI 10.1038/sj.bjc.6604715; Naito Y, 1998, CANCER RES, V58, P3491; Newcomb EW, 2006, CLIN CANCER RES, V12, P4730, DOI 10.1158/1078-0432.CCR-06-0593; Ogino T, 2003, CLIN CANCER RES, V9, P4043; Ogino T, 2006, CANCER RES, V66, P9281, DOI 10.1158/0008-5472.CAN-06-0488; Ohtsukasa S, 2003, J CANCER RES CLIN, V129, P719, DOI 10.1007/s00432-003-0492-0; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Shioya M, 2011, J RADIAT RES, V52, P821, DOI 10.1269/jrr.11117; Speetjens FM, 2008, CANCER IMMUNOL IMMUN, V57, P601, DOI 10.1007/s00262-007-0396-y; Suzuki Y, 2012, CANCER RES, V72, P3967, DOI 10.1158/0008-5472.CAN-12-0851; Takeshima T, 2010, CANCER RES, V70, P2697, DOI 10.1158/0008-5472.CAN-09-2982; Tsukahara T, 2006, CANCER SCI, V97, P1374, DOI 10.1111/j.1349-7006.2006.00317.x; Tsutsumi S, 2011, ANTICANCER RES, V31, P3963; Watson NFS, 2006, INT J CANCER, V118, P6, DOI 10.1002/ijc.21303	23	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108122	10.1371/journal.pone.0108122	http://dx.doi.org/10.1371/journal.pone.0108122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259797	gold, Green Published, Green Submitted			2022-12-27	WOS:000342685600049
J	Shan, LF; Li, M; Ma, JZ; Zhang, HD				Shan, Lianfeng; Li, Ming; Ma, Jianzhong; Zhang, Huidan			PCR-Based Assays versus Direct Sequencing for Evaluating the Effect of KRAS Status on Anti-EGFR Treatment Response in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							K-RAS MUTATIONS; PHASE-III TRIAL; MELTING CURVE ANALYSIS; 1ST-LINE TREATMENT; FINE QUANTIFICATION; CETUXIMAB; IRINOTECAN; FLUOROURACIL; PANITUMUMAB; OXALIPLATIN	Background: The survival rate of colorectal cancer (CRC) patients carrying wild-type KRAS is significantly increased by combining anti-EGFR monoclonal antibody (mAb) with standard chemotherapy. However, conflicting data exist in both the wild-type KRAS and mutant KRAS groups, which strongly challenge CRC anti-EGFR treatment. Here we conducted a meta-analysis in an effort to provide more reliable information regarding anti-EGFR treatment in CRC patients. Methods: We searched full reports of randomized clinical trials using Medline, the American Society of Clinical Oncology (ASCO), and the European Society for Medical Oncology (ESMO). Two investigators independently screened the published literature according to our inclusive and exclusive criteria and the relative data were extracted. We used Review Manager 5.2 software to analyze the data. Results: The addition of anti-EGFR mAb to standard chemotherapy significantly improved both progression-free survival (PFS) and median overall survival (mOS) in the wild-type KRAS group; hazard ratios (HRs) for PFS and mOS were 0.70 [95% confidence interval (CI), 0.58-0.84] and 0.83 [95% CI, 0.75-0.91], respectively. In sub-analyses of the wild-type KRAS group, when PCR-based assays are employed, PFS and mOS notably increase: the HRs were 0.74 [95% CI, 0.62-0.88] and 0.87 [95% CI, 0.78-0.96], respectively. In sub-analyses of the mutant KRAS group, neither PCR-based assays nor direct sequencing enhance PFS or mOS. Conclusion: Our data suggest that PCR-based assays with high sensitivity and specificity allow accurate identification of patients with wild-type KRAS and thus increase PFS and mOS. Furthermore, such assays liberate patients with mutant KRAS from unnecessary drug side effects, and provide them an opportunity to receive appropriate treatment. Thus, establishing a precise standard reference test will substantially optimize CRC-targeted therapies.	[Shan, Lianfeng; Li, Ming; Ma, Jianzhong] China Med Univ, Coll Basic Med Sci, Dept Math, Shenyang, Peoples R China; [Zhang, Huidan] China Med Univ, Dept Cell Biol, Key Lab Cell Biol, Minist Publ Hlth, Shenyang, Peoples R China; [Zhang, Huidan] China Med Univ, Key Lab Med Cell Biol, Minist Educ, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Ma, JZ (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Math, Shenyang, Peoples R China.	jzma@mail.cmu.edu.cn; hdzhang@mail.cmu.edu.cn	Zhang, Huidan/K-8399-2015		National Natural Science Foundation of China [30901727, 81372496]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by National Natural Science Foundation of China (Grant No. 30901727, 81372496). HZ received the fundings. URL for 81372496: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list. URL for 30901727: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Babayan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075038; Bae AS, 2011, J CLIN MICROBIOL, V49, P3168, DOI 10.1128/JCM.00274-11; Billard A, 2012, APPL ENVIRON MICROB, V78, P1063, DOI 10.1128/AEM.06957-11; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Chen CY, 2004, CLIN CHEM, V50, P481, DOI 10.1373/clinchem.2003.024505; Cross J, 2008, PHARMACOGENOMICS, V9, P463, DOI 10.2217/14622416.9.4.463; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Lang AH, 2011, J MOL DIAGN, V13, P23, DOI 10.1016/j.jmoldx.2010.11.007; Langer C, 2008, ANN ONCOL, V19, P133; Lenz HJ, 2006, J CLIN ONCOL, V24, P4914, DOI 10.1200/JCO.2006.06.7595; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Mao C, 2012, ANN ONCOL, V23, P1518, DOI 10.1093/annonc/mdr464; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Mattarucchi E, 2005, J BIOCHEM MOL BIOL, V38, P555; Maughan TS, 2010, AM SOC CLIN ONC GAST; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Oh JE, 2010, J MOL DIAGN, V12, P418, DOI 10.2353/jmoldx.2010.090146; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Pekin D, 2011, LAB CHIP, V11, P2156, DOI 10.1039/c1lc20128j; Ray A, 2000, FASEB J, V14, P1041, DOI 10.1096/fasebj.14.9.1041; Roma C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/385087; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Sood A, 2012, CLIN COLORECTAL CANC, V11, P143, DOI 10.1016/j.clcc.2011.12.001; Spindler KLG, 2009, ANN ONCOL, V20, P879, DOI 10.1093/annonc/mdn712; Tveit KM, 2012, J CLIN ONCOL, V30, P1755, DOI 10.1200/JCO.2011.38.0915; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Waldner MJ, 2010, MOL ASPECTS MED, V31, P171, DOI 10.1016/j.mam.2010.02.005; Wang ZH, 2012, CANCER CHEMOTH PHARM, V69, P1647, DOI 10.1007/s00280-012-1886-y	44	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107926	10.1371/journal.pone.0107926	http://dx.doi.org/10.1371/journal.pone.0107926			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25260023	gold, Green Published, Green Submitted			2022-12-27	WOS:000342685600036
J	Hassan, NMM; Painter, N; Howlett, CR; Farrell, AW; Di Girolamo, N; Lyons, JG; Halliday, GM				Hassan, Nur Mohammad Monsur; Painter, Nicole; Howlett, C. Rolfe; Farrell, Andrew W.; Di Girolamo, Nick; Lyons, J. Guy; Halliday, Gary M.			Brm Inhibits the Proliferative Response of Keratinocytes and Corneal Epithelial Cells to Ultraviolet Radiation-Induced Damage	PLOS ONE			English	Article							NONMELANOMA SKIN-CANCER; INDUCED DNA-DAMAGE; BASAL LAYER; SWI/SNF; TUMORS; MICE; CARCINOGENESIS; INDUCTION; SUBUNITS; COMPLEX	Ultraviolet radiation (UV) from sunlight is the primary cause of skin and ocular neoplasia. Brahma (BRM) is part of the SWI/SNF chromatin remodeling complex. It provides energy for rearrangement of chromatin structure. Previously we have found that human skin tumours have a hotspot mutation in BRM and that protein levels are substantially reduced. Brm-/- mice have enhanced susceptibility to photocarcinogenesis. In these experiments, Brm-/- mice, with both or a single Trp53 allele were exposed to UV for 2 or 25 weeks. In wild type mice the central cornea and stroma became atrophic with increasing time of exposure while the peripheral regions became hyperplastic, presumably as a reparative process. Brm-/-, Trp53+/-, and particularly the Brm-/- Trp53+/- mice had an exaggerated hyperplastic regeneration response in the corneal epithelium and stroma so that the central epithelial atrophy or stromal loss was reduced. UV induced hyperplasia of the epidermis and corneal epithelium, with an increase in the number of dividing cells as determined by Ki-67 expression. This response was considerably greater in both the Brm-/- Trp53+/+ and Brm-/- Trp53+/- mice indicating that Brm protects from UV-induced enhancement of cell division, even with loss of one Trp53 allele. Cell division was disorganized in Brm-/- mice. Rather than being restricted to the basement membrane region, dividing cells were also present in the suprabasal regions of both tissues. Brm appears to be a tumour suppressor gene that protects from skin and ocular photocarcinogenesis. These studies indicate that Brm protects from UV-induced hyperplastic growth in both cutaneous and corneal keratinocytes, which may contribute to the ability of Brm to protect from photocarcinogenesis.	[Hassan, Nur Mohammad Monsur; Painter, Nicole; Farrell, Andrew W.; Lyons, J. Guy; Halliday, Gary M.] Royal Prince Alfred Hosp, Sydney Med Sch, Bosch Inst, Discipline Dermatol, Sydney, NSW, Australia; [Hassan, Nur Mohammad Monsur; Painter, Nicole; Farrell, Andrew W.; Lyons, J. Guy; Halliday, Gary M.] Univ Sydney, Sydney, NSW 2006, Australia; [Howlett, C. Rolfe] Univ New S Wales, Dept Pathol, Sydney, NSW, Australia; [Howlett, C. Rolfe] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia; [Di Girolamo, Nick] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Lyons, J. Guy] Royal Prince Alfred Hosp, Sydney Head & Neck Canc Inst, Canc Serv, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney	Halliday, GM (corresponding author), Royal Prince Alfred Hosp, Sydney Med Sch, Bosch Inst, Discipline Dermatol, Sydney, NSW, Australia.	gary.halliday@sydney.edu.au	Lyons, Guy/B-1319-2012; Hassan, Nur/N-5630-2014	Lyons, Guy/0000-0002-4835-4663; Hassan, Nur/0000-0002-7223-723X	National Health and Medical Research Council [632717]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Support was provided by the National Health and Medical Research Council Project grant number 632717. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; Bock VL, 2011, BRIT J DERMATOL, V164, P1221, DOI 10.1111/j.1365-2133.2011.10267.x; Byrne SN, 2002, J INVEST DERMATOL, V119, P858, DOI 10.1046/j.1523-1747.2002.00261.x; Coisy-Quivy M, 2006, CANCER RES, V66, P5069, DOI 10.1158/0008-5472.CAN-05-0596; Conscience I, 2006, EUR J DERMATOL, V16, P518, DOI 10.1684/ejd.2006.0024; Halliday GM, 2012, EXP DERMATOL, V21, P599, DOI 10.1111/j.1600-0625.2012.01522.x; Halliday GM, 2012, J INVEST DERMATOL, V132, P265, DOI 10.1038/jid.2011.281; Halliday GM, 2009, INT J BIOCHEM CELL B, V41, P725, DOI 10.1016/j.biocel.2008.04.026; Halliday GM, 2008, DRUG DISCOVERY TODAY, V5, P201; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jiang WD, 1999, ONCOGENE, V18, P4247, DOI 10.1038/sj.onc.1202789; Kothandapani A, 2012, EXP CELL RES, V318, P1973, DOI 10.1016/j.yexcr.2012.06.011; Lans H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000941; Melnikova VO, 2005, MUTAT RES-FUND MOL M, V571, P91, DOI 10.1016/j.mrfmmm.2004.11.015; Moloney FJ, 2009, J INVEST DERMATOL, V129, P1012, DOI 10.1038/jid.2008.319; Newkirk KM, 2007, TOXICOL PATHOL, V35, P817, DOI 10.1080/01926230701584197; Ng J, 2008, INVEST OPHTH VIS SCI, V49, P5295, DOI 10.1167/iovs.08-1988; Rebel H, 2001, CANCER RES, V61, P977; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shen H, 2008, CANCER RES, V68, P10154, DOI 10.1158/0008-5472.CAN-08-1794; Stratigos AJ, 2005, J EUR ACAD DERMATOL, V19, P180, DOI 10.1111/j.1468-3083.2005.01094.x; Surjana D, 2013, CARCINOGENESIS, V34, P1144, DOI 10.1093/carcin/bgt017; van Diest PJ, 1998, J CLIN PATHOL, V51, P716, DOI 10.1136/jcp.51.10.716; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068	25	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107931	10.1371/journal.pone.0107931	http://dx.doi.org/10.1371/journal.pone.0107931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254962	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300043
J	Impheng, H; Pongcharoen, S; Richert, L; Pekthong, D; Srisawang, P				Impheng, Hathaichanok; Pongcharoen, Sutatip; Richert, Lysiane; Pekthong, Dumrongsak; Srisawang, Piyarat			The Selective Target of Capsaicin on FASN Expression and De Novo Fatty Acid Synthesis Mediated through ROS Generation Triggers Apoptosis in HepG2 Cells	PLOS ONE			English	Article							SYNTHASE INHIBITOR ORLISTAT; CARNITINE PALMITOYLTRANSFERASE I; GROWTH-FACTOR RECEPTOR-2; PROSTATE-CANCER CELLS; CYCLE ARREST; TUMOR-GROWTH; PC-3 CELLS; PATHWAY; OXYGEN; (-)-EPIGALLOCATECHIN-3-GALLATE	The inhibition of the mammalian de novo synthesis of long-chain saturated fatty acids (LCFAs) by blocking the fatty acid synthase (FASN) enzyme activity in tumor cells that overexpress FASN can promote apoptosis, without apparent cytotoxic to non-tumor cells. The present study aimed to focus on the potent inhibitory effect of capsaicin on the fatty acid synthesis pathway inducing apoptosis of capsaicin in HepG2 cells. The use of capsaicin as a source for a new FASN inhibitor will provide new insight into its possible application as a selective anti-cancer therapy. The present findings showed that capsaicin promoted apoptosis as well as cell cycle arrest in the G0/G1 phase. The onset of apoptosis was correlated with a dissipation of mitochondrial membrane potential (Delta Psi m). Apoptotic induction by capsaicin was mediated by inhibition of FASN protein expression which was accompanied by decreasing its activity on the de novo fatty acid synthesis. The expression of FASN was higher in HepG2 cells than in normal hepatocytes that were resistant to undergoing apoptosis following capsaicin administration. Moreover, the inhibitory effect of capsaicin on FASN expression and activity was found to be mediated by an increase of intracellular reactive oxygen species (ROS) generation. Treatment of HepG2 cells with capsaicin failed to alter ACC and ACLY protein expression, suggesting ACC and ACLY might not be the specific targets of capsaicin to induce apoptosis. An accumulation of malonyl-CoA level following FASN inhibition represented a major cause of mitochondrial-dependent apoptotic induction instead of deprivation of fatty acid per se. Here, we also obtained similar results with C75 that exhibited apoptosis induction by reducing the levels of fatty acid without any change in the abundance of FASN expression along with increasing ROS production. Collectively, our results provide novel evidence that capsaicin exhibits a potent anti-cancer property by targeting FASN protein in HepG2 cells.	[Impheng, Hathaichanok; Srisawang, Piyarat] Naresuan Univ, Fac Med Sci, Dept Physiol, Phitsanulok, Thailand; [Pongcharoen, Sutatip] Naresuan Univ, Fac Med, Dept Med, Phitsanulok, Thailand; [Richert, Lysiane] Univ Franche Comte, Fac Med & Pharm, Lab Toxicol Cellulaire, F-25030 Besancon, France; [Pekthong, Dumrongsak] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Phitsanulok, Thailand	Naresuan University; Naresuan University; Universite de Franche-Comte; Naresuan University	Pekthong, D (corresponding author), Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Phitsanulok, Thailand.	dumrongsakp@yahoo.com; piyarats@nu.ac.th		Impheng, Hathaichanok/0000-0001-8350-1692	Naresuan University, Thailand [R2556B068]	Naresuan University, Thailand	This work has been accomplished with supporting funds from Naresuan University, Thailand, grant number: R2556B068, http://www.research.nu.ac.th/dra_eng/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie-Viollon C, 2010, TOXICOL IN VITRO, V24, P346, DOI 10.1016/j.tiv.2009.05.021; Adan-Gokbulut A, 2013, CURR MED CHEM, V20, P108; Agostini M, 2014, MOL CANCER THER, V13, P585, DOI 10.1158/1535-7163.MCT-12-1136; Amantini C, 2007, J NEUROCHEM, V102, P977, DOI 10.1111/j.1471-4159.2007.04582.x; Amantini C, 2009, CARCINOGENESIS, V30, P1320, DOI 10.1093/carcin/bgp138; Aza-Gonzalez C, 2011, PLANT CELL REP, V30, P695, DOI 10.1007/s00299-010-0968-8; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Biswas S, 2012, CANCER METAST REV, V31, P689, DOI 10.1007/s10555-012-9384-6; Chang HC, 2011, HUM EXP TOXICOL, V30, P1657, DOI 10.1177/0960327110396530; Chang LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099254; Chen C, 2014, J BIOL CHEM, V289, P17184, DOI 10.1074/jbc.M114.550806; Chen D, 2012, INT J UROL, V19, P662, DOI 10.1111/j.1442-2042.2012.02981.x; Chen HW, 2012, PROSTATE CANCER P D, V15, P260, DOI 10.1038/pcan.2012.15; De Schrijver E, 2003, CANCER RES, V63, P3799; Flavin R, 2010, FUTURE ONCOL, V6, P551, DOI [10.2217/fon.10.11, 10.2217/FON.10.11]; Fritz V, 2013, ONCOGENE, V32, P5101, DOI 10.1038/onc.2012.523; Gelebart P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033738; Gonzales CB, 2014, ORAL ONCOL, V50, P437, DOI 10.1016/j.oraloncology.2013.12.023; Huang SP, 2009, ANTICANCER RES, V29, P165; Ip SW, 2012, HUM EXP TOXICOL, V31, P539, DOI 10.1177/0960327111417269; Ip SW, 2012, ENVIRON TOXICOL, V27, P332, DOI 10.1002/tox.20646; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 2000, BBA-MOL CELL BIOL L, V1483, P301, DOI 10.1016/S1388-1981(99)00203-6; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kant S, 2014, BBA-GEN SUBJECTS, V1840, P294, DOI 10.1016/j.bbagen.2013.09.020; Kant S, 2012, BBA-GEN SUBJECTS, V1820, P1764, DOI 10.1016/j.bbagen.2012.07.010; Koukourakis MI, 2006, CANCER SCI, V97, P1056, DOI 10.1111/j.1349-7006.2006.00298.x; Lau JK, 2014, APOPTOSIS, V19, P1190, DOI 10.1007/s10495-014-1007-y; Lee JS, 2013, PHYTOTHER RES, V27, P713, DOI 10.1002/ptr.4778; Li XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070987; Lin CH, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-46; Lu HF, 2010, J AGR FOOD CHEM, V58, P12999, DOI 10.1021/jf103335w; Macho A, 1999, CELL DEATH DIFFER, V6, P155, DOI 10.1038/sj.cdd.4400465; Manohar M, 2013, J NUTR BIOCHEM, V24, P940, DOI 10.1016/j.jnutbio.2012.06.013; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; Mergler S, 2012, CELL SIGNAL, V24, P233, DOI 10.1016/j.cellsig.2011.09.005; Do MT, 2013, FOOD CHEM, V141, P2591, DOI 10.1016/j.foodchem.2013.04.125; Notarnicola M, 2012, ANTICANCER RES, V32, P2585; Palanivel K, 2014, J CELL BIOCH; Pandey PR, 2011, BREAST CANCER RES TR, V130, P387, DOI 10.1007/s10549-010-1300-6; Paumen MB, 1997, BIOCHEM BIOPH RES CO, V231, P523, DOI 10.1006/bbrc.1997.6089; Paumen MB, 1997, J BIOL CHEM, V272, P3324, DOI 10.1074/jbc.272.6.3324; Pekthong D, 2009, CHEM-BIOL INTERACT, V179, P247, DOI 10.1016/j.cbi.2008.10.054; Pizer ES, 2000, CANCER RES, V60, P213; Pizer ES, 1998, CANCER RES, V58, P4611; Pramanik KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020151; Reilly CA, 2003, CHEM RES TOXICOL, V16, P336, DOI 10.1021/tx025599q; Relat J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-280; Rossato FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101060; Sanchez AM, 2006, APOPTOSIS, V11, P89, DOI 10.1007/s10495-005-3275-z; Sanchez AM, 2007, APOPTOSIS, V12, P2013, DOI 10.1007/s10495-007-0119-z; Seguin F, 2012, BRIT J CANCER, V107, P977, DOI 10.1038/bjc.2012.355; Shimizu M, 2005, CLIN CANCER RES, V11, P2735, DOI 10.1158/1078-0432.CCR-04-2014; Shimizu T, 2013, J GASTROENTEROL; Skrzypski M, 2014, CELL SIGNAL, V26, P41, DOI 10.1016/j.cellsig.2013.09.014; Smith B, 2014, MOLECULES, V19, P3988, DOI 10.3390/molecules19043988; Smyth MJ, 1996, BIOCHEM J, V316, P25, DOI 10.1042/bj3160025; Song HJ, 2012, PROSTAG LEUKOTR ESS, V87, P197, DOI 10.1016/j.plefa.2012.09.002; Tao L, 2014, MOL NUTR FOOD RES, V58, P665, DOI 10.1002/mnfr.201300427; Vandhana S, 2013, BBA-MOL CELL BIOL L, V1831, P1458, DOI 10.1016/j.bbalip.2013.06.005; Wang Y, 2012, ASIAN PAC J CANCER P, V13, P5573, DOI 10.7314/APJCP.2012.13.11.5573; Xue CS, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-30; Yan YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085374, 10.1371/journal.pone.0097697]; Yang G, 2010, CHEM-BIOL INTERACT, V185, P12, DOI 10.1016/j.cbi.2010.02.017; Yang KM, 2009, CELL MOL BIOL LETT, V14, P497, DOI 10.2478/s11658-009-0016-2; Yang ZH, 2010, UROLOGY, V75, P735, DOI 10.1016/j.urology.2009.03.042; Yoon S, 2007, J BIOL CHEM, V282, P26122, DOI 10.1074/jbc.M702854200; Zecchin KG, 2011, LAB INVEST, V91, P232, DOI 10.1038/labinvest.2010.157; Zhang JH, 2013, ONCOL LETT, V5, P43, DOI 10.3892/ol.2012.991; Zhao P, 2014, ONCOL LETT, V8, P765, DOI 10.3892/ol.2014.2159; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928; Zhou WB, 2003, CANCER RES, V63, P7330; Zhou WB, 2007, CANCER RES, V67, P2964, DOI 10.1158/0008-5472.CAN-06-3439	74	26	28	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107842	10.1371/journal.pone.0107842	http://dx.doi.org/10.1371/journal.pone.0107842			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255125	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300036
J	Deng, N; Liu, JW; Sun, LP; Xu, Q; Duan, ZP; Dong, NN; Yuan, Y				Deng, Na; Liu, Jing-wei; Sun, Li-ping; Xu, Qian; Duan, Zhi-Peng; Dong, Nan-Nan; Yuan, Yuan			Expression of XPG Protein in the Development, Progression and Prognosis of Gastric Cancer	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; SQUAMOUS-CELL CARCINOMA; DNA-REPAIR; XERODERMA-PIGMENTOSUM; BREAST-CANCER; LUNG-CANCER; GENES; HEAD; NECK; SUSCEPTIBILITY	Background: Xeroderma pigmentosum group G (XPG) plays a critical role in preventing cells from oxidative DNA damage. This study aimed to investigate XPG protein expression in different gastric tissues and in patients with diverse prognoses, thus providing insights into its role in the development, progression and prognosis of gastric cancer (GC). Methods: A total of 176 GC, 131 adjacent non-tumour tissues, 53 atrophic gastritis (AG) and 49 superficial gastritis (SG) samples were included. Immunohistochemical staining was used to detect XPG protein expression. Results: XPG expression was significantly higher in GC tissues compared with adjacent non-tumour tissues. In the progressive disease sequence SG -> AG -> GC, XPG expression was significantly higher in AG and GC compared with SG. Analysis of clinicopathological parameters and survival in GC patients demonstrated a significant association between XPG expression level and depth of tumour invasion, macroscopic type, Lauren's classification, smoking, Helicobacter pylori infection and family history. Cox multivariate survival analysis indicated that patients with positive XPG expression had significantly longer overall survival (P = 0.020, HR = 0.394, 95% CI 0.179-0.866), especially in aged younger than 60 years (P = 0.027, HR = 0.361, 95% CI 0.147-0.888) and male patients (P = 0.002, HR = 0.209, 95% CI 0.077-0.571). Conclusions: This study demonstrated that XPG protein expression was related to the development, progression and prognosis of GC, and might thus serve as a potential biomarker for its diagnosis and prognosis.	[Deng, Na; Liu, Jing-wei; Sun, Li-ping; Xu, Qian; Duan, Zhi-Peng; Dong, Nan-Nan; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Tumor Etiol & Screening Dept, Inst Canc, Shenyang, Peoples R China; [Deng, Na; Liu, Jing-wei; Sun, Li-ping; Xu, Qian; Duan, Zhi-Peng; Dong, Nan-Nan; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Shenyang, Peoples R China; [Deng, Na; Liu, Jing-wei; Sun, Li-ping; Xu, Qian; Duan, Zhi-Peng; Dong, Nan-Nan; Yuan, Yuan] China Med Univ, Liaoning Prov Educ Dept, Key Lab Canc Etiol & Prevent, Shenyang, Peoples R China; [Deng, Na] China Med Univ, Affiliated Hosp 4, Dept Oncol, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Yuan, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Tumor Etiol & Screening Dept, Inst Canc, Shenyang, Peoples R China.	yyuan@mail.cmu.edu.cn	Yuan, Yuan/GVS-5120-2022		National Key Basic Research Program of China (973 Program) [2010CB529304]; Foundation of Science and Technology in Liaoning Province [2011225002]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Foundation of Science and Technology in Liaoning Province	This work is supported by grants from the National Key Basic Research Program of China (973 Program ref no. 2010CB529304), and the Foundation of Science and Technology in Liaoning Province (ref no. 2011225002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2005, CANCER RES, V65, P7378, DOI 10.1158/0008-5472.CAN-05-1036; Aracil M, 2013, INT J CLIN EXP PATHO, V6, P199; Bartolucci R, 2009, CLIN LUNG CANCER, V10, P47, DOI 10.3816/CLC.2009.n.007; Berneburg M, 2001, ADV GENET, V43, P71, DOI 10.1016/S0065-2660(01)43004-5; Bi JW, 2013, PAK J MED SCI, V29, P1158; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Charames GS, 2003, CURR MOL MED, V3, P589, DOI 10.2174/1566524033479456; Cheng L, 2002, CANCER-AM CANCER SOC, V94, P393, DOI 10.1002/cncr.10231; Cheng L, 2000, CARCINOGENESIS, V21, P1527, DOI 10.1093/carcin/21.8.1527; Costa RMA, 2003, BIOCHIMIE, V85, P1083, DOI 10.1016/j.biochi.2003.10.017; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Ganzinelli M, 2011, EUR J CANCER, V47, P1086, DOI 10.1016/j.ejca.2010.11.029; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Kamileri I, 2012, TRENDS GENET, V28, P566, DOI 10.1016/j.tig.2012.06.004; Kim IJ, 2004, HUM GENET, V115, P498, DOI 10.1007/s00439-004-1186-7; KOVACS E, 1986, EUR J CANCER CLIN ON, V22, P863, DOI 10.1016/0277-5379(86)90375-5; KOVACS E, 1987, EUR J CANCER CLIN ON, V23, P1051, DOI 10.1016/0277-5379(87)90358-0; Kuraoka I, 2000, P NATL ACAD SCI USA, V97, P3832, DOI 10.1073/pnas.070471597; Latimer JJ, 2010, P NATL ACAD SCI USA, V107, P21725, DOI 10.1073/pnas.0914772107; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Liu YP, 2013, ONCOL LETT, V5, P935, DOI 10.3892/ol.2012.1096; Ramos JM, 2004, CANCER-AM CANCER SOC, V100, P1352, DOI 10.1002/cncr.20135; Sabatino MA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-259; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schoffski P, 2011, EUR J CANCER, V47, P1006, DOI 10.1016/j.ejca.2011.01.016; Skotheim RI, 2006, CELL ONCOL, V28, P315; Sugasawa K, 2008, CARCINOGENESIS, V29, P455, DOI 10.1093/carcin/bgm282; Tomicic MT, 2011, CELL MOL LIFE SCI, V68, P1785, DOI 10.1007/s00018-010-0546-9; Vaezi A, 2011, CLIN CANCER RES, V17, P5513, DOI 10.1158/1078-0432.CCR-11-0086; Walsh CS, 2008, J CLIN ONCOL, V26, P2952, DOI 10.1200/JCO.2007.13.5806; Wei Q, 2005, CANCER EPIDEM BIOMAR, V14, P1961, DOI 10.1158/1055-9965.EPI-05-0101	32	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108704	10.1371/journal.pone.0108704	http://dx.doi.org/10.1371/journal.pone.0108704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268735	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700143
J	Houk, P; Benavente, D; Iguel, J; Johnson, S; Okano, R				Houk, P.; Benavente, D.; Iguel, J.; Johnson, S.; Okano, R.			Coral Reef Disturbance and Recovery Dynamics Differ across Gradients of Localized Stressors in the Mariana Islands (vol 9, e105731, 2014)	PLOS ONE			English	Correction																		Houk P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105731	1	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e110068	10.1371/journal.pone.0110068	http://dx.doi.org/10.1371/journal.pone.0110068			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268750	Green Published, gold			2022-12-27	WOS:000343671700233
J	Jeanson, L; Guerrera, IC; Papon, JF; Chhuon, C; Zadigue, P; Pruliere-Escabasse, V; Amselem, S; Escudier, E; Coste, A; Edelman, A				Jeanson, Ludovic; Guerrera, Ida Chiara; Papon, Jean-Francois; Chhuon, Cerina; Zadigue, Patricia; Pruliere-Escabasse, Virginie; Amselem, Serge; Escudier, Estelle; Coste, Andre; Edelman, Aleksander			Proteomic Analysis of Nasal Epithelial Cells from Cystic Fibrosis Patients	PLOS ONE			English	Article							PROTEIN EXPRESSION; OXIDATIVE STRESS; LUNG; CFTR; IDENTIFICATION; BIOMARKERS; OVEREXPRESSION; INCREASE; PREVENTS; PATHWAY	The pathophysiology of cystic fibrosis (CF) lung disease remains incompletely understood. New explanations for the pathogenesis of CF lung disease may be discovered by studying the patterns of protein expression in cultured human nasal epithelial cells (HNEC). To that aim, we compared the level of protein expressions in primary cultures of HNEC from nasal polyps secondary to CF (CFNP, n = 4), primary nasal polyps (NP, n = 8) and control mucosa (CTRL, n = 4) using isobaric tag for relative and absolute quantification (iTRAQ) labeling coupled with liquid chromatography (LC)-MS-MS. The analysis of the data revealed 42 deregulated protein expressions in CFNP compared to NP and CTRL, suggesting that these alterations are related to CF. Overall, AmiGo analysis highlighted six major pathways important for cell functions that seem to be impaired: metabolism, G protein process, inflammation and oxidative stress response, protein folding, proteolysis and structural proteins. Among them, glucose and fatty acid metabolic pathways could be impaired in CF with nine deregulated proteins. Our proteomic study provides a reproducible set of differentially expressed proteins in airway epithelial cells from CF patients and reveals many novel deregulated proteins that could lead to further studies aiming to clarify the involvement of such proteins in CF pathophysiology.	[Jeanson, Ludovic; Amselem, Serge; Escudier, Estelle] Univ Paris 06, INSERM, Serv Genet & Embryol Med, Unite Mixte Rech Sci 933, Paris, France; [Jeanson, Ludovic; Amselem, Serge; Escudier, Estelle] Hop Armand Trousseau, AP HP, Paris, France; [Jeanson, Ludovic; Guerrera, Ida Chiara; Chhuon, Cerina; Edelman, Aleksander] Univ Paris 05, Unite 1151, INSERM, Paris, France; [Jeanson, Ludovic; Guerrera, Ida Chiara; Chhuon, Cerina; Edelman, Aleksander] Univ Paris 05, Plateau Proteome Necker, Struct Federat Rech Necker, Paris, France; [Papon, Jean-Francois; Zadigue, Patricia; Coste, Andre] Univ Paris 12, INSERM, Unite Mixte Rech Sci 855, Fac Med, Creteil, France; [Papon, Jean-Francois; Pruliere-Escabasse, Virginie; Coste, Andre] Hop Intercommunal Creteil, AP HP, Serv Otorhinolaryngol & Chirurg Cervicofaciale, Creteil, France; [Papon, Jean-Francois; Pruliere-Escabasse, Virginie; Coste, Andre] Grp Hosp Henri Mondor Albert Chenevier, Creteil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Edelman, A (corresponding author), Univ Paris 05, Unite 1151, INSERM, Paris, France.	aleksander.edelman@inserm.fr	Escabasse, virginie VPE Pruliere/R-1949-2018; GUERRERA, Ida Chiara/GOJ-9151-2022	Escabasse, virginie VPE Pruliere/0000-0003-0208-7544; GUERRERA, Ida Chiara/0000-0002-4832-6793; COSTE, Andre/0000-0002-8386-3455; Papon, Jean Francois/0000-0002-2323-9239	Agence Nationale pour la Recherche [-05-MRAR-02201]; European Community: Life Sciences and Health Grant NEUPROCF [LSHG-CT-2005-512044]; French Foundation for Cystic Fibrosis: "Vaincre la Mucoviscidose''; Legs Poix from Chancellerie des Universites	Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Community: Life Sciences and Health Grant NEUPROCF; French Foundation for Cystic Fibrosis: "Vaincre la Mucoviscidose''; Legs Poix from Chancellerie des Universites	Funding was provided by Agence Nationale pour la Recherche -05-MRAR-02201; European Community: Life Sciences and Health Grant (LSHG-CT-2005-512044) NEUPROCF; French Foundation for Cystic Fibrosis: "Vaincre la Mucoviscidose''; Legs Poix from Chancellerie des Universites. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer H, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008253.pub3; Bensalem N, 2005, MOL CELL PROTEOMICS, V4, P1591, DOI 10.1074/mcp.M500019-MCP200; Bensalem N, 2007, J PROTEOME RES, V6, P1595, DOI 10.1021/pr0606272; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Castellani S, 2012, LAB INVEST, V92, P1527, DOI 10.1038/labinvest.2012.123; Charro N, 2011, J PROTEOMICS, V74, P110, DOI 10.1016/j.jprot.2010.10.001; Chen JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003367; Ciavardelli D, 2013, MOL BIOSYST, V9, P1117, DOI 10.1039/c3mb25594h; Colas J, 2012, HUM MOL GENET, V21, P623, DOI 10.1093/hmg/ddr496; Coste A, 2004, LARYNGOSCOPE, V114, P839, DOI 10.1097/00005537-200405000-00009; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Ferrante JV, 2005, J IMMUNOL, V174, P3169, DOI 10.4049/jimmunol.174.6.3169; Fokkens W, 2005, ALLERGY, V60, P583, DOI 10.1111/j.1398-9995.2005.00830.x; Guerrera IC, 2014, J PROTEOME RES, V13, P1002, DOI 10.1021/pr401009f; Jeanson L, 2012, ALLERGY, V67, P403, DOI 10.1111/j.1398-9995.2011.02769.x; Jorge YC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/152860; Kelly-Aubert M, 2011, HUM MOL GENET, V20, P2745, DOI 10.1093/hmg/ddr173; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Lunardi F, 2011, LAB INVEST, V91, P945, DOI 10.1038/labinvest.2011.1; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; McMorran BJ, 2007, CLIN CHEM, V53, P1782, DOI 10.1373/clinchem.2007.087650; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Moles A, 2012, J BIOL CHEM, V287, P1178, DOI 10.1074/jbc.M111.272393; Onuoha SC, 2008, J MOL BIOL, V379, P732, DOI 10.1016/j.jmb.2008.02.013; Papon JF, 2002, LARYNGOSCOPE, V112, P2067, DOI 10.1097/00005537-200211000-00030; Pedersen SK, 2005, MOL CELL PROTEOMICS, V4, P1052, DOI 10.1074/mcp.M400175-MCP200; Playford MP, 2010, J BIOL CHEM, V285, P17156, DOI 10.1074/jbc.M109.080523; Pollard HB, 2006, MOL CELL PROTEOMICS, V5, P1628, DOI 10.1074/mcp.M600091-MCP200; Preville X, 1999, EXP CELL RES, V247, P61, DOI 10.1006/excr.1998.4347; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Roxo-Rosa M, 2006, PROTEOMICS, V6, P2314, DOI 10.1002/pmic.200500273; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Sajjan US, 2006, CELL MICROBIOL, V8, P1456, DOI 10.1111/j.1462-5822.2006.00724.x; Samanta AK, 2009, ONCOGENE, V28, P1669, DOI 10.1038/onc.2009.7; Sloane AJ, 2005, AM J RESP CRIT CARE, V172, P1416, DOI 10.1164/rccm.200409-1215OC; Takemasa A, 2012, EUR RESPIR J, V40, P1475, DOI 10.1183/09031936.00127011; Trudel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006075; Unwin RD, 2010, NAT PROTOC, V5, P1574, DOI 10.1038/nprot.2010.123; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Wetmore DR, 2010, J BIOL CHEM, V285, P30516, DOI 10.1074/jbc.M110.140806; Yu LG, 2004, J BIOL CHEM, V279, P41377, DOI 10.1074/jbc.M400017200	43	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108671	10.1371/journal.pone.0108671	http://dx.doi.org/10.1371/journal.pone.0108671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268127	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700138
J	Kanugula, AK; Dhople, VM; Volker, U; Ummanni, R; Kotamraju, S				Kanugula, Anantha Koteswararao; Dhople, Vishnu M.; Voelker, Uwe; Ummanni, Ramesh; Kotamraju, Srigiridhar			Fluvastatin Mediated Breast Cancer Cell Death: A Proteomic Approach to Identify Differentially Regulated Proteins in MDA-MB-231 Cells	PLOS ONE			English	Article							NITRIC-OXIDE; COA REDUCTASE; VIMENTIN; LOVASTATIN; STATINS; INHIBITION; EXPRESSION; APOPTOSIS; BINDING; SIP1	Statins are increasingly being recognized as anti-cancer agents against various cancers including breast cancer. To understand the molecular pathways targeted by fluvastatin and its differential sensitivity against metastatic breast cancer cells, we analyzed protein alterations in MDA-MB-231 cells treated with fluvastatin using 2-DE in combination with LC-MS/MS. Results revealed dys-regulation of 39 protein spots corresponding to 35 different proteins. To determine the relevance of altered protein profiles with breast cancer cell death, we mapped these proteins to major pathways involved in the regulation of cell-to-cell signaling and interaction, cell cycle, Rho GDI and proteasomal pathways using IPA analysis. Highly interconnected sub networks showed that vimentin and ERK1/2 proteins play a central role in controlling the expression of altered proteins. Fluvastatin treatment caused proteolysis of vimentin, a marker of epithelial to mesenchymal transition. This effect of fluvastatin was reversed in the presence of mevalonate, a downstream product of HMG-CoA and caspase-3 inhibitor. Interestingly, fluvastatin neither caused an appreciable cell death nor did modulate vimentin expression in normal mammary epithelial cells. In conclusion, fluvastatin alters levels of cytoskeletal proteins, primarily targeting vimentin through increased caspase-3- mediated proteolysis, thereby suggesting a role for vimentin in statin-induced breast cancer cell death.	[Kanugula, Anantha Koteswararao; Ummanni, Ramesh; Kotamraju, Srigiridhar] CSIR, Ctr Chem Biol, Indian Inst Chem Technol, Hyderabad, Andhra Pradesh, India; [Dhople, Vishnu M.; Voelker, Uwe] Univ Med Greifswald, Interfacultary Inst Genet & Funct Genom, Greifswald, Germany	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Greifswald Medical School	Ummanni, R (corresponding author), CSIR, Ctr Chem Biol, Indian Inst Chem Technol, Hyderabad, Andhra Pradesh, India.	ummanni@iict.res.in; giridhar@iict.res.in	Kanugula, Anantha Koteswararao/H-8187-2019	Volker, Uwe/0000-0002-5689-3448	 [BT/PR9637/BRB/10/582/2007];  [SMiLE-CSC-0111];  [EpiHeD-BSC-0118]	; ; 	This work was supported by No. BT/PR9637/BRB/10/582/2007 (http://dbtindia.nic.in/index.asp), and SMiLE-CSC-0111 and EpiHeD-BSC-0118 (http://csirhrdg.res.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aka JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031532; Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Barberis L, 2009, EUR J IMMUNOL, V39, P1136, DOI 10.1002/eji.200838884; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; Bjarnadottir O, 2013, BREAST CANCER RES TR, V138, P499, DOI 10.1007/s10549-013-2473-6; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; Campbell MJ, 2006, CANCER RES, V66, P8707, DOI 10.1158/0008-5472.CAN-05-4061; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Dong XL, 2011, J PROTEOME RES, V10, P5463, DOI 10.1021/pr200718p; Efuet ET, 2006, CANCER RES, V66, P1040, DOI 10.1158/0008-5472.CAN-05-3416; Garwood ER, 2010, BREAST CANCER RES TR, V119, P137, DOI 10.1007/s10549-009-0507-x; Gilles C, 2003, CANCER RES, V63, P2658; Goard CA, 2014, BREAST CANCER RES TR, V143, P301, DOI 10.1007/s10549-013-2800-y; Kanugula AK, 2014, FEBS J, V281, P3719, DOI 10.1111/febs.12893; Karihtala P, 2013, BREAST CANCER RES TR, V138, P81, DOI 10.1007/s10549-013-2442-0; Klawitter J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2485; Kotamraju S, 2003, P NATL ACAD SCI USA, V100, P10653, DOI 10.1073/pnas.1933581100; Kotamraju S, 2007, CANCER RES, V67, P7386, DOI 10.1158/0008-5472.CAN-07-0993; Leong S, 2012, J PROTEOME RES, V11, P3561, DOI 10.1021/pr2012335; Ludwig A, 2005, BIOCHEM PHARMACOL, V70, P520, DOI 10.1016/j.bcp.2005.04.046; Nielsen SF, 2013, NEW ENGL J MED, V368, P576, DOI 10.1056/NEJMc1214827; Ogawa K, 2004, BRIT J CANCER, V91, P282, DOI 10.1038/sj.bjc.6601941; Park IH, 2011, INVEST NEW DRUG, V29, P883, DOI 10.1007/s10637-010-9439-x; Perlson E, 2006, J MOL BIOL, V364, P938, DOI 10.1016/j.jmb.2006.09.056; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Shui HA, 2012, J PROTEOMICS, V75, P1170, DOI 10.1016/j.jprot.2011.10.029; Sivaprasad U, 2006, MOL CANCER THER, V5, P2310, DOI 10.1158/1535-7163.MCT-06-0175; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Ummanni R, 2008, CANCER LETT, V266, P171, DOI 10.1016/j.canlet.2008.02.047; Vora HH, 2009, INT J BIOL MARKER, V24, P38, DOI 10.1177/172460080902400106; Zhu QS, 2011, ONCOGENE, V30, P457, DOI 10.1038/onc.2010.421	32	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108890	10.1371/journal.pone.0108890	http://dx.doi.org/10.1371/journal.pone.0108890			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268751	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700183
J	Kou, XJ; Li, Q; Beierkuhnlein, C; Zhao, YH; Liu, SR				Kou, Xiaojun; Li, Qin; Beierkuhnlein, Carl; Zhao, Yiheng; Liu, Shirong			A New Tool for Exploring Climate Change Induced Range Shifts of Conifer Species in China	PLOS ONE			English	Article							DISTRIBUTION MODELS; ASSISTED COLONIZATION; SELECTING THRESHOLDS; CHANGE IMPACTS; PLANT; DISTRIBUTIONS; PREDICTION; LANDSCAPE; HABITAT; METRICS	It is inevitable that tree species will undergo considerable range shifts in response to anthropogenic induced climate change, even in the near future. Species Distribution Models (SDMs) are valuable tools in exploring general temporal trends and spatial patterns of potential range shifts. Understanding projections to future climate for tree species will facilitate policy making in forestry. Comparative studies for a large number of tree species require the availability of suitable and standardized indices. A crucial limitation when deriving such indices is the threshold problem in defining ranges, which has made interspecies comparison problematic until now. Here we propose a set of threshold-free indices, which measure range explosion (I), overlapping (O), and range center movement in three dimensions (Dx, Dy, Dz), based on fuzzy set theory (Fuzzy Set based Potential Range Shift Index, F-PRS Index). A graphical tool (PRS_Chart) was developed to visualize these indices. This technique was then applied to 46 Pinaceae species that are widely distributed and partly common in China. The spatial patterns of the modeling results were then statistically tested for significance. Results showed that range overlap was generally low; no trends in range size changes and longitudinal movements could be found, but northward and poleward movement trends were highly significant. Although range shifts seemed to exhibit huge interspecies variation, they were very consistent for certain climate change scenarios. Comparing the IPCC scenarios, we found that scenario A1B would lead to a larger extent of range shifts (less overlapping and more latitudinal movement) than the A2 and the B1 scenarios. It is expected that the newly developed standardized indices and the respective graphical tool will facilitate studies on PRS's for other tree species groups that are important in forestry as well, and thus support climate adaptive forest management.	[Kou, Xiaojun] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Kou, Xiaojun; Zhao, Yiheng] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Li, Qin] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Beierkuhnlein, Carl] Univ Bayreuth, Dept Biogeog, Bayreuth, Germany; [Liu, Shirong] Chinese Acad Forestry, Inst Forest Environm & Ecol, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; University of British Columbia; University of Bayreuth; Chinese Academy of Forestry	Liu, SR (corresponding author), Chinese Acad Forestry, Inst Forest Environm & Ecol, Beijing, Peoples R China.	Liusr@caf.ac.cn	Beierkuhnlein, Carl/ABF-9693-2021; Beierkuhnlein, Carl/ABF-8797-2021	Beierkuhnlein, Carl/0000-0002-6456-4628; 	Special Research Program for Public-Welfare Forestry [201404201]; NSFC's Project [31370486]	Special Research Program for Public-Welfare Forestry; NSFC's Project(National Natural Science Foundation of China (NSFC))	This research was carried out with the support of the Special Research Program for Public-Welfare Forestry (Grant No. 201404201) and NSFC's Project (Grant No. 31370486). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2002, CONSERV BIOL, V16, P1662, DOI 10.1046/j.1523-1739.2002.02068.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bittner T, 2011, J VEG SCI, V22, P699, DOI 10.1111/j.1654-1103.2011.01266.x; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Bradley BA, 2009, GLOBAL CHANGE BIOL, V15, P1511, DOI 10.1111/j.1365-2486.2008.01824.x; Carrete M, 2012, FRONT ECOL ENVIRON, V10, P12, DOI 10.1890/12.WB.004; Chambers D, 2013, FOREST ECOL MANAG, V291, P20, DOI 10.1016/j.foreco.2012.10.046; Chiarucci A, 2010, J VEG SCI, V21, P1172, DOI 10.1111/j.1654-1103.2010.01218.x; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Corlett RT, 2012, BIOL CONSERV, V151, P22, DOI 10.1016/j.biocon.2011.11.027; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Curtis JMR, 2008, CONSERV BIOL, V22, P1225, DOI 10.1111/j.1523-1739.2008.00994.x; Dobrowski SZ, 2013, GLOBAL CHANGE BIOL, V19, P241, DOI 10.1111/gcb.12026; Dobrowski SZ, 2011, SCIENCE, V334, DOI 10.1126/science.1205029; Eckenwalder J.E., 2009, CONIFERS WORLD; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Fang J., 2009, ATLAS WOODY PLANTS C; Farjon A, 2010, HANDBOOK OF THE WORLD'S CONIFERS, VOL 1, P1, DOI 10.1163/9789047430629; Farjon A., 2008, NATURAL HIST CONIFER; Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P3606, DOI 10.1111/gcb.12012; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Ficarra FVC, 2011, LECT NOTES COMPUT SC, V6616, P44, DOI 10.1007/978-3-642-20810-2_6; Frei E, 2010, BOT HELV, V120, P117, DOI 10.1007/s00035-010-0076-y; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hampe A, 2004, GLOBAL ECOL BIOGEOGR, V13, P469, DOI 10.1111/j.1466-822X.2004.00090.x; Harrison SP, 2010, J VEG SCI, V21, P300, DOI 10.1111/j.1654-1103.2009.01144.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ibanez I, 2006, ECOLOGY, V87, P1896, DOI 10.1890/0012-9658(2006)87[1896:PBCOTC]2.0.CO;2; Iverson LR, 2008, FOREST ECOL MANAG, V254, P390, DOI 10.1016/j.foreco.2007.07.023; Ives AR, 2010, AM NAT, V176, pE128, DOI 10.1086/656486; Jablonski D, 2008, ANNU REV ECOL EVOL S, V39, P501, DOI 10.1146/annurev.ecolsys.39.110707.173510; Jaeschke A, 2013, INSECT CONSERV DIVER, V6, P93, DOI 10.1111/j.1752-4598.2012.00194.x; Jentsch A, 2008, CR GEOSCI, V340, P621, DOI 10.1016/j.crte.2008.07.002; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kery M, 2010, CONSERV BIOL, V24, P1388, DOI 10.1111/j.1523-1739.2010.01479.x; Kou XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023115; Kou XJ, 2011, ECOL INFORM, V6, P196, DOI 10.1016/j.ecoinf.2011.01.004; Kreyling J, 2011, RESTOR ECOL, V19, P433, DOI 10.1111/j.1526-100X.2011.00777.x; Kupfer JA, 2012, PROG PHYS GEOG, V36, P400, DOI 10.1177/0309133312439594; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; LePage BA, 2003, ACTA HORTIC, P29, DOI 10.17660/ActaHortic.2003.615.1; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; McKenney DW, 2011, GLOBAL CHANGE BIOL, V17, P2720, DOI 10.1111/j.1365-2486.2011.02413.x; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Mouillot D, 2009, ECOGRAPHY, V32, P671, DOI 10.1111/j.1600-0587.2009.05679.x; Munkemuller T, 2012, ECOGRAPHY, V35, P468, DOI 10.1111/j.1600-0587.2011.07259.x; Oney B, 2013, ECOL EVOL, V3, P437, DOI 10.1002/ece3.426; Pearson RG, 2005, BIOL CONSERV, V123, P389, DOI 10.1016/j.biocon.2004.12.006; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; Real R, 2010, ECOGRAPHY, V33, P304, DOI 10.1111/j.1600-0587.2010.06251.x; Reyer CPO, 2013, GLOBAL CHANGE BIOL, V19, P75, DOI 10.1111/gcb.12023; Schwartz MW, 2012, BIOSCIENCE, V62, P732, DOI 10.1525/bio.2012.62.8.6; Smith W.K., 1995, ECOPHYSIOLOGY CONIFE; Summers DM, 2012, GLOBAL CHANGE BIOL, V18, P3268, DOI 10.1111/j.1365-2486.2012.02771.x; Swenson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021264; Tabor K, 2010, ECOL APPL, V20, P554, DOI 10.1890/09-0173.1; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Thomas CD, 2011, TRENDS ECOL EVOL, V26, P497, DOI 10.1016/j.tree.2011.06.006; Thomas CD, 2011, TRENDS ECOL EVOL, V26, P216, DOI 10.1016/j.tree.2011.02.006; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Uuemaa E, 2013, ECOL INDIC, V28, P100, DOI 10.1016/j.ecolind.2012.07.018; Vila M, 2011, TRENDS ECOL EVOL, V26, P496, DOI 10.1016/j.tree.2011.06.010; Webb TJ, 2003, AM NAT, V161, P553, DOI 10.1086/368296; Webber BL, 2011, TRENDS ECOL EVOL, V26, P495, DOI 10.1016/j.tree.2011.06.007; Wilson CD, 2011, DIVERS DISTRIB, V17, P182, DOI 10.1111/j.1472-4642.2010.00723.x; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Wu, 1980, VEGETATION CHINA; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	89	3	3	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e98643	10.1371/journal.pone.0098643	http://dx.doi.org/10.1371/journal.pone.0098643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268604	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700002
J	Tesfaye, M; Hanlon, C; Tessema, F; Prince, M; Alem, A				Tesfaye, Markos; Hanlon, Charlotte; Tessema, Fasil; Prince, Martin; Alem, Atalay			Common Mental Disorder Symptoms among Patients with Malaria Attending Primary Care in Ethiopia: A Cross-Sectional Survey	PLOS ONE			English	Article							SELF-REPORTING QUESTIONNAIRE; PSYCHIATRIC SCREENING INSTRUMENT; 4 DEVELOPING-COUNTRIES; PRIMARY-HEALTH-CARE; DEPRESSION; ILLNESS; SRQ; OVERDIAGNOSIS; SOMATIZATION; POPULATION	Background: Common Mental Disorders (CMDs) are frequent among patients attending primary care. In Africa, CMDs are often misdiagnosed as physical illnesses because many of the patients complain of somatic symptoms of mental distress. We explored whether there was difference in the levels of CMD symptoms between patients with thick film confirmed and clinical cases of malaria with negative thick film in primary care. Methods: A cross-sectional comparative study was conducted on 300 adults with a clinical diagnosis of malaria in primary care centres in Jimma, Ethiopia. Patients were recruited consecutively until 100 cases of 'malaria' with a negative thick film and 200 cases of malaria with a positive thick film consented to participate. The 20-item Self-Reporting Questionnaire (SRQ-20) was used to measure CMD. The non-parametric Wilcoxon rank-sum test was used to explore the association between thick film result and CMD. Results: Participants had a mean age of 28.2 (S.D = 10.9) years and the majority (57.3%) were women. The prevalence of high CMD symptoms (six or more symptoms on the SRQ-20) was 24.5%. Suicidal ideation was reported by 13.8% of the participants. CMD symptoms were significantly higher in patients who had taken medication prior to visiting the primary care (p = 0.012) and in those whose symptoms had been present for seven days or more (p = 0.041). There was no statistically significant association between level of CMD symptoms and having a negative thick film result (OR 0.98; 95% CI 0.92, 1.04) or objective presence of fever (OR 1.04; 95% CI 0.93, 1.15). Conclusions: CMD symptoms among cases of malaria did not appear to be associated with a negative thick film result. The high levels of CMD symptoms, including suicidal ideation, calls for further studies to investigate the persistence and progression of these symptoms following resolution of the acute malarial episode.	[Tesfaye, Markos] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Psychiat, Jimma, Ethiopia; [Hanlon, Charlotte; Alem, Atalay] Univ Addis Ababa, Coll Hlth Sci, Sch Med, Dept Psychiat, Addis Ababa, Ethiopia; [Hanlon, Charlotte; Prince, Martin] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, Ctr Global Mental Hlth, London, England; [Tessema, Fasil] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Epidemiol & Biostat, Jimma, Ethiopia	Jimma University; Addis Ababa University; University of London; King's College London; Jimma University	Tesfaye, M (corresponding author), Jimma Univ, Coll Publ Hlth & Med Sci, Dept Psychiat, Jimma, Ethiopia.	tesmarkos@yahoo.com	Prince, Martin J/A-9170-2010; Hanlon, Charlotte/AAH-7769-2020; Tesfaye, Markos/H-9297-2019	Prince, Martin J/0000-0003-1379-7146; Hanlon, Charlotte/0000-0002-7937-3226; Tesfaye, Markos/0000-0002-3351-701X	Jimma University	Jimma University	The study was funded by Jimma University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P48, DOI 10.1111/j.1600-0447.1999.tb10694.x; Alemu A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-173; Alemu A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-30; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Barsky AJ, 2005, ARCH GEN PSYCHIAT, V62, P903, DOI 10.1001/archpsyc.62.8.903; Beusenberg M, 1994, USERS GUIDE SELF REP; Central Statistical Agency, 2007, CENS 2007; Deressa W, 2003, B WORLD HEALTH ORGAN, V81, P261; Desta K. M., 2002, Ethiopian Journal of Health Development, V16, P53; Dugbartey AT, 1998, J NERV MENT DIS, V186, P183, DOI 10.1097/00005053-199803000-00007; EBIGBO PO, 1982, CULT MED PSYCHIAT, V6, P29, DOI 10.1007/BF00049469; Federal Ministry of Health, 2012, NAT MAL GUID, V3rd; GIEL R, 1976, BRIT J PSYCHIAT, V128, P513, DOI 10.1192/bjp.128.6.513; GIEL R, 1969, BRIT J PSYCHIAT, V115, P149, DOI 10.1192/bjp.115.519.149; Gureje O, 1997, AM J PSYCHIAT, V154, P989; Hanlon C, 2008, J AFFECT DISORDERS, V108, P251, DOI 10.1016/j.jad.2007.10.023; HARDING TW, 1980, PSYCHOL MED, V10, P231, DOI 10.1017/S0033291700043993; Harpham T, 2005, J EPIDEMIOL COMMUN H, V59, P1060, DOI 10.1136/jech.2005.039180; JACOBSSON L, 1985, ACTA PSYCHIAT SCAND, V71, P417, DOI 10.1111/j.1600-0447.1985.tb02542.x; Kassahun Mitiku, 2003, Ethiopian Journal of Health Development, V17, P197; Kauye F, 2014, PSYCHOL MED, V44, P657, DOI 10.1017/S0033291713001141; KORTMANN F, 1988, BRIT J PSYCHIAT, V153, P95, DOI 10.1192/bjp.153.1.95; KORTMANN F, 1990, CULT MED PSYCHIAT, V14, P381, DOI 10.1007/BF00117562; Krishnadas R, 2012, J NEUROL NEUROSUR PS, V83, P495, DOI 10.1136/jnnp-2011-301779; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Leslie T, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4389; Makhija K, 2013, AUST NZ J PSYCHIAT, V47, P828, DOI 10.1177/0004867413488220; Masika PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-120; Ministry of Health, 2006, HLTH HLTH REL IND 20; Mubi M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-293; Mukadi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071442; National Police ChiefsCouncil, 2020, NAT STRAT POL MENT H; Ndetei D M, 2006, East Afr Med J, V83, P280; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Stewart RC, 2009, J AFFECT DISORDERS, V112, P126, DOI 10.1016/j.jad.2008.04.001; TAFARI S, 1991, SOC SCI MED, V32, P197, DOI 10.1016/0277-9536(91)90060-P; Valkanova V, 2013, J AFFECT DISORDERS, V150, P736, DOI 10.1016/j.jad.2013.06.004; WEISS MG, 1985, CULT MED PSYCHIAT, V9, P121, DOI 10.1007/BF00117368; World Health Organization, 2016, MHGAP INT GUID MENT; Youngmann R, 2008, TRANSCULT PSYCHIATRY, V45, P566, DOI 10.1177/1363461508100783; Zeynudin A, 2006, THESIS ADDIS ABABA U	42	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108923	10.1371/journal.pone.0108923	http://dx.doi.org/10.1371/journal.pone.0108923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268347	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700190
J	Wang, ZP; Zhang, H; Yang, H; Wang, SZ; Rong, EG; Pei, WY; Li, H; Wang, N				Wang, Zhipeng; Zhang, Hui; Yang, Hua; Wang, Shouzhi; Rong, Enguang; Pei, Wenyu; Li, Hui; Wang, Ning			Genome-Wide Association Study for Wool Production Traits in a Chinese Merino Sheep Population	PLOS ONE			English	Article							MILK-PRODUCTION TRAITS; LOCI; GENES; DISEASE; REVEALS; POLYMORPHISM; PREDICTION; VARIANTS; LENGTH; SCAN	Genome-wide association studies (GWAS) provide a powerful approach for identifying quantitative trait loci without prior knowledge of location or function. To identify loci associated with wool production traits, we performed a genome-wide association study on a total of 765 Chinese Merino sheep (JunKen type) genotyped with 50 K single nucleotide polymorphisms (SNPs). In the present study, five wool production traits were examined: fiber diameter, fiber diameter coefficient of variation, fineness dispersion, staple length and crimp. We detected 28 genome-wide significant SNPs for fiber diameter, fiber diameter coefficient of variation, fineness dispersion, and crimp trait in the Chinese Merino sheep. About 43% of the significant SNP markers were located within known or predicted genes, including YWHAZ, KRTCAP3, TSPEAR, PIK3R4, KIF16B, PTPN3, GPRC5A, DDX47, TCF9, TPTE2, EPHA5 and NBEA genes. Our results not only confirm the results of previous reports, but also provide a suite of novel SNP markers and candidate genes associated with wool traits. Our findings will be useful for exploring the genetic control of wool traits in sheep.	[Wang, Zhipeng; Zhang, Hui; Wang, Shouzhi; Rong, Enguang; Pei, Wenyu; Li, Hui; Wang, Ning] Educ Dept Heilongjiang Prov, Key Lab Anim Genet Breeding & Reprod, Harbin, Peoples R China; [Wang, Zhipeng; Zhang, Hui; Wang, Shouzhi; Rong, Enguang; Pei, Wenyu; Li, Hui; Wang, Ning] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China; [Yang, Hua] Xinjiang Acad Agr & Reclamat Sci, Inst Anim Husb & Vet, Shihezi, Peoples R China	Northeast Agricultural University - China	Li, H (corresponding author), Educ Dept Heilongjiang Prov, Key Lab Anim Genet Breeding & Reprod, Harbin, Peoples R China.	lihui@neau.edu.cn; wangning@neau.edu.cn			Domain-Specific projects for transgenic biological breeding [2014ZX08009-002, 2009ZX08009-160B]; Natural Science Foundation of China [31101709]	Domain-Specific projects for transgenic biological breeding; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors appreciate the financial support provided by the Domain-Specific projects for transgenic biological breeding (2014ZX08009-002 and 2009ZX08009-160B), and Natural Science Foundation of China (No. 31101709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2007, ANIM GENET, V38, P491, DOI 10.1111/j.1365-2052.2007.01642.x; Allain D, 2006, 8 WORLD C GEN APPL L; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Bidinost F, 2006, 8 WORLD C GEN APPL L; Bolormaa S, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-43; Bonkobara M, 2003, BRIT J DERMATOL, V148, P654, DOI 10.1046/j.1365-2133.2003.05244.x; Cheng CY, 2013, AM J HUM GENET, V93, P264, DOI 10.1016/j.ajhg.2013.06.016; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Daetwyler HD, 2008, J DAIRY SCI, V91, P3225, DOI 10.3168/jds.2007-0333; Danielle M, 2010, GENOME WIDE ASS STUD; Deng M, 2013, NAT GENET, V45, P697, DOI 10.1038/ng.2627; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Forrest RH, 2009, ANIM GENET, V40, P958, DOI 10.1111/j.1365-2052.2009.01926.x; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Fujimoto J, 2012, J THORAC ONCOL, V7, P1747, DOI 10.1097/JTO.0b013e31826bb1ff; Garcia-Gamez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047782; Georges M, 2007, ANNU REV GENOM HUM G, V8, P131, DOI 10.1146/annurev.genom.8.080706.092408; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Johnston SE, 2011, MOL ECOL, V20, P2555, DOI 10.1111/j.1365-294X.2011.05076.x; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kolbehdari D, 2009, J ANIM BREED GENET, V126, P216, DOI 10.1111/j.1439-0388.2008.00793.x; Kou I, 2013, NAT GENET, V45, P676, DOI 10.1038/ng.2639; Kulbrock M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071619; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin MT, 2009, INT J CANCER, V125, P603, DOI 10.1002/ijc.24346; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074846; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Maxa J, 2012, J DAIRY SCI, V95, P5357, DOI 10.3168/jds.2011-4673; Nonneman DJ, 2013, J ANIM SCI, V91, P4043, DOI 10.2527/jas.2013-6255; PARSONS YM, 1994, GENOMICS, V20, P500, DOI 10.1006/geno.1994.1209; Ponz R, 2001, MAMM GENOME, V12, P569, DOI 10.1007/s003350030007; Roldan DL, 2010, ANIMAL, V4, P1330, DOI 10.1017/S1751731110000315; Saatchi M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-730; Safra N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003646; Schroder W, 2012, ANIM GENET, V43, P392, DOI 10.1111/j.1365-2052.2011.02265.x; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Vitezica ZG, 2007, GENET SEL EVOL, V39, P421, DOI 10.1051/gse:2007012; Wang SW, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-319; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wolc A, 2013, AVIAN DIS, V57, P395, DOI 10.1637/10409-100312-Reg.1; Wu C, 2013, NAT GENET, V45, P632, DOI 10.1038/ng.2638; Zeng XC, 2011, MOL BIOL REP, V38, P2723, DOI 10.1007/s11033-010-0416-4; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040736; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066569; Zhao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021739	50	37	47	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107101	10.1371/journal.pone.0107101	http://dx.doi.org/10.1371/journal.pone.0107101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268383	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700030
J	Ahlgren, C; Oden, A; Lycke, J				Ahlgren, Cecilia; Oden, Anders; Lycke, Jan			High Nationwide Incidence of Multiple Sclerosis in Sweden	PLOS ONE			English	Article							SEX-RATIO; DIAGNOSTIC-CRITERIA; INCREASING INCIDENCE; PREVALENCE; MS; REGISTER; COUNTY; GUIDELINES; DISEASE; WOMEN	Over recent years increased MS incidence, primarily in women, has been reported. We recently reported an unexpectedly high MS prevalence of 189/100,000 in Sweden. In the present study we estimated the nationwide age-and gender-specific MS incidence and the sex ratio in Sweden between 2001 and 2008. MS patients were identified by linking two nationwide health data registers, and the Swedish population register. The earliest registered date of MS diagnosis was determined. By logistic regression, the probability of the date of MS diagnosis being within the incidence period, depending on age and time was estimated for a subset of patients and applied to other patients. By Poisson regression, the hazard functions for the incidence of MS diagnosis were estimated. The expected number of MS patients was 7,361.4. The incidence in the average population of 9,054,658 was 10.2 per 100,000 person-years, and 6.2 and 14.0 per 100,000 person-years for men and women, respectively. The crude female to male ratio was 2.26. No increase of incidence or change of sex ratio was observed from 2001 to 2008. In conclusion, the average MS incidence in Sweden from 2001 to 2008 was 10.2 per 100.000, which was considerably higher than previous regional Swedish estimates of 4.3-6.4. No increase of female to male ratio of MS during the study period was observed. We provide supplementary data that can be used as tools for examining excess MS risk in different study materials.	[Ahlgren, Cecilia; Lycke, Jan] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Gothenburg, Sweden; [Oden, Anders] Chalmers Univ Technol, Dept Math Sci, Inst Stat Math, S-41296 Gothenburg, Sweden	University of Gothenburg; Chalmers University of Technology	Lycke, J (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Gothenburg, Sweden.	jan.lycke@neuro.gu.se		Lycke, Jan/0000-0002-7891-8466	Swedish Foundation for MS Research; Research Foundation of the Multiple Sclerosis Society of Gothenburg, Sweden; Edit Jacobson Foundation, Gothenburg, Sweden; Biogen Idec, Sweden	Swedish Foundation for MS Research; Research Foundation of the Multiple Sclerosis Society of Gothenburg, Sweden; Edit Jacobson Foundation, Gothenburg, Sweden; Biogen Idec, Sweden	The authors wish to thank the Swedish Foundation for MS Research, the Research Foundation of the Multiple Sclerosis Society of Gothenburg, Sweden and the Edit Jacobson Foundation, Gothenburg, Sweden, for research funding, and Biogen Idec, Sweden, for an unconditional research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren C, 2011, MULT SCLER J, V17, P901, DOI 10.1177/1352458511403794; Aljumah M, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/952321; Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; Alonso A, 2007, J NEUROL, V254, P1736, DOI 10.1007/s00415-007-0602-z; Andersen TF, 1999, DAN MED BULL, V46, P263; Bentzen J, 2010, MULT SCLER J, V16, P520, DOI 10.1177/1352458510364197; Bostrom I, 2013, MULT SCLER J, V19, P46, DOI 10.1177/1352458512446169; Bostrom I, 2009, MULT SCLER J, V15, P1253, DOI 10.1177/1352458509345909; Celius EG, 2009, ACTA NEUROL SCAND, V120, P27, DOI 10.1111/j.1600-0404.2009.01208.x; Debouverie M, 2007, MULT SCLER J, V13, P962, DOI 10.1177/1352458507077938; Etemadifar M, 2011, MULT SCLER J, V17, P1022, DOI 10.1177/1352458511401460; Fromont A, 2012, MULT SCLER J, V18, P1108, DOI 10.1177/1352458511433305; Houzen H, 2012, J NEUROL SCI, V323, P117, DOI 10.1016/j.jns.2012.08.032; Koch-Henriksen N, 2011, J NEUROL SCI, V311, P58, DOI 10.1016/j.jns.2011.09.003; Krokki O, 2011, MULT SCLER J, V17, P133, DOI 10.1177/1352458510384012; Lai CH, 2009, NEUROEPIDEMIOLOGY, V33, P247, DOI 10.1159/000229779; Mason K, 2012, ACTA NEUROL SCAND, V125, P213, DOI 10.1111/j.1600-0404.2011.01558.x; Mayr WT, 2003, NEUROLOGY, V61, P1373, DOI 10.1212/01.WNL.0000094316.90240.EB; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Osoegawa M, 2009, MULT SCLER J, V15, P159, DOI 10.1177/1352458508098372; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Ramagopalan SV, 2010, EUR J NEUROL, V17, P634, DOI 10.1111/j.1468-1331.2009.02850.x; Sadovnick AD, 2009, J NEUROL SCI, V286, P1, DOI 10.1016/j.jns.2009.09.005; Sahraian MA, 2010, EUR NEUROL, V64, P331, DOI 10.1159/000321649; Simpson S, 2011, J NEUROL NEUROSUR PS, V82, P180, DOI 10.1136/jnnp.2010.215186; Sumelahti ML, 2000, NEUROEPIDEMIOLOGY, V19, P67, DOI 10.1159/000026241; Sundstrom P, 2003, J NEUROL NEUROSUR PS, V74, P29, DOI 10.1136/jnnp.74.1.29; SVENNINGSSON A, 1990, ACTA NEUROL SCAND, V82, P161, DOI 10.1111/j.1600-0404.1990.tb04483.x; Taylor BV, 2010, MULT SCLER J, V16, P1422, DOI 10.1177/1352458510379614; Trojano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048078	32	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108599	10.1371/journal.pone.0108599	http://dx.doi.org/10.1371/journal.pone.0108599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265372	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400094
J	Chen, JV; Megraw, TL				Chen, Jieyan V.; Megraw, Timothy L.			Spermitin: A Novel Mitochondrial Protein in Drosophila Spermatids	PLOS ONE			English	Article							DYNAMICS; PARKIN; MELANOGASTER; ELONGATION; EXPRESSION; FUSION; PINK1	Mitochondria, important energy centers in the cell, also control sperm cell morphogenesis. Drosophila spermatids have a remarkably large mitochondrial formation called the nebenkern. Immediately following meiosis during sperm development, the mitochondria in the spermatid fuse together into two large aggregates which then wrap around one another to produce the spherical nebenkern: a giant mitochondrion about 6 micrometers in diameter. The fused mitochondria play an important role in sperm tail elongation by providing a structural platform to support the elongation of sperm cells. We have identified a novel testis-specific protein, Spermitin (Sprn), a protein with a Pleckstrin homology-like (PH) domain related to Ran-binding protein 1 at its C-terminus. Fluorescence microscopy showed that Sprn localizes at mitochondria in transfected Kc167 cells, and in the nebenkern throughout spermatid morphogenesis. The role of Sprn is unclear, as sprn mutant males are fertile, and have sperm tail length comparable to the wild-type.	[Chen, Jieyan V.; Megraw, Timothy L.] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Megraw, TL (corresponding author), Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA.	Timothy.megraw@med.fsu.edu	Megraw, Timothy/T-5186-2019; Megraw, Tim/U-1442-2019	Megraw, Timothy/0000-0001-7455-7483	National Institutes of Health [GM068756]; Bryan Robinson Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bryan Robinson Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TLM was supported by National Institutes of Health grant GM068756 (http://www.nigms.nih.gov/Pages/default.aspx), and JVC by a fellowship from the Bryan Robinson Endowment (http://www.tmh.org/BryanRobinsonEndowment). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge AC, 2007, FLY, V1, P38, DOI 10.4161/fly.3913; CHERBAS P, 1988, P NATL ACAD SCI USA, V85, P2096, DOI 10.1073/pnas.85.7.2096; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Daines B, 2011, GENOME RES, V21, P315, DOI 10.1101/gr.107854.110; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Fabian Lacramioara, 2012, Spermatogenesis, V2, P197; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Kao LR, 2004, METH MOL B, V247, P443; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Mardon G, 2010, P UBI GAL4 2; McQuibban GA, 2006, CURR BIOL, V16, P982, DOI 10.1016/j.cub.2006.03.062; Noguchi T, 2011, CURR BIOL, V21, P805, DOI 10.1016/j.cub.2011.04.016; Riparbelli MG, 2007, DEV BIOL, V303, P108, DOI 10.1016/j.ydbio.2006.10.038; Robinson SW, 2013, NUCLEIC ACIDS RES, V41, pD744, DOI 10.1093/nar/gks1141; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sedat J., 2008, SEDAT INSERTIONS; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Tates A.D., 1971, THESIS RIJKSUNIVERSI; TOKUYASU KT, 1975, J ULTRA MOL STRUCT R, V53, P93, DOI 10.1016/S0022-5320(75)80089-X; Wasbrough ER, 2010, J PROTEOMICS, V73, P2171, DOI 10.1016/j.jprot.2010.09.002	23	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108802	10.1371/journal.pone.0108802	http://dx.doi.org/10.1371/journal.pone.0108802			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265054	Green Submitted, Green Published, gold			2022-12-27	WOS:000345745400128
J	Noranate, N; Takeda, N; Chetanachan, P; Sittisaman, P; A-nuegoonpipat, A; Anantapreecha, S				Noranate, Nitchakarn; Takeda, Naokazu; Chetanachan, Prukswan; Sittisaman, Pathompong; A-nuegoonpipat, Atchareeya; Anantapreecha, Surapee			Characterization of Chikungunya Virus-Like Particles	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; CHOLESTEROL DEPENDENCE; VACCINE; PROTEIN; INFECTION; FUSION; CELLS; E2; ALPHAVIRUSES; MICE	Chikungunya virus (CHIKV) is becoming a global concern due to the increasing number of outbreaks throughout the world and the absence of any CHIKV-specific vaccine or treatment. Virus-like particles (VLPs) are multistructured proteins that mimic the organization and conformation of native viruses but lack the viral genome. They are noninfectious and potentially safer vaccine candidates. Recent studies demonstrated that the yield of CHIKV VLPs varies depending on the strains, despite the 95% amino acid similarity of the strains. This might be due to the codon usage, since protein expression is differently controlled by different organisms. We optimized the region encoding CHIKV structural proteins, C-E3-E2-6k-E1, inserted it into a mammalian expression vector, and used the resulting construct to transfect 293 cells. We detected 50-kDa proteins corresponding to E1 and/or E2 in the cell lysate and the supernatant. Transmission electron microscopy revealed spherical particles with a 50-to 60-nm diameter in the supernatant that resembled the native CHIKV virions. The buoyant density of the VLPs was 1.23 g/mL, and the yield was 20 mg purified VLPs per 10 8 cells. The VLPs aggregated when mixed with convalescent sera from chikungunya patients, indicating that their antigenicity is similar to that of native CHIKV. Antibodies elicited with the VLPs were capable of detecting native CHIKV, demonstrating that the VLPs retain immunogenicity similar to that of the native virion. These results indicated that CHIKV VLPs are morphologically, antigenically, and immunologically similar to the native CHIKV, suggesting that they have potential for use in chikungunya vaccines.	[Noranate, Nitchakarn; Takeda, Naokazu] Thailand Japan Res Collaborat Ctr Emerging & Reem, Nonthaburi, Thailand; [Chetanachan, Prukswan; Sittisaman, Pathompong; A-nuegoonpipat, Atchareeya; Anantapreecha, Surapee] Minist Publ Hlth, Dept Med Sci, Natl Inst Hlth, Nonthaburi, Thailand; [Takeda, Naokazu] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan	Ministry of Public Health - Thailand; Osaka University	Noranate, N (corresponding author), Thailand Japan Res Collaborat Ctr Emerging & Reem, Nonthaburi, Thailand.	noranate@biken.osaka-u.ac.jp			Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) - Ministry of Education, Culture, Sports, Science, and Technology of Japan; Department of Medical Sciences, Ministry of Public Health, Thailand	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) - Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Department of Medical Sciences, Ministry of Public Health, Thailand	This work was supported in part by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) sponsored by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This study was also supported by the Department of Medical Sciences, Ministry of Public Health, Thailand. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahata W, 2012, J VIROL, V86, P8879, DOI 10.1128/JVI.00370-12; Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; BRADY JN, 1978, J VIROL, V27, P436, DOI 10.1128/JVI.27.2.436-442.1978; Brandler S, 2013, VACCINE, V31, P3718, DOI 10.1016/j.vaccine.2013.05.086; Buonaguro L, 2011, EXPERT REV VACCINES, V10, P1569, DOI [10.1586/ERV.11.135, 10.1586/erv.11.135]; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381; Deml L, 2005, MOL IMMUNOL, V42, P259, DOI 10.1016/j.molimm.2004.06.028; ECKELS KH, 1970, APPL MICROBIOL, V19, P321, DOI 10.1128/AEM.19.2.321-325.1970; Edelman R, 2000, AM J TROP MED HYG, V62, P681, DOI 10.4269/ajtmh.2000.62.681; Fischer D, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-51; Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09; Hapuarachchi HC, 2010, J GEN VIROL, V91, P1067, DOI 10.1099/vir.0.015743-0; IVANOVA L, 1993, J VIROL, V67, P2546, DOI 10.1128/JVI.67.5.2546-2551.1993; Jose J, 2012, J VIROL, V86, P2585, DOI 10.1128/JVI.05860-11; Kishishita N, 2013, J CLIN MICROBIOL, V51, P1389, DOI 10.1128/JCM.03109-12; Kumar M, 2012, VACCINE, V30, P6142, DOI 10.1016/j.vaccine.2012.07.072; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; LOPEZ S, 1994, J VIROL, V68, P1316, DOI 10.1128/JVI.68.3.1316-1323.1994; Lu YPE, 1999, J VIROL, V73, P4272, DOI 10.1128/JVI.73.5.4272-4278.1999; Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304; Mallilankaraman K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000928; Martin CSS, 2009, TRENDS MICROBIOL, V17, P514, DOI 10.1016/j.tim.2009.08.002; McClain DJ, 1998, J INFECT DIS, V177, P634, DOI 10.1086/514240; Metz SW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002124; Metz SW, 2013, VACCINE; Muthumani K, 2008, VACCINE, V26, P5128, DOI 10.1016/j.vaccine.2008.03.060; Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; ROSS R. W., 1956, JOUR HYG, V54, P177; Sawabe K, 2010, J MED ENTOMOL, V47, P442, DOI 10.1603/ME09256; Sjoberg M, 2003, J VIROL, V77, P3441, DOI 10.1128/JVI.77.6.3441-3450.2003; Strauss EG, 2002, J VIROL, V76, P10188, DOI 10.1128/JVI.76.20.10188-10194.2002; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623; Tiwari M, 2009, VACCINE, V27, P2513, DOI 10.1016/j.vaccine.2009.02.062; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; Umashankar M, 2008, J VIROL, V82, P9245, DOI 10.1128/JVI.00975-08; Vashishtha M, 1998, J CELL BIOL, V140, P91, DOI 10.1083/jcb.140.1.91; WAHLBERG JM, 1992, J CELL BIOL, V116, P339, DOI 10.1083/jcb.116.2.339; Wang EY, 2011, J VIROL, V85, P9249, DOI 10.1128/JVI.00844-11; Warter L, 2011, J IMMUNOL, V186, P3258, DOI 10.4049/jimmunol.1003139; Zhi N, 2010, J VIROL, V84, P13059, DOI 10.1128/JVI.00912-10	46	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108169	10.1371/journal.pone.0108169	http://dx.doi.org/10.1371/journal.pone.0108169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265335	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400049
J	Lampen, J; Jones, K; McAuley, JD; Chang, SE; Wade, J				Lampen, Jennifer; Jones, Katherine; McAuley, J. Devin; Chang, Soo-Eun; Wade, Juli			Arrhythmic Song Exposure Increases ZENK Expression in Auditory Cortical Areas and Nucleus Taeniae of the Adult Zebra Finch	PLOS ONE			English	Article							SOCIAL-BEHAVIOR NETWORK; GENE-EXPRESSION; CONTROL-SYSTEM; BASAL GANGLIA; CAUDOMEDIAL NEOSTRIATUM; SEXUAL-DIFFERENTIATION; REARING ENVIRONMENT; NEURAL MECHANISMS; GROWTH-FACTORS; HUMAN SPEECH	Rhythm is important in the production of motor sequences such as speech and song. Deficits in rhythm processing have been implicated in human disorders that affect speech and language processing, including stuttering, autism, and dyslexia. Songbirds provide a tractable model for studying the neural underpinnings of rhythm processing due to parallels with humans in neural structures and vocal learning patterns. In this study, adult zebra finches were exposed to naturally rhythmic conspecific song or arrhythmic song. Immunohistochemistry for the immediate early gene ZENK was used to detect neural activation in response to these two types of stimuli. ZENK was increased in response to arrhythmic song in the auditory association cortex homologs, caudomedial nidopallium (NCM) and caudomedial mesopallium (CMM), and the avian amygdala, nucleus taeniae (Tn). CMM also had greater ZENK labeling in females than males. The increased neural activity in NCM and CMM during perception of arrhythmic stimuli parallels increased activity in the human auditory cortex following exposure to unexpected, or perturbed, auditory stimuli. These auditory areas may be detecting errors in arrhythmic song when comparing it to a stored template of how conspecific song is expected to sound. CMM may also be important for females in evaluating songs of potential mates. In the context of other research in songbirds, we suggest that the increased activity in Tn may be related to the value of song for assessing mate choice and bonding or it may be related to perception of arrhythmic song as aversive.	[Lampen, Jennifer; McAuley, J. Devin; Wade, Juli] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Jones, Katherine; McAuley, J. Devin; Wade, Juli] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; [Chang, Soo-Eun] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	Michigan State University; Michigan State University; University of Michigan System; University of Michigan	Lampen, J (corresponding author), Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA.	lampenje@msu.edu		Chang, Soo-Eun/0000-0003-4448-9525	GRAMMY Foundation; Michigan State University's program for Research in Autism, Intellectual and Neurodevelopmental Disabilities (RAIND); National Institutes of Health [R01-MH096705]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096705] Funding Source: NIH RePORTER	GRAMMY Foundation; Michigan State University's program for Research in Autism, Intellectual and Neurodevelopmental Disabilities (RAIND); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the GRAMMY Foundation, Michigan State University's program for Research in Autism, Intellectual and Neurodevelopmental Disabilities (RAIND), and National Institutes of Health R01-MH096705. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Allman MJ, 2012, FRONT INTEGR NEUROSC, V6, DOI [10.3389/fnint.2012.00007, 10.3389/fnint.2011.00002]; Bailey DJ, 2006, NEUROSCI LETT, V401, P86, DOI 10.1016/j.neulet.2006.02.076; Bailey DJ, 2005, BEHAV BRAIN RES, V162, P108, DOI 10.1016/j.bbr.2005.03.016; Bailey DJ, 2002, J NEUROBIOL, V52, P43, DOI 10.1002/neu.10070; Bailey DJ, 2003, MOL BRAIN RES, V116, P147, DOI 10.1016/S0169-328X(03)00288-2; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Boersma P., 2013, PRAAT DOING PHONETIC; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bolhuis JJ, 2001, EUR J NEUROSCI, V13, P2165, DOI 10.1046/j.0953-816x.2001.01588.x; Bolhuis JJ, 2000, P NATL ACAD SCI USA, V97, P2282, DOI 10.1073/pnas.030539097; Bolhuis JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041556; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Brainard MS, 2013, ANNU REV NEUROSCI, V36, P489, DOI 10.1146/annurev-neuro-060909-152826; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Cheng HY, 2004, J NEUROSCI, V24, P7503, DOI 10.1523/JNEUROSCI.1405-04.2004; CHERRY C, 1956, J PSYCHOSOM RES, V1, P233, DOI 10.1016/0022-3999(56)90001-0; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; Clark MG, 2000, J COGNITIVE NEUROSCI, V12, P828, DOI 10.1162/089892900562435; Corriveau K, 2007, J SPEECH LANG HEAR R, V50, P647, DOI 10.1044/1092-4388(2007/046); Corriveau KH, 2009, CORTEX, V45, P119, DOI 10.1016/j.cortex.2007.09.008; Crawley Jacqueline N, 2012, Dialogues Clin Neurosci, V14, P293; Cynx J, 2001, ANIM BEHAV, V62, P305, DOI 10.1006/anbe.2001.1744; De Diego-Balaguer R, 2008, BRAIN, V131, P2870, DOI 10.1093/brain/awn242; Dios AM, 2013, RES REP BIOL, V4, P33, DOI 10.2147/RRB.S46459; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Geiser E, 2012, J NEUROSCI, V32, P6177, DOI 10.1523/JNEUROSCI.5153-11.2012; Gobes SMH, 2010, P ROY SOC B-BIOL SCI, V277, P3343, DOI 10.1098/rspb.2010.0870; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Grahn JA, 2009, CORTEX, V45, P54, DOI 10.1016/j.cortex.2008.01.005; Grube M, 2013, COGN NEUROSCI-UK, V4, P225, DOI 10.1080/17588928.2013.825236; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; HANNA R, 1977, PERCEPT MOTOR SKILL, V44, P452, DOI 10.2466/pms.1977.44.2.452; Hardy MW, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00019; Helekar SA, 2003, BEHAV NEUROSCI, V117, P939, DOI 10.1037/0735-7044.117.5.939; Holveck MJ, 2014, ANIM BEHAV, V88, P125, DOI 10.1016/j.anbehav.2013.11.023; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Johnson W, 1937, J SPEECH DISORD, V2, P105, DOI 10.1044/jshd.0202.105; Jones CA, 2011, BRIT J PHARMACOL, V164, P1162, DOI 10.1111/j.1476-5381.2011.01386.x; Kumar S, 2012, J NEUROSCI, V32, P14184, DOI 10.1523/JNEUROSCI.1759-12.2012; Lauay C, 2004, ANIM BEHAV, V68, P1249, DOI 10.1016/j.anbehav.2003.12.025; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; Mello CV, 1998, J COMP NEUROL, V393, P426, DOI 10.1002/(SICI)1096-9861(19980420)393:4<426::AID-CNE3>3.0.CO;2-2; MELLO CV, 1994, J NEUROSCI, V14, P6652; Mello CV, 2004, ANN NY ACAD SCI, V1016, P263, DOI 10.1196/annals.1298.021; MELLO CV, 1995, J NEUROBIOL, V26, P145, DOI 10.1002/neu.480260112; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Muneaux M, 2004, NEUROREPORT, V15, P1255, DOI 10.1097/01.wnr.0000127459.31232.c4; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Nick TA, 2005, J NEUROBIOL, V62, P231, DOI 10.1002/neu.20087; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Nowicki S, 2002, P ROY SOC B-BIOL SCI, V269, P1949, DOI 10.1098/rspb.2002.2124; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Patel AD, 2006, MUSIC PERCEPT, V24, P99, DOI 10.1525/mp.2006.24.1.99; Pinaud R, 2008, J NEUROPHYSIOL, V100, P441, DOI 10.1152/jn.01239.2007; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Riebel K, 2000, P ROY SOC B-BIOL SCI, V267, P2553, DOI 10.1098/rspb.2000.1320; Riebel K, 2009, ANIM BEHAV, V78, P1397, DOI 10.1016/j.anbehav.2009.09.011; Riters LV, 2004, BEHAV BRAIN RES, V155, P307, DOI 10.1016/j.bbr.2004.05.002; Roy A, 2007, J NEUROSCI, V27, P6374, DOI 10.1523/JNEUROSCI.0894-07.2007; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Sockman KW, 2007, J ORNITHOL, V148, pS225, DOI 10.1007/s10336-007-0151-3; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Stripling R, 1997, J NEUROSCI, V17, P3883; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Svec LA, 2009, NEUROSCIENCE, V160, P275, DOI 10.1016/j.neuroscience.2009.02.003; Svec LA, 2009, BEHAV BRAIN RES, V199, P298, DOI 10.1016/j.bbr.2008.12.006; Tomaszycki ML, 2006, J NEUROBIOL, V66, P1175, DOI 10.1002/neu.20275; Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; Van Meir V, 2005, NEUROIMAGE, V25, P1242, DOI 10.1016/j.neuroimage.2004.12.058; VEENMAN CL, 1994, J COMP NEUROL, V339, P209, DOI 10.1002/cne.903390205; VOLMAN SF, 1993, J NEUROSCI, V13, P4737; Voss HU, 2007, P NATL ACAD SCI USA, V104, P10667, DOI 10.1073/pnas.0611515104; Voss HU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014415; Wade J, 2004, ANN NY ACAD SCI, V1016, P540, DOI 10.1196/annals.1298.015; Wade J, 2001, MICROSC RES TECHNIQ, V54, P354, DOI 10.1002/jemt.1148; Williams H, 1999, TLS-TIMES LIT SUPPL, P16; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062; Zald DH, 2002, NEUROIMAGE, V16, P746, DOI 10.1006/nimg.2002.1115; ZANN R, 1996, ZEBRA FINCH	88	20	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108841	10.1371/journal.pone.0108841	http://dx.doi.org/10.1371/journal.pone.0108841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259620	Green Submitted, Green Published, gold			2022-12-27	WOS:000342685600103
J	Ahmed, LA; Nguyen, ND; Bjornerem, A; Joakimsen, RM; Jorgensen, L; Stormer, J; Bliuc, D; Center, JR; Eisman, JA; Nguyen, TV; Emaus, N				Ahmed, Luai A.; Nguyen, Nguyen D.; Bjornerem, Ashild; Joakimsen, Ragnar M.; Jorgensen, Lone; Stormer, Jan; Bliuc, Dana; Center, Jacqueline R.; Eisman, John A.; Nguyen, Tuan V.; Emaus, Nina			External Validation of the Garvan Nomograms for Predicting Absolute Fracture Risk: The Tromso Study	PLOS ONE			English	Article							OSTEOPOROTIC FRACTURES; OLDER WOMEN; PERFORMANCE; OUTCOMES; MODELS; FRAX	Background: Absolute risk estimation is a preferred approach for assessing fracture risk and treatment decision making. This study aimed to evaluate and validate the predictive performance of the Garvan Fracture Risk Calculator in a Norwegian cohort. Methods: The analysis included 1637 women and 1355 aged 60+ years from the Tromso study. All incident fragility fractures between 2001 and 2009 were registered. The predicted probabilities of non-vertebral osteoporotic and hip fractures were determined using models with and without BMD. The discrimination and calibration of the models were assessed. Reclassification analysis was used to compare the models performance. Results: The incidence of osteoporotic and hip fracture was 31.5 and 8.6 per 1000 population in women, respectively; in men the corresponding incidence was 12.2 and 5.1. The predicted 5-year and 10-year probability of fractures was consistently higher in the fracture group than the non-fracture group for all models. The 10-year predicted probabilities of hip fracture in those with fracture was 2.8 women) to 3.1 times men) higher than those without fracture. There was a close agreement between predicted and observed risk in both sexes and up to the fifth quintile. Among those in the highest quintile of risk, the models over-estimated the risk of fracture. Models with BMD performed better than models with body weight in correct classification of risk in individuals with and without fracture. The overall net decrease in reclassification of the model with weight compared to the model with BMD was 10.6% p = 0.008) in women and 17.2% p = 0.001) in men for osteoporotic fractures, and 13.3% p = 0.07) in women and 17.5% p = 0.09) in men for hip fracture. Conclusions: The Garvan Fracture Risk Calculator is valid and clinically useful in identifying individuals at high risk of fracture. The models with BMD performed better than those with body weight in fracture risk prediction.	[Ahmed, Luai A.; Bjornerem, Ashild; Jorgensen, Lone; Emaus, Nina] UiT, Fac Hlth Sci, Dept Hlth & Care Sci, Tromso, Norway; [Nguyen, Nguyen D.; Bliuc, Dana; Center, Jacqueline R.; Eisman, John A.; Nguyen, Tuan V.] Garvan Inst Med Res, Osteoporosis & Bone Biol Program, Sydney, NSW, Australia; [Joakimsen, Ragnar M.] UiT, Fac Hlth Sci, Dept Clin Med, Tromso, Norway; [Joakimsen, Ragnar M.] Univ Hosp Northern Norway, Med Clin, Tromso, Norway; [Stormer, Jan] Univ Hosp Northern Norway, Dept Radiol, Tromso, Norway; [Center, Jacqueline R.; Eisman, John A.] St Vincents Hosp, Dept Endocrinol, Sydney, NSW 2010, Australia; [Eisman, John A.] Univ Notre Dame Australia, Sch Med Sydney, Sydney, NSW, Australia; [Center, Jacqueline R.; Eisman, John A.; Nguyen, Tuan V.] UNSW Australia, St Vincents Clin Sch, Sydney, NSW, Australia; [Nguyen, Tuan V.] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Nguyen, Tuan V.] Univ Technol Sydney, Ctr Hlth Technol, Sydney, NSW 2007, Australia	UiT The Arctic University of Tromso; Garvan Institute of Medical Research; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; St Vincents Hospital Sydney; University of Notre Dame Australia; University of New South Wales Sydney; University of New South Wales Sydney; University of Technology Sydney	Ahmed, LA (corresponding author), UiT, Fac Hlth Sci, Dept Hlth & Care Sci, Tromso, Norway.	luai.ahmed@uit.no	Center, Jacqueline/AAY-8712-2021; Eisman, John A/C-2886-2014; Bliuc, Dana/Y-7240-2018; Ahmed, Luai A./J-7225-2013; Nguyen, Tuan V./B-6147-2008	Center, Jacqueline/0000-0002-5278-4527; Bliuc, Dana/0000-0001-9682-2313; Joakimsen, Ragnar Martin/0000-0002-2125-8081; Ahmed, Luai A./0000-0001-5292-8212; Nguyen, Tuan V./0000-0002-3246-6281	UiT - The Arctic University of Norway	UiT - The Arctic University of Norway	This work was supported by an internal grant from the UiT - The Arctic University of Norway. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Bolland MJ, 2011, J BONE MINER RES, V26, P420, DOI 10.1002/jbmr.215; Cheng SY, 2011, OSTEOPOROSIS INT, V22, P2575, DOI 10.1007/s00198-011-1596-z; Cooper C, 2010, OSTEOPOROSIS INT, V21, P425, DOI 10.1007/s00198-010-1251-0; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Emaus N, 2009, EUR J EPIDEMIOL, V24, P321, DOI 10.1007/s10654-009-9333-z; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Joakimsen RM, 2001, OSTEOPOROSIS INT, V12, P1001, DOI 10.1007/s001980170008; Langsetmo L, 2011, CAN MED ASSOC J, V183, pE107, DOI 10.1503/cmaj.100458; Leslie WD, 2014, OSTEOPOROSIS INT, V25, P1, DOI 10.1007/s00198-013-2409-3; Melton LJ, 2003, J BONE MINER RES, V18, P1139, DOI 10.1359/jbmr.2003.18.6.1139; Nayak S, 2014, OSTEOPOROSIS INT, V25, P23, DOI 10.1007/s00198-013-2504-5; Nelson HD, 2010, ANN INTERN MED, V153, P99, DOI 10.7326/0003-4819-153-2-201007200-00262; Nguyen ND, 2008, OSTEOPOROSIS INT, V19, P1431, DOI 10.1007/s00198-008-0588-0; Nguyen ND, 2007, OSTEOPOROSIS INT, V18, P1109, DOI 10.1007/s00198-007-0362-8; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pluskiewicz W, 2010, BONE, V46, P1661, DOI 10.1016/j.bone.2010.02.012; Premaor M, 2013, J BONE MINER RES, V28, P188, DOI 10.1002/jbmr.1729; Rubin KH, 2013, J BONE MINER RES, V28, P1701, DOI 10.1002/jbmr.1956; Sambrook PN, 2011, J BONE MINER RES, V26, P2770, DOI 10.1002/jbmr.503; Sandhu SK, 2010, OSTEOPOROSIS INT, V21, P863, DOI 10.1007/s00198-009-1026-7; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2	23	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107695	10.1371/journal.pone.0107695	http://dx.doi.org/10.1371/journal.pone.0107695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255221	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300029
J	Liu, XW; Ridgway, ND				Liu, Xinwei; Ridgway, Neale D.			Characterization of the Sterol and Phosphatidylinositol 4-Phosphate Binding Properties of Golgi-Associated OSBP-Related Protein 9 (ORP9)	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; OXYSTEROL; TRANSPORT; MEMBRANE; CHOLESTEROL; 25-HYDROXYCHOLESTEROL; PHOSPHORYLATION; FLUORESCENT; ACTIVATION; APPARATUS	Oxysterol binding protein (OSBP) and OSBP-related proteins (ORPS) have a conserved lipid-binding fold that accommodates cholesterol, oxysterols and/or phospholipids. The diversity of OSBP/ORPs and their potential ligands has complicated the analysis of transfer and signalling properties of this mammalian gene family. In this study we explored the use of the fluorescent sterol cholestatrienol (CTL) to measure sterol binding by ORP9 and competition by other putative ligands. Relative to cholesterol, CTL and dehydroergosterol (DHE) were poor ligands for OSBP. In contrast, both long (ORP9L) and short (ORP9S) variants of ORP9 rapidly extracted CTL, and to a lesser extent DHE, from liposomes. ORP9L and ORP9S also extracted [P-32] phosphatidylinositol 4-phosphate (PI-4P) from liposomes, which was inhibited by mutating two conserved histidine residues (HH(488,489)AA) at the entrance to the binding pocket but not by a mutation in the lid region that inhibited cholesterol binding. Results of direct binding and competition assays showed that phosphatidylserine was poorly extracted from liposomes by ORP9 compared to CTL and PI-4P. ORP9L and PI-4P did not co-localize in the trans-Golgi/TGN of HeLa cells, and siRNA silencing of ORP9L expression did not affect PI-4P distribution in the Golgi apparatus. However, transient overexpression of ORP9L or ORP9S in CHO cells, but not the corresponding PI-4P binding mutants, prevented immunostaining of Golgi-associated PI-4P. The apparent sequestration of Golgi PI-4P by ORP9S was identified as a possible mechanism for its growth inhibitory effects. These studies identify ORP9 as a dual sterol/PI-4P binding protein that could regulate PI-4P in the Golgi apparatus.	[Ridgway, Neale D.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; Dalhousie Univ, Dept Biochem, Halifax, NS, Canada; Dalhousie Univ, Dept Mol Biol, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Ridgway, ND (corresponding author), Dalhousie Univ, Dept Pediat, Halifax, NS, Canada.	nridgway@dal.ca		Ridgway, Neale/0000-0002-0441-6228	Canadian Institutes of Health Research [MOP-15284]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding to NDR received from the Canadian Institutes of Health Research (Grant number MOP-15284). http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji S, 2010, MOL BIOL CELL; Beh CT, 2009, MOL CELL BIOCHEM, V326, P9, DOI 10.1007/s11010-008-9999-7; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Goto A, 2012, MOL BIOL CELL, V23, P3624, DOI 10.1091/mbc.E12-04-0283; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; KANDUTSCH AA, 1981, J BIOL CHEM, V256, P3068; Lehto M, 2005, EXP CELL RES, V310, P445, DOI 10.1016/j.yexcr.2005.08.003; Lessmann E, 2007, CELL SIGNAL, V19, P384, DOI 10.1016/j.cellsig.2006.07.009; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Nishimura T, 2013, MOL BIOL CELL, V24, P3534, DOI 10.1091/mbc.E13-05-0250; Ohvo-Rekila H, 2000, CHEM PHYS LIPIDS, V105, P167, DOI 10.1016/S0009-3084(00)00122-5; Olkkonen VM, 2013, PROG LIPID RES, V52, P529, DOI 10.1016/j.plipres.2013.06.004; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Scheidt HA, 2003, J BIOL CHEM, V278, P45563, DOI 10.1074/jbc.M303567200; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; Wang C, 2002, BIOCHEM J, V361, P461, DOI 10.1042/0264-6021:3610461; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052; Xu Z, 2008, BIOCHEMISTRY-US, V47, P11134, DOI 10.1021/bi801328u; Zhou Y, 2010, EXP CELL RES, V316, P3304, DOI 10.1016/j.yexcr.2010.06.008	34	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108368	10.1371/journal.pone.0108368	http://dx.doi.org/10.1371/journal.pone.0108368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255026	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300075
J	Murata, A; Yoshino, M; Hikosaka, M; Okuyama, K; Zhou, L; Sakano, S; Yagita, H; Hayashi, SI				Murata, Akihiko; Yoshino, Miya; Hikosaka, Mari; Okuyama, Kazuki; Zhou, Lan; Sakano, Seiji; Yagita, Hideo; Hayashi, Shin-Ichi			An Evolutionary-Conserved Function of Mammalian Notch Family Members as Cell Adhesion Molecules	PLOS ONE			English	Article							SIGNALING PATHWAY; GROWTH-FACTOR; LIGAND EXPRESSION; C-KIT; DELTA; LOCALIZATION; ACTIVATION; JAGGED1; DLL3; DELTA-LIKE-1	Notch family members were first identified as cell adhesion molecules by cell aggregation assays in Drosophila studies. However, they are generally recognized as signaling molecules, and it was unclear if their adhesion function was restricted to Drosophila. We previously demonstrated that a mouse Notch ligand, Delta-like 1 (Dll1) functioned as a cell adhesion molecule. We here investigated whether this adhesion function was conserved in the diversified mammalian Notch ligands consisted of two families, Delta-like (Dll1, Dll3 and Dll4) and Jagged (Jag1 and Jag2). The forced expression of mouse Dll1, Dll4, Jag1, and Jag2, but not Dll3, on stromal cells induced the rapid and enhanced adhesion of cultured mast cells (MCs). This was attributed to the binding of Notch1 and Notch2 on MCs to each Notch ligand on the stromal cells themselves, and not the activation of Notch signaling. Notch receptor-ligand binding strongly supported the tethering of MCs to stromal cells, the first step of cell adhesion. However, the Jag2-mediated adhesion of MCs was weaker and unlike other ligands appeared to require additional factor(s) in addition to the receptor-ligand binding. Taken together, these results demonstrated that the function of cell adhesion was conserved in mammalian as well as Drosophila Notch family members. Since Notch receptor-ligand interaction plays important roles in a broad spectrum of biological processes ranging from embryogenesis to disorders, our finding will provide a new perspective on these issues from the aspect of cell adhesion.	[Murata, Akihiko; Yoshino, Miya; Hikosaka, Mari; Hayashi, Shin-Ichi] Tottori Univ, Fac Med, Div Immunol, Dept Mol & Cellular Biol,Sch Life Sci, Yonago, Tottori 683, Japan; [Okuyama, Kazuki] Tokai Univ, Sch Med, Div Internal Med, Dept Hematol & Oncol, Isehara, Kanagawa 25911, Japan; [Zhou, Lan] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Sakano, Seiji] Asahi Kasei Corp, Corp R&D Labs, Fuji, Shizuoka, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 113, Japan	Tottori University; Tokai University; Case Western Reserve University; Asahi Kasei Corporation; Juntendo University	Murata, A (corresponding author), Tottori Univ, Fac Med, Div Immunol, Dept Mol & Cellular Biol,Sch Life Sci, Yonago, Tottori 683, Japan.	muratako@med.tottori-u.ac.jp	Yoshino, Miya/R-4623-2019; Murata, AKihiko/ABG-8254-2020; Sakano, Seiji/AAG-1640-2019	Okuyama, Kazuki/0000-0002-0262-9326; Murata, Akihiko/0000-0003-4089-5622	JSPS KAKENHI [25860295, 23590460]; Tottori University Faculty of Medicine Alumni Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103827] Funding Source: NIH RePORTER	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tottori University Faculty of Medicine Alumni Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by JSPS KAKENHI Grant Number 25860295 (to AM) and 23590460 (to SIH), and by a grant from Tottori University Faculty of Medicine Alumni Association (to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahimou F, 2004, J CELL BIOL, V167, P1217, DOI 10.1083/jcb.200407100; Ando K, 2003, ONCOGENE, V22, P7796, DOI 10.1038/sj.onc.1206965; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; Cordle J, 2008, J BIOL CHEM, V283, P11785, DOI 10.1074/jbc.M708424200; D'Souza B, 2010, CURR TOP DEV BIOL, V92, P73, DOI 10.1016/S0070-2153(10)92003-6; DASTYCH J, 1994, J IMMUNOL, V152, P213; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Estrach S, 2007, J CELL SCI, V120, P2944, DOI 10.1242/jcs.016253; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fukuda D, 2012, P NATL ACAD SCI USA, V109, pE1868, DOI 10.1073/pnas.1116889109; Gazave E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-249; Geffers I, 2007, J CELL BIOL, V178, P465, DOI 10.1083/jcb.200702009; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Imaeda H, 2011, INT J MOL MED, V28, P573, DOI 10.3892/ijmm.2011.718; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Karanu FN, 2001, BLOOD, V97, P1960, DOI 10.1182/blood.V97.7.1960; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Kayagaki N, 1999, J IMMUNOL, V163, P1906; KINASHI T, 1994, BLOOD, V83, P1033; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Mani M, 2009, BLOOD, V114, P2900, DOI 10.1182/blood-2009-01-200733; Moriyama Y, 2008, INT IMMUNOL, V20, P763, DOI 10.1093/intimm/dxn034; Murata A, 2010, J IMMUNOL, V185, P3905, DOI 10.4049/jimmunol.1000195; Murea M, 2010, KIDNEY INT, V78, P514, DOI 10.1038/ki.2010.172; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Nijjar SS, 2002, AM J PATHOL, V160, P1695, DOI 10.1016/S0002-9440(10)61116-9; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; Okuyama K, 2012, BIOCHEM BIOPH RES CO, V417, P141, DOI 10.1016/j.bbrc.2011.11.072; Outtz HH, 2010, J IMMUNOL, V185, P4363, DOI 10.4049/jimmunol.1000720; Pintar A, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-19; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Reynolds ND, 2011, J IMMUNOL, V187, P2803, DOI 10.4049/jimmunol.1100160; Sakata-Yanagimoto M, 2011, BLOOD, V117, P128, DOI 10.1182/blood-2010-07-289611; Samayawardhena LA, 2007, BLOOD, V109, P3679, DOI 10.1182/blood-2006-11-057315; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Shimizu K, 2002, EMBO J, V21, P294, DOI 10.1093/emboj/21.3.294; Shimizu K, 2000, BIOCHEM BIOPH RES CO, V276, P385, DOI 10.1006/bbrc.2000.3469; Su Y, 2006, J GASTROINTEST SURG, V10, P1230, DOI 10.1016/j.gassur.2006.08.017; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; Syed F, 2012, WOUND REPAIR REGEN, V20, P688, DOI 10.1111/j.1524-475X.2012.00823.x; Takakura N, 1996, J INVEST DERMATOL, V107, P770, DOI 10.1111/1523-1747.ep12371802; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Yabe Y, 2005, J ORTHOP SCI, V10, P589, DOI 10.1007/s00776-005-0943-3; Yamada T, 2003, BLOOD, V101, P2227, DOI 10.1182/blood-2002-06-1740; Zhou L, 2008, BLOOD, V112, P308, DOI 10.1182/blood-2007-11-115204	53	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108535	10.1371/journal.pone.0108535	http://dx.doi.org/10.1371/journal.pone.0108535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255288	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300093
J	Paracha, RZ; Ahmad, J; Ali, A; Hussain, R; Niazi, U; Tareen, SHK; Aslam, B				Paracha, Rehan Zafar; Ahmad, Jamil; Ali, Amjad; Hussain, Riaz; Niazi, Umar; Tareen, Samar Hayat Khan; Aslam, Babar			Formal Modelling of Toll like Receptor 4 and JAK/STAT Signalling Pathways: Insight into the Roles of SOCS-1, Interferon-beta and Proinflammatory Cytokines in Sepsis	PLOS ONE			English	Article							NF-KAPPA-B; BIOLOGICAL REGULATORY NETWORKS; LOGICAL ANALYSIS; UNITED-STATES; ANTIINFLAMMATORY RESPONSES; TRANSCRIPTION FACTORS; MOLECULAR-MECHANISMS; NEGATIVE REGULATION; INNATE IMMUNITY; HUMAN MONOCYTES	Sepsis is one of the major causes of human morbidity and results in a considerable number of deaths each year. Lipopolysaccharide-induced sepsis has been associated with TLR4 signalling pathway which in collaboration with the JAK/STAT signalling regulate endotoxemia and inflammation. However, during sepsis our immune system cannot maintain a balance of cytokine levels and results in multiple organ damage and eventual death. Different opinions have been made in previous studies about the expression patterns and the role of proinflammatory cytokines in sepsis that attracted our attention towards qualitative properties of TLR4 and JAK/STAT signalling pathways using computer-aided studies. Rene Thomas' formalism was used to model septic and non-septic dynamics of TLR4 and JAK/STAT signalling. Comparisons among dynamics were made by intervening or removing the specific interactions among entities. Among our predictions, recurrent induction of proinflammatory cytokines with subsequent downregulation was found as the basic characteristic of septic model. This characteristic was found in agreement with previous experimental studies, which implicate that inflammation is followed by immunomodulation in septic patients. Moreover, intervention in downregulation of proinflammatory cytokines by SOCS-1 was found desirable to boost the immune responses. On the other hand, interventions either in TLR4 or transcriptional elements such as NF kappa B and STAT were found effective in the downregulation of immune responses. Whereas, IFN-beta and SOCS-1 mediated downregulation at different levels of signalling were found to be associated with variations in the levels of proinflammatory cytokines. However, these predictions need to be further validated using wet laboratory experimental studies to further explore the roles of inhibitors such as SOCS-1 and IFN-beta, which may alter the levels of proinflammatory cytokines at different stages of sepsis.	[Paracha, Rehan Zafar; Ali, Amjad; Aslam, Babar] Natl Univ Sci & Technol NUST, Atta Ur Rahman Sch Appl Biosci ASAB, Islamabad, Pakistan; [Ahmad, Jamil; Tareen, Samar Hayat Khan] Natl Univ Sci & Technol NUST, Res Ctr Modeling & Simulat RCMS, Islamabad, Pakistan; [Hussain, Riaz] Shifa Tameer E Millat Univ, Shifa Coll Pharmaceut Sci, Islamabad, Pakistan; [Niazi, Umar] Aberystwyth Univ, IBERS, Aberystwyth, Ceredigion, Wales	National University of Sciences & Technology - Pakistan; National University of Sciences & Technology - Pakistan; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Ahmad, J (corresponding author), Natl Univ Sci & Technol NUST, Res Ctr Modeling & Simulat RCMS, Islamabad, Pakistan.	dr.ahmad.jamil@gmail.com; amjad_uni@yahoo.com	Ali, Amjad/AAG-4441-2021; Ahmad, Jamil/AAF-5499-2021; Tareen, Samar Hayat Khan/P-3416-2014	Ali, Amjad/0000-0002-0486-4661; Ahmad, Jamil/0000-0001-6618-6811; Tareen, Samar Hayat Khan/0000-0002-3902-6633; Niazi, Umar/0000-0001-7176-8883	Higher Education Commission of Pakistan [20- 1464/RD/09/5252]; COMSTECH-TWAS (Standing Committee on Scientific and Technological Cooperation (COMSTECH) Academy of Sciences for the Developing World (TWAS)) [09-047RG/ITC/AS_C]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); COMSTECH-TWAS (Standing Committee on Scientific and Technological Cooperation (COMSTECH) Academy of Sciences for the Developing World (TWAS))	This work was supported by research grants from Higher Education Commission of Pakistan (Grant No. 20- 1464/R&D/09/5252) and COMSTECH-TWAS (Grant No. 09-047RG/ITC/AS_C) (Standing Committee on Scientific and Technological Cooperation (COMSTECH) and The Academy of Sciences for the Developing World (TWAS)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033532; Ahmad Jamil, 2006, ComPlexUs, V3, P231, DOI 10.1159/000110010; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2011, JAMA-J AM MED ASSOC, V306, P2614, DOI 10.1001/jama.2011.1853; [Anonymous], COMPUTATIONAL SYSTEM; Ashare A, 2005, AM J PHYSIOL-LUNG C, V288, pL633, DOI 10.1152/ajplung.00231.2004; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BELARDELLI F, 1995, APMIS, V103, P161, DOI 10.1111/j.1699-0463.1995.tb01092.x; Bernot G, 2004, J THEOR BIOL, V229, P339, DOI 10.1016/j.jtbi.2004.04.003; Bernot G, 2007, ELECTRON NOTES THEOR, V180, P3, DOI 10.1016/j.entcs.2004.01.038; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; BONE RC, 1992, JAMA-J AM MED ASSOC, V268, P3452, DOI 10.1001/jama.268.24.3452; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brandl K, 2005, EUR J MED RES, V10, P319; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chaouiya C, 2012, METHODS MOL BIOL, V804, P463, DOI 10.1007/978-1-61779-361-5_23; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Cooney RN, 2002, SHOCK, V17, P83, DOI 10.1097/00024382-200202000-00001; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Demongeot L, 2000, CR ACAD SCI III-VIE, V323, P69, DOI 10.1016/S0764-4469(00)00112-8; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gagneur J, 2005, FEBS LETT, V579, P1867, DOI 10.1016/j.febslet.2005.02.007; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Harris MC, 2005, J PEDIATR-US, V147, P462, DOI 10.1016/j.jpeds.2005.04.037; Harter L, 2004, SHOCK, V22, P403, DOI 10.1097/01.shk.0000142256.23382.5d; Heyninck K, 1999, FEBS LETT, V442, P147, DOI 10.1016/S0014-5793(98)01645-7; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huth M., 2004, LOGIC COMPUTER SCI M; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Johnston JA, 2004, J LEUKOCYTE BIOL, V75, P743, DOI 10.1189/jlb.1003507; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kendrick SFW, 2008, COMPET-BASE CRIT CAR, P5, DOI 10.1007/978-1-84628-939-2_2; Khalis Z, 2009, GENES GENOMES GENOMI, V3, P15; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kobayashi T, 2004, MICROBES INFECT, V6, P1333, DOI 10.1016/j.micinf.2004.09.001; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Lever A, 2007, BMJ-BRIT MED J, V335, P879, DOI 10.1136/bmj.39346.495880.AE; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Loisa P, 2003, ACTA ANAESTH SCAND, V47, P319, DOI 10.1034/j.1399-6576.2003.00004.x; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mahieu T, 2007, INFECT IMMUN, V75, P22, DOI 10.1128/IAI.00829-06; Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593; Mendoza L, 2006, BIOSYSTEMS, V84, P101, DOI 10.1016/j.biosystems.2005.10.004; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; Naldi A, 2009, LECT N BIOINFORMAT, V5688, P266, DOI 10.1007/978-3-642-03845-7_18; Netea MG, 2004, TRENDS MICROBIOL, V12, P484, DOI 10.1016/j.tim.2004.09.004; Netea MG, 2003, TRENDS IMMUNOL, V24, P254, DOI 10.1016/S1471-4906(03)00079-6; Novotny AR, 2012, IMMUNOBIOLOGY, V217, P616, DOI 10.1016/j.imbio.2011.10.019; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Prele CM, 2008, J IMMUNOL, V181, P8018, DOI 10.4049/jimmunol.181.11.8018; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Remick DG, 2003, CURR PHARM DESIGN, V9, P75, DOI 10.2174/1381612033392567; Richard A, SMBIONET SELECTION M; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Saadatpour A, 2013, SIAM J APPL DYN SYST, V12, P1997, DOI 10.1137/13090537X; Samaga R, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-43; Sanchez L, 2003, J THEOR BIOL, V224, P517, DOI 10.1016/S0022-5193(03)00201-7; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Scott MJ, 2002, CLIN DIAGN LAB IMMUN, V9, P1153, DOI 10.1128/CDLI.9.6.1153-1159.2002; Sega S, 2004, CLIN NEUROL NEUROSUR, V106, P255, DOI 10.1016/j.clineuro.2004.02.010; Shi CB, 2006, SCAND J GASTROENTERO, V41, P472, DOI 10.1080/00365520500318965; SNOUSSI E, 1993, B MATH BIOL, V55, P973, DOI 10.1016/S0092-8240(05)80199-5; Solodova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018543; Stoll LL, 2006, CURR PHARM DESIGN, V12, P4229, DOI 10.2174/138161206778743501; STONE R, 1994, SCIENCE, V264, P365, DOI 10.1126/science.8153620; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tamayo E, 2011, EUR CYTOKINE NETW, V22, P82, DOI 10.1684/ecn.2011.0281; Thomas R, 1998, INT J DEV BIOL, V42, P479; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; THOMAS R, 1978, J THEOR BIOL, V73, P631, DOI 10.1016/0022-5193(78)90127-3; THOMAS R, 1991, J THEOR BIOL, V153, P1, DOI 10.1016/S0022-5193(05)80350-9; Thomas R, 2001, CHAOS, V11, P180, DOI 10.1063/1.1349893; Thomas R., 1990, BIOL FEEDBACK; Thomas R, 1979, LECT NOTES BIOMATH, V29, P507, DOI DOI 10.1007/978-3-642-49321-8; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; Ward NS, 2008, CLIN CHEST MED, V29, P617, DOI 10.1016/j.ccm.2008.06.010; Weighardt H, 2007, IMMUNOBIOLOGY, V212, P715, DOI 10.1016/j.imbio.2007.09.010; Weighardt H, 2006, J IMMUNOL, V177, P5623, DOI 10.4049/jimmunol.177.8.5623; WENZEL RP, 1992, NEW ENGL J MED, V326, P1151, DOI 10.1056/NEJM199204233261710; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; Wittebole X, 2005, CLIN EXP IMMUNOL, V141, P99, DOI 10.1111/j.1365-2249.2005.02831.x; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yang Q, 2011, MATH BIOSCI, V232, P151, DOI 10.1016/j.mbs.2011.05.005; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005	116	24	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108466	10.1371/journal.pone.0108466	http://dx.doi.org/10.1371/journal.pone.0108466			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255432	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300087
J	Deriu, MA; Grasso, G; Licandro, G; Danani, A; Gallo, D; Tuszynski, JA; Morbiducci, U				Deriu, Marco A.; Grasso, Gianvito; Licandro, Ginevra; Danani, Andrea; Gallo, Diego; Tuszynski, Jack A.; Morbiducci, Umberto			Investigation of the Josephin Domain Protein-Protein Interaction by Molecular Dynamics	PLOS ONE			English	Article							SECONDARY STRUCTURE ASSIGNMENT; SPINOCEREBELLAR ATAXIA; POLYGLUTAMINE DISEASE; CAG EXPANSIONS; AGGREGATION; SIMULATIONS; FEATURES; FIBRILLOGENESIS; VALIDATION; EFFICIENT	Spinocerebellar ataxia (SCA) 3, the most common form of SCA, is a neurodegenerative rare disease characterized by polyglutamine tract expansion and self-assembly of Ataxin3 (At3) misfolded proteins into highly organized fibrillar aggregates. The At3 N-terminal Josephin Domain (JD) has been suggested as being responsible for mediating the initial phase of the At3 double-step fibrillogenesis. Several issues concerning the residues involved in the JD's aggregation and, more generally, the JD clumping mechanism have not been clarified yet. In this paper we present an investigation focusing on the JD protein-protein interaction by means of molecular modeling. Our results suggest possible aminoacids involved in JD contact together with local and non-local effects following JD dimerization. Surprisingly, JD conformational changes following the binding may involve ubiquitin binding sites and hairpin region even though they do not pertain to the JD interaction surfaces. Moreover, the JD binding event has been found to alter the hairpin open-like conformation toward a closed-like arrangement over the simulated timescale. Finally, our results suggest that the JD aggregation might be a multi-step process, with an initial fast JD-JD binding mainly driven by Arg101, followed by slower structural global rearrangements involving the exposure to the solvent of Leu84-Trp87, which might play a role in a second step of JD aggregation.	[Deriu, Marco A.; Grasso, Gianvito; Licandro, Ginevra; Danani, Andrea] Univ Appl Sci & Arts Southern Switzerland SUPSI, Inst Comp Integrated Mfg Sustainable Innovat, Dept Innovat Technol, Manno, Switzerland; [Gallo, Diego; Morbiducci, Umberto] Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy; [Tuszynski, Jack A.] Univ Alberta, Dept Phys, Edmonton, AB, Canada	Polytechnic University of Turin; University of Alberta	Deriu, MA (corresponding author), Univ Appl Sci & Arts Southern Switzerland SUPSI, Inst Comp Integrated Mfg Sustainable Innovat, Dept Innovat Technol, Manno, Switzerland.	marco.deriu@supsi.ch	Deriu, Marco Agostino/M-5161-2016; Gallo, Diego/I-9386-2012; Deriu, Marco Agostino Agostino/GPW-8179-2022; Tuszynski, Jack/AAA-2073-2020	Deriu, Marco Agostino/0000-0003-1918-1772; Gallo, Diego/0000-0002-7409-7111; Deriu, Marco Agostino Agostino/0000-0003-1918-1772; Tuszynski, Jack/0000-0001-9976-0429; Danani, Andrea/0000-0001-6578-5089; Grasso, Gianvito/0000-0002-7761-222X				Apicella A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058794; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chow MKM, 2004, J MOL BIOL, V335, P333, DOI 10.1016/j.jmb.2003.08.064; De Simone A, 2012, P NATL ACAD SCI USA, V109, P6951, DOI 10.1073/pnas.1118048109; Deriu MA, 2007, J MATER SCI, V42, P8864, DOI 10.1007/s10853-007-1784-6; Deriu MA, 2012, PROTEINS, V80, P1598, DOI 10.1002/prot.24053; Deriu MA, 2011, J BIOMECH, V44, P630, DOI 10.1016/j.jbiomech.2010.11.014; Deriu MA, 2010, BIOPHYS J, V99, P2190, DOI 10.1016/j.bpj.2010.06.070; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Enemark S, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2913330; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gsponer J, 2003, P NATL ACAD SCI USA, V100, P5154, DOI 10.1073/pnas.0835307100; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Hsin J, 2012, P NATL ACAD SCI USA, V109, P9432, DOI 10.1073/pnas.1120761109; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Invemizzi G, 2013, BBA-GEN SUBJECTS, V1830, P5236, DOI 10.1016/j.bbagen.2013.07.007; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MACIEL P, 1995, AM J HUM GENET, V57, P54; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Marchal S, 2003, J BIOL CHEM, V278, P31554, DOI 10.1074/jbc.M304205200; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2011, FASEB J, V25, P45, DOI 10.1096/fj.10-161208; Natalello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018789; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nicastro G, 2006, J BIOMOL NMR, V36, P267, DOI 10.1007/s10858-006-9092-z; Nicastro G, 2009, BIOPOLYMERS, V91, P1203, DOI 10.1002/bip.21210; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; RANUM LPW, 1995, AM J HUM GENET, V57, P603; Riess O, 2008, CEREBELLUM, V7, P125, DOI 10.1007/s12311-008-0013-4; Saunders HM, 2011, PROTEIN SCI, V20, P1675, DOI 10.1002/pro.698; Soncini M, 2007, BIOMECH MODEL MECHAN, V6, P399, DOI 10.1007/s10237-006-0060-z; Soncini Monica, 2009, Biophysical Reviews and Letters, V4, P45, DOI 10.1142/S1793048009000922; Sugita Y, 2010, P NATL ACAD SCI USA, V107, P21465, DOI 10.1073/pnas.1015819107; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	50	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108677	10.1371/journal.pone.0108677	http://dx.doi.org/10.1371/journal.pone.0108677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268243	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700139
J	Guilhot-Gaudeffroy, A; Froidevaux, C; Aze, J; Bernauer, J				Guilhot-Gaudeffroy, Adrien; Froidevaux, Christine; Aze, Jerome; Bernauer, Julie			Protein-RNA Complexes and Efficient Automatic Docking: Expanding RosettaDock Possibilities	PLOS ONE			English	Article							PREDICTION; POTENTIALS; DESIGN; MODELS; ENERGY; SET	Protein-RNA complexes provide a wide range of essential functions in the cell. Their atomic experimental structure solving, despite essential to the understanding of these functions, is often difficult and expensive. Docking approaches that have been developed for proteins are often challenging to adapt for RNA because of its inherent flexibility and the structural data available being relatively scarce. In this study we adapted the RosettaDock protocol for protein-RNA complexes both at the nucleotide and atomic levels. Using a genetic algorithm-based strategy, and a non-redundant protein-RNA dataset, we derived a RosettaDock scoring scheme able not only to discriminate but also score efficiently docking decoys. The approach proved to be both efficient and robust for generating and identifying suitable structures when applied to two protein-RNA docking benchmarks in both bound and unbound settings. It also compares well to existing strategies. This is the first approach that currently offers a multi-level optimized scoring approach integrated in a full docking suite, leading the way to adaptive fully flexible strategies.	[Guilhot-Gaudeffroy, Adrien; Froidevaux, Christine; Aze, Jerome; Bernauer, Julie] Inria Saclay Ile France, AMIB Project, Palaiseau, France; [Guilhot-Gaudeffroy, Adrien; Froidevaux, Christine; Aze, Jerome] Univ Paris 11, Rech Informat Lab, CNRS UMR 8623, F-91405 Orsay, France; [Guilhot-Gaudeffroy, Adrien; Bernauer, Julie] Ecole Polytech, CNRS, UMR 7161, Lab Informat, F-91128 Palaiseau, France; [Aze, Jerome] Univ Montpellier 2, CNRS UMR 5506, Lab Informat Robot & Microelect Montpellier, Montpellier, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Universite de Montpellier	Bernauer, J (corresponding author), Inria Saclay Ile France, AMIB Project, Palaiseau, France.	julie.bernauer@inria.fr	Bernauer, Julie/M-7518-2014	Bernauer, Julie/0000-0003-2345-995X	GENCI (Grand Equipement National de Calcul Intensif) [t2013077065]	GENCI (Grand Equipement National de Calcul Intensif)	This work was granted access to the HPC resources of TGCC (Tres Grand Centre de calcul du CEA - http://www-hpc.cea.fr/en/complexe/tgcc-curie.htm) under the allocation t2013077065 made by GENCI (Grand Equipement National de Calcul Intensif - http://www.genci.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aze J, 2011, LECT N BIOINFORMAT, V7036, P284, DOI 10.1007/978-3-642-24855-9_25; Barik A, 2012, PROTEINS, V80, P1866, DOI 10.1002/prot.24083; Bernauer J, 2007, BIOINFORMATICS, V23, P555, DOI 10.1093/bioinformatics/btl654; Bernauer J, 2005, PHYS BIOL, V2, pS17, DOI 10.1088/1478-3975/2/2/S02; Bernauer J, 2011, RNA, V17, P1066, DOI 10.1261/rna.2543711; Bordner AJ, 2007, PROTEINS, V68, P488, DOI 10.1002/prot.21406; Bourquard T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018541; Chen Y, 2004, NUCLEIC ACIDS RES, V32, P5147, DOI 10.1093/nar/gkh785; Chen Y, 2005, FEBS J, V272, P2088, DOI 10.1111/j.1742-4658.2005.04650.x; Chen Y, 2013, FEBS J, V280, P3734, DOI 10.1111/febs.12375; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Das R, 2010, NAT METHODS, V7, P291, DOI [10.1038/nmeth.1433, 10.1038/NMETH.1433]; de Vries SJ, 2010, PROTEINS, V78, P3242, DOI 10.1002/prot.22814; Ellis JJ, 2007, PROTEINS, V66, P903, DOI 10.1002/prot.21211; Fleishman SJ, 2011, J MOL BIOL, V414, P289, DOI 10.1016/j.jmb.2011.09.031; Fleishman SJ, 2010, PROTEINS, V78, P3212, DOI 10.1002/prot.22784; Flores SC, 2012, BRIEF BIOINFORM, V13, P395, DOI 10.1093/bib/bbr077; Fonseca R, 2014, NUCL ACIDS IN PRESS; Gray JJ, 2006, CURR OPIN STRUC BIOL, V16, P183, DOI 10.1016/j.sbi.2006.03.003; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Guilhot-Gaudeffroy A, 2014, REV NOUVELLES TECHNO, V26, P479; Huang SY, 2013, J COMPUT CHEM, V34, P311, DOI 10.1002/jcc.23149; Huang SY, 2014, NUCL ACIDS RES; Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c; Ke A, 2004, METHODS, V34, P408, DOI 10.1016/j.ymeth.2004.03.027; Kilambi KP, 2013, PROTEINS, V81, P2201, DOI 10.1002/prot.24425; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Laing C, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/28/283101; Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804; Lensink MF, 2013, PROTEINS, V81, P2082, DOI 10.1002/prot.24428; Lensink MF, 2013, PROTEINS; Lewis BA, 2011, NUCLEIC ACIDS RES, V39, pD277, DOI 10.1093/nar/gkq1108; Li CH, 2012, PROTEINS, V80, P14, DOI 10.1002/prot.23117; Lipfert J, 2007, ANNU REV BIOPH BIOM, V36, P307, DOI 10.1146/annurev.biophys.36.040306.132655; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; Milek M, 2012, SEMIN CELL DEV BIOL, V23, P206, DOI 10.1016/j.semcdb.2011.12.001; Moreira IS, 2010, J COMPUT CHEM, V31, P317, DOI 10.1002/jcc.21276; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Perez-Cano L, 2012, PROTEINS, V80, P1872, DOI 10.1002/prot.24075; Perez-Cano L, 2010, BIOCOMPUT-PAC SYM, P293; Philips A, 2012, BIOINFORMATICS, V28, P198, DOI 10.1093/bioinformatics/btr636; Puton T, 2012, J STRUCT BIOL, V179, P261, DOI 10.1016/j.jsb.2011.10.001; Rother K, 2011, J MOL MODEL, V17, P2325, DOI 10.1007/s00894-010-0951-x; Scott Lincoln G., 2008, V452, P29, DOI 10.1007/978-1-60327-159-2_2; Setny P, 2011, NUCLEIC ACIDS RES, V39, P9118, DOI 10.1093/nar/gkr636; Sim AYL, 2012, J BIOINF COMPUT BIOL, V10, DOI 10.1142/S0219720012410107; Theimer CA, 2012, METHODS MOL BIOL, V831, P197, DOI 10.1007/978-1-61779-480-3_12; Tsai J, 2003, PROTEINS, V53, P76, DOI 10.1002/prot.10454; Tuszynska I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-348; Vakser IA, 2008, CURR PHARM BIOTECHNO, V9, P57, DOI 10.2174/138920108783955209; Viswanath S, 2013, PROTEINS, V81, P592, DOI 10.1002/prot.24214; Zheng S, 2007, FEBS J, V274, P6378, DOI 10.1111/j.1742-4658.2007.06155.x; Zhou ZH, 2008, CURR OPIN STRUC BIOL, V18, P218, DOI 10.1016/j.sbi.2008.03.004; Zhu XL, 2013, PROTEINS, V81, P2221, DOI 10.1002/prot.24405	56	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108928	10.1371/journal.pone.0108928	http://dx.doi.org/10.1371/journal.pone.0108928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268579	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700192
J	Rygh, CB; Wang, J; Thuen, M; Navarro, AG; Huuse, EM; Thorsen, F; Poli, A; Zimmer, J; Haraldseth, O; Lie, SA; Enger, PO; Chekenya, M				Rygh, Cecilie Brekke; Wang, Jian; Thuen, Marte; Navarro, Andrea Gras; Huuse, Else Marie; Thorsen, Frits; Poli, Aurelie; Zimmer, Jacques; Haraldseth, Olav; Lie, Stein Atle; Enger, Per Oyvind; Chekenya, Martha			Dynamic Contrast Enhanced MRI Detects Early Response to Adoptive NK Cellular Immunotherapy Targeting the NG2 Proteoglycan in a Rat Model of Glioblastoma	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; APPARENT DIFFUSION-COEFFICIENT; ACUTE MYELOID-LEUKEMIA; NATURAL-KILLER-CELLS; RADIATION-THERAPY; TUMOR MICROENVIRONMENT; ASSESSMENT CRITERIA; CLINICAL-TRIALS; BREAST-CANCER; HUMAN HOMOLOG	There are currently no established radiological parameters that predict response to immunotherapy. We hypothesised that multiparametric, longitudinal magnetic resonance imaging (MRI) of physiological parameters and pharmacokinetic models might detect early biological responses to immunotherapy for glioblastoma targeting NG2/CSPG4 with mAb9.2.27 combined with natural killer (NK) cells. Contrast enhanced conventional T1-weighted MRI at 7 +/- 1 and 17 +/- 2 days post-treatment failed to detect differences in tumour size between the treatment groups, whereas, follow-up scans at 3 months demonstrated diminished signal intensity and tumour volume in the surviving NK+mAb9.2.27 treated animals. Notably, interstitial volume fraction (v(e)), was significantly increased in the NK+mAb9.2.27 combination therapy group compared mAb9.2.27 and NK cell monotherapy groups (p = 0.002 and p = 0.017 respectively) in cohort 1 animals treated with 1 million NK cells. v(e) was reproducibly increased in the combination NK+mAb9.2.27 compared to NK cell monotherapy in cohort 2 treated with increased dose of 2 million NK cells (p<0.0001), indicating greater cell death induced by NK+mAb9.2.27 treatment. The interstitial volume fraction in the NK monotherapy group was significantly reduced compared to mAb9.2.27 monotherapy (p<0.0001) and untreated controls (p = 0.014) in the cohort 2 animals. NK cells in monotherapy were unable to kill the U87MG cells that highly expressed class I human leucocyte antigens, and diminished stress ligands for activating receptors. A significant association between apparent diffusion coefficient (ADC) of water and v(e) in combination NK+mAb9.2.27 and NK monotherapy treated tumours was evident, where increased ADC corresponded to reduced v(e) in both cases. Collectively, these data support histological measures at end-stage demonstrating diminished tumour cell proliferation and pronounced apoptosis in the NK+mAb9.2.27 treated tumours compared to the other groups. In conclusion, v(e) was the most reliable radiological parameter for detecting response to intralesional NK cellular therapy.	[Rygh, Cecilie Brekke; Wang, Jian; Navarro, Andrea Gras; Poli, Aurelie; Enger, Per Oyvind; Chekenya, Martha] Univ Bergen, Dept Biomed, Bergen, Norway; [Rygh, Cecilie Brekke] Haukeland Hosp, Cardiovasc Res Grp, N-5021 Bergen, Norway; [Thuen, Marte; Huuse, Else Marie; Haraldseth, Olav] NTNU, Dept Circulat & Med Imaging, MI Lab, Trondheim, Norway; [Thorsen, Frits] Univ Bergen, Dept Biomed, Mol Imaging Ctr, Bergen, Norway; [Poli, Aurelie; Zimmer, Jacques] CRP Sante, Lab Immunogenet Allergol, Luxembourg, Luxembourg; [Haraldseth, Olav] St Olavs Hosp, Dept Med Imaging, Trondheim, Norway; [Lie, Stein Atle; Chekenya, Martha] Univ Bergen, Inst Clin Dent, Bergen, Norway; [Enger, Per Oyvind] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; Norwegian University of Science & Technology (NTNU); University of Bergen; Luxembourg Institute of Health; Norwegian University of Science & Technology (NTNU); University of Bergen; University of Bergen; Haukeland University Hospital	Rygh, CB (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	cecilie.rygh@biomed.uib.no		Chekenya, PhD, Dr Philos, Dr. Martha/0000-0001-7241-3451; Thorsen, Frits/0000-0002-7762-3703; Poli, Aurelie/0000-0002-7986-0761; Gras Navarro, Andrea/0000-0001-6869-4529; Zimmer, Jacques/0000-0002-7118-6944	Bergen Medical Research Foundation; Meltzer Research Fund; Norwegian Research Council; Norwegian Cancer Society	Bergen Medical Research Foundation; Meltzer Research Fund; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from The Bergen Medical Research Foundation, The Meltzer Research Fund, The Norwegian Research Council and The Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Al-Mayhani MTF, 2011, NEURO-ONCOLOGY, V13, P830, DOI 10.1093/neuonc/nor088; Avril T, 2012, BRAIN PATHOL, V22, P159, DOI 10.1111/j.1750-3639.2011.00515.x; Behm FG, 1996, BLOOD, V87, P1134, DOI 10.1182/blood.V87.3.1134.bloodjournal8731134; Brekke C, 2006, NEUROIMAGE, V29, P965, DOI 10.1016/j.neuroimage.2005.08.026; BRUNBERG JA, 1995, AM J NEURORADIOL, V16, P361; Castriconi R, 2009, J IMMUNOL, V182, P3530, DOI 10.4049/jimmunol.0802845; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Chekenya M, 1999, INT J DEV NEUROSCI, V17, P421, DOI 10.1016/S0736-5748(99)00019-2; Chekenya M, 2002, NEUROPATH APPL NEURO, V28, P367, DOI 10.1046/j.1365-2990.2002.00412.x; Chekenya M, 2002, FASEB J, V16, P586, DOI 10.1096/fj.01-0632fje; Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; Chinot OL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0347-2; Chu HH, 2013, RADIOLOGY, V269, P831, DOI 10.1148/radiol.13122024; FESTING MFW, 1978, NATURE, V274, P365, DOI 10.1038/274365a0; Finn MA, 2007, SURG NEUROL, V67, P246, DOI 10.1016/j.surneu.2006.04.015; Floeth FW, 2001, AM J NEURORADIOL, V22, P1517; Fukumura D, 2007, J CELL BIOCHEM, V101, P937, DOI 10.1002/jcb.21187; Galons Jean-Philippe, 1999, Neoplasia (New York), V1, P113, DOI 10.1038/sj.neo.7900009; Henegar MM, 1996, J NEUROSURG, V84, P174, DOI 10.3171/jns.1996.84.2.0174; Huuse EM, 2012, J MAGN RESON IMAGING, V35, P1098, DOI 10.1002/jmri.23507; Hylton N, 2006, J CLIN ONCOL, V24, P3293, DOI 10.1200/JCO.2006.06.8080; JAIN RK, 1994, SCI AM, V271, P58, DOI 10.1038/scientificamerican0794-58; JAIN RK, 1987, CANCER RES, V47, P3039; Kang Y, 2011, RADIOLOGY, V261, P882, DOI 10.1148/radiol.11110686; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kauppinen RA, 2002, NMR BIOMED, V15, P6, DOI 10.1002/nbm.742; Kmiecik J, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27185; Kumar AJ, 2000, RADIOLOGY, V217, P377, DOI 10.1148/radiology.217.2.r00nv36377; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Ludemann L, 2005, MAGN RESON IMAGING, V23, P833, DOI 10.1016/j.mri.2005.06.007; Lyng H, 2000, MAGNET RESON MED, V43, P828, DOI 10.1002/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Matheus MG, 2004, AM J NEURORADIOL, V25, P1211; Mauvieux L, 1999, BRIT J HAEMATOL, V107, P674; McGrath DM, 2009, MAGN RESON MED, V61, P1173, DOI 10.1002/mrm.21959; Miller JS, 2002, CANCER INVEST, V20, P405, DOI 10.1081/CNV-120001185; Mills SJ, 2010, AM J NEURORADIOL, V31, P549, DOI 10.3174/ajnr.A1844; MORETTA A, 1993, J EXP MED, V178, P597, DOI 10.1084/jem.178.2.597; Naper C, 2002, EUR J IMMUNOL, V32, P2031, DOI 10.1002/1521-4141(200207)32:7<2031::AID-IMMU2031>3.0.CO;2-H; Poli A, 2013, ONCOTARGET, V4, P1527, DOI 10.18632/oncotarget.1291; Poli A, 2010, IMMUNOLOGY, V131, P386, DOI 10.1111/j.1365-2567.2010.03312.x; ROTH JG, 1960, J NEUROSURG, V17, P736, DOI 10.3171/jns.1960.17.4.0736; Sadeghi N, 2008, AM J NEURORADIOL, V29, P476, DOI 10.3174/ajnr.A0851; Sadeghi N, 2003, AM J ROENTGENOL, V181, P235, DOI 10.2214/ajr.181.1.1810235; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; Seo HS, 2008, AM J NEURORADIOL, V29, P458, DOI 10.3174/ajnr.A0842; Smith FO, 1996, BLOOD, V87, P1123, DOI 10.1182/blood.V87.3.1123.bloodjournal8731123; Smith MM, 1996, AM J NEURORADIOL, V17, P1065; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Svendsen A, 2011, ACTA NEUROPATHOL, V122, P495, DOI 10.1007/s00401-011-0867-2; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Ulmer S, 2006, NEUROLOGY, V67, P1668, DOI 10.1212/01.wnl.0000242894.21705.3c; van den Bent MJ, 2009, J CLIN ONCOL, V27, P2905, DOI 10.1200/JCO.2009.22.4998; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023062; Wang J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-465; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Yankeelov TE, 2007, MAGN RESON IMAGING, V25, P1, DOI 10.1016/j.mri.2006.09.006	58	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108414	10.1371/journal.pone.0108414	http://dx.doi.org/10.1371/journal.pone.0108414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268630	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700092
J	Sun, HT; Harris, WT; Kortyka, S; Kotha, K; Ostmann, AJ; Rezayat, A; Sridharan, A; Sanders, Y; Naren, AP; Clancy, JP				Sun, Hongtao; Harris, William T.; Kortyka, Stephanie; Kotha, Kavitha; Ostmann, Alicia J.; Rezayat, Amir; Sridharan, Anusha; Sanders, Yan; Naren, Anjaparavanda P.; Clancy, John P.			TGF-Beta Downregulation of Distinct Chloride Channels in Cystic Fibrosis-Affected Epithelia	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SURFACE LIQUID VOLUME; PHASIC SHEAR-STRESS; LUNG-DISEASE; AIRWAY EPITHELIA; P38 MAPK; IN-VITRO; CFTR; PROTEIN; CELLS	Rationale: The cystic fibrosis transmembrane conductance regulator (CFTR) and Calcium-activated Chloride Conductance (CaCC) each play critical roles in maintaining normal hydration of epithelial surfaces including the airways and colon. TGFbeta is a genetic modifier of cystic fibrosis (CF), but how it influences the CF phenotype is not understood. Objectives: We tested the hypothesis that TGF-beta potently downregulates chloride-channel function and expression in two CF-affected epithelia (T84 colonocytes and primary human airway epithelia) compared with proteins known to be regulated by TGF-beta. Measurements and Main Results: TGF-beta reduced CaCC and CFTR-dependent chloride currents in both epithelia accompanied by reduced levels of TMEM16A and CFTR protein and transcripts. TGF-beta treatment disrupted normal regulation of airway-surface liquid volume in polarized primary human airway epithelia, and reversed F508del CFTR correction produced by VX-809. TGF-beta effects on the expression and activity of TMEM16A, wtCFTR and corrected F508del CFTR were seen at 10-fold lower concentrations relative to TGF-beta effects on e-cadherin (epithelial marker) and vimentin (mesenchymal marker) expression. TGF-beta downregulation of TMEM16A and CFTR expression were partially reversed by Smad3 and p38 MAPK inhibition, respectively. Conclusions: TGF-beta is sufficient to downregulate two critical chloride transporters in two CF-affected tissues that precedes expression changes of two distinct TGF-beta regulated proteins. Our results provide a plausible mechanism for CF-disease modification by TGF-beta through effects on CaCC.	[Sun, Hongtao; Ostmann, Alicia J.; Rezayat, Amir; Sridharan, Anusha; Naren, Anjaparavanda P.; Clancy, John P.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Harris, William T.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Sanders, Yan] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kortyka, Stephanie] Univ Louisville, Sch Med, Louisville, KY 40292 USA; [Kotha, Kavitha] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH USA; [Naren, Anjaparavanda P.; Clancy, John P.] Univ Cincinnati, Dept Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Louisville; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; University of Cincinnati	Clancy, JP (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.	john.clancy@cchmc.org	Sanders, Yan/AAJ-3413-2020		Cystic Fibrosis Foundation [R457-CR11]; (NIH/NHLBI) MR Predictors of Inflammation and Structural Lung Damage in CF [R01HL116226]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425, UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL113229, R01HL116226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482, R01DK093045] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); (NIH/NHLBI) MR Predictors of Inflammation and Structural Lung Damage in CF; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R457-CR11 (Cystic Fibrosis Foundation) Research Development Program, and by R01HL116226 (NIH/NHLBI) MR Predictors of Inflammation and Structural Lung Damage in CF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; Arkwright PD, 2000, THORAX, V55, P459, DOI 10.1136/thorax.55.6.459; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Bremer LA, 2008, HUM MOL GENET, V17, P2228, DOI 10.1093/hmg/ddn123; Chen J, 2005, J BIOL CHEM, V280, P29912, DOI 10.1074/jbc.M504516200; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Clancy JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073905; Coakley RD, 2008, J CLIN INVEST, V118, P4025, DOI 10.1172/JCI33893; Cobb BR, 2002, AM J PHYSIOL-LUNG C, V282, pL12, DOI 10.1152/ajplung.2002.282.1.L12; Collaco JM, 2008, CURR OPIN PULM MED, V14, P559, DOI 10.1097/MCP.0b013e3283121cdc; Com Gulnur, 2009, Handb Exp Pharmacol, P363, DOI 10.1007/978-3-540-89615-9_12; Corvol H, 2008, PEDIATR PULM, V43, P1224, DOI 10.1002/ppul.20935; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Derichs N, 2010, THORAX, V65, P594, DOI 10.1136/thx.2009.125088; Dorfman R, 2008, J CLIN INVEST, V118, P1040, DOI [10.1172/JCI337S4, 10.1172/JCI33754]; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Ferrera L, 2010, PHYSIOLOGY, V25, P357, DOI 10.1152/physiol.00030.2010; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Gomes LR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-26; GRUBB BR, 1994, AM J PHYSIOL, V266, pC1478, DOI 10.1152/ajpcell.1994.266.5.C1478; Harris WT, 2011, PEDIATR PULM, V46, P688, DOI 10.1002/ppul.21430; Harris WT, 2009, PEDIATR PULM, V44, P1057, DOI 10.1002/ppul.21079; Harvey PR, 2011, AM J RESP CELL MOL, V45, P592, DOI 10.1165/rcmb.2010-0484OC; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Hirtz S, 2004, GASTROENTEROLOGY, V127, P1085, DOI 10.1053/j.gastro.2004.07.006; Howe KL, 2004, EXP CELL RES, V298, P473, DOI 10.1016/j.yexcr.2004.04.026; Ito Y, 2004, BIOCHEM BIOPH RES CO, V324, P901, DOI 10.1016/j.bbrc.2004.09.134; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Kunzelmann K, 2013, FEBS J, V280, P4417, DOI 10.1111/febs.12457; Massague J, 2012, FEBS LETT, V586, P1833, DOI 10.1016/j.febslet.2012.05.030; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Matsumura Y, 2011, MOL BIOL CELL, V22, P2797, DOI 10.1091/mbc.E11-02-0137; McLean S, 2013, CELL SIGNAL, V25, P319, DOI 10.1016/j.cellsig.2012.10.001; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Paradiso AM, 2001, J GEN PHYSIOL, V117, P53, DOI 10.1085/jgp.117.1.53; Peters DM, 2014, P NATL ACAD SCI USA, V111, pE374, DOI 10.1073/pnas.1306798111; Pierucci-Alves F, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092262; Pruliere-Escabasse V, 2005, AM J PHYSIOL-LUNG C, V288, pL77, DOI 10.1152/ajplung.00048.2004; Ren A, 2013, J BIOL CHEM; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; RESTRICK LJ, 1995, AM J RESP CRIT CARE, V151, P1211; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Rowe SM, 2010, PULM PHARMACOL THER, V23, P268, DOI 10.1016/j.pupt.2010.02.001; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Schmidt BZ, 2009, J BIOL CHEM, V284, P4168, DOI 10.1074/jbc.M806485200; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; SMITH JJ, 1992, J CLIN INVEST, V89, P1148, DOI 10.1172/JCI115696; Snodgrass SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063167; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Thiagarajah JR, 2004, FASEB J, V18, P875, DOI 10.1096/fj.03-1248fje; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; WEBSTER P, 1994, AM J PHYSIOL, V267, pC340, DOI 10.1152/ajpcell.1994.267.2.C340; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yoshida M, 2012, INT J BIOL SCI, V8, P1062, DOI 10.7150/ijbs.4488; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005	62	49	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106842	10.1371/journal.pone.0106842	http://dx.doi.org/10.1371/journal.pone.0106842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268501	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700021
J	Berlinguer-Palmini, R; Narducci, R; Merhan, K; Dilaghi, A; Moroni, F; Masi, A; Scartabelli, T; Landucci, E; Sili, M; Schettini, A; McGovern, B; Maskaant, P; Degenaar, P; Mannaioni, G				Berlinguer-Palmini, Rolando; Narducci, Roberto; Merhan, Kamyar; Dilaghi, Arianna; Moroni, Flavio; Masi, Alessio; Scartabelli, Tania; Landucci, Elisa; Sili, Maria; Schettini, Antonio; McGovern, Brian; Maskaant, Pleun; Degenaar, Patrick; Mannaioni, Guido			Arrays of MicroLEDs and Astrocytes: Biological Amplifiers to Optogenetically Modulate Neuronal Networks Reducing Light Requirement	PLOS ONE			English	Article							OPTICAL CONTROL; NMDA RECEPTORS; ACTIVATION; CHANNELRHODOPSIN-2; ANTAGONISTS; CALCIUM; MODELS; DEATH; CELLS; GLIA	In the modern view of synaptic transmission, astrocytes are no longer confined to the role of merely supportive cells. Although they do not generate action potentials, they nonetheless exhibit electrical activity and can influence surrounding neurons through gliotransmitter release. In this work, we explored whether optogenetic activation of glial cells could act as an amplification mechanism to optical neural stimulation via gliotransmission to the neural network. We studied the modulation of gliotransmission by selective photo-activation of channelrhodopsin-2 (ChR2) and by means of a matrix of individually addressable super-bright microLEDs (mu LEDs) with an excitation peak at 470 nm. We combined Ca2+ imaging techniques and concurrent patch-clamp electrophysiology to obtain subsequent glia/neural activity. First, we tested the mu LEDs efficacy in stimulating ChR2-transfected astrocyte. ChR2-induced astrocytic current did not desensitize overtime, and was linearly increased and prolonged by increasing mu LED irradiance in terms of intensity and surface illumination. Subsequently, ChR2 astrocytic stimulation by broad-field LED illumination with the same spectral profile, increased both glial cells and neuronal calcium transient frequency and sEPSCs suggesting that few ChR2-transfected astrocytes were able to excite surrounding not-ChR2-transfected astrocytes and neurons. Finally, by using the mu LEDs array to selectively light stimulate ChR2 positive astrocytes we were able to increase the synaptic activity of single neurons surrounding it. In conclusion, ChR2-transfected astrocytes and mu LEDs system were shown to be an amplifier of synaptic activity in mixed corticalneuronal and glial cells culture.	[Berlinguer-Palmini, Rolando; Merhan, Kamyar; Degenaar, Patrick] Newcastle Univ, Inst Neurosci, Sch Elect & Elect Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Narducci, Roberto; Dilaghi, Arianna; Moroni, Flavio; Masi, Alessio; Sili, Maria; Mannaioni, Guido] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Sect Pharmacol & Toxicol, Florence, Italy; [Scartabelli, Tania; Landucci, Elisa; Schettini, Antonio] Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, Florence, Italy; [McGovern, Brian] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London, England; [Maskaant, Pleun] Tyndall Natl Inst Technol, Cork, Ireland	Newcastle University - UK; University of Florence; University of Florence; Imperial College London	Mannaioni, G (corresponding author), Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Sect Pharmacol & Toxicol, Florence, Italy.	guido.mannaioni@unifi.it	Palmini, Rolando Berlinguer/K-8764-2013; Degenaar, Patrick/B-4006-2010; Masi, Alessio/AAB-4884-2022	Palmini, Rolando Berlinguer/0000-0002-1786-496X; Degenaar, Patrick/0000-0002-5984-6698; Landucci, Elisa/0000-0002-6776-2857; Masi, Alessio/0000-0002-0361-0950; mannaioni, guido/0000-0002-8273-7377	European Commission [249867]	European Commission(European CommissionEuropean Commission Joint Research Centre)	PD received funding from the European Commission (http://ec.europa.eu/) under project OptoNeuro, project number 249867 (www.optoneuro.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaya TVF, 2012, BIOMED OPT EXPRESS, V3; Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Berlinguer-Palmini R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082180; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chaudet L, 2013, PROC SPIE, V8586, DOI 10.1117/12.2002070; Chen JD, 2013, GLIA, V61, P178, DOI 10.1002/glia.22425; Degenaar P, 2010, BIOMED CIRC SYST C, P170, DOI 10.1109/BIOCAS.2010.5709598; Degenaar P, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/035007; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grossman N, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016004; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Lalo U, 2006, J NEUROSCI, V26, P2673, DOI 10.1523/JNEUROSCI.4689-05.2006; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Li DD, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00193; Li DD, 2012, J PHYSIOL-LONDON, V590, P855, DOI 10.1113/jphysiol.2011.219345; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; McAlinden N, 2013, OPT LETT, V38, P992, DOI 10.1364/OL.38.000992; McGovern B, 2010, IEEE T BIOMED CIRC S, V4, P469, DOI 10.1109/TBCAS.2010.2081988; Miesenbock G, 2011, ANNU REV CELL DEV BI, V27, P731, DOI 10.1146/annurev-cellbio-100109-104051; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nikolic K, 2007, P ANN INT IEEE EMBS, P6365; Palygin O, 2011, BRIT J PHARMACOL, V163, P1755, DOI 10.1111/j.1476-5381.2011.01374.x; Pellegrini-Giampietro DE, 1999, EUR J NEUROSCI, V11, P3637, DOI 10.1046/j.1460-9568.1999.00786.x; Pellegrini-Giampietro DE, 1999, NEUROPHARMACOLOGY, V38, P1607, DOI 10.1016/S0028-3908(99)00097-0; Perea G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4262; Porter JT, 1996, J NEUROSCI, V16, P5073; Sasaki T, 2012, P NATL ACAD SCI USA, V109, P20720, DOI 10.1073/pnas.1213458109; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Szobota S, 2010, ANNU REV BIOPHYS, V39, P329, DOI 10.1146/annurev.biophys.093008.131400; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Wolf Patrick D., 2008, P63; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	40	13	13	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108689	10.1371/journal.pone.0108689	http://dx.doi.org/10.1371/journal.pone.0108689			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265500	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400104
J	Deng, JS; Zhao, F; Yu, XY; Zhao, YW; Li, DW; Shi, H; Sun, YN				Deng, Jiangshan; Zhao, Fei; Yu, Xiaoyan; Zhao, Yuwu; Li, Dawei; Shi, Hong; Sun, Yongning			Expression of Aquaporin 4 and Breakdown of the Blood-Brain Barrier after Hypoglycemia-Induced Brain Edema in Rats	PLOS ONE			English	Article							INSULIN-INDUCED HYPOGLYCEMIA; CULTURED ASTROCYTES; NEURONAL DEATH; INJURY; COMA; PERMEABILITY; ISCHEMIA; DAMAGE; WATER; ISOFORMS	Background: Hypoglycemia-induced brain edema is a severe clinical event that often results in death. The mechanisms by which hypoglycemia induces brain edema are unclear. Methods: In a hypoglycemic injury model established in adult rats, brain edema was verified by measuring brain water content and visualizing water accumulation using hematoxylin and eosin staining. Temporal expression of aquaporin 4 (AQP4) and the integrity of the blood-brain barrier (BBB) were evaluated. We assessed the distribution and expression of AQP4 following glucose deprivation in astrocyte cultures. Results: Brain edema was induced immediately after severe hypoglycemia but continued to progress even after recovery from hypoglycemia. Upregulation of AQP4 expression and moderate breakdown of the BBB were observed 24 h after recovery. In vitro, significant redistribution of AQP4 to the plasma membrane was induced following 6 h glucose deprivation. Conclusion: Hypoglycemia-induced brain edema is caused by cytotoxic and vasogenic factors. Changes in AQP4 location and expression may play a protective role in edema resolution.	[Deng, Jiangshan; Zhao, Fei; Yu, Xiaoyan; Zhao, Yuwu; Shi, Hong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurol, Shanghai 200030, Peoples R China; [Li, Dawei] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Sun, Yongning] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Tradit Chinese Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhao, YW (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurol, Shanghai 200030, Peoples R China.	zhaoyuwu2005@126.com; daweili@sjtu.edu.cn			National Natural Science Foundation [31271125]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation NO. 31271125 (URL: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIEFF AI, 1974, J CLIN INVEST, V54, P654, DOI 10.1172/JCI107803; Auer RN, 2004, FORENSIC SCI INT, V146, P105, DOI 10.1016/j.forsciint.2004.08.001; AUER RN, 1985, ACTA NEUROPATHOL, V67, P13, DOI 10.1007/BF00688120; AUER RN, 1984, DIABETES, V33, P1090, DOI 10.2337/diabetes.33.11.1090; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Gisselsson L, 1998, EXP BRAIN RES, V120, P461, DOI 10.1007/s002210050419; Hirt L, 2009, J CEREBR BLOOD F MET, V29, P423, DOI 10.1038/jcbfm.2008.133; Huang J, 2013, BRAIN RES, V1539, P61, DOI 10.1016/j.brainres.2013.09.022; Jin BJ, 2011, BIOPHYS J, V100, P2936, DOI 10.1016/j.bpj.2011.05.012; Katada R, 2014, FASEB J, V28, P705, DOI 10.1096/fj.13-231274; Kaya M, 2001, CAN J PHYSIOL PHARM, V79, P793, DOI 10.1139/cjpp-79-9-793; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Nicchia GP, 2000, GLIA, V31, P29, DOI 10.1002/(SICI)1098-1136(200007)31:1<29::AID-GLIA30>3.0.CO;2-3; OZTAS B, 1985, EXP NEUROL, V87, P129, DOI 10.1016/0014-4886(85)90139-6; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Rao KVR, 2003, NEUROREPORT, V14, P2379, DOI 10.1097/01.wnr.0000099610.19426.a6; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Shin JA, 2011, BBA-MOL BASIS DIS, V1812, P1154, DOI 10.1016/j.bbadis.2011.05.004; SIESJO BK, 1987, J CEREBR BLOOD F MET, V7, P789, DOI 10.1038/jcbfm.1987.135; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Steiner E, 2012, GLIA, V60, P1646, DOI 10.1002/glia.22383; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Tait MJ, 2010, NEUROSCIENCE, V167, P60, DOI 10.1016/j.neuroscience.2010.01.053; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Vajda Z, 2000, BIOCHEM BIOPH RES CO, V270, P495, DOI 10.1006/bbrc.2000.2472; Wolburg-Buchholz K, 2009, ACTA NEUROPATHOL, V118, P219, DOI 10.1007/s00401-009-0558-4; Yorulmaz H, 2011, BOSNIAN J BASIC MED, V11, P108; Zhong ZH, 2013, NEUROSCI LETT, V555, P24, DOI 10.1016/j.neulet.2013.09.023	32	18	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107022	10.1371/journal.pone.0107022	http://dx.doi.org/10.1371/journal.pone.0107022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264602	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400016
J	Schindler, C; Guenther, K; Hermann, C; Ferrario, CM; Schroeder, C; Haufe, S; Jordan, J; Kirch, W				Schindler, Christoph; Guenther, Kristina; Hermann, Cosima; Ferrario, Carlos M.; Schroeder, Christoph; Haufe, Sven; Jordan, Jens; Kirch, Wilhelm			Statin Treatment in Hypercholesterolemic Men Does Not Attenuate Angiotensin II-Induced Venoconstriction	PLOS ONE			English	Article							ENDOTHELIAL NITRIC-OXIDE; HAND VEINS; BAROREFLEX; RESPONSES; SYSTEM; SENSITIVITY; DYSFUNCTION; INHIBITION; EXPRESSION; LOSARTAN	Experimental studies suggested that statins attenuate vascular AT(1) receptor responsiveness. Moreover, the augmented excessive pressor response to systemic angiotensin II infusions in hypercholesterolemic patients was normalized with statin treatment. In 12 hypercholesterolemic patients, we tested the hypothesis that statin treatment attenuates angiotensin IImediated vasoconstriction in hand veins assessed by a linear variable differential transducer. Subjects ingested daily doses of either atorvastatin (40 mg) or positive control irbesartan (150 mg) for 30 days in a randomized and cross-over fashion. Ang II-induced venoconstriction at minute 4 averaged 59%+/- 10% before and 28%+/- 69% after irbesartan (mean +/- SEM; P<0.05) compared to 65%+/- 11% before and 73%+/- 11% after 30 days of atorvastatin treatment. Plasma angiotensin levels increased significantly after irbesartan treatment (Ang II: 17 +/- 22 before vs 52 +/- 40 pg/mL after [p = 0.048]; Ang-(1-7): 18 +/- 10 before vs 37 +/- 14 pg/mL after [p = 0.002]) compared to atorvastatin treatment (Ang II: 9 +/- 4 vs 11 +/- 10 pg/mL [p = 0.40]; Ang-(1-7): 24 +/- 9 vs 32 +/- 8 pg/mL [p = 0.023]). Our study suggests that statin treatment does not elicit major changes in angiotensin II-mediated venoconstriction or in circulating angiotensin II levels whereas angiotensin-(1-7) levels increased modestly. The discrepancy between local vascular and systemic angiotensin II responses might suggest that statin treatment interferes with blood pressure buffering reflexes.	[Schindler, Christoph; Schroeder, Christoph; Haufe, Sven; Jordan, Jens] Hannover Med Sch, Clin Res Ctr Hannover, Hannover, Germany; [Schindler, Christoph; Schroeder, Christoph; Haufe, Sven; Jordan, Jens] Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany; [Schindler, Christoph; Guenther, Kristina; Hermann, Cosima; Kirch, Wilhelm] Tech Univ Dresden, Inst Clin Pharmacol, Fac Med, D-01062 Dresden, Germany; [Ferrario, Carlos M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Surg, Winston Salem, NC 27103 USA	Hannover Medical School; Hannover Medical School; Technische Universitat Dresden; Wake Forest University; Wake Forest Baptist Medical Center	Schindler, C (corresponding author), Hannover Med Sch, Clin Res Ctr Hannover, Hannover, Germany.	schindler.christoph@mh-hannover.de	Ferrario, Carlos/ABB-4165-2021; Ferrario, Carlos/ABD-2791-2020; Haufe, Sven/G-1944-2011	Ferrario, Carlos/0000-0003-0792-6239; Haufe, Sven/0000-0002-5259-4352; Schindler, Christoph/0000-0002-6779-0057	Sanofi-Aventis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051952] Funding Source: NIH RePORTER	Sanofi-Aventis(Sanofi-Aventis); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was supported by a restricted grant of Sanofi-Aventis. The company had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar Cristian, 2011, Rev. perú. med. exp. salud publica, V28, P264, DOI 10.1590/s1726-46342011000200013; Collister JP, 2003, J RENIN-ANGIO-ALDO S, V4, P176, DOI 10.3317/jraas.2003.028; Dechend R, 2001, AM J HYPERTENS, V14, p55S, DOI 10.1016/S0895-7061(01)02070-2; Durand MJ, 2010, AM J PHYSIOL-HEART C, V299, pH1024, DOI 10.1152/ajpheart.00328.2010; Goldberg MR, 1996, CLIN PHARMACOL THER, V59, P72, DOI 10.1016/S0009-9236(96)90026-0; Grossmann M, 2001, PHARMACOGENETICS, V11, P307, DOI 10.1097/00008571-200106000-00005; Harada K, 2002, HYPERTENS RES, V25, P683; Jordan J, 2002, CIRCULATION, V105, P1459, DOI 10.1161/01.CIR.0000012126.56352.FD; Kishi T, 2009, CLIN EXP HYPERTENS, V31, P698, DOI 10.3109/10641960903407066; Lee BH, 1997, ARCH PHARM RES, V20, P389, DOI 10.1007/BF02973928; Maczewski M, 2008, BRIT J PHARMACOL, V154, P1640, DOI 10.1038/bjp.2008.218; Maia LG, 2004, J CARDIOVASC PHARM, V43, P685, DOI 10.1097/00005344-200405000-00011; Martin DS, 1998, HYPERTENSION, V31, P139, DOI 10.1161/01.HYP.31.1.139; MATSUKAWA T, 1991, AM J PHYSIOL, V261, pR690, DOI 10.1152/ajpregu.1991.261.3.R690; Moreira ED, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.45; MURAD F, 1986, J CLIN INVEST, V78, P1, DOI 10.1172/JCI112536; Nazzaro P, 1999, HYPERTENSION, V33, P719, DOI 10.1161/01.HYP.33.2.719; Nickenig G, 1997, AM J PHYSIOL-HEART C, V272, pH2701, DOI 10.1152/ajpheart.1997.272.6.H2701; Nickenig G, 1999, CIRCULATION, V100, P2131, DOI 10.1161/01.CIR.100.21.2131; Pang CCY, 2001, PHARMACOL THERAPEUT, V90, P179, DOI 10.1016/S0163-7258(01)00138-3; Sampaio WO, 2007, HYPERTENSION, V49, P185, DOI 10.1161/01.HYP.0000251865.35728.2f; Savergnini SQ, 2010, HYPERTENSION, V56, P112, DOI 10.1161/HYPERTENSIONAHA.110.152942; Schindler C, 2007, J CLIN PHARMACOL, V47, P112, DOI 10.1177/0091270006294280; Schindler C, 2012, J CLIN PHARMACOL, V52, P859, DOI 10.1177/0091270011406277; Sim JSN, 2004, J RENIN-ANGIO-ALDO S, V5, P109, DOI 10.3317/jraas.2004.026; Strehlow K, 2000, ANN MED, V32, P386, DOI 10.3109/07853890008995944; Toda N, 2007, PHARMACOL REV, V59, P54, DOI 10.1124/pr.59.1.2; Tran D, 2005, DIABETES OBES METAB, V7, P273, DOI 10.1111/j.1463-1326.2005.00388.x; Wang WZ, 2007, AM J PHYSIOL-REG I, V292, pR1137, DOI 10.1152/ajpregu.00590.2006; Wassmann S, 2001, HYPERTENSION, V37, P1450, DOI 10.1161/01.HYP.37.6.1450; Wassmann S, 2001, MOL PHARMACOL, V59, P646, DOI 10.1124/mol.59.3.646; Zhang C, 2010, P NATL ACAD SCI USA, V107, P15886, DOI 10.1073/pnas.1001253107	32	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e103909	10.1371/journal.pone.0103909	http://dx.doi.org/10.1371/journal.pone.0103909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264877	Green Submitted, gold, Green Published			2022-12-27	WOS:000345745400001
J	Caceda, R; Moskovciak, T; Prendes-Alvarez, S; Wojas, J; Engel, A; Wilker, SH; Gamboa, JL; Stowe, ZN				Caceda, Ricardo; Moskovciak, Tori; Prendes-Alvarez, Stefania; Wojas, Justyna; Engel, Anzhelika; Wilker, Samantha H.; Gamboa, Jorge L.; Stowe, Zachary N.			Gender-Specific Effects of Depression and Suicidal Ideation in Prosocial Behaviors	PLOS ONE			English	Article							SOCIAL DECISION-MAKING; MAJOR DEPRESSION; SALIVARY TESTOSTERONE; ALTRUISTIC BEHAVIOR; SEX-DIFFERENCES; NEURAL BASIS; TRUST; DISORDER; MEN; METAANALYSIS	Background: Prosocial behaviors are essential to the ability to relate to others. Women typically display greater prosocial behavior than men. The impact of depression on prosocial behaviors and how gender interacts with those effects are not fully understood. We explored the role of gender in the potential effects of depression on prosocial behavior. Methods: We examined prosocial behaviors using a modified version of the Trust Game in a clinical population and community controls. Study participants were characterized on the severity of depression and anxiety, presence of suicidal ideation, history of childhood trauma, recent stressful life events, and impulsivity. We correlated behavioral outcomes with gender and clinical variables using analysis of variance and multiple regression analysis. Results: The 89 participants comprised four study groups: depressed women, depressed men, healthy women and healthy men (n = 16-36). Depressed men exhibited reciprocity more frequently than healthy men. Depression induced an inversion of the gender-specific pattern of self-centered behavior. Suicidal ideation was associated with increased reciprocity behavior in both genders, and enhancement of the effect of depression on gender-specific self-centered behavior. Conclusions: Depression, particularly suicidal ideation, is associated with reversal of gender-specific patterns of prosocial behavior, suggesting abnormalities in sexual hormones regulation. This explanation is supported by known abnormalities in the hypothalamus-pituitary-adrenal and hypothalamus-pituitary-gonadal axes found in depression.	[Caceda, Ricardo; Stowe, Zachary N.] Univ Arkansas Med Sci, Inst Psychiat Res, Little Rock, AR 72205 USA; [Moskovciak, Tori; Prendes-Alvarez, Stefania; Wojas, Justyna; Engel, Anzhelika; Wilker, Samantha H.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Gamboa, Jorge L.] Vanderbilt Univ, Dept Med, Nashville, TN USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Miami; Vanderbilt University	Caceda, R (corresponding author), Univ Arkansas Med Sci, Inst Psychiat Res, Little Rock, AR 72205 USA.	rcaceda@uams.edu	Gamboa, Jorge/AFM-0631-2022; Caceda, Ricardo/K-5054-2015; Gamboa, Jorge/AAH-3052-2022; Gamboa, Jorge/E-5879-2010	Gamboa, Jorge/0000-0002-4204-7670; Caceda, Ricardo/0000-0001-6434-488X; Gamboa, Jorge/0000-0002-4204-7670; Gamboa, Jorge/0000-0002-4204-7670	Arsht Foundation; Department of Psychiatry, University of Miami; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK100533] Funding Source: NIH RePORTER	Arsht Foundation; Department of Psychiatry, University of Miami; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded partly by the Arsht Foundation and partly by internal funds from the Department of Psychiatry, University of Miami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett Rosalind C., 1987, GENDER STRESS; Beck A.T., 1990, MANUAL BECK ANXIETY; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; BRADFORD JMW, 1983, PSYCHIAT CLIN N AM, V6, P715; Brambilla F, 2010, INT J PSYCHOPHYSIOL, V75, P291, DOI 10.1016/j.ijpsycho.2009.12.012; Buchan NR, 2008, J ECON BEHAV ORGAN, V68, P466, DOI 10.1016/j.jebo.2007.10.006; Burnham TC, 2007, P ROY SOC B-BIOL SCI, V274, P2327, DOI 10.1098/rspb.2007.0546; Caceda R, 2014, PSYCHOSOM MED, V76, P445, DOI 10.1097/PSY.0000000000000075; CARLSMITH JM, 1969, J PERS SOC PSYCHOL, V11, P232, DOI 10.1037/h0027039; Chaudhuri A, 2013, J ECON PSYCHOL, V34, P181, DOI 10.1016/j.joep.2012.09.013; Croson R, 1999, AM ECON REV, V89, P386, DOI 10.1257/aer.89.2.386; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; deJong GM, 1996, J BEHAV MED, V19, P529; Dekker J, 2007, WOMEN HEALTH, V46, P19, DOI 10.1300/J013v46n04_02; Destoop M, 2012, J AFFECT DISORDERS, V137, P98, DOI 10.1016/j.jad.2011.12.010; Diener C, 2012, NEUROIMAGE, V61, P677, DOI 10.1016/j.neuroimage.2012.04.005; DURKHEIM E, 1992, EUR J POPUL, V8, P175, DOI 10.1007/BF01797209; Elliott R, 2011, NEUROPSYCHOPHARMACOL, V36, P153, DOI 10.1038/npp.2010.77; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; FRANK E, 1988, AM J PSYCHIAT, V145, P41; Fujiwara T, 2007, J AFFECT DISORDERS, V101, P219, DOI 10.1016/j.jad.2006.11.024; Fujiwara T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004557; Giltay EJ, 2012, J PSYCHOSOM RES, V72, P205, DOI 10.1016/j.jpsychores.2011.11.014; Glynn SA, 2002, TRANSFUSION, V42, P216, DOI 10.1046/j.1537-2995.2002.00008.x; Gustavsson G, 2003, EUR NEUROPSYCHOPHARM, V13, P105, DOI 10.1016/S0924-977X(02)00131-1; Harle KM, 2010, J ABNORM PSYCHOL, V119, P440, DOI 10.1037/a0018612; Harris JA, 1996, AGGRESSIVE BEHAV, V22, P321, DOI 10.1002/(SICI)1098-2337(1996)22:5<321::AID-AB1>3.0.CO;2-M; Hastings PD, 2000, DEV PSYCHOL, V36, P531, DOI [10.1037/0012-1649.36.5.531, 10.1037//0012-1649.36.5.531]; Hay DF, 2003, CHILD DEV, V74, P1314, DOI 10.1111/1467-8624.00609; HAY DF, 1994, J CHILD PSYCHOL PSYC, V35, P29, DOI 10.1111/j.1469-7610.1994.tb01132.x; Heuser I, 2002, MATURITAS, V41, pS19; Hirschfeld RMA, 2000, J CLIN PSYCHIAT, V61, P268, DOI 10.4088/JCP.v61n0405; Innocenti A., 2008, GAMES RATIONALITY BE, P134; Isen AM, 2000, PSYCHOL INQ, V11, P184; Johnson ND, 2011, J ECON PSYCHOL, V32, P865, DOI 10.1016/j.joep.2011.05.007; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P495, DOI 10.1016/j.biopsych.2005.04.035; Keenan K, 2005, CLIN CHILD FAM PSYCH, V8, P89, DOI 10.1007/s10567-005-4750-3; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; King-Casas B, 2012, BIOL PSYCHIAT, V72, P119, DOI 10.1016/j.biopsych.2012.03.033; KYOMEN HH, 1991, J AM GERIATR SOC, V39, P1110, DOI 10.1111/j.1532-5415.1991.tb02878.x; Lai CH, 2011, J CLIN PSYCHOPHARM, V31, P39, DOI 10.1097/JCP.0b013e318205a670; LONDON P, 1968, J SOC PSYCHOL, V76, P19, DOI 10.1080/00224545.1968.9919819; Markianos M, 2009, PSYCHIAT RES, V170, P82, DOI 10.1016/j.psychres.2008.08.001; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Nolen-Hoeksema S., 1990, SEX DIFFERENCES DEPR; O'Connor LE, 2002, J AFFECT DISORDERS, V71, P19, DOI 10.1016/S0165-0327(01)00408-6; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Sacher J, 2012, J AFFECT DISORDERS, V140, P142, DOI 10.1016/j.jad.2011.08.001; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Scheele D, 2013, EUR ARCH PSY CLIN N, V263, P675, DOI 10.1007/s00406-013-0392-5; Scheele D, 2012, BIOL PSYCHIAT, V72, pE5, DOI 10.1016/j.biopsych.2012.01.028; Schultheiss OC, 1999, HORM BEHAV, V36, P234, DOI 10.1006/hbeh.1999.1542; Schwartz C, 2003, PSYCHOSOM MED, V65, P778, DOI 10.1097/01.PSY.0000079378.39062.D4; Seelig BJ, 2001, J AM PSYCHOANAL ASS, V49, P933, DOI 10.1177/00030651010490031901; Skuse DH, 2005, HUM MOL GENET, V14, pR27, DOI 10.1093/hmg/ddi112; Soga T, 2010, NEUROPHARMACOLOGY, V59, P77, DOI 10.1016/j.neuropharm.2010.03.018; Szadoczky E, 2002, INT J PSYCHIAT CLIN, V6, P31, DOI 10.1080/136515002753489399; Toren P, 1996, BIOL PSYCHIAT, V39, P378, DOI 10.1016/0006-3223(95)00473-4; Tripodianakis J, 2007, EUR ARCH PSY CLIN N, V257, P135, DOI 10.1007/s00406-006-0686-y; Uebelacker LA, 2009, PSYCHOL MED, V39, P591, DOI 10.1017/S0033291708003875; Westheide J, 2008, EUR ARCH PSY CLIN N, V258, P414, DOI 10.1007/s00406-008-0811-1; World Health Organization, 2008, GLOBAL BURDEN DIS; Yamasue H, 2008, CEREB CORTEX, V18, P2331, DOI 10.1093/cercor/bhm254; Yen ST, 2002, APPL ECON LETT, V9, P837, DOI 10.1080/13504850210148189; Zak PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008330; Zak PJ, 2005, AM ECON REV, V95, P360, DOI 10.1257/000282805774669709; Zarrour FA, 2009, J PSYCHIATR PRACT, V15, P289, DOI 10.1097/01.pra.0000358315.88931.fc; Zhang HJ, 2012, BRAIN BEHAV, V2, P415, DOI 10.1002/brb3.62	72	20	20	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108733	10.1371/journal.pone.0108733	http://dx.doi.org/10.1371/journal.pone.0108733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IP	25259712	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600096
J	Chiu, PF; Wu, CL; Huang, CH; Liou, HH; Chang, CB; Chang, HR; Chang, CC				Chiu, Ping-Fang; Wu, Chia-Lin; Huang, Ching-Hui; Liou, Hung-Hsiang; Chang, Chirn-Bin; Chang, Horng-Rong; Chang, Chia-Chu			Lower Blood Glucose and Variability Are Associated with Earlier Recovery from Renal Injury Caused by Episodic Urinary Tract Infection in Advanced Type 2 Diabetic Chronic Kidney Disease	PLOS ONE			English	Article							GLYCEMIC VARIABILITY; OXIDATIVE STRESS; MORTALITY; OUTCOMES; FLUCTUATIONS; BACTEREMIA; THERAPY; IMPACT; RISK; LONG	Purpose: In our previous study, type 2 diabetic chronic kidney disease (CKD) patients with glomerular filtration rates of <30 mL/min upon hospitalization for urinary tract infection (UTI) were at a risk for acute kidney injury. This study aimed to clarify the effect of glucose and its variability on renal outcomes during admission for the treatment of UTI. Materials and Methods: Based on the date of renal recovery (RIFLE criteria: acute kidney injury occurred within 1-7 days and was sustained over 1 day), we divided these patients into early-(<= 9 days, Group A) and late-recovery (>9 days, Group B) groups. The differences in the continuous and categorical variables of the two groups were assessed separately. The mean glucose levels and their variability (using the standard deviation and the coefficient of standard deviation) were compared at the fasting, midday pre-meal, evening pre-meal, and evening post-meal time points during hospitalization. We have organized the manuscript in a manner compliant with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement. Results: Acute kidney injury occurred within the two groups (p = 0.007 and p = 0.001, respectively). The early-morning blood glucose levels (149.7 +/- 44.0 mg/dL) and average blood glucose levels (185.6 +/- 52.0 mg/dL) were better in Group A (p = 0.01, p = 0.02). Group A patients also had lower glucose variability than Group B at the different time points (p < 0.05). Group A also had earlier renal recovery. More relevant pathogens were identified from blood in Group B (p = 0.038). Conclusions: Early-morning fasting and mean blood glucose levels and their variability can be good indicators of severe infection and predictors of renal outcome in type 2 diabetic patients with CKD and UTI.	[Chiu, Ping-Fang; Chang, Horng-Rong] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chiu, Ping-Fang; Chang, Horng-Rong; Chang, Chia-Chu] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chiu, Ping-Fang; Wu, Chia-Lin; Liou, Hung-Hsiang; Chang, Chirn-Bin; Chang, Chia-Chu] Changhua Christian Hosp, Div Nephrol, Dept Internal Med, Changhua, Taiwan; [Huang, Ching-Hui] Changhua Christian Hosp, Div Cardiol, Dept Internal Med, Changhua, Taiwan; [Chang, Horng-Rong] Chung Shan Med Univ Hosp, Div Nephrol, Dept Internal Med, Taichung, Taiwan; [Chang, Chia-Chu] China Med Univ, Coll Med, PhD Program Aging, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Changhua Christian Hospital; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan	Chang, CC (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.	27509@cch.org.tw	Bin Chang, Chirn/E-8605-2010; Wu, Chia-Lin/V-8888-2017	Wu, Chia-Lin/0000-0001-6045-6956; Chang, Chirn-Bin/0000-0001-9423-7655	Changhua Christian Hospital [97CCHIRP-31]	Changhua Christian Hospital	The study was supported by a research grant (97CCHIRP-31) from Changhua Christian Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Balachandar Mahadeva Santhakumar, 2002, Diabetologia Croatica, V31, P85; Bochicchio GV, 2010, ANN SURG, V252, P597, DOI 10.1097/SLA.0b013e3181f4e499; Bouman CSC, 2002, CRIT CARE MED, V30, P2205, DOI 10.1097/00003246-200210000-00005; Bragd J, 2008, DIABETES METAB, V34, P612, DOI 10.1016/j.diabet.2008.04.005; Chiodini I, 2006, METABOLISM, V55, P1135, DOI 10.1016/j.metabol.2006.04.010; Chiu PF, 2013, J DIABETES COMPLICAT, V27, P41, DOI 10.1016/j.jdiacomp.2012.08.005; Di Flaviani A, 2011, DIABETES CARE, V34, P1605, DOI 10.2337/dc11-0034; Eslami S, 2011, INTENS CARE MED, V37, P583, DOI 10.1007/s00134-010-2129-5; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; Haga KK, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-3; Jeon CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045616; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Luckraz H, 2005, EUR J CARDIO-THORAC, V27, P906, DOI 10.1016/j.ejcts.2005.01.057; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Monnier Louis, 2008, J Diabetes Sci Technol, V2, P1094; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Nicolle LE, 1996, CLIN INFECT DIS, V22, P1051, DOI 10.1093/clinids/22.6.1051; Pisarchik AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046582; Riedel S, 2011, AM J CLIN PATHOL, V135, P182, DOI 10.1309/AJCP1MFYINQLECV2; Rizzo MR, 2012, DIABETES CARE, V35, P2076, DOI 10.2337/dc12-0199; Robbins SL, 1944, NEW ENGL J MED, V231, P865, DOI 10.1056/NEJM194412282312601; Rodbard David, 2012, J Diabetes Sci Technol, V6, P712; Sherr J, 2012, DIABETES CARE, V35, P817, DOI 10.2337/dc11-2190; Siegelaar SE, 2011, DIABETES CARE, V34, P855, DOI [10.2337/dc10-1684, 10.2337/dc10-1882]; Siegelaar SE, 2010, ENDOCR REV, V31, P171, DOI 10.1210/er.2009-0021; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Thakar CV, 2011, CLIN J AM SOC NEPHRO, V6, P2567, DOI 10.2215/CJN.01120211; TSIGOS C, 1993, J CLIN ENDOCR METAB, V76, P554, DOI 10.1210/jc.76.3.554; Tudela P, 2012, EMERGENCIAS, V24, P348; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Zhang YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042551	34	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108531	10.1371/journal.pone.0108531	http://dx.doi.org/10.1371/journal.pone.0108531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259806	Green Submitted, Green Published, gold			2022-12-27	WOS:000342685600081
J	Kordas, G; Lagoumintzis, G; Sideris, S; Poulas, K; Tzartos, SJ				Kordas, Gregory; Lagoumintzis, George; Sideris, Sotirios; Poulas, Konstantinos; Tzartos, Socrates J.			Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients	PLOS ONE			English	Article							MAIN IMMUNOGENIC REGION; NICOTINIC ACETYLCHOLINE-RECEPTORS; PASSIVE TRANSFER; MONOCLONAL-ANTIBODIES; ANTIGENIC STRUCTURE; EPSILON-SUBUNIT; MUSCLE; MECHANISMS; DOMAINS; SERA	Several studies have suggested that the autoantibodies (autoAbs) against muscle acetylcholine receptor (AChR) of myasthenia gravis (MG) patients are the main pathogenic factor in MG; however, this belief has not yet been confirmed with direct observations. Although animals immunized with AChR or injected with anti-AChR monoclonal Abs, or with crude human MG Ig fractions exhibit MG symptoms, the pathogenic role of isolated anti-AChR autoAbs, and, more importantly, the absence of pathogenic factor(s) in the autoAb-depleted MG sera has not yet been shown by in vivo studies. Using recombinant extracellular domains of the human AChR alpha and beta subunits, we have isolated autoAbs from the sera of four MG patients. The ability of these isolated anti-subunit Abs and of the Ab-depleted sera to passively transfer experimental autoimmune MG in Lewis rats was investigated. We found that the isolated anti-subunit Abs were at least as efficient as the corresponding whole sera or whole Ig in causing experimental MG. Abs to both alpha-and beta-subunit were pathogenic although the anti-alpha-subunit were much more efficient than the anti-beta-subunit ones. Interestingly, the autoAb-depleted sera were free of pathogenic activity. The later suggests that the myasthenogenic potency of the studied anti-AChR MG sera is totally due to their anti-AChR autoAbs, and therefore selective elimination of the anti-AChR autoAbs from MG patients may be an efficient therapy for MG.	[Kordas, Gregory; Lagoumintzis, George; Sideris, Sotirios; Poulas, Konstantinos; Tzartos, Socrates J.] Univ Patras, Dept Pharm, Patras, Greece; [Tzartos, Socrates J.] Hellenic Pasteur Inst, Dept Biochem, Athens, Greece	University of Patras	Poulas, K (corresponding author), Univ Patras, Dept Pharm, Patras, Greece.	kpoulas@upatras.gr; stzartos@gmail.com	Poulas, Konstantinos/L-4874-2018	Poulas, Konstantinos/0000-0002-5397-1543; Lagoumintzis, George/0000-0002-0441-9023	Muscular Dystrophy Association of USA (MDA); Fight-MG grant of the FP7 EC program; Association Francaise contre les Myopathies (AFM); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: THALES	Muscular Dystrophy Association of USA (MDA)(Muscular Dystrophy Association); Fight-MG grant of the FP7 EC program; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: THALES	This work was funded by the Muscular Dystrophy Association of USA (MDA), the Fight-MG grant of the FP7 EC program, the Association Francaise contre les Myopathies (AFM), and by the Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: THALES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Batocchi A P, 2000, Ther Apher, V4, P275, DOI 10.1046/j.1526-0968.2000.004004275.x; Bello-Rivero I, 2004, J AUTOIMMUN, V23, P63, DOI 10.1016/j.jaut.2004.03.013; BEROUKHIM R, 1995, NEURON, V15, P323, DOI 10.1016/0896-6273(95)90037-3; BERRIH-AKNIN S, 1995, J AUTOIMMUN, V8, P139, DOI 10.1006/jaut.1995.0011; Berrih-Aknin S, 2014, J AUTOIMMUN, V52, P90, DOI 10.1016/j.jaut.2013.12.011; Berrih-Aknin S, 2014, J AUTOIMMUN, V48-49, P143, DOI 10.1016/j.jaut.2014.01.003; BUSCHMAN E, 1987, J NEUROIMMUNOL, V13, P315, DOI 10.1016/0165-5728(87)90067-1; Christadoss P, 2000, CLIN IMMUNOL, V94, P75, DOI 10.1006/clim.1999.4807; CHRISTADOSS P, 1985, J NEUROIMMUNOL, V8, P29, DOI 10.1016/S0165-5728(85)80045-X; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; De Baets M, 2002, J NEUROL SCI, V202, P5, DOI 10.1016/S0022-510X(02)00200-9; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Hoch W, 2003, TRENDS NEUROSCI, V26, P335, DOI 10.1016/S0166-2236(03)00131-0; Infante AJ, 2003, J AUTOIMMUN, V21, P167, DOI 10.1016/S0896-8411(03)00086-6; Kalamida D, 2007, FEBS J, V274, P3799, DOI 10.1111/j.1742-4658.2007.05935.x; Kostelidou K, 2007, J NEUROIMMUNOL, V190, P44, DOI 10.1016/j.jneuroim.2007.07.018; Lindstrom JM, 2000, MUSCLE NERVE, V23, P453, DOI 10.1002/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O; LINDSTROM JM, 1976, J EXP MED, V144, P726, DOI 10.1084/jem.144.3.726; Lindstrom J, 2008, ANN NY ACAD SCI, V1132, P29, DOI 10.1196/annals.1405.007; Lindstrom J, 2012, ANN NY ACAD SCI, V1274, P9, DOI 10.1111/j.1749-6632.2012.06766.x; Marino M, 2014, J AUTOIMMUN, V52, P113, DOI 10.1016/j.jaut.2013.12.007; Meriggioli MN, 2012, EXPERT REV CLIN IMMU, V8, P427, DOI [10.1586/ECI.12.34, 10.1586/eci.12.34]; MOSSMAN S, 1988, J NEUROL SCI, V84, P15, DOI 10.1016/0022-510X(88)90170-0; NEWSOMDAVIS J, 1978, NEUROLOGY, V28, P266, DOI 10.1212/WNL.28.3.266; PATRICK J, 1973, SCIENCE, V180, P871, DOI 10.1126/science.180.4088.871; Ragheb S, 2005, J NEUROIMMUNOL, V159, P137, DOI 10.1016/j.jneuroim.2004.09.017; Sideris S, 2007, J NEUROIMMUNOL, V189, P111, DOI 10.1016/j.jneuroim.2007.06.014; TOYKA KV, 1975, SCIENCE, V190, P397, DOI 10.1126/science.1179220; TOYKA KV, 1977, NEW ENGL J MED, V296, P125, DOI 10.1056/NEJM197701202960301; TZARTOS S, 1987, J NEUROIMMUNOL, V15, P185, DOI 10.1016/0165-5728(87)90092-0; Tzartos S J, 1988, In Vivo, V2, P105; TZARTOS SJ, 1990, CLIN EXP IMMUNOL, V80, P376; TZARTOS SJ, 1982, P NATL ACAD SCI-BIOL, V79, P188, DOI 10.1073/pnas.79.1.188; Tzartos SJ, 1998, IMMUNOL REV, V163, P89, DOI 10.1111/j.1600-065X.1998.tb01190.x; Vernet-der Garabedian B, 1989, J NEUROIMMUNOL, V21, P41; Vincent A, 2001, LANCET, V357, P2122, DOI 10.1016/S0140-6736(00)05186-2; Zhang B, 2012, ARCH NEUROL-CHICAGO, V69, P445, DOI 10.1001/archneurol.2011.2393; Zisimopoulou P, 2014, J AUTOIMMUN, V52, P139, DOI 10.1016/j.jaut.2013.12.004; Zisimopoulou P, 2008, J NEUROIMMUNOL, V200, P133, DOI 10.1016/j.jneuroim.2008.06.002	40	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108327	10.1371/journal.pone.0108327	http://dx.doi.org/10.1371/journal.pone.0108327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259739	Green Published, gold			2022-12-27	WOS:000342685600064
J	Lee, S; Lee, K; Yoon, S; Lee, JW; Lee, D				Lee, Sunjae; Lee, KiYoung; Yoon, Seyeol; Lee, Jae W.; Lee, Doheon			Anomalies in Network Bridges Involved in Bile Acid Metabolism Predict Outcomes of Colorectal Cancer Patients	PLOS ONE			English	Article							SMALL HETERODIMER PARTNER; NUCLEAR RECEPTOR; COLON-CANCER; TUMOR; RISK; HOMEOSTASIS; EXPRESSION; SURVIVAL; MARKERS; MOUSE	Biomarkers prognostic for colorectal cancer (CRC) would be highly desirable in clinical practice. Proteins that regulate bile acid (BA) homeostasis, by linking metabolic sensors and metabolic enzymes, also called bridge proteins, may be reliable prognostic biomarkers for CRC. Based on a devised metric, "bridgeness,'' we identified bridge proteins involved in the regulation of BA homeostasis and identified their prognostic potentials. The expression patterns of these bridge proteins could distinguish between normal and diseased tissues, suggesting that these proteins are associated with CRC pathogenesis. Using a supervised classification system, we found that these bridge proteins were reproducibly prognostic, with high prognostic ability compared to other known markers.	[Lee, Sunjae; Yoon, Seyeol; Lee, Doheon] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Lee, KiYoung] Ajou Univ, Sch Med, Dept Med Informat, Suwon, South Korea; [Lee, Jae W.] Oregon Hlth & Sci Univ, Dept Pediat, Neurosci Sect, Pape Family Pediat Res Inst, Portland, OR 97201 USA	Korea Advanced Institute of Science & Technology (KAIST); Ajou University; Oregon Health & Science University	Lee, JW (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, Neurosci Sect, Pape Family Pediat Res Inst, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.	leejae@ohsu.edu; dhlee@kaist.ac.kr	Lee, Sunjae/H-9815-2019; Lee, Doheon/B-7303-2011	Lee, Sunjae/0000-0002-6428-5936; Lee, Doheon/0000-0001-9070-4316	NIH [DK064678]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A2A2A04013317]; Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A112022]; Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation [NRF-2012M3A9C4048758]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064678] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH (DK064678 to J.W.L.). K.L. was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A2A2A04013317). D.L. was supported by grants of the Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A112022); and also by the Bio-Synergy Research Project (NRF-2012M3A9C4048758) of the Ministry of Science, ICT and Future Planning through the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein C, 2011, ARCH TOXICOL, V85, P863, DOI 10.1007/s00204-011-0648-7; Bernstein H, 2009, WORLD J GASTROENTERO, V15, P3329, DOI 10.3748/wjg.15.3329; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chen N, 2011, CELL RES, V21, P983, DOI 10.1038/cr.2011.66; Chey WD, 2012, AM J GASTROENTEROL, V107, P140, DOI 10.1038/ajg.2011.379; Csardi ~ G, 2006, INTERJ COMP SYST, V1695; Davies RJ, 2005, NAT REV CANCER, V5, P199, DOI 10.1038/nrc1569; Ferley J, 2013, IARC CANCERBASE; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Guarani V, 2010, CURR OPIN PHARMACOL, V10, P139, DOI 10.1016/j.coph.2010.01.001; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Hall M., 2009, ACM SIGKDD EXPLOR; Hao T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-393; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Joensuu H, 2008, HUM PATHOL, V39, P1411, DOI 10.1016/j.humpath.2008.06.025; Kim DH, 2011, MOL ENDOCRINOL, V25, P2076, DOI 10.1210/me.2011-1198; Kim DH, 2011, P NATL ACAD SCI USA, V108, P12266, DOI 10.1073/pnas.1019678108; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakau M, 2002, CANCER RES, V62, P4549; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Schwarz M, 2001, J LIPID RES, V42, P1594; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thorgeirsson SS, 2003, HEPATOLOGY, V37, P739, DOI 10.1053/jhep.2003.50174; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang YX, 2004, J CLIN ONCOL, V22, P1564, DOI 10.1200/JCO.2004.08.186; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wertheim BC, 2012, CANCER PREV RES, V5, P197, DOI 10.1158/1940-6207.CAPR-11-0320; WILLETT WC, 1990, NEW ENGL J MED, V323, P1664, DOI 10.1056/NEJM199012133232404; Xulvi-Brunet R, 2010, BIOINFORMATICS, V26, P205, DOI 10.1093/bioinformatics/btp632	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107925	10.1371/journal.pone.0107925	http://dx.doi.org/10.1371/journal.pone.0107925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259881	gold, Green Published, Green Submitted			2022-12-27	WOS:000342685600035
J	Edvardsen, RB; Leininger, S; Kleppe, L; Skaftnesmo, KO; Wargelius, A				Edvardsen, Rolf B.; Leininger, Sven; Kleppe, Lene; Skaftnesmo, Kai Ove; Wargelius, Anna			Targeted Mutagenesis in Atlantic Salmon (Salmo salar L.) Using the CRISPR/Cas9 System Induces Complete Knockout Individuals in the F0 Generation	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; RAINBOW-TROUT; OCULOCUTANEOUS ALBINISM; XENOPUS-TROPICALIS; TYROSINASE GENE; IMMUNE-SYSTEM; FISH EMBRYOS; MEDAKA FISH; ZEBRAFISH; GENOME	Understanding the biological function behind key proteins is of great concern in Atlantic salmon, both due to a high commercial importance and an interesting life history. Until recently, functional studies in salmonids appeared to be difficult. However, the recent discovery of targeted mutagenesis using the CRISPR/Cas9 (clustered regularly interspaced palindromic repeats/CRISPR-associated) system enables performing functional studies in Atlantic salmon to a great extent. We used the CRISPR/Cas9 system to target two genes involved in pigmentation, tyrosinase (tyr) and solute carrier family 45, member 2 (slc45a2). Embryos were assayed for mutation rates at the 17 somite stage, where 40 and 22% of all injected embryos showed a high degree of mutation induction for slc45a2 and tyr, respectively. At hatching this mutation frequency was also visible for both targeted genes, displaying a graded phenotype ranging from complete lack of pigmentation to partial loss and normal pigmentation. CRISPRslc45a2/Cas9 injected embryos showing a complete lack of pigmentation or just a few spots of pigments also lacked wild type sequences when assaying more than 80 (slc45a2) sequence clones from whole embryos. This indicates that CRISPR/Cas9 can induce double-allelic knockout in the F0 generation. However, types and frequency of indels might affect the phenotype. Therefore, the variation of indels was assayed in the graded pigmentation phenotypes produced by CRISPR/Cas9-slc45a2. The results show a tendency for fewer types of indels formed in juveniles completely lacking pigmentation compared to juveniles displaying partial pigmentation. Another interesting observation was a high degree of the same indel type in different juveniles. This study shows for the first time successful use of the CRISPR/Cas9 technology in a marine cold water species. Targeted double-allelic mutations were obtained and, though the level of mosaicism has to be considered, we demonstrate that F0 fish can be used for functional studies in Atlantic salmon.	[Edvardsen, Rolf B.; Leininger, Sven; Kleppe, Lene; Skaftnesmo, Kai Ove; Wargelius, Anna] Inst Marine Res, N-5024 Bergen, Norway	Institute of Marine Research - Norway	Wargelius, A (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	anna.wargelius@imr.no	Skaftnesmo, kai ove/AAF-6071-2021; Kleppe, Lene/AGH-3308-2022	Edvardsen, Rolf/0000-0001-8430-8042	Norwegian Research Council [221648/O30]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The project was supported by the Norwegian Research Council (http://www.forskningsradet.no), project number 221648/O30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Boonanuntanasarn S, 2005, BIOCHEM BIOPH RES CO, V336, P438, DOI 10.1016/j.bbrc.2005.08.113; Boonanuntanasarn S, 2004, PIGM CELL RES, V17, P413, DOI 10.1111/j.1600-0749.2004.00166.x; Boonanuntanasarn S, 2003, BIOCHEM BIOPH RES CO, V310, P1089, DOI 10.1016/j.bbrc.2003.09.127; Boonanuntanasarn S, 2002, MAR BIOTECHNOL, V4, P256, DOI 10.1007/s10126-002-0017-x; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; Dong ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028897; Dooley CM, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12053; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fukamachi S, 2008, GENETICS, V178, P761, DOI 10.1534/genetics.107.073387; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gorodilov YN, 1996, ENVIRON BIOL FISH, V47, P109, DOI 10.1007/BF00005034; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Iida A, 2004, PIGM CELL RES, V17, P158, DOI 10.1046/j.1600-0749.2003.00122.x; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koga A, 1999, PIGM CELL RES, V12, P252, DOI 10.1111/j.1600-0749.1999.tb00758.x; Li M, 2014, GENETICS; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Page-McCaw PS, 2004, NAT NEUROSCI, V7, P1329, DOI 10.1038/nn1344; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yano A, 2013, EVOL APPL, V6, P486, DOI 10.1111/eva.12032; Yoshizaki G, 2000, INT J DEV BIOL, V44, P323	32	106	117	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108622	10.1371/journal.pone.0108622	http://dx.doi.org/10.1371/journal.pone.0108622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254960	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000344862300099
J	Aldini, R; Micucci, M; Cevenini, M; Fato, R; Bergamini, C; Nanni, C; Cont, M; Camborata, C; Spinozzi, S; Montagnani, M; Roda, G; D'Errico-Grigioni, A; Rosini, F; Roda, A; Mazzella, G; Chiarini, A; Budriesi, R				Aldini, Rita; Micucci, Matteo; Cevenini, Monica; Fato, Romana; Bergamini, Christian; Nanni, Cristina; Cont, Massimiliano; Camborata, Cecilia; Spinozzi, Silvia; Montagnani, Marco; Roda, Giulia; D'Errico-Grigioni, Antonia; Rosini, Francesca; Roda, Aldo; Mazzella, Giuseppe; Chiarini, Alberto; Budriesi, Roberta			Antiinflammatory Effect of Phytosterols in Experimental Murine Colitis Model: Prevention, Induction, Remission Study	PLOS ONE			English	Article							NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; SULFATE-INDUCED COLITIS; BETA-SITOSTEROL; PLANT STEROLS; IN-VITRO; CHOLESTEROL-METABOLISM; PENTACYCLIC TRITERPENE; MUSCARINIC RECEPTORS; PROTIUM-HEPTAPHYLLUM	Phytosterols, besides hypocholesterolemic effect, present anti-inflammatory properties. Little information is available about their efficacy in Inflammatory Bowel Disease (IBD). Therefore, we have evaluated the effect of a mixture of phytosterols on prevention/induction/remission in a murine experimental model of colitis. Phytosterols were administered x os before, during and after colitis induction with Dextran Sodium Sulfate (DSS) in mice. Disease Activity Index (DAI), colon length, histopathology score, F-18-FDG microPET, oxidative stress in the intestinal tissue (ileum and colon) and gallbladder ileum and colon spontaneous and carbachol (CCh) induced motility, plasma lipids and plasma, liver and biliary bile acids (BA) were evaluated. A similar longitudinal study was performed in a DSS colitis control group. Mice treated with DSS developed severe colitis as shown by DAI, colon length, histopathology score, F-18-FDG microPET, oxidative stress. Both spontaneous and induced ileal and colonic motility were severely disturbed. The same was observed with gallbladder. DSS colitis resulted in an increase in plasma cholesterol, and a modification of the BA pattern. Phytosterols feeding did not prevent colitis onset but significantly reduced the severity of the disease and improved clinical and histological remission. It had strong antioxidant effects, almost restored colon, ileal and gallbladder motility. Plasmatic levels of cholesterol were also reduced. DSS induced a modification in the BA pattern consistent with an increase in the intestinal BA deconjugating bacteria, prevented by phytosterols. Phytosterols seem a potential nutraceutical tool for gastrointestinal inflammatory diseases, combining metabolic systematic and local anti-inflammatory effects.	[Aldini, Rita; Micucci, Matteo; Fato, Romana; Bergamini, Christian; Chiarini, Alberto; Budriesi, Roberta] Univ Bologna, Dept Pharm & Biotecnol, Bologna, Italy; [Cevenini, Monica; Montagnani, Marco; Roda, Giulia; Mazzella, Giuseppe] Univ Bologna, Dept Med & Surg, Policlin S Orsola, Bologna, Italy; [Nanni, Cristina; Cont, Massimiliano] Univ Bologna, Dept Nucl Med, Azienda Osped, Policlin S Orsola Malpighi, Bologna, Italy; [Camborata, Cecilia; Spinozzi, Silvia; Roda, Aldo] Univ Bologna, Dept Chem Giacomo Ciamician, Bologna, Italy; [D'Errico-Grigioni, Antonia; Rosini, Francesca] Univ Bologna, DIMES Dept, Policlin S Orsola, Bologna, Italy	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Aldini, R (corresponding author), Univ Bologna, Dept Pharm & Biotecnol, Bologna, Italy.	rita.aldini@unibo.it; roberta.budriesi@unibo.it	mazzella, giuseppe/A-1865-2016; Micucci, Matteo/AAM-6126-2020; NANNI, CRISTINA/AAS-1757-2021; Roda, Giulia/E-5521-2011	Roda, Aldo/0000-0001-7649-4797; Mazzella, Giuseppe/0000-0001-8656-8112; MONTAGNANI, MARCO/0000-0003-0103-0327; MICUCCI, MATTEO/0000-0003-3525-1531; Nanni, Cristina/0000-0003-2000-1599; D'ERRICO, ANTONIETTA/0000-0003-2747-3732	Alisal [Mazz100136- 2010]; Ministero delle Politiche Agricole, Alimentari e Forestali [D.M. 11008/7303/10]	Alisal; Ministero delle Politiche Agricole, Alimentari e Forestali	This work was supported by Alisal (Mazz100136- 2010). ALISAL is a project supported by the Ministero delle Politiche Agricole, Alimentari e Forestali, with D.M 11008/7303/10, dated 17/05/2010. The title of the project is: Miglioramento delle proprieta igienico-sanitarie, salutistiche e funzionali di commodity per l'alimentazione dell'uomo e/o degli animali (Improvement of sanitary properties, healthy and functional food commodities for human and/or animals). Prof. Mazzella was supported with materials, reagents, animals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldini R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044650; [Anonymous], GRAPHPAD VERS 5 0; Aragao Gislei Frota, 2007, Journal of Herbal Pharmacotherapy, V7, P31, DOI [10.1080/J157v07n02_03, 10.1300/J157v07n02_03]; Ardizzone S, 2005, DRUGS, V65, P2253, DOI 10.2165/00003495-200565160-00002; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Bak MJ, 2012, MOLECULES, V17, P13769, DOI 10.3390/molecules171213769; Baskar AA, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-24; Baskar AA, 2012, J MED FOOD, V15, P335, DOI 10.1089/jmf.2011.1780; Brewer S, 2008, GASTROENTEROLOGY, V135, P744, DOI 10.1053/j.gastro.2008.06.040; Brufau G, 2008, NUTR RES, V28, P217, DOI 10.1016/j.nutres.2008.02.003; Buege J A, 1978, Methods Enzymol, V52, P302; Calpe-Berdiel L, 2007, LIFE SCI, V80, P1951, DOI 10.1016/j.lfs.2007.02.032; Cheon JH, 2006, INFLAMM BOWEL DIS, V12, P1152, DOI 10.1097/01.mib.0000235830.94057.c6; Choi M, 2006, NAT MED, V12, P1253, DOI 10.1038/nm1501; De Jong A, 2008, EUR J CLIN NUTR, V62, P263, DOI 10.1038/sj.ejcn.1602733; de Jong A, 2003, J NUTR BIOCHEM, V14, P362, DOI 10.1016/S0955-2863(03)00002-0; De Smet E, 2012, MOL NUTR FOOD RES, V56, P1058, DOI 10.1002/mnfr.201100722; Demonty I, 2005, LIPIDS, V40, P695, DOI 10.1007/s11745-005-1432-y; Durkee BY, 2010, METHODS, V50, P36, DOI 10.1016/j.ymeth.2009.07.008; Fenoglio-Preiser CM, 2008, GASTROINTESTINAL PAT, P64; Fitzpatrick LR, 2000, DIGEST DIS SCI, V45, P2327, DOI 10.1023/A:1005630723111; Gilani AH, 2008, FUND CLIN PHARMACOL, V22, P87, DOI 10.1111/j.1472-8206.2007.00561.x; GROSSI L, 1993, GASTROENTEROLOGY, V104, P1049, DOI 10.1016/0016-5085(93)90273-F; Hac-Wydro K, 2013, COLLOID SURFACE B, V110, P113, DOI 10.1016/j.colsurfb.2013.04.041; Hallikainen M, 2008, ATHEROSCLEROSIS, V199, P432, DOI 10.1016/j.atherosclerosis.2007.10.033; Heylen M, 2013, INFLAMM BOWEL DIS, V19, P967, DOI 10.1097/MIB.0b013e3182802c7c; Hindryckx P, 2011, INFLAMM BOWEL DIS, V17, P2058, DOI 10.1002/ibd.21578; Hirota CL, 2006, BRIT J PHARMACOL, V149, P463, DOI 10.1038/sj.bjp.0706889; Hokama A, 2012, INTERN EMERG MED, V7, P487, DOI 10.1007/s11739-012-0834-5; Hur SJ, 2012, NUTR RES, V32, P801, DOI 10.1016/j.nutres.2012.09.013; Islam MS, 2008, BRIT J PHARMACOL, V154, P812, DOI 10.1038/bjp.2008.137; KERR PM, 1995, BRIT J PHARMACOL, V115, P1518, DOI 10.1111/j.1476-5381.1995.tb16645.x; Khan MRI, 2014, BBA-MOL BASIS DIS, V1842, P635, DOI 10.1016/j.bbadis.2013.12.007; Khan MRI, 2013, J GASTROENTEROL, V48, P885, DOI 10.1007/s00535-012-0718-5; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Kim JM, 2010, LAB INVEST, V90, P1004, DOI 10.1038/labinvest.2010.54; Ko JK, 2014, CURR PHARM DESIGN, V20, P1082, DOI 10.2174/13816128113199990416; Lavoie B, 2010, J PHYSIOL-LONDON, V588, P3295, DOI 10.1113/jphysiol.2010.192146; Lee IA, 2012, PLANTA MED, V78, P896, DOI 10.1055/s-0031-1298486; Li TT, 2011, MOL ENDOCRINOL, V25, P1066, DOI 10.1210/me.2010-0460; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liz R, 2013, J PHARM PHARMACOL, V65, P115, DOI 10.1111/j.2042-7158.2012.01568.x; Liz R, 2011, INT IMMUNOPHARMACOL, V11, P1991, DOI 10.1016/j.intimp.2011.08.009; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Manz M, 2012, DIGESTION, V86, P11, DOI 10.1159/000341952; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Medeiros R, 2007, EUR J PHARMACOL, V559, P227, DOI 10.1016/j.ejphar.2006.12.005; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Micucci M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080925; Moghadasian MH, 2000, LIFE SCI, V67, P605, DOI 10.1016/S0024-3205(00)00665-2; Moreau RA, 2002, PROG LIPID RES, V41, P457, DOI 10.1016/S0163-7827(02)00006-1; Moreno JJ, 2003, FREE RADICAL BIO MED, V35, P1073, DOI 10.1016/S0891-5849(03)00465-9; Naito Y, 2000, TOXICOL LETT, V116, P209, DOI 10.1016/S0378-4274(00)00224-1; O'Hara JR, 2007, GUT, V56, P186, DOI 10.1136/gut.2006.102780; Ostlund RE, 2002, ANNU REV NUTR, V22, P533, DOI 10.1146/annurev.nutr.22.020702.075220; Ostlund Richard E Jr, 2006, Curr Atheroscler Rep, V8, P487, DOI 10.1007/s11883-006-0024-x; Othman RA, 2011, NUTR REV, V69, P371, DOI 10.1111/j.1753-4887.2011.00399.x; Perlman SB, 2013, SEMIN NUCL MED, V43, P420, DOI 10.1053/j.semnuclmed.2013.06.006; Pinto S. A. Holanda, 2008, Inflammopharmacology, V16, P48, DOI 10.1007/s10787-007-1609-x; Plat J, 2000, EUR J CLIN NUTR, V54, P671, DOI 10.1038/sj.ejcn.1601071; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; RODA A, 1995, J CHROMATOGR B, V665, P281, DOI 10.1016/0378-4347(94)00544-F; Shi XZ, 2011, AM J PHYSIOL-GASTR L, V300, pG41, DOI 10.1152/ajpgi.00358.2010; Shishodia S, 2004, J BIOL CHEM, V279, P47148, DOI 10.1074/jbc.M408093200; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; TAKADA M, 1984, METHOD ENZYMOL, V105, P147; TALLARIDA RJ, 1987, MANUAL PHARM CALCULA; Vaughn Byron P, 2014, Curr Treat Options Gastroenterol, V12, P103, DOI 10.1007/s11938-013-0008-1; Villanacci V, 2008, NEUROGASTROENT MOTIL, V20, P1009, DOI 10.1111/j.1365-2982.2008.01146.x; Villasenor IM, 2002, PHYTOTHER RES, V16, P417, DOI 10.1002/ptr.910; Vitor CE, 2009, BRIT J PHARMACOL, V157, P1034, DOI 10.1111/j.1476-5381.2009.00271.x; Waldner MJ, 2009, CURR PROTOC PHARM, V46; Wells RW, 2004, PFLUG ARCH EUR J PHY, V448, P515, DOI 10.1007/s00424-004-1286-1; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41	75	74	79	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108112	10.1371/journal.pone.0108112	http://dx.doi.org/10.1371/journal.pone.0108112			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268769	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700064
J	Choudhury, S; Bae, S; Ke, QG; Lee, JY; Singh, SS; St-Arnaud, R; del Monte, F; Kang, PM				Choudhury, Sangita; Bae, Soochan; Ke, Qingen; Lee, Ji Yoo; Singh, Sylvia S.; St-Arnaud, Rene; del Monte, Federica; Kang, Peter M.			Abnormal Calcium Handling and Exaggerated Cardiac Dysfunction in Mice with Defective Vitamin D Signaling	PLOS ONE			English	Article							D-DEFICIENCY RICKETS; HEART-FAILURE; CARDIOVASCULAR-DISEASE; 1,25-DIHYDROXYVITAMIN D-3; KNOCKOUT MICE; D-RECEPTOR; HYPERTROPHY; HEMODIALYSIS; SURVIVAL; THERAPY	Aim: Altered vitamin D signaling is associated with cardiac dysfunction, but the pathogenic mechanism is not clearly understood. We examine the mechanism and the role of vitamin D signaling in the development of cardiac dysfunction. Methods and Results: We analyzed 1 alpha-hydroxylase (1 alpha-OHase) knockout (1 alpha-OHase(-/-)) mice, which lack 1 alpha-OH enzymes that convert the inactive form to hormonally active form of vitamin D. 1 alpha-OHase(-/-) mice showed modest cardiac hypertrophy at baseline. Induction of pressure overload by transverse aortic constriction (TAC) demonstrated exaggerated cardiac dysfunction in 1 alpha-OHase(-/-) mice compared to their WT littermates with a significant increase in fibrosis and expression of inflammatory cytokines. Analysis of calcium (Ca2+) transient demonstrated profound Ca2+ handling abnormalities in 1 alpha-OHase(-/-) mouse cardiomyocytes (CMs), and treatment with paricalcitol (PC), an activated vitamin D-3 analog, significantly attenuated defective Ca2+ handling in 1 alpha-OHase(-/-) CMs. We further delineated the effect of vitamin D deficiency condition to TAC by first correcting the vitamin D deficiency in 1 alpha-OHase(-/-) mice, followed then by either a daily maintenance dose of vitamin D or vehicle (to achieve vitamin D deficiency) at the time of sham or TAC. In mice treated with vitamin D, there was a significant attenuation of TAC-induced cardiac hypertrophy, interstitial fibrosis, inflammatory markers, Ca2+ handling abnormalities and cardiac function compared to the vehicle treated animals. Conclusions: Our results provide insight into the mechanism of cardiac dysfunction, which is associated with severely defective Ca2+ handling and defective vitamin D signaling in 1 alpha-OHase(-/-) mice.	[Choudhury, Sangita; Bae, Soochan; Ke, Qingen; Lee, Ji Yoo; Singh, Sylvia S.; del Monte, Federica; Kang, Peter M.] Beth Israel Deaconess Med Ctr, Cardiovasc Inst, Boston, MA 02215 USA; [Choudhury, Sangita; Bae, Soochan; Ke, Qingen; Lee, Ji Yoo; Singh, Sylvia S.; del Monte, Federica; Kang, Peter M.] Harvard Univ, Sch Med, Boston, MA USA; [St-Arnaud, Rene] McGill Univ, Shriners Hosp, Montreal, PQ, Canada; [St-Arnaud, Rene] McGill Univ, Dept Surg & Human Genet, Montreal, PQ, Canada	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; McGill University; McGill University	Kang, PM (corresponding author), Beth Israel Deaconess Med Ctr, Cardiovasc Inst, Boston, MA 02215 USA.	pkang@bidmc.harvard.edu	del Monte, Federica/AAB-3982-2019; del Monte, Federica/AAF-3961-2020	del Monte, Federica/0000-0001-9506-9665	NIH [R01 HL65742]; World Class University program from the Ministry of Education, Science and Technology, South Korea [R31-20029]; Shriners Hospitals for Children, Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065742] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class University program from the Ministry of Education, Science and Technology, South Korea; Shriners Hospitals for Children, Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by NIH Grants R01 HL65742 (P.M.K.) and the World Class University program (R31-20029) from the Ministry of Education, Science and Technology, South Korea (P.M.K.). Support for generating the 1 alpha-OHase -/- mice was provided by a grant from Shriners Hospitals for Children, Canada (R.St-A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Bae S, 2011, CARDIOVASC RES, V91, P632, DOI 10.1093/cvr/cvr133; Bae S, 2010, AM J PHYSIOL-HEART C, V299, pH1374, DOI 10.1152/ajpheart.00168.2010; BASSANI JWM, 1995, BIOPHYS J, V68, P1453, DOI 10.1016/S0006-3495(95)80318-8; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; Bodyak N, 2007, P NATL ACAD SCI USA, V104, P16810, DOI 10.1073/pnas.0611202104; Chen S, 2008, HYPERTENSION, V52, P1106, DOI 10.1161/HYPERTENSIONAHA.108.119602; Chien KR, 2003, NAT MED, V9, P508, DOI 10.1038/nm0503-508; Choudhury S, 2011, BASIC RES CARDIOL, V106, P397, DOI 10.1007/s00395-011-0164-1; Dardenne O, 2003, J BONE MINER RES, V18, P637, DOI 10.1359/jbmr.2003.18.4.637; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; del Monte F, 2008, HEART FAIL REV, V13, P151, DOI 10.1007/s10741-007-9071-9; Demay MB, 2006, ANN NY ACAD SCI, V1068, P204, DOI 10.1196/annals.1346.026; Di Rosa M, 2011, IMMUNOLOGY, V134, P123, DOI 10.1111/j.1365-2567.2011.03482.x; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Gotsman I, 2012, EUR J HEART FAIL, V14, P357, DOI 10.1093/eurjhf/hfr175; Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kubo H, 2001, CIRCULATION, V104, P1012, DOI 10.1161/hc3401.095073; Lee W, 2010, CURR OPIN INVEST DR, V11, P309; McCullough PA, 2007, ARCH INTERN MED, V167, P1122, DOI 10.1001/archinte.167.11.1122; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; MORGAN JP, 1991, NEW ENGL J MED, V325, P625; Park CW, 1999, AM J KIDNEY DIS, V33, P73, DOI 10.1016/S0272-6386(99)70260-X; PERREAULT CL, 1992, J CLIN INVEST, V89, P932, DOI 10.1172/JCI115674; PIESKE B, 1995, CIRCULATION, V92, P1169, DOI 10.1161/01.CIR.92.5.1169; Pilz S, 2011, CLIN ENDOCRINOL, V75, P575, DOI 10.1111/j.1365-2265.2011.04147.x; Rigor DL, 2009, AM J PHYSIOL-HEART C, V296, pH566, DOI 10.1152/ajpheart.00562.2008; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Vacek JL, 2012, AM J CARDIOL, V109, P359, DOI 10.1016/j.amjcard.2011.09.020; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Xiang W, 2005, AM J PHYSIOL-ENDOC M, V288, pE125, DOI 10.1152/ajpendo.00224.2004; Xue YB, 2005, HUM MOL GENET, V14, P1515, DOI 10.1093/hmg/ddi160; Zhou CL, 2008, KIDNEY INT, V74, P170, DOI 10.1038/ki.2008.101; Zittermann A, 2006, PROG BIOPHYS MOL BIO, V92, P39, DOI 10.1016/j.pbiomolbio.2006.02.001	41	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108382	10.1371/journal.pone.0108382	http://dx.doi.org/10.1371/journal.pone.0108382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268137	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700088
J	Rai, V; Yadav, U; Kumar, P; Yadav, SK; Mishra, OP				Rai, Vandana; Yadav, Upendra; Kumar, Pradeep; Yadav, Sushil Kumar; Mishra, Om Prakesh			Maternal Methylenetetrahydrofolate Reductase C677T Polymorphism and Down Syndrome Risk: A Meta-Analysis from 34 Studies	PLOS ONE			English	Article							FOLATE-METABOLIZING GENES; HOMOCYSTEINE METABOLISM; SYNDROME PREGNANCIES; CHROMOSOME-DAMAGE; VASCULAR-DISEASE; COMMON MUTATION; MTHFR C677T; HYPOMETHYLATION; ASSOCIATION; DEFICIENCY	Background: Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme of folate metabolic pathway which catalyzes the irreversible conversion of 5, 10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. 5-methyltetrahydrofolate donates methyl group for the methylation of homocysteine to methionine. Several studies have investigated maternal MTHFR C677T polymorphism as a risk factor for DS, but the results were controversial and inconclusive. To come into a conclusive estimate, authors performed a meta-analysis. Aim: A meta-analysis of published case control studies was performed to investigate the association between maternal MTHFR C677T polymorphism and Down syndrome. Methods: PubMed, Google Scholar, Elsevier, Springer Link databases were searched to select the eligible case control studies using appropriate keywords. The pooled odds ratio (OR) with 95% confidence interval were calculated for risk assessment. Results: Thirty four studies with 3,098 DS case mothers and 4,852 control mothers were included in the present meta-analysis. The pooled OR was estimated under five genetic models and significant association was found between maternal MTHFR 677C>T polymorphism and Down syndrome under four genetic models except recessive model (for T vs. C, OR = 1.26, 95% CI = 1.09-1.46, p = 0.001; for TT vs. CC, OR = 1.49, 95% CI = 1.13-1.97, p = 0.008; for CT vs. CC, OR = 1.29, 95% CI = 1.10-1.51, p = 0.001; for TT+CT vs. CC, OR = 1.35, 95% CI = 1.13-1.60, p = 0.0008; for TT vs. CT+CC, OR = 0.76, 95% CI = 0.60-0.94, p = 0.01). Conclusion: The results of the present meta-analysis support that maternal MTHFR C677T polymorphism is a risk factor for DS-affected pregnancy.	[Rai, Vandana; Yadav, Upendra; Kumar, Pradeep; Yadav, Sushil Kumar] VBS Purvanchal Univ, Dept Biotechnol, Human Mol Genet Lab, Jaunpur, India; [Mishra, Om Prakesh] Banaras Hindu Univ, Inst Med Sci, Dept Pediat, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Rai, V (corresponding author), VBS Purvanchal Univ, Dept Biotechnol, Human Mol Genet Lab, Jaunpur, India.	raivandana@rediffmail.com	Kumar, Pradeep/V-4100-2019; Kumar, Pradeep/W-8364-2019; Yadav, Upendra/J-7872-2013; Rai, Vandana/H-1463-2017	Kumar, Pradeep/0000-0002-0695-1996; Yadav, Upendra/0000-0003-2469-8071; Rai, Vandana/0000-0001-8590-9675				Acacio GL, 2005, PRENATAL DIAG, V25, P1196, DOI 10.1002/pd.1296; Bagley PJ, 1998, P NATL ACAD SCI USA, V95, P13217, DOI 10.1073/pnas.95.22.13217; BALAGHI M, 1993, BIOCHEM BIOPH RES CO, V193, P1184, DOI 10.1006/bbrc.1993.1750; Bax Leon, 2006, BMC Med Res Methodol, V6, P50, DOI 10.1186/1471-2288-6-50; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benes P, 2001, MOL GENET METAB, V73, P188, DOI 10.1006/mgme.2001.3188; Biselli JM, 2008, GENET MOL RES, V7, P33, DOI 10.4238/vol7-1gmr388; Blanton SH, 2011, BIRTH DEFECTS RES A, V91, P50, DOI 10.1002/bdra.20740; Boduroglu K, 2004, AM J MED GENET A, V127A, P5, DOI 10.1002/ajmg.a.20432; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Bozovic IB, 2011, PEDIATR INT, V53, P546, DOI 10.1111/j.1442-200X.2010.03310.x; Brattstrom L, 1998, CIRCULATION, V98, P2520, DOI 10.1161/01.CIR.98.23.2520; Brandalize APC, 2009, AM J MED GENET A, V149A, P2080, DOI 10.1002/ajmg.a.32989; Chadefaux-Vekemans B, 2002, PEDIATR RES, V51, P766, DOI 10.1203/01.PDR.0000017484.64723.43; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Clark MF, 2006, INTENS CARE MED, V32, P1706, DOI 10.1007/s00134-006-0327-y; Coppede F, 2006, AM J MED GENET A, V140A, P1083, DOI 10.1002/ajmg.a.31217; Coppede F, 2009, NEUROSCI LETT, V449, P15, DOI 10.1016/j.neulet.2008.10.074; Coppede F, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-42; Cyril Cyrus, 2009, Indian J Hum Genet, V15, P60, DOI 10.4103/0971-6866.55217; da Silva LRJ, 2005, AM J MED GENET A, V135A, P263, DOI 10.1002/ajmg.a.30591; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elsayed GM, 2013, EGYPTIAN J MED HUM G, V15, P39; Fenech M, 2001, MUTAT RES-FUND MOL M, V475, P57, DOI 10.1016/S0027-5107(01)00079-3; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Hobbs CA, 2000, AM J HUM GENET, V67, P623, DOI 10.1086/303055; Hua Y, 2011, INT J NEUROSCI, V121, P462, DOI 10.3109/00207454.2011.578778; James SJ, 2002, J NUTR, V132, p2361S, DOI 10.1093/jn/132.8.2361S; James SJ, 1999, AM J CLIN NUTR, V70, P495; Jonsson EG, 2008, AM J MED GENET B, V147B, P976, DOI 10.1002/ajmg.b.30671; Kaur Anupam, 2013, Indian J Hum Genet, V19, P412, DOI 10.4103/0971-6866.124368; Kohli Utkarsh, 2008, Downs Syndr Res Pract, V12, P133, DOI 10.3104/reports.2004; Kokotas H, 2009, DIS MARKERS, V27, P279, DOI [10.1155/2009/725614, 10.3233/DMA-2009-0673]; LEYTON C, 1995, CELL PROLIFERAT, V28, P481, DOI 10.1111/j.1365-2184.1995.tb00087.x; Liang X, 2005, CHINA J MODERN MED, V20; Liao Ya-Ping, 2010, Yichuan, V32, P461, DOI 10.3724/SP.J.1005.2010.00461; LIBBUS BL, 1990, CANCER GENET CYTOGEN, V46, P231, DOI 10.1016/0165-4608(90)90108-M; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martinez-Frias ML, 2008, AM J MED GENET A, V146A, P1477, DOI 10.1002/ajmg.a.32308; Medica I, 2009, CENT EUR J MED, V4, P395, DOI 10.2478/s11536-009-0055-0; Meguid NA, 2008, DIS MARKERS, V24, P19, DOI 10.1155/2008/214027; O'Leary VB, 2002, AM J MED GENET, V107, P151, DOI 10.1002/ajmg.10121; Pandey SK, 2013, INT J PHARM BIO SCI, V4, P249; Parry EM, 2002, MUTAGENESIS, V17, P509, DOI 10.1093/mutage/17.6.509; Peerbooms OLJ, 2011, BRAIN BEHAV IMMUN, V25, P1530, DOI 10.1016/j.bbi.2010.12.006; Pogribna M, 2001, AM J HUM GENET, V69, P88, DOI 10.1086/321262; Pogribny IP, 2004, MUTAT RES-FUND MOL M, V548, P53, DOI 10.1016/j.mrfmmm.2003.12.014; POGRIBNY IP, 1995, CANCER RES, V55, P1894; Pozzi E, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.046; Rai AK, 2006, J HUM GENET, V51, P278, DOI 10.1007/s10038-005-0356-3; Sadiq MF, 2011, GENET TEST MOL BIOMA, V15, P51, DOI 10.1089/gtmb.2010.0057; Santos-Reboucas CB, 2008, DIS MARKERS, V25, P149, DOI 10.1155/2008/487023; Scala I, 2006, GENET MED, V8, P409, DOI 10.1097/01.gim.0000228206.21793.82; Stuppia L, 2002, EUR J HUM GENET, V10, P388, DOI 10.1038/sj.ejhg.5200819; Tayeb M. T., 2012, EGYPT J MED HUM GENE, V13, P263, DOI [10.1016/j.ejmhg.2012.04.003, DOI 10.1016/J.EJMHG.2012.04.003]; Titenko-Holland N, 1998, MUTAT RES-GEN TOX EN, V417, P101, DOI 10.1016/S1383-5718(98)00104-1; vanderPut NMJ, 1997, QJM-MON J ASSOC PHYS, V90, P111, DOI 10.1093/qjmed/90.2.111; Vranekovic J, 2010, DIS MARKERS, V28, P293, DOI 10.3233/DMA-2010-0704; Wang SS, 2008, J ZHEJIANG UNIV-SC B, V9, P93, DOI 10.1631/jzus.B0710599; Wang Wen, 2007, Zhonghua Yixue Yichuanxue Zazhi, V24, P533; Wu XM, 2013, EUR J OBSTET GYN R B, V167, P154, DOI 10.1016/j.ejogrb.2012.11.022; Yadav S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057305; Yadav U, 2015, METAB BRAIN DIS, V30, P7, DOI 10.1007/s11011-014-9575-7; Yang M, 2013, MUTAGENESIS, V28, P661, DOI 10.1093/mutage/get045; Zampieri BL, 2012, DIS MARKERS, V32, P73, DOI [10.3233/DMA-2011-0869, 10.1155/2012/693864]; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059570; Zhao MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088242; Zintzaras E, 2007, J HUM GENET, V52, P943, DOI 10.1007/s10038-007-0202-x	69	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108552	10.1371/journal.pone.0108552	http://dx.doi.org/10.1371/journal.pone.0108552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265565	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400087
J	Wang, XH; Yu, HJ; Xu, LL; Zhu, TG; Zheng, F; Fu, CH; Wang, ZY; Dou, Z				Wang, Xinghui; Yu, Huijuan; Xu, Leilei; Zhu, Tongge; Zheng, Fan; Fu, Chuanhai; Wang, Zhiyong; Dou, Zhen			Dynamic Autophosphorylation of Mps1 Kinase Is Required for Faithful Mitotic Progression	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; PROTEIN FUNCTION; CELL-DIVISION; HELA-CELLS; PHOSPHORYLATION; MITOSIS; LOCALIZATION; ACTIVATION; BUBR1; PHOSPHOREGULATION	The spindle assembly checkpoint (SAC) is a surveillance mechanism monitoring cell cycle progression, thus ensuring accurate chromosome segregation. The conserved mitotic kinase Mps1 is a key component of the SAC. The human Mps1 exhibits comprehensive phosphorylation during mitosis. However, the related biological relevance is largely unknown. Here, we demonstrate that 8 autophosphorylation sites within the N-terminus of Mps1, outside of the catalytic domain, are involved in regulating Mps1 kinetochore localization. The phospho-mimicking mutant of the 8 autophosphorylation sites impairs Mps1 localization to kinetochore and also affects the kinetochore recruitment of BubR1 and Mad2, two key SAC effectors, subsequently leading to chromosome segregation errors. Interestingly, the non-phosphorylatable mutant of the 8 autophosphorylation sites enhances Mps1 kinetochore localization and delays anaphase onset. We further show that the Mps1 phospho-mimicking and non-phosphorylatable mutants do not affect metaphase chromosome congression. Thus, our results highlight the importance of dynamic autophosphorylation of Mps1 in regulating accurate chromosome segregation and ensuring proper mitotic progression.	[Wang, Xinghui; Yu, Huijuan; Xu, Leilei; Zhu, Tongge; Wang, Zhiyong; Dou, Zhen] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Wang, Xinghui; Yu, Huijuan; Xu, Leilei; Zhu, Tongge; Wang, Zhiyong; Dou, Zhen] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230026, Peoples R China; [Zheng, Fan; Fu, Chuanhai] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Zheng, Fan; Fu, Chuanhai] Univ Hong Kong, HKU Shenzhen Inst Res & Innovat, Shenzhen, Peoples R China; [Wang, Zhiyong] Univ Sci & Technol China, Hefei 230026, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Hong Kong; University of Hong Kong; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Dou, Z (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.	douzhen@ustc.edu.cn	Wang, Zhiyong/F-7955-2010; Zheng, Fan/GNM-9399-2022; Fu, Chuanhai/G-8303-2016; DOU, ZHEN/N-2022-2013	Zheng, Fan/0000-0001-7005-0941; Fu, Chuanhai/0000-0003-4354-3796; DOU, ZHEN/0000-0003-3303-9393	Chinese 973 Project [2013CB911203, 2012CB945002, 2012CB917204]; Chinese Natural Science Foundation [31071184, 31371363, 31271439, 31301109]; Hong Kong Research Grants Council; HKU seed funding programme; Research Funds for Central Universities [WK2340000021]	Chinese 973 Project(National Basic Research Program of China); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Hong Kong Research Grants Council(Hong Kong Research Grants Council); HKU seed funding programme; Research Funds for Central Universities	This project was supported by Chinese 973 Project Grants 2013CB911203, 2012CB945002, 2012CB917204; Chinese Natural Science Foundation Grants 31071184, 31371363 (to Z.D.), 31271439 and 31301109 (to C.F.); grants from Hong Kong Research Grants Council and HKU seed funding programme (to C.F.) and Research Funds for Central Universities WK2340000021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao XW, 2005, J BIOL CHEM, V280, P13584, DOI 10.1074/jbc.M411941200; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Collin P, 2013, NAT CELL BIOL, V15, P1378, DOI 10.1038/ncb2855; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dick AE, 2013, NAT CELL BIOL, V15, P1370, DOI 10.1038/ncb2842; Dou Z, 2003, CELL RES, V13, P443, DOI 10.1038/sj.cr.7290186; Dou Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018793; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Heinrich S, 2013, NAT CELL BIOL, V15, P1328, DOI 10.1038/ncb2864; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jelluma N, 2010, J CELL BIOL, V191, P281, DOI 10.1083/jcb.201003038; Jelluma N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002415; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lan WJ, 2010, J CELL BIOL, V190, P21, DOI 10.1083/jcb.201006080; Lee S, 2012, J BIOL CHEM, V287, P5988, DOI 10.1074/jbc.M111.307355; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Ma HT, 2011, BIOCHEM J, V435, P17, DOI 10.1042/BJ20100284; Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032; Morin V, 2012, CURR BIOL, V22, P289, DOI 10.1016/j.cub.2011.12.048; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Petsalaki E, 2014, J CELL BIOL, V205, P339, DOI 10.1083/jcb.201310071; Petsalaki E, 2013, J CELL SCI, V126, P1235, DOI 10.1242/jcs.119677; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Shepperd LA, 2012, CURR BIOL, V22, P891, DOI 10.1016/j.cub.2012.03.051; Sliedrecht T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010251; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Thebault P, 2012, BIOCHEM J, V448, P321, DOI 10.1042/BJ20121448; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Tyler RK, 2009, BIOCHEM J, V417, P173, DOI 10.1042/BJ20081310; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yamagishi Y, 2012, NAT CELL BIOL, V14, P746, DOI 10.1038/ncb2515; Yeh CW, 2014, J BIOL CHEM, V289, P15319, DOI 10.1074/jbc.M114.552273; Yuan K, 2011, CELL SIGNAL, V23, P1, DOI 10.1016/j.cellsig.2010.07.003; Yuan K, 2009, J BIOL CHEM, V284, P23072, DOI 10.1074/jbc.M109.001990; Zhu TG, 2013, J BIOL CHEM, V288, P36149, DOI 10.1074/jbc.M113.507970	51	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e104723	10.1371/journal.pone.0104723	http://dx.doi.org/10.1371/journal.pone.0104723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265012	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400002
J	Fraser, MD; Fleming, HR; Moorby, JM				Fraser, Mariecia D.; Fleming, Hannah R.; Moorby, Jon M.			Traditional vs Modern: Role of Breed Type in Determining Enteric Methane Emissions from Cattle Grazing as Part of Contrasting Grassland-Based Systems	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; BEEF-CATTLE; FEED-INTAKE; DIET; DIGESTIBILITY; PERFORMANCE; LIVESTOCK; BIODIVERSITY; STRATEGIES; EFFICIENCY	Ruminant livestock turn forages and poor-quality feeds into human edible products, but enteric methane (CH4) emissions from ruminants are a significant contributor to greenhouse gases (GHGs) and hence to climate change. Despite the predominance of pasture-based beef production systems in many parts of Europe there are little data available regarding enteric CH4 emissions from free-ranging grazing cattle. It is possible that differences in physiology or behaviour could influence comparative emissions intensities for traditional and modern breed types depending on the nutritional characteristics of the herbage grazed. This study investigated the role of breed type in influencing CH4 emissions from growing beef steers managed on contrasting grasslands typical of intensive (lowland) and extensive (upland) production systems. Using the SF6 dilution technique CH4 emissions were estimated for a modern, fast-growing crossbred (Limousin cross) and a smaller and hardier native breed (Welsh Black) when grazing lowland perennial ryegrass (high nutritional density, low sward heterogeneity) and semi-improved upland pasture (low/medium nutritional density, high sward heterogeneity). Live-weight gain was substantially lower for steers on the upland system compared to the lowland system (0.31 vs. 1.04 kg d(-1); s.e.d. = 0.085 kg d(-1); P < 0.001), leading to significant differences in estimated dry matter intakes (8.0 vs. 11.1 kg DM d(-1) for upland and lowland respectively; s.e.d. = 0.68 kg DM d(-1); P < 0.001). While emissions per unit feed intake were similar for the lowland and upland systems, CH4 emissions per unit of live-weight gain (LWG) were substantially higher when the steers grazed the poorer quality hill pasture (760 vs 214 g kg(-1) LWG; s.e.d. = 133.5 g kg(-1) LWG; P < 0.001). Overall any effects of breed type were relatively small relative to the combined influence of pasture type and location.	[Fraser, Mariecia D.; Fleming, Hannah R.; Moorby, Jon M.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Fraser, MD (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales.	mariecia.fraser@aber.ac.uk	Moorby, Jon/L-4586-2018; Fraser, Mariecia/W-7321-2019	Moorby, Jon/0000-0002-4449-8432; Fraser, Mariecia/0000-0003-3999-1270	UK Department for Environment, Food and Rural Affairs; Scottish Government; Northern Ireland Department for Agriculture and Rural development; Welsh Government, as part of the UK's Agricultural GHG Research Platform; BBSRC [BBS/E/C/00005190] Funding Source: UKRI	UK Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Scottish Government; Northern Ireland Department for Agriculture and Rural development; Welsh Government, as part of the UK's Agricultural GHG Research Platform; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was collectively funded by the UK Department for Environment, Food and Rural Affairs, the Scottish Government, the Northern Ireland Department for Agriculture and Rural development, and the Welsh Government, as part of the UK's Agricultural GHG Research Platform (www.ghgplatform.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcok M. M., 1986, HFRO HILL FARMING RE, P29; Alderman G., 1993, EN PROT REQ RUM ADV; Beauchemin KA, 2006, J ANIM SCI, V84, P1489, DOI 10.2527/2006.8461489x; Beauchemin KA, 2007, CAN J ANIM SCI, V87, P431, DOI 10.4141/CJAS07011; Beauchemin KA, 2006, CAN J ANIM SCI, V86, P401, DOI 10.4141/A06-021; Carey PD, 2002, BIOL CONSERV, V108, P183, DOI 10.1016/S0006-3207(02)00105-2; Chaves AV, 2006, CAN J ANIM SCI, V86, P409, DOI 10.4141/A05-081; Cooprider KL, 2011, J ANIM SCI, V89, P2643, DOI 10.2527/jas.2010-3539; Dawson LER, 2011, ANIMAL, V5, P1432, DOI 10.1017/S175173111100053X; DAWSON LER, 2010, ADV ANIMAL BIOSCIENC, P42; Degen AA, 1983, CANADIAN J ANIMAL SC, V73, P207; DeRamus HA, 2003, J ENVIRON QUAL, V32, P269, DOI 10.2134/jeq2003.0269; Dijkstra J, 2011, CURR OPIN ENV SUST, V3, P414, DOI 10.1016/j.cosust.2011.07.008; Doreau M, 2011, J ANIM SCI, V89, P2518, DOI 10.2527/jas.2010-3140; Dove H, 1996, J NUTR, V126, P13, DOI 10.1093/jn/126.1.13; Eggleston HS, 2006, GUIDELINES NATL GREE, V4, P107; Fothergill M, 2001, GRASS FORAGE SCI, V56, P105, DOI 10.1046/j.1365-2494.2001.00254.x; FOX DG, 1992, J ANIM SCI, V70, P3578, DOI 10.2527/1992.70113578x; Fraser MD, 2011, AGR ECOSYST ENVIRON, V144, P102, DOI 10.1016/j.agee.2011.08.004; Fraser MD, 2009, AGR ECOSYST ENVIRON, V129, P182, DOI 10.1016/j.agee.2008.08.013; Fraser MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089054; Gill M, 2010, ANIMAL, V4, P323, DOI 10.1017/S1751731109004662; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Grainger C, 2011, ANIM FEED SCI TECH, V166-67, P308, DOI 10.1016/j.anifeedsci.2011.04.021; Hales KE, 2012, J ANIM SCI, V90, P3174, DOI 10.2527/jas.2011-4441; Harper LA, 1999, J ANIM SCI, V77, P1392; Hunerberg M, 2013, J ANIM SCI, V91, P2846, DOI 10.2527/jas.2012-5564; JONES DIH, 1975, J SCI FOOD AGR, V26, P711, DOI 10.1002/jsfa.2740260518; Jones FM, 2011, ANIM FEED SCI TECH, V166-67, P302, DOI 10.1016/j.anifeedsci.2011.04.020; Kitessa S, 1999, AUST J AGR RES, V50, P825, DOI 10.1071/AR98169; Lassey KR, 2008, AUST J EXP AGR, V48, P114, DOI 10.1071/EA07220; Laubach J, 2008, AUST J EXP AGR, V48, P132, DOI 10.1071/EA07256; Lowman BG, 1976, REV ED B, V6; Martin C, 2010, ANIMAL, V4, P351, DOI 10.1017/S1751731109990620; Mc Geough EJ, 2010, J ANIM SCI, V88, P2703, DOI 10.2527/jas.2009-2750; Mc Geough EJ, 2010, J ANIM SCI, V88, P1479, DOI 10.2527/jas.2009-2380; McGinn SM, 2009, CAN J ANIM SCI, V89, P409, DOI 10.4141/CJAS08133; Met Office, 2012, MET OFF CLIM REP 201; Munoz C, 2012, J DAIRY SCI, V95, P3139, DOI 10.3168/jds.2011-4298; NRC, 1981, WAT ENV INT EFF ENV, DOI [DOI 10.17226/4963, 10.17226/4963?]; O'Mara FP, 2011, ANIM FEED SCI TECH, V166-67, P7, DOI 10.1016/j.anifeedsci.2011.04.074; Pavao-Zuckerman MA, 1999, J ENVIRON QUAL, V28, P1963, DOI 10.2134/jeq1999.00472425002800060036x; Pinares-Patino CS, 2007, AGR ECOSYST ENVIRON, V121, P30, DOI 10.1016/j.agee.2006.03.024; Pinares-Patino CS, 2003, CAN J ANIM SCI, V83, P769, DOI 10.4141/A03-034; Richmond AS, 2013, ADV ANIMAL AGR, V4, P550; Rook AJ, 2004, BIOL CONSERV, V119, P137, DOI 10.1016/j.biocon.2003.11.010; THOMAS TA, 1977, J SCI FOOD AGR, V28, P639, DOI 10.1002/jsfa.2740280711; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Waghorn G.C., 2006, INT, V1293, P107, DOI [10.1016/j.ics.2006.02.025, DOI 10.1016/J.ICS.2006.02.025]	50	15	15	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107861	10.1371/journal.pone.0107861	http://dx.doi.org/10.1371/journal.pone.0107861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259617	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600031
J	Miroshnikov, A; Conlon, EM				Miroshnikov, Alexey; Conlon, Erin M.			parallelMCMCcombine: An R Package for Bayesian Methods for Big Data and Analytics	PLOS ONE			English	Article								Recent advances in big data and analytics research have provided a wealth of large data sets that are too big to be analyzed in their entirety, due to restrictions on computer memory or storage size. New Bayesian methods have been developed for data sets that are large only due to large sample sizes. These methods partition big data sets into subsets and perform independent Bayesian Markov chain Monte Carlo analyses on the subsets. The methods then combine the independent subset posterior samples to estimate a posterior density given the full data set. These approaches were shown to be effective for Bayesian models including logistic regression models, Gaussian mixture models and hierarchical models. Here, we introduce the R package parallelMCMCcombine which carries out four of these techniques for combining independent subset posterior samples. We illustrate each of the methods using a Bayesian logistic regression model for simulation data and a Bayesian Gamma model for real data; we also demonstrate features and capabilities of the R package. The package assumes the user has carried out the Bayesian analysis and has produced the independent subposterior samples outside of the package. The methods are primarily suited to models with unknown parameters of fixed dimension that exist in continuous parameter spaces. We envision this tool will allow researchers to explore the various methods for their specific applications and will assist future progress in this rapidly developing field.	[Miroshnikov, Alexey; Conlon, Erin M.] Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Conlon, EM (corresponding author), Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA.	econlon@mathstat.umass.edu	Miroshnikov, Alexey/A-1314-2016	Miroshnikov, Alexey/0000-0003-2669-6336				Carlin BP, 2009, CH CRC TEXT STAT SCI, V78, P1; Duong T, 2003, J NONPARAMETR STAT, V15, P17, DOI 10.1080/10485250306039; Gelman A, 2013, BAYESIAN DATA ANAL, V3rd; HJORT NL, 1995, ANN STAT, V23, P882, DOI 10.1214/aos/1176324627; HUANG Z., 2005, SAMPLING BAYESIAN CO; Kruschke J. K, 2010, DOING BAYESIAN DATA; Langford J., 2009, ADV NEURAL INFORM PR, V22, P2331; Laskey KB, 2003, MACH LEARN, V50, P175, DOI 10.1023/A:1020206129842; Le Cam L., 2000, ASYMPTOTICS STAT SOM; Liu J.S., 2001, MONTE CARLO STRATEGI; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Murray LM, 2010, P NEUR INF PROC SYST; Neiswanger W, 2014, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, P623; Newman D, 2009, J MACH LEARN RES, V10, P1801; Oliva J., 2013, PROC 30 INT C MACH L, P1049; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; RCore Team, 2020, R LANG ENV STAT COMP; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Scott Steven L, 2013, EFABBAYES 250 C, V16; Silverman B.W., 1986, DENSITY ESTIMATION S; Smola A, 2010, PROC VLDB ENDOW, V3, P703, DOI 10.14778/1920841.1920931; Stan Development Team, 2022, STAN US GUID VERS 2; Stan Development Team, 2014, STAN C LIB PROB SAMP; Van der Vaart AW, 2000, ASYMPTOTIC STAT, V3; WAND MP, 1993, J AM STAT ASSOC, V88, P520, DOI 10.2307/2290332; Wand MP., 1994, KERNEL SMOOTHING; Wilkinson DJ, 2006, STAT TEXTB MONOG, V184, P477	27	6	6	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108425	10.1371/journal.pone.0108425	http://dx.doi.org/10.1371/journal.pone.0108425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259608	gold, Green Submitted, Green Published			2022-12-27	WOS:000342685600071
J	Esteves, LM; Bulhoes, SM; Branco, CC; Mota, FM; Paiva, C; Cabral, R; Vieira, ML; Mota-Vieira, L				Esteves, Lisa M.; Bulhoes, Sara M.; Branco, Claudia C.; Mota, Francisco M.; Paiva, Clara; Cabral, Rita; Vieira, Maria Luisa; Mota-Vieira, Luisa			Human Leptospirosis: Seroreactivity and Genetic Susceptibility in the Population of Sao Miguel Island (Azores, Portugal)	PLOS ONE			English	Article							ASSOCIATION; POLYMORPHISMS; LIPOPOLYSACCHARIDE; PROTECTION; VARIANTS; SEVERITY; PROTEINS; JAPANESE; VACCINE; CIS	Background: Leptospirosis is a worldwide zoonotic and recognized neglected infectious disease. It has been observed that only a proportion of individuals exposed to pathogenic species of Leptospira become infected and develop clinically evident disease. Moreover, little information is available in subsequent reinfections. In the present study, we determine if a first infection with leptospirosis protects against subsequent reinfection, and investigate which of the host genetic factors are involved in the susceptibility and resistance to leptospirosis. Methodology and Findings: We conducted, in 2011, a retrospective hospital-based case-control study in the Sao Miguel Island population (Azores archipelago). In order to determine the seropositivity against pathogenic Leptospira after the first episode of leptospirosis, we performed a serological evaluation in 97 unrelated participants diagnosed with leptospirosis between 1992 and 2011. The results revealed that 46.4% of the 97 participants have circulating anti-Leptospira antibodies, and from these participants 35.6% maintained the seroprevalence for the same serogroup. Moreover, three of them were reinfected with unrelated Leptospira serovars. The genetic study was carried out by adding a control group composed of 470 unrelated healthy blood donors, also from Sao Miguel Island. Twenty five SNPs among twelve innate immune genes IL1 alpha, IL1 beta, IL6, IL10, IL12RB1, TLR2, TLR4, TLR9, CD14, CISH, LTA and TNF - were genotyped, as well as HLA class I (-A and -B) genes. Association analysis indicates that genotypes -511GG (OR = 1.6, 95% CI 1.01-2.56, p = 0.04) in IL1 beta, + 1196CG (OR = 2.0, 95% CI 1.26-3.27, p = 0.003) in IL12RB1, -292TA (OR = 1.8, 95% CI 1.06-2.1, p = 0.03) and +3415CG (OR = 1.8, 95% CI 1.08-3.08, p = 0.02), both in CISH confer susceptibility to pathogenic Leptospira. Conclusion: The present study suggests some degree of long-term protection against leptospires with an attenuation of symptoms in case of reinfection. Moreover, our data supports the genetic influence of IL1 beta, IL12RB1 and CISH genes and the susceptibility to leptospirosis infection.	[Esteves, Lisa M.; Bulhoes, Sara M.; Branco, Claudia C.; Cabral, Rita; Mota-Vieira, Luisa] Hosp Divino Espirito Santo Ponta Delgada, Mol Genet & Pathol Unit, EPE, Sao Miguel Isl, Azores, Portugal; [Mota, Francisco M.] Hosp Divino Espirito Santo Ponta Delgada, Dept Infect Dis, Sao Miguel Isl, Azores, Portugal; [Paiva, Clara] Hosp Divino Espirito Santo Ponta Delgada, EPE, Dept Internal Med, Sao Miguel Isl, Azores, Portugal; [Vieira, Maria Luisa] Univ Nova Lisboa, Leptospirosis & Lyme Borreliosis Grp, Unit Med Microbiol, Inst Higiene & Med Trop,Ctr Recursos Microbiol, P-1200 Lisbon, Portugal; [Branco, Claudia C.; Cabral, Rita; Mota-Vieira, Luisa] Inst Gulbenkian Ciencias, Azores Genet Res Grp, Oeiras, Portugal; [Branco, Claudia C.; Mota-Vieira, Luisa] Univ Lisbon, Fac Sci, Ctr Biodivers Funct & Integrat Genom, P-1699 Lisbon, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Instituto Gulbenkian de Ciencia; Universidade de Lisboa	Mota-Vieira, L (corresponding author), Hosp Divino Espirito Santo Ponta Delgada, Mol Genet & Pathol Unit, EPE, Sao Miguel Isl, Azores, Portugal.	Luisa.MQ.Vieira@azores.gov.pt	Cabral, Rita/AAW-7550-2021; Branco, CC/I-6654-2013; Vieira, Maria Luísa/B-3310-2008; Esteves, Lisa/M-5577-2013; Mota-Vieira, Luisa/I-5909-2013	Cabral, Rita/0000-0002-5140-6989; Branco, CC/0000-0002-7028-4657; Vieira, Maria Luísa/0000-0002-8586-5534; Esteves, Lisa/0000-0002-0799-0567; Mota-Vieira, Luisa/0000-0003-1451-6705; Bulhoes, Sara/0000-0002-9122-7563	Fundacao Calouste Gulbenkian [P-99888]; Direccao Regional da Ciencia e Tecnologia from Azores Government [M121/I/OLD/2002]; Fundo Regional da Ciencia e Tecnologia from Azores Government [M316/F/425/2009]	Fundacao Calouste Gulbenkian(European Commission); Direccao Regional da Ciencia e Tecnologia from Azores Government; Fundo Regional da Ciencia e Tecnologia from Azores Government	The present work was supported by grants from Fundacao Calouste Gulbenkian (P-99888), the Direccao Regional da Ciencia e Tecnologia (M121/I/OLD/2002, from Azores Government) and Fundo Regional da Ciencia e Tecnologia (M316/F/425/2009 to SMB, from Azores Government). The authorities who provided funding for this project had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branco CC, 2011, DIJANA PLASESKA KARA, P129; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; CollaresPereira M, 1997, EUR J EPIDEMIOL, V13, P435, DOI 10.1023/A:1007383405833; Dellagostin OA, 2011, HUM VACCINES, V7, P1215, DOI 10.4161/hv.7.11.17944; Esteves Lisa M, 2013, BMC Res Notes, V6, P54, DOI 10.1186/1756-0500-6-54; Fialho RN, 2009, HUM IMMUNOL, V70, P915, DOI 10.1016/j.humimm.2009.08.007; Glas J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034349; Goncalves AT, 2010, INT J INFECT DIS, V14, pE148, DOI 10.1016/j.ijid.2009.12.004; Goris MGA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018279; Guerrier G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002436; Khor CC, 2010, NEW ENGL J MED, V362, P2092, DOI 10.1056/NEJMoa0905606; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Kusuhara K, 2007, INT J IMMUNOGENET, V34, P35, DOI 10.1111/j.1744-313X.2007.00653.x; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Libraty DH, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000111; Lingappa J, 2004, GENES IMMUN, V5, P197, DOI 10.1038/sj.gene.6364058; Martinez R, 2004, REV PANAM SALUD PUBL, V15, P249, DOI 10.1590/S1020-49892004000400005; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Morahan G, 2007, TISSUE ANTIGENS, V69, P234, DOI 10.1111/j.1399-0039.2006.773_3.x; Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022; Noguchi E, 2004, CLIN EXP ALLERGY, V34, P177, DOI 10.1111/j.1365-2222.2004.01839.x; Pacheco Paula R, 2010, BMC Res Notes, V3, P134, DOI 10.1186/1756-0500-3-134; Rosario LA, 2012, ADV CLIN EXP MED, V21, P581; Srikram A, 2011, J INFECT DIS, V203, P870, DOI 10.1093/infdis/jiq127; Sugimoto M, 2009, J GASTROEN HEPATOL, V24, P1725, DOI 10.1111/j.1440-1746.2009.06047.x; Trengove MC, 2013, AM J CLIN EXP IMMUNO, V2, P1; Velez DR, 2010, HUM GENET, V127, P65, DOI 10.1007/s00439-009-0741-7; Verma R, 2013, HUM VACC IMMUNOTHER, V9, P763, DOI 10.4161/hv.23059; Vieira ML, 2006, INT J INFECT DIS, V10, P378, DOI 10.1016/j.ijid.2005.07.006; Wan QQ, 2012, TRANSPL P, V44, P3026, DOI 10.1016/j.transproceed.2012.05.081; Werts Catherine, 2010, Chang Gung Med J, V33, P591; Xue F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002477; Yang CW, 2006, KIDNEY INT, V69, P815, DOI 10.1038/sj.ki.5000119; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zhao ZZ, 2007, HUM REPROD, V22, P2389, DOI 10.1093/humrep/dem182	35	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108534	10.1371/journal.pone.0108534	http://dx.doi.org/10.1371/journal.pone.0108534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255143	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300092
J	Lian, J; Lu, Y; Xu, P; Ai, A; Zhou, GD; Liu, W; Cao, YL; Zhang, WJ				Lian, Jie; Lu, Yang; Xu, Peng; Ai, Ai; Zhou, Guangdong; Liu, Wei; Cao, Yilin; Zhang, Wen Jie			Prevention of Liver Fibrosis by Intrasplenic Injection of High-Density Cultured Bone Marrow Cells in a Rat Chronic Liver Injury Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; PARTIAL-HEPATECTOMY; CO-TRANSPLANTATION; PROGENITOR CELLS; STROMAL CELLS; PORTAL-HYPERTENSION; IN-VIVO; ANGIOGENESIS; THERAPY	Endothelial progenitor cells (EPCs) from bone marrow have proven to be functional for the prevention of liver fibrosis in chronic liver injury. However, expansion of EPCs in culture is complicated and expansive. Previously, we have established a simple method that could enrich and expand EPCs by simple seeding bone marrow cells in high density dots. The purpose of this study is to evaluate whether cells derived from high-density (HD) culture of rat bone marrow cells could prevent the liver fibrosis in a chronic liver injury rat model, induced by carbon tetrachloride (CCl4). Flow cytometric analysis showed that cells from HD culture were enriched for EPCs, expressing high levels of EPC markers. Intrasplenic injection of HD cultured bone marrow cells in the CCl4-induced liver injury rat showed an enhanced antifibrogenic effect compared with animals treated with cells from regular-density culture. The antifibrogenic effect was demonstrated by biochemical and histological analysis 4 weeks post-transplantation. Furthermore, cells from HD culture likely worked through increasing neovascularization, stimulating liver cell proliferation, and suppressing pro-fibrogenic factor expression. HD culture, which is a simple and cost-effective procedure, could potentially be used to expand bone marrow cells for the treatment of liver fibrosis.	[Lian, Jie; Lu, Yang; Xu, Peng; Ai, Ai; Zhou, Guangdong; Liu, Wei; Cao, Yilin; Zhang, Wen Jie] Shanghai Jiao Tong Univ, Dept Plast & Reconstruct Surg, Sch Med,Shanghai Peoples Hosp 9, Shanghai Key Lab Tissue Engn,Natl Tissue Engn Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhang, WJ (corresponding author), Shanghai Jiao Tong Univ, Dept Plast & Reconstruct Surg, Sch Med,Shanghai Peoples Hosp 9, Shanghai Key Lab Tissue Engn,Natl Tissue Engn Ctr, Shanghai 200030, Peoples R China.	wenjieboshi@aliyun.cn	Xu, Pengcheng/J-1429-2012	Xu, Pengcheng/0000-0001-8651-208X	Major State Basic Research Development Program of China [2007CB948004, 2011CB964704]; National Basic Research Program of China [30800231, 31170944]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the Major State Basic Research Development Program of China (2007CB948004, 2011CB964704), and the National Basic Research Program of China (30800231, 31170944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Porada G, 2010, EXP HEMATOL, V38, P574, DOI 10.1016/j.exphem.2010.04.007; Assy N, 1999, J HEPATOL, V30, P911, DOI 10.1016/S0168-8278(99)80147-0; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Carvalho AB, 2008, STEM CELLS, V26, P1307, DOI 10.1634/stemcells.2007-0941; Chamberlain J, 2007, HEPATOLOGY, V46, P1935, DOI 10.1002/hep.21899; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; Couto BG, 2011, LIVER INT, V31, P391, DOI 10.1111/j.1478-3231.2010.02424.x; Foubert P, 2008, CIRC RES, V103, P751, DOI 10.1161/CIRCRESAHA.108.175083; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lee DS, 2004, TRANSPL P, V36, P2255, DOI 10.1016/j.transproceed.2004.08.073; Lee JS, 2007, HEPATOLOGY, V45, P817, DOI 10.1002/hep.21564; Lu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107127; Mallet VO, 2002, HEPATOLOGY, V35, P799, DOI 10.1053/jhep.2002.32530; Mohammad-Gharibani P, 2013, CYTOTHERAPY, V15, P1073, DOI 10.1016/j.jcyt.2013.05.002; Muller AMS, 2012, P NATL ACAD SCI USA, V109, P5820, DOI 10.1073/pnas.1120237109; Nakamura T, 2007, GASTROENTEROLOGY, V133, P91, DOI 10.1053/j.gastro.2007.03.110; Nakamura T, 2012, EUR J CLIN INVEST, V42, P717, DOI 10.1111/j.1365-2362.2011.02637.x; Patsenker E, 2009, HEPATOLOGY, V50, P1501, DOI 10.1002/hep.23144; Peng L, 2011, HEPATOLOGY, V54, P820, DOI 10.1002/hep.24434; Ross MA, 2001, HEPATOLOGY, V34, P1135, DOI 10.1053/jhep.2001.29624; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Sakamoto M, 2013, J GASTROEN HEPATOL, V28, P168, DOI 10.1111/j.1440-1746.2012.07238.x; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Shimizu H, 2001, J HEPATOL, V34, P683, DOI 10.1016/S0168-8278(00)00055-6; Stockmann C, 2010, P NATL ACAD SCI USA, V107, P4329, DOI 10.1073/pnas.0912766107; Taniguchi E, 2006, GASTROENTEROLOGY, V130, P521, DOI 10.1053/j.gastro.2005.10.050; Taniguchi E, 2001, J HISTOCHEM CYTOCHEM, V49, P121, DOI 10.1177/002215540104900112; Taura K, 2008, GASTROENTEROLOGY, V135, P1729, DOI 10.1053/j.gastro.2008.07.065; Terai S, 2006, STEM CELLS, V24, P2292, DOI 10.1634/stemcells.2005-0542; Thabut D, 2010, J HEPATOL, V53, P976, DOI 10.1016/j.jhep.2010.07.004; Ueno T, 2006, MED MOL MORPHOL, V39, P16, DOI 10.1007/s00795-006-0311-1; Wang XL, 2003, BLOOD, V101, P4201, DOI 10.1182/blood-2002-05-1338; Xiao N, 2013, CYTOTHERAPY, V15, P1374, DOI 10.1016/j.jcyt.2013.06.013; Yoshiji H, 2003, GUT, V52, P1347, DOI 10.1136/gut.52.9.1347	37	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e103603	10.1371/journal.pone.0103603	http://dx.doi.org/10.1371/journal.pone.0103603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255097	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300004
J	Watanabe, S; Horie, T; Nagao, K; Kuwabara, Y; Baba, O; Nishi, H; Sowa, N; Narazaki, M; Matsuda, T; Takemura, G; Wada, H; Hasegawa, K; Kimura, T; Ono, K				Watanabe, Shin; Horie, Takahiro; Nagao, Kazuya; Kuwabara, Yasuhide; Baba, Osamu; Nishi, Hitoo; Sowa, Naoya; Narazaki, Michiko; Matsuda, Tetsuya; Takemura, Genzou; Wada, Hiromichi; Hasegawa, Koji; Kimura, Takeshi; Ono, Koh			Cardiac-Specific Inhibition of Kinase Activity in Calcium/Calmodulin-Dependent Protein Kinase Kinase-beta Leads to Accelerated Left Ventricular Remodeling and Heart Failure after Transverse Aortic Constriction in Mice	PLOS ONE			English	Article							RECEPTOR-GAMMA; MITOCHONDRIAL BIOGENESIS; MOLECULAR-CLONING; OXIDATIVE STRESS; HYPERTROPHY; PGC-1-ALPHA; ALPHA; CALMODULIN; CASCADE; GLUCOSE	Background: The mechanism of cardiac energy production against sustained pressure overload remains to be elucidated. Methods and Results: We generated cardiac-specific kinase-dead (kd) calcium/calmodulin-dependent protein kinase kinase-beta (CaMKK beta) transgenic (alpha-MHC CaMKK beta(kd) TG) mice using alpha-myosin heavy chain (alpha-MHC) promoter. Although CaMKK beta activity was significantly reduced, these mice had normal cardiac function and morphology at baseline. Here, we show that transverse aortic binding (TAC) in alpha-MHC CaMKK beta(kd) TG mice led to accelerated death and left ventricular (LV) dilatation and dysfunction, which was accompanied by significant clinical signs of heart failure. CaMKK beta downstream signaling molecules, including adenosine monophosphate-activated protein kinase (AMPK), were also suppressed in alpha-MHC CaMKK beta(kd) TG mice compared with wild-type (WT) mice. The expression levels of peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1 alpha, which is a downstream target of both of CaMKK beta and calcium/calmodulin kinases, were also significantly reduced in alpha-MHC CaMKK beta(kd) TG mice compared with WT mice after TAC. In accordance with these findings, mitochondrial morphogenesis was damaged and creatine phosphate/beta-ATP ratios assessed by magnetic resonance spectroscopy were suppressed in alpha-MHC CaMKK beta(kd) TG mice compared with WT mice after TAC. Conclusions: These data indicate that CaMKK beta exerts protective effects on cardiac adaptive energy pooling against pressure-overload possibly through phosphorylation of AMPK and by upregulation of PGC-1 alpha. Thus, CaMKK beta may be a therapeutic target for the treatment of heart failure.	[Watanabe, Shin; Horie, Takahiro; Nagao, Kazuya; Kuwabara, Yasuhide; Baba, Osamu; Nishi, Hitoo; Sowa, Naoya; Kimura, Takeshi; Ono, Koh] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Narazaki, Michiko; Matsuda, Tetsuya] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto, Japan; [Takemura, Genzou] Asahi Univ, Dept Internal Med, Gifu, Japan; [Wada, Hiromichi; Hasegawa, Koji] Natl Hosp Org, Kyoto Med Ctr, Div Translat Res, Kyoto, Japan	Kyoto University; Kyoto University; Asahi University	Ono, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan.	kohono@kuhp.kyoto-u.ac.jp		Wada, Hiromichi/0000-0002-8980-224X	Global COE program "Center for Frontier Medicine"; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [26860556] Funding Source: KAKEN	Global COE program "Center for Frontier Medicine"; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Global COE program "Center for Frontier Medicine" and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to K. Ono, K. Hasegawa, T. Kita, and T. Kimura, and in part by the Innovative Techno-Hub for Integrated Medical Bio-imaging of the Project for Developing Innovation Systems, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to M. Narazaki and T. Matsuda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Anderson KA, 2012, MOL ENDOCRINOL, V26, P281, DOI 10.1210/me.2011-1299; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cho Andrew, 2009, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1911s42; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Colbran RJ, 2004, J NEUROSCI, V24, P8404, DOI 10.1523/JNEUROSCI.3602-04.2004; Date M, 2002, J AM COLL CARDIOL, V39, P907, DOI 10.1016/S0735-1097(01)01826-5; Depre C, 1999, CIRCULATION, V99, P578, DOI 10.1161/01.CIR.99.4.578; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Horie T, 2008, J CELL PHYSIOL, V215, P733, DOI 10.1002/jcp.21353; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kawashima T, 2011, J MOL CELL CARDIOL, V51, P1026, DOI 10.1016/j.yjmcc.2011.09.013; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lopaschuk GD, 2002, CIRCULATION, V105, P140, DOI 10.1161/circ.105.2.140; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Murakami Y, 1999, CIRCULATION, V99, P942, DOI 10.1161/01.CIR.99.7.942; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Sambandam Nandakumar, 2002, Heart Fail Rev, V7, P161; Sartoretto JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044627; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Tokumitsu H, 2001, BIOCHEMISTRY-US, V40, P13925, DOI 10.1021/bi010863k; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108201	10.1371/journal.pone.0108201	http://dx.doi.org/10.1371/journal.pone.0108201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255457	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300063
J	Bennett, EJ; Mead, RJ; Azzouz, M; Shaw, PJ; Grierson, AJ				Bennett, Ellen J.; Mead, Richard J.; Azzouz, Mimoun; Shaw, Pamela J.; Grierson, Andrew J.			Early Detection of Motor Dysfunction in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis (ALS) Using Home Cage Running Wheels	PLOS ONE			English	Article							TRANSGENIC MODEL; NEURON LOSS; DISEASE; SOD1; RILUZOLE; MICE; MUTATIONS	The SOD1(G93A) mouse has been used since 1994 for preclinical testing in amyotrophic lateral sclerosis (ALS). Despite recent genetic advances in our understanding of ALS, transgenic mice expressing mutant SOD1 remain the best available, and most widely used, vertebrate model of the disease. We previously described an optimised and rapid approach for preclinical studies in the SOD1(G93A) mouse. Here we describe improvements to this approach using home cage running wheels to obtain daily measurements of motor function, with minimal intervention. We show that home cage running wheels detect reductions in motor function at a similar time to the rotarod test, and that the data obtained are less variable allowing the use of smaller groups of animals to obtain satisfactory results. This approach refines use of the SOD1(G93A) model, and reduces the number of animals undergoing procedures of substantial severity, two central principles of the 3Rs (replacement, reduction and refinement of animal use in research). The small group sizes and rapid timescales enable affordable large-scale therapeutic pre-screening in the SOD1(G93A) mouse, as well as rapid validation of published positive effects in a second laboratory, one of the major stumbling blocks in ALS preclinical therapy development.	[Bennett, Ellen J.; Mead, Richard J.; Azzouz, Mimoun; Shaw, Pamela J.; Grierson, Andrew J.] Univ Sheffield, Sheffield Inst Translat Neurosci, Dept Neurosci, Sheffield, S Yorkshire, England	University of Sheffield	Grierson, AJ (corresponding author), Univ Sheffield, Sheffield Inst Translat Neurosci, Dept Neurosci, Sheffield, S Yorkshire, England.	a.j.grierson@sheffield.ac.uk	Grierson, Andy/A-5067-2009; Azzouz, Mimoun/B-3979-2009; Mead, Richard/B-4779-2009	Grierson, Andy/0000-0001-7039-6731; Azzouz, Mimoun/0000-0001-6564-5967; Bennett, Ellen/0000-0002-9818-827X; Mead, Richard/0000-0002-3207-0068; Shaw, Pamela/0000-0002-8925-2567	NC3Rs project grant [G0700628]; NC3Rs small award [26102007]; Project MitoTarget [HEALTH-F2-2008-223388]; National Institute for Health Research [NF-SI-0512-10082] Funding Source: researchfish; National Centre for the Replacement [G0700628/1] Funding Source: researchfish; Motor Neurone Disease Association [SITraN/Apr13/983-797] Funding Source: researchfish	NC3Rs project grant(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); NC3Rs small award(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Project MitoTarget; National Institute for Health Research(National Institute for Health Research (NIHR)); National Centre for the Replacement; Motor Neurone Disease Association	This work was supported by an NC3Rs project grant: G0700628 to AJG PJS MA and RJM, NC3Rs small award: Grierson. A. 26102007 to AJG, and Project MitoTarget: Grant Agreement HEALTH-F2-2008-223388 to AJG and PJS. PJS is an NIHR senior investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Arozena A, 2011, DIS MODEL MECH, V4, P686, DOI 10.1242/dmm.007237; Aggarwal A, 2002, J NEUROL NEUROSUR PS, V73, P199, DOI 10.1136/jnnp.73.2.199; Barneoud P, 1999, EXP NEUROL, V155, P243, DOI 10.1006/exnr.1998.6984; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; CAVANAGH JB, 1964, INT REV EXP PATHOL, V3, P219; De Bono JP, 2006, AM J PHYSIOL-REG I, V290, pR926, DOI 10.1152/ajpregu.00694.2005; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Ferraiuolo L, 2009, J NEUROCHEM, V109, P1714, DOI 10.1111/j.1471-4159.2009.06080.x; Festing M.F.W., 2002, DESIGN ANIMAL EXPT R; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frey D, 2000, J NEUROSCI, V20, P2534; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Hayworth CR, 2009, NEUROSCIENCE, V164, P975, DOI 10.1016/j.neuroscience.2009.08.031; Joyce PI, 2011, MAMM GENOME, V22, P420, DOI 10.1007/s00335-011-9339-1; Kennel PF, 1996, NEUROREPORT, V7, P1427, DOI 10.1097/00001756-199605310-00021; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; Ludolph Albert C, 2007, Amyotroph Lateral Scler, V8, P217, DOI 10.1080/17482960701292837; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Mead RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023244; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584	28	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107918	10.1371/journal.pone.0107918	http://dx.doi.org/10.1371/journal.pone.0107918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268710	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000343671700053
J	Huo, J; Zhu, XF; Dong, Y; Yuan, ZY; Wang, P; Wang, XM; Wang, G; Hu, XH; Feng, YM				Huo, Jie; Zhu, Xianfeng; Dong, Yang; Yuan, Zhiyong; Wang, Ping; Wang, Xuemin; Wang, Gang; Hu, Xin-Hua; Feng, Yuanming			Feasibility Study of Dual Energy Radiographic Imaging for Target Localization in Radiotherapy for Lung Tumors	PLOS ONE			English	Article							CHEST RADIOGRAPHS; OPTIMIZATION; NODULES; CT; MAMMOGRAPHY; SUBTRACTION; SYSTEM	Purpose: Dual-energy (DE) radiographic imaging improves tissue discrimination by separating soft from hard tissues in the acquired images. This study was to establish a mathematic model of DE imaging based on intrinsic properties of tissues and quantitatively evaluate the feasibility of applying the DE imaging technique to tumor localization in radiotherapy. Methods: We investigated the dependence of DE image quality on the radiological equivalent path length (EPL) of tissues with two phantoms using a stereoscopic x-ray imaging unit. 10 lung cancer patients who underwent radiotherapy each with gold markers implanted in the tumor were enrolled in the study approved by the hospital's Ethics Committee. The displacements of the centroids of the delineated gross tumor volumes (GTVs) in the digitally reconstructed radiograph (DRR) and in the bone-canceled DE image were compared with the averaged displacements of the centroids of gold markers to evaluate the feasibility of using DE imaging for tumor localization. Results: The results of the phantom study indicated that the contrast-to-noise ratio (CNR) was linearly dependent on the difference of EPL and a mathematical model was established. The objects and backgrounds corresponding to Delta EPL less than 0.08 are visually indistinguishable in the bone-canceled DE image. The analysis of patient data showed that the tumor contrast in the bone-canceled images was improved significantly as compared with that in the original radiographic images and the accuracy of tumor localization using the DE imaging technique was comparable with that of using fiducial makers. Conclusion: It is feasible to apply the technique for tumor localization in radiotherapy.	[Huo, Jie; Zhu, Xianfeng; Wang, Xuemin; Wang, Gang; Feng, Yuanming] Tianjin Univ, Dept Biomed Engn, Tianjin 300072, Peoples R China; [Dong, Yang; Yuan, Zhiyong; Wang, Ping; Feng, Yuanming] Tianjin Canc Hosp, Dept Radiat Oncol, Tianjin, Peoples R China; [Hu, Xin-Hua] E Carolina Univ, Dept Phys, Greenville, NC 27858 USA; [Feng, Yuanming] E Carolina Univ, Dept Radiat Oncol, Greenville, NC USA	Tianjin University; Tianjin Medical University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Wang, P (corresponding author), Tianjin Canc Hosp, Dept Radiat Oncol, Tianjin, Peoples R China.	wangping@tjmuch.com; fengyu@ecu.edu		Hu, Xin/0000-0002-4353-9028; Hu, Xin-Hua/0000-0001-5038-7651				Arvanitis CD, 2009, PHYS MED BIOL, V54, P6041, DOI 10.1088/0031-9155/54/20/002; Bazatova M, 2008, RADIOTHER ONCOL, V86, P93, DOI 10.1016/j.radonc.2007.11.008; Carton AK, 2010, MED PHYS, V37, P5896, DOI 10.1118/1.3490556; Collins BT, 2007, RADIAT ONCOL, V2, p717X; Ducote JL, 2007, PHYS MED BIOL, V52, P183, DOI 10.1088/0031-9155/52/1/012; Goldstone K., 1990, 44 ICRU; Kappadath SC, 2004, PHYS MED BIOL, V49, P2563, DOI 10.1088/0031-9155/49/12/007; LEHMANN LA, 1981, MED PHYS, V8, P659, DOI 10.1118/1.595025; Murphy M J, 2000, Comput Aided Surg, V5, P278, DOI 10.1002/1097-0150(2000)5:4<278::AID-IGS6>3.0.CO;2-K; Richard S, 2007, MED PHYS, V34, P127, DOI 10.1118/1.2400620; Richard S, 2005, MED PHYS, V32, P1397, DOI 10.1118/1.1901203; Sabol JM, 2001, PROC SPIE, V4320, P399, DOI 10.1117/12.430897; Samei E, 1999, RADIOLOGY, V213, P727, DOI 10.1148/radiology.213.3.r99dc19727; Schilham AMR, 2006, MED IMAGE ANAL, V10, P247, DOI 10.1016/j.media.2005.09.003; Shkumat NA, 2007, MED PHYS, V34, P3904, DOI 10.1118/1.2777278; SIDDON RL, 1985, MED PHYS, V12, P252, DOI 10.1118/1.595715; Szucs-Farkas Z, 2008, EUR RADIOL, V18, P24, DOI 10.1007/s00330-007-0758-z; Szucs-Farkas Z, 2013, AM J ROENTGENOL, V200, P1006, DOI 10.2214/AJR.12.8877; Williams DB, 2007, MED PHYS, V34, P3619; Yeh BM, 2009, AM J ROENTGENOL, V193, P47, DOI 10.2214/AJR.09.2592	20	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108823	10.1371/journal.pone.0108823	http://dx.doi.org/10.1371/journal.pone.0108823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268643	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700172
J	Lamarque, P; Meyfroidt, P; Nettier, B; Lavorel, S				Lamarque, Penelope; Meyfroidt, Patrick; Nettier, Baptiste; Lavorel, Sandra			How Ecosystem Services Knowledge and Values Influence Farmers' Decision-Making	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; LIVESTOCK FARMERS; MANAGEMENT; FRAMEWORK; CONSERVATION; VALUATION; ATTITUDES; TRAITS	The ecosystem services (ES) concept has emerged and spread widely recently, to enhance the importance of preserving ecosystems through global change in order to maintain their benefits for human well-being. Numerous studies consider various dimensions of the interactions between ecosystems and land use via ES, but integrated research addressing the complete feedback loop between biodiversity, ES and land use has remained mostly theoretical. Few studies consider feedbacks from ecosystems to land use systems through ES, exploring how ES are taken into account in land management decisions. To fill this gap, we carried out a role-playing game to explore how ES cognition mediates feedbacks from environmental change on farmers' behaviors in a mountain grassland system. On a close to real landscape game board, farmers were faced with changes in ES under climatic and socio-economic scenarios and prompted to plan for the future and to take land management decisions as they deemed necessary. The outcomes of role-playing game were complemented with additional agronomic and ecological data from interviews and fieldwork. The effects of changes in ES on decision were mainly direct, i.e. not affecting knowledge and values, when they constituted situations with which farmers were accustomed. For example, a reduction of forage quantity following droughts led farmers to shift from mowing to grazing. Sometimes, ES cognitions were affected by ES changes or by external factors, leading to an indirect feedback. This happened when fertilization was stopped after farmers learned that it was inefficient in a drought context. Farmers' behaviors did not always reflect their attitudes towards ES because other factors including topographic constraints, social value of farming or farmer individual and household characteristics also influenced land-management decisions. Those results demonstrated the interest to take into account the complete feedback loop between ES and land management decisions to favor more sustainable ES management.	[Lamarque, Penelope; Lavorel, Sandra] Univ Grenoble 1, CNRS, Lab Ecol Alpine, Unite Mixte Rech 5553, Grenoble, France; [Meyfroidt, Patrick] Fonds Rech Sci FRS FNRS, Louvain, Belgium; [Meyfroidt, Patrick] Univ Louvain, Georges Lemaitre Ctr Earth & Climate Res, Earth & Life Inst, Louvain, Belgium; [Nettier, Baptiste] Irstea Ctr Grenoble, Unite Rech Dev Terr Montagnards, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Fonds de la Recherche Scientifique - FNRS; INRAE	Lamarque, P (corresponding author), Univ Grenoble 1, CNRS, Lab Ecol Alpine, Unite Mixte Rech 5553, Grenoble, France.	penelope.lamarque@gmail.com	Alpes, Zone Atelier Alpes LTER/P-4132-2015; Meyfroidt, Patrick/G-7768-2012	Meyfroidt, Patrick/0000-0002-1047-9794	Agence National de la Recherche through the FP6 BiodivERsA Eranet VITAL project; French Ministry through the GICC-2 SECALP project	Agence National de la Recherche through the FP6 BiodivERsA Eranet VITAL project; French Ministry through the GICC-2 SECALP project	This work was funded by the Agence National de la Recherche through the FP6 BiodivERsA Eranet VITAL project and by the French Ministry responsible for environment through the GICC-2 SECALP project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Banerjee S, 2013, FRONT ECOL ENVIRON, V11, P297, DOI 10.1890/120044; Barnaud C., 2011, VERTIGO, V11; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Deboeuf E, 2009, ADAPTABILITE SYSTEME, P91; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Diaz S, 2011, P NATL ACAD SCI USA, V108, P895, DOI 10.1073/pnas.1017993108; Dietz T, 2005, ANNU REV ENV RESOUR, V30, P335, DOI 10.1146/annurev.energy.30.050504.144444; Duguma LA, 2011, ENVIRON MANAGE, V47, P969, DOI 10.1007/s00267-011-9657-9; Edwards-Jones G, 2006, ANIM SCI, V82, P783, DOI 10.1017/ASC2006112; Etienne Michel, 2010, MODELISATION ACCOMPA; Feola G, 2010, ECOL ECON, V69, P2323, DOI 10.1016/j.ecolecon.2010.07.023; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Fleury P, 1996, AGR SYST, V52, P199, DOI 10.1016/0308-521X(96)00008-X; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fontaine CM, 2014, J LAND USE SCI, V9, P278, DOI 10.1080/1747423X.2013.786150; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; George A L, 2005, CASE STUDIES THEORY; Girel J., 2010, HIST AGR OISANS HAUT; Haines-Young R, 2010, LINKS BIODIVERSITY E; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Jones NA, 2011, ECOL SOC, V16; Kaiser FG, 2005, J APPL SOC PSYCHOL, V35, P2150, DOI 10.1111/j.1559-1816.2005.tb02213.x; Kumar M, 2008, ECOL ECON, V64, P808, DOI 10.1016/j.ecolecon.2007.05.008; Kumar Pushpam, 2010, EC ECOSYSTEMS BIODIV, DOI DOI 10.1017/S1355770X11000088; Lamarque P, 2014, P NATL ACAD SCI USA, V111, P13751, DOI 10.1073/pnas.1216051111; Lamarque P, 2013, LANDSCAPE URBAN PLAN, V119, P147, DOI 10.1016/j.landurbplan.2013.07.012; Lamarque P, 2011, REG ENVIRON CHANGE, V11, P791, DOI 10.1007/s10113-011-0214-0; Lamarque P, 2011, CR BIOL, V334, P441, DOI 10.1016/j.crvi.2010.11.007; Lauer M, 2010, ENVIRON MANAGE, V45, P985, DOI 10.1007/s00267-010-9471-9; Lavorel S, 2011, J ECOL, V99, P135, DOI 10.1111/j.1365-2745.2010.01753.x; Lewan L, 2002, ECOL ECON, V42, P459, DOI 10.1016/S0921-8009(02)00127-1; Liu JG, 2007, AMBIO, V36, P639, DOI 10.1579/0044-7447(2007)36[639:CHANS]2.0.CO;2; Lugnot M, 2013, REG ENVIRON CHANGE, V13, P1145, DOI 10.1007/s10113-013-0426-6; Mace G.M., 2011, UK NATL ECOSYSTEM AS; Martin-Lopez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038970; Meyfroidt P, 2013, J LAND USE SCI, V8, P341, DOI 10.1080/1747423X.2012.667452; Meyfroidt P, 2013, HUM ECOL, V41, P367, DOI 10.1007/s10745-012-9560-x; Mottet A, 2006, AGR ECOSYST ENVIRON, V114, P296, DOI 10.1016/j.agee.2005.11.017; Nettier B, 2011, FOURRAGES, P283; Nettier B, 2010, REV GEOGR ALP, V98, P383; O'Farrell PJ, 2007, AGR ECOSYST ENVIRON, V122, P312, DOI 10.1016/j.agee.2007.01.025; Poppenborg P, 2013, LAND USE POLICY, V31, P422, DOI 10.1016/j.landusepol.2012.08.007; Quetier, 2006, VULNERABILITE ECOSYS, P269; Quetier F, 2007, ECOL MONOGR, V77, P33, DOI 10.1890/06-0054; Quetier F, 2010, REG ENVIRON CHANGE, V10, P119, DOI 10.1007/s10113-009-0099-3; Reyers B, 2013, FRONT ECOL ENVIRON, V11, P268, DOI 10.1890/120144; Robertson M, 2014, FRONT ECOL ENVIRON, V12, P186, DOI 10.1890/110292; Salzman J, 2001, STAN ENV LJ, V20, P309; St John FAV, 2010, WILDLIFE RES, V37, P658, DOI 10.1071/WR10032; Stern P.C., 1999, HUM ECOL REV, V6, P81; Svarstad H, 2008, LAND USE POLICY, V25, P116, DOI 10.1016/j.landusepol.2007.03.005; TEEB, 2009, EC EC BIOD POL MARK; Tengo M, 2004, ECOL SOC, V9; Termorshuizen JW, 2009, LANDSCAPE ECOL, V24, P1037, DOI 10.1007/s10980-008-9314-8; Vatn A, 2010, ECOL ECON, V69, P1245, DOI 10.1016/j.ecolecon.2009.11.018; Vignola R, 2010, LAND USE POLICY, V27, P1132, DOI 10.1016/j.landusepol.2010.03.003; Vihervaara P, 2010, AMBIO, V39, P314, DOI 10.1007/s13280-010-0048-x; Voinov A, 2010, ENVIRON MODELL SOFTW, V25, P1268, DOI 10.1016/j.envsoft.2010.03.007; von Glasenapp M, 2011, HUM ECOL, V39, P769, DOI 10.1007/s10745-011-9427-6; von Haaren Christina, 2011, International Journal of Biodiversity Science Ecosystem Services & Management, V7, P150, DOI 10.1080/21513732.2011.616534; Wise RM, GLOBAL ENV CHANGE	62	61	62	1	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107572	10.1371/journal.pone.0107572	http://dx.doi.org/10.1371/journal.pone.0107572			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268490	Green Submitted, gold, Green Published			2022-12-27	WOS:000343671700041
J	Navarro, C; Lopez, FJ; Cano, C; Garcia-Alcalde, F; Blanco, A				Navarro, Carmen; Lopez, Francisco J.; Cano, Carlos; Garcia-Alcalde, Fernando; Blanco, Armando			CisMiner: Genome-Wide In-Silico Cis-Regulatory Module Prediction by Fuzzy Itemset Mining	PLOS ONE			English	Article							FACTOR-BINDING SITES; TRANSCRIPTION FACTORS; COMBINATORIAL REGULATION; ASSOCIATION RULES; ELEMENT CLUSTERS; DNA; IDENTIFICATION; DROSOPHILA; EXPRESSION; GENES	Eukaryotic gene control regions are known to be spread throughout non-coding DNA sequences which may appear distant from the gene promoter. Transcription factors are proteins that coordinately bind to these regions at transcription factor binding sites to regulate gene expression. Several tools allow to detect significant co-occurrences of closely located binding sites (cis-regulatory modules, CRMs). However, these tools present at least one of the following limitations: 1) scope limited to promoter or conserved regions of the genome; 2) do not allow to identify combinations involving more than two motifs; 3) require prior information about target motifs. In this work we present CisMiner, a novel methodology to detect putative CRMs by means of a fuzzy itemset mining approach able to operate at genome-wide scale. CisMiner allows to perform a blind search of CRMs without any prior information about target CRMs nor limitation in the number of motifs. CisMiner tackles the combinatorial complexity of genome-wide cis-regulatory module extraction using a natural representation of motif combinations as itemsets and applying the Top-Down Fuzzy Frequent-Pattern Tree algorithm to identify significant itemsets. Fuzzy technology allows CisMiner to better handle the imprecision and noise inherent to regulatory processes. Results obtained for a set of well-known binding sites in the S. cerevisiae genome show that our method yields highly reliable predictions. Furthermore, CisMiner was also applied to putative in-silico predicted transcription factor binding sites to identify significant combinations in S. cerevisiae and D. melanogaster, proving that our approach can be further applied genome-wide to more complex genomes. CisMiner is freely accesible at: http://genome2.ugr.es/cisminer. CisMiner can be queried for the results presented in this work and can also perform a customized cis-regulatory module prediction on a query set of transcription factor binding sites provided by the user.	[Navarro, Carmen; Cano, Carlos; Blanco, Armando] Univ Granada, Dept Comp Sci & AI, Granada, Spain; [Lopez, Francisco J.] Med Genome Project, Andalusian Human Genome Sequencing Ctr CASEGH, Seville, Spain; [Garcia-Alcalde, Fernando] Max Planck Inst Infect Biol, Berlin, Germany	University of Granada; Max Planck Society	Navarro, C (corresponding author), Univ Granada, Dept Comp Sci & AI, Granada, Spain.	cnluzon@decsai.ugr.es	Gutierrez, Carlos Cano/ABH-2343-2020	Navarro Luzon, Carmen/0000-0001-5438-9654	J. A., Sevilla [PI-0710-2013]; DGICT, Madrid [TIN2013-41990-R]	J. A., Sevilla; DGICT, Madrid	This work has been carried out as part of projects PI-0710-2013 of J. A., Sevilla and TIN2013-41990-R of DGICT, Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Arnone MI, 1997, DEVELOPMENT, V124, P1851; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Cameroni E, 2004, CELL CYCLE, V3, P462; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Ceglar A., 2006, ACM COMPUT SURV, V38, P1, DOI DOI 10.1145/1132956.1132958; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Costas J, 2003, GENE, V310, P215, DOI 10.1016/S0378-1119(03)00556-0; Delgado M, 2003, IEEE T FUZZY SYST, V11, P214, DOI 10.1109/TFUZZ.2003.809896; Delgado M, 2003, P BISC INT WORKSH SO; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Deyneko IV, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-241; Emberly E, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-57; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878; Gallo A, 2007, LECT NOTES ARTIF INT, V4702, P438; Ha N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052055; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hazbun TR, 2002, MOL CELL PROTEOMICS, V1, P538, DOI 10.1074/mcp.T200002-MCP200; Herrmann C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks543; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; HERTZ GZ, 1990, COMPUT APPL BIOSCI, V6, P81; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Jegga AG, 2002, GENOME RES, V12, P1408, DOI 10.1101/gr.255002; Jones EA, 2005, J IMMUNOL, V175, P7437, DOI 10.4049/jimmunol.175.11.7437; Kim TS, 2004, MOL CELL BIOL, V24, P7695, DOI 10.1128/MCB.24.17.7695-7706.2004; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Laimer J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-140; Leoncini Mauro, 2013, Learning and Intelligent Optimization. 7th International Conference, LION 7. Revised Selected Papers: LNCS 7997, P196, DOI 10.1007/978-3-642-44973-4_21; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Lopez FJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-107; Lutfiyya LL, 1998, GENETICS, V150, P1377; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Matyash A, 2004, J BIOL CHEM, V279, P30689, DOI 10.1074/jbc.M403345200; Morgan XC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-445; Nandi S, 2013, NUCLEIC ACIDS RES, V41, P8822, DOI 10.1093/nar/gkt578; Naulaerts S, 2015, BRIEF BIOINFORM, V16, P216, DOI 10.1093/bib/bbt074; Nikulova AA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks235; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Pham Tho Hoan, 2004, Genome Inform, V15, P287; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rohr CO, 2013, BIOINFORMATICS, V29, P2852, DOI 10.1093/bioinformatics/btt506; Ronen M, 2006, P NATL ACAD SCI USA, V103, P389, DOI 10.1073/pnas.0509978103; Ryu T, 2007, BIOTECHNOL BIOENG, V97, P1594, DOI 10.1002/bit.21354; Salgado H, 2004, NUCLEIC ACIDS RES, V32, pD303, DOI 10.1093/nar/gkh140; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Santos PM, 2009, PROTEOMICS, V9, P657, DOI 10.1002/pmic.200800452; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Sun H, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks237; Sun H, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S30; Teixeira MC, 2006, FEMS YEAST RES, V6, P230, DOI 10.1111/j.1567-1364.2006.00041.x; Testa A, 2005, J BIOL CHEM, V280, P13606, DOI 10.1074/jbc.M414039200; Tomovic A, 2007, BIOINFORMATICS, V23, P933, DOI 10.1093/bioinformatics/btm055; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Van Loo P, 2009, BRIEF BIOINFORM, V10, P509, DOI 10.1093/bib/bbp025; Vavouri T, 2005, CURR OPIN GENET DEV, V15, P395, DOI 10.1016/j.gde.2005.05.002; Weisser S, 2014, MOL CELL BIOL; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yu Q, 2003, NUCLEIC ACIDS RES, V31, P1224, DOI 10.1093/nar/gkg200; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	70	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108065	10.1371/journal.pone.0108065	http://dx.doi.org/10.1371/journal.pone.0108065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268582	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700062
J	Yan, Y; Shao, XW; Jiang, ZR				Yan, Yan; Shao, Xinwei; Jiang, Zhenran			Inferring Novel Indications of Approved Drugs via a Learning Method with Local and Global Consistency	PLOS ONE			English	Article							GENES	Inferring new indication of approved drugs is critical not only for the elucidation of the interaction mechanisms between these drugs and their associated diseases, but also for the development of drug therapy for various human diseases. This paper proposes a network-based approach to reveal the association between 52 human diseases and potential therapeutic drugs based on multiple types of data. The advantage of the approach is that it can obtain the global relevance features for each drug-disease pair in the network by the learning local and global consistency method (LLGC). Cross-validation tests results demonstrate the proposed approach can achieve better performance comparing with previous methods. More importantly, it provides a promising strategy to maximize the value of therapeutic drugs and offer safe and effective treatments for different diseases.	[Yan, Yan; Jiang, Zhenran] E China Normal Univ, Dept Comp Sci & Technol, Shanghai 200062, Peoples R China; [Shao, Xinwei] E China Normal Univ, Dept Math, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	Jiang, ZR (corresponding author), E China Normal Univ, Dept Comp Sci & Technol, Shanghai 200062, Peoples R China.	zrjiang@cs.ecnu.edu.cn			National Basic Research Program of China [2012CB910400]; Fundamental Research Funds for the Central Universities [78260026]	National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Basic Research Program of China (Grants No. 2012CB910400) and the Fundamental Research Funds for the Central Universities (Grants No. 78260026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen X, 2012, MOL BIOSYST, V8, P1970, DOI 10.1039/c2mb00002d; Chiang AP, 2009, CLIN PHARMACOL THER, V86, P507, DOI 10.1038/clpt.2009.103; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Glaab E, 2010, BIOINFORMATICS, V26, P1271, DOI 10.1093/bioinformatics/btq131; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000450; Lipscomb CE, 2000, B MED LIBR ASSOC, V88, P265; Perlman L, 2011, J COMPUT BIOL, V18, P133, DOI 10.1089/cmb.2010.0213; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shigemizu D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002347; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; van Laarhoven T, 2011, BIOINFORMATICS, V27, P3036, DOI 10.1093/bioinformatics/btr500; Xia Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S6; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Zhou DY, 2004, ADV NEUR IN, V16, P321	22	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107100	10.1371/journal.pone.0107100	http://dx.doi.org/10.1371/journal.pone.0107100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268268	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700029
J	Benamara, H; Rihouey, C; Abbes, I; Ben Mlouka, MA; Hardouin, J; Jouenne, T; Alexandre, S				Benamara, Hayette; Rihouey, Christophe; Abbes, Imen; Ben Mlouka, Mohamed Amine; Hardouin, Julie; Jouenne, Thierry; Alexandre, Stephane			Characterization of Membrane Lipidome Changes in Pseudomonas aeruginosa during Biofilm Growth on Glass Wool	PLOS ONE			English	Article							OUTER-MEMBRANE; ANTIBIOTIC-RESISTANCE; BACTERIAL BIOFILMS; MECHANISMS; CELLS	Bacteria cells within biofilms are physiologically distinct from their planktonic counterparts. In particular they are more resistant to detrimental environmental conditions. In this study, we monitored the evolution of the phospholipid composition of the inner and outer membranes of P. aeruginosa during the biofilm formation (i. e., from 1-, 2-, to 6-day-old biofilm). Lipidome analyses were performed by electrospray ionization mass spectrometry. In addition to the lipidomic analysis, the fatty acid composition was analysed by gas chromatography/mass spectrometry. We found that the lipidome alterations of the inner and the outer membranes varied with the biofilm age. These alterations in phospholipid compositions reflect a higher diversity in sessile organisms than in planktonic counterparts. The diversity is characterized by the presence of PE 30:1, PE 31:0 and PG 31:0 for the lower masses as well as PE 38:1, 38:2, 39:1, 39:2 and PG 38:0, 38:1, 38:2, 39:1, 39:2 for the higher masses. However, this lipidomic feature tends to disappear with the biofilm age, in particular the high mass phospholipids tend to disappear. The amount of branched chains phospholipids mainly located in the outer membrane decreased with the biofilm age, whereas the proportion of cyclopropylated phospholipids increased in both membranes. In bacteria present in oldest biofilms, i.e., 6-day-old, the phospholipid distribution moved closer to that of planktonic bacteria.	[Benamara, Hayette; Rihouey, Christophe; Abbes, Imen; Ben Mlouka, Mohamed Amine; Hardouin, Julie; Jouenne, Thierry; Alexandre, Stephane] Univ Rouen, CNRS, UMR 6270, Surfaces Lab, Mont St Aignan, France; [Benamara, Hayette; Rihouey, Christophe; Abbes, Imen; Ben Mlouka, Mohamed Amine; Hardouin, Julie; Jouenne, Thierry; Alexandre, Stephane] Normandie Univ, Mont St Aignan, France; [Rihouey, Christophe; Ben Mlouka, Mohamed Amine; Hardouin, Julie; Jouenne, Thierry] Univ Rouen, IRIB, PISSARO Prote Facil, Mont St Aignan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rouen Normandie; Universite de Rouen Normandie	Alexandre, S (corresponding author), Univ Rouen, CNRS, UMR 6270, Surfaces Lab, Mont St Aignan, France.	stephane.alexandre@univ-rouen.fr		ALEXANDRE, Stephane/0000-0003-0717-8592; Hardouin, Julie/0000-0003-4588-9811; jouenne, thierry/0000-0003-0994-9944	CNRS (Centre National de la Recherche Scientifique); MESR (Ministere de l'Enseignement Superieur et de la Recherche)	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); MESR (Ministere de l'Enseignement Superieur et de la Recherche)(Ministry of Research, France)	Financial support came from the CNRS (Centre National de la Recherche Scientifique) and from the MESR (Ministere de l'Enseignement Superieur et de la Recherche). H. Benamara and I. Abbes were supported by a MESR grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benamara H, 2011, BBA-BIOMEMBRANES, V1808, P98, DOI 10.1016/j.bbamem.2010.09.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chao J, 2010, CAN J MICROBIOL, V56, P1028, DOI 10.1139/W10-093; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Denich TJ, 2003, J MICROBIOL METH, V52, P149, DOI 10.1016/S0167-7012(02)00155-0; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Folsom JP, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-294; Hoffmann M, 2008, J BIOL CHEM, V283, P22352, DOI 10.1074/jbc.M802377200; Junter GA, 2004, BIOTECHNOL ADV, V22, P633, DOI 10.1016/j.biotechadv.2004.06.003; KAWAI Y, 1988, EUR J BIOCHEM, V175, P633; Lambert PA, 2002, J ROY SOC MED, V95, P22; Lattif AA, 2011, MICROBIOL-SGM, V157, P3232, DOI 10.1099/mic.0.051086-0; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Milne S, 2006, METHODS, V39, P92, DOI 10.1016/j.ymeth.2006.05.014; MIZUNO T, 1978, J BIOCHEM, V84, P179, DOI 10.1093/oxfordjournals.jbchem.a132106; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Petrova OE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000668; RAHEJA RK, 1973, J LIPID RES, V14, P695; Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x; Schierholz JM, 1999, J ANTIMICROB CHEMOTH, V43, P158, DOI 10.1093/jac/43.1.158; Steger K, 2003, J MICROBIOL METH, V55, P371, DOI 10.1016/S0167-7012(03)00187-8; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; TUMMLER B, 1991, J CLIN MICROBIOL, V29, P1265; Vasseur P, 2007, BIOCHIMIE, V89, P903, DOI 10.1016/j.biochi.2007.04.002; Vilain S, 2004, ANAL BIOCHEM, V329, P120, DOI 10.1016/j.ab.2004.02.014; Vilain S, 2004, J PROTEOME RES, V3, P132, DOI 10.1021/pr034044t; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Zhang B, 2012, FUTURE MED CHEM, V4, P1273, DOI [10.4155/FMC.12.59, 10.4155/fmc.12.59]	32	38	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108478	10.1371/journal.pone.0108478	http://dx.doi.org/10.1371/journal.pone.0108478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265483	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400077
J	Elobaid, YE; Aw, TC; Grivna, M; Nagelkerke, N				Elobaid, Yusra E.; Aw, Tar Ching; Grivna, Michal; Nagelkerke, Nico			Breast Cancer Screening Awareness, Knowledge, and Practice among Arab Women in the United Arab Emirates: A Cross-Sectional Survey	PLOS ONE			English	Article							COUNTRIES	Background: Breast cancer screening can reduce morbidity and mortality and improve the survival rate for this malignancy. Low participation in screening programs has been attributable to many factors including lack of knowledge. The aim of this study was to assess breast cancer screening knowledge, attitudes and practices among women of screening age (>= 40 years old) in the city of Al Ain, United Arab Emirates (UAE). Methods: A cross-sectional survey was conducted in 2013 using the Breast Cancer Awareness Measure (CAM). Four out of twelve cultural and religious community centers in Al Ain city were randomly selected. Two hundred and forty seven women were interviewed. Chi Square test and regression analysis were used to analyze the data. Results: Despite the increase in the uptake of screening modalities in our study group, a lack of knowledge about breast cancer screening is still evident. Almost half (44.8%) of women who never had a Clinical Breast Exam (CBE) and 44.1% of women who never had a mammography expressed a lack of knowledge about the existence of these screening techniques. Nearly one third of the participants interpreted the presence of a breast lump incorrectly and, moreover, expressed fewer worries about the nature of the lump than would normally be expected. Conclusions: The National screening program needs to be improved and directed towards more efficient and targeted utilization of resources. Healthcare professionals play a major role in alerting women to the importance of periodic screening.	[Elobaid, Yusra E.; Aw, Tar Ching; Grivna, Michal; Nagelkerke, Nico] United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates	United Arab Emirates University	Elobaid, YE (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates.	yusraelobaid@hotmail.com	Elobaid, Yusra/A-7726-2019	Elobaid, Yusra/0000-0002-1531-7743; Grivna, Michal/0000-0003-2349-0922	UAE University [31M104]	UAE University	This study was funded by an interdisciplinary UAE University grant (NO. 31M104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin TT, 2009, ASIAN PAC J CANCER P, V10, P133; Anderson BO, 2008, WORLD J SURG, V32, P2578, DOI 10.1007/s00268-007-9454-z; Anderson Benjamin O, 2003, Breast J, V9 Suppl 2, pS40, DOI 10.1046/j.1524-4741.9.s2.2.x; Azaiza F, 2006, J WOMENS HEALTH, V15, P520, DOI 10.1089/jwh.2006.15.520; Bener A, 2001, J CANCER EDUC, V16, P215; Bener A, 2009, ASIAN PAC J CANCER P, V10, P599; Cancer research UK, 2008, CANC AW MEAS CAM; Davis TC, 1996, CANCER-AM CANCER SOC, V78, P1912, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1912::AID-CNCR11>3.0.CO;2-0; Dundar PE, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-43; Fakhro A E, 1999, East Mediterr Health J, V5, P430; FLETCHER SW, 1993, J NATL CANCER I, V85, P1644, DOI 10.1093/jnci/85.20.1644; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Friedman LC, 1999, GEN HOSP PSYCHIAT, V21, P374, DOI 10.1016/S0163-8343(99)00036-5; Najjar H, 2010, INT J SURG, V8, P448, DOI 10.1016/j.ijsu.2010.05.012; Pearlman DN, 2008, WOMEN HLTH, V28, P37, DOI [10.1300/J013v28n04, DOI 10.1300/J013V28N04]; Radi SM, 2013, ASIAN PAC J CANCER P, V14, P4307, DOI 10.7314/APJCP.2013.14.7.4307; Sadler GR, 2001, PUBLIC HEALTH NURS, V18, P357, DOI 10.1046/j.1525-1446.2001.00357.x; Smith RA, 2010, BREAST J S1, V12, pS16; Statistics Canada, 2009, UPD MAMM US CAN; Stockton D, 1997, BMJ-BRIT MED J, V314, P70; Taher J, 2008, COMMUNITY PROFILE SU; Thomas S M, 1995, J La State Med Soc, V147, P149; WHO, 2008, WORLD HLTH STAT	23	43	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e105783	10.1371/journal.pone.0105783	http://dx.doi.org/10.1371/journal.pone.0105783			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265385	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400005
J	Bradbury, IR; Bowman, S; Borza, T; Snelgrove, PVR; Hutchings, JA; Berg, PR; Rodriguez-Ezpeleta, N; Lighten, J; Ruzzante, DE; Taggart, C; Bentzen, P				Bradbury, Ian R.; Bowman, Sharen; Borza, Tudor; Snelgrove, Paul V. R.; Hutchings, Jeffrey A.; Berg, Paul R.; Rodriguez-Ezpeleta, Naiara; Lighten, Jackie; Ruzzante, Daniel E.; Taggart, Christopher; Bentzen, Paul			Long Distance Linkage Disequilibrium and Limited Hybridization Suggest Cryptic Speciation in Atlantic Cod	PLOS ONE			English	Article							GENOMIC DIVERGENCE; GENE FLOW; LOCAL ADAPTATION; ISLANDS; HITCHHIKING; EVOLUTION; SELECTION; REVEALS; PROGRAM; CONSEQUENCES	Hybrid zones provide unprecedented opportunity for the study of the evolution of reproductive isolation, and the extent of hybridization across individuals and genomes can illuminate the degree of isolation. We examine patterns of interchromosomal linkage disequilibrium (ILD) and the presence of hybridization in Atlantic cod, Gadus morhua, in previously identified hybrid zones in the North Atlantic. Here, previously identified clinal loci were mapped to the cod genome with most (similar to 70%) occurring in or associated with (<5 kb) coding regions representing a diverse array of possible functions and pathways. Despite the observation that clinal loci were distributed across three linkage groups, elevated ILD was observed among all groups of clinal loci and strongest in comparisons involving a region of low recombination along linkage group 7. Evidence of ILD supports a hypothesis of divergence hitchhiking transitioning to genome hitchhiking consistent with reproductive isolation. This hypothesis is supported by Bayesian characterization of hybrid classes present and we find evidence of common F1 hybrids in several regions consistent with frequent interbreeding, yet little evidence of F2 or backcrossed individuals. This work suggests that significant barriers to hybridization and introgression exist among these co-occurring groups of cod either through strong selection against hybrid individuals, or genetic incompatibility and intrinsic barriers to hybridization. In either case, the presence of strong clinal trends, and little gene flow despite extensive hybridization supports a hypothesis of reproductive isolation and cryptic speciation in Atlantic cod. Further work is required to test the degree and nature of reproductive isolation in this species.	[Bradbury, Ian R.] Fisheries & Oceans Canada, St John, NF, Canada; [Hutchings, Jeffrey A.; Lighten, Jackie; Ruzzante, Daniel E.; Bentzen, Paul] Dalhousie Univ, Dept Biol, Marine Gene Probe Lab, Halifax, NS, Canada; [Bowman, Sharen; Borza, Tudor] Atlantic Genome Ctr, Halifax, NS, Canada; [Bradbury, Ian R.; Snelgrove, Paul V. R.] Mem Univ Newfoundland, Ctr Ocean Sci, St John, NF, Canada; [Berg, Paul R.] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Rodriguez-Ezpeleta, Naiara] AZTI Tecnalia, Div Marine Res, Sukarrieta, Spain; [Taggart, Christopher] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada	Fisheries & Oceans Canada; Dalhousie University; Memorial University Newfoundland; University of Oslo; AZTI; Dalhousie University	Bradbury, IR (corresponding author), Fisheries & Oceans Canada, St John, NF, Canada.	ibradbur@me.ca	Borza, Tudor/A-8510-2012; Berg, Paul/A-3648-2011; Hutchings, Jeffrey/ABA-1098-2020; Borza, Tudor/M-4937-2019; Berg, Paul Ragnar/Q-1584-2019; Rodriguez-Ezpeleta, Naiara/B-7138-2014	Borza, Tudor/0000-0002-2527-6551; Berg, Paul/0000-0002-4974-8509; Borza, Tudor/0000-0002-2527-6551; Berg, Paul Ragnar/0000-0002-4974-8509; Rodriguez-Ezpeleta, Naiara/0000-0001-6735-6755; Bentzen, Paul/0000-0003-4288-7730; Lighten, Jackie/0000-0002-4228-1037; Hutchings, Jeffrey/0000-0003-1572-5429; Ruzzante, Daniel/0000-0002-8536-8335	Genome Canada; Genome Atlantic; Atlantic Canada Opportunities Agency through the Atlantic Cod Genomics and Broodstock Development Project; NSERC	Genome Canada(Genome Canada); Genome Atlantic; Atlantic Canada Opportunities Agency through the Atlantic Cod Genomics and Broodstock Development Project; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Research was supported in part by Genome Canada, Genome Atlantic and the Atlantic Canada Opportunities Agency through the Atlantic Cod Genomics and Broodstock Development Project. Supporting organizations include industrial partners (e.g., Ag West Bio Tech, SUN Microsystems, IBM, and pharmaceutical and biotechnology companies), and a complete list of supporting partners can be found at www.codgene.ca/partners.php. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders, including commercial partners, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Research funding and support was also provided by an NSERC Strategic Grant on Connectivity in Marine Fish and an NSERC Discovery Grant.	Adagu IS, 2001, PARASITOLOGY, V123, P219, DOI 10.1017/S0031182001008344; Anderson EC, 2002, GENETICS, V160, P1217; ARNOLD ML, 1997, OXFORD SERIES ECOLOG; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Barton NH, 1993, HYBRID ZONES EVOLUTI, P13, DOI DOI 10.1111/J.1558-5646.2009.00849.X; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Borza Tudor, 2010, BMC Research Notes, V3, DOI 10.1186/1756-0500-3-261; Bowman S, 2011, MAR BIOTECHNOL, V13, P242, DOI 10.1007/s10126-010-9285-z; Bradbury IR, 2013, EVOL APPL, V6, P450, DOI 10.1111/eva.12026; Bradbury IR, 2011, MOL ECOL RESOUR, V11, P218, DOI 10.1111/j.1755-0998.2010.02949.x; Bradbury IR, 2010, P ROY SOC B-BIOL SCI, V277, P3725, DOI 10.1098/rspb.2010.0985; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; COSEWIC, 2010, COSEWIC ASS UPD STAT; CRAWFORD DL, 1990, J EXP ZOOL, V255, P110, DOI 10.1002/jez.1402550114; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feder JL, 2013, J EVOLUTION BIOL, V26, P261, DOI 10.1111/jeb.12009; Feder JL, 2013, ANNU REV ECOL EVOL S, V44, P73, DOI 10.1146/annurev-ecolsys-110512-135825; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Feder JL, 2010, EVOLUTION, V64, P1729, DOI [10.1111/j.1558-5646.2009.00943.x, 10.1111/j.1558-5646.2010.00943.x]; Fierst JL, 2010, EVOLUTION, V64, P675, DOI 10.1111/j.1558-5646.2009.00861.x; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Gompert Z, 2012, PHILOS T R SOC B, V367, P439, DOI 10.1098/rstb.2011.0196; Hahn MW, 2012, PHILOS T R SOC B, V367, P374, DOI 10.1098/rstb.2011.0188; Hemmer-Hansen J, 2013, MOL ECOL, V22, P2653, DOI 10.1111/mec.12284; Hohenlohe PA, 2012, PHILOS T R SOC B, V367, P395, DOI 10.1098/rstb.2011.0245; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Hubert S, 2009, AQUACULTURE, V296, P7, DOI 10.1016/j.aquaculture.2009.07.027; Hutchings JA, 2007, P ROY SOC B-BIOL SCI, V274, P1693, DOI 10.1098/rspb.2007.0263; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Knutsen H, 2003, MOL ECOL, V12, P385, DOI 10.1046/j.1365-294X.2003.01750.x; Lamichhaney S, 2012, P NATL ACAD SCI USA, V109, P19345, DOI 10.1073/pnas.1216128109; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; McGaugh SE, 2012, PHILOS T R SOC B, V367, P422, DOI 10.1098/rstb.2011.0250; Michel AP, 2010, P NATL ACAD SCI USA, V107, P9724, DOI 10.1073/pnas.1000939107; Nadeau NJ, 2013, MOL ECOL, V22, P814, DOI 10.1111/j.1365-294X.2012.05730.x; Navarro A, 2003, SCIENCE, V300, P321, DOI 10.1126/science.1080600; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Nielsen EE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-276; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nosil P, 2012, PHILOS T R SOC B, V367, P332, DOI 10.1098/rstb.2011.0263; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Pampoulie C, 2006, CAN J FISH AQUAT SCI, V63, P2660, DOI 10.1139/F06-150; Pritchard JK, 2000, GENETICS, V155, P945; Purchase CF, 2000, CAN J FISH AQUAT SCI, V57, P2223, DOI 10.1139/cjfas-57-11-2223; Robbins MD, 2011, J EXP BOT, V62, P1831, DOI 10.1093/jxb/erq367; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schmidt PS, 2008, ECOLOGY, V89, pS91, DOI 10.1890/07-1162.1; Sotka EE, 2004, MOL ECOL, V13, P2143, DOI 10.1111/j.1365-294X.2004.02225.x; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Taggart CT, 1996, MICROSATELLITE GENET, P13; Therkildsen NO, 2013, EVOL APPL, V6, P690, DOI 10.1111/eva.12055; Turner TL, 2010, MOL ECOL, V19, P848, DOI 10.1111/j.1365-294X.2010.04532.x; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x; Via S, 2012, PHILOS T R SOC B, V367, P451, DOI 10.1098/rstb.2011.0260; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x	61	30	30	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e106380	10.1371/journal.pone.0106380	http://dx.doi.org/10.1371/journal.pone.0106380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259573	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000342685600006
J	Louber, J; Kowalinski, E; Bloyet, LM; Brunel, J; Cusack, S; Gerlier, D				Louber, Jade; Kowalinski, Eva; Bloyet, Louis-Marie; Brunel, Joanna; Cusack, Stephen; Gerlier, Denis			RIG-I Self-Oligomerization Is Either Dispensable or Very Transient for Signal Transduction	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; MEASLES-VIRUS PHOSPHOPROTEIN; INNATE IMMUNE-RESPONSE; C-TERMINAL DOMAINS; STRUCTURAL BASIS; VIRAL-RNA; PATTERN-RECOGNITION; RECEPTOR; ACTIVATION	Effective host defence against viruses depends on the rapid triggering of innate immunity through the induction of a type I interferon (IFN) response. To this end, microbe-associated molecular patterns are detected by dedicated receptors. Among them, the RIG-I-like receptors RIG-I and MDA5 activate IFN gene expression upon sensing viral RNA in the cytoplasm. While MDA5 forms long filaments in vitro upon activation, RIG-I is believed to oligomerize after RNA binding in order to transduce a signal. Here, we show that in vitro binding of synthetic RNA mimicking that of Mononegavirales (Ebola, rabies and measles viruses) leader sequences to purified RIG-I does not induce RIG-I oligomerization. Furthermore, in cells devoid of endogenous functional RIG-I-like receptors, after activation of exogenous Flag-RIG-I by a 62-mer-5'ppp-dsRNA or by polyinosinic: polycytidylic acid, a dsRNA analogue, or by measles virus infection, anti-Flag immunoprecipitation and specific elution with Flag peptide indicated a monomeric form of RIG-I. Accordingly, when using the Gaussia Luciferase-Based Protein Complementation Assay (PCA), a more sensitive in cellula assay, no RIG-I oligomerization could be detected upon RNA stimulation. Altogether our data indicate that the need for self-oligomerization of RIG-I for signal transduction is either dispensable or very transient.	[Louber, Jade; Bloyet, Louis-Marie; Brunel, Joanna; Gerlier, Denis] Univ Lyon 1, Ctr Int Rech Infectiol, INSERM, U1111,CNRS,UMR5308,ENS Lyon, F-69365 Lyon, France; [Kowalinski, Eva; Cusack, Stephen] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; [Kowalinski, Eva; Cusack, Stephen] UJF EMBL CNRS, Unit Virus Host Cell Interact, UMI 3265, Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Gerlier, D (corresponding author), Univ Lyon 1, Ctr Int Rech Infectiol, INSERM, U1111,CNRS,UMR5308,ENS Lyon, F-69365 Lyon, France.	denis.gerlier@inserm.fr	Gerlier, Denis/L-6094-2014; BRUNEL, JOANNA/C-6322-2015; Bloyet, Louis-Marie/AAB-6244-2022	Gerlier, Denis/0000-0001-5539-456X; BRUNEL, JOANNA/0000-0002-3978-9833; Bloyet, Louis-Marie/0000-0002-5648-3190; Kowalinski, Eva/0000-0002-9785-9027; Cusack, Stephen/0000-0002-9324-0796	FINOVI foundation; ANR (CARDINNATE)	FINOVI foundation; ANR (CARDINNATE)(French National Research Agency (ANR))	This work was supported by grant from FINOVI foundation and ANR (CARDINNATE grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Beckham SA, 2013, NUCLEIC ACIDS RES, V41, P3436, DOI 10.1093/nar/gks1477; Binder M, 2011, J BIOL CHEM, V286, P27278, DOI 10.1074/jbc.M111.256974; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blocquel D, 2012, PROTEIN SCI, V21, P1577, DOI 10.1002/pro.2138; Brunel J, 2014, J VIROL, V88, P10851, DOI 10.1128/JVI.00664-14; Cassonnet P, 2011, NAT METHODS, V8, P990, DOI 10.1038/nmeth.1773; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen MZ, 2005, J VIROL, V79, P11824, DOI 10.1128/JVI.79.18.11824-11836.2005; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Dixit E, 2013, ADV IMMUNOL, V117, P99, DOI 10.1016/B978-0-12-410524-9.00004-9; Eguchi H, 2000, CLIN CANCER RES, V6, P2881; Fitzgerald ME, 2014, CURR OPIN MICROBIOL, V20, P76, DOI 10.1016/j.mib.2014.05.004; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gely S, 2010, J MOL RECOGNIT, V23, P435, DOI 10.1002/jmr.1010; Gerlier D, 2011, MICROBIOL MOL BIOL R, V75, P468, DOI 10.1128/MMBR.00007-11; GIRAUDON P, 1988, VIRUS RES, V10, P137, DOI 10.1016/0168-1702(88)90011-1; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Imaizumi T, 2002, BIOCHEM BIOPH RES CO, V292, P274, DOI 10.1006/bbrc.2002.6650; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; Kohlway A, 2013, EMBO REP, V14, P772, DOI 10.1038/embor.2013.108; Kolakofsky D, 2012, RNA, V18, P2118, DOI 10.1261/rna.035949.112; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Li XJ, 2009, ARCH BIOCHEM BIOPHYS, V488, P23, DOI 10.1016/j.abb.2009.06.008; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Longhi S, 2009, CURR TOP MICROBIOL, V329, P103; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Marq JB, 2011, J BIOL CHEM, V286, P6108, DOI 10.1074/jbc.M110.186262; Marq JB, 2010, J BIOL CHEM, V285, P18208, DOI 10.1074/jbc.M109.089425; Moresco EMY, 2010, P NATL ACAD SCI USA, V107, P1261, DOI 10.1073/pnas.0914011107; Onoguchi K, 2011, J INTERF CYTOK RES, V31, P27, DOI 10.1089/jir.2010.0057; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Patel JR, 2013, EMBO REP, V14, P780, DOI 10.1038/embor.2013.102; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Peisley A, 2013, MOL CELL, V51, P573, DOI 10.1016/j.molcel.2013.07.024; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Ranjan P, 2009, TRENDS MOL MED, V15, P359, DOI 10.1016/j.molmed.2009.06.003; Ranjith-Kumar CT, 2009, J BIOL CHEM, V284, P1155, DOI 10.1074/jbc.M806219200; Rawling DC, 2014, CURR OPIN STRUC BIOL, V25, P25, DOI 10.1016/j.sbi.2013.11.011; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Runge S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004081; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Shu YL, 2012, J BIOL CHEM, V287, P11951, DOI 10.1074/jbc.M111.333088; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takahasi K, 2009, J BIOL CHEM, V284, P17465, DOI 10.1074/jbc.M109.007179; Vela A, 2012, J BIOL CHEM, V287, P42564, DOI 10.1074/jbc.M112.385146; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Weber M, 2013, CELL HOST MICROBE, V13, P336, DOI 10.1016/j.chom.2013.01.012; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Yasumura Y., 1963, NIHON RINSHO, V21, P1201; Yoneyama M, 2007, CYTOKINE GROWTH F R, V18, P545, DOI 10.1016/j.cytogfr.2007.06.023; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; ZIMM BH, 1948, J PHYS COLLOID CHEM, V52, P260	65	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108770	10.1371/journal.pone.0108770	http://dx.doi.org/10.1371/journal.pone.0108770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259935	gold, Green Published, Green Submitted			2022-12-27	WOS:000342685600100
J	Risitano, R; Curro, M; Cirmi, S; Ferlazzo, N; Campiglia, P; Caccamo, D; Ientile, R; Navarra, M				Risitano, Roberto; Curro, Monica; Cirmi, Santa; Ferlazzo, Nadia; Campiglia, Pietro; Caccamo, Daniela; Ientile, Riccardo; Navarra, Michele			Flavonoid Fraction of Bergamot Juice Reduces LPS-Induced Inflammatory Response through SIRT1-Mediated NF-kappa B Inhibition in THP-1 Monocytes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; IN-VITRO; POLYPHENOLS; DEACETYLASES; ACETYLATION; ACTIVATION; NUTRITION; CELLS	Plant polyphenols exert anti-inflammatory activity through both anti-oxidant effects and modulation of pivotal pro-inflammatory genes. Recently, Citrus bergamia has been studied as a natural source of bioactive molecules with antioxidant activity, but few studies have focused on molecular mechanisms underlying their potential beneficial effects. Several findings have suggested that polyphenols could influence cellular function by acting as activators of SIRT1, a nuclear histone deacetylase, involved in the inhibition of NF-kappa B signaling. On the basis of these observations we studied the anti-inflammatory effects produced by the flavonoid fraction of the bergamot juice (BJe) in a model of LPS-stimulated THP-1 cell line, focusing on SIRT1-mediated NF-kappa B inhibition. We demonstrated that BJe inhibited both gene expression and secretion of LPS-induced pro-inflammatory cytokines (IL-6, IL-1b, TNF-alpha) by a mechanism involving the inhibition of NF-kappa B activation. In addition, we showed that BJe treatment reversed the LPS-enhanced acetylation of p65 in THP-1 cells. Interestingly, increasing concentrations of Sirtinol were able to suppress the inhibitory effect of BJe via p65 acetylation, underscoring that NF-kappa B-mediated inflammatory cytokine production may be directly linked to SIRT1 activity. These results suggest that BJe may be useful for the development of alternative pharmacological strategies aimed at reducing the inflammatory process.	[Cirmi, Santa; Ferlazzo, Nadia; Navarra, Michele] Univ Messina, Dept Drug Sci & Prod Hlth, Messina, Italy; [Risitano, Roberto; Curro, Monica; Caccamo, Daniela; Ientile, Riccardo] Univ Messina, Dept Biomed Sci & Morphofunct Imaging, Messina, Italy; [Campiglia, Pietro] Univ Salerno, Dept Pharmaceut & Biomed Sci, I-84100 Salerno, Italy	University of Messina; University of Messina; University of Salerno	Navarra, M (corresponding author), Univ Messina, Dept Drug Sci & Prod Hlth, Messina, Italy.	mnavarra@unime.it	Campiglia, Pietro/J-5625-2018; Caccamo, Daniela/A-5249-2018; Ientile, Riccardo/AAL-6349-2020	Caccamo, Daniela/0000-0001-8593-9495; Curro, Monica/0000-0001-8852-7023; Navarra, Michele/0000-0002-6492-7820; Campiglia, Pietro/0000-0002-1069-2181; Ientile, Riccardo/0000-0003-2067-0418	Sicily Region (PO FESR Sicilia) [CUP G73F11000050004]	Sicily Region (PO FESR Sicilia)	Research was supported by a grant from Sicily Region (PO FESR Sicilia 2007/2013, CUP G73F11000050004 to MN, project "MEPRA", no 133 of Linea d'Intervento 4.1.1.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bengmark S, 2006, CURR OPIN CLIN NUTR, V9, P2, DOI 10.1097/01.mco.0000171129.29278.26; Chanput W, 2010, FOOD FUNCT, V1, P254, DOI 10.1039/c0fo00113a; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Corasaniti MT, 2007, BRIT J PHARMACOL, V151, P518, DOI 10.1038/sj.bjp.0707237; Delle Monache S, 2013, PLOS ONE, V8; Eberhardt MV, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Gonzalez R, 2011, CRIT REV FOOD SCI, V51, P331, DOI 10.1080/10408390903584094; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Harborne J. B., 1990, CIBA F SYMP, V154, P126; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hegde PS, 2004, DRUG DISCOV TODAY, V9, pS53; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim DO, 2002, J AGR FOOD CHEM, V50, P3713, DOI 10.1021/jf020071c; Kim D, 2014, MOL IMMUNOL, V57, P210, DOI 10.1016/j.molimm.2013.09.009; Kostyuk VA, 2011, EUR J PHARMACOL, V658, P248, DOI 10.1016/j.ejphar.2011.02.022; Manabe I, 2011, CIRC J, V75, P2739, DOI 10.1253/circj.CJ-11-1184; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Manach C, 2005, CURR OPIN LIPIDOL, V16, P77, DOI 10.1097/00041433-200502000-00013; Miceli N, 2007, J AGR FOOD CHEM, V55, P10671, DOI 10.1021/jf071772i; Middleton E, 2000, PHARMACOL REV, V52, P673; Mollace V, 2011, FITOTERAPIA, V82, P309, DOI 10.1016/j.fitote.2010.10.014; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Navarra M, 2014, FITOTERAPIA, V95, P83, DOI 10.1016/j.fitote.2014.02.009; Potapovich AI, 2011, TOXICOL APPL PHARM, V255, P138, DOI 10.1016/j.taap.2011.06.007; Prasad S, 2012, PREV MED, V54, pS29, DOI 10.1016/j.ypmed.2011.11.011; Sakharwade SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076583; Schildberger A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/697972; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Sommella E, 2013, J SEP SCI, V36, P3351, DOI 10.1002/jssc.201300591; Trapp J, 2006, J MED CHEM, V49, P7307, DOI 10.1021/jm060118b; Tripathi P, 2006, CURR SCI INDIA, V90, P519; Visalli G, 2014, ANTICANCER AGENTS ME, V14; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Xie J, 2013, PHARMACOL RES, V67, P60, DOI 10.1016/j.phrs.2012.10.010; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yao HW, 2012, BIOCHEM PHARMACOL, V84, P1332, DOI 10.1016/j.bcp.2012.06.031	43	78	81	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107431	10.1371/journal.pone.0107431	http://dx.doi.org/10.1371/journal.pone.0107431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25260046	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600020
J	Torres-Barcelo, C; Arias-Sanchez, FI; Vasse, M; Ramsayer, J; Kaltz, O; Hochberg, ME				Torres-Barcelo, Clara; Arias-Sanchez, Flor I.; Vasse, Marie; Ramsayer, Johan; Kaltz, Oliver; Hochberg, Michael E.			A Window of Opportunity to Control the Bacterial Pathogen Pseudomonas aeruginosa Combining Antibiotics and Phages	PLOS ONE			English	Article							DRUG-INTERACTIONS; IN-VITRO; RESISTANCE; EVOLUTION; BACTERIOPHAGE; THERAPY; FLUORESCENS; POPULATIONS; SELECTION; EXPOSURE	The evolution of antibiotic resistance in bacteria is a global concern and the use of bacteriophages alone or in combined therapies is attracting increasing attention as an alternative. Evolutionary theory predicts that the probability of bacterial resistance to both phages and antibiotics will be lower than to either separately, due for example to fitness costs or to trade-offs between phage resistance mechanisms and bacterial growth. In this study, we assess the population impacts of either individual or combined treatments of a bacteriophage and streptomycin on the nosocomial pathogen Pseudomonas aeruginosa. We show that combining phage and antibiotics substantially increases bacterial control compared to either separately, and that there is a specific time delay in antibiotic introduction independent of antibiotic dose, that minimizes both bacterial density and resistance to either antibiotics or phage. These results have implications for optimal combined therapeutic approaches.	[Torres-Barcelo, Clara; Arias-Sanchez, Flor I.; Vasse, Marie; Ramsayer, Johan; Kaltz, Oliver; Hochberg, Michael E.] Univ Montpellier 2, CNRS, Inst Sci Evolut, Montpellier, France; [Hochberg, Michael E.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Hochberg, Michael E.] Wissenshaftskolleg Berlin, Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; The Santa Fe Institute	Torres-Barcelo, C (corresponding author), Univ Montpellier 2, CNRS, Inst Sci Evolut, Montpellier, France.	clara.torres@univ-montp2.fr; mhochber@univ-montp2.fr		Torres-Barcelo, Clara/0000-0003-2116-1471; Vasse, Marie/0000-0003-4081-6664; Arias-Sanchez, Flor I./0000-0003-4422-7496	McDonnell Foundation [JSMF 220020294/SCS]; Agence National de la Recherche [ANR-09-PEXT-011, ANR-09-BLAN-099-01]; Erasmus Mundus Masters Programme; CONACyT	McDonnell Foundation; Agence National de la Recherche(French National Research Agency (ANR)); Erasmus Mundus Masters Programme; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the McDonnell Foundation (JSMF 220020294/SCS-Research Award), Agence National de la Recherche for funding ('EVORANGE' (ANR-09-PEXT-011) and 'EvolStress' (ANR-09-BLAN-099-01)), Erasmus Mundus Masters Programme and the CONACyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2013, TRENDS MICROBIOL, V21, P114, DOI 10.1016/j.tim.2012.11.001; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Betts A, 2013, EVOL APPL, V6, P1054, DOI 10.1111/eva.12085; Bourguet D, 2013, TRENDS ECOL EVOL, V28, P110, DOI 10.1016/j.tree.2012.09.001; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Brockhurst MA, 2005, P ROY SOC B-BIOL SCI, V272, P1385, DOI 10.1098/rspb.2005.3086; Brown EM, 2013, NAT IMMUNOL, V14, P660, DOI 10.1038/ni.2611; Cairns BJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000253; Canton R, 2011, FEMS MICROBIOL REV, V35, P977, DOI 10.1111/j.1574-6976.2011.00295.x; Ceyssens PJ, 2010, VIROLOGY, V405, P26, DOI 10.1016/j.virol.2010.06.011; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/FMB.13.47, 10.2217/fmb.13.47]; Cottarel G, 2007, TRENDS BIOTECHNOL, V25, P547, DOI 10.1016/j.tibtech.2007.09.004; De Paepe M, 2006, PLOS BIOL, V4, P1248, DOI 10.1371/journal.pbio.0040193; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Escobar-Paramo P, 2012, EVOL APPL, V5, P583, DOI 10.1111/j.1752-4571.2012.00248.x; Filippov AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025486; Fischbach MA, 2011, CURR OPIN MICROBIOL, V14, P519, DOI 10.1016/j.mib.2011.08.003; Garcia-Quintanilla M, 2013, TRENDS MICROBIOL, V21, P157, DOI 10.1016/j.tim.2012.12.002; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P3781, DOI 10.1128/AAC.01533-06; Hall AR, 2012, APPL ENVIRON MICROB, V78, P5646, DOI 10.1128/AEM.00757-12; Hall AR, 2011, GENETICS, V187, P817, DOI 10.1534/genetics.110.124628; Hegreness M, 2008, P NATL ACAD SCI USA, V105, P13977, DOI 10.1073/pnas.0805965105; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Leggett HC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002512; Levin BR, 1996, AM NAT, V147, P881, DOI 10.1086/285884; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Martin G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0088; Michel JB, 2008, P NATL ACAD SCI USA, V105, P14918, DOI 10.1073/pnas.0800944105; Pirnay JP, 2012, FUTURE VIROL, V7, P379, DOI 10.2217/FVL.12.24; Poole K, 2005, ANTIMICROB AGENTS CH, V49, P479, DOI 10.1128/AAC.49.2.479-487.2005; Ramsayer J, 2013, EVOL APPL, V6, P608, DOI 10.1111/eva.12046; Read AF, 2011, P NATL ACAD SCI USA, V108, P10871, DOI 10.1073/pnas.1100299108; Rodriguez-Rojas A, 2013, INT J MED MICROBIOL, V303, P293, DOI 10.1016/j.ijmm.2013.02.004; Ryan EM, 2011, J PHARM PHARMACOL, V63, P1253, DOI 10.1111/j.2042-7158.2011.01324.x; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Springer B, 2001, ANTIMICROB AGENTS CH, V45, P2877, DOI 10.1128/AAC.45.10.2877-2884.2001; Statistical Analysis Software (SAS) Institute, 2012, JMP STAT GRAPH GUID; Ward H, 2009, J EVOLUTION BIOL, V22, P997, DOI 10.1111/j.1420-9101.2009.01712.x; Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133; Zembower TR, 1998, INT J ANTIMICROB AG, V10, P95, DOI 10.1016/S0924-8579(98)00033-8; Zhang QG, 2012, EVOL APPL, V5, P575, DOI 10.1111/j.1752-4571.2011.00236.x; Zinner SH, 2013, J ANTIMICROB CHEMOTH, V68, P881, DOI 10.1093/jac/dks463	44	98	103	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e106628	10.1371/journal.pone.0106628	http://dx.doi.org/10.1371/journal.pone.0106628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259735	Green Submitted, Green Published, gold			2022-12-27	WOS:000342685600008
J	Wang, H; Raleigh, DP				Wang, Hui; Raleigh, Daniel P.			General Amyloid Inhibitors? A Critical Examination of the Inhibition of IAPP Amyloid Formation by Inositol Stereoisomers	PLOS ONE			English	Article							POLYPEPTIDE FIBRIL FORMATION; A-BETA; DIABETES-MELLITUS; SCYLLO-INOSITOL; EPIGALLOCATECHIN GALLATE; COMMON MECHANISM; INDUCED TOXICITY; ISLET; AMYLIN; OLIGOMERS	Islet amyloid polypeptide (IAPP or amylin) forms amyloid deposits in the islets of Langerhans; a process that is believed to contribute to the progression of type 2 diabetes and to the failure of islet transplants. An emerging theme in amyloid research is the hypothesis that the toxic species produced during amyloid formation by different polypeptides share common features and exert their effects by common mechanisms. If correct, this suggests that inhibitors of amyloid formation by one polypeptide might be effective against other amyloidogenic sequences. IAPP and A beta, the peptide responsible for amyloid formation in Alzheimer's disease, are particularly interesting in this regard as they are both natively unfolded in their monomeric states and share some common characteristics. Comparatively little effort has been expended on the design of IAPP amyloid inhibitors, thus it is natural to inquire if A beta inhibitors are effective against IAPP, especially since no IAPP inhibitors have been clinically approved. A range of compounds inhibit A beta amyloid formation, including various stereoisomers of inositol. Myo-, scyllo-, and epi-inositol have been shown to induce conformational changes in A beta and prevent A beta amyloid fibril formation by stabilizing non-fibrillar beta-sheet structures. We investigate the ability of inositol stereoisomers to inhibit amyloid formation by IAPP. The compounds do not induce a conformational change in IAPP and are ineffective inhibitors of IAPP amyloid formation, although some do lead to modest apparent changes in IAPP amyloid fibril morphology. Thus not all classes of A beta inhibitors are effective against IAPP. This work provides a basis of comparison to work on polyphenol based inhibitors of IAPP amyloid formation and helps provide clues as to the features which render them effective. The study also helps provide information for further efforts in rational inhibitor design.	[Wang, Hui; Raleigh, Daniel P.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Raleigh, Daniel P.] SUNY Stony Brook, Grad Program Biochem & Struct Biol, Grad Program Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Raleigh, DP (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.	daniel.raleigh@stonybrook.edu		raleigh, daniel/0000-0003-3248-7493	National Institutes of Health [GM078114]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (http://www.nih.gov/) grant GM078114 to DPR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2006, ANAL BIOCHEM, V351, P181, DOI 10.1016/j.ab.2005.11.029; Abedini A, 2005, ORG LETT, V7, P693, DOI 10.1021/ol047480+; Abedini A, 2007, J AM CHEM SOC, V129, P11300, DOI 10.1021/ja072157y; Andersson A, 2008, EXP DIABETES RES, DOI 10.1155/2008/562985; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bleiholder C, 2013, J AM CHEM SOC, V135, P16926, DOI 10.1021/ja406197f; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cao P, 2012, BIOCHEMISTRY-US, V51, P2670, DOI 10.1021/bi2015162; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Clementi G, 1996, EXPERIENTIA, V52, P677, DOI 10.1007/BF01925572; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Gedulin BR, 1997, METABOLISM, V46, P67, DOI 10.1016/S0026-0495(97)90170-0; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Li G, 2013, J PHYS CHEM B, V117, P6603, DOI 10.1021/jp311350r; Li G, 2012, J PHYS CHEM B, V116, P1111, DOI 10.1021/jp208567n; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Marek P, 2010, ORG LETT, V12, P4848, DOI 10.1021/ol101981b; McLaurin J, 1998, J MOL BIOL, V278, P183, DOI 10.1006/jmbi.1998.1677; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; McLaurin J, 2006, NAT MED, V12, P801, DOI 10.1038/nm1423; Meng FL, 2010, J AM CHEM SOC, V132, P14340, DOI 10.1021/ja1046186; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; MICHAELIS T, 1993, NMR BIOMED, V6, P105, DOI 10.1002/nbm.1940060116; Mishra R, 2008, ANGEW CHEM INT EDIT, V47, P4679, DOI 10.1002/anie.200705372; Mishra R, 2009, CHEMBIOCHEM, V10, P445, DOI 10.1002/cbic.200800762; Noor H, 2012, PROTEIN SCI, V21, P373, DOI 10.1002/pro.2023; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Potter KJ, 2010, P NATL ACAD SCI USA, V107, P4305, DOI 10.1073/pnas.0909024107; Rushing PA, 2001, ENDOCRINOLOGY, V142, P5035, DOI 10.1210/en.142.11.5035; Scherbaum WA, 1998, EXP CLIN ENDOCR DIAB, V106, P97, DOI 10.1055/s-0029-1211958; Sciacca MFM, 2012, BIOPHYS J, V103, P702, DOI 10.1016/j.bpj.2012.06.045; Sinha S, 2012, ACS CHEM NEUROSCI, V3, P451, DOI 10.1021/cn200133x; SIPE JD, 1994, CRIT REV CL LAB SCI, V31, P325, DOI 10.3109/10408369409084679; Vendruscolo M, 2003, PHILOS T R SOC A, V361, P1205, DOI 10.1098/rsta.2003.1194; WESTERMARK P, 1978, DIABETOLOGIA, V15, P417, DOI 10.1007/BF01219652; WESTERMARK P, 1987, AM J PATHOL, V127, P414; WESTERMARK P, 1973, ACTA PATH MICRO IM A, VA 81, P291; Yan LM, 2013, ANGEW CHEM INT EDIT, V52, P10378, DOI 10.1002/anie.201302840; Yan LM, 2006, P NATL ACAD SCI USA, V103, P2046, DOI 10.1073/pnas.0507471103; Young LM, 2014, J AM CHEM SOC, V136, P660, DOI 10.1021/ja406831n	47	87	88	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e104023	10.1371/journal.pone.0104023	http://dx.doi.org/10.1371/journal.pone.0104023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25260075	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600004
J	Seifert, L; Komar, J; Crettenand, F; Millet, G				Seifert, Ludovic; Komar, John; Crettenand, Florent; Millet, Gregoire			Coordination Pattern Adaptability: Energy Cost of Degenerate Behaviors	PLOS ONE			English	Article							BIOLOGICAL-SYSTEMS; DYNAMICAL-SYSTEMS; MOVEMENT SYSTEMS; VARIABILITY; COMPLEXITY; VELOCITY; BREASTSTROKE; PERSPECTIVE; SWIMMERS; VALIDITY	This study investigated behavioral adaptability, which could be defined as a blend between stability and flexibility of the limbs movement and their inter-limb coordination, when individuals received informational constraints. Seven expert breaststroke swimmers performed three 200-m in breaststroke at constant submaximal intensity. Each trial was performed randomly in a different coordination pattern: 'freely-chosen', 'maximal glide' and 'minimal glide'. Two underwater and four aerial cameras enabled 3D movement analysis in order to assess elbow and knee angles, elbow-knee pair coordination, intra-cyclic velocity variations of the center of mass, stroke rate and stroke length and inter-limb coordination. The energy cost of locomotion was calculated from gas exchanges and blood lactate concentration. The results showed significantly higher glide, intra-cyclic velocity variations and energy cost under 'maximal glide' compared to 'freely-chosen' instructional conditions, as well as higher reorganization of limb movement and inter-limb coordination (p < 0.05). In the 'minimal glide' condition, the swimmers did not show significantly shorter glide and lower energy cost, but they exhibited significantly lower deceleration of the center of mass, as well as modified limb movement and inter-limb coordination (p < .05). These results highlight that a variety of structural adaptations can functionally satisfy the task-goal.	[Seifert, Ludovic; Komar, John] Univ Rouen, Fac Sports Sci, CETAPS, EA 3832, Mont St Aignan, France; [Crettenand, Florent; Millet, Gregoire] Univ Lausanne, Fac Biol & Med, Dept Physiol, ISSUL Inst Sport Sci, Lausanne, Switzerland	Universite de Rouen Normandie; University of Lausanne	Seifert, L (corresponding author), Univ Rouen, Fac Sports Sci, CETAPS, EA 3832, Mont St Aignan, France.	ludovic.seifert@univ-rouen.fr	SEIFERT, Ludovic/AAI-7486-2020; Millet, Grégoire/M-3220-2019; Millet, Gregoire P/F-4104-2012; Komar, John/ABD-4094-2020	SEIFERT, Ludovic/0000-0003-1712-5013; Millet, Grégoire/0000-0001-8081-4423; Millet, Gregoire P/0000-0001-8081-4423; Komar, John/0000-0002-2063-4065				Barbosa T, 2006, PORTUGUESE J SPORTS, VX, P192, DOI DOI 10.1055/s-2005-837450; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein NA, 1996, DEXTERITY ITS DEV, P9; Chollet D, 2004, INT J SPORTS MED, V25, P486, DOI 10.1055/s-2004-820943; Cohen D., 1988, STAT POWER ANAL BEHA; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; Davids K, 2008, DYNAMICS SKILL ACQUI; Davids K., 2006, MOVEMENT SYSTEM VARI; Davids K, 2010, EXERC SPORT SCI REV, V38, P86, DOI 10.1097/JES.0b013e3181d4968b; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; di Prampero PE, 1999, RESP PHYSIOL, V118, P103, DOI 10.1016/S0034-5687(99)00083-3; DIEDRICH FJ, 1995, J EXP PSYCHOL HUMAN, V21, P183, DOI 10.1037/0096-1523.21.1.183; DIPRAMPERO PE, 1986, INT J SPORTS MED, V7, P55, DOI 10.1055/s-2008-1025736; Duffield R, 2004, J SCI MED SPORT, V7, P11, DOI 10.1016/S1440-2440(04)80039-2; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Fernandes RJ, 2006, J SPORT MED PHYS FIT, V46, P373; Glazier PS, 2009, J BIOMECH, V42, P2694, DOI 10.1016/j.jbiomech.2009.08.001; Hamill J, 2000, J APPL BIOMECH, V16, P407, DOI 10.1123/jab.16.4.407; Howell D, 2002, STAT METHODS PSYCHOL; Johnson H.W., 1961, PERCEPT MOTOR SKILLS, V13, P163; Kelso S., 1995, DYNAMIC PATTERNS SEL; Komar J, 2013, J APPL BIOMECH; Leblanc H, 2007, INT J SPORTS MED, V28, P140, DOI 10.1055/s-2006-924205; Mason Paul H., 2010, Biology Theory, V5, P277; MCELROY K, 1976, AUSTR J HLTH PHYS ED, V71, P25; Newell K., 1985, DIFFERING PERSPECTIV, P295, DOI [https://doi.org/10.1016/S0166-4115(08)62541-8, DOI 10.1016/S0166-4115(08)62541-8, 10.1016/S0166-4115(08)62541-8]; Nigg BM, 1983, BIOMECHANICS MED SWI, VV, P72; Price CJ, 2002, TRENDS COGN SCI, V6, P416, DOI 10.1016/S1364-6613(02)01976-9; Psycharakis SG, 2011, J BIOMECH, V44, P1752, DOI 10.1016/j.jbiomech.2011.04.004; Psycharakis SG, 2009, J SCI MED SPORT, V12, P262, DOI 10.1016/j.jsams.2007.11.008; Ranganathan R, 2010, EXP BRAIN RES, V202, P755, DOI 10.1007/s00221-010-2177-7; Rodriguez FA, 2008, INT J SPORTS MED, V29, P120, DOI 10.1055/s-2007-964973; Rodriguez FA, 2000, J SPORT MED PHYS FIT, V40, P87; Seifert L, 2011, HUM MOVEMENT SCI, V30, P550, DOI 10.1016/j.humov.2010.12.003; Seifert L, 2013, J SCI MED SPORT; Seifert L, 2007, HUM MOVEMENT SCI, V26, P68, DOI 10.1016/j.humov.2006.09.003; Seifert L, 2013, SPORTS MED, V43, P167, DOI 10.1007/s40279-012-0011-z; Seifert L, 2010, HUM MOVEMENT SCI, V29, P103, DOI 10.1016/j.humov.2009.05.003; Sparrow WA, 1998, PSYCHON B REV, V5, P173, DOI 10.3758/BF03212943; Takagi Hideki, 2004, Sports Biomech, V3, P15, DOI 10.1080/14763140408522827; Tononi G, 1999, P NATL ACAD SCI USA, V96, P3257, DOI 10.1073/pnas.96.6.3257; Toussaint H, 2005, ANIM BIOL, V55, P17, DOI 10.1163/1570756053276907; van Emmerik REA, 2000, J APPL BIOMECH, V16, P394, DOI 10.1123/jab.16.4.394; Vilas-Boas J P, 1996, BIOMECHANICS MED SWI, P167; Vilas-Boas J.P., 2011, WORLD BOOK SWIMMING, P119; Warren WH, 2006, PSYCHOL REV, V113, P358, DOI 10.1037/0033-295X.113.2.358; Whitacre JM, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-6; Winter EM, 2001, J SPORT SCI, V19, P761, DOI 10.1080/026404101317015429	48	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107839	10.1371/journal.pone.0107839	http://dx.doi.org/10.1371/journal.pone.0107839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255016	gold, Green Published, Green Submitted			2022-12-27	WOS:000344862300035
J	Venkataswamy, MM; Ng, TW; Kharkwal, SS; Carreno, LJ; Johnson, AJ; Kunnath-Velayudhan, S; Liu, Z; Bittman, R; Jervis, PJ; Cox, LR; Besra, GS; Wen, XS; Yuan, WM; Tsuji, M; Li, XM; Ho, DD; Chan, J; Lee, S; Frothingham, R; Haynes, BF; Panas, MW; Gillard, GO; Sixsmith, JD; Korioth-Schmitz, B; Schmitz, JE; Larsen, MH; Jacobs, WR; Porcelli, SA				Venkataswamy, Manjunatha M.; Ng, Tony W.; Kharkwal, Shalu S.; Carreno, Leandro J.; Johnson, Alison J.; Kunnath-Velayudhan, Shajo; Liu, Zheng; Bittman, Robert; Jervis, Peter J.; Cox, Liam R.; Besra, Gurdyal S.; Wen, Xiangshu; Yuan, Weiming; Tsuji, Moriya; Li, Xiangming; Ho, David D.; Chan, John; Lee, Sunhee; Frothingham, Richard; Haynes, Barton F.; Panas, Michael W.; Gillard, Geoffrey O.; Sixsmith, Jaimie D.; Korioth-Schmitz, Birgit; Schmitz, Joern E.; Larsen, Michelle H.; Jacobs, William R., Jr.; Porcelli, Steven A.			Improving Mycobacterium bovis Bacillus Calmette-Guerin as a Vaccine Delivery Vector for Viral Antigens by Incorporation of Glycolipid Activators of NKT Cells	PLOS ONE			English	Article							KILLER T-CELLS; SIMIAN IMMUNODEFICIENCY VIRUS; LIGAND ALPHA-GALACTOSYLCERAMIDE; RECOMBINANT BCG; DENDRITIC CELLS; LYMPHOCYTE RESPONSE; RHESUS-MONKEYS; IN-VIVO; IMMUNOGENICITY; TUBERCULOSIS	Recombinant Mycobacterium bovis bacillus Calmette-Guerin (rBCG) has been explored as a vector for vaccines against HIV because of its ability to induce long lasting humoral and cell mediated immune responses. To maximize the potential for rBCG vaccines to induce effective immunity against HIV, various strategies are being employed to improve its ability to prime CD8(+) T cells, which play an important role in the control of HIV infections. In this study we adopted a previously described approach of incorporating glycolipids that activate CD1d-restricted natural killer T (NKT) cells to enhance priming of CD8(+) T cells by rBCG strains expressing an SIV Gag antigen (rBCG-SIV gag). We found that the incorporation of the synthetic NKT activating glycolipid alpha-galactosylceramide (alpha-GC) into rBCG-SIV gag significantly enhanced CD8(+) T cell responses against an immunodominant Gag epitope, compared to responses primed by unmodified rBCG-SIV gag. The abilities of structural analogues of alpha-GC to enhance CD8(+) T cell responses to rBCG were compared in both wild type and partially humanized mice that express human CD1d molecules in place of mouse CD1d. These studies identified an alpha-GC analogue known as 7DW8-5, which has previously been used successfully as an adjuvant in non-human primates, as a promising compound for enhancing immunogenicity of antigens delivered by rBCG. vectors. Our findings support the incorporation of synthetic glycolipid activators of NKT cells as a novel approach to enhance the immunogenicity of rBCG-vectored antigens for induction of CD8(+) T cell responses. The glycolipid adjuvant 7DW8-5 may be a promising candidate for advancing to non-human primate and human clinical studies for the development of HIV vaccines based on rBCG vectors.	[Venkataswamy, Manjunatha M.; Ng, Tony W.; Kharkwal, Shalu S.; Carreno, Leandro J.; Johnson, Alison J.; Kunnath-Velayudhan, Shajo; Larsen, Michelle H.; Jacobs, William R., Jr.; Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Venkataswamy, Manjunatha M.] Natl Inst Mental Hlth & Neurosci, Bangalore 560029, Karnataka, India; [Carreno, Leandro J.] Univ Chile, Fac Med, Millennium Inst Immunol & Immunotherapy, Santiago 7, Chile; [Liu, Zheng; Bittman, Robert] CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA; [Jervis, Peter J.; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Cox, Liam R.] Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England; [Wen, Xiangshu; Yuan, Weiming] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Tsuji, Moriya; Li, Xiangming; Ho, David D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Chan, John; Porcelli, Steven A.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Lee, Sunhee; Frothingham, Richard; Haynes, Barton F.] Duke Univ, Med Ctr, Durham, NC USA; [Panas, Michael W.; Gillard, Geoffrey O.; Sixsmith, Jaimie D.; Korioth-Schmitz, Birgit; Schmitz, Joern E.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Larsen, Michelle H.; Jacobs, William R., Jr.] Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; National Institute of Mental Health & Neurosciences - India; Universidad de Chile; City University of New York (CUNY) System; Queens College NY (CUNY); University of Birmingham; University of Birmingham; University of Southern California; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Duke University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine	Porcelli, SA (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	steven.porcelli@einstein.yu.edu	Cox, Liam/AAG-9351-2020; Jervis, Peter/AAD-6106-2020; Schmitz, Joern/A-4929-2018; Korioth-Schmitz, Birgit/M-7816-2015	Cox, Liam/0000-0001-7018-3904; Schmitz, Joern/0000-0001-8803-0922; Korioth-Schmitz, Birgit/0000-0002-5271-9223; Besra, Gurdyal/0000-0002-5605-0395; Jacobs, William/0000-0003-3321-3080; Jervis, Peter/0000-0002-5550-4535; Tsuji, Moriya/0000-0001-8587-277X; Ng, Tony/0000-0002-2460-7929; sharma, shalu/0000-0003-0901-0259	Bill and Melinda Gates Foundation [OPP38614, OPP1033104]; National Institutes of Health [RO1 AI45889, RO1 AI093649]; Einstein Cancer Center [P30 CA013330]; Einstein Center for AIDS Research [P30 AI051519]; Personal Research Chair from Mr. James Bardrick, a Royal Society Wolfson Research Merit Award; Medical Research Council; Wellcome Trust [084923/B/08/Z];  [RO1 AI070258];  [PO1 AI063537];  [R01 AI091987];  [HL-083187]; Medical Research Council [G1001750] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL083187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045889, R01AI093649, P30AI051519, P01AI063537, R01AI091987, R01AI070258] Funding Source: NIH RePORTER; MRC [G1001750] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein Cancer Center; Einstein Center for AIDS Research; Personal Research Chair from Mr. James Bardrick, a Royal Society Wolfson Research Merit Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); ; ; ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants OPP38614 and OPP1033104 from the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/). Portions of this work were also supported by grants RO1 AI45889 and RO1 AI093649 to SAP from the National Institutes of Health (http://nih.gov/); RO1 AI070258 to MT; PO1 AI063537 to SAP, WRJ and JC; R01 AI091987 to WY, and HL-083187 to RB. Flow cytometry resources were supported by the Einstein Cancer Center (P30 CA013330) and the Einstein Center for AIDS Research (P30 AI051519) (http://www.einstein.yu.edu/). GSB acknowledges support from a Personal Research Chair from Mr. James Bardrick, a Royal Society Wolfson Research Merit Award, a former Lister Institute-Jenner Research Fellowship, the Medical Research Council and The Wellcome Trust (084923/B/08/Z). LJC is a Pew Latin American Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; ALDOVINI A, 1991, NATURE, V351, P479, DOI 10.1038/351479a0; Ami Y, 2005, J VIROL, V79, P12871, DOI 10.1128/JVI.79.20.12871-12879.2005; Arora P, 2014, IMMUNITY, V40, P105, DOI 10.1016/j.immuni.2013.12.004; Arora P, 2013, ADV EXP MED BIOL, V783, P199, DOI 10.1007/978-1-4614-6111-1_11; Arora P, 2011, J AM CHEM SOC, V133, P5198, DOI 10.1021/ja200070u; Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x; Bastos RG, 2009, VACCINE, V27, P6495, DOI 10.1016/j.vaccine.2009.08.044; Behar SM, 2007, CURR TOP MICROBIOL, V314, P215; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Cayabyab MJ, 2009, J VIROL, V83, P5505, DOI 10.1128/JVI.02544-08; Cerundolo V, 2010, CURR OPIN IMMUNOL, V22, P417, DOI 10.1016/j.coi.2010.04.003; Chapman R, 2010, CURR HIV RES, V8, P282, DOI 10.2174/157016210791208686; Dennehy M, 2005, VACCINE, V23, P1209, DOI 10.1016/j.vaccine.2004.08.039; Dhodapkar MV, 2009, FRONT BIOSCI-LANDMRK, V14, P796, DOI 10.2741/3278; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Fujii S, 2010, SEMIN IMMUNOL, V22, P97, DOI 10.1016/j.smim.2009.10.002; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Giaccone G, 2002, CLIN CANCER RES, V8, P3702; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Hopkins R, 2011, EUR J IMMUNOL, V41, P3542, DOI 10.1002/eji.201141962; Huang YX, 2008, VACCINE, V26, P1807, DOI 10.1016/j.vaccine.2008.02.002; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; KAMEOKA M, 1994, VACCINE, V12, P153, DOI 10.1016/0264-410X(94)90054-X; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Lagranderie M, 1998, AIDS RES HUM RETROV, V14, P1625, DOI 10.1089/aid.1998.14.1625; Li XM, 2010, P NATL ACAD SCI USA, V107, P13010, DOI 10.1073/pnas.1006662107; Li XM, 2009, J IMMUNOL, V183, P4415, DOI 10.4049/jimmunol.0901021; Li XM, 2009, IMMUNOLOGY, V127, P216, DOI 10.1111/j.1365-2567.2008.02943.x; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Padte NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078407; Padte NN, 2011, CLIN IMMUNOL, V140, P142, DOI 10.1016/j.clim.2010.11.009; Parekh VV, 2005, J CLIN INVEST, V115, P2572, DOI 10.1172/JCI24762; Patel O, 2011, J IMMUNOL, V187, P4705, DOI 10.4049/jimmunol.1100794; Quinn KM, 2013, J IMMUNOL, V190, P2720, DOI 10.4049/jimmunol.1202861; Reynolds MR, 2005, J VIROL, V79, P9228, DOI 10.1128/JVI.79.14.9228-9235.2005; Rosario M, 2010, EUR J IMMUNOL, V40, P1973, DOI 10.1002/eji.201040344; Sadagopal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005531; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Singh AK, 2014, HUM IMMUNOL, V75, P250, DOI 10.1016/j.humimm.2013.12.004; Sun R, 2009, VACCINE, V27, P4412, DOI 10.1016/j.vaccine.2009.05.048; Van Kaer L, 2011, IMMUNOTHERAPY-UK, V3, P59, DOI 10.2217/IMT.10.85; Venkataswamy MM, 2010, SEMIN IMMUNOL, V22, P68, DOI 10.1016/j.smim.2009.10.003; Venkataswamy MM, 2009, J IMMUNOL, V183, P1644, DOI 10.4049/jimmunol.0900858; Wen XS, 2013, P NATL ACAD SCI USA, V110, P2963, DOI 10.1073/pnas.1300200110; WINTER N, 1995, VACCINE, V13, P471, DOI 10.1016/0264-410X(94)00001-4; Wu TN, 2011, P NATL ACAD SCI USA, V108, P17275, DOI 10.1073/pnas.1114255108; YASUTOMI Y, 1993, J IMMUNOL, V150, P3101; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102	51	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108383	10.1371/journal.pone.0108383	http://dx.doi.org/10.1371/journal.pone.0108383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255287	Green Published, gold			2022-12-27	WOS:000344862300077
J	Brand, Y; Radojevic, V; Sung, M; Wei, E; Setz, C; Glutz, A; Leitmeyer, K; Bodmer, D				Brand, Yves; Radojevic, Vesna; Sung, Michael; Wei, Eric; Setz, Cristian; Glutz, Andrea; Leitmeyer, Katharina; Bodmer, Daniel			Role of Somatostatin Receptor-2 in Gentamicin-Induced Auditory Hair Cell Loss in the Mammalian Inner Ear	PLOS ONE			English	Article							INDUCED APOPTOSIS; RETINA; OTOTOXICITY; INHIBITION; RESCUE; KINASE; JNK; PHOSPHORYLATION; NEUROPEPTIDES; INVOLVEMENT	Hair cells and spiral ganglion neurons of the mammalian auditory system do not regenerate, and their loss leads to irreversible hearing loss. Aminoglycosides induce auditory hair cell death in vitro, and evidence suggests that phosphatidylinositol-3-kinase/Akt signaling opposes gentamicin toxicity via its downstream target, the protein kinase Akt. We previously demonstrated that somatostatin-a peptide with hormone/neurotransmitter properties-can protect hair cells from gentamicin-induced hair cell death in vitro, and that somatostatin receptors are expressed in the mammalian inner ear. However, it remains unknown how this protective effect is mediated. In the present study, we show a highly significant protective effect of octreotide (a drug that mimics and is more potent than somatostatin) on gentamicin-induced hair cell death, and increased Akt phosphorylation in octreotide-treated organ of Corti explants in vitro. Moreover, we demonstrate that somatostatin receptor-1 knockout mice overexpress somatostatin receptor-2 in the organ of Corti, and are less susceptible to gentamicin-induced hair cell loss than wild-type or somatostatin-1/somatostatin-2 double-knockout mice. Finally, we show that octreotide affects auditory hair cells, enhances spiral ganglion neurite number, and decreases spiral ganglion neurite length.	[Bodmer, Daniel] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; Univ Basel Hosp, Clin Otolaryngol Head & Neck Surg, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Bodmer, D (corresponding author), Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.	Daniel.bodmer@usb.ch		Setz, Cristian/0000-0001-9011-2898; Petkovic, Vesna/0000-0002-0741-9774	The Forschungsfonds der Universitat Basel; Schwerhorigenverein Nordwestschweiz	The Forschungsfonds der Universitat Basel; Schwerhorigenverein Nordwestschweiz	This study was supported by The Forschungsfonds der Universitat Basel (YB) and the Schwerhorigenverein Nordwestschweiz (DB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnoli P, 2003, HISTOL HISTOPATHOL, V18, P1219, DOI 10.14670/HH-18.1219; Battaglia A, 2003, NEUROSCIENCE, V122, P1025, DOI 10.1016/j.neuroscience.2003.08.041; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, BIOCHEM SOC SYMP, V70, P233, DOI 10.1042/bss0700233; Bodmer D, 2002, LARYNGO RHINO OTOL, V81, P853, DOI 10.1055/s-2002-36100; Bodmer D, 2002, HEARING RES, V172, P81, DOI 10.1016/S0378-5955(02)00514-2; Bodmer D, 2012, DEV NEUROSCI-BASEL, V34, P342, DOI 10.1159/000341291; Brand Y, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-114; Caelers A, 2009, LARYNGOSCOPE, V119, P933, DOI 10.1002/lary.20058; Casini G, 2005, ARCH ITAL BIOL, V143, P191; Casini G, 2005, HISTOL HISTOPATHOL, V20, P615, DOI 10.14670/HH-20.615; Catalani E, 2007, EUR J NEUROSCI, V25, P1447, DOI 10.1111/j.1460-9568.2007.05419.x; Celiker Ulku, 2002, Documenta Ophthalmologica, V105, P327, DOI 10.1023/A:1021243126512; Cervia D, 2008, MOL CELL ENDOCRINOL, V286, P112, DOI 10.1016/j.mce.2007.12.009; Cheng Alan G, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P343, DOI 10.1097/01.moo.0000186799.45377.63; Chung WH, 2006, JARO-J ASSOC RES OTO, V7, P373, DOI 10.1007/s10162-006-0050-y; Dal Monte M, 2003, NEUROPHARMACOLOGY, V45, P1080, DOI 10.1016/S0028-3908(03)00296-X; Dal Monte M, 2007, INVEST OPHTH VIS SCI, V48, P3480; Du LH, 2004, J BIOL CHEM, V279, P11957, DOI 10.1074/jbc.M304935200; EPELBAUM J, 1994, CRIT REV NEUROBIOL, V8, P25; Huang T, 2000, INT J DEV NEUROSCI, V18, P259, DOI 10.1016/S0736-5748(99)00094-5; Kopke RD, 2002, LARYNGOSCOPE, V112, P1515, DOI 10.1097/00005537-200209000-00001; Kreienkamp HJ, 1999, FEBS LETT, V462, P464, DOI 10.1016/S0014-5793(99)01582-3; Lallemend F, 2007, NEUROSCIENCE, V150, P212, DOI 10.1016/j.neuroscience.2007.08.032; Lautermann J, 2004, LARYNGO RHINO OTOL, V83, P317, DOI 10.1055/s-2004-814280; Lesche S, 2009, J CLIN ENDOCR METAB, V94, P654, DOI 10.1210/jc.2008-1919; Mastrodimou N, 2005, N-S ARCH PHARMACOL, V371, P44, DOI 10.1007/s00210-004-1011-9; Matsui Jonathan Isamu, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P418, DOI 10.1097/01.moo.0000136873.56878.56; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Mullen LM, 2012, BRAIN RES, V1430, P25, DOI 10.1016/j.brainres.2011.10.054; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; Okuda T, 2005, AURIS NASUS LARYNX, V32, P33, DOI 10.1016/j.anl.2004.11.006; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; Pilar G, 1996, LIFE SCI, V58, P1979, DOI 10.1016/0024-3205(96)00188-9; Pirvola U, 2000, J NEUROSCI, V20, P43, DOI 10.1523/JNEUROSCI.20-01-00043.2000; Priuska EM, 1995, BIOCHEM PHARMACOL, V50, P1749, DOI 10.1016/0006-2952(95)02160-4; Radojevic V, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-89; Reisine T, 1995, AM J PHYSIOL-GASTR L, V269, pG813, DOI 10.1152/ajpgi.1995.269.6.G813; Rybak LP, 2005, DRUG DISCOV TODAY, V10, P1313, DOI 10.1016/S1359-6446(05)03552-X; Sellers LA, 2000, MOL CELL BIOL, V20, P5974, DOI 10.1128/MCB.20.16.5974-5985.2000; SOBKOWICZ HM, 1993, ACTA OTO-LARYNGOL, P3; Tenneti L, 2000, J NEUROCHEM, V74, P134, DOI 10.1046/j.1471-4159.2000.0740134.x; Tentler JJ, 1997, MOL ENDOCRINOL, V11, P859, DOI 10.1210/me.11.7.859; Theodoropoulou M, 2013, FRONT NEUROENDOCRIN, V34, P228, DOI 10.1016/j.yfrne.2013.07.005; War Sajad A, 2012, J Mol Signal, V7, P5, DOI 10.1186/1750-2187-7-5; Weckbecker G, 2003, NAT REV DRUG DISCOV, V2, P999, DOI 10.1038/nrd1255; Zheng H, 1997, MOL ENDOCRINOL, V11, P1709, DOI 10.1210/me.11.11.1709	47	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108146	10.1371/journal.pone.0108146	http://dx.doi.org/10.1371/journal.pone.0108146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268135	Green Submitted, gold, Green Published			2022-12-27	WOS:000343671700068
J	Cottontail, VM; Kalko, EKV; Cottontail, I; Wellinghausen, N; Tschapka, M; Perkins, SL; Pinto, CM				Cottontail, Veronika M.; Kalko, Elisabeth K. V.; Cottontail, Iain; Wellinghausen, Nele; Tschapka, Marco; Perkins, Susan L.; Miguel Pinto, C.			High Local Diversity of Trypanosoma in a Common Bat Species, and Implications for the Biogeography and Taxonomy of the T. cruzi Clade	PLOS ONE			English	Article							ARTIBEUS-JAMAICENSIS; RIBOSOMAL-RNA; DELIMITATION; GENE; SCHIZOTRYPANUM; IDENTIFICATION; PHYLOGENY; GRADIENTS; RANGELI; MAMMALS	The Trypanosoma cruzi clade is a group of parasites that comprises T. cruzi sensu lato and its closest relatives. Although several species have been confirmed phylogenetically to belong to this clade, it is uncertain how many more species can be expected to belong into this group. Here, we present the results of a survey of trypanosome parasites of the bat Artibeus jamaicensis from the Panama Canal Zone, an important seed disperser. Using a genealogical species delimitation approach, the Poisson tree processes (PTP), we tentatively identified five species of trypanosomes - all belonging to the T. cruzi clade. A small monophyletic group of three putative Trypanosoma species places at the base of the clade phylogeny, providing evidence for at least five independent colonization events of these parasites into the New World. Artibeus jamaicensis presents a high diversity of these blood parasites and is the vertebrate with the highest number of putative trypanosome species reported from a single locality. Our results emphasize the need for continued efforts to survey mammalian trypanosomes.	[Cottontail, Veronika M.; Kalko, Elisabeth K. V.; Tschapka, Marco] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Cottontail, Veronika M.; Wellinghausen, Nele] Univ Ulm, Inst Med Microbiol & Hyg, D-89069 Ulm, Germany; [Kalko, Elisabeth K. V.; Tschapka, Marco] Smithsonian Trop Res Inst, Balboa, Panama; [Cottontail, Iain] Kbo Isar Amper Klinikum, Taufkirchen, Vils, Germany; [Wellinghausen, Nele] Gaertner & Colleagues Lab, Ravensburg, Germany; [Perkins, Susan L.; Miguel Pinto, C.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Miguel Pinto, C.] Amer Museum Nat Hist, Dept Mammal, New York, NY 10024 USA; [Miguel Pinto, C.] CUNY, Grad Ctr, New York, NY USA; [Miguel Pinto, C.] Pontificia Univ Catolica Ecuador, Ctr Invest Enfermedades Infecciosas, Quito, Ecuador	Ulm University; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); City University of New York (CUNY) System; Pontificia Universidad Catolica del Ecuador	Pinto, CM (corresponding author), Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA.	mpinto@amnh.org	; Perkins, Susan/D-3408-2018	Pinto, C. Miguel/0000-0002-3640-2357; Perkins, Susan/0000-0002-5400-5662	STRI trust funds; University of Ulm; Annette Kade Fellowship through the American Museum of Natural History; NSF-DDIG [DEB-1311582]; German national Academic Foundation; Cusanuswerk	STRI trust funds; University of Ulm; Annette Kade Fellowship through the American Museum of Natural History; NSF-DDIG(National Science Foundation (NSF)); German national Academic Foundation; Cusanuswerk	Field work was supported by STRI trust funds to EKVK, and field and laboratory work was funded by grants of the Promotionsprogramm in Experimental Medicine of the University of Ulm and the Cusanuswerk to VMC. Data analyses were supported by an Annette Kade Fellowship through the American Museum of Natural History to CMP and NSF-DDIG grant DEB-1311582 to SLP and CMP, and the German national Academic Foundation to VMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER JR, 1978, AM J TROP MED HYG, V27, P483, DOI 10.4269/ajtmh.1978.27.483; Bardsley J.E., 1973, Advances Parasit, V11, P1, DOI 10.1016/S0065-308X(08)60184-0; Barnabe C, 2003, INFECT GENET EVOL, V2, P201, DOI 10.1016/S1567-1348(02)00130-2; BAUM DA, 1995, MONOG SYST BOTAN, V53, P289; Boenigk J, 2012, EUR J PROTISTOL, V48, P96, DOI 10.1016/j.ejop.2011.11.004; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Cottontail VM, 2009, PARASITOLOGY, V136, P1133, DOI 10.1017/S0031182009990485; Da Silva FM, 2004, PARASITOLOGY, V129, P549, DOI 10.1017/S0031182004005931; Dick CW, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P179, DOI 10.1007/978-4-431-36025-4_11; Dobigny G, 2011, ACTA TROP, V117, P183, DOI 10.1016/j.actatropica.2010.11.004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gardner A.L., 1991, Smithsonian Contributions to Zoology, P53; Hamilton PB, 2009, INFECT GENET EVOL, V9, P81, DOI 10.1016/j.meegid.2008.10.011; Hamilton PB, 2007, MOL PHYLOGENET EVOL, V44, P15, DOI 10.1016/j.ympev.2007.03.023; Hamilton PB, 2012, TRENDS PARASITOL, V28, P136, DOI 10.1016/j.pt.2012.01.006; Hamilton PB, 2012, MOL PHYLOGENET EVOL, V63, P521, DOI 10.1016/j.ympev.2012.01.007; Hoare C, 1972, TRYPANOSOMES MAMMALS; Kirchhoff LV, 1996, J CLIN MICROBIOL, V34, P1171, DOI 10.1128/JCM.34.5.1171-1175.1996; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; Lima L, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-221; Lima L, 2012, PROTIST, V163, P856, DOI 10.1016/j.protis.2011.12.003; MORRISON DW, 1978, ECOLOGY, V59, P716, DOI 10.2307/1938775; Noyes HA, 1999, INT J PARASITOL, V29, P331, DOI 10.1016/S0020-7519(98)00167-2; Pinto CM, 2006, J PARASITOL, V92, P1251, DOI 10.1645/GE-886R.1; Pinto C. Miguel, 2012, Infection Genetics and Evolution, V12, P1328, DOI 10.1016/j.meegid.2012.04.013; Pinto CM, 2010, EMERG INFECT DIS, V16, P356, DOI 10.3201/eid1602.090998; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Ramirez JD, INFECT GENET EVOL; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sehgal RNM, 2001, MOL ECOL, V10, P2319, DOI 10.1046/j.1365-294X.2001.01339.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stevens JR, 1999, PARASITOLOGY, V118, P107, DOI 10.1017/S0031182098003473; Stevens JR, 1999, INT J PARASITOL, V29, P749, DOI 10.1016/S0020-7519(99)00016-8; Stevens RD, 2004, J BIOGEOGR, V31, P665, DOI 10.1111/j.1365-2699.2003.01042.x; Thompson CK, INT J PARASITOL PARA; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Votypka J, 2002, PARASITOLOGY, V125, P253, DOI 10.1017/S0031182002002093; Wheeler RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079581; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; ZELEDON R, 1969, ANN TROP MED PARASIT, V63, P221, DOI 10.1080/00034983.1969.11686623; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	44	35	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108603	10.1371/journal.pone.0108603	http://dx.doi.org/10.1371/journal.pone.0108603			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268381	Green Published, gold			2022-12-27	WOS:000343671700120
J	Fonseca, MM; Harris, DJ; Posada, D				Fonseca, Miguel M.; Harris, D. James; Posada, David			The Inversion of the Control Region in Three Mitogenomes Provides Further Evidence for an Asymmetric Model of Vertebrate mtDNA Replication	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; RNA GENE INVERSION; NUCLEOTIDE COMPOSITION; STRAND ASYMMETRY; LAGGING-STRAND; GENOME; EVOLUTION; SEQUENCE; ORIGIN; TRANSCRIPTION	Mitochondrial genomes are known to have a strong strand-specific compositional bias that is more pronounced at fourfold redundant sites of mtDNA protein-coding genes. This observation suggests that strand asymmetries, to a large extent, are caused by mutational asymmetric mechanisms. In vertebrate mitogenomes, replication and not transcription seems to play a major role in shaping compositional bias. Hence, one can better understand how mtDNA is replicated - a debated issue - through a detailed picture of mitochondrial genome evolution. Here, we analyzed the compositional bias (AT and GC skews) in protein-coding genes of almost 2,500 complete vertebrate mitogenomes. We were able to identify three fish mitogenomes with inverted AT/GC skew coupled with an inversion of the Control Region. These findings suggest that the vertebrate mitochondrial replication mechanism is asymmetric and may invert its polarity, with the leading-strand becoming the lagging-strand and vice-versa, without compromising mtDNA maintenance and expression. The inversion of the strand-specific compositional bias through the inversion of the Control Region is in agreement with the strand-displacement model but it is also compatible with the RITOLS model of mtDNA replication.	[Fonseca, Miguel M.; Posada, David] Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain; [Fonseca, Miguel M.; Harris, D. James] Univ Porto, CIBIO InBIO, Res Ctr Biodivers & Genet Resources, Vairao, Portugal	Universidade de Vigo; Universidade do Porto	Fonseca, MM (corresponding author), Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain.	mig.m.fonseca@gmail.com	Fonseca, Miguel M/L-7944-2013; Posada, David/C-4502-2008	Fonseca, Miguel M/0000-0003-4598-670X; Posada, David/0000-0003-1407-3406	FEDER (Fundo Europeu de Desenvolvimento Regional) funds through the Programa Operacional Factores de Competitividade (COMPETE program); Portuguese national funds through the Fundacao para a Ciencia e a Tecnologia (FCT) [PEst-C/BIA/UI0609/2013, SFRH/BPD/70654/2010]; Programa Operacional Potencial Humano (POPH) - Quadro de Referencia Estrategico Nacional (QREN) funds from the European Social Fund; Portuguese Ministerio da Educacao; European Research Council [ERC- 2007-Stg 203161-PHYGENOM]	FEDER (Fundo Europeu de Desenvolvimento Regional) funds through the Programa Operacional Factores de Competitividade (COMPETE program); Portuguese national funds through the Fundacao para a Ciencia e a Tecnologia (FCT); Programa Operacional Potencial Humano (POPH) - Quadro de Referencia Estrategico Nacional (QREN) funds from the European Social Fund; Portuguese Ministerio da Educacao; European Research Council(European Research Council (ERC)European Commission)	This work was partially supported by FEDER (Fundo Europeu de Desenvolvimento Regional) funds through the Programa Operacional Factores de Competitividade (COMPETE program) and Portuguese national funds through the Fundacao para a Ciencia e a Tecnologia (FCT, PEst-C/BIA/UI0609/2013, SFRH/BPD/70654/2010 post-doctoral grant to MMF); and by Programa Operacional Potencial Humano (POPH) - Quadro de Referencia Estrategico Nacional (QREN) funds from the European Social Fund and Portuguese Ministerio da Educacao. DP was financially supported by the European Research Council (ERC- 2007-Stg 203161-PHYGENOM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer SAM, 2007, MOL BIOL EVOL, V24, P1330, DOI 10.1093/molbev/msm054; AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Anson RM, 1998, NUCLEIC ACIDS RES, V26, P662, DOI 10.1093/nar/26.2.662; ASAKAWA S, 1991, J MOL EVOL, V32, P511, DOI 10.1007/BF02102653; Bielawski JP, 2002, GENETICS, V161, P1589; Boore JL, 2000, COMP GENOMICS, V1, P133, DOI DOI 10.1007/978-94-011-4309-7_13; Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200; Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014; Dowton M, 2001, TRENDS ECOL EVOL, V16, P269, DOI 10.1016/S0169-5347(01)02182-6; Driggers WJ, 1997, NUCLEIC ACIDS RES, V25, P4362, DOI 10.1093/nar/25.21.4362; Faith JJ, 2003, GENETICS, V165, P735; Fonseca MM, 2008, MOL BIOL EVOL, V25, P805, DOI 10.1093/molbev/msn050; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; Frank AC, 1999, GENE, V238, P65, DOI 10.1016/S0378-1119(99)00297-8; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Fuste JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021; Gong L, 2013, MITOCHONDR DNA, V24, P671, DOI 10.3109/19401736.2013.773984; Graves SW, 1998, BIOCHEMISTRY-US, V37, P6050, DOI 10.1021/bi972685u; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Inoue JG, 2004, MOL PHYLOGENET EVOL, V32, P274, DOI 10.1016/j.ympev.2003.11.009; Juhling F, 2012, NUCLEIC ACIDS RES, V40, P2833, DOI 10.1093/nar/gkr1131; KAINZ M, 1992, SCIENCE, V255, P838, DOI 10.1126/science.1536008; Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794; Kilpert F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-241; Kong XY, 2009, GENOME, V52, P975, DOI 10.1139/G09-069; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lavrov DV, 2007, INTEGR COMP BIOL, V47, P734, DOI 10.1093/icb/icm045; Lavrov DV, 2002, MOL BIOL EVOL, V19, P163, DOI 10.1093/oxfordjournals.molbev.a004068; Lee DY, 1998, J BIOL CHEM, V273, P30614, DOI 10.1074/jbc.273.46.30614; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LOBRY JR, 1995, J MOL EVOL, V40, P326, DOI 10.1007/BF00163237; MARTENS PA, 1979, J MOL BIOL, V135, P327, DOI 10.1016/0022-2836(79)90440-6; McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI [10.1590/S1415-47572013000300002, 10.1590/s1415-47572013000300002]; Miya M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-58; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Mrazek J, 1998, P NATL ACAD SCI USA, V95, P3720, DOI 10.1073/pnas.95.7.3720; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; Raina SZ, 2005, GENOME RES, V15, P665, DOI 10.1101/gr.3128605; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Reyes A, 2005, J BIOL CHEM, V280, P3242, DOI 10.1074/jbc.M411916200; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Reyes A., 2012, COLD SPRING HARB PER, V4; Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196; Sahyoun AH, 2014, MITOCHONDRION, V17, P56, DOI 10.1016/j.mito.2014.05.009; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; Satoh TP, 2006, MOL PHYLOGENET EVOL, V40, P129, DOI 10.1016/j.ympev.2006.02.014; Sbisa E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6; Scouras A, 2004, MOL PHYLOGENET EVOL, V31, P50, DOI 10.1016/j.ympev.2003.07.005; Seligmann H, 2008, J MOL BIOL, V379, P188, DOI 10.1016/j.jmb.2008.03.066; Seligmann H, 2006, J THEOR BIOL, V241, P321, DOI 10.1016/j.jtbi.2005.11.035; Seligmann H, 2010, BIOSYSTEMS, V99, P85, DOI 10.1016/j.biosystems.2009.09.003; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161; Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015; WONG TW, 1985, CELL, V42, P951, DOI 10.1016/0092-8674(85)90291-0; Xia XH, 2012, CURR GENOMICS, V13, P16, DOI 10.2174/138920212799034776; XU BJ, 1995, MOL CELL BIOL, V15, P580, DOI 10.1128/MCB.15.1.580; Xu T, 2013, MITOCHONDRI IN PRESS; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; Zhang ZH, 2013, MITOCHONDR DNA, V24, P504, DOI 10.3109/19401736.2013.770505; Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012; Zhuang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073561	74	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106654	10.1371/journal.pone.0106654	http://dx.doi.org/10.1371/journal.pone.0106654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268704	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700013
J	Liao, J; Jijon, HB; Kim, IR; Goel, G; Sokol, H; Bauer, H; Herrmann, BG; Lassen, KG; Xavier, RJ				Liao, Juan; Jijon, Humberto B.; Kim, Ira R.; Goel, Gautam; Sokol, Harry; Bauer, Hermann; Herrmann, Bernhard G.; Lassen, Kara G.; Xavier, Ramnik J.			An Image-Based Genetic Assay Identifies Genes in T1D Susceptibility Loci Controlling Cellular Antiviral Immunity in Mouse	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; GENOME-WIDE ASSOCIATION; NF-KAPPA-B; TOLL-LIKE RECEPTORS; RHEUMATOID-ARTHRITIS RISK; I INTERFERON-PRODUCTION; GAMMA-INTERFERON; RIG-I; INTERLEUKIN-27 EXPRESSION; SIGNALING PROTEIN	The pathogenesis of complex diseases, such as type 1 diabetes (T1D), derives from interactions between host genetics and environmental factors. Previous studies have suggested that viral infection plays a significant role in initiation of T1D in genetically predisposed individuals. T1D susceptibility loci may therefore be enriched in previously uncharacterized genes functioning in antiviral defense pathways. To identify genes involved in antiviral immunity, we performed an image-based high-throughput genetic screen using short hairpin RNAs (shRNAs) against 161 genes within T1D susceptibility loci. RAW 264.7 cells transduced with shRNAs were infected with GFP-expressing herpes simplex virus type 1 (HSV-1) and fluorescent microscopy was performed to assess the viral infectivity by fluorescence reporter activity. Of the 14 candidates identified with high confidence, two candidates were selected for further investigation, Il27 and Tagap. Administration of recombinant IL-27 during viral infection was found to act synergistically with interferon gamma (IFN-gamma) to activate expression of type I IFNs and proinflammatory cytokines, and to enhance the activities of interferon regulatory factor 3 (IRF3). Consistent with a role in antiviral immunity, Tagap-deficient macrophages demonstrated increased viral replication, reduced expression of proinflammatory chemokines and cytokines, and decreased production of IFN-beta. Taken together, our unbiased loss-of-function genetic screen identifies genes that play a role in host antiviral immunity and delineates roles for IL-27 and Tagap in the production of antiviral cytokines.	[Liao, Juan; Jijon, Humberto B.; Kim, Ira R.; Goel, Gautam; Lassen, Kara G.; Xavier, Ramnik J.] Broad Inst Massachusetts Inst Technol & Harvard U, Cambridge, MA 02142 USA; [Liao, Juan; Jijon, Humberto B.; Kim, Ira R.; Goel, Gautam; Sokol, Harry; Lassen, Kara G.; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA USA; [Jijon, Humberto B.; Kim, Ira R.; Goel, Gautam; Bauer, Hermann; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Ctr Study Inflammatory Bowe, Boston, MA USA; [Jijon, Humberto B.] Univ Calgary, Dept Med, Div Gastroenterol, Calgary, AB, Canada; [Sokol, Harry] St Antoine Hosp, AP HP, Dept Gastroenterol, Paris, France; [Bauer, Hermann; Herrmann, Bernhard G.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Calgary; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Max Planck Society	Xavier, RJ (corresponding author), Broad Inst Massachusetts Inst Technol & Harvard U, Cambridge, MA 02142 USA.	xavier@molbio.mgh.harvard.edu	Sokol, Harry/E-2290-2019; sokol, harry/ABA-8991-2020	Sokol, Harry/0000-0002-2914-1822; sokol, harry/0000-0002-2914-1822	Leona M. and Harry B. Helmsley Charitable Trust; Juvenile Diabetes Research Foundation	Leona M. and Harry B. Helmsley Charitable Trust; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This research was funded by the Leona M. and Harry B. Helmsley Charitable Trust (www.helmsleytrust.org) and Juvenile Diabetes Research Foundation (www.jdrf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Arpaia N, 2011, CURR OPIN VIROL, V1, P447, DOI 10.1016/j.coviro.2011.10.006; BARBIERI G, 1994, EUR J BIOCHEM, V223, P427, DOI 10.1111/j.1432-1033.1994.tb19010.x; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bauer H, 2005, NAT GENET, V37, P969, DOI 10.1038/ng1617; Broz P, 2013, NAT REV IMMUNOL, V13, P551, DOI 10.1038/nri3479; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cao YH, 2014, J IMMUNOL, V192, P691, DOI 10.4049/jimmunol.1300252; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cherpes TL, 2013, VIRAL IMMUNOL, V26, P172, DOI 10.1089/vim.2012.0093; Conway KL, 2013, GASTROENTEROLOGY, V145, P1347, DOI 10.1053/j.gastro.2013.08.035; Costa-Pereira AP, 2002, J VIROL, V76, P9060, DOI 10.1128/JVI.76.18.9060-9068.2002; Decman V, 2005, J VIROL, V79, P10339, DOI 10.1128/JVI.79.16.10339-10347.2005; Dixit E, 2013, ADV IMMUNOL, V117, P99, DOI 10.1016/B978-0-12-410524-9.00004-9; Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eyre S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3139; Foxman EF, 2011, NAT REV MICROBIOL, V9, P254, DOI 10.1038/nrmicro2541; Frank AC, 2010, J INTERF CYTOK RES, V30, P427, DOI 10.1089/jir.2009.0093; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Guzzo C, 2010, J BIOL CHEM, V285, P24404, DOI 10.1074/jbc.M110.112599; Harker JA, 2013, IMMUNITY, V39, P548, DOI 10.1016/j.immuni.2013.08.010; Hause L, 2007, ANTIVIR RES, V76, P159, DOI 10.1016/j.antiviral.2007.06.013; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Hober D, 2010, NAT REV ENDOCRINOL, V6, P279, DOI 10.1038/nrendo.2010.27; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Horan KA, 2013, J IMMUNOL, V190, P2311, DOI 10.4049/jimmunol.1202749; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; Jaidane H, 2008, DIABETES METAB, V34, P537, DOI 10.1016/j.diabet.2008.05.008; Kalliolias GD, 2008, J IMMUNOL, V180, P6325, DOI 10.4049/jimmunol.180.9.6325; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; Leoni V, 2012, J VIROL, V86, P6555, DOI 10.1128/JVI.00295-12; Levy DE, 2002, J INTERF CYTOK RES, V22, P87, DOI 10.1089/107999002753452692; Liu L, 2012, J BIOL CHEM, V287, P11899, DOI 10.1074/jbc.M111.308064; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Ma YJ, 2014, J MOL BIOL, V426, P1133, DOI 10.1016/j.jmb.2013.11.012; MacLeod IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009560; Melchjorsen J, 2010, J VIROL, V84, P11350, DOI 10.1128/JVI.01106-10; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Mo X, 2011, CURR MOL MED, V11, P481, DOI 10.2174/156652411796268696; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nelson DA, 2010, CYTOKINE, V51, P184, DOI 10.1016/j.cyto.2010.04.015; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Pham TH, 2013, J VIROL, V87, P3076, DOI 10.1128/JVI.02860-12; Piskurich JF, 1998, J IMMUNOL, V160, P233; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; Prchal-Murphy M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039141; Rasmussen SB, 2007, J VIROL, V81, P13315, DOI 10.1128/JVI.01167-07; Rasmussen SB, 2009, J GEN VIROL, V90, P74, DOI 10.1099/vir.0.005389-0; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Reich NC, 2002, J INTERF CYTOK RES, V22, P103, DOI 10.1089/107999002753452719; Rubins KH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r174; Sainz B, 2002, J VIROL, V76, P11541, DOI 10.1128/JVI.76.22.11541-11550.2002; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Severa M, 2007, CURR TOP MICROBIOL, V316, P167; Simmons A, 2010, NATURE, V466, P699, DOI 10.1038/466699a; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Tanaka M, 2004, MICROBES INFECT, V6, P485, DOI 10.1016/j.micinf.2004.01.011; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhu CL, 2009, CLIN IMMUNOL, V131, P92, DOI 10.1016/j.clim.2008.10.011	77	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108777	10.1371/journal.pone.0108777	http://dx.doi.org/10.1371/journal.pone.0108777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268627	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700162
J	Park, JH; Shin, YJ; Riew, TR; Lee, MY				Park, Joo-Hee; Shin, Yoo-Jin; Riew, Tae-Ryong; Lee, Mun-Yong			The Indolinone MAZ51 Induces Cell Rounding and G2/M Cell Cycle Arrest in Glioma Cells without the Inhibition of VEGFR-3 Phosphorylation: Involvement of the RhoA and Akt/GSK3 beta Signaling Pathways	PLOS ONE			English	Article							GROWTH-FACTOR-C; UP-REGULATION; ACTIVATION; EXPRESSION; RAC1; LYMPHANGIOGENESIS; LOCALIZATION; RETRACTION; GSK-3-BETA; RECEPTOR-3	MAZ51 is an indolinone-based molecule originally synthesized as a selective inhibitor of vascular endothelial growth factor receptor (VEGFR)-3 tyrosine kinase. This study shows that exposure of two glioma cell lines, rat C6 and human U251MG, to MAZ51 caused dramatic shape changes, including the retraction of cellular protrusions and cell rounding. These changes were caused by the clustering and aggregation of actin filaments and microtubules. MAZ51 also induced G2/M phase cell cycle arrest. This led to an inhibition of cellular proliferation, without triggering significant cell death. These alterations induced by MAZ51 occurred with similar dose- and time-dependent patterns. Treatment of glioma cells with MAZ51 resulted in increased levels of phosphorylated GSK3 beta through the activation of Akt, as well as increased levels of active RhoA. Interestingly, MAZ51 did not affect the morphology and cell cycle patterns of rat primary cortical astrocytes, suggesting it selectively targeted transformed cells. Immunoprecipitation-western blot analyses indicated that MAZ51 did not decrease, but rather increased, tyrosine phosphorylation of VEGFR-3. To confirm this unanticipated result, several additional experiments were conducted. Enhancing VEGFR-3 phosphorylation by treatment of glioma cells with VEGF-C affected neither cytoskeleton arrangements nor cell cycle patterns. In addition, the knockdown of VEGFR-3 in glioma cells did not cause morphological or cytoskeletal alterations. Furthermore, treatment of VEGFR-3-silenced cells with MAZ51 caused the same alterations of cell shape and cytoskeletal arrangements as that observed in control cells. These data indicate that MAZ51 causes cytoskeletal alterations and G2/M cell cycle arrest in glioma cells. These effects are mediated through phosphorylation of Akt/GSK3 beta and activation of RhoA. The anti-proliferative activity of MAZ51 does not require the inhibition of VEGFR-3 phosphorylation, suggesting that it is a potential candidate for further clinical investigation for treatment of gliomas, although the precise mechanism(s) underlying its effects remain to be determined.	[Park, Joo-Hee; Shin, Yoo-Jin; Riew, Tae-Ryong; Lee, Mun-Yong] Catholic Univ Korea, Coll Med, Catholic Neurosci Inst, Dept Anat, Seoul, South Korea	Catholic University of Korea	Lee, MY (corresponding author), Catholic Univ Korea, Coll Med, Catholic Neurosci Inst, Dept Anat, Seoul, South Korea.	munylee@catholic.ac.kr		Riew, Tae Ryong/0000-0001-7951-8176	National Research Foundation of Korea (NRF) [MEST-2011-0028319]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This study was supported by the Mid-career Researcher Program through the National Research Foundation of Korea (NRF; http://www.nrf.re.kr) and the grant number is MEST-2011-0028319. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins RJ, 2012, J CLIN NEUROSCI, V19, P1558, DOI 10.1016/j.jocn.2012.07.002; AUER RN, 1981, CAN J NEUROL SCI, V8, P325, DOI 10.1017/S0317167100043468; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Bisping G, 2006, BLOOD, V107, P2079, DOI 10.1182/blood-2004-11-4250; Brozzi F, 2009, J BIOL CHEM, V284, P8788, DOI 10.1074/jbc.M805897200; Cho TP, 2010, J MED CHEM, V53, P8140, DOI 10.1021/jm101036c; Cramer LP, 1997, MOL BIOL CELL, V8, P109, DOI 10.1091/mbc.8.1.109; David B, 2012, MECH CELL; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Farooqui R, 2006, EXP CELL RES, V312, P1514, DOI 10.1016/j.yexcr.2006.01.018; Grau SJ, 2007, J NEURO-ONCOL, V82, P141, DOI 10.1007/s11060-006-9272-4; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; He M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-170; Jenny B, 2006, J PATHOL, V209, P34, DOI 10.1002/path.1943; Kalman D, 1999, MOL BIOL CELL, V10, P1665, DOI 10.1091/mbc.10.5.1665; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Karrasch T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026340; Kazenwadel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040497; Kirkin V, 2004, INT J CANCER, V112, P986, DOI 10.1002/ijc.20509; Kirkin V, 2001, EUR J BIOCHEM, V268, P5530, DOI 10.1046/j.1432-1033.2001.02476.x; Klopocka W, 2013, ADV EXP MED BIOL, V986, P103, DOI 10.1007/978-94-007-4719-7_6; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Lancaster OM, 2014, SEMIN CELL DEV BIOL; Lee JY, 2013, J CLIN IMMUNOL, V33, P826, DOI 10.1007/s10875-013-9877-2; Liu J, 2014, GYNECOL ENDOCRINOL; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Maeda M, 2011, MOL BIOL CELL, V22, P3840, DOI 10.1091/mbc.E11-04-0364; Majumdar M, 1998, J BIOL CHEM, V273, P10099, DOI 10.1074/jbc.273.17.10099; Matsuura M, 2009, AM J PATHOL, V175, P1709, DOI 10.2353/ajpath.2009.081139; Matthews HK, 2012, BIOESSAYS, V34, P1017, DOI 10.1002/bies.201200109; Matthews HK, 2012, DEV CELL, V23, P371, DOI 10.1016/j.devcel.2012.06.003; Prakash CR, 2012, PHARM PHARM, V3; Racchetti G, 2012, GLIA, V60, P465, DOI 10.1002/glia.22280; Rodnight RB, 2013, J NEUROCHEM, V124, P263, DOI 10.1111/jnc.12087; Seasholtz TM, 2004, J NEUROCHEM, V91, P501, DOI 10.1111/j.1471-4159.2004.02749.x; Tas PWL, 2007, J CELL BIOCHEM, V102, P368, DOI 10.1002/jcb.21294; Vaidya RJ, 2006, CELL MOL LIFE SCI, V63, P2871, DOI 10.1007/s00018-006-6379-x; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xiong XS, 2010, INVEST NEW DRUG, V28, P26, DOI 10.1007/s10637-008-9211-7; Zhou YT, 2006, ONCOGENE, V25, P2393, DOI 10.1038/sj.onc.1209274; Zou HB, 2011, EUR J MED CHEM, V46, P5970, DOI 10.1016/j.ejmech.2011.10.009	42	17	17	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e109055	10.1371/journal.pone.0109055	http://dx.doi.org/10.1371/journal.pone.0109055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268128	Green Submitted, gold, Green Published			2022-12-27	WOS:000343671700218
J	Tang, XC; Xu, T; Feng, X; Yang, GQ				Tang, Xianchao; Xu, Tao; Feng, Xia; Yang, Guoqing			Uncovering Community Structures with Initialized Bayesian Nonnegative Matrix Factorization	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; NETWORKS	Uncovering community structures is important for understanding networks. Currently, several nonnegative matrix factorization algorithms have been proposed for discovering community structure in complex networks. However, these algorithms exhibit some drawbacks, such as unstable results and inefficient running times. In view of the problems, a novel approach that utilizes an initialized Bayesian nonnegative matrix factorization model for determining community membership is proposed. First, based on singular value decomposition, we obtain simple initialized matrix factorizations from approximate decompositions of the complex network's adjacency matrix. Then, within a few iterations, the final matrix factorizations are achieved by the Bayesian nonnegative matrix factorization method with the initialized matrix factorizations. Thus, the network's community structure can be determined by judging the classification of nodes with a final matrix factor. Experimental results show that the proposed method is highly accurate and offers competitive performance to that of the state-of-the-art methods even though it is not designed for the purpose of modularity maximization.	[Tang, Xianchao; Yang, Guoqing] Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300072, Peoples R China; [Xu, Tao; Feng, Xia] Civil Aviat Univ China, Sch Comp Sci & Technol, Tianjin, Peoples R China; [Xu, Tao; Feng, Xia; Yang, Guoqing] Informat Technol Res Base Civil Aviat Adm China, Tianjin, Peoples R China	Tianjin University; Civil Aviation University of China	Tang, XC (corresponding author), Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300072, Peoples R China.	riemannfly@163.com			State Key Program of National Natural Science of China [61139002]; National High Technology Research and Development Program of China [2012AA063301]; Fundamental Research Funds for the Central Universities [3122013P013, 3122013C005]	State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the State Key Program of National Natural Science of China (61139002), National High Technology Research and Development Program of China (2012AA063301), the Fundamental Research Funds for the Central Universities (3122013P013, 3122013C005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; [Anonymous], 2013, SINGULAR VALUE DECOM; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 2003, SEEDING NONNEGATIVE; [Anonymous], [No title captured]; Berry MW, 2007, COMPUT STAT DATA AN, V52, P155, DOI 10.1016/j.csda.2006.11.006; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boutsidis C, 2008, PATTERN RECOGN, V41, P1350, DOI 10.1016/j.patcog.2007.09.010; Choudrey RA, 2003, NEURAL COMPUT, V15, P213, DOI 10.1162/089976603321043766; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gopalan PK, 2013, P NATL ACAD SCI USA, V110, P14534, DOI 10.1073/pnas.1221839110; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; MACKAY DJC, 1995, NETWORK-COMP NEURAL, V6, P469, DOI 10.1088/0954-898X/6/3/011; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman M. E. J., 2001, PHYS REV E, V64; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Psorakis I, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066114; Pujol JM, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016107; Roberts S, 2005, LECT NOTES ARTIF INT, V3635, P159, DOI 10.1007/11559887_10; Roberts S, 2003, PATTERN RECOGN, V36, P1813, DOI 10.1016/S0031-3203(03)00002-5; Ronhovde P, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016109; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Wang F, 2011, DATA MIN KNOWL DISC, V22, P493, DOI 10.1007/s10618-010-0181-y; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhang Y., 2012, P 18 ACM SIGKDD INT, P606, DOI [DOI 10.1145/2339530.2339629, 10.1145/2339530.2339629]	36	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107884	10.1371/journal.pone.0107884	http://dx.doi.org/10.1371/journal.pone.0107884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268494	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700051
J	De Angelis, M; Bottacini, F; Fosso, B; Kelleher, P; Calasso, M; Di Cagno, R; Ventura, M; Picardi, E; van Sinderen, D; Gobbetti, M				De Angelis, Maria; Bottacini, Francesca; Fosso, Bruno; Kelleher, Philip; Calasso, Maria; Di Cagno, Raffaella; Ventura, Marco; Picardi, Ernesto; van Sinderen, Douwe; Gobbetti, Marco			Lactobacillus rossiae, a Vitamin B-12 Producer, Represents a Metabolically Versatile Species within the Genus Lactobacillus	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; GENOME SEQUENCE; SANFRANCISCENSIS; ETHANOLAMINE; PLANTARUM; REUTERI; WHEAT; MICROBIOTA; ALGORITHM; SELECTION	Lactobacillus rossiae is an obligately hetero-fermentative lactic acid bacterium, which can be isolated from a broad range of environments including sourdoughs, vegetables, fermented meat and flour, as well as the gastrointestinal tract of both humans and animals. In order to unravel distinctive genomic features of this particular species and investigate the phylogenetic positioning within the genus Lactobacillus, comparative genomics and phylogenomic approaches, followed by functional analyses were performed on L. rossiae DSM 15814(T), showing how this type strain not only occupies an independent phylogenetic branch, but also possesses genomic features underscoring its biotechnological potential. This strain in fact represents one of a small number of bacteria known to encode a complete de novo biosynthetic pathway of vitamin B-12 (in addition to other B vitamins such as folate and riboflavin). In addition, it possesses the capacity to utilize an extensive set of carbon sources, a characteristic that may contribute to environmental adaptation, perhaps enabling the strain's ability to populate different niches.	[De Angelis, Maria; Calasso, Maria; Di Cagno, Raffaella; Gobbetti, Marco] Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy; [Bottacini, Francesca; Kelleher, Philip; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Fosso, Bruno; Picardi, Ernesto] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Ventura, Marco] Univ Parma, Dept Life Sci, Lab Probiogen, I-43100 Parma, Italy; [Picardi, Ernesto] CNR, Inst Biomembranes & Bioenerget IBBE, I-70126 Bari, Italy; [Picardi, Ernesto] INBB, Rome, Italy; [van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	Universita degli Studi di Bari Aldo Moro; University College Cork; Universita degli Studi di Bari Aldo Moro; University of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomembrane e Bioenergetica (IBBE-CNR); University College Cork	van Sinderen, D (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland.	d.vansinderen@ucc.ie; marco.gobbetti@uniba.it	Bottacini, Francesca/AAO-2431-2021; Fosso, Bruno/P-1538-2018; De Angelis, Maria/AAA-9909-2019; Van Sinderen, Douwe/A-6778-2015; Picardi, Ernesto/A-5863-2015; ventura, marco/M-8230-2015; Gobbetti, Marco/K-4138-2014	Bottacini, Francesca/0000-0002-0142-2956; Fosso, Bruno/0000-0003-2324-086X; Van Sinderen, Douwe/0000-0003-1823-7957; Picardi, Ernesto/0000-0002-6549-0114; Calasso, Maria/0000-0003-2500-8650; Ventura, Marco/0000-0002-4875-4560; Di Cagno, Raffaella/0000-0002-9431-4427; De Angelis, Maria/0000-0002-2010-884X; Kelleher, Philip/0000-0003-3423-7930; Gobbetti, Marco/0000-0003-0869-2737				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Boekhorst J, 2004, MICROBIOL-SGM, V150, P3601, DOI 10.1099/mic.0.27392-0; Brinsmade SR, 2005, J BACTERIOL, V187, P8039, DOI 10.1128/JB.187.23.8039-8046.2005; Burgess C, 2004, APPL ENVIRON MICROB, V70, P5769, DOI 10.1128/AEM.70.10.5769-5777.2004; Cai H, 2009, GENOME BIOL EVOL, V1, P239, DOI 10.1093/gbe/evp019; Callanan M, 2008, J BACTERIOL, V190, P727, DOI 10.1128/JB.01295-07; Claesson MJ, 2007, FEMS MICROBIOL LETT, V269, P22, DOI 10.1111/j.1574-6968.2006.00596.x; Coda R, 2010, J APPL MICROBIOL, V108, P925, DOI 10.1111/j.1365-2672.2009.04497.x; Corsetti A, 2005, INT J SYST EVOL MICR, V55, P35, DOI 10.1099/ijs.0.63075-0; Crowley S, 2013, TRENDS FOOD SCI TECH, V33, P93, DOI 10.1016/j.tifs.2013.07.004; De Angelis M, 2007, INT J FOOD MICROBIOL, V114, P69, DOI 10.1016/j.ijfoodmicro.2006.10.036; De Angelis M, 2002, APPL ENVIRON MICROB, V68, P6193, DOI 10.1128/AEM.68.12.6193-6201.2002; De Angelis M, 2012, ENCY DAIRY SCI, P78, DOI DOI 10.1016/B978-0-12-374407-4.00259-4; De Angelis M, 2006, RES MICROBIOL, V157, P792, DOI 10.1016/j.resmic.2006.05.003; Di Cagno R, 2007, J APPL MICROBIOL, V103, P821, DOI 10.1111/j.1365-2672.2007.03389.x; Di Cagno R, 2012, J BACTERIOL, V194, P5460, DOI 10.1128/JB.01248-12; Di Cagno R, 2010, FOOD MICROBIOL, V27, P381, DOI 10.1016/j.fm.2009.11.012; Di Cagno R, 2009, APPL ENVIRON MICROB, V75, P3963, DOI 10.1128/AEM.02793-08; Nguyen DTL, 2013, FOOD RES INT, V50, P232, DOI 10.1016/j.foodres.2012.09.029; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334; Gobbetti M, 2005, TRENDS FOOD SCI TECH, V16, P57, DOI 10.1016/j.tifs.2004.02.013; Goh YJ, 2009, FRONT BIOSCI-LANDMRK, V14, P1362, DOI 10.2741/3313; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Hagiwara H, 2004, BIOSCI BIOTECH BIOCH, V68, P444, DOI 10.1271/bbb.68.444; Jones SE, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-35; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Minervini F, 2010, FOOD MICROBIOL, V27, P897, DOI 10.1016/j.fm.2010.05.021; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Rico J, 2008, J IND MICROBIOL BIOT, V35, P579, DOI 10.1007/s10295-008-0319-8; Rizzello CG, 2014, INT J FOOD MICROBIOL, V180, P78, DOI 10.1016/j.ijfoodmicro.2014.04.005; Rizzello CG, 2010, FOOD CHEM, V119, P1079, DOI 10.1016/j.foodchem.2009.08.016; Scheirlinek I, 2009, SYST APPL MICROBIOL, V32, P151, DOI 10.1016/j.syapm.2008.12.006; Schmid R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-180; Singh SK, 2011, MICROB CELL FACT, V10, DOI [10.1186/1475-2859-10-114, 10.1186/1475-2859-10-55]; Siragusa S, 2007, APPL ENVIRON MICROB, V73, P7283, DOI 10.1128/AEM.01064-07; Siragusa S, 2009, APPL ENVIRON MICROB, V75, P1099, DOI 10.1128/AEM.01524-08; Stromeck A, 2011, J AGR FOOD CHEM, V59, P1392, DOI 10.1021/jf103546t; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valerio F, 2009, SYST APPL MICROBIOL, V32, P438, DOI 10.1016/j.syapm.2009.01.004; Vogel RF, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S6	48	43	44	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107232	10.1371/journal.pone.0107232	http://dx.doi.org/10.1371/journal.pone.0107232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264826	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400018
J	Angelo, MF; Aguirre, A; Reyes, RXA; Villarreal, A; Lukin, J; Melendez, M; Vanasco, V; Barker, P; Alvarez, S; Epstein, A; Jerusalinsky, D; Ramos, AJ				Florencia Angelo, Maria; Aguirre, Alejandra; Aviles Reyes, Rolando X.; Villarreal, Alejandro; Lukin, Jeronimo; Melendez, Matias; Vanasco, Virginia; Barker, Phil; Alvarez, Silvia; Epstein, Alberto; Jerusalinsky, Diana; Javier Ramos, Alberto			The Proinflammatory RAGE/NF-kappa B Pathway Is Involved in Neuronal Damage and Reactive Gliosis in a Model of Sleep Apnea by Intermittent Hypoxia	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; GLYCATION END-PRODUCTS; HERPES-SIMPLEX-VIRUS; OXIDATIVE STRESS; DAYTIME SLEEPINESS; COGNITIVE FUNCTION; SERUM S100B; INFLAMMATION; ASTROCYTES; RAT	Sleep apnea (SA) causes long-lasting changes in neuronal circuitry, which persist even in patients successfully treated for the acute effects of the disease. Evidence obtained from the intermittent hypoxia (IH) experimental model of SA has shown neuronal death, impairment in learning and memory and reactive gliosis that may account for cognitive and structural alterations observed in human patients. However, little is known about the mechanism controlling these deleterious effects that may be useful as therapeutic targets in SA. The Receptor for Advanced Glycation End products (RAGE) and its downstream effector Nuclear Factor Kappa B (NF-kappa B) have been related to neuronal death and astroglial conversion to the pro-inflammatory neurodegenerative phenotype. RAGE expression and its ligand S100B were shown to be increased in experimental models of SA. We here used dissociated mixed hippocampal cell cultures and male Wistar rats exposed to IH cycles and observed that NF-kappa B is activated in glial cells and neurons after IH. To disclose the relative contribution of the S100B/RAGE/NF-kappa B pathway to neuronal damage and reactive gliosis after IH we performed sequential loss of function studies using RAGE or S100B neutralizing antibodies, a herpes simplex virus (HSV)-derived amplicon vector that induces the expression of RAGE Delta cyto (dominant negative RAGE) and a chemical blocker of NF-kappa B. Our results show that NF-kappa B activation peaks 3 days after IH exposure, and that RAGE or NF-kappa B blockage during this critical period significantly improves neuronal survival and reduces reactive gliosis. Both in vitro and in vivo, S100B blockage altered reactive gliosis but did not have significant effects on neuronal survival. We conclude that both RAGE and downstream NF-kappa B signaling are centrally involved in the neuronal alterations found in SA models, and that blockage of these pathways is a tempting strategy for preventing neuronal degeneration and reactive gliosis in SA.	[Florencia Angelo, Maria; Aguirre, Alejandra; Aviles Reyes, Rolando X.; Villarreal, Alejandro; Lukin, Jeronimo; Jerusalinsky, Diana; Javier Ramos, Alberto] Univ Buenos Aires, Fac Med, Inst Biol Celular & Neurociencia Prof E De Robert, Buenos Aires, DF, Argentina; [Melendez, Matias; Epstein, Alberto] Univ Lyon 1, Ecole Normale Super, Ctr Int Rech Infectiol, INSERM,U1111,CNRS,UMR5038, F-69365 Lyon, France; [Barker, Phil] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Vanasco, Virginia; Alvarez, Silvia] Univ Buenos Aires, Fac Farm & Bioquim, Inst Bioquim & Med Mol, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; McGill University; University of Buenos Aires	Ramos, AJ (corresponding author), Univ Buenos Aires, Fac Med, Inst Biol Celular & Neurociencia Prof E De Robert, Buenos Aires, DF, Argentina.	jramos@fmed.uba.ar	Ramos, Alberto Javier/AAR-7796-2020; Vanasco, Virginia/AAF-9593-2021	Ramos, Alberto Javier/0000-0003-4009-6337; Vanasco, Virginia/0000-0001-5117-3540; Aviles-Reyes, Rolando/0000-0002-2297-4215; Epstein, Alberto/0000-0002-4322-1511; Alvarez, Silvia/0000-0002-9691-2631; Lukin, Jeronimo/0000-0002-2284-7152; Villarreal, Alejandro/0000-0001-8624-8119	Consejo Nacional de Investigaciones Cientificas y Tecnicas-Argentina [CONICET PIP 1728]; Agencia Nacional de Promocion Cientifica y Tecnica, Argentina [ANPCYT PICT 2008-1590, PICT 2012-1424]; UBACYT (Universidad de Buenos Aires); LIA-DEVENIR CNRS/UCBL-CONICET/UBA (France-Argentina); IBRO-FRSQ-INMHA Alberto Aguayo fellowship (Canada)	Consejo Nacional de Investigaciones Cientificas y Tecnicas-Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnica, Argentina(ANPCyT); UBACYT (Universidad de Buenos Aires)(University of Buenos Aires); LIA-DEVENIR CNRS/UCBL-CONICET/UBA (France-Argentina); IBRO-FRSQ-INMHA Alberto Aguayo fellowship (Canada)	Funding provided by CONICET PIP 1728 (Consejo Nacional de Investigaciones Cientificas y Tecnicas-Argentina)(AJR, DJ) www.conicet.gov.ar, ANPCYT PICT 2008-1590 and PICT 2012-1424 (Agencia Nacional de Promocion Cientifica y Tecnica, Argentina) (AJR) (www.agencia.mincyt.gov.ar), UBACYT (Universidad de Buenos Aires)(AJR) (www.uba.ar), LIA-DEVENIR CNRS/UCBL-CONICET/UBA (France-Argentina)(DJ, AE), IBRO-FRSQ-INMHA Alberto Aguayo fellowship (Canada)(RXAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baronio D, 2013, RESP PHYSIOL NEUROBI, V185, P217, DOI 10.1016/j.resp.2012.10.012; Basner RC, 2007, NEW ENGL J MED, V356, P1751, DOI 10.1056/NEJMct066953; Bernardini C, 2010, GENE EXPRESSION, V14, P345, DOI 10.3727/105221610X12718619643013; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Bierhaus A, 2006, CURR OPIN INVEST DR, V7, P985; Braga CW, 2006, SLEEP MED, V7, P431, DOI 10.1016/j.sleep.2005.12.012; BRETT J, 1993, AM J PATHOL, V143, P1699; Burckhardt IC, 2008, AM J RESP CRIT CARE, V177, P1135, DOI 10.1164/rccm.200701-110OC; da Rosa DP, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/879419; da Silva LG, 2008, OBES SURG, V18, P993, DOI 10.1007/s11695-007-9386-6; Bravo MD, 2007, SLEEP BREATH, V11, P177, DOI 10.1007/s11325-007-0100-7; Decary A, 2000, SLEEP, V23, P369; Duru S, 2012, NEUROL NEUROCHIR POL, V46, P450, DOI 10.5114/ninp.2012.31355; Engleman HM, 2000, SLEEP, V23, pS102; Feuerstein C, 1997, ACTA NEUROL BELG, V97, P96; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; FRAGA CG, 1988, FREE RADICAL BIO MED, V4, P155, DOI 10.1016/0891-5849(88)90023-8; Fung SJ, 2007, BRAIN RES, V1179, P42, DOI 10.1016/j.brainres.2007.08.044; Gozal D, 2001, J NEUROSCI, V21, P2442, DOI 10.1523/JNEUROSCI.21-07-02442.2001; Gozal D, 2008, AM J RESP CRIT CARE, V177, P369, DOI 10.1164/rccm.200608-1190PP; Gozal D, 2007, CURR OPIN PULM MED, V13, P505, DOI 10.1097/MCP.0b013e3282ef6880; Gozal E, 2002, J NEUROCHEM, V83, P331, DOI 10.1046/j.1471-4159.2002.01134.x; Hung MW, 2008, J PINEAL RES, V44, P214, DOI 10.1111/j.1600-079X.2007.00514.x; Inta I, 2006, J NEUROSCI, V26, P12896, DOI 10.1523/JNEUROSCI.3670-06.2006; Krisky DM, 1998, GENE THER, V5, P1517, DOI 10.1038/sj.gt.3300755; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; Lavie L, 2003, SLEEP MED REV, V7, P35, DOI 10.1053/smrv.2002.0261; Lee William, 2012, Methods Mol Biol, V846, P261, DOI 10.1007/978-1-61779-536-7_23; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Logvinoff C, 2001, HUM GENE THER, V12, P161, DOI 10.1089/104303401750061221; MACHUCA I, 1986, VIROLOGY, V150, P117, DOI 10.1016/0042-6822(86)90271-0; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Naegele B, 1998, SLEEP, V21, P392, DOI 10.1093/sleep/21.4.392; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; PARPURA V, 1993, J CELL SCI, V104, P427; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Payne RS, 2004, BRAIN RES, V1029, P195, DOI 10.1016/j.brainres.2004.09.045; Ponath G, 2007, J NEUROIMMUNOL, V184, P214, DOI 10.1016/j.jneuroim.2006.12.011; Privat A, 2003, GLIA, V43, P91, DOI 10.1002/glia.10249; Ramos AJ, 2013, J NEUROCHEM, V125, P117; Ramos A, 2007, J NEUROSCI, V27, P1498, DOI 10.1523/JNEUROSCI.4806-06.2007; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Roure N, 2008, SLEEP MED, V9, P727, DOI 10.1016/j.sleep.2008.02.006; Row BW, 2007, ADV EXP MED BIOL, V618, P51; Row BW, 2003, AM J RESP CRIT CARE, V167, P1548, DOI 10.1164/rccm.200209-1050OC; Selmi C, 2007, EXP BIOL MED, V232, P1409, DOI 10.3181/0704-MR-103; Shan XY, 2007, NEUROBIOL DIS, V28, P206, DOI 10.1016/j.nbd.2007.07.013; Sizonenko SV, 2003, PEDIATR RES, V54, P263, DOI 10.1203/01.PDR.0000072517.01207.87; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Thomas RJ, 2005, J APPL PHYSIOL, V98, P2226, DOI 10.1152/japplphysiol.01225.2004; Villarreal A, 2011, J NEUROCHEM, V117, P321, DOI 10.1111/j.1471-4159.2011.07207.x; Vincent AM, 2007, ENDOCRINOLOGY, V148, P548, DOI 10.1210/en.2006-0073; Wang BS, 2013, SLEEP MED, V14, P165, DOI 10.1016/j.sleep.2012.10.020; Williams A, 2007, SLEEP BREATH, V11, P69, DOI 10.1007/s11325-007-0106-1; Wu KM, 2010, CHEST, V137, P303, DOI 10.1378/chest.09-0936; Aviles-Reyes RX, 2010, J NEUROCHEM, V112, P854, DOI 10.1111/j.1471-4159.2009.06535.x; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zaupa C, 2003, HUM GENE THER, V14, P1049, DOI 10.1089/104303403322124774; Zimmerman ME, 2006, J CLIN SLEEP MED, V2, P461	61	35	36	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107901	10.1371/journal.pone.0107901	http://dx.doi.org/10.1371/journal.pone.0107901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265561	Green Published, gold			2022-12-27	WOS:000345745400033
J	Habash, DZ; Baudo, M; Hindle, M; Powers, SJ; Defoin-Platel, M; Mitchell, R; Saqi, M; Rawlings, C; Latiri, K; Araus, JL; Abdulkader, A; Tuberosa, R; Lawlor, DW; Nachit, MM				Habash, Dimah Z.; Baudo, Marcela; Hindle, Matthew; Powers, Stephen J.; Defoin-Platel, Michael; Mitchell, Rowan; Saqi, Mansoor; Rawlings, Chris; Latiri, Kawther; Araus, Jose L.; Abdulkader, Ahmad; Tuberosa, Roberto; Lawlor, David W.; Nachit, Miloudi M.			Systems Responses to Progressive Water Stress in Durum Wheat	PLOS ONE			English	Article							IMPROVE DROUGHT TOLERANCE; QUANTITATIVE TRAIT LOCI; ABIOTIC STRESS; GENE-EXPRESSION; STOMATAL CONDUCTANCE; PHOTOSYNTHETIC RATE; METABOLIC PATHWAYS; XYLEM SAP; ARABIDOPSIS; YIELD	Durum wheat is susceptible to terminal drought which can greatly decrease grain yield. Breeding to improve crop yield is hampered by inadequate knowledge of how the physiological and metabolic changes caused by drought are related to gene expression. To gain better insight into mechanisms defining resistance to water stress we studied the physiological and transcriptome responses of three durum breeding lines varying for yield stability under drought. Parents of a mapping population (Lahn x Cham1) and a recombinant inbred line (RIL2219) showed lowered flag leaf relative water content, water potential and photosynthesis when subjected to controlled water stress time transient experiments over a six-day period. RIL2219 lost less water and showed constitutively higher stomatal conductance, photosynthesis, transpiration, abscisic acid content and enhanced osmotic adjustment at equivalent leaf water compared to parents, thus defining a physiological strategy for high yield stability under water stress. Parallel analysis of the flag leaf transcriptome under stress uncovered global trends of early changes in regulatory pathways, reconfiguration of primary and secondary metabolism and lowered expression of transcripts in photosynthesis in all three lines. Differences in the number of genes, magnitude and profile of their expression response were also established amongst the lines with a high number belonging to regulatory pathways. In addition, we documented a large number of genes showing constitutive differences in leaf transcript expression between the genotypes at control non-stress conditions. Principal Coordinates Analysis uncovered a high level of structure in the transcriptome response to water stress in each wheat line suggesting genome-wide co-ordination of transcription. Utilising a systems-based approach of analysing the integrated wheat's response to water stress, in terms of biological robustness theory, the findings suggest that each durum line transcriptome responded to water stress in a genome-specific manner which contributes to an overall different strategy of resistance to water stress.	[Habash, Dimah Z.; Baudo, Marcela; Lawlor, David W.] Rothamsted Res, Plant Biol & Crop Sci, Harpenden, Herts, England; [Hindle, Matthew; Powers, Stephen J.; Defoin-Platel, Michael; Mitchell, Rowan; Saqi, Mansoor; Rawlings, Chris] Rothamsted Res, Computat & Syst Biol, Harpenden, Herts, England; [Latiri, Kawther] Natl Agr Res Inst Tunisia, Lab Agron, Ariana, Tunisia; [Araus, Jose L.] Univ Barcelona, Fac Biol, Dept Biol Vegetal, Barcelona, Spain; [Abdulkader, Ahmad] Gen Commiss Sci Agr Res, Dept Biotechnol, Damascus, Syria; [Tuberosa, Roberto] Univ Bologna, Dept Agroenvironm Sci & Technol, Bologna, Italy; [Nachit, Miloudi M.] Int Ctr Agr Res Dry Areas, Biodivers & Integrated Gene Management Program, Rabat, Morocco	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Barcelona; University of Bologna	Habash, DZ (corresponding author), Securewheat Res, Securewheat, St Albans, England.	Dimah.Habash@securewheat.com	Tuberosa, Roberto/A-2781-2016; Ortega, Jose Luis Araus/E-4129-2016; Habash, Dimah/HHZ-3819-2022	Tuberosa, Roberto/0000-0001-9143-9569; Saqi, Mansoor/0000-0003-1222-475X; Defoin-Platel, Michael/0000-0001-7227-1414; Mitchell, Rowan Andrew Craig/0000-0002-1412-8828; Habash, Dimah/0000-0003-2222-4825; Hindle, Matthew/0000-0002-6870-4069; Rawlings, Christopher/0000-0003-3702-1633	European Union FPVI programme [INCO-CT-509136]; Lawes Agricultural Trust studentship; Biotechnology and Biological Sciences Research Council (BBSRC) of the UK; BBSRC [BB/F006039/]; International Center for Agricultural Research in the Dry Areas	European Union FPVI programme; Lawes Agricultural Trust studentship; Biotechnology and Biological Sciences Research Council (BBSRC) of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); International Center for Agricultural Research in the Dry Areas	DH, RT, JA, AA, KL, and MN gratefully acknowledge support from the European Union FPVI programme (INCO-CT-509136) which funded material, overheads and salaries. MH was supported by a Lawes Agricultural Trust studentship. DH, CR, SP, MD-P, RM, MB, and MS acknowledge strategic funding support from the Biotechnology and Biological Sciences Research Council (BBSRC) of the UK, and CR was also supported by BBSRC grant BB/F006039/. MN received support from the International Center for Agricultural Research in the Dry Areas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Alvarez S, 2008, PLANT CELL ENVIRON, V31, P325, DOI 10.1111/j.1365-3040.2007.01770.x; Aprile A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-279; Araus JL, 2002, ANN BOT-LONDON, V89, P925, DOI 10.1093/aob/mcf049; Araus JL, 2001, APPL PHYSL WHEAT BRE, P59; Bahar B, 2009, NOT BOT HORTI AGROBO, V37, P45; Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P2493, DOI 10.1093/bioinformatics/bth283; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bates B.C., 2008, TECHNICAL PAPER INTE, DOI DOI 10.1016/J.JMB.2010.08.039; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blum A., 1996, INCREASING YIELD POT, P90; Brennan JP, 2007, J AGR SCI, V145, P187, DOI 10.1017/S0021859607007009; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Claverie JM, 1999, HUM MOL GENET, V8, P1821, DOI 10.1093/hmg/8.10.1821; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; Cramer GR, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-163; Degenkolbe T, 2009, PLANT MOL BIOL, V69, P133, DOI 10.1007/s11103-008-9412-7; Delgado MI, 1994, 30 CIMMYT; Ergen NZ, 2009, FUNCT INTEGR GENOMIC, V9, P377, DOI 10.1007/s10142-009-0123-1; Fernandez-Garcia N, 2011, PLANT CELL ENVIRON, V34, P821, DOI 10.1111/j.1365-3040.2011.02285.x; Fischer RA, 1998, CROP SCI, V38, P1467, DOI 10.2135/cropsci1998.0011183X003800060011x; Fleury D, 2010, J EXP BOT, V61, P3211, DOI 10.1093/jxb/erq152; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Gasca M, 2000, J COMPUT APPL MATH, V122, P23, DOI 10.1016/S0377-0427(00)00353-8; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Giunta F, 2008, FIELD CROP RES, V106, P68, DOI 10.1016/j.fcr.2007.10.018; Guo WJ, 2008, PLANT PHYSIOL, V147, P1710, DOI 10.1104/pp.108.120238; Habash DZ, 2009, J EXP BOT, V60, P2805, DOI 10.1093/jxb/erp211; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Hoerling M, 2012, J CLIMATE, V25, P2146, DOI 10.1175/JCLI-D-11-00296.1; Khamssi NN, 2012, PHOTOCHEM PHOTOBIOL, V88, P76, DOI 10.1111/j.1751-1097.2011.01008.x; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Konno H, 2008, J PLANT PHYSIOL, V165, P745, DOI 10.1016/j.jplph.2007.07.007; Krugman T, 2010, FUNCT INTEGR GENOMIC, V10, P167, DOI 10.1007/s10142-010-0166-3; Krzanowski WJ, 2000, PRINCIPLES MULTIVARI; Lawlor DW, 2013, J EXP BOT, V64, P83, DOI 10.1093/jxb/ers326; Lawlor DW, 2009, ANN BOT-LONDON, V103, P561, DOI [10.1093/aob/mcn244, 10.1093/aob/mcn256]; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Mastroianni G, 2008, SPRINGER MONOGR MATH, P1; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; Mochida K, 2010, PLANT CELL PHYSIOL, V51, P497, DOI 10.1093/pcp/pcq027; Moinuddin, 2005, AGRON J, V97, P1062, DOI 10.2134/agronj2004.0152; Monneveux P, 2006, PLANT SCI, V170, P867, DOI 10.1016/j.plantsci.2005.12.008; Moumeni A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-174; Nachit M.M., 2004, CSSA SPECIAL PUBLICA, P203, DOI DOI 10.2135/CSSASPECPUB32.C13; NACHIT MM, 1992, THEOR APPL GENET, V83, P597, DOI 10.1007/BF00226903; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Qin D., 2014, CLIM CHANG 2013 PHYS, P5; Reguera M, 2012, BBA-GENE REGUL MECH, V1819, P186, DOI 10.1016/j.bbagrm.2011.08.005; Reynolds M.P., 2001, APPL PHYSL WHEAT BRE, P88; Richards RA, 2010, FUNCT PLANT BIOL, V37, P85, DOI 10.1071/FP09219; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; Sasidharan R, 2011, CRIT REV PLANT SCI, V30, P548, DOI 10.1080/07352689.2011.615706; SCHOLANDER PF, 1964, P NATL ACAD SCI USA, V52, P119, DOI 10.1073/pnas.52.1.119; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Swarbreck SM, 2011, J EXP BOT, V62, P1511, DOI 10.1093/jxb/erq356; Talame V, 2007, J EXP BOT, V58, P229, DOI 10.1093/jxb/erl163; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tuberosa R, 2006, TRENDS PLANT SCI, V11, P405, DOI 10.1016/j.tplants.2006.06.003; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; van Dongen JT, 2011, J PLANT PHYSIOL, V168, P1434, DOI 10.1016/j.jplph.2010.11.004; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; WHEAT, 2011, GLOB ALL IMPR FOOD S; Whitacre James Michael, 2012, Frontiers in Genetics, V3, P67, DOI 10.3389/fgene.2012.00067; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xue GP, 2008, PLANT MOL BIOL, V67, P197, DOI 10.1007/s11103-008-9311-y; Xue GP, 2006, PLANT MOL BIOL, V61, P863, DOI 10.1007/s11103-006-0055-2; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Zheng J, 2010, PLANT MOL BIOL, V72, P407, DOI 10.1007/s11103-009-9579-6	74	24	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108431	10.1371/journal.pone.0108431	http://dx.doi.org/10.1371/journal.pone.0108431			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265161	gold, Green Published			2022-12-27	WOS:000345745400074
J	Kakar, SS; Ratajczak, MZ; Powell, KS; Moghadamfalahi, M; Miller, DM; Batra, SK; Singh, SK				Kakar, Sham S.; Ratajczak, Mariusz Z.; Powell, Karen S.; Moghadamfalahi, Mana; Miller, Donald M.; Batra, Surinder K.; Singh, Sanjay K.			Withaferin A Alone and in Combination with Cisplatin Suppresses Growth and Metastasis of Ovarian Cancer by Targeting Putative Cancer Stem Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ACUTE MYELOID-LEUKEMIA; BREAST-CANCER; WITHANIA-SOMNIFERA; DOWN-REGULATION; ALDEHYDE DEHYDROGENASE; INDUCED INFLAMMATION; UP-REGULATION; APOPTOSIS; EXPRESSION	Currently, the treatment for ovarian cancer entails cytoreductive surgery followed by chemotherapy, mainly, carboplatin combined with paclitaxel. Although this regimen is initially effective in a high percentage of cases, unfortunately within few months of initial treatment, tumor relapse occurs because of platinum-resistance. This is attributed to chemo-resistance of cancer stem cells (CSCs). Herein we show for the first time that withaferin A (WFA), a bioactive compound isolated from the plant Withania somnifera, when used alone or in combination with cisplatin (CIS) targets putative CSCs. Treatment of nude mice bearing orthotopic ovarian tumors generated by injecting human ovarian epithelial cancer cell line (A2780) with WFA and cisplatin (WFA) alone or in combination resulted in a 70 to 80% reduction in tumor growth and complete inhibition of metastasis to other organs compared to untreated controls. Histochemical and Western blot analysis of the tumors revealed that inclusion of WFA (2 mg/kg) resulted in a highly significant elimination of cells expressing CSC markers -CD44, CD24, CD34, CD117 and Oct4 and downregulation of Notch1, Hes1 and Hey1 genes. In contrast treatment of mice with CIS alone (6 mg/kg) had opposite effect on those cells. Increase in cells expressing CSC markers and Notch1 signaling pathway in tumors exposed to CIS may explain recurrence of cancer in patients treated with carboplatin and paclitaxel. Since, WFA alone or in combination with CIS eliminates putative CSCs, we conclude that WFA in combination with CIS may present more efficacious therapy for ovarian cancer.	[Kakar, Sham S.; Singh, Sanjay K.] Univ Louisville, Dept Physiol & Biophys, Louisville, KY 40292 USA; [Kakar, Sham S.; Ratajczak, Mariusz Z.; Miller, Donald M.; Singh, Sanjay K.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Ratajczak, Mariusz Z.; Miller, Donald M.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Powell, Karen S.] Univ Louisville, Res Resources Ctr, Louisville, KY 40292 USA; [Moghadamfalahi, Mana] Univ Louisville, Dept Pathol, Louisville, KY 40292 USA; [Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Nebraska System; University of Nebraska Medical Center	Kakar, SS (corresponding author), Univ Louisville, Dept Physiol & Biophys, Louisville, KY 40292 USA.	sskaka01@louisville.edu	Ratajczak, Mariusz Zdzisław MZR/N-1599-2014; Ratajczak, Mariusz Z/I-2376-2014	Ratajczak, Mariusz Z/0000-0002-0071-0198	NIH/NCI [CA124630]; James Graham Brown Cancer Center Research Funds; School of Medicine Basic Research program Research Grant; NATIONAL CANCER INSTITUTE [R01CA124630] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); James Graham Brown Cancer Center Research Funds; School of Medicine Basic Research program Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH/NCI CA124630, James Graham Brown Cancer Center Research Funds, School of Medicine Basic Research program Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker K, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-24; Ahmed N, 2010, CURR CANCER DRUG TAR, V10, P268, DOI 10.2174/156800910791190175; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alvero AB, 2009, STEM CELLS, V27, P2405, DOI 10.1002/stem.191; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; BROWN R, 1993, INT J CANCER, V55, P678, DOI 10.1002/ijc.2910550428; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033544; Choi MJ, 2011, TOXICOL IN VITRO, V25, P692, DOI 10.1016/j.tiv.2011.01.010; CHRISTEN RD, 1994, CANCER METAST REV, V13, P175, DOI 10.1007/BF00689635; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Dyall S, 2010, J ONCOL, V2010, DOI 10.1155/2010/105269; El-Awady EE, 2011, EUR J PHARMACOL, V650, P335, DOI 10.1016/j.ejphar.2010.09.085; Fong MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042265; FUGNER A, 1973, ARZNEIMITTEL-FORSCH, V23, P932; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gangopadhyay S, 2013, CLIN BREAST CANCER, V13, P7, DOI 10.1016/j.clbc.2012.09.017; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Guo XD, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-44; Gupta SK, 2004, MOL CELL BIOCHEM, V260, P39; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Hermann PC, 2008, CELL CYCLE, V7, P188, DOI 10.4161/cc.7.2.5326; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Hunn J, 2012, CLIN OBSTET GYNECOL, V55, P3, DOI 10.1097/GRF.0b013e31824b4611; Jain P, 2011, FRONT BIOSCI-LANDMRK, V16, P1824, DOI 10.2741/3824; Kakar SS, 2012, BIOCHEM BIOPH RES CO, V423, P819, DOI 10.1016/j.bbrc.2012.06.047; Kintzel PE, 2001, DRUG SAFETY, V24, P19, DOI 10.2165/00002018-200124010-00003; Koduru S, 2010, MOL CANCER THER, V9, P202, DOI 10.1158/1535-7163.MCT-09-0771; Kurrey NK, 2005, GYNECOL ONCOL, V97, P155, DOI 10.1016/j.ygyno.2004.12.043; Kwon MJ, 2013, INT J MOL SCI, V14, P6624, DOI 10.3390/ijms14046624; Landen CN, 2010, MOL CANCER THER, V9, P3186, DOI 10.1158/1535-7163.MCT-10-0563; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Latifi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046858; Lee TJ, 2009, FREE RADICAL BIO MED, V46, P1639, DOI 10.1016/j.freeradbiomed.2009.03.022; Lieberthal W, 1996, AM J PHYSIOL-RENAL, V270, pF700, DOI 10.1152/ajprenal.1996.270.4.F700; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Malik MT, 2006, MOL CANCER, V5, P61; Matsuo K, 2010, EXPERT OPIN INV DRUG, V19, P1339, DOI 10.1517/13543784.2010.515585; Mayola E, 2011, APOPTOSIS, V16, P1014, DOI 10.1007/s10495-011-0625-x; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Mimeault M, 2012, WORLD J CLIN ONCOL, V3, P32, DOI 10.5306/wjco.v3.i3.32; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Munagala R, 2011, CARCINOGENESIS, V32, P1697, DOI 10.1093/carcin/bgr192; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Nunez-Cruz S, 2010, J VIS EXP, V28; Oh DH, 2011, LUPUS, V20, P855, DOI 10.1177/0961203310394895; Oh J, 2008, APOPTOSIS, V13, P1494, DOI 10.1007/s10495-008-0273-y; Oh JH, 2009, INT IMMUNOPHARMACOL, V9, P614, DOI 10.1016/j.intimp.2009.02.002; Perego P, 1996, CANCER RES, V56, P556; Piccart MJ, 2003, INT J GYNECOL CANCER, V13, P144, DOI 10.1111/j.1525-1438.2003.13357.x; Ponnusamy MP, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-4; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ramdass Bharathi, 2013, J Stem Cells, V8, P189, DOI jsc.2014.8.3/4.189; Rasool M, 2006, VASC PHARMACOL, V44, P406, DOI 10.1016/j.vph.2006.01.015; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roy RV, 2013, J NAT PROD, V76, P1909, DOI 10.1021/np400441f; Samadi AK, 2010, SURGERY, V148, P1228, DOI 10.1016/j.surg.2010.09.026; Samadi AK, 2010, J NAT PROD, V73, P1476, DOI 10.1021/np100112p; Scartezzini P, 2000, J ETHNOPHARMACOL, V71, P23, DOI 10.1016/S0378-8741(00)00213-0; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Shi W, 2006, J MAMMARY GLAND BIOL, V11, P41, DOI 10.1007/s10911-006-9011-7; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Silva IA, 2011, CANCER RES, V71, P3991, DOI 10.1158/0008-5472.CAN-10-3175; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Suman S, 2013, BRIT J CANCER, V109, P2587, DOI 10.1038/bjc.2013.642; Surowiak P, 2006, ANTICANCER RES, V26, P4943; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Tomao F, 2014, J CANCER, V5, P301, DOI 10.7150/jca.8610; Vathipadiekal V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029079; Wu KJ, 2011, BIOSCIENCE REP, V31, P449, DOI 10.1042/BSR20100114; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017	84	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107596	10.1371/journal.pone.0107596	http://dx.doi.org/10.1371/journal.pone.0107596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264898	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400027
J	Lee, SJ; Boscardin, WJ; Kirby, KA; Covinsky, KE				Lee, Sei J.; Boscardin, W. John; Kirby, Katharine A.; Covinsky, Kenneth E.			Individualizing Life Expectancy Estimates for Older Adults Using the Gompertz Law of Human Mortality	PLOS ONE			English	Article							RISK; SURVIVAL; PREDICTION; PROGNOSIS; MODELS; CANCER; INDEX	Background: Guidelines recommend incorporating life expectancy (LE) into clinical decision-making for preventive interventions such as cancer screening. Previous research focused on mortality risk (e.g. 28% at 4 years) which is more difficult to interpret than LE (e.g. 7.3 years) for both patients and clinicians. Our objective was to utilize the Gompertz Law of Human Mortality which states that mortality risk doubles in a fixed time interval to transform the Lee mortality index into a LE calculator. Methods: We examined community-dwelling older adults age 50 and over enrolled in the nationally representative 1998 wave of the Health and Retirement Study or HRS (response rate 81%), dividing study respondents into development (n = 11701) and validation (n = 8009) cohorts. In the development cohort, we fit proportional hazards Gompertz survival functions for each of the risk groups defined by the Lee mortality index. We validated our LE estimates by comparing our predicted LE with observed survival in the HRS validation cohort and an external validation cohort from the 2004 wave of the English Longitudinal Study on Ageing or ELSA (n = 7042). Results: The ELSA cohort had a lower 8-year mortality risk (14%) compared to our HRS development (23%) and validation cohorts (25%). Our model had good discrimination in the validation cohorts (Harrell's c 0.78 in HRS and 0.80 in the ELSA). Our predicted LE's were similar to observed survival in the HRS validation cohort without evidence of miscalibration (Hosmer-Lemeshow, p = 0.2 at 8 years). However, our predicted LE's were longer than observed survival in the ELSA cohort with evidence of miscalibration (Hosmer-Lemeshow, p < 0.001 at 8 years) reflecting the lower mortality rate in ELSA. Conclusion: We transformed a previously validated mortality index into a LE calculator that incorporated patient-level risk factors. Our LE calculator may help clinicians determine which preventive interventions are most appropriate for older US adults.	[Lee, Sei J.; Boscardin, W. John; Kirby, Katharine A.; Covinsky, Kenneth E.] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lee, SJ (corresponding author), Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA.	Sei.lee@ucsf.edu		Kirby, Katharine/0000-0003-0876-8113	National Institute on Aging [K24AG029812]; American Federation of Aging Research [K23AG040779]; SD Bechtel Foundation; NATIONAL INSTITUTE ON AGING [P30AG044281, K24AG029812, K23AG040779] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation of Aging Research; SD Bechtel Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Lee's effort on this project was supported through the Beeson Career Development Award from the National Institute on Aging (http://www.afar.org/research/funding/beeson) and the American Federation of Aging Research (K23AG040779) (http://www.afar.org) and an Early Career Award from the SD Bechtel Foundation. Dr Covinsky's effort on this project was supported through the Mid-Career Mentoring Award from the National Institute on Aging (K24AG029812) (http://www.nia.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias E, 2008, NATL VITAL STAT REPO, V57; Carter H. B., 2013, J UROL; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Cho H, 2013, ANN INTERN MED, V159, P667, DOI 10.7326/0003-4819-159-10-201311190-00005; Cruz M, 2013, JAMA-J AM MED ASSOC, V309, P874, DOI 10.1001/jama.2013.1184; DeLong ER, 1997, STAT MED, V16, P2645, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2645::AID-SIM696>3.0.CO;2-D; Gill TM, 2012, JAMA-J AM MED ASSOC, V307, P199, DOI 10.1001/jama.2011.1992; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hayes AJ, 2011, DIABETIC MED, V28, P428, DOI 10.1111/j.1464-5491.2010.03189.x; Henderson R, 2005, J MED ETHICS, V31, P703, DOI 10.1136/jme.2005.012427; Hippocrates, 1994, BOOK PROGNOSTICS; Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265; Iwashyna TJ, 2001, WESTERN J MED, V174, P253, DOI 10.1136/ewjm.174.4.253; Keeler E, 2010, J GERONTOL A-BIOL, V65, P727, DOI 10.1093/gerona/glq029; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; Krueger PM, 2008, AM J PUBLIC HEALTH, V98, P889, DOI 10.2105/AJPH.2007.114454; Lee ET, 1997, ANNU REV PUBL HEALTH, V18, P105, DOI 10.1146/annurev.publhealth.18.1.105; Lee SJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8441; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Matheny ME, 2005, J BIOMED INFORM, V38, P367, DOI 10.1016/j.jbi.2005.02.007; Olshansky SJ, 1997, DEMOGRAPHY, V34, P1, DOI 10.2307/2061656; PARKES CM, 1972, BRIT MED J, V2, P29, DOI 10.1136/bmj.2.5804.29; Peterson ED, 2000, J AM COLL CARDIOL, V36, P2174, DOI 10.1016/S0735-1097(00)01022-6; Schmidt M, 2009, ANN ONCOL, V20, P258, DOI 10.1093/annonc/mdn590; Tan A, 2013, AM J EPIDEMIOL, V178, P974, DOI 10.1093/aje/kwt054; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966; Zimmer Z, 2005, SOC SCI MED, V60, P457, DOI 10.1016/j.socscimed.2004.06.006	31	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108540	10.1371/journal.pone.0108540	http://dx.doi.org/10.1371/journal.pone.0108540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6XR	25265291	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400084
J	Meng, T; Li, XZ; Ao, X; Zhong, Y; Tang, R; Peng, WS; Yang, JH; Zou, MX; Zhou, QL				Meng, Ting; Li, Xiaozhao; Ao, Xiang; Zhong, Yong; Tang, Rong; Peng, Weisheng; Yang, Jinghua; Zou, Mingxiang; Zhou, Qiaoling			Hemolytic Streptococcus May Exacerbate Kidney Damage in IgA Nephropathy through CCL20 Response to the Effect of Th17 Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; DISEASE	Background: The exacerbation of IgA nephropathy (IgAN) is related to respiratory tract infection with hemolytic streptococcus (HS), but the mechanism is unknown. In this study we investigated the role of chemokine ligand 20 (CCL20) in response to the effect of T helper 17 (Th17) cells in the pathogenesis of IgAN associated with HS. Methods: Thirty mice were randomly divided into five groups: control mice (control), IgAN mice (IgAN), HS-infected IgAN mice (HS-IgAN), CCL20-treated IgAN mice (CCL20-IgAN), and CCL20-treated HS infected IgAN mice (CCL20-HS-IgAN). IgAN mice were induced with lipopolysaccharide, carbon tetrachloride and bovine serum albumin. Then the mice were sensitized with CCL20 antibody and infected with alpha-hemolytic streptococcus (alpha-HS) isolated from tonsils in sequence. Urine Albumin-Creatinine ratio and sediments were measured. The pathological changes in kidney and lung tissues were observed under microscopy. Th17 cells and regulatory T cells (Tregs) in kidneys were tested by flow cytometry. CCL20, IL-17A, IL-6 and IL-21 in the kidneys were detected by ELISA. Results: The IgAN mice had albuminuria and microscopic hematuria, renal mesangial proliferation, IgA deposition, high electron dense deposition in glomerular mesangial region, decreased frequency of Tregs, increased frequency of Th17 and Th17-Treg ratio. Furthermore, Th17-related cytokines CCL20, IL-17A, IL-6 and IL-21 were all increased in the kidneys of IgAN mice. Compared with IgAN mice, the manifestations in HS-IgAN mice were more severe, but alleviated in CCL20-treated groups. Conclusion: alpha-HS may exacerbate kidney damage in IgAN through CCL20 response to the effect of Th17 cells.	[Meng, Ting; Li, Xiaozhao; Ao, Xiang; Zhong, Yong; Tang, Rong; Peng, Weisheng; Yang, Jinghua; Zhou, Qiaoling] Cent South Univ, Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China; [Zou, Mingxiang] Cent South Univ, Xiangya Hosp, Dept Clin Lab, Changsha, Hunan, Peoples R China	Central South University; Central South University	Zhou, QL (corresponding author), Cent South Univ, Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China.	zqling8315@163.com			National Natural Science Foundation of China [81173401, 81270786]; China Postdoctoral Science Foundation [201003523]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (nos. 81173401; 81270786) (http://www.nsfc.gov.cn/), and special grade of the financial support from China Postdoctoral Science Foundation (nos. 201003523) (http://res.chinapostdoctor.org.cn/Program/Main.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Dasgupta A, 2012, NATL MED J INDIA, V25, P341; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; ENDO Y, 1993, NEPHRON, V65, P196, DOI 10.1159/000187474; GESUALDO L, 1990, J CLIN INVEST, V86, P715, DOI 10.1172/JCI114767; Huang HD, 2010, J NEPHROL, V23, P202; ISAACS K, 1981, CLIN IMMUNOL IMMUNOP, V20, P419, DOI 10.1016/0090-1229(81)90152-5; Kagami Shinji, 2011, Nihon Rinsho Meneki Gakkai Kaishi, V34, P13; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Lai KN, 2012, NAT REV NEPHROL, V8, P275, DOI 10.1038/nrneph.2012.58; Leung S, 2010, CELL MOL IMMUNOL, V7, P182, DOI 10.1038/cmi.2010.22; Lin FJ, 2012, SCAND J CLIN LAB INV, V72, P221, DOI 10.3109/00365513.2011.652158; Nistala K, 2009, RHEUMATOLOGY, V48, P602, DOI 10.1093/rheumatology/kep028; Noma Takeshi, 2010, Nihon Rinsho Meneki Gakkai Kaishi, V33, P262; Paust HJ, 2009, J AM SOC NEPHROL, V20, P969, DOI 10.1681/ASN.2008050556; Radeke HH, 2002, CLIN IMMUNOL, V104, P161, DOI 10.1006/clim.2002.5246; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Strippoli GFM, 2009, AM J KIDNEY DIS, V53, P5, DOI 10.1053/j.ajkd.2008.10.035; Summers SA, 2009, J AM SOC NEPHROL, V20, P2518, DOI 10.1681/ASN.2009030337; Turner JE, 2010, J AM SOC NEPHROL, V21, P974, DOI 10.1681/ASN.2009070741; Turner JE, 2010, KIDNEY INT, V77, P1070, DOI 10.1038/ki.2010.102; Van Kooten C, 1998, J AM SOC NEPHROL, V9, P1526; Waite JC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/819467; Wang BN, 2010, P NATL ACAD SCI USA, V107, P5937, DOI 10.1073/pnas.0904831107; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200	28	21	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108723	10.1371/journal.pone.0108723	http://dx.doi.org/10.1371/journal.pone.0108723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265199	Green Submitted, Green Published, gold			2022-12-27	WOS:000345745400111
J	Pearce, E; Sivaprasad, S; Chong, NV				Pearce, Elizabeth; Sivaprasad, Sobha; Chong, Ngaihang V.			Factors Affecting Reading Speed in Patients with Diabetic Macular Edema Treated with Laser Photocoagulation	PLOS ONE			English	Article							TRIAMCINOLONE; RANIBIZUMAB; FIXATION	Purpose: To study the factors that may affect reading speed in patients with diabetic macular edema previously treated with laser photocoagulation. Methods: Consecutive patients with type II diabetes treated with laser photocoagulation for diabetic macular edema (DME) at least twelve months previously, with best corrected visual acuity of better than 65 letters (approximately 20/40) measured with Early Treatment Diabetic Retinopathy Study (ETDRS) charts were included in this study. Patients previously treated with pan-retinal photocoagulation, vitrectomy, intravitreal steroid or anti-VEGF therapy were excluded. Any other ocular co-morbidities that may influence reading ability such as cataract, glaucoma or macular degeneration were also excluded. All patients were refracted by a certified examiner, the following measurements were collected: best corrected visual acuity (BCVA), contrast sensitivity with Pelli-Robson chart, reading speed with MNREAD chart, microperimetry with Nidek MP1, and central subfield thickness with Zeiss spectral domain optical coherent topography. Results: The slow reading group had poorer contrast sensitivity (p = 0.001), reduced retinal sensitivity (p = 0.027) and less stable fixation (p = 0.013). Most interestingly the reduced retinal sensitivity findings were driven by the microperimetry value on the right subfield (p = 0.033), (nasal to the fovea in the right eye and temporal to the fovea in the left eye). Multiple linear regression analysis showed that contrast sensitivity is probably the most important factor that affects reading speed (p = 0.001). Conclusion: Reduced retinal sensitivity after laser treatment is associated with reduced reading speed in patients with diabetic macular edema.	[Pearce, Elizabeth; Sivaprasad, Sobha] Kings Coll Hosp London, Dept Ophthalmol, London, England; [Sivaprasad, Sobha] Moorfields Biomed Res Ctr, Dept Med Retina, Natl Inst Hlth Res, London, England; [Chong, Ngaihang V.] Oxford Univ Hosp, Oxford Eye Hosp, Oxford, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Chong, NV (corresponding author), Oxford Univ Hosp, Oxford Eye Hosp, Oxford, England.	victor@eretina.org	Chong, Victor/Q-6565-2018; Sivaprasad, S./D-6876-2015	Chong, Victor/0000-0002-7693-522X; Sivaprasad, S./0000-0001-8952-0659				Baldwin AS, 2012, J VIS, V25, P12; Beck RW, 2009, ARCH OPHTHALMOL-CHIC, V127, P245, DOI 10.1001/archophthalmol.2008.610; Crossland MD, 2009, RETINA-J RET VIT DIS, V29, P651, DOI 10.1097/IAE.0b013e318196bd65; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Kabanarou SA, 2006, OPHTHALMOLOGY, V113, P2251, DOI 10.1016/j.ophtha.2006.06.028; Kiss CG, 2006, AM J OPHTHALMOL, V142, P620, DOI 10.1016/j.ajo.2006.05.001; Macedo AF, 2011, INVEST OPHTH VIS SCI, V52, P1275, DOI 10.1167/iovs.09-4334; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Vujosevic S, 2010, RETINA-J RET VIT DIS, V30, P908, DOI 10.1097/IAE.0b013e3181c96986	9	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e105696	10.1371/journal.pone.0105696	http://dx.doi.org/10.1371/journal.pone.0105696			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265280	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400004
J	Zhao, XQ; Wang, WS; Zhang, F; Deng, JL; Li, ZK; Fu, BY				Zhao, Xiuqin; Wang, Wensheng; Zhang, Fan; Deng, Jianli; Li, Zhikang; Fu, Binying			Comparative Metabolite Profiling of Two Rice Genotypes with Contrasting Salt Stress Tolerance at the Seedling Stage	PLOS ONE			English	Article							SALINITY STRESS; PROLINE ACCUMULATION; ORGANIC-ACIDS; AMINO-ACID; SUGAR; RESPONSES; GROWTH; METABOLOMICS; GERMINATION; EXPRESSION	Background: Rice is sensitive to salt stress, especially at the seedling stage, with rice varieties differing remarkably in salt tolerance (ST). To understand the physiological mechanisms of ST, we investigated salt stress responses at the metabolite level. Methods: Gas chromatography-mass spectrometry was used to profile metabolite changes in the salt-tolerant line FL478 and the sensitive variety IR64 under a salt-stress time series. Additionally, several physiological traits related to ST were investigated. Results: We characterized 92 primary metabolites in the leaves and roots of the two genotypes under stress and control conditions. The metabolites were temporally, tissue-specifically and genotype-dependently regulated under salt stress. Sugars and amino acids (AAs) increased significantly in the leaves and roots of both genotypes, while organic acids (OAs) increased in roots and decreased in leaves. Compared with IR64, FL478 experienced greater increases in sugars and AAs and more pronounced decreases in OAs in both tissues; additionally, the maximum change in sugars and AAs occurred later, while OAs changed earlier. Moreover, less Na+ and higher relative water content were observed in FL478. Eleven metabolites, including AAs and sugars, were specifically increased in FL478 over the course of the treatment. Conclusions: Metabolic responses of rice to salt stress are dynamic and involve many metabolites. The greater ST of FL478 is due to different adaptive reactions at different stress times. At early salt-stress stages, FL478 adapts to stress by decreasing OA levels or by quickly depressing growth; during later stages, more metabolites are accumulated, thereby serving as compatible solutes against osmotic challenge induced by salt stress.	[Zhao, Xiuqin; Wang, Wensheng; Zhang, Fan; Deng, Jianli; Li, Zhikang; Fu, Binying] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Fu, BY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	fubinying@caas.cn			Bill & Melinda Gates Foundation [OPP51587]; Program of Introducing International Super Agricultural Science and Technology [2011-G2B]; Program of International Science and Technology Cooperation [2012DFB32280]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Program of Introducing International Super Agricultural Science and Technology; Program of International Science and Technology Cooperation	This work was supported by the Bill & Melinda Gates Foundation Project (Grant No. OPP51587); The Program of Introducing International Super Agricultural Science and Technology (Grant No. 2011-G2B) and The Program of International Science and Technology Cooperation (Grant No. 2012DFB32280). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar M., 1974, Japanese Journal of Breeding, V24, P176; Basu S, 2002, PLANT CELL TISS ORG, V69, P55, DOI 10.1023/A:1015028919620; Bowne JB, 2012, MOL PLANT, V5, P418, DOI 10.1093/mp/ssr114; Chang KJ, 1991, BIOCHIM BIOPHYS ACTA, V1092, P29; Chiou TJ, 1998, P NATL ACAD SCI USA, V95, P4784, DOI 10.1073/pnas.95.8.4784; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; FLOWERS TJ, 1988, PLANT CELL ENVIRON, V11, P453, DOI 10.1111/j.1365-3040.1988.tb01783.x; FLOWERS TJ, 1981, NEW PHYTOL, V88, P363, DOI 10.1111/j.1469-8137.1981.tb01731.x; FOUGERE F, 1991, PLANT PHYSIOL, V96, P1228, DOI 10.1104/pp.96.4.1228; Garcia AB, 1997, PLANT PHYSIOL, V115, P159, DOI 10.1104/pp.115.1.159; Ghoulam C, 2002, ENVIRON EXP BOT, V47, P39, DOI 10.1016/S0098-8472(01)00109-5; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; GOOD AG, 1994, PHYSIOL PLANTARUM, V90, P9, DOI 10.1111/j.1399-3054.1994.tb02185.x; Gupta AK, 2005, J BIOSCIENCES, V30, P761, DOI 10.1007/BF02703574; Hoai NTT, 2003, PLANT GROWTH REGUL, V41, P159, DOI 10.1023/A:1027305522741; JAIN S, 1991, PLANT CELL REP, V9, P684, DOI 10.1007/BF00235357; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Joshi V, 2010, AMINO ACIDS, V39, P933, DOI 10.1007/s00726-010-0505-7; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; KHATUN S, 1995, PLANT CELL ENVIRON, V18, P61, DOI 10.1111/j.1365-3040.1995.tb00544.x; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Kumari S, 2009, FUNCT INTEGR GENOMIC, V9, P109, DOI 10.1007/s10142-008-0088-5; Lin CC, 1996, PLANT SCI, V114, P121, DOI 10.1016/0168-9452(96)04323-3; Liu T, 2000, PLANT GROWTH REGUL, V31, P195, DOI 10.1023/A:1006391400927; LOESCHER WH, 1992, PLANT PHYSIOL, V98, P1396, DOI 10.1104/pp.98.4.1396; Maas E. V., 1977, Journal of the Irrigation and Drainage Division, American Society of Civil Engineers, V103, P115; Malakshah SN, 2007, BIOSCI BIOTECH BIOCH, V71, P2144, DOI 10.1271/bbb.70027; MUNNS R, 1986, AUST J PLANT PHYSIOL, V13, P143, DOI 10.1071/PP9860143; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Pandit A, 2011, J PLANT BIOCHEM BIOT, V20, P149, DOI 10.1007/s13562-010-0022-5; Patonnier MP, 1999, J EXP BOT, V50, P1223, DOI 10.1093/jexbot/50.336.1223; PEARSON GA, 1966, SOIL SCI, V102, P151, DOI 10.1097/00010694-196609000-00003; Roitsch T, 1999, CURR OPIN PLANT BIOL, V2, P198, DOI 10.1016/S1369-5266(99)80036-3; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; Sanchez DH, 2008, PHYSIOL PLANTARUM, V132, P209, DOI 10.1111/j.1399-3054.2007.00993.x; Sangita Basu, 1999, Plant tissue culture and biotechnology: emerging trends. Proceedings of a symposium held at Hyderabad, India, 29-31 January 1997., P275; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Teusink B, 1998, METHOD MICROBIOL, V26, P297; THOMAS JC, 1995, PLANT CELL ENVIRON, V18, P801, DOI 10.1111/j.1365-3040.1995.tb00584.x; Walia H, 2005, PLANT PHYSIOL, V139, P822, DOI 10.1104/pp.105.065961; Walia H, 2007, PLANT MOL BIOL, V63, P609, DOI 10.1007/s11103-006-9112-0; Wang WS, 2011, J GENET GENOMICS, V38, P419, DOI 10.1016/j.jgg.2011.07.006; Widodo, 2009, J EXP BOT, V60, P4089, DOI 10.1093/jxb/erp243; Wu DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056624, 10.1371/journal.pone.0053932, 10.1371/journal.pone.0055431]; Yang CW, 2010, AGRON J, V102, P1081, DOI 10.2134/agronj2009.0471; YEO AR, 1983, PHYSIOL PLANTARUM, V59, P189, DOI 10.1111/j.1399-3054.1983.tb00756.x; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zang X, 2007, PHYTOCHEMISTRY, V68, P426, DOI 10.1016/j.phytochem.2006.11.005; Zhao XQ, 2013, RICE, V6, DOI 10.1186/1939-8433-6-23; Zuther E, 2007, ADV MOL BREEDING DRO, P285, DOI DOI 10.1007/978-1-4020-5578-2_12	52	50	52	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108020	10.1371/journal.pone.0108020	http://dx.doi.org/10.1371/journal.pone.0108020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265195	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400039
J	Zheng, CK; Xu, JL; Li, JQ; Hu, LH; Xia, JD; Fan, JY; Guo, WN; Chen, HC; Bei, WC				Zheng, Chengkun; Xu, Jiali; Li, Jinquan; Hu, Luohong; Xia, Jiandong; Fan, Jingyan; Guo, Weina; Chen, Huanchun; Bei, Weicheng			Two Spx Regulators Modulate Stress Tolerance and Virulence in Streptococcus suis Serotype 2	PLOS ONE			English	Article							GLOBAL TRANSCRIPTIONAL CONTROL; OXIDATIVE STRESS; FUNCTIONAL DEFINITION; BIOFILM FORMATION; FULL VIRULENCE; GENE; PROTEIN; SYSTEM; CONTRIBUTES; IDENTIFICATION	Streptococcus suis serotype 2 is an important zoonotic pathogen causing severe infections in pigs and humans. The pathogenesis of S. suis 2 infections, however, is still poorly understood. Spx proteins are a group of global regulators involved in stress tolerance and virulence. In this study, we characterized two orthologs of the Spx regulator, SpxA1 and SpxA2 in S. suis 2. Two mutant strains (Delta spxA1 and Delta spxA2) lacking the spx genes were constructed. The Delta spxA1 and Delta spxA2 mutants displayed different phenotypes. Delta spxA1 exhibited impaired growth in the presence of hydrogen peroxide, while Delta spxA2 exhibited impaired growth in the presence of SDS and NaCl. Both mutants were defective in medium lacking newborn bovine serum. Using a murine infection model, we demonstrated that the abilities of the mutant strains to colonize the tissues were significantly reduced compared to that of the wild-type strain. The mutant strains also showed a decreased level of survival in pig blood. Microarray analysis revealed a global regulatory role for SpxA1 and SpxA2. Furthermore, we demonstrated for the first time that Spx is involved in triggering the host inflammatory response. Collectively, our data suggest that SpxA1 and SpxA2 are global regulators that are implicated in stress tolerance and virulence in S. suis 2.	[Zheng, Chengkun; Xu, Jiali; Hu, Luohong; Xia, Jiandong; Fan, Jingyan; Guo, Weina; Chen, Huanchun; Bei, Weicheng] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Zheng, Chengkun; Xu, Jiali; Chen, Huanchun; Bei, Weicheng] Huazhong Agr Univ, Minist Agr, Key Lab Dev Vet Diagnost Prod, Wuhan, Hubei, Peoples R China; [Li, Jinquan] Huazhong Agr Univ, Coll Food Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Bei, WC (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	beiwc@mail.hzau.edu.cn			National Basic Research Program [2011CB518805]; National Natural Science Foundation of China [31172352, 31372466]; Education Ministry's New Century Excellent Talents Supporting Plan [NCET-12-0858]; Fundamental Research Funds for the Central Universities [2013SC18, 2013PY014, 52902-0900206143]; National Programs for High Technology Research and Development of China [2011AA10A210]; Hubei Province Technology Program [2011BBB082]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Ministry's New Century Excellent Talents Supporting Plan(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Programs for High Technology Research and Development of China(National High Technology Research and Development Program of China); Hubei Province Technology Program	This work was supported by grants from the National Basic Research Program (No. 2011CB518805), the National Natural Science Foundation of China (No. 31172352 and No. 31372466), the Education Ministry's New Century Excellent Talents Supporting Plan (NCET-12-0858), the Fundamental Research Funds for the Central Universities (No. 2013SC18, No. 2013PY014 and No. 52902-0900206143), the National Programs for High Technology Research and Development of China (No. 2011AA10A210), and the Hubei Province Technology Program (No. 2011BBB082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda J, 2010, VET MICROBIOL, V144, P246, DOI 10.1016/j.vetmic.2009.12.037; Cao M, 2011, J MICROBIOL, V49, P1000, DOI 10.1007/s12275-011-1523-1; Charland N, 2000, INFECT IMMUN, V68, P637, DOI 10.1128/IAI.68.2.637-643.2000; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040034; Choi SM, 2012, J CLIN NEUROL, V8, P79, DOI 10.3988/jcn.2012.8.1.79; de Greeff A, 2002, MICROB PATHOGENESIS, V33, P185, DOI 10.1006/mpat.2002.0526; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Feng YJ, 2008, J BACTERIOL, V190, P7567, DOI 10.1128/JB.01532-07; Feng YJ, 2010, TRENDS MICROBIOL, V18, P124, DOI 10.1016/j.tim.2009.12.003; Firon A, 2014, J BIOL CHEM, V289, P5479, DOI 10.1074/jbc.M113.545632; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Han HM, 2012, MICROBIOL-SGM, V158, P1852, DOI 10.1099/mic.0.057448-0; Hill JE, 2005, VET MICROBIOL, V107, P63, DOI 10.1016/j.vetmic.2005.01.003; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jousselin A, 2013, ANTIMICROB AGENTS CH, V57, P3283, DOI 10.1128/AAC.00220-13; Kajfasz JK, 2012, INFECT IMMUN, V80, P2265, DOI 10.1128/IAI.00026-12; Kajfasz JK, 2010, J BACTERIOL, V192, P2546, DOI 10.1128/JB.00028-10; Lamour V, 2009, J STRUCT BIOL, V168, P352, DOI 10.1016/j.jsb.2009.07.001; Li JQ, 2011, VET MICROBIOL, V148, P99, DOI 10.1016/j.vetmic.2010.08.005; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Liu Mengyao, 2008, Open Microbiol J, V2, P89, DOI 10.2174/1874285800802010089; Liu MY, 2006, MICROBIOL-SGM, V152, P967, DOI 10.1099/mic.0.28706-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Nakano S, 2005, MOL MICROBIOL, V55, P498, DOI 10.1111/j.1365-2958.2004.04395.x; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Nakano S, 2003, P NATL ACAD SCI USA, V100, P4233, DOI 10.1073/pnas.0637648100; Newberry KJ, 2005, P NATL ACAD SCI USA, V102, P15839, DOI 10.1073/pnas.0506592102; NORRBYTEGLUND A, 1995, SCAND J INFECT DIS, V27, P125, DOI 10.3109/00365549509018991; Okahashi N, 2010, BIOCHEM BIOPH RES CO, V391, P1192, DOI 10.1016/j.bbrc.2009.12.029; Pamp SJ, 2006, J BACTERIOL, V188, P4861, DOI 10.1128/JB.00194-06; Pan XZ, 2009, J BACTERIOL, V191, P2601, DOI 10.1128/JB.01309-08; Pian YY, 2012, INFECT IMMUN, V80, P2402, DOI 10.1128/IAI.06294-11; Rochat T, 2012, NUCLEIC ACIDS RES, V40, P9571, DOI 10.1093/nar/gks755; Runde S, 2014, MOL MICROBIOL, V91, P1036, DOI 10.1111/mmi.12521; Segura M, 1999, INFECT IMMUN, V67, P4646, DOI 10.1128/IAI.67.9.4646-4654.1999; Segura M, 2009, J INFECT DIS, V199, P4, DOI 10.1086/594371; Song MC, 2005, CRIT CARE MED, V33, pS463, DOI 10.1097/01.CCM.0000186784.62662.A1; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Tang YL, 2012, J MICROBIOL, V50, P994, DOI 10.1007/s12275-012-2035-3; Tang YL, 2012, VET MICROBIOL, V158, P360, DOI 10.1016/j.vetmic.2012.02.028; Turlan C, 2009, MOL MICROBIOL, V73, P492, DOI 10.1111/j.1365-2958.2009.06789.x; Turner MS, 2007, APPL ENVIRON MICROB, V73, P6144, DOI 10.1128/AEM.00413-07; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Wang HH, 2012, FEMS MICROBIOL LETT, V333, P160, DOI 10.1111/j.1574-6968.2012.02611.x; Wang Y, 2011, VET MICROBIOL, V152, P151, DOI 10.1016/j.vetmic.2011.04.029; Wei Y, 2011, ANN MICROBIOL, V61, P505, DOI 10.1007/s13213-010-0165-6; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Willenborg J, 2011, MICROBIOL-SGM, V157, P1823, DOI 10.1099/mic.0.046417-0; Wu T, 2009, FEMS MICROBIOL LETT, V292, P170, DOI 10.1111/j.1574-6968.2008.01486.x; Xu J, 2014, MICROBIOL RES, V169, P541, DOI 10.1016/j.micres.2013.11.002; Yen Muh-Yong, 1994, Journal of the Formosan Medical Association, V93, P349; Zeng XT, 2011, VECTOR-BORNE ZOONOT, V11, P215, DOI 10.1089/vbz.2009.0225; Zhang AD, 2009, VACCINE, V27, P5209, DOI 10.1016/j.vaccine.2009.06.074; Zhang TF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-85; Zheng F, 2011, INFECT IMMUN, V79, P1319, DOI 10.1128/IAI.00193-10; Zhu H, 2009, INFECT IMMUN, V77, P5225, DOI 10.1128/IAI.00636-09; Zhu LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070363; Zuber P, 2004, J BACTERIOL, V186, P1911, DOI 10.1128/JB.186.7.1911-1918.2004	64	33	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108197	10.1371/journal.pone.0108197	http://dx.doi.org/10.1371/journal.pone.0108197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264876	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400054
J	Horiyama, T; Nishino, K				Horiyama, Tsukasa; Nishino, Kunihiko			AcrB, AcrD, and MdtABC Multidrug Efflux Systems Are Involved in Enterobactin Export in Escherichia coli	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; OUTER-MEMBRANE; ENTEROCHELIN ESTERASE; ENZYMATIC-HYDROLYSIS; IRON TRANSPORT; BILE-SALTS; TOLC; RESISTANCE; PUMP; EXPRESSION	Escherichia coli produces the iron-chelating compound enterobactin to enable growth under iron-limiting conditions. After biosynthesis, enterobactin is released from the cell. However, the enterobactin export system is not fully understood. Previous studies have suggested that the outer membrane channel TolC is involved in enterobactin export. There are several multidrug efflux transporters belonging to resistance-nodulation-cell division (RND) family that require interaction with TolC to function. Therefore, several RND transporters may be responsible for enterobactin export. In this study, we investigated whether RND transporters are involved in enterobactin export using deletion mutants of multidrug transporters in E. coli. Single deletions of acrB, acrD, mdtABC, acrEF, or mdtEF did not affect the ability of E. coli to excrete enterobactin, whereas deletion of tolC did affect enterobactin export. We found that multiple deletion of acrB, acrD, and mdtABC resulted in a significant decrease in enterobactin export and that plasmids carrying the acrAB, acrD, or mdtABC genes restored the decrease in enterobactin export exhibited by the Delta acrB acrD mdtABC mutant. These results indicate that AcrB, AcrD, and MdtABC are required for the secretion of enterobactin.	[Horiyama, Tsukasa; Nishino, Kunihiko] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan; [Nishino, Kunihiko] Osaka Univ, Inst Sci & Ind Res, Lab Microbiol & Infect Dis, Osaka, Japan	Osaka University; Osaka University	Nishino, K (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan.	nishino@sanken.osaka-u.ac.jp			Japan Society for the Promotion of Science; Kanae Foundation for the Promotion of Medical Science; Senri Life Science Foundation; Grants-in-Aid for Scientific Research [26713004] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanae Foundation for the Promotion of Medical Science; Senri Life Science Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Young Scientists from the Japan Society for the Promotion of Science (to KN), the Kanae Foundation for the Promotion of Medical Science (to KN) and the Senri Life Science Foundation (to KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono R, 1998, J BACTERIOL, V180, P938, DOI 10.1128/JB.180.4.938-944.1998; Bina JE, 2001, INFECT IMMUN, V69, P4681, DOI 10.1128/IAI.69.7.4681-4685.2001; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bleuel C, 2005, J BACTERIOL, V187, P6701, DOI 10.1128/JB.187.19.6701-6707.2005; BRICKMAN TJ, 1992, J BIOL CHEM, V267, P12350; BRYCE GF, 1972, BIOCHEMISTRY-US, V11, P1708, DOI 10.1021/bi00759a028; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Crouch MLV, 2008, MOL MICROBIOL, V67, P971, DOI 10.1111/j.1365-2958.2007.06089.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delgado MA, 2005, J BACTERIOL, V187, P3465, DOI 10.1128/JB.187.10.3465-3470.2005; Fralick JA, 1996, J BACTERIOL, V178, P5803, DOI 10.1128/jb.178.19.5803-5805.1996; Furrer JL, 2002, MOL MICROBIOL, V44, P1225, DOI 10.1046/j.1365-2958.2002.02885.x; Gerken H, 2004, MOL MICROBIOL, V54, P620, DOI 10.1111/j.1365-2958.2004.04301.x; GILSON L, 1990, EMBO J, V9, P3875, DOI 10.1002/j.1460-2075.1990.tb07606.x; GREENWOOD KT, 1978, BIOCHIM BIOPHYS ACTA, V525, P209, DOI 10.1016/0005-2744(78)90216-4; GRIFFITHS E, 1991, BIOL MET, V4, P7, DOI 10.1007/BF01135551; Guo XX, 2006, J BACTERIOL, V188, P2383, DOI 10.1128/JB.188.7.2383-2391.2006; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Koronakis V, 2003, FEBS LETT, V555, P66, DOI 10.1016/S0014-5793(03)01125-6; LANGMAN L, 1972, J BACTERIOL, V112, P1142, DOI 10.1128/JB.112.3.1142-1149.1972; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LIU J, 1990, BIOCHEMISTRY-US, V29, P1417, DOI 10.1021/bi00458a012; Ma Dzwokai, 1994, Trends in Microbiology, V2, P489, DOI 10.1016/0966-842X(94)90654-8; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nakashima R, 2011, NATURE, V480, P565, DOI 10.1038/nature10641; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Nikaido Hiroshi, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P1; Nishino K, 2003, ANTIMICROB AGENTS CH, V47, P3030, DOI 10.1128/AAC.47.9.3030-3033.2003; Nishino Kunihiko, 2008, Journal of Infection and Chemotherapy, V14, P23, DOI 10.1007/s10156-007-0575-y; Nishino K, 2011, J ANTIMICROB CHEMOTH, V66, P291, DOI 10.1093/jac/dkq420; Nishino K, 2010, ANTIMICROB AGENTS CH, V54, P2239, DOI 10.1128/AAC.01677-09; Nishino K, 2009, J ANTIBIOT, V62, P251, DOI 10.1038/ja.2009.23; OBRIEN IG, 1970, BIOCHIM BIOPHYS ACTA, V215, P393, DOI 10.1016/0304-4165(70)90038-3; POLLACK JR, 1970, BIOCHEM BIOPH RES CO, V38, P989, DOI 10.1016/0006-291X(70)90819-3; Rosenberg EY, 2003, MOL MICROBIOL, V48, P1609, DOI 10.1046/j.1365-2958.2003.03531.x; Ruiz C, 2014, J ANTIMICROB CHEMOTH, V69, P390, DOI 10.1093/jac/dkt352; RUTZ JM, 1992, SCIENCE, V258, P471, DOI 10.1126/science.1411544; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; Vakharia H, 2001, J BACTERIOL, V183, P6908, DOI 10.1128/JB.183.23.6908-6916.2001; WANDERSMAN C, 1990, P NATL ACAD SCI USA, V87, P4776, DOI 10.1073/pnas.87.12.4776; WINKELMANN G, 1994, BIOMETALS, V7, P149; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190	44	74	78	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108642	10.1371/journal.pone.0108642	http://dx.doi.org/10.1371/journal.pone.0108642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259870	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600091
J	Du, Y; Li, JJ; Zhang, YJ; Li, KJ; He, JF				Du, Yi; Li, Jing-Jing; Zhang, Yu-Jiao; Li, Kaijun; He, Jian-Feng			Risk Factors for Idiopathic Optic Neuritis Recurrence	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; NEUROPATHY	Background: Approximately 30-50% of idiopathic optic neuritis (ION) patients experience one or multiple episodes of recurrence. The aim of this study was to search for risk factors for ION recurrence. Methods: Clinical data on hospitalized patients diagnosed with ION between January 2003 and January 2011 at the First Affiliated Hospital of Guangxi Medical University were retrospectively collected. Univariate and multivariate analyses were performed on factors that might cause ION recurrence. In total, 115 ION cases (32 recurrent and 83 non-recurrent cases) with complete data were analyzed. The length of the follow-up period ranged from 12 to 108 months (median: 42 months). Results: The univariate analysis showed that the recurrence rate for unilateral ION was higher than that for bilateral ION (40% vs. 12%, p = 0.001). Underlying diseases had a significant impact on recurrence (p<0.001): the recurrence rates due to neuromyelitis optica (NMO), multiple sclerosis (MS), demyelinating lesions alone of the central nervous system, and unknown causes were 89%, 70%, 41%, and 8.7%, respectively. The multivariate analysis showed that the factors causing relatively high recurrence rates included NMO (odds ratio [OR], 73.5; 95% confidence interval [CI], 7.3 to 740.9), MS (OR, 33.9; 95% CI, 5.2 to 222.2), and demyelinating lesions alone (OR, 8.9; 95% CI, 2.3 to 34.4), unilateral involvement (OR, 5.7; 95% CI, 1.5 to 21.3), relatively low initial glucocorticoid dosage (equivalent to <= 100 mg prednisone/day) (OR, 4.3; 95% CI, 1.0 to 17.9). Conclusion: Underlying diseases, laterality (unilateral or bilateral), and initial glucocorticoid dosage are important risk factors of ION recurrence. Clinical physicians are advised to treat ION patients with a sufficient dose of glucocorticoid in the initial treatment stage to reduce the recurrence risk.	[Du, Yi; Li, Jing-Jing; Zhang, Yu-Jiao; Li, Kaijun; He, Jian-Feng] Guangxi Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanning, Guangxi, Peoples R China	Guangxi Medical University	He, JF (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanning, Guangxi, Peoples R China.	hejianf@foxmail.com	Du, Yi/C-3009-2008	Du, Yi/0000-0003-4879-5159	National Natural Science Foundation of China [81260149, 81360152]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81260149, No. 81360152). Website: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt C, 2008, J FR OPHTALMOL, V31, P363, DOI 10.1016/S0181-5512(08)71430-X; Beck RW, 2008, ARCH OPHTHALMOL-CHIC, V126, P994, DOI 10.1001/archopht.126.7.994; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; Beck RW, 2004, AM J OPHTHALMOL, V137, P77, DOI 10.1016/S0002-9394(02)00862-6; Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727; Buttgereit F, 2002, ANN RHEUM DIS, V61, P718, DOI 10.1136/ard.61.8.718; de la Cruz J, 2006, BRIT J OPHTHALMOL, V90, P551, DOI 10.1136/bjo.2005.085399; de Seze J, 2013, NEURO-OPHTHALMOLOGY, V37, P141, DOI 10.3109/01658107.2013.804232; Du Y, 2014, CURR EYE RES, V39, P532, DOI 10.3109/02713683.2013.848901; Du Y, 2012, J CLIN NEUROSCI, V19, P1380, DOI 10.1016/j.jocn.2011.10.020; Du Y, 2011, J CLIN NEUROSCI, V18, P902, DOI 10.1016/j.jocn.2010.11.011; FRANCIS DA, 1987, J NEUROL NEUROSUR PS, V50, P758, DOI 10.1136/jnnp.50.6.758; Frederiksen JL, 1997, NEURO-OPHTHALMOLOGY, V17, P175, DOI 10.3109/01658109709044663; Kaut O, 2008, J NEUROL, V255, P1419, DOI 10.1007/s00415-008-0919-2; Kidd D, 2003, BRAIN, V126, P276, DOI 10.1093/brain/awg045; Kurne A, 2010, EYE BRAIN, V2, P15; Lai CT, 2011, J NEURO-OPHTHALMOL, V31, P16, DOI 10.1097/WNO.0b013e3181f8a693; Lin YC, 2006, JPN J OPHTHALMOL, V50, P170, DOI 10.1007/s10384-005-0281-1; Lucchinetti CF, 1997, NEUROLOGY, V49, P1413, DOI 10.1212/WNL.49.5.1413; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; Moss HE, 2014, JAMA OPHTHALMOL, V132, P421, DOI 10.1001/jamaophthalmol.2013.7995; Petzold A, 2014, J NEUROL, V261, P17, DOI 10.1007/s00415-013-6957-4; Phillips PH, 1998, ARCH NEUROL-CHICAGO, V55, P186, DOI 10.1001/archneur.55.2.186; Pirko I, 2004, ARCH NEUROL-CHICAGO, V61, P1401, DOI 10.1001/archneur.61.9.1401; SMITH CH, 2005, WALSH HOYTS CLIN NEU, P293; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; Woung LC, 2011, NEURO-OPHTHALMOLOGY, V35, P65, DOI 10.3109/01658107.2011.557851; Zhang XJ, 2007, NEURO-OPHTHALMOLOGY, V31, P133, DOI 10.1080/01658100701647506; Zhou W, 2000, YAN KE YAN JIU, V18, P51	29	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108580	10.1371/journal.pone.0108580	http://dx.doi.org/10.1371/journal.pone.0108580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255372	gold, Green Published, Green Submitted			2022-12-27	WOS:000344862300094
J	Healy, K; Hamilton, G; Crepeau, T; Healy, S; Unlu, I; Farajollahi, A; Fonseca, DM				Healy, Kristen; Hamilton, George; Crepeau, Taryn; Healy, Sean; Unlu, Isik; Farajollahi, Ary; Fonseca, Dina M.			Integrating the Public in Mosquito Management: Active Education by Community Peers Can Lead to Significant Reduction in Peridomestic Container Mosquito Habitats	PLOS ONE			English	Article							AEDES-AEGYPTI CONTROL; ASIAN TIGER MOSQUITO; WILLINGNESS-TO-PAY; INFORMATION PACKETS; HEALTH-EDUCATION; CONTROL PROGRAM; ALBOPICTUS; PARTICIPATION; NEIGHBORHOODS; INVOLVEMENT	Mosquito species that utilize peridomestic containers for immature development are commonly aggressive human biters, and because they often reach high abundance, create significant nuisance. One of these species, the Asian tiger mosquito Aedes albopictus, is an important vector of emerging infectious diseases, such as dengue, chikungunya, and Zika fevers. Integrated mosquito management (IMM) of Ae. albopictus is particularly difficult because it requires access to private yards in urban and suburban residences. It has become apparent that in the event of a public health concern due to this species, homeowners will have to be active participants in the control process by reducing mosquito habitats in their properties, an activity known as source reduction. However, limited attempts at quantifying the effect of source reduction by homeowners have had mixed results. Of note, many mosquito control programs in the US have some form of education outreach, however the primary approach is often passive focusing on the distribution of education materials as flyers. In 2010, we evaluated the use of active community peer education in a source reduction program, using AmeriCorps volunteers. The volunteers were mobilized over a 4-week period, in two areas with approximately 1,000 residences each in urban Mercer and suburban Monmouth counties in New Jersey, USA. The volunteers were first provided training on peridomestic mosquitoes and on basic approaches to reducing the number of container habitats for mosquito larvae in backyards. Within the two treatment areas the volunteers successfully engaged 758 separate homes. Repeated measures analysis of variance showed a significant reduction in container habitats in the sites where the volunteers actively engaged the community compared to untreated control areas in both counties. Our results suggest that active education using community peer educators can be an effective means of source reduction, and a critical tool in the arsenal against peridomestic mosquitoes.	[Healy, Kristen; Hamilton, George; Fonseca, Dina M.] Rutgers State Univ, Dept Entomol, Ctr Vector Biol, New Brunswick, NJ 08903 USA; [Crepeau, Taryn; Healy, Sean] Monmouth Cty Mosquito Exterminat Commiss, Eatontown, NJ USA; [Unlu, Isik; Farajollahi, Ary] Mercer Cty Mosquito Commiss, West Trenton, NJ USA	Rutgers State University New Brunswick	Healy, K (corresponding author), Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA.	khealy@lsu.edu	Fonseca, Dina/HHS-1320-2022; Fonseca, Dina Madeira/B-9951-2011	Fonseca, Dina Madeira/0000-0003-4726-7100; Healy, Kristen/0000-0002-3208-6537	United States Department of Agriculture (USDA) [USDA-ARS-58-6615-8-105]; Rutgers University [USDA-ARS-58-6615-8-105]	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Rutgers University	This work was funded by a cooperative Agreement between the United States Department of Agriculture (USDA) and Rutgers University (USDA-ARS-58-6615-8-105) entitled "Area-wide Pest Management Program for the Asian Tiger Mosquito in New Jersey." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baly A, 2007, T ROY SOC TROP MED H, V101, P578, DOI 10.1016/j.trstmh.2007.01.002; Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031; Bartlett-Healy K, 2011, INT J ENV RES PUB HE, V8, P1358, DOI 10.3390/ijerph8051358; Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848; Brieger WR, 1996, ACTA TROP, V61, P93, DOI 10.1016/0001-706X(95)00104-M; Crepeau TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060524; Dickinson K, 2012, VECTOR-BORNE ZOONOT, V12, P886, DOI 10.1089/vbz.2011.0810; Focks AD, 2003, REV ENTOMOLOGICAL RE; Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511; Fonseca DM, 2014, MED VET ENT IN PRESS; Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L; Halasa YA, 2012, J AM MOSQUITO CONTR, V28, P225, DOI 10.2987/12-6243R.1; Hawley W. A., 1988, J AM MOSQ CONTROL S, V1, P1; LaDeau SL, 2013, INT J ENV RES PUB HE, V10, P1505, DOI 10.3390/ijerph10041505; LEONTSINI E, 1993, T ROY SOC TROP MED H, V87, P267, DOI 10.1016/0035-9203(93)90120-F; LLOYD LS, 1992, AM J TROP MED HYG, V46, P635, DOI 10.4269/ajtmh.1992.46.635; Medical Reserve Corps, 2011, DIV CIV VOL MED RES; MITCHELL CJ, 1991, J AM MOSQUITO CONTR, V7, P446; New Jersey Weather and Climate Network, 2014, MONTHL PREC SO NEW J; Perez D, 2007, TROP MED INT HEALTH, V12, P664, DOI 10.1111/j.1365-3156.2007.01833.x; Phanthumachinda B., 1985, Mosquito-Borne Diseases Bulletin, V2, P1; Richards SL, 2008, J MED ENTOMOL, V45, P617, DOI 10.1603/0022-2585(2008)45[617:IOSROT]2.0.CO;2; SCHREIBER ET, 1995, J AM MOSQUITO CONTR, V11, P186; SCHREIBER ET, 1994, J AM MOSQUITO CONTR, V10, P154; Soedarmo Sumarmo Poorwo, 1993, Tropical Medicine, V35, P315; Spiegel JM, 2007, TROP MED INT HEALTH, V12, P503, DOI 10.1111/j.1365-3156.2007.01818.x; Swaddiwudhipong Witaya, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P200; United State Department of Agriculture, 2014, COOP EXT SYST OFF; Unlu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077999; Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140; Warner DG, 2005, J MED LIBR ASSOC, V93, P243; WINCH P, 1992, HEALTH POLICY PLANN, V7, P342, DOI 10.1093/heapol/7.4.342; Worobey J, 2013, J AM MOSQUITO CONTR, V29, P78, DOI 10.2987/12-6296R.1	33	43	43	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108504	10.1371/journal.pone.0108504	http://dx.doi.org/10.1371/journal.pone.0108504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255027	Green Submitted, gold, Green Published			2022-12-27	WOS:000344862300091
J	Tarella, C; Gueli, A; Delaini, F; Rossi, A; Barbui, AM; Gritti, G; Boschini, C; Caracciolo, D; Bruna, R; Ruella, M; Gottardi, D; Passera, R; Rambaldi, A				Tarella, Corrado; Gueli, Angela; Delaini, Federica; Rossi, Andrea; Barbui, Anna Maria; Gritti, Giuseppe; Boschini, Cristina; Caracciolo, Daniele; Bruna, Riccardo; Ruella, Marco; Gottardi, Daniela; Passera, Roberto; Rambaldi, Alessandro			Rate of Primary Refractory Disease in B and T-Cell Non-Hodgkin's Lymphoma: Correlation with Long-Term Survival	PLOS ONE			English	Article							ELDERLY-PATIENTS; CHOP CHEMOTHERAPY; RITUXIMAB; MULTICENTER; IMPROVES; TRANSPLANTATION; MANAGEMENT; FEATURES; LIFE	Background: Primary refractory disease is a main challenge in the management of non-Hodgkin's Lymphoma (NHL). This survey was performed to define the rate of refractory disease to first-line therapy in B and T-cell NHL subtypes and the long-term survival of primary refractory compared to primary responsive patients. Methods: Medical records were reviewed of 3,106 patients who had undergone primary treatment for NHL between 1982 and 2012, at the Hematology Centers of Torino and Bergamo, Italy. Primary treatment included CHOP or CHOP-like regimens (63.2%), intensive therapy with autograft (16.9%), or other therapies (19.9%). Among B-cell NHL, 1,356 (47.8%) received first-line chemotherapy with rituximab. Refractory disease was defined as stable/progressive disease, or transient response with disease progression within six months. Results: Overall, 690 (22.2%) patients showed primary refractory disease, with a higher incidence amongst T-cell compared to B-cell NHL (41.9% vs. 20.5%, respectively, p<0.001). Several other clinico-pathological factors at presentation were variably associated with refractory disease, including histological aggressive disease, unfavorable clinical presentation, Bone Marrow involvement, low lymphocyte/ monocyte ration and male gender. Amongst B-cell NHL, the addition of rituximab was associated with a marked reduction of refractory disease (13.6% vs. 26.7% for non-supplemented chemotherapy, p<0.001). Overall, primary responsive patients had a median survival of 19.8 years, compared to 1.3 yr. for refractory patients. A prolonged survival was consistently observed in all primary responsive patients regardless of the histology. The long life expectancy of primary responsive patients was documented in both series managed before and after 2.000. Response to first line therapy resulted by far the most predictive factor for long-term outcome (HR for primary refractory disease: 16.52, p<0.001). Conclusion: Chemosensitivity to primary treatment is crucial for the long-term survival in NHL. This supports the necessity of studies aimed to early identify refractory disease and to develop different treatment strategies for responsive and refractory patients.	[Tarella, Corrado; Gueli, Angela; Caracciolo, Daniele; Bruna, Riccardo; Ruella, Marco; Gottardi, Daniela] Univ Turin, Dept Biotechnol & Life Sci, Turin, Italy; [Tarella, Corrado; Gueli, Angela; Bruna, Riccardo; Ruella, Marco; Gottardi, Daniela] Mauriziano Hosp, Hematol & Cell Therapy Div, Turin, Italy; [Delaini, Federica; Rossi, Andrea; Barbui, Anna Maria; Gritti, Giuseppe; Boschini, Cristina] AO Papa Giovanni XXIII, Hematol Unit, Bergamo, Italy; [Delaini, Federica; Rossi, Andrea; Barbui, Anna Maria; Gritti, Giuseppe; Boschini, Cristina] AO Papa Giovanni XXIII, Bone Marrow Transplant Unit, Bergamo, Italy; [Caracciolo, Daniele; Rambaldi, Alessandro] AO Citta Salute, Div Hematol 1, Turin, Italy; [Passera, Roberto] Univ Turin, Div Nucl Med, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; ASST Papa Giovanni XXIII; ASST Papa Giovanni XXIII; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin	Tarella, C (corresponding author), Univ Turin, Dept Biotechnol & Life Sci, Turin, Italy.	corrado.tarella@unito.it	gueli, angela/K-9786-2016; Rambaldi, Alessandro/M-6172-2019; Ruella, Marco/GQP-8473-2022; Gritti, Giuseppe/K-7321-2019; Rambaldi, Alessandro/P-2603-2018; Passera, Roberto/ABI-7086-2020	gueli, angela/0000-0003-3674-109X; Rambaldi, Alessandro/0000-0002-3739-7502; Gritti, Giuseppe/0000-0002-6789-5123; Rambaldi, Alessandro/0000-0002-3739-7502; Passera, Roberto/0000-0003-3372-2248; Boschini, Cristina/0000-0001-6905-7038; Ruella, Marco/0000-0003-4301-5811	Associazione Italiana per la Ricerca contro il Cancro (AIRC); Associazione Italiana Lotta alla Leucemia (AIL); Ministero dell'Istruzione; dell'Universitae della Ricerca (MIUR); Regione Piemonte (Ricerca Finalizzata and the Piedmont Regional Government)	Associazione Italiana per la Ricerca contro il Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana Lotta alla Leucemia (AIL); Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universitae della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Regione Piemonte (Ricerca Finalizzata and the Piedmont Regional Government)	This work was supported in part by grants from Associazione Italiana per la Ricerca contro il Cancro (AIRC), Associazione Italiana Lotta alla Leucemia (AIL), Ministero dell'Istruzione, dell'Universitae della Ricerca (MIUR) and Regione Piemonte (Ricerca Finalizzata and the Piedmont Regional Government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JO, 2012, AM J HEMATOL, V87, P512, DOI 10.1002/ajh.23144; Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Cabanillas Fernando, 2011, Clin Lymphoma Myeloma Leuk, V11 Suppl 1, pS87, DOI 10.1016/j.clml.2011.03.029; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Cheson BD, 2012, CANCER-AM CANCER SOC, V118, P3128, DOI 10.1002/cncr.26510; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; COX DR, 1972, J R STAT SOC B, V34, P187; Cuccuini W, 2012, BLOOD, V119, P4619, DOI 10.1182/blood-2012-01-406033; d'Amore F, 2012, J CLIN ONCOL, V30, P3093, DOI 10.1200/JCO.2011.40.2719; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Elstrom RL, 2012, LEUKEMIA LYMPHOMA, V53, P1469, DOI 10.3109/10428194.2012.656629; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Gallamini A, 2007, BLOOD, V110, P2316, DOI 10.1182/blood-2007-02-074641; Galli M, 2005, HAEMATOLOGICA, V90, P1643; Gisselbrecht C, 1998, BLOOD, V92, P76; Leskov I, 2013, ONCOGENE, V32, P1066, DOI 10.1038/onc.2012.117; Li ZM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041658, 10.1371/journal.pone.0053176]; Lunning MA, 2012, BLOOD REV, V26, P279, DOI 10.1016/j.blre.2012.09.004; Mahadevan D, 2011, J CLIN ONCOL, V29, P1876, DOI 10.1200/JCO.2010.32.7171; Maloney DG, 2008, BONE MARROW TRANSPL, V42, pS35, DOI 10.1038/bmt.2008.110; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moskowitz C, 2012, BEST PRACT RES CL HA, V25, P41, DOI 10.1016/j.beha.2012.01.008; Mounier N, 2003, BLOOD, V101, P4279, DOI 10.1182/blood-2002-11-3442; Muller C, 2012, BLOOD, V119, P3276, DOI 10.1182/blood-2011-09-380949; Pfreundschuh M, 2011, LANCET ONCOL, V12, P1013, DOI 10.1016/S1470-2045(11)70235-2; Piccaluga PP, 2013, J CLIN ONCOL, V31, P3019, DOI 10.1200/JCO.2012.42.5611; Rambaldi A, 2013, AM J HEMATOL, V88, P1062, DOI 10.1002/ajh.23566; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Royo C, 2011, SEMIN CANCER BIOL, V21, P322, DOI 10.1016/j.semcancer.2011.09.007; Sawas A, 2011, CURR OPIN HEMATOL, V18, P280, DOI 10.1097/MOH.0b013e328347786d; Schneider CK, 2012, NAT BIOTECHNOL, V30, P1179, DOI 10.1038/nbt.2447; Sehn LH, 2005, J CLIN ONCOL, V23, P5027, DOI 10.1200/JCO.2005.09.137; Snuderl M, 2010, AM J SURG PATHOL, V34, P327, DOI 10.1097/PAS.0b013e3181cd3aeb; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; Sweetenham J, 2008, HEMATOL ONCOL CLIN N, V22, P965, DOI 10.1016/j.hoc.2008.07.009; Tan D, 2013, BLOOD, V122, P981, DOI 10.1182/blood-2013-03-491514; Tarella C, 2008, J CLIN ONCOL, V26, P3166, DOI 10.1200/JCO.2007.14.4204; Tarella C, 2011, J CLIN ONCOL, V29, P814, DOI 10.1200/JCO.2010.28.9777; Wilson WH, 2012, HAEMATOL-HEMATOL J, V97, P758, DOI 10.3324/haematol.2011.056531; Zinzani PL, 2013, AM J HEMATOL, V88, P185, DOI 10.1002/ajh.23372	40	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e106745	10.1371/journal.pone.0106745	http://dx.doi.org/10.1371/journal.pone.0106745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255081	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300012
J	Wang, HL; Zhang, TE; Yin, LT; Pang, M; Guan, L; Liu, HL; Zhang, JH; Meng, XL; Bai, JZ; Zheng, GP; Yin, GR				Wang, Hai-Long; Zhang, Tie-E; Yin, Li-Tian; Pang, Min; Guan, Li; Liu, Hong-Li; Zhang, Jian-Hong; Meng, Xiao-Li; Bai, Ji-Zhong; Zheng, Guo-Ping; Yin, Guo-Rong			Partial Protective Effect of Intranasal Immunization with Recombinant Toxoplasma gondii Rhoptry Protein 17 against Toxoplasmosis in Mice	PLOS ONE			English	Article							IMMUNE-RESPONSE; IMMUNOGLOBULIN-A; DNA VACCINE; ORAL INFECTION; TISSUE CYSTS; BALB/C MICE; T-CELLS; SAG1; ANTIGEN; RESISTANCE	Toxoplasma gondii (T. gondii) is an obligate intracellular protozoan parasite that infects a variety of mammals, including humans. An effective vaccine for this parasite is therefore needed. In this study, RH strain T. gondii rhoptry protein 17 was expressed in bacteria as a fusion with glutathione S-transferase (GST) and the recombinant proteins (rTgROP17) were purified via GST-affinity chromatography. BALB/c mice were nasally immunised with rTgROP17, and induction of immune responses and protection against chronic and lethal T. gondii infections were investigated. The results revealed that mice immunised with rTgROP17 produced high levels of specific anti-rTgROP17 IgGs and a mixed IgG1/IgG2a response of IgG2a predominance. The systemic immune response was associated with increased production of Th1 (IFN-gamma and IL-2) and Th2 (IL-4) cytokines, and enhanced lymphoproliferation (stimulation index, SI) in the mice immunised with rTgROP17. Strong mucosal immune responses with increased secretion of TgROP17-specific secretory IgA (SIgA) in nasal, vaginal and intestinal washes were also observed in these mice. The vaccinated mice displayed apparent protection against chronic RH strain infection as evidenced by their lower liver and brain parasite burdens (59.17% and 49.08%, respectively) than those of the controls. The vaccinated mice also exhibited significant protection against lethal infection of the virulent RH strain (survival increased by 50%) compared to the controls. Our data demonstrate that rTgROP17 can trigger strong systemic and mucosal immune responses against T. gondii and that ROP17 is a promising candidate vaccine for toxoplasmosis.	[Wang, Hai-Long; Zhang, Tie-E; Guan, Li; Liu, Hong-Li; Zhang, Jian-Hong; Meng, Xiao-Li; Yin, Guo-Rong] Shanxi Med Univ, Res Inst Med Parasitol, Taiyuan, Shanxi, Peoples R China; [Yin, Li-Tian] Shanxi Med Univ, Dept Physiol, Key Lab Cellular Physiol Coconstructed Prov, Taiyuan, Shanxi, Peoples R China; [Pang, Min] Shanxi Med Univ, Affiliated Hosp 1, Dept Resp, Taiyuan, Shanxi, Peoples R China; [Bai, Ji-Zhong] Univ Auckland, Dept Physiol, Fac Med & Hlth Sci, Auckland, New Zealand; [Zheng, Guo-Ping] Shanxi Med Univ, Dept Biochem & Mol Biol, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; University of Auckland; Shanxi Medical University	Wang, HL (corresponding author), Shanxi Med Univ, Res Inst Med Parasitol, Taiyuan, Shanxi, Peoples R China.	longwty@163.com; guorongyin@163.com	Zheng, Guoping/AAF-2332-2019	Bai, Jizhong/0000-0003-0667-8640; zheng, guoping/0000-0002-5551-4522	National Natural Science Foundation of China [81071374]; Natural Science Found of Shanxi Province [2012011036-2]; Technique Innovation of Shanxi Medical University [01201103]; Shanxi Medical University [201202]; Research Fund for the Doctoral Program of Shanxi Medical University [03201307]; College Students Innovation and Entrepreneurship Training Programs of Shanxi Province [2011120]; Advanced Program for Returned Scholars of Shanxi Province Science and Technology Activities; Biology Postdoctoral Mobile Research Station of Shanxi Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Found of Shanxi Province; Technique Innovation of Shanxi Medical University; Shanxi Medical University; Research Fund for the Doctoral Program of Shanxi Medical University; College Students Innovation and Entrepreneurship Training Programs of Shanxi Province; Advanced Program for Returned Scholars of Shanxi Province Science and Technology Activities; Biology Postdoctoral Mobile Research Station of Shanxi Medical University	This work was supported by the National Natural Science Foundation of China (No. 81071374), the Natural Science Found of Shanxi Province (No. 2012011036-2), the Technique Innovation of Shanxi Medical University (No. 01201103), the 331 Early Career Researcher Grant of Shanxi Medical University (No. 201202), the Research Fund for the Doctoral Program of Shanxi Medical University (No. 03201307), the College Students Innovation and Entrepreneurship Training Programs of Shanxi Province (No. 2011120) and the Advanced Program for Returned Scholars of Shanxi Province Science and Technology Activities. This work was also supported by the Biology Postdoctoral Mobile Research Station of Shanxi Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Bradley PJ, 2007, CURR OPIN MICROBIOL, V10, P582, DOI 10.1016/j.mib.2007.09.013; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; BRINKMANN V, 1993, MOL IMMUNOL, V30, P353, DOI 10.1016/0161-5890(93)90064-I; Butcher BA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002236; Buxton D, 2007, VET PARASITOL, V149, P25, DOI 10.1016/j.vetpar.2007.07.003; Debard N, 1996, INFECT IMMUN, V64, P2158, DOI 10.1128/IAI.64.6.2158-2166.1996; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Dlugonska H, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/632424; Doskaya M, 2007, VACCINE, V25, P1824, DOI 10.1016/j.vaccine.2006.10.060; Dubey JP, 2009, VET PARASITOL, V164, P89, DOI 10.1016/j.vetpar.2009.05.018; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Dziadek B, 2012, EXP PARASITOL, V131, P133, DOI 10.1016/j.exppara.2012.02.026; Dziadek B, 2011, VACCINE, V29, P821, DOI 10.1016/j.vaccine.2010.11.002; Dziadek B, 2009, EXP PARASITOL, V123, P81, DOI 10.1016/j.exppara.2009.06.002; El Hajj H, 2006, PROTEOMICS, V6, P5773, DOI 10.1002/pmic.200600187; Fentress SJ, 2012, CELL MICROBIOL, V14, P1921, DOI 10.1111/cmi.12022; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Golkar M, 2007, VACCINE, V25, P4301, DOI 10.1016/j.vaccine.2007.02.057; Hutchings AB, 2004, J VIROL, V78, P947, DOI 10.1128/JVI.78.2.947-957.2004; Igarashi M, 2010, REV BRAS PARASITOL V, V19, P210, DOI 10.1590/S1984-29612010000400004; Jensen KDC, 2013, INFECT IMMUN, V81, P2156, DOI 10.1128/IAI.01185-12; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Khosroshahi KH, 2012, PARASITOL RES, V111, P403, DOI 10.1007/s00436-012-2852-7; Letscher-Bru V, 1998, INFECT IMMUN, V66, P4503; Liu CS, 2010, VACCINE, V28, P4153, DOI 10.1016/j.vaccine.2010.04.016; Liu Q, 2013, HUM VACCIN IMMUNOTHE, V10; Liu Q, 2012, HUM VACC IMMUNOTHER, V8, P1305, DOI 10.4161/hv.21006; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; LUNDEN A, 1993, INFECT IMMUN, V61, P2639; Martin V, 2004, CLIN DIAGN LAB IMMUN, V11, P704, DOI 10.1128/CDLI.11.4.704-710.2004; MICHETTI P, 1992, INFECT IMMUN, V60, P1786, DOI 10.1128/IAI.60.5.1786-1792.1992; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nie H, 2011, VET PARASITOL, V181, P215, DOI 10.1016/j.vetpar.2011.04.039; Ong YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026369; Ong YC, 2010, J BIOL CHEM, V285, P28731, DOI 10.1074/jbc.M110.112359; Parmley S, 2002, J INFECT DIS, V185, pS90, DOI 10.1086/338464; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Qiu W, 2009, EMBO J, V28, P969, DOI 10.1038/emboj.2009.24; Qu DF, 2013, EXP PARASITOL, V135, P234, DOI 10.1016/j.exppara.2013.07.013; Sibley LD, 2010, CURR OPIN BIOTECH, V21, P592, DOI 10.1016/j.copbio.2010.05.009; TAGUCHI T, 1990, J IMMUNOL METHODS, V128, P65, DOI 10.1016/0022-1759(90)90464-7; Velge-Roussel F, 2000, INFECT IMMUN, V68, P969, DOI 10.1128/IAI.68.2.969-972.2000; Wang Hai-long, 2014, Chinese Journal of Parasitology and Parasitic Diseases, V32, P29; Wang HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070884; Wang Hai-long, 2012, Chinese Journal of Parasitology and Parasitic Diseases, V30, P27; Wang HX, 2009, EXP PARASITOL, V122, P226, DOI 10.1016/j.exppara.2009.04.002; WINNER L, 1991, INFECT IMMUN, V59, P977, DOI 10.1128/IAI.59.3.977-982.1991; Xiang W, 2009, VET PARASITOL, V166, P1, DOI 10.1016/j.vetpar.2009.08.014; Yamamoto M, 2012, VIRULENCE, V3, P77, DOI 10.4161/viru.3.1.18340; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Yang XY, 2010, VACCINE, V28, P737, DOI 10.1016/j.vaccine.2009.10.065; Yin Guo-rong, 2007, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V25, P290; Yin LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082765; Yu HJ, 2013, VET PARASITOL, V197, P670, DOI 10.1016/j.vetpar.2013.06.013; Yuan ZG, 2011, VACCINE, V29, P6614, DOI 10.1016/j.vaccine.2011.06.110; Yuan ZG, 2011, CLIN VACCINE IMMUNOL, V18, P119, DOI 10.1128/CVI.00312-10; Zaman M, 2013, DRUG DELIV TRANSL RE, V3, P100, DOI 10.1007/s13346-012-0085-z	58	18	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108377	10.1371/journal.pone.0108377	http://dx.doi.org/10.1371/journal.pone.0108377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255141	gold, Green Published, Green Submitted			2022-12-27	WOS:000344862300076
J	Wang, H; Yang, LL; Hu, YF; Wang, BW; Huang, YY; Zhang, C; Chen, YH; Xu, DX				Wang, Hua; Yang, Lu-Lu; Hu, Yong-Fang; Wang, Bi-Wei; Huang, Yin-Yin; Zhang, Cheng; Chen, Yuan-Hua; Xu, De-Xiang			Maternal LPS Exposure during Pregnancy Impairs Testicular Development, Steroidogenesis and Spermatogenesis in Male Offspring	PLOS ONE			English	Article							INTRAUTERINE FETAL-DEATH; GRAM-NEGATIVE BACTEREMIA; MALE-MICE LACKING; ANDROGEN RECEPTOR; LEYDIG-CELLS; DEFECTIVE SPERMATOGENESIS; GROWTH RESTRICTION; AMNIOTIC-FLUID; PRETERM LABOR; NITRIC-OXIDE	Lipopolysaccharide (LPS) is associated with adverse developmental outcomes including embryonic resorption, fetal death, congenital teratogenesis and fetal growth retardation. Here, we explored the effects of maternal LPS exposure during pregnancy on testicular development, steroidogenesis and spermatogenesis in male offspring. The pregnant mice were intraperitoneally injected with LPS (50 mg/kg) daily from gestational day (GD) 13 to GD 17. At fetal period, a significant decrease in body weight and abnormal Leydig cell aggregations were observed in males whose mothers were exposed to LPS during pregnancy. At postnatal day (PND) 26, anogenital distance (AGD), a sensitive index of altered androgen action, was markedly reduced in male pups whose mothers were exposed to LPS daily from GD13 to GD 17. At PND35, the weight of testes, prostates and seminal vesicles, and serum testosterone (T) level were significantly decreased in LPS-treated male pups. At adulthood, the number of sperm was significantly decreased in male offspring whose mothers were exposed to LPS on GD 13-17. Maternal LPS exposure during gestation obviously diminished the percent of seminiferous tubules in stages I-VI, increased the percent of seminiferous tubules in stages IX-XII, and caused massive sloughing of germ cells in seminiferous tubules in mouse testes. Moreover, maternal LPS exposure significantly reduced serum T level in male mice whose mothers were exposed to LPS challenge during pregnancy. Taken together, these results suggest that maternal LPS exposure during pregnancy disrupts T production. The decreased T synthesis might be associated with LPS-induced impairments for spermatogenesis in male offspring.	[Wang, Hua; Yang, Lu-Lu; Hu, Yong-Fang; Wang, Bi-Wei; Huang, Yin-Yin; Zhang, Cheng; Chen, Yuan-Hua; Xu, De-Xiang] Anhui Med Univ, Dept Toxicol, Sch Publ Hlth, Hefei, Anhui, Peoples R China; [Wang, Hua; Zhang, Cheng; Chen, Yuan-Hua; Xu, De-Xiang] Anhui Prov Key Lab Populat Hlth & Aristogen, Hefei, Anhui, Peoples R China; [Chen, Yuan-Hua] Anhui Med Univ, Dept Histol & Embryol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Xu, DX (corresponding author), Anhui Med Univ, Dept Toxicol, Sch Publ Hlth, Hefei, Anhui, Peoples R China.	xudex@126.com			National Natural Science Foundation of China [30901617, 30901217, 81172711]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (30901617, 30901217 and 81172711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; Aisemberg J, 2007, P NATL ACAD SCI USA, V104, P7534, DOI 10.1073/pnas.0702279104; Biswas B, 2011, AM J REPROD IMMUNOL, V65, P557, DOI 10.1111/j.1600-0897.2010.00937.x; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Bonde JP, 2014, ASIAN J ANDROL, V16, P3, DOI 10.4103/1008-682X.122191; Bosmann HB, 1996, ENDOCRINOLOGY, V137, P4522, DOI 10.1210/en.137.10.4522; Chang CS, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109132; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; Chen GH, 2011, BEHAV BRAIN RES, V218, P267, DOI 10.1016/j.bbr.2010.11.001; Chen YH, 2012, J IMMUNOL, V189, P454, DOI 10.4049/jimmunol.1103579; COLLINS JG, 1994, INFECT IMMUN, V62, P4652, DOI 10.1128/IAI.62.10.4652-4655.1994; Fisch H, 2013, ASIAN J ANDROL, V15, P169, DOI 10.1038/aja.2012.143; Gow RM, 2001, J ENDOCRINOL, V168, P193, DOI 10.1677/joe.0.1680193; Haider SG, 2004, INT REV CYTOL, V233, P181, DOI 10.1016/S0074-7696(04)33005-6; HAZAN Y, 1995, ACTA OBSTET GYN SCAN, V74, P275, DOI 10.3109/00016349509024449; Hurley JC, 2010, EUR J CLIN MICROBIOL, V29, P207, DOI 10.1007/s10096-009-0841-2; HURLEY JC, 1994, J CLIN MICROBIOL, V32, P2120, DOI 10.1128/JCM.32.9.2120-2127.1994; Iwasa T, 2009, INT J DEV NEUROSCI, V27, P345, DOI 10.1016/j.ijdevneu.2009.03.004; Joensen UN, 2008, BASIC CLIN PHARMACOL, V102, P155, DOI 10.1111/j.1742-7843.2007.00197.x; Jurewicz J, 2014, ANN HUM BIOL, V41, P220, DOI 10.3109/03014460.2013.849755; Leazer TM, 2002, REPROD TOXICOL, V16, P173, DOI 10.1016/S0890-6238(02)00011-4; Liew SH, 2007, J ANDROL, V28, P176, DOI 10.2164/jandrol.106.000752; Mahood IK, 2007, ENVIRON HEALTH PERSP, V115, P55, DOI 10.1289/ehp.9366; Mahood IK, 2005, ENDOCRINOLOGY, V146, P613, DOI 10.1210/en.2004-0671; Mendis-Handagama SMLC, 2001, BIOL REPROD, V65, P660, DOI 10.1095/biolreprod65.3.660; O'Bryan MK, 2000, ENDOCRINOLOGY, V141, P238, DOI 10.1210/en.141.1.238; Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095; ORNOY A, 1976, AM J OBSTET GYNECOL, V124, P196, DOI 10.1016/S0002-9378(16)33298-7; PLATZCHRISTENSEN JJ, 1993, AM J OBSTET GYNECOL, V169, P1161, DOI 10.1016/0002-9378(93)90274-M; Reddy MM, 2006, REPROD TOXICOL, V22, P493, DOI 10.1016/j.reprotox.2006.03.003; Romero E, 2010, MOL PSYCHIATR, V15, P372, DOI 10.1038/mp.2008.44; ROMERO R, 1988, AM J OBSTET GYNECOL, V158, P1044, DOI 10.1016/0002-9378(88)90216-5; Smith LB, 2014, SEMIN CELL DEV BIOL, V30, P2, DOI 10.1016/j.semcdb.2014.02.012; Walker AK, 2011, BRAIN BEHAV IMMUN, V25, P674, DOI 10.1016/j.bbi.2011.01.004; Wang H, 2010, TOXICOL LETT, V192, P245, DOI 10.1016/j.toxlet.2009.10.030; Xu DX, 2007, TOXICOLOGY, V234, P167, DOI 10.1016/j.tox.2007.02.010; Xu DX, 2006, AM J OBSTET GYNECOL, V195, P1707, DOI 10.1016/j.ajog.2006.03.047; Xu DX, 2005, TOXICOL SCI, V88, P525, DOI 10.1093/toxsci/kfi300; Xu QQ, 2007, ENDOCRINE, V32, P96, DOI 10.1007/s12020-007-9015-0; Zhao L, 2008, TOXICOL SCI, V103, P149, DOI 10.1093/toxsci/kfn027; Zhao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082713; Zhao M, 2014, TOXICOL LETT, V224, P201, DOI 10.1016/j.toxlet.2013.10.021	42	27	29	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e106786	10.1371/journal.pone.0106786	http://dx.doi.org/10.1371/journal.pone.0106786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255222	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300013
J	Lemasson, BH; Haefner, JW; Bowen, MD				Lemasson, Bertrand H.; Haefner, James W.; Bowen, Mark D.			Schooling Increases Risk Exposure for Fish Navigating Past Artificial Barriers	PLOS ONE			English	Article							ATLANTIC SALMON; CLOSE ENCOUNTERS; WATER DIVERSION; 2-VECTOR FLOWS; PREDATION RISK; CHINOOK SALMON; ANIMAL GROUPS; BEHAVIOR; PASSAGE; MOVEMENT	Artificial barriers have become ubiquitous features in freshwater ecosystems and they can significantly impact a region's biodiversity. Assessing the risk faced by fish forced to navigate their way around artificial barriers is largely based on assays of individual swimming behavior. However, social interactions can significantly influence fish movement patterns and alter their risk exposure. Using an experimental flume, we assessed the effects of social interactions on the amount of time required for juvenile palmetto bass (Morone chrysops x M. saxatilis) to navigate downstream past an artificial barrier. Fish were released either individually or in groups into the flume using flow conditions that approached the limit of their expected swimming stamina. We compared fish swimming behaviors under solitary and schooling conditions and measured risk as the time individuals spent exposed to the barrier. Solitary fish generally turned with the current and moved quickly downstream past the barrier, while fish in groups swam against the current and displayed a 23-fold increase in exposure time. Solitary individuals also showed greater signs of skittish behavior than those released in groups, which was reflected by larger changes in their accelerations and turning profiles. While groups displayed fission-fusion dynamics, interindividual positions were highly structured and remained steady over time. These spatial patterns align with theoretical positions necessary to reduce swimming exertion through either wake capturing or velocity sheltering, but diverge from any potential gains from channeling effects between adjacent neighbors. We conclude that isolated performance trials and projections based on individual behaviors can lead to erroneous predictions of risk exposure along engineered structures. Our results also suggest that risk perception and behavior may be more important than a fish's swimming stamina in artificially modified systems.	[Lemasson, Bertrand H.; Haefner, James W.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Lemasson, Bertrand H.; Haefner, James W.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Bowen, Mark D.] US Bur Reclamat, Fisheries & Wildlife Resources Grp, Denver, CO 80225 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Lemasson, BH (corresponding author), US Army Engineer Res & Dev Ctr, Environm Lab, Santa Barbara, CA USA.	brilraven@gmail.com			Bureau of Reclamation's Tracy Fish Improvement Program [FC810748]; U.S. Army Engineer Research & Development Center's basic research program in network sciences [BT25/NS/14-63]	Bureau of Reclamation's Tracy Fish Improvement Program; U.S. Army Engineer Research & Development Center's basic research program in network sciences	Funding for this work was provided by the Bureau of Reclamation's Tracy Fish Improvement Program (No. FC810748) and the U.S. Army Engineer Research & Development Center's basic research program in network sciences (BT25/NS/14-63). Dr. Mark Bowen, a co-author on this study, is a former employee of this institution and contributed to the design of the experiment. Mark did not participate in data collection and analyses, nor was he involved in the decision to publish the findings. While Mark did not write the manuscript, he has commented on the final product.	Aasen G, 2010, R0785504 CA DEP FISH; AFS, 2004, TECHNICAL REPORT; Bates D, 1956, T AM FISH SOC, V86, P38; BEACH MH, 1984, 78 MIN AGR FISH FOOD; Beamish F.W.H., 1978, FISH PHYSIOL, V7, P101; Berdahl A, 2013, SCIENCE, V339, P574, DOI 10.1126/science.1225883; Bowen M, 2004, TECHNICAL REPORT, V11; Brown C, 2002, J FISH BIOL, V61, P987, DOI [10.1006/jfbi.2002.2114, 10.1111/j.1095-8649.2002.tb01857.x]; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Castro-Santos T, 2003, CAN J FISH AQUAT SCI, V60, P986, DOI 10.1139/F03-086; Castro-Santos T, 2006, FISH PHYSIOL, V23, P469, DOI 10.1016/S1546-5098(05)23012-1; Codling EA, 2007, ECOLOGY, V88, P1864, DOI 10.1890/06-0854.1; Coutant CC, 2000, T AM FISH SOC, V129, P351, DOI 10.1577/1548-8659(2000)129<0351:FBIRTP>2.0.CO;2; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Dahlbom SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023565; FLETCHER RI, 1985, T AM FISH SOC, V114, P652, DOI 10.1577/1548-8659(1985)114<652:RAFFDE>2.0.CO;2; Fox HE, 1997, J NEUROSCI, V17, P6463; Frid A, 2002, CONSERV ECOL, V6; Gazzola M, 2011, J COMPUT PHYS, V230, P7093, DOI 10.1016/j.jcp.2011.04.025; Goodwin RA, 2006, ECOL MODEL, V192, P197, DOI 10.1016/j.ecolmodel.2005.08.004; Haefner JW, 2002, ECOL MODEL, V152, P227, DOI 10.1016/S0304-3800(02)00006-6; HAMMER C, 1995, COMP BIOCHEM PHYS A, V112, P1, DOI 10.1016/0300-9629(95)00060-K; Haro A, 2004, CAN J FISH AQUAT SCI, V61, P1590, DOI 10.1139/F04-093; Haro A, 1998, T AM FISH SOC, V127, P118, DOI 10.1577/1548-8659(1998)127<0118:EOWAOD>2.0.CO;2; Hemelrijk CK, 2014, FISH FISH, P1467; HOAR WS, 1958, J FISH RES BOARD CAN, V15, P251, DOI 10.1139/f58-014; Institute of Laboratory Animal Resources NRC, 1996, GUIDE CARE USE LAB A; Killen SS, 2012, P ROY SOC B-BIOL SCI, V279, P357, DOI 10.1098/rspb.2011.1006; Krause J, 2000, FISH FISH, V1, P82, DOI 10.1111/j.1467-2979.2000.tb00001.x; Krause J, 2002, LIVING GROUPS; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; LARKIN PA, 1969, J FISH RES BOARD CAN, V26, P1372, DOI 10.1139/f69-121; Lemasson BH, 2008, ECOL MODEL, V219, P178, DOI 10.1016/j.ecolmodel.2008.08.013; Liao JC, 2007, PHILOS T R SOC B, V362, P1973, DOI 10.1098/rstb.2007.2082; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; McCormick SD, 1998, CAN J FISH AQUAT SCI, V55, P77, DOI 10.1139/d98-011; Miller N, 2013, P NATL ACAD SCI USA, V110, P5263, DOI 10.1073/pnas.1217513110; Naughton GP, 2011, CAN J FISH AQUAT SCI, V68, P1615, DOI 10.1139/F2011-064; Patrick WS, 2001, ESTUARIES, V24, P425, DOI 10.2307/1353243; Plaut I, 2001, COMP BIOCHEM PHYS A, V131, P41, DOI 10.1016/S1095-6433(01)00462-7; Poff NL, 2002, BIOSCIENCE, V52, P659, DOI 10.1641/0006-3568(2002)052[0659:HDVAWI]2.0.CO;2; Rash J, 2012, AM FISH SOC S, V79, P1; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Reebs SG, 2010, BEHAV PROCESS, V84, P685, DOI 10.1016/j.beproc.2010.03.003; Schilt CR, 2007, APPL ANIM BEHAV SCI, V104, P295, DOI 10.1016/j.applanim.2006.09.004; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Svendsen JC, 2003, J FISH BIOL, V62, P834, DOI 10.1046/j.1095-8649.2003.00068.x; Swanson C, 2005, T AM FISH SOC, V134, P1111, DOI 10.1577/T04-121.1; Swanson C, 2004, T AM FISH SOC, V133, P265, DOI 10.1577/03-068; Tudorache C, 2008, ECOL FRESHW FISH, V17, P284, DOI 10.1111/j.1600-0633.2007.00280.x; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108; Weihs D., 1975, S SWIMM FLYING NAT, P203; Young PS, 2010, T AM FISH SOC, V139, P713, DOI 10.1577/T09-029.1	56	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108220	10.1371/journal.pone.0108220	http://dx.doi.org/10.1371/journal.pone.0108220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268736	gold, Green Published			2022-12-27	WOS:000343671700073
J	Navaratnarajah, M; Siedlecka, U; Ibrahim, M; van Doorn, C; Soppa, G; Gandhi, A; Shah, A; Kukadia, P; Yacoub, MH; Terracciano, CM				Navaratnarajah, Manoraj; Siedlecka, Urszula; Ibrahim, Michael; van Doorn, Carin; Soppa, Gopal; Gandhi, Ajay; Shah, Adarsh; Kukadia, Punam; Yacoub, Magdi H.; Terracciano, Cesare M.			Impact of Combined Clenbuterol and Metoprolol Therapy on Reverse Remodelling during Mechanical Unloading	PLOS ONE			English	Article							VENTRICULAR ASSIST DEVICE; CONGESTIVE-HEART-FAILURE; ADRENOCEPTOR AGONISTS; CIRCULATORY SUPPORT; RYANODINE RECEPTORS; PRESSURE-OVERLOAD; CELL-DEATH; RAT-HEART; RECOVERY; TRANSPLANTATION	Background: Clenbuterol (Cl), a beta(2) agonist, is associated with enhanced myocardial recovery during left ventricular assist device (LVAD) support, and exerts beneficial remodelling effects during mechanical unloading (MU) in rodent heart failure (HF). However, the specific effects of combined Cl+beta(1) blockade during MU are unknown. Methods and Results: We studied the chronic effects (4 weeks) of beta(2)-adrenoceptor (AR) stimulation via Cl (2 mg/kg/day) alone, and in combination with beta(1)-AR blockade using metoprolol ((Met), 250 mg/kg/day), on whole heart/cell structure, function and excitation-contraction (EC) coupling in failing (induced by left coronary artery (LCA) ligation), and unloaded (induced by heterotopic abdominal heart transplantation (HATx)) failing rat hearts. Combined Cl+Met therapy displayed favourable effects in HF: Met enhanced Cl's improvement in ejection fraction (EF) whilst preventing Cl-induced hypertrophy and tachycardia. During MU combined therapy was less beneficial than either mono-therapy. Met, not Cl, prevented MU-induced myocardial atrophy, with increased atrophy occurring during combined therapy. MU-induced recovery of Ca2+ transient amplitude, speed of Ca2+ release and sarcoplasmic reticulum Ca2+ content was enhanced equally by Cl or Met mono-therapy, but these benefits, together with Cl's enhancement of sarcomeric contraction speed, and MU-induced recovery of Ca2+ spark frequency, disappeared during combined therapy. Conclusions: Combined Cl+Met therapy shows superior functional effects to mono-therapy in rodent HF, but appears inferior to either mono-therapy in enhancing MU-induced recovery of EC coupling. These results suggest that combined beta(2)-AR simulation +beta(1)-AR blockade therapy is likely to be a safe and beneficial therapeutic HF strategy, but is not as effective as mono-therapy in enhancing myocardial recovery during LVAD support.	[Navaratnarajah, Manoraj; Siedlecka, Urszula; Ibrahim, Michael; van Doorn, Carin; Soppa, Gopal; Gandhi, Ajay; Shah, Adarsh; Kukadia, Punam; Yacoub, Magdi H.; Terracciano, Cesare M.] Univ London Imperial Coll Sci Technol & Med, Harefield Heart Sci Ctr, Natl Heart & Lung Inst, Lab Cellular Electrophysiol,Harefield Hosp, Harefield, Middx, England	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital	Navaratnarajah, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Harefield Heart Sci Ctr, Natl Heart & Lung Inst, Lab Cellular Electrophysiol,Harefield Hosp, Harefield, Middx, England.	manonava@hotmail.com		Shah, Adarsh/0000-0002-7004-1751	Magdi Yacoub Institute [HSC 87/04]	Magdi Yacoub Institute	The authors are grateful to the Magdi Yacoub Institute (HSC 87/04) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmet I, 2008, J PHARMACOL EXP THER, V325, P491, DOI 10.1124/jpet.107.135335; Au DH, 2003, CHEST, V123, P1964, DOI 10.1378/chest.123.6.1964; AWAN NA, 1981, AM HEART J, V102, P555, DOI 10.1016/0002-8703(81)90744-4; Baskin KK, 2011, CARDIOVASC RES, V90, P243, DOI 10.1093/cvr/cvr060; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063; Birks EJ, 2011, CIRCULATION, V123, P381, DOI 10.1161/CIRCULATIONAHA.109.933960; Bristow MR, 2011, CIRC RES, V109, P1176, DOI 10.1161/CIRCRESAHA.111.245092; BRODDE OE, 1991, PHARMACOL REV, V43, P203; Colucci WS, 1996, CIRCULATION, V94, P2800, DOI 10.1161/01.CIR.94.11.2800; COLUCCI WS, 1981, AM HEART J, V102, P564, DOI 10.1016/0002-8703(81)90745-6; DAWSON JR, 1982, EUR HEART J, V3, P135; Dipla K, 1998, CIRCULATION, V97, P2316, DOI 10.1161/01.CIR.97.23.2316; Drakos SG, 2010, J AM COLL CARDIOL, V56, P382, DOI 10.1016/j.jacc.2010.04.019; Heerdt PM, 2000, CIRCULATION, V102, P2713, DOI 10.1161/01.CIR.102.22.2713; Hon JKF, 2001, J THORAC CARDIOV SUR, V122, P767, DOI 10.1067/mtc.2001.114354; Ibrahim M, 2010, FASEB J, V24, P3321, DOI 10.1096/fj.10-156638; IRMER M, 1981, KLIN WOCHENSCHR, V59, P639, DOI 10.1007/BF02593855; Ito K, 2003, CIRCULATION, V107, P1176, DOI 10.1161/01.CIR.0000051463.72137.96; Kirklin JK, 2011, J HEART LUNG TRANSPL, V30, P115, DOI 10.1016/j.healun.2010.12.001; Klotza S, 2008, PROG BIOPHYS MOL BIO, V97, P479, DOI 10.1016/j.pbiomolbio.2008.02.002; Kolloch R, 2008, EUR HEART J, V29, P1327, DOI 10.1093/eurheartj/ehn123; KORECKY B, 1991, J CARDIOVASC PHARM, V17, pS105, DOI 10.1097/00005344-199117002-00021; Lechat P, 1997, CIRCULATION, V96, P2197; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Mancini DM, 1998, CIRCULATION, V98, P2383, DOI 10.1161/01.CIR.98.22.2383; Margulies KB, 2002, J CARD FAIL, V8, pS500, DOI 10.1054/jcaf.2002.129264; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; Matera MG, 2010, PULM PHARMACOL THER, V23, P1, DOI 10.1016/j.pupt.2009.10.001; Maybaum S, 2007, CIRCULATION, V115, P2497, DOI 10.1161/CIRCULATIONAHA.106.633180; Navaratnarajah M, 2013, CARDIOVASC RES, V97, P230, DOI 10.1093/cvr/cvs318; Oriyanhan W, 2007, J HEART LUNG TRANSPL, V26, P16, DOI 10.1016/j.healun.2006.10.016; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Soppa GKR, 2005, AM J PHYSIOL-HEART C, V288, pH1468, DOI 10.1152/ajpheart.00624.2004; Soppa GKR, 2008, CARDIOVASC RES, V77, P695, DOI 10.1093/cvr/cvm106; SUTTON MS, 1994, CIRCULATION, V89, P68, DOI 10.1161/01.CIR.89.1.68; Terracciano CMN, 2004, CIRCULATION, V109, P2263, DOI 10.1161/01.CIR.0000129233.51320.92; Tevaearai HT, 2002, CIRCULATION, V106, P124, DOI 10.1161/01.CIR.0000020220.79105.FD; Tsuneyoshi H, 2005, ASAIO J, V51, P116, DOI 10.1097/01.MAT.0000150325.05589.8B; Tsuneyoshi H, 2005, CIRCULATION, V112, pI51, DOI 10.1161/CIRCULATIONAHA.104.525097; WAAGSTEIN F, 1993, LANCET, V342, P1441, DOI 10.1016/0140-6736(93)92930-R; Wang Jian, 2008, Interact Cardiovasc Thorac Surg, V7, P27, DOI 10.1510/icvts.2007.165563; Wei S, 2000, J AM COLL CARDIOL, V36, P276, DOI 10.1016/S0735-1097(00)00671-9; Wong K, 1998, CARDIOVASC RES, V37, P115, DOI 10.1016/S0008-6363(97)00190-9; Xydas S, 2006, J PHARMACOL EXP THER, V317, P553, DOI 10.1124/JPET.105.099432; Yacoub MH, 2001, TRANSPL P, V33, P2762, DOI 10.1016/S0041-1345(01)02183-2; Zhao MM, 2011, AM J PHYSIOL-HEART C, V301, pH1461, DOI 10.1152/ajpheart.00453.2010; Zheng M, 2005, PHARMACOL THERAPEUT, V108, P257, DOI 10.1016/j.pharmthera.2005.04.006; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607	50	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e92909	10.1371/journal.pone.0092909	http://dx.doi.org/10.1371/journal.pone.0092909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268495	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700001
J	Nilsson, L; Wieringa, WG; Pundziute, G; Gjerde, M; Engvall, J; Swahn, E; Jonasson, L				Nilsson, Lennart; Wieringa, Wouter G.; Pundziute, Gabija; Gjerde, Marcus; Engvall, Jan; Swahn, Eva; Jonasson, Lena			Neutrophil/Lymphocyte Ratio Is Associated with Non-Calcified Plaque Burden in Patients with Coronary Artery Disease	PLOS ONE			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; DIFFERENTIAL LEUKOCYTE COUNT; INCREMENTAL PROGNOSTIC VALUE; NEUTROPHIL-LYMPHOCYTE RATIO; C-REACTIVE PROTEIN; HEART-DISEASE; INFLAMMATORY MARKERS; ELEVATED NEUTROPHIL; EUROPEAN-SOCIETY; CARDIAC EVENTS	Background: Elevations in soluble markers of inflammation and changes in leukocyte subset distribution are frequently reported in patients with coronary artery disease (CAD). Lately, the neutrophil/lymphocyte ratio has emerged as a potenti al marker of both CAD severity and cardiovascular prognosis. Objectives: The aim of the study was to investigate whether neutrophil/lymphocyte ratio and other immune-inflammatory markers were related to plaque burden, as assessed by coronary computed tomography angiography (CCTA), in patients with CAD. Methods: Twenty patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) and 30 patients with stable angina (SA) underwent CCTA at two occasions, immediately prior to coronary angiography and after three months. Atherosclerotic plaques were classified as calcified, mixed and non-calcified. Blood samples were drawn at both occasions. Leukocyte subsets were analyzed by white blood cell differential counts and flow cytometry. Levels of C-reactive protein (CRP) and interleukin(IL)-6 were measured in plasma. Blood analyses were also performed in 37 healthy controls. Results: Plaque variables did not change over 3 months, total plaque burden being similar in NSTE-ACS and SA. However, non-calcified/total plaque ratio was higher in NSTE-ACS, 0.25(0.09-0.44) vs 0.11(0.00-0.25), p<0.05. At admission, levels of monocytes, neutrophils, neutrophil/lymphocyte ratios, CD4+ T cells, CRP and IL-6 were significantly elevated, while levels of NK cells were reduced, in both patient groups as compared to controls. After 3 months, levels of monocytes, neutrophils, neutrophil/lymphocyte ratios and CD4+ T cells remained elevated in patients. Neutrophil/lymphocyte ratios and neutrophil counts correlated significantly with numbers of non-calcified plaques and also with non-calcified/total plaque ratio (r = 0.403, p = 0.010 and r = 0.382, p = 0.024, respectively), but not with total plaque burden. Conclusions: Among immune-inflammatory markers in NSTE-ACS and SA patients, neutrophil counts and neutrophil/lymphocyte ratios were significantly correlated with non-calcified plaques. Data suggest that these easily measured biomarkers reflect the burden of vulnerable plaques in CAD.	[Nilsson, Lennart; Gjerde, Marcus; Engvall, Jan; Swahn, Eva; Jonasson, Lena] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Nilsson, Lennart; Gjerde, Marcus; Swahn, Eva; Jonasson, Lena] Linkoping Univ, Dept Cardiol, Linkoping, Sweden; [Engvall, Jan] Linkoping Univ, Dept Clin Physiol, Linkoping, Sweden; [Wieringa, Wouter G.; Pundziute, Gabija] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands	Linkoping University; Linkoping University; Linkoping University; University of Groningen	Nilsson, L (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden.	lennart.nilsson@liu.se	Engvall, Jan Edvin/I-5019-2019	Engvall, Jan Edvin/0000-0002-5716-5098				Abdelmouttaleb I, 1999, AM HEART J, V137, P346, DOI 10.1053/hj.1999.v137.92052; Ahmadi N, 2011, AM J CARDIOL, V107, P10, DOI 10.1016/j.amjcard.2010.08.034; Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Arbel Y, 2012, ATHEROSCLEROSIS, V225, P456, DOI 10.1016/j.atherosclerosis.2012.09.009; Austen W G, 1975, Circulation, V51, P5; Azab B, 2013, ANGIOLOGY, V64, P456, DOI 10.1177/0003319712455216; Backteman K, 2014, CLIN EXP IMMUNOL, V175, P104, DOI 10.1111/cei.12210; Backteman K, 2007, J IMMUNOL METHODS, V322, P20, DOI 10.1016/j.jim.2007.01.021; Bamberg F, 2012, INT J CARDIOVAS IMAG, V28, P183, DOI 10.1007/s10554-010-9773-2; Bergstrom I, 2012, ATHEROSCLEROSIS, V224, P515, DOI 10.1016/j.atherosclerosis.2012.07.033; Boogers MJ, 2010, JACC-CARDIOVASC IMAG, V3, P699, DOI 10.1016/j.jcmg.2010.01.010; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Duffy BK, 2006, AM J CARDIOL, V97, P993, DOI 10.1016/j.amjcard.2005.10.034; Gaemperli O, 2008, EUR RADIOL, V18, P1162, DOI 10.1007/s00330-008-0871-7; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Guasti L, 2011, THROMB HAEMOSTASIS, V106, P591, DOI 10.1160/TH11-02-0096; Hadamitzky M, 2009, JACC-CARDIOVASC IMAG, V2, P404, DOI 10.1016/j.jcmg.2008.11.015; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harada K, 2013, INT J CARDIOVAS IMAG, V29, P1149, DOI 10.1007/s10554-013-0181-2; Jialal I, 2001, CIRCULATION, V103, P1933; Jonasson L, 2005, ATHEROSCLEROSIS, V183, P316, DOI 10.1016/j.atherosclerosis.2005.03.011; Kalay N, 2012, ANGIOLOGY, V63, P213, DOI 10.1177/0003319711412763; Kashiwagi M, 2010, ATHEROSCLEROSIS, V212, P171, DOI 10.1016/j.atherosclerosis.2010.05.004; Kawaguchi H, 1996, AM HEART J, V132, P9, DOI 10.1016/S0002-8703(96)90384-1; Kitagawa T, 2009, JACC-CARDIOVASC IMAG, V2, P153, DOI 10.1016/j.jcmg.2008.09.015; Kolodgie FD, 2001, CURR OPIN CARDIOL, V16, P285, DOI 10.1097/00001573-200109000-00006; Leber AW, 2004, J AM COLL CARDIOL, V43, P1241, DOI 10.1016/j.jacc.2003.10.059; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; Nijm J, 2005, AM J CARDIOL, V95, P452, DOI 10.1016/j.amjcard.2004.10.009; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Papa A, 2008, CLIN CHIM ACTA, V395, P27, DOI 10.1016/j.cca.2008.04.019; Park BJ, 2011, CLIN CHIM ACTA, V412, P925, DOI 10.1016/j.cca.2011.01.021; Pundziute G, 2007, J AM COLL CARDIOL, V49, P62, DOI 10.1016/j.jacc.2006.07.070; Rana JS, 2007, J INTERN MED, V262, P678, DOI 10.1111/j.1365-2796.2007.01864.x; Rifai N, 1999, CLIN CHEM, V45, P1967; Rotzius P, 2010, AM J PATHOL, V177, P493, DOI 10.2353/ajpath.2010.090480; Russo V, 2010, CIRC-CARDIOVASC IMAG, V3, P351, DOI 10.1161/CIRCIMAGING.109.880625; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; van Werkhoven JM, 2009, EUR HEART J, V30, P2622, DOI 10.1093/eurheartj/ehp272; Voros S, 2011, JACC-CARDIOVASC IMAG, V4, P537, DOI 10.1016/j.jcmg.2011.03.006; Wheeler JG, 2004, EUR HEART J, V25, P1287, DOI 10.1016/j.ehj.2004.05.002	43	23	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108183	10.1371/journal.pone.0108183	http://dx.doi.org/10.1371/journal.pone.0108183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268632	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700072
J	Suzuki, A; Taniguchi, H; Watanabe, N; Kondoh, Y; Kimura, T; Kataoka, K; Matsuda, T; Yokoyama, T; Sakamoto, K; Nishiyama, O; Hasegawa, Y				Suzuki, Atsushi; Taniguchi, Hiroyuki; Watanabe, Naohiro; Kondoh, Yasuhiro; Kimura, Tomoki; Kataoka, Kensuke; Matsuda, Toshiaki; Yokoyama, Toshiki; Sakamoto, Koji; Nishiyama, Osamu; Hasegawa, Yoshinori			Significance of Pulmonary Arterial Pressure as a Prognostic Indicator in Lung-Dominant Connective Tissue Disease	PLOS ONE			English	Article							IDIOPATHIC INTERSTITIAL PNEUMONIA; 6-MINUTE WALK TEST; SYSTEMIC-SCLEROSIS; REVISED CRITERIA; HYPERTENSION; FIBROSIS; CLASSIFICATION; DERMATOMYOSITIS; STATEMENT; SURVIVAL	Background: Lung-dominant connective tissue disease (LD-CTD) is a new concept for classifying the subset of patients with interstitial pneumonia who have clinical features suggesting an associated CTD, but whose features fall short of a clear diagnosis of CTD under the current rheumatologic classification systems. The impact of mean pulmonary arterial pressure (MPAP) in LD-CTD has not been sufficiently elucidated. Objectives: To evaluate the survival impact of MPAP measured during the initial evaluation in patients with LD-CTD. Methods: We retrospectively analyzed the initial evaluation data of 100 LD-CTD patients undergoing pulmonary function test, 6-min walk test (6MWT), and right heart catheterization (RHC). Results: The mean MPAP was 16.2 +/- 4.4 mm Hg, and 18 patients had MPAP >= 20 mm Hg. A univariate Cox proportional hazard model showed that MPAP and several variables have a statistically significant impact on survival. With stepwise, multivariate Cox proportional analysis, MPAP (HR = 1.293; 95% CI 1.130-1.480; p<0.001) and mean forced vital capacity (FVC) % predicted (HR = 0.958; 95% CI 0.930-0.986; p = 0.004) were shown to be independent determinants of survival. Conclusions: Higher MPAP and lower % FVC at the initial evaluation were significant independent prognostic factors of LD-CTD. MPAP evaluation provides additional information of disease status and will help physicians to predict mortality in LD-CTD.	[Suzuki, Atsushi; Taniguchi, Hiroyuki; Kondoh, Yasuhiro; Kimura, Tomoki; Kataoka, Kensuke; Matsuda, Toshiaki; Yokoyama, Toshiki] Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Aichi, Japan; [Watanabe, Naohiro; Sakamoto, Koji; Hasegawa, Yoshinori] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4648601, Japan; [Nishiyama, Osamu] Kinki Univ, Fac Med, Dept Resp Med & Allergol, Osaka, Japan	Tosei General Hospital; Nagoya University; Kindai University (Kinki University)	Taniguchi, H (corresponding author), Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Aichi, Japan.	taniguchi@tosei.or.jp	SAKAMOTO, Koji/E-2138-2017; Suzuki, Atsushi/AAX-9649-2021; Kondo, Yasuhiro/AAP-3658-2020; Hasegawa, Yoshinori/I-1277-2012	SAKAMOTO, Koji/0000-0002-1794-576X; Nishiyama, Osamu/0000-0002-9163-9605	Japanese Ministry of Health, Labor and Welfare; NPO Respiratory Disease Conference	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); NPO Respiratory Disease Conference	This work was supported in part by a grant-in-aid for the respiratory failure research group from the Japanese Ministry of Health, Labor and Welfare and NPO Respiratory Disease Conference. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamad EH, 2012, RESP MED, V106, P1575, DOI 10.1016/j.rmed.2012.07.009; American Thoracic Society, 1995, AM J RESP CRIT CARE, V152, P1107; [Anonymous], 2002, AM J RESP CRIT CARE, V166, P111; [Anonymous], 2004, NIHON KOKYUKI GAKKAI, P1; Arcasoy SM, 2003, AM J RESP CRIT CARE, V167, P735, DOI 10.1164/rccm.200210-1130OC; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Behr J, 2008, EUR RESPIR J, V31, P1357, DOI 10.1183/09031936.00171307; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Chung L, 2010, CHEST, V138, P1383, DOI 10.1378/chest.10-0260; Corte TJ, 2012, EUR RESPIR J, V39, P661, DOI 10.1183/09031936.00174910; Cottin V, 2010, EUR RESPIR J, V35, P105, DOI 10.1183/09031936.00038709; Dweik RA, 2014, AM J RESP CRIT CARE, V189, P345, DOI 10.1164/rccm.201311-1954ST; EUWER RL, 1991, J AM ACAD DERMATOL, V24, P959, DOI 10.1016/0190-9622(91)70153-S; Farkas L, 2011, AM J RESP CELL MOL, V45, P1, DOI 10.1165/rcmb.2010-0365TR; Fischer A, 2008, CHEST, V134, P601, DOI 10.1378/chest.08-0053; Fischer A, 2012, LANCET, V380, P689, DOI 10.1016/S0140-6736(12)61079-4; Fischer A, 2010, CHEST, V138, P251, DOI 10.1378/chest.10-0194; Kimura M, 2013, RESPIRATION, V85, P456, DOI 10.1159/000345221; Lama VN, 2003, AM J RESP CRIT CARE, V168, P1084, DOI 10.1164/rccm.200302-219OC; Mathai SC, 2012, HEART FAIL CLIN, V8, P413, DOI 10.1016/j.hfc.2012.04.001; Mejia M, 2009, CHEST, V136, P10, DOI 10.1378/chest.08-2306; Nathan SD, 2008, RESP MED, V102, P1305, DOI 10.1016/j.rmed.2008.03.022; Nishiyama O, 2010, EUR RESPIR J, V36, P1067, DOI 10.1183/09031936.00152609; Patel NM, 2007, CHEST, V132, P998, DOI 10.1378/chest.06-3087; Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; Sanchez O, 2006, CHEST, V130, P182, DOI 10.1378/chest.130.1.182; Smolen JS, 1998, ARTHRITIS RHEUM, V41, P768, DOI 10.1002/1529-0131(199805)41:5<768::AID-ART3>3.0.CO;2-Z; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Trad S, 2006, ARTHRITIS RHEUM-US, V54, P184, DOI 10.1002/art.21538; Valerio CJ, 2013, ARTHRITIS RHEUM-US, V65, P1074, DOI 10.1002/art.37838; Vij R, 2013, CHEST, V143, P814, DOI 10.1378/chest.12-0741; VITALI C, 1993, ARTHRITIS RHEUM, V36, P340, DOI 10.1002/art.1780360309; Watanabe N, 2014, RESPIRATION, V87, P469, DOI 10.1159/000358098	33	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108339	10.1371/journal.pone.0108339	http://dx.doi.org/10.1371/journal.pone.0108339			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268705	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700083
J	Brettschneider, C; Riedel-Heller, S; Konig, HH				Brettschneider, Christian; Riedel-Heller, Steffi; Koenig, Hans-Helmut			A Systematic Review of Economic Evaluations of Treatments for Borderline Personality Disorder	PLOS ONE			English	Review							DIALECTICAL BEHAVIOR-THERAPY; COST-EFFECTIVENESS; PARTIAL HOSPITALIZATION; PSYCHOTHERAPY; COMORBIDITY; DISABILITY; UTILITY; WOMEN	Purpose: The borderline personality disorder is a common mental disorder. It is frequently associated with various mental co-morbidities and a fundamental loss of functioning. The borderline personality disorder causes high costs to society. The aim of this study was to perform a systematic literature review of existing economic evaluations of treatments for borderline personality disorder. Materials and Methods: We performed a systematic literature search in MEDLINE, EMBASE, PsycINFO and NHSEED for partial and full economic evaluations regarding borderline personality disorder. Reported cost data were inflated to the year 2012 and converted into US-$ using purchasing power parities to allow for comparability. Quality assessment of the studies was performed by means of the Consensus on Health Economic Criteria checklist, a checklist developed by a Delphi method in cooperation with 23 international experts. Results: We identified 6 partial and 9 full economic evaluations. The methodical quality was moderate (fulfilled quality criteria: 79.2% [SD: 15.4%] in partial economic evaluations, 77.3% [SD: 8.5%] in full economic evaluations). Most evaluations analysed psychotherapeutic interventions. Although ambiguous, most evidence exists on dialectical-behavioural therapy. Cognitive behavioural therapy and schema-focused therapy are cost-saving. Evidence on other interventions is scarce. Conclusion: The economic evidence is not sufficient to draw robust conclusions for all treatments. It is possible that some treatments are cost-effective. Most evidence exists on dialectical-behavioural therapy. Yet, it is ambiguous. Further research concerning the cost-effectiveness of treatments is necessary as well as the identification of relevant cost categories and the validation of effect measures.	[Brettschneider, Christian; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany; [Riedel-Heller, Steffi] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Leipzig University	Brettschneider, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany.	c.brettschneider@uke.de	König, Hans-Helmut/P-1211-2018; Brettschneider, Christian/H-5920-2019; Riedel-Heller, Steffi/ABG-1537-2021	König, Hans-Helmut/0000-0001-5711-6862; Brettschneider, Christian/0000-0002-5280-1075; 	German Federal Ministry of Education and Research [01KQ1002B]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was funded by the German Federal Ministry of Education and Research (Grant number: 01KQ1002B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arntz A, 2003, J PERS DISORD, V17, P45, DOI 10.1521/pedi.17.1.45.24053; Bateman A, 2003, AM J PSYCHIAT, V160, P169, DOI 10.1176/appi.ajp.160.1.169; Bateman A, 1999, AM J PSYCHIAT, V156, P1563, DOI 10.1176/ajp.156.10.1563; Berrino A, 2011, PSYCHIAT RES, V186, P287, DOI 10.1016/j.psychres.2010.06.018; Borschmann R, 2013, BRIT J PSYCHIAT, V202, P357, DOI 10.1192/bjp.bp.112.117762; Brazier J, 2006, HEALTH TECHNOL ASSES, V10, P1; Chhatwal J, 2013, VALUE HEALTH, V16, P973, DOI 10.1016/j.jval.2013.07.006; Davidson K, 2006, J PERS DISORD, V20, P450, DOI 10.1521/pedi.2006.20.5.450; Davidson KM, 2010, BRIT J PSYCHIAT, V197, P456, DOI 10.1192/bjp.bp.109.074286; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Evers S, 2005, INT J TECHNOL ASSESS, V21, P240, DOI 10.1017/S0266462305050324; Goodman M, 2011, J PERS DISORD, V25, P59, DOI 10.1521/pedi.2011.25.1.59; Grant BF, 2008, J CLIN PSYCHIAT, V69, P533, DOI 10.4088/JCP.v69n0404; Havrilesky LJ, 2012, CANCER-AM CANCER SOC, V118, P386, DOI 10.1002/cncr.26199; Hofmann SG, 2013, BEHAV THER, V44, P199, DOI 10.1016/j.beth.2009.01.007; Jerschke S, 1998, FORTSCHR NEUROL PSYC, V66, P545, DOI 10.1055/s-2007-995297; Kaltenthaler E, 2006, HEALTH TECHNOL ASSES, V10, P1, DOI 10.3310/hta10330; Koons CR, 2001, BEHAV THER, V32, P371, DOI 10.1016/S0005-7894(01)80009-5; Kristian B, 2013, ACTA NEUROL SCAND, V127, P419, DOI 10.1111/ane.12077; Lee CP, 2009, VALUE HEALTH, V12, P80, DOI 10.1111/j.1524-4733.2008.00401.x; Lenzenweger MF, 2007, BIOL PSYCHIAT, V62, P553, DOI 10.1016/j.biopsych.2006.09.019; LINEHAN MM, 1991, ARCH GEN PSYCHIAT, V48, P1060; Longworth L, 2013, VALUE HEALTH, V16, P202, DOI 10.1016/j.jval.2012.10.010; Organisation for Economic Co-operation and Development (OECD), 2013, OECD HLTH DAT EC REF; Palmer S, 2006, J PERS DISORD, V20, P466, DOI 10.1521/pedi.2006.20.5.466; Pasieczny N, 2011, BEHAV RES THER, V49, P4, DOI 10.1016/j.brat.2010.09.006; Priebe S, 2012, PSYCHOTHER PSYCHOSOM, V81, P356, DOI 10.1159/000338897; Schoenbaum M, 2012, PEDIATRICS, V130, pE380, DOI 10.1542/peds.2011-3241; Soeteman DI, 2010, BRIT J PSYCHIAT, V196, P396, DOI 10.1192/bjp.bp.109.070482; Stoffers JM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005652.pub2; Turner RM, 2000, COGN BEHAV PRACT, V7, P413, DOI 10.1016/S1077-7229(00)80052-8; Tyrer P, 2003, PSYCHOL MED, V33, P969, DOI 10.1017/S0033291703008171; van Asselt ADI, 2007, EUR PSYCHIAT, V22, P354, DOI 10.1016/j.eurpsy.2007.04.001; van Asselt ADI, 2008, VALUE HEALTH, V11, P637, DOI 10.1111/j.1524-4733.2007.00288.x; van Asselt ADI, 2008, BRIT J PSYCHIAT, V192, P450, DOI 10.1192/bjp.bp.106.033597; van den Bosch LMC, 2002, ADDICT BEHAV, V27, P911, DOI 10.1016/S0306-4603(02)00293-9; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn; Zanarini MC, 2010, AM J PSYCHIAT, V167, P663, DOI 10.1176/appi.ajp.2009.09081130	38	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107748	10.1371/journal.pone.0107748	http://dx.doi.org/10.1371/journal.pone.0107748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6XR	25265185	Green Submitted, gold, Green Published			2022-12-27	WOS:000345745400029
J	Chandra, PK; Gunduz, F; Hazari, S; Kurt, R; Panigrahi, R; Poat, B; Bruce, D; Cohen, AJ; Behorquez, HE; Carmody, I; Loss, G; Balart, LA; Wu, T; Dash, S				Chandra, Partha K.; Gunduz, Feyza; Hazari, Sidhartha; Kurt, Ramazan; Panigrahi, Rajesh; Poat, Bret; Bruce, David; Cohen, Ari J.; Behorquez, Humberto E.; Carmody, Ian; Loss, George; Balart, Luis A.; Wu, Tong; Dash, Srikanta			Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; ENDOPLASMIC-RETICULUM STRESS; PLUS RIBAVIRIN; HEPATOCELLULAR-CARCINOMA; VIROLOGICAL RESPONSE; VIRUS-INFECTION; RNA LEVELS; ACTIVATION; THERAPY; ALPHA	Purpose: Chronic Hepatitis C Virus (HCV)-infected patients with liver cirrhosis (LC) respond poorly to interferon-alpha (IFN-alpha) and ribavirin (RBV) combination therapy, but the reason for this is unclear. We previously reported that HCV-infection induces endoplasmic reticulum (ER) stress and autophagy response that selectively down regulates the type I IFN-alpha receptor-1 (IFNAR1) and RBV transporters (CNT1 and ENT1), leading to IFN-alpha/RBV resistance. The goal of this study is to verify whether an increase in ER stress and autophagy response is also associated with the reduced expression of IFNAR1 and RBV transporters in chronic HCV-infected patients. Methods: Primary human hepatocytes (PHH) were infected with cell culture grown HCV particles (JFH-Delta V3-Rluc). HCV replication was confirmed by the detection of viral RNA by RT-qPCR and HCV-core protein by Western blotting. The ER stress and autophagy response and expression of IFN receptors and RBV transporters in HCV infected PHH and liver tissues derived from patients were measured by Western blotting. Result: HCV infection of PHH showed impaired expression of IFNAR1, IFN gamma R1 (Type II IFN receptor) and RBV transporters but not IL10R beta (Type III IFN-lambda receptor). ER stress markers (BiP, IRE1 alpha and peIF2 alpha) and autophagy response (LC3II, Beclin 1 and ATG5) were induced in HCV infected chronic liver disease (CLD) and LC patients. Liver biopsies (CLD) show a 50% reduced expression of IFNAR1 and RBV transporters. Furthermore, the expression of IFNAR1 and RBV transporters was impaired in almost all LC patients. Conclusion: HCV infection induces ER stress and autophagy response in infected PHH and chronically infected liver tissues. The expression of IFNAR1, IFNcR1 and RBV transporters were significantly impaired in CLD and cirrhotic livers. Our study provides a potential explanation for the reduced response rate of IFN-alpha and RBV combination therapy in HCV infected patients with liver cirrhosis.	[Chandra, Partha K.; Gunduz, Feyza; Hazari, Sidhartha; Panigrahi, Rajesh; Poat, Bret; Wu, Tong; Dash, Srikanta] Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Kurt, Ramazan; Balart, Luis A.; Dash, Srikanta] Tulane Univ, Hlth Sci Ctr, Dept Med Gastroenterol & Hepatol, New Orleans, LA 70118 USA; [Bruce, David; Cohen, Ari J.; Behorquez, Humberto E.; Carmody, Ian; Loss, George] Ochsner Med Ctr, Transplant Surg Sect, New Orleans, LA USA	Tulane University; Tulane University; Ochsner Health System	Dash, S (corresponding author), Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA.	sdash@tulane.edu	Cohen, Ari/A-5799-2011; Cohen, Ari/AAF-9449-2019; Carmody, Ian/A-5524-2011	Cohen, Ari/0000-0003-1224-8647; Panigrahi, Rajesh/0000-0002-6704-0029; Bohorquez, Humberto/0000-0002-5441-0684	NIH [CA127481, CA089121, AI103106]; Tulane University Health Sciences Center; NATIONAL CANCER INSTITUTE [R01CA089121, R01CA127481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103106] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University Health Sciences Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the following: NIH grants: CA127481, CA089121, AI103106; and bridge funding: Tulane University Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07; Asselah T, 2010, LIVER INT, V30, P1259, DOI 10.1111/j.1478-3231.2010.02283.x; Asselah T, 2010, J PATHOL, V221, P264, DOI 10.1002/path.2703; Booth DR, 2012, GENOME MED, V4, DOI 10.1186/gm400; Bota S, 2013, WORLD J HEPATOL, V5, P120, DOI 10.4254/wjh.v5.i3.120; Buck M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002660; Chandra PK, 2014, AM J PATHOL, V184, P214, DOI 10.1016/j.ajpath.2013.10.005; Chandra PK, 2012, MOL THER, V20, P1724, DOI 10.1038/mt.2012.107; Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dash S, 2000, J VIROL METHODS, V90, P15, DOI 10.1016/S0166-0934(00)00199-3; Datta S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-351; Forestier N, 2012, LIVER INT, V32, P44, DOI 10.1111/j.1478-3231.2011.02720.x; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; GERBER MA, 1992, AM J PATHOL, V141, P1271; Gondeau C, 2013, GENOME WIDE ASS STUD, P1; Gunduz F, 2014, EXP MOL PATHOL, V96, P36, DOI 10.1016/j.yexmp.2013.10.016; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hazari S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-36; Lemoine M, 2014, SEMIN LIVER DIS, V34, P89, DOI 10.1055/s-0034-1371082; Lemon SM, 2010, J BIOL CHEM, V285, P22739, DOI 10.1074/jbc.R109.099556; Li X, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-73; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Liu SH, 2011, ANTIVIR RES, V89, P54, DOI 10.1016/j.antiviral.2010.11.004; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Pietrocola F, 2013, SEMIN CANCER BIOL, V23, P310, DOI 10.1016/j.semcancer.2013.05.008; Rautou PE, 2011, AM J PATHOL, V178, P2708, DOI 10.1016/j.ajpath.2011.02.021; Roffi L, 2008, ANTIVIR THER, V13, P663; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Soza A, 2005, J HEPATOL, V43, P67, DOI 10.1016/j.jhep.2005.02.023; Steenbergen RH, 2013, HEPATOLOGY, V58, P1907, DOI 10.1002/hep.26566; Su IJ, 2008, J GASTROEN HEPATOL, V23, P1169, DOI 10.1111/j.1440-1746.2008.05348.x; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Toshikuni N, 2014, WORLD J GASTROENTERO, V20, P2876, DOI 10.3748/wjg.v20.i11.2876; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Wright TL, 2002, HEPATOLOGY, V36, pS185, DOI 10.1053/jhep.2002.36812; Zeuzem S, 2004, ANN INTERN MED, V140, P370, DOI 10.7326/0003-4819-140-5-200403020-00033; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhu Y, 2013, WORLD J GASTROENTERO, V19, P8963, DOI 10.3748/wjg.v19.i47.8963	43	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108616	10.1371/journal.pone.0108616	http://dx.doi.org/10.1371/journal.pone.0108616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265476	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400095
J	Doronin, VB; Parkhomenko, TA; Castellazzi, M; Padroni, M; Pastore, M; Buneva, VN; Granieri, E; Nevinsky, GA				Doronin, Visilii B.; Parkhomenko, Taisiya A.; Castellazzi, Massimiliano; Padroni, Marina; Pastore, Michela; Buneva, Valentina N.; Granieri, Enrico; Nevinsky, Georgy A.			Comparison of Antibodies Hydrolyzing Myelin Basic Protein from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis	PLOS ONE			English	Article							ANTIIDIOTYPIC ANTIBODY; CATALYTIC HETEROGENEITY; IGG ANTIBODIES; AUTOANTIBODIES; DEGRADATION; AFFINITY; DISEASES	It was found that antibodies (Abs) against myelin basic protein (MBP) are the major components of the antibody response in multiple sclerosis (MS) patients. We have recently shown that IgGs from sera of MS patients are active in the hydrolysis of MBP. However, in literature there are no available data concerning possible MBP-hydrolyzing Abs in cerebrospinal fluid (CSF) of MS patients. We have shown that the average content of IgGs in their sera is about 195-fold higher than that in their CSF. Here we have compared, for the first time, the average content of lambda-and kappa-IgGs as well as IgGs of four different subclasses (IgG1-IgG4) in CSF and sera of MS patients. The average relative content of lambda-IgGs and kappa -IgGs in the case of CSFs (8.0 and 92.0%) and sera (12.3 and 87.7%) are comparable, while IgG1, IgG2, IgG3, and IgG4: CSF - 40.4, 49.0, 8.2, and 2.5% of total IgGs, respectively and the sera - 53.6, 36.0, 5.6, and 4.8%, decreased in different order. Electrophoretically and immunologically homogeneous IgGs were obtained by sequential affinity chromatography of the CSF proteins on protein G-Sepharose and FPLC gel filtration. We present first evidence showing that IgGs from CSF efficiently hydrolyze MBP and that their average specific catalytic activity is unpredictably similar to 54-fold higher than that of Abs from sera of the same MS patients. Some possible reasons of these findings are discussed. We suggest that anti-MBP abzymes of CSF may promote important neuropathologic mechanisms in this chronic inflammatory disorder and in MS pathogenesis development.	[Doronin, Visilii B.] Novosibirsk Med Univ, Minist Publ Hlth Russian Federat, Novosibirsk, Russia; [Parkhomenko, Taisiya A.; Buneva, Valentina N.; Nevinsky, Georgy A.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Div, Novosibirsk, Russia; [Castellazzi, Massimiliano; Padroni, Marina; Pastore, Michela; Granieri, Enrico] Univ Ferrara, Dept Neurol, Multiple Sclerosis Ctr, I-44100 Ferrara, Italy; [Buneva, Valentina N.; Nevinsky, Georgy A.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; University of Ferrara; Novosibirsk State University	Granieri, E (corresponding author), Univ Ferrara, Dept Neurol, Multiple Sclerosis Ctr, I-44100 Ferrara, Italy.	enrico.granieri@unife.it; nevinsky@niboch.nsc.ru	Castellazzi, Massimiliano/K-5083-2016; Nevinsky, Georgy/E-6053-2012; Castellazzi, Massimiliano/X-3499-2019; Buneva, Valentina Nikolaevna/I-6329-2012	Castellazzi, Massimiliano/0000-0001-6555-6075; Castellazzi, Massimiliano/0000-0001-6555-6075; Buneva, Valentina Nikolaevna/0000-0003-2556-979X; Padroni, Marina/0000-0001-8410-3039; Granieri, Enrico/0000-0003-4038-3192; Menzorova, Natalia/0000-0002-2616-7023	Presidium of the Russian Academy of Sciences [6.2]; Russian Foundation for Basic Research [13-04-00208, 13-04-00205]; Siberian Division of the Russian Academy of Sciences; Regione Emilia Romagna, Italy (Ricerca Sanitaria Finalizzata)	Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Siberian Division of the Russian Academy of Sciences(Russian Academy of Sciences); Regione Emilia Romagna, Italy (Ricerca Sanitaria Finalizzata)	This study was in part supported in part by grants from the Presidium of the Russian Academy of Sciences (Molecular and Cellular Biology Program, 6.2; Russian Foundation for Basic Research (13-04-00208 and 13-04-00205), funds from the Siberian Division of the Russian Academy of Sciences and funds from the Regione Emilia Romagna, Italy (Ricerca Sanitaria Finalizzata). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN O, 1993, J NEUROL, V240, P417, DOI 10.1007/BF00867354; Andryushkova AA, 2007, J CELL MOL MED, V11, P531, DOI 10.1111/j.1582-4934.2007.00048.x; Andryushkova AA, 2006, FEBS LETT, V580, P5089, DOI 10.1016/j.febslet.2006.08.036; Andryushkova AA, 2009, INT IMMUNOL, V21, P935, DOI 10.1093/intimm/dxp060; Avalle B, 1998, APPL BIOCHEM BIOTECH, V75, P3; Baranova SV, 2010, INT IMMUNOL, V22, P671, DOI 10.1093/intimm/dxq051; Baranova SV, 2009, BIOCHIMIE, V91, P1081, DOI 10.1016/j.biochi.2009.06.018; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; Bezuglova AM, 2012, INT IMMUNOL, V24, P759, DOI 10.1093/intimm/dxs071; Bezuglova AM, 2011, J MOL RECOGNIT, V24, P960, DOI 10.1002/jmr.1143; BOIKO AN, 1995, MOL BIOL+, V29, P413; D'Souza CA, 2005, BIOCHEMISTRY-US, V44, P12905, DOI 10.1021/bi051152f; DEIBLER GE, 1984, NEUROCHEM RES, V9, P1371, DOI 10.1007/BF00964664; Fainardi E, 2004, J NEUROL SCI, V217, P181, DOI 10.1016/j.jns.2003.09.012; FRIBOULET A, 1994, APPL BIOCHEM BIOTECH, V47, P229, DOI 10.1007/BF02787937; Gusev EI, 1997, MULTIPLE SCLEROSIS M, P1; Hu R, 1998, J BIOTECHNOL, V61, P109, DOI 10.1016/S0168-1656(98)00009-1; IKEHARA S, 1990, P NATL ACAD SCI USA, V87, P8341, DOI 10.1073/pnas.87.21.8341; IZADYAR L, 1993, P NATL ACAD SCI USA, V90, P8876, DOI 10.1073/pnas.90.19.8876; KALAGA R, 1995, J IMMUNOL, V155, P2695; KAMHOLZ J, 1986, P NATL ACAD SCI USA, V83, P4962, DOI 10.1073/pnas.83.13.4962; Keinan E, 2021, ASIACHEM, V2, P96; Kolesnikov AV, 2000, P NATL ACAD SCI USA, V97, P13526, DOI 10.1073/pnas.200360497; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Legostaeva GA, 2010, J CELL MOL MED, V14, P699, DOI 10.1111/j.1582-4934.2009.00738.x; Lerner R A, 1995, EXS, V73, P121; LERNER RA, 1987, TRENDS BIOCHEM SCI, V12, P427, DOI 10.1016/0968-0004(87)90208-8; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Martin AB, 1999, TRENDS BIOCHEM SCI, V24, pM24, DOI 10.1016/S0968-0004(99)01498-X; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Meinl E, 1999, CURR OPIN NEUROL, V12, P303, DOI 10.1097/00019052-199906000-00009; Nevinsky G.A., 2010, AUTOIMMUNE DIS SYMPT, P1; Nevinsky G.A., 2005, CATALYTIC ANTIBODIES, P503; Nevinsky GA, 2012, ADV NEUROIMMUNE BIOL, V3, P157, DOI 10.3233/NIB-2012-012042; O'Connor KC, 2001, J CLIN IMMUNOL, V21, P81, DOI 10.1023/A:1011064007686; Odintsova ES, 2006, BIOCHEMISTRY-MOSCOW+, V71, P251, DOI 10.1134/S0006297906030047; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Pihlaja H, 2003, GENES IMMUN, V4, P138, DOI 10.1038/sj.gene.6363943; Polosukhina DI, 2006, IMMUNOL LETT, V103, P75, DOI 10.1016/j.imlet.2005.10.018; Polosukhina DI, 2005, MED SCI MONITOR, V11, pBR266; Polosukhina DI, 2004, J CELL MOL MED, V8, P359, DOI 10.1111/j.1582-4934.2004.tb00325.x; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Reindl M, 1999, BRAIN, V122, P2047, DOI 10.1093/brain/122.11.2047; SALDEN HJM, 1988, CLIN CHEM, V34, P1594; Saveliev AN, 2003, IMMUNOL LETT, V86, P291, DOI 10.1016/S0165-2478(03)00042-7; SCHULTZ PG, 1995, SCIENCE, V269, P1835, DOI 10.1126/science.7569920; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Stewart J D, 1993, Int Rev Immunol, V10, P229, DOI 10.3109/08830189309061698; Talbot PJ, 1996, ANN NEUROL, V39, P233, DOI 10.1002/ana.410390213; Terryberry JW, 1998, NEUROBIOL AGING, V19, P205, DOI 10.1016/S0197-4580(98)00049-9	50	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107807	10.1371/journal.pone.0107807	http://dx.doi.org/10.1371/journal.pone.0107807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265393	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400031
J	Kun, J; Szitter, I; Kemeny, A; Perkecz, A; Kereskai, L; Pohoczky, K; Vincze, A; Godi, S; Szabo, I; Szolcsanyi, J; Pinter, E; Helyes, Z				Kun, Jozsef; Szitter, Istvan; Kemeny, Agnes; Perkecz, Aniko; Kereskai, Laszlo; Pohoczky, Krisztina; Vincze, Aron; Godi, Szilard; Szabo, Imre; Szolcsanyi, Janos; Pinter, Erika; Helyes, Zsuzsanna			Upregulation of the Transient Receptor Potential Ankyrin 1 Ion Channel in the Inflamed Human and Mouse Colon and Its Protective Roles	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; VANILLOID CAPSAICIN RECEPTORS; INTESTINAL POLYPEPTIDE VIP; GENE-RELATED PEPTIDE; INDUCED COLITIS; SUBSTANCE-P; TRP CHANNELS; ULCERATIVE-COLITIS; SENSORY NEURONS; GASTROINTESTINAL MOTILITY	Transient Receptor Potential Ankyrin 1 (TRPA1) channels are localized on sensory nerves and several non-neural cells, but data on their functional significance are contradictory. We analysed the presence and alterations of TRPA1 in comparison with TRP Vanilloid 1 (TRPV1) at mRNA and protein levels in human and mouse intact and inflamed colons. The role of TRPA1 in a colitis model was investigated using gene-deficient mice. TRPA1 and TRPV1 expressions were investigated in human colon biopsies of healthy subjects and patients with inflammatory bowel diseases (IBD: ulcerative colitis, Crohn's disease) with quantitative PCR and immunohistochemistry. Mouse colitis was induced by oral 2% dextran-sulphate (DSS) for 10 days. For investigating the functions of TRPA1, Disease Activity Index (weight loss, stool consistency, blood content) was determined in C57BL/6-based Trpa1-deficient (knockout: KO) and wildtype (WT) mice. Sensory neuropeptides, their receptors, and inflammatory cytokines/chemokines were determined with qPCR or Luminex. In human and mouse colons TRPA1 and TRPV1 are located on epithelial cells, macrophages, enteric ganglia. Significant upregulation of TRPA1 mRNA was detected in inflamed samples. In Trpa1 KO mice, Disease Activity Index was significantly higher compared to WTs. It could be explained by the greater levels of substance P, neurokinins A and B, neurokinin 1 receptor, pituitary adenylate-cyclase activating polypeptide, vasoactive intestinal polypeptide, and also interleukin-1beta, macrophage chemoattractant protein1, monokine induced by gamma interferon-1, tumor necrosis factor-alpha and B-lymphocyte chemoattractant in the distal colon. TRPA1 is upregulated in colitis and its activation exerts protective roles by decreasing the expressions of several proinflammatory neuropeptides, cytokines and chemokines.	[Kun, Jozsef; Szitter, Istvan; Kemeny, Agnes; Perkecz, Aniko; Pohoczky, Krisztina; Szolcsanyi, Janos; Pinter, Erika; Helyes, Zsuzsanna] Univ Pecs, Sch Med, Dept Pharmacol & Pharmacotherapy, Pecs, Hungary; [Kun, Jozsef; Szitter, Istvan; Kemeny, Agnes; Pinter, Erika; Helyes, Zsuzsanna] Univ Pecs, Mol Pharmacol Res Grp, Janos Szentagothai Res Ctr, Pecs, Hungary; [Kereskai, Laszlo] Univ Pecs, Sch Med, Dept Pathol, Pecs, Hungary; [Vincze, Aron; Godi, Szilard; Szabo, Imre] Univ Pecs, Dept Internal Med 1, Pecs, Hungary	University of Pecs; University of Pecs; University of Pecs; University of Pecs	Helyes, Z (corresponding author), Univ Pecs, Sch Med, Dept Pharmacol & Pharmacotherapy, Pecs, Hungary.	zsuzsanna.helyes@aok.pte.hu	Vincze, Aron/A-7048-2011; Zsuzsanna, Helyes/GLU-8236-2022; Vincze, Aron/J-6724-2019	Vincze, Aron/0000-0003-2217-7686; Zsuzsanna, Helyes/0000-0003-2435-4367; Vincze, Aron/0000-0003-2217-7686	Social Renewal Operational Programme (SROP) [4.2.2.A-11/1/KONV-2012-0024, 4.2.4.A/2-11-1-2012-0001]; National Development Agency - Government of Hungary; European Union; European Social Fund; Office of Justice and Public Administration	Social Renewal Operational Programme (SROP); National Development Agency - Government of Hungary; European Union(European Commission); European Social Fund(European Social Fund (ESF)); Office of Justice and Public Administration	The research was supported by the Social Renewal Operational Programme (SROP)-4.2.2.A-11/1/KONV-2012-0024. Funding agency: National Development Agency - Government of Hungary. http://palyazat.gov.hu/. E. Pinter and J. Kun were supported by scholarships of the Social Renewal Operational Programme (SROP)-4.2.4.A/2-11-1-2012-0001 "National Excellence Program - Elaborating and operating an inland student and researcher personal support system convergence program.'' The project was subsidized by the European Union and co-financed by the European Social Fund. Funding agency: Office of Justice and Public Administration. http://kih.gov.hu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2005, INFLAMM BOWEL DIS, V11, P674, DOI 10.1097/01.MIB.0000171872.70738.58; Ahern GP, 2011, CURR OPIN PHARMACOL, V11, P29, DOI 10.1016/j.coph.2011.02.004; Akbar A, 2008, GUT, V57, P923, DOI 10.1136/gut.2007.138982; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Anavi-Goffer S, 2002, NEUROSCI LETT, V319, P53, DOI 10.1016/S0304-3940(01)02480-6; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bartho L, 2004, EUR J PHARMACOL, V500, P143, DOI 10.1016/j.ejphar.2004.07.020; Bauer C, 2007, DIGEST DIS SCI, V52, P1642, DOI 10.1007/s10620-007-9802-8; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; BERNSTEIN CN, 1993, AM J GASTROENTEROL, V88, P908; BRAIN SD, 1985, NATURE, V313, P54, DOI 10.1038/313054a0; Brederson JD, 2013, EUR J PHARMACOL, V716, P61, DOI 10.1016/j.ejphar.2013.03.003; Brynskov J, 2002, GUT, V51, P37, DOI 10.1136/gut.51.1.37; Carlsen HS, 2002, GUT, V51, P364, DOI 10.1136/gut.51.3.364; Cattaruzza F, 2010, AM J PHYSIOL-GASTR L, V298, pG81, DOI 10.1152/ajpgi.00221.2009; Chan CLH, 2003, LANCET, V361, P385, DOI 10.1016/S0140-6736(03)12392-6; Chojnacki C, 2013, WORLD J GASTROENTERO, V19, P3602, DOI 10.3748/wjg.v19.i23.3602; Deleporte S, 2013, INT J INTERF CYTOKIN, V5, P11, DOI DOI 10.2147/IJICMR.S21705; Doihara H, 2009, EUR J PHARMACOL, V617, P124, DOI 10.1016/j.ejphar.2009.06.038; Engel MA, 2012, J GASTROENTEROL, V47, P256, DOI 10.1007/s00535-011-0495-6; Engel MA, 2012, DIGEST LIVER DIS, V44, P24, DOI 10.1016/j.dld.2011.08.030; Engel MA, 2011, GASTROENTEROLOGY, V141, P1346, DOI 10.1053/j.gastro.2011.07.002; Engel MA, 2011, INFLAMM BOWEL DIS, V17, P1030, DOI 10.1002/ibd.21422; Evangelista S, 2008, NEUROPEPTIDES, V42, P663, DOI 10.1016/j.npep.2008.07.001; Feng B, 2012, AM J PHYSIOL-GASTR L, V302, pG1085, DOI 10.1152/ajpgi.00542.2011; Fernandes ES, 2012, BRIT J PHARMACOL, V166, P510, DOI 10.1111/j.1476-5381.2012.01851.x; Fujino K, 2004, J GASTROINTEST SURG, V8, P842, DOI 10.1016/j.gassur.2004.07.011; Goode T, 2000, GUT, V47, P387, DOI 10.1136/gut.47.3.387; GOSO C, 1993, EUR J PHARMACOL, V249, P185, DOI 10.1016/0014-2999(93)90431-G; Han P, 2013, J MOL NEUROSCI, V50, P23, DOI 10.1007/s12031-012-9849-7; Helyes Z, 2010, NEUROPEPTIDES, V44, P399, DOI 10.1016/j.npep.2010.05.004; Holzer P, 2004, NEUROGASTROENT MOTIL, V16, P697, DOI 10.1111/j.1365-2982.2004.00598.x; Holzer P, 2004, EUR J PHARMACOL, V500, P231, DOI 10.1016/j.ejphar.2004.07.028; Holzer P, 2003, CURR OPIN PHARMACOL, V3, P618, DOI 10.1016/j.coph.2003.06.008; HOLZER P, 1992, REV PHYSIOL BIOCH P, V121, P49, DOI 10.1007/BFb0033194; Holzer P, 2011, PHARMACOL THERAPEUT, V131, P142, DOI 10.1016/j.pharmthera.2011.03.006; Holzer P, 2011, CURR PHARM BIOTECHNO, V12, P24, DOI 10.2174/138920111793937862; Holzer Peter, 2001, Current Opinion in Pharmacology, V1, P583, DOI 10.1016/S1471-4892(01)00100-X; Izzo AA, 2012, BRIT J PHARMACOL, V166, P1444, DOI 10.1111/j.1476-5381.2012.01879.x; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kaneko Y, 2013, BR J PHARM; Keszthelyi D, 2013, EUR J PAIN, V17, P1299, DOI 10.1002/j.1532-2149.2013.00309.x; Kimball ES, 2007, NEUROGASTROENT MOTIL, V19, P390, DOI 10.1111/j.1365-2982.2007.00939.x; Kimball ES, 2004, NEUROGASTROENT MOTIL, V16, P811, DOI 10.1111/j.1365-2982.2004.00549.x; Knowlton WM, 2010, PAIN, V150, P340, DOI 10.1016/j.pain.2010.05.021; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Kondo T, 2010, DIGESTION, V82, P150, DOI 10.1159/000310836; Kun J, 2012, J MOL NEUROSCI, V48, P795, DOI 10.1007/s12031-012-9766-9; Lakhan SE, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-37; Lee J, 2012, AUTON NEUROSCI-BASIC, V166, P72, DOI 10.1016/j.autneu.2011.07.008; Li LM, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-16; Massa F, 2006, J MOL MED, V84, P142, DOI 10.1007/s00109-005-0016-2; Matsumoto K, 2012, LAB INVEST, V92, P769, DOI 10.1038/labinvest.2012.14; Matsumoto K, 2009, AM J PHYSIOL-GASTR L, V297, pG348, DOI 10.1152/ajpgi.90578.2008; McLean MH, 2014, INFLAMM BOWEL DIS, V20, P389, DOI 10.1097/01.MIB.0000437616.37000.41; Menzies JRW, 2001, REGUL PEPTIDES, V99, P151, DOI 10.1016/S0167-0115(01)00244-0; Moura JC De, 2014, BRIT J PHARMACOL, V1, P1; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Newman R, 2005, CLIN EXP IMMUNOL, V139, P411, DOI 10.1111/j.1365-2249.2005.02673.x; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; Nilius B, 2012, PFLUG ARCH EUR J PHY, V464, P425, DOI 10.1007/s00424-012-1158-z; Nozawa K, 2009, P NATL ACAD SCI USA, V106, P3408, DOI 10.1073/pnas.0805323106; Pecze L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003419; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Poole DP, 2011, GASTROENTEROLOGY, V141, P565, DOI 10.1053/j.gastro.2011.04.049; Pozsgai G, 2013, NITRIC OXIDE-BIOL CH, V31, pS53, DOI 10.1016/j.niox.2013.06.104; Renzi D, 2000, AM J PATHOL, V157, P1511, DOI 10.1016/S0002-9440(10)64789-X; Romano B, 2013, BRIT J PHARMACOL, V169, P213, DOI 10.1111/bph.12120; Rubin DC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00107; Sanger GJ, 2004, BRIT J PHARMACOL, V141, P1303, DOI 10.1038/sj.bjp.0705742; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Sigalet DL, 2007, AM J PHYSIOL-GASTR L, V293, pG211, DOI 10.1152/ajpgi.00530.2006; Solomon L., 2010, COMP CLIN PATHOL, V19, DOI [10.1007/s00580-010-0979-4, DOI 10.1007/S00580-010-0979-4]; Spahn V, 2014, MOL PHARMACOL, V85, P335, DOI 10.1124/mol.113.088997; Steenland HW, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-34; Steinbach EC, 2014, INFLAMM BOWEL DIS, V20, P166, DOI 10.1097/MIB.0b013e3182a69dca; Storti B, 2012, J BIOL CHEM, V287, P7803, DOI 10.1074/jbc.M111.332296; Szallasi A, 1995, BRAIN RES, V703, P175, DOI 10.1016/0006-8993(95)01094-7; Szallasi A, 1999, PHARMACOL REV, V51, P159; Szitter I, 2014, INFLAMM RES; Szitter I, 2010, J MOL NEUROSCI, V42, P80, DOI 10.1007/s12031-010-9366-5; Szolcsanyi J, 2004, NEUROPEPTIDES, V38, P377, DOI 10.1016/j.npep.2004.07.005; Szolcsanyi J, 1996, PROG BRAIN RES, V113, P343, DOI 10.1016/S0079-6123(08)61097-3; Szolcsanyi J, 1998, BRIT J PHARMACOL, V123, P936, DOI 10.1038/sj.bjp.0701685; SZOLCSANYI J, 1976, ARZNEIMITTEL-FORSCH, V26, P33; Szolcsanyi J, 1982, PYRETICS ANTIPYRETIC; Szolcsanyi J, 2011, CURR TOP MED CHEM, V11, P2253, DOI 10.2174/156802611796904852; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Takahashi N, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00058; Taylor-Clark TE, 2008, J PHYSIOL-LONDON, V586, P3447, DOI 10.1113/jphysiol.2008.153585; Tixier E, 2006, BIOCHEM BIOPH RES CO, V344, P554, DOI 10.1016/j.bbrc.2006.03.159; Todorovic V, 1996, HEPATO-GASTROENTEROL, V43, P483; Tohda C, 2001, J NEUROCHEM, V76, P1628, DOI 10.1046/j.1471-4159.2001.00193.x; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Vinuesa AG, 2012, CANCER RES, V72, P1705, DOI 10.1158/0008-5472.CAN-11-3693; Vu JP, 2014, J MOL NEUROSCI, V52, P37, DOI 10.1007/s12031-013-0205-3; Yadav M, 2011, CELL IMMUNOL, V267, P124, DOI 10.1016/j.cellimm.2011.01.001; Yang J, 2008, NEUROSCI LETT, V440, P237, DOI 10.1016/j.neulet.2008.05.093; Yiangou Y, 2001, LANCET, V357, P1338, DOI 10.1016/S0140-6736(00)04503-7; Yu YB, 2010, NEUROCHEM RES, V35, P797, DOI 10.1007/s11064-010-0137-z	101	87	89	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108164	10.1371/journal.pone.0108164	http://dx.doi.org/10.1371/journal.pone.0108164			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265225	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400048
J	Mountain, E; Mishra, S; Vickerman, P; Pickles, M; Gilks, C; Boily, MC				Mountain, Elisa; Mishra, Sharmistha; Vickerman, Peter; Pickles, Michael; Gilks, Charles; Boily, Marie-Claude			Antiretroviral Therapy Uptake, Attrition, Adherence and Outcomes among HIV-Infected Female Sex Workers: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; HIGH-RISK WOMEN; PROSPECTIVE COHORT; BURKINA-FASO; HETEROSEXUAL TRANSMISSION; DRUG-RESISTANCE; NORTH-AMERICA; CARE; PREVENTION	Purpose: We aimed to characterize the antiretroviral therapy (ART) cascade among female sex workers (FSWs) globally. Methods: We systematically searched PubMed, Embase and MEDLINE in March 2014 to identify studies reporting on ART uptake, attrition, adherence, and outcomes (viral suppression or CD4 count improvements) among HIV-infected FSWs globally. When possible, available estimates were pooled using random effects meta-analyses (with heterogeneity assessed using Cochran's Q test and I-2 statistic). Results: 3(studies, reporting on 21 different FSW study populations in Asia, Africa, North America, South America, and Central America and the Caribbean, were included. Current ART use among HIV-infected FSWs was 38% (95% CI: 29%-48%, I-2 = 96%, 15 studies), and estimates were similar between high-, and low-and middle-income countries. Ever ART use among HIV-infected FSWs was greater in high-income countries (80%; 95% CI: 48%-94%, I-2 = 70%, 2 studies) compared to low- and middle-income countries (36%; 95% CI: 7%-81%, I-2 = 99%, 3 studies). Loss to follow-up after ART initiation was 6% (95% CI: 3%-11%, I-2 = 0%, 3 studies) and death after ART initiation was 6% (95% CI: 3%-11%, I-2 = 0%, 3 studies). The fraction adherent to >= 95% of prescribed pills was 76% (95% CI: 68%-83%, I-2 = 36%, 4 studies), and 57% (95% CI: 46%-68%, I-2 = 82%, 4 studies) of FSWs on ART were virally suppressed. Median gains in CD4 count after 6 to 36 months on ART, ranged between 103 and 241 cells/mm(3) (4 studies). Conclusions: Despite global increases in ART coverage, there is a concerning lack of published data on HIV treatment for FSWs. Available data suggest that FSWs can achieve levels of ART uptake, retention, adherence, and treatment response comparable to that seen among women in the general population, but these data are from only a few research settings. More routine programme data on HIV treatment among FSWs across settings should be collected and disseminated.	[Mountain, Elisa; Mishra, Sharmistha; Pickles, Michael; Boily, Marie-Claude] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Mishra, Sharmistha] Univ Toronto, St Michaels Hosp, Div Infect Dis, Toronto, ON, Canada; [Mishra, Sharmistha] Univ Toronto, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Vickerman, Peter] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Gilks, Charles] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Imperial College London; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University of Bristol; University of Queensland	Mountain, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	elisa.mountain08@imperial.ac.uk	Gilks, Charles/B-4184-2012	Gilks, Charles/0000-0002-8953-3123; Pickles, Michael/0000-0002-6754-3945; Vickerman, Peter/0000-0002-8291-5890; Boily, Marie-Claude/0000-0003-3919-006X; Mishra, Sharmistha/0000-0001-8492-5470	Canadian Foundation for AIDS Research (CANFAR) [023-015]; UNAIDS	Canadian Foundation for AIDS Research (CANFAR); UNAIDS	This work was funded by the Canadian Foundation for AIDS Research (CANFAR) (grant #023-015), and UNAIDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary M, 2013, AIDS, V27, P1369, DOI 10.1097/QAD.0b013e32835fd7bd; Baggaley RF, 2013, EPIDEMIOLOGY, V24, P110, DOI 10.1097/EDE.0b013e318276cad7; Balkus JE, 2013, SEX TRANSM DIS, V40, P499, DOI 10.1097/OLQ.0b013e31828fce34; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Barber TJ, 2011, ANTIVIR THER, V16, P805, DOI 10.3851/IMP1818; Becker ML, 2012, INT J STD AIDS, V23, P36, DOI 10.1258/ijsa.2011.011017; Bila B, 2009, SOC SCI MED, V69, P854, DOI 10.1016/j.socscimed.2009.05.035; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Braunstein SL, 2011, JAIDS-J ACQ IMM DEF, V57, pE70, DOI 10.1097/QAI.0b013e3182170fd3; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Chakrapani V, 2009, AIDS PATIENT CARE ST, V23, P973, DOI 10.1089/apc.2009.0035; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Comulada WS, 2003, AM J HEALTH BEHAV, V27, P389, DOI 10.5993/AJHB.27.4.11; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Cowan FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077080; Cox J, 2014, DRUG ALCOHOL DEPEN, V137, P121, DOI 10.1016/j.drugalcdep.2014.01.014; Day S, 2012, J INVEST MED, V60, P195; Dean J, 2011, AIDS RES HUM RETROV, V27, P797, DOI 10.1089/aid.2011.0013; Deering KN, 2009, AIDS PATIENT CARE ST, V23, P603, DOI 10.1089/apc.2009.0022; Delva W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001258; Dennis AM, 2013, JAIDS-J ACQ IMM DEF, V63, P135, DOI 10.1097/QAI.0b013e318288b246; Diabate S, 2011, WORLD J AIDS, V1, P94, DOI [10.4236/wja.2011.13014, DOI 10.4236/WJA.2011.13014]; Donastorg Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088157; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Engels EA, 2000, STAT MED, V19, P1707, DOI 10.1002/1097-0258(20000715)19:13<1707::AID-SIM491>3.0.CO;2-P; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Ghimire L, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-79; Gitau RW, 2010, AIDS, V24, P2733, DOI 10.1097/QAD.0b013e32833f9f43; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Graham SM, 2013, AIDS, V27, P1803, DOI 10.1097/QAD.0b013e328360e9fb; Graham SM, 2013, AIDS BEHAV, V17, P1255, DOI 10.1007/s10461-013-0445-9; Graham SM, 2012, JAIDS-J ACQ IMM DEF, V60, P511, DOI 10.1097/QAI.0b013e31825bd703; Graham SM, 2011, SEX TRANSM INFECT, V87, P114, DOI 10.1136/sti.2010.045369; Graham SM, 2010, J INFECT DIS, V202, P1538, DOI 10.1086/656790; Graham SM, 2009, JAIDS-J ACQ IMM DEF, V52, P600, DOI 10.1097/QAI.0b013e3181b065cf; Hallett TB, 2013, JAIDS-J ACQ IMM DEF, V63, pS228, DOI 10.1097/QAI.0b013e318298721b; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Huet Charlotte, 2011, BMC Public Health, V11, P700, DOI 10.1186/1471-2458-11-700; Hughes AJ, 2014, JAIDS-J ACQ IMM DEF, V66, P80, DOI 10.1097/QAI.0000000000000084; Hull MW, 2012, CURR OPIN HIV AIDS, V7, P579, DOI 10.1097/COH.0b013e3283590617; Jadhav A, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/878151; Jean K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041353; Kalokhe AS, 2012, AIDS PATIENT CARE ST, V26, P234, DOI 10.1089/apc.2011.0275; Kato M, 2013, JAIDS-J ACQ IMM DEF, V63, pE142, DOI 10.1097/QAI.0b013e31829b535b; Kilmarx PH, 2000, J INFECT DIS, V181, P1598, DOI 10.1086/315469; Konate I, 2011, JAIDS-J ACQ IMM DEF, V57, pS50, DOI 10.1097/QAI.0b013e3182207a3f; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Lazarus L, 2012, CULT HEALTH SEX, V14, P139, DOI 10.1080/13691058.2011.628411; Lester RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005644; Low AJ, 2014, SEX TRANSM INFECT, V90, P100, DOI 10.1136/sextrans-2013-051233; Low AJ, 2014, JAIDS-J ACQ IMM DEF, V65, P237, DOI 10.1097/QAI.0000000000000049; Low AJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-20; Masese LN, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-307; Maskew M, 2013, J WOMENS HEALTH, V22, P113, DOI 10.1089/jwh.2012.3585; Mawji E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000565; McClelland L, 2011, AIDS EDUC PREV, V23, P299, DOI 10.1521/aeap.2011.23.4.299; McClelland RS, 2010, AIDS, V24, P891, DOI 10.1097/QAD.0b013e32833616c7; McKinnon LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011434; McMahon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056047; Mehta M, 2012, EXPERT REV ANTI-INFE, V10, P1287, DOI [10.1586/eri.12.129, 10.1586/ERI.12.129]; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Mosha F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-38; Mtetwa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-698; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Ortego C, 2012, AIDS CARE, V24, P1519, DOI 10.1080/09540121.2012.672722; Pereira TV, 2010, RES SYNTH METHODS, V1, P149, DOI 10.1002/jrsm.13; Phrasisombath Ketkesone, 2012, BMC Health Serv Res, V12, P37, DOI 10.1186/1472-6963-12-37; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Reddon H, 2011, AIDS EDUC PREV, V23, P412, DOI 10.1521/aeap.2011.23.5.412; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Schuelter-Trevisol F, 2007, REV SOC BRAS MED TRO, V40, P259, DOI 10.1590/S0037-86822007000300001; Shannon K, 2005, J URBAN HEALTH, V82, P488, DOI 10.1093/jurban/jti076; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tapp C, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-86; Tyurina A, 2013, DRUG ALCOHOL DEPEN, V132, P74, DOI 10.1016/j.drugalcdep.2013.01.009; Vickerman P, 2010, AIDS, V24, P2554, DOI 10.1097/QAD.0b013e32833e8663; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wilson DP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001231	80	100	100	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e105645	10.1371/journal.pone.0105645	http://dx.doi.org/10.1371/journal.pone.0105645			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6XR	25265158	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400003
J	Cui, ZN; Ito, J; Dohi, H; Amemiya, Y; Nishida, Y				Cui, Zining; Ito, Jun; Dohi, Hirofumi; Amemiya, Yoshimiki; Nishida, Yoshihiro			Molecular Design and Synthesis of Novel Salicyl Glycoconjugates as Elicitors against Plant Diseases	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; HOST-PATHOGEN INTERACTIONS; FUNGICIDAL ACTIVITY; DEFENSE RESPONSES; N,N'-DIACYLHYDRAZINE DERIVATIVES; BETA-1,3 GLUCANS; FURAN; BIOACTIVITY; TOBACCO; ACID	A new series of salicyl glycoconjugates containing hydrazide and hydrazone moieties were designed and synthesized. The bioassay indicated that the novel compounds had no in vitro fungicidal activity but showed significant in vivo antifungal activity against the tested fungal pathogens. Some compounds even had superior activity than the commercial fungicides in greenhouse trial. The results of RT-PCR analysis showed that the designed salicyl glycoconjugates could induce the expression of LOX1 and Cs-AOS2, which are the specific marker genes of jasmonate signaling pathway, to trigger the plant defense resistance.	[Cui, Zining] South China Agr Univ, Coll Nat Resource & Environm, Dept Plant Pathol, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou, Guangdong, Peoples R China; [Cui, Zining; Dohi, Hirofumi; Nishida, Yoshihiro] Chiba Univ, Grad Sch Adv Integrat Sci, Dept Nanobiol, Chiba, Japan; [Ito, Jun; Amemiya, Yoshimiki] Chiba Univ, Grad Sch Hort, Dept Environm Sci Bioprod, Chiba, Japan; [Cui, Zining] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	South China Agricultural University; Chiba University; Chiba University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Cui, ZN (corresponding author), South China Agr Univ, Coll Nat Resource & Environm, Dept Plant Pathol, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou, Guangdong, Peoples R China.	ziningcui@scau.edu.cn; YNishida@faculty.chiba-u.jp	Dohi, Hirofumi/S-9149-2017	Dohi, Hirofumi/0000-0001-9087-995X	National Key Project for Basic Research [2015CB150605]; National Natural Science Foundation of China [21102173]; State Key Laboratory for Biology of Plant Diseases and Insect Pests [SKLOF201411]; Specialty and Innovation Projects of Guangdong Province University; President Science Foundation of South China Agricultural University [4200-K13014]; Japan Society for the Promotion of Science (JSPS) [P10100]; Advanced Multi-Career Training Program for Postdoctoral Scholars from JST; VBL project from Chiba University	National Key Project for Basic Research(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Biology of Plant Diseases and Insect Pests; Specialty and Innovation Projects of Guangdong Province University; President Science Foundation of South China Agricultural University; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Advanced Multi-Career Training Program for Postdoctoral Scholars from JST; VBL project from Chiba University	Financial support was provided by the National Key Project for Basic Research (2015CB150605), the National Natural Science Foundation of China (21102173), the State Key Laboratory for Biology of Plant Diseases and Insect Pests (SKLOF201411), the Specialty and Innovation Projects of Guangdong Province University, the President Science Foundation of South China Agricultural University (4200-K13014), the Japan Society for the Promotion of Science (JSPS, ID No. P10100), Advanced Multi-Career Training Program for Postdoctoral Scholars from JST, and the VBL project funding from Chiba University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz A, 2007, J EXP BOT, V58, P1463, DOI 10.1093/jxb/erm008; Bautista-Banos S, 2006, CROP PROT, V25, P108, DOI 10.1016/j.cropro.2005.03.010; Beckers GJM, 2006, PLANT BIOLOGY, V8, P1, DOI 10.1055/s-2005-872705; Bovie Catherine, 2004, BMC Plant Biology, V4, P15, DOI 10.1186/1471-2229-4-15; Cui ZN, 2008, ACTA CHIM SINICA, V66, P1417; Cui ZN, 2007, CHINESE J ORG CHEM, V27, P1300; Cui ZN, 2012, J AGR FOOD CHEM, V60, P11649, DOI 10.1021/jf303807a; Cui ZN, 2012, CHEM BIOL DRUG DES, V79, P121, DOI 10.1111/j.1747-0285.2011.01266.x; Cui ZN, 2011, BIOORG MED CHEM LETT, V21, P7193, DOI 10.1016/j.bmcl.2011.09.068; Cui ZN, 2010, EUR J MED CHEM, V45, P5576, DOI 10.1016/j.ejmech.2010.09.007; Cui ZN, 2010, CHINESE J CHEM, V28, P1257, DOI 10.1002/cjoc.201090218; Cui ZN, 2010, MOLECULES, V15, P4267, DOI 10.3390/molecules15064267; Cui ZN, CHIN J CHEM, V26, P916; Du QS, 2012, J AGR FOOD CHEM, V60, P346, DOI 10.1021/jf203974p; Fan ZJ, 2009, J AGR FOOD CHEM, V57, P4279, DOI 10.1021/jf8031364; Fan ZI, 2010, J AGR FOOD CHEM, V58, P2630, DOI 10.1021/jf9029628; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Ferreira RB, 2007, MOL PLANT PATHOL, V8, P677, DOI 10.1111/J.1364-3703.2007.00419.X; Franco G, 2003, J AGR FOOD CHEM, V51, P4487; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Gorlach J, 1996, PLANT CELL, V8, P629, DOI 10.1105/tpc.8.4.629; Jamois F, 2005, GLYCOBIOLOGY, V15, P393, DOI 10.1093/glycob/cwi020; Kano A, 2010, PHYTOPATHOLOGY, V100, P85, DOI 10.1094/PHYTO-100-1-0085; Klarzynski O, 2000, PLANT PHYSIOL, V124, P1027, DOI 10.1104/pp.124.3.1027; Kombrink A, 2011, MICROBES INFECT, V13, P1168, DOI 10.1016/j.micinf.2011.07.010; Li XC, 2010, CHINESE J CHEM, V28, P1233, DOI 10.1002/cjoc.201090214; Li XH, 2013, LETT DRUG DES DISCOV, V10, P353, DOI 10.2174/1570180811310040009; Li XH, 2010, J AGR FOOD CHEM, V58, P11384, DOI 10.1021/jf102348x; Li XH, 2013, INT J MOL SCI, V14, P22544, DOI 10.3390/ijms141122544; Li Y, 2009, CARBOHYD POLYM, V75, P612, DOI 10.1016/j.carbpol.2008.09.005; Liu HM, 2008, J AGR FOOD CHEM, V56, P5634, DOI 10.1021/jf800326r; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Nita-Lazar M, 2004, ACTA BIOCHIM POL, V51, P625; SHARP JK, 1984, J BIOL CHEM, V259, P1321; SHARP JK, 1984, J BIOL CHEM, V259, P1312; Shinya T, 2006, FEBS J, V273, P2421, DOI 10.1111/j.1742-4658.2006.05249.x; Tamm L, 2011, NJAS-WAGEN J LIFE SC, V58, P131, DOI 10.1016/j.njas.2011.01.001; Terry LA, 2004, POSTHARVEST BIOL TEC, V32, P1, DOI 10.1016/j.postharvbio.2003.09.016; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang BL, 2010, J AGR FOOD CHEM, V58, P5515, DOI 10.1021/jf100300a; Wang JJ, 2011, J AGR FOOD CHEM, V59, P12527, DOI 10.1021/jf203775q; Xu YF, 2006, J AGR FOOD CHEM, V54, P8793, DOI 10.1021/jf0618574; Yamaguchi T, 2000, TRENDS GLYCOSCI GLYC, V12, P113, DOI 10.4052/tigg.12.113; [杨新玲 Yang Xinling], 2002, [合成化学, Chinese Journal of Synthetic Chemistry], V10, P510; Yang XL, 1998, PESTIC SCI, V52, P282, DOI 10.1002/(SICI)1096-9063(199803)52:3&lt;282::AID-PS723&gt;3.0.CO;2-J; Yin H, 2010, CARBOHYD POLYM, V82, P1, DOI 10.1016/j.carbpol.2010.03.066; Zhang L, 2010, SCI CHINA CHEM, V53, P1322, DOI 10.1007/s11426-010-3185-y; Zuo X, 2010, J AGR FOOD CHEM, V58, P2755, DOI 10.1021/jf902863z	48	11	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108338	10.1371/journal.pone.0108338	http://dx.doi.org/10.1371/journal.pone.0108338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259805	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600065
J	Goldenberg, DM; Rooney, RJ; Loo, M; Liu, D; Chang, CH				Goldenberg, David M.; Rooney, Robert J.; Loo, Meiyu; Liu, Donglin; Chang, Chien-Hsing			In-Vivo Fusion of Human Cancer and Hamster Stromal Cells Permanently Transduces and Transcribes Human DNA	PLOS ONE			English	Article							HUMAN TUMOR XENOGRAFTS; FREE NUCLEIC-ACIDS; HOST-CELLS; HORIZONTAL TRANSMISSION; BREAST-CANCER; NUDE-MICE; MALIGNANT-TRANSFORMATION; EXPRESSION; MURINE; INDUCTION	After demonstrating, with karyotyping, polymerase chain reaction (PCR) and fluorescence in-situ hybridization, the retention of certain human chromosomes and genes following the spontaneous fusion of human tumor and hamster cells in-vivo, it was postulated that cell fusion causes the horizontal transmission of malignancy and donor genes. Here, we analyzed gene expression profiles of 3 different hybrid tumors first generated in the hamster cheek pouch after human tumor grafting, and then propagated in hamsters and in cell cultures for years: two Hodgkin lymphomas (GW-532, GW-584) and a glioblastoma multiforme (GB-749). Based on the criteria of MAS 5.0 detection P-values <= 0.065 and at least a 2-fold greater signal expression value than a hamster melanoma control, we identified 3,759 probe sets (ranging from 1,040 to 1,303 in each transplant) from formalin-fixed, paraffin-embedded sections of the 3 hybrid tumors, which unambiguously mapped to 3,107 unique Entrez Gene IDs, representative of all human chromosomes; however, by karyology, one of the hybrid tumors (GB-749) had a total of 15 human chromosomes in its cells. Among the genes mapped, 39 probe sets, representing 33 unique Entrez Gene IDs, complied with the detection criteria in all hybrid tumor samples. Five of these 33 genes encode transcription factors that are known to regulate cell growth and differentiation; five encode cell adhesion- and transmigration-associated proteins that participate in oncogenesis and/or metastasis and invasion; and additional genes encode proteins involved in signaling pathways, regulation of apoptosis, DNA repair, and multidrug resistance. These findings were corroborated by PCR and reverse transcription PCR, showing the presence of human alphoid (alpha)-satellite DNA and the F11R transcripts in additional tumor transplant generations. We posit that in-vivo fusion discloses genes implicated in tumor progression, and gene families coding for the organoid phenotype. Thus, cancer cells can transduce adjacent stromal cells, with the resulting progeny having permanently transcribed genes with malignant and other gene functions of the donor DNA. Using heterospecific in-vivo cell fusion, genes encoding oncogenic and organogenic traits may be identified.	[Goldenberg, David M.] Garden State Canc Ctr, Ctr Mol Med & Immunol, Morris Plains, NJ 07950 USA; [Goldenberg, David M.; Loo, Meiyu; Liu, Donglin; Chang, Chien-Hsing] Immunomedics Inc, Morris Plains, NJ USA; [Rooney, Robert J.] Genome Explorat Inc, Memphis, TN USA	Immunomedics Inc	Goldenberg, DM (corresponding author), Garden State Canc Ctr, Ctr Mol Med & Immunol, Morris Plains, NJ 07950 USA.	dmg.gscancer@att.net			American Cancer Society [IN-581]; USPHS grants from the National Institutes of Health [CA11327, CA12374]; Damon Runyon Memorial Fund for Cancer Research	American Cancer Society(American Cancer Society); USPHS grants from the National Institutes of Health; Damon Runyon Memorial Fund for Cancer Research	The initial transplantation and characterization studies were supported in part by American Cancer Society Grant IN-581, USPHS grants CA11327 and CA12374 from the National Institutes of Health, and the Damon Runyon Memorial Fund for Cancer Research (to DMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TL, 2007, J PATHOL, V211, P10, DOI 10.1002/path.2078; BEATTIE GM, 1982, P NATL ACAD SCI-BIOL, V79, P3033, DOI 10.1073/pnas.79.9.3033; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Berndt B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063711; Berndt Benjamin, 2013, Critical Reviews in Oncogenesis, V18, P97; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; BOWEN JM, 1983, IN VITRO CELL DEV B, V19, P635, DOI 10.1007/BF02619577; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Caretti V, 2014, ACTA NEUROPATHOL, V127, P897, DOI 10.1007/s00401-014-1272-4; Cattley RC, 2003, MICROSC RES TECHNIQ, V61, P179, DOI 10.1002/jemt.10327; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chakraborty AK, 2001, CELL GROWTH DIFFER, V12, P623; Chakraborty AK, 2001, GENE, V275, P103, DOI 10.1016/S0378-1119(01)00647-3; Chakraborty AK, 2000, CANCER RES, V60, P2512; Cives Mauro, 2013, Critical Reviews in Oncogenesis, V18, P75; Clawson GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041052; Davies PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006530; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Dittmar T, 2011, CELL FUSION HLTH DIS, P950; Duelli D, 2007, NAT REV CANCER, V7, P968, DOI 10.1038/nrc2272; DUNHAM I, 1992, HUM GENET, V88, P457, DOI 10.1007/BF00215682; Ehrlich P, 1905, BERLINER KLIN WOCHEN, V42, P871; FIDLER IJ, 1986, CANCER METAST REV, V5, P29, DOI 10.1007/BF00049529; FISHER ER, 1970, CANCER-AM CANCER SOC, V25, P1286, DOI 10.1002/1097-0142(197006)25:6<1286::AID-CNCR2820250606>3.0.CO;2-U; Friedl P, 2005, LANCET ONCOL, V6, P916, DOI 10.1016/S1470-2045(05)70439-3; Garcia-Olmo Dolores C., 2013, Critical Reviews in Oncogenesis, V18, P153; Garcia-Olmo DC, 2010, CANCER RES, V70, P560, DOI 10.1158/0008-5472.CAN-09-3513; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GIOVANELLA BC, 1978, CANCER, V42, P2269, DOI 10.1002/1097-0142(197811)42:5<2269::AID-CNCR2820420527>3.0.CO;2-F; Gogvadze E, 2009, CELL MOL LIFE SCI, V66, P3727, DOI 10.1007/s00018-009-0107-2; GOLDENBE.DM, 1971, EXP MOL PATHOL, V14, P134, DOI 10.1016/0014-4800(71)90059-1; GOLDENBERG D M, 1968, European Journal of Cancer, V4, P547, DOI 10.1016/0014-2964(68)90011-X; Goldenberg DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055324; Goldenberg DM, 2012, EXPERT OPIN BIOL TH, V12, pS133, DOI 10.1517/14712598.2012.671807; Goldenberg DM, 2012, INT J CANCER, V131, P49, DOI 10.1002/ijc.26327; GOLDENBERG DAVID M., 1967, EUR J CANCER, V3, P315, DOI 10.1016/0014-2964(67)90013-8; GOLDENBERG DM, 1981, NEW ENGL J MED, V305, P283; GOLDENBERG DM, 1968, KLIN WOCHENSCHR, V46, P898, DOI 10.1007/BF01746251; GOLDENBERG DM, 1974, NATURE, V250, P649, DOI 10.1038/250649a0; GOLDENBERG DM, 1971, CANCER RES, V31, P1148; GOLDENBERG DM, 1975, INT J CANCER, V15, P282, DOI 10.1002/ijc.2910150214; GOLDENBERG DM, 1981, SCIENCE, V212, P65, DOI 10.1126/science.7209521; GOLDENBERG DM, 1982, P NATL ACAD SCI-BIOL, V79, P2389, DOI 10.1073/pnas.79.7.2389; Goldenberg DM, 1979, P AM ASS CANC RES 70; GOTZ H, 1968, EXPERIENTIA, V24, P957, DOI 10.1007/BF02138681; GUPTA V, 1987, CANCER RES, V47, P5194; Harkness Ty, 2013, Critical Reviews in Oncogenesis, V18, P19; Heckman CA, 2006, ONCOGENE, V25, P888, DOI 10.1038/sj.onc.1209127; Holmgren L, 2002, VOX SANG S1, pS305; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; HUEBNER RJ, 1979, P NATL ACAD SCI USA, V76, P1793, DOI 10.1073/pnas.76.4.1793; Humbert PO, 1997, J IMMUNOL, V159, P5273; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Jacobsen BM, 2006, CANCER RES, V66, P8274, DOI 10.1158/0008-5472.CAN-06-1456; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kawamoto T, 2003, INT J ONCOL, V22, P815; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Konkel MK, 2010, SEMIN CANCER BIOL, V20, P211, DOI 10.1016/j.semcancer.2010.03.001; Konopka G, 2007, J BIOL CHEM, V282, P28137, DOI 10.1074/jbc.M703592200; KRONTIRIS TG, 1981, P NATL ACAD SCI-BIOL, V78, P1181, DOI 10.1073/pnas.78.2.1181; LAMPERT F, 1968, Archiv fuer Geschwulstforschung, V32, P309; Larsson LI, 2008, HISTOCHEM CELL BIOL, V129, P551, DOI 10.1007/s00418-008-0411-1; Lazova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066731; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Lu X, 2009, CANCER RES, V69, P8536, DOI 10.1158/0008-5472.CAN-09-2159; Lu X, 2009, P NATL ACAD SCI USA, V106, P9385, DOI 10.1073/pnas.0900108106; Marafioti T, 2000, BLOOD, V95, P1443, DOI 10.1182/blood.V95.4.1443.004k55_1443_1450; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Moinfar F, 2000, CANCER RES, V60, P2562; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; MUKHOPADHYAY KD, 2011, PLOS ONE, V0006; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Ozen M, 1997, ONCOL RES, V9, P433; Palermo A, 2009, FASEB J, V23, P1431, DOI 10.1096/fj.08-122903; Parris George E., 2013, Critical Reviews in Oncogenesis, V18, P1; Pathak S, 1997, BRIT J CANCER, V76, P1134, DOI 10.1038/bjc.1997.524; Pathak S, 1998, CANCER, V83, P1891, DOI 10.1002/(SICI)1097-0142(19981101)83:9<1891::AID-CNCR3>3.0.CO;2-U; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Pelham RJ, 2006, P NATL ACAD SCI USA, V103, P19848, DOI 10.1073/pnas.0609635104; PERKINS AC, 1993, EMBO J, V12, P3835, DOI 10.1002/j.1460-2075.1993.tb06062.x; POPESCU NC, 1970, EUR J CANCER, V6, P175, DOI 10.1016/0014-2964(70)90019-8; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Ramakrishnan M, 2013, CANCER RES, V73, P5360, DOI 10.1158/0008-5472.CAN-13-0896; Rappa G, 2012, AM J PATHOL, V180, P2504, DOI 10.1016/j.ajpath.2012.02.020; Redecke V, 2013, NAT METHODS, V10, P795, DOI [10.1038/nmeth.2510, 10.1038/NMETH.2510]; Roberts RA, 2002, TOXICOLOGY, V181, P167, DOI 10.1016/S0300-483X(02)00275-5; Robinson KM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003877; Rubio-Viqueira B, 2009, CLIN PHARMACOL THER, V85, P217, DOI 10.1038/clpt.2008.200; RUSSELL PJ, 1990, INT J CANCER, V46, P299, DOI 10.1002/ijc.2910460227; Salmanidis M, 2013, CELL DEATH DIFFER, V20, P1370, DOI 10.1038/cdd.2013.92; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Singec I, 2008, NAT CELL BIOL, V10, P503, DOI 10.1038/ncb0508-503; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; SPARROW S, 1986, BRIT J CANCER, V53, P793, DOI 10.1038/bjc.1986.134; STAAB HJ, 1983, J CANCER RES CLIN, V106, P27, DOI 10.1007/BF00399894; Stoecklin NH, 2012, INT J CANCER, V126, P589; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Trejo-Becerril C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052754; Vider BZ, 1997, BIOCHEM BIOPH RES CO, V232, P742, DOI 10.1006/bbrc.1997.6364; Vignery A, 2005, TRENDS CELL BIOL, V15, P188, DOI 10.1016/j.tcb.2005.02.008; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Xu MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087893; Youssef J, 2011, BRIT J PHARMACOL, V164, P68, DOI 10.1111/j.1476-5381.2011.01383.x; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	113	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107927	10.1371/journal.pone.0107927	http://dx.doi.org/10.1371/journal.pone.0107927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259521	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600037
J	Krasowska, E; Zablocki, K; Gorecki, DC; Swinny, JD				Krasowska, Elzbieta; Zablocki, Krzysztof; Gorecki, Dariusz C.; Swinny, Jerome D.			Aberrant Location of Inhibitory Synaptic Marker Proteins in the Hippocampus of Dystrophin-Deficient Mice: Implications for Cognitive Impairment in Duchenne Muscular Dystrophy	PLOS ONE			English	Article							GABA(A) RECEPTOR SUBUNITS; AXON INITIAL SEGMENT; CA1 PYRAMIDAL CELLS; RAT HIPPOCAMPUS; GABAERGIC NEURONS; MDX MICE; IMMUNOCYTOCHEMICAL DISTRIBUTION; DIFFERENTIAL EXPRESSION; NETWORK OSCILLATIONS; GLYCOPROTEIN COMPLEX	Duchenne muscular dystrophy (DMD) is a neuromuscular disease that arises from mutations in the dystrophin-encoding gene. Apart from muscle pathology, cognitive impairment, primarily of developmental origin, is also a significant component of the disorder. Convergent lines of evidence point to an important role for dystrophin in regulating the molecular machinery of central synapses. The clustering of neurotransmitter receptors at inhibitory synapses, thus impacting on synaptic transmission, is of particular significance. However, less is known about the role of dystrophin in influencing the precise expression patterns of proteins located within the pre- and postsynaptic elements of inhibitory synapses. To this end, we exploited molecular markers of inhibitory synapses, interneurons and dystrophin-deficient mouse models to explore the role of dystrophin in determining the stereotypical patterning of inhibitory connectivity within the cellular networks of the hippocampus CA1 region. In tissue from wild-type (WT) mice, immunoreactivity of neuroligin2 (NL2), an adhesion molecule expressed exclusively in postsynaptic elements of inhibitory synapses, and the vesicular GABA transporter (VGAT), a marker of GABAergic presynaptic elements, were predictably enriched in strata pyramidale and lacunosum moleculare. In acute contrast, NL2 and VGAT immunoreactivity was relatively evenly distributed across all CA1 layers in dystrophin-deficient mice. Similar changes were evident with the cannabinoid receptor 1, vesicular glutamate transporter 3, parvalbumin, somatostatin and the GABAA receptor alpha1 subunit. The data show that in the absence of dystrophin, there is a rearrangement of the molecular machinery, which underlies the precise spatio-temporal pattern of GABAergic synaptic transmission within the CA1 sub-field of the hippocampus.	[Krasowska, Elzbieta; Zablocki, Krzysztof] Nencki Inst Expt Biol, Cellular Metab Lab, Warsaw, Poland; [Krasowska, Elzbieta; Gorecki, Dariusz C.; Swinny, Jerome D.] Univ Portsmouth, Inst Biomed & Biomol Sci, Sch Pharm & Biomed Sci, Portsmouth, Hants, England	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Portsmouth	Swinny, JD (corresponding author), Univ Portsmouth, Inst Biomed & Biomol Sci, Sch Pharm & Biomed Sci, Portsmouth, Hants, England.	jerome.swinny@port.ac.uk	; Zablocki, Krzysztof/R-4181-2016	Swinny, Jerome/0000-0002-8194-5481; Zablocki, Krzysztof/0000-0002-9987-1257; Gorecki, Dariusz/0000-0003-3584-1654	Foundation for Polish Science [MPD/2009/4]; European Union Regional Development Fund [MPD4-109]; Interreg IV (TC2N) grant	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union Regional Development Fund(European Commission); Interreg IV (TC2N) grant	This work was supported by the 'International PhD Studies in Neurobiology' project (MPD/2009/4) from the Foundation for Polish Science (EK), co-financed from the European Union Regional Development Fund (grant nr MPD4-109) (KZ and DCG) and the Interreg IV (TC2N) grant to DCG and JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrazzak H, 2001, MOL CELL NEUROSCI, V17, P500, DOI 10.1006/mcne.2000.0950; Anderson JL, 2003, BRAIN RES, V982, P280, DOI 10.1016/S0006-8993(03)03018-X; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; BENKE D, 1994, J BIOL CHEM, V269, P27100; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Corteen NL, 2011, EUR J NEUROSCI, V34, P250, DOI 10.1111/j.1460-9568.2011.07740.x; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Del Tongo C, 2009, ACTA NEUROPATHOL, V118, P803, DOI 10.1007/s00401-009-0567-3; DELECEA L, 1995, MOL BRAIN RES, V32, P1, DOI 10.1016/0169-328X(95)00056-X; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Duchenne G B, 1968, Arch Neurol, V19, P629; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fukudome Y, 2004, EUR J NEUROSCI, V19, P2682, DOI 10.1111/j.0953-816X.2004.03384.x; GORECKI DC, 1995, NEUROREPORT, V6, P893, DOI 10.1097/00001756-199504190-00017; Gorecki DC, 1997, EUR J NEUROSCI, V9, P965, DOI 10.1111/j.1460-9568.1997.tb01447.x; GORECKI DC, 1992, HUM MOL GENET, V1, P505, DOI 10.1093/hmg/1.7.505; Graciotti L, 2008, NEUROMUSCULAR DISORD, V18, P220, DOI 10.1016/j.nmd.2007.11.009; Gronborg M, 2010, J NEUROSCI, V30, P2, DOI 10.1523/JNEUROSCI.4074-09.2010; Gulyas AI, 2003, EUR J NEUROSCI, V17, P1861, DOI 10.1046/j.1460-9568.2003.02630.x; HOUZELSTEIN D, 1992, J CELL BIOL, V119, P811, DOI 10.1083/jcb.119.4.811; Hughes DI, 2000, J NEUROSCI METH, V101, P107, DOI 10.1016/S0165-0270(00)00254-5; Iwakura A, 2012, J NEUROSCI, V32, P9438, DOI 10.1523/JNEUROSCI.1651-12.2012; Kasugai Y, 2010, EUR J NEUROSCI, V32, P1868, DOI 10.1111/j.1460-9568.2010.07473.x; Katona I, 1999, J NEUROSCI, V19, P4544; KATSUMARU H, 1988, EXP BRAIN RES, V72, P347; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Knuesel I, 1999, EUR J NEUROSCI, V11, P4457, DOI 10.1046/j.1460-9568.1999.00887.x; Knuesel I, 2000, J COMP NEUROL, V422, P594, DOI 10.1002/1096-9861(20000710)422:4<594::AID-CNE8>3.0.CO;2-Q; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Lapray D, 2012, NAT NEUROSCI, V15, P1265, DOI 10.1038/nn.3176; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Mento G, 2011, CLIN NEUROPSYCHOL, V25, P1359, DOI 10.1080/13854046.2011.617782; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Miranda R, 2009, CEREB CORTEX, V19, P876, DOI 10.1093/cercor/bhn135; Misonou H, 2006, J NEUROSCI, V26, P13505, DOI 10.1523/JNEUROSCI.3970-06.2006; Missler M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005694; Morozov YM, 2003, NEUROSCIENCE, V120, P923, DOI 10.1016/S0306-4522(03)00409-3; Moukhles H, 2001, J NEUROCHEM, V78, P824, DOI 10.1046/j.1471-4159.2001.00466.x; NICHOLSON LVB, 1993, J MED GENET, V30, P737, DOI 10.1136/jmg.30.9.737; NITSCH R, 1990, NEUROSCI LETT, V118, P147, DOI 10.1016/0304-3940(90)90613-E; NUNZI MG, 1985, J COMP NEUROL, V237, P485, DOI 10.1002/cne.902370406; O'Keefe J., 1978, HIPPOCAMPUS COGNITIV, Vxiv; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Pilgram GSK, 2010, MOL NEUROBIOL, V41, P1, DOI 10.1007/s12035-009-8089-5; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Schwaller B, 1999, AM J PHYSIOL-CELL PH, V276, pC395, DOI 10.1152/ajpcell.1999.276.2.C395; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Takacs VT, 2014, BRAIN STRUCT FUNCT; Thomson AM, 2002, J NEUROCYTOL, V31, P239, DOI 10.1023/A:1024117908539; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; Vaillend C, 2002, HIPPOCAMPUS, V12, P713, DOI 10.1002/hipo.10068; Vaillend C, 1999, SYNAPSE, V33, P59, DOI 10.1002/(SICI)1098-2396(199907)33:1<59::AID-SYN6>3.0.CO;2-K; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Waite A, 2009, ANN MED, V41, P344, DOI 10.1080/07853890802668522; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Watts J, 2005, J PHYSIOL-LONDON, V562, P89, DOI 10.1113/jphysiol.2004.076984; Wertz K, 1998, DEV DYNAM, V212, P229, DOI 10.1002/(SICI)1097-0177(199806)212:2<229::AID-AJA7>3.0.CO;2-J	68	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108364	10.1371/journal.pone.0108364	http://dx.doi.org/10.1371/journal.pone.0108364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25260053	Green Submitted, Green Published, gold			2022-12-27	WOS:000342685600068
J	Aabakke, AJM; Krebs, L; Ladelund, S; Secher, NJ				Aabakke, Anna J. M.; Krebs, Lone; Ladelund, Steen; Secher, Niels J.			Incidence of Incisional Hernia after Cesarean Delivery: A Register-Based Cohort Study	PLOS ONE			English	Article							MIDLINE LAPAROTOMY; GLOBAL SURVEY; LOW-RISK; MORBIDITY; MORTALITY; OUTCOMES; CLOSURE; HEALTH; TRIAL	Objective: To estimate the incidence of incisional hernias requiring surgical repair after cesarean delivery over a 10-year period. Methods: This population-and register-based cohort study identified all women in Denmark with no history of previous abdominal surgery who had a cesarean delivery between 1991 and 2000. The cohort was followed from their first until 10 years after their last cesarean delivery within the inclusion period or until the first of the following events: hernia repair, death, emigration, abdominal surgery, or cesarean delivery after the inclusion period. For women who had a hernia repair, hospital records regarding the surgery and previous cesarean deliveries were tracked and manually analyzed to validate the relationship between hernia repair and cesarean delivery. Data were analyzed with a competing risk analysis that included each cesarean delivery. Results: We identified 57,564 women who had had 68,271 cesarean deliveries during the inclusion period. During follow-up, 134 of these women had a hernia requiring repair. Of these 68 (51% [95% CI 42-60%]) were in a midline incision although the transverse incision was the primary approach at cesarean delivery during the inclusion period. The cumulated incidence of a hernia repair within 10 years after a cesarean delivery was 0.197% (95% CI 0.164-0.234%). The risk of a hernia repair was higher during the first 3 years after a cesarean delivery, with an incidence after 3 years of 0.157% (95% CI 0.127-0.187%). Conclusions: The overall risk of an incisional hernia requiring surgical repair within 10 years after a cesarean delivery was 2 per 1000 deliveries in a population in which the transverse incision was the primary approach at cesarean delivery.	[Aabakke, Anna J. M.; Krebs, Lone] Univ Copenhagen, Holbaek Hosp, Dept Obstet & Gynecol, Holbaek, Denmark; [Ladelund, Steen] Univ Copenhagen, Hvidovre Hosp, Clin Res Ctr, DK-2650 Hvidovre, Denmark; [Secher, Niels J.] Copenhagen Univ Hosp, Juliane Marie Ctr, Res Unit Womens & Childrens Hlth, Copenhagen, Denmark; [Secher, Niels J.] Aarhus Univ Hosp, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark	Holbaek Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University	Aabakke, AJM (corresponding author), Univ Copenhagen, Holbaek Hosp, Dept Obstet & Gynecol, Holbaek, Denmark.	aabakke@gmail.com	Ladelund, Steen/I-7205-2012; Krebs, Lone/AAD-8273-2021	Ladelund, Steen/0000-0001-5695-8419; Krebs, Lone/0000-0001-5433-4776; Aabakke, Anna/0000-0003-4754-506X	Faculty of Health, University of Copenhagen; Region Zealand Health Sciences Research Foundation; Department of Obstetrics and Gynecology, University of Copenhagen, Holbaek Hospital	Faculty of Health, University of Copenhagen; Region Zealand Health Sciences Research Foundation; Department of Obstetrics and Gynecology, University of Copenhagen, Holbaek Hospital	This work was supported by grants from the Faculty of Health, University of Copenhagen (www.sund.ku.dk), The Region Zealand Health Sciences Research Foundation (http://www.regionsjaelland.dk/sundhed/forskning/praktisk%20om%20forskning/sider/den-regionale-forskningsfond.aspx), and Department of Obstetrics and Gynecology, University of Copenhagen, Holbaek Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesunkanmi A R K, 2003, J Obstet Gynaecol, V23, P258, DOI 10.1080/01443610306063; Bay-Nielsen M, 2001, LANCET, V358, P1124, DOI 10.1016/S0140-6736(01)06251-1; Berghella V, 2005, AM J OBSTET GYNECOL, V193, P1607, DOI 10.1016/j.ajog.2005.03.063; BISWAS KK, 1973, OBSTET GYNECOL, V41, P303; Brocklehurst P, 2010, BJOG-INT J OBSTET GY, V117, P1366, DOI 10.1111/j.1471-0528.2010.02686.x; Brown S, 2005, AM POETRY REV, V34, P4; CORONIS Collaborative Grp, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-215; D'Alton ME, 2006, OBSTET GYNECOL, V107, P1386; EURO-PERISTAT, 2012, HLTH CAR PREGN WOM B; Grantcharov TP, 2001, EUR J SURG, V167, P260; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Helgstrand F, 2011, SURG ENDOSC, V25, P3678, DOI 10.1007/s00464-011-1776-0; Hoer J, 2002, CHIRURG, V73, P474, DOI 10.1007/s00104-002-0425-5; Israelsson LA, 1996, EUR J SURG, V162, P125; Jargon D, 2008, ZBL CHIR, V133, P453, DOI 10.1055/s-2008-1076961; KNUDSEN LB, 1986, COMMUNITY MED, V8, P29; Li Z, 2013, PERINATAL STAT SERIE, V28; Liu SL, 2007, CAN MED ASSOC J, V176, P455, DOI 10.1503/cmaj.060870; Luijendijk RW, 1997, ANN SURG, V225, P365, DOI 10.1097/00000658-199704000-00004; Lykke JA, 2012, ACTA OBSTET GYN SCAN, V91, P1053, DOI 10.1111/j.1600-0412.2012.01479.x; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Maaloe N, 2014, INT J GYNECOL OBSTET, V125, P1, DOI 10.1016/j.ijgo.2013.09.030; Martin JA, 2013, BIRTHS FINAL DATA 20; MUDGE M, 1985, BRIT J SURG, V72, P70, DOI 10.1002/bjs.1800720127; Nordic Medico-Statistical Committee, 2010, NOMESCO CLASS SURG P; Ottesen Marianne, 2009, Ugeskr Laeger, V171, P404; Schneider K. T. M., 2002, Gynaekologisch-Geburtshilfliche Rundschau, V42, P12, DOI 10.1159/000057932; Seiler CM, 2009, ANN SURG, V249, P576, DOI 10.1097/SLA.0b013e31819ec6c8; Silver RM, 2012, SEMIN PERINATOL, V36, P315, DOI 10.1053/j.semperi.2012.04.013; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; Thisted DLA, 2014, EUR J OBSTET GYN R B, V173, P23, DOI 10.1016/j.ejogrb.2013.10.033; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Veljkovic R, 2010, J AM COLL SURGEONS, V210, P210, DOI 10.1016/j.jamcollsurg.2009.10.013; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; WISSING J, 1987, BRIT J SURG, V74, P738, DOI 10.1002/bjs.1800740831	36	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108829	10.1371/journal.pone.0108829	http://dx.doi.org/10.1371/journal.pone.0108829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268746	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700173
J	Gil-Diaz, T; Haroun, R; Tuya, F; Betancor, S; Viera-Rodriguez, MA				Gil-Diaz, Teba; Haroun, Ricardo; Tuya, Fernando; Betancor, Sefora; Viera-Rodriguez, Maria A.			Effects of Ocean Acidification on the Brown Alga Padina pavonica: Decalcification Due to Acute and Chronic Events	PLOS ONE			English	Article							CLIMATE-CHANGE; CARBON-DIOXIDE; MACROALGAL ASSEMBLAGES; ECOLOGICAL STATUS; PHAEOPHYCEAE; PATTERNS; CORAL; COMMUNITIES; TEMPERATURE; ORGANISMS	Since the industrial revolution, anthropogenic CO2 emissions have caused ocean acidification, which particularly affects calcified organisms. Given the fan-like calcified fronds of the brown alga Padina pavonica, we evaluated the acute (short-term) effects of a sudden pH drop due to a submarine volcanic eruption (October 2011-early March 2012) affecting offshore waters around El Hierro Island (Canary Islands, Spain). We further studied the chronic (long-term) effects of the continuous decrease in pH in the last decades around the Canarian waters. In both the observational and retrospective studies (using herbarium collections of P. pavonica thalli from the overall Canarian Archipelago), the percent of surface calcium carbonate coverage of P. pavonica thalli were contrasted with oceanographic data collected either in situ (volcanic eruption event) or from the ESTOC marine observatory data series (herbarium study). Results showed that this calcified alga is sensitive to acute and chronic environmental pH changes. In both cases, pH changes predicted surface thallus calcification, including a progressive decalcification over the last three decades. This result concurs with previous studies where calcareous organisms decalcify under more acidic conditions. Hence, Padina pavonica can be implemented as a bio-indicator of ocean acidification (at short and long time scales) for monitoring purposes over wide geographic ranges, as this macroalga is affected and thrives (unlike strict calcifiers) under more acidic conditions.	[Gil-Diaz, Teba; Haroun, Ricardo; Tuya, Fernando; Betancor, Sefora; Viera-Rodriguez, Maria A.] Univ Las Palmas Gran Canaria, Ctr Biodiversidad & Gest Ambiental, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria	Gil-Diaz, T (corresponding author), Univ Las Palmas Gran Canaria, Ctr Biodiversidad & Gest Ambiental, Las Palmas Gran Canaria, Spain.	tebagil90@gmail.com	Haroun, Ricardo/L-7067-2019	Haroun, Ricardo/0000-0003-1348-692X; Gil-Diaz, Teba/0000-0003-2320-2708	Spanish MINECO "Plan Nacional" ANTROTIDAL [CGL 2011-23833]; ECOLIFE [CGL08-05407 C03]; Canary Islands CEI: Tricontinental Atlantic Campus; MINECO "Ramon y Cajal" program; University of Las Palmas de Gran Canaria	Spanish MINECO "Plan Nacional" ANTROTIDAL; ECOLIFE; Canary Islands CEI: Tricontinental Atlantic Campus; MINECO "Ramon y Cajal" program; University of Las Palmas de Gran Canaria	This study was partially funded by the Spanish MINECO "Plan Nacional" ANTROTIDAL (CGL 2011-23833) and ECOLIFE (CGL08-05407 C03). Research by all authors was supported by Canary Islands CEI: Tricontinental Atlantic Campus. Fenando Tuya was supported by the MINECO "Ramon y Cajal" program and Sefora Betancor was supported by Postgraduate Scholarship of the University of Las Palmas de Gran Canaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Isabella A., 2003, Phycological Research, V51, P173, DOI 10.1111/j.1440-1835.2003.tb00185.x; Anderson MJ, 2005, PERMANOVA FORTRAN CO; Arevalo R, 2007, MAR POLLUT BULL, V55, P104, DOI 10.1016/j.marpolbul.2006.08.023; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Bellissimo G, 2014, PLANT BIOSYST, V148, P21, DOI 10.1080/11263504.2013.778350; Betancor S, 2014, J SEA RES, V87, P68, DOI 10.1016/j.seares.2013.09.008; Collado-Vides L, 2007, ESTUAR COAST SHELF S, V73, P680, DOI 10.1016/j.ecss.2007.03.009; Crook ED, 2012, CORAL REEFS, V31, P239, DOI 10.1007/s00338-011-0839-y; Diaz-Pulido G, 2012, J PHYCOL, V48, P32, DOI 10.1111/j.1529-8817.2011.01084.x; Eugenio F, 2014, INT J APPL EARTH OBS, V29, P53, DOI 10.1016/j.jag.2013.12.009; Fabricius KE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2479; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Fraile-Nuez E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00486; Gomez I, 2010, PHOTOCHEM PHOTOBIOL, V86, P1056, DOI 10.1111/j.1751-1097.2010.00786.x; Gonzalez A.R., 2012, GEOL TODAY, P53, DOI DOI 10.1111/j.1365-2451.2012.00827.x; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hiscock K, 2004, AQUAT CONSERV, V14, P333, DOI 10.1002/aqc.628; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Hydes DJ, 2013, 319 ICES; ICES, 2013, 2012ACOM83 ICES CM; Ivesa L, 2009, AQUAT CONSERV, V19, P14, DOI 10.1002/aqc.964; Johnson MD, 2012, J EXP MAR BIOL ECOL, V434, P94, DOI 10.1016/j.jembe.2012.08.005; Johnson VR, 2012, GLOBAL CHANGE BIOL, V18, P2792, DOI 10.1111/j.1365-2486.2012.02716.x; Johnson VR, 2012, STUDY MARINE BENTHIC; Juanes JA, 2008, ECOL INDIC, V8, P351, DOI 10.1016/j.ecolind.2007.04.005; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Lewis E., 1998, PROGRAM DEV CO2 SYST; LITTLER M M, 1976, Micronesica, V12, P27; Martin S, 2008, BIOL LETTERS, V4, P689, DOI 10.1098/rsbl.2008.0412; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; N'Yeurt ADR, 2006, CRYPTOGAMIE ALGOL, V27, P111; OKAZAKI M, 1986, BRIT PHYCOL J, V21, P217, DOI 10.1080/00071618600650251; Olabarria C, 2013, OIKOS, V122, P1065, DOI 10.1111/j.1600-0706.2012.20825.x; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pettit LR, 2013, MAR POLLUT BULL, V73, P452, DOI 10.1016/j.marpolbul.2013.02.011; Porzio L, 2011, J EXP MAR BIOL ECOL, V400, P278, DOI 10.1016/j.jembe.2011.02.011; Price NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043843; Riebesell U, 2008, NATURE, V454, P46, DOI 10.1038/454046a; Riley J, 2003, REV UK SCOTTISH SURV; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Roleda MY, 2012, J PHYCOL, V48, P840, DOI 10.1111/j.1529-8817.2012.01195.x; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Saderne V, 2013, PLOS ONE, V8, P1; Santana-Casiano JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01140; Secretariat of the Convention on Biological Diversity, 2009, SECR CONV BIOL DIV T; Silberfeld T, 2013, J PHYCOL, V49, P130, DOI 10.1111/jpy.12027; Solomon S., 2007, PHYS SCI BASIS WORKI; Tuya F, 2006, MAR ECOL PROG SER, V311, P15, DOI 10.3354/meps311015; Tyler-Walters H, 2003, REPORT ENGLISH NATUR; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; VANALSTYNE KL, 1990, OECOLOGIA, V84, P158, DOI 10.1007/BF00318266; WEFER G, 1980, NATURE, V285, P323, DOI 10.1038/285323a0; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x	56	11	11	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108630	10.1371/journal.pone.0108630	http://dx.doi.org/10.1371/journal.pone.0108630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268231	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700129
J	Winder, L; Alexander, CJ; Woolley, C; Perry, JN; Holland, JM				Winder, Linton; Alexander, Colin J.; Woolley, Chris; Perry, Joe N.; Holland, John M.			Cereal Aphid Colony Turnover and Persistence in Winter Wheat	PLOS ONE			English	Article							DIFFERENT SPATIAL SCALES; SITOBION-AVENAE; LINYPHIID SPIDERS; TEMPORAL DISTRIBUTION; POPULATION-DYNAMICS; COUNT DATA; PREY; PREDATORS; MANAGEMENT; FIELD	An understanding of spatial and temporal processes in agricultural ecosystems provides a basis for rational decision-making with regards to the management and husbandry of crops, supporting the implementation of integrated farming strategies. In this study we investigated the spatial and temporal distribution of aphid pests (Sitobion avenae and Metopolophium dirhodum) within winter wheat fields. Using an intensive sampling programme we investigated distributions at both the small (single shoot) and large (field) scales. Within two fields, a grid with 82 locations was established (area 120 m by 168 m). At each location, 25 shoots were individually marked and aphid counts by observation conducted on 21 and 22 occasions as the crop matured, resulting in 43,050 and 45,100 counts being conducted in the two fields respectively. We quantified field scale spatial distributions, demonstrating that spatial pattern generally emerged, with temporal stability being both species-and field-dependent. We then measured turnover of colonies at the small (individual shoot) and large (field) scales by comparing consecutive pairs of sampling occasions. Four turnover categories were defined: Empty (no aphids recorded on either occasion); Colonised (aphids recorded on the second occasion but not the first); Extinction (aphids recorded on the first occasion but not the second); Stable (aphids recorded on both occasions). At the field scale, population stability soon established, but, at the small scale there was a consistently high proportion of unoccupied shoots with considerable colonisation and extinction and low stability. The redistribution of aphids within the crop at the local scale is a vulnerability which could be used to disrupt population development - by mediating exposure to ground-active natural enemies and by incurring a metabolic cost caused by the physiological demands to re-establish on a nearby host plant.	[Winder, Linton] Unitec Inst Technol, Dept Nat Sci, Auckland, New Zealand; [Alexander, Colin J.] James Hutton Inst, Biomath & Stat Scotland, Perth Kinross, Invergowrie, England; [Woolley, Chris] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, Gauteng, South Africa; [Perry, Joe N.] Rothamsted Res, Plant & Invertebrate Ecol, Harpenden, Herts, England; [Holland, John M.] Game & Wildlife Conservat Trust, Farmland Ecol Unit, Fordingbridge, Hants, England	Unitec NZ; James Hutton Institute; University of Witwatersrand; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Winder, L (corresponding author), Unitec Inst Technol, Dept Nat Sci, Auckland, New Zealand.	lwinder@unitec.ac.nz	Alexander, Colin/C-5802-2009	Alexander, Colin/0000-0003-4995-1678; holland, john/0000-0003-3742-7035	UK's Biotechnology and Biological Sciences Research Council; BBSRC	UK's Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study, which was part of the project 'Measurement and simulation of spatio-temporal dynamics to reduce pesticide inputs' was supported by the UK's Biotechnology and Biological Sciences Research Council (www.BBSRC.AC.UK). Rothamsted Research receives grant-aided support from the BBSRC. Funding was received by LW and JP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CJ, 2005, ANN APPL BIOL, V146, P361, DOI 10.1111/j.1744-7348.2005.040129.x; Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; Aqueel MA, 2011, CROP PROT, V30, P216, DOI 10.1016/j.cropro.2010.09.013; Basky Z, 2007, J SCI FOOD AGR, V87, P2488, DOI 10.1002/jsfa.3009; Bell JR, 2010, ECOGRAPHY, V33, P64, DOI 10.1111/j.1600-0587.2009.06046.x; Bommarco R, 2007, ECOL MODEL, V201, P163, DOI 10.1016/j.ecolmodel.2006.09.012; Chapin JW, 2001, J ECON ENTOMOL, V94, P410, DOI 10.1603/0022-0493-94.2.410; Duffield SJ, 1996, ENTOMOL EXP APPL, V78, P9, DOI 10.1007/BF00304452; Emden H.F.V., 2007, APHIDS CROP PESTS; Fiedler AK, 2008, BIOL CONTROL, V45, P254, DOI 10.1016/j.biocontrol.2007.12.009; Fievet V, 2007, AGR FOREST ENTOMOL, V9, P125, DOI 10.1111/j.1461-9563.2007.00331.x; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Griffiths GJK, 2008, MOL ECOL, V17, P1828, DOI 10.1111/j.1365-294X.2007.03682.x; Harwood JD, 2004, MOL ECOL, V13, P3549, DOI 10.1111/j.1365-294X.2004.02331.x; Harwood JD, 2001, J APPL ECOL, V38, P88, DOI 10.1046/j.1365-2664.2001.00572.x; HUGHES RD, 1963, J ANIM ECOL, V32, P393, DOI 10.2307/2600; Irwin ME, 2007, APHIDS AS CROP PESTS, P153, DOI 10.1079/9780851998190.0153; Kerzicnik LM, 2010, ARTHROPOD-PLANT INTE, V4, P129, DOI 10.1007/s11829-010-9085-4; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; [李丹 Li Dan], 2010, [生态学报, Acta Ecologica Sinica], V30, P4986; MANN JA, 1995, ANN APPL BIOL, V126, P417, DOI 10.1111/j.1744-7348.1995.tb05376.x; Monsrud C, 1999, ANN APPL BIOL, V134, P265, DOI 10.1111/j.1744-7348.1999.tb05263.x; Morrison WR, 2013, J ECON ENTOMOL, V106, P1218, DOI 10.1603/EC13018; Mowes M, 1997, Z PFLANZENK PFLANZEN, V104, P569; Obrycki JJ, 2009, BIOL CONTROL, V51, P244, DOI 10.1016/j.biocontrol.2009.05.009; Oberg S, 2008, AGR ECOSYST ENVIRON, V123, P211, DOI 10.1016/j.agee.2007.06.005; Peixoto MS, 2011, CELLULAR AUTOMATA, V2011, P59; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Perry JN, 2002, ECOSCIENCE, V9, P133, DOI 10.1080/11956860.2002.11682699; Perry JN, 1999, ECOL LETT, V2, P106, DOI 10.1046/j.1461-0248.1999.22057.x; Romero SA, 2010, BIOL CONTROL, V52, P84, DOI 10.1016/j.biocontrol.2009.09.013; Schellhorn NA, 2005, POPUL ECOL, V47, P71, DOI 10.1007/s10144-004-0204-x; Schmidt MH, 2005, J APPL ECOL, V42, P281, DOI 10.1111/j.1365-2664.2005.01014.x; Snyder WE, 2006, ECOL LETT, V9, P789, DOI 10.1111/j.1461-0248.2006.00922.x; SOPP PI, 1987, ANN APPL BIOL, V111, P53, DOI 10.1111/j.1744-7348.1987.tb01432.x; Sunderland K, 2000, ENTOMOL EXP APPL, V95, P1, DOI 10.1023/A:1003986225443; SUNDERLAND KD, 1986, J APPL ECOL, V23, P433, DOI 10.2307/2404027; SUNDERLAND KD, 1986, PEDOBIOLOGIA, V29, P367; VOLKL W, 1994, OECOLOGIA, V100, P177, DOI 10.1007/BF00317144; Way MJ, 1970, P ADV STUDY I DYNAMI, p[7, 232]; Weisser WW, 2005, ANN ZOOL FENN, V42, P363; WEISZ R, 1995, J ECON ENTOMOL, V88, P1069, DOI 10.1093/jee/88.5.1069; Welch KD, 2014, BIOL CONTROL, V75, P18, DOI 10.1016/j.biocontrol.2014.01.004; Winder L, 2005, B ENTOMOL RES, V95, P579, DOI 10.1079/BER2005387; Winder L, 1999, ENTOMOL EXP APPL, V93, P277, DOI 10.1023/A:1003982111689; Winder L, 2001, ECOL LETT, V4, P568, DOI 10.1046/j.1461-0248.2001.00269.x; Winder L, 1990, ECOL ENTOMOL, V101, P569; Winder L, 2013, ARTHROPOD-PLANT INTE, V7, P21, DOI 10.1007/s11829-012-9216-1; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang W, 2010, RESOUR ENERGY ECON, V32, P551, DOI 10.1016/j.reseneeco.2010.04.006	50	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106822	10.1371/journal.pone.0106822	http://dx.doi.org/10.1371/journal.pone.0106822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268240	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700019
J	Sassoli, C; Frati, A; Tani, A; Anderloni, G; Pierucci, F; Matteini, F; Chellini, F; Orlandini, SZ; Formigli, L; Meacci, E				Sassoli, Chiara; Frati, Alessia; Tani, Alessia; Anderloni, Giulia; Pierucci, Federica; Matteini, Francesca; Chellini, Flaminia; Orlandini, Sandra Zecchi; Formigli, Lucia; Meacci, Elisabetta			Mesenchymal Stromal Cell Secreted Sphingosine 1-Phosphate (S1P) Exerts a Stimulatory Effect on Skeletal Myoblast Proliferation	PLOS ONE			English	Article							BONE-MARROW; MUSCLE REGENERATION; STEM-CELLS; MUSCULAR-DYSTROPHY; ENDOTHELIAL-CELLS; MYOGENIC DIFFERENTIATION; C2C12 MYOBLASTS; SATELLITE CELLS; SPHINGOSINE-1-PHOSPHATE; RECEPTOR	Bone-marrow-derived mesenchymal stromal cells (MSCs) have the potential to significantly contribute to skeletal muscle healing through the secretion of paracrine factors that support proliferation and enhance participation of the endogenous muscle stem cells in the process of repair/regeneration. However, MSC-derived trophic molecules have been poorly characterized. The aim of this study was to investigate paracrine signaling effects of MSCs on skeletal myoblasts. It was found, using a biochemical and morphological approach that sphingosine 1-phosphate (S1P), a natural bioactive lipid exerting a broad range of muscle cell responses, is secreted by MSCs and represents an important factor by which these cells exert their stimulatory effects on C2C12 myoblast and satellite cell proliferation. Indeed, exposure to conditioned medium obtained from MSCs cultured in the presence of the selective sphingosine kinase inhibitor (iSK), blocked increased cell proliferation caused by the conditioned medium from untreated MSCs, and the addition of exogenous S1P in the conditioned medium from MSCs pre-treated with iSK further increased myoblast proliferation. Finally, we also demonstrated that the myoblast response to MSC-secreted vascular endothelial growth factor (VEGF) involves the release of S1P from C2C12 cells. Our data may have important implications in the optimization of cell-based strategies to promote skeletal muscle regeneration.	[Sassoli, Chiara; Tani, Alessia; Chellini, Flaminia; Orlandini, Sandra Zecchi; Formigli, Lucia] Univ Florence, Dept Expt & Clin Med, Sect Anat & Histol, Florence, Italy; [Frati, Alessia; Anderloni, Giulia; Pierucci, Federica; Matteini, Francesca; Meacci, Elisabetta] Univ Florence, Unit Biochem Sci & Mol Biol, Dept Biomed Expt & Clin Sci Mario Serio, Florence, Italy	University of Florence; University of Florence	Meacci, E (corresponding author), Univ Florence, Unit Biochem Sci & Mol Biol, Dept Biomed Expt & Clin Sci Mario Serio, Florence, Italy.	elisabetta.meacci@unifi.it	SASSOLI, CHIARA/AAC-4023-2019	SASSOLI, CHIARA/0000-0002-1337-0938; MATTEINI, FRANCESCA/0000-0002-4347-1414	MIUR (Ministero dell'Istruzione dell'Universita e della Ricerca)-Italy; Ente Cassa di Risparmio di Firenze; Fondazione Cassa di Risparmio di Pistoia e Pescia	MIUR (Ministero dell'Istruzione dell'Universita e della Ricerca)-Italy(Ministry of Education, Universities and Research (MIUR)); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Fondazione Cassa di Risparmio di Pistoia e Pescia	This study was supported by research funding from MIUR (Ministero dell'Istruzione dell'Universita e della Ricerca)-Italy to E.M., L.F., C.S., S.Z.-O. and the Ente Cassa di Risparmio di Firenze to E.M. and Fondazione Cassa di Risparmio di Pistoia e Pescia to E.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2014, TISSUE EN B IN PRESS; Balthasar S, 2008, ENDOCR-RELAT CANCER, V15, P521, DOI 10.1677/ERC-07-0253; Bassi R, 2006, GLIA, V53, P621, DOI 10.1002/glia.20324; Bencini C, 2003, J MUSCLE RES CELL M, V24, P539, DOI 10.1023/B:JURE.0000009898.02325.58; Bergelin N, 2010, ENDOCRINOLOGY, V151, P2994, DOI [10.1210/en.2009-1387, 10.1210//en.2009-1387]; Bini F, 2012, NEUROPHARMACOLOGY, V63, P524, DOI 10.1016/j.neuropharm.2012.04.026; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; Brooks NE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00099; Carosio S, 2011, AGEING RES REV, V10, P35, DOI 10.1016/j.arr.2009.08.001; Danieli-Betto D, 2005, AM J PHYSIOL-CELL PH, V288, pC1367, DOI 10.1152/ajpcell.00246.2004; Danieli-Betto D, 2010, AM J PHYSIOL-CELL PH, V298, pC550, DOI 10.1152/ajpcell.00072.2009; Das Madhurima, 2013, J Stem Cells, V8, P1; de la Garza-Rodea AS, 2014, FASEB J, V28, P506, DOI 10.1096/fj.13-233155; de la Garza-Rodea AS, 2011, CELL TRANSPLANT, V20, P217, DOI 10.3727/096368910X522117; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Dobson KR, 1999, CALCIFIED TISSUE INT, V65, P411, DOI 10.1007/s002239900723; Donati C, 2004, FASEB J, V18, P449, DOI 10.1096/fj.04-1780fje; Fieber CB, 2006, EXP CELL RES, V312, P1164, DOI 10.1016/j.yexcr.2006.01.022; Formigli L, 2013, J REGEN MED, V2, P1; Formigli L, 2009, J CELL SCI, V122, P1322, DOI 10.1242/jcs.035402; Fortier M, 2013, DEV BIOL, V382, P504, DOI 10.1016/j.ydbio.2013.07.006; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hoffmann J, 2010, THORAC CARDIOV SURG, V58, P136, DOI 10.1055/s-0029-1240758; Huang YC, 2006, AM J PHYSIOL-CELL PH, V291, pC11, DOI 10.1152/ajpcell.00366.2005; Igarashi J, 2003, P NATL ACAD SCI USA, V100, P10664, DOI 10.1073/pnas.1934494100; Kanemaru S, 2013, LARYNGOSCOPE, V123, P2728, DOI 10.1002/lary.24060; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; Lee RH, 2011, J CELL BIOCHEM, V112, P3073, DOI 10.1002/jcb.23250; Li MH, 2011, CANCER PREV RES, V4, P1325, DOI 10.1158/1940-6207.CAPR-11-0017; Li Z, 2011, CYTOTHERAPY, V13, P69, DOI 10.3109/14653249.2010.510502; Loh KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037218; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Meacci E, 2008, J CELL PHYSIOL, V214, P210, DOI 10.1002/jcp.21187; Meacci Elisabetta, 2012, Methods Mol Biol, V874, P155, DOI 10.1007/978-1-61779-800-9_12; Meacci E, 2010, CELL MOL LIFE SCI, V67, P4269, DOI 10.1007/s00018-010-0442-3; Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Natsu K, 2004, TISSUE ENG, V10, P1093, DOI 10.1089/1076327041887754; Nikolova-Karakashian MN, 2011, ANTIOXID REDOX SIGN, V15, P2501, DOI 10.1089/ars.2011.3940; Nitahara-Kasahara Y, 2012, MOL THER, V20, P168, DOI 10.1038/mt.2011.181; O'Sullivan C, 2013, TRENDS PHARMACOL SCI, V34, P401, DOI 10.1016/j.tips.2013.05.002; Pileggi A, 2013, CURR OPIN ORGAN TRAN, V18, P672, DOI 10.1097/MOT.0000000000000029; Pretheeban T, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-20; Price FD, 2007, BBA-MOL BASIS DIS, V1772, P272, DOI 10.1016/j.bbadis.2006.08.011; Riccitelli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068229; Ryu JM, 2014, STEM CELL RES, V12, P69, DOI 10.1016/j.scr.2013.08.013; Sammels LM, 2004, TRANSPLANTATION, V77, P1790, DOI 10.1097/01.tp.0000131150.76841.75; Sassoli C, 2014, EXP CELL RES, V323, P297, DOI 10.1016/j.yexcr.2014.03.003; Sassoli Chiara, 2012, Cells, V1, P832, DOI 10.3390/cells1040832; Sassoli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037512; Sassoli C, 2011, J CELL MOL MED, V15, P2498, DOI 10.1111/j.1582-4934.2010.01250.x; Shabbir A, 2009, TRANSPLANTATION, V87, P1275, DOI 10.1097/TP.0b013e3181a1719b; Shu XD, 2002, MOL CELL BIOL, V22, P7758, DOI 10.1128/MCB.22.22.7758-7768.2002; Squecco R, 2006, MOL BIOL CELL, V17, P4896, DOI 10.1091/mbc.E06-03-0243; Tanimoto T, 2002, J BIOL CHEM, V277, P42997, DOI 10.1074/jbc.M204764200; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; von Roth P, 2012, GENDER MED, V9, P129, DOI 10.1016/j.genm.2012.01.007; Winkler T, 2012, J TISSUE ENG REGEN M, V6, ps60, DOI 10.1002/term.1542; Yatomi Y, 2000, BLOOD, V96, P3431	61	29	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108662	10.1371/journal.pone.0108662	http://dx.doi.org/10.1371/journal.pone.0108662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264785	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400098
J	Kong, ST; Lim, SH; Lee, WB; Kumar, PK; Wang, HYS; Ng, YLS; Wong, PS; Ho, PC				Kong, Sing Teang; Lim, Shih-Hui; Lee, Wee Beng; Kumar, Pasikanthi Kishore; Wang, Hwee Yi Stella; Ng, Yan Lam Shannon; Wong, Pei Shieen; Ho, Paul C.			Clinical Validation and Implications of Dried Blood Spot Sampling of Carbamazepine, Valproic Acid and Phenytoin in Patients with Epilepsy	PLOS ONE			English	Article							ANTIEPILEPTIC DRUGS; LC-MS/MS; THERAPEUTIC STRATEGIES; MASS-SPECTROMETRY; ILAE-COMMISSION; HUMAN PLASMA; WHOLE-BLOOD; RED CELLS; COMBINATION; BINDING	To facilitate therapeutic monitoring of antiepileptic drugs (AEDs) by healthcare professionals for patients with epilepsy (PWE), we applied a GC-MS assay to measure three AEDs: carbamazepine (CBZ), phenytoin (PHT) and valproic acid (VPA) levels concurrently in one dried blood spot (DBS), and validated the DBS-measured levels to their plasma levels. 169 PWE on either mono-or polytherapy of CBZ, PHT or/and VPA were included. One DBS, containing similar to 15 mu L of blood, was acquired for the simultaneous measurement of the drug levels using GC-MS. Simple Deming regressions were performed to correlate the DBS levels with the plasma levels determined by the conventional immunoturbimetric assay in clinical practice. Statistical analyses of the results were done using MedCalc Version 12.6.1.0 and SPSS 21. DBS concentrations (C-dbs) were well-correlated to the plasma concentrations (C-plasma): r = 0.8381, 0.9305 and 0.8531 for CBZ, PHT and VPA respectively, The conversion formulas from C-dbs to plasma concentrations were [0.89xC(dbs)CBZ+1.00]mu g/mL, [1.11xC(dbs)PHT-1.00]mu g/mL and [0.92xC(dbs)VPA+12.48]mu g/mL respectively. Inclusion of the red blood cells (RBC)/plasma partition ratio (K) and the individual hematocrit levels in the estimation of the theoretical C-plasma from C-dbs of PHT and VPA further improved the identity between the observed and the estimated theoretical C-plasma. Bland-Altman plots indicated that the theoretical and observed C-plasma of PHT and VPA agreed well, and >93.0% of concentrations was within 95% CI (+/- 2SD); and similar agreement (1:1) was also found between the observed C-dbs and C-plasma of CBZ. As the C-plasma of CBZ, PHT and VPA can be accurately estimated from their C-dbs, DBS can therefore be used for drug monitoring in PWE on any of these AEDs.	[Kong, Sing Teang; Lee, Wee Beng; Kumar, Pasikanthi Kishore; Ho, Paul C.] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Lim, Shih-Hui; Wang, Hwee Yi Stella; Ng, Yan Lam Shannon; Wong, Pei Shieen] Singapore Gen Hosp, Dept Neurol, Singapore, Singapore; [Lim, Shih-Hui] Natl Neurosci Inst, Dept Neurol, Singapore, Singapore; [Lim, Shih-Hui] Duke Natl Univ Singapore, Grad Sch Med, Dept Neurol, Singapore, Singapore	National University of Singapore; Singapore General Hospital; National Neuroscience Institute (NNI); National University of Singapore	Ho, PC (corresponding author), Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore.	phahocl@nus.edu.sg		LEE, WEE BENG/0000-0002-4354-867X				BONNETON J, 1992, BIOPHARM DRUG DISPOS, V13, P411, DOI 10.1002/bdd.2510130604; Deglon J, 2012, BIOANALYSIS, V4, P1337, DOI [10.4155/bio.12.42, 10.4155/BIO.12.42]; Diem K, 1975, DOCUMENTA GEIGY SCI; DRIESSEN O, 1989, THER DRUG MONIT, V11, P384; DRIESSEN O, 1989, METHOD FIND EXP CLIN, V11, P11; Edelbroek PM, 2009, THER DRUG MONIT, V31, P327, DOI 10.1097/FTD.0b013e31819e91ce; EHRNEBO M, 1975, EUR J CLIN PHARMACOL, V8, P445, DOI 10.1007/BF00562320; Froscher W, 2013, FORTSCHR NEUROL PSYC, V81, P9, DOI 10.1055/s-0031-1299361; GRAVES NM, 1987, EPILEPSIA, V28, P713, DOI 10.1111/j.1528-1157.1987.tb03705.x; HAIDUKEWYCH D, 1986, CLIN CHEM, V32, P204; Han S, 2012, B KOREAN CHEM SOC, V33, P1681, DOI 10.5012/bkcs.2012.33.5.1681; Highley MS, 1996, PHARM RES-DORDR, V13, P186, DOI 10.1023/A:1016074627293; Hilzenbecher C, 1972, THESIS L MAXIMILIAN; Hinderling PH, 1997, PHARMACOL REV, V49, P279; HINDERLING PH, 1984, J PHARM SCI, V73, P1042, DOI 10.1002/jps.2600730807; HOLDER LB, 1965, MOL PHARMACOL, V1, P266; Krouwer J.S., 2010, METHOD COMP BIAS EST; KURATA D, 1974, CLIN PHARMACOL THER, V16, P355; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Li WK, 2010, BIOMED CHROMATOGR, V24, P49, DOI 10.1002/bmc.1367; Lim S, 2012, EPILEPSIA, V53, P194; Linnet K, 1999, CLIN CHEM, V45, P882; Mohammed BS, 2010, BRIT J CLIN PHARMACO, V70, P52, DOI 10.1111/j.1365-2125.2010.03668.x; MONACO F, 1979, EPILEPSIA, V20, P705, DOI 10.1111/j.1528-1157.1979.tb04854.x; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Patsalos PN, 2013, THER DRUG MONIT, V35, P4, DOI 10.1097/FTD.0b013e31827c11e7; PIREDDA S, 1981, THER DRUG MONIT, V3, P321, DOI 10.1097/00007691-198104000-00001; Rani S, 2012, J SEP SCI, V35, P2970, DOI 10.1002/jssc.201200439; SCHANKER LS, 1964, AM J PHYSIOL, V207, P503, DOI 10.1152/ajplegacy.1964.207.2.503; Serralheiro A, 2013, J CHROMATOGR B, V925, P1, DOI 10.1016/j.jchromb.2013.02.026; Shah NM, 2013, EPILEPSIA; Shibata M, 2012, BIOMED CHROMATOGR, V26, P1519, DOI 10.1002/bmc.2726; SHIRKEY RJ, 1985, EUR J CLIN PHARMACOL, V28, P447, DOI 10.1007/BF00544365; SVENSSON C, 1986, PSYCHOPHARMACOLOGY, V89, P291; Tai SSC, 2011, ANAL BIOANAL CHEM, V401, P1915, DOI 10.1007/s00216-011-5251-5; Tan WW, 2012, PHARMACOEPIDEM DR S, V21, P1074, DOI 10.1002/pds.3293	36	25	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108190	10.1371/journal.pone.0108190	http://dx.doi.org/10.1371/journal.pone.0108190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255292	Green Submitted, gold, Green Published			2022-12-27	WOS:000344862300061
J	Takagishi, H; Koizumi, M; Fujii, T; Schug, J; Kameshima, S; Yamagishi, T				Takagishi, Haruto; Koizumi, Michiko; Fujii, Takayuki; Schug, Joanna; Kameshima, Shinya; Yamagishi, Toshio			The Role of Cognitive and Emotional Perspective Taking in Economic Decision Making in the Ultimatum Game	PLOS ONE			English	Article							STRONG RECIPROCITY; PREFRONTAL CORTEX; BEHAVIOR; MIND; FAIRNESS; PRESCHOOLERS; COOPERATION; EVOLUTION; REJECTION; INEQUITY	We conducted a simple resource allocation game known as the ultimatum game (UG) with preschoolers to examine the role of cognitive and emotional perspective-taking ability on allocation and rejection behavior. A total of 146 preschoolers played the UG and completed a false belief task and an emotional perspective-taking test. Results showed that cognitive perspective taking ability had a significant positive effect on the proposer's offer and a negative effect on the responder's rejection behavior, whereas emotional perspective taking ability did not impact either the proposer's or responder's behavior. These results imply that the ability to anticipate the responder's beliefs, but not their emotional state, plays an important role in the proposer's choice of a fair allocation in an UG, and that children who have not acquired theory of mind still reject unfair offers.	[Takagishi, Haruto] Tamagawa Univ, Brain Sci Inst, Tokyo, Japan; [Koizumi, Michiko] Univ Fukui, Res Ctr Child Mental Dev, Fukui 910, Japan; [Fujii, Takayuki] Tamagawa Univ, Dept Brain Sci, Tokyo, Japan; [Schug, Joanna] Coll William & Mary, Dept Psychol, Williamsburg, VA 23185 USA; [Kameshima, Shinya] Kansai Univ Welf Sci, Dept Social Welf, Osaka, Japan; [Yamagishi, Toshio] Hitotsubashi Univ, Grad Sch Int Corp Strategy, Tokyo, Japan	University of Fukui; William & Mary; Hitotsubashi University	Takagishi, H (corresponding author), Tamagawa Univ, Brain Sci Inst, Tokyo, Japan.	takagishi@lab.tamagawa.ac.jp	Takagishi, Haruto/AFR-1157-2022	Schug, Joanna/0000-0003-1925-9496	JSPS KAKENHI [08J01020, 19046005, 26780345]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 08J01020, 19046005, 26780345. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Blake PR, 2011, COGNITION, V120, P215, DOI 10.1016/j.cognition.2011.04.006; BLOUNT S, 1995, ORGAN BEHAV HUM DEC, V63, P131, DOI 10.1006/obhd.1995.1068; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Burford HC, 1996, J SOC BEHAV PERS, V11, P17; DENHAM SA, 1986, CHILD DEV, V57, P194, DOI 10.1111/j.1467-8624.1986.tb00020.x; DUNN J, 1995, COGNITION EMOTION, V9, P187, DOI 10.1080/02699939508409008; Falk A, 2003, ECON INQ, V41, P20, DOI 10.1093/ei/41.1.20; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Henrich J., 2005, FDN HUMAN SOCIALITY; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Krajbich I, 2009, J NEUROSCI, V29, P2188, DOI 10.1523/JNEUROSCI.5086-08.2009; Moore C, 1998, SOC DEV, V7, P198, DOI 10.1111/1467-9507.00062; Moore C, 2009, PSYCHOL SCI, V20, P944, DOI 10.1111/j.1467-9280.2009.02378.x; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Ohmura Y, 2005, PSYCHOL REP, V96, P533; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Sally D, 2006, J ECON PSYCHOL, V27, P73, DOI 10.1016/j.joep.2005.06.015; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Shamay-Tsoory SG, 2006, SOC NEUROSCI-UK, V1, P149, DOI 10.1080/17470910600985589; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Sober W, 1998, OTHERS EVOLUTION PSY; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Takagishi H, 2009, NEUROENDOCRINOL LETT, V30, P643; Takagishi H, 2010, J EXP CHILD PSYCHOL, V105, P130, DOI 10.1016/j.jecp.2009.09.005; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	34	18	20	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108462	10.1371/journal.pone.0108462	http://dx.doi.org/10.1371/journal.pone.0108462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3UZ	25255309	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300086
J	Hurba, O; Mancikova, A; Krylov, V; Pavlikova, M; Pavelka, K; Stiburkova, B				Hurba, Olha; Mancikova, Andrea; Krylov, Vladimir; Pavlikova, Marketa; Pavelka, Karel; Stiburkova, Blanka			Complex Analysis of Urate Transporters SLC2A9, SLC22A12 and Functional Characterization of Non-Synonymous Allelic Variants of GLUT9 in the Czech Population: No Evidence of Effect on Hyperuricemia and Gout	PLOS ONE			English	Article							SERUM URIC-ACID; GENOME-WIDE ASSOCIATION; RENAL HYPOURICEMIA; MOLECULAR ANALYSIS; METABOLIC SYNDROME; HAN CHINESE; GENE; IDENTIFICATION; EXCRETION; DISEASE	Objective: Using European descent Czech populations, we performed a study of SLC2A9 and SLC22A12 genes previously identified as being associated with serum uric acid concentrations and gout. This is the first study of the impact of nonsynonymous allelic variants on the function of GLUT9 except for patients suffering from renal hypouricemia type 2. Methods: The cohort consisted of 250 individuals (150 controls, 54 nonspecific hyperuricemics and 46 primary gout and/or hyperuricemia subjects). We analyzed 13 exons of SLC2A9 (GLUT9 variant 1 and GLUT9 variant 2) and 10 exons of SLC22A12 by PCR amplification and sequenced directly. Allelic variants were prepared and their urate uptake and subcellular localization were studied by Xenopus oocytes expression system. The functional studies were analyzed using the nonparametric Wilcoxon and Kruskall-Wallis tests; the association study used the Fisher exact test and linear regression approach. Results: We identified a total of 52 sequence variants (12 unpublished). Eight non-synonymous allelic variants were found only in SLC2A9: rs6820230, rs2276961, rs144196049, rs112404957, rs73225891, rs16890979, rs3733591 and rs2280205. None of these variants showed any significant difference in the expression of GLUT9 and in urate transport. In the association study, eight variants showed a possible association with hyperuricemia. However, seven of these were in introns and the one exon located variant, rs7932775, did not show a statistically significant association with serum uric acid concentration. Conclusion: Our results did not confirm any effect of SLC22A12 and SLC2A9 variants on serum uric acid concentration. Our complex approach using association analysis together with functional and immunohistochemical characterization of nonsynonymous allelic variants did not show any influence on expression, subcellular localization and urate uptake of GLUT9.	[Hurba, Olha; Pavlikova, Marketa; Stiburkova, Blanka] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague, Czech Republic; [Hurba, Olha; Pavlikova, Marketa; Stiburkova, Blanka] Gen Univ Hosp Prague, Prague, Czech Republic; [Mancikova, Andrea; Krylov, Vladimir] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic; [Pavelka, Karel; Stiburkova, Blanka] Inst Rheumatol, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague; Institute of Rheumatology	Stiburkova, B (corresponding author), Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague, Czech Republic.	blanka.stiburkova@lf1.cuni.cz	Pavelka, Karel/E-6578-2017; Krylov, Vladimir/A-2369-2014; Mancikova, Andrea/U-9553-2017; Pavlikova, Marketa/F-4563-2016; Stiburkova, Blanka/N-8824-2013	Pavelka, Karel/0000-0003-1952-8422; Krylov, Vladimir/0000-0001-8678-7155; Mancikova, Andrea/0000-0003-4487-1943; Pavlikova, Marketa/0000-0003-4314-4357; Stiburkova, Blanka/0000-0003-2465-1476	Czech Republic, Ministry of Health [IGA MZ NT/11322-4/2010]	Czech Republic, Ministry of Health(Ministry of Health, Czech Republic)	This study was supported by grants from the Czech Republic, Ministry of Health IGA MZ NT/11322-4/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Anzai N, 2007, CURR OPIN RHEUMATOL, V19, P151, DOI 10.1097/BOR.0b013e328032781a; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Bahn A, 2008, J BIOL CHEM, V283, P16332, DOI 10.1074/jbc.M800737200; CHONG SS, 1993, GENOMICS, V18, P355, DOI 10.1006/geno.1993.1476; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Dinour D, 2010, J AM SOC NEPHROL, V21, P64, DOI 10.1681/ASN.2009040406; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Ebrahimpour Pantea, 2008, Endocr Pract, V14, P298; Ekaratanawong S, 2004, J PHARMACOL SCI, V94, P297, DOI 10.1254/jphs.94.297; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; Heinig M, 2006, CLEV CLIN J MED, V73, P1059, DOI 10.3949/ccjm.73.12.1059; Hollis-Moffatt JE, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3356; Hollis-Moffatt JE, 2009, ARTHRITIS RHEUM-US, V60, P3485, DOI 10.1002/art.24938; Ichida K, 2004, J AM SOC NEPHROL, V15, P164, DOI 10.1097/01.ASN.0000105320.04395.D0; Janosikova B, 2003, MOL GENET METAB, V79, P167, DOI 10.1016/S1096-7192(03)00079-9; Jutabha P, 2010, J BIOL CHEM, V285, P35123, DOI 10.1074/jbc.M110.121301; Karns R, 2012, ANN HUM GENET, V76, P121, DOI 10.1111/j.1469-1809.2011.00698.x; Kimura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084996; Li CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024561; Li CG, 2010, J MED GENET, V47, P204, DOI 10.1136/jmg.2009.068619; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; McArdle PF, 2008, ARTHRITIS RHEUM-US, V58, P2874, DOI 10.1002/art.23752; Nath SD, 2007, J AM SOC NEPHROL, V18, P3156, DOI 10.1681/ASN.2007040426; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; Stiburkova B, 2013, EUR J HUM GENET, V21, P1067, DOI 10.1038/ejhg.2013.3; Stiburkova B, 2012, PEDIATR NEPHROL, V27, P1411, DOI 10.1007/s00467-012-2174-0; Stiburkova B, 2011, MOL GENET METAB, V102, P430, DOI 10.1016/j.ymgme.2010.12.016; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; Takiue Y, 2011, NUCLEOS NUCLEOT NUCL, V30, P113, DOI 10.1080/15257770.2010.551645; Tang WH, 2003, DIABETES, V52, P2840, DOI 10.2337/diabetes.52.11.2840; Tin A, 2011, HUM MOL GENET, V20, P4056, DOI 10.1093/hmg/ddr307; Torres RJ, 2012, J RHEUMATOL, V39, P1901, DOI 10.3899/jrheum.120451; Tu HP, 2010, ANN RHEUM DIS, V69, P887, DOI 10.1136/ard.2009.113357; Urano W, 2010, ANN RHEUM DIS, V69, P1232, DOI 10.1136/ard.2008.106856; Vazquez-Mellado J, 2007, RHEUMATOLOGY, V46, P215, DOI 10.1093/rheumatology/kel205; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Wilk JB, 2000, HUM GENET, V106, P355, DOI 10.1007/s004390051050; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Yakut S, 2013, RHEUMATOL INT, V33, P2921, DOI 10.1007/s00296-012-2533-y; Yang Q, 2005, METABOLISM, V54, P1435, DOI 10.1016/j.metabol.2005.05.007	46	31	32	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107902	10.1371/journal.pone.0107902	http://dx.doi.org/10.1371/journal.pone.0107902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268603	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700052
J	Kolivand, H; Sunar, MS				Kolivand, Hoshang; Sunar, Mohd Shahrizal			Realistic Real-Time Outdoor Rendering in Augmented Reality	PLOS ONE			English	Article							ILLUMINATION ESTIMATION; MODEL	Realistic rendering techniques of outdoor Augmented Reality (AR) has been an attractive topic since the last two decades considering the sizeable amount of publications in computer graphics. Realistic virtual objects in outdoor rendering AR systems require sophisticated effects such as: shadows, daylight and interactions between sky colours and virtual as well as real objects. A few realistic rendering techniques have been designed to overcome this obstacle, most of which are related to non real-time rendering. However, the problem still remains, especially in outdoor rendering. This paper proposed a much newer, unique technique to achieve realistic real-time outdoor rendering, while taking into account the interaction between sky colours and objects in AR systems with respect to shadows in any specific location, date and time. This approach involves three main phases, which cover different outdoor AR rendering requirements. Firstly, sky colour was generated with respect to the position of the sun. Second step involves the shadow generation algorithm, Z-Partitioning: Gaussian and Fog Shadow Maps (Z-GaF Shadow Maps). Lastly, a technique to integrate sky colours and shadows through its effects on virtual objects in the AR system, is introduced. The experimental results reveal that the proposed technique has significantly improved the realism of real-time outdoor AR rendering, thus solving the problem of realistic AR systems.	[Kolivand, Hoshang; Sunar, Mohd Shahrizal] Univ Teknol Malaysia, MaGIC X Media & Games Innovat Ctr Excellence, UTM IRDA Digital Media Ctr, Skudai, Johor, Malaysia	Universiti Teknologi Malaysia	Sunar, MS (corresponding author), Univ Teknol Malaysia, MaGIC X Media & Games Innovat Ctr Excellence, UTM IRDA Digital Media Ctr, Skudai, Johor, Malaysia.	shahrizal@utm.com	Sunar, Mohd Shahrizal/AFQ-7366-2022; Kolivand, Hoshang/B-2501-2016	Sunar, Mohd Shahrizal/0000-0002-0244-1622; Kolivand, Hoshang/0000-0001-5460-5679	Universiti Teknologi Malaysia (UTM); Ministry of Higher Education (MOHE); Research Management Centre (RMC)	Universiti Teknologi Malaysia (UTM); Ministry of Higher Education (MOHE)(Ministry of Higher Education & Scientific Research (MHESR)); Research Management Centre (RMC)	The research paper was supported by Universiti Teknologi Malaysia (UTM) using Exploratory Research Grant Scheme (ERGS) vot number R.J130000.7828.4L092. Special thanks to Ministry of Higher Education (MOHE) and Research Management Centre (RMC) for providing financial support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEA, 2003, CIE STAND; Agusanto K, 2003, SECOND IEEE AND ACM INTERNATIONAL SYMPOSIUM ON MIXED AND AUGMENTED REALITY, PROCEEDINGS, P208, DOI 10.1109/ISMAR.2003.1240704; Aittala M, 2010, VISUAL COMPUT, V26, P669, DOI 10.1007/s00371-010-0501-7; Annen T, 2007, P 18 EUR C REND TECH, P51; Annen T, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360633; Arief I, 2012, COLOR IMAG CONF, P111; Azuma RT, 1997, PRESENCE-VIRTUAL AUG, V6, P355, DOI 10.1162/pres.1997.6.4.355; BLINN JF, 1976, COMMUN ACM, V19, P542, DOI 10.1145/965143.563322; Boun Vinh Lu, 2010, 2010 9th IEEE International Symposium on Mixed and Augmented Reality (ISMAR). Science & Technology Papers, P109, DOI 10.1109/ISMAR.2010.5643558; de Castro T. K., 2012, 2012 14th Symposium on Virtual and Augmented Reality (SVR), P36, DOI 10.1109/SVR.2012.9; Debevec P, 2002, IEEE COMPUT GRAPH, V22, P26, DOI 10.1109/38.988744; Dimitrov R, 2007, CASCADED SHADOW MAPS; Dobashi Y, 1997, J VISUAL COMP ANIMAT, V8, P115, DOI 10.1002/(SICI)1099-1778(199703)8:2<115::AID-VIS165>3.0.CO;2-R; Dobashi Y, 1996, COMP GRAPH FOR P EUR, V15, P112; Dobashi Yoshinori, 2002, P ACM SIGGRAPH EUROG, P99; Donnelly W., 2006, P 2006 S INT 3D GRAP, P161, DOI DOI 10.1145/1111411.1111440; Gibson S., 2003, Eurographics Symposium on Rendering. 14th Eurographics Workshop on Rendering, P219; GREENE N, 1986, IEEE COMPUT GRAPH, V6, P21, DOI 10.1109/MCG.1986.276658; Guan T, 2011, IEEE COMPUT GRAPH, V31, P56, DOI 10.1109/MCG.2010.23; Haller M., 2003, P ACM S VIRT REAL SO, P56, DOI DOI 10.1145/1008653.1008665; Hartmann W, 2003, IEEE INTERNATIONAL AUGMENTED REALITY TOOLKIT WORKSHOP, P44, DOI 10.1109/ART.2003.1320426; Hensley J, 2005, COMPUT GRAPH FORUM, V24, P547, DOI 10.1111/j.1467-8659.2005.00880.x; Herdtweck C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081462; Hosek L, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185591; Jacobs K, 2004, EUROGRAPHICS; Jacobs K, 2005, GI 05, V2005, P113; Jensen B, 2009, SIMPLIFYING REAL TIM; Ji RR, 2012, INT J COMPUT VISION, V96, P290, DOI 10.1007/s11263-011-0472-9; Ji RR, 2013, IEEE T MULTIMEDIA, V15, P153, DOI 10.1109/TMM.2012.2225035; Kan P, 2012, INT SYM MIX AUGMENT, P99, DOI 10.1109/ISMAR.2012.6402546; Kanbara M, 2004, INT C PATT RECOG, P911, DOI 10.1109/ICPR.2004.1334407; Kaneda K., 1991, Visual Computer, V7, P247, DOI 10.1007/BF01905690; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Kim Y. H., 2010, 2010 IEEE 37th International Conference on Plasma Sciences (ICOPS 2010), DOI 10.1109/PLASMA.2010.5534009; Kittler R, 1998, SOL ENERGY, V62, P93, DOI 10.1016/S0038-092X(97)00117-5; Kittler R, 1999, PUBLICATIONS COMMISS, V133, P243; Kittler R, 1998, RES REPORT AM SLOVAK, V92, P240, DOI DOI 10.13140/RG.2.1.4798.7048; KLASSEN RV, 1987, ACM T GRAPHIC, V6, P215, DOI 10.1145/35068.35071; Knecht M, 2012, COMPUTERS GRAPHICS; Kolivand H, 2011, INT J COMPUTER SCI I, V8, P80; Kolivand H, 2013, MULTIMED TOOLS APPL, P1; Lauritzen A, 2008, GI 08, P139; Liu YL, 2010, COMPUT ANIMAT VIRT W, V21, P321, DOI 10.1002/cav.357; Liu YL, 2009, VISUAL COMPUT, V25, P637, DOI 10.1007/s00371-009-0342-4; Loscos C, 2000, IEEE T VIS COMPUT GR, V6, P289, DOI 10.1109/2945.895874; Madsen C, 2003, P 6 ANN INT WORKSH P; Madsen C, 2008, PROBE LESS AUGMENTED; Madsen CB, 2013, COMPUTER VISION IMAG, P33; Miller G, 1984, SIGGRAPH 84 COURSE N, P1; Naemura T, 2002, T VIRTUAL REALITY SO, V7, P227; Nishita T, 1986, COMPUTER GRAPHICS, V20, P112, DOI DOI 10.1145/15886.15900; Nishita T, 1996, P SIGGRAPH 96, P379; Noh Z, 2010, ADV MULTIMEDIA INT J, V1, P26; PEREZ R, 1993, SOL ENERGY, V50, P235, DOI 10.1016/0038-092X(93)90017-I; Preetham AJ, 1999, COMP GRAPH, P91, DOI 10.1145/311535.311545; Reeves W, 1987, P SIGGRAPH 87, V21, P557; Seokjun Lee, 2011, 2011 International Symposium on Ubiquitous Virtual Reality, P17, DOI 10.1109/ISUVR.2011.17; Shao MZ, 1993, GATHERING SHOOTING P; Sik-Lanyi C, 2014, ACTA POLYTECHNICA HU, P11; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Stumpfel J, 2004, HDR LIGHTING CAPTURE; Sunar M, 2001, THESIS; Sunar M, 2011, INT J SCI ENG RES, V2, P2229; Sunar MS, 2003, IASTED INT C APPL SI, P3; Tadamura K, 1993, COMPUT GRAPH FORUM, V12, P189; Tadamura K, 1999, CGI 99 P INT C COMP, P66; Ward G. J., 1994, Computer Graphics Proceedings. Annual Conference Series 1994. SIGGRAPH 94 Conference Proceedings, P459, DOI 10.1145/192161.192286; Williams L, 1978, SIGGRAPH 78, P12; Wilson KL, 2013, MIL MED, V178, P981, DOI 10.7205/MILMED-D-13-00074; Xing G, 2011, 12 INT C COMP AID DE, P43; Xing GY, 2012, COMPUT GRAPH-UK, V36, P857, DOI 10.1016/j.cag.2012.07.005; Yan F, 2008, CISP 2008: FIRST INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING, VOL 3, PROCEEDINGS, P771, DOI 10.1109/CISP.2008.87; Yeoh RC, 2009, INT SYM MIX AUGMENT, P223, DOI 10.1109/ISMAR.2009.5336453; Zhao F, 2013, P 12 ACM SIGGRAPH IN, P157; Zhu J, 2015, INT J COMPUT INTEG M, V28, P213, DOI 10.1080/0951192X.2013.874589	75	17	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108334	10.1371/journal.pone.0108334	http://dx.doi.org/10.1371/journal.pone.0108334			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268480	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000343671700081
J	Lemos, MP; Lama, JR; Karuna, ST; Fong, YY; Montano, SM; Ganoza, C; Gottardo, R; Sanchez, J; McElrath, MJ				Lemos, Maria P.; Lama, Javier R.; Karuna, Shelly T.; Fong, Youyi; Montano, Silvia M.; Ganoza, Carmela; Gottardo, Raphael; Sanchez, Jorge; McElrath, M. Juliana			The Inner Foreskin of Healthy Males at Risk of HIV Infection Harbors Epithelial CD4+CCR5+Cells and Has Features of an Inflamed Epidermal Barrier	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; TIGHT-JUNCTIONS; MALE CIRCUMCISION; TARGET-CELLS; UNCIRCUMCISED MEN; IN-VIVO; SKIN; EXPRESSION; PSORIASIS; OCCLUDIN	Male circumcision provides partial protection against multiple sexually transmitted infections (STIs), including HIV, but the mechanisms are not fully understood. To examine potential vulnerabilities in foreskin epithelial structure, we used Wilcoxon paired tests adjusted using the false discovery rate method to compare inner and outer foreskin samples from 20 healthy, sexually active Peruvian males who have sex with males or transgender females, ages 21-29, at elevated risk of HIV infection. No evidence of epithelial microtrauma was identified, as assessed by keratinocyte activation, fibronectin deposition, or parakeratosis. However, multiple suprabasal tight junction differences were identified: 1) inner foreskin stratum corneum was thinner than outer (p = 0.035); 2) claudin 1 had extended membrane-bound localization throughout inner epidermis stratum spinosum (p = 0.035); 3) membrane-bound claudin 4 was absent from inner foreskin stratum granulosum (p = 0.035); and 4) occludin had increased membrane deposition in inner foreskin stratum granulosum (p = 0.042) versus outer. Together, this suggests subclinical inflammation and paracellular transport modifications to the inner foreskin. A setting of inflammation was further supported by inner foreskin epithelial explant cultures secreting higher levels of GM-CSF (p = 0.029), IP-10 (p = 0.035) and RANTES (p = 0.022) than outer foreskin, and also containing an increased density of CCR5+ and CD4+ CCR5+ cells (p = 0.022). Inner foreskin dermis also secreted more RANTES than outer (p = 0.036), and had increased density of CCR5+ cells (p = 0.022). In conclusion, subclinical changes to the inner foreskin of sexually active males may support an inflammatory state, with availability of target cells for HIV infection and modifications to epidermal barriers, potentially explaining the benefits of circumcision for STI prevention.	[Lemos, Maria P.; Karuna, Shelly T.; Fong, Youyi; Gottardo, Raphael; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Lama, Javier R.; Ganoza, Carmela; Sanchez, Jorge] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Montano, Silvia M.] US Naval Med Res Unit 6 NAMRU 6, Lima, Peru; [McElrath, M. Juliana] Univ Washington, Dept Med, Seattle, WA USA; [McElrath, M. Juliana] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McElrath, MJ (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	jmcelrat@fhcrc.org	Gottardo, Raphael/HCH-3169-2022	Gottardo, Raphael/0000-0002-3867-0232	National Institute of Allergy and Infectious Disease of the National Institutes of Health [UM1AI068618]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068635, UM1AI068614, UM1AI068618] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Disease of the National Institutes of Health under award number UM1AI068618. The content is solely the responsibility of the authors and does not necessarily represent the official views, policy or position of the National Institutes of Health, the Department of the Navy, the Department of Defense, or the United States Government. Dr. Silvia Montano is an employee of the United States Government who contributed to this work as part of her official duties. No copyright protection is available for her work as defined by Titles 17 U.S.C. 1105 and 101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Dinh MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041271; Dinh MH, 2010, AIDS, V24, P899, DOI 10.1097/QAD.0b013e3283367779; Donoval BA, 2006, AM J CLIN PATHOL, V125, P386, DOI 10.1309/JVHQVDJDYKM58EPH; Fahrbach KM, 2010, MUCOSAL IMMUNOL, V3, P410, DOI 10.1038/mi.2010.18; Fong YY, 2013, BIOINFORMATICS, V29, P2653, DOI 10.1093/bioinformatics/btt456; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Ganor Y, 2010, MUCOSAL IMMUNOL, V3, P506, DOI 10.1038/mi.2010.32; Ganor Yonatan, 2011, Am J Reprod Immunol, V65, P284, DOI 10.1111/j.1600-0897.2010.00933.x; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; GRINNELL F, 1981, J INVEST DERMATOL, V76, P181, DOI 10.1111/1523-1747.ep12525694; Hendrix SW, 2007, SKIN RES TECHNOL, V13, P330, DOI 10.1111/j.1600-0846.2007.00235.x; Hirbod T, 2010, AM J PATHOL, V176, P2798, DOI 10.2353/ajpath.2010.090926; Itoh K, 2005, EXP DERMATOL, V14, P667, DOI 10.1111/j.0906-6705.2005.00338.x; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kigozi G, 2009, AIDS, V23, P2209, DOI 10.1097/QAD.0b013e328330eda8; Kirschner N, 2010, EUR J CELL BIOL, V89, P839, DOI 10.1016/j.ejcb.2010.07.010; Kirschner N, 2009, AM J PATHOL, V175, P1095, DOI 10.2353/ajpath.2009.080973; Liu CM, 2013, MBIO, V4, DOI 10.1128/mBio.00076-13; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; MURTHY S, 1993, J STRUCT BIOL, V111, P68, DOI 10.1006/jsbi.1993.1037; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; O'Farrell N, 2008, INT J STD AIDS, V19, P821, DOI 10.1258/ijsa.2008.008106; O'Farrell N, 2006, JAIDS-J ACQ IMM DEF, V43, P69, DOI 10.1097/01.qai.0000225014.61192.98; Ohnemus U, 2008, J INVEST DERMATOL, V128, P906, DOI 10.1038/sj.jid.5701070; Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2; Peltonen S, 2007, BRIT J DERMATOL, V156, P466, DOI 10.1111/j.1365-2133.2006.07642.x; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Prodger JL, 2012, MUCOSAL IMMUNOL, V5, P121, DOI 10.1038/mi.2011.56; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Qin Q, 2009, INT UROL NEPHROL, V41, P747, DOI 10.1007/s11255-008-9521-x; Sanchez J, 2007, JAIDS-J ACQ IMM DEF, V44, P578, DOI 10.1097/QAI.0b013e318033ff82; Sanchez J, 2009, JAIDS-J ACQ IMM DEF, V51, pS47, DOI 10.1097/QAI.0b013e3181a2671d; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Simpson CL, 2011, NAT REV MOL CELL BIO, V12, P565, DOI 10.1038/nrm3175; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; STOREY WF, 1951, ANN NY ACAD SCI, V53, P537, DOI 10.1111/j.1749-6632.1951.tb31955.x; Van Itallie CM, 2010, J CELL SCI, V123, P2844, DOI 10.1242/jcs.065581; Wallace L, 2012, J CELL SCI, V125, P1750, DOI 10.1242/jcs.097139; Watson CJ, 2005, J CELL SCI, V118, P5221, DOI 10.1242/jcs.02630; Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032	49	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108954	10.1371/journal.pone.0108954	http://dx.doi.org/10.1371/journal.pone.0108954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268493	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700201
J	Skip, B; Bednarska, AJ; Laskowski, R				Skip, Boris; Bednarska, Agnieszka J.; Laskowski, Ryszard			Toxicokinetics of Metals in Terrestrial Invertebrates: Making Things Straight with the One-Compartment Principle	PLOS ONE			English	Article							CARNIVOROUS INVERTEBRATES; CADMIUM EXCRETION; GROUND BEETLE; ZINC; KINETICS; ACCUMULATION; DECONTAMINATION; EXPOSURE; ELIMINATION; POPULATIONS	In this analysis, we first performed a critical review of one-compartment models used to describe metal toxicokinetics in invertebrates and found mathematical or conceptual errors in almost all published studies. In some publications, the models used do not represent the exact solution of the underlying one-compartment differential equations; others use unrealistic assumptions about constant background metal concentration and/or zero metal concentration in uncontaminated medium. Herein we present exact solutions of two differential-equation models, one describing simple two-stage toxicokinetics (metal toxicokinetic follows the experimental phases: the uptake phase and the decontamination phase) and another that can be applied for more complex three-stage patterns (toxicokinetic pattern does not follow two phases determined by an experimenter). Using two case studies for carabids exposed via food, based on previously published data, we discuss and compare our models to those originally used to analyze the data. Our conclusion is that when metal toxicokinetic follows a one-compartment model, the exact solution of a set of differential equations should be used. The proposed models allow assimilation and elimination rates to change between toxicokinetic stages, and the three-stage model is flexible enough to fit patterns that are more complex than the classic two-stage model can handle.	[Skip, Boris; Laskowski, Ryszard] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland; [Bednarska, Agnieszka J.] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland; [Skip, Boris] Chernivtsi Natl Univ, Dept Phys Chem & Environm Chem, Chernovtsy, Ukraine	Jagiellonian University; Polish Academy of Sciences; Ministry of Education & Science of Ukraine; Yuri Fedkovych Chernivtsi National University	Bednarska, AJ (corresponding author), Polish Acad Sci, Inst Nat Conservat, Krakow, Poland.	bednarska@iop.krakow.pl	Skip, Borys/C-4362-2016; Laskowski, Ryszard/Q-1505-2019; Bednarska, Agnieszka J/C-6856-2015	Skip, Borys/0000-0003-3692-1939; Laskowski, Ryszard/0000-0002-1968-3230; Bednarska, Agnieszka J/0000-0002-1030-3414	Polish Ministry of Science and Higher Education [NN304 038440]; Jagiellonian University [DS-758]; Institute of Nature Conservation PAS; Erasmus Mundus European Mobility with Neighbouring Region in the East: Ukraine, Moldova, Belarus	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Jagiellonian University; Institute of Nature Conservation PAS; Erasmus Mundus European Mobility with Neighbouring Region in the East: Ukraine, Moldova, Belarus	The study was supported financially by the Polish Ministry of Science and Higher Education (Project No. NN304 038440) and partly by Jagiellonian University (DS-758) and Institute of Nature Conservation PAS. Boris Skip was supported by Erasmus Mundus European Mobility with Neighbouring Region in the East: Ukraine, Moldova, Belarus (http://emerge.uaic.ro/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardestani MM, 2013, ECOTOXICOLOGY, V22, P308, DOI 10.1007/s10646-012-1027-8; Argasinski K, 2012, ECOTOXICOLOGY, V21, P2186, DOI 10.1007/s10646-012-0972-6; Atkins G, 1969, MULTICOMPARTMENT MOD; Bednarska AJ, 2011, ARCH ENVIRON CON TOX, V60, P722, DOI 10.1007/s00244-010-9581-7; Bednarska AJ, 2009, THESIS JAGIELLONIAN; Bibic A, 1997, B ENVIRON CONTAM TOX, V58, P814, DOI 10.1007/s001289900407; Descamps M, 1996, ARCH ENVIRON CON TOX, V31, P350, DOI 10.1007/BF00212673; Heugens EHW, 2003, ENVIRON SCI TECHNOL, V37, P2145, DOI 10.1021/es0264347; JANSSEN MPM, 1991, ARCH ENVIRON CON TOX, V20, P305, DOI 10.1007/BF01064395; Kabata-Pendias A., 2007, TRACE ELEMEN SOIL HU, DOI [10.1007/978-3-540-32714-1, DOI 10.1007/978-3-540-32714-1, 10.1007/978-3-540-32714-1_20]; Korn G. A., 1968, MATH HDB SCI ENG; Kramarz P, 1999, B ENVIRON CONTAM TOX, V63, P538, DOI 10.1007/s001289901014; Kramarz P, 1999, B ENVIRON CONTAM TOX, V63, P531, DOI 10.1007/s001289901013; Lagisz M, 2005, ARCH ENVIRON CON TOX, V48, P484, DOI 10.1007/s00244-004-0023-2; Lane TW, 2005, NATURE, V435, P42, DOI 10.1038/435042a; Laskowski R, 2010, SCI TOTAL ENVIRON, V408, P3794, DOI 10.1016/j.scitotenv.2009.11.017; Lister LJ, 2011, ENVIRON INT, V37, P663, DOI 10.1016/j.envint.2011.01.006; Maryanski M, 2002, ECOTOXICOLOGY, V11, P127, DOI 10.1023/A:1014425113481; McElroy Anne E., 2011, Integrated Environmental Assessment and Management, V7, P50, DOI 10.1002/ieam.132; MORGAN JE, 1990, OECOLOGIA, V84, P559, DOI 10.1007/BF00328174; Nahmani J, 2009, ENVIRON POLLUT, V157, P2622, DOI 10.1016/j.envpol.2009.05.002; POSTHUMA L, 1992, ARCH ENVIRON CON TOX, V22, P146, DOI 10.1007/BF00213314; Postma JF, 1996, ENVIRON TOXICOL CHEM, V15, P332, DOI [10.1897/1551-5028(1996)015&lt;0332:ICEIMA&gt;2.3.CO;2, 10.1002/etc.5620150317]; Smith BA, 2010, ARCH ENVIRON CON TOX, V59, P264, DOI 10.1007/s00244-009-9459-8; Spurgeon DJ, 2011, PEDOBIOLOGIA, V54, pS217, DOI 10.1016/j.pedobi.2011.09.002; Spurgeon DJ, 1999, APPL SOIL ECOL, V11, P227, DOI 10.1016/S0929-1393(98)00150-4; Sterenborg I, 2003, ENVIRON TOXICOL CHEM, V22, P1167, DOI 10.1002/etc.5620220528; Tsai JW, 2013, ENVIRON SCI POLLUT R, V20, P3771, DOI 10.1007/s11356-012-1304-3; van Straalen NM, 2005, ENVIRON POLLUT, V136, P409, DOI 10.1016/j.envpol.2005.01.019; Vijver MG, 2006, ENVIRON TOXICOL CHEM, V25, P807, DOI 10.1897/05-128R.1; Vijver MG, 2004, ENVIRON SCI TECHNOL, V38, P4705, DOI 10.1021/es040354g; Widianarko B, 2001, ENVIRON TOXICOL CHEM, V20, P763, DOI 10.1002/etc.5620200410; Zauke GP, 2008, HYDROBIOLOGIA, V614, P3, DOI 10.1007/s10750-008-9532-8	33	19	19	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108740	10.1371/journal.pone.0108740	http://dx.doi.org/10.1371/journal.pone.0108740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268739	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700153
J	Heikkinen, RK; Bocedi, G; Kuussaari, M; Heliola, J; Leikola, N; Poyry, J; Travis, JMJ				Heikkinen, Risto K.; Bocedi, Greta; Kuussaari, Mikko; Heliola, Janne; Leikola, Niko; Poyry, Juha; Travis, Justin M. J.			Impacts of Land Cover Data Selection and Trait Parameterisation on Dynamic Modelling of Species' Range Expansion	PLOS ONE			English	Article							CLIMATE-CHANGE; SEMINATURAL GRASSLANDS; DISTRIBUTION PATTERNS; POPULATION-DYNAMICS; SPATIAL SPREAD; DISPERSAL; CONSERVATION; BUTTERFLIES; HABITAT; CONNECTIVITY	Dynamic models for range expansion provide a promising tool for assessing species' capacity to respond to climate change by shifting their ranges to new areas. However, these models include a number of uncertainties which may affect how successfully they can be applied to climate change oriented conservation planning. We used RangeShifter, a novel dynamic and individual-based modelling platform, to study two potential sources of such uncertainties: the selection of land cover data and the parameterization of key life-history traits. As an example, we modelled the range expansion dynamics of two butterfly species, one habitat specialist (Maniola jurtina) and one generalist (Issoria lathonia). Our results show that projections of total population size, number of occupied grid cells and the mean maximal latitudinal range shift were all clearly dependent on the choice made between using CORINE land cover data vs. using more detailed grassland data from three alternative national databases. Range expansion was also sensitive to the parameterization of the four considered life-history traits (magnitude and probability of long-distance dispersal events, population growth rate and carrying capacity), with carrying capacity and magnitude of long-distance dispersal showing the strongest effect. Our results highlight the sensitivity of dynamic species population models to the selection of existing land cover data and to uncertainty in the model parameters and indicate that these need to be carefully evaluated before the models are applied to conservation planning.	[Heikkinen, Risto K.; Kuussaari, Mikko; Heliola, Janne; Leikola, Niko; Poyry, Juha] Nat Environm Ctr, Finnish Environm Inst, Helsinki, Finland; [Bocedi, Greta; Travis, Justin M. J.] Univ Aberdeen, Inst Biol Sci, Aberdeen, Scotland	Finnish Environment Institute; University of Aberdeen	Heikkinen, RK (corresponding author), Nat Environm Ctr, Finnish Environm Inst, Helsinki, Finland.	risto.heikkinen@ymparisto.fi	Heikkinen, Risto K./AAN-6257-2020; Pöyry, Juha/B-7487-2013; Kuussaari, Mikko/Y-4070-2019; Travis, Justin/B-8571-2014	Heikkinen, Risto K./0000-0003-4190-5108; Pöyry, Juha/0000-0002-5548-1046; Kuussaari, Mikko/0000-0003-0264-9316; Travis, Justin/0000-0002-5785-4272	SCALES project (Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal, and Ecological Scales) - European Commission as a Large-scale Integrating Project within FP 7 [226 852]; Finnish Research Programme on Climate Change (FICCA) - Academy of Finland [140846]	SCALES project (Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal, and Ecological Scales) - European Commission as a Large-scale Integrating Project within FP 7; Finnish Research Programme on Climate Change (FICCA) - Academy of Finland	This work was supported by the SCALES project (Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal, and Ecological Scales) funded by the European Commission as a Large-scale Integrating Project within FP 7 under grant 226 852 and the Finnish Research Programme on Climate Change (FICCA) project A-LA-CARTE (Assessing limits of adaptation to climate change and opportunities for resilience to be enhanced), funded by the Academy of Finland (decision no. 140846). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BJ, 2009, P ROY SOC B-BIOL SCI, V276, P1415, DOI 10.1098/rspb.2008.1681; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Arponen A, 2013, BIOL CONSERV, V160, P234, DOI 10.1016/j.biocon.2013.01.018; Baguette M, 2003, J APPL ECOL, V40, P404, DOI 10.1046/j.1365-2664.2003.00791.x; Best AS, 2007, OIKOS, V116, P1531, DOI 10.1111/j.0030-1299.2007.16047.x; Bink F.A., 1992, ECOLOGISCHE ATLAS DA; Bocedi G, 2014, ECOGRAPHY, V37, P1240, DOI 10.1111/ecog.01041; Bocedi G, 2014, METHODS ECOL EVOL, V5, P388, DOI 10.1111/2041-210X.12162; Bocedi G, 2012, METHODS ECOL EVOL, V3, P1008, DOI 10.1111/j.2041-210X.2012.00235.x; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; Conlisk E, 2013, GLOBAL CHANGE BIOL, V19, P858, DOI 10.1111/gcb.12090; del Barrio G, 2006, ENVIRON SCI POLICY, V9, P129, DOI 10.1016/j.envsci.2005.11.005; Dennis RLH, 2004, ECOL ENTOMOL, V29, P744, DOI 10.1111/j.0307-6946.2004.00646.x; DOVER J W, 1992, Entomologist's Gazette, V43, P29; Franklin J, 2010, DIVERS DISTRIB, V16, P321, DOI 10.1111/j.1472-4642.2010.00641.x; Grill A, 2008, J INSECT CONSERV, V12, P617, DOI 10.1007/s10841-007-9098-1; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Heikkinen RK, 2012, ECOGRAPHY, V35, P276, DOI 10.1111/j.1600-0587.2011.06999.x; Heliola J, 2010, FINNISH ENV, V2/2010, P1; Hill JK, 2001, ECOL LETT, V4, P313, DOI 10.1046/j.1461-0248.2001.00222.x; Hodgson JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047141; Hodgson JA, 2009, J APPL ECOL, V46, P964, DOI 10.1111/j.1365-2664.2009.01695.x; Hovestadt T, 2011, J ANIM ECOL, V80, P1070, DOI 10.1111/j.1365-2656.2011.01848.x; Huntley B, 2010, ECOGRAPHY, V33, P621, DOI 10.1111/j.1600-0587.2009.06023.x; Iverson LR, 2004, GLOBAL ECOL BIOGEOGR, V13, P209, DOI 10.1111/j.1466-822X.2004.00093.x; Jimenez-Valverde A, 2008, ANN ZOOL FENN, V45, P200, DOI 10.5735/086.045.0305; Jonason D, 2010, J NAT CONSERV, V18, P22, DOI 10.1016/j.jnc.2009.02.001; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Komonen A, 2004, OIKOS, V105, P41, DOI 10.1111/j.0030-1299.2004.12958.x; Luoto M, 2006, J BIOGEOGR, V33, P1764, DOI 10.1111/j.1365-2699.2005.01395.x; Maes D, 2006, BIOL CONSERV, V133, P490, DOI 10.1016/j.biocon.2006.08.001; McInerny G, 2007, ECOL INFORM, V2, P1, DOI 10.1016/j.ecoinf.2006.12.001; Menendez Rosa, 2007, Tijdschrift voor Entomologie, V150, P355; Merckx T, 2010, J INSECT CONSERV, V14, P499, DOI 10.1007/s10841-010-9279-1; Minor ES, 2008, BIOL CONSERV, V141, P956, DOI 10.1016/j.biocon.2007.12.032; Mustin K, 2009, OIKOS, V118, P131, DOI 10.1111/j.1600-0706.2008.17025.x; Nathan R, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P187; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Ockinger E, 2007, J APPL ECOL, V44, P50, DOI 10.1111/j.1365-2664.2006.01250.x; Ockinger E, 2008, LANDSCAPE ECOL, V23, P27, DOI 10.1007/s10980-007-9167-6; Ockinger E, 2007, ECOGRAPHY, V30, P288, DOI [10.1111/j.2007.0906-7590.05048.x, 10.1111/j.0906-7590.2007.05048.x]; Ockinger E, 2006, BIOL CONSERV, V133, P291, DOI 10.1016/j.biocon.2006.06.009; Oliver T, 2009, ECOL LETT, V12, P1091, DOI 10.1111/j.1461-0248.2009.01367.x; Ouin A, 2008, AGR ECOSYST ENVIRON, V124, P193, DOI 10.1016/j.agee.2007.09.010; Poyry J, 2009, GLOBAL CHANGE BIOL, V15, P732, DOI 10.1111/j.1365-2486.2008.01789.x; Polus E, 2007, BIODIVERS CONSERV, V16, P3423, DOI 10.1007/s10531-006-9008-y; Poyry J, 2005, BIOL CONSERV, V122, P465, DOI 10.1016/j.biocon.2004.09.007; Poyry J, 2008, GLOBAL ECOL BIOGEOGR, V17, P403, DOI 10.1111/j.1466-8238.2007.00373.x; Poyry J, 2011, GLOBAL ECOL BIOGEOGR, V20, P289, DOI 10.1111/j.1466-8238.2010.00597.x; Pykala J, 2000, CONSERV BIOL, V14, P705, DOI 10.1046/j.1523-1739.2000.99119.x; Saarinen K, 2003, BIODIVERS CONSERV, V12, P2147, DOI 10.1023/A:1024189828387; Saarinen K, 2002, ANN ZOOL FENN, V39, P173; Saarinen Kimmo, 2004, Baptria (Helsinki), V29, P106; Schneider C, 2003, ECOL ENTOMOL, V28, P252, DOI 10.1046/j.1365-2311.2003.00495.x; Schulman A, 2005, FINNISH ENV, V734, P1; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; SMITH JM, 1973, ECOLOGY, V54, P384, DOI 10.2307/1934346; Sondgerath D, 2002, LANDSCAPE ECOL, V17, P57, DOI 10.1023/A:1015237002145; South A, 1999, CONSERV BIOL, V13, P1039, DOI 10.1046/j.1523-1739.1999.98236.x; Stevens VM, 2010, BIOL REV, V85, P625, DOI 10.1111/j.1469-185X.2009.00119.x; Storch D, 2003, J BIOGEOGR, V30, P1195, DOI 10.1046/j.1365-2699.2003.00917.x; Strijker D, 2005, BASIC APPL ECOL, V6, P99, DOI 10.1016/j.baae.2005.01.001; Svitra G., 2010, EUROPEAN BUTTERFLY I, P10; Syphard AD, 2009, ECOGRAPHY, V32, P907, DOI 10.1111/j.1600-0587.2009.05883.x; Thomas JA, 1995, BIOL J LINN SOC, V56, P55, DOI 10.1111/j.1095-8312.1995.tb01120.x; Titeux N, 2009, J BIOGEOGR, V36, P1459, DOI 10.1111/j.1365-2699.2009.02088.x; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Travis JMJ, 2011, METHODS ECOL EVOL, V2, P477, DOI 10.1111/j.2041-210X.2011.00104.x; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Vainio M, 2001, FINNISH ENV, V527; Van Swaay C. A. M., 2003, Entomologische Berichten (Amsterdam), V63, P82; Virkkala R, 2013, BIODIVERS CONSERV, V22, P459, DOI 10.1007/s10531-012-0423-y; Vos CC, 2008, J APPL ECOL, V45, P1722, DOI 10.1111/j.1365-2664.2008.01569.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wenzel M, 2006, BIOL CONSERV, V128, P542, DOI 10.1016/j.biocon.2005.10.022; Willis SG, 2009, ECOGRAPHY, V32, P5, DOI 10.1111/j.1600-0587.2008.05711.x; Wilson RJ, 2011, J INSECT CONSERV, V15, P259, DOI 10.1007/s10841-010-9342-y; Wilson RJ, 2009, P R SOC B, V276, P1421, DOI 10.1098/rspb.2008.0724	83	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108436	10.1371/journal.pone.0108436	http://dx.doi.org/10.1371/journal.pone.0108436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265281	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400075
J	Kimura, R; Murata, C; Kuroki, Y; Kuroiwa, A				Kimura, Ryutaro; Murata, Chie; Kuroki, Yoko; Kuroiwa, Asato			Mutations in the Testis-Specific Enhancer of SOX9 in the SRY Independent Sex-Determining Mechanism in the Genus Tokudaia	PLOS ONE			English	Article							OKINAWA SPINY RAT; Y-CHROMOSOME; CAMPOMELIC DYSPLASIA; OSIMENSIS-OSIMENSIS; DETERMINING REGION; SF1 ACTIVATION; SERTOLI-CELLS; REVERSAL; MICE; MUENNINKI	SRY (sex-determining region Y) is widely conserved in eutherian mammals as a sex-determining gene located on the Y chromosome. SRY proteins bind to the testis-specific enhancer of SOX9 (TES) with SF1 to upregulate SOX9 expression in undifferentiated gonads of XY embryos of humans and mice. The core region within TES, named TESCO, is an important enhancer for mammalian sex determination. We show that TESCO of the genus Tokudaia lost enhancer activity caused by mutations in its SRY and SF1 binding sites. Two species of Tokudaia do not have the Y chromosome or SRY, and one species has multiple SRYs located on the neo-Y chromosome consisting of the Y fused with an autosome. The sequence of Tokudaia TESCO exhibited more than 83% identity with mouse TESCO, however, nucleotide substitution(s) were found in two out of three SRY binding sites and in five out of six SF1 binding sites. TESCO of all species showed low enhancer activity in cells co-transfected with SRY and SF1, and SOX9 and SF1 in reporter gene assays. Mutated TESCO, in which nucleotide substitutions found in SRY and SF1 binding sites were replaced with mouse sequence, recovered the activity. Furthermore, SRYs of the SRY-positive species could not activate the mutated TESCO or mouse TESCO, suggesting that SRYs lost function as a sex-determining gene any more. Our results indicate that the SRY dependent sex-determining mechanism was lost in a common ancestor of the genus Tokudaia caused by nucleotide substitutions in SRY and SF1 binding sites after emergence of a new sex-determining gene. We present the first evidence for an intermediate stage of the switchover from SRY to a new sex-determining gene in the evolution of mammalian sex-determining mechanism.	[Kimura, Ryutaro; Murata, Chie; Kuroiwa, Asato] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Kuroki, Yoko] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Kuroiwa, Asato] Hokkaido Univ, Fac Sci, Lab Anim Cytogenet, Dept Biol Sci, Sapporo, Hokkaido 060, Japan	Hokkaido University; RIKEN; Hokkaido University	Kuroiwa, A (corresponding author), Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan.	asatok@sci.hokudai.ac.jp		Kuroiwa, Asato/0000-0002-3942-3372				Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Bagheri-Fam S, 2012, CHROMOSOME RES, V20, P191, DOI 10.1007/s10577-011-9269-5; Bernard P, 2012, ENDOCRINOLOGY, V153, P901, DOI 10.1210/en.2011-1347; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Fujiyama A, 2002, SCIENCE, V295, P131, DOI 10.1126/science.1065199; Gordon CT, 2009, J MED GENET, V46, P649, DOI 10.1136/jmg.2009.068361; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HONDA T, 1978, JPN J GENET, V53, P297, DOI 10.1266/jjg.53.297; HONDA T, 1977, JPN J GENET, V52, P247, DOI 10.1266/jjg.52.247; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Kanai Y, 1999, HUM MOL GENET, V8, P691, DOI 10.1093/hmg/8.4.691; Karl J, 1998, DEV BIOL, V203, P323, DOI 10.1006/dbio.1998.9068; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Kropatsch R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073734; Kuroiwa A, 2011, CHROMOSOME RES, V19, P635, DOI 10.1007/s10577-011-9223-6; Lovell-Badge R, 2002, NOVART FDN SYMP, V244, P4; Ludbrook LM, 2012, ENDOCRINOLOGY, V153, P1948, DOI 10.1210/en.2011-1428; MATSUDA Y, 1995, ELECTROPHORESIS, V16, P261, DOI 10.1002/elps.1150160142; MATSUDA Y, 1992, CYTOGENET CELL GENET, V61, P282, DOI 10.1159/000133423; Murata C, 2012, CHROMOSOME RES, V20, P111, DOI 10.1007/s10577-011-9268-6; Murata C, 2010, CHROMOSOME RES, V18, P623, DOI 10.1007/s10577-010-9142-y; Pannetier M, 2006, FEBS LETT, V580, P3715, DOI 10.1016/j.febslet.2006.05.060; Qin YJ, 2004, HUM MOL GENET, V13, P1213, DOI 10.1093/hmg/ddh141; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Soullier S, 1998, MAMM GENOME, V9, P590, DOI 10.1007/s003359900823; Sutou S, 2001, MAMM GENOME, V12, P17, DOI 10.1007/s003350010228; Tsuchiya K., 1989, MEMOIRS NATL SCI MUS, V22, P227; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Yamada F, 2010, MAMM STUDY, V35, P243, DOI 10.3106/041.035.0404	37	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108779	10.1371/journal.pone.0108779	http://dx.doi.org/10.1371/journal.pone.0108779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265165	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400119
J	Qiu, J; Wang, Y; Wu, SL; Wang, YY; Ye, CY; Bai, XF; Li, ZF; Yan, CH; Wang, WD; Wang, ZQ; Shu, QY; Xie, JH; Lee, SH; Fan, LJ				Qiu, Jie; Wang, Yu; Wu, Sanling; Wang, Ying-Ying; Ye, Chu-Yu; Bai, Xuefei; Li, Zefeng; Yan, Chenghai; Wang, Weidi; Wang, Ziqiang; Shu, Qingyao; Xie, Jiahua; Lee, Suk-Ha; Fan, Longjiang			Genome Re-Sequencing of Semi-Wild Soybean Reveals a Complex Soja Population Structure and Deep Introgression	PLOS ONE			English	Article							GLYCINE-SOJA; GENETIC DIVERSITY; CULTIVATED SOYBEANS; CHLOROPLAST GENOME; WILD; DOMESTICATION; ORIGIN; MAX; POLYMORPHISM; LANDRACES	Semi-wild soybean is a unique type of soybean that retains both wild and domesticated characteristics, which provides an important intermediate type for understanding the evolution of the subgenus Soja population in the Glycine genus. In this study, a semi-wild soybean line (Maliaodou) and a wild line (Lanxi 1) collected from the lower Yangtze regions were deeply sequenced while nine other semi-wild lines were sequenced to a 3-fold genome coverage. Sequence analysis revealed that (1) no independent phylogenetic branch covering all 10 semi-wild lines was observed in the Soja phylogenetic tree; (2) besides two distinct subpopulations of wild and cultivated soybean in the Soja population structure, all semi-wild lines were mixed with some wild lines into a subpopulation rather than an independent one or an intermediate transition type of soybean domestication; (3) high heterozygous rates (0.19-0.49) were observed in several semi-wild lines; and (4) over 100 putative selective regions were identified by selective sweep analysis, including those related to the development of seed size. Our results suggested a hybridization origin for the semi-wild soybean, which makes a complex Soja population structure.	[Qiu, Jie; Wang, Yu; Wu, Sanling; Wang, Ying-Ying; Ye, Chu-Yu; Bai, Xuefei; Li, Zefeng; Yan, Chenghai; Wang, Weidi; Wang, Ziqiang; Fan, Longjiang] Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China; [Qiu, Jie; Wang, Yu; Wu, Sanling; Wang, Ying-Ying; Ye, Chu-Yu; Bai, Xuefei; Li, Zefeng; Yan, Chenghai; Wang, Weidi; Wang, Ziqiang; Fan, Longjiang] Zhejiang Univ, James D Watson Inst Genome Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Shu, Qingyao] Zhejiang Univ, Inst Nucl Agr Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xie, Jiahua] N Carolina Cent Univ, Dept Pharmaceut Sci, Durham, NC USA; [Lee, Suk-Ha] Seoul Natl Univ, Dept Plant Sci, Seoul, South Korea; [Lee, Suk-Ha] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Zhejiang University; Zhejiang University; Zhejiang University; University of North Carolina; North Carolina Central University; Seoul National University (SNU); Seoul National University (SNU)	Fan, LJ (corresponding author), Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China.	fanlj@zju.edu.cn	Qiu, Jie/ABC-9247-2021; Shu, Qing-Yao/C-4859-2008	Qiu, Jie/0000-0003-1799-1907; Shu, Qing-Yao/0000-0002-9201-0593; Wang, Yingying/0000-0002-0603-6691; Xie, Jiahua/0000-0003-2786-0281; Fan, Longjiang/0000-0003-4846-0500; Wang, Yu/0000-0002-2819-4551	National Basic Research Program of China [2011CB109306]; Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008117]; National Science Foundation of China [31301046]; China Postdoctoral Science Foundation [2013M531467]	National Basic Research Program of China(National Basic Research Program of China); Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Basic Research Program of China (2011CB109306) (to L.F.), the Next Generation BioGreen 21 Program (PJ008117), Rural Development Administration, Republic of Korea (to S.-H.L.) and National Science Foundation of China (31301046) and China Postdoctoral Science Foundation (2013M531467) (to Y.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 1999, ECON BOT, V53, P285, DOI 10.1007/BF02866640; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; BROICH SL, 1980, EUPHYTICA, V29, P23, DOI 10.1007/BF00037246; Carter T.E., 2004, AGRONOMY, P303, DOI DOI 10.2134/AGR0NM0N0GR16.3ED.C8; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chen YW, 2004, CROP SCI, V44, P316, DOI 10.2135/cropsci2004.0316; Chung WH, 2013, DNA RES; CLOSE PS, 1989, THEOR APPL GENET, V77, P768, DOI 10.1007/BF00268325; Concibido VC, 2003, THEOR APPL GENET, V106, P575, DOI 10.1007/s00122-002-1071-5; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fujita R, 1997, J HERED, V88, P124, DOI 10.1093/oxfordjournals.jhered.a023070; FUKUDA YASONA, 1933, JAP JOUR BOT, V6, P489; Hao DR, 2012, THEOR APPL GENET, V124, P447, DOI 10.1007/s00122-011-1719-0; Hermann F, 1962, REVISION GENUS GLYCI; Hirota T, 2011, BREEDING SCI, V61, P593, DOI 10.1270/jsbbs.61.593; Hu M, 1993, CHINESE SOYBEAN BREE; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; HYMOWITZ T, 1970, ECON BOT, V24, P408, DOI 10.1007/BF02860745; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r28; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar V, 2006, J FOOD COMPOS ANAL, V19, P188, DOI 10.1016/j.jfca.2005.06.005; Kuroda Y, 2010, MOL ECOL, V19, P2346, DOI 10.1111/j.1365-294X.2010.04636.x; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LEROY AR, 1991, CROP SCI, V31, P693, DOI 10.2135/cropsci1991.0011183X003100030029x; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li YH, 2010, NEW PHYTOL, V188, P242, DOI 10.1111/j.1469-8137.2010.03344.x; Li YH, 2008, THEOR APPL GENET, V117, P857, DOI 10.1007/s00122-008-0825-0; Li YY, 2013, BMC GENOMICS, V14, DOI [10.1186/1471-2164-14-553, 10.1186/1471-2164-14-579]; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mullis K, 1992, Biotechnology, V24, P17; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nakayama Yuichiro, 2002, Weed Biology and Management, V2, P25, DOI 10.1046/j.1445-6664.2002.00043.x; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sambrook J., 2001, MOL CLONING LAB MANU; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Skvortzow BV, 1927, NATURAL HIST PUBLI A, V22; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Stanke M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s11; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang KJ, 2011, PLANT BREEDING, V130, P117, DOI 10.1111/j.1439-0523.2010.01815.x; Wang KJ, 2013, GENET RESOUR CROP EV, V60, P2303, DOI 10.1007/s10722-013-9998-8; Wang KJ, 2012, J HERED, V103, P13, DOI 10.1093/jhered/esr102; Wang KJ, 2010, GENET RESOUR CROP EV, V57, P747, DOI 10.1007/s10722-009-9513-4; Wang KJ, 2000, REV CHINA AGR SCI TE, V2, P69; Wen ZX, 2009, THEOR APPL GENET, V119, P371, DOI 10.1007/s00122-009-1045-y; Xu DH, 2002, THEOR APPL GENET, V105, P645, DOI 10.1007/s00122-002-0972-7; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; Yang K, 2010, J HERED, V101, P757, DOI 10.1093/jhered/esq078; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao TuanJie, 2004, Scientia Agricultura Sinica, V37, P954	60	17	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108479	10.1371/journal.pone.0108479	http://dx.doi.org/10.1371/journal.pone.0108479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265539	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400078
J	Savoy-Burke, G; Gilels, FA; Pan, W; Pratt, D; Que, JW; Gan, L; White, PM; Kiernan, AE				Savoy-Burke, Grace; Gilels, Felicia A.; Pan, Wei; Pratt, Diana; Que, Jianwen; Gan, Lin; White, Patricia M.; Kiernan, Amy E.			Activated Notch Causes Deafness by Promoting a Supporting Cell Phenotype in Developing Auditory Hair Cells	PLOS ONE			English	Article							MAMMALIAN INNER-EAR; ORGAN DEVELOPMENT; STEM-CELLS; EXPRESSION; SOX2; DIFFERENTIATION; GENE; PROGENITOR; DROSOPHILA; LIGANDS	Purpose: To determine whether activated Notch can promote a supporting cell fate during sensory cell differentiation in the inner ear. Methods: An activated form of the Notch1 receptor (NICD) was expressed in early differentiating hair cells using a Gfi1-Cre mouse allele. To determine the effects of activated Notch on developing hair cells, Gfi1-NICD animals and their littermate controls were assessed at 5 weeks for hearing by measuring auditory brainstem responses (ABRs) and distortion product otoacoustic emissions (DPOAEs). The differentiation of NICD-expressing hair cells was assessed at postnatal day (P) 6, 11 and 20, using histological and molecular markers for hair cells, as well as supporting cells/progenitor cells. We also examined whether the effects of Notch were mediated by SOX2, a gene expressed in supporting cells and a likely downstream target of Notch, by crossing an inducible form of SOX2 to the Gfi1-Cre. Results: Activation of Notch1 in developing auditory hair cells causes profound deafness. The NICD-expressing hair cells switch off a number of hair cell markers and lose their characteristic morphology. Instead, NICD-expressing hair cells adopt a morphology resembling supporting cells and upregulate a number of supporting cell markers. These effects do not appear to be mediated by SOX2, because although expression of SOX2 caused some hearing impairment, the SOX2-expressing hair cells did not downregulate hair cell markers nor exhibit a supporting cell-like phenotype. Conclusions: Our data show that Notch signaling inhibits hair cell differentiation and promotes a supporting cell-like phenotype, and that these effects are unlikely to be mediated by SOX2.	[Savoy-Burke, Grace; Pan, Wei; Pratt, Diana; Gan, Lin; Kiernan, Amy E.] Univ Rochester, Med Ctr, Dept Ophthalmol, Rochester, NY 14642 USA; [Pan, Wei; Que, Jianwen; Kiernan, Amy E.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Gilels, Felicia A.; Gan, Lin; White, Patricia M.] Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Kiernan, AE (corresponding author), Univ Rochester, Med Ctr, Dept Ophthalmol, Rochester, NY 14642 USA.	amy_kiernan@urmc.rochester.edu	Pan, Wei/G-7547-2015	Pan, Wei/0000-0002-8827-8650; Gilels, Felicia/0000-0001-9083-062X	National Institutes of Health [DC009250, DC008856, DK082650]; Research to Prevent Blindness; Schmitt Program on Integrative Brain Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK082650, K99DK082650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008856, R01DC009250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Schmitt Program on Integrative Brain Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support was provided by the National Institutes of Health www.nih.gov; DC009250 (AK), DC008856 (LG), DK082650 (JQ), Research to Prevent Blindness, http://www.rpbusa.org/rpb/; Research to Prevent Blindness unrestricted grant to the Department of Ophthalmology at the University of Rochester Medical Center, the Schmitt Program on Integrative Brain Research (AK and PW) (http://www.urmc.rochester.edu/neurobiology-anatomy/schmitt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam J, 1998, DEVELOPMENT, V125, P4645; Barry DS, 2014, INT J BIOCHEM CELL B, V46, P76, DOI 10.1016/j.biocel.2013.11.013; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Eddison M, 2000, P NATL ACAD SCI USA, V97, P11692, DOI 10.1073/pnas.97.22.11692; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Fekete DM, 1998, J NEUROSCI, V18, P7811; Freeman SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046387; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; Haddon C, 1998, DEVELOPMENT, V125, P4637; Hertzano R, 2004, HUM MOL GENET, V13, P2143, DOI 10.1093/hmg/ddh218; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Hume CR, 2007, GENE EXPR PATTERNS, V7, P798, DOI 10.1016/j.modgep.2007.05.002; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kiernan AE, 2013, SEMIN CELL DEV BIOL, V24, P470, DOI 10.1016/j.semcdb.2013.04.002; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; LEWIS J, 1991, CIBA F SYMP, V160, P25, DOI 10.4171/RMI/104; Liu ZY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034123, 10.1371/journal.pone.0050367]; Liu ZY, 2012, DEV DYNAM, V241, P684, DOI 10.1002/dvdy.23754; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011022; McLean WJ, 2009, JARO-J ASSOC RES OTO, V10, P37, DOI 10.1007/s10162-008-0152-9; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Oesterle EC, 2007, J ASS RES OTOLARYNGO; Pan W, 2013, J NEUROSCI, V33, P16146, DOI 10.1523/JNEUROSCI.3150-12.2013; Pan W, 2010, P NATL ACAD SCI USA, V107, P15798, DOI 10.1073/pnas.1003089107; Peters TA, 2001, EUR ARCH OTO-RHINO-L, V258, P67, DOI 10.1007/s004050000304; Riley BB, 1999, DEVELOPMENT, V126, P5669; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; Weller M, 2006, DEV NEUROSCI-BASEL, V28, P70, DOI 10.1159/000090754; Yang H, 2010, GENESIS, V48, P400, DOI 10.1002/dvg.20632	36	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108160	10.1371/journal.pone.0108160	http://dx.doi.org/10.1371/journal.pone.0108160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264928	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400046
J	Shahul, S; Hacker, MR; Novack, V; Mueller, A; Shaefi, S; Mahmood, B; Ali, SH; Talmor, D				Shahul, Sajid; Hacker, Michele R.; Novack, Victor; Mueller, Ariel; Shaefi, Shahzad; Mahmood, Bilal; Ali, Syed Haider; Talmor, Daniel			The Effect of Hospital Volume on Mortality in Patients Admitted with Severe Sepsis	PLOS ONE			English	Article							SURGERY; CARE; OUTCOMES; PROGRAM; TRENDS	Importance: The association between hospital volume and inpatient mortality for severe sepsis is unclear. Objective: To assess the effect of severe sepsis case volume and inpatient mortality. Design Setting and Participants: Retrospective cohort study from 646,988 patient discharges with severe sepsis from 3,487 hospitals in the Nationwide Inpatient Sample from 2002 to 2011. Exposures: The exposure of interest was the mean yearly sepsis case volume per hospital divided into tertiles. Main Outcomes and Measures: Inpatient mortality. Results: Compared with the highest tertile of severe sepsis volume (>60 cases per year), the odds ratio for inpatient mortality among persons admitted to hospitals in the lowest tertile (<= 10 severe sepsis cases per year) was 1.188 (95% CI: 1.074-1.315), while the odds ratio was 1.090 (95% CI: 1.031-1.152) for patients admitted to hospitals in the middle tertile. Similarly, improved survival was seen across the tertiles with an adjusted inpatient mortality incidence of 35.81 (95% CI: 33.64-38.03) for hospitals with the lowest volume of severe sepsis cases and a drop to 32.07 (95% CI: 31.51-32.64) for hospitals with the highest volume. Conclusions and Relevance: We demonstrate an association between a higher severe sepsis case volume and decreased mortality. The need for a systems-based approach for improved outcomes may require a high volume of severely septic patients.	[Shahul, Sajid; Mueller, Ariel; Shaefi, Shahzad; Mahmood, Bilal; Talmor, Daniel] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Anesthesiol, Sch Med, Boston, MA 02215 USA; [Hacker, Michele R.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Sch Med, Boston, MA 02215 USA; [Novack, Victor] Ben Gurion Univ Negev, Clin Res Ctr, Soroka Univ Med Ctr, IL-84105 Beer Sheva, Israel; [Novack, Victor] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Ali, Syed Haider] Washington & Lee Univ, Lexington, VA 24450 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Washington & Lee University	Shahul, S (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Anesthesiol, Sch Med, Boston, MA 02215 USA.	sshahul@bidmc.harvard.edu	Hacker, Michele/ABC-5031-2021	Ali, Syed/0000-0003-0524-5376	FAER (foundation for anesthesia research); The Harvard Clinical and Translational Science Center (NIH) [UL1 RR 025758]; Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	FAER (foundation for anesthesia research); The Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	S. Shahul is funded by FAER (foundation for anesthesia research). MH is funded by The Harvard Clinical and Translational Science Center (NIH Award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MED CARE; Birkmeyer JD, 2007, ANN SURG, V245, P777, DOI 10.1097/01.sla.0000252402.33814.dd; Birkmeyer NJO, 2010, JAMA-J AM MED ASSOC, V304, P435, DOI 10.1001/jama.2010.1034; Carey JS, 2003, AM SURGEON, V69, P63; Checkley W, 2014, CRIT CARE MED, V42, P344, DOI 10.1097/CCM.0b013e3182a275d7; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077414; Djogovic D, 2012, CAN J EMERG MED, V14, P36, DOI 10.2310/8000.2011.110610; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Hendryx MS, 1998, AM J RESP CRIT CARE, V158, P418, DOI 10.1164/ajrccm.158.2.9608068; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Mayr FB, 2013, VIRULENCE, V5; Powell ES, 2010, CRIT CARE MED, V38, P2161, DOI 10.1097/CCM.0b013e3181f3e09c; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Reinikainen M, 2010, INTENS CARE MED, V36, P673, DOI 10.1007/s00134-009-1688-9; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Shahin J, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3394; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Walkey AJ, 2014, AM J RESP CRIT CARE; Walkey AJ, 2011, JAMA-J AM MED ASSOC, V306, P2248, DOI 10.1001/jama.2011.1615	21	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108754	10.1371/journal.pone.0108754	http://dx.doi.org/10.1371/journal.pone.0108754			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264788	gold, Green Submitted, Green Published			2022-12-27	WOS:000345745400116
J	Kovacs, AM; Kuhn, S; Gergely, G; Csibra, G; Brass, M				Kovacs, Agnes Melinda; Kuehn, Simone; Gergely, Gyoergy; Csibra, Gergely; Brass, Marcel			Are All Beliefs Equal? Implicit Belief Attributions Recruiting Core Brain Regions of Theory of Mind	PLOS ONE			English	Article							TEMPORO-PARIETAL JUNCTION; MECHANISMS; TASK; INHIBITION; INFANTS; SYSTEMS; OTHERS; PEOPLE; SENSE; FMRI	Humans possess efficient mechanisms to behave adaptively in social contexts. They ascribe goals and beliefs to others and use these for behavioural predictions. Researchers argued for two separate mental attribution systems: an implicit and automatic one involved in online interactions, and an explicit one mainly used in offline deliberations. However, the underlying mechanisms of these systems and the types of beliefs represented in the implicit system are still unclear. Using neuroimaging methods, we show that the right temporo-parietal junction and the medial prefrontal cortex, brain regions consistently found to be involved in explicit mental state reasoning, are also recruited by spontaneous belief tracking. While the medial prefrontal cortex was more active when both the participant and another agent believed an object to be at a specific location, the right temporo-parietal junction was selectively activated during tracking the false beliefs of another agent about the presence, but not the absence of objects. While humans can explicitly attribute to a conspecific any possible belief they themselves can entertain, implicit belief tracking seems to be restricted to beliefs with specific contents, a content selectivity that may reflect a crucial functional characteristic and signature property of implicit belief attribution.	[Kovacs, Agnes Melinda; Gergely, Gyoergy; Csibra, Gergely] Cent European Univ, Cognit Dev Ctr, Budapest, Hungary; [Kuehn, Simone] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany; [Brass, Marcel] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Brass, Marcel] Univ Ghent, Ghent Inst Funct & Metab Imaging, B-9000 Ghent, Belgium; [Brass, Marcel] Radboud Univ Nijmegen, Inst Behav Sci, Nijmegen, Netherlands	Central European University; Max Planck Society; Ghent University; Ghent University; Radboud University Nijmegen	Kovacs, AM (corresponding author), Cent European Univ, Cognit Dev Ctr, Budapest, Hungary.	kovacsag@ceu.hu	Csibra, Gergely/C-4345-2008; Brass, Marcel/J-7082-2012; Kuehn, Simone/P-6145-2014	Csibra, Gergely/0000-0002-7044-3056; Brass, Marcel/0000-0002-3364-4019; Kovacs, Agnes Melinda/0000-0003-3452-7727; Gergely, Gyorgy/0000-0002-2094-4258; Kuhn, Simone/0000-0001-6823-7969	Special Research Fund of Ghent University [BOF06/24JZAP]; European Research Council under the European Union [249519-OSTREECOM]; ERC [284236-REPCOLLAB]; Hungarian Science Foundation [OTKA NK 83997]	Special Research Fund of Ghent University(Ghent University); European Research Council under the European Union(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	MB was supported by a grant of the Special Research Fund of Ghent University (BOF06/24JZAP). Further support came from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Advanced Investigator Grant to GC (249519-OSTREECOM), by an ERC Starting Grant to AMK (284236-REPCOLLAB) and by a grant from the Hungarian Science Foundation (OTKA NK 83997) to GG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichhorn M, 2009, J COGNITIVE NEUROSCI, V21, P1179, DOI 10.1162/jocn.2009.21082; Apperly IA, 2004, J COGNITIVE NEUROSCI, V16, P1773, DOI 10.1162/0898929042947928; Apperly IA, 2007, COGNITION, V103, P300, DOI 10.1016/j.cognition.2006.04.012; Apperly IA, 2009, PSYCHOL REV, V116, P953, DOI 10.1037/a0016923; Bargh J.A., 1994, HDB SOCIAL COGNITION, P1; Brass M, 2009, PHILOS T R SOC B, V364, P2359, DOI 10.1098/rstb.2009.0066; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; FODOR JA, 1992, COGNITION, V44, P283, DOI 10.1016/0010-0277(92)90004-2; Friedman O, 2004, PSYCHOL SCI, V15, P547, DOI 10.1111/j.0956-7976.2004.00717.x; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; Ma N, 2012, SOC COGN AFFECT NEUR, V7, P937, DOI 10.1093/scan/nsr064; Mitchell JP, 2008, CEREB CORTEX, V18, P262, DOI 10.1093/cercor/bhm051; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Ramsey R, 2013, J COGNITIVE NEUROSCI, V25, P670, DOI 10.1162/jocn_a_00345; Ramsey R, 2012, SOC COGN AFFECT NEUR, V7, P242, DOI 10.1093/scan/nsq102; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Samson D, 2004, NAT NEUROSCI, V7, P499, DOI 10.1038/nn1223; Samson D, 2010, J EXP PSYCHOL HUMAN, V36, P1255, DOI 10.1037/a0018729; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Sebanz N, 2005, J EXP PSYCHOL HUMAN, V31, P1234, DOI 10.1037/0096-1523.31.6.1234; Spiers HJ, 2006, NEUROPSYCHOLOGIA, V44, P1674, DOI 10.1016/j.neuropsychologia.2006.03.028; Spunt RP, 2013, PSYCHOL SCI, V24, P80, DOI 10.1177/0956797612450884; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Wagner DD, 2011, CEREB CORTEX, V21, P2788, DOI 10.1093/cercor/bhr074; Young L, 2009, J COGNITIVE NEUROSCI, V21, P1396, DOI 10.1162/jocn.2009.21137	35	45	45	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e106558	10.1371/journal.pone.0106558	http://dx.doi.org/10.1371/journal.pone.0106558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IP	25259625	gold, Green Published, Green Accepted			2022-12-27	WOS:000342685600007
J	Liu, C; Guo, QP; Li, J; Wang, SH; Wang, YB; Li, B; Yang, HL				Liu, Chen; Guo, Qianping; Li, Jun; Wang, Shenghao; Wang, Yibin; Li, Bin; Yang, Huilin			Identification of Rabbit Annulus Fibrosus-Derived Stem Cells	PLOS ONE			English	Article							TENDON STEM/PROGENITOR CELLS; INTERVERTEBRAL DISC; PROGENITOR CELLS; NUCLEUS PULPOSUS; BONE-MARROW; ANULUS FIBROSUS; ADIPOSE-TISSUE; MATRIX; DEGENERATION; EXPRESSION	Annulus fibrosus (AF) injuries can lead to substantial deterioration of intervertebral disc (IVD) which characterizes degenerative disc disease (DDD). However, treatments for AF repair/regeneration remain challenging due to the intrinsic heterogeneity of AF tissue at cellular, biochemical, and biomechanical levels. In this study, we isolated and characterized a sub-population of cells from rabbit AF tissue which formed colonies in vitro and could self-renew. These cells showed gene expression of typical surface antigen molecules characterizing mesenchymal stem cells (MSCs), including CD29, CD44, and CD166. Meanwhile, they did not express negative markers of MSCs such as CD4, CD8, and CD14. They also expressed Oct-4, nucleostemin, and SSEA-4 proteins. Upon induced differentiation they showed typical osteogenesis, chondrogenesis, and adipogenesis potential. Together, these AF-derived colony-forming cells possessed clonogenicity, self-renewal, and multipotential differentiation capability, the three criteria characterizing MSCs. Such AF-derived stem cells may potentially be an ideal candidate for DDD treatments using cell therapies or tissue engineering approaches.	[Liu, Chen; Guo, Qianping; Li, Jun; Li, Bin; Yang, Huilin] Soochow Univ, Affiliated Hosp 1, Dept Orthopaed, Suzhou, Jiangsu, Peoples R China; [Liu, Chen; Guo, Qianping; Wang, Shenghao; Wang, Yibin; Li, Bin; Yang, Huilin] Soochow Univ, Inst Orthoped, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Li, B (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Orthopaed, Suzhou, Jiangsu, Peoples R China.	binli@suda.edu.cn; suzhouspine@163.com	Li, Bin/B-7802-2012	Li, Jun/0000-0002-3257-9315; Wang, Shenghao/0000-0003-0595-5845	National Natural Science Foundation of China [81171479]; Natural Science Foundation of Jiangsu Province [BK2011291]; Jiangsu Provincial Special Program of Medical Science [BL2012004]; National Undergraduate Training Program for Innovation and Entrepreneurship, Soochow University [201210285044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Provincial Special Program of Medical Science; National Undergraduate Training Program for Innovation and Entrepreneurship, Soochow University	This study was supported by National Natural Science Foundation of China (81171479), Natural Science Foundation of Jiangsu Province (BK2011291), Jiangsu Provincial Special Program of Medical Science (BL2012004), and National Undergraduate Training Program for Innovation and Entrepreneurship, Soochow University (201210285044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bowles RD, 2011, P NATL ACAD SCI USA, V108, P13106, DOI 10.1073/pnas.1107094108; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x; Bruno S, 2009, STEM CELLS DEV, V18, P867, DOI 10.1089/scd.2008.0320; Driscoll TP, 2013, J ORTHOP RES, V31, P864, DOI 10.1002/jor.22312; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009; Feng G, 2010, J BONE JOINT SURG AM, V92A, P675, DOI 10.2106/JBJS.H.01672; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Garcia-Prat L, 2013, FEBS J, V280, P4051, DOI 10.1111/febs.12221; Gibbings D, 2009, J LEUKOCYTE BIOL, V86, P251, DOI 10.1189/jlb.0109040; Greco SJ, 2007, STEM CELLS, V25, P3143, DOI 10.1634/stemcells.2007-0351; Guterl CC, 2013, EUR CELLS MATER, V25, P1; Henriksson HB, 2009, SPINE, V34, P2278, DOI 10.1097/BRS.0b013e3181a95ad2; Henriksson HB, 2009, SPINE, V34, P141, DOI 10.1097/BRS.0b013e31818f8c20; Henriksson HB, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt315; Henriksson HB, 2012, SPINE, V37, P722, DOI 10.1097/BRS.0b013e318231c2f7; Horner HA, 2002, SPINE, V27, P1018, DOI 10.1097/00007632-200205150-00004; Hudson KD, 2013, CURR OPIN BIOTECH, V24, P872, DOI 10.1016/j.copbio.2013.04.012; Koepsell L, 2011, J BIOMED MATER RES A, V99A, P564, DOI 10.1002/jbm.a.33216; Kohler J, 2013, AGING CELL, V12, P988, DOI 10.1111/acel.12124; Levesque MC, 1998, ARTHRITIS RHEUM, V41, P2221, DOI 10.1002/1529-0131(199812)41:12<2221::AID-ART18>3.0.CO;2-I; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091799; Liu TM, 2007, STEM CELLS, V25, P750, DOI 10.1634/stemcells.2006-0394; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Mizuno H, 2004, SPINE, V29, P1290, DOI 10.1097/01.BRS.0000128264.46510.27; Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]; Paesold G, 2007, EUR SPINE J, V16, P447, DOI 10.1007/s00586-006-0220-y; POSTACCHINI F, 1984, SPINE, V9, P596, DOI 10.1097/00007632-198409000-00010; Qu J, 2012, J CELL BIOL, V197, P731, DOI 10.1083/jcb.201103071; Risbud MV, 2007, SPINE, V32, P2537, DOI 10.1097/BRS.0b013e318158dea6; Sabatino M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-23; Sakai D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2226; Seo KW, 2009, BIOCHEM BIOPH RES CO, V384, P120, DOI 10.1016/j.bbrc.2009.04.094; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Wan YQ, 2008, BIOMATERIALS, V29, P643, DOI 10.1016/j.biomaterials.2007.10.031; Yasen M, 2013, ACTA BIOCH BIOPH SIN, V45, P368, DOI 10.1093/abbs/gmt019; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Yu Y, 2006, STEM CELLS, V24, P1605, DOI 10.1634/stemcells.2005-0298; Zhang JY, 2011, BIOMATERIALS, V32, P6972, DOI 10.1016/j.biomaterials.2011.05.088; Zuk PA, 2009, J CELL BIOCHEM, V106, P867, DOI 10.1002/jcb.22054	43	46	52	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108239	10.1371/journal.pone.0108239	http://dx.doi.org/10.1371/journal.pone.0108239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259600	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600055
J	Maldifassi, MC; Atienza, G; Arnalich, F; Lopez-Collazo, E; Cedillo, JL; Martin-Sanchez, C; Bordas, A; Renart, J; Montiel, C				Maldifassi, Maria C.; Atienza, Gema; Arnalich, Francisco; Lopez-Collazo, Eduardo; Cedillo, Jose L.; Martin-Sanchez, Carolina; Bordas, Anna; Renart, Jaime; Montiel, Carmen			A New IRAK-M-Mediated Mechanism Implicated in the Anti-Inflammatory Effect of Nicotine via alpha 7 Nicotinic Receptors in Human Macrophages	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; CIGARETTE-SMOKING; NEGATIVE REGULATION; HUMAN MONOCYTES; ENDOTOXIN TOLERANCE; UP-REGULATION; M EXPRESSION; CROSS-TALK; KINASE-M	Nicotine stimulation of alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChR) powerfully inhibits pro-inflammatory cytokine production in lipopolysaccharide (LPS)-stimulated macrophages and in experimental models of endotoxemia. A signaling pathway downstream from the alpha 7 nAChRs, which involves the collaboration of JAK2/STAT3 and NF-kappa B to interfere with signaling by Toll-like receptors (TLRs), has been implicated in this anti-inflammatory effect of nicotine. Here, we identifiy an alternative mechanism involving interleukin-1 receptor-associated kinase M (IRAK-M), a negative regulator of innate TLR-mediated immune responses. Our data show that nicotine up-regulates IRAK-M expression at the mRNA and protein level in human macrophages, and that this effect is secondary to alpha 7 nAChR activation. By using selective inhibitors of different signaling molecules downstream from the receptor, we provide evidence that activation of STAT3, via either JAK2 and/or PI3K, through a single (JAK2/PI3K/STAT3) or two convergent cascades (JAK2/STAT3 and PI3K/STAT3), is necessary for nicotine-induced IRAK-M expression. Moreover, down-regulation of this expression by small interfering RNAs specific to the IRAK-M gene significantly reverses the anti-inflammatory effect of nicotine on LPS-induced TNF-alpha production. Interestingly, macrophages pre-exposed to nicotine exhibit higher IRAK-M levels and reduced TNF-alpha response to an additional LPS challenge, a behavior reminiscent of the 'endotoxin tolerant' phenotype identified in monocytes either pre-exposed to LPS or from immunocompromised septic patients. Since nicotine is a major component of tobacco smoke and increased IRAK-M expression has been considered one of the molecular determinants for the induction of the tolerant phenotype, our findings showing IRAK-M overexpression could partially explain the known influence of smoking on the onset and progression of inflammatory and infectious diseases.	[Maldifassi, Maria C.; Atienza, Gema; Cedillo, Jose L.; Martin-Sanchez, Carolina; Bordas, Anna; Montiel, Carmen] Univ Autonoma Madrid, Fac Med, IdiPAZ, Dept Farmacol & Terapeut, Madrid, Spain; [Arnalich, Francisco] Hosp Univ La Paz Madrid, IdiPAZ, Serv Med Interna, Madrid, Spain; [Lopez-Collazo, Eduardo] Hosp Univ La Paz Madrid, IdiPAZ, Lab Inmunol Tumoral, Madrid, Spain; [Renart, Jaime] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, IdiPAZ, Madrid, Spain	Autonomous University of Madrid; Hospital Universitario La Paz; Hospital Universitario La Paz; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Montiel, C (corresponding author), Univ Autonoma Madrid, Fac Med, IdiPAZ, Dept Farmacol & Terapeut, Madrid, Spain.	carmen.montiel@uam.es	Montiel, Carmen/L-1407-2017; Arnalich, Francisco/J-8184-2017; Arnalich, Francisco/AAF-5924-2021; Arnalich, Francisco/K-7723-2014; Renart, Jaime/B-7661-2009; Lopez-Collazo, Eduardo/U-6634-2018	Montiel, Carmen/0000-0003-4845-0484; Arnalich, Francisco/0000-0003-2943-0373; Renart, Jaime/0000-0001-6620-3706; Martin Sanchez, Carolina/0000-0003-4687-5884; Lopez-Collazo, Eduardo/0000-0003-1957-877X	Ministerio de Economia y Competitividad, Government of Spain [SAF2011-23575]; Fundacion Mutua Madrilena, Spain [FMM2011]	Ministerio de Economia y Competitividad, Government of Spain; Fundacion Mutua Madrilena, Spain	This work was supported by grants to C. Montiel and F. Arnalich from the Ministerio de Economia y Competitividad, Government of Spain (SAF2011-23575) and Fundacion Mutua Madrilena (FMM2011), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Arredondo J, 2006, FASEB J, V20, P2093, DOI 10.1096/fj.06-6191com; Bastida G, 2011, WORLD J GASTROENTERO, V17, P2740, DOI [10.3748/wjg.v17.i22.2740, 10.3748/wjg.v17.i22.2734]; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bitner RS, 2007, J NEUROSCI, V27, P10578, DOI 10.1523/JNEUROSCI.2444-07.2007; Blanchet MR, 2006, AM J PHYSIOL-LUNG C, V291, pL757, DOI 10.1152/ajplung.00409.2005; Bode JG, 2012, CELL SIGNAL, V24, P1185, DOI 10.1016/j.cellsig.2012.01.018; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Buckingham SD, 2009, PHARMACOL REV, V61, P39, DOI 10.1124/pr.108.000562; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Clark AR, 2003, FEBS LETT, V546, P37, DOI 10.1016/S0014-5793(03)00439-3; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; de Lucas-Cerrillo AM, 2011, J BIOL CHEM, V286, P594, DOI 10.1074/jbc.M110.180067; del Fresno C, 2005, J IMMUNOL, V174, P3032, DOI 10.4049/jimmunol.174.5.3032; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; Deng H, 2013, J BIOL CHEM, V288, P3897, DOI 10.1074/jbc.M112.424390; El Kouhen R, 2009, BRIT J PHARMACOL, V156, P638, DOI 10.1111/j.1476-5381.2008.00069.x; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Goncalves RB, 2011, INFLAMM RES, V60, P409, DOI 10.1007/s00011-011-0308-7; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Heldsinger A, 2011, J BIOL CHEM, V286, P11707, DOI 10.1074/jbc.M110.198945; Hoentjen F, 2005, BLOOD, V105, P689, DOI 10.1182/blood-2004-04-1309; Hubbard LLN, 2010, INFECT DIS REP, V2, P22, DOI 10.4081/idr.2010.e9; Huston JM, 2007, CRIT CARE MED, V35, P2762, DOI 10.1097/01.CCM.0000288102.15975.BA; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Johnson GK, 2004, J PERIODONTOL, V75, P196, DOI 10.1902/jop.2004.75.2.196; Kim TH, 2014, J INFECT DIS, V209, P1668, DOI 10.1093/infdis/jit669; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Li Q, 2011, CELL PHYSIOL BIOCHEM, V27, P605, DOI 10.1159/000329982; Liu Q, 2007, FASEB J, V21, P61, DOI 10.1096/fj.06-5841com; Lopez-Collazo E, 2006, CURR OPIN INFECT DIS, V19, P237, DOI 10.1097/01.qco.0000224817.35105.7d; Mabley J, 2011, INFLAMMATION, V34, P231, DOI 10.1007/s10753-010-9228-x; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Marrero MB, 2009, BRAIN RES, V1256, P1, DOI 10.1016/j.brainres.2008.11.053; Martinez FO., 2012, CURR PROTOC IMMUNOL, V28, P1; Matsunaga K, 2001, J IMMUNOL, V167, P6518, DOI 10.4049/jimmunol.167.11.6518; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nakayama K, 2004, J BIOL CHEM, V279, P6629, DOI 10.1074/jbc.M308620200; Parkes GC, 2014, J CROHNS COLITIS, V8, P717, DOI 10.1016/j.crohns.2014.02.002; Rom O, 2013, RESP PHYSIOL NEUROBI, V187, P5, DOI 10.1016/j.resp.2013.01.013; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Rosati O, 2002, BIOCHEM BIOPH RES CO, V293, P1472, DOI 10.1016/S0006-291X(02)00411-4; Serantes R, 2006, J BIOL CHEM, V281, P14632, DOI 10.1074/jbc.M512489200; Shaw S, 2002, J BIOL CHEM, V277, P44920, DOI 10.1074/jbc.M204610200; Solis-Garrido LM, 2004, J BIOL CHEM, V279, P52414, DOI 10.1074/jbc.M408872200; Sugano N, 1998, BIOCHEM BIOPH RES CO, V252, P25, DOI 10.1006/bbrc.1998.9599; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Vogt PK, 2011, CANCER DISCOV, V1, P481, DOI 10.1158/2159-8290.CD-11-0218; Wada T, 2007, ENDOCRINOLOGY, V148, P790, DOI 10.1210/en.2006-0907; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang YY, 2014, ONCOL REP, V31, P1480, DOI 10.3892/or.2013.2962; Wannamethee SG, 2005, EUR HEART J, V26, P1765, DOI 10.1093/eurheartj/ehi183; Warnakulasuriya S, 2010, INT DENT J, V60, P7, DOI 10.1922/IDJ_2532Warnakulasuriya24; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Xiong YB, 2011, J LEUKOCYTE BIOL, V90, P1141, DOI 10.1189/jlb.0611273; Yang Q, 2011, MATH BIOSCI, V232, P151, DOI 10.1016/j.mbs.2011.05.005; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200; Young KF, 2009, NEUROCHEM INT, V55, P796, DOI 10.1016/j.neuint.2009.08.002; Zacharioudaki V, 2009, J IMMUNOL, V182, P6444, DOI 10.4049/jimmunol.0803694; Zhou YO, 2012, RHEUMATOL INT, V32, P97, DOI 10.1007/s00296-010-1549-4	70	43	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108397	10.1371/journal.pone.0108397	http://dx.doi.org/10.1371/journal.pone.0108397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259522	Green Submitted, gold, Green Published			2022-12-27	WOS:000342685600069
J	Mendes-Jorge, L; Ramos, D; Valenca, A; Lopez-Luppo, M; Pires, VMR; Catita, J; Nacher, V; Navarro, M; Carretero, A; Rodriguez-Baeza, A; Ruberte, J				Mendes-Jorge, Luisa; Ramos, David; Valenca, Andreia; Lopez-Luppo, Mariana; Rico Pires, Virginia Maria; Catita, Joana; Nacher, Victor; Navarro, Marc; Carretero, Ana; Rodriguez-Baeza, Alfonso; Ruberte, Jesus			L-Ferritin Binding to Scara5: A New Iron Traffic Pathway Potentially Implicated in Retinopathy	PLOS ONE			English	Article							RETINAL DEGENERATION; MACULAR DEGENERATION; SCAVENGER RECEPTOR; NUCLEAR FERRITIN; SERUM FERRITIN; BLOOD-VESSELS; SODIUM IODATE; H-FERRITIN; CELLS; TRANSFERRIN	Iron is essential in the retina because the heme-containing enzyme guanylate cyclase modulates phototransduction in rods and cones. Transferrin endocytosis is the classical pathway for obtaining iron from the blood circulation in the retina. However, the iron storage protein ferritin has been also recently proposed as an iron carrier. In this study, the presence of Scara5 and its binding to L-ferritin was investigated in the retina. Our results showed that Scara5, the specific receptor for L-ferritin, was expressed in mouse and human retinas in many cell types, including endothelial cells. Furthermore, we showed that intravenously injected ferritin crossed the blood retinal barrier through L-ferritin binding to Scara5 in endothelial cells. Thus, suggesting the existence of a new pathway for iron delivery and trafficking in the retina. In a murine model of photoreceptor degeneration, Scara5 was downregulated, pointing out this receptor as a potential player implicated in retinopathy and also as a possible therapeutic target.	[Mendes-Jorge, Luisa; Ramos, David; Valenca, Andreia; Lopez-Luppo, Mariana; Rico Pires, Virginia Maria; Nacher, Victor; Navarro, Marc; Carretero, Ana; Ruberte, Jesus] Univ Lisbon, Fac Vet Med, Interdisciplinary Ctr Res Anim Hlth, P-1699 Lisbon, Portugal; [Mendes-Jorge, Luisa] Univ Lisbon, Fac Vet Med, Dept Morphol & Funct, P-1699 Lisbon, Portugal; [Mendes-Jorge, Luisa; Ramos, David; Lopez-Luppo, Mariana; Catita, Joana; Nacher, Victor; Navarro, Marc; Carretero, Ana; Ruberte, Jesus] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, Bellaterra, Spain; [Lopez-Luppo, Mariana; Nacher, Victor; Navarro, Marc; Carretero, Ana; Ruberte, Jesus] Univ Autonoma Barcelona, Sch Vet Med, Dept Anim Hlth & Anat, Bellaterra, Spain; [Rodriguez-Baeza, Alfonso] Univ Autonoma Barcelona, Sch Med, Dept Morphol Sci, Bellaterra, Spain; [Ruberte, Jesus] CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona, Spain	Universidade de Lisboa; Universidade de Lisboa; Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Ruberte, J (corresponding author), Univ Lisbon, Fac Vet Med, Interdisciplinary Ctr Res Anim Hlth, P-1699 Lisbon, Portugal.	jesus.ruberte@uab.es	Rodríguez-Baeza, Alfonso/L-8284-2014; Pires, Virginia/J-4799-2013; Ruberte, Jesus/AAS-9240-2021	Rodríguez-Baeza, Alfonso/0000-0002-9181-5613; Pires, Virginia/0000-0003-1307-3797; RUBERTE, JESUS/0000-0003-1540-1432; Mendes-Jorge, Luisa/0000-0002-3767-2826; Catita, Joana/0000-0001-6000-2970; Valenca, Andreia/0000-0002-1241-9701; Navarro, Marc/0000-0002-9678-6129; Nacher, Victor/0000-0002-1340-4675	Fundacao para a Ciencia e a Tecnologia do Ministerio da Educacao e Ciencia, Portugal [PTDC/SAU-ORG/110856/2009]; Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Spain [PI12/00605]	Fundacao para a Ciencia e a Tecnologia do Ministerio da Educacao e Ciencia, Portugal; Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Spain(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by grants from PTDC/SAU-ORG/110856/2009 from Fundacao para a Ciencia e a Tecnologia do Ministerio da Educacao e Ciencia, Portugal and from Instituto de Salud Carlos III (PI12/00605), Ministerio de Ciencia e Innovacion, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, INT J CLIN EXP PATHO, V6, P622; Alkhateeb AA, 2010, BBA-GEN SUBJECTS, V1800, P793, DOI 10.1016/j.bbagen.2010.03.017; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Aslan M, 2008, FREE RADICAL BIO MED, V45, P367, DOI 10.1016/j.freeradbiomed.2008.04.026; Burdo JR, 2003, NEUROSCIENCE, V121, P883, DOI 10.1016/S0306-4522(03)00590-6; Chen TT, 2005, J EXP MED, V202, P955, DOI 10.1084/jem.20042433; Cunha-Vaz JG, 2004, EXP EYE RES, V78, P715, DOI 10.1016/S0014-4835(03)00213-6; Dunaief JL, 2006, INVEST OPHTH VIS SCI, V47, P4660, DOI 10.1167/iovs.06-0568; Feng YX, 2007, OPHTHALMOLOGICA, V221, P269, DOI 10.1159/000101930; Fisher J, 2007, AM J PHYSIOL-CELL PH, V293, pC641, DOI 10.1152/ajpcell.00599.2006; FRASER I, 1993, NATURE, V364, P343, DOI 10.1038/364343a0; Garcia-Castineiras S, 2010, EXP EYE RES, V90, P664, DOI 10.1016/j.exer.2010.03.003; Ghosh S, 2004, BLOOD, V103, P2369, DOI 10.1182/blood-2003-09-3050; Gnana-Prakasam JP, 2010, IUBMB LIFE, V62, P363, DOI 10.1002/iub.326; Goralska M, 2009, EXP EYE RES, V88, P204, DOI 10.1016/j.exer.2008.10.026; Hahn P, 2004, P NATL ACAD SCI USA, V101, P13850, DOI 10.1073/pnas.0405146101; Hahn P, 2004, MOL VIS, V10, P598; Han J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023800; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hashizume H, 2002, ARCH HISTOL CYTOL, V65, P347, DOI 10.1679/aohc.65.347; Haurigot V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041511; He XN, 2007, PROG RETIN EYE RES, V26, P649, DOI 10.1016/j.preteyeres.2007.07.004; HENRY CBS, 1995, MICROVASC RES, V49, P201, DOI 10.1006/mvre.1995.1016; HUNT RC, 1989, J CELL SCI, V92, P655; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Kiuchi K, 2002, CURR EYE RES, V25, P373, DOI 10.1076/ceyr.25.6.373.14227; LEVI S, 1992, BIOCHEM J, V288, P591, DOI 10.1042/bj2880591; Li JY, 2009, DEV CELL, V16, P35, DOI 10.1016/j.devcel.2008.12.002; Li L, 2010, P NATL ACAD SCI USA, V107, P3505, DOI 10.1073/pnas.0913192107; Li Y, 2006, INVEST OPHTH VIS SCI, V47, P1646, DOI 10.1167/iovs.05-1092; Linder MC, 1996, J GASTROEN HEPATOL, V11, P1033, DOI 10.1111/j.1440-1746.1996.tb00030.x; Mendes-Jorge L, 2012, EXP EYE RES, V98, P79, DOI 10.1016/j.exer.2012.03.010; Mendes-Jorge L, 2009, INVEST OPHTH VIS SCI, V50, P5997, DOI 10.1167/iovs.09-3515; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Saraswathy S, 2008, OPHTHALMIC RES, V40, P160, DOI 10.1159/000119869; SHICHI H, 1969, EXP EYE RES, V8, P60, DOI 10.1016/S0014-4835(69)80081-3; Siu TL, 2008, CLIN EXP OPHTHALMOL, V36, P176, DOI 10.1111/j.1442-9071.2008.01699.x; SKALLI O, 1989, J HISTOCHEM CYTOCHEM, V37, P315, DOI 10.1177/37.3.2918221; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stewart EA, 2011, EXP EYE RES, V93, P761, DOI 10.1016/j.exer.2011.09.010; Surguladze N, 2005, BIOCHEM J, V388, P731, DOI 10.1042/BJ20041853; Thompson KJ, 2002, J CELL SCI, V115, P2165; Ugarte M, 2013, SURV OPHTHALMOL, V58, P585, DOI 10.1016/j.survophthal.2012.12.002; Wang JM, 2014, INVEST OPHTH VIS SCI, V55, P1941, DOI 10.1167/iovs.13-13075; Wang W, 2010, BBA-GEN SUBJECTS, V1800, P760, DOI 10.1016/j.bbagen.2010.03.011; Yan N, 2012, CANCER SCI, V103, P1631, DOI 10.1111/j.1349-7006.2012.02350.x; Yanyan JY, 2006, J BIOL CHEM, V281, P11834, DOI 10.1074/jbc.M507599200; Yau KW, 1989, ANNU REV NEUROSCI, V12, P2785; Yefimova MG, 2000, INVEST OPHTH VIS SCI, V41, P2343; Zaia DAM, 1998, QUIM NOVA, V21, P787, DOI 10.1590/S0100-40421998000600020	51	35	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e106974	10.1371/journal.pone.0106974	http://dx.doi.org/10.1371/journal.pone.0106974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259650	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600015
J	Lucas, J; Dressman, HK; Suchindran, S; Nakamura, M; Chao, NJ; Himburg, H; Minor, K; Phillips, G; Ross, J; Abedi, M; Terbrueggen, R; Chute, JP				Lucas, Joseph; Dressman, Holly K.; Suchindran, Sunil; Nakamura, Mai; Chao, Nelson J.; Himburg, Heather; Minor, Kerry; Phillips, Gary; Ross, Joel; Abedi, Majid; Terbrueggen, Robert; Chute, John P.			A Translatable Predictor of Human Radiation Exposure	PLOS ONE			English	Article							GENE-EXPRESSION; MEDICAL RESPONSE; MANAGEMENT; SIGNATURES; MICE	Terrorism using radiological dirty bombs or improvised nuclear devices is recognized as a major threat to both public health and national security. In the event of a radiological or nuclear disaster, rapid and accurate biodosimetry of thousands of potentially affected individuals will be essential for effective medical management to occur. Currently, health care providers lack an accurate, high-throughput biodosimetric assay which is suitable for the triage of large numbers of radiation injury victims. Here, we describe the development of a biodosimetric assay based on the analysis of irradiated mice, ex vivo-irradiated human peripheral blood (PB) and humans treated with total body irradiation (TBI). Interestingly, a gene expression profile developed via analysis of murine PB radiation response alone was inaccurate in predicting human radiation injury. In contrast, generation of a gene expression profile which incorporated data from ex vivo irradiated human PB and human TBI patients yielded an 18-gene radiation classifier which was highly accurate at predicting human radiation status and discriminating medically relevant radiation dose levels in human samples. Although the patient population was relatively small, the accuracy of this classifier in discriminating radiation dose levels in human TBI patients was not substantially confounded by gender, diagnosis or prior exposure to chemotherapy. We have further incorporated genes from this human radiation signature into a rapid and high-throughput chemical ligation-dependent probe amplification assay (CLPA) which was able to discriminate radiation dose levels in a pilot study of ex vivo irradiated human blood and samples from human TBI patients. Our results illustrate the potential for translation of a human genetic signature for the diagnosis of human radiation exposure and suggest the basis for further testing of CLPA as a candidate biodosimetric assay.	[Lucas, Joseph] Duke Univ, Informat Initiat Duke, Durham, NC USA; [Dressman, Holly K.; Suchindran, Sunil] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Nakamura, Mai; Chao, Nelson J.; Himburg, Heather; Minor, Kerry; Phillips, Gary; Ross, Joel; Chute, John P.] Duke Univ, Med Ctr, Dept Med, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27710 USA; [Chao, Nelson J.] Duke Univ, Dept Immunol, Durham, NC USA; [Abedi, Majid; Terbrueggen, Robert] Dxter Diagnost, Los Angeles, CA USA; [Chute, John P.] Univ Calif Los Angeles, Jonnson Comprehens Canc Ctr, Broad Stem Cell Res Ctr, Div Hematol Oncol,Dept Med, Los Angeles, CA USA	Duke University; Duke University; Duke University; Duke University; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Chute, JP (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27710 USA.	jchute@mednet.ucla.edu		Nakamura, Mai/0000-0002-0180-1235	Biomedical Advanced Research and Development Authority (BARDA), H.H.S.; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER	Biomedical Advanced Research and Development Authority (BARDA), H.H.S.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Robert Terbrueggen and Majid Abedi are employees of Dxterity Diagnostics, Inc., which holds a license from Duke University to develop the human radiation gene signature described herein for diagnostic purposes. The research studies herein were funded by the Biomedical Advanced Research and Development Authority (BARDA), H.H.S. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese J, 2007, EXP HEMATOL, V35, P47, DOI 10.1016/j.exphem.2007.01.012; Amundson S A, 2001, Expert Rev Mol Diagn, V1, P211, DOI 10.1586/14737159.1.2.211; Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2; Amundson SA, 2003, HEALTH PHYS, V85, P36, DOI 10.1097/00004032-200307000-00009; Amundson SA, 2001, RADIAT RES, V156, P657, DOI 10.1667/0033-7587(2001)156[0657:IOGEAA]2.0.CO;2; Badie C, 2013, RADIAT RES, V180, P138, DOI 10.1667/RR3236.1; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Blakely WF, 2010, HEALTH PHYS, V99, pS184, DOI 10.1097/HP.0b013e3181f26895; Coleman CN, 2009, ANN EMERG MED, V53, P213, DOI 10.1016/j.annemergmed.2007.12.021; Coleman CN, 2009, J RADIOL PROT, V29, pA159, DOI 10.1088/0952-4746/29/2A/S11; Dainiak N, 2011, DISASTER MED PUBLIC, V5, P202, DOI 10.1001/dmp.2011.68; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Fliedner TM, 2008, BLOOD, V111, P5757, DOI 10.1182/blood-2008-04-150243; Fliedner TM, 2009, STEM CELLS, V27, P1205, DOI 10.1002/stem.16; Matsumoto T, 2009, P NATL ACAD SCI USA, V106, P14542, DOI 10.1073/pnas.0904229106; Meadows SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011535; Meadows SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001912; Meineke V, 2012, HEALTH PHYS, V103, P217, DOI 10.1097/HP.0b013e31825b5809; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; Murrain-Hill P, 2011, DISASTER MED PUBLIC, V5, pS89, DOI 10.1001/dmp.2011.13; Paul S, 2011, RADIAT RES, V175, P257, DOI 10.1667/RR2420.1; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Riecke A, 2012, RADIAT RES, V178, P234, DOI 10.1667/RR2738.1; Schreyer S, 2002, BR J RADIOL S, V26, P129; Straume Tore, 2008, Radiat Res, V170, P393, DOI 10.1667/RR1382.1; Sullivan JM, 2013, HEALTH PHYS, V105, P540, DOI 10.1097/HP.0b013e31829cf221; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Weinstock DM, 2008, BLOOD, V111, P5440, DOI 10.1182/blood-2008-01-134817; Wilkins R C, 1998, Radiat Oncol Investig, V6, P209, DOI 10.1002/(SICI)1520-6823(1998)6:5<209::AID-ROI2>3.0.CO;2-G	30	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107897	10.1371/journal.pone.0107897	http://dx.doi.org/10.1371/journal.pone.0107897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255453	Green Submitted, Green Published, gold			2022-12-27	WOS:000344862300039
J	Giner-Lamia, J; Lopez-Maury, L; Florencio, FJ				Giner-Lamia, Joaquin; Lopez-Maury, Luis; Florencio, Francisco J.			Global Transcriptional Profiles of the Copper Responses in the Cyanobacterium Synechocystis sp PCC 6803	PLOS ONE			English	Article							DNA MICROARRAY ANALYSIS; CAMP RECEPTOR PROTEIN; IRON-SULFUR CLUSTERS; SP STRAIN PCC-6803; ESCHERICHIA-COLI; GENE-EXPRESSION; MYCOBACTERIUM-TUBERCULOSIS; MONOTHIOL GLUTAREDOXINS; 2-COMPONENT SYSTEM; ELECTRON-TRANSPORT	Copper is an essential element involved in fundamental processes like respiration and photosynthesis. However, it becomes toxic at high concentration, which has forced organisms to control its cellular concentration. We have recently described a copper resistance system in the cyanobacterium Synechocystis sp. PCC 6803, which is mediated by the two-component system, CopRS, a RND metal transport system, CopBAC and a protein of unknown function, CopM. Here, we report the transcriptional responses to copper additions at non-toxic (0.3 mu M) and toxic concentrations (3 mu M) in the wild type and in the copper sensitive copR mutant strain. While 0.3 mu M copper slightly stimulated metabolism and promoted the exchange between cytochrome c(6) and plastocyanin as soluble electron carriers, the addition of 3 mu M copper catalyzed the formation of ROS, led to a general stress response and induced expression of Fe-S cluster biogenesis genes. According to this, a double mutant strain copRsufR, which expresses constitutively the sufBCDS operon, tolerated higher copper concentration than the copR mutant strain, suggesting that Fe-S clusters are direct targets of copper toxicity in Synechocystis. In addition we have also demonstrated that InrS, a nickel binding transcriptional repressor that belong to the CsoR family of transcriptional factor, was involved in heavy metal homeostasis, including copper, in Synechocystis. Finally, global gene expression analysis of the copR mutant strain suggested that CopRS only controls the expression of copMRS and copBAC operons in response to copper.	[Giner-Lamia, Joaquin; Lopez-Maury, Luis; Florencio, Francisco J.] Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF)	Lopez-Maury, L (corresponding author), Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Seville, Spain.	llopez1@us.es; floren@us.es	lamia, joaquin giner/L-7474-2019; Lopez-Maury, Luis/B-3715-2015; Florencio, Francisco J/K-7716-2014	lamia, joaquin giner/0000-0003-1553-8295; Lopez-Maury, Luis/0000-0002-3510-0621; Florencio, Francisco J/0000-0002-2068-7861	Ministerio de Economia y Competitividad (MINECO); European Regional Fund (FEDER) [BFU2010-15708, plan E-CLPN09-001]; Junta de Andalucia [BIO-284]; Junta de Ampliacion de Estudios-Doctor contract from Consejo Superior de Investigaciones Cientificas (CSIC); Junta de Andalucia	Ministerio de Economia y Competitividad (MINECO); European Regional Fund (FEDER); Junta de Andalucia(Junta de Andalucia); Junta de Ampliacion de Estudios-Doctor contract from Consejo Superior de Investigaciones Cientificas (CSIC); Junta de Andalucia(Junta de Andalucia)	This work was supported by Ministerio de Economia y Competitividad (MINECO) and the European Regional Fund (FEDER) to F.J.F. (grant BFU2010-15708, and plan E-CLPN09-001); and by Junta de Andalucia (group BIO-284). L.L.M. was recipient of a Junta de Ampliacion de Estudios-Doctor contract from Consejo Superior de Investigaciones Cientificas (CSIC). J.G.L was recipient of an Excelencia fellowship from the Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 2005, PLANT PHYSIOL, V137, P263, DOI 10.1104/pp.104.054478; Baker J, 2010, APPL ENVIRON MICROB, V76, P150, DOI 10.1128/AEM.02268-09; Balasubramanian R, 2006, J BACTERIOL, V188, P3182, DOI 10.1128/JB.188.9.3182-3191.2006; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Balk J, 2011, TRENDS PLANT SCI, V16, P218, DOI 10.1016/j.tplants.2010.12.006; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; CAI YP, 1990, J BACTERIOL, V172, P3138, DOI 10.1128/jb.172.6.3138-3145.1990; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Chillappagari S, 2010, J BACTERIOL, V192, P2512, DOI 10.1128/JB.00058-10; Chitnis PR, 2001, ANNU REV PLANT PHYS, V52, P593, DOI 10.1146/annurev.arplant.52.1.593; Danika T, 2012, DNA RES, V19, P435, DOI 10.1093/dnares/dss024; Dienst D, 2008, MICROBIOL-SGM, V154, P3134, DOI 10.1099/mic.0.2008/020222-0; Dur n RV, 2004, J BIOL CHEM, V279, P7229, DOI 10.1074/jbc.M311565200; Perez-Perez ME, 2012, AUTOPHAGY, V8, P376, DOI 10.4161/auto.18864; Foster AW, 2014, MOL MICROBIOL, V92, P797, DOI 10.1111/mmi.12594; Foster AW, 2012, J BIOL CHEM, V287, P12142, DOI 10.1074/jbc.M111.338301; Garcia-Dominguez M, 2000, J BACTERIOL, V182, P1507, DOI 10.1128/JB.182.6.1507-1514.2000; Garcia-Dominguez M, 1997, PLANT MOL BIOL, V35, P723, DOI 10.1023/A:1005846626187; Giner-Lamia J, 2012, PLANT PHYSIOL, V159, P1806, DOI 10.1104/pp.112.200659; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Grass G, 2011, APPL ENVIRON MICROB, V77, P1541, DOI 10.1128/AEM.02766-10; Hihara Y, 2003, J BACTERIOL, V185, P1719, DOI 10.1128/JB.185.5.1719-1725.2003; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Hong R, 2012, APPL ENVIRON MICROB, V78, P1776, DOI 10.1128/AEM.07068-11; Houot L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-350; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; Jamers A, 2006, AQUAT TOXICOL, V80, P249, DOI 10.1016/j.aquatox.2006.09.002; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Kahlon S, 2006, MICROBIOL-SGM, V152, P647, DOI 10.1099/mic.0.28510-0; Kershaw CJ, 2005, MICROBIOL-SGM, V151, P1187, DOI 10.1099/mic.0.27650-0; Kim EH, 2010, NAT PROD REP, V27, P711, DOI 10.1039/b906681k; Li H, 2004, J BACTERIOL, V186, P3331, DOI 10.1128/JB.186.11.3331-3345.2004; Liu T, 2004, J BIOL CHEM, V279, P17810, DOI 10.1074/jbc.M310560200; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Lopez-Maury L, 2003, J BACTERIOL, V185, P5363, DOI 10.1128/JB.185.18.5363-5371.2003; Lopez-Maury L, 2002, MOL MICROBIOL, V43, P247, DOI 10.1046/j.1365-2958.2002.02741.x; Lopez-Maury L, 2012, PLANT SIGNAL BEHAV, V7, P1712, DOI 10.4161/psb.22323; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Mata-Cabana A, 2012, ANTIOXID REDOX SIGN, V17, P521, DOI 10.1089/ars.2011.4483; MILLS SD, 1993, J BACTERIOL, V175, P1656, DOI 10.1128/JB.175.6.1656-1664.1993; Montesinos ML, 1998, J BIOL CHEM, V273, P31463, DOI 10.1074/jbc.273.47.31463; Munson GP, 2000, J BACTERIOL, V182, P5864, DOI 10.1128/JB.182.20.5864-5871.2000; Muramatsu M, 2012, J PLANT RES, V125, P11, DOI 10.1007/s10265-011-0454-6; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Nagarajan S, 2014, MOL MICROBIOL, V91, P79, DOI 10.1111/mmi.12442; Nagarajan S, 2012, J BACTERIOL, V194, P448, DOI 10.1128/JB.06207-11; ODERMATT A, 1995, J BIOL CHEM, V270, P4349, DOI 10.1074/jbc.270.9.4349; Osanai T, 2006, DNA RES, V13, P185, DOI 10.1093/dnares/dsl010; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Pesaresi P, 2009, MOL PLANT, V2, P236, DOI 10.1093/mp/ssn041; Picciocchi A, 2007, BIOCHEMISTRY-US, V46, P15018, DOI 10.1021/bi7013272; Rademacher C, 2012, MICROBIOL-SGM, V158, P2451, DOI 10.1099/mic.0.058487-0; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Reyes JC, 1997, J BACTERIOL, V179, P2678, DOI 10.1128/jb.179.8.2678-2689.1997; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rutherford JC, 1999, J BIOL CHEM, V274, P25827, DOI 10.1074/jbc.274.36.25827; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Singh AK, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-105; Singh AK, 2009, PLANT PHYSIOL, V151, P1596, DOI 10.1104/pp.109.144824; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Speer A, 2013, J BACTERIOL, V195, P5133, DOI 10.1128/JB.00763-13; Stuart RK, 2009, APPL ENVIRON MICROB, V75, P5047, DOI 10.1128/AEM.00271-09; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Summerfield TC, 2011, MICROBIOL-SGM, V157, P301, DOI 10.1099/mic.0.041053-0; Tajima N, 2011, DNA RES, V18, P393, DOI 10.1093/dnares/dsr026; Teitzel GM, 2006, J BACTERIOL, V188, P7242, DOI 10.1128/JB.00837-06; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; Tottey S, 2002, J BIOL CHEM, V277, P5490, DOI 10.1074/jbc.M105857200; Tottey S, 2001, J BIOL CHEM, V276, P19999, DOI 10.1074/jbc.M011243200; Tottey S, 2012, P NATL ACAD SCI USA, V109, P95, DOI 10.1073/pnas.1117515109; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wang T, 2004, J BACTERIOL, V186, P956, DOI 10.1128/JB.186.4.956-967.2004; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Yoshimura H, 2002, MOL MICROBIOL, V43, P843, DOI 10.1046/j.1365-2958.2002.02790.x; Yoshimura H, 2002, PLANT CELL PHYSIOL, V43, P460, DOI 10.1093/pcp/pcf050; Yu JP, 2003, J BACTERIOL, V185, P3878, DOI 10.1128/JB.185.13.3878-3887.2003; ZHANG L, 1992, J BIOL CHEM, V267, P19054; Zhang XX, 2008, ENVIRON MICROBIOL, V10, P3284, DOI 10.1111/j.1462-2920.2008.01720.x; Zhang Z, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-344	89	39	40	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108912	10.1371/journal.pone.0108912	http://dx.doi.org/10.1371/journal.pone.0108912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268225	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700189
J	Gineste, C; Ottenheijm, C; Le Fur, Y; Banzet, S; Pecchi, E; Vilmen, C; Cozzone, PJ; Koulmann, N; Hardeman, EC; Bendahan, D; Gondin, J				Gineste, Charlotte; Ottenheijm, Coen; Le Fur, Yann; Banzet, Sebastien; Pecchi, Emilie; Vilmen, Christophe; Cozzone, Patrick J.; Koulmann, Nathalie; Hardeman, Edna C.; Bendahan, David; Gondin, Julien			Alterations at the Cross-Bridge Level Are Associated with a Paradoxical Gain of Muscle Function In Vivo in a Mouse Model of Nemaline Myopathy	PLOS ONE			English	Article							SKELETAL-MUSCLE; THIN FILAMENT; ALPHA-TROPOMYOSIN; FORCE GENERATION; INTRACELLULAR PH; MUTATION; TROPONIN; CARDIOMYOPATHY; ACTIVATION; MICE	Nemaline myopathy is the most common disease entity among non-dystrophic skeletal muscle congenital diseases. The first disease causing mutation (Met9Arg) was identified in the gene encoding alpha-tropomyosin(slow) gene (TPM3). Considering the conflicting findings of the previous studies on the transgenic (Tg) mice carrying the TPM3(Met9Arg) mutation, we investigated carefully the effect of the Met9Arg mutation in 8-9 month-old Tg(TPM3)(Met9Arg) mice on muscle function using a multiscale methodological approach including skinned muscle fibers analysis and in vivo investigations by magnetic resonance imaging and 31-phosphorus magnetic resonance spectroscopy. While in vitro maximal force production was reduced in Tg(TPM3)(Met9Arg) mice as compared to controls, in vivo measurements revealed an improved mechanical performance in the transgenic mice as compared to the former. The reduced in vitro muscle force might be related to alterations occuring at the cross-bridges level with muscle-specific underlying mechanisms. In vivo muscle improvement was not associated with any changes in either muscle volume or energy metabolism. Our findings indicate that TPM3(Met9Arg) mutation leads to a mild muscle weakness in vitro related to an alteration at the cross-bridges level and a paradoxical gain of muscle function in vivo. These results clearly point out that in vitro alterations are muscle-dependent and do not necessarily translate into similar changes in vivo.	[Gineste, Charlotte; Le Fur, Yann; Pecchi, Emilie; Vilmen, Christophe; Cozzone, Patrick J.; Bendahan, David; Gondin, Julien] Aix Marseille Univ, CNRS, Ctr Resonance Magnet Biol & Med, Unite Mixte Rech, Marseille, France; [Ottenheijm, Coen] Vrije Univ Amsterdam Med Ctr, Dept Physiol, Inst Cardiovasc Res, Amsterdam, Netherlands; [Banzet, Sebastien; Koulmann, Nathalie] Inst Rech Biomed Armees, Bretigny Sur Orge, France; [Hardeman, Edna C.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of New South Wales Sydney	Gondin, J (corresponding author), Aix Marseille Univ, CNRS, Ctr Resonance Magnet Biol & Med, Unite Mixte Rech, Marseille, France.	julien.gondin@univ-amu.fr	Bendahan, David/AAU-1420-2020; GONDIN, Julien/D-6877-2019; BANZET, Sébastien/C-6448-2008	BANZET, Sébastien/0000-0003-0785-0019; Hardeman, Edna/0000-0003-1649-7712	ERA-NET E-Rare "European research projects on rare diseases" (grant NEMMYOP); French Ministry of Higher Education and Research; Association Francaise contre les Myopathies (AFM-TELETHON); Reseau franco-neerlandais	ERA-NET E-Rare "European research projects on rare diseases" (grant NEMMYOP); French Ministry of Higher Education and Research; Association Francaise contre les Myopathies (AFM-TELETHON); Reseau franco-neerlandais	This work was supported by the ERA-NET E-Rare "European research projects on rare diseases" (grant NEMMYOP). Charlotte GINESTE was supported by a fellowship from the French Ministry of Higher Education and Research, the Association Francaise contre les Myopathies (AFM-TELETHON) and the Reseau franco-neerlandais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andruchov O, 2004, AM J PHYSIOL-CELL PH, V287, pC1725, DOI 10.1152/ajpcell.00255.2004; Bang ML, 2006, J CELL BIOL, V173, P905, DOI 10.1083/jcb.200603119; Bang ML, 2009, FASEB J, V23, P4117, DOI 10.1096/fj.09-137729; BOTTINELLI R, 1991, J PHYSIOL-LONDON, V437, P655, DOI 10.1113/jphysiol.1991.sp018617; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; BRONSON DD, 1982, J BIOL CHEM, V257, P3937; BROWN HR, 1985, P NATL ACAD SCI USA, V82, P2359, DOI 10.1073/pnas.82.8.2359; Burhop J, 2001, J BIOL CHEM, V276, P20788, DOI 10.1074/jbc.M101110200; Canepari M, 2010, ACTA PHYSIOL, V199, P465, DOI 10.1111/j.1748-1716.2010.02118.x; Chandra M, 2009, J BIOL CHEM, V284, P30889, DOI 10.1074/jbc.M109.049718; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Corbett MA, 2005, ANN NEUROL, V57, P42, DOI 10.1002/ana.20305; Corbett MA, 2001, HUM MOL GENET, V10, P317, DOI 10.1093/hmg/10.4.317; de Haan A, 2002, NEUROMUSCULAR DISORD, V12, P952, DOI 10.1016/S0960-8966(02)00138-4; de Tombe PP, 2007, AM J PHYSIOL-REG I, V292, pR1129, DOI 10.1152/ajpregu.00630.2006; de Winter JM, 2013, J MED GENET; Filatov VL, 1999, BIOCHEMISTRY-MOSCOW+, V64, P969; Giannesini B, 2007, MUSCLE NERVE, V36, P505, DOI 10.1002/mus.20843; Giannesini B, 2010, MAGN RESON MED, V64, P262, DOI 10.1002/mrm.22386; Gineste C, 2013, NEUROMUSCULAR DISORD, V23, P357, DOI 10.1016/j.nmd.2012.12.011; Gineste C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061517; Gollapudi SK, 2012, BIOPHYS J, V103, P940, DOI 10.1016/j.bpj.2012.07.035; HEAD JG, 1995, EUR J BIOCHEM, V227, P694, DOI 10.1111/j.1432-1033.1995.tb20190.x; Ilkovski B, 2008, J NEUROPATH EXP NEUR, V67, P867, DOI 10.1097/NEN.0b013e318183a44f; Jain RK, 2012, NEUROLOGY, V78, P1100, DOI 10.1212/WNL.0b013e31824e8ebe; Karpicheva OE, 2014, ARCH BIOCHEM BIOPHYS, V549, P12, DOI 10.1016/j.abb.2014.03.007; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; LAING N, 1995, NAT GENET, V10, P249, DOI 10.1038/ng0695-249a; Le Fur Y, 2010, MAGN RESON MATER PHY, V23, P23, DOI 10.1007/s10334-009-0186-y; Lindqvist J, 2012, ACTA NEUROPATHOL, V123, P739, DOI 10.1007/s00401-012-0962-z; Marttila M, 2014, HUM MUTAT, V35, P779, DOI 10.1002/humu.22554; MOON RB, 1973, J BIOL CHEM, V248, P7276; North KN, 1997, J MED GENET, V34, P705, DOI 10.1136/jmg.34.9.705; Nowak KJ, 2012, EUR J HUM GENET, V20, DOI 10.1038/ejhg.2012.70; Ochala J, 2012, HUM MOL GENET, V21, P4473, DOI 10.1093/hmg/dds289; Ottenheijm CAC, 2008, FASEB J, V22, P2912, DOI 10.1096/fj.07-104372; Ottenheijm CAC, 2011, HUM MOL GENET, V20, P2015, DOI 10.1093/hmg/ddr084; Palm T, 2003, BIOPHYS J, V84, P3181, DOI 10.1016/S0006-3495(03)70042-3; Periasamy M, 2008, CARDIOVASC RES, V77, P265, DOI 10.1093/cvr/cvm056; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; Ravenscroft G, 2013, AM J HUM GENET; Sanoudou D, 2001, TRENDS MOL MED, V7, P362, DOI 10.1016/S1471-4914(01)02089-5; Sanoudou D, 2006, HUM MOL GENET, V15, P2603, DOI 10.1093/hmg/ddl186; Sequeira V, 2013, CIRC RES, V112, P1491, DOI 10.1161/CIRCRESAHA.111.300436; Smith SH, 1999, J MOL CELL CARDIOL, V31, P2115, DOI 10.1006/jmcc.1999.1043; TADA M, 1983, J MOL CELL CARDIOL, V15, P565, DOI 10.1016/0022-2828(83)90267-5; Tesi C, 2000, BIOPHYS J, V78, P3081, DOI 10.1016/S0006-3495(00)76845-7; Tobacman LS, 2002, J BIOL CHEM, V277, P27636, DOI 10.1074/jbc.M201768200; Zaremba R, 2007, PROTEOM CLIN APPL, V1, P1285, DOI 10.1002/prca.200600891	49	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e109066	10.1371/journal.pone.0109066	http://dx.doi.org/10.1371/journal.pone.0109066			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268244	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700219
J	Huang, XW; Li, DD; Xi, LY; Mylonakis, E				Huang, Xiaowen; Li, Dedong; Xi, Liyan; Mylonakis, Eleftherios			Caenorhabditis elegans: A Simple Nematode Infection Model for Penicillium marneffei	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; FUNGAL-INFECTION; PATHOGENESIS; RESISTANCE; VIRULENCE; IMMUNITY; PATHWAY	Penicillium marneffei, one of the most important thermal dimorphic fungi, is a severe threat to the life of immunocompromised patients. However, the pathogenic mechanisms of P. marneffei remain largely unknown. In this work, we developed a model host by using nematode Caenorhabditis elegans to investigate the virulence of P. marneffei. Using two P. marneffei clinical isolate strains 570 and 486, we revealed that in both liquid and solid media, the ingestion of live P. marneffei was lethal to C. elegans (P<0.001). Meanwhile, our results showed that the strain 570, which can produce red pigment, had stronger pathogenicity in C. elegans than the strain 486, which can't produce red pigment (P<0.001). Microscopy showed the formation of red pigment and hyphae within C. elegans after incubation with P. marneffei for 4 h, which are supposed to be two contributors in nematodes killing. In addition, we used C. elegans as an in vivo model to evaluate different antifungal agents against P. marneffei, and found that antifungal agents including amphotericin B, terbinafine, fluconazole, itraconazole and voriconazole successfully prolonged the survival of nematodesinfected by P. marneffei. Overall, this alternative model host can provide us an easy tool to study the virulence of P. marneffei and screen antifungal agents.	[Huang, Xiaowen; Li, Dedong; Mylonakis, Eleftherios] Brown Univ, Div Infect Dis, Rhode Isl Hosp, Warren Alpert Med Sch, Providence, RI 02912 USA; [Huang, Xiaowen; Xi, Liyan] Sun Yat Sen Univ, Dept Dermatol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Li, Dedong] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Sun Yat Sen University; Naval Medical University	Mylonakis, E (corresponding author), Brown Univ, Div Infect Dis, Rhode Isl Hosp, Warren Alpert Med Sch, Providence, RI 02912 USA.	xiliyan@mail.sysu.edu.cn; emylonakis@lifespan.org	Li, Dedong/R-7044-2019	Xi, Liyan/0000-0003-1504-0147	National Natural Science Foundation of China NSFC [81171545]	National Natural Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China NSFC (http://www.nsfc.gov.cn/), grant number 81171545 to LX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanitis M, 2013, BBA-MOL BASIS DIS, V1832, P1378, DOI 10.1016/j.bbadis.2013.03.008; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Chamilos G, 2007, LANCET INFECT DIS, V7, P42, DOI 10.1016/S1473-3099(06)70686-7; Hsueh PR, 2000, J INFECT DIS, V181, P1706, DOI 10.1086/315432; Jain C, 2009, EUKARYOT CELL, V8, P1218, DOI 10.1128/EC.00367-08; Johnson CH, 2009, MED MYCOL, V47, P808, DOI 10.3109/13693780802660532; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kudeken N, 1997, CLIN EXP IMMUNOL, V107, P468, DOI 10.1046/j.1365-2249.1997.d01-945.x; Kudeken N, 1996, J MED VET MYCOL, V34, P371; Liu DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092610; Liu DH, 2013, J INFECT CHEMOTHER, V19, P776, DOI 10.1007/s10156-012-0511-7; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Muhammed Maged, 2012, Methods Mol Biol, V845, P447, DOI 10.1007/978-1-61779-539-8_31; Mylonakis E, 2004, MOL MICROBIOL, V54, P407, DOI 10.1111/j.1365-2958.2004.04310.x; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; Sobottka I, 1996, EUR J CLIN MICROBIOL, V15, P256, DOI 10.1007/BF01591368; SUPPARATPINYO K, 1994, LANCET, V344, P110, DOI 10.1016/S0140-6736(94)91287-4; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Wong SSY, 1999, J MED MICROBIOL, V48, P973, DOI 10.1099/00222615-48-11-973; Woo PCY, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001871	20	28	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108764	10.1371/journal.pone.0108764	http://dx.doi.org/10.1371/journal.pone.0108764			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268236	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700159
J	Ryu, YJ; Choi, SH; Park, SJ; Yun, TJ; Kim, JH; Sohn, CH				Ryu, Young Jin; Choi, Seung Hong; Park, Sang Joon; Yun, Tae Jin; Kim, Ji-Hoon; Sohn, Chul-Ho			Glioma: Application of Whole-Tumor Texture Analysis of Diffusion-Weighted Imaging for the Evaluation of Tumor Heterogeneity	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; MAGNETIC-RESONANCE SPECTROSCOPY; LOW-GRADE ASTROCYTOMAS; HISTOGRAM ANALYSIS; CT TEXTURE; 3 T; COEFFICIENT; MRI; DIFFERENTIATION; CANCER	Background and Purpose: To apply a texture analysis of apparent diffusion coefficient (ADC) maps to evaluate glioma heterogeneity, which was correlated with tumor grade. Materials and Methods: Forty patients with glioma (WHO grade II (n = 8), grade III (n = 10) and grade IV (n = 22)) underwent diffusion-weighted imaging (DWI), and the corresponding ADC maps were obtained. Regions of interest containing the lesions were drawn on every section of the ADC map containing the tumor, and volume-based data of the entire tumor were constructed. Texture and first order features including entropy, skewness and kurtosis were derived from the ADC map using in-house software. A histogram analysis of the ADC map was also performed. The texture and histogram parameters were compared between low-grade and high-grade gliomas using an unpaired student's t-test. Additionally, a one-way analysis of variance analysis with a post-hoc test was performed to compare the parameters of each grade. Results: Entropy was observed to be significantly higher in high-grade gliomas than low-grade tumors (6.861 +/- 0.539 vs. 6.261 +/- 0.412, P = 0.006). The fifth percentiles of the ADC cumulative histogram also showed a significant difference between high and low grade gliomas (836 +/- 235 vs. 1030 +/- 185, P = 0.037). Only entropy proved to be significantly different between grades III and IV (6.295 +/- 0.4963 vs. 7.119 +/- 0.3165, P<0.001). The diagnostic accuracy of ADC entropy was significantly higher than that of the fifth percentile of the ADC histogram (P = 0.0034) in distinguishing high-from low-grade glioma. Conclusion: A texture analysis of the ADC map based on the entire tumor volume can be useful for evaluating glioma grade, which provides tumor heterogeneity.	[Ryu, Young Jin; Choi, Seung Hong; Park, Sang Joon; Yun, Tae Jin; Kim, Ji-Hoon; Sohn, Chul-Ho] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Inst Basic Sci, Ctr Nanoparticle Res, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea; [Park, Sang Joon] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul 110744, South Korea; [Park, Sang Joon] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea	Seoul National University (SNU); Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	verocay@snuh.org; lunao78@snu.ac.kr	Sohn, ChulHo/AAV-4565-2021	Choi, Seung Hong/0000-0002-0412-2270	Korea Healthcare technology R&D Projects, Ministry for Health, Welfare Family Affairs [A112028, HI13C0015]; Research Center Program of IBS (Institute for Basic Science) in Korea	Korea Healthcare technology R&D Projects, Ministry for Health, Welfare Family Affairs; Research Center Program of IBS (Institute for Basic Science) in Korea	This study was supported by a grant from the Korea Healthcare technology R&D Projects, Ministry for Health, Welfare & Family Affairs (A112028 and HI13C0015) and by the Research Center Program of IBS (Institute for Basic Science) in Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alvarez-Linera J, 2008, EUR J RADIOL, V67, P415, DOI 10.1016/j.ejrad.2008.02.045; [Anonymous], 2010, HS, V122, p[1, 4]; Baehring JM, 2007, J NEURO-ONCOL, V82, P221, DOI 10.1007/s11060-006-9273-3; Castillo M, 2001, AM J NEURORADIOL, V22, P60; Cha S, 2005, AM J NEURORADIOL, V26, P266; Chen W, 2007, MAGN RESON MED, V58, P562, DOI 10.1002/mrm.21347; DAUMASDUPORT C, 1988, CANCER-AM CANCER SOC, V62, P2152, DOI 10.1002/1097-0142(19881115)62:10<2152::AID-CNCR2820621015>3.0.CO;2-T; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; Eliat PA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/195176; Emblem KE, 2008, RADIOLOGY, V247, P808, DOI 10.1148/radiol.2473070571; Fan GG, 2006, BRIT J RADIOL, V79, P652, DOI 10.1259/bjr/25349497; Ganeshan B, 2007, CLIN RADIOL, V62, P761, DOI 10.1016/j.crad.2007.03.004; Ganeshan B, 2012, CLIN RADIOL, V67, P157, DOI 10.1016/j.crad.2011.08.012; Ganeshan B, 2010, CANCER IMAGING, V10, P137, DOI 10.1102/1470-7330.2010.0021; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Gupta RK, 2000, J NEURO-ONCOL, V50, P215, DOI 10.1023/A:1006431120031; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Higano S, 2006, RADIOLOGY, V241, P839, DOI 10.1148/radiol.2413051276; Hilario A, 2012, AM J NEURORADIOL, V33, P701, DOI 10.3174/ajnr.A2846; Kang Y, 2011, RADIOLOGY, V261, P882, DOI 10.1148/radiol.11110686; Kanno H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041669; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063462; Kiss R, 1997, AM J CLIN PATHOL, V107, P321, DOI 10.1093/ajcp/107.3.321; Kono K, 2001, AM J NEURORADIOL, V22, P1081; Law M, 2007, AM J NEURORADIOL, V28, P761; Lee EJ, 2008, AM J NEURORADIOL, V29, P1872, DOI 10.3174/ajnr.A1254; Levine MD, 1985, VISION MAN MACHINE M; Maia ACM, 2005, AM J NEURORADIOL, V26, P777; Materka A., 1998, TEXTURE ANAL METHODS; Murakami R, 2008, ACTA RADIOL, V49, P462, DOI 10.1080/02841850801918555; Ng F, 2013, RADIOLOGY, V266, P177, DOI 10.1148/radiol.12120254; Pauleit D, 2004, J MAGN RESON IMAGING, V20, P758, DOI 10.1002/jmri.20177; Rosenfeld A., 2014, DIGITAL PICTURE PROC; Saito T, 2012, EUR J RADIOL, V81, P1863, DOI 10.1016/j.ejrad.2011.04.009; SCHAD LR, 1993, MAGN RESON IMAGING, V11, P889, DOI 10.1016/0730-725X(93)90206-S; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Skogen K, 2013, J NEURO-ONCOL, V111, P213, DOI 10.1007/s11060-012-1010-5; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Sunwoo L, 2013, J MAGN RESON IMAGING, V37, P351, DOI 10.1002/jmri.23838; Tozer DJ, 2007, NMR BIOMED, V20, P49, DOI 10.1002/nbm.1091; van den Bent M, 2003, NEURO-ONCOLOGY, V5, P128, DOI 10.1215/S1522851702000285; Wilke M, 2001, ACTA RADIOL, V42, P39, DOI 10.1034/j.1600-0455.2001.042001039.x; Win T, 2013, CLIN CANCER RES, V19, P3591, DOI 10.1158/1078-0432.CCR-12-1307; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147	46	140	152	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108335	10.1371/journal.pone.0108335	http://dx.doi.org/10.1371/journal.pone.0108335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268588	Green Published, gold			2022-12-27	WOS:000343671700082
J	Shirazi, F; Farmakiotis, D; Yan, Y; Albert, N; Do, KA; Kontoyiannis, DP				Shirazi, Fazal; Farmakiotis, Dimitrios; Yan, Yuanqing; Albert, Nathaniel; Do, Kim-Anh; Kontoyiannis, Dimitrios P.			Diet Modification and Metformin Have a Beneficial Effect in a Fly Model of Obesity and Mucormycosis	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; LIFE-SPAN; ZYGOMYCOSIS; SUSCEPTIBILITY; PATHOGENESIS; INFECTIONS; DISEASE; HOST	In an experimental model of obesity and hyperglycemia in Drosophila melanogaster we studied the effect of diet modification and administration of metformin on systemic infection with Rhizopus, a common cause of mucormycosis in diabetic patients. Female Wt-type Drosophila flies were fed regular (RF) or high-fat diet (HFD; 30% coconut oil) food with or without metformin for 48 h and then injected with R. oryzae. Survival rates, glucose and triglyceride levels were compared between 1) normal-weight flies (RF), 2) obese flies (HFD), 3) obese flies fed with RF, 4) flies continuously on HFD + metformin, 5) flies fed on HFD + metformin, then transferred to RF, and 6) obese flies administered metformin after infection. Glucose levels were compared across groups of non-infected flies and across groups of infected flies. Survival was significantly decreased (P = 0.003) in obese flies, while post-infection glucose levels were significantly increased (P = 0.0001), compared to normal-weight flies. Diet and administration of metformin led to weight loss, normalized glucose levels during infection, and were associated with decreased mortality and tissue fungal burden. In conclusion, diet and metformin help control infection-associated hyperglycemia and improve survival in Drosophila flies with mucormycosis. Fly models of obesity bear intriguing similarities to the pathophysiology of insulin resistance and diabetes in humans, and can provide new insights into the pathogenesis and treatment of infections in obese and diabetic patients.	[Shirazi, Fazal; Farmakiotis, Dimitrios; Albert, Nathaniel; Kontoyiannis, Dimitrios P.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA; [Yan, Yuanqing; Do, Kim-Anh] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kontoyiannis, DP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA.	dkontoyi@mdanderson.org	Shirazi, Fazal/C-7398-2014	Shirazi, Fazal/0000-0002-6097-1779	Frances King Black Endowed Professorship for Cancer Research; National Institutes of Health Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Frances King Black Endowed Professorship for Cancer Research; National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	D.P.K. is a recipient of the Frances King Black Endowed Professorship for Cancer Research. This research was supported in part by the National Institutes of Health Cancer Center Support Grant CA016672 to The University of Texas MD Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Al-Zahrani MS, 2003, J PERIODONTOL, V74, P610, DOI 10.1902/jop.2003.74.5.610; Almond MH, 2013, THORAX, V68, P684, DOI 10.1136/thoraxjnl-2012-203009; Anisimov VN, 2011, AGING-US, V3, P148, DOI 10.18632/aging.100273; Anisimov VN, 2010, AGING-US, V2, P945, DOI 10.18632/aging.100245; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Bharucha KN, 2009, PEDIATR RES, V65, P132, DOI 10.1203/PDR.0b013e318191fc68; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Chamilos G, 2008, P NATL ACAD SCI USA, V105, P9367, DOI 10.1073/pnas.0709578105; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Foss NT, 2007, DIABETES METAB, V33, P439, DOI 10.1016/j.diabet.2007.10.001; Gleissner B, 2004, LEUKEMIA LYMPHOMA, V45, P1351, DOI 10.1080/10428190310001653691; Hamill R, 2013, DRUGS, V73, P919, DOI 10.1007/s40265-013-0069-4; Heinrichsen ET, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042587; Hjartaker A, 2008, ADV EXP MED BIOL, V630, P72; Hong JW, 2010, EXP MOL MED, V42, P12, DOI 10.3858/emm.2010.42.1.007; KAPLAN NM, 1989, ARCH INTERN MED, V149, P1514, DOI 10.1001/archinte.149.7.1514; Kontoyiannis DP, 2006, INFECT DIS CLIN N AM, V20, P581, DOI 10.1016/j.idc.2006.06.003; Kontoyiannis DP, 2011, BLOOD, V118, P1216, DOI 10.1182/blood-2011-03-316430; Kontoyiannis DP, 2005, J INFECT DIS, V191, P1350, DOI 10.1086/428780; Kwong JC, 2011, CLIN INFECT DIS, V53, P413, DOI 10.1093/cid/cir442; Libert S, 2008, MOL IMMUNOL, V45, P810, DOI 10.1016/j.molimm.2007.06.353; MacIntyre EJ, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2012.01.026; Mancuso P, 2002, J IMMUNOL, V168, P4018, DOI 10.4049/jimmunol.168.8.4018; Marik PE, 2013, CRIT CARE MED, V41, pE93, DOI 10.1097/CCM.0b013e318283d124; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Plotkin BJ, 1996, J MED MICROBIOL, V44, P277, DOI 10.1099/00222615-44-4-277; Rammaert B, 2012, DIABETES METAB, V38, P193, DOI 10.1016/j.diabet.2012.01.002; Saliba W, 2013, EUR J INTERN MED, V24, P127, DOI 10.1016/j.ejim.2012.11.006; Scheen AJ, 2013, DIABETES METAB, V39, P179, DOI 10.1016/j.diabet.2013.02.006; Slack C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047699; Teleman AA, 2012, EXP CLIN ENDOCR DIAB, V120, P184, DOI 10.1055/s-0032-1304566; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vilar-Compte D, 2000, AM J INFECT CONTROL, V28, P14, DOI 10.1016/S0196-6553(00)90006-3; Wareham NJ, 1999, DIABETES CARE, V22, P262, DOI 10.2337/diacare.22.2.262; World Health Organization, 2013, WORLD HLTH STAT	38	16	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108635	10.1371/journal.pone.0108635	http://dx.doi.org/10.1371/journal.pone.0108635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268492	Green Submitted, gold, Green Published			2022-12-27	WOS:000343671700131
J	Solovieva, S; Pensola, T; Kausto, J; Shiri, R; Heliovaara, M; Burdorf, A; Husgafvel-Pursiainen, K; Viikari-Juntura, E				Solovieva, Svetlana; Pensola, Tiina; Kausto, Johanna; Shiri, Rahman; Heliovaara, Markku; Burdorf, Alex; Husgafvel-Pursiainen, Kirsti; Viikari-Juntura, Eira			Evaluation of the Validity of Job Exposure Matrix for Psychosocial Factors at Work	PLOS ONE			English	Article							OCCUPATIONAL EXPOSURES; DECISION LATITUDE; MENTAL-HEALTH; STRAIN; POPULATION; DISEASE; RISK; METAANALYSIS; PERFORMANCE; DEPRESSION	Objective: To study the performance of a developed job exposure matrix (JEM) for the assessment of psychosocial factors at work in terms of accuracy, possible misclassification bias and predictive ability to detect known associations with depression and low back pain (LBP). Materials and Methods: We utilized two large population surveys (the Health 2000 Study and the Finnish Work and Health Surveys), one to construct the JEM and another to test matrix performance. In the first study, information on job demands, job control, monotonous work and social support at work was collected via face-to-face interviews. Job strain was operationalized based on job demands and job control using quadrant approach. In the second study, the sensitivity and specificity were estimated applying a Bayesian approach. The magnitude of misclassification error was examined by calculating the biased odds ratios as a function of the sensitivity and specificity of the JEM and fixed true prevalence and odds ratios. Finally, we adjusted for misclassification error the observed associations between JEM measures and selected health outcomes. Results: The matrix showed a good accuracy for job control and job strain, while its performance for other exposures was relatively low. Without correction for exposure misclassification, the JEM was able to detect the association between job strain and depression in men and between monotonous work and LBP in both genders. Conclusions: Our results suggest that JEM more accurately identifies occupations with low control and high strain than those with high demands or low social support. Overall, the present JEM is a useful source of job-level psychosocial exposures in epidemiological studies lacking individual-level exposure information. Furthermore, we showed the applicability of a Bayesian approach in the evaluation of the performance of the JEM in a situation where, in practice, no gold standard of exposure assessment exists.	[Solovieva, Svetlana; Pensola, Tiina; Kausto, Johanna; Shiri, Rahman; Husgafvel-Pursiainen, Kirsti] Finnish Inst Occupat Hlth, Ctr Expertise Hlth & Work Abil, Helsinki, Finland; [Solovieva, Svetlana; Kausto, Johanna; Shiri, Rahman; Husgafvel-Pursiainen, Kirsti; Viikari-Juntura, Eira] Finnish Inst Occupat Hlth, Disabil Prevent Ctr, Helsinki, Finland; [Heliovaara, Markku] Natl Inst Hlth & Welf, Helsinki, Finland; [Burdorf, Alex] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands	Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; Finland National Institute for Health & Welfare; Erasmus University Rotterdam; Erasmus MC	Solovieva, S (corresponding author), Finnish Inst Occupat Hlth, Ctr Expertise Hlth & Work Abil, Helsinki, Finland.	svetlana.solovieva@ttl.fi	Burdorf, Alex/A-2226-2008; Shiri, Rahman/ABB-1780-2021	Burdorf, Alex/0000-0003-3129-2862; Shiri, Rahman/0000-0002-9312-3100; Kausto, Johanna/0000-0002-2898-0018	Finnish Work Environment Fund [109364]	Finnish Work Environment Fund	The study was financially supported by the Finnish Work Environment Fund (project no 109364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651; Aromaa A, 2004, BASELINE RESULT HLTH, P11; Blair A, 2007, AM J IND MED, V50, P199, DOI 10.1002/ajim.20281; Bonde JPE, 2008, OCCUP ENVIRON MED, V65, P438, DOI 10.1136/oem.2007.038430; BOUYER J, 1993, INT J EPIDEMIOL, V22, pS65, DOI 10.1093/ije/22.Supplement_2.S65; BOUYER J, 1995, SCAND J WORK ENV HEA, V21, P265, DOI 10.5271/sjweh.36; Cifuentes M, 2007, AM J IND MED, V50, P545, DOI 10.1002/ajim.20480; Cohidon C, 2012, J OCCUP ENVIRON MED, V54, P184, DOI 10.1097/JOM.0b013e31823fdf3b; Cosgrove MP, 2012, OCCUP MED-OXFORD, V62, P167, DOI 10.1093/occmed/kqs002; Diene E, 2012, ARCH CARDIOVASC DIS, V105, P33, DOI 10.1016/j.acvd.2011.10.001; Hartvigsen J, 2004, OCCUP ENVIRON MED, V61; JOHNSON JV, 1993, SCAND J WORK ENV HEA, V19, P21, DOI 10.5271/sjweh.1508; JOHNSON JV, 1988, AM J PUBLIC HEALTH, V78, P1336, DOI 10.2105/AJPH.78.10.1336; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Karasek R, 1990, HLTH WORK STRESS PRO; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kauppinen T, 1998, AM J IND MED, V33, P409, DOI 10.1002/(SICI)1097-0274(199804)33:4<409::AID-AJIM12>3.0.CO;2-2; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Laiho J, 2006, METHODOLOGY REPORT B, V26, P13; Landsbergis P, 2000, OCCUP MED, V15, P163; Lang J, 2012, SOC SCI MED, V75, P1163, DOI 10.1016/j.socscimed.2012.04.015; Le Moual N, 2000, OCCUP ENVIRON MED, V57, P126, DOI 10.1136/oem.57.2.126; Macfarlane GJ, 2009, ANN RHEUM DIS, V68, P885, DOI 10.1136/ard.2008.090829; Macleod J, 2003, J EPIDEMIOL COMMUN H, V57, P565, DOI 10.1136/jech.57.8.565; Netterstrom B, 2008, EPIDEMIOL REV, V30, P118, DOI 10.1093/epirev/mxn004; Niedhammer I, 2008, INT ARCH OCC ENV HEA, V82, P87, DOI 10.1007/s00420-008-0311-7; Niedhammer I, 2014, INT ARCH OCC ENV HEA, V87, P403, DOI 10.1007/s00420-013-0879-4; Ostry AS, 2001, AM J IND MED, V39, P397, DOI 10.1002/ajim.1030.abs; Perkio-Makela M, 2010, TYO JA TERVEYS HAAST; Rijs KJ, 2014, ANN OCCUP HYG, V58, P152, DOI 10.1093/annhyg/met052; SCHWARTZ JE, 1988, AM J PUBLIC HEALTH, V78, P904, DOI 10.2105/AJPH.78.8.904; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; SIEMIATYCKI J, 1989, AM J EPIDEMIOL, V130, P1236, DOI 10.1093/oxfordjournals.aje.a115452; Solovieva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048680; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Tabanelli MC, 2008, INT ARCH OCC ENV HEA, V82, P1, DOI 10.1007/s00420-008-0312-6; Theorell T, 2005, INT ARCH OCC ENV HEA, V78, P517, DOI 10.1007/s00420-005-0618-6; Theorell T, 1998, AM J PUBLIC HEALTH, V88, P382, DOI 10.2105/AJPH.88.3.382; Tielemans E, 1999, OCCUP ENVIRON MED, V56, P145, DOI 10.1136/oem.56.3.145; Wieclaw J, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-280	42	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108987	10.1371/journal.pone.0108987	http://dx.doi.org/10.1371/journal.pone.0108987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268276	Green Submitted, gold, Green Published			2022-12-27	WOS:000343671700209
J	Cai, B; Liao, K; Song, XQ; Wei, WY; Zhuang, Y; Zhang, S				Cai, Bin; Liao, Kai; Song, Xian-qing; Wei, Wei-yuan; Zhuang, Yuan; Zhang, Sen			Patients with Chronically Diseased Livers Have Lower Incidence of Colorectal Liver Metastases: A Meta-Analysis	PLOS ONE			English	Article							HEPATITIS-B; CANCER METASTASIS; RARE OCCURRENCE; KUPFFER CELLS; EXPRESSION; CIRRHOSIS; PERFORIN	Background: 70 years ago, it was put forward that the diseased liver was not a favorable soil for metastatic tumor cells. In addition, a few studies have demonstrated that rare occurrence of colorectal liver metastases among patients with fatty liver, cirrhosis or chronic hepatitis B and C virus infection. We performed a meta-analysis to verify the association between the incidences of colorectal liver metastases with chronically diseased livers. Methods: Relevant studies were identified by a search of electronic database PubMed, Cochrane Library, OVID, Web of Science and CNKI (up to February 24, 2014). Pooled odds ratio (OR) with 95% confidence interval (CI) was calculated using random-or fixed-effect models when appropriate. Meta-analysis and publication bias (Bgger's test) was evaluated with STATA 12.0. Results: A total of 10,349 colorectal cancer patients from 10 studies were included. The meta-analysis result showed there was a significant difference in the incidences of colorectal liver metastases between patients with normal and chronically diseased livers (OR = 0.32; 95% CI 95%: 0.26-0.38, P = 0.000 fixed-effects model). The result of Begg's test (Pr>vertical bar Z vertical bar = 0.089; P > 0.05) revealed no publication bias. Conclusions: The results of this meta-analysis demonstrated that patients with chronically diseased livers had significantly lower incidences of colorectal liver metastases than those with normal livers.	[Cai, Bin; Liao, Kai; Song, Xian-qing; Zhang, Sen] Guangxi Med Univ, Affiliated Hosp 1, Dept Colorectal Surg, Nanning, Guangxi, Peoples R China; [Wei, Wei-yuan] Guangxi Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Nanning, Guangxi, Peoples R China; [Zhuang, Yuan] Guangxi Med Univ, Sch Preclin Med, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Zhang, S (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Colorectal Surg, Nanning, Guangxi, Peoples R China.	zs1770@126.com	zhang, sen/GXH-3513-2022		National Natural Science Foundation of China [81160235]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This article is supported by the National Natural Science Foundation of China (grants No. 81160235). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 1997, J IMMUNOL, V158, P5283; ANTHONY PP, 1977, B WORLD HEALTH ORGAN, V55, P521; Asbun H J, 1994, Cancer Treat Res, V69, P33; AUGUST DA, 1984, CANCER METAST REV, V3, P303, DOI 10.1007/BF00051457; Coe BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071670; Consolo M, 2009, INT J MOL MED, V24, P143, DOI 10.3892/ijmm_00000217; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Deb G, 2014, MOL CANCER RES, V12, P639, DOI 10.1158/1541-7786.MCR-13-0546; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Hayashi S, 1997, HEPATO-GASTROENTEROL, V44, P1069; Iascone C, 2005, Minerva Chir, V60, P185; Karube H, 2000, HEPATO-GASTROENTEROL, V47, P1541; Lara-Pezzi E, 1998, HEPATOLOGY, V28, P1013, DOI 10.1002/hep.510280416; LIEBER MM, 1957, AM J MED SCI, V233, P145, DOI 10.1097/00000441-195702000-00005; Mittal P, 2011, IRAN J RADIOL, V8, P211, DOI 10.5812/iranjradiol.4489; Murono K, 2013, INT J COLORECTAL DIS, V28, P1065, DOI 10.1007/s00384-013-1656-2; Otto C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-122; Qian Hong-gang, 2010, Zhonghua Wei Chang Wai Ke Za Zhi, V13, P202; Qiu HB, 2011, WORLD J GASTROENTERO, V17, P804, DOI 10.3748/wjg.v17.i6.804; SEITZ G, 1989, ULTRASCHALL MED, V10, P123, DOI 10.1055/s-2007-1005976; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song E, 2001, AM J SURG, V181, P529, DOI 10.1016/S0002-9610(01)00634-1; Song E, 2001, BRIT J CANCER, V84, P1265, DOI 10.1054/bjoc.2000.1737; Tordjmann T, 1998, LIVER, V18, P391; UETSUJI S, 1992, AM J SURG, V164, P176, DOI 10.1016/S0002-9610(05)80380-0; Utsunomiya T, 1999, AM J SURG, V177, P279, DOI 10.1016/S0002-9610(99)00045-8; Villeneuve JP, 2005, J CLIN VIROL, V34, pS139, DOI 10.1016/S1386-6532(05)80024-1; Wang FS, 2012, HEPATO-GASTROENTEROL, V59, P1390, DOI 10.5754/hge11747; Wang WH, 2011, HEPATOLOGY, V53, P1137, DOI 10.1002/hep.24163; WINWOOD PJ, 1993, SEMIN LIVER DIS, V13, P50, DOI 10.1055/s-2007-1007337; Yu HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051239; Zeng Y, 2013, HEPATO-GASTROENTEROL, V60, P37, DOI 10.5754/hge12564	32	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108618	10.1371/journal.pone.0108618	http://dx.doi.org/10.1371/journal.pone.0108618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265536	Green Submitted, Green Published, gold			2022-12-27	WOS:000345745400096
J	Chojnicka, I; Fudalej, S; Walczak, A; Wasilewska, K; Fudalej, M; Stawinski, P; Strawa, K; Pawlak, A; Wojnar, M; Krajewski, P; Ploski, R				Chojnicka, Izabela; Fudalej, Sylwia; Walczak, Anna; Wasilewska, Krystyna; Fudalej, Marcin; Stawinski, Piotr; Strawa, Katarzyna; Pawlak, Aleksandra; Wojnar, Marcin; Krajewski, Pawel; Ploski, Rafal			Inverse Association between Obesity Predisposing FTO Genotype and Completed Suicide	PLOS ONE			English	Article							BODY-MASS INDEX; FAT MASS; RISK-FACTORS; PSYCHOLOGICAL DISTRESS; DEPRESSIVE DISORDER; ENERGY-INTAKE; GENE; ALCOHOL; VARIANT; POLYMORPHISMS	The A allele of rs9939609 in the FTO gene predisposes to increased body mass index (BMI) and obesity. Recently we showed an inverse association between the obesity related A allele of rs9939609 and alcohol dependence which was replicated by others. Since this finding raises a possibility that FTO may be associated with other psychiatric phenotypes, we aimed to examine association of rs9939609 with completed suicide. We genotyped rs9939609 in 912 suicide victims and 733 controls using TaqMan approach. We observed an inverse association between suicide and the rs9939609 A allele (OR = 0.80, P = 0.002, P-cor = 0.006) with genotype distribution suggesting a co-dominant effect. Given the link between alcoholism and suicide under influence of alcohol reported in Polish population, confounding by alcohol addiction was unlikely due to apparently similar effect size among cases who were under influence of ethanol at the time of death (OR = 0.76, P = 0.003, N = 361) and those who were not (OR = 0.80, P = 0.007, N = 469). The search for genotype-phenotype correlations did not show significant results. In conclusion, our study proves that there is an inverse association between rs9939609 polymorphism in FTO gene and completed suicide which is independent from association between FTO and alcohol addiction.	[Chojnicka, Izabela; Walczak, Anna; Wasilewska, Krystyna; Stawinski, Piotr; Strawa, Katarzyna; Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Chojnicka, Izabela] Univ Warsaw, Dept Rehabil Psychol, Warsaw, Poland; [Fudalej, Sylwia; Wojnar, Marcin] Med Univ Warsaw, Dept Psychiat, Warsaw, Poland; [Fudalej, Marcin; Pawlak, Aleksandra; Krajewski, Pawel] Med Univ Warsaw, Dept Forens Med, Warsaw, Poland; [Wojnar, Marcin] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	Medical University of Warsaw; University of Warsaw; Medical University of Warsaw; Medical University of Warsaw; University of Michigan System; University of Michigan	Ploski, R (corresponding author), Med Univ Warsaw, Dept Med Genet, Warsaw, Poland.	rploski@wp.pl	Wojnar, Marcin/N-7111-2018; Fudalej, Sylwia/X-1511-2018	Wojnar, Marcin/0000-0001-5138-9050; Fudalej, Sylwia/0000-0003-3610-7312; krajewski, Pawel/0000-0001-8352-4077; Chojnicka, Izabela/0000-0001-8723-6873; Walczak, Anna/0000-0003-2011-5334; Ploski, Rafal/0000-0001-6286-5526; Wasilewska, Krystyna/0000-0001-5760-2713	Medical University of Warsaw, Poland [1WY/N/2012, 1WY/N/2013]	Medical University of Warsaw, Poland	The study was supported by the following grants from the Medical University of Warsaw, Poland: 1WY/N/2012 and 1WY/N/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainen TO, 2014, HUM MOL GENET; Austin AE, 2014, AM J FOREN MED PATH, V35, P145, DOI 10.1097/PAF.0000000000000094; Carpenter KM, 2000, AM J PUBLIC HEALTH, V90, P251, DOI 10.2105/AJPH.90.2.251; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Cedernaes J, 2014, MOL METAB, V3, P505, DOI 10.1016/j.molmet.2014.05.003; Corella D, 2012, PLOS ONE, P7; CRISP AH, 1976, BRIT MED J, V1, P7, DOI 10.1136/bmj.1.6000.7; Crump C, 2014, PSYCHOL MED, V44, P279, DOI 10.1017/S0033291713000810; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fudalej S, 2009, ALCOHOL ALCOHOLISM, V44, P437, DOI 10.1093/alcalc/agp045; Galfalvy H, 2013, WORLD J BIOL PSYCHIA, V14, P574, DOI 10.3109/15622975.2011.597875; Kivimaki M, 2011, J INTERN MED, V269, P519, DOI 10.1111/j.1365-2796.2011.02357.x; Kivimaki M, 2011, AM J EPIDEMIOL, V173, P421, DOI 10.1093/aje/kwq444; Lawlor DA, 2007, PSYCHOL MED, V37, P1151, DOI 10.1017/S0033291707000384; Lawlor DA, 2011, J INTERN MED, V269, P525, DOI 10.1111/j.1365-2796.2011.02343.x; Lin L, 2014, HUM MOL GENET, V23, P3299, DOI 10.1093/hmg/ddu043; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; McTaggart JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027968; Meyer K, 2012, CELL; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mullins N, 2014, AM J MED GENET B, V165, P428, DOI 10.1002/ajmg.b.32247; Perez-Iglesias R, 2010, J CLIN PSYCHOPHARM, V30, P661, DOI 10.1097/JCP.0b013e3181fae248; Rivera M, 2012, MOL PSYCHIATR, V17, P604, DOI 10.1038/mp.2011.45; Samaan Z, 2013, MOL PSYCHIATR, V18, P1281, DOI 10.1038/mp.2012.160; Schosser A, 2011, PLOS ONE, P6; Smemo S, 2014, NATURE; Sobczyk-Kopciol A, 2011, ADDICTION, V106, P739, DOI 10.1111/j.1360-0443.2010.03248.x; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Wang L, 2013, J MOL NEUROSCI, V51, P416, DOI 10.1007/s12031-013-0044-2; Willour VL, 2012, MOL PSYCHIATR, V17, P433, DOI 10.1038/mp.2011.4	31	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108900	10.1371/journal.pone.0108900	http://dx.doi.org/10.1371/journal.pone.0108900			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265168	Green Submitted, gold, Green Published			2022-12-27	WOS:000345745400137
J	Loos, M; Koopmans, B; Aarts, E; Maroteaux, G; van der Sluis, S; Verhage, M; Smit, AB				Loos, Maarten; Koopmans, Bastijn; Aarts, Emmeke; Maroteaux, Gregoire; van der Sluis, Sophie; Verhage, Matthijs; Smit, August B.		Neuro-BSIK Mouse Phenomics	Sheltering Behavior and Locomotor Activity in 11 Genetically Diverse Common Inbred Mouse Strains Using Home-Cage Monitoring	PLOS ONE			English	Article							ETHANOL INTOXICATION; MICE; MODEL; ARCHITECTURE; BATTERY; DISEASE; ANXIETY	Functional genetic analyses in mice rely on efficient and in-depth characterization of the behavioral spectrum. Automated home-cage observation can provide a systematic and efficient screening method to detect unexplored, novel behavioral phenotypes. Here, we analyzed high-throughput automated home-cage data using existing and novel concepts, to detect a plethora of genetic differences in spontaneous behavior in a panel of commonly used inbred strains (129S1/SvImJ, A/J, C3H/HeJ, C57BL/6J, BALB/cJ, DBA/2J, NOD/LtJ, FVB/NJ, WSB/EiJ, PWK/PhJ and CAST/EiJ). Continuous video-tracking observations of sheltering behavior and locomotor activity were segmented into distinguishable behavioral elements, and studied at different time scales, yielding a set of 115 behavioral parameters of which 105 showed highly significant strain differences. This set of 115 parameters was highly dimensional; principal component analysis identified 26 orthogonal components with eigenvalues above one. Especially novel parameters of sheltering behavior and parameters describing aspects of motion of the mouse in the home-cage showed high genetic effect sizes. Multi-day habituation curves and patterns of behavior surrounding dark/light phase transitions showed striking strain differences, albeit with lower genetic effect sizes. This spontaneous home-cage behavior study demonstrates high dimensionality, with a strong genetic contribution to specific sets of behavioral measures. Importantly, spontaneous home-cage behavior analysis detects genetic effects that cannot be studied in conventional behavioral tests, showing that the inclusion of a few days of undisturbed, labor extensive home-cage assessment may greatly aid gene function analyses and drug target discovery.	[Loos, Maarten; Koopmans, Bastijn] Syl Synaptol BV, Amsterdam, Netherlands; [Loos, Maarten; Smit, August B.] Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, CNCR, Amsterdam, Netherlands; [Aarts, Emmeke; Maroteaux, Gregoire; van der Sluis, Sophie; Verhage, Matthijs] Vrije Univ Amsterdam, Dept Funct Genom, CNCR, Amsterdam, Netherlands; [van der Sluis, Sophie] Vrije Univ Amsterdam Med Ctr, Sect Complex Trait Genet, Dept Clin Genet, Amsterdam, Netherlands; [Verhage, Matthijs] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Loos, M (corresponding author), Syl Synaptol BV, Amsterdam, Netherlands.	maarten.loos@sylics.com	Loos, Maarten/A-2768-2012; Elgersma, Ype/F-5164-2013; Aarts, Emmeke/K-7238-2019; van der Horst, Gijsbertus TJ/E-3661-2015; Pennartz, Cyriel/B-7508-2015	Loos, Maarten/0000-0003-1629-2928; Elgersma, Ype/0000-0002-3758-1297; van der Horst, Gijsbertus TJ/0000-0002-7773-6396; verhage, matthijs/0000-0002-6085-7503; Pennartz, Cyriel/0000-0001-8328-1175; van der Sluis, Sophie/0000-0001-9958-7216; Aarts, Emmeke/0000-0002-2432-7564	Agentschap NL (NeuroBSIK Mouse Phenomics Consortium) [BSIK03053]; Agentschap NL (NeuroBasic PharmaPhenomics Consortium, LSH) [FES0908]; Netherlands Organization for Scientific Research [VENI-451-08-025]	Agentschap NL (NeuroBSIK Mouse Phenomics Consortium); Agentschap NL (NeuroBasic PharmaPhenomics Consortium, LSH); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by Agentschap NL (NeuroBSIK Mouse Phenomics Consortium, BSIK03053 and NeuroBasic PharmaPhenomics Consortium, LSH framework FES0908) and the Netherlands Organization for Scientific Research (VENI-451-08-025 to S.V.D.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2010, NEUROSCI BIOBEHAV R, V34, P1351, DOI 10.1016/j.neubiorev.2010.04.004; Crabbe JC, 2003, GENES BRAIN BEHAV, V2, P201, DOI 10.1034/j.1601-183X.2003.00023.x; de Mooij-van Malsen JG, 2013, GENES BRAIN BEHAV, V12, P653, DOI 10.1111/gbb.12055; de Mooij-van Malsen JG, 2009, NEUROSCIENCE, V164, P1477, DOI 10.1016/j.neuroscience.2009.09.008; Visser L, 2006, GENES BRAIN BEHAV, V5, P458, DOI 10.1111/j.1601-183X.2005.00181.x; Faizi M, 2011, NEUROBIOL DIS, V43, P397, DOI 10.1016/j.nbd.2011.04.011; Fonio E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048414; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; HEGMANN JP, 1981, BEHAV GENET, V11, P103, DOI 10.1007/BF01065621; Hen I, 2004, J NEUROSCI METH, V133, P161, DOI 10.1016/j.jneumeth.2003.10.013; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Jhuang H, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1064; Jyoti A, 2010, J ALZHEIMERS DIS, V22, P873, DOI 10.3233/JAD-2010-100879; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kas MJH, 2009, GENES BRAIN BEHAV, V8, P13, DOI 10.1111/j.1601-183X.2008.00435.x; Krackow S, 2010, GENES BRAIN BEHAV, V9, P722, DOI 10.1111/j.1601-183X.2010.00606.x; Kramvis I, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00172; Lad HV, 2010, PHYSIOL BEHAV, V99, P301, DOI 10.1016/j.physbeh.2009.11.007; Loos M, 2009, GENES BRAIN BEHAV, V8, P817, DOI 10.1111/j.1601-183X.2009.00528.x; Loos M, 2010, BEHAV BRAIN RES, V214, P216, DOI 10.1016/j.bbr.2010.05.027; Lynch M., 1998, GENETICS ANAL QUANTI; Maroteaux G, 2012, GENES BRAIN BEHAV, V11, P772, DOI 10.1111/j.1601-183X.2012.00820.x; Milner LC, 2007, GENES BRAIN BEHAV; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Nishi A, 2010, MAMM GENOME, V21, P477, DOI 10.1007/s00335-010-9289-z; Portal E, 2013, BEHAV BRAIN RES, V250, P157, DOI 10.1016/j.bbr.2013.04.042; Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1; Robinson L, 2014, J NEUROSCI METHODS; Rustay NR, 2003, P NATL ACAD SCI USA, V100, P2917, DOI 10.1073/pnas.0437273100; Spruijt B.M., 2014, J NEUROSCI METHODS; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; van Gaalen MM, 2000, BEHAV BRAIN RES, V115, P95, DOI 10.1016/S0166-4328(00)00240-0; Vannoni E, 2014, J NEUROSCI METHODS	34	53	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108563	10.1371/journal.pone.0108563	http://dx.doi.org/10.1371/journal.pone.0108563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264768	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400089
J	Wang, ZJ; Han, ZJ; Tao, J; Lu, P; Liu, XZ; Wang, J; Wu, B; Huang, ZK; Yin, CJ; Tan, RY; Gu, M				Wang, Zijie; Han, Zhijian; Tao, Jun; Lu, Pei; Liu, Xuzhong; Wang, Jun; Wu, Bian; Huang, Zhengkai; Yin, Changjun; Tan, Ruoyun; Gu, Min			Clinical Efficacy and Safety of Pamidronate Therapy on Bone Mass Density in Early Post-Renal Transplant Period: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							MINERAL DENSITY; BISPHOSPHONATES; ALENDRONATE; PREVENTION; ACTIVATION; INCREASES	Introduction: The overall effect of pamidronate on bone mass density (BMD) in the early renal transplant period varies considerably among studies. The effects of pamidronate on graft function have not been determined. Materials and Methods: A comprehensive search was conducted in PubMed, the Cochrane Central Register of Controlled Trials (CENTRAL) and Embase independently by two authors. Randomized controlled trials of pamidronate evaluating bone loss in the first year of renal transplantation were included. Methods reported in the "Cochrane Handbook for Systematic Reviews of Interventions 5.0.2'' were used to evaluate changes of lumbar spine and femoral neck BMD, and serum creatinine, calcium and intact parathyroid hormone (iPTH) levels. Fixed or random effect models were used as appropriate. Results: Six randomized trials evaluating 281 patients were identified. One hundred forty-four were treated with pamidronate and 137 were control patients. Administration of pamidronate was associated with significant reduction of bone loss in the lumbar spine, compared to the control group (standardized mean difference (SMD) = 24.62 [16.25, 32.99]). There was no difference between the pamidronate treated and control femoral neck BMD (SMD = 3.53 [-1.84, 8.90]). A significant increase in the serum creatinine level of the intervention group was seen, compared to the control group. The serum calcium and iPTH of the pamidronate and control groups were not different after 1 year (serum creatinine: SMD = -3.101 [-5.33, -0.89]; serum calcium: SMD = 2.18 [-0.8, 5.16]; serum iPTH: SMD = 0.06 [-0.19, 0.31]). Heterogeneity was low for serum calcium and iPTH and high for serum creatinine. Conclusions: This meta-analysis demonstrated the beneficial clinical efficacy of pamidronate on BMD with no association with any alteration in graft function during the first year of renal transplantation. Significant heterogeneity precludes the conclusion of the relationship between serum creatinine and pamidronate.	[Wang, Zijie; Han, Zhijian; Tao, Jun; Lu, Pei; Liu, Xuzhong; Wang, Jun; Wu, Bian; Huang, Zhengkai; Yin, Changjun; Tan, Ruoyun; Gu, Min] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Tan, RY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China.	njmuwzj@qq.com; njmuwzj1990@hotmail.com		Torregrosa, Jose-Vicente/0000-0001-5160-3248	National Natural Science Foundation of China [81100532]; Science and Education Health Project of Jiangsu Province [RC2011055]; "333 high level talents project" in Jiangsu province; Jiangsu province six talents peak from Department of human resources, social security office of Jiangsu Province of China [2010WSN-56, 2011-WS-033]; General program of Department of Health of Jiangsu Province of China [H2009907]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Education Health Project of Jiangsu Province; "333 high level talents project" in Jiangsu province; Jiangsu province six talents peak from Department of human resources, social security office of Jiangsu Province of China; General program of Department of Health of Jiangsu Province of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This project is sponsored by the grants from the National Natural Science Foundation of China(81100532), the Science and Education Health Project of Jiangsu Province for important talent (RC2011055), "333 high level talents project" in Jiangsu province (2011 and 2013), Jiangsu province six talents peak from Department of human resources, social security office of Jiangsu Province of China (2010WSN-56 and 2011-WS-033), General program of Department of Health of Jiangsu Province of China(H2009907), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX10231801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biondi-Zoccai G, 2011, HEART LUNG VESSEL, V3, P161; Biver E, 2012, CURR OPIN ENDOCRINOL, V19, P468, DOI 10.1097/MED.0b013e3283591492; Body JJ, 2004, SEMIN ONCOL, V31, P73, DOI 10.1053/j.seminoncol.2004.07.030; Boyce RW, 1996, J BONE MINER RES, V11, P600; CHAPPARD D, 1991, J BONE MINER RES, V6, P673; Coco M, 2003, J AM SOC NEPHROL, V14, P2669, DOI 10.1097/01.ASN.0000087092.53894.80; Cremers S, 2011, BONE, V49, P42, DOI 10.1016/j.bone.2011.01.014; Durieux S, 2002, TRANSPLANTATION, V74, P496, DOI 10.1097/00007890-200208270-00011; EBPG Expert Group on Renal Transplantation, 2002, Nephrol Dial Transplant, V17 Suppl 4, P1; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Epstein S, 2011, ENDOKRYNOL POL, V62, P472; Fan SLS, 2003, KIDNEY INT, V63, P2275, DOI 10.1046/j.1523-1755.2003.00012.x; Fan SLS, 2000, KIDNEY INT, V57, P684, DOI 10.1046/j.1523-1755.2000.t01-1-00890.x; GUY JA, 1993, CALCIFIED TISSUE INT, V53, P283, DOI 10.1007/BF01320915; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JULIAN BA, 1991, NEW ENGL J MED, V325, P544, DOI 10.1056/NEJM199108223250804; Lee S, 2004, NEPHROL DIAL TRANSPL, V19, P2870, DOI 10.1093/ndt/gfh504; Meier RPH, 2012, ARCH INTERN MED, V172, P930, DOI 10.1001/archinternmed.2012.1796; Migliorati CA, 2003, J CLIN ONCOL, V21, P4253, DOI 10.1200/JCO.2003.99.132; Mitterbauer C, 2006, NEPHROL DIAL TRANSPL, V21, P2275, DOI 10.1093/ndt/gfl104; Nam JH, 2000, TRANSPLANT P, V32, P1876, DOI 10.1016/S0041-1345(00)01898-4; Okamoto M, 2010, TRANSPLANTATION, V89, P1391, DOI 10.1097/TP.0b013e3181d9e17b; Omidvar B, 2011, IRAN J KIDNEY DIS, V5, P420; Papapoulos SE, 2008, BEST PRACT RES CL EN, V22, P831, DOI 10.1016/j.beem.2008.07.001; Pasin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082913; Roschger P, 2001, BONE, V29, P185, DOI 10.1016/S8756-3282(01)00485-9; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Sanders JM, 2004, J MED CHEM, V47, P375, DOI 10.1021/jm0303709; Smerud KT, 2012, AM J TRANSPLANT, V12, P3316, DOI 10.1111/j.1600-6143.2012.04233.x; Thompson K, 2004, J BONE MINER RES, V19, P278, DOI 10.1359/JBMR.0301230; Torregrosa JV, 2011, OSTEOPOROSIS INT, V22, P281, DOI 10.1007/s00198-010-1197-2; Walsh SB, 2009, AM J KIDNEY DIS, V53, P856, DOI 10.1053/j.ajkd.2008.11.036	33	7	8	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108106	10.1371/journal.pone.0108106	http://dx.doi.org/10.1371/journal.pone.0108106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265508	gold, Green Published, Green Submitted			2022-12-27	WOS:000345745400042
J	Brandt, LO; Schmidt, AL; Mannering, U; Sarret, M; Kelstrup, CD; Olsen, JV; Cappellini, E				Brandt, Luise Orsted; Schmidt, Anne Lisbeth; Mannering, Ulla; Sarret, Mathilde; Kelstrup, Christian D.; Olsen, Jesper V.; Cappellini, Enrico			Species Identification of Archaeological Skin Objects from Danish Bogs: Comparison between Mass Spectrometry-Based Peptide Sequencing and Microscopy-Based Methods	PLOS ONE			English	Article							HAIR; DNA; PROTEIN	Denmark has an extraordinarily large and well-preserved collection of archaeological skin garments found in peat bogs, dated to approximately 920 BC - AD 775. These objects provide not only the possibility to study prehistoric skin costume and technologies, but also to investigate the animal species used for the production of skin garments. Until recently, species identification of archaeological skin was primarily performed by light and scanning electron microscopy or the analysis of ancient DNA. However, the efficacy of these methods can be limited due to the harsh, mostly acidic environment of peat bogs leading to morphological and molecular degradation within the samples. We compared species assignment results of twelve archaeological skin samples from Danish bogs using Mass Spectrometry (MS)-based peptide sequencing, against results obtained using light and scanning electron microscopy. While it was difficult to obtain reliable results using microscopy, MS enabled the identification of several species-diagnostic peptides, mostly from collagen and keratins, allowing confident species discrimination even among taxonomically close organisms, such as sheep and goat. Unlike previous MS-based methods, mostly relying on peptide fingerprinting, the shotgun sequencing approach we describe aims to identify the complete extracted ancient proteome, without preselected specific targets. As an example, we report the identification, in one of the samples, of two peptides uniquely assigned to bovine foetal haemoglobin, indicating the production of skin from a calf slaughtered within the first months of its life. We conclude that MS-based peptide sequencing is a reliable method for species identification of samples from bogs. The mass spectrometry proteomics data were deposited in the ProteomeXchange Consortium with the dataset identifier PXD001029.	[Brandt, Luise Orsted; Mannering, Ulla] Univ Copenhagen, Ctr Text Res, Copenhagen, Denmark; [Brandt, Luise Orsted; Cappellini, Enrico] Univ Copenhagen, Ctr GeoGenet, Copenhagen, Denmark; [Schmidt, Anne Lisbeth] Natl Museum Denmark, Dept Environm Archaeol & Mat Sci, Copenhagen, Denmark; [Mannering, Ulla] Natl Museum Denmark, Dept Ancient Cultures Denmark & Mediterranean, Copenhagen, Denmark; [Sarret, Mathilde] Univ Strasbourg, European Sch Chem Polymers & Mat Sci, Strasbourg, France; [Kelstrup, Christian D.; Olsen, Jesper V.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Copenhagen	Brandt, LO (corresponding author), Univ Copenhagen, Ctr Text Res, Copenhagen, Denmark.	luisebrandt@hotmail.com; ecappellini@gmail.com	Olsen, Jesper/ABH-4638-2020; Cappellini, Enrico/F-9346-2013	Olsen, Jesper/0000-0002-4747-4938; Cappellini, Enrico/0000-0001-7885-7811; Brandt, Luise Orsted/0000-0002-9777-0356; Kelstrup, Christian Dahl/0000-0003-4647-1425	Danish National Research Foundation [DNRF64, DNRF94]; Ministry of Culture (KUF); Danish Independant Research Council 'Sapere Aude'	Danish National Research Foundation(Danmarks Grundforskningsfond); Ministry of Culture (KUF); Danish Independant Research Council 'Sapere Aude'	This study was funded by the Danish National Research Foundation (DNRF64 and DNRF94), the Ministry of Culture (KUF), and the Danish Independant Research Council 'Sapere Aude'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1836, ANNALER NORDISK OLDK, P159; Appleyard HM, 1960, GUIDE IDENTIFICATION; BENECKE N, 1994, ARCHAOLOGISCHE STUDI; Brandt LO, 2011, ARCHAEOL ANTHROP SCI, V3, P209, DOI 10.1007/s12520-011-0055-2; Brunner H., 1974, IDENTIFICATION MAMMA, DOI [10.1017/S0030605300014253, DOI 10.1017/S0030605300014253]; Buckley M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059614; Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316; Buckley M, 2010, J ARCHAEOL SCI, V37, P13, DOI 10.1016/j.jas.2009.08.020; Campana MG, 2013, J ARCHAEOL SCI, V40, P1421, DOI 10.1016/j.jas.2012.09.007; Cappellini E, 2014, ZOOL J LINN SOC-LOND, V170, P222, DOI 10.1111/zoj12084; Cappellini E, 2012, J PROTEOME RES, V11, P917, DOI 10.1021/pr200721u; Chernova OF, 2002, BIOL BULL+, V29, P238, DOI 10.1023/A:1015482430438; Dam I, 2010, DANSKE LANDRACEGED; Deedrick D.W., 2004, FORENSIC SCI COMMUNI, V6; Dove CJ, 2002, ALEUTIANS ANTHR WS L, P51; Ebbesen K, 2009, AARBOGER NORDISK OLD, V2006, P37; Fatou JG, 1978, APPL FIBRE SCI, V1, P69; GRIMES RM, 1958, J DAIRY SCI, V41, P1527, DOI 10.3168/jds.S0022-0302(58)91130-5; Groenman-van Waateringe W, 1999, ANTIQUITY, V73, P884, DOI 10.1017/S0003598X00065637; Hald M., 1980, ANCIENT DANISH TEXTI; Harris S, 2006, PAPERS I ARCHAEOLOGY, V16, P115; Harris S, 2012, EUR J ARCHAEOL, V15, P61, DOI 10.1179/1461957112Y.0000000006; Hausman L.A., 1920, AM NAT, V54, P96; Hollemeyer K, 2002, ANAL CHEM, V74, P5960, DOI 10.1021/ac020347f; Hollemeyer K, 2008, RAPID COMMUN MASS SP, V22, P2751, DOI 10.1002/rcm.3679; Hollemeyer K, 2012, RAPID COMMUN MASS SP, V26, P1735, DOI 10.1002/rcm.6277; HUGHES MA, 1986, NATURE, V323, P208, DOI 10.1038/323208c0; Kirby DP, 2013, ANALYST, V138, P4849, DOI 10.1039/c3an00925d; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lochte T, 1938, ATLAS MENSCHLICHEN T; LUBEC G, 1994, FASEB J, V8, P1166, DOI 10.1096/fasebj.8.14.7958623; Luniak B., 1953, IDENTIFICATION TEXTI; Mannering U, 2012, TEXTILES TEXTILE PRO; Mannering U., 2014, ENCY GLOBAL ARCHAEOL, P7282, DOI [10.1007/978-1-4419-0465-2_488, DOI 10.1007/978-1-4419-0465-2_488]; Mannering U, 2012, TEXTILES TEXTILE PRO, P89; Mannering U, 2010, J ARCHAEOL SCI, V37, P261, DOI 10.1016/j.jas.2009.09.037; Meyer M, 2002, REM ATLAS HAARKUTIKU; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Ostergaard E, 1971, MEDDELELSER KONSERVE, V10, P3; Rast-Eicher A., 2008, TEXTILIEN WOLLE SCHA; Rast-Eicher A, 2013, J ARCHAEOL SCI, V40, P1224, DOI 10.1016/j.jas.2012.09.030; Reed R., 1972, ANCIENT SKINS PARCHM; Richter KK, 2011, J ARCHAEOL SCI, V38, P1502, DOI 10.1016/j.jas.2011.02.014; Robertson J, 1999, TAYL & FRAN FORENS S, P79; Ryder M.L., 1990, MITTEILUNGEN ANTHR G, V120, P103; Ryder ML, 1987, OXFORD J ARCHAEOL, V6, P369; Ryder ML, 1990, OXFORD J ARCHAEOL, V9, P37; Schlumbaum A, 2010, J ARCHAEOL SCI, V37, P1247, DOI 10.1016/j.jas.2009.12.025; Schmidt A. L, 2011, ICOM CC 16 TRIENN C, P1; Solazzo C, 2013, RAPID COMMUNICATION, V27, P1; Stoves J.L., 1957, FIBRE MICROSCOPY ITS; Strand EA, 2010, EUR J ARCHAEOL, V13, P149, DOI 10.1177/1461957110365513; Teerink B. J., 2003, HAIR W EUROPEAN MAMM; The British Leather Manufacturers' Research Association, 1957, HID SKINS LEATH MICR; Toniolo L, 2012, J PROTEOMICS, V75, P3365, DOI 10.1016/j.jprot.2012.03.051; Van der Sanden Wijnand, 1996, NATURE ETERNITY BOG; Verginelli F, 2005, MOL BIOL EVOL, V22, P2541, DOI 10.1093/molbev/msi248; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vuissoz A, 2007, J ARCHAEOL SCI, V34, P823, DOI 10.1016/j.jas.2006.09.002; Wechsler B, 1984, BERLINER BEITRAGE AR, V9, P113; WILD J. P., 1988, TEXTILES ARCHAEOLOGY; Wildman A.B., 1954, MICROSCOPY ANIMAL TE; Wilson AS, 2007, BRIT J DERMATOL, V157, P450, DOI 10.1111/j.1365-2133.2007.07973.x; Wilson AS, 2010, ARCHAEOMETRY, V52, P467, DOI 10.1111/j.1475-4754.2010.00524.x; Wilson AS, 1999, J RAMAN SPECTROSC, V30, P367, DOI 10.1002/(SICI)1097-4555(199905)30:5<367::AID-JRS384>3.0.CO;2-I	66	49	49	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e106875	10.1371/journal.pone.0106875	http://dx.doi.org/10.1371/journal.pone.0106875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AQ3IP	25260035	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600012
J	Pham-Kanter, G; Zinner, DE; Campbell, EG				Pham-Kanter, Genevieve; Zinner, Darren E.; Campbell, Eric G.			Codifying Collegiality: Recent Developments in Data Sharing Policy in the Life Sciences	PLOS ONE			English	Article							PATENTS	Over the last decade, there have been significant changes in data sharing policies and in the data sharing environment faced by life science researchers. Using data from a 2013 survey of over 1600 life science researchers, we analyze the effects of sharing policies of funding agencies and journals. We also examine the effects of new sharing infrastructure and tools (i.e., third party repositories and online supplements). We find that recently enacted data sharing policies and new sharing infrastructure and tools have had a sizable effect on encouraging data sharing. In particular, third party repositories and online supplements as well as data sharing requirements of funding agencies, particularly the NIH and the National Human Genome Research Institute, were perceived by scientists to have had a large effect on facilitating data sharing. In addition, we found a high degree of compliance with these new policies, although noncompliance resulted in few formal or informal sanctions. Despite the overall effectiveness of data sharing policies, some significant gaps remain: about one third of grant reviewers placed no weight on data sharing plans in their reviews, and a similar percentage ignored the requirements of material transfer agreements. These patterns suggest that although most of these new policies have been effective, there is still room for policy improvement.	[Pham-Kanter, Genevieve] Drexel Univ, Sch Publ Hlth, Dept Hlth Management & Policy, Philadelphia, PA 19104 USA; [Pham-Kanter, Genevieve] Harvard Univ, Edmond J Safra Ctr Eth, Boston, MA 02115 USA; [Zinner, Darren E.] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA; [Campbell, Eric G.] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; [Campbell, Eric G.] Harvard Univ, Sch Med, Boston, MA USA	Drexel University; Harvard University; Brandeis University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Pham-Kanter, G (corresponding author), Drexel Univ, Sch Publ Hlth, Dept Hlth Management & Policy, Philadelphia, PA 19104 USA.	gpkanter@drexel.edu		Kanter, Genevieve/0000-0002-3044-7829	National Human Genome Research Institute [R01 HG006281]; Edmond J. Safra Center for Ethics at Harvard University; Brandeis University's Health Industry Forum; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006281] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Edmond J. Safra Center for Ethics at Harvard University; Brandeis University's Health Industry Forum; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by the National Human Genome Research Institute (R01 HG006281). Genevieve Pham-Kanter is partially supported by the Edmond J. Safra Center for Ethics at Harvard University. Darren Zinner is partially supported by Brandeis University's Health Industry Forum, an independent policy consortium of major health care insurers, delivery systems, and biopharmaceutical and medical device firms. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; DASGUPTA P, 1994, RES POLICY, V23, P487; Eisenberg RS, 2006, IND CORP CHANGE, V15, P1013, DOI 10.1093/icc/dtl025; Evans JA, 2010, SOC STUD SCI, V40, P757, DOI 10.1177/0306312710379931; Fischer BA, 2010, SCI ENG ETHICS, V16, P783, DOI 10.1007/s11948-010-9239-x; Grushcow JM, 2004, J LEGAL STUD, V33, P59, DOI 10.1086/381288; Hechter M., 2001, SOCIAL NORMS; Howard Hughes Medical Institute, 2007, POL SHAR PUBL REL MA; Mas-Colell A., 1995, MICROECONOMIC THEORY; MERTON Robert King., 1973, THEORETICAL SOCIOLOG; Mowery DC, 2007, J TECHNOL TRANSFER, V32, P157, DOI 10.1007/s10961-006-9011-1; National Institutes of Health, 2003, FIN NIH STAT SHAR RE; National Science Foundation, 2013, NAT SCI FDN GRANT PR; Nelson B, 2009, NATURE, V461, P160, DOI 10.1038/461160a; Piwowar HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018657; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Stephan PE, 2010, HDB EC INNOVATION, V1; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; Walsh JP, 2007, RES POLICY, V36, P1184, DOI 10.1016/j.respol.2007.04.006; Wellcome Trust, 2010, POS STAT DAT MAN SHA; Wheeland DG, 2014, FED REGISTER, V79, P51345; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828; Zinner D, 2014, CHANGING NATURE SCI	24	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108451	10.1371/journal.pone.0108451	http://dx.doi.org/10.1371/journal.pone.0108451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IP	25259842	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600074
J	Jiang, YL; Zhang, SH; Xu, J; Feng, JX; Mahboob, S; Al-Ghanim, KA; Sun, XW; Xu, P				Jiang, Yanliang; Zhang, Songhao; Xu, Jian; Feng, Jianxin; Mahboob, Shahid; Al-Ghanim, Khalid A.; Sun, Xiaowen; Xu, Peng			Comparative Transcriptome Analysis Reveals the Genetic Basis of Skin Color Variation in Common Carp	PLOS ONE			English	Article							COAT-COLOR; AGOUTI GENE; BROWN LOCUS; PIGMENT; PROTEIN; TYRP1; TYROSINASE; EVOLUTION; MELANIN; CELLS	Background: The common carp is an important aquaculture species that is widely distributed across the world. During the long history of carp domestication, numerous carp strains with diverse skin colors have been established. Skin color is used as a visual criterion to determine the market value of carp. However, the genetic basis of common carp skin color has not been extensively studied. Methodology/Principal Findings: In this study, we performed Illumina sequencing on two common carp strains: the reddish Xingguo red carp and the brownish-black Yellow River carp. A total of 435,348,868 reads were generated, resulting in 198,781 assembled contigs that were used as reference sequences. Comparisons of skin transcriptome files revealed 2,012 unigenes with significantly different expression in the two common carp strains, including 874 genes that were upregulated in Xingguo red carp and 1,138 genes that were up-regulated in Yellow River carp. The expression patterns of 20 randomly selected differentially expressed genes were validated using quantitative RT-PCR. Gene pathway analysis of the differentially expressed genes indicated that melanin biosynthesis, along with the Wnt and MAPK signaling pathways, is highly likely to affect the skin pigmentation process. Several key genes involved in the skin pigmentation process, including TYRP1, SILV, ASIP and xCT, showed significant differences in their expression patterns between the two strains. Conclusions: In this study, we conducted a comparative transcriptome analysis of Xingguo red carp and Yellow River carp skins, and we detected key genes involved in the common carp skin pigmentation process. We propose that common carp skin pigmentation depends upon at least three pathways. Understanding fish skin color genetics will facilitate future molecular selection of the fish skin colors with high market values.	[Jiang, Yanliang; Zhang, Songhao; Xu, Jian; Sun, Xiaowen; Xu, Peng] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, CAFS Key Lab Aquat Genom, Beijing, Peoples R China; [Jiang, Yanliang; Zhang, Songhao; Xu, Jian; Sun, Xiaowen; Xu, Peng] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing Key Lab Fishery Biotechnol, Beijing, Peoples R China; [Feng, Jianxin] Henan Acad Fishery Sci, Zhengzhou, Henan, Peoples R China; [Mahboob, Shahid; Al-Ghanim, Khalid A.; Xu, Peng] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia	Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences; King Saud University	Xu, P (corresponding author), Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, CAFS Key Lab Aquat Genom, Beijing, Peoples R China.	xupeng@cafs.ac.cn	Rana, Shahid Mahboob/P-1131-2014; Xu, Peng/J-4018-2012; Xu, Jian/H-5349-2019	Rana, Shahid Mahboob/0000-0003-4969-5387; Xu, Peng/0000-0002-1531-5078; Xu, Jian/0000-0003-0274-4268	Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences [2014C011, 2013C010, 2013C011]; National High-Technology Research and Development Program of China (863 program) [2011AA100401]; Visiting Professorship Program, Deanship of Scientific Research, College of Sciences at King Saud University, Riyadh	Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences; National High-Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Visiting Professorship Program, Deanship of Scientific Research, College of Sciences at King Saud University, Riyadh	This work was supported by the Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences (2014C011, 2013C010 and 2013C011), the National High-Technology Research and Development Program of China (863 program; 2011AA100401), and PX was supported by the Visiting Professorship Program, Deanship of Scientific Research, College of Sciences at King Saud University, Riyadh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-74; Bar Ido, 2013, Frontiers in Genetics, V4, P6, DOI 10.3389/fgene.2013.00006; Berryere TG, 2003, ANIM GENET, V34, P169, DOI 10.1046/j.1365-2052.2003.00985.x; Braasch I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-74; Braasch I, 2009, PIGM CELL MELANOMA R, V22, P839, DOI 10.1111/j.1755-148X.2009.00614.x; Brunberg E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-46; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Chakraborty AK, 1996, EUR J BIOCHEM, V236, P180, DOI 10.1111/j.1432-1033.1996.t01-1-00180.x; Chang JHT, 1999, HUM MOL GENET, V8, P575, DOI 10.1093/hmg/8.4.575; Chintala S, 2005, P NATL ACAD SCI USA, V102, P10964, DOI 10.1073/pnas.0502856102; DELMARMOL V, 1993, FEBS LETT, V327, P307, DOI 10.1016/0014-5793(93)81010-W; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gratten J, 2007, P ROY SOC B-BIOL SCI, V274, P619, DOI 10.1098/rspb.2006.3762; Hellstrom AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002285; Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; JACKSON IJ, 1988, P NATL ACAD SCI USA, V85, P4392, DOI 10.1073/pnas.85.12.4392; Karlsson AC, 2009, VET OPHTHALMOL, V12, P292, DOI 10.1111/j.1463-5224.2009.00714.x; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kelsh RN, 2004, PIGM CELL RES, V17, P326, DOI 10.1111/j.1600-0749.2004.00174.x; Kelsh RN, 2004, MECH DEVELOP, V121, P841, DOI 10.1016/j.mod.2004.01.004; KOBAYASHI T, 1994, EMBO J, V13, P5818, DOI 10.1002/j.1460-2075.1994.tb06925.x; Kobayashi T, 2007, J CELL SCI, V120, P4261, DOI 10.1242/jcs.017913; Kuramoto T, 2001, MAMM GENOME, V12, P469, DOI 10.1007/s003350020010; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leeb T, 2000, ANIM GENET, V31, P335, DOI 10.1046/j.1365-2052.2000.00656.x; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lim JC, 2011, EXP EYE RES, V92, P162, DOI 10.1016/j.exer.2010.05.007; Lin Sh, 2010, THESIS U IOWA; Parichy DM, 2006, HEREDITY, V97, P200, DOI 10.1038/sj.hdy.6800867; Rad HH, 2004, EXP CELL RES, V298, P317, DOI 10.1016/j.yexcr.2004.04.045; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakai C, 1997, EMBO J, V16, P3544, DOI 10.1093/emboj/16.12.3544; Sarangarajan R, 2001, PIGM CELL RES, V14, P437, DOI 10.1034/j.1600-0749.2001.140603.x; Schmidt-Kuntzel A, 2005, J HERED, V96, P289, DOI 10.1093/jhered/esi066; Schmutz SM, 2002, MAMM GENOME, V13, P380, DOI 10.1007/s00335-001-2147-2; SHIBAHARA S, 1992, PIGM CELL RES, P90; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Squarzoni P, 2011, DEVELOPMENT, V138, P1421, DOI 10.1242/dev.057323; STOCKER KM, 1991, DEVELOPMENT, V111, P635; Vage DI, 1997, NAT GENET, V15, P311, DOI 10.1038/ng0397-311; Voisey J, 2001, PIGM CELL RES, V14, P264, DOI 10.1034/j.1600-0749.2001.140406.x; Wang CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090074; WILSON BD, 1995, HUM MOL GENET, V4, P223, DOI 10.1093/hmg/4.2.223; Xu J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-682; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Yan B, 2013, J CELL SCI, V126, P3401, DOI 10.1242/jcs.125831; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhou Jianfeng, 2004, Genetika, V40, P1389	54	77	85	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108200	10.1371/journal.pone.0108200	http://dx.doi.org/10.1371/journal.pone.0108200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255374	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300062
J	Ramnath, NWM; de Luijtgaarden, KMV; van der Pluijm, I; van Nimwegen, M; van Heijningen, PM; Swagemakers, SMA; van Thiel, BS; Ridwan, RY; van Vliet, N; Vermeij, M; Hawinkels, LJAC; de Munck, A; Dzyubachyk, O; Meijering, E; van der Spek, P; Rottier, R; Yanagisawa, H; Hendriks, RW; Kanaar, R; Rouwet, EV; Kleinjan, A; Essers, J				Ramnath, Natasja W. M.; de Luijtgaarden, Koen M. van; van der Pluijm, Ingrid; van Nimwegen, Menno; van Heijningen, Paula M.; Swagemakers, Sigrid M. A.; van Thiel, Bibi S.; Ridwan, Ruziedi Y.; van Vliet, Nicole; Vermeij, Marcel; Hawinkels, Luuk J. A. C.; de Munck, Anne; Dzyubachyk, Oleh; Meijering, Erik; van der Spek, Peter; Rottier, Robbert; Yanagisawa, Hiromi; Hendriks, Rudi W.; Kanaar, Roland; Rouwet, Ellen V.; Kleinjan, Alex; Essers, Jeroen			Extracellular Matrix Defects in Aneurysmal Fibulin-4 Mice Predispose to Lung Emphysema	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ABDOMINAL AORTIC-ANEURYSM; CUTIS LAXA; CARDIOVASCULAR-DISEASE; AIRSPACE ENLARGEMENT; INFLAMMATION; PATHOGENESIS; DEFICIENCY; COPD; GENE	Background: In this study we set out to investigate the clinically observed relationship between chronic obstructive pulmonary disease (COPD) and aortic aneurysms. We tested the hypothesis that an inherited deficiency of connective tissue might play a role in the combined development of pulmonary emphysema and vascular disease. Methods: We first determined the prevalence of chronic obstructive pulmonary disease in a clinical cohort of aortic aneurysms patients and arterial occlusive disease patients. Subsequently, we used a combined approach comprising pathological, functional, molecular imaging, immunological and gene expression analysis to reveal the sequence of events that culminates in pulmonary emphysema in aneurysmal Fibulin-4 deficient (Fibulin-4(R)) mice. Results: Here we show that COPD is significantly more prevalent in aneurysm patients compared to arterial occlusive disease patients, independent of smoking, other clinical risk factors and inflammation. In addition, we demonstrate that aneurysmal Fibulin-4(R/R) mice display severe developmental lung emphysema, whereas Fibulin-4(+/R) mice acquire alveolar breakdown with age and upon infectious stress. This vicious circle is further exacerbated by the diminished antiprotease capacity of the lungs and ultimately results in the development of pulmonary emphysema. Conclusions: Our experimental data identify genetic susceptibility to extracellular matrix degradation and secondary inflammation as the common mechanisms in both COPD and aneurysm formation.	[Ramnath, Natasja W. M.; van der Pluijm, Ingrid; van Heijningen, Paula M.; Swagemakers, Sigrid M. A.; van Thiel, Bibi S.; Ridwan, Ruziedi Y.; van Vliet, Nicole; Kanaar, Roland; Essers, Jeroen] Erasmus MC, Canc Genom Ctr, Dept Genet, Rotterdam, Netherlands; [van Nimwegen, Menno; Hendriks, Rudi W.; Kleinjan, Alex] Erasmus MC, Dept Pulm Dis, Rotterdam, Netherlands; [Swagemakers, Sigrid M. A.; van der Spek, Peter] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [Vermeij, Marcel] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Dzyubachyk, Oleh; Meijering, Erik] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Dzyubachyk, Oleh; Meijering, Erik] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Kanaar, Roland; Essers, Jeroen] Erasmus MC, Dept Radiat Oncol, Rotterdam, Netherlands; [Ramnath, Natasja W. M.; de Luijtgaarden, Koen M. van; van der Pluijm, Ingrid; van Thiel, Bibi S.; Ridwan, Ruziedi Y.; Rouwet, Ellen V.; Essers, Jeroen] Erasmus MC, Dept Vasc Surg, Rotterdam, Netherlands; [van Thiel, Bibi S.; Ridwan, Ruziedi Y.] Erasmus MC, Dept Pharmacol, Rotterdam, Netherlands; [Hawinkels, Luuk J. A. C.] Dept Mol Cell Biol, Leiden, Netherlands; [Hawinkels, Luuk J. A. C.] Ctr Biomed Genet, Leiden, Netherlands; [de Munck, Anne; Rottier, Robbert] Erasmus MC, Dept Pediat Surg, Rotterdam, Netherlands; [Dzyubachyk, Oleh] Leiden Univ Med Ctr, Dept Radiol, Leiden, Netherlands; [Yanagisawa, Hiromi] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); University of Texas System; University of Texas Southwestern Medical Center Dallas	Kleinjan, A (corresponding author), Erasmus MC, Dept Pulm Dis, Rotterdam, Netherlands.	a.kleinjan@erasmusmc.nl; j.essers@erasmusmc.nl	Hawinkels, Lukas/Q-5098-2019; Meijering, Erik/AAL-8143-2020; Dzyubachyk, Oleh/Y-3913-2018; Yanagisawa, Hiromi/Y-2843-2019	Hawinkels, Lukas/0000-0002-2274-9325; Dzyubachyk, Oleh/0000-0003-1344-7189; Yanagisawa, Hiromi/0000-0002-7576-9186; Rottier, Robbert/0000-0002-9291-4971	'Lijf en Leven' grant 'Early detection and diagnosis of aneurysms and heart valve abnormalities'; Alp d'HuZes/Bas Mulder award [UL 2011-5051]	'Lijf en Leven' grant 'Early detection and diagnosis of aneurysms and heart valve abnormalities'; Alp d'HuZes/Bas Mulder award	This work was supported by the 'Lijf en Leven' grant ( 2008): 'Early detection and diagnosis of aneurysms and heart valve abnormalities' (to JE and PvH). LH is supported by the Alp d'HuZes/Bas Mulder award 2011 (UL 2011-5051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P333, DOI 10.1164/rccm.2110093; Antoniou GA, 2011, J VASC SURG, V54, P1175, DOI 10.1016/j.jvs.2011.02.065; Bhattacharya S, 2009, AM J RESP CELL MOL, V40, P359, DOI 10.1165/rcmb.2008-0114OC; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Corsonello A, 2011, CURR OPIN PULM MED, V17, pS21, DOI 10.1097/01.mcp.0000410744.75216.d0; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Fowkes FGR, 2006, J VASC SURG, V43, P474, DOI 10.1016/j.jvs.2005.11.018; Greene CM, 2011, EXPERT REV RESP MED, V5, P395, DOI [10.1586/ERS.11.20, 10.1586/ers.11.20]; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hanada K, 2007, CIRC RES, V100, P738, DOI 10.1161/01.RES.0000260181.19449.95; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Hoyer J, 2009, CLIN GENET, V76, P276, DOI 10.1111/j.1399-0004.2009.01204.x; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; Jacob RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006670; Jobse BN, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-42; Johnsen SH, 2010, ARTERIOSCL THROM VAS, V30, P1263, DOI 10.1161/ATVBAHA.110.203588; Kaijzel EL, 2010, CIRC-CARDIOVASC IMAG, V3, P567, DOI 10.1161/CIRCIMAGING.109.933093; Kobayashi S, 2013, AM J RESP CELL MOL, V49, P971, DOI 10.1165/rcmb.2013-0074OC; Lapierre M, 2007, CANCER RES, V67, P9030, DOI 10.1158/0008-5472.CAN-07-0807; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Lederle FA, 2000, ARCH INTERN MED, V160, P1425, DOI 10.1001/archinte.160.10.1425; Lindholt JS, 1998, J VASC SURG, V28, P226, DOI 10.1016/S0741-5214(98)70158-2; Lindsay ME, 2012, NAT GENET, V44, P922, DOI 10.1038/ng.2349; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Meijer CA, 2012, EUR J VASC ENDOVASC; Nahrendorf M, 2009, ARTERIOSCL THROM VAS, V29, P1444, DOI 10.1161/ATVBAHA.109.193086; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Pauwels NS, 2011, EUR RESPIR J, V38, P1019, DOI 10.1183/09031936.00158110; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; REED D, 1992, CIRCULATION, V85, P205, DOI 10.1161/01.CIR.85.1.205; Renard M, 2010, EUR J HUM GENET, V18, P895, DOI 10.1038/ejhg.2010.45; Sakamaki F, 2002, J VASC SURG, V36, P35, DOI 10.1067/mva.2002.123087; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Stoller JK, 2012, AM J RESP CRIT CARE, V185, P246, DOI 10.1164/rccm.201108-1428CI; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Wendel DP, 2000, AM J RESP CELL MOL, V23, P320, DOI 10.1165/ajrcmb.23.3.3906; WHO, 2007, WORLD HLTH REP CHRON; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	42	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e106054	10.1371/journal.pone.0106054	http://dx.doi.org/10.1371/journal.pone.0106054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255451	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300007
J	Tomaiuolo, F; Campana, S; Collins, DL; Fonov, VS; Ricciardi, E; Sartori, G; Pietrini, P; Kupers, R; Ptito, M				Tomaiuolo, Francesco; Campana, Serena; Collins, D. Louis; Fonov, Vladimir S.; Ricciardi, Emiliano; Sartori, Giuseppe; Pietrini, Pietro; Kupers, Ron; Ptito, Maurice			Morphometric Changes of the Corpus Callosum in Congenital Blindness	PLOS ONE			English	Article							VISUAL-CORTEX; FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; SHAPE; TOPOGRAPHY; PLASTICITY; MORPHOLOGY; DARK; MRI; REORGANIZATION	We examined the effects of visual deprivation at birth on the development of the corpus callosum in a large group of congenitally blind individuals. We acquired high-resolution T1-weighted MRI scans in 28 congenitally blind and 28 normal sighted subjects matched for age and gender. There was no overall group effect of visual deprivation on the total surface area of the corpus callosum. However, subdividing the corpus callosum into five subdivisions revealed significant regional changes in its three most posterior parts. Compared to the sighted controls, congenitally blind individuals showed a 12% reduction in the splenium, and a 20% increase in the isthmus and the posterior part of the body. A shape analysis further revealed that the bending angle of the corpus callosum was more convex in congenitally blind compared to the sighted control subjects. The observed morphometric changes in the corpus callosum are in line with the well-described cross-modal functional and structural neuroplastic changes in congenital blindness.	[Tomaiuolo, Francesco] Auxilium Vitae Volterra, Volterra, Italy; [Campana, Serena; Sartori, Giuseppe] Univ Padua, Dept Gen Psychol, Padua, Italy; [Collins, D. Louis; Fonov, Vladimir S.] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Ricciardi, Emiliano; Pietrini, Pietro] Univ Pisa, Lab Clin Biochem & Mol Biol, Dept Surg Med Mol & Crit Area Pathol, Pisa, Italy; [Ricciardi, Emiliano] Fdn Toscana G Monasterio, MRI Lab, Pisa, Italy; [Pietrini, Pietro] Pisa Univ Hosp, Clin Psychol Branch, Pisa, Italy; [Kupers, Ron; Ptito, Maurice] Univ Montreal, Ecole Optometrie, Montreal, PQ H3C 3J7, Canada; [Kupers, Ron; Ptito, Maurice] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, BRAINlab, DK-2200 Copenhagen, Denmark	University of Padua; McGill University; University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Universite de Montreal; University of Copenhagen	Kupers, R (corresponding author), Univ Montreal, Ecole Optometrie, Montreal, PQ H3C 3J7, Canada.	kupers@sund.ku.dk	Fonov, Vladimir/AAG-9572-2019; Ptito, Maurice/G-3422-2013; Ricciardi, Emiliano/E-6929-2011; Tomaiuolo, Francesco/AAC-1534-2019; Sartori, Giuseppe/B-8140-2008; Campana, Serena/ABD-2707-2020; Pietrini, Pietro/Z-4202-2019; Collins, D. Louis/ABD-7708-2021	Fonov, Vladimir/0000-0003-3402-7749; Ptito, Maurice/0000-0002-5173-5862; Ricciardi, Emiliano/0000-0002-7178-9534; Collins, D. Louis/0000-0002-8432-7021; Tomaiuolo, Fancesco/0000-0003-1230-2770; kupers, ron/0000-0001-7237-4245; Campana, Serena/0000-0001-6791-100X; Pietrini, Pietro/0000-0002-6768-5556; Sartori, Giuseppe/0000-0002-6026-0133	Lundbeck foundation (Denmark); Harland Sanders foundation (Canada)	Lundbeck foundation (Denmark)(Lundbeckfonden); Harland Sanders foundation (Canada)	This research was supported by the Lundbeck foundation (Denmark) to RK and the Harland Sanders foundation (Canada) to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Ansado J, 2013, NEUROPSYCHOLOGY, V27, P464, DOI 10.1037/a0032854; Beer AL, 2011, EXP BRAIN RES, V213, P299, DOI 10.1007/s00221-011-2715-y; BERMAN NE, 1983, BRAIN RES, V274, P201, DOI 10.1016/0006-8993(83)90697-2; Bermudez P, 2001, NEUROIMAGE, V13, P1121, DOI 10.1006/nimg.2001.0772; Bock AS, 2013, NEUROIMAGE, V81, P325, DOI 10.1016/j.neuroimage.2013.05.038; Bridge H, 2009, BRAIN, V132, P3467, DOI 10.1093/brain/awp279; Chebat DR, 2007, NEUROREPORT, V18, P329, DOI 10.1097/WNR.0b013e32802b70f8; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Desgent S, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/590725; DeVolder AG, 1997, BRAIN RES, V750, P235, DOI 10.1016/S0006-8993(96)01352-2; Dougherty RF, 2005, P NATL ACAD SCI USA, V102, P7350, DOI 10.1073/pnas.0500003102; Eskildsen SF, 2012, NEUROIMAGE, V59, P2362, DOI 10.1016/j.neuroimage.2011.09.012; Fabri M, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/251308; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; FROST DO, 1989, EXP BRAIN RES, V78, P203; Hampel H, 2002, J NEURAL TRANSM, V109, P837, DOI 10.1007/s007020200069; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; INNOCENTI GM, 1985, J NEUROSCI, V5, P255; Ioannides AA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00429; Ishaq O, 2007, P ANN INT IEEE EMBS, P2110, DOI 10.1109/IEMBS.2007.4352738; Jarbo K, 2012, NEUROIMAGE, V59, P1988, DOI 10.1016/j.neuroimage.2011.09.056; Jiang JF, 2009, J NEUROSCI, V29, P2205, DOI 10.1523/JNEUROSCI.5451-08.2009; Joseph R, 1996, CONTUSIONS HEAD INJU, P864; Kim M, 2006, NEUROIMAGE, V32, P1243, DOI 10.1016/j.neuroimage.2006.06.006; Kupers R, 2006, P NATL ACAD SCI USA, V103, P13256, DOI 10.1073/pnas.0602925103; Kupers R, 2014, NEUROSCI BIOBEHAV R, V41, P36, DOI 10.1016/j.neubiorev.2013.08.001; Kupers R, 2011, PROG BRAIN RES, V192, P17, DOI 10.1016/B978-0-444-53355-5.00002-6; Kupers R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00019; Lepore N, 2010, NEUROIMAGE, V49, P134, DOI 10.1016/j.neuroimage.2009.07.048; Lepore N, 2009, NEUROIMAGE, V46, P949, DOI 10.1016/j.neuroimage.2009.01.071; Li JJ, 2013, CEREB CORTEX, V23, P542, DOI [10.1093/cercor/bhs034, 10.1093/cercor/bhs410]; Liu Y, 2007, BRAIN, V130, P2085, DOI 10.1093/brain/awm121; LUND RD, 1979, BRAIN RES, V167, P172, DOI 10.1016/0006-8993(79)90273-7; MILLERET C, 1994, BEHAV BRAIN RES, V64, P85, DOI 10.1016/0166-4328(94)90121-X; Narr KL, 2000, CEREB CORTEX, V10, P40, DOI 10.1093/cercor/10.1.40; Noppeney U, 2005, CURR BIOL, V15, pR488, DOI 10.1016/j.cub.2005.06.053; Pan WJ, 2007, NEUROIMAGE, V37, P212, DOI 10.1016/j.neuroimage.2007.05.014; Park HJ, 2008, HUM BRAIN MAPP, V29, P503, DOI 10.1002/hbm.20314; Park HJ, 2009, NEUROIMAGE, V47, P98, DOI 10.1016/j.neuroimage.2009.03.076; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; Ptito M, 2008, EXP BRAIN RES, V187, P41, DOI 10.1007/s00221-008-1273-4; Putnam MC, 2010, J COGNITIVE NEUROSCI, V22, P1662, DOI 10.1162/jocn.2009.21290; Ricciardi E, 2014, NEUROSCI BIOBEHAV R, V41, P64, DOI 10.1016/j.neubiorev.2013.10.006; Ricciardi E, 2011, CURR OPIN NEUROL, V24, P357, DOI 10.1097/WCO.0b013e328348bdbf; Schmitt JE, 2011, ARCH NEUROL-CHICAGO, V58, P283; Shimony JS, 2006, CEREB CORTEX, V16, P1653, DOI 10.1093/cercor/bhj102; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Tomaiuolo F, 2002, NEUROREPORT, V13, P2281, DOI 10.1097/00001756-200212030-00022; Tomaiuolo F, 2007, DEMENT GERIATR COGN, V23, P96, DOI 10.1159/000097371; Walterfang M, 2011, AM J NEURORADIOL, V32, P1340, DOI 10.3174/ajnr.A2490; Walterfang M, 2008, BRIT J PSYCHIAT, V192, P429, DOI 10.1192/bjp.bp.107.041251; Wang DW, 2014, HUM BRAIN MAPP, V35, P2573, DOI 10.1002/hbm.22350; Weinberg SM, 2013, AM J MED GENET A, V161A, P1002, DOI 10.1002/ajmg.a.35835; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Wittenberg GF, 2004, EUR J NEUROSCI, V20, P1923, DOI 10.1111/j.1460-9568.2004.03630.x; Yu CS, 2008, HUM BRAIN MAPP, V29, P533, DOI 10.1002/hbm.20420; Yu CS, 2007, NEUROIMAGE, V36, P411, DOI 10.1016/j.neuroimage.2007.03.003; Zaidel E, 2003, PARALLEL BRAIN COGNI, P551	60	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107871	10.1371/journal.pone.0107871	http://dx.doi.org/10.1371/journal.pone.0107871			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255324	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000344862300038
J	Quintela, M; Skaug, HJ; Oien, N; Haug, T; Seliussen, BB; Solvang, HK; Pampoulie, C; Kanda, N; Pastene, LA; Glover, KA				Quintela, Maria; Skaug, Hans J.; Oien, Nils; Haug, Tore; Seliussen, Bjorghild B.; Solvang, Hiroko K.; Pampoulie, Christophe; Kanda, Naohisa; Pastene, Luis A.; Glover, Kevin A.			Investigating Population Genetic Structure in a Highly Mobile Marine Organism: The Minke Whale Balaenoptera acutorostrata acutorostrata in the North East Atlantic	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; MITOCHONDRIAL-DNA; HUMPBACK WHALES; MEGAPTERA-NOVAEANGLIAE; MICROSATELLITE LOCI; SPERM-WHALES; FIN WHALES; NUCLEAR; IDENTIFICATION; CONSERVATION	Inferring the number of genetically distinct populations and their levels of connectivity is of key importance for the sustainable management and conservation of wildlife. This represents an extra challenge in the marine environment where there are few physical barriers to gene-flow, and populations may overlap in time and space. Several studies have investigated the population genetic structure within the North Atlantic minke whale with contrasting results. In order to address this issue, we analyzed ten microsatellite loci and 331 bp of the mitochondrial D-loop on 2990 whales sampled in the North East Atlantic in the period 2004 and 2007-2011. The primary findings were: (1) No spatial or temporal genetic differentiations were observed for either class of genetic marker. (2) mtDNA identified three distinct mitochondrial lineages without any underlying geographical pattern. (3) Nuclear markers showed evidence of a single panmictic population in the NE Atlantic according STRUCTURE's highest average likelihood found at K = 1. (4) When K = 2 was accepted, based on the Evanno's test, whales were divided into two more or less equally sized groups that showed significant genetic differentiation between them but without any sign of underlying geographic pattern. However, mtDNA for these individuals did not corroborate the differentiation. (5) In order to further evaluate the potential for cryptic structuring, a set of 100 in silico generated panmictic populations was examined using the same procedures as above showing genetic differentiation between two artificially divided groups, similar to the aforementioned observations. This demonstrates that clustering methods may spuriously reveal cryptic genetic structure. Based upon these data, we find no evidence to support the existence of spatial or cryptic population genetic structure of minke whales within the NE Atlantic. However, in order to conclusively evaluate population structure within this highly mobile species, more markers will be required.	[Quintela, Maria; Skaug, Hans J.; Seliussen, Bjorghild B.; Glover, Kevin A.] Inst Marine Res, Dept Populat Genet, N-5024 Bergen, Norway; [Quintela, Maria] Univ A Coruna, BIOCOST Res Grp, Dept Anim Biol Plant Biol & Ecol, La Coruna, Spain; [Skaug, Hans J.] Univ Bergen, Dept Math, N-5007 Bergen, Norway; [Oien, Nils; Solvang, Hiroko K.] Inst Marine Res, Dept Marine Mammals, N-5024 Bergen, Norway; [Haug, Tore] Inst Marine Res, Dept Marine Mammals, Tromso, Norway; [Pampoulie, Christophe] Marine Res Inst Iceland, Reykjavik, Iceland; [Kanda, Naohisa; Pastene, Luis A.] Inst Cetacean Res, Tokyo, Japan; [Glover, Kevin A.] Univ Bergen, Dept Informat, Fac Math & Nat Sci, N-5008 Bergen, Norway	Institute of Marine Research - Norway; Universidade da Coruna; University of Bergen; Institute of Marine Research - Norway; Institute of Marine Research - Norway; Marine & Freshwater Research Institute (MFRI); University of Bergen	Glover, KA (corresponding author), Inst Marine Res, Dept Populat Genet, POB 1870, N-5024 Bergen, Norway.	kevin.glover@imr.no		Breistein, Bjorghild/0000-0002-1805-7190	Norwegian Ministry of Fisheries and Coastal Affairs	Norwegian Ministry of Fisheries and Coastal Affairs	Funding was provided by Norwegian Ministry of Fisheries and Coastal Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F.W., 2006, CONSERVATION GENETIC; Andersen LW, 2003, MAR ECOL PROG SER, V247, P263, DOI 10.3354/meps247263; Anderwald P, 2011, BIOL CONSERV, V144, P2479, DOI 10.1016/j.biocon.2011.07.002; Anonymous, 2010, Journal of Cetacean Research and Management, V11, P1; [Anonymous], 1985, HDB MARINE MAMMALS; Arnason A, 1995, DEV MAR BIO, V4, P91; ARNASON U, 1993, MOL BIOL EVOL, V10, P960; AVISE JC, 1986, PHILOS T ROY SOC B, V312, P325, DOI 10.1098/rstb.1986.0011; BAKER CS, 1994, MOL ECOL, V3, P313, DOI 10.1111/j.1365-294X.1994.tb00071.x; Bakke I, 1996, MAR BIOL, V125, P1, DOI 10.1007/BF00350755; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Berube M, 1998, MOL ECOL, V7, P585, DOI 10.1046/j.1365-294x.1998.00359.x; Berube M, 2002, CONSERV GENET, V3, P183, DOI 10.1023/A:1015224730394; Berube M, 2000, MOL ECOL, V9, P2181; Berube M, 1996, MOL ECOL, V5, P283; Besnier F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070651; BIRKY CW, 1983, GENETICS, V103, P513; BIRKY CW, 1989, GENETICS, V121, P613; Born EW, 2003, J MARINE SYST, V43, P1, DOI 10.1016/S0924-7963(03)00085-X; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Corander J, 2003, GENETICS, V163, P367; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Danielsdottir AK, 1995, DEV MAR BIO, V4, P105; DANIELSDOTTIR AK, 1992, BIOCHEM GENET, V30, P189, DOI 10.1007/BF02399708; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Donovan G.P., 1991, Reports of the International Whaling Commission Special Issue, P39; DORSEY EM, 1983, CAN J ZOOL, V61, P174, DOI 10.1139/z83-022; Dorsey EM, 1990, MINKE WHALES BALAENO; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Engelhaupt D, 2009, MOL ECOL, V18, P4193, DOI 10.1111/j.1365-294X.2009.04355.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Frankham R, 2005, J EVOLUTION BIOL, V18, P750, DOI 10.1111/j.1420-9101.2005.00885.x; Fu YX, 1997, GENETICS, V147, P915; Gill A, 1995, DEV MAR BIO, V4, P129; Glover KA, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-25; Glover KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043129; Glover KA, 2012, FISH FISH, V13, P313, DOI 10.1111/j.1467-2979.2011.00447.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Haaland OA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-36; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hobbs KE, 2003, ENVIRON POLLUT, V121, P239, DOI 10.1016/S0269-7491(02)00218-X; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; HOELZEL AR, 1991, NATURE, V352, P481, DOI 10.1038/352481a0; Hoelzel AR, 2009, POPULATION GENETICS, P410; Horwood J., 1990, BIOL EXPLOITATION MI; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; IUCN, 2013, INT UN CONS NAT NAT; IWC, 1992, REP INT WHAL COMM, V42, P246; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jonsgard A, 1951, NORSK HVALFANGSTTID, V40; Jonsgard A., 1966, WHALES DOLPHINS PORP, P114; Jorde PE, 2007, MOL ECOL, V16, P1993, DOI 10.1111/j.1365-294X.2007.03268.x; Kanda N, 2009, STOCK STRUCTURE SEI; Kanda N, 2007, CONSERV GENET, V8, P853, DOI 10.1007/s10592-006-9232-8; Laidre KL, 2009, ICES J MAR SCI, V66, P2253, DOI 10.1093/icesjms/fsp191; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Lang AR, 2010, GENETIC DIFFERENTIAT; Larsen AH, 1996, P ROY SOC B-BIOL SCI, V263, P1611, DOI 10.1098/rspb.1996.0236; Leduc R.G., 2007, Journal of Cetacean Research and Management, V9, P73; LeDuc R. G., 2002, Journal of Cetacean Research and Management, V4, P1; Lyrholm T, 1999, P ROY SOC B-BIOL SCI, V266, P347, DOI 10.1098/rspb.1999.0644; Martinez I, 1997, ICES J MAR SCI, V54, P478, DOI 10.1006/jmsc.1996.0168; Martinez I, 1999, ICES J MAR SCI, V56, P640, DOI 10.1006/jmsc.1999.0511; Morin Phillip A., 2012, Endangered Species Research, V19, P129, DOI 10.3354/esr00459; Mossman CA, 1999, MOL ECOL, V8, P1063, DOI 10.1046/j.1365-294x.1999.00652.x; Oien N., 1988, International Whaling Commission Report of the Commission, V38, P289; Olavarria C, 2007, MAR ECOL PROG SER, V330, P257, DOI 10.3354/meps330257; Palsboll PJ, 1997, MOL ECOL, V6, P893; PALSBOLL PJ, 1995, MAR ECOL PROG SER, V116, P1, DOI 10.3354/meps116001; Palsboll PJ, 1989, RESTRICTION FRAGMENT; PALUMBI SR, 1994, MOL BIOL EVOL, V11, P426; Patenaude NJ, 2007, J HERED, V98, P147, DOI 10.1093/jhered/esm005; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Pritchard JK, 2000, GENETICS, V155, P945; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rice D. W., 1998, SOC MARINE MAMMALOGY, V4, P231; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1983, GENETICS, V105, P985; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruegg KC, 2010, MOL ECOL, V19, P281, DOI 10.1111/j.1365-294X.2009.04447.x; Schneider S, 1999, GENETICS, V152, P1079; SERGEANT DE, 1963, J FISH RES BOARD CAN, V20, P1489, DOI 10.1139/f63-101; SKARE M, 1994, ENVIRONMENT, V36, P12, DOI 10.1080/00139157.1994.9929180; Skaug HJ, 2010, MOL ECOL RESOUR, V10, P693, DOI 10.1111/j.1755-0998.2010.02833.x; SLATKIN M, 1991, GENETICS, V129, P555; SLATKIN M, 1995, GENETICS, V139, P457; Sremba AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032579; Stevick PT, 2002, MARINE MAMMAL BIOLOGY: AN EVOLUTIONARY APPROACH, P185; TAJIMA F, 1989, GENETICS, V123, P585; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Wada S, 1991, GENETIC DISTINCTION; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitehead H, 1998, J ANIM ECOL, V67, P253, DOI 10.1046/j.1365-2656.1998.00187.x; Wright S., 1969, EVOLUTION GENETICS P; Yim HS, 2014, NAT GENET, V46, P88, DOI 10.1038/ng.2835	102	9	10	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108640	10.1371/journal.pone.0108640	http://dx.doi.org/10.1371/journal.pone.0108640			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268591	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700132
J	Roh, SJ; Kim, HN; Shim, U; Kim, BH; Kim, SJ; Chung, HW; Lee, H; Sung, YA; Kim, HL				Roh, Seung-Ju; Kim, Han-Na; Shim, Unjin; Kim, Bo-Hye; Kim, Su-Jin; Chung, Hye Won; Lee, Hyejin; Sung, Yeon-Ah; Kim, Hyung-Lae			Association between Blood Lipid Levels and Personality Traits in Young Korean Women	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; BODY-MASS INDEX; 5 FACTOR MODEL; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; PLANNED BEHAVIOR; NATIONAL-HEALTH; 5-FACTOR MODEL; HOSTILITY; DISEASE	Abnormal lipid levels are important etiological factors associated with the development of atherosclerosis and with increased cardiovascular morbidity and mortality. Lipid levels are also influenced by lifestyle and behavioral factors, which suggests that personality traits might be related to abnormal lipid profiles. Studies on personality traits and lipid levels are relatively scarce in Korea. Therefore, the objective of this study was to examine the association between lipid levels and personality traits in young Korean women. A total of 1,701 young Korean women [mean age = 24.9 +/- 4.6 years (range 17-39)] who volunteered for personality trait evaluation were recruited for this study. Lipid levels, including total cholesterol, high density lipoprotein (HDL) cholesterol, and triglyceride, were measured in all subjects after an overnight fast, and a low density lipoprotein (LDL) cholesterol level was calculated. The study population was divided into abnormal and normal lipid level groups according to the clinical criteria. Personality traits were measured using the Revised NEO Personality Inventory for the Five-Factor Model of personality. High neuroticism was associated with low HDL cholesterol levels. Low extraversion and openness were associated with high levels of triglyceride. At the facet level, the association between personality and lipid levels were generally consistent. Angry hostility, self-consciousness, vulnerability to stress, activity, and straightforwardness were associated with HDL cholesterol levels. Activity, positive emotion, aesthetics, actions, and deliberation were associated with triglyceride. When applying clinical criteria, conscientiousness was less likely to have abnormal total cholesterol levels. Our results showed that the women with the low HDL cholesterol levels are like to be more neurotic and the hyperglycemic women are prone to lower extraversion and openness in Korea. Understanding the associations between blood lipid levels and personality traits may have a beneficial effect for the managing of dyslipidemia.	[Roh, Seung-Ju; Kim, Han-Na; Kim, Bo-Hye; Kim, Su-Jin; Kim, Hyung-Lae] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea; [Shim, Unjin] Ewha Womans Univ, Med Ctr, Seoul Seonam Hosp, Dept Internal Med, Seoul, South Korea; [Chung, Hye Won; Lee, Hyejin; Sung, Yeon-Ah] Ewha Womans Univ, Sch Med, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Kim, HN (corresponding author), Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea.	o147942@gmail.com; hyung@ewha.ac.kr			Ministry of Education, Science, and Technology [NRF-2010-0026606, NRF-2014R1A2A2A04006291]; Basic Science Research Program through the National Research Foundation of Korea (NRF)	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, and Technology (NRF-2010-0026606 and NRF-2014R1A2A2A04006291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn C-K., 1997, KOREAN J COUNS PSYCH, V9, P443; Armon G, 2013, EUROPEAN J PERSONALI, DOI [10.1002/per.1943:n/a-n/a, DOI 10.1002/PER.1943:N/A-N/A]; BAREFOOT JC, 1983, PSYCHOSOM MED, V45, P59, DOI 10.1097/00006842-198303000-00008; Boehm JK, 2013, AM J CARDIOL, V111, P1425, DOI 10.1016/j.amjcard.2013.01.292; Brummett BH, 2008, BEHAV MED, V34, P5, DOI 10.3200/BMED.34.1.5-10; Brummett BH, 2006, J RES PERS, V40, P222, DOI 10.1016/j.jrp.2004.12.002; Chapman BP, 2009, HEALTH PSYCHOL, V28, P419, DOI 10.1037/a0015212; Cilla M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0866; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Costa PT, 2007, REVISED NEO PERSONAL; Courneya KS, 2002, ANN BEHAV MED, V24, P257, DOI 10.1207/S15324796ABM2404_02; Delavar MA, 2011, IRAN J PUBLIC HEALTH, V40, P89; DEMBROSKI TM, 1985, PSYCHOSOM MED, V47, P219, DOI 10.1097/00006842-198505000-00001; DIAMOND EL, 1982, PSYCHOL BULL, V92, P410, DOI 10.1037/0033-2909.92.2.410; Dormann C, 2001, STRUCT EQU MODELING, V8, P575, DOI 10.1207/S15328007SEM0804_04; Dortland AKBV, 2012, PROG NEURO-PSYCHOPH, V36, P85, DOI 10.1016/j.pnpbp.2011.10.001; Elovainio M, 2011, BIOL PSYCHOL, V87, P234, DOI 10.1016/j.biopsycho.2011.03.002; Franks P, 2009, BRIT J HEALTH PSYCH, V14, P473, DOI 10.1348/135910708X360700; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gupta N, 2013, INDIAN J PEDIATR, V80, pS28, DOI 10.1007/s12098-012-0923-5; Hoyt AL, 2009, PSYCHOL SPORT EXERC, V10, P565, DOI 10.1016/j.psychsport.2009.02.008; Jokela M, 2013, OBES REV, V14, P315, DOI 10.1111/obr.12007; Jokela M, 2014, HEALTH PSYCHOL, V33, P1618, DOI 10.1037/hea0000003; Kikuchi Y, 2000, J Epidemiol, V10, P191; Kinder LS, 2004, PSYCHOSOM MED, V66, P316, DOI 10.1097/01.psy.0000124755.91880.f4; Lasaite L, 2009, MEDICINA-LITHUANIA, V45, P85, DOI 10.3390/medicina45020012; Lee MH, 2012, DIABETES METAB J, V36, P43, DOI 10.4093/dmj.2012.36.1.43; McCrae RR, 2005, J PERS SOC PSYCHOL, V88, P547, DOI 10.1037/0022-3514.88.3.547; McCrae RR, 2003, PERSONALITY ADULTHOO, DOI DOI 10.4324/9780203428412; Mottus R, 2013, HEALTH PSYCHOL, V32, P353, DOI 10.1037/a0025537; Nesic J, 2008, ALCOHOL ALCOHOLISM, V43, P151, DOI 10.1093/alcalc/agm179; Newby PK, 2004, AM J CLIN NUTR, V80, P759; Parks EJ, 2000, AM J CLIN NUTR, V71, P412; Pietrobelli A, 1999, AM J CLIN NUTR, V69, P614; Provencher Veronique, 2008, Eat Behav, V9, P294, DOI 10.1016/j.eatbeh.2007.10.004; Raikkonen K, 2004, PSYCHOSOM MED, V66, P903, DOI 10.1097/01.psy.0000143638.31297.11; Rhodes RE, 2006, BRIT J SPORT MED, V40, P958, DOI 10.1136/bjsm.2006.028860; Richards JC, 2000, HEALTH PSYCHOL, V19, P393, DOI 10.1037//0278-6133.19.4.393; SHEKELLE RB, 1983, PSYCHOSOM MED, V45, P109, DOI 10.1097/00006842-198305000-00003; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Smith SC, 2001, J AM COLL CARDIOL, V38, P1581, DOI 10.1016/S0735-1097(01)01682-5; Sutin AR, 2011, J PERS SOC PSYCHOL, V101, P579, DOI 10.1037/a0024286; Sutin AR, 2010, AGE, V32, P513, DOI 10.1007/s11357-010-9153-9; Sutin AR, 2010, BIOL PSYCHOL, V84, P186, DOI 10.1016/j.biopsycho.2010.01.012; Terracciano A, 2008, PSYCHOSOM MED, V70, P621, DOI 10.1097/PSY.0b013e31817b9371; Terracciano A, 2009, PSYCHOSOM MED, V71, P682, DOI 10.1097/PSY.0b013e3181a2925b; Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008; Turley ML, 1998, EUR J CLIN NUTR, V52, P728, DOI 10.1038/sj.ejcn.1600634; Vainik U, 2013, NEUROSCI BIOBEHAV R, V37, P279, DOI 10.1016/j.neubiorev.2012.11.008; Xie XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064564; Yang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049253	52	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108406	10.1371/journal.pone.0108406	http://dx.doi.org/10.1371/journal.pone.0108406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268499	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700091
J	Burnham, DR; De Vlaminck, I; Henighan, T; Dekker, C				Burnham, Daniel R.; De Vlaminck, Iwijn; Henighan, Thomas; Dekker, Cees			Skewed Brownian Fluctuations in Single-Molecule Magnetic Tweezers	PLOS ONE			English	Article							OPTICAL TWEEZERS; DNA-MOLECULES; ERROR BARS; ELASTICITY; TRACKING	Measurements in magnetic tweezers rely upon precise determination of the position of a magnetic microsphere. Fluctuations in the position due to Brownian motion allows calculation of the applied force, enabling deduction of the force-extension response function for a single DNA molecule that is attached to the microsphere. The standard approach relies upon using the mean of position fluctuations, which is valid when the microsphere axial position fluctuations obey a normal distribution. However, here we demonstrate that nearby surfaces and the non-linear elasticity of DNA can skew the distribution. Through experiment and simulations, we show that such a skewing leads to inaccurate position measurements which significantly affect the extracted DNA extension and mechanical properties, leading to up to two-fold errors in measured DNA persistence length. We develop a simple, robust and easily implemented method to correct for such mismeasurements.	[Burnham, Daniel R.; De Vlaminck, Iwijn; Henighan, Thomas; Dekker, Cees] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands	Delft University of Technology	Dekker, C (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands.	c.dekker@tudelft.nl	De Vlaminck, Iwijn/P-6479-2015	De Vlaminck, Iwijn/0000-0001-6085-7311; Dekker, Cees/0000-0001-6273-071X; Burnham, Daniel/0000-0002-3017-8964	Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program; European Research Council [247072]; NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands	Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program; European Research Council(European Research Council (ERC)European Commission); NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands	This work was financially supported by the Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program, the European Research Council Research grant Nano for Bio (no. 247072) and NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Belia S, 2005, PSYCHOL METHODS, V10, P389, DOI 10.1037/1082-989X.10.4.389; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; De Vlaminck I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041432; GRASSIA PS, 1995, J FLUID MECH, V282, P373, DOI 10.1017/S0022112095000176; Kauert DJ, 2011, NANO LETT, V11, P5558, DOI 10.1021/nl203503s; Kim K, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp725; Lansdorp BM, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4802678; Lindner M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011916; Lipfert J, 2010, NAT METHODS, V7, P977, DOI [10.1038/nmeth.1520, 10.1038/NMETH.1520]; Lipfert J, 2009, BIOPHYS J, V96, P5040, DOI 10.1016/j.bpj.2009.03.055; Manosas M, 2010, METHOD ENZYMOL, V475, P297, DOI 10.1016/S0076-6879(10)75013-8; Mehraeen S, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021902; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Ribeck N, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2981687; Rohrbach A, 2004, REV SCI INSTRUM, V75, P2197, DOI 10.1063/1.1753097; Schaffer E, 2007, LANGMUIR, V23, P3654, DOI 10.1021/la0622368; Seol Y, 2007, BIOPHYS J, V93, P4360, DOI 10.1529/biophysj.107.112995; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Tempestini A, 2013, NUCLEIC ACIDS RES, V41, P2009, DOI 10.1093/nar/gks1206; Vafabakhsh R, 2012, SCIENCE, V337, P1097, DOI 10.1126/science.1224139; van der Heijden T, 2005, NUCLEIC ACIDS RES, V33, P2099, DOI 10.1093/nar/gki512; van Loenhout MTJ, 2012, SCIENCE, V338, P94, DOI 10.1126/science.1225810; van Loenhout MTJ, 2012, BIOPHYS J, V102, P2362, DOI 10.1016/j.bpj.2012.03.073; Velthuis AJWT, 2010, BIOPHYS J, V99, P1292, DOI 10.1016/j.bpj.2010.06.008; Vlijm R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046306; Wenner JR, 2002, BIOPHYS J, V82, P3160, DOI 10.1016/S0006-3495(02)75658-0	30	8	8	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108271	10.1371/journal.pone.0108271	http://dx.doi.org/10.1371/journal.pone.0108271			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265383	Green Submitted, gold, Green Published			2022-12-27	WOS:000345745400058
J	Hsiao, AS; Haslam, RP; Michaelson, LV; Liao, P; Napier, JA; Chye, ML				Hsiao, An-Shan; Haslam, Richard P.; Michaelson, Louise V.; Liao, Pan; Napier, Johnathan A.; Chye, Mee-Len			Gene Expression in Plant Lipid Metabolism in Arabidopsis Seedlings	PLOS ONE			English	Article							COA-BINDING PROTEIN; ACID BETA-OXIDATION; FATTY ACYL-COENZYME; STORAGE OIL MOBILIZATION; CIRCADIAN CLOCK; DIACYLGLYCEROL ACYLTRANSFERASE; TRIACYLGLYCEROL SYNTHESIS; TRANSGENIC ARABIDOPSIS; CASSETTE TRANSPORTER; ECERIFERUM MUTANTS	Events in plant lipid metabolism are important during seedling establishment. As it has not been experimentally verified whether lipid metabolism in 2- and 5-day-old Arabidopsis thaliana seedlings is diurnally-controlled, quantitative real-time PCR analysis was used to investigate the expression of target genes in acyl-lipid transfer, beta-oxidation and triacylglycerol (TAG) synthesis and hydrolysis in wild-type Arabidopsis WS and Col-0. In both WS and Col-0, ACYL-COA-BINDING PROTEIN-3 (ACBP3), DIACYLGLYCEROL ACYLTRANSFERASE1 (DGAT1) and DGAT3 showed diurnal control in 2- and 5-day-old seedlings. Also, COMATOSE (CTS) was diurnally regulated in 2-day-old seedlings and LONG-CHAIN ACYL-COA SYNTHETASE6 (LACS6) in 5-day-old seedlings in both WS and Col-0. Subsequently, the effect of CIRCADIAN CLOCK ASSOCIATED1 (CCA1) and LATE ELONGATED HYPOCOTYL (LHY) from the core clock system was examined using the cca1lhy mutant and CCA1-overexpressing (CCA1-OX) lines versus wild-type WS and Col-0, respectively. Results revealed differential gene expression in lipid metabolism between 2- and 5-day-old mutant and wild-type WS seedlings, as well as between CCA1-OX and wild-type Col-0. Of the ACBPs, ACBP3 displayed the most significant changes between cca1lhy and WS and between CCA1-OX and Col-0, consistent with previous reports that ACBP3 is greatly affected by light/dark cycling. Evidence of oil body retention in 4- and 5-day-old seedlings of the cca1lhy mutant in comparison to WS indicated the effect of cca1lhy on storage lipid reserve mobilization. Lipid profiling revealed differences in primary lipid metabolism, namely in TAG, fatty acid methyl ester and acyl-CoA contents amongst cca1lhy, CCA1-OX, and wild-type seedlings. Taken together, this study demonstrates that lipid metabolism is subject to diurnal regulation in the early stages of seedling development in Arabidopsis.	[Hsiao, An-Shan; Liao, Pan; Chye, Mee-Len] Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Haslam, Richard P.; Michaelson, Louise V.; Napier, Johnathan A.] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England	University of Hong Kong; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Chye, ML (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	mlchye@hkucc.hku.hk	Liao, Pan/GSM-8793-2022; LIAO, Pan/AAV-8138-2020; Chye, Mee Len/A-2740-2010	Chye, Mee Len/0000-0003-3505-3674; Michaelson, Louise/0000-0001-5621-4495; Haslam, Richard/0000-0001-6226-5643; Liao, Pan/0000-0002-1156-8916; Napier, Johnathan/0000-0003-3580-3607	Wilson and Amelia Wong Endowment Fund; Hong Kong Research Grants Council [HKU765813M]; HKU Postgraduate Studentship; University Postgraduate Fellowship; Institute Strategic Program Grant (Designing Seeds) from the BBSRC (United Kingdom); Biotechnology and Biological Sciences Research Council [BB/H531551/1, BBS/E/C/00005207] Funding Source: researchfish; BBSRC [BB/H531551/1, BBS/E/C/00005207] Funding Source: UKRI	Wilson and Amelia Wong Endowment Fund; Hong Kong Research Grants Council(Hong Kong Research Grants Council); HKU Postgraduate Studentship; University Postgraduate Fellowship; Institute Strategic Program Grant (Designing Seeds) from the BBSRC (United Kingdom); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wilson and Amelia Wong Endowment Fund and the Hong Kong Research Grants Council (HKU765813M). ASH and PL were supported by a HKU Postgraduate Studentship and a University Postgraduate Fellowship, respectively. Work done by JAN, LVM and RPH investigating the dynamics of seed oil synthesis was funded by an Institute Strategic Program Grant (Designing Seeds) from the BBSRC (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Bates PD, 2013, CURR OPIN PLANT BIOL, V16, P358, DOI 10.1016/j.pbi.2013.02.015; Baudry A, 2010, PLANT CELL, V22, P606, DOI 10.1105/tpc.109.072843; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chapman KD, 2012, J BIOL CHEM, V287, P2288, DOI 10.1074/jbc.R111.290072; Chapman KD, 2012, J LIPID RES, V53, P215, DOI 10.1194/jlr.R021436; Chen QF, 2008, PLANT PHYSIOL, V148, P304, DOI 10.1104/pp.108.123331; Chen QF, 2010, NEW PHYTOL, V186, P843, DOI 10.1111/j.1469-8137.2010.03231.x; Chen XB, 2003, PLANT CELL, V15, P1170, DOI 10.1105/tpc.010926; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Dixon LE, 2011, CURR BIOL, V21, P120, DOI 10.1016/j.cub.2010.12.013; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Domergue F, 2010, PLANT PHYSIOL, V153, P1539, DOI 10.1104/pp.110.158238; Du ZY, 2013, PLANT J, V74, P294, DOI 10.1111/tpj.12121; Du ZY, 2013, PLANT CELL ENVIRON, V36, P300, DOI 10.1111/j.1365-3040.2012.02574.x; Du ZY, 2010, PLANT PHYSIOL, V152, P1585, DOI 10.1104/pp.109.147066; Eastmond PJ, 2006, PLANT CELL, V18, P665, DOI 10.1105/tpc.105.040543; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; Farinas B, 2011, PLANT J, V66, P318, DOI 10.1111/j.1365-313X.2011.04484.x; Farre EM, 2012, CURR OPIN PLANT BIOL, V15, P293, DOI 10.1016/j.pbi.2012.01.013; Fiebig A, 2000, PLANT CELL, V12, P2001, DOI 10.1105/tpc.12.10.2001; Footitt S, 2002, EMBO J, V21, P2912, DOI 10.1093/emboj/cdf300; Fujiwara S, 2008, PLANT CELL, V20, P2960, DOI 10.1105/tpc.108.061531; Fukushima A, 2009, P NATL ACAD SCI USA, V106, P7251, DOI 10.1073/pnas.0900952106; Fulda M, 2004, PLANT CELL, V16, P394, DOI 10.1105/tpc.019646; Gao W, 2009, NEW PHYTOL, V181, P89, DOI 10.1111/j.1469-8137.2008.02631.x; Gao W, 2010, PLANT J, V62, P989, DOI 10.1111/j.1365-313X.2010.04209.x; Gardner MJ, 2006, BIOCHEM J, V397, P15, DOI 10.1042/BJ20060484; Germain V, 2001, PLANT J, V28, P1, DOI 10.1046/j.1365-313X.2001.01095.x; Gibon Y, 2004, PLANT J, V39, P847, DOI 10.1111/j.1365-313X.2004.02173.x; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Graham IA, 2002, PROG LIPID RES, V41, P156, DOI 10.1016/S0163-7827(01)00022-4; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; Green RM, 2008, PLANT PHYSIOL, V129, P576; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Hall A, 2003, PLANT CELL, V15, P2719, DOI 10.1105/tpc.013730; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hayashi M, 2002, PLANT CELL PHYSIOL, V43, P1, DOI 10.1093/pcp/pcf023; Haynes CA, 2008, J LIPID RES, V49, P1113, DOI 10.1194/jlr.D800001-JLR200; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; Holman TJ, 2009, P NATL ACAD SCI USA, V106, P4549, DOI 10.1073/pnas.0810280106; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; ICHIHARA K, 1988, BIOCHIM BIOPHYS ACTA, V958, P125, DOI 10.1016/0005-2760(88)90253-6; JENKS MA, 1995, PLANT PHYSIOL, V108, P369, DOI 10.1104/pp.108.1.369; Kelly AA, 2011, PLANT PHYSIOL, V157, P866, DOI 10.1104/pp.111.181784; Khan S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-126; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; Leung KC, 2006, PLANTA, V223, P871, DOI 10.1007/s00425-005-0139-2; Leung KC, 2004, PLANT MOL BIOL, V55, P297, DOI 10.1007/s11103-004-0642-z; Li G, 2011, NAT CELL BIOL, V13, P616, DOI 10.1038/ncb2219; Li MY, 2014, PLANT J, V77, P160, DOI 10.1111/tpj.12365; Li-Beisson YH, 2010, ARABIDOPSIS BOOK, V8, DOI [10.1199/tab.0133, DOI 10.1199/TAB.0133]; Liao P, 2014, PLANT CELL PHYSIOL, V55, P1055, DOI 10.1093/pcp/pcu037; Linka N, 2008, PLANT CELL, V20, P3241, DOI 10.1105/tpc.108.062042; Lu SX, 2009, PLANT PHYSIOL, V150, P834, DOI 10.1104/pp.108.133272; Lu Y, 2005, PLANT PHYSIOL, V138, P2280, DOI 10.1104/pp.105.061903; Hernandez ML, 2012, PLANT PHYSIOL, V160, P215, DOI 10.1104/pp.112.201541; Martiniere A, 2011, NEW PHYTOL, V192, P328, DOI 10.1111/j.1469-8137.2011.03821.x; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; MURPHY DJ, 1994, PROG LIPID RES, V33, P71, DOI 10.1016/0163-7827(94)90010-8; Nakamura Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4553; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Penfield S, 2009, PLANT CELL, V21, P1722, DOI 10.1105/tpc.108.064022; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Pinfield-Wells H, 2005, PLANT J, V43, P861, DOI 10.1111/j.1365-313X.2005.02498.x; Pritchard SL, 2002, PLANT J, V31, P639, DOI 10.1046/j.1365-313X.2002.01376.x; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Rashotte AM, 2001, PHYTOCHEMISTRY, V57, P115, DOI 10.1016/S0031-9422(00)00513-6; RIKIN A, 1993, PLANT PHYSIOL, V101, P31, DOI 10.1104/pp.101.1.31; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Ruts T, 2012, PLANT J, V72, P154, DOI 10.1111/j.1365-313X.2012.05073.x; Rylott EL, 2006, PLANT J, V45, P930, DOI 10.1111/j.1365-313X.2005.02650.x; Rylott EL, 2001, BIOCHEM SOC T, V29, P283, DOI 10.1042/BST0290283; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; Smith MA, 2013, PLANT PHYSIOL, V161, P81, DOI 10.1104/pp.112.202325; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Soy J, 2012, PLANT J, V71, P390, DOI 10.1111/j.1365-313X.2012.04992.x; Stymne S., 1987, Biochemistry of Plants, V9, P175; Theodoulou FL, 2012, CURR OPIN PLANT BIOL, V15, P322, DOI 10.1016/j.pbi.2012.03.017; Wang W, 2011, NATURE, V470, P110, DOI 10.1038/nature09766; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Xiao S, 2008, PLANT J, V54, P141, DOI 10.1111/j.1365-313X.2008.03402.x; Xiao S, 2011, PLANT PHYSIOL, V156, P2069, DOI 10.1104/pp.111.176933; Xiao S, 2010, PLANT CELL, V22, P1463, DOI 10.1105/tpc.110.075333; Xiao S, 2009, PLANT SIGNAL BEHAV, V4, P1063, DOI 10.4161/psb.4.11.9718; Xiao S, 2009, PLANT PHYSIOL BIOCH, V47, P926, DOI 10.1016/j.plaphy.2009.06.007; Zheng SX, 2012, J EXP BOT, V63, P2985, DOI 10.1093/jxb/ers009; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	96	20	21	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107372	10.1371/journal.pone.0107372	http://dx.doi.org/10.1371/journal.pone.0107372			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264899	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400019
J	Jacomella, V; Gerber, PA; Mosimann, K; Husmann, M; Thalhammer, C; Wilkinson, I; Berneis, K; Amann-Vesti, BR				Jacomella, Vincenzo; Gerber, Philipp A.; Mosimann, Kathrin; Husmann, Marc; Thalhammer, Christoph; Wilkinson, Ian; Berneis, Kaspar; Amann-Vesti, Beatrice R.			Small Dense Low Density Lipoprotein Particles Are Associated with Poor Outcome after Angioplasty in Peripheral Artery Disease	PLOS ONE			English	Article							SIZE; SUBCLASSES; SUBFRACTIONS; RESTENOSIS; PLASMA	Purpose: In patients suffering from symptomatic peripheral artery disease (PAD), percutaneous revascularization is the treatment of choice. However, restenosis may occur in 10 to 60% in the first year depending on a variety of factors. Small dense low density lipoprotein (sdLDL) particles are associated with an increased risk for cardiovascular events, but their role in the process of restenosis is not known. We conducted a prospective study to analyze the association of sdLDL particles with the outcome of balloon angioplasty in PAD. The composite primary endpoint was defined as improved walking distance and absence of restenosis. Methods: Patients with angiographically documented PAD of the lower extremities who were scheduled for lower limb revascularization were consecutively recruited for the study. At baseline and at three month follow-up triglyceride, total cholesterol, LDL size and subclasses and HDL cholesterol and ankle-brachial index (ABI) were measured. Three months after the intervention duplex sonography was performed to detect restenosis. Results: Sixty-four patients (53% male) with a mean age of 68.6 +/- 9.9 years were included. The proportion of small-dense LDL particles (class III and IV) was significantly lower (33.1 +/- 11.0% vs. 39.4 +/- 12.1%, p = 0.038) in patients who reached the primary end-point compared with those who did not. Patients with improved walking distance and without restenosis had a significantly higher LDL size at baseline (26.6 +/- 1.1 nm vs. 26.1 +/- 1.1 nm, p = 0.046) and at follow-up (26.7 +/- 1.1 nm vs. 26.2 +/- 0.9 nm, p = 0.044) than patients without improvement. Conclusions: Small-dense LDL particles are associated with worse early outcome in patients undergoing percutaneous revascularization for symptomatic PAD.	[Jacomella, Vincenzo; Mosimann, Kathrin; Husmann, Marc; Thalhammer, Christoph; Amann-Vesti, Beatrice R.] Univ Zurich Hosp, Clin Angiol, CH-8091 Zurich, Switzerland; [Gerber, Philipp A.; Berneis, Kaspar] Univ Zurich Hosp, Clin Endocrinol, CH-8091 Zurich, Switzerland; [Wilkinson, Ian] Univ Cambridge, Clin Pharmacol Unit, Cambridge, England	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Cambridge	Jacomella, V (corresponding author), Univ Zurich Hosp, Clin Angiol, CH-8091 Zurich, Switzerland.	vincenzo.jacomella@usz.ch	Gerber, Philipp/C-2145-2015	Gerber, Philipp/0000-0002-2476-7076; wilkinson, ian/0000-0001-6598-9399				AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917; Berneis K, 2005, METABOLISM, V54, P227, DOI 10.1016/j.metabol.2004.08.017; Berneis K, 2010, EUR HEART J, V31, P1633, DOI 10.1093/eurheartj/ehq181; Berneis K, 2009, CLIN CHIM ACTA, V406, P36, DOI 10.1016/j.cca.2009.05.002; Bjornheden T, 1996, ATHEROSCLEROSIS, V123, P43, DOI 10.1016/0021-9150(95)05770-6; Criqui MH, 2001, VASC MED, V6, P3, DOI 10.1177/1358836X0100600i102; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Galeano NF, 1998, J LIPID RES, V39, P1263; Gerber PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072763; Giovanetti F, 2009, J ENDOVASC THER, V16, P389, DOI 10.1583/09-2733.1; Hayashi Y, 2007, METABOLISM, V56, P608, DOI 10.1016/j.metabol.2007.01.001; Hiatt WR, 2001, NEW ENGL J MED, V344, P1608, DOI 10.1056/NEJM200105243442108; Hirano T, 2003, J LIPID RES, V44, P2193, DOI 10.1194/jlr.D300007-JLR200; Kim JS, 2008, CIRC J, V72, P1059, DOI 10.1253/circj.72.1059; KRAUSS RM, 1982, J LIPID RES, V23, P97; Kugler CFA, 2003, VASC MED, V8, P109, DOI 10.1191/1358863x03vm478ra; Maca TH, 2002, DIABETIC MED, V19, P300, DOI 10.1046/j.1464-5491.2002.00645.x; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Rizzo M, 2008, ATHEROSCLEROSIS, V197, P237, DOI 10.1016/j.atherosclerosis.2007.03.034; Simon DI, 2012, CIRC J, V76, P1811, DOI 10.1253/circj.CJ-12-0801; Tribble DL, 2001, AM J MED, V110, P103, DOI 10.1016/S0002-9343(00)00700-2	21	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108813	10.1371/journal.pone.0108813	http://dx.doi.org/10.1371/journal.pone.0108813			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265512	gold, Green Accepted, Green Published			2022-12-27	WOS:000345745400132
J	Wens, I; Dalgas, U; Vandenabeele, F; Krekels, M; Grevendonk, L; Eijnde, BO				Wens, Inez; Dalgas, Ulrik; Vandenabeele, Frank; Krekels, Maartje; Grevendonk, Lotte; Eijnde, Bert O.			Multiple Sclerosis Affects Skeletal Muscle Characteristics	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BIOPSY TECHNIQUES; VASTUS LATERALIS; BODY-COMPOSITION; SAMPLING ERRORS; FIBER TYPES; STRENGTH; FATIGUE; WOMEN; MEN	Background: The impact of multiple sclerosis (MS) on skeletal muscle characteristics, such as muscle fiber cross sectional area (CSA), fiber type proportion, muscle strength and whole muscle mass, remains conflicting. Methods: In this cross sectional study, body composition and muscle strength of the quadriceps were assessed in 34 MS (EDSS: 2.560.19) patients and 18 matched healthy controls (HC). Hereafter a muscle biopsy (m. vastus lateralis) was taken. Results: Compared to HC, mean muscle fiber CSA of all fibers, as well as CSA of type I, II and IIa fibers were smaller and muscle strength of the quadriceps was lower in MS patients. Whole body composition was comparable between groups. However, compared to HC, the biopsied leg tended to have a higher fat percentage (p = 0.1) and a lower lean mass (p = 0.06) in MS patients. Conclusion: MS seems to negatively influence skeletal muscle fiber CSA, muscle strength and muscle mass of the lower limbs of mildly affected	[Wens, Inez; Vandenabeele, Frank; Krekels, Maartje; Grevendonk, Lotte; Eijnde, Bert O.] Hasselt Univ, Fac Med & Life Sci, BIOMED Biomed Res Inst, REVAL Rehabil Res Ctr, Hasselt, Belgium; [Dalgas, Ulrik] Aarhus Univ, Dept Publ Hlth, Sect Sport Sci, Aarhus C, Denmark	Hasselt University; Aarhus University	Wens, I (corresponding author), Hasselt Univ, Fac Med & Life Sci, BIOMED Biomed Res Inst, REVAL Rehabil Res Ctr, Hasselt, Belgium.	inez.wens@uhasselt.be	Vandenabeele, Frank/G-9292-2019; Op 't Eijnde, Bert/AHA-6777-2022	Vandenabeele, Frank/0000-0001-5556-8937; Op 't Eijnde, Bert/0000-0002-2262-4661; Wens, Inez/0000-0002-8171-5686; Grevendonk, Lotte/0000-0001-9540-1832; Cleeren TEST, Hilde/0000-0002-8756-8904; Dalgas, Ulrik/0000-0003-4132-2789	MS Fund Limburg, Flanders	MS Fund Limburg, Flanders	Inez Wens and Bert Op't Eijnde received support from MS Fund Limburg, Flanders. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JL, 1999, J APPL PHYSIOL, V86, P455, DOI 10.1152/jappl.1999.86.2.455; Athanasios Zakas, 2005, PHYS TRAINING; Broekmans T, 2011, MULT SCLER J, V17, P468, DOI 10.1177/1352458510391339; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; Carroll CC, 2005, ARCH PHYS MED REHAB, V86, P224, DOI 10.1016/j.apmr.2004.03.035; Dalgas U, 2010, MULT SCLER; de Haan A, 2000, MUSCLE NERVE, V23, P1534, DOI 10.1002/1097-4598(200010)23:10<1534::AID-MUS9>3.0.CO;2-D; Formica CA, 1997, CALCIFIED TISSUE INT, V61, P129; FRONTERA WR, 1991, J APPL PHYSIOL, V71, P644, DOI 10.1152/jappl.1991.71.2.644; Gallagher P, 2005, ACTA PHYSIOL SCAND, V185, P61, DOI 10.1111/j.1365-201X.2005.01457.x; Garner DJP, 2003, MUSCLE NERVE, V27, P456, DOI 10.1002/mus.10346; Hakkinen K, 1981, SCAND J SPORTS SCI, V3, P50; Hortobagyi T, 2000, J PHYSIOL-LONDON, V524, P293, DOI 10.1111/j.1469-7793.2000.00293.x; KentBraun JA, 1997, J APPL PHYSIOL, V83, P1998, DOI 10.1152/jappl.1997.83.6.1998; Klaren RE, 2013, ARCH PHYS MED REHAB, V94, P2342, DOI 10.1016/j.apmr.2013.07.011; Lambert CP, 2002, ARCH PHYS MED REHAB, V83, P1559, DOI 10.1053/apmr.2002.35663; Lambert CP, 2001, MED SCI SPORT EXER, V33, P1613, DOI 10.1097/00005768-200110000-00001; LEXELL J, 1985, J APPL PHYSIOL, V59, P1228, DOI 10.1152/jappl.1985.59.4.1228; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; LEXELL J, 1989, CLIN PHYSIOL, V9, P333, DOI 10.1111/j.1475-097X.1989.tb00987.x; Mahler A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043675; McCurdy K, 2005, J SPORT SCI MED, V4, P153; Miller A, 2006, QUAL LIFE RES, V15, P259, DOI 10.1007/s11136-005-0891-6; Ng AV, 2004, MUSCLE NERVE, V29, P843, DOI 10.1002/mus.20038; Rietberg MB, 2014, NEUROREHAB NEURAL RE, V28, P516, DOI 10.1177/1545968313520412; Sandroff BM, 2012, ACTA NEUROL SCAND, V126, P256, DOI 10.1111/j.1600-0404.2011.01634.x; Savci S, 2005, DISABIL REHABIL, V27, P1365, DOI 10.1080/09638280500164479; Schwid SR, 1999, NEUROLOGY, V53, P743, DOI 10.1212/WNL.53.4.743; SHARMA KR, 1995, MUSCLE NERVE, V18, P1403, DOI 10.1002/mus.880181210; Sioka C, 2011, J CLIN DENSITOM, V14, P465, DOI 10.1016/j.jocd.2011.04.012; Siqueira Cássio Marinho, 2002, Rev. Hosp. Clin., V57, P19, DOI 10.1590/S0041-87812002000100004; Sparks JR, 2011, COMP DOMINANT NONDOM; Terzis G, 2008, J STRENGTH COND RES, V22, P1198, DOI 10.1519/JSC.0b013e31816d5c97; Thoumie P, 2002, J NEUROL NEUROSUR PS, V73, P313, DOI 10.1136/jnnp.73.3.313; uthomoglu S., 2004, TURK J MED SCI, V34, P43; Wens I, 2013, MULT SCLER J, V19, P1556, DOI 10.1177/1352458513504252	36	65	65	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108158	10.1371/journal.pone.0108158	http://dx.doi.org/10.1371/journal.pone.0108158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264868	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400045
J	Yang, F; Wang, Y; Chan, ZL				Yang, Fan; Wang, Yong; Chan, Zhulong			Perspectives on Screening Winter-Flood-Tolerant Woody Species in the Riparian Protection Forests of the Three Gorges Reservoir	PLOS ONE			English	Article							PHOSPHORUS; SOIL; ACCUMULATION; RESPONSES; SEEDLINGS; NITROGEN; REGION; CHINA; ZONE; AREA	The establishment of riparian protection forests in the Three Gorges Reservoir (TGR) is an ideal measure to cope with the eco-environmental problems of the water-level fluctuation zone (WLFZ). Thus, the information for screening winter-flood-tolerant woody plant species is useful for the recovery and re-establishment of the riparian protection forests in the TGR WLFZ. Therefore, we discussed the possibilities of constructing and popularizing riparian protection forests in the TGR WLFZ from several aspects, including the woody plant species distribution in the WLFZ, the survival rate analyses of suitable candidate woody species under controlled flooding conditions, the survival rate investigation of some woody plant species planted in the TGR WLFZ, and the physiological responses of some woody plant species during the recovery stage after winter floods. The results of woody species investigation showed that most woody plant species that existed as annual seedlings in the TGR WLFZ are not suitable candidates for the riparian protection forests. However, arbor species (e.g., Salix matsudana, Populusxcanadensis, Morus alba, Pterocarya stenoptera, Taxodium ascendens, and Metasequoia glyptostroboides) and shrub species (e.g., Salix variegata, Distylium chinensis, Lycium chinense, Myricaria laxiflora, and Rosa multiflora) might be considered suitable candidates for the riparian protection forests in the TGR WLFZ by survival rate analyses under controlled winter flooding conditions, and survival rate investigations of woody plant species planted in the TGR WLFZ, respectively. Physiological analyses showed that P. xcanadensis, M. alba, L. chinense, and S. variegata could develop specific self-repairing mechanisms to stimulate biomass accumulation and carbohydrate synthesis via the increases in chlorophyll pigments and photosynthesis during recovery after winter floods. Our results suggested these woody plant species could endure the winter flooding stress and recover well, and be used as candidate for the construction of riparian protection forests in the TGR WLFZ.	[Yang, Fan; Wang, Yong; Chan, Zhulong] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Yang, F (corresponding author), Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China.	yangfan@wbgcas.cn	Chan, Zhulong/AAM-5018-2020	Chan, Zhulong/0000-0002-1933-6837; Yang, Fan/0000-0002-0049-5459	National Natural Science Foundation of China [31270449]; Executive Office of the State Council Three Gorges Construction Committee [SX2008-005]; Hubei Immigration Bureau [Y2392639261P0126]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Executive Office of the State Council Three Gorges Construction Committee; Hubei Immigration Bureau	The study was sponsored by National Natural Science Foundation of China (No. 31270449), the Executive Office of the State Council Three Gorges Construction Committee (No. SX2008-005), and Hubei Immigration Bureau (No. Y2392639261P0126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu P, 1996, J BIOTECHNOL, V52, P151, DOI 10.1016/S0168-1656(96)01626-4; Chen FQ, 2009, AQUAT BOT, V90, P333, DOI 10.1016/j.aquabot.2008.12.006; Fortier J, 2010, AGR ECOSYST ENVIRON, V137, P276, DOI 10.1016/j.agee.2010.02.013; Gleick P.H., 2009, WORLDS WATER 2008 20, P139; Lei ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091394; Li X, 2011, ACTA ECOLOGICA SINIC, V31, P31, DOI DOI 10.1002/SIM.4341; Liu Y, 2013, ENVIRON SCI POLLUT R, V20, P7142, DOI 10.1007/s11356-013-1896-2; Lu ZJ, 2010, PLANT ECOL, V209, P153, DOI 10.1007/s11258-010-9732-y; Ma X, 2011, SCI TOTAL ENVIRON, V412, P154, DOI 10.1016/j.scitotenv.2011.09.034; Madejon P, 2004, ENVIRON POLLUT, V132, P145, DOI 10.1016/j.envpol.2004.03.015; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; New T, 2008, BIODIVERS CONSERV, V17, P3149, DOI 10.1007/s10531-008-9416-2; Nilsson C, 2002, ENVIRON MANAGE, V30, P468, DOI 10.1007/s00267-002-2735-2; Schade JD, 2001, ECOLOGY, V82, P3363, DOI 10.1890/0012-9658(2001)082[3363:TIOARS]2.0.CO;2; Shen ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071194; Shi RJ, 2011, PROCEDIA ENVIRON SCI, V10, P1431, DOI 10.1016/j.proenv.2011.09.228; Song YX, 2010, GEODERMA, V159, P286, DOI 10.1016/j.geoderma.2010.07.020; Stone R, 2008, SCIENCE, V321, P628, DOI 10.1126/science.321.5889.628; Wang J. Z., 2008, FRONT ECOL ENVIRON, V8, P13; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100889; Wang Y, 2009, J HAZARD MATER, V162, P92, DOI 10.1016/j.jhazmat.2008.05.013; Wasser L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054776; Wu JG, 2004, FRONT ECOL ENVIRON, V2, P241, DOI 10.1890/1540-9295(2004)002[0241:TTGDAE]2.0.CO;2; Yang F., 2012, ACTA ECOLOGICA SINIC, V32, P89, DOI [10.1016/j.chnaes.2012.02.004, DOI 10.1016/J.CHNAES.2012.02.004]; Yang F, 2011, FOREST ECOL MANAG, V262, P1963, DOI 10.1016/j.foreco.2011.08.039; Yang YJ, 2013, ENVIRON SCI POLLUT R, V20, P7112, DOI 10.1007/s11356-013-1878-4; Ye C, 2013, ENVIRON MONIT ASSESS, V185, P231, DOI 10.1007/s10661-012-2547-7; Yi Ying-Hua, 2006, Zhiwu Shengtai Xuebao, V30, P960; Zhang B, 2004, CATENA, V57, P77, DOI 10.1016/j.catena.2003.07.001; Zhang B, 2012, ECOL ENG, V40, P153, DOI 10.1016/j.ecoleng.2011.12.024; Zhang QF, 2011, ENVIRON SCI POLICY, V14, P1132, DOI 10.1016/j.envsci.2011.07.008	31	19	23	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108725	10.1371/journal.pone.0108725	http://dx.doi.org/10.1371/journal.pone.0108725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265326	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400112
J	Barnable, P; Calenda, G; Ouattara, L; Gettie, A; Blanchard, J; Jean-Pierre, N; Kizima, L; Rodriguez, A; Abraham, C; Menon, R; Seidor, S; Cooney, ML; Roberts, KD; Sperling, R; Piatak, M; Lifson, JD; Fernandez-Romero, JA; Zydowsky, TM; Robbiani, M; Teleshova, N				Barnable, Patrick; Calenda, Giulia; Ouattara, Louise; Gettie, Agegnehu; Blanchard, James; Jean-Pierre, Ninochka; Kizima, Larisa; Rodriguez, Aixa; Abraham, Ciby; Menon, Radhika; Seidor, Samantha; Cooney, Michael L.; Roberts, Kevin D.; Sperling, Rhoda; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Fernandez-Romero, Jose A.; Zydowsky, Thomas M.; Robbiani, Melissa; Teleshova, Natalia			A MIV-150/Zinc Acetate Gel Inhibits SHIV-RT Infection in Macaque Vaginal Explants	PLOS ONE			English	Article							IMMUNE FUNCTION; ZINC; TRANSMISSION; MICROBICIDES; RESISTANCE; TYPE-1; SEMEN	To extend our observations that single or repeated application of a gel containing the NNRTI MIV-150 (M) and zinc acetate dihydrate (ZA) in carrageenan (CG) (MZC) inhibits vaginal transmission of simian/human immunodeficiency virus (SHIV)-RT in macaques, we evaluated safety and anti-SHIV-RT activity of MZC and related gel formulations ex vivo in macaque mucosal explants. In addition, safety was further evaluated in human ectocervical explants. The gels did not induce mucosal toxicity. A single ex vivo exposure to diluted MZC (1:30, 1:100) and MC (1:30, the only dilution tested), but not to ZC gel, up to 4 days prior to viral challenge, significantly inhibited SHIV-RT infection in macaque vaginal mucosa. MZC's activity was not affected by seminal plasma. The antiviral activity of unformulated MIV-150 was not enhanced in the presence of ZA, suggesting that the antiviral activity of MZC was mediated predominantly by MIV-150. In vivo administration of MZC and CG significantly inhibited ex vivo SHIV-RT infection (51-62% inhibition relative to baselines) of vaginal (but not cervical) mucosa collected 24 h post last gel exposure, indicating barrier effect of CG. Although the inhibitory effect of MZC (65-74%) did not significantly differ from CG (32-45%), it was within the range of protection (similar to 75%) against vaginal SHIV-RT challenge 24 h after gel dosing. Overall, the data suggest that evaluation of candidate microbicides in macaque explants can inform macaque efficacy and clinical studies design. The data support advancing MZC gel for clinical evaluation.	[Barnable, Patrick; Calenda, Giulia; Ouattara, Louise; Jean-Pierre, Ninochka; Kizima, Larisa; Rodriguez, Aixa; Abraham, Ciby; Menon, Radhika; Seidor, Samantha; Cooney, Michael L.; Roberts, Kevin D.; Fernandez-Romero, Jose A.; Zydowsky, Thomas M.; Robbiani, Melissa; Teleshova, Natalia] Populat Council, New York, NY 10021 USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Blanchard, James] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA; [Sperling, Rhoda] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] Frederick Natl Lab Canc Res, SAIC Frederick Inc, AIDS & Canc Virus Program, Frederick, MD USA	Population Council; Rockefeller University; Tulane University; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Teleshova, N (corresponding author), Populat Council, 1230 York Ave, New York, NY 10021 USA.	nteleshova@popcouncil.org		Cooney, Michael/0000-0001-7943-1951	United States Agency for International Development (USAID) [GPO-A-00-04-00019-00]; Swedish Ministry of Foreign Affairs (SMFA); Primate Center base grant [P51 OD011104-51]; National Cancer Institute, National Institutes of Health (NIH) [HHSN261200800001E]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Swedish Ministry of Foreign Affairs (SMFA); Primate Center base grant; National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the United States Agency for International Development (USAID) Cooperative Agreement GPO-A-00-04-00019-00, by the Swedish Ministry of Foreign Affairs (SMFA) and Primate Center base grant P51 OD011104-51. This research is made possible by the generous support of the American people through the USAID and supported in part with federal funds from the National Cancer Institute, National Institutes of Health (NIH), under contract HHSN261200800001E (J.D.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, COMM CAR US LAB AN I, VMD 85-23, P1; Aravantinou M, 2012, AIDS RES HUM RETROVI; Cline AN, 2005, J MED PRIMATOL, V34, P303; Crostarosa F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008060; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; Fenstermacher KJ, 2011, J BIOL CHEM, V286, P40433, DOI 10.1074/jbc.M111.289850; Fernandez-Romero JA, 2007, SEX TRANSM DIS, V34, P9, DOI 10.1097/01.olq.0000223287.46097.4b; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Ibs KH, 2003, J NUTR, V133, p1452S, DOI 10.1093/jn/133.5.1452S; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Katz DF, 2011, DRUG DELIV TRANSL RE, V1, P256, DOI 10.1007/s13346-011-0029-z; Kenney J, 2012, AIDS RES HUM RETROVI; Kenney J, 2013, ANTIMICROB AGENTS CH; Kenney J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015835; Kizima L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094547; Lai BE, 2008, J PHARM SCI-US, V97, P1030, DOI 10.1002/jps.21132; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malcolm RK, 2012, ANTIMICROB AGENTS CH, V56, P2251, DOI 10.1128/AAC.05810-11; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; Ouattara LA, 2014, ANTIMICROB AGENTS CH; Owen DH, 2005, J ANDROL, V26, P459, DOI 10.2164/jandrol.04104; Richardson-Harman N, 2012, AIDS RES HUM RETROV, V28, P1422, DOI [10.1089/aid.2012.0073, 10.1089/AID.2012.0073]; Richardson-Harman N, 2009, J CLIN MICROBIOL, V47, P3530, DOI 10.1128/JCM.00673-09; Rink L, 2000, J NUTR, V130, p1407S, DOI 10.1093/jn/130.5.1407S; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; Singer R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003936; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; Wellinghausen N, 1997, IMMUNOL TODAY, V18, P519, DOI 10.1016/S0167-5699(97)01146-8	29	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108109	10.1371/journal.pone.0108109	http://dx.doi.org/10.1371/journal.pone.0108109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259616	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600047
J	Carlier, G; Maugein, A; Cordier, C; Pechberty, S; Garfa-Traore, M; Martin, P; Scharfmann, R; Albagli, O				Carlier, Geraldine; Maugein, Alicia; Cordier, Corinne; Pechberty, Severine; Garfa-Traore, Meriem; Martin, Patrick; Scharfmann, Raphael; Albagli, Olivier			Human Fucci Pancreatic Beta Cell Lines: New Tools to Study Beta Cell Cycle and Terminal Differentiation	PLOS ONE			English	Article							STEM-CELLS; PROLIFERATION; PROTEIN; INDUCTION; PROGENITORS; EXPRESSION; EXPANSION; ROAD; RAT	Regulation of cell cycle in beta cells is poorly understood, especially in humans. We exploited here the recently described human pancreatic beta cell line EndoC-beta H2 to set up experimental systems for cell cycle studies. We derived 2 populations from EndoC-beta H2 cells that stably harbor the 2 genes encoding the Fucci fluorescent indicators of cell cycle, either from two vectors, or from a unique bicistronic vector. In proliferating non-synchronized cells, the 2 Fucci indicators revealed cells in the expected phases of cell cycle, with orange and green cells being in G1 and S/G2/M cells, respectively, and allowed the sorting of cells in different substeps of G1. The Fucci indicators also faithfully red out alterations in human beta cell proliferative activity since a mitogen-rich medium decreased the proportion of orange cells and inflated the green population, while reciprocal changes were observed when cells were induced to cease proliferation and increased expression of some beta cell genes. In the last situation, acquisition of a more differentiated beta cell phenotype correlates with an increased intensity in orange fluorescence. Hence Fucci beta cell lines provide new tools to address important questions regarding human beta cell cycle and differentiation.	[Carlier, Geraldine; Maugein, Alicia; Pechberty, Severine; Garfa-Traore, Meriem; Scharfmann, Raphael; Albagli, Olivier] Univ Paris 05, Fac Med Cochin, Res Ctr Growth & Signaling, INSERM,U845, Paris, France; [Cordier, Corinne] Cytometry Facil, INSERM IFR94, Paris, France; [Pechberty, Severine] Inst Cerveau & Moelle Epiniere, Endocells, Paris, France; [Martin, Patrick] Univ Nice Sophia Antipolis, IBDC, CNRS, UMR 6543, F-06189 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Albagli, O (corresponding author), Inst Cochin, INSERM, U1016, Paris, France.	olivier.albagli-curiel@inserm.fr	Cordier, Corinne/F-9966-2018; scharfmann, raphael/L-3296-2017	Cordier, Corinne/0000-0003-4799-6143; Scharfmann, Raphael/0000-0001-7619-337X; GARFA TRAORE, Meriem/0000-0001-8597-6472	European Union [241883]; Innovative Medicines Initiative Joint Undertaking (IMIDIA) [155005]	European Union(European Commission); Innovative Medicines Initiative Joint Undertaking (IMIDIA)	This work was supported by grants from the 7th Framework Program of the European Union under grant agreements no 241883, from the Innovative Medicines Initiative Joint Undertaking under grant agreement no 155005 (IMIDIA), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution. The RS laboratory belongs to the Laboratoire d'Excellence consortium Revive and to the Departement Hospitalo-Universitaire (DHU) Autoimmune and Hormonal diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albagli-Curiel O, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-85; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Avrahami D, 2014, J CLIN INVEST, V124, P670, DOI 10.1172/JCI69519; Calder A, 2013, STEM CELLS DEV, V22, P279, DOI 10.1089/scd.2012.0168; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Cozar-Castellano I, 2004, DIABETES, V53, P149, DOI 10.2337/diabetes.53.1.149; Davis DB, 2010, MOL ENDOCRINOL, V24, P1822, DOI 10.1210/me.2010-0082; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Feillet C, 2014, P NATL ACAD IN PRESS; Fiaschi-Taesch NM, 2013, DIABETES, V62, P2450, DOI 10.2337/db12-0777; German MS, 2013, J CLIN INVEST, V123, P1936, DOI 10.1172/JCI69297; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Kapinas K, 2013, J CELL PHYSIOL, V228, P9, DOI 10.1002/jcp.24104; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Karslioglu E, 2011, MOL ENDOCRINOL, V25, P1760, DOI 10.1210/me.2011-1074; Klochendler A, 2012, DEV CELL, V23, P681, DOI 10.1016/j.devcel.2012.08.009; Kulkarni RN, 2012, DIABETES, V61, P2205, DOI 10.2337/db12-0018; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Mangeot PE, 2011, MOL THER, V19, P1656, DOI 10.1038/mt.2011.138; Mechali M, 2008, CELL, V132, P341, DOI 10.1016/j.cell.2008.01.031; Menge BA, 2008, DIABETES, V57, P142, DOI 10.2337/db07-1294; Mezza T, 2014, DIABETES, V63, P994, DOI 10.2337/db13-1013; Miyatsuka T, 2011, P NATL ACAD SCI USA, V108, P185, DOI 10.1073/pnas.1004842108; Newman RH, 2008, CHEM BIOL, V15, P97, DOI 10.1016/j.chembiol.2008.02.003; Pajalunga D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011559; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Ridenour DA, 2012, DEV BIOL, V365, P189, DOI 10.1016/j.ydbio.2012.02.026; Rieck S, 2012, MOL ENDOCRINOL, V26, P1590, DOI 10.1210/me.2012-1019; Roccio M, 2013, DEVELOPMENT, V140, P459, DOI 10.1242/dev.086215; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sakaue-Sawano A, 2008, CHEM BIOL, V15, P1243, DOI 10.1016/j.chembiol.2008.10.015; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Scharfmann R, 2014, J CLIN INVEST, V124, P2087, DOI 10.1172/JCI72674; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takane KK, 2012, DIABETES, V61, P418, DOI 10.2337/db11-0580; Tiainen M, 1996, MOL CELL BIOL, V16, P5302; Traganos F, 2005, CELL CYCLE, V3, P32; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Zariwala M, 1998, ONCOGENE, V17, P2787, DOI 10.1038/sj.onc.1202505	43	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108202	10.1371/journal.pone.0108202	http://dx.doi.org/10.1371/journal.pone.0108202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259951	Green Submitted, Green Published, gold			2022-12-27	WOS:000342685600052
J	Feldman, BS; Cohen-Stavi, CJ; Leibowitz, M; Hoshen, MB; Singer, SR; Bitterman, H; Lieberman, N; Balicer, RD				Feldman, Becca S.; Cohen-Stavi, Chandra J.; Leibowitz, Morton; Hoshen, Moshe B.; Singer, Shepherd R.; Bitterman, Haim; Lieberman, Nicky; Balicer, Ran D.			Defining the Role of Medication Adherence in Poor Glycemic Control among a General Adult Population with Diabetes	PLOS ONE			English	Article							METABOLIC-CONTROL; GLUCOSE CONTROL; TYPE-2; ASSOCIATION; COMPLICATIONS; CARE	Aims: This study assesses the attributable impact of adherence to oral glucose medications as a risk factor for poor glycemic control in population subgroups of a large general population, using an objective medication adherence measure. Methods: Using electronic health records data, adherence to diabetes medications over a two-year period was calculated by prescription-based Medication Possession Ratios for adults with diabetes diagnosed before January 1, 2010. Glycemic control was determined by the HbA1c test closest to the last drug prescription during 2010-2012. Poor control was defined as HbA1c>75 mmol/mol (9.0%). Medication adherence was categorized as "good'' (>80%), "moderate'' (50-80%), or "poor'' (<50%). Logistic regression models assessed the role medication adherence plays in the association between disease duration, age, and poor glycemic control. We calculated the change in the attributable fraction of glucose control if the non-adherent diabetic medication population would become adherent by age-groups. Results: Among 228,846 diabetes patients treated by oral antiglycemic medication, 46.4% had good, 28.8% had moderate, and 24.8% had poor adherence. Good adherence rates increased with increasing disease duration, while glycemic control became worse. There was a strong inverse association between adherence level and poor control (OR = 2.50; CI = 2.43-2.58), and adherence was a significant mediator between age and poor control. Conclusions: A large portion of the diabetes population is reported to have poor adherence to oral diabetes medications, which is strongly associated with poor glycemic control in all disease durations. While poor adherence does not mediate the poorer glycemic control seen in patients with longer-standing disease, it is a significant mediator of poor glycemic control among younger diabetes patients. A greater fraction of poorly controlled younger patients, compared to older patients, could be prevented if at least 80% adherence to their medications was achieved. Therefore, our results suggest that interventions to improve adherence should focus on this younger sub-group.	[Feldman, Becca S.; Cohen-Stavi, Chandra J.; Leibowitz, Morton; Hoshen, Moshe B.; Bitterman, Haim; Balicer, Ran D.] Clalit Hlth Serv, Chief Phys Off, Clalit Res Inst, Tel Aviv, Israel; [Leibowitz, Morton] NYU, Sch Med, Dept Med, New York, NY USA; [Singer, Shepherd R.] Israeli Minist Hlth, Div Epidemiol, Jerusalem, Israel; [Bitterman, Haim] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Lieberman, Nicky] Clalit Hlth Serv, Community Med Div, Tel Aviv, Israel; [Balicer, Ran D.] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Publ Hlth, Beer Sheva, Israel	Clalit Health Services; New York University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Clalit Health Services; Ben Gurion University	Feldman, BS (corresponding author), Clalit Hlth Serv, Chief Phys Off, Clalit Res Inst, Tel Aviv, Israel.	BeccaFe@clalit.org.il			Clalit Health Services through the Clalit Research Institute; Clalit Health Services, a public, non-for-profit national health care	Clalit Health Services through the Clalit Research Institute; Clalit Health Services, a public, non-for-profit national health care	This internal research study was sponsored by Clalit Health Services through the Clalit Research Institute. Support for internal research projects conducted within the Clalit Research Institute, is provided by Clalit Health Services, a public, non-for-profit national health care provider in Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 2011, WILLIAMS TXB ENDOCRI, V12th, P868; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Arifulla M, 2014, MALAYS J MED SCI, V21, P44; Asche C, 2011, CLIN THER, V33, P74, DOI 10.1016/j.clinthera.2011.01.019; Choudhry NK, 2009, AM J MANAG CARE, V15, P457; Cohen HW, 2010, DIABETIC MED, V27, P210, DOI 10.1111/j.1464-5491.2009.02898.x; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x; Duckworth WC, 2011, J DIABETES COMPLICAT, V25, P355, DOI 10.1016/j.jdiacomp.2011.10.003; Egede LE, 2011, DIABETES CARE, V34, P938, DOI 10.2337/dc10-1504; Gonzalez JS, 2011, CURR DIABETES REP, V11, P472, DOI 10.1007/s11892-011-0229-4; Guillausseau PJ, 2003, DIABETES METAB, V29, P79, DOI 10.1016/S1262-3636(07)70011-3; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Huang ES, 2011, DIABETES CARE, V34, P1329, DOI 10.2337/dc10-2377; Juarez DT, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120065; Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008; Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801; Krapek K, 2004, ANN PHARMACOTHER, V38, P1357, DOI 10.1345/aph.1D612; Lawrence DB, 2006, J MANAGE CARE PHARM, V12, P466; Long JA, 2014, DIABETES CARE, V37, P2261, DOI 10.2337/dc13-0051; Lopez JMS, 2014, CLIN THER, V36, P494, DOI 10.1016/j.clinthera.2013.12.016; Moreira ED, 2010, DIABETES RES CLIN PR, V87, P407, DOI 10.1016/j.diabres.2009.12.014; Nagrebetsky A, 2012, DIABETES RES CLIN PR, V96, P119, DOI 10.1016/j.diabres.2011.12.003; NCQA, 2008, COMPR DIAB CAR HEDIS, V2; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pladevall M, 2004, DIABETES CARE, V27, P2800, DOI 10.2337/diacare.27.12.2800; Rhee MK, 2005, DIABETES EDUCATOR, V31, P240, DOI 10.1177/0145721705274927; Rosen B, 2011, INT J QUAL HEALTH C, V23, P15, DOI 10.1093/intqhc/mzq065; Rozenfeld Y, 2008, AM J MANAG CARE, V14, P71; Schectman JM, 2002, DIABETES CARE, V25, P1015, DOI 10.2337/diacare.25.6.1015; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Singer SR, 2012, AM J MANAG CARE, V18; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tiv M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032412	34	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108145	10.1371/journal.pone.0108145	http://dx.doi.org/10.1371/journal.pone.0108145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259843	gold, Green Published, Green Submitted			2022-12-27	WOS:000342685600050
J	McGowan, ML; Fishman, JR; Settersten, RA; Lambrix, MA; Juengst, ET				McGowan, Michelle L.; Fishman, Jennifer R.; Settersten, Richard A., Jr.; Lambrix, Marcie A.; Juengst, Eric T.			Gatekeepers or Intermediaries? The Role of Clinicians in Commercial Genomic Testing	PLOS ONE			English	Article							PRIMARY-CARE PHYSICIANS; CONSUMER; GENETICS; EXPERIENCE	Background: Many commentators on "direct-to-consumer'' genetic risk information have raised concerns that giving results to individuals with insufficient knowledge and training in genomics may harm consumers, the health care system, and society. In response, several commercial laboratories offering genomic risk profiling have shifted to more traditional "direct-to-provider'' (DTP) marketing strategies, repositioning clinicians as the intended recipients of advertising of laboratory services and as gatekeepers to personal genomic information. Increasing popularity of next generation sequencing puts a premium on ensuring that those who are charged with interpreting, translating, communicating and managing commercial genomic risk information are appropriately equipped for the job. To shed light on their gatekeeping role, we conducted a study to assess how and why early clinical users of genomic risk assessment incorporate these tools in their clinical practices and how they interpret genomic information for their patients. Methods and Findings: We conducted qualitative in-depth interviews with 18 clinicians providing genomic risk assessment services to their patients in partnership with DNA Direct and Navigenics. Our findings suggest that clinicians learned most of what they knew about genomics directly from the commercial laboratories. Clinicians rely on the expertise of the commercial laboratories without the ability to critically evaluate the knowledge or assess risks. Conclusions: DTP service delivery model cannot guarantee that providers will have adequate expertise or sound clinical judgment. Even if clinicians want greater genomic knowledge, the current market structure is unlikely to build the independent substantive expertise of clinicians, but rather promote its continued outsourcing. Because commercial laboratories have the most "skin in the game'' financially, genetics professionals and policymakers should scrutinize the scientific validity and clinical soundness of the process by which these laboratories interpret their findings to assess whether self-interested commercial sources are the most appropriate entities for gate-keeping genomic interpretation.	[McGowan, Michelle L.; Lambrix, Marcie A.] Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA; [Fishman, Jennifer R.] McGill Univ, Fac Med, Biomed Eth Unit, Montreal, PQ, Canada; [Settersten, Richard A., Jr.] Oregon State Univ, Coll Publ Hlth & Human Sci, Corvallis, OR 97331 USA; [Juengst, Eric T.] Univ N Carolina, Ctr Bioeth, Dept Social Med, Chapel Hill, NC USA	Case Western Reserve University; McGill University; Oregon State University; University of North Carolina; University of North Carolina Chapel Hill	McGowan, ML (corresponding author), Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA.	michelle.mcgowan@case.edu		Juengst, Eric/0000-0002-8374-5774; Fishman, Jennifer/0000-0001-8140-4645	US National Human Genome Research Institute [NIH R01 HG005277]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005277] Funding Source: NIH RePORTER	US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Support for the preparation of this article was provided by the US National Human Genome Research Institute, Grant NIH R01 HG005277. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison M, 2012, NAT BIOTECHNOL, V30, P1027, DOI 10.1038/nbt.2409; Ambry Genetics, 2014, EX SEQ; Baars MJH, 2005, GENET MED, V7, P605, DOI 10.1097/01.gim.0000182895.28432.c7; Bernhardt BA, 2012, PERS MED, V9, P683, DOI 10.2217/PME.12.80; Borry P, 2010, J COMMUN GENET, V1, P101, DOI 10.1007/s12687-010-0023-z; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brett GR, 2012, EUR J HUM GENET, V20, P825, DOI 10.1038/ejhg.2012.13; Burke S, 2006, J ADV NURS, V54, P228, DOI 10.1111/j.1365-2648.2006.03805.x; Business Wire, 2008, BUSINESS WIRE; Collins HM, 2002, SOC STUD SCI, V32, P235, DOI 10.1177/0306312702032002003; DNA Direct, 2014, PHYS; DNA Direct, 2013, PERS MED; DNA DTC, 2014, EX SEQ; Dorfman R, 2013, NAT BIOTECHNOL, V31, P785, DOI 10.1038/nbt.2693; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P793, DOI 10.1001/jama.2014.148; Evans JP, 2008, GENET MED, V10, P500, DOI [10.1097/GIM.0b013e31817f280a, 10.1097GIM.0b013e31817f280a]; Evans JP, 2011, JAMA-J AM MED ASSOC, V306, P2376, DOI 10.1001/jama.2011.1788; Gene Dx, 2014, XOMEDX; Giovanni MA, 2010, GENET TEST MOL BIOMA, V14, P817, DOI 10.1089/gtmb.2010.0051; Goldsmith L, 2013, J COMMUN GENET, V4, P169, DOI 10.1007/s12687-012-0135-8; Gollust SE, 2012, PUBLIC HEALTH GENOM, V15, P22, DOI 10.1159/000327296; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Haga SB, 2011, J GEN INTERN MED, V26, P834, DOI 10.1007/s11606-011-1651-7; Harries A, 2013, J BUILD PERFORM SIMU, V6, P401, DOI 10.1080/19401493.2012.718796; Hock KT, 2011, GENET MED, V13, P325, DOI 10.1097/GIM.0b013e3182011636; Howard HC, 2012, J COMMUN GENET, V3, P105, DOI 10.1007/s12687-011-0062-0; Hruschka DJ, 2004, FIELD METHODS, V16; Illumina, 2014, TRUGENOME CLIN SEQ S; Juengst ET, 2012, PERS MED, V9, P429, DOI 10.2217/PME.12.37; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Leachman SA, 2011, AM SOC CLIN ONCOLOGY, V2011, P33; Lo B, 2011, ANN INTERN MED, V155, P641, DOI 10.7326/0003-4819-155-9-201111010-00016; Matloff E, 2008, AM J BIOETHICS, V8, P5, DOI 10.1080/15265160802248179; McGowan ML, 2008, AM J BIOETHICS, V8, P18, DOI 10.1080/15265160802248302; McGowan ML, 2013, PERS MED, V10, P339, DOI 10.2217/PME.13.32; McGowan ML, 2010, NEW GENET SOC, V29, P261, DOI 10.1080/14636778.2010.507485; McGuire AL, 2013, JAMA-J AM MED ASSOC, V309, P1465, DOI 10.1001/jama.2013.1438; McLellan E., 2003, FIELD METHOD, V15, P63, DOI [DOI 10.1177/1525822X02239573, 10.1177/1525822X02239573]; Merriam S. B., 2009, QUALITATIVE RES GUID; Mountcastle-Shah E, 2000, AM J MED GENET, V94, P409, DOI 10.1002/1096-8628(20001023)94:5<409::AID-AJMG13>3.0.CO;2-U; Murray MF, 2014, ANN INTERN MED, V160, P507, DOI 10.7326/M13-2804; Navigenics, 2008, APPL PREV GEN MED CL; Ohata T, 2009, J HUM GENET, V54, P203, DOI 10.1038/jhg.2009.11; Pandey A, 2013, JAMA-J AM MED ASSOC, V309, P1471, DOI 10.1001/jama.2012.116971; Pollack A., 2010, NY TIMES; Powell KP, 2012, J GENET COUNS, V21, P469, DOI 10.1007/s10897-011-9471-9; Powell KP, 2012, J GENET COUNS, V21, P113, DOI 10.1007/s10897-011-9390-9; Rogers EM., 2010, INTEGRATED APPROACH	48	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108484	10.1371/journal.pone.0108484	http://dx.doi.org/10.1371/journal.pone.0108484			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259512	Green Submitted, Green Published, gold			2022-12-27	WOS:000342685600077
J	Nie, BB; Liu, H; Chen, KW; Jiang, XF; Shan, BC				Nie, Binbin; Liu, Hua; Chen, Kewei; Jiang, Xiaofeng; Shan, Baoci			A Statistical Parametric Mapping Toolbox Used for Voxel-Wise Analysis of FDG-PET Images of Rat Brain	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; SPATIAL NORMALIZATION; OLFACTORY DEFICITS; TEMPLATE; ATLAS; MRI; PERFORMANCE; MICROPET	Purpose: PET (positron emission tomography) imaging researches of functional metabolism using fluorodeoxyglucose (F-18-FDG) of animal brain are important in neuroscience studies. FDG-PET imaging studies are often performed on groups of rats, so it is desirable to establish an objective voxel-based statistical methodology for group data analysis. Material and Methods: This study establishes a statistical parametric mapping (SPM) toolbox (plug-ins) named spmratIHEP for voxel-wise analysis of FDG-PET images of rat brain, in which an FDG-PET template and an intracranial mask image of rat brain in Paxinos & Watson space were constructed, and the default settings were modified according to features of rat brain. Compared to previous studies, our constructed rat brain template comprises not only the cerebrum and cerebellum, but also the whole olfactory bulb which made the later cognitive studies much more exhaustive. And with an intracranial mask image in the template space, the brain tissues of individuals could be extracted automatically. Moreover, an atlas space is used for anatomically labeling the functional findings in the Paxinos & Watson space. In order to standardize the template image with the atlas accurately, a synthetic FDG-PET image with six main anatomy structures is constructed from the atlas, which performs as a target image in the co-registration. Results: The spatial normalization procedure is evaluated, by which the individual rat brain images could be standardized into the Paxinos & Watson space successfully and the intracranial tissues could also be extracted accurately. The practical usability of this toolbox is evaluated using FDG-PET functional images from rats with left side middle cerebral artery occlusion (MCAO) in comparison to normal control rats. And the two-sample t-test statistical result is almost related to the left side MCA. Conclusion: We established a toolbox of SPM8 named spmratIHEP for voxel-wise analysis of FDG-PET images of rat brain.	[Nie, Binbin; Liu, Hua; Shan, Baoci] Chinese Acad Sci, Beijing Engn Res Ctr Radiog Techn & Equipment, Key Lab Nucl Anal Tech, Inst High Energy Phys, Beijing, Peoples R China; [Chen, Kewei] Banner Good Samaritan Positron Emiss Tomog Ctr, Banner Alzheimers Inst, Phoenix, AZ USA; [Chen, Kewei] Arizona State Univ, Dept Math & Stat, Tempe, AZ USA; [Chen, Kewei] Univ Arizona, Dept Radiol, Tucson, AZ 85724 USA; [Chen, Kewei] Arizona Alzheimers Consortium, Phoenix, AZ USA; [Jiang, Xiaofeng] Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Banner Research; Banner Health; Banner Alzheimer's Institute; Arizona State University; Arizona State University-Tempe; University of Arizona; Capital Medical University	Shan, BC (corresponding author), Chinese Acad Sci, Beijing Engn Res Ctr Radiog Techn & Equipment, Key Lab Nucl Anal Tech, Inst High Energy Phys, Beijing, Peoples R China.	shanbc@ihep.ac.cn		Nie, Binbin/0000-0002-8038-7772; Shan, Baoci/0000-0001-7417-5063; Liu, Hua/0000-0002-0301-3144	National Basic Research Program of China (973 Program) [2013CB835100]; National Natural Science Foundation of China [81201147, 91232713]; Xie Jialin Foundation of IHEP [3546370U2]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xie Jialin Foundation of IHEP	This work was supported by grants from National Basic Research Program of China (973 Program) (2013CB835100), the National Natural Science Foundation of China (81201147 and 91232713) and the Xie Jialin Foundation of IHEP (3546370U2). All these funders support this study. In detail, 2013CB835100 support the modal construction and data collection of the MCAO group, 81201147 and 91232713 support the data collection of the group for template construction, 3546370U2 support the data collection of the group for intracranial mask image evaluation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Buiter Hans J C, 2012, Int J Mol Imaging, V2012, P580717, DOI 10.1155/2012/580717; Casteels C, 2006, J NUCL MED, V47, P1858; Chupin M, 2007, NEUROIMAGE, V34, P996, DOI 10.1016/j.neuroimage.2006.10.035; Coello C, 2011, J NEUROSCI METH, V199, P166, DOI 10.1016/j.jneumeth.2011.04.026; Devanand DP, 2000, AM J PSYCHIAT, V157, P1399, DOI 10.1176/appi.ajp.157.9.1399; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P89; Fueger BJ, 2006, J NUCL MED, V47, P999; Huang YC, 2011, NEUROIMAGE, V54, P142, DOI 10.1016/j.neuroimage.2010.07.058; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jagust WJ, 2010, ALZHEIMERS DEMENT, V6, P221, DOI 10.1016/j.jalz.2010.03.003; KUGE Y, 1995, STROKE, V26, P1655, DOI 10.1161/01.STR.26.9.1655; Li W, 2010, BRAIN, V133, P2714, DOI 10.1093/brain/awq209; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Matsumura A, 2003, NEUROIMAGE, V20, P2040, DOI 10.1016/j.neuroimage.2003.08.020; MINEMATSU K, 1992, NEUROLOGY, V42, P235, DOI 10.1212/WNL.42.1.235; Murugavel M, 2009, NEUROIMAGE, V45, P845, DOI 10.1016/j.neuroimage.2008.12.021; Nie B, 2013, HUM BRAIN MAPP, V34, P1306, DOI 10.1002/hbm.21511; Nie BB, 2010, J MAGN RESON IMAGING, V32, P830, DOI 10.1002/jmri.22283; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Paxinos G., 2004, J CHEM INF MODEL, V5th; Peters JM, 2003, AM J PSYCHIAT, V160, P1995, DOI 10.1176/appi.ajp.160.11.1995; Rodionov R, 2009, MAGN RESON IMAGING, V27, P1104, DOI 10.1016/j.mri.2009.01.008; Rubins DJ, 2003, NEUROIMAGE, V20, P2100, DOI 10.1016/j.neuroimage.2003.07.011; Schiffman SS, 2002, NEUROBIOL AGING, V23, P397, DOI 10.1016/S0197-4580(01)00337-2; Schubert CR, 2008, J AM GERIATR SOC, V56, P1517, DOI 10.1111/j.1532-5415.2008.01826.x; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; Talairach P., 1988, STEREOTACTIC COPLANA; Wong KK, 2010, NEUROSCI LETT, V484, P163, DOI 10.1016/j.neulet.2010.08.037; Zhilkin P, 2004, MAGN RESON IMAGING, V22, P55, DOI 10.1016/j.mri.2003.05.004; Zimmer L, 2012, NEUROIMAGE, V61, P363, DOI 10.1016/j.neuroimage.2011.12.037	33	38	40	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108295	10.1371/journal.pone.0108295	http://dx.doi.org/10.1371/journal.pone.0108295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259529	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600061
J	Rizzo, AM; Corsetto, PA; Farina, F; Montorfano, G; Pani, G; Battaglia, C; Sancini, G; Palestini, P				Rizzo, Angela Maria; Corsetto, Paola Antonia; Farina, Francesca; Montorfano, Gigliola; Pani, Giuseppe; Battaglia, Cristina; Sancini, Giulio; Palestini, Paola			Repeated Intratracheal Instillation of PM10 Induces Lipid Reshaping in Lung Parenchyma and in Extra-Pulmonary Tissues	PLOS ONE			English	Article							PARTICULATE MATTER; AIR-POLLUTION; OXIDATIVE STRESS; ULTRAFINE PARTICLES; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; INFLAMMATION; EXPOSURE; TRANSLOCATION; PEROXIDATION	Adverse health effects of air pollution attributed mainly to airborne particulate matter have been well documented in the last couple of decades. Short term exposure, referring to a few hours exposure, to high ambient PM10 concentration is linked to increased hospitalization rates for cardiovascular events, typically 24 h after air pollution peaks. Particulate matter exposure is related to pulmonary and cardiovascular diseases, with increased oxidative stress and inflammatory status. Previously, we have demonstrated that repeated intratracheal instillation of PM10sum in BALB/c mice leads to respiratory tract inflammation, creating in lung a condition which could potentially evolve in a systemic toxic reaction. Additionally, plasma membrane and tissue lipids are easily affected by oxidative stress and directly correlated with inflammatory products. With this aim, in the present investigation using the same model, we analyzed the toxic potential of PM10sum exposure on lipid plasma membrane composition, lipid peroxidation and the mechanisms of cells protection in multiple organs such as lung, heart, liver and brain. Obtained results indicated that PM10 exposure led to lung lipid reshaping, in particular phospholipid and cholesterol content increases; concomitantly, the generation of oxidative stress caused lipid peroxidation. In liver we found significant changes in lipid content, mainly due to an increase of phosphatidylcholine, and in total fatty acid composition with a more pronounced level of docosahexaenoic acid; these changes were statistically correlated to lung molecular markers. Heart and brain were similarly affected; heart was significantly enriched in triglycerides in half of the PM10sum treated mice. These results demonstrated a direct involvement of PM10sum in affecting lipid metabolism and oxidative stress in peripheral tissues that might be related to the serious systemic air-pollution effects on human health.	[Rizzo, Angela Maria; Corsetto, Paola Antonia; Montorfano, Gigliola; Pani, Giuseppe] Univ Milan, Dept Pharmacol & Biomol Sci DiSFEB, Lab Membrane Biochem & Appl Nutr, Milan, Italy; [Farina, Francesca; Sancini, Giulio; Palestini, Paola] Univ Milano Bicocca, POLARIS Res Ctr, Dept Hlth Sci DISS, Monza, Italy; [Battaglia, Cristina] Univ Milan, Lab Genom Technol, Dept Med Biotechnol & Translat Med BIOMETRA, Segrate, Italy	University of Milan; University of Milano-Bicocca; University of Milan	Rizzo, AM (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci DiSFEB, Lab Membrane Biochem & Appl Nutr, Milan, Italy.	angelamaria.rizzo@unimi.it	Battaglia, Cristina/E-5166-2017; CORSETTO, PAOLA ANTONIA/O-2244-2015; Palestini, PAOLA/AAD-9376-2019; RIzzo, Angela Maria/E-4786-2012; Sancini, Giulio/I-5136-2012	Battaglia, Cristina/0000-0003-3025-9657; CORSETTO, PAOLA ANTONIA/0000-0003-3849-8548; Palestini, PAOLA/0000-0002-1045-8838; RIzzo, Angela Maria/0000-0002-8582-0432; Sancini, Giulio/0000-0003-2567-109X; PANI, GIUSEPPE/0000-0001-5198-8205	CARIPLO Foundation	CARIPLO Foundation(Fondazione Cariplo)	This research received financial support from CARIPLO Foundation to the projects: 1) Toxicity of particulate matter and marker of risk; 2) Biological effects and human health impacts of ultrafine particles sources. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrish MM, 2013, TOXICOL SCI, V131, P108, DOI 10.1093/toxsci/kfs277; Asgharian B, 2006, INHAL TOXICOL, V18, P795, DOI 10.1080/08958370600748687; Bahat-Stroomza M, 2005, EUR J NEUROSCI, V21, P637, DOI 10.1111/j.1460-9568.2005.03889.x; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; Bengalli R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/801214; Beretta E, 2007, TOXICOL LETT, V173, P191, DOI 10.1016/j.toxlet.2007.07.012; Bessette EE, 2009, J BIOCHEM MOL TOXIC, V23, P222, DOI 10.1002/jbt.20283; Block ML, 2012, NEUROTOXICOLOGY, V33, P972, DOI 10.1016/j.neuro.2012.08.014; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Brandenberger C, 2010, SMALL, V6, P1669, DOI 10.1002/smll.201000528; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Calderon-Garciduenas L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/161687; Camatini M, 2012, ENVIRON TOXICOL, V27, P63, DOI 10.1002/tox.20611; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Case SR, 2011, EXP LUNG RES, V37, P500, DOI 10.3109/01902148.2011.596895; Chen JM, 2006, TOXICOLOGY, V222, P195, DOI 10.1016/j.tox.2006.02.016; Choi BM, 2003, FREE RADICAL BIO MED, V34, P1136, DOI 10.1016/S0891-5849(03)00064-9; Conklin DJ, 2013, J HEPATOL, V58, P8, DOI 10.1016/j.jhep.2012.10.008; CORRIN B, 1978, THORAX, V33, P565, DOI 10.1136/thx.33.5.565; Corsetto PA, 2012, CELL BIOCHEM BIOPHYS, V64, P45, DOI 10.1007/s12013-012-9365-y; Cortie CH, 2012, INT J MOL SCI, V13, P15447, DOI 10.3390/ijms131115447; Costa DL, 1997, ENVIRON HEALTH PERSP, V105, P1053, DOI 10.2307/3433509; Cotogni P, 2011, JPEN-PARENTER ENTER, V35, P114, DOI 10.1177/0148607110372392; Damaceno-Rodrigues NR, 2009, INHAL TOXICOL, V21, P1129, DOI 10.1080/08958370902798430; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; El Kossi MMH, 2000, STROKE, V31, P1889, DOI 10.1161/01.STR.31.8.1889; ESTERBAUER H, 1985, BIOCHEM J, V228, P363, DOI 10.1042/bj2280363; Fajersztajn L, 2013, NAT REV CANCER, V13, P674, DOI 10.1038/nrc3572; Farina F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056636; Farina F, 2011, TOXICOL LETT, V202, P209, DOI 10.1016/j.toxlet.2011.01.031; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Franchini M, 2009, SEMIN THROMB HEMOST, V35, P665, DOI 10.1055/s-0029-1242720; Franzetti A, 2011, APPL MICROBIOL BIOT, V90, P745, DOI 10.1007/s00253-010-3048-7; Furuichi K, 2006, CRIT CARE MED, V34, P2447, DOI 10.1097/01.CCM.0000233878.36340.10; Graff DW, 2009, ENVIRON HEALTH PERSP, V117, P1089, DOI 10.1289/ehp0900558; Gualtieri M, 2009, TOXICOL LETT, V188, P52, DOI 10.1016/j.toxlet.2009.03.003; Guo L, 2012, J HAZARD MATER, V213, P28, DOI 10.1016/j.jhazmat.2012.01.034; Henderson RF, 2005, EXP TOXICOL PATHOL, V57, P155, DOI 10.1016/j.etp.2005.05.004; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Jung YY, 2013, KOREAN J PHYSIOL PHA, V17, P209, DOI 10.4196/kjpp.2013.17.3.209; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kampfrath T, 2011, CIRC RES, V108, P716, DOI 10.1161/CIRCRESAHA.110.237560; Kelly FJ, 2003, OCCUP ENVIRON MED, V60, P612, DOI 10.1136/oem.60.8.612; Kendall M, 2007, AM J PHYSIOL-LUNG C, V293, pL1053, DOI 10.1152/ajplung.00131.2007; Kido T, 2011, AM J RESP CELL MOL, V44, P197, DOI 10.1165/rcmb.2009-0427OC; Kloog I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034664; Levesque S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-105; Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000; Li N, 2008, FREE RADICAL BIO MED, V44, P1689, DOI 10.1016/j.freeradbiomed.2008.01.028; Liu Q, 2005, FREE RADICAL BIO MED, V38, P746, DOI 10.1016/j.freeradbiomed.2004.11.005; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacNee W, 2003, EUR RESPIR J, V21, p47S, DOI 10.1183/09031936.03.00403203; Manrique C, 2013, ENDOCRINOLOGY, V154, P3632, DOI 10.1210/en.2013-1256; Mantecca P, 2010, TOXICOL LETT, V198, P244, DOI 10.1016/j.toxlet.2010.07.002; Mantecca P, 2009, TOXICOL LETT, V189, P206, DOI 10.1016/j.toxlet.2009.05.023; Miyata R, 2013, TOXICOL APPL PHARM, V272, P1, DOI 10.1016/j.taap.2013.05.033; MohanKumar SMJ, 2008, NEUROTOXICOLOGY, V29, P479, DOI 10.1016/j.neuro.2007.12.004; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Muhlfeld C, 2008, SWISS MED WKLY, V138, P387, DOI 2008/27/smw-12153; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; Nemmar A, 2001, AM J RESP CRIT CARE, V164, P1665, DOI 10.1164/ajrccm.164.9.2101036; NISHIMURA I, 1995, TOXICOL LETT, V75, P185, DOI 10.1016/0378-4274(94)03184-9; Orsini F, 2012, BBA-BIOMEMBRANES, V1818, P2943, DOI 10.1016/j.bbamem.2012.07.024; Perluigi M, 2005, FREE RADICAL BIO MED, V38, P960, DOI 10.1016/j.freeradbiomed.2004.12.021; Peters A, 2006, PART FIBRE TOXICOL, V3, DOI 10.1186/1743-8977-3-13; Pleil JD, 2010, J CHROMATOGR B, V878, P1753, DOI 10.1016/j.jchromb.2010.04.035; Puthanveetil P, 2011, FREE RADICAL BIO MED, V51, P352, DOI 10.1016/j.freeradbiomed.2011.04.009; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Rizzo AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032361; Ruge CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040775; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Schicker B, 2009, EUR J APPL PHYSIOL, V105, P771, DOI 10.1007/s00421-008-0962-9; Schwarze PE, 2006, HUM EXP TOXICOL, V25, P559, DOI 10.1177/096032706072520; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shah KB, 2009, CLIN CHEM, V55, P59, DOI 10.1373/clinchem.2008.108159; Shannahan JH, 2012, INHAL TOXICOL, V24, P320, DOI 10.3109/08958378.2012.668229; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029; Spalding J. W., 1988, NATL TOXICOL PROGRAM, V331, P5; Takahashi HK, 2013, EUR J PHARMACOL, V701, P194, DOI 10.1016/j.ejphar.2012.11.058; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Treutiger CJ, 2003, J INTERN MED, V254, P375, DOI 10.1046/j.1365-2796.2003.01204.x; Valencak TG, 2013, AGE, V35, P2303, DOI 10.1007/s11357-013-9533-z; Wallenborn JG, 2007, TOXICOL SCI, V98, P231, DOI 10.1093/toxsci/kfm088; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; YAU TM, 1979, MECH AGEING DEV, V11, P137, DOI 10.1016/0047-6374(79)90031-9; Zheng Z, 2013, J HEPATOL, V58, P148, DOI 10.1016/j.jhep.2012.08.009	91	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e106855	10.1371/journal.pone.0106855	http://dx.doi.org/10.1371/journal.pone.0106855			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259850	gold, Green Published			2022-12-27	WOS:000342685600010
J	Haase, D; Rieger, JK; Witten, A; Stoll, M; Bornberg-Bauer, E; Kalbe, M; Reusch, TBH				Haase, David; Rieger, Jennifer K.; Witten, Anika; Stoll, Monika; Bornberg-Bauer, Erich; Kalbe, Martin; Reusch, Thorsten B. H.			Specific Gene Expression Responses to Parasite Genotypes Reveal Redundancy of Innate Immunity in Vertebrates	PLOS ONE			English	Article							DIPLOSTOMUM-PSEUDOSPATHACEUM; 3-SPINED STICKLEBACKS; EYE FLUKE; RNA-SEQ; SYSTEM; INFECTION; EVOLUTION; RECOGNITION; SPATHACEUM	Vertebrate innate immunity is the first line of defense against an invading pathogen and has long been assumed to be largely unspecific with respect to parasite/pathogen species. However, recent phenotypic evidence suggests that immunogenetic variation, i.e. allelic variability in genes associated with the immune system, results in host-parasite genotype-by-genotype interactions and thus specific innate immune responses. Immunogenetic variation is common in all vertebrate taxa and this reflects an effective immunological function in complex environments. However, the underlying variability in host gene expression patterns as response of innate immunity to within-species genetic diversity of macroparasites in vertebrates is unknown. We hypothesized that intra-specific variation among parasite genotypes must be reflected in host gene expression patterns. Here we used high-throughput RNA-sequencing to examine the effect of parasite genotypes on gene expression patterns of a vertebrate host, the three-spined stickleback (Gasterosteus aculeatus). By infecting naive fish with distinct trematode genotypes of the species Diplostomum pseudospathaceum we show that gene activity of innate immunity in three-spined sticklebacks depended on the identity of an infecting macroparasite genotype. In addition to a suite of genes indicative for a general response against the trematode we also find parasite-strain specific gene expression, in particular in the complement system genes, despite similar infection rates of single clone treatments. The observed discrepancy between infection rates and gene expression indicates the presence of alternative pathways which execute similar functions. This suggests that the innate immune system can induce redundant responses specific to parasite genotypes.	[Haase, David; Rieger, Jennifer K.; Reusch, Thorsten B. H.] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Witten, Anika; Stoll, Monika] Univ Munster, Leibniz Inst Arteriosclerosis Res, D-48149 Munster, Germany; [Bornberg-Bauer, Erich] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany; [Kalbe, Martin] Max Planck Inst Evolutionary Biol, Dept Evolutionary Ecol, Plon, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Munster; University of Munster; Max Planck Society	Haase, D (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	dhaase@geomar.de	Bornberg-Bauer, Erich/A-1563-2013; Witten, Anika/C-5297-2019; Reusch, Thorsten B. H./B-9311-2019; Reusch, Thorsten B.H./G-4141-2011	Bornberg-Bauer, Erich/0000-0002-1826-3576; Reusch, Thorsten B. H./0000-0002-8961-4337	Deutsche Forschungsgemeinschaft (DFG) [SPP 1399, RE 1108/13-2, RE 1108/13-1]; GEOMAR Helmholtz Centre for Ocean Research Kiel; Max Planck Institute for Evolutionary Biology	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); GEOMAR Helmholtz Centre for Ocean Research Kiel(Helmholtz Association); Max Planck Institute for Evolutionary Biology(Max Planck Society)	This study was financially supported by the Deutsche Forschungsgemeinschaft (DFG, Priority Programme SPP 1399 "Host-parasite Coevolution"; grant no. RE 1108/13-2 and RE 1108/13-1; dfg.de), GEOMAR Helmholtz Centre for Ocean Research Kiel (www.geomar.de) and the Max Planck Institute for Evolutionary Biology (www.evolbio.mpg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barribeau SM, 2014, P NATL ACAD SCI USA, V111, P3496, DOI 10.1073/pnas.1318628111; Chappell L.H., 1994, P59; Chen HW, 2013, J IMMUNOL, V191, P4194, DOI 10.4049/jimmunol.1300799; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CROWDEN AE, 1980, ANIM BEHAV, V28, P287, DOI 10.1016/S0003-3472(80)80031-5; de Roode JC, 2010, EVOLUTION, V64, P502, DOI 10.1111/j.1558-5646.2009.00845.x; Feulner PGD, 2013, MOL ECOL, V22, P635, DOI 10.1111/j.1365-294X.2012.05680.x; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; Gibson G, 2005, SCIENCE, V307, P1890, DOI 10.1126/science.1109835; Haase D, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0044; Jokela J, 2000, OIKOS, V89, P267, DOI 10.1034/j.1600-0706.2000.890207.x; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kalbe M, 2006, PARASITOLOGY, V132, P105, DOI 10.1017/S0031182005008681; Karvonen A, 2012, P ROY SOC B-BIOL SCI, V279, P171, DOI 10.1098/rspb.2011.0879; Koehler AV, 2012, PARASITOLOGY, V139, P128, DOI 10.1017/S0031182011001739; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Lenz TL, 2013, MOL ECOL, V22, P774, DOI 10.1111/j.1365-294X.2012.05756.x; Magnadottir B, 2006, FISH SHELLFISH IMMUN, V20, P137, DOI 10.1016/j.fsi.2004.09.006; Maizels RM, 2013, NAT IMMUNOL, V14, P879, DOI 10.1038/ni.2643; Maizels RM, 2012, CURR OPIN IMMUNOL, V24, P459, DOI 10.1016/j.coi.2012.06.003; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Medzhitov R, 2010, NAT IMMUNOL, V11, P551, DOI 10.1038/ni0710-551; Mikes L, 2001, INT J PARASITOL, V31, P245, DOI 10.1016/S0020-7519(00)00165-X; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; OWEN SF, 1993, J FISH BIOL, V42, P803; Press CM, 1999, FISH SHELLFISH IMMUN, V9, P309, DOI 10.1006/fsim.1998.0181; Rauch G, 2005, J EVOLUTION BIOL, V18, P1069, DOI 10.1111/j.1420-9101.2005.00895.x; Rauch G, 2008, OIKOS, V117, P399, DOI 10.1111/j.2007.0030-1299.16301.x; Rauch G, 2006, BIOL LETT-UK, V2, P382, DOI 10.1098/rsbl.2006.0462; Reusch TBH, 2004, MOL ECOL NOTES, V4, P577, DOI 10.1111/j.1471-8286.2004.00740.x; Seppala O, 2009, P ROY SOC B-BIOL SCI, V276, P691, DOI 10.1098/rspb.2008.1229; Smith KA, 2012, INFECT IMMUN, V80, P3481, DOI 10.1128/IAI.00436-12; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Whyte SK, 2007, FISH SHELLFISH IMMUN, V23, P1127, DOI 10.1016/j.fsi.2007.06.005; WHYTE SK, 1990, J FISH DIS, V13, P281, DOI 10.1111/j.1365-2761.1990.tb00784.x; Workenhe ST, 2010, MOL IMMUNOL, V47, P2525, DOI 10.1016/j.molimm.2010.06.009	41	22	23	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108001	10.1371/journal.pone.0108001	http://dx.doi.org/10.1371/journal.pone.0108001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254967	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000344862300051
J	Moreira, DP; Griesi-Oliveira, K; Bossolani-Martins, AL; Lourenco, NCV; Takahashi, VNO; da Rocha, KM; Moreira, ES; Vadasz, E; Meira, JGC; Bertola, D; O' Halloran, E; Magalhaes, TR; Fett-Conte, AC; Passos-Bueno, MR				Moreira, Danielle P.; Griesi-Oliveira, Karina; Bossolani-Martins, Ana L.; Lourenco, Naila C. V.; Takahashi, Vanessa N. O.; da Rocha, Katia M.; Moreira, Eloisa S.; Vadasz, Estevao; Castro Meira, Joanna Goes; Bertola, Debora; O' Halloran, Eoghan; Magalhaes, Tiago R.; Fett-Conte, Agnes C.; Passos-Bueno, Maria Rita			Investigation of 15q11-q13, 16p11.2 and 22q13 CNVs in Autism Spectrum Disorder Brazilian Individuals with and without Epilepsy	PLOS ONE			English	Article							COPY NUMBER VARIANTS; MENTAL-RETARDATION; CYTOGENETIC ABNORMALITIES; INCOMPLETE PENETRANCE; CLINICAL-SIGNIFICANCE; BREAKPOINTS 1; MICRODELETION; 15Q13.3; ASSOCIATION; POPULATION	Copy number variations (CNVs) are an important cause of ASD and those located at 15q11-q13, 16p11.2 and 22q13 have been reported as the most frequent. These CNVs exhibit variable clinical expressivity and those at 15q11-q13 and 16p11.2 also show incomplete penetrance. In the present work, through multiplex ligation-dependent probe amplification (MLPA) analysis of 531 ethnically admixed ASD-affected Brazilian individuals, we found that the combined prevalence of the 15q11-q13, 16p11.2 and 22q13 CNVs is 2.1% (11/531). Parental origin could be determined in 8 of the affected individuals, and revealed that 4 of the CNVs represent de novo events. Based on CNV prediction analysis from genome-wide SNP arrays, the size of those CNVs ranged from 206 kb to 2.27 Mb and those at 15q11-q13 were limited to the 15q13.3 region. In addition, this analysis also revealed 6 additional CNVs in 5 out of 11 affected individuals. Finally, we observed that the combined prevalence of CNVs at 15q13.3 and 22q13 in ASD-affected individuals with epilepsy (6.4%) was higher than that in ASD-affected individuals without epilepsy (1.3%; p < 0.014). Therefore, our data show that the prevalence of CNVs at 15q13.3, 16p11.2 and 22q13 in Brazilian ASD-affected individuals is comparable to that estimated for ASD-affected individuals of pure or predominant European ancestry. Also, it suggests that the likelihood of a greater number of positive MLPA results might be found for the 15q13.3 and 22q13 regions by prioritizing ASD-affected individuals with epilepsy.	[Moreira, Danielle P.; Griesi-Oliveira, Karina; Lourenco, Naila C. V.; Takahashi, Vanessa N. O.; da Rocha, Katia M.; Moreira, Eloisa S.; Castro Meira, Joanna Goes; Bertola, Debora; Passos-Bueno, Maria Rita] Univ Sao Paulo, Inst Biociencias, Ctr Pesquisas Genoma Humano & Celulas Tronco, Dept Genet & Biol Evolut, Sao Paulo, Brazil; [Bossolani-Martins, Ana L.; Fett-Conte, Agnes C.] Fac Med Sao Jose do Rio Preto, Dept Biol Mol, Sao Jose Do Rio Preto, SP, Brazil; [Vadasz, Estevao] Univ Sao Paulo, Fac Med, Hosp Clin, Inst Psiquiatria, Sao Paulo, Brazil; [Bertola, Debora] Univ Sao Paulo, Fac Med, Inst Crianca, Sao Paulo, Brazil; [O' Halloran, Eoghan; Magalhaes, Tiago R.] Natl Univ Ireland Univ Coll Dublin, Sch Med & Med Sci, Acad Ctr Rare Dis, Dublin 4, Ireland; [Magalhaes, Tiago R.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland	Universidade de Sao Paulo; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo; Universidade de Sao Paulo; University College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin	Passos-Bueno, MR (corresponding author), Univ Sao Paulo, Inst Biociencias, Ctr Pesquisas Genoma Humano & Celulas Tronco, Dept Genet & Biol Evolut, Sao Paulo, Brazil.	passos@ib.usp.br	Passos-Bueno, Maria Rita/I-6796-2016; MEIRA, JOANNA/GQP-2816-2022; Bertola, Débora/I-5120-2016; Moreira, Eloisa/K-9155-2014	Passos-Bueno, Maria Rita/0000-0002-9248-3008; MEIRA, JOANNA/0000-0002-9267-404X; Bertola, Débora/0000-0002-4701-6777; O'Halloran, Eoghan/0000-0002-3332-7443; R Magalhaes, Tiago/0000-0002-5528-2119	FAPESP-INCT [2008/57899-7]; FAPESP-CEPID [2013/08028-1]; CNPq	FAPESP-INCT; FAPESP-CEPID(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Support was provided by FAPESP-INCT - grant number: 2008/57899-7; FAPESP-CEPID - grant number: 2013/08028-1; CNPq [http://www.fapesp.br/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Beal JC, 2013, J CHILD NEUROL, P13; Bedoyan JK, 2010, AM J MED GENET A, V152A, P1567, DOI 10.1002/ajmg.a.33415; Ben-Shachar S, 2009, J MED GENET, V46, P382, DOI 10.1136/jmg.2008.064378; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bisgaard AM, 2007, EUR J MED GENET, V50, P243, DOI 10.1016/j.ejmg.2007.03.004; Bonaglia MC, 2006, J MED GENET, V43, P822, DOI 10.1136/jmg.2005.038604; Bonaglia MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002173; Brito LA, 2011, AM J MED GENET A, V155A, P1581, DOI 10.1002/ajmg.a.34036; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Cann HM, 2002, SCIENCE, V296, P261; Carter MT, 2013, CLIN GENET, V83, P399, DOI 10.1111/cge.12101; Chaste P, 2014, AUTISM RES, V7, P355, DOI 10.1002/aur.1378; Chilian B, 2013, CLIN GENET, V3, P9; Ciuladaite Z, 2011, J APPL GENET, V52, P443, DOI 10.1007/s13353-011-0063-z; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; Degenhardt F, 2012, AM J MED GENET B, V159B, P263, DOI 10.1002/ajmg.b.32034; Depienne C, 2009, BIOL PSYCHIAT, V66, P349, DOI 10.1016/j.biopsych.2009.01.025; Doornbos M, 2009, EUR J MED GENET, V52, P108, DOI 10.1016/j.ejmg.2009.03.010; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Fernandez BA, 2010, J MED GENET, V47, P195, DOI 10.1136/jmg.2009.069369; Galizia EC, 2012, EUR J MED GENET, V55, P342, DOI 10.1016/j.ejmg.2011.12.011; Giarelli E, 2010, DISABIL HEALTH J, V3, P107, DOI 10.1016/j.dhjo.2009.07.001; Gillberg C, 2000, ACTA PSYCHIAT SCAND, V102, P321, DOI 10.1034/j.1600-0447.2000.102005321.x; Giolo SR, 2012, EUR J HUM GENET, V20, P111, DOI 10.1038/ejhg.2011.144; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Griesi-Oliveira K, 2013, AUTISM RES, V6, P354, DOI 10.1002/aur.1296; Griesi-Oliveira K, 2012, AM J MED GENET B, V159B, P529, DOI 10.1002/ajmg.b.32059; Haddad LA, 1996, HUM GENET, V97, P808; Heil KM, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0334-3; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jehee FS, 2011, EUR J MED GENET, V54, pE425, DOI 10.1016/j.ejmg.2011.03.007; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lazoff T, 2010, CAN J PSYCHIAT, V55, P715, DOI 10.1177/070674371005501105; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Magalhaes TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049438; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Marshall CR, 2012, METHODS MOL BIOL, V838, P115, DOI 10.1007/978-1-61779-507-7_5; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Melchior L, 2013, AM J MED GENET B, P1; Menashe I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066707; Miles JH, 2011, GENET MED, V13, P278, DOI 10.1097/GIM.0b013e3181ff67ba; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Ming X, 2008, J CHILD NEUROL, V23, P6, DOI 10.1177/0883073807307102; Mulley JC, 2011, EPILEPSIA, V52, pE139, DOI 10.1111/j.1528-1167.2011.03188.x; NESSLINGER NJ, 1994, AM J HUM GENET, V54, P464; Orabona GM, 2009, BRAIN RES, V1250, P14, DOI 10.1016/j.brainres.2008.11.007; Pagnamenta AT, 2009, EUR J HUM GENET, V17, P687, DOI 10.1038/ejhg.2008.228; Paula CS, 2011, J AUTISM DEV DISORD, V41, P1738, DOI 10.1007/s10803-011-1200-6; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Phelan K, 2011, MOL SYNDROMOL, V2, P186, DOI 10.1159/000334260; Phelan MC, 2001, AM J MED GENET, V101, P91, DOI 10.1002/1096-8628(20010615)101:2<91::AID-AJMG1340>3.0.CO;2-C; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiao Y, 2013, CLIN GENET, V83, P145, DOI 10.1111/j.1399-0004.2012.01860.x; R Core Team, 2021, R LANGUAGE ENV STAT; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rosenfeld JA, 2011, EUR J HUM GENET, V19, P547, DOI 10.1038/ejhg.2010.237; Rosenfeld JA, 2010, GENET MED, V12, P694, DOI 10.1097/GIM.0b013e3181f0c5f3; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Schaaf CP, 2011, EUR J HUM GENET, V19, P152, DOI 10.1038/ejhg.2010.168; Schaefer GB, 2013, GENET MED, V15, P669, DOI 10.1038/gim.2013.32; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Soorya L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-18; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Striano P, 2012, ARCH NEUROL-CHICAGO, V69, P322, DOI 10.1001/archneurol.2011.1999; Szafranski P, 2010, HUM MUTAT, V31, P840, DOI 10.1002/humu.21284; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Vu TH, 2011, AM J MED GENET B, V156B, P808, DOI 10.1002/ajmg.b.31225; Walsh KM, 2011, GENET MED, V13, P377, DOI 10.1097/GIM.0b013e3182076c0c; Wang L, 2010, BMC MED GENET, P9; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Williams NM, 2012, AM J PSYCHIAT, V169, P195, DOI 10.1176/appi.ajp.2011.11060822; Wisniowiecka-Kowalnik B, 2013, EUR J HUM GENET, V21, P620, DOI 10.1038/ejhg.2012.219; Wu DJ, 2009, MOL CYTOGENET, V2, DOI 10.1186/1755-8166-2-27; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162	88	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107705	10.1371/journal.pone.0107705	http://dx.doi.org/10.1371/journal.pone.0107705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255310	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300030
J	Collina, S; Seurinck, R; Hartsuiker, RJ				Collina, Simona; Seurinck, Ruth; Hartsuiker, Robert J.			Inside the Syntactic Box: The Neural Correlates of the Functional and Positional Level in Covert Sentence Production	PLOS ONE			English	Article							BROCAS AREA; HUMAN BRAIN; WORD; FMRI; COMPREHENSION; INFORMATION; LANGUAGE; PHRASE; ORDER	The aim of the present fMRI study was to investigate the neural circuits of two stages of grammatical encoding in sentence production. Participants covertly produced sentences on the basis of three words (one verb and two nouns). In the functional level condition both nouns were animate and so were potential competitors for the grammatical function of subject. In the positional level condition the first noun was animate whereas the second was inanimate. We found activation of Broca's and adjacent areas, previously indicated as responsible for syntactic processing. Additionally, a later onset of the activation in three brain areas in the functional level condition suggests that there is indeed a competition for assignment of subjecthood. The results constrain theories of grammatical encoding, which differ in whether they assume two separate processing levels or only one.	[Collina, Simona] Univ Suor Orsola Benincasa, Naples, Italy; [Seurinck, Ruth] Univ Ghent, Dept Data Anal, B-9000 Ghent, Belgium; [Seurinck, Ruth] Univ Ghent, Ghent Inst Funct & Metab Imaging, B-9000 Ghent, Belgium; [Collina, Simona; Hartsuiker, Robert J.] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium	Suor Orsola Benincasa University Naples; Ghent University; Ghent University; Ghent University	Collina, S (corresponding author), Univ Suor Orsola Benincasa, Naples, Italy.	simona.collina@unisob.na.it	Hartsuiker, Robert J./N-1668-2019	Hartsuiker, Robert/0000-0002-3680-6765	Research Foundation Flanders [G.0427.04]	Research Foundation Flanders(FWO)	The research was supported by the grant G.0427.04 from the Research Foundation Flanders to Prof. Robert Hartsuiker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binder JR, 1996, BRAIN, V119, P1239, DOI 10.1093/brain/119.4.1239; BOCK JK, 1985, COGNITION, V21, P47; Bock K., 1994, HDB PSYCHOLINGUISTIC, P741; Bornkessel-Schlesewsky I, 2009, LANG LINGUIST COMPAS, V3, P19, DOI 10.1111/j.1749-818x.2008.00099.x; Brett M., 2002, INT C FUNCT MAPP HUM, V16, DOI 10.1016/S1053-8119(02)90013-3; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Comrie B, 1989, LINGUISTIC U LANGUAG; Cunnington R, 2003, NEUROIMAGE, V20, P404, DOI 10.1016/S1053-8119(03)00291-X; Dogil G, 2002, J NEUROLINGUIST, V15, P59, DOI 10.1016/S0911-6044(00)00021-X; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Ferreira F, 2006, HDB PSYCHOLINGUISTIC, P61; Ferreira VS, 2007, OXFORD HDB PSYCHOL O; Friederici AD, 2000, CEREB CORTEX, V10, P698, DOI 10.1093/cercor/10.7.698; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fromkin V., 1973, SPEECH ERRORS LINGUI; Garrett M., 1980, LANGUAGE PRODUCTION, V1, P177; Garrett MF, 1976, NEW APPROACHES LANGU, P231; Garrett MF., 1975, PSYCHOL LEARN MOTIV, P133, DOI DOI 10.1016/S0079-7421(08)60270-4; Gennari SP, 2012, COGNITIVE PSYCHOL, V65, P141, DOI 10.1016/j.cogpsych.2012.03.002; Golestani N, 2006, NEUROPSYCHOLOGIA, V44, P1029, DOI 10.1016/j.neuropsychologia.2005.11.009; Grodzinsky Y., 2006, BROCAS REGION; Haller S, 2005, NEUROPSYCHOLOGIA, V43, P807, DOI 10.1016/j.neuropsychologia.2004.09.007; Hartsuiker RJ, 2000, COGNITION, V75, pB27, DOI 10.1016/S0010-0277(99)00080-3; Heim S, 2002, NEUROSCI LETT, V328, P101, DOI 10.1016/S0304-3940(02)00494-9; Indefrey P, 2001, NEUROIMAGE, V14, P546, DOI 10.1006/nimg.2001.0867; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Kaan E, 2002, TRENDS COGN SCI, V6, P350, DOI 10.1016/S1364-6613(02)01947-2; KEENAN EL, 1977, LINGUIST INQ, V8, P63; Keuleers E, 2010, BEHAV RES METHODS, V42, P643, DOI 10.3758/BRM.42.3.643; Levelt W., 1989, SPEAKING INTENTION A; MCDONALD JL, 1993, COGNITIVE PSYCHOL, V25, P188, DOI 10.1006/cogp.1993.1005; Menenti L, 2012, BRAIN LANG, V122, P71, DOI 10.1016/j.bandl.2012.04.012; Meyer AS, 1996, J MEM LANG, V35, P477, DOI 10.1006/jmla.1996.0026; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patel A. D., 2012, LANGUAGE MUSIC COGNI; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Pickering MJ, 2002, J MEM LANG, V46, P586, DOI 10.1006/jmla.2001.2824; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Seidel EM, 2010, SOC NEUROSCI-UK, V5, P335, DOI 10.1080/17470911003615997; Smith M, 2004, J EXP PSYCHOL LEARN, V30, P675, DOI 10.1037/0278-7393.30.3.675; Tettamanti M, 2006, CORTEX, V42, P491, DOI 10.1016/S0010-9452(08)70384-8; Thothathiri M, 2012, BRAIN LANG, V120, P259, DOI 10.1016/j.bandl.2011.12.004; Vigliocco G, 1998, COGNITION, V68, pB13, DOI 10.1016/S0010-0277(98)00041-9; Vigliocco G, 2011, NEUROSCI BIOBEHAV R, V35, P407, DOI 10.1016/j.neubiorev.2010.04.007; Wiggett AJ, 2009, NEUROPSYCHOLOGIA, V47, P3111, DOI 10.1016/j.neuropsychologia.2009.07.008; WISE R, 1991, BRAIN, V114, P1803, DOI 10.1093/brain/114.4.1803	49	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106122	10.1371/journal.pone.0106122	http://dx.doi.org/10.1371/journal.pone.0106122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268230	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700009
J	De Silva, JR; Lau, YL; Fong, MY				De Silva, Jeremy Ryan; Lau, Yee Ling; Fong, Mun Yik			Genotyping of the Duffy Blood Group among Plasmodium knowlesi-Infected Patients in Malaysia	PLOS ONE			English	Article							GROUP GENE; VIVAX; MALARIA; POLYMORPHISM; ALLOIMMUNIZATION; TRANSFUSION; EXPRESSION; ANTIBODIES; RELEVANCE; DISEASE	The Duffy blood group is of major interest in clinical medicine as it plays an important role in Plasmodium knowlesi and Plasmodium vivax infection. In the present study, the distribution of Duffy blood group genotypes and allelic frequencies among P. knowlesi infected patients as well as healthy individuals in Peninsular Malaysia were determined. The blood group of 60 healthy blood donors and 51 P. knowlesi malaria patients were genotyped using allele specific polymerase chain reaction (ASP-PCR). The data was analyzed using Fisher's exact test in order to assess the significance of the variables. Our results show a high proportion of the FY*A/FY*A genotype (>85% for both groups) and a high frequency of the FY*A allele (>90% for both groups). The FY*A/FY*A genotype was the most predominant genotype in both infected and healthy blood samples. The genotype frequency did not differ significantly between the donor blood and the malaria patient groups. Also, there was no significant correlation between susceptibility to P. knowlesi infection with any Duffy blood genotype.	[De Silva, Jeremy Ryan; Lau, Yee Ling; Fong, Mun Yik] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Lau, Yee Ling; Fong, Mun Yik] Univ Malaya, Fac Med, Trop Dis Res & Educ Ctr, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Fong, MY (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	fongmy@um.edu.my	FONG, MUN YIK/B-5443-2010; Lau, Yee Ling/C-6996-2009; Singh, Balbir/A-3610-2009; de Silva, Jeremy Ryan/P-5565-2017	Lau, Yee Ling/0000-0002-2037-2165; de Silva, Jeremy Ryan/0000-0001-9378-3830	University of Malaya High Impact Research Fund, UM-MOHE [E000050 : UM.C/HIR/MOHE/MED/16]	University of Malaya High Impact Research Fund, UM-MOHE	This study was funded by the University of Malaya High Impact Research Fund, UM-MOHE (E000050 : UM.C/HIR/MOHE/MED/16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babinszki A, 1999, PRENATAL DIAG, V19, P533, DOI 10.1002/(SICI)1097-0223(199906)19:6<533::AID-PD570>3.0.CO;2-5; Cavasini CE, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-167; Cavasini CE, 2007, T ROY SOC TROP MED H, V101, P1042, DOI 10.1016/j.trstmh.2007.04.011; CHAUDHURI A, 1995, BLOOD, V85, P615, DOI 10.1182/blood.V85.3.615.bloodjournal853615; Cotorruelo C, 2009, CLIN EXP MED, V9, P249, DOI 10.1007/s10238-009-0032-6; FONG YL, 1971, T ROY SOC TROP MED H, V65, P839, DOI 10.1016/0035-9203(71)90103-9; GeifmanHoltzman O, 1997, OBSTET GYNECOL, V89, P272, DOI 10.1016/S0029-7844(96)00434-6; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265; IKIN EW, 1951, NATURE, V168, P1077, DOI 10.1038/1681077b0; IWAMOTO S, 1995, BLOOD, V85, P622, DOI 10.1182/blood.V85.3.622.bloodjournal853622; King CL, 2011, P NATL ACAD SCI USA, V108, P20113, DOI 10.1073/pnas.1109621108; Lau YL, 2011, EMERG INFECT DIS, V17, P1314, DOI 10.3201/eid1707.101295; Lee WC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-88; LEWIS GE, 1988, T ROY SOC TROP MED H, V82, P509, DOI 10.1016/0035-9203(88)90180-0; MATHEW S, 1994, CYTOGENET CELL GENET, V67, P68, DOI 10.1159/000133801; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Moulds JM, 1998, VOX SANG, V74, P248, DOI 10.1159/000030943; Noizat-Pirenne F, 2012, TRANSFUS CLIN BIOL, V19, P132, DOI 10.1016/j.tracli.2012.03.004; Noizat-Pirenne F, 2013, CR BIOL, V336, P152, DOI 10.1016/j.crvi.2012.09.011; Olsson ML, 1998, TRANSFUSION, V38, P168, DOI 10.1046/j.1537-2995.1998.38298193099.x; Ryan JR, 2006, AM J TROP MED HYG, V75, P575, DOI 10.4269/ajtmh.2006.75.575; Shimizu Y, 2000, HUM BIOL, V72, P511; Shimizu Yuko, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P32; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; SZABO MC, 1995, J BIOL CHEM, V270, P25348, DOI 10.1074/jbc.270.43.25348; Vythilingam I, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-26; Yazdanbakhsh K, 2000, TRANSFUSION, V40, P310, DOI 10.1046/j.1537-2995.2000.40030310.x	30	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108951	10.1371/journal.pone.0108951	http://dx.doi.org/10.1371/journal.pone.0108951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268233	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700199
J	Keerthy, HK; Garg, M; Mohan, CD; Madan, V; Kanojia, D; Shobith, R; Nanjundaswamy, S; Mason, DJ; Bender, A; Basappa; Rangappa, KS; Koeffler, P				Keerthy, Hosadurga K.; Garg, Manoj; Mohan, Chakrabhavi D.; Madan, Vikas; Kanojia, Deepika; Shobith, Rangappa; Nanjundaswamy, Shivananju; Mason, Daniel J.; Bender, Andreas; Basappa; Rangappa, Kanchugarakoppal S.; Koeffler, Phillip			Synthesis and Characterization of Novel 2-Amino-Chromene-Nitriles that Target Bcl-2 in Acute Myeloid Leukemia Cell Lines	PLOS ONE			English	Article							MOLECULE INHIBITOR; APOPTOSIS; DISCOVERY; SERIES; ABT-737; KINASE; FAMILY; POTENT; GENE	The anti-apoptotic protein Bcl-2 is a well-known and attractive therapeutic target for cancer. In the present study the solution-phase T3P-DMSO mediated efficient synthesis of 2-amino-chromene-3-carbonitriles from alcohols, malanonitrile and phenols is reported. These novel 2-amino-chromene-3-carbonitriles showed cytotoxicity in human acute myeloid leukemia (AML) cell lines. Compound 4g was found to be the most bioactive, decreasing growth and increasing apoptosis of AML cells. Moreover, compound 4g (at a concentration of 5 mu M) increased the G2/M and sub-G1 (apoptosis) phases of AML cells. The AML cells treated with compound 4g exhibited decreased levels of Bcl-2 and increased levels of caspase-9. In silico molecular interaction analysis showed that compound 4g shared a similar global binding motif with navitoclax (another small molecule that binds Bcl-2), however compound 4g occupies a smaller volume within the P2 hot spot of Bcl-2. The intermolecular pi-stacking interaction, direct electrostatic interactions, and docking energy predicted for 4g in complex with Bcl-2 suggest a strong affinity of the complex, rendering 4g as a promising Bcl-2 inhibitor for evaluation as a new anticancer agent.	[Keerthy, Hosadurga K.; Basappa] Bangalore Univ, Dept Chem, Biol Chem Lab, Bangalore 560056, Karnataka, India; [Garg, Manoj; Madan, Vikas; Kanojia, Deepika; Koeffler, Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Genom Oncol Programme, Singapore 117548, Singapore; [Mohan, Chakrabhavi D.; Nanjundaswamy, Shivananju; Rangappa, Kanchugarakoppal S.] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India; [Shobith, Rangappa] Singapore MIT Alliance Res & Technol Ctr SMART, Interdisciplinary Res Grp Infect Dis, Singapore, Singapore; [Mason, Daniel J.; Bender, Andreas] Univ Cambridge, Dept Chem, Unilever Ctr Mol Sci Informat, Cambridge CB2 1EW, England; [Koeffler, Phillip] Cedar Sinai Med Ctr, Div Hematol & Oncol, Los Angeles, CA USA	Bangalore University; National University of Singapore; University of Mysore; Singapore-MIT Alliance for Research & Technology Centre (SMART); University of Cambridge; Cedars Sinai Medical Center	Basappa (corresponding author), Bangalore Univ, Dept Chem, Biol Chem Lab, Bangalore 560056, Karnataka, India.	salundibasappa@gmail.com; rangappaks@gmail.com	Bender, Andreas/C-6942-2009; Mohan, Chakrabhavi Dhananjaya/AGO-1276-2022; Garg, Manoj/C-4076-2019; Rangappa, Shobith/AAI-2169-2020	Bender, Andreas/0000-0002-6683-7546; Garg, Manoj/0000-0002-3492-2957; Rangappa, Shobith/0000-0002-9800-7192; Mohan, Chakrabhavi Dhananjaya/0000-0002-6810-9219; Basappa, Basappa/0000-0002-8844-468X	USA National Institutes of Health [R01CA02603830]; Singapore Ministry of Health's National Medical Research Council (NMRC) under its Singapore Translational Research (STaR) Investigator Award; Singapore Ministry of Education; University Grants Commission [41-257-2012-SR]; Vision Group Science and Technology; Department of Science and Technology [SR/FT/LS-142/2012, SR/SO/HS-006/2010 [G]]; University Grant Commission [39-106/2010]; UGC; DST-INSPIRE; PAVATE foundation	USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore Ministry of Health's National Medical Research Council (NMRC) under its Singapore Translational Research (STaR) Investigator Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore); University Grants Commission(University Grants Commission, India); Vision Group Science and Technology; Department of Science and Technology(Department of Science & Technology (India)); University Grant Commission(University Grants Commission, India); UGC(University Grants Commission, India); DST-INSPIRE(Department of Science & Technology (India)); PAVATE foundation	This work was supported by grants from USA National Institutes of Health (R01CA02603830); the Singapore Ministry of Health's National Medical Research Council (NMRC) under its Singapore Translational Research (STaR) Investigator Award; and the Singapore Ministry of Education (to HPK.). This research was also supported by University Grants Commission (41-257-2012-SR), Vision Group Science and Technology, Department of Science and Technology (NO. SR/FT/LS-142/2012) to B. KSR thanks Department of Science and Technology (F.NO.SR/SO/HS-006/2010 [G]) and University Grant Commission (F.No.39-106/2010 [SR Dated 24-12-2010]) for funding. HKK, CDM, and B are thankful to UGC, DST-INSPIRE, and PAVATE foundation for providing fellowships respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Basappa, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039444; Basappa, 2010, CANCER LETT, V297, P231, DOI 10.1016/j.canlet.2010.05.016; Basappa, 2003, BIOORGAN MED CHEM, V11, P4539, DOI 10.1016/j.bmc.2003.08.007; Bharathkumar H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102759; Chapuis N, 2010, CLIN CANCER RES, V16, P5424, DOI 10.1158/1078-0432.CCR-10-1102; Chen JF, 2012, J MED CHEM, V55, P8502, DOI 10.1021/jm3010306; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; Doshi JM, 2006, J MED CHEM, V49, P7731, DOI 10.1021/jm060968r; El-Subbagh HI, 2000, J MED CHEM, V43, P2915, DOI 10.1021/jm000038m; Fischer U, 2005, CELL DEATH DIFFER, V12, P942, DOI 10.1038/sj.cdd.4401556; Gourdeau H, 2004, MOL CANCER THER, V3, P1375; Grundy M, 2010, MOL CANCER THER, V9, P661, DOI 10.1158/1535-7163.MCT-09-1144; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayano T, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-17; Kemnitzer W, 2007, J MED CHEM, V50, P2858, DOI 10.1021/jm070216c; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Magedov IV, 2008, J MED CHEM, V51, P2561, DOI 10.1021/jm701499n; Manero F, 2006, CANCER RES, V66, P2757, DOI 10.1158/0008-5472.CAN-05-2097; Park CM, 2008, J MED CHEM, V51, P6902, DOI 10.1021/jm800669s; Patil SA, 2013, FUTURE MED CHEM, V5, P1647, DOI 10.4155/fmc.13.126; Pei XY, 2004, MOL CANCER THER, V3, P1513; Piedfer M, 2013, BBA-MOL CELL RES, V1833, P1316, DOI 10.1016/j.bbamcr.2013.02.016; Rangappa KS, 2005, J PHYS ORG CHEM, V18, P773, DOI 10.1002/poc.936; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schoenwaelder SM, 2012, BLOOD, V119, P1320, DOI 10.1182/blood-2011-10-387399; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Sukhorukov AY, 2014, BIOORG MED CHEM LETT, V24, P3618, DOI 10.1016/j.bmcl.2014.05.040; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	32	47	49	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107118	10.1371/journal.pone.0107118	http://dx.doi.org/10.1371/journal.pone.0107118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268519	Green Published, Green Accepted, gold			2022-12-27	WOS:000343671700031
J	Murach, K; Raue, U; Wilkerson, B; Minchev, K; Jemiolo, B; Bagley, J; Luden, N; Trappe, S				Murach, Kevin; Raue, Ulrika; Wilkerson, Brittany; Minchev, Kiril; Jemiolo, Bozena; Bagley, James; Luden, Nicholas; Trappe, Scott			Single Muscle Fiber Gene Expression with Run Taper	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; MESSENGER-RNA EXPRESSION; RESISTANCE EXERCISE; PROTEIN-SYNTHESIS; MYOSTATIN EXPRESSION; SATELLITE CELLS; TIME-COURSE; INCREASES; ATROPHY; HUMANS	This study evaluated gene expression changes in gastrocnemius slow-twitch myosin heavy chain I (MHC I) and fast-twitch (MHC IIa) muscle fibers of collegiate cross-country runners (n = 6, 20 +/- 1 y, VO2max= 70 +/- 1 ml.kg(-1).min(-1)) during two distinct training phases. In a controlled environment, runners performed identical 8 kilometer runs (30:18 +/- 0:30 min:s, 89 +/- 1% HRmax) while in heavy training (similar to 72 km/wk) and following a 3 wk taper. Training volume during the taper leading into peak competition was reduced similar to 50% which resulted in improved race times and greater cross-section and improved function of MHC IIa fibers. Single muscle fibers were isolated from pre and 4 hour post run biopsies in heavily trained and tapered states to examine the dynamic acute exercise response of the growth-related genes Fibroblast growth factor-inducible 14 (FN14), Myostatin (MSTN), Heat shock protein 72 (HSP72), Muscle ring-finger protein-1 (MURF1), Myogenic factor 6 (MRF4), and Insulin-like growth factor 1 (IGF1) via qPCR. FN14 increased 4.3-fold in MHC IIa fibers with exercise in the tapered state (P<0.05). MSTN was suppressed with exercise in both fiber types and training states (P<0.05) while MURF1 and HSP72 responded to running in MHC IIa and I fibers, respectively, regardless of training state (P<0.05). Robust induction of FN14 (previously shown to strongly correlate with hypertrophy) and greater overall transcriptional flexibility with exercise in the tapered state provides an initial molecular basis for fast-twitch muscle fiber performance gains previously observed after taper in competitive endurance athletes.	[Murach, Kevin; Raue, Ulrika; Wilkerson, Brittany; Minchev, Kiril; Jemiolo, Bozena; Bagley, James; Luden, Nicholas; Trappe, Scott] Ball State Univ, Human Performance Lab, Muncie, IN 47306 USA	Ball State University	Trappe, S (corresponding author), Ball State Univ, Human Performance Lab, Muncie, IN 47306 USA.	strappe@bsu.edu	Bagley, James R./H-9982-2019	Bagley, James R./0000-0002-2709-548X	National Institutes of Health [AG 038576]; NATIONAL INSTITUTE ON AGING [R01AG038576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by National Institutes of Health (AG 038576). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arounleut P, 2013, EXP GERONTOL, V48, P898, DOI 10.1016/j.exger.2013.06.004; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Carlson CJ, 1999, AM J PHYSIOL-REG I, V277, pR601, DOI 10.1152/ajpregu.1999.277.2.R601; Chen YW, 2010, INT J BIOCHEM CELL B, V42, P2072, DOI 10.1016/j.biocel.2010.09.017; Coffey VG, 2009, AM J PHYSIOL-REG I, V297, pR1441, DOI 10.1152/ajpregu.00351.2009; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Costa A, 2007, EUR J APPL PHYSIOL, V101, P427, DOI 10.1007/s00421-007-0510-z; COSTILL D L, 1985, Physician and Sportsmedicine, V13, P94, DOI 10.1080/00913847.1985.11708748; COSTILL DL, 1971, J APPL PHYSIOL, V31, P353, DOI 10.1152/jappl.1971.31.3.353; Dickinson JM, 2010, J APPL PHYSIOL, V108, P1410, DOI 10.1152/japplphysiol.00905.2009; Dogra C, 2007, J BIOL CHEM, V282, P15000, DOI 10.1074/jbc.M608668200; Egan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074098; FITTS RH, 1989, J APPL PHYSIOL, V66, P465, DOI 10.1152/jappl.1989.66.1.465; Galpin AJ, 2012, ANAL BIOCHEM, V425, P175, DOI 10.1016/j.ab.2012.03.018; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; HAKKINEN K, 1985, ACTA PHYSIOL SCAND, V125, P587, DOI 10.1111/j.1748-1716.1985.tb07760.x; Hameed M, 2003, J PHYSIOL-LONDON, V547, P247, DOI 10.1113/jphysiol.2002.032136; Harber MP, 2010, AM J PHYSIOL-REG I, V299, pR1254, DOI 10.1152/ajpregu.00348.2010; Harber MP, 2009, AM J PHYSIOL-REG I, V296, pR708, DOI [10.1152/ajpregu.00354.2009, 10.1152/ajpregu.90906.2008]; Harridge SDR, 2007, EXP PHYSIOL, V92, P783, DOI 10.1113/expphysiol.2006.036525; Hernando R, 1997, EUR J BIOCHEM, V243, P460, DOI 10.1111/j.1432-1033.1997.0460a.x; Hittel DS, 2010, MED SCI SPORT EXER, V42, P2023, DOI 10.1249/MSS.0b013e3181e0b9a8; Jemiolo B, 2004, BIOCHEM BIOPH RES CO, V320, P1043, DOI 10.1016/j.bbrc.2004.05.223; Jespersen JG, 2011, SCAND J MED SCI SPOR, V21, P215, DOI 10.1111/j.1600-0838.2009.01044.x; Kim JS, 2007, J APPL PHYSIOL, V103, P1488, DOI 10.1152/japplphysiol.01194.2006; Kohn TA, 2011, SCAND J MED SCI SPOR, V21, P765, DOI 10.1111/j.1600-0838.2010.01136.x; Larkins NT, 2012, AM J PHYSIOL-CELL PH, V302, pC228, DOI 10.1152/ajpcell.00266.2011; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Liu CM, 2008, GENE THER, V15, P155, DOI 10.1038/sj.gt.3303016; Liu YF, 1999, J APPL PHYSIOL, V86, P101, DOI 10.1152/jappl.1999.86.1.101; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOCKE M, 1991, AM J PHYSIOL, V261, pC774, DOI 10.1152/ajpcell.1991.261.5.C774; Louis E, 2007, J APPL PHYSIOL, V103, P1744, DOI 10.1152/japplphysiol.00679.2007; Luden N, 2010, J APPL PHYSIOL, V108, P1501, DOI 10.1152/japplphysiol.00045.2010; Magee TR, 2006, J GENE MED, V8, P1171, DOI 10.1002/jgm.946; Matsakas A, 2005, ACTA PHYSIOL SCAND, V183, P299, DOI 10.1111/j.1365-201X.2005.01406.x; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Neary JP, 2003, MED SCI SPORT EXER, V35, P1875, DOI 10.1249/01.MSS.0000093617.28237.20; Nedergaard A, 2007, J APPL PHYSIOL, V103, P1513, DOI 10.1152/japplphysiol.01445.2006; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Psilander N, 2003, J APPL PHYSIOL, V95, P1038, DOI 10.1152/japplphysiol.00903.2002; Raue U, 2007, J GERONTOL A-BIOL, V62, P1407, DOI 10.1093/gerona/62.12.1407; Raue U, 2006, J APPL PHYSIOL, V101, P53, DOI 10.1152/japplphysiol.01616.2005; Raue U, 2012, J APPL PHYSIOL, V112, P1625, DOI 10.1152/japplphysiol.00435.2011; Raue U, 2009, J APPL PHYSIOL, V106, P1611, DOI 10.1152/japplphysiol.91587.2008; Reardon KA, 2001, MUSCLE NERVE, V24, P893, DOI 10.1002/mus.1086.abs; Roth SM, 2003, EXP BIOL MED, V228, P706, DOI 10.1177/153537020322800609; Saltin B, 1977, Ann N Y Acad Sci, V301, P3, DOI 10.1111/j.1749-6632.1977.tb38182.x; Schmutz S, 2006, PFLUG ARCH EUR J PHY, V451, P678, DOI 10.1007/s00424-005-1497-0; Trappe S, 2001, MED SCI SPORT EXER, V33, P48; Trappe TA, 2008, AM J PHYSIOL-REG I, V294, pR192, DOI 10.1152/ajpregu.00669.2007; Tupling AR, 2007, J APPL PHYSIOL, V103, P2105, DOI 10.1152/japplphysiol.00771.2007; Wehling M, 2000, FASEB J, V14, P103, DOI 10.1096/fasebj.14.1.103; Welle S, 2009, AM J PHYSIOL-ENDOC M, V297, pE935, DOI 10.1152/ajpendo.00179.2009; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Wojick S., 2008, Folia Morphologica, V67, P6; Woolstenhulme MT, 2006, J APPL PHYSIOL, V100, P1876, DOI 10.1152/japplphysiol.01592.2005; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Yamada P, 2008, SPORTS MED, V38, P715, DOI 10.2165/00007256-200838090-00002; Yang YF, 2005, J APPL PHYSIOL, V98, P1745, DOI 10.1152/japplphysiol.01185.2004; Yang YF, 2006, J APPL PHYSIOL, V101, P1442, DOI 10.1152/japplphysiol.00438.2006	61	43	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108547	10.1371/journal.pone.0108547	http://dx.doi.org/10.1371/journal.pone.0108547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268477	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700111
J	Zhou, T; Ye, LL; Bai, Y; Sun, AM; Cox, B; Liu, DH; Li, Y; Liotta, D; Snyder, JP; Fu, HA; Huang, B				Zhou, Tao; Ye, Lili; Bai, Yu; Sun, Aiming; Cox, Bryan; Liu, Dahai; Li, Yong; Liotta, Dennis; Snyder, James P.; Fu, Haian; Huang, Bei			Autophagy and Apoptosis in Hepatocellular Carcinoma Induced by EF25-(GSH)(2): A Novel Curcumin Analog	PLOS ONE			English	Article							INDUCED CYTOTOXICITY; CANCER-CELLS; EF24; DEATH; ANGIOGENESIS; INHIBITION; ANTICANCER; INDUCTION; PATHWAYS; GROWTH	Curcumin, a spice component as well as a traditional Asian medicine, has been reported to inhibit proliferation of a variety of cancer cells but is limited in application due to its low potency and bioavailability. Here, we have assessed the therapeutic effects of a novel and water soluble curcumin analog, 3,5-bis(2-hydroxybenzylidene) tetrahydro-4H-pyran-4-one glutathione conjugate [EF25-(GSH)(2)], on hepatoma cells. Using the MTT and colony formation assays, we determined that EF25-(GSH)(2) drastically inhibits the proliferation of hepatoma cell line HepG2 with minimal cytotoxicity for the immortalized human hepatic cell line HL-7702. Significantly, EF25-(GSH)(2) suppressed growth of HepG2 xenografts in mice with no observed toxicity to the animals. Mechanistic investigation revealed that EF25-(GSH)(2) induces autophagy by means of a biphasic mechanism. Low concentrations (<5 mu mol/L) induced autophagy with reversible and moderate cytoplasmic vacuolization, while high concentrations (> 10 mu mol/L) triggered an arrested autophagy process with irreversible and extensive cytoplasmic vacuolization. Prolonged treatment with EF25-(GSH)(2) induced cell death through both an apoptosis-dependent and a non-apoptotic mechanism. Chloroquine, a late stage inhibitor of autophagy which promoted cytoplasmic vacuolization, led to significantly enhanced apoptosis and cytotoxicity when combined with EF25-(GSH)(2). Taken together, these data imply a fail-safe mechanism regulated by autophagy in the action of EF25-(GSH)(2), suggesting the therapeutic potential of the novel curcumin analog against hepatocellular carcinoma (HCC), while offering a novel and effective combination strategy with chloroquine for the treatment of patients with HCC.	[Zhou, Tao; Ye, Lili; Bai, Yu; Liu, Dahai; Li, Yong; Huang, Bei] Anhui Univ, Sch Life Sci, Hefei 230039, Peoples R China; [Sun, Aiming; Cox, Bryan; Liotta, Dennis; Snyder, James P.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Sun, Aiming; Liotta, Dennis; Snyder, James P.] Emory Univ, Emory Inst Drug Dev, Atlanta, GA 30322 USA; [Fu, Haian] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Fu, Haian] Emory Univ, Emory Chem Biol Discovery Ctr, Atlanta, GA 30322 USA; [Liu, Dahai; Li, Yong; Huang, Bei] Anhui Univ, Ctr Stem Cell & Translat Med, Hefei 230039, Peoples R China	Anhui University; Emory University; Emory University; Emory University; Emory University; Anhui University	Huang, B (corresponding author), Anhui Univ, Sch Life Sci, Hefei 230039, Peoples R China.	beihuang@163.com		Bai, Yu/0000-0002-5698-0023	Natural Science Foundation of the Education Department in Anhui Province, China [KJ2012A030]; NCI SPORE in Head and Neck Cancer [5 P50 CA128613]; NATIONAL CANCER INSTITUTE [P50CA128613] Funding Source: NIH RePORTER	Natural Science Foundation of the Education Department in Anhui Province, China; NCI SPORE in Head and Neck Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by the Natural Science Foundation of the Education Department in Anhui Province, China (KJ2012A030, to Bei Huang) and NCI 5 P50 CA128613 SPORE in Head and Neck Cancer (to Haian Fu and J. P. Snyder). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BK, 2005, ANTI-CANCER DRUG, V16, P263, DOI 10.1097/00001813-200503000-00005; Adams BK, 2004, BIOORGAN MED CHEM, V12, P3871, DOI 10.1016/j.bmc.2004.05.006; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Bhanot H, 2010, MOL CANCER RES, V8, P1358, DOI 10.1158/1541-7786.MCR-10-0090; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Bunchorntavakul C, 2012, PRIMARY LIVER CANC, P161; Chen TS, 2008, CANCER LETT, V270, P164, DOI 10.1016/j.canlet.2008.05.008; Choi MJ, 2011, CANCER LETT, V306, P190, DOI 10.1016/j.canlet.2011.03.005; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Gao JA, 2011, BIOORG MED CHEM LETT, V21, P622, DOI 10.1016/j.bmcl.2010.12.046; Hui ICF, 2010, LIVER INT, V30, P65, DOI 10.1111/j.1478-3231.2009.02117.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kasinski AL, 2008, MOL PHARMACOL, V74, P654, DOI 10.1124/mol.108.046201; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kuck D, 2010, MOL CANCER THER, V9, P3015, DOI 10.1158/1535-7163.MCT-10-0609; Lin Y, 2012, MED ONCOL, V29, P311, DOI 10.1007/s12032-010-9808-5; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Lu B, 2008, CLIN CANCER RES, V14, P7405, DOI 10.1158/1078-0432.CCR-08-0409; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; O'Sullivan-Coyne G, 2009, BRIT J CANCER, V101, P1585, DOI 10.1038/sj.bjc.6605308; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Okamoto K, 2011, BIOCHEM J, V440, P63, DOI 10.1042/BJ20110610; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Prause M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087067; Selvendiran K, 2007, J BIOL CHEM, V282, P28609, DOI 10.1074/jbc.M703796200; Shea FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050557; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Steele S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003562; Steward WP, 2008, MOL NUTR FOOD RES, V52, P1005, DOI 10.1002/mnfr.200700148; Sun AM, 2009, BIOORG MED CHEM LETT, V19, P6627, DOI 10.1016/j.bmcl.2009.10.023; Sy LK, 2008, CANCER RES, V68, P10229, DOI 10.1158/0008-5472.CAN-08-1983; Tang B, 2009, J AM CHEM SOC, V131, P3016, DOI 10.1021/ja809149g; Thomas SL, 2008, CELL CYCLE, V7, P2409, DOI 10.4161/cc.6410; Thomas SL, 2010, BIOCHEM PHARMACOL, V80, P1309, DOI 10.1016/j.bcp.2010.06.048; Yadav VR, 2013, J PHARMACOL EXP THER, V347, P346, DOI 10.1124/jpet.113.208009; Yang CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071130; Yoon MJ, 2010, FREE RADICAL BIO MED, V48, P713, DOI 10.1016/j.freeradbiomed.2009.12.016	41	37	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107876	10.1371/journal.pone.0107876	http://dx.doi.org/10.1371/journal.pone.0107876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268357	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700050
J	Gatsi, R; Schulze, B; Rodriguez-Palero, MJ; Hernando-Rodriguez, B; Baumeister, R; Artal-Sanz, M				Gatsi, Roxani; Schulze, Bettina; Jesus Rodriguez-Palero, Maria; Hernando-Rodriguez, Blanca; Baumeister, Ralf; Artal-Sanz, Marta			Prohibitin-Mediated Lifespan and Mitochondrial Stress Implicate SGK-1, Insulin/IGF and mTORC2 in C. elegans	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; UNFOLDED PROTEIN RESPONSE; SIGNALING PATHWAY; TRANSCRIPTION FACTOR; RETROGRADE RESPONSE; ELECTRON-TRANSPORT; KINASE-1 PDK1; DNA NUCLEOIDS; LONGEVITY; DAF-16	Lifespan regulation by mitochondrial proteins has been well described, however, the mechanism of this regulation is not fully understood. Amongst the mitochondrial proteins profoundly affecting ageing are prohibitins (PHB-1 and PHB-2). Paradoxically, in C. elegans prohibitin depletion shortens the lifespan of wild type animals while dramatically extending that of metabolically compromised animals, such as daf-2-insulin-receptor mutants. Here we show that amongst the three kinases known to act downstream of daf-2, only loss of function of sgk-1 recapitulates the ageing phenotype observed in daf-2 mutants upon prohibitin depletion. Interestingly, signalling through SGK-1 receives input from an additional pathway, parallel to DAF-2, for the prohibitin-mediated lifespan phenotype. We investigated the effect of prohibitin depletion on the mitochondrial unfolded protein response (UPRmt). Remarkably, the lifespan extension upon prohibitin elimination, of both daf-2 and sgk-1 mutants, is accompanied by suppression of the UPRmt induced by lack of prohibitin. On the contrary, gain of function of SGK-1 results in further shortening of lifespan and a further increase of the UPRmt in prohibitin depleted animals. Moreover, SGK-1 interacts with RICT-1 for the regulation of the UPRmt in a parallel pathway to DAF-2. Interestingly, prohibitin depletion in rict-1 loss of function mutant animals also causes lifespan extension. Finally, we reveal an unprecedented role for mTORC2-SGK-1 in the regulation of mitochodrial homeostasis. Together, these results give further insight into the mechanism of lifespan regulation by mitochondrial function and reveal a cross-talk of mitochondria with two key pathways, Insulin/IGF and mTORC2, for the regulation of ageing and stress response.	[Gatsi, Roxani; Jesus Rodriguez-Palero, Maria; Hernando-Rodriguez, Blanca; Artal-Sanz, Marta] CSIC Univ Pablo de Olavide Junta Andalucia, CABD, Seville, Spain; [Schulze, Bettina; Baumeister, Ralf; Artal-Sanz, Marta] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79106 Freiburg, Germany; [Schulze, Bettina; Baumeister, Ralf; Artal-Sanz, Marta] Univ Freiburg, Fac Biol, Lab Bioinformat & Mol Genet, D-79106 Freiburg, Germany; [Baumeister, Ralf] Univ Freiburg, Fac Med, Ctr Biochem & Mol Cell Res, D-79106 Freiburg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); University of Freiburg; University of Freiburg; University of Freiburg	Artal-Sanz, M (corresponding author), CSIC Univ Pablo de Olavide Junta Andalucia, CABD, Seville, Spain.	martsan@upo.es	Rodriguez-Palero, Maria Jesus/B-1910-2017; Artal-Sanz, Marta/J-6186-2012	Rodriguez-Palero, Maria Jesus/0000-0003-4714-1460; Artal-Sanz, Marta/0000-0003-1126-0492; Gatsi, Roxani/0000-0003-4678-7884	European Research Council [ERC-2011-StG-281691]; Spanish Ministerio de Economia y Competitividad [BFU2012-35509]; Deutsche Forschungsgemeinschaft DFG [SFB746, SFB850]; BIOSS Centre for Biological Signalling Studies	European Research Council(European Research Council (ERC)European Commission); Spanish Ministerio de Economia y Competitividad(Spanish Government); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); BIOSS Centre for Biological Signalling Studies	This work was funded by grants from the European Research Council (ERC-2011-StG-281691) and the Spanish Ministerio de Economia y Competitividad (BFU2012-35509) to M.A.S. The study was also supported by grants from the Deutsche Forschungsgemeinschaft DFG (SFB746, SFB850) to R.B. and from BIOSS Centre for Biological Signalling Studies to R.B and M.A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam H, 2010, CELL METAB, V12, P30, DOI 10.1016/j.cmet.2010.05.004; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andres-Mateos E, 2013, EMBO MOL MED, V5, P80, DOI 10.1002/emmm.201201443; Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Baker BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002760; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Bennett CF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4483; Berger KH, 1998, MOL CELL BIOL, V18, P4043, DOI 10.1128/MCB.18.7.4043; Bess AS, 2012, NUCLEIC ACIDS RES, V40, P7916, DOI 10.1093/nar/gks532; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Chen ATY, 2013, AGING CELL, V12, P932, DOI 10.1111/acel.12120; Coates PJ, 2001, EXP CELL RES, V265, P262, DOI 10.1006/excr.2001.5166; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; Delaney JR, 2013, AGING CELL, V12, P156, DOI 10.1111/acel.12032; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Evans EA, 2008, AGING CELL, V7, P879, DOI 10.1111/j.1474-9726.2008.00435.x; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Gaskova D, 2007, BIOCHEM BIOPH RES CO, V354, P814, DOI 10.1016/j.bbrc.2007.01.073; Hansen M, 2007, WESTERN HUM REV, V61, P6; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; Jazwinski SM, 2013, BBA-MOL CELL RES, V1833, P400, DOI 10.1016/j.bbamcr.2012.02.010; Jensen MB, 2014, CELL METAB; Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060; Kasashima K, 2008, EXP CELL RES, V314, P988, DOI 10.1016/j.yexcr.2008.01.005; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kayser EB, 2004, MECH AGEING DEV, V125, P455, DOI 10.1016/j.mad.2004.04.002; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lehmann S, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-71; Lemire BD, 2009, MECH AGEING DEV, V130, P461, DOI 10.1016/j.mad.2009.05.001; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Martinez-Reyes I, 2012, BIOCHEM J, V444, P249, DOI 10.1042/BJ20111829; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Mizunuma M, 2014, AGING CELL; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Piantadosi CA, 2008, J BIOL CHEM, V283, P10967, DOI 10.1074/jbc.M709741200; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Rooney JP, 2014, EXP GERONTOL; Ruf V, 2013, DEV BIOL, V384, P214, DOI 10.1016/j.ydbio.2013.08.011; Runkel ED, 2014, EXP GERONTOL; Runkel ED, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003346; Sanz MA, 2003, J BIOL CHEM, V278, P32091, DOI 10.1074/jbc.M304877200; Schleit J, 2013, AGING CELL, V12, P1050, DOI 10.1111/acel.12130; Shore DE, 2013, TRENDS CELL BIOL, V23, P409, DOI 10.1016/j.tcb.2013.04.007; Shore DE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002792; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stout GJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.35; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Thuaud F, 2013, CHEM BIOL, V20, P316, DOI 10.1016/j.chembiol.2013.02.006; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Wang XW, 2008, NAT CELL BIOL, V10, P1090, DOI 10.1038/ncb1769; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Webster CM, 2013, DEVELOPMENT, V140, P3601, DOI 10.1242/dev.094292; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	81	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107671	10.1371/journal.pone.0107671	http://dx.doi.org/10.1371/journal.pone.0107671			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265021	Green Submitted, gold, Green Published			2022-12-27	WOS:000345745400028
J	Khan, A; Faheem, M; Danishuddin, M; Khan, AU				Khan, Arbab; Faheem, Mohammad; Danishuddin, Mohd; Khan, Asad U.			Evaluation of Inhibitory Action of Novel Non beta-Lactam Inhibitor against Klebsiella pneumoniae Carbapenemase (KPC-2)	PLOS ONE			English	Article							RESISTANT STRAIN	The use of three classical beta-lactamase inhibitors (Clavulanic acid, tazobactam and sulbactam) in combination with beta-lactam antibiotics is presently the mainstay of antibiotic therapy against Gram-negative bacterial infections. However these inhibitors are unable to inhibit carbapenemase KPC-2 effectively. They being beta-lactam derivatives behave as substrates for this enzyme instead of inactivating it. We have initiated our study to check the in vitro inhibition activity of the two novel screened inhibitors (ZINC01807204 and ZINC02318494) in combination with carbapenems against KPC-2 expressing bacterial strain and their effect on purified enzyme KPC-2. The MIC values of meropenem and ertapenem showed maximum reduction (8 folds) in combination with screened compounds (ZINC01807204 and ZINC02318494). CLSM images also depicted their strong antibacterial activity in comparison to conventional beta-lactamase inhibitors. Moreover no toxic effect has been shown on HeLa cell line. Though the IC50 value of ZINC01807204 was high (200 mu M), it exhibited fairly good affinity for KPC-2 (K-i = 43.82 mu M). With promising results this study identifies ZINC01807204 as a lead molecule for further optimization and development of more potent non beta-lactam inhibitors against KPC-2.	[Khan, Arbab; Faheem, Mohammad; Danishuddin, Mohd; Khan, Asad U.] Aligarh Muslim Univ, Med Microbiol & Mol Biol Lab, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Khan, AU (corresponding author), Aligarh Muslim Univ, Med Microbiol & Mol Biol Lab, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	asadukhan72@gmail.com	Khan, Asad U/K-8157-2013	Khan, Asad U/0000-0001-9191-9423	Department of Biotechnology [BT/HRD/NBA/34/01/2012]; Council of Scientific and Industrial Research Fellowship; Indian Council Medical Resaerch-fellowship	Department of Biotechnology; Council of Scientific and Industrial Research Fellowship(Council of Scientific & Industrial Research (CSIR) - India); Indian Council Medical Resaerch-fellowship	This work was funded by Department of Biotechnology Award BT/HRD/NBA/34/01/2012 to AUK. AK and MF acknowledge Council of Scientific and Industrial Research Fellowship and Indian Council Medical Resaerch-fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebrone C, 2010, DRUGS, V70, P651, DOI 10.2165/11318430-000000000-00000; Bratu S, 2005, ANTIMICROB AGENTS CH, V49, P3018, DOI 10.1128/AAC.49.7.3018-3020.2005; Bush K., 2010, ANTIMICROB AGENTS CH, V54, P969, DOI [DOI 10.1128/AAC.01009-09, 10.1128/aac.01009-09]; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Clinical and Laboratory Standards Institute, 2014, M100S24 CLSI; Danishuddin M, 2014, J BIOMOL STRUCT DYN, V32, P741, DOI 10.1080/07391102.2013.789988; Faheem M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056926; FRERE JM, 1982, BIOCHEM J, V207, P429, DOI 10.1042/bj2070429; Hanes MS, 2009, BIOCHEMISTRY-US, V48, P9185, DOI 10.1021/bi9007963; Hasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040319; Jafarian Abbas, 2014, Adv Biomed Res, V3, P38, DOI 10.4103/2277-9175.125727; Ke W, 2007, BIOCHEMISTRY-US, V46, P5732, DOI 10.1021/bi700300u; Papp-Wallace KM, 2012, ANTIMICROB AGENTS CH, V56, P4428, DOI 10.1128/AAC.05769-11; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P890, DOI 10.1128/AAC.00693-09; Queenan AM, 2004, J CLIN MICROBIOL, V42, P269, DOI 10.1128/JCM.42.1.269-275.2004; Walther-Rasmussen J, 2007, J ANTIMICROB CHEMOTH, V60, P470, DOI 10.1093/jac/dkm226; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Yigit H, 2003, ANTIMICROB AGENTS CH, V47, P3881, DOI 10.1128/AAC.47.12.3881-3889.2003	18	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108246	10.1371/journal.pone.0108246	http://dx.doi.org/10.1371/journal.pone.0108246			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265157	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400056
J	Marqueze-Pouey, B; Mailfert, S; Rouger, V; Goaillard, JM; Marguet, D				Marqueze-Pouey, Beatrice; Mailfert, Sebastien; Rouger, Vincent; Goaillard, Jean-Marc; Marguet, Didier			Physiological Epidermal Growth Factor Concentrations Activate High Affinity Receptors to Elicit Calcium Oscillations	PLOS ONE			English	Article							K+ CHANNEL ACTIVITY; POTASSIUM CHANNELS; A431 CELLS; NEGATIVE COOPERATIVITY; INTRACELLULAR STORES; CYTOSOLIC CA-2+; PROTEIN-KINASE; FACTOR BINDING; UP-REGULATION; EGF RECEPTOR	Signaling mediated by the epidermal growth factor (EGF) is crucial in tissue development, homeostasis and tumorigenesis. EGF is mitogenic at picomolar concentrations and is known to bind its receptor on high affinity binding sites depending of the oligomerization state of the receptor (monomer or dimer). In spite of these observations, the cellular response induced by EGF has been mainly characterized for nanomolar concentrations of the growth factor, and a clear definition of the cellular response to circulating (picomolar) concentrations is still lacking. We investigated Ca2+ signaling, an early event in EGF responses, in response to picomolar doses in COS-7 cells where the monomer/dimer equilibrium is unaltered by the synthesis of exogenous EGFR. Using the fluo5F Ca2+ indicator, we found that picomolar concentrations of EGF induced in 50% of the cells a robust oscillatory Ca2+ signal quantitatively similar to the Ca2+ signal induced by nanomolar concentrations. However, responses to nanomolar and picomolar concentrations differed in their underlying mechanisms as the picomolar EGF response involved essentially plasma membrane Ca2+ channels that are not activated by internal Ca2+ store depletion, while the nanomolar EGF response involved internal Ca2+ release. Moreover, while the picomolar EGF response was modulated by charybdotoxin-sensitive K+ channels, the nanomolar response was insensitive to the blockade of these ion channels.	[Marqueze-Pouey, Beatrice; Mailfert, Sebastien; Rouger, Vincent; Marguet, Didier] UM2 Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France; [Marqueze-Pouey, Beatrice; Mailfert, Sebastien; Rouger, Vincent; Marguet, Didier] INSERM, U1104, F-13258 Marseille, France; [Marqueze-Pouey, Beatrice; Mailfert, Sebastien; Rouger, Vincent; Marguet, Didier] CNRS, UMR7280, Marseille, France; [Goaillard, Jean-Marc] INSERM, UMR S 1072, F-13258 Marseille, France; [Goaillard, Jean-Marc] Aix Marseille Univ, UNIS, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Marqueze-Pouey, B (corresponding author), INSERM, UMR S 1072, F-13258 Marseille, France.	beatrice.marqueze@univ-amu.fr	Mailfert, Sébastien/X-6986-2019; Marquèze-Pouey, Béatrice/P-3800-2017; Mailfert, Sébastien/M-7064-2016; Marguet, Didier/AGO-5421-2022; Marguet, Didier/B-9946-2008	Mailfert, Sébastien/0000-0002-0409-0432; Marquèze-Pouey, Béatrice/0000-0002-8053-2685; Marguet, Didier/0000-0003-3198-5095; 	INSERM; CNRS; Fondation pour la Recherche Medicale (FRM) [FRM-DEQ-20090515412]; Agence Nationale de la Recherche (ANR) [ANR-10-BLAN-1214, ANR-10-INBS-04, ANR-11-LABX-0054, ANR-11-IDEX-0001-02]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by institutional grants from INSERM and CNRS, and by specific grants from the Fondation pour la Recherche Medicale (FRM) FRM-DEQ-20090515412, the Agence Nationale de la Recherche (ANR) ANR-10-BLAN-1214 (nanoDIGICODE), ANR-10-INBS-04 (France BioImaging), ANR-11-LABX-0054 (Investissements d'Avenir - Labex INFORM), ANR-11-IDEX-0001-02 (Investissements d'Avenir - A*MIDEX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; BARNES DW, 1982, J CELL BIOL, V93, P1, DOI 10.1083/jcb.93.1.1; Birk D, 1999, INT J PANCREATOL, V25, P89, DOI 10.1385/IJGC:25:2:89; Boulware MJ, 2008, CURR BIOL, V18, pR769, DOI 10.1016/j.cub.2008.07.018; CHEYETTE TE, 1991, CELL REGUL, V2, P827, DOI 10.1091/mbc.2.10.827; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; DRAHEIM HJ, 1995, BBA-MOL CELL RES, V1269, P57, DOI 10.1016/0167-4889(95)00106-3; ENOMOTO K, 1986, FEBS LETT, V203, P181, DOI 10.1016/0014-5793(86)80738-4; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Fast VG, 2005, J ELECTROCARDIOL, V38, P107, DOI 10.1016/j.jelectrocard.2005.06.023; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Fioretti B, 2005, BIOPHYS CHEM, V113, P17, DOI 10.1016/j.bpc.2004.07.037; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; GILL GN, 1984, J BIOL CHEM, V259, P7755; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; HASHIMOTO K, 1994, J BIOL CHEM, V269, P20060; HEPLER JR, 1987, J BIOL CHEM, V262, P2951; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Ivanov A, 2006, J PHYSIOL-LONDON, V570, P73, DOI 10.1113/jphysiol.2005.100883; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; KAMATA N, 1986, CANCER RES, V46, P1648; Kleger A, 2011, TRENDS CARDIOVAS MED, V21, P74, DOI 10.1016/j.tcm.2012.03.003; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Krall JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015945; Kupzig S, 2005, P NATL ACAD SCI USA, V102, P7577, DOI 10.1073/pnas.0409611102; LICHTNER RB, 1990, J CELL PHYSIOL, V144, P303, DOI 10.1002/jcp.1041440217; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; MACKINNON R, 1988, NEURON, V1, P997, DOI 10.1016/0896-6273(88)90156-0; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Ouadid-Ahidouch H, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00220; PANDIELLA A, 1989, J BIOL CHEM, V264, P12914; PANDIELLA A, 1987, EXP CELL RES, V170, P175, DOI 10.1016/0014-4827(87)90127-3; PANDIELLA A, 1988, BIOCHEM J, V254, P223, DOI 10.1042/bj2540223; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Sciaccaluga M, 2010, AM J PHYSIOL-CELL PH, V299, pC175, DOI 10.1152/ajpcell.00344.2009; SMITH C, 1986, J BIOL CHEM, V261, P4607; Tanaka Y, 2008, CELL BIOL INT, V32, P505, DOI 10.1016/j.cellbi.2007.12.012; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; Tynan CJ, 2011, MOL CELL BIOL, V31, P2241, DOI 10.1128/MCB.01431-10; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zhang BX, 2002, J BIOL CHEM, V277, P48165, DOI 10.1074/jbc.M208077200	47	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e106803	10.1371/journal.pone.0106803	http://dx.doi.org/10.1371/journal.pone.0106803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265278	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400012
J	Marx, I; Krause, J; Berger, C; Hassier, F				Marx, Ivo; Krause, John; Berger, Christoph; Haessier, Frank			Dissociable Patterns in the Control of Emotional Interference in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD) and in Adults with Alcohol Dependence	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; NATIONAL EPIDEMIOLOGIC SURVEY; WORKING-MEMORY; FOLLOW-UP; SEX-DIFFERENCES; RATING-SCALE; STIMULANT MEDICATION; INTEGRATIVE THEORY; PREFRONTAL CORTEX; COGNITIVE CONTROL	Objectives: To effectively manage current task demands, attention must be focused on task-relevant information while task-irrelevant information is rejected. However, in everyday life, people must cope with emotions, which may interfere with actual task demands and may challenge functional attention allocation. Control of interfering emotions has been associated with the proper functioning of the dorsolateral prefrontal cortex (DLPFC). As DLPFC dysfunction is evident in subjects with ADHD and in subjects with alcohol dependence, the current study sought to examine the bottom-up effect of emotional distraction on task performance in both disorders. Methods: Male adults with ADHD (n = 22), male adults with alcohol dependence (n = 16), and healthy controls (n = 30) performed an emotional working memory task (n-back task). In the background of the task, we presented neutral and negative stimuli that varied in emotional saliency. Results: In both clinical groups, a working memory deficit was evident. Moreover, both clinical groups displayed deficient emotional interference control. The n-back performance of the controls was not affected by the emotional distractors, whereas that of subjects with ADHD deteriorated in the presence of low salient distractors, and that of alcoholics did not deteriorate until high salient distractors were presented. Subsequent to task performance, subjects with ADHD accurately recognized more distractors than did alcoholics and controls. In alcoholics, picture recognition accuracy was negatively associated with n-back performance, suggesting a functional association between the ability to suppress emotional distractors and successful task performance. In subjects with ADHD, performance accuracy was negatively associated with ADHD inattentive symptoms, suggesting that inattention contributes to the performance deficit. Conclusions: Subjects with ADHD and alcoholics both display an emotional interference control deficit, which is especially pronounced in subjects with ADHD. Beyond dysfunctional attention allocation processes, a more general attention deficit seems to contribute to the more pronounced performance deficit pattern in ADHD.	[Marx, Ivo; Krause, John; Berger, Christoph] Univ Med Rostock, Dept Psychiat & Psychotherapy, Rostock, Germany; [Krause, John] Univ Med Rostock, Dept Forens Psychiat, Rostock, Germany; [Berger, Christoph; Haessier, Frank] Univ Med Rostock, Dept Child & Adolescent Psychiat Psychotherapy &, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Marx, I (corresponding author), Univ Med Rostock, Dept Psychiat & Psychotherapy, Rostock, Germany.	ivo.marx@med.uni-rostock.de	Marx, Ivo/G-5584-2011	Berger, Christoph/0000-0002-0832-5526; Marx, Ivo/0000-0002-3054-598X				Abe M, 2009, BEHAV BRAIN RES, V198, P13, DOI 10.1016/j.bbr.2008.10.046; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anastopoulos AD, 2011, J ATTEN DISORD, V15, P583, DOI 10.1177/1087054710370567; Balint S, 2009, PSYCHOL MED, V39, P1337, DOI 10.1017/S0033291708004236; Barkley RA, 2006, ATTENTION DEFICIT HY; Barkley RA., 2010, J ADHD RELATED DISOR, V1, P5, DOI DOI 10.1176/APPI.AIP.2010.10081172; Barratt ES, 1985, MOTIVATION EMOTION P; Biederman J, 2000, AM J PSYCHIAT, V157, P816, DOI 10.1176/appi.ajp.157.5.816; Biederman J, 2006, PSYCHOL MED, V36, P167, DOI 10.1017/S0033291705006410; Biederman J, 2012, J CLIN PSYCHIAT, V73, P941, DOI 10.4088/JCP.11m07529; Biederman J, 2012, J DEV BEHAV PEDIATR, V33, P236, DOI 10.1097/DBP.0b013e3182475267; Biederman J, 2010, AM J PSYCHIAT, V167, P409, DOI 10.1176/appi.ajp.2009.09050736; Boonstra AM, 2005, PSYCHOL MED, V35, P1097, DOI 10.1017/S003329170500499X; Burgess GC, 2010, BIOL PSYCHIAT, V67, P632, DOI 10.1016/j.biopsych.2009.10.036; Carlson CL, 2000, COGNITIVE THER RES, V24, P87, DOI 10.1023/A:1005455009154; Casey B. J., 2000, FUNCTIONAL NEUROIMAG, P155; Casey BJ, 2001, CLIN NEUROSCI RES, V1, P267, DOI 10.1016/S1566-2772(01)00013-5; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; Conners C.K., 1998, CONNERS ADULT ADHD R; Cromheeke S, 2013, BRAIN STRUCT FUNCT; Cubillo A, 2014, PSYCHOL MED, V44, P633, DOI 10.1017/S0033291713000676; Cumyn L, 2009, CAN J PSYCHIAT, V54, P673, DOI 10.1177/070674370905401004; Dichter GS, 2009, J AFFECT DISORDERS, V114, P131, DOI 10.1016/j.jad.2008.06.027; Domes G, 2006, PSYCHOL MED, V36, P1163, DOI 10.1017/S0033291706007756; Domes G, 2010, HUM BRAIN MAPP, V31, P758, DOI 10.1002/hbm.20903; Fairholme CP, 2013, BEHAV RES THER, V51, P540, DOI 10.1016/j.brat.2013.05.014; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Faraone SV, 2005, J ATTEN DISORD, V2, P384; Fox HC, 2008, ADDICT BEHAV, V33, P388, DOI 10.1016/j.addbeh.2007.10.002; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Goldstein RB, 2012, J STUD ALCOHOL DRUGS, V73, P938, DOI 10.15288/jsad.2012.73.938; Gross-Lesch S, 2016, J ATTEN DISORD, V20, P855, DOI 10.1177/1087054713510353; Haberstick BC, 2014, DRUG ALCOHOL DEPEN, V136, P158, DOI 10.1016/j.drugalcdep.2013.11.022; Halperin JM, 2008, J CHILD PSYCHOL PSYC, V49, P958, DOI 10.1111/j.1469-7610.2008.01926.x; HASE, 2008, HASE HOMBURGER ADHS; Hautzel H, 2009, NEUROIMAGE, V47, P2073, DOI 10.1016/j.neuroimage.2009.06.005; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Iordan AD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00200; Joormann J, 2010, COGN AFFECT BEHAV NE, V10, P21, DOI 10.3758/CABN.10.1.21; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kuhl J, 1997, PERSONLICHEKIT STIL; Kuvaas NJ, 2014, ADDICT BEHAV, V39, P146, DOI 10.1016/j.addbeh.2013.09.020; Lang P. J., 2008, TECHNICAL REPORT A 8; Lee SS, 2011, CLIN PSYCHOL REV, V31, P328, DOI 10.1016/j.cpr.2011.01.006; Maedgen JW, 2000, J CLIN CHILD PSYCHOL, V29, P30, DOI 10.1207/S15374424jccp2901_4; Mak AKY, 2009, NEUROPSYCHOLOGIA, V47, P2900, DOI 10.1016/j.neuropsychologia.2009.06.017; Marx I, 2011, WORLD J BIOL PSYCHIA, V12, P70, DOI 10.3109/15622975.2011.599213; Melka SE, 2011, J CLIN PSYCHOL, V67, P1283, DOI 10.1002/jclp.20836; Melnick SM, 2000, J ABNORM CHILD PSYCH, V28, P73, DOI 10.1023/A:1005174102794; Mensebach Christoph, 2009, Cogn Neuropsychiatry, V14, P524, DOI 10.1080/13546800903049853; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Murphy KR, 2002, J NERV MENT DIS, V190, P147, DOI 10.1097/00005053-200203000-00003; Niederhofer H, 2008, PSYCHOL REP, V102, P616, DOI 10.2466/PRO.102.2.616-620; Nigg JT, 2005, DEV PSYCHOPATHOL, V17, P785, DOI 10.1017/S0954579405050376; Norman D.A., 1986, CONSCIOUSNESS SELF R, V4; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ohlmeier MD, 2008, ALCOHOL ALCOHOLISM, V43, P300, DOI 10.1093/alcalc/agn014; Putman P, 2012, INT J PSYCHOPHYSIOL, V84, P194, DOI 10.1016/j.ijpsycho.2012.02.006; Retz W, 2012, EXPERT REV NEUROTHER, V12, P1241, DOI [10.1586/ERN.12.109, 10.1586/ern.12.109]; Retz-Junginger P, 2003, NERVENARZT, V74, P987, DOI 10.1007/s00115-002-1447-4; Retz-Junginger P, 2002, NERVENARZT, V73, P830, DOI 10.1007/s00115-001-1215-x; Retz-Junginger P, 2012, PSYCHIAT PRAX, V39, P345, DOI 10.1055/s-0032-1305193; Rey G, 2014, PSYCHIAT RES-NEUROIM, V223, P84, DOI 10.1016/j.pscychresns.2014.04.016; Rheinberg F, 2001, DIAGNOSTICA, V47, P57, DOI 10.1026//0012-1924.47.2.57; Rosler M, 2010, WORLD J BIOL PSYCHIA, V11, P684, DOI 10.3109/15622975.2010.483249; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; Rucklidge JJ, 2002, J CHILD PSYCHOL PSYC, V43, P988, DOI 10.1111/1469-7610.00227; Rucklidge Julia, 2007, J Atten Disord, V10, P288, DOI 10.1177/1087054706289942; Schoechlin C, 2005, ARCH CLIN NEUROPSYCH, V20, P727, DOI 10.1016/j.acn.2005.04.005; Segrave RA, 2012, J AFFECT DISORDERS, V141, P185, DOI 10.1016/j.jad.2012.03.004; SHEKIM WO, 1990, COMPR PSYCHIAT, V31, P416, DOI 10.1016/0010-440X(90)90026-O; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Sjoerds Z, 2013, PSYCHOL MED, P1; Sjowall D, 2013, J CHILD PSYCHOL PSYC, V54, P619, DOI 10.1111/jcpp.12006; Smith BH, 2002, ALCOHOL RES HEALTH, V26, P122; Stavro K, 2013, ADDICT BIOL, V18, P203, DOI 10.1111/j.1369-1600.2011.00418.x; Stevens JS, 2012, NEUROPSYCHOLOGIA, V50, P1578, DOI 10.1016/j.neuropsychologia.2012.03.011; Strand MT, 2012, J ABNORM CHILD PSYCH, V40, P1193, DOI 10.1007/s10802-012-9627-6; Taanila AM, 2009, INT J CIRCUMPOL HEAL, V68, P133, DOI 10.3402/ijch.v68i2.18324; Tewes U, 1994, HAMBURG WECHSLER INT, V2; Thorberg FA, 2006, ADDICT BEHAV, V31, P811, DOI 10.1016/j.addbeh.2005.06.008; Valera EM, 2010, AM J PSYCHIAT, V167, P86, DOI 10.1176/appi.ajp.2009.09020249; Van der Elst W, 2006, ASSESSMENT, V13, P62, DOI 10.1177/1073191105283427; van Mourik R, 2005, J CHILD PSYCHOL PSYC, V46, P150, DOI 10.1111/j.1469-7610.2004.00345.x; Vollmeyer R, 1998, Z PADAGOG PSYCHOL, V12, P11; Walcott CM, 2004, J CLIN CHILD ADOLESC, V33, P772, DOI 10.1207/s15374424jccp3304_12; Wang LH, 2008, PSYCHIAT RES-NEUROIM, V163, P143, DOI 10.1016/j.pscychresns.2007.10.004; Welborn BL, 2009, SOC COGN AFFECT NEUR, V4, P328, DOI 10.1093/scan/nsp028; Wetterling T, 1997, ALCOHOL ALCOHOLISM, V32, P753; Wilens TE, 2004, J CLIN PSYCHIAT, V65, P38; Wittchen H.-U., 1997, SKID STRUKTURIERTES; Wong CG, 2012, BIOL PSYCHIAT, V71, P458, DOI 10.1016/j.biopsych.2011.11.011	92	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e107750	10.1371/journal.pone.0107750	http://dx.doi.org/10.1371/journal.pone.0107750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6XR	25265290	Green Published, gold			2022-12-27	WOS:000345745400030
J	Hoai, TD; Hutson, KS				Truong Dinh Hoai; Hutson, Kate S.			Reproductive Strategies of the Insidious Fish Ectoparasite, Neobenedenia sp (Capsalidae: Monogenea)	PLOS ONE			English	Article							ZEUXAPTA-SERIOLAE MONOGENEA; PARASITE ENTOBDELLA-SOLEAE; EGG-PRODUCTION; SKIN PARASITE; GILL PARASITE; PLATYHELMINTH PARASITES; BENEDENIA-SERIOLAE; PROTOPOLYSTOMA-XENOPODIS; HETERAXINE-HETEROCERCA; LUTJANUS-CARPONOTATUS	Fish monogeneans are lethal parasites in aquaculture. We provide the first experimental evidence that a notorious fish monogenean, Neobenedenia sp., can produce viable eggs in isolation for three consecutive generations. We infected individual, isolated, farmed barramundi, Lates calcarifer (Bloch) with a single oncomiracidium (larva) of the hermaphroditic monogenean Neobenedenia sp. Isolated parasites reached sexual maturity at day 10 post-hatch (24 degrees C, 35%) and laid similar to 3,300 embryonated eggs over 17 days. Egg production rapidly increased following sexually maturity on day 10 (58 +/- 15 eggs) and peaked on day 15 (496 +/- 68 eggs) before gradually decreasing. Neobenedenia sp. exhibited egg laying and egg hatching rhythms. Parasites laid eggs continuously, but egg production increased in periods of darkness (64.3%), while the majority of oncomiracidia (81%) emerged from eggs in the first three hours of light. Eggs laid by isolated 'parent' parasites hatched and individual emerging oncomiracidia were used to infect more individual, isolated fish, with three consecutive, isolated, parasite generations (F1, F2 and F3) raised in the laboratory. Infection success and egg hatching success did not differ between generations. Our data show that one parasite, in the absence of a mate, presents a severe threat to captive fish populations.	[Truong Dinh Hoai; Hutson, Kate S.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Marine Parasitol Lab, Townsville City, Qld, Australia; [Truong Dinh Hoai; Hutson, Kate S.] James Cook Univ, Sch Marine & Trop Biol, Townsville City, Qld, Australia; [Truong Dinh Hoai] Vietnam Natl Univ Agr, Fac Anim Sci & Aquaculture, Aquat Environm & Fish Pathol Dept, Hanoi, Vietnam	James Cook University; James Cook University; Vietnam National University of Agriculture (VNUA)	Hutson, KS (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Marine Parasitol Lab, Townsville City, Qld, Australia.	kate.hutson@jcu.edu.au	Hoai, Truong Dinh/AAQ-7367-2021; Hoai, Truong Dinh/AAJ-5831-2021	Hoai, Truong Dinh/0000-0002-2271-849X; Hutson, Kate/0000-0003-2408-3990	AusAID Scholarship; Australian Society for Parasitology	AusAID Scholarship; Australian Society for Parasitology	This work was funded by an AusAID Scholarship (www.ausaid.gov.au) awarded to TDH. The Australian Society for Parasitology (http://parasite.org.au/) provided a Student Travel Award for TDH to present this research at the annual conference in Launceston, Tasmania, Australia in 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Combes C., 1972, , Behavioural aspects of parasite transmission., P151; CUSHMAN JH, 1994, OECOLOGIA, V99, P194, DOI 10.1007/BF00317101; Deveney MR, 2001, DIS AQUAT ORGAN, V46, P79, DOI 10.3354/dao046079; Ernst I, 1996, INT J PARASITOL, V26, P1191, DOI 10.1016/S0020-7519(96)00118-X; Ganias K, 2003, MAR BIOL, V142, P1169, DOI 10.1007/s00227-003-1028-5; Gannicott AM, 1997, PARASITOLOGY, V114, P569; Glennon V, 2006, PARASITOLOGY, V133, P55, DOI 10.1017/S003118200600998X; Haag KL, 1999, PARASITOLOGY, V118, P63, DOI 10.1017/S0031182098003485; HARRIS PD, 1987, J ZOOL, V212, P325, DOI 10.1111/j.1469-7998.1987.tb05993.x; Hirazawa N, 2004, AQUACULTURE, V238, P83, DOI 10.1016/j.aquaculture.2004.05.015; Hirazawa N, 2010, AQUACULTURE, V299, P2, DOI 10.1016/j.aquaculture.2009.11.025; Hutson KS, 2014, BIOLOGY AND CULTURE OF ASIAN SEABASS: LATES CALCARIFER, P102; Hutson KS, 2012, INT J PARASITOL, V42, P1135, DOI 10.1016/j.ijpara.2012.09.007; JACKSON HC, 1988, INT J PARASITOL, V18, P585, DOI 10.1016/0020-7519(88)90091-4; KANEKO JJ, 1988, J FISH DIS, V11, P295, DOI 10.1111/j.1365-2761.1988.tb01225.x; Kearn G. C., 1986, Advances in Parasitology, V25, P175, DOI 10.1016/S0065-308X(08)60344-9; Kearn G. C., 1992, Publications of the Seto Marine Biological Laboratory, V35, P347; Kearn G. C., 1992, Publications of the Seto Marine Biological Laboratory, V35, P351; KEARN GC, 1973, PARASITOLOGY, V66, P101, DOI 10.1017/S0031182000044486; KEARN GC, 1992, ZOOL SCI, V9, P451; KEARN GC, 1974, PARASITOLOGY, V68, P173, DOI 10.1017/S0031182000045716; KEARN GC, 1970, PARASITOLOGY, V60, P301, DOI 10.1017/S0031182000078136; KEARN GC, 1992, PARASITOLOGY, V104, P489, DOI 10.1017/S0031182000063757; KEARN GC, 1974, PARASITOLOGY, V68, P161, DOI 10.1017/S0031182000045704; KEARN GC, 1985, INT J PARASITOL, V15, P187, DOI 10.1016/0020-7519(85)90086-4; Leong TakSeng, 2002, Diseases and disorders of finfish in cage culture, P193, DOI 10.1079/9780851994437.0193; MACDONALD S, 1978, CHRONOBIOLOGIA, V5, P277; MACDONALD S, 1974, PARASITOLOGY, V68, P331, DOI 10.1017/S0031182000045868; MACDONALD S, 1975, PARASITOLOGY, V71, P211, DOI 10.1017/S0031182000046667; MACDONALD S, 1978, J HELMINTHOL, V52, P23, DOI 10.1017/S0022149X00005071; Militz TA, 2014, J FISH DIS, V37, P451, DOI 10.1111/jfd.12129; Mooney AJ, 2008, PARASITOLOGY, V135, P1295, DOI 10.1017/S0031182008004691; Mooney AJ, 2006, AQUACULTURE, V253, P10, DOI 10.1016/j.aquaculture.2004.11.029; Novoseltsev VN, 2003, J GERONTOL A-BIOL, V58, P484; Ogawa K, 2014, PARASITOL INT, V63, P473, DOI 10.1016/j.parint.2013.10.009; Ogawa K, 2002, INT J PARASITOL, V32, P373, DOI 10.1016/S0020-7519(01)00338-1; Ogawa K, 1998, FISH PATHOL, V33, P303, DOI 10.3147/jsfp.33.303; Ogawa K, 2006, FISH PATHOL, V41, P51, DOI 10.3147/jsfp.41.51; OLIVER J, 1992, BIOL BULL, V183, P409, DOI 10.2307/1542017; Pethiyagoda R, 2014, Biology and Culture of Asian Seabass: Lates Calcarifer, P1; Poulin R, 2007, PARASITOLOGY, V134, P763, DOI 10.1017/S0031182006002150; SCOTT ME, 1982, PARASITOLOGY, V85, P217, DOI 10.1017/S0031182000055207; SNELL TW, 1977, EVOLUTION, V31, P882, DOI 10.1111/j.1558-5646.1977.tb01082.x; STUNKARD HW, 1957, SYST ZOOL, V6, P7, DOI 10.2307/2411703; TAYLOR MH, 1979, COPEIA, P291, DOI 10.2307/1443417; Thoney D. A., 1991, Annual Review of Fish Diseases, V1, P133, DOI 10.1016/0959-8030(91)90027-H; THONEY DA, 1990, J FISH DIS, V13, P385, DOI 10.1111/j.1365-2761.1990.tb00797.x; TINSLEY RC, 1978, PARASITOLOGY, V77, P121, DOI 10.1017/S0031182000049313; TINSLEY RC, 1975, PARASITOLOGY, V71, P445, DOI 10.1017/S0031182000047211; TINSLEY RC, 1983, PARASITOLOGY, V86, P161, DOI 10.1017/S0031182000050885; Tubbs LA, 2005, INT J PARASITOL, V35, P315, DOI 10.1016/j.ijpara.2004.11.008; Wedekind C, 1998, PARASITOLOGY, V117, P373, DOI 10.1017/S0031182098003114; WHARTON DA, 1983, PARASITOLOGY, V86, P85, DOI 10.1017/S003118200005085X; Whittington I. D., 2008, Fish diseases, Volume 2, P683; Whittington ID, 2012, FISH PARASITES: PATHOBIOLOGY AND PROTECTION, P225, DOI 10.1079/9781845938062.0225; Whittington ID, 2011, INTEGR COMP BIOL, V51, P91, DOI 10.1093/icb/icr003; WHITTINGTON ID, 1987, J MAR BIOL ASSOC UK, V67, P729, DOI 10.1017/S0025315400057003; WHITTINGTON ID, 1988, INT J PARASITOL, V18, P847, DOI 10.1016/0020-7519(88)90127-0; Whittington ID, 1996, J NAT HIST, V30, P1113, DOI 10.1080/00222939600770611; Whittington ID, 2004, FOLIA PARASIT, V51, P109, DOI 10.14411/fp.2004.016; WHITTINGTON ID, 1986, J MAR BIOL ASSOC UK, V66, P93, DOI 10.1017/S0025315400039679; WHITTINGTON ID, 1989, J MAR BIOL ASSOC UK, V69, P609, DOI 10.1017/S0025315400031015; Whittington ID, 2002, PARASITOLOGY, V124, P423, DOI 10.1017/S0031182001001287; Whittington ID, 2000, INT J PARASITOL, V30, P305, DOI 10.1016/S0020-7519(00)00006-0; Whittington ID, 1997, INT J PARASITOL, V27, P705, DOI 10.1016/S0020-7519(97)00012-X; Yoshinaga T, 2000, FISH PATHOL, V35, P85, DOI 10.3147/jsfp.35.85	66	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108801	10.1371/journal.pone.0108801	http://dx.doi.org/10.1371/journal.pone.0108801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264931	Green Published, gold, Green Accepted			2022-12-27	WOS:000345745400127
J	Zadran, S; Remacle, F; Levine, R				Zadran, Sohila; Remacle, Francoise; Levine, Raphael			Surprisal Analysis of Glioblastoma Multiform (GBM) MicroRNA Dynamics Unveils Tumor Specific Phenotype	PLOS ONE			English	Article							GENE; CELLS; SUBTYPES; GROWTH	Gliomablastoma multiform (GBM) is the most fatal form of all brain cancers in humans. Currently there are limited diagnostic tools for GBM detection. Here, we applied surprisal analysis, a theory grounded in thermodynamics, to unveil how biomolecule energetics, specifically a redistribution of free energy amongst microRNAs (miRNAs), results in a system deviating from a non-cancer state to the GBM cancer -specific phenotypic state. Utilizing global miRNA microarray expression data of normal and GBM patients tumors, surprisal analysis characterizes a miRNA system response capable of distinguishing GBM samples from normal tissue biopsy samples. We indicate that the miRNAs contributing to this system behavior is a disease phenotypic state specific to GBM and is therefore a unique GBM-specific thermodynamic signature. MiRNAs implicated in the regulation of stochastic signaling processes crucial in the hallmarks of human cancer, dominate this GBM-cancer phenotypic state. With this theory, we were able to distinguish with high fidelity GBM patients solely by monitoring the dynamics of miRNAs present in patients' biopsy samples. We anticipate that the GBM-specific thermodynamic signature will provide a critical translational tool in better characterizing cancer types and in the development of future therapeutics for GBM.	[Zadran, Sohila] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Med, Los Angeles, CA 90095 USA; [Remacle, Francoise] Univ Liege, Dept Chem, Liege, Belgium; [Levine, Raphael] Univ Calif Los Angeles, David Geffen Sch Med, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA; [Levine, Raphael] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Levine, Raphael] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Liege; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Hebrew University of Jerusalem	Levine, R (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA.	rafi@chem.ucla.edu		Remacle, Francoise/0000-0001-7434-5245	European Commission FP7 Future and Emerging Technologies-Open Project [BAMBI 618024]	European Commission FP7 Future and Emerging Technologies-Open Project	FR and RDL acknowledge support from the European Commission FP7 Future and Emerging Technologies-Open Project BAMBI 618024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Costa PM, 2012, HUM MOL GENET, V21, P5118, DOI 10.1093/hmg/dds358; Costa PM, 2012, HUMAN MOL GENETICS; Fowler A, 2011, EUR J CANCER, V47, P953, DOI 10.1016/j.ejca.2010.11.026; Graeber TG, 2010, P NATL ACAD SCI USA, V107, P6112, DOI 10.1073/pnas.1001149107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Haldar Subrata, 2011, Mol Cell Pharmacol, V3, P135; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Holter NS, 2000, P NATL ACAD SCI USA, V97, P8409, DOI 10.1073/pnas.150242097; Hua DS, 2012, OMICS, V16, P690, DOI 10.1089/omi.2012.0069; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Karsy Michael, 2012, Genes Cancer, V3, P3, DOI 10.1177/1947601912448068; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Kravchenko-Balasha N, 2012, P NATL ACAD SCI USA, V109, P4702, DOI 10.1073/pnas.1200790109; Kravchenko-Balasha N, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-42; Li JR, 2012, INT J MOL SCI, V13, P16053, DOI 10.3390/ijms131216053; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Olarerin-George AO, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-19; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Qiu SW, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-10; Remacle F, 2010, P NATL ACAD SCI USA, V107, P10324, DOI 10.1073/pnas.1005283107; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Zadran S, 2012, APPL MICROBIOL BIOT, V96, P895, DOI 10.1007/s00253-012-4449-6; Zhang Y, 2013, NAT CELL BIOL, V15, P284, DOI 10.1038/ncb2690; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106; Zisoulis DG, 2012, NATURE, V486, P541, DOI 10.1038/nature11134	35	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108171	10.1371/journal.pone.0108171	http://dx.doi.org/10.1371/journal.pone.0108171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265448	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400050
J	Zhou, XJ; Qian, K; Tong, Y; Zhu, JJ; Qiu, XH; Zeng, XP				Zhou, Xiaojie; Qian, Kun; Tong, Ying; Zhu, Junwei Jerry; Qiu, Xinghui; Zeng, Xiaopeng			De Novo Transcriptome of the Hemimetabolous German Cockroach (Blattella germanica)	PLOS ONE			English	Article							PROTEIN GENE FAMILY; DOUBLE-STRANDED-RNA; ODORANT-BINDING; COMPARATIVE GENOMICS; INNATE IMMUNITY; DROSOPHILA; EXPRESSION; FLY; ANNOTATION; RECEPTORS	Background: The German cockroach, Blattella germanica, is an important insect pest that transmits various pathogens mechanically and causes severe allergic diseases. This insect has long served as a model system for studies of insect biology, physiology and ecology. However, the lack of genome or transcriptome information heavily hinder our further understanding about the German cockroach in every aspect at a molecular level and on a genome-wide scale. To explore the transcriptome and identify unique sequences of interest, we subjected the B. germanica transcriptome to massively parallel pyrosequencing and generated the first reference transcriptome for B. germanica. Methodology/Principal Findings: A total of 1,365,609 raw reads with an average length of 529 bp were generated via pyrosequencing the mixed cDNA library from different life stages of German cockroach including maturing oothecae, nymphs, adult females and males. The raw reads were de novo assembled to 48,800 contigs and 3,961 singletons with high-quality unique sequences. These sequences were annotated and classified functionally in terms of BLAST, GO and KEGG, and the genes putatively coding detoxification enzyme systems, insecticide targets, key components in systematic RNA interference, immunity and chemoreception pathways were identified. A total of 3,601 SSRs (Simple Sequence Repeats) loci were also predicted. Conclusions/Significance: The whole transcriptome pyrosequencing data from this study provides a usable genetic resource for future identification of potential functional genes involved in various biological processes.	[Zhou, Xiaojie; Qian, Kun; Tong, Ying; Zeng, Xiaopeng] Beijing Ctr Dis Control & Prevent, Inst Disinfect & Vector Control, Beijing, Peoples R China; [Zhou, Xiaojie; Qiu, Xinghui] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Zhu, Junwei Jerry] ARS, USDA, Lincoln, NE USA	Chinese Academy of Sciences; Institute of Zoology, CAS; United States Department of Agriculture (USDA)	Qiu, XH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	qiuxh@ioz.ac.cn; xpzeng@126.com		Zhou, Xiaojie/0000-0001-5828-1560	China Postdoctoral Science Foundation [2013M530727]; Beijing Municipal Postdoctoral Scientific Research Foundation [2013ZZ-94]; Public Welfare Industry Scientific Research Foundation of National General Administration of Quality Supervision, Inspection and Quarantine [201310255-02]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Beijing Municipal Postdoctoral Scientific Research Foundation; Public Welfare Industry Scientific Research Foundation of National General Administration of Quality Supervision, Inspection and Quarantine	This study was supported by the grants from China Postdoctoral Science Foundation (2013M530727), Beijing Municipal Postdoctoral Scientific Research Foundation (2013ZZ-94) and Public Welfare Industry Scientific Research Foundation of National General Administration of Quality Supervision, Inspection and Quarantine (201310255-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026228; Appel Arthur G., 1995, P1; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Brenner Richard J., 1995, P77; Carvalho RA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-695; Chen YA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-416; Chung Hyang Suk, 2005, Korean Journal of Parasitology, V43, P149, DOI 10.3347/kjp.2005.43.4.149; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; de Moura TR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002242; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; Garbutt JS, 2013, J INSECT PHYSIOL, V59, P171, DOI 10.1016/j.jinsphys.2012.05.013; Gomez-Orte E, 2009, P NATL ACAD SCI USA, V106, P21678, DOI 10.1073/pnas.0907391106; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gore JC, 2007, ANNU REV ENTOMOL, V52, P439, DOI 10.1146/annurev.ento.52.110405.091313; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gotzek D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016289; Gregory R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017418; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Irles P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-206; Jaworski DC, 2010, INSECT MOL BIOL, V19, P617, DOI 10.1111/j.1365-2583.2010.01037.x; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Jiao YC, 2008, CURR BIOL, V18, P1797, DOI 10.1016/j.cub.2008.10.009; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028525; Kim T, 2005, J BIOCHEM MOL BIOL, V38, P121; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Kulmuni J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063688; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; Lee S, 2012, PATHOG GLOB HEALTH, V106, P218, DOI 10.1179/2047773212Y.0000000033; Liu FS, 2012, MOL BIOL REP, V39, P1927, DOI 10.1007/s11033-011-0939-3; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu ZQ, 2000, INSECT BIOCHEM MOLEC, V30, P991, DOI 10.1016/S0965-1748(00)00074-6; Manoharan M, 2013, GENOME BIOL EVOL, V5, P163, DOI 10.1093/gbe/evs131; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Nirmala X, 2013, GENE, V517, P212, DOI 10.1016/j.gene.2012.12.012; Niu JZ, 2012, INSECT MOL BIOL, V21, P422, DOI 10.1111/j.1365-2583.2012.01148.x; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Peng X, 2011, INSECT MOL BIOL, V20, P745, DOI 10.1111/j.1365-2583.2011.01104.x; Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573; Ramirez Perez J, 1989, Bol Oficina Sanit Panam, V107, P41; Ribeiro JMC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002594; Ribeiro JMC, 2014, INSECT BIOCHEM MOLEC, V44, P23, DOI 10.1016/j.ibmb.2013.10.006; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Ross M.H., 1975, P35; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Shen GM, 2013, INSECT MOL BIOL, V22, P354, DOI 10.1111/imb.12026; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Valles SM, 1998, PESTIC BIOCHEM PHYS, V62, P190, DOI 10.1006/pest.1998.2381; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Wada-Katsumata A, 2013, SCIENCE, V340, P972, DOI 10.1126/science.1234854; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Wei YP, 2001, PEST MANAG SCI, V57, P1055, DOI 10.1002/ps.383; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhou JJ, 2006, CHEM SENSES, V31, P453, DOI 10.1093/chemse/bjj050	73	22	25	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e106932	10.1371/journal.pone.0106932	http://dx.doi.org/10.1371/journal.pone.0106932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265537	gold, Green Published			2022-12-27	WOS:000345745400015
J	Boschloo, L; Spijker, AT; Hoencamp, E; Kupka, R; Nolen, WA; Schoevers, RA; Penninx, BWJH				Boschloo, Lynn; Spijker, Annet T.; Hoencamp, Erik; Kupka, Ralph; Nolen, Willem A.; Schoevers, Robert A.; Penninx, Brenda W. J. H.			Predictors of the Onset of Manic Symptoms and a (Hypo)Manic Episode in Patients with Major Depressive Disorder	PLOS ONE			English	Article							BIPOLAR-DISORDER; UNIPOLAR; NETHERLANDS; COMORBIDITY; QUESTIONNAIRE; PREVALENCE; PRODROME; IMPACT	Objective: One third of patients with a major depressive episode also experience manic symptoms or, even, a (hypo) manic episode. Retrospective studies on the temporal sequencing of symptomatology suggest that the majority of these patients report depressive symptoms before the onset of manic symptoms. However, prospective studies are scarce and this study will, therefore, prospectively examine the onset of either manic symptoms or a (hypo) manic episode in patients with a major depressive disorder. In addition, we will consider the impact of a large set of potential risk factors on both outcomes. Methodology: Four-year follow-up data were used to determine the onset of manic symptoms as well as a CIDI-based (hypo) manic episode in a large sample (n = 889, age: 18-65 years) of outpatients with a major depressive disorder and without manic symptoms at baseline. Baseline vulnerability (i.e., sociodemographics, family history of depression, childhood trauma, life-events) and clinical (i.e., isolated manic symptoms, depression characteristics, and psychiatric comorbidity) factors were considered as potential risk factors. Results: In our sample of depressed patients, 15.9% developed manic symptoms and an additional 4.7% developed a (hypo) manic episode during four years. Baseline isolated manic symptoms and comorbid alcohol dependence predicted both the onset of manic symptoms and a (hypo) manic episode. Low education only predicted the onset of manic symptoms, whereas male gender, childhood trauma and severity of depressive symptoms showed strong associations with, especially, the onset of (hypo) manic episodes. Conclusions: A substantial proportion (20.6%) of patients with a major depressive disorder later developed manic symptoms or a (hypo) manic episode. Interestingly, some identified risk factors differed for the two outcomes, which may indicate that pathways leading to the onset of manic symptoms or a (hypo) manic episode might be different. Our findings indirectly support a clinical staging model.	[Boschloo, Lynn; Nolen, Willem A.; Schoevers, Robert A.; Penninx, Brenda W. J. H.] Univ Groningen, Univ Med Ctr Groningen, UCP, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Boschloo, Lynn; Kupka, Ralph; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Boschloo, Lynn; Kupka, Ralph; Penninx, Brenda W. J. H.] Extramuraal Geneeskundig Onderzoek EMGO, Inst Hlth & Care Res, Amsterdam, Netherlands; [Spijker, Annet T.] PsyQ, Dept Mood Disorders, The Hague, Netherlands; [Hoencamp, Erik] Parnassia Grp, The Hague, Netherlands; [Hoencamp, Erik] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Penninx, Brenda W. J. H.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands	University of Groningen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Parnassia Psychiatric Institute; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Boschloo, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, UCP, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	L.Boschloo@umcg.nl	Kupka, Ralph/HDM-4184-2022; Penninx, Brenda WJH/S-7627-2017	Penninx, Brenda WJH/0000-0001-7779-9672; Kupka, Ralph/0000-0002-1662-7436; Schoevers, Robert A/0000-0003-0760-9866	Netherlands Organization for Health Research and Development [10-000-1002]; Astra Zeneca Nederland; Astra Zeneca; Parnassia Group; Lundbeck; Bristol Myers Squibb; European Union; Stanley Medical Research Institute; GlaxoSmithKline; Wyeth	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Astra Zeneca Nederland; Astra Zeneca(AstraZeneca); Parnassia Group; Lundbeck(Lundbeck Corporation); Bristol Myers Squibb(Bristol-Myers Squibb); European Union(European Commission); Stanley Medical Research Institute; GlaxoSmithKline(GlaxoSmithKline); Wyeth(Wyeth)	This study was supported by the Geestkracht program of the Netherlands Organization for Health Research and Development (A.T.F. Beekman; grant number 10-000-1002; www.zonmw.nl/en) and Astra Zeneca Nederland (ATS and EH; www.astrazeneca.nl). There was no additional funding for this specific study. LB and ATS were supported by Astra Zeneca; EH was supported by Astra Zeneca and Parnassia Group; RK was supported by Astra Zeneca, Lundbeck and Bristol Myers Squibb; WAN was supported by the Netherlands Organization for Health Research and Development, the European Union, the Stanley Medical Research Institute, Astra Zeneca, GlaxoSmithKline and Wyeth; BWJHP was supported by the Netherlands Organization for Health Research and Development; and, RAS did not report any funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKISKAL HS, 1995, ARCH GEN PSYCHIAT, V52, P114; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Angst J, 2006, CAN J PSYCHIAT, V51, P3, DOI 10.1177/070674370605100102; Angst J, 2011, ARCH GEN PSYCHIAT, V68, P791, DOI 10.1001/archgenpsychiatry.2011.87; Angst J, 2010, AM J PSYCHIAT, V167, P1194, DOI 10.1176/appi.ajp.2010.09071011; Babor T.F., 1992, AUDIT ALCOHOL USE DI; Berk M, 2007, BIPOLAR DISORD, V9, P671, DOI 10.1111/j.1399-5618.2007.00484.x; Boschloo L, 2013, J CLIN PSYCHIAT, V74, P1233, DOI 10.4088/JCP.12m08159; Boschloo L, 2013, J AFFECT DISORDERS, V151, P203, DOI 10.1016/j.jad.2013.05.078; Boschloo L, 2010, J AFFECT DISORDERS, V126, P441, DOI 10.1016/j.jad.2010.04.019; Bowden CL, 2005, J AFFECT DISORDERS, V84, P117, DOI 10.1016/S0165-0327(03)00194-0; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Conus P, 2008, BIPOLAR DISORD, V10, P555, DOI 10.1111/j.1399-5618.2008.00610.x; Fiedorowicz JG, 2011, AM J PSYCHIAT, V168, P40, DOI 10.1176/appi.ajp.2010.10030328; Fyer AJ, 1999, AM J MED GENET, V88, P173, DOI 10.1002/(SICI)1096-8628(19990416)88:2<173::AID-AJMG15>3.0.CO;2-#; Goldberg JF, 2001, AM J PSYCHIAT, V158, P1265, DOI 10.1176/appi.ajp.158.8.1265; Hays J C, 1998, Depress Anxiety, V7, P76, DOI 10.1002/(SICI)1520-6394(1998)7:2<76::AID-DA5>3.0.CO;2-3; Hirschfeld RMA, 2000, AM J PSYCHIAT, V157, P1873, DOI 10.1176/appi.ajp.157.11.1873; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P161, DOI 10.4088/JCP.v64n0209; Hirschfeld Robert M. A., 2002, Prim Care Companion J Clin Psychiatry, V4, P9; Holma KM, 2008, J CLIN PSYCHIAT, V69, P1267, DOI 10.4088/JCP.v69n0809; Hyun M, 2000, BIPOLAR DISORD, V2, P131, DOI 10.1034/j.1399-5618.2000.020206.x; Jabben N, 2011, J AFFECT DISORDERS, V131, P224, DOI 10.1016/j.jad.2010.12.012; Kapczinski F, 2009, PROG NEURO-PSYCHOPH, V33, P1366, DOI 10.1016/j.pnpbp.2009.07.027; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lamers F, 2012, COMPR PSYCHIAT, V53, P63, DOI 10.1016/j.comppsych.2011.01.011; LISH JD, 1994, J AFFECT DISORDERS, V31, P281, DOI 10.1016/0165-0327(94)90104-X; Mantere O, 2006, J CLIN PSYCHIAT, V67, P584, DOI 10.4088/JCP.v67n0409; Mesman E, 2013, AM J PSYCHIAT, V170, P542, DOI 10.1176/appi.ajp.2012.12030401; Novick JS, 2005, J CLIN PSYCHIAT, V66, P1002, DOI 10.4088/JCP.v66n0807; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Schurhoff F, 2000, J AFFECT DISORDERS, V58, P215, DOI 10.1016/S0165-0327(99)00111-1; Scott J, 2013, BRIT J PSYCHIAT, V202, P243, DOI 10.1192/bjp.bp.112.110858; Wiersma JE, 2009, J CLIN PSYCHIAT, V70, P983, DOI 10.4088/JCP.08m04521; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; Zimmerman M, 2011, HARVARD REV PSYCHIAT, V19, P219, DOI 10.3109/10673229.2011.614101; Zimmermann P, 2009, ARCH GEN PSYCHIAT, V66, P1341, DOI 10.1001/archgenpsychiatry.2009.158	38	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e106871	10.1371/journal.pone.0106871	http://dx.doi.org/10.1371/journal.pone.0106871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259889	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600011
J	Nithaniyal, S; Newmaster, SG; Ragupathy, S; Krishnamoorthy, D; Vassou, SL; Parani, M				Nithaniyal, Stalin; Newmaster, Steven G.; Ragupathy, Subramanyam; Krishnamoorthy, Devanathan; Vassou, Sophie Lorraine; Parani, Madasamy			DNA Barcode Authentication of Wood Samples of Threatened and Commercial Timber Trees within the Tropical Dry Evergreen Forest of India	PLOS ONE			English	Article							LAND PLANTS; MOLECULAR PHYLOGENY; IDENTIFICATION; RBCL; LEGUMINOSAE; SEQUENCE; SPACER; FABACEAE; TAXONOMY; DISCRIMINATE	Background: India is rich with biodiversity, which includes a large number of endemic, rare and threatened plant species. Previous studies have used DNA barcoding to inventory species for applications in biodiversity monitoring, conservation impact assessment, monitoring of illegal trading, authentication of traded medicinal plants etc. This is the first tropical dry evergreen forest (TDEF) barcode study in the World and the first attempt to assemble a reference barcode library for the trees of India as part of a larger project initiated by this research group. Methodology/Principal Findings: We sampled 429 trees representing 143 tropical dry evergreen forest (TDEF) species, which included 16 threatened species. DNA barcoding was completed using rbcL and matK markers. The tiered approach (1st tier rbcL; 2nd tier matK) correctly identified 136 out of 143 species (95%). This high level of species resolution was largely due to the fact that the tree species were taxonomically diverse in the TDEF. Ability to resolve taxonomically diverse tree species of TDEF was comparable among the best match method, the phylogenetic method, and the characteristic attribute organization system method. Conclusions: We demonstrated the utility of the TDEF reference barcode library to authenticate wood samples from timber operations in the TDEF. This pilot research study will enable more comprehensive surveys of the illegal timber trade of threatened species in the TDEF. This TDEF reference barcode library also contains trees that have medicinal properties, which could be used to monitor unsustainable and indiscriminate collection of plants from the wild for their medicinal value.	[Nithaniyal, Stalin; Krishnamoorthy, Devanathan; Vassou, Sophie Lorraine; Parani, Madasamy] SRM Univ, Ctr DNA Barcoding, Dept Genet Engn, Chennai, Tamil Nadu, India; [Nithaniyal, Stalin] SRM Univ, Interdisciplinary Sch Indian Syst Med, Chennai, Tamil Nadu, India; [Newmaster, Steven G.; Ragupathy, Subramanyam] Univ Guelph, Ctr Biodivers Genom, Guelph, ON N1G 2W1, Canada	SRM Institute of Science & Technology Chennai; SRM Institute of Science & Technology Chennai; University of Guelph	Newmaster, SG (corresponding author), Univ Guelph, Ctr Biodivers Genom, Guelph, ON N1G 2W1, Canada.	snewmast@uoguelph.ca; parani.m@ktr.srmuniv.ac.in	Madasamy, Parani/H-4911-2012; Stalin, Nithaniyal/AAJ-2041-2020; Krishnamoorthy, Devanathan/CAH-1623-2022	Stalin, Nithaniyal/0000-0002-9799-1386; Parani, Madasamy/0000-0002-2265-1715	Department of Science and Technology, Government of India [VI-DP/372/10-11/TDT]; Department of Biotechnology, Cutting-edge Research Enhancement and Scientific Training Fellowship; Government of India [BT/IN/DBT-CREST Awards/09/PM/2011-12]; Biodiversity Institute of Ontario, University of Guelph, Canada	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology, Cutting-edge Research Enhancement and Scientific Training Fellowship; Government of India; Biodiversity Institute of Ontario, University of Guelph, Canada	Support for this study was provided by the following institutions: Funding Institute: Department of Science and Technology, Government of India. Grant No:VI-D&P/372/10-11/TDT URLs: (http://www.dst.gov.in) Author: SN. Funding Institute: Department of Biotechnology, Cutting-edge Research Enhancement and Scientific Training Fellowship. Government of India. Grant No BT/IN/DBT-CREST Awards/09/PM/2011-12. URLs: (http://dbtindia.nic.in/index.asp). Author PM. Funding Institute: Biodiversity Institute of Ontario, University of Guelph, Canada. Grant No nil. URL: (http://www.biodiversity.uoguelph.ca) Author MP, SN, SR 2. Funding Institute: SRM University, India. Grant No nil. URL: (www.srmuniv.ac.in) Author MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arca M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034089; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bergmann T, 2009, BERL MUNCH TIERARZTL, V122, P446, DOI 10.2376/0005-9366-122-446; Bruneau A, 2001, SYST BOT, V26, P487; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Champion HG, 1968, REV SURVEY FOREST TY; Chappill J.A., 1995, ADV LEGUM SYSTEMAT 7, P77; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Convention on International Trade in Endangered Species of Wild Fauna and Flora, 2013, CONVENTION INT TRADE; Costion C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026841; de Carvalho MR, 2005, SCIENCE, V307, P353; De Mattia F, 2012, BOT J LINN SOC, V169, P518, DOI 10.1111/j.1095-8339.2012.01251.x; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Doyle JJ, 1997, AM J BOT, V84, P541, DOI 10.2307/2446030; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fazekas AJ, 2010, BIOTECHNIQUES, V48, P277, DOI 10.2144/000113369; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; Gao T, 2011, PLANTA MED, V77, P92, DOI 10.1055/s-0030-1250050; Geesink R, 1984, SCALA MILLETTIEARUM; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Goyal AK, 2009, INDIAS 4 NATL REP CO; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; KASS E, 1995, BOT ACTA, V108, P149; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kumar NK, 2012, STATE FOREST GENETIC; Kuzmina ML, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-25; Kvist S, 2010, MOL PHYLOGENET EVOL, V57, P687, DOI 10.1016/j.ympev.2010.08.018; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lavin M, 1998, AM J BOT, V85, P412, DOI 10.2307/2446334; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Maddison WP, 2009, MESQUITE MODULAR SYS; Maia VH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029877; MARGULES CR, 1994, PHILOS T ROY SOC B, V344, P69, DOI 10.1098/rstb.1994.0053; MEHER-HOMJI V M, 1974, International Journal of Ecology and Environmental Sciences, V1, P19; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Miller JT, 2001, AM J BOT, V88, P697, DOI 10.2307/2657071; Miller JT, 2000, ADV LEGUME SYSTEMATI, V9', P181; Ministry of Environment and Forests, 2005, STAT FOR REP; Morejon NF, 2011, MITOCHONDR DNA, V21, P51; National Environment Policy, 2006, EN LAAD TOIM VUOD 20; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Parmentier I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054921; Parthasarathy N, 2008, TROP CONSERV SCI, V1, P89, DOI 10.1177/194008290800100203; Pei NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021273; Pettengill JB, 2010, AM J BOT, V97, P1391, DOI 10.3732/ajb.0900176; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Purushothaman N, 2014, GENET MOL RES, V13, P2959, DOI 10.4238/2014.April.16.4; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Rao RR, 1994, BIODIVERSITY INDIA F; Rao RV, 1988, ACIAR P, P101; Reid WR, 1992, TROPICAL DEFORESTATI; Rieseberg LH, 2006, NATURE, V440, P524, DOI 10.1038/nature04402; Rodgers WA, 1988, BIOGEOGRAPHICAL CLAS; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Saarela JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077982; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Simpson MG, 2010, PLANT SYSTEMATICS, 2ND EDITION, P1; SULAIMAN SF, 2003, ASIA-PAC J MOL BIOL, V11, P9; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson KA, 2014, BIODIVERS CONSERV, V23, P1411, DOI 10.1007/s10531-014-0672-z; Tripathi AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057934; Ved DK, 2008, DEMAND SUPPLY MED PL; Venkateswaran R., 2003, Ecotropica (Bonn), V9, P45; Wang NA, 2012, BOT STUD, V53, P265; Yu Hua, 2014, Plant Omics, V7, P47; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x	79	30	30	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107669	10.1371/journal.pone.0107669	http://dx.doi.org/10.1371/journal.pone.0107669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259794	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600025
J	Houdek, P; Sumova, A				Houdek, Pavel; Sumova, Alena			In Vivo Initiation of Clock Gene Expression Rhythmicity in Fetal Rat Suprachiasmatic Nuclei	PLOS ONE			English	Article							REV-ERB-ALPHA; MOUSE PERIPHERAL-TISSUES; CIRCADIAN CLOCK; MESSENGER-RNA; NURSING MOTHERS; TRANSCRIPTION; OSCILLATOR; MECHANISM; PROMOTER; NETWORK	The mammalian suprachiasmatic nuclei (SCN) and their intrinsic rhythmicity develop gradually during ontogenesis. In the rat, the SCN forms between embryonic day (E) 14 and E17, with gestation terminating at E21-22. Overt SCN rhythmicity is already present in the late embryonic stage. The aim of the present study was to determine when the fetal SCN clock develops in vivo and whether overt rhythmicity results from a functional fetal clock. To achieve this goal, the prenatal development of rhythmic expression of clock genes was measured with a more sensitive method for detection of the clock gene expression than previously. Fetal SCN were collected at 3 h intervals during the 24 h period on E19 and E21 by laser dissection and expression of clock genes (Per2, Nr1d1 and Bmal1) and genes related to cellular activity (c-fos, Avp and Vip) was measured by qRT PCR. At E19, the expression of canonical clock genes Per2 and Bmal1 was not rhythmic; however, the expression of all other studied genes followed clear circadian rhythms. At E21, Per2 and Bmal1 expression exhibited low amplitude but significant rhythmicity. From E19 to E21, the levels of the non-rhythmic transcripts (Per2 and Bmal1) decreased; however, the levels of the rhythmic transcripts (Nr1d1, c-fos, Avp and Vip) increased. In summary, these data demonstrate that at E19, rhythms in Per2 and Bmal1 expression were absent in the fetal SCN; however, the expression of Nr1d1 and other genes related to cellular activity was driven rhythmically. Therefore, at the early stage in vivo, the developing fetal SCN clock could theoretically be entrained by oscillation of Nr1d1 which may be driven by the maternal rather than fetal circadian system.	[Houdek, Pavel; Sumova, Alena] Acad Sci Czech Republ, Inst Physiol, Dept Neurohumoral Regulat, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Sumova, A (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Neurohumoral Regulat, Prague, Czech Republic.	sumova@biomed.cas.cz	Sumova, Alena/C-3390-2012	Sumova, Alena/0000-0003-4126-5470	Czech Science Foundation [P303121108];  [RV0 67985823]	Czech Science Foundation(Grant Agency of the Czech Republic); 	This work was supported by Czech Science Foundation Grant No. P303121108 and by research project RV0 67985823. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Gervois P, 1999, MOL ENDOCRINOL, V13, P400, DOI 10.1210/me.13.3.400; GILLETTE MU, 1987, BRAIN RES BULL, V19, P135, DOI 10.1016/0361-9230(87)90176-6; Hahm SH, 1998, J BIOL CHEM, V273, P17086, DOI 10.1074/jbc.273.27.17086; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; HILL JM, 1994, J COMP NEUROL, V342, P186, DOI 10.1002/cne.903420204; Iwasaki Y, 1997, ENDOCRINOLOGY, V138, P5266, DOI 10.1210/en.138.12.5266; Jac M, 2000, BRAIN RES, V887, P472, DOI 10.1016/S0006-8993(00)03050-X; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Jud C, 2006, J BIOL RHYTHM, V21, P149, DOI [10.1177/0748730406286264, 10.1177/0748730405286264]; Kornhauser JM, 1993, MOL GENETICS BIOL RH, P271; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kovacikova Z, 2006, J BIOL RHYTHM, V21, P140, DOI 10.1177/0748730405285876; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Mazzoccoli G, 2012, J BIOL REG HOMEOS AG, V26, P265; Meng QJ, 2008, J CELL SCI, V121, P3629, DOI 10.1242/jcs.035048; MOORE RY, 1991, SUPRACHIASMATIC NUCL, P197; Ohta H, 2003, EUR J NEUROSCI, V17, P1628, DOI 10.1046/j.1460-9568.2003.02584.x; Ohta H, 2002, EUR J NEUROSCI, V15, P1953, DOI 10.1046/j.1460-9568.2002.02016.x; Polidarova L, 2011, CHRONOBIOL INT, V28, P204, DOI 10.3109/07420528.2010.548615; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; REPPERT SM, 1984, J NEUROSCI, V4, P1677; REPPERT SM, 1987, ENDOCRINOLOGY, V120, P2483, DOI 10.1210/endo-120-6-2483; Saini C, 2011, COLD SH Q B, V76, P39, DOI 10.1101/sqb.2011.76.010918; Saxena MT, 2007, MOL IMAGING, V6, P68, DOI 10.2310/7290.2007.00003; Schwartz WJ, 1991, SUPRACHIASMATIC NUCL, P144; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; SHIBATA S, 1987, DEV BRAIN RES, V34, P311, DOI 10.1016/0165-3806(87)90220-3; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Shimomura H, 2001, EUR J NEUROSCI, V13, P687, DOI 10.1046/j.0953-816x.2000.01438.x; Sladek M, 2004, P NATL ACAD SCI USA, V101, P6231, DOI 10.1073/pnas.0401149101; Sumova A, 1998, BRAIN RES, V801, P254, DOI 10.1016/S0006-8993(98)00619-2; Sumova A, 2000, AM J PHYSIOL-REG I, V279, pR2262, DOI 10.1152/ajpregu.2000.279.6.R2262; Sumova A, 2012, PROG BRAIN RES, V199, P83, DOI 10.1016/B978-0-444-59427-3.00005-8; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18	40	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107360	10.1371/journal.pone.0107360	http://dx.doi.org/10.1371/journal.pone.0107360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255311	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300022
J	Maiditsch, IP; Ladich, F				Maiditsch, Isabelle Pia; Ladich, Friedrich			Effects of Temperature on Auditory Sensitivity in Eurythermal Fishes: Common Carp Cyprinus carpio (Family Cyprinidae) versus Wels Catfish Silurus glanis (Family Siluridae)	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; BRAIN-STEM; TEMPORAL RESOLUTION; THERMAL-ACCLIMATION; HEARING; DEPENDENCE; GOLDFISH; FROG; CARASSIUS; SOUNDS	Background: In ectothermal animals such as fish, -temperature affects physiological and metabolic processes. This includes sensory organs such as the auditory system. The reported effects of temperature on hearing in eurythermal otophysines are contradictory. We therefore investigated the effect on the auditory system in species representing two different orders. Methodology/Principal Findings: Hearing sensitivity was determined using the auditory evoked potentials (AEP) recording technique. Auditory sensitivity and latency in response to clicks were measured in the common carp Cyprinus carpio (order Cypriniformes) and the Wels catfish Silurus glanis (order Siluriformes) after acclimating fish for at least three weeks to two different water temperatures (15 degrees C, 25 degrees C and again 15 degrees C). Hearing sensitivity increased with temperature in both species. Best hearing was detected between 0.3 and 1 kHz at both temperatures. The maximum increase occurred at 0.8 kHz (7.8 dB) in C. carpio and at 0.5 kHz (10.3 dB) in S. glanis. The improvement differed between species and was in particular more pronounced in the catfish at 4 kHz. The latency in response to single clicks was measured from the onset of the sound stimulus to the most constant positive peak of the AEP. The latency decreased at the higher temperature in both species by 0.37 ms on average. Conclusions/Significance: The current study shows that higher temperature improves hearing (lower thresholds, shorter latencies) in eurythermal species from different orders of otophysines. Differences in threshold shifts between eurythermal species seem to reflect differences in absolute sensitivity at higher frequencies and they furthermore indicate differences to stenothermal (tropical) species.	[Maiditsch, Isabelle Pia; Ladich, Friedrich] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Vienna	Ladich, F (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	friedrich.ladich@univie.ac.at		Maiditsch, Isabelle/0000-0002-2351-7809	Open Access Publishing Fund of the University of Vienna	Open Access Publishing Fund of the University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MCP, 2006, J FISH BIOL, V69, P1892, DOI 10.1111/j.1095-8649.2006.01247.x; Amorim M. Clara P., 2005, Acta Zoologica Sinica, V51, P1013; Amoser S, 2007, ACOUSTIC COMMUNICATI; Banarescu PM, 2001, GASTEROSTEIDAE, V5; CAMPBELL HW, 1969, PHYSIOL ZOOL, V42, P183, DOI 10.1086/physzool.42.2.30158472; CAREY MB, 1993, HEARING RES, V70, P216, DOI 10.1016/0378-5955(93)90160-3; Connaughton MA, 2000, J EXP BIOL, V203, P1503; Copp GH, 2009, FISH FISH, V10, P252, DOI 10.1111/j.1467-2979.2008.00321.x; COSSINS AR, 1977, J COMP PHYSIOL, V120, P109, DOI 10.1007/BF00619309; David JA, 2006, WATER ENVIRON J, V20, P233, DOI 10.1111/j.1747-6593.2006.00021.x; DAVIES WD, 1973, PROG FISH CULT, V35, P214, DOI 10.1577/1548-8659(1973)35[214:ROTAFH]2.0.CO;2; EATOCK RA, 1981, J COMP PHYSIOL, V142, P219, DOI 10.1007/BF00605740; Fay R, 2009, INTEGR ZOOL, V4, P26, DOI 10.1111/j.1749-4877.2008.00132.x; Fay RR, 2000, HEARING RES, V149, P1, DOI 10.1016/S0378-5955(00)00168-4; FAY RR, 1992, HEARING RES, V58, P9, DOI 10.1016/0378-5955(92)90003-6; Fonseca PJ, 2007, J EXP BIOL, V210, P1834, DOI 10.1242/jeb.001495; Franz A, 2002, J COMP PHYSIOL A, V188, P261, DOI 10.1007/s00359-002-0298-6; HILGE V, 1985, Zeitschrift fuer Angewandte Ichthyologie, V1, P27; HUBER M, 1993, J EXP BIOL, V175, P195; HUBL L, 1977, BEHAV PROCESS, V2, P305, DOI 10.1016/0376-6357(77)90001-8; Itoi S, 2003, FISH PHYSIOL BIOCHEM, V29, P237, DOI 10.1023/B:FISH.0000045721.26261.a4; Jones EA, 2008, J EXP BIOL, V211, P1386, DOI 10.1242/jeb.014688; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Ladich F, 2003, CATFISHES, VOLS 1-2, P701; Ladich F, 2004, SPR HDB AUD, V22, P95, DOI 10.1007/978-1-4419-8957-4_4; Ladich F., 2006, COMMUNICATION FISHES, P122; Ladich F, 2013, REV FISH BIOL FISHER, V23, P317, DOI 10.1007/s11160-012-9297-z; Long GR, 1996, HEARING RES, V98, P22, DOI 10.1016/0378-5955(96)00057-3; Lugli M, 1996, J FISH BIOL, V49, P648; Mann DA, 2009, T AM FISH SOC, V138, P1000, DOI 10.1577/T08-052.1; Myrberg A.A. Jr, 1978, P137; OLDFIELD BP, 1988, HEARING RES, V35, P151, DOI 10.1016/0378-5955(88)90114-1; Papes S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026479; SMOLDERS JWT, 1984, J COMP PHYSIOL, V155, P19, DOI 10.1007/BF00610927; Smotherman MS, 1998, J NEUROPHYSIOL, V79, P312, DOI 10.1152/jn.1998.79.1.312; Sollid J, 2005, J EXP BIOL, V208, P1109, DOI 10.1242/jeb.01505; TORRICELLI P, 1990, Bioacoustics, V2, P261; vanDijk P, 1997, HEARING RES, V114, P243, DOI 10.1016/S0378-5955(97)00169-X; VANHEEL WHD, 1956, EXPERIENTIA, V12, P75; Vasconcelos RO, 2011, P ROY SOC B-BIOL SCI, V278, P826, DOI 10.1098/rspb.2010.1376; WALKOWIAK W, 1980, BEHAV PROCESS, V5, P363, DOI 10.1016/0376-6357(80)90019-4; Wiersinga-Post JEC, 2000, J COMP PHYSIOL A, V186, P949, DOI 10.1007/s003590000147; Wysocki LE, 2005, HEARING RES, V201, P27, DOI 10.1016/j.heares.2004.08.015; Wysocki LE, 2003, J EXP BIOL, V206, P2229, DOI 10.1242/jeb.00417; Wysocki LE, 2002, HEARING RES, V169, P36, DOI 10.1016/S0378-5955(02)00336-2; Wysocki LE, 2009, J EXP BIOL, V212, P3091, DOI 10.1242/jeb.033274; Wysocki Lidia Eva, 2006, P177; Zitek A, 2004, J FISH BIOL, V65, P1339, DOI 10.1111/j.0022-1112.2004.00534.x	48	16	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108583	10.1371/journal.pone.0108583	http://dx.doi.org/10.1371/journal.pone.0108583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255456	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300095
J	Hanauer, DA; Gardner, M; Sandberg, DE				Hanauer, David A.; Gardner, Melissa; Sandberg, David E.			Unbiased Identification of Patients with Disorders of Sex Development	PLOS ONE			English	Article							CONSENSUS STATEMENT; ADMINISTRATIVE DATA; PRIMARY-CARE; RECORDS; INFORMATION; DIAGNOSES; CHILDREN; ICD-10; ADULTS; RELIABILITY	Disorders of sex development (DSD) represent a collection of rare diseases that generate substantial controversy regarding best practices for diagnosis and treatment. A significant barrier preventing a better understanding of how patients with these conditions should be evaluated and treated, especially from a psychological standpoint, is the lack of systematic and standardized approaches to identify cases for study inclusion. Common approaches include "hand-picked" subjects already known to the practice, which could introduce bias. We implemented an informatics-based approach to identify patients with DSD from electronic health records (EHRs) at three large, academic children's hospitals. The informatics approach involved comprehensively searching EHRs at each hospital using a combination of structured billing codes as an initial filtering strategy followed by keywords applied to the free text clinical documentation. The informatics approach was implemented to replicate the functionality of an EHR search engine (EMERSE) available at one of the hospitals. At the two hospitals that did not have EMERSE, we compared case ascertainment using the informatics method to traditional approaches employed for identifying subjects. Potential cases identified using all approaches were manually reviewed by experts in DSD to verify eligibility criteria. At the two institutions where both the informatics and traditional approaches were applied, the informatics approach identified substantially higher numbers of potential study subjects. The traditional approaches yielded 14 and 28 patients with DSD, respectively; the informatics approach yielded 226 and 77 patients, respectively. The informatics approach missed only a few cases that the traditional approaches identified, largely because those cases were known to the study team, but patient data were not in the particular children's hospital EHR. The use of informatics approaches to search electronic documentation can result in substantially larger numbers of subjects identified for studies of rare diseases such as DSD, and these approaches can be applied across hospitals.	[Hanauer, David A.; Gardner, Melissa] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Sandberg, David E.] Univ Michigan, Pediat & Communicable Dis & Child Hlth Evaluat &, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sandberg, DE (corresponding author), Univ Michigan, Pediat & Communicable Dis & Child Hlth Evaluat &, Ann Arbor, MI 48109 USA.	dsandber@med.umich.edu	Sandberg, David E./Q-5106-2019	Sandberg, David E./0000-0002-7389-8283	Eunice Kennedy Shriver National Institute of Child Health and Human Development [3R01HD053637-02S1, R01HD068138]; University of Michigan Institute for Clinical and Health Research through the Clinical Translational Science Award [UL1RR024986]; National Institutes of Health [CA46592]; University of Michigan Comprehensive Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068138] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053637] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Michigan Institute for Clinical and Health Research through the Clinical Translational Science Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Comprehensive Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported by award nos. 3R01HD053637-02S1 and R01HD068138 (DSD-Translational Research Network) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health. This study utilized the Electronic Medical Record Search Engine (EMERSE). Support for EMERSE has come from the University of Michigan Institute for Clinical and Health Research through the Clinical Translational Science Award (UL1RR024986), as well as the University of Michigan Comprehensive Cancer Center Informatics Core with support from the National Institutes of Health (CA46592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson IA, 2011, J UROLOGY, V185, P388, DOI 10.1016/j.juro.2010.11.009; Abhyankar S, 2014, J AM MED INFORM ASS; Al-Holou WN, 2011, J NEUROSURG, V115, P1106, DOI 10.3171/2011.6.JNS11506; Arboleda VA, 2013, CLIN GENET, V83, P35, DOI 10.1111/j.1399-0004.2012.01879.x; Arboleda VA, 2014, NAT REV END IN PRESS; Asmar R, 2013, PROSTATE CANCER P D, V16, P61, DOI 10.1038/pcan.2012.32; Brinkmann L, 2007, J SEX MED, V4, P964, DOI 10.1111/j.1743-6109.2007.00524.x; Casez P, 2010, J CLIN EPIDEMIOL, V63, P790, DOI 10.1016/j.jclinepi.2009.09.002; Choi SW, 2012, BIOL BLOOD MARROW TR, V18, P1525, DOI 10.1016/j.bbmt.2012.03.013; Christensen T, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-12; Cooke CR, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-37; Cox K, 2013, J CLIN ENDOCRINOL ME; DeBenedet AT, 2011, DIGEST DIS SCI, V56, P1776, DOI 10.1007/s10620-010-1506-9; DiMagno MJ, 2013, PANCREAS, V42, P996, DOI 10.1097/MPA.0b013e31827e95e9; Embi PJ, 2013, J AM MED INFORM ASSN, V20, P718, DOI 10.1136/amiajnl-2012-000946; Farzandipour M, 2010, INT J INFORM MANAGE, V30, P78, DOI 10.1016/j.ijinfomgt.2009.07.002; Ford E, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-105; Griggs RC, 2009, MOL GENET METAB, V96, P20, DOI 10.1016/j.ymgme.2008.10.003; Groman JD, 2002, NEW ENGL J MED, V347, P401, DOI 10.1056/NEJMoa011899; Hanauer David A, 2006, AMIA Annu Symp Proc, P941; Hanauer DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070585; Hanauer DA, 2009, J AM COLL SURGEONS, V208, P37, DOI 10.1016/j.jamcollsurg.2008.08.030; Hiort O, 2012, J PEDIATR UROL, V8, P624, DOI 10.1016/j.jpurol.2012.09.004; Houk CP, 2006, PEDIATRICS, V118, P753, DOI 10.1542/peds.2006-0737; Hullmann SE, 2011, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2011-16; Jensen KM, 2013, J INTELL DISABIL RES, V57, P947, DOI 10.1111/j.1365-2788.2012.01589.x; Jha AK, 2011, JAMA-J AM MED ASSOC, V306, P880, DOI 10.1001/jama.2011.1219; Jurgensen M, 2007, HORM BEHAV, V51, P443, DOI 10.1016/j.yhbeh.2007.01.001; Knowles MR, 2002, NEW ENGL J MED, V347, P439, DOI 10.1056/NEJMe020070; Kohler B, 2012, J CLIN ENDOCR METAB, V97, P577, DOI 10.1210/jc.2011-1441; Langner I, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-193; Lee PA, 2006, PEDIATRICS, V118, pE488, DOI 10.1542/peds.2006-0738; Lilford RJ, 1995, BMJ-BRIT MED J, V311, P1621, DOI 10.1136/bmj.311.7020.1621; Lux A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-110; Magritte E, 2012, J PEDIATR UROL, V8, P571, DOI 10.1016/j.jpurol.2012.07.011; Meystre S M, 2008, Yearb Med Inform, P128; Michala L, 2008, BJOG-INT J OBSTET GY, V115, P737, DOI 10.1111/j.1471-0528.2008.01703.x; MORRISON Z, 2013, J AM MED INFORM ASS; Munk-Jorgensen P, 1999, NORD J PSYCHIAT, V53, P5; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Nermoen I, 2010, EUR J ENDOCRINOL, V163, P453, DOI 10.1530/EJE-10-0284; Nilsson G, 2000, METHOD INFORM MED, V39, P325; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Paczesny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000406; Parisi MA, 2007, GENET MED, V9, P348, DOI 10.1097/GIM.0b013e3180653c47; Patrick SW, 2013, PEDIATRICS, V131, pS75, DOI 10.1542/peds.2012-1427i; Quach S, 2010, CAN J CARDIOL, V26, pE306, DOI 10.1016/S0828-282X(10)70438-4; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Reker DM, 2002, MED CARE, V40, P96, DOI 10.1097/00005650-200202000-00004; Rhodes ET, 2007, DIABETES CARE, V30, P141, DOI 10.2337/dc06-1142; Rosenbloom ST, 2011, J AM MED INFORM ASSN, V18, P181, DOI 10.1136/jamia.2010.007237; Rosenthal Robert, 2009, ARTIFACTS BEHAV RES; Sandberg DE, 2012, SEMIN REPROD MED, V30, P443, DOI 10.1055/s-0032-1324729; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Seyfried L, 2009, INT J MED INFORM, V78, pE13, DOI 10.1016/j.ijmedinf.2009.05.002; Sickbert-Bennett EE, 2010, AM J EPIDEMIOL, V172, P1299, DOI 10.1093/aje/kwq285; Singh B, 2012, MAYO CLIN PROC, V87, P817, DOI 10.1016/j.mayocp.2012.04.015; Stanfill MH, 2010, J AM MED INFORM ASSN, V17, P646, DOI 10.1136/jamia.2009.001024; Stausberg J, 2008, INT J MED INFORM, V77, P50, DOI 10.1016/j.ijmedinf.2006.11.005; Tamar-Mattis A, 2014, PSYCHOL SEX, V5, P44, DOI 10.1080/19419899.2013.831215; Turchin A, 2006, J AM MED INFORM ASSN, V13, P691, DOI 10.1197/jamia.M2078; Wit JM, 2007, HORM RES S2, V68, P21; Wockenfuss R, 2009, SCAND J PRIM HEALTH, V27, P131, DOI 10.1080/02813430903072215; Wolfe-Christensen C, 2013, J PEDIAT UROLOGY; Yang Lei, 2011, AMIA Annu Symp Proc, V2011, P915; Zheng Kai, 2011, AMIA Annu Symp Proc, V2011, P1630; Zheng K, 2011, J AM MED INFORM ASSN, V18, P282, DOI 10.1136/amiajnl-2011-000009	67	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108702	10.1371/journal.pone.0108702	http://dx.doi.org/10.1371/journal.pone.0108702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268640	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700142
J	Jiang, MY; Wang, Q; Karasawa, T; Koo, JW; Li, HZ; Steyger, PS				Jiang, Meiyan; Wang, Qi; Karasawa, Takatoshi; Koo, Ja-Won; Li, Hongzhe; Steyger, Peter S.			Sodium-Glucose Transporter-2 (SGLT2; SLC5A2) Enhances Cellular Uptake of Aminoglycosides	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; RECESSIVE RENAL GLUCOSURIA; INDUCED HYPERTENSIVE-RATS; OUTER HAIR-CELLS; COTRANSPORTER SGLT2; STRIA VASCULARIS; LOW-AFFINITY; LLC-PK1 CELLS; KIDNEY-CELLS; OXIDATIVE STRESS	Aminoglycoside antibiotics, like gentamicin, continue to be clinically essential worldwide to treat life-threatening bacterial infections. Yet, the ototoxic and nephrotoxic side-effects of these drugs remain serious complications. A major site of gentamicin uptake and toxicity resides within kidney proximal tubules that also heavily express electrogenic sodium-glucose transporter-2 (SGLT2; SLC5A2) in vivo. We hypothesized that SGLT2 traffics gentamicin, and promotes cellular toxicity. We confirmed in vitro expression of SGLT2 in proximal tubule-derived KPT2 cells, and absence in distal tubule-derived KDT3 cells. D-glucose competitively decreased the uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino)-2-deoxyglucose (2-NBDG), a fluorescent analog of glucose, and fluorescently-tagged gentamicin (GTTR) by KPT2 cells. Phlorizin, an SGLT2 antagonist, strongly inhibited uptake of 2-NBDG and GTTR by KPT2 cells in a dose-and time-dependent manner. GTTR uptake was elevated in KDT3 cells transfected with SGLT2 (compared to controls); and this enhanced uptake was attenuated by phlorizin. Knock-down of SGLT2 expression by siRNA reduced gentamicin-induced cytotoxicity. In vivo, SGLT2 was robustly expressed in kidney proximal tubule cells of heterozygous, but not null, mice. Phlorizin decreased GTTR uptake by kidney proximal tubule cells in Sglt2(+/-) mice, but not in Sglt2(-/-) mice. However, serum GTTR levels were elevated in Sglt2(-/-) mice compared to Sglt2(+/-) mice, and in phlorizin-treated Sglt2(+/-) mice compared to vehicle-treated Sglt2(+/-) mice. Loss of SGLT2 function by antagonism or by gene deletion did not affect gentamicin cochlear loading or auditory function. Phlorizin did not protect wild-type mice from kanamycin-induced ototoxicity. We conclude that SGLT2 can traffic gentamicin and contribute to gentamicin-induced cytotoxicity.	[Jiang, Meiyan; Wang, Qi; Karasawa, Takatoshi; Koo, Ja-Won; Li, Hongzhe; Steyger, Peter S.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Koo, Ja-Won] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol, Coll Med, Songnam, Gyeonggi, South Korea	Oregon Health & Science University; Seoul National University (SNU)	Steyger, PS (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	steygerp@ohsu.edu	Steyger, Peter S./B-9147-2011	Steyger, Peter S./0000-0002-6103-5237; Jiang, Meiyan/0000-0002-6498-5094	NIH-NDCD [R01 DC004555, R01 DC012588, R03 DC011622, P30 DC005983]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012588, P30DC005983, R01DC004555, R03DC011622] Funding Source: NIH RePORTER	NIH-NDCD; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The colony-founding Sglt2+/ mice were a gift of the Wellcome Trust Sanger Institute (Hinxton, Cambridge, UK). This work was supported by NIH-NDCD grants R01 DC004555, R01 DC012588 (PSS), R03 DC011622 (HL), and P30 DC005983 [URL: https://www.nidcd.nih.gov/]. The funding agencies had no role in study design, data collection and analysis, preparation of the manuscript, or decision to publish.	Alharazneh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022347; Ando M, 2008, CELL TISSUE RES, V331, P763, DOI 10.1007/s00441-007-0495-2; Banday AA, 2008, LIFE SCI, V82, P450, DOI 10.1016/j.lfs.2007.11.014; Blodgett AB, 2011, DIABETES TECHNOL THE, V13, P743, DOI 10.1089/dia.2011.0041; Crouch JJ, 1997, J HISTOCHEM CYTOCHEM, V45, P773, DOI 10.1177/002215549704500601; Cuzzocrea S, 2002, EUR J PHARMACOL, V450, P67, DOI 10.1016/S0014-2999(02)01749-1; Dai CF, 2008, HEARING RES, V235, P114, DOI 10.1016/j.heares.2007.10.010; Dzhagalov IL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001566; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Fetoni AR, 2004, INT J AUDIOL, V43, P166, DOI 10.1080/14992020400050023; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Fujimori Y, 2008, J PHARMACOL EXP THER, V327, P268, DOI 10.1124/jpet.108.140210; GARRY F, 1990, AM J VET RES, V51, P420; Han SP, 2008, DIABETES, V57, P1723, DOI 10.2337/db07-1472; Hashino E, 1995, BRAIN RES, V704, P135, DOI 10.1016/0006-8993(95)01198-6; HIEL H, 1992, HEARING RES, V57, P157, DOI 10.1016/0378-5955(92)90148-G; Higashiyama K, 2003, HEARING RES, V186, P1, DOI 10.1016/S0378-5955(03)00226-0; Hirose K, 1997, HEARING RES, V104, P1, DOI 10.1016/S0378-5955(96)00169-4; Humes HD, 1999, ANN NY ACAD SCI, V884, P15, DOI 10.1111/j.1749-6632.1999.tb00278.x; Jiang MY, 2011, CLIN EXP PHARMACOL P, V38, P380, DOI 10.1111/j.1440-1681.2011.05521.x; Jiang MY, 2011, LIFE SCI, V89, P182, DOI 10.1016/j.lfs.2011.06.003; KANAI Y, 1994, J CLIN INVEST, V93, P397, DOI 10.1172/JCI116972; Karahan I, 2005, TOXICOLOGY, V215, P198, DOI 10.1016/j.tox.2005.07.007; Karasawa T, 2008, J CELL SCI, V121, P2871, DOI 10.1242/jcs.023705; Karasawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066220; Karasawa T, 2011, TOXICOL SCI, V124, P378, DOI 10.1093/toxsci/kfr196; Karasawa T, 2011, INTEGR BIOL-UK, V3, P879, DOI 10.1039/c1ib00034a; Katsuno K, 2007, J PHARMACOL EXP THER, V320, P323, DOI 10.1124/jpet.106.110296; Kolodkin-Gal I, 2008, PLOS BIOL, V6, P2774, DOI 10.1371/journal.pbio.0060319; Li HZ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00159; Li HZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019130; Liu T, 2009, BIOCHEM BIOPH RES CO, V378, P133, DOI 10.1016/j.bbrc.2008.11.015; Magen D, 2005, KIDNEY INT, V67, P34, DOI 10.1111/j.1523-1755.2005.00053.x; Mamdouh Z, 1996, BBA-BIOMEMBRANES, V1282, P171, DOI 10.1016/0005-2736(96)00077-6; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Meyers JR, 2003, J NEUROSCI, V23, P4054; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P1003, DOI 10.1128/AAC.43.5.1003; Mitchell C, 1996, HEARING RES, V99, P38, DOI 10.1016/S0378-5955(96)00081-0; Mohr PE, 2000, INT J TECHNOL ASSESS, V16, P1120, DOI 10.1017/S0266462300103162; Myrdal SE, 2005, HEARING RES, V204, P170, DOI 10.1016/j.heares.2005.02.005; Myrdal SE, 2005, HEARING RES, V204, P156, DOI 10.1016/j.heares.2005.02.002; Naftalin RJ, 2008, BIOPHYS J, V94, P3912, DOI 10.1529/biophysj.107.122531; Nagai Junya, 2004, Drug Metab Pharmacokinet, V19, P159, DOI 10.2133/dmpk.19.159; Nagai J, 2013, J PHARM PHARMACOL, V65, P441, DOI 10.1111/jphp.12005; Nauck MA, 2011, DIABETES CARE, V34, P2015, DOI 10.2337/dc11-0606; Nomura S, 2010, J MED CHEM, V53, P6355, DOI 10.1021/jm100332n; NONCLERCQ D, 1992, RENAL FAILURE, V14, P507, DOI 10.3109/08860229209047660; Obermeier MT, 2009, DRUG METAB DISPOS; Pajor AM, 2008, J PHARMACOL EXP THER, V324, P985, DOI 10.1124/jpet.107.129825; Raggi C, 2011, PFLUG ARCH EUR J PHY, V462, P851, DOI 10.1007/s00424-011-1026-2; Sabolic I, 2012, AM J PHYSIOL-CELL PH, V302, pC1174, DOI 10.1152/ajpcell.00450.2011; Sandoval R, 1998, J AM SOC NEPHROL, V9, P167; Sandoval RM, 2000, AM J PHYSIOL-RENAL, V279, pF884, DOI 10.1152/ajprenal.2000.279.5.F884; Sandoval RM, 2004, AM J PHYSIOL-RENAL, V286, pF617, DOI 10.1152/ajprenal.00130.2003; Santer R, 2003, J AM SOC NEPHROL, V14, P2873, DOI 10.1097/01.ASN.0000092790.89332.D2; Santer R, 2010, CLIN J AM SOC NEPHRO, V5, P133, DOI 10.2215/CJN.04010609; Servais H, 2005, TOXICOL APPL PHARM, V206, P321, DOI 10.1016/j.taap.2004.11.024; Sha S, 2011, DIABETES OBES METAB, V13, P669, DOI 10.1111/j.1463-1326.2011.01406.x; Stepanyan RS, 2011, JARO-J ASSOC RES OTO, V12, P729, DOI 10.1007/s10162-011-0288-x; Takeuchi S, 1997, HEARING RES, V114, P69, DOI 10.1016/S0378-5955(97)00157-3; Tanaka R, 2008, J PHARMACOL SCI, V108, P179, DOI 10.1254/jphs.08133FP; Vallon V, 2013, AM J PHYSL RENAL PHY; van den Heuvel LP, 2002, HUM GENET, V111, P544, DOI 10.1007/s00439-002-0820-5; Vu AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054794; Wang Q, 2009, JARO-J ASSOC RES OTO, V10, P205, DOI 10.1007/s10162-009-0160-4; Wang T, 2013, CELL BIOCHEM BIOPHYS, V65, P381, DOI 10.1007/s12013-012-9442-2; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10, DOI 10.1152/ajprenal.2001.280.1.F10; Wu WJ, 2001, HEARING RES, V158, P165, DOI 10.1016/S0378-5955(01)00303-3; Xiao F, 2013, NEUROPHARMACOLOGY, V67, P16, DOI 10.1016/j.neuropharm.2012.10.021; YOU GF, 1995, J BIOL CHEM, V270, P29365, DOI 10.1074/jbc.270.49.29365; Zhang CR, 2013, BRAIN RES BULL, V97, P53, DOI 10.1016/j.brainresbull.2013.05.013; Zhang F, 2013, FASEB J, V27, P3730, DOI 10.1096/fj.13-232892	72	20	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108941	10.1371/journal.pone.0108941	http://dx.doi.org/10.1371/journal.pone.0108941			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268124	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700198
J	Maciel, BLL; Valverde, JG; Rodrigues-Neto, JF; Freire-Neto, F; Keesen, TSL; Jeronimo, SMB				Lima Maciel, Bruna L.; Valverde, Joanna Gardel; Rodrigues-Neto, Joao Firmino; Freire-Neto, Francisco; Keesen, Tatjana S. L.; Bezerra Jeronimo, Selma Maria			Dual Immune Modulatory Effect of Vitamin A in Human Visceral Leishmaniasis	PLOS ONE			English	Article							REGULATORY T-CELLS; TRANS-RETINOIC ACID; INDIAN KALA-AZAR; TGF-BETA; INTERFERON-GAMMA; SUBCLINICAL INFECTION; DONOVANI INFECTION; NORTHEAST BRAZIL; TH17 CELLS; CYTOKINE	Vitamin A supplementation has shown to prevent mortality by diarrheal and respiratory diseases in several countries. Nevertheless, there are few studies investigating the effect of vitamin A in visceral leishmaniasis (VL), although there are reports of its deficiency in children with symptomatic VL in Brazil and Bangladesh. This study analyzed the effect of vitamin A on a subset of Treg cells and monocytes isolated from symptomatic VL and from healthy children residing in an endemic area for VL in Northeast Brazil. Serum retinol concentrations correlated inversely with IL-10 and TGF-beta productions in CD4(+)CD25(high)Foxp3(+) T cells isolated from children with VL stimulated with leishmanial antigens. All-trans retinoic acid in vitro induced IL-10 in CD4(+)CD25(high)Foxp(3+) T cells; IL-10 and TGF-beta production in CD4(+)CD25(-)Foxp(3-) T cells, and IL-10 in monocytes isolated from healthy children. However, the use of all-trans retinoic acid together with leishmanial antigens in vitro prevented increases in IL-10 production in Treg cells and monocytes isolated from VL children. Strikingly, those results show a potential dual role of vitamin A in the immune system: improvement of a regulatory profile in cells from healthy children after leishmanial stimulation and down modulation of IL-10 in Treg cells and monocytes during symptomatic VL. Therefore, the use of vitamin A concomitant to VL therapy might be useful in improving recovery from disease status caused by Leishmania infantum infection and warrants additional study.	[Lima Maciel, Bruna L.] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Dept Nutr, BR-59072970 Natal, RN, Brazil; [Lima Maciel, Bruna L.; Valverde, Joanna Gardel; Rodrigues-Neto, Joao Firmino; Freire-Neto, Francisco; Keesen, Tatjana S. L.; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59072970 Natal, RN, Brazil; [Lima Maciel, Bruna L.; Freire-Neto, Francisco; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande do Norte, BR-59072970 Natal, RN, Brazil; [Bezerra Jeronimo, Selma Maria] Natl Inst Sci & Technol Trop Dis INCT DT, Salvador, BA, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59072970 Natal, RN, Brazil.	smbj@cb.ufrn.br	Valverde, Joanna G/C-1284-2014; Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020	Valverde, Joanna G/0000-0001-8064-6255; Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo, Selma/0000-0002-4784-9904; Rodrigues Neto, Joao Firmino/0000-0001-8897-4341	National Institutes of Health, USA [AI-30639]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq, Brazil; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI030639] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by the National Institutes of Health, USA (AI-30639) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalid-Peralta L, 2011, INT J BIOL SCI, V7, P1412, DOI 10.7150/ijbs.7.1412; ADINOLFI LE, 1985, INFECT IMMUN, V48, P409, DOI 10.1128/IAI.48.2.409-416.1985; Anstead GM, 2001, INFECT IMMUN, V69, P4709, DOI 10.1128/IAI.69.8.4709-4718.2001; Bacellar O, 1996, J INFECT DIS, V173, P1515, DOI 10.1093/infdis/173.6.1515; BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639; BARRALNETTO M, 1992, SCIENCE, V257, P545, DOI 10.1126/science.1636092; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bern C, 2007, AM J TROP MED HYG, V76, P909; Bottrel RLA, 2001, INFECT IMMUN, V69, P3232, DOI 10.1128/IAI.69.5.3232-3239.2001; Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344; Caldas A, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-113; Cantorna MT, 1996, J IMMUNOL, V156, P2674; Carrier Y, 2007, J IMMUNOL, V178, P179, DOI 10.4049/jimmunol.178.1.179; CARVALHO EM, 1985, J CLIN INVEST, V76, P2066, DOI 10.1172/JCI112209; CERF BJ, 1987, J INFECT DIS, V156, P1030, DOI 10.1093/infdis/156.6.1030; Cippitelli M, 1996, J BIOL CHEM, V271, P26783, DOI 10.1074/jbc.271.43.26783; Davies CR, 1999, PARASITOLOGY, V119, P247, DOI 10.1017/S0031182099004680; Dawson HD, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-27; Di Caro V, 2013, CLIN EXP IMMUNOL, V174, P302, DOI 10.1111/cei.12177; DOENHOFF MJ, 1991, PARASITOL TODAY, V7, P16, DOI 10.1016/0169-4758(91)90079-4; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124; Ganguly S, 2010, J INVEST DERMATOL, V130, P1013, DOI 10.1038/jid.2009.393; Gantt KR, 2003, J IMMUNOL, V170, P2613, DOI 10.4049/jimmunol.170.5.2613; Garg R, 2004, PARASITOLOGY, V129, P685, DOI 10.1017/S0031182004006055; Gautam S, 2014, J INFECT DIS, V209, P290, DOI 10.1093/infdis/jit401; GLASZIOU PP, 1993, BMJ-BRIT MED J, V306, P366, DOI 10.1136/bmj.306.6874.366; Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390; HAIDARIS CG, 1983, AM J TROP MED HYG, V32, P286, DOI 10.4269/ajtmh.1983.32.286; HARRISON LH, 1986, REV INFECT DIS, V8, P447; Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357; Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682; Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451; Joshi T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000431; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; KARP CL, 1993, J CLIN INVEST, V91, P1644, DOI 10.1172/JCI116372; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kenney RT, 1998, J INFECT DIS, V177, P815, DOI 10.1086/517817; Liu LM, 2006, PARASITOL RES, V99, P189, DOI 10.1007/s00436-006-0168-1; Ma J, 2013, J LEUKOC BIOL; Maciel BLL, 2008, AM J TROP MED HYG, V79, P591, DOI 10.4269/ajtmh.2008.79.591; Maggini S, 2007, BRIT J NUTR, V98, pS29, DOI 10.1017/S0007114507832971; Maynard CL, 2009, J EXP MED, V206, P343, DOI 10.1084/jem.20080950; Mayne ST, 1998, AM J CLIN NUTR, V68, P642, DOI 10.1093/ajcn/68.3.642; Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470; Montenegro J, 1926, ARCH DERMATOL SYPH, V13, P187, DOI 10.1001/archderm.1926.02370140053003; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murray HW, 2005, INFECT IMMUN, V73, P3903, DOI 10.1128/IAI.73.7.3903-3911.2005; Murray HW, 2003, J INFECT DIS, V188, P458, DOI 10.1086/376510; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141; Nylen S, 2010, J GLOB INFECT DIS, V2, P135, DOI 10.4103/0974-777X.62876; PASATIEMPO AMG, 1990, FASEB J, V4, P2518, DOI 10.1096/fasebj.4.8.2110538; Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813; Qiao Z, 1999, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V17, P21; Rai AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031551; Rodrigues OR, 2009, IMMUNOBIOLOGY, V214, P101, DOI 10.1016/j.imbio.2008.07.001; SACKS DL, 1987, J IMMUNOL, V138, P908; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sankaranarayanan S, 2007, J NUTR, V137, P1229, DOI 10.1093/jn/137.5.1229; Singh OP, 2012, CLIN VACCINE IMMUNOL, V19, P961, DOI 10.1128/CVI.00143-12; SOKAL JE, 1975, NEW ENGL J MED, V293, P501, DOI 10.1056/NEJM197509042931013; Stephensen CB, 2004, J NUTR, V134, P2660, DOI 10.1093/jn/134.10.2660; Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; WHO UNICEF IVACG Task Force, 1997, VIT SUPPL GUID THEIR; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yin G, 1998, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V16, P251; Ziegler SF, 2009, MICROBES INFECT, V11, P594, DOI 10.1016/j.micinf.2009.04.002	71	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107564	10.1371/journal.pone.0107564	http://dx.doi.org/10.1371/journal.pone.0107564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268355	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700040
J	Marczak, M; Matysiak, P; Kutkowska, J; Skorupska, A				Marczak, Malgorzata; Matysiak, Paulina; Kutkowska, Jolanta; Skorupska, Anna			PssP2 Is a Polysaccharide Co-Polymerase Involved in Exopolysaccharide Chain-Length Determination in Rhizobium leguminosarum	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE O-ANTIGEN; GRAM-NEGATIVE BACTERIA; GROUP-1 CAPSULAR POLYSACCHARIDES; PROTEIN-TYROSINE KINASE; TRIFOLII STRAIN TA1; ESCHERICHIA-COLI; BV-TRIFOLII; SHIGELLA-FLEXNERI; PSEUDOMONAS-AERUGINOSA; SINORHIZOBIUM-MELILOTI	Production of extracellular polysaccharides is a complex process engaging proteins localized in different subcellular compartments, yet communicating with each other or even directly interacting in multicomponent complexes. Proteins involved in polymerization and transport of exopolysaccharide (EPS) in Rhizobium leguminosarum are encoded within the chromosomal Pss-I cluster. However, genes implicated in polysaccharide synthesis are common in rhizobia, with several homologues of pss genes identified in other regions of the R. leguminosarum genome. One such region is chromosomally located Pss-II encoding proteins homologous to known components of the Wzx/Wzy-dependent polysaccharide synthesis and transport systems. The pssP2 gene encodes a protein similar to polysaccharide co-polymerases involved in determination of the length of polysaccharide chains in capsule and O-antigen biosynthesis. In this work, a mutant with a disrupted pssP2 gene was constructed and its capabilities to produce EPS and enter into a symbiotic relationship with clover were studied. The pssP2 mutant, while not altered in lipopolysaccharide (LPS), displayed changes in molecular mass distribution profile of EPS. Lack of the full-length PssP2 protein resulted in a reduction of high molecular weight EPS, yet polymerized to a longer length than in the RtTA1 wild type. The mutant strain was also more efficient in symbiotic performance. The functional interrelation between PssP2 and proteins encoded within the Pss-I region was further supported by data from bacterial two-hybrid assays providing evidence for PssP2 interactions with PssT polymerase, as well as glycosyltransferase PssC. A possible role for PssP2 in a complex involved in EPS chain-length determination is discussed.	[Marczak, Malgorzata; Kutkowska, Jolanta; Skorupska, Anna] Marie Curie Sklodowska Univ, Dept Genet & Microbiol, Inst Microbiol & Biotechnol, Lublin, Poland; [Matysiak, Paulina] Med Univ Lublin, Chair & Dept Forens Med 2, Fac Med, Lublin, Poland	Maria Curie-Sklodowska University; Medical University of Lublin	Marczak, M (corresponding author), Marie Curie Sklodowska Univ, Dept Genet & Microbiol, Inst Microbiol & Biotechnol, Lublin, Poland.	malgorzata.marczak@poczta.umcs.lublin.pl	Całka, Paulina/E-6430-2015	Kutkowska, Jolanta/0000-0002-3307-591X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apicella Michael A., 2008, V431, P3; BATTISTI L, 1992, P NATL ACAD SCI USA, V89, P5625, DOI 10.1073/pnas.89.12.5625; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Carter JA, 2009, MICROBIOL-SGM, V155, P3260, DOI 10.1099/mic.0.028944-0; CHAKRAVORTY A K, 1982, Journal of Molecular and Applied Genetics, V1, P585; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Daniels C, 1998, MOL MICROBIOL, V28, P1211, DOI 10.1046/j.1365-2958.1998.00884.x; Daniels C, 1999, MOL MICROBIOL, V34, P181, DOI 10.1046/j.1365-2958.1999.01591.x; Doublet P, 2002, J BIOL CHEM, V277, P37339, DOI 10.1074/jbc.M204465200; Drummelsmith J, 2000, EMBO J, V19, P57, DOI 10.1093/emboj/19.1.57; Tran ENH, 2014, MICROBIOL-SGM, V160, P589, DOI 10.1099/mic.0.074955-0; Tran ENH, 2013, MICROBIOL-SGM, V159, P701, DOI 10.1099/mic.0.065631-0; Franco AV, 1998, J BACTERIOL, V180, P2670, DOI 10.1128/JB.180.10.2670-2675.1998; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; Galvan EM, 2013, GLYCOBIOLOGY, V23, P259, DOI 10.1093/glycob/cws146; Gharzouli R, 2013, APPL ENVIRON MICROB, V79, P1764, DOI 10.1128/AEM.02903-12; GLUCKSMANN MA, 1993, J BACTERIOL, V175, P7033, DOI 10.1128/jb.175.21.7033-7044.1993; Grangeasse C, 2002, J BIOL CHEM, V277, P7127, DOI 10.1074/jbc.M110880200; Grangeasse C, 1997, GENE, V204, P259, DOI 10.1016/S0378-1119(97)00554-4; Guerreiro N, 2000, J BACTERIOL, V182, P4521, DOI 10.1128/JB.182.16.4521-4532.2000; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hong M, 1997, MOL MICROBIOL, V24, P779, DOI 10.1046/j.1365-2958.1997.3731744.x; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; Islam ST, 2013, SCI REP-UK, V3, DOI 10.1038/srep03441; Islam ST, 2013, MBIO, V4, DOI 10.1128/mBio.00678-13; Islam ST, 2013, ENVIRON MICROBIOL, V15, P1001, DOI 10.1111/j.1462-2920.2012.02890.x; Jadeau F, 2012, NUCLEIC ACIDS RES, V40, pD321, DOI 10.1093/nar/gkr915; Janczarek M, 2003, RES MICROBIOL, V154, P433, DOI 10.1016/S0923-2508(03)00113-X; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kalynych S, 2012, PROTEIN ENG DES SEL, V25, P797, DOI 10.1093/protein/gzs075; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; King JD, 2014, P NATL ACAD SCI USA, V111, P6407, DOI 10.1073/pnas.1400814111; Kintz E, 2008, J BACTERIOL, V190, P2709, DOI 10.1128/JB.01646-07; Kintz EN, 2011, J BIOL CHEM, V286, P44277, DOI 10.1074/jbc.M111.273979; Kos V, 2010, J BIOL CHEM, V285, P19668, DOI 10.1074/jbc.M110.122598; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Krol J, 1998, MOL PLANT MICROBE IN, V11, P1142, DOI 10.1094/MPMI.1998.11.11.1142; Krol JE, 2007, GENOMICS, V89, P237, DOI 10.1016/j.ygeno.2006.08.015; Kutkowska J, 2011, BIOCHEMISTRY-MOSCOW+, V76, P840, DOI 10.1134/S0006297911070157; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marczak M, 2006, J BACTERIOL, V188, P6943, DOI 10.1128/JB.00651-06; Marczak M, 2013, BIOL CHEM, V394, P541, DOI 10.1515/hsz-2012-0161; Marolda CL, 2006, J BACTERIOL, V188, P5124, DOI 10.1128/JB.00461-06; Mazur A, 2005, ARCH MICROBIOL, V184, P1, DOI 10.1007/s00203-005-0018-z; Mazur A, 2003, J BACTERIOL, V185, P2503, DOI 10.1128/JB.185.8.2503-2511.2003; Mazur A, 2002, MOL PLANT MICROBE IN, V15, P388, DOI 10.1094/MPMI.2002.15.4.388; Mazur A, 2001, DNA SEQUENCE, V12, P1, DOI 10.3109/10425170109042046; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Morona R, 2000, MICROBIOL-UK, V146, P1, DOI 10.1099/00221287-146-1-1; Murray GL, 2005, MICROBES INFECT, V7, P1296, DOI 10.1016/j.micinf.2005.04.015; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Nickerson NN, 2014, P NATL ACAD SCI USA, V111, P8203, DOI 10.1073/pnas.1400341111; Niemeyer D, 2001, J BACTERIOL, V183, P5163, DOI 10.1128/JB.183.17.5163-5170.2001; Papadopoulos M, 2010, J BACTERIOL, V192, P3385, DOI 10.1128/JB.01134-09; Pellock BJ, 2000, J BACTERIOL, V182, P4310, DOI 10.1128/JB.182.15.4310-4318.2000; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Pollock TJ, 1998, J BACTERIOL, V180, P586, DOI 10.1128/JB.180.3.586-593.1998; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Sambrook J., 2002, MOL CLONING LAB MANU; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SKORUPSKA A, 1995, J PLANT PHYSIOL, V147, P93, DOI 10.1016/S0176-1617(11)81419-7; Skorupska A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-7; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sorroche FG, 2012, APPL ENVIRON MICROB, V78, P4092, DOI 10.1128/AEM.07826-11; Sorroche FG, 2010, CURR MICROBIOL, V61, P465, DOI 10.1007/s00284-010-9639-9; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Taylor VL, 2013, J BACTERIOL, V195, P4735, DOI 10.1128/JB.00903-13; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; VanDenBosch L, 1997, MOL MICROBIOL, V23, P765, DOI 10.1046/j.1365-2958.1997.2541625.x; vanWorkum WAT, 1997, MOL PLANT MICROBE IN, V10, P290, DOI 10.1094/MPMI.1997.10.2.290; VINCENT J. M., 1941, PROC LINN SOC N S WALES, V66, P145; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001; Wielbo J, 2004, CAN J MICROBIOL, V50, P201, DOI [10.1139/w04-004, 10.1139/W04-004]; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Yamamoto S, 1999, J BACTERIOL, V181, P5176, DOI 10.1128/JB.181.17.5176-5184.1999; Yasar S, 2005, ACTA CHIM SLOV, V52, P435	87	8	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e109106	10.1371/journal.pone.0109106	http://dx.doi.org/10.1371/journal.pone.0109106			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268738	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700223
J	Mosoni, L; Gatineau, E; Gatellier, P; Migne, C; Savary-Auzeloux, I; Remond, D; Rocher, E; Dardevet, D				Mosoni, Laurent; Gatineau, Eva; Gatellier, Philippe; Migne, Carole; Savary-Auzeloux, Isabelle; Remond, Didier; Rocher, Emilie; Dardevet, Dominique			High Whey Protein Intake Delayed the Loss of Lean Body Mass in Healthy Old Rats, whereas Protein Type and Polyphenol/Antioxidant Supplementation Had No Effects	PLOS ONE			English	Article							AMINO-ACID SUPPLEMENTATION; TERM LEUCINE SUPPLEMENTATION; MUSCLE PROTEIN; SKELETAL-MUSCLE; VITAMIN-D; IMPROVES PROTEIN; OXIDATIVE STRESS; AGING RATS; METABOLISM; INSULIN	Our aim was to compare and combine 3 nutritional strategies to slow down the age-related loss of muscle mass in healthy old rats: 1) increase protein intake, which is likely to stimulate muscle protein anabolism; 2) use leucine rich, rapidly digested whey proteins as protein source (whey proteins are recognized as the most effective proteins to stimulate muscle protein anabolism). 3) Supplement animals with a mixture of chamomile extract, vitamin E, vitamin D (reducing inflammation and oxidative stress is also effective to improve muscle anabolism). Such comparisons and combinations were never tested before. Nutritional groups were: casein 12% protein, whey 12% protein, whey 18% protein and each of these groups were supplemented or not with polyphenols/antioxidants. During 6 months, we followed changes of weight, food intake, inflammation (plasma fibrinogen and alpha-2-macroglobulin) and body composition (DXA). After 6 months, we measured muscle mass, in vivo and ex-vivo fed and post-absorptive muscle protein synthesis, ex-vivo muscle proteolysis, and oxidative stress parameters (liver and muscle glutathione, SOD and total antioxidant activities, muscle carbonyls and TBARS). We showed that although micronutrient supplementation reduced inflammation and oxidative stress, the only factor that significantly reduced the loss of lean body mass was the increase in whey protein intake, with no detectable effect on muscle protein synthesis, and a tendency to reduce muscle proteolysis. We conclude that in healthy rats, increasing protein intake is an effective way to delay sarcopenia.	[Mosoni, Laurent; Gatineau, Eva; Migne, Carole; Savary-Auzeloux, Isabelle; Remond, Didier; Dardevet, Dominique] INRA, Unite Mixte Rech Nutr Humaine 1019, F-63122 St Genes Champanelle, France; [Mosoni, Laurent; Gatineau, Eva; Migne, Carole; Savary-Auzeloux, Isabelle; Remond, Didier; Dardevet, Dominique] Univ Clermont 1, Unite Format & Rech, Unite Mixte Rech, Clermont Ferrand, France; [Gatellier, Philippe] INRA, Unite Rech QuaPA 370, F-63122 St Genes Champanelle, France; [Rocher, Emilie] Danone Res, Palaiseau, France	INRAE; Universite Clermont Auvergne (UCA); INRAE; Danone Nutricia	Mosoni, L (corresponding author), INRA, Unite Mixte Rech Nutr Humaine 1019, F-63122 St Genes Champanelle, France.	laurent.mosoni@clermont.inra.fr	Gatineau, Eva/S-7508-2018	Gatineau, Eva/0000-0001-7354-0049; Mosoni, Laurent/0000-0002-5409-6760; Remond, Didier/0000-0003-4430-0067; Savary-Auzeloux, Isabelle/0000-0002-3298-9787; Dardevet, Dominique/0000-0001-7320-9970	Danone Research, France	Danone Research, France	This study was supported by Danone Research, France. The protocol was discussed and designed in collaboration with the funder, and it was agreed that we would publish the results. We then performed data collection and analysis, and wrote the manuscript. The funder assisted in reviewing the manuscript.	Adechian S, 2012, NUTRITION, V28, P566, DOI 10.1016/j.nut.2011.08.020; Arnal MA, 1999, AM J CLIN NUTR, V69, P1202; Balage M, 2010, J NUTR BIOCHEM, V21, P325, DOI 10.1016/j.jnutbio.2009.01.005; Barker T, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-16; BOOTH FW, 1994, MED SCI SPORT EXER, V26, P556; Borsheim E, 2008, CLIN NUTR, V27, P189, DOI 10.1016/j.clnu.2008.01.001; Brouwer DAJ, 1998, BRIT J NUTR, V79, P527, DOI 10.1079/BJN19980091; Capel F, 2009, J NUTR BIOCHEM, V20, P570, DOI 10.1016/j.jnutbio.2008.05.017; Carmeli E, 2002, EXP GERONTOL, V37, P477, DOI 10.1016/S0531-5565(01)00220-0; Cerullo F, 2016, CLINICAL NUTRITION AND AGING: SARCOPENIA AND MUSCLE METABOLISM, P221, DOI 10.1155/2012/316943; Chevalier S, 2003, AM J CLIN NUTR, V78, P422; Chirumbolo Salvatore, 2010, Inflammation & Allergy Drug Targets, V9, P263; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; Dangin M, 2003, J PHYSIOL-LONDON, V549, P635, DOI 10.1113/jphysiol.2002.036897; Dardevet D, 1998, J ENDOCRINOL, V156, P83, DOI 10.1677/joe.0.1560083; Dardevet D, 2002, J NUTR, V132, P95, DOI 10.1093/jn/132.1.95; Dardevet D, 2000, J NUTR, V130, P2630, DOI 10.1093/jn/130.11.2630; Dillon EL, 2011, AM J PHYSIOL-REG I, V301, pR1408, DOI 10.1152/ajpregu.00211.2011; Dillon EL, 2009, J CLIN ENDOCR METAB, V94, P1630, DOI 10.1210/jc.2008-1564; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Girgis CM, 2013, ENDOCR REV, V34, P33, DOI 10.1210/er.2012-1012; Glynn EL, 2010, J NUTR, V140, P1970, DOI 10.3945/jn.110.127647; Gweon HS, 2010, NUTR RES PRACT, V4, P375, DOI 10.4162/nrp.2010.4.5.375; Hays NP, 2009, J AM DIET ASSOC, V109, P1082, DOI 10.1016/j.jada.2009.03.003; Holecek M, 2011, FOOD CHEM TOXICOL, V49, P3336, DOI 10.1016/j.fct.2011.09.016; HOLLOSZY JO, 1991, MECH AGEING DEV, V60, P199, DOI 10.1016/0047-6374(91)90131-I; Jackson JR, 2011, J GERONTOL A-BIOL, V66, P751, DOI 10.1093/gerona/glr047; Jackson JR, 2010, AM J PHYSIOL-REG I, V299, pR1572, DOI 10.1152/ajpregu.00489.2010; Katsanos CS, 2006, AM J PHYSIOL-ENDOC M, V291, pE381, DOI 10.1152/ajpendo.00488.2005; Katsanos CS, 2005, AM J CLIN NUTR, V82, P1065, DOI 10.1093/ajcn/82.5.1065; Kim HP, 2004, J PHARMACOL SCI, V96, P229, DOI 10.1254/jphs.CRJ04003X; Kim JS, 2010, J NUTR BIOCHEM, V21, P1, DOI 10.1016/j.jnutbio.2009.06.014; Leenders M, 2011, J NUTR, V141, P1070, DOI 10.3945/jn.111.138495; Magne H, 2012, J PHYSIOL-LONDON, V590, P2035, DOI 10.1113/jphysiol.2011.226266; Malmezat T, 1998, J NUTR, V128, P97, DOI 10.1093/jn/128.1.97; Marzani B, 2008, J NUTR, V138, P2205, DOI 10.3945/jn.108.094029; Mayot G, 2007, EXP GERONTOL, V42, P498, DOI 10.1016/j.exger.2007.01.003; Meng SJ, 2010, INT J MOL SCI, V11, P1509, DOI 10.3390/ijms11041509; Mercier Y, 1998, MEAT SCI, V48, P301, DOI 10.1016/S0309-1740(97)00113-7; MOSONI L, 1995, AM J PHYSIOL-ENDOC M, V268, pE328, DOI 10.1152/ajpendo.1995.268.2.E328; MOSONI L, 1993, AM J PHYSIOL, V264, pE614, DOI 10.1152/ajpendo.1993.264.4.E614; Mosoni L, 2010, NUTRITION, V26, P1157, DOI 10.1016/j.nut.2009.09.016; Murakami H, 2012, EXP GERONTOL, V47, P129, DOI 10.1016/j.exger.2011.11.007; Pansarasa O, 2008, AM J CARDIOL, V101, p35E, DOI 10.1016/j.amjcard.2008.02.079; Prod'homme M, 2005, J PHYSIOL-LONDON, V563, P235, DOI 10.1113/jphysiol.2004.068841; Rieu I, 2003, J NUTR, V133, P1198, DOI 10.1093/jn/133.4.1198; Rieu I, 2007, NUTRITION, V23, P323, DOI 10.1016/j.nut.2006.12.013; Rieu I, 2009, J PHYSIOL-LONDON, V587, P5483, DOI 10.1113/jphysiol.2009.178319; Scarabelli CC, 2008, AM J CARDIOL, V101, p42E, DOI 10.1016/j.amjcard.2008.02.080; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Sinha-Hikim I, 2013, J GERONTOL A; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Solerte SB, 2008, AM J CARDIOL, V101, p69E, DOI 10.1016/j.amjcard.2008.03.004; Tesseraud S, 2007, DOMEST ANIM ENDOCRIN, V33, P123, DOI 10.1016/j.domaniend.2006.06.002; Verhoeven S, 2009, AM J CLIN NUTR, V89, P1468, DOI 10.3945/ajcn.2008.26668; Vianna D, 2012, NUTRITION, V28, P182, DOI 10.1016/j.nut.2011.04.004; WAALKES TP, 1957, J LAB CLIN MED, V50, P733; Walrand S, 2011, BRIT J NUTR, V106, P1683, DOI 10.1017/S0007114511002182; Wolfe RR, 2013, J AM MED DIRECTORS A, V14; Zeanandin G, 2012, AGE, V34, P371, DOI 10.1007/s11357-011-9246-0	61	15	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e109098	10.1371/journal.pone.0109098	http://dx.doi.org/10.1371/journal.pone.0109098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268515	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700221
J	Nijman, J; Mandemaker, FS; Verboon-Maciolek, MA; Aitken, SC; van Loon, AM; de Vries, LS; Schuurman, R				Nijman, Joppe; Mandemaker, Femke S.; Verboon-Maciolek, Malgorzata A.; Aitken, Susan C.; van Loon, Anton M.; de Vries, Linda S.; Schuurman, Rob			Genotype Distribution, Viral Load and Clinical Characteristics of Infants with Postnatal or Congenital Cytomegalovirus Infection	PLOS ONE			English	Article							DRIED BLOOD SPOTS; GLYCOPROTEIN-B GENOTYPE; PRETERM INFANTS; UL144 VARIABILITY; HEARING-LOSS; STRAINS; EPIDEMIOLOGY; TRANSMISSION; CHILDREN; SEQUELAE	Background: Congenital cytomegalovirus infection is a leading cause of long-term sequelae. Cytomegalovirus is also frequently transmitted to preterm infants postnatally, but these infections are mostly asymptomatic. A correlation between cytomegalovirus genotypes and clinical manifestations has been reported previously in infants with congenital infection, but not in preterm infants with postnatal infection. Objectives: The main objective of this study was to investigate cytomegalovirus genotype distribution in postnatal and congenital cytomegalovirus infection and its association with disease severity. Methods: Infants admitted to the neonatal intensive care unit of the University Medical Center Utrecht, The Netherlands between 2003-2010 and diagnosed with postnatal or congenital cytomegalovirus infection were included. Classification of cytomegalovirus isolates in genotypes was performed upon amplification and sequencing of the cytomegalovirus UL55 (gB) and UL144 genes. Clinical data, cerebral abnormalities, neurodevelopmental outcome and viral load were studied in relation to genotype distribution. Results: Genotyping results were obtained from 58 preterm infants with postnatal cytomegalovirus infection and 13 infants with congenital cytomegalovirus infection. Postnatal disease was mild in all preterm infants and all had favourable outcome. Infants with congenital infection were significantly more severely affected than infants with postnatal infection. Seventy-seven percent of these infants were symptomatic at birth, 2/13 died and 3/13 developed long-term sequelae (median follow-up 6 (range 2-8) years). The distribution of cytomegalovirus genotypes was comparable for postnatal and congenital infection. UL55 genotype 1 and UL144 genotype 3 were predominant genotypes in both groups. Conclusions: Distribution of UL55 and UL144 genotypes was similar in asymptomatic postnatal and severe congenital CMV infection suggesting that other factors rather than cytomegalovirus UL55 and UL144 genotype are responsible for the development of severe disease.	[Mandemaker, Femke S.; Aitken, Susan C.; van Loon, Anton M.; Schuurman, Rob] Univ Med Ctr, Dept Virol, Utrecht, Netherlands; [Nijman, Joppe; Verboon-Maciolek, Malgorzata A.; de Vries, Linda S.] Univ Med Ctr, Dept Neonatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Nijman, J (corresponding author), Univ Med Ctr, Dept Neonatol, Utrecht, Netherlands.	j.nijman@umcutrecht.nl	de Vries, Linda S/AAB-6454-2021; Schuurman, Rob/M-4687-2019; de Lima, Antonio Marcos Oliveira/AAT-2148-2021	Schuurman, Rob/0000-0002-0060-9831; 				Arav-Boger R, 2002, J INFECT DIS, V186, P1057, DOI 10.1086/344238; Bale JF, 2001, J MED VIROL, V65, P90, DOI 10.1002/jmv.2006; Barbi M, 2001, J CLIN VIROL, V21, P75, DOI 10.1016/S1386-6532(00)00188-8; Bevot A, 2012, ACTA PAEDIATR, V101, pE167, DOI 10.1111/j.1651-2227.2011.02538.x; Boppana SB, 2005, J PEDIATR-US, V146, P817, DOI 10.1016/j.jpeds.2005.01.059; Chang CL, 2006, BRAIN DEV-JPN, V28, P426, DOI 10.1016/j.braindev.2006.01.002; CHOU SW, 1991, J INFECT DIS, V163, P1229, DOI 10.1093/infdis/163.6.1229; CHOU SW, 1990, J INFECT DIS, V162, P738, DOI 10.1093/infdis/162.3.738; de Jong EP, 2010, NEONATOLOGY, V97, P274, DOI 10.1159/000255166; de Vries JJC, 2011, J MED VIROL, V83, P1777, DOI 10.1002/jmv.22181; De Vries LS, 2004, NEUROPEDIATRICS, V35, P113, DOI 10.1055/s-2004-815833; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005; Hamprecht K, 2001, LANCET, V357, P513, DOI 10.1016/S0140-6736(00)04043-5; Leijser LM, 2010, ARCH DIS CHILD-FETAL, V95, pF42, DOI 10.1136/adc.2009.161935; Leruez-Ville M, 2011, CLIN INFECT DIS, V52, P575, DOI 10.1093/cid/ciq241; Lurain NS, 1999, J VIROL, V73, P10040, DOI 10.1128/JVI.73.12.10040-10050.1999; Manuel O, 2009, CLIN INFECT DIS, V49, P1160, DOI 10.1086/605633; Meyer-Konig U, 1998, J INFECT DIS, V177, P1162, DOI 10.1086/515262; Murayama T, 2005, INTERVIROLOGY, V48, P201, DOI 10.1159/000081749; Mussi-Pinhata MM, 2003, J MED VIROL, V69, P232, DOI 10.1002/jmv.10271; Nijman J, 2012, PEDIATR INFECT DIS J, V31, P1082, DOI 10.1097/INF.0b013e31825eb3e5; Nijman J, 2012, ARCH DIS CHILD-FETAL, V97, pF259, DOI 10.1136/archdischild-2011-300405; Nijman J, 2012, J CLIN VIROL, V54, P121, DOI 10.1016/j.jcv.2012.02.017; Paradowska E, 2012, EUR J CLIN MICROBIOL, V31, P1335, DOI 10.1007/s10096-011-1447-z; Paradowska E, 2014, J MED VIROL, P1, DOI [10.1002/jmv, DOI 10.1002/JMV]; Paradowska E, 2013, J CLIN VIROL, V58, P271, DOI 10.1016/j.jcv.2013.05.024; Picone O, 2004, PRENATAL DIAG, V24, P1001, DOI 10.1002/pd.942; Pignatelli S, 2010, CLIN INFECT DIS, V51, P33, DOI 10.1086/653423; Revello MG, 2008, J MED VIROL, V80, P1415, DOI 10.1002/jmv.21243; Revello MG, 1999, J CLIN VIROL, V14, P57, DOI 10.1016/S1386-6532(99)00016-5; Ross SA, 2009, PEDIATR INFECT DIS J, V28, P588, DOI 10.1097/INF.0b013e3181979a27; Scanga L, 2006, J MOL DIAGN, V8, P240, DOI 10.2353/jmoldx.2006.050075; Shepp DH, 1998, RES VIROLOGY, V149, P109, DOI 10.1016/S0923-2516(98)80086-1; Stranska R, 2006, J CLIN MICROBIOL, V44, P1108, DOI 10.1128/JCM.44.3.1108-1110.2006; Vollmer B, 2004, PEDIATR INFECT DIS J, V23, P322, DOI 10.1097/00006454-200404000-00009; Waters A, 2010, J CLIN MICROBIOL, V48, P3956, DOI 10.1128/JCM.01133-10; Yan H, 2008, ARCH VIROL, V153, P667, DOI 10.1007/s00705-008-0044-7; Yu ZS, 2006, INTERVIROLOGY, V49, P281, DOI 10.1159/000093458	39	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108018	10.1371/journal.pone.0108018	http://dx.doi.org/10.1371/journal.pone.0108018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268349	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700060
J	Petrov, A; Beer, M; Blome, S				Petrov, Anja; Beer, Martin; Blome, Sandra			Development and Validation of a Harmonized TaqMan-Based Triplex Real-Time RT-PCR Protocol for the Quantitative Detection of Normalized Gene Expression Profiles of Seven Porcine Cytokines	PLOS ONE			English	Article							AFRICAN-SWINE-FEVER; RESPIRATORY SYNDROME VIRUS; BLOOD MONONUCLEAR-CELLS; MESSENGER-RNA; MYCOBACTERIUM-TUBERCULOSIS; INFLAMMATORY CYTOKINES; INFECTION; PIGS; INTERFERON; QUANTIFICATION	Dysregulation of cytokine responses plays a major role in the pathogenesis of severe and life-threatening infectious diseases like septicemia or viral hemorrhagic fevers. In pigs, diseases like African and classical swine fever are known to show exaggerated cytokine releases. To study these responses and their impact on disease severity and outcome in detail, reliable, highly specific and sensitive methods are needed. For cytokine research on the molecular level, real-time RT-PCRs have been proven to be suitable. Yet, the currently available and most commonly used SYBR Green I assays or heterogeneous gel-based RT-PCRs for swine show a significant lack of specificity and sensitivity. The latter is however absolutely essential for an accurate quantification of rare cytokine transcripts as well as for detection of small changes in gene expressions. For this reason, a harmonized TaqMan-based triplex real-time RT-PCR protocol for the quantitative detection of normalized gene expression profiles of seven porcine cytokines was designed and validated within the presented study. Cytokines were chosen to represent different immunological pathways and targets known to be involved in the pathogenesis of the above mentioned porcine diseases, namely interleukin (IL)-1 beta, IL-2, IL-4, IL-6, IL-8, tumor necrosis factor (TNF)-alpha and interferon (IFN)-alpha. Beta-Actin and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) served as reference genes for normalization. For absolute quantification a synthetic standard plasmid was constructed comprising all target cytokines and reference genes within a single molecule allowing the generation of positive control RNA. The standard as well as positive RNAs from samples, and additionally more than 400 clinical samples, which were collected from animal trials, were included in the validation process to assess analytical sensitivity and applicability under routine conditions. The resulting assay allows the reliable assessment of gene expression profiles and provides a broad applicability to any kind of immunological research in swine.	[Petrov, Anja; Beer, Martin; Blome, Sandra] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany	Friedrich Loeffler Institute	Blome, S (corresponding author), Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany.	sandra.blome@fli.bund.de			network of competence PHANOMICS (BMBF) [0315536F]	network of competence PHANOMICS (BMBF)	The research leading to these results has received funding through the network of competence PHANOMICS (BMBF support code 0315536F), http://www.phaenomics.auf.uni-rostock.de/en-home.html. Funding only covered salaries and consumables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista EA, 2005, J VIROL, V79, P4838, DOI 10.1128/JVI.79.8.4838-4847.2005; Blome S, 2013, VIRUS RES, V173, P122, DOI 10.1016/j.virusres.2012.10.026; Bray M, 2005, CURR OPIN IMMUNOL, V17, P399, DOI 10.1016/j.coi.2005.05.001; Charerntantanakul W, 2013, VET IMMUNOL IMMUNOP, V153, P107, DOI 10.1016/j.vetimm.2013.02.013; CHARLEY B, 1990, VET IMMUNOL IMMUNOP, V25, P117, DOI 10.1016/0165-2427(90)90029-R; Choi C, 2006, J COMP PATHOL, V134, P40, DOI 10.1016/j.jcpa.2005.06.009; Costard S, 2009, PHILOS T R SOC B, V364, P2683, DOI 10.1098/rstb.2009.0098; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; de Jager W, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-52; Demissie A, 2004, J IMMUNOL, V172, P6938, DOI 10.4049/jimmunol.172.11.6938; Duvigneau JC, 2005, J IMMUNOL METHODS, V306, P16, DOI 10.1016/j.jim.2005.06.021; Espino AM, 2010, VET PARASITOL, V169, P82, DOI 10.1016/j.vetpar.2009.12.018; Facci MR, 2011, VET IMMUNOL IMMUNOP, V141, P11, DOI 10.1016/j.vetimm.2011.01.005; Ferrari L, 2013, VET IMMUNOL IMMUNOP, V151, P193, DOI 10.1016/j.vetimm.2012.11.006; Fletcher HA, 2004, IMMUNOLOGY, V112, P669, DOI 10.1111/j.1365-2567.2004.01922.x; Forlenza M, 2012, METHODS MOL BIOL, V820, P7, DOI 10.1007/978-1-61779-439-1_2; Hoffmann B, 2013, VET MICROBIOL, V167, P289, DOI 10.1016/j.vetmic.2013.09.002; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Islam MA, 2012, CYTOKINE, V60, P707, DOI 10.1016/j.cyto.2012.08.011; Iwasaki A, 2011, CELL, V146, P861, DOI 10.1016/j.cell.2011.08.027; Knoetig SM, 2002, ANTIVIR RES, V53, P75, DOI 10.1016/S0166-3542(01)00193-0; Kumar N, 2013, PARASITOL RES, V112, P3561, DOI 10.1007/s00436-013-3540-y; Lange A, 2010, VITRO VIVO DETEMINAT, P96; Lange A, 2011, BERL MUNCH TIERARZTL, V124, P36, DOI 10.2376/0005-9366-124-36; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Manual OT, 2018, AVIAN INFECT BRONCHI; Sanchez-Vizcaino JM, 2013, VET MICROBIOL, V165, P45, DOI 10.1016/j.vetmic.2012.11.030; OGARRA A, 1994, CURR OPIN IMMUNOL, V6, P458, DOI 10.1016/0952-7915(94)90128-7; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; PDTW J, 1996, ZELLULARE MOL GRUNDL, P183; Razzuoli E, 2011, SCAND J IMMUNOL, V74, P412, DOI 10.1111/j.1365-3083.2011.02586.x; Sanchez-Matamoros A, 2013, CYTOKINE, V61, P50, DOI 10.1016/j.cyto.2012.10.004; Santagati S, 1997, BRAIN RES PROTOC, V1, P217, DOI 10.1016/S1385-299X(96)00033-5; Segura M, 2006, FEMS IMMUNOL MED MIC, V47, P92, DOI 10.1111/j.1574-695X.2006.00067.x; Shi KC, 2010, VET MICROBIOL, V140, P155, DOI 10.1016/j.vetmic.2009.07.021; Sorensen NS, 2011, VET IMMUNOL IMMUNOP, V139, P296, DOI 10.1016/j.vetimm.2010.10.016; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Techau ME, 2007, VET RES, V38, P25, DOI 10.1051/vetres:2006042; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947; Vanysacker L, 2014, J MICROBIOL METH, V97, P6, DOI 10.1016/j.mimet.2013.11.016; Verfaillie T, 2001, VET IMMUNOL IMMUNOP, V81, P97, DOI 10.1016/S0165-2427(01)00339-7; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Yang XQ, 2012, MOL BIOL REP, V39, P7003, DOI 10.1007/s11033-012-1530-2	44	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108910	10.1371/journal.pone.0108910	http://dx.doi.org/10.1371/journal.pone.0108910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268123	Green Submitted, gold, Green Published			2022-12-27	WOS:000343671700188
J	Sun, J; Wang, XD; Cheng, GW; Wu, JB; Hong, JT; Niu, SL				Sun, Jian; Wang, Xiaodan; Cheng, Genwei; Wu, Jianbo; Hong, Jiangtao; Niu, Shuli			Effects of Grazing Regimes on Plant Traits and Soil Nutrients in an Alpine Steppe, Northern Tibetan Plateau	PLOS ONE			English	Article							BELOW-GROUND BIOMASS; INNER-MONGOLIA; CARBON STORAGE; ABOVEGROUND BIOMASS; PHYSICAL-PROPERTIES; GLOBAL PATTERNS; ORGANIC-CARBON; LOESS PLATEAU; GRASSLAND; ALLOCATION	Understanding the impact of grazing intensity on grassland production and soil fertility is of fundamental importance for grassland conservation and management. We thus compared three types of alpine steppe management by studying vegetation traits and soil properties in response to three levels of grazing pressure: permanent grazing (M1), seasonal grazing (M2), and grazing exclusion (M3) in the alpine steppe in Xainza County, Tibetan Plateau. The results showed that community biomass allocation did not support the isometric hypothesis under different grassland management types. Plants in M1 had less aboveground biomass but more belowground biomass in the top soil layer than those in M2 and M3, which was largely due to that root/shoot ratios of dominant plants in M1 were far greater than those in M2 and M3. The interramet distance and the tiller size of the dominant clonal plants were greater in M3 than in M1 and M2, while the resprouting from rhizome buds did not differ significantly among the three greezing regimes. Both soil bulk density and soil available nitrogen in M3 were greater than in M1 at the 15-30 cm soil depth (P = 0.05). Soil organic carbon and soil total nitrogen were greater in M3 than in M1 and M2 (P = 0.05). We conclude that the isometric hypothesis is not supported in this study and fencing is a helpful grassland management in terms of plant growth and soil nutrient retention in alpine steppe. The extreme cold, scarce precipitation and short growing period may be the causation of the unique plant and soil responses to different management regimes.	[Sun, Jian; Niu, Shuli] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modelling, Synth Res Ctr,Chinese Ecosyst Res Network, Beijing, Peoples R China; [Wang, Xiaodan; Cheng, Genwei; Wu, Jianbo; Hong, Jiangtao] Chinese Acad Sci, Inst Mt Hazard & Environm, Key Lab Mt Surface Proc & Ecoregulat, Chengdu, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS	Wang, XD (corresponding author), Chinese Acad Sci, Inst Mt Hazard & Environm, Key Lab Mt Surface Proc & Ecoregulat, Chengdu, Peoples R China.	wxd@imde.ac.cn	Sun, Jian/I-9740-2016	Sun, Jian/0000-0001-8765-5015; Niu, Shuli/0000-0002-2394-2864	Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-XB3-08]; CAS Strategic Priority Research Program [XDA05050602]; Open Fund of Key Laboratory of Ecosystem Network Observation and Modelling [110301A1PA]	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); CAS Strategic Priority Research Program; Open Fund of Key Laboratory of Ecosystem Network Observation and Modelling	This research was jointly funded by the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-XB3-08), CAS Strategic Priority Research Program (XDA05050602), and the Open Fund of Key Laboratory of Ecosystem Network Observation and Modelling (110301A1PA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo JR, 2007, AGR ECOSYST ENVIRON, V118, P291, DOI 10.1016/j.agee.2006.05.029; Bao SD, 2000, SOIL CHEM ANLYSIS AG; BARUCH Z, 1994, PLANT SOIL, V164, P87, DOI 10.1007/BF00010114; Burke IC, 1999, ECOSYSTEMS, V2, P422, DOI 10.1007/s100219900091; Cheng DL, 2007, ANN BOT-LONDON, V99, P95, DOI 10.1093/aob/mcl206; Cheng J, 2011, PLANT SOIL ENVIRON, V57, P40, DOI 10.17221/153/2010-PSE; Cheplick GP, 1997, OIKOS, V79, P581, DOI 10.2307/3546902; Enquist BJ, 2002, TREE PHYSIOL, V22, P1045, DOI 10.1093/treephys/22.15-16.1045; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Evans CRW, 2012, CAN J SOIL SCI, V92, P685, DOI [10.4141/CJSS2011-070, 10.4141/cjss2011-070]; Fan YJ, 2013, RUSS J ECOL+, V44, P80, DOI 10.1134/S1067413612050165; Gao QZ, 2009, CLIMATIC CHANGE, V97, P515, DOI 10.1007/s10584-009-9617-z; Gao Y, 2012, PLANT SOIL, V359, P137, DOI 10.1007/s11104-012-1148-0; Gao YZ, 2008, PLANT SOIL, V307, P41, DOI 10.1007/s11104-008-9579-3; Gao YH, 2009, J FOOD AGRIC ENVIRON, V7, P749; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Haynes AG, 2014, PLANT SOIL, V374, P579, DOI 10.1007/s11104-013-1905-8; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; HILBERT DW, 1981, OECOLOGIA, V51, P14, DOI 10.1007/BF00344645; Hu JY, 2007, THESIS I BOT CHINESE; JONSDOTTIR IS, 1991, OIKOS, V62, P177, DOI 10.2307/3545263; Li HT, 2006, J INTEGR PLANT BIOL, V48, P268, DOI 10.1111/j.1744-7909.2006.00222.x; Liu M, 2014, CHINESE GEOGR SCI, V24, P471, DOI 10.1007/s11769-014-0706-1; Lkhagva A, 2013, GRASSL SCI, V59, P135, DOI 10.1111/grs.12022; Lu XY, 2011, AFR J AGR RES, V6, P2066; Lu XY, 2013, PLOS ONE, V8; Ma WH, 2010, SCI CHINA LIFE SCI, V53, P841, DOI 10.1007/s11427-010-4020-6; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; Medina-Roldan E, 2012, AGR ECOSYST ENVIRON, V149, P118, DOI 10.1016/j.agee.2011.12.012; Niklas KJ, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P25; PANDEY CB, 1992, CAN J BOT, V70, P1885, DOI 10.1139/b92-233; Patty L, 2010, FLORA, V205, P695, DOI 10.1016/j.flora.2009.12.039; Reich PB, 2010, P ROY SOC B-BIOL SCI, V277, P877, DOI 10.1098/rspb.2009.1818; Risch AC, 2013, ECOSYSTEMS, V16, P1192, DOI 10.1007/s10021-013-9676-x; RODRIGUEZ MA, 1995, J VEG SCI, V6, P63, DOI 10.2307/3236257; Sanchez-Vilas J, 2012, ANN BOT-LONDON, V110, P839, DOI 10.1093/aob/mcs157; Shi XM, 2013, ECOL ENG, V57, P183, DOI 10.1016/j.ecoleng.2013.04.032; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Smit C, 2010, BASIC APPL ECOL, V11, P685, DOI 10.1016/j.baae.2010.08.010; Sosnova M, 2010, AQUAT BOT, V92, P33, DOI 10.1016/j.aquabot.2009.09.005; Steffens M, 2008, GEODERMA, V143, P63, DOI 10.1016/j.geoderma.2007.09.004; Sun DS, 2011, PLANT SOIL ENVIRON, V57, P271, DOI 10.17221/7/2011-PSE; Sun J, 2013, BIOGEOSCIENCES, V10, P1707, DOI 10.5194/bg-10-1707-2013; Sun J, 2013, REMOTE SENS-BASEL, V5, P1894, DOI 10.3390/rs5041894; Tolvanen A, 2001, EVOL ECOL, V15, P443, DOI 10.1023/A:1016049301905; Wang GX, 2003, CHINESE SCI BULL, V48, P118, DOI 10.1360/03tb9023; Wang LA, 2010, SCI CHINA LIFE SCI, V53, P851, DOI 10.1007/s11427-010-4027-z; Wang XD, 2006, GEODERMA, V134, P56, DOI 10.1016/j.geoderma.2005.08.014; Wang XD, 2012, PLANT SOIL, V354, P173, DOI 10.1007/s11104-011-1053-y; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Whitford WG, 2012, J ARID ENVIRON, V83, P10, DOI 10.1016/j.jaridenv.2012.03.021; Wu GL, 2010, PLANT SOIL, V332, P331, DOI 10.1007/s11104-010-0299-0; Wu GL, 2009, PLANT SOIL, V319, P115, DOI 10.1007/s11104-008-9854-3; Xie JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041502; Xie YZ, 2004, ACTA OECOL, V25, P197, DOI 10.1016/j.actao.2004.01.004; Yang XH, 2012, INT J REMOTE SENS, V33, P5087, DOI 10.1080/01431161.2012.657372; Yang YH, 2011, J ECOL, V99, P431, DOI 10.1111/j.1365-2745.2010.01774.x; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Yates CJ, 2000, AUSTRAL ECOL, V25, P36, DOI 10.1046/j.1442-9993.2000.01030.x; Yu FH, 2004, NEW PHYTOL, V162, P697, DOI 10.1111/j.1469-8137.2004.01073.x; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Zheng SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051750; Zhou ZC, 2010, CATENA, V82, P87, DOI 10.1016/j.catena.2010.05.005	64	18	32	14	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108821	10.1371/journal.pone.0108821	http://dx.doi.org/10.1371/journal.pone.0108821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268517	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700171
J	Tsao, CM; Jhang, JG; Chen, SJ; Ka, SM; Wu, TC; Liaw, WJ; Huang, HC; Wu, CC				Tsao, Cheng-Ming; Jhang, Jhih-Gang; Chen, Shiu-Jen; Ka, Shuk-Man; Wu, Tao-Cheng; Liaw, Wen-Jinn; Huang, Hsieh-Chou; Wu, Chin-Chen			Adjuvant Potential of Selegiline in Attenuating Organ Dysfunction in Septic Rats with Peritonitis	PLOS ONE			English	Article							MONOAMINE-OXIDASE-B; CARDIOVASCULAR-RESPONSES; PARKINSONS-DISEASE; IMPROVES SURVIVAL; OXIDATIVE STRESS; NITRIC-OXIDE; L-DOPA; SEPSIS; APOPTOSIS; INHIBITORS	Selegiline, an anti-Parkinson drug, has antioxidant and anti-apoptotic effects. To explore the effect of selegiline on sepsis, we used a clinically relevant animal model of polymicrobial sepsis. Cecal ligation and puncture (CLP) or sham operation was performed in male rats under anesthesia. Three hours after surgery, animals were randomized to receive intravenously selegiline (3 mg/kg) or an equivalent volume of saline. The administration of CLP rats with selegiline (i) increased arterial blood pressure and vascular responsiveness to norepinephrine, (ii) reduced plasma liver and kidney dysfunction, (iii) attenuated metabolic acidosis, (iv) decreased neutrophil infiltration in liver and lung, and (v) improved survival rate (from 44% to 65%), compared to those in the CLP alone rats. The CLP-induced increases of plasma interleukin-6, organ superoxide levels, and liver inducible nitric oxide synthase and caspase-3 expressions were ameliorated by selegiline treatment. In addition, the histological changes in liver and lung were significantly attenuated in the selegiline -treated CLP group compared to those in the CLP group. The improvement of organ dysfunction and survival through reducing inflammation, oxidative stress and apoptosis in peritonitis-induced sepsis by selegiline has potential as an adjuvant agent for critical ill.	[Tsao, Cheng-Ming] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Tsao, Cheng-Ming] Natl Yang Ming Univ, Taipei 112, Taiwan; [Tsao, Cheng-Ming; Liaw, Wen-Jinn] Natl Def Med Ctr, Triserv Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Jhang, Jhih-Gang; Wu, Chin-Chen] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Chen, Shiu-Jen] Kang Ning Jr Coll Med Care & Management, Dept Nursing, Taipei, Taiwan; [Chen, Shiu-Jen] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Ka, Shuk-Man] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan; [Wu, Tao-Cheng] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Wu, Tao-Cheng] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Liaw, Wen-Jinn] Tungs Taichung MetroHarbor Hosp, Dept Anesthesiol, Taichung, Taiwan; [Huang, Hsieh-Chou] Cheng Hsin Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Wu, Chin-Chen] Taipei Med Univ, Dept Pharmacol, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Tungs' Taichung MetroHarbor Hospital; Cheng Hsin General Hospital; Taipei Medical University	Huang, HC (corresponding author), Cheng Hsin Gen Hosp, Dept Anesthesiol, Taipei, Taiwan.	hc1.huang@xuite.net; ccwu@office365.ndmctsgh.edu.tw			National Science Council, Taiwan, R.O.C. [NSC 97-2320-B-016-006-MY3, 98-2314-B-075-005-MY3, 100-2320-B-016-008]; Cheng Hsin General Hospital, Taiwan, R.O.C. [CHGH 99-61]	National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Cheng Hsin General Hospital, Taiwan, R.O.C.	This work supported by grants from National Science Council, Taiwan, R.O.C. (NSC 97-2320-B-016-006-MY3, 98-2314-B-075-005-MY3 and 100-2320-B-016-008) and Cheng Hsin General Hospital, Taiwan, R.O.C. (CHGH 99-61). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi ZA, 2004, BRIT J PHARMACOL, V143, P371, DOI 10.1038/sj.bjp.0705962; Allard J, 2002, INT J IMPOT RES, V14, P518, DOI 10.1038/sj.ijir.3900934; Alvarez S, 2007, FRONT BIOSCI-LANDMRK, V12, P964, DOI 10.2741/2117; Bexis S, 2006, BRIT J PHARMACOL, V147, P926, DOI 10.1038/sj.bjp.0706688; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bommhardt U, 2004, J IMMUNOL, V172, P7583, DOI 10.4049/jimmunol.172.12.7583; Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Chen JJ, 2010, AM J MANAG CARE, V16, pS87; Finberg JPM, 2006, BRIT J PHARMACOL, V149, P647, DOI 10.1038/sj.bjp.0706908; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Glezer S, 2003, EUR J PHARMACOL, V472, P173, DOI 10.1016/S0014-2999(03)01906-X; Hattori Y, 2010, J PHARMACOL SCI, V114, P354, DOI 10.1254/jphs.10R04CR; Hauser RA, 2009, PARKINSONISM RELAT D, V15, pS17, DOI 10.1016/S1353-8020(09)70772-2; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1999, J IMMUNOL, V162, P4148; Jaeschke H, 2006, LIVER INT, V26, P912, DOI 10.1111/j.1478-3231.2006.01327.x; Kiray M, 2007, ACTA HISTOCHEM, V109, P480, DOI 10.1016/j.acthis.2007.04.008; KNOLLEMA S, 1995, STROKE, V26, P1883, DOI 10.1161/01.STR.26.10.1883; Magyar K, 2004, NEUROTOXICOLOGY, V25, P233, DOI 10.1016/S0161-813X(03)00102-5; Mizuno Y, 2010, CLIN NEUROPHARMACOL, V33, P1, DOI 10.1097/WNF.0b013e3181bbf45c; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nagatsu T, 2006, J NEURAL TRANSM-SUPP, P53; Naoi M, 2009, J NEURAL TRANSM, V116, P1371, DOI 10.1007/s00702-009-0309-7; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Oberholzer C, 2001, FASEB J, V15, P879, DOI 10.1096/fj.00-058rev; Olguner CG, 2013, EXP THER MED, V5, P1581, DOI 10.3892/etm.2013.1034; Qin FZ, 2003, EUR J PHARMACOL, V461, P149, DOI 10.1016/S0014-2999(03)01306-2; REYNOLDS GP, 1978, BRIT J CLIN PHARMACO, V6, P542, DOI 10.1111/j.1365-2125.1978.tb00883.x; Schlichting D, 2007, SOUTH MED J, V100, P594, DOI 10.1097/SMJ.0b013e31804aa29f; Simon L, 2001, EUR J PHARMACOL, V430, P235, DOI 10.1016/S0014-2999(01)01375-9; Sivenius J, 2001, NEUROREHAB NEURAL RE, V15, P183, DOI 10.1177/154596830101500305; Tatton W, 2003, J NEURAL TRANSM, V110, P509, DOI 10.1007/s00702-002-0827-z; Tharakan B, 2010, SHOCK, V33, P56, DOI 10.1097/SHK.0b013e3181a7fb7c; Tsai KL, 2014, J SURG RES, V186, P278, DOI 10.1016/j.jss.2013.08.010; Tsao CM, 2010, INTENS CARE MED, V36, P1571, DOI 10.1007/s00134-010-1839-z; Wesche-Soldato DE, 2007, CURR DRUG TARGETS, V8, P493, DOI 10.2174/138945007780362764; Whaley JG, 2009, J BURN CARE RES, V30, P1018, DOI 10.1097/BCR.0b013e3181bfb825; Yamada M, 2004, NEUROTOXICOLOGY, V25, P215, DOI 10.1016/S0161-813X(03)00097-4; Yang SL, 2002, SHOCK, V17, P55, DOI 10.1097/00024382-200201000-00010	41	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108455	10.1371/journal.pone.0108455	http://dx.doi.org/10.1371/journal.pone.0108455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268350	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700100
J	Zaghloul, N; Patel, H; Codipilly, C; Marambaud, P; Dewey, S; Frattini, S; Huerta, PT; Nasim, M; Miller, EJ; Ahmed, M				Zaghloul, Nahla; Patel, Hardik; Codipilly, Champa; Marambaud, Philippe; Dewey, Stephen; Frattini, Stephen; Huerta, Patricio T.; Nasim, Mansoor; Miller, Edmund J.; Ahmed, Mohamed			Overexpression of Extracellular Superoxide Dismutase Protects against Brain Injury Induced by Chronic Hypoxia	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NEURONAL CELL-DEATH; OXIDATIVE STRESS; NITRIC-OXIDE; NEURODEGENERATIVE DISEASES; INDUCIBLE FACTOR-1-ALPHA; INTERMITTENT HYPOXIA; EXPRESSION; MICE; ACTIVATION	Extracellular superoxide dismutase (EC-SOD) is an isoform of SOD normally found both intra- and extra-cellularly and accounting for most SOD activity in blood vessels. Here we explored the role of EC-SOD in protecting against brain damage induced by chronic hypoxia. EC-SOD Transgenic mice, were exposed to hypoxia (FiO2.1%) for 10 days (H-KI) and compared to transgenic animals housed in room air (RA-KI), wild type animals exposed to hypoxia (H-WT or wild type mice housed in room air (RA-WT). Overall brain metabolism evaluated by positron emission tomography (PET) showed that H-WT mice had significantly higher uptake of (18)FDG in the brain particularly the hippocampus, hypothalamus, and cerebellum. H-KI mice had comparable uptake to the RA-KI and RA-WT groups. To investigate the functional state of the hippocampus, electrophysiological techniques in ex vivo hippocampal slices were performed and showed that H-KI had normal synaptic plasticity, whereas H-WT were severely affected. Markers of oxidative stress, GFAP, IBA1, MIF, and pAMPK showed similar values in the H-KI and RA-WT groups, but were significantly increased in the H-WT group. Caspase-3 assay and histopathological studies showed significant apoptosis/cell damage in the H-WT group, but no significant difference in the H-KI group compared to the RA groups. The data suggest that EC-SOD has potential prophylactic and therapeutic roles in diseases with compromised brain oxygenation.	[Zaghloul, Nahla; Ahmed, Mohamed] Ohio State Univ, Div Neonatal Perinatal Med, Columbus, OH 43210 USA; [Zaghloul, Nahla; Ahmed, Mohamed] Nationwide Childrens Hosp, Columbus, OH USA; [Marambaud, Philippe] Feinstein Inst Med Res, Lab Memory Disorders, Manhasset, NY USA; [Dewey, Stephen] Feinstein Inst Med Res, Neuroimaging Dept, Manhasset, NY USA; [Frattini, Stephen; Huerta, Patricio T.] Feinstein Inst Med Res, Lab Immune & Neural Networks, Manhasset, NY USA; [Huerta, Patricio T.; Miller, Edmund J.] Hofstra North Shore LIJ Sch Med, Dept Mol Med, New York, NY USA; [Nasim, Mansoor] NSL IJ, Dept Pathol, Manhasset, NY USA; [Patel, Hardik; Codipilly, Champa; Miller, Edmund J.; Ahmed, Mohamed] Cohen Childrens Med Ctr, Div Neonatal Perinatal Med, Manhasset, NY USA; [Patel, Hardik; Codipilly, Champa; Miller, Edmund J.; Ahmed, Mohamed] Feinstein Inst Med Res, Lilling Family Res Lab, Manhasset, NY USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Northwell Health; Northwell Health; Northwell Health; Hofstra University; Northwell Health; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Northwell Health	Ahmed, M (corresponding author), Ohio State Univ, Div Neonatal Perinatal Med, Columbus, OH 43210 USA.	mahmed2@nshs.edu	Patel, Hardik/L-9000-2013	Patel, Hardik/0000-0003-3819-4691; Marambaud, Philippe/0000-0002-8983-1497; Huerta, Patricio/0000-0003-0270-2308	NIAID NIH HHS [P01 AI102852] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI102852] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agani FH, 2000, J BIOL CHEM, V275, P35863, DOI 10.1074/jbc.M005643200; Ahmed MN, 2003, AM J RESP CRIT CARE, V167, P400, DOI 10.1164/rccm.200202-108OC; Ahmed MN, 2004, PED RES A; Ahmed MN, 2012, MOL MED, V18, P38, DOI 10.2119/molmed.2011.00339; Ahmed MN, 2011, EXP LUNG RES, V37, P10, DOI 10.3109/01902148.2010.497893; Armogida M, 2011, BJ PHARM, V166, P1211; Avshalumov MV, 2004, NEURON GLIA BIOL, V1, P365, DOI 10.1017/S1740925X05000311; Bacher M, 1998, MOL MED, V4, P217, DOI 10.1007/BF03401919; Bass JL, 2004, PEDIATRICS, V114, P805, DOI 10.1542/peds.2004-0227; Bickler PE, 2004, J EXP BIOL, V207, P3243, DOI 10.1242/jeb.00977; Bickler PE, 2004, NEUROSCIENCE, V127, P673, DOI 10.1016/j.neuroscience.2004.05.035; Bickler PE, 2010, J NEUROSCI RES, V88, P3520, DOI 10.1002/jnr.22508; Brahimi-Horn MC, 2007, BIOCHEM PHARMACOL, V73, P450, DOI 10.1016/j.bcp.2006.10.013; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Carvalho C, 2010, CURR NEUROVASC RES, V7, P288, DOI 10.2174/156720210793180765; CERVOSNAVARRO J, 1991, EXP PATHOL-JENA, V42, P205, DOI 10.1016/S0232-1513(11)80067-8; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chang EH, 2006, P NATL ACAD SCI USA, V103, P3410, DOI 10.1073/pnas.0507313103; Chavez JC, 2000, J APPL PHYSIOL, V89, P1937, DOI 10.1152/jappl.2000.89.5.1937; Demchenko IT, 2002, CIRC RES, V91, P1031, DOI 10.1161/01.RES.0000043500.03647.81; Di Paola M, 2008, HIPPOCAMPUS, V18, P719, DOI 10.1002/hipo.20432; Dingyu H, 2009, BIOINFORMATICS BIOME, V20; Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004; Fabian RH, 2004, INT J DEV NEUROSCI, V22, P225, DOI 10.1016/j.ijdevneu.2004.03.006; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Fujimura M, 2000, J NEUROSCI, V20, P2817; Fukai T, 2000, J CLIN INVEST, V105, P1631, DOI 10.1172/JCI9551; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Han BH, 2000, NEUROBIOL DIS, V7, P38; Himadri P, 2010, HIGH ALT MED BIOL, V11, P231, DOI 10.1089/ham.2009.1057; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Huang LE, 1999, J BIOL CHEM, V274, P9038, DOI 10.1074/jbc.274.13.9038; Jin K, 2002, J CLIN INVEST, V110, P311, DOI 10.1172/JCI200215251; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Kim GW, 2002, STROKE, V33, P809, DOI 10.1161/hs0302.103745; Kim Y, 2011, FREE RADICAL BIO MED, V51, P1985, DOI 10.1016/j.freeradbiomed.2011.08.027; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Lee HM, 2008, FREE RADICAL BIO MED, V44, P807, DOI 10.1016/j.freeradbiomed.2007.11.005; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lu Q, 2012, FREE RADICAL BIO MED, V53, P1139, DOI 10.1016/j.freeradbiomed.2012.06.012; MARKLUND SL, 1984, J CLIN INVEST, V74, P1398, DOI 10.1172/JCI111550; Mateo AO, 2000, PHARMACOL RES, V42, P421, DOI 10.1006/phrs.2000.0701; Narasimhan P, 2003, MOL BRAIN RES, V113, P28, DOI 10.1016/S0169-328X(03)00062-7; Noshita N, 2002, J NEUROSCI, V22, P7923; Oury TD, 1996, LAB INVEST, V75, P617; Oury TD, 1999, BRAIN RES, V850, P96, DOI 10.1016/S0006-8993(99)02103-4; Oury TD, 1996, FREE RADICAL BIO MED, V20, P957, DOI 10.1016/0891-5849(95)02222-8; OURY TD, 1992, P NATL ACAD SCI USA, V89, P9715, DOI 10.1073/pnas.89.20.9715; Petersen SV, 2008, J BIOL CHEM, V283, P15031, DOI 10.1074/jbc.M801548200; Sheng H, 1999, NEUROSCIENCE, V88, P185, DOI 10.1016/S0306-4522(98)00208-5; Sheng H, 2000, EXP NEUROL, V163, P392, DOI 10.1006/exnr.2000.7363; Sheng HX, 1999, NEUROSCI LETT, V267, P13, DOI 10.1016/S0304-3940(99)00316-X; Sibenaller ZA, 2014, FREE RADICAL BIO MED, V69, P357, DOI 10.1016/j.freeradbiomed.2014.02.002; Sogawa K, 1998, P NATL ACAD SCI USA, V95, P7368, DOI 10.1073/pnas.95.13.7368; Sugawara T, 2002, J NEUROSCI, V22, P209, DOI 10.1523/JNEUROSCI.22-01-00209.2002; Sutter CH, 2000, P NATL ACAD SCI USA, V97, P4748, DOI 10.1073/pnas.080072497; Ten VS, 2010, J NEUROSCI, V30, P2077, DOI 10.1523/JNEUROSCI.5249-09.2010; Veasey SC, 2004, SLEEP, V27, P194, DOI 10.1093/sleep/27.2.194; Wang JY, 2006, CURR PHARM DESIGN, V12, P3521, DOI 10.2174/138161206778343109; Wang Li-li, 2011, Sichuan Da Xue Xue Bao Yi Xue Ban, V42, P199; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; Zaghloul N, 2012, FEBS J, V279, P871, DOI 10.1111/j.1742-4658.2012.08478.x; Zagorska A, 2004, ACTA BIOCHIM POL, V51, P563, DOI 10.18388/abp.2004_3545; Zelko IN, 2005, ENDOCRINOLOGY, V146, P332, DOI 10.1210/en.2004-1007; Zhan GX, 2005, AM J RESP CRIT CARE, V172, P921, DOI 10.1164/rccm.200504-581OC; Zhou M, 2007, J NEUROCHEM, V103, P2212, DOI 10.1111/j.1471-4159.2007.04906.x	67	19	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108168	10.1371/journal.pone.0108168	http://dx.doi.org/10.1371/journal.pone.0108168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268361	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700070
J	Dewari, PS; Bhargava, P				Dewari, Pooran Singh; Bhargava, Purnima			Genome-Wide Mapping of Yeast Histone Chaperone Anti-Silencing Function 1 Reveals Its Role in Condensin Binding with Chromatin	PLOS ONE			English	Article							RNA-POLYMERASE-II; REPLICATION FORK PROGRESSION; DNA-REPLICATION; S-PHASE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; REPLISOME INTEGRITY; REMODELING COMPLEX; GENE-EXPRESSION; ASF1 INCREASES	Genome-wide participation and importance of the histone chaperone Asf1 (Anti-Silencing Function 1) in diverse DNA transactions like replication, repair, heterochromatic silencing and transcription are well documented. Yet its genome-wide targets have not been reported. Using ChIP-seq method, we found that yeast Asf1 associates with 590 unique targets including centromeres, telomeres and condensin-binding sites. It is found selectively on highly transcribed regions, which include replication fork pause sites. Asf1 preferentially associates with the genes transcribed by RNA polymerase (pol) III where its presence affects RNA production and replication-independent histone exchange. On pol II-transcribed genes, a negative correlation is found between Asf1 and nucleosome occupancy. It is not enriched on most of the reported sites of histone exchange or on the genes, which are misregulated in the asf1 Delta cells. Interestingly, chromosome-wide distributions of Asf1 and one of the condensin subunits, Brn1 show a nearly identical pattern. Moreover, Brn1 shows reduced occupancy at various condensin-binding sites in asf1 Delta cells. These results along with high association of Asf1 with heterochromatic centromeres and telomeres ascribe novel roles to Asf1 in condensin loading and chromatin dynamics.	[Dewari, Pooran Singh; Bhargava, Purnima] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Bhargava, P (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	purnima@ccmb.res.in	Dewari, Pooran/N-3843-2018	Dewari, Pooran/0000-0002-0256-0218	Department of Biotechnology, Govt. of India [BT/PR8568/BRB/10/524/2006]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This work was partially supported by the in-house Institutional funding and partially by a research grant (BT/PR8568/BRB/10/524/2006, www.dbtindia.nic.in) to PB from the Department of Biotechnology, Govt. of India. The grant term is over now. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Adkins MW, 2004, J BIOL CHEM, V279, P52069, DOI 10.1074/jbc.M406113200; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Arimbasseri AG, 2008, MOL CELL BIOL, V28, P2598, DOI 10.1128/MCB.01953-07; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Bhargava P, 2010, PROTEOMICS, V10, P749, DOI 10.1002/pmic.200900464; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Damelin M, 2002, MOL CELL, V9, P563, DOI 10.1016/S1097-2765(02)00475-6; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Franco AA, 2005, GENE DEV, V19, P1365, DOI 10.1101/gad.1305005; G-Viks I, 2009, PLOS COMPUT BIOL, V5; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Jamai A, 2007, MOL CELL, V25, P345, DOI 10.1016/j.molcel.2007.01.019; Jansen A, 2011, MICROBIOL MOL BIOL R, V75, P301, DOI 10.1128/MMBR.00046-10; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; Kumar Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-402; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; Lin LJ, 2011, P NATL ACAD SCI USA, V108, P19599, DOI 10.1073/pnas.1111501108; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Mahapatra S, 2011, NUCLEIC ACIDS RES, V39, P4023, DOI 10.1093/nar/gkq1286; Minard LV, 2011, J BIOL CHEM, V286, P7082, DOI 10.1074/jbc.M110.193813; Misteli T, 2013, CELL, V152, P1209, DOI 10.1016/j.cell.2013.02.048; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Mousson F, 2007, CHROMOSOMA, V116, P79, DOI 10.1007/s00412-006-0087-z; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Prado F, 2004, EMBO REP, V5, P497, DOI 10.1038/sj.embor.7400128; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Sala A, 2011, EMBO J, V30, P1766, DOI 10.1038/emboj.2011.98; Schulz LL, 2006, FASEB J, V20, P488, DOI 10.1096/fj.05-5020fje; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Takahata S, 2009, MOL CELL, V34, P405, DOI 10.1016/j.molcel.2009.04.010; Thiriet C, 2005, GENE DEV, V19, P677, DOI 10.1101/gad.1265205; Tyler JK, 2002, EUR J BIOCHEM, V269, P2268, DOI 10.1046/j.1432-1033.2002.02890.x; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Zabaronick SR, 2005, MOL CELL BIOL, V25, P652, DOI 10.1128/MCB.25.2.652-660.2005; Zunder RM, 2012, MOL CELL BIOL, V32, P4337, DOI 10.1128/MCB.00871-12	54	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108652	10.1371/journal.pone.0108652	http://dx.doi.org/10.1371/journal.pone.0108652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264624	Green Submitted, Green Published, gold			2022-12-27	WOS:000345745400097
J	Harris, E; Rakobowchuk, M; Birch, KM				Harris, Emma; Rakobowchuk, Mark; Birch, Karen M.			Sprint Interval and Sprint Continuous Training Increases Circulating CD34(+) Cells and Cardio-Respiratory Fitness in Young Healthy Women	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; FLOW-MEDIATED VASODILATION; NITRIC-OXIDE SYNTHASE; PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; CARDIOVASCULAR EVENTS; BRACHIAL-ARTERY; ENOS CONTENT; SHEAR RATE; LOW-VOLUME	Introduction: The improvement of vascular health in the exercising limb can be attained by sprint interval training (SIT). However, the effects on systemic vascular function and on circulating angiogenic cells (CACs) which may contribute to endothelial repair have not been investigated. Additionally, a comparison between SIT and sprint continuous training (SCT) which is less time committing has not been made. Methods: 12 women (22 +/- 2 yrs) completed 12 sessions of either SIT (n=6) or work-matched SCT (n=6) on 3 days/week. Pre and post-training assessments included brachial artery endothelial function and peripheral blood analysis for CAC number (CD34(+)/CD34(+)CD45(dim)). CAC function was measured by migration and adhesion assays. Cardio-respiratory fitness, carotid arterial stiffness and carotid-radial and brachial-foot pulse wave velocity (PWV) were also evaluated. Results: CD34(+)CACs increased following training in both groups but CD34(+)CD45(dim) did not (Pre CD34(+): 40 +/- 21/10(5) leukocytes, Post CD34(+): 56 +/- 24/10(5) leukocytes, main time effect p<0.05). Brachial artery flow- mediated dilation (FMD) increased following SIT but SCT had no effect (Pre SIT: 5.0 +/- 3.4%, Post SIT: 5.9 +/- 3.0%, Pre SCT: 7.2 +/- 2.7%, Post SCT: 6.5 +/- 2.9%; group x time interaction rho=0.08). (V) over dotO(2max) increased in both training groups (Pre: 34.6 +/- 4.6 ml.kg.ml(-1), Post: 36.9 +/- 5.4 ml.kg.ml(-) (1), main time effect p<0.05). CAC function, carotid arterial stiffness and PWV did not change after training (p>0.05). Discussion: SCT involving little time commitment is comparable to SIT in increasing CD34(+) cell number and (V) over dotO(2max). An increased mobilisation of CD34(+) CACs suggests that sprint training may be an effective method to enhance vascular repair.	[Harris, Emma; Birch, Karen M.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England; [Rakobowchuk, Mark] Brunel Univ, Sch Sport & Educ, Uxbridge UB8 3PH, Middx, England	University of Leeds; Brunel University	Birch, KM (corresponding author), Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England.	k.m.birch@leeds.ac.uk	Harris, Emma/AAJ-8194-2020	Harris, Emma/0000-0002-7649-9763; Birch, Karen/0000-0001-7796-8640	University of Leeds; British Heart Foundation [PG/08/060/25340] Funding Source: researchfish	University of Leeds; British Heart Foundation(British Heart Foundation)	The work was supported by the University of Leeds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, BRIT HEART FDN PHYS; [Anonymous], 2010, BRIT HEART FDN COR H; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Birk GK, 2012, J APPL PHYSIOL, V8, P8; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; CHIU YC, 1991, AM HEART J, V121, P1460, DOI 10.1016/0002-8703(91)90153-9; Cocks M, 2013, J PHYSIOL-LONDON, V591, P641, DOI 10.1113/jphysiol.2012.239566; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Crosby JR, 2000, CIRC RES, V87, P728, DOI 10.1161/01.RES.87.9.728; Cubbon RM, 2010, ARTERIOSCL THROM VAS, V30, P878, DOI 10.1161/ATVBAHA.109.201012; Currie KD, 2013, MED SCI SPORT EXER, V45, P1436, DOI 10.1249/MSS.0b013e31828bbbd4; Doshi SN, 2001, CLIN SCI, V101, P629, DOI 10.1042/CS20010033; Dusserre N, 2004, ARTERIOSCL THROM VAS, V24, P1796, DOI 10.1161/01.ATV.0000141133.32496.41; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; George J, 2003, ARTERIOSCL THROM VAS, V23, pE57, DOI 10.1161/01.ATV.0000107029.65274.db; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Goto C, 2003, CIRCULATION, V108, P530, DOI 10.1161/01.CIR.0000080893.55729.28; Green DJ, 2011, HYPERTENSION, V57, P363, DOI 10.1161/HYPERTENSIONAHA.110.167015; Hambrecht R, 2003, CIRCULATION, V107, P3152, DOI 10.1161/01.CIR.0000074229.93804.5C; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Jenkins NT, 2013, HYPERTENSION, V61, P615, DOI 10.1161/HYPERTENSIONAHA.111.00561; KUCHAN MJ, 1994, AM J PHYSIOL, V266, pC628, DOI 10.1152/ajpcell.1994.266.3.C628; Laufs U, 2005, EUR J CARDIOV PREV R, V12, P407, DOI 10.1097/01.hjr.0000174823.87269.2e; Laughlin MH, 2008, J APPL PHYSIOL, V104, P588, DOI 10.1152/japplphysiol.01096.2007; Laughlin MH, 2004, J APPL PHYSIOL, V96, P233, DOI 10.1152/japplphysiol.00105.2003; Laukkanen JA, 2004, EUR HEART J, V25, P1428, DOI 10.1016/j.ehj.2004.06.013; McEleavy OD, 2004, DIABETIC MED, V21, P262, DOI 10.1111/j.1464-5491.2004.01127.x; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Morici G, 2005, AM J PHYSIOL-REG I, V289, pR1496, DOI 10.1152/ajpregu.00338.2005; Myers J, 1998, ANN INTERN MED, V129, P286, DOI 10.7326/0003-4819-129-4-199808150-00004; Naseem Khalid M., 2005, Molecular Aspects of Medicine, V26, P33, DOI 10.1016/j.mam.2004.09.003; Neunteufl T, 1997, ATHEROSCLEROSIS, V129, P111, DOI 10.1016/S0021-9150(96)06018-2; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; O'Rourke MF, 2001, BRIT J CLIN PHARMACO, V51, P507, DOI 10.1046/j.0306-5251.2001.01400.x; Rakobowchuk M, 2012, EUROPEAN J APPL PHYS, P1; Rakobowchuk M, 2008, AM J PHYSIOL-REG I, V295, pR236, DOI 10.1152/ajpregu.00069.2008; Rakobowchuk M, 2012, EXP PHYSIOL, V97, P375, DOI 10.1113/expphysiol.2011.062836; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rossiter HB, 2006, J APPL PHYSIOL, V100, P764, DOI 10.1152/japplphysiol.00932.2005; Sandri M, 2005, CIRCULATION, V111, P3391, DOI 10.1161/CIRCULATIONAHA.104.527135; Sarto P, 2007, J CARD FAIL, V13, P701, DOI 10.1016/j.cardfail.2007.06.722; Schmidt-Lucke C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013790; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Simmons GH, 2011, J APPL PHYSIOL, V110, P389, DOI 10.1152/japplphysiol.00936.2010; Simons PCG, 1999, CIRCULATION, V100, P951, DOI 10.1161/01.CIR.100.9.951; Steiner S, 2005, ATHEROSCLEROSIS, V181, P305, DOI 10.1016/j.atherosclerosis.2005.01.006; Takase B, 1998, AM J CARDIOL, V82, P1535, DOI 10.1016/S0002-9149(98)00702-4; Tanaka H, 2002, J APPL PHYSIOL, V92, P1458, DOI 10.1152/japplphysiol.00824.2001; Thijssen DHJ, 2006, AGING CELL, V5, P495, DOI 10.1111/j.1474-9726.2006.00242.x; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Thijssen DHJ, 2009, HYPERTENSION, V53, P986, DOI 10.1161/HYPERTENSIONAHA.109.131508; Tinken TM, 2010, HYPERTENSION, V55, P312, DOI 10.1161/HYPERTENSIONAHA.109.146282; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Whipp B J, 1986, Adv Cardiol, V35, P47; Whyte LJ, 2013, METABOLISM, V62, P212, DOI 10.1016/j.metabol.2012.07.019; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081	61	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108720	10.1371/journal.pone.0108720	http://dx.doi.org/10.1371/journal.pone.0108720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265043	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000345745400110
J	Lillis, L; Lehman, D; Singhal, MC; Cantera, J; Singleton, J; Labarre, P; Toyama, A; Piepenburg, O; Parker, M; Wood, R; Overbaugh, J; Boyle, DS				Lillis, Lorraine; Lehman, Dara; Singhal, Mitra C.; Cantera, Jason; Singleton, Jered; Labarre, Paul; Toyama, Anthony; Piepenburg, Olaf; Parker, Mathew; Wood, Robert; Overbaugh, Julie; Boyle, David S.			Non-Instrumented Incubation of a Recombinase Polymerase Amplification Assay for the Rapid and Sensitive Detection of Proviral HIV-1 DNA	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; DIAGNOSIS; LAMP; TUBERCULOSIS; FALCIPARUM; POINT; CARE	Sensitive diagnostic tests for infectious diseases often employ nucleic acid amplification technologies (NAATs). However, most NAAT assays, including many isothermal amplification methods, require power-dependent instrumentation for incubation. For use in low resource settings (LRS), diagnostics that do not require consistent electricity supply would be ideal. Recombinase polymerase amplification (RPA) is an isothermal amplification technology that has been shown to typically work at temperatures ranging from 25-43 degrees C, and does not require a stringent incubation temperature for optimal performance. Here we evaluate the ability to incubate an HIV-1 RPA assay, intended for use as an infant HIV diagnostic in LRS, at ambient temperatures or with a simple non-instrumented heat source. To determine the range of expected ambient temperatures in settings where an HIV-1 infant diagnostic would be of most use, a dataset of the seasonal range of daily temperatures in sub Saharan Africa was analyzed and revealed ambient temperatures as low as 10 degrees C and rarely above 43 degrees C. All 24 of 24 (100%) HIV-1 RPA reactions amplified when incubated for 20 minutes between 31 degrees C and 43 degrees C. The amplification from the HIV-1 RPA assay under investigation at temperatures was less consistent below 30 degrees C. Thus, we developed a chemical heater to incubate HIV-1 RPA assays when ambient temperatures are between 10 degrees C and 30 degrees C. All 12/12 (100%) reactions amplified with chemical heat incubation from ambient temperatures of 15 degrees C, 20 degrees C, 25 degrees C and 30 degrees C. We also observed that incubation at 30 minutes improved assay performance at lower temperatures where detection was sporadic using 20 minutes incubation. We have demonstrated that incubation of the RPA HIV-1 assay via ambient temperatures or using chemical heaters yields similar results to using electrically powered devices. We propose that this RPA HIV-1 assay may not need dedicated equipment to be a highly sensitive tool to diagnose infant HIV-1 in LRS.	[Lillis, Lorraine; Singhal, Mitra C.; Cantera, Jason; Singleton, Jered; Labarre, Paul; Toyama, Anthony; Boyle, David S.] PATH, Seattle, WA 98109 USA; [Lehman, Dara; Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Piepenburg, Olaf; Parker, Mathew] TwistDx Ltd, Cambridge, England; [Wood, Robert] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Boyle, DS (corresponding author), PATH, Seattle, WA 98109 USA.	dboyle@path.org	Wood, Robert/A-2989-2008	Wood, Robert/0000-0002-1401-3828; Cantera, Jason/0000-0001-7665-5458	United States National Institutes of Health, National Institute of Allergy and Infectious Diseases [R01AI097038]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097038] Funding Source: NIH RePORTER	United States National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the United States National Institutes of Health, National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx)via award number R01AI097038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almassian DR, 2013, CHEM SOC REV, V42, P8769, DOI 10.1039/c3cs60144g; Boyle DS, 2013, MBIO, V4, DOI 10.1128/mBio.00135-13; Byrnes S, 2013, ANAL METHODS-UK, V5, P3177, DOI 10.1039/c3ay40162f; Chow WHA, 2008, J MOL DIAGN, V10, P452, DOI 10.2353/jmoldx.2008.080008; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; CLOUSE KA, 1989, J IMMUNOL, V142, P431; COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Fang RD, 2009, J CLIN MICROBIOL, V47, P845, DOI 10.1128/JCM.01528-08; Hatano B, 2010, JPN J INFECT DIS, V63, P36; Huang SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060059; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kersting S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-99; Kim HJ, 2011, J CLIN VIROL, V50, P26, DOI 10.1016/j.jcv.2010.09.006; LaBarre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019738; LaBarre P, 2010, IEEE ENG MED BIO, P1097, DOI 10.1109/IEMBS.2010.5627346; McElgunn CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083808; Mitarai S, 2011, INT J TUBERC LUNG D, V15, P1211, DOI 10.5588/ijtld.10.0629; Mohon A, 2014, ACTA TROP, V134, P52, DOI 10.1016/j.actatropica.2014.02.016; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Niemz A, 2012, EXPERT REV MOL DIAGN, V12, P687, DOI [10.1586/ERM.12.71, 10.1586/erm.12.71]; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Pai NP, 2012, DISCOV MED, V13, P35; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Ratliff AE, 2014, J CLIN MICROBIOL, V52, P1060, DOI 10.1128/JCM.02913-13; Roskos K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069355; Sheffield J, 2006, J CLIMATE, V19, P3088, DOI 10.1175/JCLI3790.1; Surabattula R, 2013, EXP PARASITOL, V134, P333, DOI 10.1016/j.exppara.2013.03.031; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Vincent M, 2004, EMBO REP, V5, P795, DOI 10.1038/sj.embor.7400200; World Health Organization, 2007, PROM SAF MED CHILDR, P1	33	103	113	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108189	10.1371/journal.pone.0108189	http://dx.doi.org/10.1371/journal.pone.0108189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264766	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400053
J	Bourgeois, EB; Johnson, BN; McCoy, AJ; Trippa, L; Cohen, AS; Marsh, ED				Bourgeois, Elliot B.; Johnson, Brian N.; McCoy, Almedia J.; Trippa, Lorenzo; Cohen, Akiva S.; Marsh, Eric D.			A Toolbox for Spatiotemporal Analysis of Voltage-Sensitive Dye Imaging Data in Brain Slices	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; IN-VITRO; HIPPOCAMPUS; MUTATIONS; MODEL	Voltage-sensitive dye imaging (VSDI) can simultaneously monitor the spatiotemporal electrical dynamics of thousands of neurons and is often used to identify functional differences in models of neurological disease. While the chief advantage of VSDI is the ability to record spatiotemporal activity, there are no tools available to visualize and statistically compare activity across the full spatiotemporal range of the VSDI dataset. Investigators commonly analyze only a subset of the data, and a majority of the dataset is routinely excluded from analysis. We have developed a software toolbox that simplifies visual inspection of VSDI data, and permits unaided statistical comparison across spatial and temporal dimensions. First, the three-dimensional VSDI dataset (x, y, time) is geometrically transformed into a two-dimensional spatiotemporal map of activity. Second, statistical comparison between groups is performed using a non-parametric permutation test. The result is a 2D map of all significant differences in both space and time. Here, we used the toolbox to identify functional differences in activity in VSDI data from acute hippocampal slices obtained from epileptic Arx conditional knock-out and control mice. Maps of spatiotemporal activity were produced and analyzed to identify differences in the activity evoked by stimulation of each of two axonal inputs to the hippocampus: the perforant pathway and the temporoammonic pathway. In mutant hippocampal slices, the toolbox identified a widespread decrease in spatiotemporal activity evoked by the temporoammonic pathway. No significant differences were observed in the activity evoked by the perforant pathway. The VSDI toolbox permitted us to visualize and statistically compare activity across the spatiotemporal scope of the VSDI dataset. Sampling error was minimized because the representation of the data is standardized by the toolbox. Statistical comparisons were conducted quickly, across the spatiotemporal scope of the data, without a priori knowledge of the character of the responses or the likely differences between them.	[Bourgeois, Elliot B.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bourgeois, Elliot B.] Harvard Univ, Sch Med, Boston, MA USA; [Johnson, Brian N.; McCoy, Almedia J.; Cohen, Akiva S.; Marsh, Eric D.] Childrens Hosp Philadelphia, Dept Pediat, Div Pediat Neurol, Philadelphia, PA 19104 USA; [Trippa, Lorenzo] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Cohen, Akiva S.; Marsh, Eric D.] Univ Penn, Dept Neurol, Div Pediat Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Dana-Farber Cancer Institute; University of Pennsylvania; Pennsylvania Medicine	Bourgeois, EB (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	ebbourgeois@partners.org		Mccoy, Almedia/0000-0002-4843-1788	US National Institutes of Health [F32 NS080556, K02 NS065975, R01 NS082761, R01 HD059288, R01 NS069629, R01 NS046616]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046616, R01NS069629, K02NS065975, R01NS082761, F32NS080556] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this work was provided by the US National Institutes of Health to EBB (F32 NS080556), EDM (K02 NS065975 and R01 NS082761), ASC (R01 HD059288 and R01 NS069629), and Jeffrey A. Golden (R01 NS046616). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Ang CW, 2006, J NEUROSCI, V26, P11850, DOI 10.1523/JNEUROSCI.2354-06.2006; Bachtel AD, 2011, IEEE T BIO-MED ENG, V58, P2120, DOI 10.1109/TBME.2011.2148719; Bourgeois EB, 2009, IEEE T BIO-MED ENG, V56, P855, DOI 10.1109/TBME.2008.2007501; Carlson GC, 2008, NAT PROTOC, V3, P249, DOI 10.1038/nprot.2007.539; Contreras D, 2001, J NEUROSCI, V21, P9403, DOI 10.1523/JNEUROSCI.21-23-09403.2001; Friocourt G, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00004; Kitamura K, 2009, HUM MOL GENET, V18, P3708, DOI 10.1093/hmg/ddp318; Llinas RR, 2002, P NATL ACAD SCI USA, V99, P449, DOI 10.1073/pnas.012604899; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Marsh E, 2009, BRAIN, V132, P1563, DOI 10.1093/brain/awp107; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pathak HR, 2007, J NEUROSCI, V27, P14012, DOI 10.1523/JNEUROSCI.4390-07.2007; Slonim DK, 2002, NAT GENET, V32, P502, DOI 10.1038/ng1033; Tominaga T, 2002, J NEUROPHYSIOL, V88, P1523, DOI 10.1152/jn.2002.88.3.1523; Trippa L, 2011, ANN APPL STAT, V5, P1360, DOI 10.1214/10-AOAS438; Tsuda S, 2013, NEUROSCI RES, V75, P76, DOI 10.1016/j.neures.2012.11.006; Wester JC, 2012, J NEUROSCI, V32, P5454, DOI 10.1523/JNEUROSCI.5006-11.2012; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	19	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108686	10.1371/journal.pone.0108686	http://dx.doi.org/10.1371/journal.pone.0108686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259520	gold, Green Published, Green Submitted			2022-12-27	WOS:000342685600093
J	Gagliardi, AR; Straus, SE; Shojania, KG; Urbach, DR				Gagliardi, Anna R.; Straus, Sharon E.; Shojania, Kaveh G.; Urbach, David R.			Multiple Interacting Factors Influence Adherence, and Outcomes Associated with Surgical Safety Checklists: A Qualitative Study	PLOS ONE			English	Article							HEALTH-CARE; ADVERSE EVENTS; IMPLEMENTATION; CHALLENGES; MANAGEMENT; SURGEONS; PROTOCOL; NURSES	Objectives: The surgical safety checklist (SSC) is meant to enhance patient safety but studies of its impact conflict. This study explored factors that influenced SSC adherence to suggest how its impact could be optimized. Methods: Participants were recruited purposively by profession, region, hospital type and time using the SSC. They were asked to describe how the SSC was adopted, associated challenges, perceived impact, and suggestions for improving its use. Grounded theory and thematic analysis were used to collect and analyse data. Findings were interpreted using an implementation fidelity conceptual framework. Results: Fifty-one participants were interviewed (29 nurses, 13 surgeons, 9 anaesthetists; 18 small, 14 large and 19 teaching hospitals; 8 regions; 31 had used the SC for <= 12 months, 20 for 13+ months). The SSC was inconsistently reviewed, and often inaccurately documented as complete. Adherence was influenced by multiple issues. Extensive modification to accommodate existing practice patterns eliminated essential interaction at key time points to discuss patient management. Staff were often absent or not paying attention. They did not feel it was relevant to their work given limited evidence of its effectiveness, and because they were not engaged in its implementation. Organizations provided little support for implementation, training, monitoring and feedback, which are needed to overcome these, and other individual and team factors that challenged SSC adherence. Responses were similar across participants with different characteristics. Conclusions: Multiple processes and factors influenced SSC adherence. This may explain why, in studies evaluating SSC impact, outcomes were variable. Recommendations included continuing education, time for pilot-testing, and engaging all staff in SSC review. Others may use the implementation fidelity framework to plan SSC implementation or evaluate SSC adherence. Further research is needed to establish which SSC components can be modified without compromising its effectiveness.	[Gagliardi, Anna R.; Urbach, David R.] Univ Hlth Network, Toronto, ON, Canada; [Straus, Sharon E.] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Shojania, Kaveh G.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Gagliardi, AR (corresponding author), Univ Hlth Network, Toronto, ON, Canada.	anna.gagliardi@uhnresearch.ca			Canadian Foundation for Healthcare Improvement	Canadian Foundation for Healthcare Improvement	Research funding that supported this work was awarded to SES and KGS by the Canadian Health Services Research Foundation (now called Canadian Foundation for Healthcare Improvement) which took no part in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aveling EL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003039; Barbour RS, 2011, BMJ-BRIT MED J, V322, P1157; Bergs J, 2014, BRIT J SURG, V101, P150, DOI 10.1002/bjs.9381; Borchard A, 2012, ANN SURG, V256, P925, DOI 10.1097/SLA.0b013e3182682f27; Carroll C, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-40; Clark J., 2003, PEER REV HLTH SCI, V2nd ed.; Davies HTO, 2007, MED CARE RES REV, V64, P46, DOI 10.1177/1077558706296240; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; Dopson S, 2007, NURS RES, V56, pS72, DOI 10.1097/01.NNR.0000280635.71278.e9; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Fourcade A, 2012, BMJ QUAL SAF, V21, P191, DOI 10.1136/bmjqs-2011-000094; Gawande AA, 1999, SURGERY, V126, P66, DOI 10.1067/msy.1999.98664; Hagedorn HJ, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-46; Hales B, 2008, INT J QUAL HEALTH C, V20, P22, DOI 10.1093/intqhc/mzm062; Hannam JA, 2013, BMJ QUAL SAF, V22, P940, DOI 10.1136/bmjqs-2012-001749; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Healy JM, 2012, INT J QUAL HEALTH C, V24, P88, DOI 10.1093/intqhc/mzr078; Huijg JM, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-33; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Kable AK, 2002, INT J QUAL HEALTH C, V14, P269, DOI 10.1093/intqhc/14.4.269; Kash BA, 2014, J HEALTHC MANAG, V59, P65, DOI 10.1097/00115514-201401000-00011; Kaufman DM, 2003, BMJ-BRIT MED J, V326, P213, DOI 10.1136/bmj.326.7382.213; Lemieux-Charles L, 2006, MED CARE RES REV, V63, P263, DOI 10.1177/1077558706287003; Li LC, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-27; Lingard L, 2008, ARCH SURG-CHICAGO, V143, P12, DOI 10.1001/archsurg.2007.21; Lubbeke A, 2013, MED CARE, V51, P425, DOI 10.1097/MLR.0b013e31828d1489; Mannion R, 2005, J Health Organ Manag, V19, P431, DOI 10.1108/14777260510629689; Miles M., 1994, QUALITATIVE ANAL EXP; O'Connor P, 2013, PATIENT SAF SURG, V7, DOI 10.1186/1754-9493-7-14; Owen JA, 2014, J INTERPROF CARE, V28, P212, DOI 10.3109/13561820.2014.890581; Pickering SP, 2013, BRIT J SURG, V100, P1664, DOI 10.1002/bjs.9305; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Porter AJ, 2014, JT COMM J QUAL PATIE, V40, P3, DOI 10.1016/S1553-7250(14)40001-1; Rogers D, 2011, MED EDUC, V45, P939, DOI 10.1111/j.1365-2923.2011.04040.x; Russ S, 2013, ANN SURG, V258, P856, DOI 10.1097/SLA.0000000000000206; Saturno PJ, 2014, WORLD J SURG, V38, P287, DOI 10.1007/s00268-013-2300-6; Scott A, 2011, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD008451.PUB2; Simpson KM, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-2; Siriwardena AN, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-17; Strauss A.L., 2003, QUALITATIVE ANAL SOC; Tang R, 2014, ANZ J SURG, V84, P148, DOI 10.1111/ans.12168; Tillman M, 2013, J SURG RES, V184, P150, DOI 10.1016/j.jss.2013.03.048; Treadwell JR, 2014, BMJ QUAL SAF, V23, P299, DOI 10.1136/bmjqs-2012-001797; Urbach DR, 2014, NEW ENGL J MED, V370, P1029, DOI 10.1056/NEJMsa1308261; Vats A, 2010, BMJ-BRIT MED J, V340, P133; Waehle HV, 2012, BMC NURS, V11, DOI 10.1186/1472-6955-11-16; Wales A, 2012, SCOT MED J, V57, P221, DOI 10.1258/smj.2012.012122	47	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108585	10.1371/journal.pone.0108585	http://dx.doi.org/10.1371/journal.pone.0108585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IP	25260030	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600084
J	Wan, X; Torregrossa, MM; Sanchez, H; Nairn, AC; Taylor, JR				Wan, Xun; Torregrossa, Mary M.; Sanchez, Hayde; Nairn, Angus C.; Taylor, Jane R.			Activation of Exchange Protein Activated by cAMP in the Rat Basolateral Amygdala Impairs Reconsolidation of a Memory Associated with Self-Administered Cocaine	PLOS ONE			English	Article							HIPPOCAMPUS-DEPENDENT MEMORY; LONG-TERM-MEMORY; KINASE-A; NUCLEUS-ACCUMBENS; SEEKING BEHAVIOR; DRUG-SEEKING; CYCLIC-AMP; SYNAPTIC PLASTICITY; D-AMPHETAMINE; EPAC	The intracellular mechanisms underlying memory reconsolidation critically involve cAMP signaling. These events were originally attributed to PKA activation by cAMP, but the identification of Exchange Protein Activated by cAMP (Epac), as a distinct mediator of cAMP signaling, suggests that cAMP-regulated processes that subserve memory reconsolidation are more complex. Here we investigated how activation of Epac with 8-pCPT-cAMP (8-CPT) impacts reconsolidation of a memory that had been associated with cocaine self-administration. Rats were trained to lever press for cocaine on an FR-1 schedule, in which each cocaine delivery was paired with a tone+light cue. Lever pressing was then extinguished in the absence of cue presentations and cocaine delivery. Following the last day of extinction, rats were put in a novel context, in which the conditioned cue was presented to reactivate the cocaine-associated memory. Immediate bilateral infusions of 8-CPT into the basolateral amygdala (BLA) following reactivation disrupted subsequent cue-induced reinstatement in a dose-dependent manner, and modestly reduced responding for conditioned reinforcement. When 8-CPT infusions were delayed for 3 hours after the cue reactivation session or were given after a cue extinction session, no effect on cue-induced reinstatement was observed. Co-administration of 8-CPT and the PKA activator 6-Bnz-cAMP (10 nmol/side) rescued memory reconsolidation while 6-Bnz alone had no effect, suggesting an antagonizing interaction between the two cAMP signaling substrates. Taken together, these studies suggest that activation of Epac represents a parallel cAMP-dependent pathway that can inhibit reconsolidation of cocaine-cue memories and reduce the ability of the cue to produce reinstatement of cocaine-seeking behavior.	[Wan, Xun; Torregrossa, Mary M.; Sanchez, Hayde; Nairn, Angus C.; Taylor, Jane R.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA	Yale University	Taylor, JR (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	jane.taylor@yale.edu	Torregrossa, Mary/AAW-6740-2020; Torregrossa, Mary/N-6053-2017	Torregrossa, Mary/0000-0003-2083-0231; Torregrossa, Mary/0000-0003-2083-0231; Nairn, Angus/0000-0002-7075-0195	National Institutes on Drug Abuse [DA015222, K01DA031745]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015222, K01DA031745, P01DA010044] Funding Source: NIH RePORTER	National Institutes on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institutes on Drug Abuse, DA015222 (JRT) and K01DA031745 (MMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 2008, PROG BRAIN RES, V169, P97, DOI 10.1016/S0079-6123(07)00006-4; Alberini CM, 2006, CELL MOL LIFE SCI, V63, P999, DOI 10.1007/s00018-006-6025-7; Amaral OB, 2008, HIPPOCAMPUS, V18, P584, DOI 10.1002/hipo.20420; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; BOUTON ME, 1993, PSYCHOL BULL, V114, P80, DOI 10.1037/0033-2909.114.1.80; Bozon B, 2002, HIPPOCAMPUS, V12, P570, DOI 10.1002/hipo.10100; Brown TE, 2008, LEARN MEMORY, V15, P857, DOI 10.1101/lm.1152808; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Conklin CA, 2002, ADDICTION, V97, P155, DOI 10.1046/j.1360-0443.2002.00014.x; Crombag HS, 2008, PHILOS T R SOC B, V363, P3233, DOI 10.1098/rstb.2008.0090; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Debiec J, 2006, ANN NY ACAD SCI, V1071, P521, DOI 10.1196/annals.1364.056; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Gelinas JN, 2008, LEARN MEMORY, V15, P403, DOI 10.1101/lm.830008; George P, 2005, RAT BRAIN STEREOTAXI; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Grimm JW, 2000, NEUROPSYCHOPHARMACOL, V22, P473, DOI 10.1016/S0893-133X(99)00157-8; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Huang YY, 2004, P NATL ACAD SCI USA, V101, P859, DOI 10.1073/pnas.2237201100; Kantak KM, 2002, J NEUROSCI, V22, P1126, DOI 10.1523/JNEUROSCI.22-03-01126.2002; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kelley JB, 2007, NEUROREPORT, V18, P777, DOI 10.1097/WNR.0b013e3280c1e2e7; Lee JLC, 2006, J NEUROSCI, V26, P5881, DOI 10.1523/JNEUROSCI.0323-06.2006; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Ma N, 2009, LEARN MEMORY, V16, P367, DOI 10.1101/lm.1231009; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; McCleery JM, 2004, J TRAUMA STRESS, V17, P485, DOI 10.1007/s10960-004-5797-5; Miller RR, 2006, LEARN MEMORY, V13, P491, DOI 10.1101/lm.241006; Milton AL, 2008, J NEUROSCI, V28, P8230, DOI 10.1523/JNEUROSCI.1723-08.2008; Ouyang M, 2008, P NATL ACAD SCI USA, V105, P11993, DOI 10.1073/pnas.0804172105; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Sanchez H, 2010, J NEUROSCI, V30, P4401, DOI 10.1523/JNEUROSCI.3149-09.2010; Taylor JR, 2009, NEUROPHARMACOLOGY, V56, P186, DOI 10.1016/j.neuropharm.2008.07.027; TAYLOR JR, 1986, PSYCHOPHARMACOLOGY, V90, P390; TAYLOR JR, 1984, PSYCHOPHARMACOLOGY, V84, P405, DOI 10.1007/BF00555222; Torregrossa MM, 2010, J NEUROSCI, V30, P10526, DOI 10.1523/JNEUROSCI.2523-10.2010; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Tronson NC, 2006, NAT NEUROSCI, V9, P167, DOI 10.1038/nn1628; Volkow ND, 2008, PHILOS T R SOC B, V363, P3191, DOI 10.1098/rstb.2008.0107; Weiss F, 2001, ANN NY ACAD SCI, V937, P1, DOI 10.1111/j.1749-6632.2001.tb03556.x; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Xue YX, 2012, SCIENCE, V336, P241, DOI 10.1126/science.1215070	47	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107359	10.1371/journal.pone.0107359	http://dx.doi.org/10.1371/journal.pone.0107359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259911	gold, Green Published, Green Submitted			2022-12-27	WOS:000342685600019
J	Ashworth, J; Plaisier, CL; Lo, FY; Reiss, DJ; Baliga, NS				Ashworth, Justin; Plaisier, Christopher L.; Lo, Fang Yin; Reiss, David J.; Baliga, Nitin S.			Inference of Expanded Lrp-Like Feast/Famine Transcription Factor Targets in a Non-Model Organism Using Protein Structure-Based Prediction	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNA-BINDING; REGULATORY PROTEINS; CONTROL REGION; SS-LRPB; SULFOLOBUS-SOLFATARICUS; SEQUENCE; SPECIFICITY; SITES; RECOGNITION	Widespread microbial genome sequencing presents an opportunity to understand the gene regulatory networks of non-model organisms. This requires knowledge of the binding sites for transcription factors whose DNA-binding properties are unknown or difficult to infer. We adapted a protein structure-based method to predict the specificities and putative regulons of homologous transcription factors across diverse species. As a proof-of-concept we predicted the specificities and transcriptional target genes of divergent archaeal feast/famine regulatory proteins, several of which are encoded in the genome of Halobacterium salinarum. This was validated by comparison to experimentally determined specificities for transcription factors in distantly related extremophiles, chromatin immunoprecipitation experiments, and cis-regulatory sequence conservation across eighteen related species of halobacteria. Through this analysis we were able to infer that Halobacterium salinarum employs a divergent local trans-regulatory strategy to regulate genes (carA and carB) involved in arginine and pyrimidine metabolism, whereas Escherichia coli employs an operon. The prediction of gene regulatory binding sites using structure-based methods is useful for the inference of gene regulatory relationships in new species that are otherwise difficult to infer.	[Ashworth, Justin; Plaisier, Christopher L.; Lo, Fang Yin; Reiss, David J.; Baliga, Nitin S.] Inst Syst Biol, Seattle, WA 98109 USA; [Baliga, Nitin S.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle	Ashworth, J (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.	justin.ashworth@systemsbiology.org; nitin.baliga@systemsbiology.org	Plaisier, Christopher/HGD-5631-2022; Plaisier, Christohper L/H-3238-2019	Plaisier, Christohper L/0000-0003-3273-5717; baliga, nitin/0000-0001-9157-5974; Ashworth, Justin/0000-0003-4835-6551	NIH [P50 GM076547]; National Science Foundation (NSF); U.S. Department of Energy (DOE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (P50 GM076547), National Science Foundation (NSF) and the U.S. Department of Energy (DOE) to NSB. JA is a Gordon and Betty Moore Foundation Fellow of the Life Sciences Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashworth J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp242; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BOUVIER J, 1984, P NATL ACAD SCI-BIOL, V81, P4139, DOI 10.1073/pnas.81.13.4139; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cho BK, 2008, P NATL ACAD SCI USA, V105, P19462, DOI 10.1073/pnas.0807227105; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Contreras-Moreira B, 2007, BIOINFORMATICS, V23, P1694, DOI 10.1093/bioinformatics/btm148; Dufour YS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001027; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Facciotti MT, 2007, P NATL ACAD SCI USA, V104, P4630, DOI 10.1073/pnas.0611663104; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Gasch AP, 2004, PLOS BIOL, V2, P2202, DOI 10.1371/journal.pbio.0020398; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Gromiha MM, 2004, J MOL BIOL, V337, P285, DOI 10.1016/j.jmb.2004.01.033; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Havranek JJ, 2004, J MOL BIOL, V344, P59, DOI 10.1016/j.jmb.2004.09.029; Koike H, 2004, P NATL ACAD SCI USA, V101, P2840, DOI 10.1073/pnas.0400109101; KOLLING R, 1985, J BACTERIOL, V164, P310; Kono H, 1999, PROTEINS, V35, P114, DOI 10.1002/(SICI)1097-0134(19990401)35:1<114::AID-PROT11>3.0.CO;2-T; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lynch EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041389; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Morozov AV, 2007, P NATL ACAD SCI USA, V104, P7068, DOI 10.1073/pnas.0701356104; Morozov AV, 2005, NUCLEIC ACIDS RES, V33, P5781, DOI 10.1093/nar/gki875; Myers KS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003565; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Okamura H, 2007, STRUCTURE, V15, P1325, DOI 10.1016/j.str.2007.07.018; Ouhammouch M, 2001, EMBO J, V20, P146, DOI 10.1093/emboj/20.1.146; Peeters E, 2004, MOL MICROBIOL, V54, P321, DOI 10.1111/j.1365-2958.2004.04274.x; Peeters E, 2007, NUCLEIC ACIDS RES, V35, P623, DOI 10.1093/nar/gkl1095; Peeters E, 2010, ARCHAEA, V2010, DOI 10.1155/2010/750457; PIETTE J, 1984, P NATL ACAD SCI-BIOL, V81, P4134, DOI 10.1073/pnas.81.13.4134; Plaisier CL, 2014, EVOLUTION CONT UNPUB; Price MN, 2007, PLOS COMPUT BIOL, V3, P1739, DOI 10.1371/journal.pcbi.0030175; Reiss DJ, 2008, BIOINFORMATICS, V24, P396, DOI 10.1093/bioinformatics/btm592; Robertson TA, 2007, PROTEINS, V66, P359, DOI 10.1002/prot.21162; Sahota G, 2010, BIOINFORMATICS, V26, P2672, DOI 10.1093/bioinformatics/btq501; Seitzer P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-317; Song NN, 2013, NUCLEIC ACIDS RES, V41, P2932, DOI 10.1093/nar/gkt021; Trong ND, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-828; Wiese DE, 1997, J MOL BIOL, V270, P152, DOI 10.1006/jmbi.1997.1057; Wilbanks EG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks063; YANOVER C, 2011, NUCL ACIDS RES; Yokoyama K, 2006, FEMS MICROBIOL REV, V30, P89, DOI 10.1111/j.1574-6976.2005.00005.x; Yokoyama K, 2007, STRUCTURE, V15, P1542, DOI 10.1016/j.str.2007.10.015; Yokoyama K, 2009, NUCLEIC ACIDS RES, V37, P4407, DOI 10.1093/nar/gkp378; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	49	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107863	10.1371/journal.pone.0107863	http://dx.doi.org/10.1371/journal.pone.0107863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255272	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300037
J	Zhang, J; Sun, X; Zheng, SX; Liu, X; Jin, JH; Ren, Y; Luo, JH				Zhang, Jie; Sun, Xin; Zheng, Sixin; Liu, Xiao; Jin, Jinghua; Ren, Yi; Luo, Jianhong			Myelin Basic Protein Induces Neuron-Specific Toxicity by Directly Damaging the Neuronal Plasma Membrane	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; AXONAL REGENERATION; SPINAL-CORD; CELL-DEATH; IN-VITRO; HIPPOCAMPAL DEMYELINATION; PHOSPHOLIPID ASYMMETRY; UNSTRUCTURED PROTEINS; ACTIN-BINDING	The central nervous system (CNS) insults may cause massive demyelination and lead to the release of myelin-associated proteins including its major component myelin basic protein (MBP). MBP is reported to induce glial activation but its effect on neurons is still little known. Here we found that MBP specifically bound to the extracellular surface of the neuronal plasma membrane and induced neurotoxicity in vitro. This effect of MBP on neurons was basicity-dependent because the binding was blocked by acidic lipids and competed by other basic proteins. Further studies revealed that MBP induced damage to neuronal membrane integrity and function by depolarizing the resting membrane potential, increasing the permeability to cations and other molecules, and decreasing the membrane fluidity. At last, artificial liposome vesicle assay showed that MBP directly disturbed acidic lipid bilayer and resulted in increased membrane permeability. These results revealed that MBP induces neurotoxicity through its direct interaction with acidic components on the extracellular surface of neuronal membrane, which may suggest a possible contribution of MBP to the pathogenesis in the CNS disorders with myelin damage.	[Zhang, Jie; Sun, Xin; Zheng, Sixin; Liu, Xiao; Jin, Jinghua; Luo, Jianhong] Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Dept Neurobiol,Key Lab Med Neurobiol,Minist Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Xin] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, Baltimore, MD 21205 USA; [Ren, Yi] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	Zhejiang University; Johns Hopkins University; State University System of Florida; Florida State University	Luo, JH (corresponding author), Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Dept Neurobiol,Key Lab Med Neurobiol,Minist Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	luojianhong@zju.edu.cn	Luo, jian/HGE-7331-2022; ZHANG, Jie/S-6936-2019	ZHANG, Jie/0000-0002-5492-8088; Sun, Xin/0000-0001-8922-6361	National Natural Science Foundation of China [81171164]; National Basic Research Program of China [2010CB912002, 2014CB910300]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was support by the grants from National Natural Science Foundation of China (81171164) to Jianhong Luo, National Basic Research Program of China (2010CB912002 and 2014CB910300) to Jianhong Luo, and by the Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUGHAZALEH RI, 1992, J MEMBRANE BIOL, V128, P153; Aggarwal S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001577; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; BLAKEMORE WF, 1972, J NEUROCYTOL, V1, P413, DOI 10.1007/BF01102943; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Boggs J.M., 1982, LIPID PROTEIN INTERA, P1; Boggs JM, 2006, BIOCHEMISTRY-US, V45, P391, DOI 10.1021/bi0519194; Boggs JM, 2005, BIOCHEMISTRY-US, V44, P3524, DOI 10.1021/bi0473760; Boggs JM, 2000, BIOCHEMISTRY-US, V39, P7799, DOI 10.1021/bi0002129; BOGGS JM, 1977, BIOCHEMISTRY-US, V16, P5420, DOI 10.1021/bi00644a003; Bonetti B, 1997, ANN NEUROL, V42, P74, DOI 10.1002/ana.410420113; BOOTH DA, 1962, J NEUROCHEM, V9, P265, DOI 10.1111/j.1471-4159.1962.tb09448.x; Brosnan CF, 1996, BRAIN PATHOL, V6, P243, DOI 10.1111/j.1750-3639.1996.tb00853.x; Bruckheimer EM, 1996, J LEUKOCYTE BIOL, V59, P784, DOI 10.1002/jlb.59.6.784; Businaro R, 2002, GLIA, V37, P83, DOI 10.1002/glia.10018; Calderon TM, 2006, J NEUROIMMUNOL, V177, P27, DOI 10.1016/j.jneuroim.2006.05.003; Cammer W, 1999, J NEUROL SCI, V168, P116, DOI 10.1016/S0022-510X(99)00181-1; CARLTON WILLIAM W., 1967, LIFE SCI, V6, P11, DOI 10.1016/0024-3205(67)90356-6; Carre JL, 2002, NEUROSCI LETT, V330, P17, DOI 10.1016/S0304-3940(02)00709-7; Daigle JL, 2001, CANCER RES, V61, P8859; DOBROWOLSKI Z, 1986, EUR J CELL BIOL, V41, P65; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; DSouza SD, 1996, J EXP MED, V184, P2361, DOI 10.1084/jem.184.6.2361; Dutta R, 2013, ANN NEUROL, V73, P637, DOI 10.1002/ana.23860; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Filbin MT, 2008, NEURON, V60, P740, DOI 10.1016/j.neuron.2008.12.001; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GAHWILER BH, 1979, NEUROSCI LETT, V11, P317, DOI 10.1016/0304-3940(79)90015-6; GENDELMAN HE, 1985, ANN NEUROL, V18, P324, DOI 10.1002/ana.410180309; Geurts JJG, 2007, J NEUROPATH EXP NEUR, V66, P819, DOI 10.1097/nen.0b013e3181461f54; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hagemeier K, 2013, GLIA, V61, P1712, DOI 10.1002/glia.22552; Harauz G, 2004, MICRON, V35, P503, DOI 10.1016/j.micron.2004.04.005; Harauz G, 2009, BIOCHEMISTRY-US, V48, P8094, DOI 10.1021/bi901005f; HASTIE AT, 1987, AM REV RESPIR DIS, V135, P848, DOI 10.1164/arrd.1987.135.4.848; Hill CMD, 2005, BIOCHEMISTRY-US, V44, P16672, DOI 10.1021/bi050646+; Hoffmann J A, 1990, Protein Expr Purif, V1, P127, DOI 10.1016/1046-5928(90)90005-J; Hoffmann K, 2008, EXP NEUROL, V210, P308, DOI 10.1016/j.expneurol.2007.11.005; Jeon SB, 2008, J IMMUNOL, V181, P8077, DOI 10.4049/jimmunol.181.11.8077; JO EJ, 1995, BIOCHEMISTRY-US, V34, P13705, DOI 10.1021/bi00041a053; Klein C, 2003, BRAIN RES PROTOC, V11, P46, DOI 10.1016/S1385-299X(03)00016-3; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Kumar S, 2002, J NEUROCHEM, V82, P110, DOI 10.1046/j.1471-4159.2002.00943.x; LaPlaca MC, 2009, IEEE ENG MED BIO, P1113, DOI 10.1109/IEMBS.2009.5334457; LAUBSCHER A, 1979, EXPERIENTIA, V35, P1081, DOI 10.1007/BF01949954; LAUBSCHER A, 1979, N-S ARCH PHARMACOL, V310, P87, DOI 10.1007/BF00499878; Lee DHS, 2003, NAT REV DRUG DISCOV, V2, P872, DOI 10.1038/nrd1228; LEHNINGER AL, 1968, P NATL ACAD SCI USA, V60, P1069, DOI 10.1073/pnas.60.4.1069; Libich DS, 2003, PROTEIN SCI, V12, P1507, DOI 10.1110/ps.0303603; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Liuzzo JP, 1999, MOL MED, V5, P334, DOI 10.1007/BF03402069; MARTIN R, 1990, J IMMUNOL, V145, P540; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; McMahon EJ, 2002, J NEUROIMMUNOL, V130, P32, DOI 10.1016/S0165-5728(02)00205-9; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Meyer R, 2001, J NEUROSCI, V21, P6214, DOI 10.1523/JNEUROSCI.21-16-06214.2001; MODESTI NM, 1986, BIOCHEM BIOPH RES CO, V136, P482, DOI 10.1016/0006-291X(86)90466-3; MORGAN DML, 1989, J CELL SCI, V94, P553; Moscarello MA, 1997, ALTSCHUL SY, V4, P13; Powl AM, 2008, BIOCHEMISTRY-US, V47, P4317, DOI 10.1021/bi702409t; Prasad K, 1995, J BIOL CHEM, V270, P30551, DOI 10.1074/jbc.270.51.30551; Qiu S, 2009, J BIOL CHEM, V284, P20285, DOI 10.1074/jbc.M109.004960; Quinn Peter J, 2002, Subcell Biochem, V36, P39; READHEAD C, 1990, ANN NY ACAD SCI, V605, P280; SANKARAM MB, 1989, BIOCHEMISTRY-US, V28, P9699, DOI 10.1021/bi00451a024; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; South SA, 2000, GLIA, V29, P81, DOI 10.1002/(SICI)1098-1136(20000101)29:1<81::AID-GLIA8>3.0.CO;2-O; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Stapulionis R, 2008, J IMMUNOL, V180, P3946, DOI 10.4049/jimmunol.180.6.3946; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Sun X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009380; TERBEEST MBA, 1993, EUR J BIOCHEM, V211, P689; Tian Y, 2008, J NEUROSURG, V109, P881, DOI 10.3171/JNS/2008/109/11/0881; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsiperson V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015748; Tzeng SF, 1999, NEUROCHEM RES, V24, P255, DOI 10.1023/A:1022514105129; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vallieres N, 2006, GLIA, V53, P103, DOI 10.1002/glia.20266; Verkleij AJ, 2000, J MEMBRANE BIOL, V178, P1, DOI 10.1007/s002320010009; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; WESTALL FC, 1974, IMMUNOCHEMISTRY, V11, P513, DOI 10.1016/0019-2791(74)90124-4; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhao HY, 2012, J NEUROSCI, V32, P4600, DOI 10.1523/JNEUROSCI.6184-11.2012	87	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108646	10.1371/journal.pone.0108646	http://dx.doi.org/10.1371/journal.pone.0108646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255088	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300100
J	Chen, YL; Tsai, YT; Lee, CY; Lee, CH; Chen, CY; Liu, CM; Chen, JJ; Loh, SH; Tsai, CS				Chen, Yen-Ling; Tsai, Yi-Ting; Lee, Chung-Yi; Lee, Chien-Hsing; Chen, Chung-Yi; Liu, Chi-Ming; Chen, Jin-Jer; Loh, Shih-Hurng; Tsai, Chien-Sung			Urotensin II Inhibits Doxorubicin-Induced Human Umbilical Vein Endothelial Cell Death by Modulating ATF Expression and via the ERK and Akt Pathway	PLOS ONE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; SMOOTH-MUSCLE-CELLS; CARDIOMYOCYTE APOPTOSIS; TREATED-CELLS; CARDIOTOXICITY; PROMOTES; PROLIFERATION; PROTECTS; MYOCYTES	Background and Purpose: Regulation of the homeostasis of vascular endothelium is critical for the processes of vascular remodeling and angiogenesis under physiological and pathological conditions. Urotensin II (U-II), a potent vasoactive peptide, participates in vascular and myocardial remodeling after injury. We investigated the protective effect of U-II on doxorubicin (DOX)-induced apoptosis in cultured human umbilical vein endothelial cells (HUVECs) and the potential mechanisms involved in this process. Experimental Approach: Cultured HUVECs were treated with vehicle, DOX (1 mu M), U-II, or U-II plus DOX. Apoptosis was evaluated by DNA strand break level with TdT-mediated dUTP nick-end labeling (TUNEL) staining. Western blot analysis was employed to determine the related protein expression and flow cytometry assay was used to determine the TUNEL positive cells. Key Results: U-II reduced the quantity of cleaved caspase-3 and cytosol cytochrome c and increased Bcl-2 expression, which results in protecting HUVECs from DOX-induced apoptosis. U-II induced Activating transcription factor 3 (ATF3) at both mRNA and protein levels in U-II-treated cells. Knockdown of ATF3 with ATF3 siRNA significantly reduced ATF3 protein levels and U-II protective effect under DOX-treated condition. U-II downregulated p53 expression in DOX-induced HUVECs apoptosis, and it rapidly activated extracellular signal-regulated protein kinase (ERK) and Akt. The DOX induced change of p53 was not affected by U-II antagonist (urantide) under ATF-3 knockdown. The inhibitory effect of U-II on DOX-increased apoptosis was attenuated by inhibitors of ERK (U0126) and PI3K/Akt (LY294002). Conclusion and Implications: Our observations provide evidence that U-II protects HUVECs from DOX-induced apoptosis. ERK-Akt phosphorylation, ATF3 activation, and p53 downregulation may play a signal-transduction role in this process.	[Chen, Yen-Ling; Tsai, Yi-Ting; Loh, Shih-Hurng; Tsai, Chien-Sung] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lee, Chien-Hsing] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Chen, Chung-Yi; Liu, Chi-Ming] Fooyin Univ, Sch Med & Hlth Sci, Kaohsiung, Taiwan; [Chen, Jin-Jer] China Med Univ, Dept Internal Med, Div Cardiol, Taichung, Taiwan; [Chen, Jin-Jer] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Chen, Jin-Jer] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Jin-Jer] China Med Univ Hosp, Div Cardiol, Dept Internal Med, Taichung, Taiwan; [Loh, Shih-Hurng] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Tsai, Yi-Ting; Lee, Chung-Yi; Tsai, Chien-Sung] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan	National Defense Medical Center; Fooyin University; China Medical University Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Loh, SH (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	shloh@mail.ndmctsgh.edu.tw; sung1500@mail.ndmctsgh.edu.tw		Loh, Shih-hurng/0000-0001-9269-5580	National Science Council Foundation [NSC103-2314-B-016-022-MY3, NSC101-2314-B-016-007-MY2, DV103-04]; National Defense Medical Bureau [DOD102-I-30, D103-M084]; Tri-Service General Hospital, Taipei, Taiwan, Republic of China [TSGH-C103-028, TSGH-C102-028]	National Science Council Foundation(Ministry of Science and Technology, Taiwan); National Defense Medical Bureau; Tri-Service General Hospital, Taipei, Taiwan, Republic of China	This study was supported by grants from the National Science Council Foundation (NSC103-2314-B-016-022-MY3 and NSC101-2314-B-016-007-MY2; DV103-04), National Defense Medical Bureau (DOD102-I-30; D103-M084), and Tri-Service General Hospital (TSGH-C103-028; TSGH-C102-028), Taipei, Taiwan, Republic of China to SH Loh and CS Tsai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Arola OJ, 2000, CANCER RES, V60, P1789; Bottone FG, 2005, MOL CANCER THER, V4, P693, DOI 10.1158/1535-7163.MCT-04-0337; Bruynzeel AME, 2007, BRIT J CANCER, V96, P450, DOI 10.1038/sj.bjc.6603598; Chao HH, 2011, INT J CARDIOL, V146, P145, DOI 10.1016/j.ijcard.2009.06.010; Chen YL, 2012, EUR J PHARMACOL, V680, P88, DOI 10.1016/j.ejphar.2012.01.034; D'Amelio M, 2012, TRENDS NEUROSCI, V35, P700, DOI 10.1016/j.tins.2012.06.004; Diebold I, 2012, J CELL SCI, V125, P956, DOI 10.1242/jcs.094060; Dong Q, 2014, BR J PHARM; Fleissner F, 2011, ANTIOXID REDOX SIGN, V15, P933, DOI 10.1089/ars.2010.3502; Hasin T, 2011, BASIC RES CARDIOL, V106, P175, DOI 10.1007/s00395-010-0145-9; Kotamraju S, 2000, J BIOL CHEM, V275, P33585, DOI 10.1074/jbc.M003890200; Lorenzo E, 2002, J BIOL CHEM, V277, P10883, DOI 10.1074/jbc.M107442200; Lv D, 2011, IUBMB LIFE, V63, P62, DOI 10.1002/iub.416; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Papadopoulos P, 2008, PEPTIDES, V29, P764, DOI 10.1016/j.peptides.2007.09.012; Park C, 2006, AM J CHINESE MED, V34, P695, DOI 10.1142/S0192415X06004211; Park EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044990; Raphael J, 2006, J PHARMACOL EXP THER, V318, P186, DOI 10.1124/jpet.105.100537; Shizukuda Y, 2001, J MOL CELL CARDIOL, V33, P1791, DOI 10.1006/jmcc.2001.1442; Watanabe T, 2001, CIRCULATION, V104, P16, DOI 10.1161/hc2601.092848; Watanabe T, 2009, CURR MED CHEM, V16, P550, DOI 10.2174/092986709787458515; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Woodley-Cook J, 2006, MOL CANCER THER, V5, P3303, DOI 10.1158/1535-7163.MCT-06-0154; Xu SK, 2012, MOL MED REP, V6, P197, DOI 10.3892/mmr.2012.899; Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024; Zanotto A, 2009, BIOCHEM PHARMACOL, V77, P1291, DOI 10.1016/j.bcp.2008.12.010	31	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106812	10.1371/journal.pone.0106812	http://dx.doi.org/10.1371/journal.pone.0106812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268131	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700018
J	Sveaas, SH; Berg, IJ; Provan, SA; Semb, AG; Hagen, KB; Vollestad, N; Fongen, C; Olsen, IC; Michelsen, A; Ueland, T; Aukrust, P; Kvien, TK; Dagfinrud, H				Sveaas, Silje Halvorsen; Berg, Inger Jorid; Provan, Sella Aarrestad; Semb, Anne Grete; Hagen, Kare Birger; Vollestad, Nina; Fongen, Camilla; Olsen, Inge C.; Michelsen, Annika; Ueland, Thor; Aukrust, Pal; Kvien, Tore K.; Dagfinrud, Hanne			Efficacy of High Intensity Exercise on Disease Activity and Cardiovascular Risk in Active Axial Spondyloarthritis: A Randomized Controlled Pilot Study	PLOS ONE			English	Article							ASAS/EULAR MANAGEMENT RECOMMENDATIONS; ALL-CAUSE MORTALITY; ANKYLOSING-SPONDYLITIS; CARDIORESPIRATORY FITNESS; WAVE REFLECTION; AORTIC PRESSURE; 1ST UPDATE; MECHANISMS; EVENTS; WOMEN	Background: Physical therapy is recommended for the management of axial spondyloarthritis (axSpA) and flexibility exercises have traditionally been the main focus. Cardiovascular (CV) diseases are considered as a major health concern in axSpA and there is strong evidence that endurance and strength exercise protects against CV diseases. Therefore, the aim of this study was to investigate the efficacy of high intensity endurance and strength exercise on disease activity and CV health in patients with active axSpA. Methods: In a single blinded randomized controlled pilot study the exercise group (EG) performed 12 weeks of endurance and strength exercise while the control group (CG) received treatment as usual. The primary outcome was the Ankylosing Spondylitis (AS) Disease Activity Score (ASDAS). Secondary outcomes included patient reported disease activity (Bath AS Disease Activity Index [BASDAI]), physical function (Bath AS Functional Index [BASFI]), and CV risk factors measured by arterial stiffness (Augmentation Index [Alx]) and Pulse Wave Velocity [PWV]), cardiorespiratory fitness (VO2 peak) and body composition. ANCOVA on the post intervention values with baseline values as covariates was used to assess group differences, and Mann Whitney U-test was used for outcomes with skewed residuals. Results: Twenty-eight patients were included and 24 (EG, n = 10, CG, n = 14) completed the study. A mean treatment effect of -0.7 (95%CI: -1.4, 0.1) was seen in ASDAS score. Treatment effects were also observed in secondary outcomes (mean group difference [95%CI]): BASDAI: -2.0 (-3.6, -0.4), BASFI: -1.4 (-2.6, -0.3), arterial stiffness (estimated median group differences [95% CI]): AIx (%): -5.3 (-11.0, -0.5), and for PVW (m/s): -0.3 (-0.7, 0.0), VO2 peak (ml/kg/min) (mean group difference [95% CI]: 3.7 (2.1, 5.2) and trunk fat (%): -1.8 (-3.0, -0.6). No adverse events occurred. Conclusion: High intensity exercise improved disease activity and reduced CV risk factors in patients with active axSpA. These effects will be further explored in a larger trial.	[Sveaas, Silje Halvorsen; Hagen, Kare Birger; Fongen, Camilla; Dagfinrud, Hanne] Diakonhjemmet Hosp, Dept Rheumatol, Natl Advisory Unit Rehabil Rheumatol, Oslo, Norway; [Sveaas, Silje Halvorsen; Hagen, Kare Birger; Vollestad, Nina; Dagfinrud, Hanne] Univ Oslo, Dept Hlth Sci, Oslo, Norway; [Berg, Inger Jorid; Provan, Sella Aarrestad; Semb, Anne Grete; Olsen, Inge C.; Kvien, Tore K.] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway; [Michelsen, Annika; Ueland, Thor; Aukrust, Pal] Oslo Univ Hosp, Internal Med Res Inst, Rikshosp, Oslo, Norway; [Aukrust, Pal] Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, Rikshosp, Oslo, Norway; [Ueland, Thor; Aukrust, Pal] Univ Oslo, Inst Clin Med, Oslo, Norway; [Aukrust, Pal] Univ Oslo, KG Jebsen Inflammatory Res Ctr, Oslo, Norway	Diakonhjemmet Hospital; University of Oslo; Diakonhjemmet Hospital; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo	Sveaas, SH (corresponding author), Diakonhjemmet Hosp, Dept Rheumatol, Natl Advisory Unit Rehabil Rheumatol, Oslo, Norway.	silje.halvorsen@medisin.uio.no	Vøllestad, Nina/AAA-3274-2021; Olsen, Inge Christoffer/R-9128-2019; emery, paul/B-3560-2013	Vøllestad, Nina/0000-0002-7575-6625; Olsen, Inge Christoffer/0000-0001-6889-5873; Provan, Sella/0000-0001-5442-902X	Norwegian Foundation for Postgraduate Physiotherapist	Norwegian Foundation for Postgraduate Physiotherapist	The present study was supported by grants from the Norwegian Foundation for Postgraduate Physiotherapist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli A, 2009, RADIOL MED, V114, P286, DOI 10.1007/s11547-009-0369-7; Armijo-Olivo S, 2009, PHYS THER REV, V14, P36, DOI 10.1179/174328809X405928; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c; Baeten D, 2013, LANCET, V382, P1705, DOI 10.1016/S0140-6736(13)61134-4; Baraliakos X, 2012, RHEUMATOLOGY, V51, P1378, DOI 10.1093/rheumatology/kes026; Braun J, 2011, ANN RHEUM DIS, V70, P896, DOI 10.1136/ard.2011.151027; Bremander A, 2011, ARTHRIT CARE RES, V63, P550, DOI 10.1002/acr.20408; CALIN A, 1994, J RHEUMATOL, V21, P2281; Cornelissen VA, 2005, HYPERTENSION, V46, P667, DOI 10.1161/01.HYP.0000184225.05629.51; Corrigan B, 1978, Aust Fam Physician, V7, P1007; Crilly MA, 2013, SCAND J RHEUMATOL, V42, P27, DOI 10.3109/03009742.2012.697915; D'Ascenzo F, 2012, EUR HEART J, V33, P875, DOI 10.1093/eurheartj/ehr456; Dagfinrud H, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002822.pub3; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; Edwards DG, 2004, AM J HYPERTENS, V17, P540, DOI 10.1016/j.amjhyper.2003.12.001; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Halvorsen S, 2012, PHYS THER, V92, P298, DOI 10.2522/ptj.20110137; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Heydari M, 2013, CLIN AUTON RES, V23, P57, DOI 10.1007/s10286-012-0179-1; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Laukkanen JA, 2004, EUR HEART J, V25, P1428, DOI 10.1016/j.ehj.2004.06.013; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021; Mathieu S, 2011, ARTHRIT CARE RES, V63, P557, DOI 10.1002/acr.20364; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Niedermann K, 2013, ARTHRITIS CARE RES H; Pauca AL, 2001, HYPERTENSION, V38, P932, DOI 10.1161/hy1001.096106; Perk Joep, 2012, Int J Behav Med, V19, P403, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092, 10.1007/s12529-012-9242-5]; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Poddubnyy D, 2014, ANN RHEUM DIS, V73, P817, DOI 10.1136/annrheumdis-2013-204248; Rehn TA, 2013, OPEN CARDIOVASC MED, V7, P1, DOI 10.2174/1874192401307010001; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Schuler G, 2013, EUR HEART J, V34, P1790, DOI 10.1093/eurheartj/eht111; Scotece M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/125458; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Stavropoulos-Kalinoglou A, 2012, ANN RHEUM DIS; Stavropoulos-Kalinoglou A, 2013, ANN RHEUM DIS, V72, P1819, DOI 10.1136/annrheumdis-2012-202075; Szabo SM, 2011, ARTHRITIS RHEUM-US, V63, P3294, DOI 10.1002/art.30581; van den Berg R, 2012, RHEUMATOLOGY, V51, P1388, DOI 10.1093/rheumatology/kes066; van der Heijde D, 2008, ANN RHEUM DIS, V67, P489, DOI 10.1136/ard.2007.074724; van der Heijde D, 2009, ANN RHEUM DIS, V68, P1811, DOI 10.1136/ard.2008.100826; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	47	61	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108688	10.1371/journal.pone.0108688	http://dx.doi.org/10.1371/journal.pone.0108688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268365	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700140
J	Voss, R; Quaas, MF; Schmidt, JO; Tahvonen, O; Lindegren, M; Mollmann, C				Voss, Rudi; Quaas, Martin F.; Schmidt, Joern O.; Tahvonen, Olli; Lindegren, Martin; Moellmann, Christian			Assessing Social - Ecological Trade-Offs to Advance Ecosystem-Based Fisheries Management	PLOS ONE			English	Article							LARGE MARINE ECOSYSTEM; TROPHIC CASCADES; BALTIC SEA; COD STOCK; FORAGE FISH; COLLAPSE; CONSERVATION; SERVICES; MODEL; BIODIVERSITY	Modern resource management faces trade-offs in the provision of various ecosystem goods and services to humanity. For fisheries management to develop into an ecosystem-based approach, the goal is not only to maximize economic profits, but to consider equally important conservation and social equity goals. We introduce such a triple-bottom line approach to the management of multi-species fisheries using the Baltic Sea as a case study. We apply a coupled ecological-economic optimization model to address the actual fisheries management challenge of trading-off the recovery of collapsed cod stocks versus the health of ecologically important forage fish populations. Management strategies based on profit maximization would rebuild the cod stock to high levels but may cause the risk of stock collapse for forage species with low market value, such as Baltic sprat (Fig. 1A). Economically efficient conservation efforts to protect sprat would be borne almost exclusively by the forage fishery as sprat fishing effort and profits would strongly be reduced. Unless compensation is paid, this would challenge equity between fishing sectors (Fig. 1B). Optimizing equity while respecting sprat biomass precautionary levels would reduce potential profits of the overall Baltic fishery, but may offer an acceptable balance between overall profits, species conservation and social equity (Fig. 1C). Our case study shows a practical example of how an ecosystem-based fisheries management will be able to offer society options to solve common conflicts between different resource uses. Adding equity considerations to the traditional trade-off between economy and ecology will greatly enhance credibility and hence compliance to management decisions, a further footstep towards healthy fish stocks and sustainable fisheries in the world ocean.	[Voss, Rudi; Quaas, Martin F.; Schmidt, Joern O.] Univ Kiel, Dept Econ, Kiel, Germany; [Quaas, Martin F.] Kiel Inst World Econ, Kiel, Germany; [Tahvonen, Olli] Univ Helsinki, Dept Forest Sci, Helsinki, Finland; [Lindegren, Martin] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA; [Moellmann, Christian] Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Ctr Earth Syst Res & Sustainabil CEN, Hamburg, Germany	University of Kiel; Institut fur Weltwirtschaft an der Universitat Kiel (IFW); University of Helsinki; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hamburg	Voss, R (corresponding author), Univ Kiel, Dept Econ, Kiel, Germany.	voss@economics.uni-kiel.de	Möllmann, Christian/M-8006-2019; Quaas, Martin/C-4220-2012; Voss, Rudi/A-6113-2011; Möllmann, Christian/C-4788-2011; Schmidt, Jörn Oliver/A-7714-2008	Quaas, Martin/0000-0003-0812-8829; Möllmann, Christian/0000-0001-9161-6342; Schmidt, Jörn Oliver/0000-0002-4420-6532; Lindegren, Martin/0000-0002-9185-951X; Voss, Rudi/0000-0002-4299-8791	Cluster of Excellence "Future Ocean" of Kiel University; European Community's Seventh Framework Programme (FP7) [289257 (MYFISH)]	Cluster of Excellence "Future Ocean" of Kiel University; European Community's Seventh Framework Programme (FP7)	This study has been carried out with financial support from the Cluster of Excellence "Future Ocean" of Kiel University. The research leading to the paper has also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 289257 (MYFISH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Bastardie F, 2010, ICES J MAR SCI, V67, P71, DOI 10.1093/icesjms/fsp228; Bundy A, 2008, FRONT ECOL ENVIRON, V6, P152, DOI 10.1890/060112; Casini M, 2008, P ROY SOC B-BIOL SCI, V275, P1793, DOI 10.1098/rspb.2007.1752; Casini M, 2012, P NATL ACAD SCI USA, V109, P8185, DOI 10.1073/pnas.1113286109; Casini M, 2011, POPUL ECOL, V53, P511, DOI 10.1007/s10144-011-0269-2; Cook RM, 1997, NATURE, V385, P521, DOI 10.1038/385521a0; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Eero M, 2012, CONSERV LETT, V5, P486, DOI 10.1111/j.1755-263X.2012.00266.x; Eero M, 2012, MAR POLICY, V36, P235, DOI 10.1016/j.marpol.2011.05.010; Ehrlich PR, 2012, NATURE, V486, P68, DOI 10.1038/nature11157; Frank KT, 2011, NATURE, V477, P86, DOI 10.1038/nature10285; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Froese R, 2011, MAR ECOL PROG SER, V434, P197, DOI 10.3354/meps09247; Frost H, 2013, CAN J AGR ECON, V61, P283, DOI 10.1111/cjag.12014; Gardmark A, 2013, ECOL APPL, V23, P742, DOI 10.1890/12-0267.1; Gardmark A, 2012, ICES J MAR SCI, V69, P1448, DOI 10.1093/icesjms/fss099; Gini C., 1921, ECON J, V31, P124, DOI [10.2307/2223319, DOI 10.2307/2223319]; Halpern BS, 2013, P NATL ACAD SCI USA, V110, P6229, DOI 10.1073/pnas.1217689110; Hilborn R, 2007, MAR POLICY, V31, P153, DOI 10.1016/j.marpol.2006.05.014; ICES (International Council for the Exploration of the Sea), 2012, 2012ACOM10 ICES CM; ICES (International Council for the Exploration of the Sea), 2013, BENCHM WORKSH BALT M; ICES (International Council for the Exploration of the Sea), 2014, 2014ACOM10 ICES CM; Kellner JB, 2011, CONSERV LETT, V4, P21, DOI 10.1111/j.1755-263X.2010.00132.x; Koster F.W, 2009, J NW ATLANTIC FISHER, V41, P205, DOI DOI 10.2960/J.V41.M636; Koster FW, 2005, ICES J MAR SCI, V62, P1408, DOI 10.1016/j.icesjms.2005.05.004; Kurlansky Mark, 1997, COD BIOGRAPHY FISH C; Lam ME, 2012, ECOL SOC, V17, DOI 10.5751/ES-04156-170419; Lam ME, 2012, CURR OPIN ENV SUST, V4, P364, DOI 10.1016/j.cosust.2012.06.008; Lester SE, 2013, MAR POLICY, V38, P80, DOI 10.1016/j.marpol.2012.05.022; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Lewy P., 2004, 2004FF20 ICES CM; Lindegren M, 2009, P NATL ACAD SCI USA, V106, P14722, DOI 10.1073/pnas.0906620106; LOOMIS DK, 1993, FISHERIES, V18, P14, DOI 10.1577/1548-8446(1993)018<0014:DJIFM>2.0.CO;2; McLeod K., 2009, ECOSYSTEM BASED MANA; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; Mollmann C, 2008, ICES J MAR SCI, V66, P109; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Nelson E, 2008, P NATL ACAD SCI USA, V105, P9471, DOI 10.1073/pnas.0706178105; Osterblom H, 2006, MAR ECOL PROG SER, V323, P233, DOI 10.3354/meps323233; Pikitch EK, 2014, FISH FISH, V15, P43, DOI 10.1111/faf.12004; Pitcher T, 2009, NATURE, V457, P658, DOI 10.1038/457658a; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Pope JG, 2006, ICES J MAR SCI, V63, P1029, DOI 10.1016/j.icesjms.2006.04.015; Quaas MF, 2013, RESOUR ENERGY ECON, V35, P113, DOI 10.1016/j.reseneeco.2012.12.004; Quaas MF, 2012, ECOL ECON, V82, P45, DOI 10.1016/j.ecolecon.2012.08.002; Shelton PA, 2000, CAN J FISH AQUAT SCI, V57, P2230, DOI 10.1139/cjfas-57-11-2230; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; SPENCE A. M., 1974, SYSTEM APPROACHES EN, P97; Tahvonen O, 2013, ENVIRON RESOUR ECON, V54, P21, DOI 10.1007/s10640-012-9579-x; Uzars D, 1994, COD CLIM CHANG, P612; Voss R, 2014, MAR ECOL PROG SER, V498, P1, DOI 10.3354/meps10639; White C, 2012, ECOL LETT, V15, P509, DOI 10.1111/j.1461-0248.2012.01773.x; White C, 2012, P NATL ACAD SCI USA, V109, P4696, DOI 10.1073/pnas.1114215109	55	39	41	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107811	10.1371/journal.pone.0107811	http://dx.doi.org/10.1371/journal.pone.0107811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268117	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700048
J	Wong, PS; Tanaka, M; Sunaga, Y; Tanaka, M; Taniguchi, T; Yoshino, T; Tanaka, T; Fujibuchi, W; Aburatani, S				Wong, Pui Shan; Tanaka, Michihiro; Sunaga, Yoshihiko; Tanaka, Masayoshi; Taniguchi, Takeaki; Yoshino, Tomoko; Tanaka, Tsuyoshi; Fujibuchi, Wataru; Aburatani, Sachiyo			Tracking Difference in Gene Expression in a Time-Course Experiment Using Gene Set Enrichment Analysis	PLOS ONE			English	Article							MASS CULTIVATION; KEGG; PATHWAY; DIATOM	Fistulifera sp. strain JPCC DA0580 is a newly sequenced pennate diatom that is capable of simultaneously growing and accumulating lipids. This is a unique trait, not found in other related microalgae so far. It is able to accumulate between 40 to 60% of its cell weight in lipids, making it a strong candidate for the production of biofuel. To investigate this characteristic, we used RNA-Seq data gathered at four different times while Fistulifera sp. strain JPCC DA0580 was grown in oil accumulating and non-oil accumulating conditions. We then adapted gene set enrichment analysis (GSEA) to investigate the relationship between the difference in gene expression of 7,822 genes and metabolic functions in our data. We utilized information in the KEGG pathway database to create the gene sets and changed GSEA to use re-sampling so that data from the different time points could be included in the analysis. Our GSEA method identified photosynthesis, lipid synthesis and amino acid synthesis related pathways as processes that play a significant role in oil production and growth in Fistulifera sp. strain JPCC DA0580. In addition to GSEA, we visualized the results by creating a network of compounds and reactions, and plotted the expression data on top of the network. This made existing graph algorithms available to us which we then used to calculate a path that metabolizes glucose into triacylglycerol (TAG) in the smallest number of steps. By visualizing the data this way, we observed a separate up-regulation of genes at different times instead of a concerted response. We also identified two metabolic paths that used less reactions than the one shown in KEGG and showed that the reactions were up-regulated during the experiment. The combination of analysis and visualization methods successfully analyzed time-course data, identified important metabolic pathways and provided new hypotheses for further research.	[Wong, Pui Shan; Fujibuchi, Wataru; Aburatani, Sachiyo] AIST, CBRC, Tokyo, Japan; [Tanaka, Michihiro; Fujibuchi, Wataru] Kyoto Univ, Ctr iPS Res & Applicat, Kyoto, Japan; [Sunaga, Yoshihiko; Tanaka, Masayoshi; Yoshino, Tomoko; Tanaka, Tsuyoshi] Tokyo Univ Agr & Technol, Inst Engn, Tokyo, Japan; [Sunaga, Yoshihiko; Yoshino, Tomoko; Tanaka, Tsuyoshi] CREST, JST, Chiyoda Ku, Tokyo, Japan; [Taniguchi, Takeaki] Mitsubishi Res Inst Inc, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Kyoto University; Tokyo University of Agriculture & Technology; Japan Science & Technology Agency (JST); Mitsubishi Research Institute	Wong, PS (corresponding author), AIST, CBRC, Tokyo, Japan.	shan.wong@aist.go.jp	Yoshino, Tomoko/E-9066-2013; ABURATANI, Sachiyo/M-1613-2018; Tanaka, Masayoshi/O-5259-2018; Wong, Pui Shan/AAP-9945-2020; Tanaka, Tsuyoshi/B-9949-2013	Yoshino, Tomoko/0000-0002-4505-2774; Tanaka, Masayoshi/0000-0002-4701-5352; Wong, Pui Shan/0000-0002-1242-5845; Tanaka, Tsuyoshi/0000-0003-2601-2256	JST-CREST	JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This study was supported by JST-CREST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Croce R, 2013, PHOTOSYNTHESIS RES; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Ettema TJG, 2008, EXTREMOPHILES, V12, P75, DOI 10.1007/s00792-007-0082-1; Grasso EJ, 2011, CELL BIOCHEM BIOPHYS, V61, P157, DOI 10.1007/s12013-011-9172-x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Maia C, 2011, MECDF MULTIVARIATE E; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Muto M, 2013, MAR BIOTECHNOL, V15, P48, DOI 10.1007/s10126-012-9457-0; Nojima D, 2013, J PROTEOME RES; R Core Team, 2013, R LANG ENV STAT COMP; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; Ripley BD, 1987, WILEY INTERSCIENCE P; Rismani-Yazdi H, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-74; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Satoh A, 2013, BIORESOURCE TECHNOL, V137, P132, DOI [10.1016/j.biortech.2013.03.087, 10.1016/j.biortech.2]; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Warden DC, 2013, INT J COMPUTATIONAL, V2, P285; Yamada K, 2013, BIOINFORMATICS; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167; Zheng Q, 2008, NUCL ACIDS RES, V36	28	3	3	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107629	10.1371/journal.pone.0107629	http://dx.doi.org/10.1371/journal.pone.0107629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268590	Green Submitted, gold, Green Published			2022-12-27	WOS:000343671700042
J	Pardo, JD; Huttenlocker, AK; Small, BJ				Pardo, Jason D.; Huttenlocker, Adam K.; Small, Bryan J.			An Exceptionally Preserved Transitional Lungfish from the Lower Permian of Nebraska, USA, and the Origin of Modern Lungfishes	PLOS ONE			English	Article							DEVONIAN LUNGFISH; MORPHOLOGICAL EVOLUTION; NEOCERATODUS-FORSTERI; CRANIAL MORPHOLOGY; BIOGEOGRAPHICAL IMPLICATIONS; THREESPINE STICKLEBACK; AUSTRALIAN LUNGFISH; OSTEICHTHYES-DIPNOI; ESKRIDGE FORMATION; NORTH-AMERICA	Complete, exceptionally-preserved skulls of the Permian lungfish Persephonichthys chthonica gen. et sp. nov. are described. Persephonichthys chthonica is unique among post-Devonian lungfishes in preserving portions of the neurocranium, permitting description of the braincase of a stem-ceratodontiform for the first time. The completeness of P. chthonica permits robust phylogenetic analysis of the relationships of the extant lungfish lineage within the Devonian lungfish diversification for the first time. New analyses of the relationships of this new species within two published matrices using both maximum parsimony and Bayesian inference robustly place P. chthonica and modern lungfishes within dipterid-grade dipnoans rather than within a clade containing Late Devonian 'phaneropleurids' and common Late Paleozoic lungfishes such as Sagenodus. Monophyly of post-Devonian lungfishes is not supported and the Carboniferous-Permian taxon Sagenodus is found to be incidental to the origins of modern lungfishes, suggesting widespread convergence in Late Paleozoic lungfishes. Morphology of the skull, hyoid arch, and pectoral girdle suggests a deviation in feeding mechanics from that of Devonian lungfishes towards the more dynamic gape cycle and more effective buccal pumping seen in modern lungfishes. Similar anatomy observed previously in 'Rhinodipterus' kimberyensis likely represents an intermediate state between the strict durophagy observed in most Devonian lungfishes and the more dynamic buccal pump seen in Persephonichthys and modern lungfishes, rather than adaptation to air-breathing exclusively.	[Pardo, Jason D.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Huttenlocker, Adam K.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Huttenlocker, Adam K.] Nat Hist Museum Utah, Salt Lake City, UT USA; [Small, Bryan J.] Texas Tech Univ Museum, Lubbock, TX 79409 USA; [Small, Bryan J.] Rocky Mt Dinosaur Resource Ctr, Woodland Pk, CO USA	University of Calgary; Utah System of Higher Education; University of Utah; Texas Tech University System; Texas Tech University	Pardo, JD (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	jdpardo@ucalgary.ca			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	HRXCT and segmentation facilities used in this research are supported by an NSERC Discovery Grant awarded to J.S. Anderson of University of Calgary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBERG PE, 1991, ZOOL J LINN SOC-LOND, V103, P241, DOI 10.1111/j.1096-3642.1991.tb00905.x; Ahlberg PE, 2001, J VERTEBR PALEONTOL, V21, P1, DOI 10.1671/0272-4634(2001)021[0001:TLDLSS]2.0.CO;2; AHLBERG PE, 1995, T ROY SOC EDIN-EARTH, V85, P159, DOI 10.1017/S0263593300003588; Ahlberg PE, 2006, EVOL DEV, V8, P331, DOI 10.1111/j.1525-142X.2006.00106.x; Barrett RDH, 2008, SCIENCE, V322, P255, DOI 10.1126/science.1159978; BARTSCH P, 1994, ZOOMORPHOLOGY, V114, P1, DOI 10.1007/BF00574911; BELL MA, 1993, EVOLUTION, V47, P906, DOI 10.1111/j.1558-5646.1993.tb01243.x; BEMIS WE, 1986, J MORPHOL, V187, P81, DOI 10.1002/jmor.1051870108; BERMAN DS, 1976, J PALEONTOL, V50, P1020; Boardman D.R., 2009, KANS GEOL SURV BULL, V255, P1; Campbell KSW, 2012, J VERTEBR PALEONTOL, V32, P781, DOI 10.1080/02724634.2012.679588; CAMPBELL KSW, 1990, PALEOBIOLOGY, V16, P143, DOI 10.1017/S0094837300009854; Carlstrom D., 1963, BIOL BULL, V125, P124; Cavin L, 2007, ZOOL J LINN SOC-LOND, V149, P141, DOI 10.1111/j.1096-3642.2007.00238.x; Clack JA, 1996, J VERTEBR PALEONTOL, V16, P168, DOI 10.1080/02724634.1996.10011295; Clement AM, 2012, PALAEONTOLOGY, V55, P51, DOI 10.1111/j.1475-4983.2011.01118.x; Clement AM, 2010, BIOL LETTERS, V6, P509, DOI 10.1098/rsbl.2009.1033; Cloutier Richard, 1996, P198; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Darwin C, 1859, ORIGIN SPECIES MEANS; Dutel H, 2013, NATURWISSENSCHAFTEN, V100, P1007, DOI 10.1007/s00114-013-1104-8; Englehorn J, 2008, J VERTEBR PALEONTOL, V28, P291, DOI 10.1671/0272-4634(2008)28[291:AROAVT]2.0.CO;2; Foster-Cooper C, 1937, T ROY SOC EDINBURGH, V59, P223; Friedman M, 2007, EARTH ENV SCI T R SO, V98, P179, DOI 10.1017/S175569100700607X; Friedman M, 2007, ZOOL J LINN SOC-LOND, V151, P115, DOI 10.1111/j.1096-3642.2007.00320.x; Friedman M, 2006, PALAEONTOLOGY, V49, P1167, DOI 10.1111/j.1475-4983.2006.00594.x; GAULDIE RW, 1986, NEW ZEAL J MAR FRESH, V20, P81, DOI 10.1080/00288330.1986.9516132; Gunther A., 1871, PHILOS T ROYAL SOC L, V161, P511, DOI DOI 10.1098/RSTL.1871.0020; Heiss E, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1028; Huttenlocker AK, 2007, J VERTEBR PALEONTOL, V27, P316, DOI 10.1671/0272-4634(2007)27[316:PSGESN]2.0.CO;2; Huttenlocker AK, 2013, J VERTEBR PALEONTOL, V33, P540, DOI 10.1080/02724634.2013.728998; Huttenlocker AK, 2005, NEW MEXICO MUSEUM NA, V30, P133; JOECKEL RM, 1991, J SEDIMENT PETROL, V61, P234; KEMP A, 1986, J MORPHOL, P181; Kemp A, 1999, J ZOOL, V248, P97, DOI 10.1017/S0952836999005117; Kemp A, 1998, J VERTEBR PALEONTOL, V18, P43, DOI 10.1080/02724634.1998.10011033; Krupina NI, 2001, CAN J EARTH SCI, V38, P1301, DOI 10.1139/e01-028; LAUDER GV, 1980, J MORPHOL, V163, P283, DOI 10.1002/jmor.1051630305; Lloyd GT, 2012, EVOLUTION, V66, P330, DOI 10.1111/j.1558-5646.2011.01460.x; Long John A., 1993, Memoir of the Association of Australasian Palaeontologists, V15, P199; LUND R, 1970, ANNALS OF CARNEGIE MUSEUM, V41, P231; MILES RS, 1977, ZOOL J LINN SOC-LOND, V61, P1, DOI 10.1111/j.1096-3642.1977.tb01031.x; Mlewa CM, 2004, AFR J ECOL, V42, P338, DOI 10.1111/j.1365-2028.2004.00536.x; Pardo JD, 2010, J VERTEBR PALEONTOL, V30, P1352, DOI 10.1080/02724634.2010.501430; Qiao T, 2009, ACTA ZOOL-STOCKHOLM, V90, P236, DOI 10.1111/j.1463-6395.2008.00381.x; Sallan LC, 2010, P NATL ACAD SCI USA, V107, P10131, DOI 10.1073/pnas.0914000107; Sawin RS, 2006, CURRENT RES EARTH SC, V252, P1; Schultze HP, 2009, PALAEOGEOGR PALAEOCL, V281, P126, DOI 10.1016/j.palaeo.2009.07.017; Schultze HP, 1997, CONTRIB ZOOL, V67, P9, DOI 10.1163/18759866-06701002; Schultze HP, 2001, J VERTEBR PALEONTOL, V21, P781, DOI 10.1671/0272-4634(2001)021[0781:MAPDFT]2.0.CO;2; Smith MM, 2001, J ANAT, V199, P161; Spence R, 2013, ECOL EVOL, V3, P1717, DOI 10.1002/ece3.581; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Westneat MW, 2004, INTEGR COMP BIOL, V44, P378, DOI 10.1093/icb/44.5.378; WEsToLL T. s., 1949, GENETICS PALEONTOLOG, P21	55	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108542	10.1371/journal.pone.0108542	http://dx.doi.org/10.1371/journal.pone.0108542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265394	Green Published, gold, Green Submitted			2022-12-27	WOS:000345745400085
J	Taugbol, A; Arntsen, T; Ostbye, K; Vollestad, LA				Taugbol, Annette; Arntsen, Tina; Ostbye, Kjartan; Vollestad, Leif Asbjorn			Small Changes in Gene Expression of Targeted Osmoregulatory Genes When Exposing Marine and Freshwater Threespine Stickleback (Gasterosteus aculeatus) to Abrupt Salinity Transfers	PLOS ONE			English	Article							KILLIFISH FUNDULUS-HETEROCLITUS; CFTR ANION CHANNEL; HEAT-SHOCK-PROTEIN; NA+/K+-ATPASE; INTRASPECIFIC VARIATION; PHENOTYPIC PLASTICITY; OXYGEN-CONSUMPTION; ADAPTIVE EVOLUTION; LOCAL ADAPTATION; QUANTITATIVE PCR	Salinity is one of the key factors that affects metabolism, survival and distribution of fish species, as all fish osmoregulate and euryhaline fish maintain osmotic differences between their extracellular fluid and either freshwater or seawater. The threespine stickleback (Gasterosteus aculeatus) is a euryhaline species with populations in both marine and freshwater environments, where the physiological and genomic basis for salinity tolerance adaptation is not fully understood. Therefore, our main objective in this study was to investigate gene expression of three targeted osmoregulatory genes (Na+/K+-ATPase (ATPA13), cystic fibrosis transmembrane regulator (CFTR) and a voltage gated potassium channel gene (KCNH4) and one stress related heat shock protein gene (HSP70)) in gill tissue from marine and freshwater populations when exposed to non-native salinity for periods ranging from five minutes to three weeks. Overall, the targeted genes showed highly plastic expression profiles, in addition the expression of ATP1A3 was slightly higher in saltwater adapted fish and KCNH4 and HSP70 had slightly higher expression in freshwater. As no pronounced changes were observed in the expression profiles of the targeted genes, this indicates that the osmoregulatory apparatuses of both the marine and landlocked freshwater stickleback population have not been environmentally canalized, but are able to respond plastically to abrupt salinity challenges.	[Taugbol, Annette; Arntsen, Tina; Ostbye, Kjartan; Vollestad, Leif Asbjorn] Univ Oslo, Dept Biosci, CEES, Blindern, Norway; [Ostbye, Kjartan] Hedmark Univ Coll, Dept Forestry & Wildlife Management, Elverum, Norway	University of Oslo; Inland Norway University of Applied Sciences	Taugbol, A (corresponding author), Univ Oslo, Dept Biosci, CEES, Blindern, Norway.	annette.taugbol@ibv.uio.no	Vøllestad, Leif Asbjørn/H-7305-2019	Vøllestad, Leif Asbjørn/0000-0002-9389-7982	Norwegian Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The study was supported by the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell M.A., 1994, EVOLUTIONARY BIOL TH; BELL MA, 1977, COPEIA, P277; Bjaerke O, 2010, ECOL FRESHW FISH, V19, P249, DOI 10.1111/j.1600-0633.2010.00409.x; Bonting S. L., 1970, MEMBRANE ION TRANSPO, P257; Bystriansky JS, 2011, J EXP BIOL, V214, P2435, DOI 10.1242/jeb.050633; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Deane EE, 2002, MAR BIOTECHNOL, V4, P193, DOI 10.1007/s1012602-0091-5; DeFaveri J, 2013, EVOLUTION, V67, P2530, DOI 10.1111/evo.12097; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Edwards SL, 2012, FISH PHYSIOL, P1; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Evans DH, 2008, AM J PHYSIOL-REG I, V295, pR704, DOI 10.1152/ajpregu.90337.2008; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Fangue NA, 2006, J EXP BIOL, V209, P2859, DOI 10.1242/jeb.02260; FOLMAR LC, 1980, AQUACULTURE, V21, P1, DOI 10.1016/0044-8486(80)90123-4; GRIFFITH RW, 1974, COPEIA, P319; Grotan K, 2012, CAN J ZOOL, V90, P1386, DOI 10.1139/cjz-2012-0121; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Havird JC, 2013, COMP BIOCHEM PHYS D, V8, P131, DOI 10.1016/j.cbd.2013.01.003; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; HEUTS MJ, 1947, EVOLUTION, V1, P89, DOI 10.2307/2405407; Hiroi J, 2005, J EXP BIOL, V208, P2023, DOI 10.1242/jeb.01611; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Jensen MK, 1998, J EXP ZOOL, V282, P290, DOI 10.1002/(SICI)1097-010X(19981015)282:3<290::AID-JEZ2>3.0.CO;2-H; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kinnison MT, 2001, GENETICA, V112, P145, DOI 10.1023/A:1013375419520; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kirschner LB, 2004, J EXP BIOL, V207, P1439, DOI 10.1242/jeb.00907; Knag AC, 2013, COMP BIOCHEM PHYS C, V158, P173, DOI 10.1016/j.cbpc.2013.07.004; Krogh A., 1937, Zeitschrift fuer Vergleichende Physiologie, V24, P656, DOI 10.1007/BF00592303; Laayouni H, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-42; Lande R, 2009, J EVOLUTION BIOL, V22, P1435, DOI 10.1111/j.1420-9101.2009.01754.x; Larsen PF, 2008, HEREDITY, V101, P247, DOI 10.1038/hdy.2008.54; Larsen PF, 2012, BIOCHEM GENET, V50, P454, DOI 10.1007/s10528-011-9490-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshall WS, 2002, J EXP BIOL, V205, P1265; Masel J, 2007, AM NAT, V169, P38, DOI 10.1086/510212; Matzkin LM, 2005, GENETICS, V170, P1143, DOI 10.1534/genetics.104.038810; McCairns RJS, 2008, MOL ECOL, V17, P3901, DOI 10.1111/j.1365-294X.2008.03884.x; McCairns RJS, 2010, EVOLUTION, V64, P1029, DOI 10.1111/j.1558-5646.2009.00886.x; McCormick SD, 2003, J EXP BIOL, V206, P4575, DOI 10.1242/jeb.00711; McPhail J.D., 1994, P399; Mobasheri A, 2000, BIOSCIENCE REP, V20, P51, DOI 10.1023/A:1005580332144; Moseley P, 2000, IMMUNOPHARMACOLOGY, V48, P299, DOI 10.1016/S0162-3109(00)00227-7; Moyle P. B., 1996, FISHES INTRO ICHTHYO; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Perry SF, 1997, ANNU REV PHYSIOL, V59, P325, DOI 10.1146/annurev.physiol.59.1.325; Pertl H, 2010, PLANT PHYSIOL, V154, P1921, DOI 10.1104/pp.110.165696; Raeymaekers JAM, 2005, MOL ECOL, V14, P1001, DOI 10.1111/j.1365-294X.2005.02456.x; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; Sanogo YO, 2011, BRAIN BEHAV EVOLUT, V77, P270, DOI 10.1159/000328221; Schultz ET, 2013, FISH PHYSIOL, V32, P477, DOI 10.1016/B978-0-12-396951-4.00010-4; Scott GR, 2004, AM J PHYSIOL-CELL PH, V287, pC300, DOI 10.1152/ajpcell.00054.2004; Shrimpton JM, 2005, J EXP BIOL, V208, P4069, DOI 10.1242/jeb.01871; SILVA P, 1977, J EXP ZOOL, V199, P419, DOI 10.1002/jez.1401990316; Singer TD, 2002, CAN J FISH AQUAT SCI, V59, P125, DOI 10.1139/F01-205; Madsen SS, 2007, J ENDOCRINOL, V192, P249, DOI 10.1677/JOE-06-0016; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; STAGG RM, 1982, J COMP PHYSIOL, V147, P93, DOI 10.1007/BF00689296; SZCZESNASKORUPA E, 1988, P NATL ACAD SCI USA, V85, P738, DOI 10.1073/pnas.85.3.738; Taugbol A, 2014, ECOL EVOL, V4, P144, DOI 10.1002/ece3.918; Varsamos S, 2005, COMP BIOCHEM PHYS A, V141, P401, DOI 10.1016/j.cbpb.2005.01.013; Von Hippel FA, 2004, BEHAVIOUR, V141, P1441, DOI 10.1163/1568539042948259; West-Eberhard MJ, 2005, J EXP ZOOL PART B, V304B, P610, DOI 10.1002/jez.b.21071; Whitehead A, 2012, J EXP BIOL, V215, P1293, DOI 10.1242/jeb.062075; Wilson JM, 2004, CAN J FISH AQUAT SCI, V61, P432, DOI 10.1139/F04-010; Wootton R.J., 1976, BIOL STICKLEBACKS; [No title captured]	70	27	27	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e106894	10.1371/journal.pone.0106894	http://dx.doi.org/10.1371/journal.pone.0106894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265477	gold, Green Submitted, Green Published			2022-12-27	WOS:000345745400014
J	Contreras-Jurado, C; Garcia-Serrano, L; Martinez-Fernandez, M; Ruiz-Llorente, L; Paramio, JM; Aranda, A				Contreras-Jurado, Constanza; Garcia-Serrano, Laura; Martinez-Fernandez, Monica; Ruiz-Llorente, Lidia; Paramio, Jesus M.; Aranda, Ana			Impaired Hair Growth and Wound Healing in Mice Lacking Thyroid Hormone Receptors	PLOS ONE			English	Article							STEM-CELLS; KERATINOCYTE PROLIFERATION; EPIDERMAL HOMEOSTASIS; FOLLICLE; SKIN; ALPHA; PPAR; DIFFERENTIATION; MECHANISMS; EXPRESSION	Both clinical and experimental observations show that the skin is affected by the thyroidal status. In hypothyroid patients the epidermis is thin and alopecia is common, indicating that thyroidal status might influence not only skin proliferation but also hair growth. We demonstrate here that the thyroid hormone receptors (TRs) mediate these effects of the thyroid hormones on the skin. Mice lacking TR alpha 1 and TR beta (the main thyroid hormone binding isoforms) display impaired hair cycling associated to a decrease in follicular hair cell proliferation. This was also observed in hypothyroid mice, indicating the important role of the hormone-bound receptors in hair growth. In contrast, the individual deletion of either TR alpha 1 or TR beta did not impair hair cycling, revealing an overlapping or compensatory role of the receptors in follicular cell proliferation. In support of the role of the receptors in hair growth, TR alpha 1/TR beta-deficient mice developed alopecia after serial depilation. These mice also presented a wound-healing defect, with retarded re-epithelialization and wound gaping, associated to impaired keratinocyte proliferation. These results reinforce the idea that the thyroid hormone nuclear receptors play an important role on skin homeostasis and suggest that they could be targets for the treatment of cutaneous pathologies.	[Contreras-Jurado, Constanza; Garcia-Serrano, Laura; Ruiz-Llorente, Lidia; Aranda, Ana] CSIC, Inst Invest Biomed Alberto Sols, Dept Physiopathol Endocrine & Nervous Syst, Madrid, Spain; [Contreras-Jurado, Constanza; Garcia-Serrano, Laura; Ruiz-Llorente, Lidia; Aranda, Ana] Univ Autonoma Madrid, Madrid, Spain; [Martinez-Fernandez, Monica; Paramio, Jesus M.] CIEMAT, Div Biomed, Mol Oncol Unit, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas	Paramio, JM (corresponding author), CIEMAT, Div Biomed, Mol Oncol Unit, E-28040 Madrid, Spain.	jesusm.paramio@ciemat.es; aaranda@iib.uam.es	Paramio, Jesus M/M-8482-2014; Aranda, Ana/ABG-8820-2020; Ruiz, Lidia/L-1620-2014	Paramio, Jesus M/0000-0001-7520-3177; Aranda, Ana/0000-0002-8338-9589; Ruiz, Lidia/0000-0003-1430-9618	'Juan de la Cierva' research fellowship [JCI-2010-06167];  [BFU2011-28058];  [RD12/0036/0030];  [S2011/BMD-2328];  [SAF2012-34378];  [RD12/0036/0009];  [S2010/BMD-2470]	'Juan de la Cierva' research fellowship; ; ; ; ; ; 	This work was supported by Grants BFU2011-28058, RD12/0036/0030 and S2011/BMD-2328 to AA, and SAF2012-34378, RD12/0036/0009 and S2010/BMD-2470 to JMP. MM-F is funded by a 'Juan de la Cierva' research fellowship (JCI-2010-06167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan Mohammad Kamrul, 1998, Journal of Medical Investigation, V44, P179; ALEXANDER MV, 1982, ARCH OTOLARYNGOL, V108, P289; Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Aranda Ana, 2013, Pediatr Endocrinol Rev, V11, P2; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Bikle DD, 2012, REV ENDOCR METAB DIS, V13, P3, DOI 10.1007/s11154-011-9194-0; Billoni N, 2000, BRIT J DERMATOL, V142, P645, DOI 10.1046/j.1365-2133.2000.03408.x; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; Chapellier B, 2002, EMBO J, V21, P3402, DOI 10.1093/emboj/cdf331; Cianferotti L, 2007, P NATL ACAD SCI USA, V104, P9428, DOI 10.1073/pnas.0702884104; Contreras-Jurado C, 2011, J BIOL CHEM, V286, P24079, DOI 10.1074/jbc.M111.218487; Coulombe PA, 2003, J INVEST DERMATOL, V121, P219, DOI 10.1046/j.1523-1747.2003.12387.x; Feng X, 1997, GENE DEV, V11, P59, DOI 10.1101/gad.11.1.59; Forrest D, 1996, NAT GENET, V13, P354, DOI 10.1038/ng0796-354; Forrest D, 2000, THYROID, V10, P41, DOI 10.1089/thy.2000.10.41; FREINKEL RK, 1972, ARCH DERMATOL, V106, P349, DOI 10.1001/archderm.106.3.349; Garcia-Serrano L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023825; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Guran T, 2009, J PEDIATR ENDOCR MET, V22, P1075; Hanley K, 1997, J CLIN INVEST, V100, P705, DOI 10.1172/JCI119583; Hyter S, 2013, FEBS LETT, V587, P529, DOI 10.1016/j.febslet.2013.01.041; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Li JJ, 2010, BIOORG MED CHEM LETT, V20, P306, DOI 10.1016/j.bmcl.2009.10.109; Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595; Lindenbaum ES, 2001, PLAST RECONSTR SURG, V108, P104, DOI 10.1097/00006534-200107000-00016; Liu YY, 2003, J BIOL CHEM, V278, P38913, DOI 10.1074/jbc.M306120200; Mahajan MA, 2004, MOL CELL BIOL, V24, P4994, DOI 10.1128/MCB.24.11.4994-5004.2004; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; Messenger AG, 2000, BRIT J DERMATOL, V142, P633, DOI 10.1046/j.1365-2133.2000.03521.x; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Pascual A, 2013, BBA-GEN SUBJECTS, V1830, P3908, DOI 10.1016/j.bbagen.2012.03.012; Paus R, 2010, J INVEST DERMATOL, V130, P7, DOI 10.1038/jid.2009.359; Raja, 2007, Front Biosci, V12, P2849; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Rodriguez-Puebla ML, 1998, CELL GROWTH DIFFER, V9, P31; Safer JD, 2005, ENDOCRINOLOGY, V146, P4425, DOI 10.1210/en.2005-0192; Safer JD, 2004, ENDOCRINOLOGY, V145, P2357, DOI 10.1210/en.2003-1696; Safer JD, 2001, THYROID, V11, P717, DOI 10.1089/10507250152484547; Safer JD, 2013, J THROID RES, V2013, DOI 10.1155/2013/124538; Schmuth M, 2007, HORM METAB RES, V39, P96, DOI 10.1055/s-2007-961808; Schmuth M, 2014, BBA-MOL CELL BIOL L, V1841, P463, DOI 10.1016/j.bbalip.2013.11.012; Schneider IC, 2009, MOL BIOL CELL, V20, P3155, DOI 10.1091/mbc.E09-03-0219; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2002, J INVEST DERMATOL, V119, P1449, DOI 10.1046/j.1523-1747.2002.19617.x; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; TALMI YP, 1989, ANN OTO RHINOL LARYN, V98, P267, DOI 10.1177/000348948909800405; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; van Beek N, 2008, J CLIN ENDOCR METAB, V93, P4381, DOI 10.1210/jc.2008-0283; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455; WILSON C, 1994, DIFFERENTIATION, V55, P127, DOI 10.1046/j.1432-0436.1994.5520127.x; Wondisford FE, 2003, J INVEST MED, V51, P215, DOI 10.1136/jim-51-04-22; Zhang B, 2012, INT J IMMUNOPATH PH, V25, P859, DOI 10.1177/039463201202500404	60	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108137	10.1371/journal.pone.0108137	http://dx.doi.org/10.1371/journal.pone.0108137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254665	gold, Green Published			2022-12-27	WOS:000344862300058
J	Gaudichon, J; Milano, F; Cahu, J; DaCosta, L; Martens, AC; Renoir, JM; Sola, B				Gaudichon, Jeremie; Milano, Francesco; Cahu, Julie; DaCosta, Laetitia; Martens, Anton C.; Renoir, Jack-Michel; Sola, Brigitte			Deazaneplanocin A Is a Promising Drug to Kill Multiple Myeloma Cells in Their Niche	PLOS ONE			English	Article							COMBINED EPIGENETIC THERAPY; GLOBAL HISTONE METHYLATION; INHIBITOR 3-DEAZANEPLANOCIN; PHARMACOLOGICAL DISRUPTION; SOMATIC MUTATIONS; EZH2; H3K27; PROLIFERATION; CONTRIBUTES; AUTOPHAGY	Tumoral plasma cells has retained stemness features and in particular, a polycomb-silenced gene expression signature. Therefore, epigenetic therapy could be a mean to fight for multiple myeloma (MM), still an incurable pathology. Deazaneplanocin A (DZNep), a S-adenosyl-L-homocysteine hydrolase inhibitor, targets enhancer of zest homolog 2 (EZH2), a component of polycomb repressive complex 2 (PRC2) and is capable to induce the death of cancer cells. We show here that, in some MM cell lines, DZNep induced both caspase-dependent and -independent apoptosis. However, the induction of cell death was not mediated through its effect on EZH2 and the trimethylation on lysine 27 of histone H3 (H3K27me3). DZNep likely acted through non-epigenetic mechanisms in myeloma cells. In vivo, in xenograft models, and in vitro DZNep showed potent antimyeloma activity alone or in combination with bortezomib. These preclinical data let us to envisage new therapeutic strategies for myeloma.	[Gaudichon, Jeremie; Milano, Francesco; Cahu, Julie; Sola, Brigitte] Normandie Univ, Univ Caen, Equipe Associee 4652, Caen, France; [DaCosta, Laetitia; Renoir, Jack-Michel] Inst Gustave Roussy, Inst Natl Sante & Rech Med U749, Villejuif, France; [Martens, Anton C.] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands	Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Utrecht University; Utrecht University Medical Center	Sola, B (corresponding author), Normandie Univ, Univ Caen, Equipe Associee 4652, Caen, France.	brigitte.sola@unicaen.fr		Sola, Brigitte/0000-0001-7278-9651	Canceropole Nord-Ouest; Ligue contre le Cancer-Comitede la Manche; Conseil Regional de Basse-Normandie	Canceropole Nord-Ouest; Ligue contre le Cancer-Comitede la Manche; Conseil Regional de Basse-Normandie(Region Normandie)	This work was funded by grants from the Canceropole Nord-Ouest (canceropole-nordouest.org), the Ligue contre le Cancer-Comitede la Manche (ligue-cancer.net) (to BS). JC was financially supported by the Conseil Regional de Basse-Normandie. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blotta S, 2012, BLOOD, V120, P5002, DOI 10.1182/blood-2011-07-368142; Cahu J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.183; Chaidos A, 2013, BLOOD, V121, P318, DOI 10.1182/blood-2012-06-436220; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Cheng LL, 2012, CLIN CANCER RES, V18, P4201, DOI 10.1158/1078-0432.CCR-12-0036; Choudhury SR, 2011, CARCINOGENESIS, V32, P1525, DOI 10.1093/carcin/bgr171; Cirstea D, 2010, MOL CANCER THER, V9, P963, DOI 10.1158/1535-7163.MCT-09-0763; Crea F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-40; Croonquist PA, 2005, ONCOGENE, V24, P6269, DOI 10.1038/sj.onc.1208771; DUPERRAY C, 1989, BLOOD, V73, P566; Fiskus W, 2012, CLIN CANCER RES, V18, P6227, DOI 10.1158/1078-0432.CCR-12-0873; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Gannon OM, 2013, CLIN CANCER RES, V19, P428, DOI 10.1158/1078-0432.CCR-12-2505; GAZDAR AF, 1986, BLOOD, V67, P1542; Herath NI, 2014, BLOOD CANC IN PRESS; Hoang B, 2009, MOL CANCER THER, V8, P1974, DOI 10.1158/1535-7163.MCT-08-1177; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; Kalushkova A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011483; KATAGIRI S, 1985, INT J CANCER, V36, P241, DOI 10.1002/ijc.2910360217; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; PEGORARO L, 1989, BLOOD, V73, P1020; Rajkumar SV, 2012, HEMATOL-AM SOC HEMAT, P354, DOI 10.1182/asheducation-2012.1.354; Reghunathan R, 2013, ONCOTARGET, V4, P1230, DOI 10.18632/oncotarget.1145; Roerdink J. B. T. M., 2000, Fundamenta Informaticae, V41, P187; Rozemuller H, 2008, HAEMATOL-HEMATOL J, V93, P1049, DOI 10.3324/haematol.12349; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Schueler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079939; Smith EM, 2010, BRIT J HAEMATOL, V148, P702, DOI 10.1111/j.1365-2141.2009.07976.x; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Sola B, 2013, ONCOTARGET, V4, P911, DOI 10.18632/oncotarget.1066; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Urbinati G, 2010, PHARM RES-DORDR, V27, P327, DOI 10.1007/s11095-009-0023-z; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Velichutina I, 2010, BLOOD, V116, P5247, DOI 10.1182/blood-2010-04-280149; Xie ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021583; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Zhou JB, 2011, BLOOD, V118, P2830, DOI 10.1182/blood-2010-07-294827	44	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107009	10.1371/journal.pone.0107009	http://dx.doi.org/10.1371/journal.pone.0107009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255316	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300014
J	Choi, JJY; Ting, CT; Trogrlic, L; Milevski, SV; Familari, M; Martinez, G; de Iongh, RU				Choi, Janet J. Y.; Ting, Chao-Tung; Trogrlic, Lidia; Milevski, Stefan V.; Familari, Mary; Martinez, Gemma; de Iongh, Robb U.			A Role for Smoothened during Murine Lens and Cornea Development	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; CELL-CYCLE PROGRESSION; SONIC HEDGEHOG; NEURAL CREST; EYE MORPHOGENESIS; MICE LACKING; EPITHELIAL PROLIFERATION; EMBRYONIC-DEVELOPMENT; RECEPTOR EXPRESSION; ANTERIOR SEGMENT	Various studies suggest that Hedgehog (Hh) signalling plays roles in human and zebrafish ocular development. Recent studies (Kerr et al., Invest Ophthalmol Vis Sci. 2012; 53, 3316-30) showed that conditionally activating Hh signals promotes murine lens epithelial cell proliferation and disrupts fibre differentiation. In this study we examined the expression of the Hh pathway and the requirement for the Smoothened gene in murine lens development. Expression of Hh pathway components in developing lens was examined by RT-PCR, immunofluorescence and in situ hybridisation. The requirement of Smo in lens development was determined by conditional loss-of-function mutations, using LeCre and MLR10 Cre transgenic mice. The phenotype of mutant mice was examined by immunofluorescence for various markers of cell cycle, lens and cornea differentiation. Hh pathway components (Ptch1, Smo, Gli2, Gli3) were detected in lens epithelium from E12.5. Gli2 was particularly localised to mitotic nuclei and, at E13.5, Gli3 exhibited a shift from cytosol to nucleus, suggesting distinct roles for these transcription factors. Conditional deletion of Smo, from similar to E12.5 (MLR10 Cre) did not affect ocular development, whereas deletion from similar to E9.5 (LeCre) resulted in lens and corneal defects from E14.5. Mutant lenses were smaller and showed normal expression of p57Kip2, c-Maf, E-cadherin and Pax6, reduced expression of FoxE3 and Ptch1 and decreased nuclear Hes1. There was normal G1-S phase but decreased G2-M phase transition at E16.5 and epithelial cell death from E14.5-E16.5. Mutant corneas were thicker due to aberrant migration of Nrp2(+) cells from the extraocular mesenchyme, resulting in delayed corneal endothelial but normal epithelial differentiation. These results indicate the Hh pathway is required during a discrete period (E9.5-E12.5) in lens development to regulate lens epithelial cell proliferation, survival and FoxE3 expression. Defective corneal development occurs secondary to defects in lens and appears to be due to defective migration of peri-ocular Nrp2(+) neural crest/mesenchymal cells.	[Choi, Janet J. Y.; Ting, Chao-Tung; Trogrlic, Lidia; Milevski, Stefan V.; Martinez, Gemma; de Iongh, Robb U.] Univ Melbourne, Ocular Dev Lab, Parkville, Vic 3052, Australia; [Familari, Mary] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne	de Iongh, RU (corresponding author), Univ Melbourne, Ocular Dev Lab, Parkville, Vic 3052, Australia.	r.deiongh@unimelb.edu.au	Trogrlic, Lidia/C-8215-2015; De Iongh, Robb U/H-9646-2019	Trogrlic, Lidia/0000-0002-2127-7979; De Iongh, Robb U/0000-0001-7013-1610; Milevski, Stefan V/0000-0003-0959-9235; Familari, Mary/0000-0002-2275-9582	Melbourne Research Scholarship; Melbourne Research Grant Scheme and departmental research funds	Melbourne Research Scholarship; Melbourne Research Grant Scheme and departmental research funds	This work was funded by institutional research support (Melbourne Research Grant Scheme and departmental research funds) and a Melbourne Research Scholarship to CTT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberger F, 2014, SEMIN CELL DEV BIOL, V33, P93, DOI 10.1016/j.semcdb.2014.05.003; Adolphe C, 2006, CANCER RES, V66, P2081, DOI 10.1158/0008-5472.CAN-05-2146; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bakrania P, 2008, AM J HUM GENET, V82, P304, DOI 10.1016/j.ajhg.2007.09.023; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Beebe DC, 2000, DEV BIOL, V220, P424, DOI 10.1006/dbio.2000.9638; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Benazeraf B, 2006, DEV BIOL, V294, P133, DOI 10.1016/j.ydbio.2006.02.035; Black GCM, 2003, HUM MOL GENET, V12, P3269, DOI 10.1093/hmg/ddg356; Blixt A, 2000, GENE DEV, V14, P245; Blixt A, 2007, DEV BIOL, V302, P218, DOI 10.1016/j.ydbio.2006.09.021; Brennan D, 2012, VITAM HORM, V88, P55, DOI 10.1016/B978-0-12-394622-5.00003-1; Buxton P, 2004, DIFFERENTIATION, V72, P348, DOI 10.1111/j.1432-0436.2004.07207006.x; Cain S, 2008, DEV BIOL, V321, P420, DOI 10.1016/j.ydbio.2008.07.002; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cornesse Y, 2005, DEV BIOL, V277, P296, DOI 10.1016/j.ydbio.2004.09.016; Creuzet S, 2005, INT J DEV BIOL, V49, P161, DOI 10.1387/ijdb.041937sc; Davey MG, 2006, GENE DEV, V20, P1365, DOI 10.1101/gad.369106; de Iongh R, 2004, MOL VIS, V10, P566; De Iongh RU, 2001, EXP EYE RES, V72, P649, DOI 10.1006/exer.2001.1001; Dutta S, 2005, DEVELOPMENT, V132, P1579, DOI 10.1242/dev.01723; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; EVANS DGR, 1993, J MED GENET, V30, P460, DOI 10.1136/jmg.30.6.460; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Gage PJ, 2005, INVEST OPHTH VIS SCI, V46, P4200, DOI 10.1167/iovs.05-0691; Gammill LS, 2007, DEV NEUROBIOL, V67, P47, DOI 10.1002/dneu.20326; Gritli-Linde A, 2007, DEV CELL, V12, P99, DOI 10.1016/j.devcel.2006.12.006; Gunhaga L, 2011, PHILOS T R SOC B, V366, P1193, DOI 10.1098/rstb.2010.0175; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Ittner Lars M, 2005, J Biol, V4, P11, DOI 10.1186/jbiol29; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; Kerr CL, 2012, INVEST OPHTH VIS SCI, V53, P3316, DOI 10.1167/iovs.12-9595; Kokkinos MI, 2007, MOL VIS, V13, P418; Kondoh H, 2000, MECH DEVELOP, V96, P165, DOI 10.1016/S0925-4773(00)00387-7; KURPAKUS MA, 1994, CURR EYE RES, V13, P805, DOI 10.3109/02713689409025135; Le TT, 2012, DEV DYNAM, V241, P493, DOI 10.1002/dvdy.23739; Li HS, 1997, DEVELOPMENT, V124, P603; Long FX, 2001, DEVELOPMENT, V128, P5099; Lovicu FJ, 2011, PHILOS T R SOC B, V366, P1204, DOI 10.1098/rstb.2010.0339; Lwigale PY, 2009, DEV BIOL, V336, P257, DOI 10.1016/j.ydbio.2009.10.008; Lwigale PY, 2005, DEV BIOL, V288, P284, DOI 10.1016/j.ydbio.2005.09.046; Martinez G, 2010, INT J BIOCHEM CELL B, V42, P1945, DOI 10.1016/j.biocel.2010.09.012; Martinez G, 2009, INVEST OPHTH VIS SCI, V50, P4794, DOI 10.1167/iovs.09-3567; Mill P, 2005, DEV CELL, V9, P293, DOI 10.1016/j.devcel.2005.05.009; Ragge NK, 2005, BRIT J OPHTHALMOL, V89, P988, DOI 10.1136/bjo.2004.061390; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Rowan S, 2008, DEV BIOL, V321, P111, DOI 10.1016/j.ydbio.2008.06.002; Ryan KE, 2012, J BIOL CHEM, V287, P17905, DOI 10.1074/jbc.R112.356006; Saika S, 2001, DEV BIOL, V240, P419, DOI 10.1006/dbio.2001.0480; Sasagawa S, 2002, GENESIS, V33, P86, DOI 10.1002/gene.10095; Tanifuji-Terai N, 2006, INVEST OPHTH VIS SCI, V47, P545, DOI 10.1167/iovs.05-1182; Taylor SF, 2006, OPHTHAL PLAST RECONS, V22, P259, DOI 10.1097/01.iop.0000225421.60264.68; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Tsonis PA, 2004, DEV BIOL, V267, P450, DOI 10.1016/j.ydbio.2003.12.005; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Villani RM, 2010, CANCER PREV RES, V3, P1222, DOI 10.1158/1940-6207.CAPR-10-0082; Wall DS, 2009, J CELL BIOL, V184, P101, DOI 10.1083/jcb.200805155; Wang YP, 2005, DEVELOPMENT, V132, P5103, DOI 10.1242/dev.02096; Yin YL, 2009, DEVELOPMENT, V136, P655, DOI 10.1242/dev.028464; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zhang W, 2009, FEBS J, V276, P5998, DOI 10.1111/j.1742-4658.2009.07310.x; Zhang XM, 2001, DEV BIOL, V233, P271, DOI 10.1006/dbio.2000.0195; Zhao HT, 2004, INVEST OPHTH VIS SCI, V45, P1930, DOI 10.1167/iovs.03-0856; Zhou JX, 2006, HUM REPROD, V21, P1698, DOI 10.1093/humrep/del086	66	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108037	10.1371/journal.pone.0108037	http://dx.doi.org/10.1371/journal.pone.0108037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268479	Green Published, gold			2022-12-27	WOS:000343671700061
J	Gasparoto, TH; de Oliveira, CE; de Freitas, LT; Pinheiro, CR; Hori, JI; Garlet, GP; Cavassani, KA; Schillaci, R; da Silva, JS; Zamboni, DS; Campanelli, AP				Gasparoto, Thais Helena; de Oliveira, Carine Ervolino; de Freitas, Luisa Thomazini; Pinheiro, Claudia Ramos; Hori, Juliana Issa; Garlet, Gustavo Pompermaier; Cavassani, Karen Angelica; Schillaci, Roxana; da Silva, Joao Santana; Zamboni, Dario Simoes; Campanelli, Ana Paula			Inflammasome Activation Is Critical to the Protective Immune Response during Chemically Induced Squamous Cell Carcinoma	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; REGULATORY T-CELLS; DENDRITIC CELLS; CANCER; ASC; INNATE; DEATH; IMMUNOSURVEILLANCE; EXPRESSION; STRESS	Chronic inflammation affects most stages of tumorigenesis, including initiation, promotion, malignant differentiation, invasion and metastasis. Inflammasomes have been described as involved with persistent inflammation and are known to exert both pro and antitumour effects. We evaluated the influence of apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) and caspase (CASP)-1 in the antitumor immune response using a multistage model of squamous cell carcinoma (SCC) development. Absence of ASC and CASP-1 resulted in an earlier incidence and increased number of papilloma. Loss of inflammassome function in mice resulted in decreased presence of natural killer (NK), dendritic (DC), CD4(+), CD8(+) and CD45RB(+) T cells in the tumor lesions as well as in lymph nodes (LN) compared with WT mice. Increased percentage of CD4(+)CD25(+)Foxp3(+) T cells was associated with association with inflammasome loss of function. Moreover, significant differences were also found with neutrophils and macrophage infiltrating the lesions. Myeloperoxidase (MPO), but not elastase (ELA), activity oscillated among the groups during the SCC development. Levels of proinflammatory cytokines IL-1 beta, IL-18, Tumor Necrosis Factor (TNF)-alpha and Interferon (IFN)-gamma were decreased in the tumor microenvironment in the absence of inflammasome proteins. These observations suggest a link between inflammasome function and SCC tumorigenesis, indicating an important role for inflammasome activation in the control of SCC development.	[Gasparoto, Thais Helena; de Oliveira, Carine Ervolino; de Freitas, Luisa Thomazini; Pinheiro, Claudia Ramos; Garlet, Gustavo Pompermaier; Campanelli, Ana Paula] Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci Microbiol & Immunol, Bauru, SP, Brazil; [de Oliveira, Carine Ervolino] Univ Sao Paulo, Bauru Sch Dent, Dept Stomatol Oral Pathol, Bauru, SP, Brazil; [Cavassani, Karen Angelica] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Schillaci, Roxana] Consejo Nacl Invest Cient & Tecn Argentina, Inst Biol & Med Expt, Lab Mecanismos Mol Carcinogenesis, Buenos Aires, DF, Argentina; [da Silva, Joao Santana] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, BR-14049 Ribeirao Preto, SP, Brazil; [Hori, Juliana Issa; Zamboni, Dario Simoes] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell Biol, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Michigan System; University of Michigan; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Universidade de Sao Paulo; Universidade de Sao Paulo	Campanelli, AP (corresponding author), Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci Microbiol & Immunol, Bauru, SP, Brazil.	apcampan@usp.br	Hori, Juliana I/L-2302-2016; Zamboni, Dario S/D-3024-2012; Campanelli, Ana Paula/B-9144-2012; Garlet, Gustavo Pompermaier/E-6762-2012; de Oliveira, Carine Ervolino/I-3087-2013; Silva, Joao/A-4484-2008; Hori, Juliana Issa/D-3486-2014	Zamboni, Dario S/0000-0002-7856-7512; Garlet, Gustavo Pompermaier/0000-0002-5071-8382; Silva, Joao/0000-0002-3410-3927; Hori, Juliana Issa/0000-0002-5421-3728; Campanelli, Ana Paula/0000-0002-0536-5469; Schillaci, Roxana/0000-0002-7776-3378	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2011/03195-1, 2012/15331-0, 2009/14127-7, 2011/09664-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [grant 2011/03195-1 and 2012/15331-0; scholarship to T.H.G. (2009/14127-7) and L.T.F. (2011/09664-3)]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; scholarship to C.E.O. and C.R.P.), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; scholarship to J.S.S., G.P.G., D.S.Z. and A.P.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Aymeric L, 2010, CANCER RES, V70, P855, DOI 10.1158/0008-5472.CAN-09-3566; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Berger-Achituv S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00048; Beynon V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039576; Brilot F, 2008, FRONT BIOSCI-LANDMRK, V13, P6443, DOI 10.2741/3165; Chan CW, 2008, CELL DEATH DIFFER, V15, P58, DOI 10.1038/sj.cdd.4402235; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Chow MT, 2012, CANCER RES, V72, P5721, DOI 10.1158/0008-5472.CAN-12-0509; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dinarello CA, 2012, EUR J IMMUNOL, V42, P1385, DOI 10.1002/eji.201242635; Dobrzanski MJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00063; Dostert C, 2013, CURR OPIN IMMUNOL, V25, P359, DOI 10.1016/j.coi.2013.02.008; Drexler SK, 2012, P NATL ACAD SCI USA, V109, P18384, DOI 10.1073/pnas.1209171109; Dudek AM, 2013, CYTOKINE GROWTH F R, V24, P319, DOI 10.1016/j.cytogfr.2013.01.005; Dungan LS, 2011, CYTOKINE, V56, P126, DOI 10.1016/j.cyto.2011.07.007; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Duray A, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/701657; Ferrer IR, 2014, IMMUNOL REV, V258, P102, DOI 10.1111/imr.12158; Gasparoto TH, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-46; Gasparoto TH, 2010, CANCER IMMUNOL IMMUN, V59, P819, DOI 10.1007/s00262-009-0803-7; Grone A, 2002, VET IMMUNOL IMMUNOP, V88, P1, DOI 10.1016/S0165-2427(02)00136-8; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Hong S, 2013, CANCER LETT, V331, P183, DOI 10.1016/j.canlet.2012.12.020; Hotta K, 2011, BRIT J CANCER, V105, P1191, DOI 10.1038/bjc.2011.368; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Lavieri R, 2014, J IMMUNOL, V192, P5373, DOI 10.4049/jimmunol.1303480; Malhotra A, 2011, IMMUNOTHERAPY-UK, V3, P1143, DOI [10.2217/IMT.11.102, 10.2217/imt.11.102]; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mocellin S, 2005, CYTOKINE GROWTH F R, V16, P35, DOI 10.1016/j.cytogfr.2004.11.001; Narayan S, 2011, IMMUNOLOGY, V134, P33, DOI 10.1111/j.1365-2567.2011.03462.x; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Oleinika K, 2013, CLIN EXP IMMUNOL, V171, P36, DOI 10.1111/j.1365-2249.2012.04657.x; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Pomie C, 2008, HUM IMMUNOL, V69, P708, DOI 10.1016/j.humimm.2008.08.288; Ramos RN, 2012, CARCINOGENESIS, V33, P902, DOI 10.1093/carcin/bgs103; Rangwala S, 2011, BRIT J DERMATOL, V165, P953, DOI 10.1111/j.1365-2133.2011.10507.x; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Schon MP, 2008, ONCOGENE, V27, P190, DOI 10.1038/sj.onc.1210913; Seki I, 2010, IMMUNOL LETT, V129, P39, DOI 10.1016/j.imlet.2009.12.020; Seki S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868345; Stojanovic A, 2013, CANCER MICROENVIRON, V6, P135, DOI 10.1007/s12307-012-0125-8; Sutterwala FS, 2009, CLIN IMMUNOL, V130, P2, DOI 10.1016/j.clim.2008.08.011; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Uppaluri Ravindra, 2008, Cancer Immun, V8, P16; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	55	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107170	10.1371/journal.pone.0107170	http://dx.doi.org/10.1371/journal.pone.0107170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268644	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700032
J	Morishima, Y; Mizushima, T; Yamauchi, K; Morikawa, M; Masuki, S; Nose, H				Morishima, Yutaka; Mizushima, Takashi; Yamauchi, Katsuya; Morikawa, Mayuko; Masuki, Shizue; Nose, Hiroshi			Effects of Home-Based Interval Walking Training on Thigh Muscle Strength and Aerobic Capacity in Female Total Hip Arthroplasty Patients: A Randomized, Controlled Pilot Study	PLOS ONE			English	Article							ANAEROBIC THRESHOLD; FUNCTIONAL RECOVERY; FOLLOW-UP; REPLACEMENT; PROGRAM; ACCELEROMETRY; FRACTURE; GAIT; WEAR	Due to the reduced physical activity of patients who have undergone total hip arthroplasty (THA), there are no home-based exercise training regimens for preventing muscle atrophy and aerobic capacity impairment in these patients. We examined whether interval walking training (IWT) could prevented these issues. Twenty-eight female patients (similar to 60 years of age) who had undergone THA more than 2 months prior were randomly divided into IWT (n = 14) and control (CNT, n = 14) groups. The IWT subjects trained at a target of 60 min of fast walking at >70% peak aerobic capacity for walking ((V) over dotO(2peak)) per wk for 12 wk, while those in the CNT maintained their previous sedentary life during the same period. We measured the energy expenditure of the daily physical activity, except during sleeping and bathing, every minute and every day during the intervention. We also measured the isometric knee extension (F-EXT) and flexion (F-FLX) forces, (V) over dotO(2peak), and anaerobic threshold during the graded cycling exercise ((V) over dotO(2AT)) before and after the intervention. All subjects, except for one in IWT, completed the protocol. FFLX increased by 23% on the operated side (P = 0.003) and 14% on the non-operated side of IWT (P = 0.006), while it only increased on the operated side of CNT (P = 0.03). The (V) over dotO(2peak) and (V) over dotO(2AT) in IWT increased by 8% (P = 0.08) and 13% (P = 0.002), respectively, and these changes were significantly higher in the IWT than in CNT group (both, P < 0.05). In conclusion, IWT might be an effective home-based training regimen for preventing the muscle atrophy from reduced daily physical activity in THA patients.	[Morishima, Yutaka; Morikawa, Mayuko; Masuki, Shizue; Nose, Hiroshi] Shinshu Univ, Grad Sch Med, Dept Sports Med Sci, Matsumoto, Nagano 390, Japan; [Morishima, Yutaka; Mizushima, Takashi; Yamauchi, Katsuya] Hamamatsu Univ, Sch Med, Dept Rehabil, Hamamatsu, Shizuoka, Japan; [Morikawa, Mayuko; Nose, Hiroshi] Jukunen Taiikudaigaku Res Ctr, Matsumoto, Nagano, Japan	Shinshu University; Hamamatsu University School of Medicine	Nose, H (corresponding author), Shinshu Univ, Grad Sch Med, Dept Sports Med Sci, Matsumoto, Nagano 390, Japan.	nosehir@shinshu-u.ac.jp	Yamauchi, Katsuya/AAD-7350-2022		Ministry of Health, Labor, and Welfare (Comprehensive Research on Aging and Health); Japan Society for the Promotion of Science	Ministry of Health, Labor, and Welfare (Comprehensive Research on Aging and Health)(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by grants from the Ministry of Health, Labor, and Welfare (Comprehensive Research on Aging and Health) and the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, ACSMS GUIDELINES EXE; Bennett D, 2008, CLIN BIOMECH, V23, P571, DOI 10.1016/j.clinbiomech.2007.12.006; DAVIS JA, 1979, J APPL PHYSIOL, V46, P1039, DOI 10.1152/jappl.1979.46.6.1039; Dorr LD, 1998, CLIN ORTHOP RELAT R, P144; Dowson D, 2001, P I MECH ENG H, V215, P335, DOI 10.1243/0954411011535939; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Iwashita S, 2003, MED SCI SPORT EXER, V35, P1766, DOI 10.1249/01.MSS.0000089350.54959.CB; Jan MH, 2004, ARCH PHYS MED REHAB, V85, P1943, DOI 10.1016/j.apmr.2004.02.011; Judd DL, 2013, CLIN ORTHOPAEDICS RE; Lachiewicz PF, 2002, CLIN ORTHOP RELAT R, P65, DOI 10.1097/01.blo.0000038056.29678.f9; LONG WT, 1993, CLIN ORTHOP RELAT R, P73; Madsen MS, 2004, J ORTHOP RES, V22, P44, DOI 10.1016/S0736-0266(03)00151-7; MAGAZINER J, 1990, J GERONTOL, V45, pM101, DOI 10.1093/geronj/45.3.M101; Morikawa M, 2011, BRIT J SPORT MED, V45, P216, DOI 10.1136/bjsm.2009.064816; MOSSEY JM, 1989, AM J PUBLIC HEALTH, V79, P279, DOI 10.2105/AJPH.79.3.279; MURRAY MP, 1979, ACTA ORTHOP SCAND, V50, P563, DOI 10.3109/17453677908989805; Nilsdotter AK, 2001, ARTHRIT RHEUM-ARTHR, V45, P258, DOI 10.1002/1529-0131(200106)45:3<258::AID-ART258>3.3.CO;2-C; Nose H, 2009, J PHYSIOL-LONDON, V587, P5569, DOI 10.1113/jphysiol.2009.179499; Okazaki K, 2013, SCANDINAVIAN J MED S; PERRIN T, 1985, CLIN ORTHOP RELAT R, P252; Rasch A, 2009, J BONE JOINT SURG BR, V91B, P583, DOI 10.1302/0301-620X.91B5.21477; Rasch A, 2010, ACTA ORTHOP, V81, P183, DOI 10.3109/17453671003793204; Sakai A, 2000, SHINSHU MED J, V48, P89; Sashika H, 1996, ARCH PHYS MED REHAB, V77, P273, DOI 10.1016/S0003-9993(96)90111-2; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Sicard-Rosenbaum L, 2002, J GERONTOL A-BIOL, V57, pM47, DOI 10.1093/gerona/57.1.M47; Trudelle-Jackson E, 2004, ARCH PHYS MED REHAB, V85, P1056, DOI 10.1016/j.apmr.2003.11.022; VICTOR C R, 1987, International Journal of Rehabilitation Research, V10, P162, DOI 10.1097/00004356-198712005-00032; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236; Yamazaki T, 2009, MED SCI SPORT EXER, V41, P2213, DOI 10.1249/MSS.0b013e3181a9c452	31	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108690	10.1371/journal.pone.0108690	http://dx.doi.org/10.1371/journal.pone.0108690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268505	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700141
J	Capece, A; Vasieva, O; Meher, S; Alfirevic, Z; Alfirevic, A				Capece, Antonio; Vasieva, Olga; Meher, Shireen; Alfirevic, Zarko; Alfirevic, Ana			Pathway Analysis of Genetic Factors Associated with Spontaneous Preterm Birth and Pre-Labor Preterm Rupture of Membranes	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA GENE; PREMATURE RUPTURE; ETHNIC-DIFFERENCES; RACIAL DISPARITY; FETAL MEMBRANES; INTERLEUKIN-6 IL-6; FAMILIAL PATTERNS; INCREASED RISK; TNF-ALPHA	Background: Pre-term birth (PTB) remains the leading cause of infant mortality and morbidity. Its etiology is multifactorial, with a strong genetic component. Genetic predisposition for the two subtypes, spontaneous PTB with intact membranes (sPTB) and preterm prelabor rapture of membranes (PPROM), and differences between them, have not yet been systematically summarised. Methods and findings: Our literature search identified 15 association studies conducted in 3,600 women on 2175 SNPs in 274 genes. We used Ingenuity software to impute gene pathways and networks related to sPTB and PPROM. Detailed insight in the defined functional ontologies clearly separated integrated datasets for sPTB and PPROM. Our analysis of upstream regulators of genes suggests that glucocorticoid receptor (NR3C1), peroxisome proliferator activated receptor gamma (PPARG) and interferon regulating factor 3 (IRF3) may be sPTB specific. PPROM-specific genes may be regulated by estrogen receptor2 (ESR2) and signal transducer and activator of transcription (STAT1). The inflammatory transcription factor NF kappa B is linked to both sPTB and PPROM, however, their inflammatory response is distinctly different. Conclusions: Based on our analyses, we propose an autoimmune/hormonal regulation axis for sPTB, whilst pathways implicated in the etiology of PPROM include hematologic/coagulation function disorder, collagen metabolism, matrix degradation and local inflammation. Our hypothesis generating study has identified new candidate genes in the pathogenesis of PPROM and sPTB, which should be validated in large cohorts.	[Capece, Antonio; Meher, Shireen; Alfirevic, Zarko] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [Vasieva, Olga] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Alfirevic, Ana] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool; University of Liverpool	Alfirevic, A (corresponding author), Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England.	Ana.Alfirevic@liverpool.ac.uk						Amory JH, 2004, AM J OBSTET GYNECOL, V191, P1362, DOI 10.1016/j.ajog.2004.05.067; Annells MF, 2004, AM J OBSTET GYNECOL, V191, P2056, DOI 10.1016/j.ajog.2004.04.021; Ayalew M, 2012, MOL PSYCHIATR, V17, P887, DOI 10.1038/mp.2012.37; Bertalan R, 2008, J STEROID BIOCHEM, V111, P91, DOI 10.1016/j.jsbmb.2008.05.002; Biggio J, 2008, AM J OBSTET GYNECOL, V199, P95, DOI 10.1016/j.ajog.2008.06.012; Boyd HA, 2009, AM J EPIDEMIOL, V170, P1358, DOI 10.1093/aje/kwp324; Chaudhari BP, 2008, CLIN GENET, V74, P493, DOI 10.1111/j.1399-0004.2008.01124.x; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; DALE TC, 1989, P NATL ACAD SCI USA, V86, P1203, DOI 10.1073/pnas.86.4.1203; DizonTownson DS, 1997, AM J OBSTET GYNECOL, V177, P810, DOI 10.1016/S0002-9378(97)70273-4; Dolan SM, 2010, PUBLIC HEALTH GENOM, V13, P514, DOI 10.1159/000294202; Erez O, 2008, J MATERN-FETAL NEO M, V21, P732, DOI 10.1080/14767050802361807; Fortunato SJ, 2001, AM J OBSTET GYNECOL, V184, P1399, DOI 10.1067/mob.2001.115122; Fortunato SJ, 2002, AM J OBSTET GYNECOL, V187, P1159, DOI 10.1067/mob.2002.127457; Fujimoto T, 2002, J BIOL CHEM, V277, P6296, DOI 10.1074/jbc.M107865200; Go H, 2013, J PEDIATR ENDOCR MET, V26, P77, DOI 10.1515/jpem-2012-0170; Goldenberg RL, 1996, AM J OBSTET GYNECOL, V175, P1317, DOI 10.1016/S0002-9378(96)70048-0; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hallwirth U, 2002, EARLY HUM DEV, V67, P1, DOI 10.1016/S0378-3782(01)00245-6; JUN Z, 1992, EPIDEMIOLOGY, V3, P428, DOI 10.1097/00001648-199209000-00008; Kalish RB, 2005, AM J OBSTET GYNECOL, V192, P208, DOI 10.1016/j.ajog.2004.06.106; Kalish RB, 2006, J REPROD IMMUNOL, V70, P109, DOI 10.1016/j.jri.2005.12.002; Kistka ZAF, 2007, AM J OBSTET GYNECOL, V196, P241, DOI [10.1016/j.ajog.2006.10.873, 10.1016/j.ajog.2006.06.093]; Liang MW, 2010, J BIOMED BIOTECHNOL, DOI DOI 10.1155/2010/396184; Luo XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079897; Macones GA, 2004, AM J OBSTET GYNECOL, V190, P1504, DOI 10.1016/j.ajog.2004.01.001; Matsubara S, 2000, PLACENTA, V21, P273, DOI 10.1053/plac.1999.0463; McCarthy FP, 2013, BRIT J PHARMACOL, V168, P1074, DOI 10.1111/bph.12069; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Meirhaeghe A, 2007, DIABETES, V56, P494, DOI 10.2337/db06-0915; Menon R, 2004, J PERINAT MED, V32, P391, DOI 10.1515/JPM.2004.134; Menon R, 2008, HUM GENET, V124, P243, DOI 10.1007/s00439-008-0547-z; Menon R, 2007, BEST PRACT RES CL OB, V21, P467, DOI 10.1016/j.bpobgyn.2007.01.008; Menon R, 2007, REPROD SCI, V14, P253, DOI 10.1177/1933719107301336; Menon R, 2006, HUM HERED, V62, P107, DOI 10.1159/000096301; Menon R, 2006, AM J REPROD IMMUNOL, V56, P112, DOI 10.1111/j.1600-0897.2006.00394.x; Menon R, 2010, ANN HUM GENET, V74, P165, DOI 10.1111/j.1469-1809.2010.00562.x; Menon R, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-62; Moore S, 2004, BJOG-INT J OBSTET GY, V111, P125, DOI [10.1046/j.1471-0528.2003.00044.x, 10.1046/j.1471-0528.2003.00024.x-i1]; Myking S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061781; Najjar I, 2010, BIOCHIMIE, V92, P425, DOI 10.1016/j.biochi.2010.02.009; Napolitano M, 2000, J CLIN ENDOCR METAB, V85, P2318, DOI 10.1210/jc.85.6.2318; Neta GI, 2010, AM J EPIDEMIOL, V171, P859, DOI 10.1093/aje/kwq028; Nguyen DP, 2004, OBSTET GYNECOL, V104, P293, DOI 10.1097/01.AOG.0000133486.85400.5e; Noh HJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003523; Palomar L, 2007, AM J OBSTET GYNECOL, V197, pe151; Plunkett J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001365; Plunkett J, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-44; Porter TF, 1997, OBSTET GYNECOL, V90, P63, DOI 10.1016/S0029-7844(97)00215-9; Roberts AK, 1999, AM J OBSTET GYNECOL, V180, P1297, DOI 10.1016/S0002-9378(99)70632-0; Romero R., 2010, AM J OBSTET GYNECOL, V203; Romero R, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.026; Sata F, 2009, MOL HUM REPROD, V15, P121, DOI 10.1093/molehr/gan078; Satou R, 2012, FASEB J, V26, P1821, DOI 10.1096/fj.11-195198; Simhan HN, 2003, AM J OBSTET GYNECOL, V189, P915, DOI 10.1067/S0002-9378(03)00843-3; Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Sundrani DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029855; Thomas Sterling, 2010, Human Genomics, V4, P353; Treloar S A, 2000, Twin Res, V3, P80, DOI 10.1375/twin.3.2.80; Uzun A, 2013, GENOMICS, V101, P163, DOI 10.1016/j.ygeno.2012.12.005; Valdez-Velazquez LL, 2007, J RENIN-ANGIO-ALDO S, V8, P160, DOI 10.3317/jraas.2007.026; Velez DR, 2007, ANN HUM GENET, V71, P586, DOI 10.1111/j.1469-1809.2007.00352.x; Velez DR, 2008, HUM MOL GENET, V17, P1619, DOI 10.1093/hmg/ddn049; Velez DR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003283; Velez DR, 2009, AM J OBSTET GYNECOL, V200, pe201; Wang HY, 2006, P NATL ACAD SCI USA, V103, P13463, DOI 10.1073/pnas.0603676103; Wesemann DR, 2004, NAT IMMUNOL, V5, P199, DOI 10.1038/ni1025; Wilcox AJ, 2008, AM J EPIDEMIOL, V167, P474, DOI 10.1093/aje/kwm319; Williams KC, 2012, MOL ENDOCRINOL, V26, P1857, DOI 10.1210/me.2012-1199; Winkvist A, 1998, INT J EPIDEMIOL, V27, P248, DOI 10.1093/ije/27.2.248	72	54	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108578	10.1371/journal.pone.0108578	http://dx.doi.org/10.1371/journal.pone.0108578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264875	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400090
J	Herrador, Z; Sordo, L; Gadisa, E; Moreno, J; Nieto, J; Benito, A; Aseffa, A; Canavate, C; Custodio, E				Herrador, Zaida; Sordo, Luis; Gadisa, Endalamaw; Moreno, Javier; Nieto, Javier; Benito, Agustin; Aseffa, Abraham; Canavate, Carmen; Custodio, Estefania			Cross-Sectional Study of Malnutrition and Associated Factors among School Aged Children in Rural and Urban Settings of Fogera and Libo Kemkem Districts, Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; VISCERAL LEISHMANIASIS; NUTRITIONAL-STATUS; INFECTION; PREVALENCE; GROWTH; COUNTRIES; MALARIA; ANEMIA	Introduction: Little information is available on malnutrition-related factors among school-aged children >= 5 years in Ethiopia. This study describes the prevalence of stunting and thinness and their related factors in Libo Kemkem and Fogera, Amhara Regional State and assesses differences between urban and rural areas. Methods: In this cross-sectional study, anthropometrics and individual and household characteristics data were collected from 886 children. Height-for-age z-score for stunting and body-mass-index-for-age z-score for thinness were computed. Dietary data were collected through a 24-hour recall. Bivariate and backward stepwise multivariable statistical methods were employed to assess malnutrition-associated factors in rural and urban communities. Results: The prevalence of stunting among school-aged children was 42.7% in rural areas and 29.2% in urban areas, while the corresponding figures for thinness were 21.6% and 20.8%. Age differences were significant in both strata. In the rural setting, fever in the previous 2 weeks (OR: 1.62; 95% CI: 1.23-2.32), consumption of food from animal sources (OR: 0.51; 95% CI: 0.29-0.91) and consumption of the family's own cattle products (OR: 0.50; 95% CI: 0.27-0.93), among others factors were significantly associated with stunting, while in the urban setting, only age (OR: 4.62; 95% CI: 2.09-10.21) and years of schooling of the person in charge of food preparation were significant (OR: 0.88; 95% CI: 0.79-0.97). Thinness was statistically associated with number of children living in the house (OR: 1.28; 95% CI: 1.03-1.60) and family rice cultivation (OR: 0.64; 95% CI: 0.41-0.99) in the rural setting, and with consumption of food from animal sources (OR: 0.26; 95% CI: 0.10-0.67) and literacy of head of household (OR: 0.24; 95% CI: 0.09-0.65) in the urban setting. Conclusion: The prevalence of stunting was significantly higher in rural areas, whereas no significant differences were observed for thinness. Various factors were associated with one or both types of malnutrition, and varied by type of setting. To effectively tackle malnutrition, nutritional programs should be oriented to local needs.	[Herrador, Zaida; Benito, Agustin; Custodio, Estefania] ISCIII, Natl Ctr Trop Med, Madrid, Spain; [Herrador, Zaida; Benito, Agustin; Custodio, Estefania] Trop Dis Res Network RICET Spanish, Madrid, Spain; [Sordo, Luis] ISCIII, Natl Ctr Epidemiol, Madrid, Spain; [Sordo, Luis] Univ Complutense, Fac Med, Dept Prevent Med & Publ Hlth, E-28040 Madrid, Spain; [Sordo, Luis] Epidemiol & Publ Hlth CIBERESP Spanish, Network Biomed Res Ctr, Madrid, Spain; [Gadisa, Endalamaw; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Moreno, Javier; Nieto, Javier; Canavate, Carmen] ISCIII, Natl Ctr Microbiol, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Instituto de Salud Carlos III; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Custodio, E (corresponding author), ISCIII, Natl Ctr Trop Med, Madrid, Spain.	ecustodio2014@gmail.com	Moreno, Javier/AAB-5386-2021; Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150; Benito, Agustin/0000-0001-8229-5540; sordo, Luis/0000-0003-1760-9472; Herrador, Zaida/0000-0002-6508-3818; Moreno, Javier/0000-0003-0087-4659	UBS-Optimus Foundation in Switzerland via the Visceral Leishmaniasis and Malnutrition in Amhara State, Ethiopia project; Tropical Diseases Research Network in Spain via the VI PN de I+D+I, ISCIII -Subdireccion General de Redes y Centros de Investigacion Cooperativa [RD12/0018/0001, RD12/0018/0003]	UBS-Optimus Foundation in Switzerland via the Visceral Leishmaniasis and Malnutrition in Amhara State, Ethiopia project; Tropical Diseases Research Network in Spain via the VI PN de I+D+I, ISCIII -Subdireccion General de Redes y Centros de Investigacion Cooperativa	The authors gratefully acknowledge the financial support of the UBS-Optimus Foundation in Switzerland, (www.ubs.com/global/en/wealth_management/optimusfoundation.html), via the Visceral Leishmaniasis and Malnutrition in Amhara State, Ethiopia project, and the Tropical Diseases Research Network in Spain (www.ricet.es/es/) via the VI PN de I+D+I 2008-2011, ISCIII -Subdireccion General de Redes y Centros de Investigacion Cooperativa RD12/0018/0001 and RD12/0018/0003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar A, 2012, INT J ENV RES PUB HE, V9, P3506, DOI 10.3390/ijerph9103506; Abuya BA, 2011, MATERN CHILD HLTH J, V15, P1389, DOI 10.1007/s10995-010-0670-z; Amare B, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-7; Amati L, 2003, CURR PHARM DESIGN, V9, P1924, DOI 10.2174/1381612033454252; [Anonymous], 1986, B WORLD HEALTH ORGAN, V64, P929; [Anonymous], GLOBAL BURDEN DIS RI; Ayele DG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-195; Ayele Z, 2003, J NUTR, V133, p3981S, DOI 10.1093/jn/133.11.3981S; Belachew T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057643; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Custodio E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001813; Custodio E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-225; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P1603, DOI 10.1017/S136898001200105X; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P142, DOI 10.1017/S1368980011001315; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; Demissie T, 2009, J HEALTH POPUL NUTR, V27, P666; Dorosh Paul, 2010, 13 INT FOOD POL RES; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; FAO, 2009, DECL WORLD SUMM FOOD; Filmer D, 2009, WORLD BANK ECON REV, V23, P371, DOI 10.1093/wber/lhp009; Food and Agriculture Organization of the United Nations, 2008, GUID MEAS HOUS IND D; Food and Agriculture Organization of the United Nations (FAO), 2010, ASS NUTR STAT URB AR; Fotso Jean-Christophe, 2006, Int J Equity Health, V5, P9, DOI 10.1186/1475-9276-5-9; Frank E, 1999, GENDER AGR DEV FOOD; Gadisa E, 2012, AM J TROP MED HYG, V86, P792, DOI 10.4269/ajtmh.2012.11-0196; Girma W, 2002, DETERMINATS NUTR STA; Glewwe Paul, 2005, Food and Nutrition Bulletin, V26, pS235; Haidar J, 2009, East Afr Med J, V86, P69; Inter-Agency Standing Committee (IASC), 2006, GEND HDB HUM ACT; International Food Policy Research Institute, 2005, ASS CAUS MALN ETH CO; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Lyons S, 2003, TROP MED INT HEALTH, V8, P733, DOI 10.1046/j.1365-3156.2003.01088.x; Mahmud MA, 2013, PATHOG GLOB HEALTH, V107, P58, DOI 10.1179/2047773213Y.0000000074; Mekonnen A., 2005, TACKLING CHILD MALNU; Mekonnen H, 2013, J NUTR DISORD THER S, VS12; Owusu WB, 2004, ACTA PAEDIATR, V93, P1115, DOI [10.1111/j.1651-2227.2004.tb02726.x, 10.1080/08035250410032746]; Ricci JA, 1996, AM J CLIN NUTR, V63, P966, DOI 10.1093/ajcn/63.6.966; Siddiqi Arjumand, 2007, EARLY CHILD DEV POWE; Sordo L, 2012, AM J TROP MED HYG, V86, P955, DOI 10.4269/ajtmh.2012.11-0436; Engebretsen IMS, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-418; Tools for Food Security and Nutrition Analysis Household Economy Approach and Cost of the Diet, 2007, LIV PROF AMH REG ETH; UN System Standing Committee on Nutrition, 2010, 6 UN SYST STAND COMM; UNICEF, 1991, STRAT IMPR NUTR CHIL; United Nation's Children's Fund, 2012, UNICEF WHO WORLD BAN; USAID Collaborative Research Support Programs Team, 2000, AMH NAT REG STAT FOO; Van de Poel E, 2007, SOC SCI MED, V65, P1986, DOI 10.1016/j.socscimed.2007.06.032; Woldehann T, 2005, 20 YOUNG LIV SAV CHI; Woldehanna T., 2008, YOUNG LIVES ETHIOPIA	50	52	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e105880	10.1371/journal.pone.0105880	http://dx.doi.org/10.1371/journal.pone.0105880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265481	gold, Green Published			2022-12-27	WOS:000345745400006
J	Ihnatovych, I; Sielski, NL; Hofmann, WA				Ihnatovych, Ivanna; Sielski, Neil L.; Hofmann, Wilma A.			Selective Expression of Myosin IC Isoform A in Mouse and Human Cell Lines and Mouse Prostate Cancer Tissues	PLOS ONE			English	Article							NUCLEAR MYOSIN; TRANSCRIPTION; ROLES; ACTIN; MICE	Myosin IC is a single headed member of the myosin superfamily. We recently identified a novel isoform and showed that the MYOIC gene in mammalian cells encodes three isoforms (isoforms A, B, and C). Furthermore, we demonstrated that myosin IC isoform A but not isoform B exhibits a tissue specific expression pattern. In this study, we extended our analysis of myosin IC isoform expression patterns by analyzing the protein and mRNA expression in various mammalian cell lines and in various prostate specimens and tumor tissues from the transgenic mouse prostate (TRAMP) model by immunoblotting, qRT-PCR, and by indirect immunohistochemical staining of paraffin embedded prostate specimen. Analysis of a panel of mammalian cell lines showed an increased mRNA and protein expression of specifically myosin IC isoform A in a panel of human and mouse prostate cancer cell lines but not in non-cancer prostate or other (non-prostate-) cancer cell lines. Furthermore, we demonstrate that myosin IC isoform A expression is significantly increased in TRAMP mouse prostate samples with prostatic intraepithelial neoplasia (PIN) lesions and in distant site metastases in lung and liver when compared to matched normal tissues. Our observations demonstrate specific changes in the expression of myosin IC isoform A that are concurrent with the occurrence of prostate cancer in the TRAMP mouse prostate cancer model that closely mimics clinical prostate cancer. These data suggest that elevated levels of myosin IC isoform A may be a potential marker for the detection of prostate cancer.	[Ihnatovych, Ivanna; Sielski, Neil L.; Hofmann, Wilma A.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hofmann, WA (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA.	whofmann@buffalo.edu		Hofmann, Wilma/0000-0003-2401-5154	Department of Defense, Congressionally Directed Medical Research Programs [W81XWH-12-1-0234]; University at Buffalo	Department of Defense, Congressionally Directed Medical Research Programs(United States Department of Defense); University at Buffalo	This study was funded by the Department of Defense, Congressionally Directed Medical Research Programs (http://cdmrp.army.mil/default.shtml) (grant # W81XWH-12-1-0234) to WAH and by a University at Buffalo startup grant to WAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baade PD, 2009, MOL NUTR FOOD RES, V53, P171, DOI 10.1002/mnfr.200700511; Barylko B, 2005, ACTA BIOCHIM POL, V52, P373; Bond LM, 2013, CELL SIGNAL, V25, P229, DOI 10.1016/j.cellsig.2012.09.026; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Brandstaetter H, 2012, J CELL SCI, V125, P1991, DOI 10.1242/jcs.097212; Cantalupo PG, 2009, VIROLOGY, V386, P183, DOI 10.1016/j.virol.2008.12.038; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Cyr JL, 2002, J NEUROSCI, V22, P2487, DOI 10.1523/JNEUROSCI.22-07-02487.2002; Dimakakos A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/890697; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Foster BA, 1997, CANCER RES, V57, P3325; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; Gingrich JR, 1996, CANCER RES, V56, P4096; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hofmann WA, 2006, BIOCHEM CELL BIOL, V84, P418, DOI 10.1139/O06-069; Hofmann WA, 2006, J CELL BIOCHEM, V99, P1001, DOI 10.1002/jcb.21035; Ihnatovych I, 2012, CYTOSKELETON, V69, P555, DOI 10.1002/cm.21040; Kahle M, 2007, HISTOCHEM CELL BIOL, V127, P139, DOI 10.1007/s00418-006-0231-0; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Percipalle P, 2006, CURR OPIN CELL BIOL, V18, P267, DOI 10.1016/j.ceb.2006.03.001; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Robles MTS, 2009, SEMIN CANCER BIOL, V19, P229, DOI 10.1016/j.semcancer.2009.02.002; Sarshad A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003397; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sielski NL, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-8; SIGMUND CD, 1990, J BIOL CHEM, V265, P19916	30	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108609	10.1371/journal.pone.0108609	http://dx.doi.org/10.1371/journal.pone.0108609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259793	gold, Green Published, Green Submitted			2022-12-27	WOS:000342685600089
J	Lanca, MJ; Machado, M; Mateus, CS; Lourenco, M; Ferreira, AF; Quintella, BR; Almeida, PR				Lanca, Maria Joao; Machado, Maria; Mateus, Catarina S.; Lourenco, Marta; Ferreira, Ana F.; Quintella, Bernardo R.; Almeida, Pedro R.			Investigating Population Structure of Sea Lamprey (Petromyzon marinus, L.) in Western Iberian Peninsula Using Morphological Characters and Heart Fatty Acid Signature Analyses	PLOS ONE			English	Article							SEBASTES-MENTELLA; MORPHOMETRIC CHARACTERS; STOCK IDENTIFICATION; GEOGRAPHIC-VARIATION; FAROE-ISLANDS; CHEMOMETRY; TISSUE; FISH; DISCRIMINATION; DISPERSAL	This study hypothesizes the existence of three groups of sea lamprey Petromyzon marinus L. in Portugal (North/Central group, Tagus group, and Guadiana group), possibly promoted by seabed topography isolation during the oceanic phase of the life cycle. Within this context, our purpose was to analyze the existence of a stock structure on sea lamprey populations sampled in the major Portuguese river basins using both morphological characters and heart tissue fatty acid signature. In both cases, the multiple discriminant analysis revealed statistically significant differences among groups, and the overall corrected classification rate estimated from cross-validation procedure was particularly high for the cardiac muscle fatty acid profiles (i.e. 83.8%). Morphometric characters were much more useful than meristic ones to discriminate stocks, and the most important variables for group differentiation were eye length, second dorsal fin length and branchial length. Fatty acid analysis showed that all lampreys from the southern Guadiana group were correctly classified and not mixing with individuals from any other group, reflecting a typical heart fatty acid signature. Our results revealed that 89.5% and 72.2% of the individuals from the Tagus and North/Central groups, respectively, were also correctly classified, despite some degree of overlap between individuals from these groups. The fatty acids that contributed to the observed segregation were C16:0; C17:0; C18:1 omega 9; C20:3 omega 6 and C22:2 omega 6. Detected differences are probably related with environmental variables to which lampreys may have been exposed, which leaded to different patterns of gene expression. These results suggest the existence of three different sea lamprey stocks in Portugal, with implication in terms of management and conservation.	[Lanca, Maria Joao] Univ Evora, Dept Zootecnia, Escola Ciencias & Tecnol, Evora, Portugal; [Lanca, Maria Joao; Machado, Maria] Univ Evora, Inst Ciencias Agr & Ambientais Mediterran, Evora, Portugal; [Mateus, Catarina S.; Lourenco, Marta; Ferreira, Ana F.; Quintella, Bernardo R.] Univ Lisbon, Fac Ciencias, Ctr Oceanog, Lisbon, Portugal; [Mateus, Catarina S.; Almeida, Pedro R.] Univ Lisbon, Museu Nacl Hist Nat & Ciencia, P-1699 Lisbon, Portugal; [Mateus, Catarina S.; Almeida, Pedro R.] Univ Lisbon, Ctr Biol Ambiental, P-1699 Lisbon, Portugal; [Quintella, Bernardo R.] Univ Lisbon, Fac Ciencias, Dept Anim Biol, Lisbon, Portugal; [Almeida, Pedro R.] Univ Evora, Dept Biol, Escola Ciencias & Tecnol, Evora, Portugal	University of Evora; University of Evora; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; University of Evora	Quintella, BR (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Oceanog, Lisbon, Portugal.	bsquintella@fc.ul.pt	Lança, Maria João/F-6285-2013; Quintella, Bernardo/B-4028-2012; Almeida, Pedro R./B-1895-2012	Lança, Maria João/0000-0001-6372-9702; Quintella, Bernardo/0000-0002-0509-4515; Almeida, Pedro R./0000-0002-2776-5420; Ferreira, Ana Filipa/0000-0001-9724-5909; Mateus, Catarina/0000-0002-8067-4536; , Marta/0000-0003-3542-0729	Foundation for Science and Technology (FCT) [PTDC/BIA-BDE/71826/2006]; FEDER Funds through the Operational Programme for Competitiveness Factors - COMPETE; National Funds through FCT - Foundation for Science and Technology under the Strategic Project [PEst-C/AGR/UI0115/2011]	Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER Funds through the Operational Programme for Competitiveness Factors - COMPETE; National Funds through FCT - Foundation for Science and Technology under the Strategic Project	This work was financially supported by Foundation for Science and Technology (FCT) through project PTDC/BIA-BDE/71826/2006 and also by FEDER Funds through the Operational Programme for Competitiveness Factors - COMPETE and National Funds through FCT - Foundation for Science and Technology under the Strategic Project PEst-C/AGR/UI0115/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PR, 2008, HYDROBIOLOGIA, V602, P47, DOI 10.1007/s10750-008-9285-4; Amarasekare P, 2004, J THEOR BIOL, V226, P159, DOI 10.1016/j.jtbi.2003.08.007; Ambar I, 2002, DEEP-SEA RES PT II, V49, P4163, DOI 10.1016/S0967-0645(02)00148-0; Arts MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P237, DOI 10.1007/978-0-387-89366-2_10; Bancroft JD, 2002, THEORY PRACTICE HIST, V5th; BARLOW GW, 1961, SYST ZOOL, V10, P105, DOI 10.2307/2411595; Bashmachnikov I, 2014, OCEAN SCI DISCUSS, V11, P1473, DOI [10.5194/osd-11-1473-2014, DOI 10.5194/OSD-11-1473-2014]; BEAMISH FWH, 1980, CAN J FISH AQUAT SCI, V37, P1924, DOI 10.1139/f80-233; Begg GA, 1999, FISH RES, V43, P35, DOI 10.1016/S0165-7836(99)00065-X; BERGSTEDT RA, 1995, T AM FISH SOC, V124, P235, DOI 10.1577/1548-8659(1995)124<0235:EFLOHB>2.3.CO;2; Black J.T, 1992, MULTIVARIATE DATA AN; Brooks S, 2002, J EXP BIOL, V205, P3989; Casadei MA, 2002, APPL ENVIRON MICROB, V68, P5965, DOI 10.1128/AEM.68.12.5965-5972.2002; CLARIDGE P N, 1974, Acta Zoologica (Stockholm), V55, P61; Claytor RR, 1987, 1531 MIN SUPPL SERV; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; COSSINS AR, 1978, P NATL ACAD SCI USA, V75, P2040, DOI 10.1073/pnas.75.4.2040; FARMER GJ, 1980, CAN J FISH AQUAT SCI, V37, P1751, DOI 10.1139/f80-220; Genner MJ, 2012, MAR FRESHWATER RES, V63, P827, DOI 10.1071/MF12062; Gill HS, 2003, COPEIA, P687, DOI 10.1643/IA02-085.1; Grahl-Nielsen O, 2011, AQUAT BIOL, V13, P1, DOI 10.3354/ab00355; Grahl-Nielsen O., 2005, P247, DOI 10.1016/B978-012154351-8/50014-9; Grahl-Nielsen O, 1990, AM FISH SOC S, V7, P566; GRAHLNIELSEN O, 1992, T AM FISH SOC, V121, P307, DOI 10.1577/1548-8659(1992)121<0307:DOSBSA>2.3.CO;2; HALLIDAY RG, 1991, CAN J FISH AQUAT SCI, V48, P832, DOI 10.1139/f91-099; Hardisty M.W, 1971, P127; Hardisty MW, 1986, FRESHWATER FISHES 1, V1, P249; Hardisty MW, 1972, BIOL LAMPREYS, V2, P241; Helfman GS, 2009, DIVERSITY FISHES BIO; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Holcik J, 1986, FRESHWATER FISHES EU, V1, P24; IHSSEN PE, 1981, CAN J FISH AQUAT SCI, V38, P1838, DOI 10.1139/f81-230; Irwin AJ, 2000, THEOR POPUL BIOL, V58, P321, DOI 10.1006/tpbi.2000.1490; Joensen H, 2004, ICES J MAR SCI, V61, P113, DOI 10.1016/j.icesjms.2003.10.002; Joensen H, 2001, COMP BIOCHEM PHYS B, V129, P73, DOI 10.1016/S1096-4959(01)00305-0; Joensen H, 2000, COMP BIOCHEM PHYS B, V126, P69, DOI 10.1016/S0305-0491(00)00172-3; Joensen H, 2000, MAR BIOL, V136, P573, DOI 10.1007/s002270050717; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kucheryavyi AV, 2007, J ICHTHYOL, V47, P481, DOI DOI 10.1134/S0032945207070016; Lanca MJ, 2013, SCI MAR, V77, P281, DOI 10.3989/scimar.03779.27B; Lanca MJ, 2011, COMP BIOCHEM PHYS B, V159, P26, DOI 10.1016/j.cbpb.2011.01.006; LECHEVALIER MP, 1982, CRC HDB MICROBIOLOGY, P435; LELEK A, 1987, FRESHWATER FISHES EU; Logue JA, 2000, J EXP BIOL, V203, P2105; Marr JC, 1957, CONTRIBUTIONS STUDY, P1; Mateus Catarina S., 2012, Endangered Species Research, V16, P183, DOI 10.3354/esr00405; MAYZAUD P, 1989, MAR ECOL PROG SER, V56, P189, DOI 10.3354/meps056189; MELVIN GD, 1992, CAN J FISH AQUAT SCI, V49, P266, DOI 10.1139/f92-031; MORRISON WR, 1964, J LIPID RES, V5, P600; POTTER I C, 1968, Proceedings of the Linnean Society of London, V179, P229; Potter IC, 1968, ZOOL J LINN SOC-LOND, V47, P533; Poupa A, 1969, ANN NY ACAD SCI, V156, P445; Quintella B.R., 2006, THESIS U LISBON; RAJENDRAN N, 1993, MAR CHEM, V42, P39, DOI 10.1016/0304-4203(93)90248-M; Renaud CB, 1997, J APPL ICHTHYOL, V13, P143, DOI 10.1111/j.1439-0426.1997.tb00114.x; Rogado L., 2005, LIVRO VERMELHO VERTE; Saila S, 1983, NA83BA0078 PO US NAT; SCHAEFER KM, 1991, FISH B-NOAA, V89, P289; SIDELL BD, 1987, PHYSIOL ZOOL, V60, P221, DOI 10.1086/physzool.60.2.30158646; Silva S, 2013, HYDROBIOLOGIA, V700, P277, DOI 10.1007/s10750-012-1237-3; Silva S, 2013, AQUAT BIOL, V18, P59, DOI 10.3354/ab00488; Spice EK, 2012, MOL ECOL, V21, P2916, DOI 10.1111/j.1365-294X.2012.05585.x; TANING AV, 1952, BIOL REV, V27, P169, DOI 10.1111/j.1469-185X.1952.tb01392.x; Tanner SE, 2013, J SEA RES, V76, P82, DOI 10.1016/j.seares.2012.11.005; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; van der Vusse GJ, 2000, CARDIOVASC RES, V45, P279, DOI 10.1016/S0008-6363(99)00263-1; VLADYKOV VD, 1967, J FISH RES BOARD CAN, V24, P1067, DOI 10.1139/f67-091; Waldman J.R., 1988, North American Journal of Fisheries Management, V8, P410, DOI 10.1577/1548-8675(1988)008<0410:ROSDTF>2.3.CO;2; Waldman J, 2008, BIOL LETTERS, V4, P659, DOI 10.1098/rsbl.2008.0341	69	19	20	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108110	10.1371/journal.pone.0108110	http://dx.doi.org/10.1371/journal.pone.0108110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259723	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600048
J	Noden, BH; Tshavuka, FI; van der Colf, BE; Chipare, I; Wilkinson, R				Noden, Bruce H.; Tshavuka, Filippus I.; van der Colf, Berta E.; Chipare, Israel; Wilkinson, Rob			Exposure and Risk Factors to Coxiella burnetii, Spotted Fever Group and Typhus Group Rickettsiae, and Bartonella henselae among Volunteer Blood Donors in Namibia	PLOS ONE			English	Article							HOSPITALIZED FEBRILE PATIENTS; NEGLECTED TROPICAL DISEASES; TICK-BITE FEVER; BORNE RICKETTSIOSES; SOUTHERN AFRICA; SPP. INFECTION; DOMESTIC CATS; ANTIBODIES; PREVALENCE; SEROPREVALENCE	Background: The role of pathogen-mediated febrile illness in sub-Saharan Africa is receiving more attention, especially in Southern Africa where four countries (including Namibia) are actively working to eliminate malaria. With a high concentration of livestock and high rates of companion animal ownership, the influence of zoonotic bacterial diseases as causes of febrile illness in Namibia remains unknown. Methodology/Principal Findings: The aim of the study was to evaluate exposure to Coxiella burnetii, spotted fever and typhus group rickettsiae, and Bartonella henselae using IFA and ELISA (IgG) in serum collected from 319 volunteer blood donors identified by the Blood Transfusion Service of Namibia (NAMBTS). Serum samples were linked to a basic questionnaire to identify possible risk factors. The majority of the participants (64.8%) had extensive exposure to rural areas or farms. Results indicated a C. burnetii prevalence of 26.1% (screening titre 1:16), and prevalence rates of 11.9% and 14.9% (screening titre 1:100) for spotted fever group and typhus group rickettsiae, respectively. There was a significant spatial association between C. burnetii exposure and place of residence in southern Namibia (P < 0.021). Donors with occupations involving animals (P > 0.012), especially cattle (P > 0.006), were also significantly associated with C. burnetii exposure. Males were significantly more likely than females to have been exposed to spotted fever (P < 0.013) and typhus (P < 0.011) group rickettsiae. Three (2.9%) samples were positive for B. henselae possibly indicating low levels of exposure to a pathogen never reported in Namibia. Conclusions/Significance: These results indicate that Namibians are exposed to pathogenic fever-causing bacteria, most of which have flea or tick vectors/reservoirs. The epidemiology of febrile illnesses in Namibia needs further evaluation in order to develop comprehensive local diagnostic and treatment algorithms.	[Noden, Bruce H.; van der Colf, Berta E.] Polytech Namibia, Dept Biomed Sci, Windhoek, Namibia; [Tshavuka, Filippus I.] Namibia Inst Pathol, Dept Microbiol, Oshakati, Namibia; [Chipare, Israel; Wilkinson, Rob] Blood Transfus Serv Namibia, Windhoek, Namibia	Namibia University of Science & Technology	Noden, BH (corresponding author), Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA.	bruce.noden@okstate.edu			Institutional Research and Publications Committee at the Polytechnic of Namibia	Institutional Research and Publications Committee at the Polytechnic of Namibia	All the funding for this project came from a grant awarded by the Institutional Research and Publications Committee at the Polytechnic of Namibia. The article was approved for publication by the Director of Oklahoma Agricultural Experiment Station and BHN was partially supported during the writing stage by the Oklahoma Agricultural Experiment Station (OKL 02909). Equipment was purchased for this study through a CDC Cooperative Agreement (5U2GP5002902). Contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm JS, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-13; Alegana VA, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-6; ANACKER RL, 1987, J CLIN MICROBIOL, V25, P167, DOI 10.1128/JCM.25.1.167-171.1987; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Azad AF, 1997, EMERG INFECT DIS, V3, P319, DOI 10.3201/eid0303.970308; Biggs HM, 2011, AM J TROP MED HYG, V85, P275, DOI 10.4269/ajtmh.2011.11-0176; Bitam I, 2012, TICKS TICK-BORNE DIS, V3, P381, DOI 10.1016/j.ttbdis.2012.10.011; Bouley AJ, 2012, AM J TROP MED HYG, V87, P1105, DOI 10.4269/ajtmh.2012.12-0327; Casalta JP, 2009, CLIN MICROBIOL INFEC, V15, P152, DOI 10.1111/j.1469-0691.2008.02185.x; Cisak E, 2003, ANN AGR ENV MED, V10, P265; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; de Almeida DN, 2010, TICKS TICK-BORNE DIS, V1, P149, DOI 10.1016/j.ttbdis.2010.05.002; DUPONT HT, 1995, CLIN INFECT DIS, V21, P1126, DOI 10.1093/clinids/21.5.1126; Elfving K, 2008, SCAND J INFECT DIS, V40, P74, DOI 10.1080/00365540701509907; Frean J, 2002, T ROY SOC TROP MED H, V96, P549, DOI 10.1016/S0035-9203(02)90437-2; HEBERT GA, 1980, J CLIN MICROBIOL, V11, P503; HECHEMY KE, 1989, J MED MICROBIOL, V29, P199, DOI 10.1099/00222615-29-3-199; Hertz JT, 2012, AM J TROP MED HYG, V86, P171, DOI 10.4269/ajtmh.2012.11-0393; Hogema BM, 2012, TRANSFUSION, V52, P144, DOI 10.1111/j.1537-2995.2011.03250.x; Honarmand H, 2012, INTERDISCIP PERSPECT; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Karabay O, 2011, INDIAN J MED MICROBI, V29, P418, DOI 10.4103/0255-0857.90183; Kazondovi L, 2012, STUBBORN HIV AIDS PA; Kelly PJ, 2004, J S AFR VET ASSOC, V75, P116; Kelly PJ, 1996, J S AFR VET ASSOC, V67, P182; KELLY PJ, 1993, S AFR MED J, V83, P21; KELLY PJ, 1991, J TROP MED HYG, V94, P304; Kersh GJ, 2013, TRANSFUSION, V53, P1493, DOI 10.1111/j.1537-2995.2012.03912.x; Kilic S, 2008, NEW MICROBIOL, V31, P527; LaScola B, 1997, J CLIN MICROBIOL, V35, P2715, DOI 10.1128/JCM.35.11.2715-2727.1997; Leiby DA, 2004, TRANSFUS MED REV, V18, P293, DOI 10.1016/j.tmrv.2004.07.001; Lofgren SM, 2012, T ROY SOC TROP MED H, V106, P504, DOI 10.1016/j.trstmh.2012.05.009; Magalhaes RF, 2008, TRANSFUSION MED, V18, P287, DOI 10.1111/j.1365-3148.2008.00871.x; Magwedere Kudakwashe, 2012, Infect Ecol Epidemiol, V2, DOI 10.3402/iee.v2i0.18365; Mansueto P, 2012, J IMMUNOASS IMMUNOCH, V33, P18, DOI 10.1080/15321819.2011.591476; Matthewman L, 1997, EUR J EPIDEMIOL, V13, P109, DOI 10.1023/A:1007375718204; Matthewman L, 1997, EUR J EPIDEMIOL, V13, P477, DOI 10.1023/A:1007317032647; Mediannikov O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000821; Monno R, 2009, ANN AGR ENV MED, V16, P205; Mosbacher ME, 2011, VECTOR-BORNE ZOONOT, V11, P471, DOI 10.1089/vbz.2010.0106; Mura A, 2008, T ROY SOC TROP MED H, V102, P945, DOI 10.1016/j.trstmh.2008.03.015; Naing C, 2012, T ROY SOC TROP MED H, V106, P331, DOI 10.1016/j.trstmh.2012.03.003; Ndip LM, 2011, AM J TROP MED HYG, V84, P608, DOI 10.4269/ajtmh.2011.10-0191; Negri Elaine Cristina, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P211, DOI 10.1016/S2221-1691(13)60052-0; Nett RJ, 2012, CASE REP INFECT DIS, V2012, DOI 10.1155/2012/916142; Noden BH, 2011, 31 ASTMH, P31; Noden BH, 2013, ACTA TROP, V125, P1, DOI 10.1016/j.actatropica.2012.09.007; Noor AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063350; Noor AM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-184; Okabayashi T, 1999, AM J TROP MED HYG, V61, P70, DOI 10.4269/ajtmh.1999.61.70; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Pons I, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-58; Portillo A, 2007, AM J TROP MED HYG, V77, P376, DOI 10.4269/ajtmh.2007.77.376; Prabhu M, 2011, CLIN INFECT DIS, V53, pe8, DOI 10.1093/cid/cir411; Premaratna R, 2011, INT J INFECT DIS, V15, pE871, DOI 10.1016/j.ijid.2011.09.010; Pretorius AM, 2004, VECTOR-BORNE ZOONOT, V4, P249, DOI 10.1089/vbz.2004.4.249; Sackal C, 2008, EMERG INFECT DIS, V14, P1972, DOI 10.3201/eid1412.080610; Schwartz RA, 2012, INT J DERMATOL, V51, P960, DOI 10.1111/j.1365-4632.2011.05362.x; Sun JM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-121; Trataris AN, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i2.452; Tsai YL, 2011, VECTOR-BORNE ZOONOT, V11, P1023, DOI 10.1089/vbz.2010.0085; Turnbull ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027125; Vardas E, 1999, B WORLD HEALTH ORGAN, V77, P965; Vermeulen MJ, 2010, J MED MICROBIOL, V59, P743, DOI 10.1099/jmm.0.015248-0; Walsh MG, 2012, EPIDEMIOL INFECT, V140, P42, DOI 10.1017/S0950268811000227; WESSELS G, 1986, T ROY SOC TROP MED H, V80, P848, DOI 10.1016/0035-9203(86)90401-3; WHO. Policy Statement, 2011, FLUOR LIGHT EM DIOD	67	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108674	10.1371/journal.pone.0108674	http://dx.doi.org/10.1371/journal.pone.0108674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259959	Green Submitted, Green Published, gold			2022-12-27	WOS:000342685600092
J	Xu, LX; Yang, F; Lin, R; Han, CQ; Liu, J; Ding, Z				Xu, Lixia; Yang, Fen; Lin, Rong; Han, Chaoqun; Liu, Jun; Ding, Zhen			Induction of M2 Polarization in Primary Culture Liver Macrophages from Rats with Acute Pancreatitis	PLOS ONE			English	Article							KUPFFER CELLS; IN-VITRO; PLASTICITY; INJURY; ACTIVATION; PROTECTS; REPAIR; MODEL	Background and Aims: Systemic inflammatory response syndrome (SIRS), a major process of severe acute pancreatitis (SAP), usually occurs after various activated proinflammatory cytokines, which are produced by macrophages such as liver macrophages. Macrophages can secrete not only proinflammatory mediators but also inhibitory inflammatory cytokines such as IL-10, leading to two different functional states defined as "polarization''. The main purpose of this study was to demonstrate the polarization of liver macrophages during severe acute pancreatitis and to explore whether the polarization of these activated Liver macrophages could be reversed in vitro. Methods: Liver macrophages were isolated from rats with acute pancreatitis. These primary culture macrophages were treated with IL-4 or regulatory T cells in vitro to reverse their polarization and was evaluated by measuring M1/M2 marker expression using real time PCR and immunofluorescence staining. Results: Acute pancreatitis was induced successfully by intra-pancreatic ductal injection of 5% sodium taurocholate. The liver macrophages demonstrated M1 polarization from 4 h to 16 h after the onset of acute pancreatitis. However, after IL-4 or Treg treatment, the polarization of the liver macrophages was reversed as indicated by increased expression of M2 markers and reduced expression of M1 markers. Furthermore, the effect of Treg on modulating macrophage polarization was slightly better than that of IL-4 in vitro. Conclusion: Liver macrophages, a pivotal cell type in the pathogenesis of SAP, become M1 polarized during pancreatic inflammation. Treatment of these cells with IL-4 and Treg can reverse this activation in vitro. This method of altering macrophage polarization could be a prospective therapy for SAP.	[Xu, Lixia; Yang, Fen; Lin, Rong; Han, Chaoqun; Liu, Jun; Ding, Zhen] Huazhong Univ Sci & Technol, Dept Gastroenterol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Ding, Z (corresponding author), Huazhong Univ Sci & Technol, Dept Gastroenterol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	docd720@126.com			National Nature Science Foundation of China [30900664, 81170373, 81272656, 81000160]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been partly supported by the National Nature Science Foundation of China (No.30900664, No.81170373, No.81272656 and No.81000160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding sources for this study.	Akbarshahi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042654; Antonios JK, 2013, CELL MOL IMMUNOL, V10, P471, DOI 10.1038/cmi.2013.39; Bakoyiannis Andreas, 2010, Infectious Disorders - Drug Targets, V10, P2; Barros MHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080908; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Ding Z, 2012, J DIGEST DIS, V13, P179, DOI 10.1111/j.1751-2980.2011.00568.x; Folch-Puy E, 2007, J PATHOL, V211, P383, DOI 10.1002/path.2123; Gea-Sorli Sabrina, 2010, World J Gastrointest Pharmacol Ther, V1, P107, DOI 10.4292/wjgpt.v1.i5.107; Gea-Sorli S, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-42; Gunjaca I, 2012, INFLAMMATION, V35, P758, DOI 10.1007/s10753-011-9371-z; He LZ, 2013, AM J PATHOL, V182, P2407, DOI 10.1016/j.ajpath.2013.02.032; Liu HB, 2006, WORLD J GASTROENTERO, V12, P403, DOI 10.3748/wjg.v12.i3.403; Iwata Y, 2012, J IMMUNOL, V188, P4568, DOI 10.4049/jimmunol.1102154; Kempuraj D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056866; Kennedy BC, 2013, J ONCOL, V2013, DOI 10.1155/2013/486912; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lin R, 2013, STEM CELLS DEV, V22, P2836, DOI 10.1089/scd.2013.0166; Majowicz A, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-172; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Nagashio Y, 2004, LAB INVEST, V84, P1610, DOI 10.1038/labinvest.3700191; Ploeger DTA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-29; Que RS, 2010, PANCREAS, V39, P536, DOI 10.1097/MPA.0b013e3181c0e199; Saeki K, 2012, GASTROENTEROLOGY, V142, P1010, DOI 10.1053/j.gastro.2011.12.054; van Minnen LP, 2007, J GASTROINTEST SURG, V11, P682, DOI 10.1007/s11605-007-0088-0; Wang ZM, 2013, INT J MED SCI, V10, P286, DOI 10.7150/ijms.5343; Wei SD, 2012, INFLAMMATION, V35, P690, DOI 10.1007/s10753-011-9362-0	27	18	22	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108014	10.1371/journal.pone.0108014	http://dx.doi.org/10.1371/journal.pone.0108014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259888	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600043
J	Leuck, AM; Johnson, JR; Dunny, GM				Leuck, Anne-Marie; Johnson, James R.; Dunny, Gary M.			A Widely Used In Vitro Biofilm Assay Has Questionable Clinical Significance for Enterococcal Endocarditis	PLOS ONE			English	Article							SURFACE PROTEIN; GENE-EXPRESSION; FAECALIS; ESP; AGGREGATION; VIRULENCE; FREQUENCY; SLIME; VIVO; EEP	Biofilm formation may play an important role in the pathogenesis of infections caused by Enterococcus faecalis, including endocarditis. Most biofilm studies use a polystyrene dish assay to quantify biofilm biomass. However, recent studies of E. faecalis strains in tissue and animal models suggest that polystyrene dish results need to be interpreted with caution. We evaluated 158 clinical E. faecalis isolates using a polystyrene dish assay and found variation in biofilm formation, with many isolates forming little biofilm even when different types of media were used. However, all tested clinical isolates were able to form biofilms on porcine heart valve explants. Dextrose-enhanced biofilm formation in the polystyrene dish assay was found in 6/12 (50%) of clinical isolates tested and may explain some, but not all of the differences between the polystyrene dish assay and the heart valve assay. These findings suggest that in studies assessing the clinical relevance of enterococcal biofilm-forming ability, ex vivo biofilm formation on a relevant tissue surface may be warranted to validate results of in vitro assays.	[Leuck, Anne-Marie; Johnson, James R.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Johnson, James R.] VA Hlth Care Syst, Minneapolis, MN USA; [Dunny, Gary M.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Leuck, AM (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	leuck002@umn.edu			National Institutes of Health Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant [5T32AI055433-09]; National Institute of Allergy and Infectious Diseases at the National Institutes of Health [AI058134]; Office of Research and Development, Medical Research Service, Department of Veterans Affairs [1 I01 CX000192 01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI058134, T32AI055433, R01AI058134] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000920] Funding Source: NIH RePORTER	National Institutes of Health Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a National Institutes of Health Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant [5T32AI055433-09] and the National Institute of Allergy and Infectious Diseases at the National Institutes of Health [AI058134 to GMD]. This material also is based partly upon work supported by the Office of Research and Development, Medical Research Service, Department of Veterans Affairs [1 I01 CX000192 01 to JRJ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldassarri L, 2001, MED MICROBIOL IMMUN, V190, P113, DOI 10.1007/s00430-001-0096-8; BALDASSARRI L, 1993, EUR J CLIN MICROBIOL, V12, P866, DOI 10.1007/BF02000411; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Chuang-Smith ON, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015798; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; Frank KL, 2013, INFECT IMMUN, V81, P1696, DOI 10.1128/IAI.01210-12; Frank KL, 2012, INFECT IMMUN, V80, P539, DOI 10.1128/IAI.05964-11; Gao P, 2010, J BACTERIOL, V192, P5489, DOI 10.1128/JB.00725-10; HUYCKE MM, 1995, PLASMID, V34, P152, DOI 10.1006/plas.1995.9992; Kristich CJ, 2008, APPL ENVIRON MICROB, V74, P3377, DOI 10.1128/AEM.02665-07; Kristich CJ, 2004, J BACTERIOL, V186, P154, DOI 10.1128/JB.186.1.154-163.2004; Lebeaux D, 2013, PATHOGENS, V2, P288, DOI 10.3390/pathogens2020288; Lizcano A, 2010, MICROB PATHOGENESIS, V48, P124, DOI 10.1016/j.micpath.2010.01.002; Lopez-Sala P, 2013, ARCH MED RES, V44, P422, DOI 10.1016/j.arcmed.2013.07.003; McBride SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000582; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; OSTROLENK M, 1946, J BACTERIOL, V51, P735, DOI 10.1128/JB.51.6.735-741.1946; Paganelli FL, 2012, TRENDS MICROBIOL, V20, P40, DOI 10.1016/j.tim.2011.11.001; Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837; Sandoe JAT, 2006, J ANTIMICROB CHEMOTH, V57, P767, DOI 10.1093/jac/dkl013; Sandoe JAT, 2003, J MED MICROBIOL, V52, P547, DOI 10.1099/jmm.0.05201-0; Schlievert PM, 1998, INFECT IMMUN, V66, P218, DOI 10.1128/IAI.66.1.218-223.1998; Shankar V, 1999, INFECT IMMUN, V67, P193, DOI 10.1128/IAI.67.1.193-200.1999; Tendolkar PM, 2004, INFECT IMMUN, V72, P6032, DOI 10.1128/IAI.72.10.6032-6039.2004; Toledo-Arana A, 2001, APPL ENVIRON MICROB, V67, P4538, DOI 10.1128/AEM.67.10.4538-4545.2001; Udo EE, 2011, MED PRIN PRACT, V20, P259, DOI 10.1159/000321230	26	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107282	10.1371/journal.pone.0107282	http://dx.doi.org/10.1371/journal.pone.0107282			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255085	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300020
J	Lin, WS; Hu, LY; Liu, CJ; Hsu, CC; Shen, CC; Wang, YP; Hu, YW; Tsai, CF; Yeh, CM; Chen, PM; Su, TP; Chen, TJ; Lu, T				Lin, Wan-Shan; Hu, Li-Yu; Liu, Chia-Jen; Hsu, Chih-Chao; Shen, Cheng-Che; Wang, Yen-Po; Hu, Yu-Wen; Tsai, Chia-Fen; Yeh, Chiu-Mei; Chen, Pan-Ming; Su, Tung-Ping; Chen, Tzeng-Ji; Lu, Ti			Gastroesophageal Reflux Disease and Risk for Bipolar Disorder: A Nationwide Population-Based Study	PLOS ONE			English	Article							INFLAMMATORY DISEASE; GENERAL-POPULATION; DEPRESSION; ASSOCIATION; SYMPTOMS; PATHOPHYSIOLOGY; INTERLEUKIN-8; PREVALENCE; PERCEPTION; ACTIVATION	Background: Studies have shown that chronic inflammation may play a vital role in the pathophysiology of both gastroesophageal reflux disease (GERD) and bipolar disorder. Among patients with GERD, the risk of bipolar disorder has not been well characterized. Objective: We explored the relationship between GERD and the subsequent development of bipolar disorder, and examined the risk factors for bipolar disorder in patients with GERD. Methods: We identified patients who were diagnosed with GERD in the Taiwan National Health Insurance Research Database. A comparison cohort without GERD was matched according to age, sex, and comorbidities. The occurrence of bipolar disorder was evaluated in both cohorts based on diagnosis and the prescription of medications. Results: The GERD cohort consisted of 21,674 patients, and the comparison cohort consisted of 21,674 matched control patients without GERD. The incidence of bipolar disorder (incidence rate ratio [IRR] 2.29, 95% confidence interval [CI] 1.58-3.36, P < .001) was higher among GERD patients than among comparison cohort. Multivariate, matched regression models showed that the female sex (hazard ratio [HR] 1.78, 95% CI 1.76-2.74, P = .008), being younger than 60 years old (HR 2.35, 95% CI 1.33-4.16, P = .003), and alcohol use disorder (HR 4.89, 95% CI 3.06-7.84, P = .004) were independent risk factors for the development of bipolar disorder among GERD patients. Conclusions: GERD may increase the risk of developing bipolar disorder. Based on our data, we suggest that attention should be focused on female patients younger than 60 years, and patients with alcohol use disorder, following a GERD diagnosis.	[Lin, Wan-Shan; Hu, Li-Yu; Hsu, Chih-Chao; Lu, Ti] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Hu, Li-Yu; Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Hu, Li-Yu; Liu, Chia-Jen; Wang, Yen-Po; Hu, Yu-Wen; Tsai, Chia-Fen; Su, Tung-Ping; Chen, Tzeng-Ji] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Liu, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Shen, Cheng-Che] Taichung Vet Gen Hosp, Dept Psychiat, Chiayi Branch, Taipei, Taiwan; [Wang, Yen-Po] Taipei Vet Gen Hosp, Endoscopy Ctr Diag & Treatment, Taipei, Taiwan; [Wang, Yen-Po] Taipei Vet Gen Hosp, Div Gastroenterol, Dept Med, Taipei, Taiwan; [Hu, Yu-Wen] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Tsai, Chia-Fen; Su, Tung-Ping] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Yeh, Chiu-Mei; Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chen, Pan-Ming] Taipei Vet Gen Hosp, Dept Psychiat, Su Ao & Yuanshan Branch, Taipei, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taichung Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Lu, T (corresponding author), Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan.	tlu@vghks.gov.tw	Chen, TJ/AAH-8430-2021	Hu, Yu-Wen/0000-0002-7983-415X; Wang, Yen-Po/0000-0002-3769-0020	Taipei Veterans General Hospital [V103B-022, V103E10-001]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study is supported by a grant from Taipei Veterans General Hospital (V103B-022 and V103E10-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Altomare A, 2013, WORLD J GASTROENTERO, V19, P6523, DOI 10.3748/wjg.v19.i39.6523; Avidan B, 2001, ALIMENT PHARM THER, V15, P1907, DOI 10.1046/j.1365-2036.2001.01131.x; Berk M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-200; Brietzke E, 2009, J AFFECT DISORDERS, V116, P214, DOI 10.1016/j.jad.2008.12.001; Chou PH, 2013, PSYCHOSOMATICS; Etain B, 2008, BIPOLAR DISORD, V10, P867, DOI 10.1111/j.1399-5618.2008.00635.x; Farren CK, 2012, CURR PSYCHIAT REP, V14, P659, DOI 10.1007/s11920-012-0320-9; Fass R, 2008, GASTROENTEROLOGY, V134, P696, DOI 10.1053/j.gastro.2007.12.010; Frey B.N., 2013, BIPOLAR DISORD; Goldstein BI, 2009, J CLIN PSYCHIAT, V70, P1078, DOI 10.4088/JCP.08r04505; Graae L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032304; Hamdani Nora, 2012, Front Biosci (Elite Ed), V4, P2170; Isomoto H, 2004, AM J GASTROENTEROL, V99, P589, DOI 10.1111/j.1572-0241.2004.04110.x; Jansson C, 2007, ALIMENT PHARM THER, V26, P683, DOI 10.1111/j.1365-2036.2007.03411.x; Jansson C, 2010, SCAND J GASTROENTERO, V45, P21, DOI 10.3109/00365520903401967; Jansson C, 2009, CLIN GASTROENTEROL H, V7, P960, DOI 10.1016/j.cgh.2009.03.007; Jung HK, 2011, J NEUROGASTROENTEROL, V17, P14, DOI 10.5056/jnm.2011.17.1.14; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Kim JY, 2013, J NEUROGASTROENTEROL, V19, P344, DOI 10.5056/jnm.2013.19.3.344; Kivimaki M, 2013, MOL PSYCHIAT; Kroon JS, 2013, BIPOLAR DISORD, V15, P306, DOI 10.1111/bdi.12058; Lampa J, 2012, P NATL ACAD SCI USA, V109, P12728, DOI 10.1073/pnas.1118748109; Lu CL, 2005, ALIMENT PHARM THER, V22, P739, DOI 10.1111/j.1365-2036.2005.02664.x; Mikocka-Walus A, 2009, INTERN MED J, V39, P127, DOI 10.1111/j.1445-5994.2008.01862.x; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Minatsuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069891; Monkemuller K, 2009, DIGESTION, V79, P186, DOI 10.1159/000211714; Moshkowitz M, 2011, WORLD J GASTROENTERO, V17, P1332, DOI 10.3748/wjg.v17.i10.1332; Pettinati HM, 2013, AM J PSYCHIAT, V170, P23, DOI 10.1176/appi.ajp.2012.12010112; Proudfoot J, 2012, J AFFECT DISORDERS, V143, P196, DOI 10.1016/j.jad.2012.05.052; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Schoeyen HK, 2011, J AFFECT DISORDERS, V129, P68, DOI 10.1016/j.jad.2010.08.012; Souza RF, 2009, GASTROENTEROLOGY, V137, P1776, DOI 10.1053/j.gastro.2009.07.055; Stertz L, 2013, CURR OPIN PSYCHIATR, V26, P19, DOI 10.1097/YCO.0b013e32835aa4b4; Wager-Smith K, 2011, NEUROSCI BIOBEHAV R, V35, P742, DOI 10.1016/j.neubiorev.2010.09.010; Waxmonsky JA, 2005, GEN HOSP PSYCHIAT, V27, P321, DOI 10.1016/j.genhosppsych.2005.05.003; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	38	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107694	10.1371/journal.pone.0107694	http://dx.doi.org/10.1371/journal.pone.0107694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3UZ	25255080	Green Published, gold, Green Submitted			2022-12-27	WOS:000344862300028
J	Schneeberger, K; Courtiol, A; Czirjak, GA; Voigt, CC				Schneeberger, Karin; Courtiol, Alexandre; Czirjak, Gabor A.; Voigt, Christian C.			Immune Profile Predicts Survival and Reflects Senescence in a Small, Long-Lived Mammal, the Greater Sac-Winged Bat (Saccopteryx bilineata)	PLOS ONE			English	Article							BODY ELECTRICAL-CONDUCTIVITY; INNATE IMMUNITY; LIFE-HISTORY; ENVIRONMENTAL-CONDITIONS; PARASITE RESISTANCE; TROPICAL BAT; SOAY SHEEP; IMMUNOSENESCENCE; ECOLOGY; SEX	The immune system imposes costs that may have to be traded against investment of resources in other costly life-history traits. Yet, it is unknown if a trade-off between immunity and longevity occurs in free-ranging mammals. Here, we tested if age and survival, two aspects associated with longevity, are linked to immune parameters in an 8 g bat species. Using a combination of cross-sectional and longitudinal data, we assessed whether total white blood cell (WBC) counts, bacterial killing ability of the plasma (BKA) and immunoglobulin G (IgG) concentration change with age. Furthermore, we asked if these immune parameters impose costs resulting in decreased survival probabilities. We found that WBC counts decreased with age both within and among individuals. IgG concentrations were higher in older individuals, but did not change with age within individuals. Furthermore, individuals with above average WBC counts or IgG concentration had lower probabilities to survive the next six months. High WBC counts and IgG concentrations may reflect infections with parasites and pathogens, however, individuals that were infected with trypanosomes or nematodes showed neither higher WBC counts or IgG concentrations, nor was infection connected with survival rates. BKA was higher in infected compared with uninfected bats, but not related to age or survival. In conclusion, cellular (WBC) and humoral (IgG) parts of the immune system were both connected to age and survival, but not to parasite infections, which supports the hypothesis that energetically costly immunological defences are traded against other costly life-history traits, leading to a reduced lifespan in this free-ranging mammal.	[Schneeberger, Karin; Courtiol, Alexandre; Czirjak, Gabor A.; Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Schneeberger, Karin; Voigt, Christian C.] Free Univ Berlin, Dept Anim Behav, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Free University of Berlin	Schneeberger, K (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	schneeberger@izw-berlin.de	Czirják, Gábor Árpád/F-5440-2011; Courtiol, Alexandre/O-3040-2017	Czirják, Gábor Árpád/0000-0001-9488-0069; Courtiol, Alexandre/0000-0003-0637-2959; Schneeberger, Karin/0000-0003-2098-2542	Deutsche Forschungsgemeinschaft (DFG) [Vo 890/25]; Leibniz Institute for Zoo and Wildlife Research	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Leibniz Institute for Zoo and Wildlife Research	Funding was provided by the Deutsche Forschungsgemeinschaft (DFG Vo 890/25) and the Leibniz Institute for Zoo and Wildlife Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LC, 2009, J COMP PHYSIOL B, V179, P315, DOI 10.1007/s00360-008-0315-3; Balomenos D, 2000, IMMUNOL TODAY, V21, P551, DOI 10.1016/S0167-5699(00)01748-5; Belloni V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012940; Bize P, 2014, OECOLOGIA, V174, P1097, DOI 10.1007/s00442-013-2840-3; Blount DG, 2005, VET IMMUNOL IMMUNOP, V108, P399, DOI 10.1016/j.vetimm.2005.06.015; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bradbury J. W, 1974, Z TIERPSYCHOL, V36, P137, DOI DOI 10.1111/J.1439-0310.1974.TB02130.X; Christe P, 2001, OECOLOGIA, V126, P333, DOI 10.1007/s004420000527; Christe P, 2000, ECOL LETT, V3, P207; Christe P, 2007, J ANIM ECOL, V76, P703, DOI 10.1111/j.1365-2656.2007.01255.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Devevey G, 2009, BIOL J LINN SOC, V97, P328, DOI 10.1111/j.1095-8312.2009.01216.x; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Durbin C, 2009, VET CLIN PATH, V38, P157, DOI 10.1111/j.1939-165X.2009.00110.x; Eraud C, 2009, EVOLUTION, V63, P1036, DOI 10.1111/j.1558-5646.2008.00540.x; Fox J., 2014, R COMPANION APPL REG; Franceschi C, 2000, VACCINE, V18, P1717, DOI 10.1016/S0264-410X(99)00513-7; Frasca D, 2005, SEMIN IMMUNOL, V17, P378, DOI 10.1016/j.smim.2005.05.005; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Ginaldi L, 2001, MICROBES INFECT, V3, P851, DOI 10.1016/S1286-4579(01)01443-5; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Greiner S, 2014, ETHOLOGY, V120, P197, DOI 10.1111/eth.12193; Greiner S, 2011, CAN J ZOOL, V89, P1157, DOI 10.1139/Z11-092; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; Hakim FT, 2007, TISSUE ANTIGENS, V70, P179, DOI 10.1111/j.1399-0039.2007.00891.x; Hanssen SA, 2004, P ROY SOC B-BIOL SCI, V271, P925, DOI 10.1098/rspb.2004.2678; Harman D., 1955, AGING THEORY BASED F; Hayward AD, 2011, J EVOLUTION BIOL, V24, P1664, DOI 10.1111/j.1420-9101.2011.02300.x; Hayward AD, 2009, P ROY SOC B-BIOL SCI, V276, P3477, DOI 10.1098/rspb.2009.0906; Kraus C, 2008, P ROY SOC B-BIOL SCI, V275, P1635, DOI 10.1098/rspb.2008.0200; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; LEHMANN T, 1993, PARASITOL TODAY, V9, P8, DOI 10.1016/0169-4758(93)90153-7; Linton P-J, 2006, CLIN APPL IMMUNOLOGY, V6, P73; Listi F, 2006, ANN NY ACAD SCI, V1089, P487, DOI 10.1196/annals.1386.013; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Meyer-Lucht Y, 2005, MOL ECOL, V14, P2233, DOI 10.1111/j.1365-294X.2005.02557.x; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; Moore MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058976; Moore MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027430; Moore MS, 2011, THESIS BOSTON U; Nagy M, 2007, P ROY SOC B-BIOL SCI, V274, P3019, DOI 10.1098/rspb.2007.1008; Noreen E, 2011, J COMP PHYSIOL B, V181, P649, DOI 10.1007/s00360-011-0553-7; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Nussey DH, 2012, AGING CELL, V11, P178, DOI 10.1111/j.1474-9726.2011.00771.x; Panda A, 2009, TRENDS IMMUNOL, V30, P325, DOI 10.1016/j.it.2009.05.004; Pearce RD, 2008, ACTA CHIROPTEROL, V10, P153, DOI 10.3161/150811008X331171; R Development Core Team, 2005, R LANG ENV STAT COMP; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Reynolds DS, 2009, J WILDLIFE MANAGE, V73, P1197, DOI 10.2193/2008-151; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; ROSS PS, 1993, J WILDLIFE DIS, V29, P21, DOI 10.7589/0090-3558-29.1.21; Saino N, 1997, P NATL ACAD SCI USA, V94, P549, DOI 10.1073/pnas.94.2.549; Schinnerl M, 2011, J ZOO WILDLIFE MED, V42, P382, DOI 10.1638/2010-0060.1; Schneeberger K, 2013, J EXP BIOL, V216, P4514, DOI 10.1242/jeb.090837; Schneeberger K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054023; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Speakman JR, 2011, BIOESSAYS, V33, P255, DOI 10.1002/bies.201000132; Stobel K, 2002, INT J MED MICROBIOL, V291, P88; Tieleman BI, 2005, P ROY SOC B-BIOL SCI, V272, P1715, DOI 10.1098/rspb.2005.3155; UTSUYAMA M, 1992, MECH AGEING DEV, V63, P57, DOI 10.1016/0047-6374(92)90016-7; van de Pol M, 2006, AM NAT, V167, P766, DOI 10.1086/503331; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Venables W.N., 2013, MODERN APPL STAT S; Viau M, 2005, CLIN IMMUNOL, V114, P17, DOI 10.1016/j.clim.2004.08.019; Voigt CC, 2001, BEHAV ECOL SOCIOBIOL, V50, P31, DOI 10.1007/s002650100337; Voigt CC, 2008, J MAMMAL, V89, P50, DOI 10.1644/06-MAMM-A-432.1; Voigt CC, 2007, ACTA CHIROPTEROL, V9, P463, DOI 10.3161/1733-5329(2007)9[463:AOFTMA]2.0.CO;2; Wellehan JFX, 2009, COMP IMMUNOL MICROB, V32, P379, DOI 10.1016/j.cimid.2007.11.002; WHITLOCK H. V., 1950, JOUR HELMINTHOL, V24, P47, DOI 10.1017/S0022149X00019106; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x	71	30	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108268	10.1371/journal.pone.0108268	http://dx.doi.org/10.1371/journal.pone.0108268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254988	Green Published, Green Submitted, gold			2022-12-27	WOS:000344862300067
J	Edamura, M; Murakami, G; Meng, HR; Itakura, M; Shigemoto, R; Fukuda, A; Nakahara, D				Edamura, Mitsuhiro; Murakami, Gen; Meng, Hongrui; Itakura, Makoto; Shigemoto, Ryuichi; Fukuda, Atsuo; Nakahara, Daiichiro			Functional Deficiency of MHC Class I Enhances LTP and Abolishes LTD in the Nucleus Accumbens of Mice	PLOS ONE			English	Article							LONG-TERM DEPRESSION; SYNAPTIC PLASTICITY; BEHAVIORAL SENSITIZATION; IMMUNE PROTEINS; AREA CA1; SYNAPSES; EXPRESSION; RECEPTORS; GLUTAMATE; HIPPOCAMPUS	Major histocompatibility complex class I (MHCI) molecules were recently identified as novel regulators of synaptic plasticity. These molecules are expressed in various brain areas, especially in regions undergoing activity-dependent synaptic plasticity, but their role in the nucleus accumbens (NAc) is unknown. In this study, we investigated the effects of genetic disruption of MHCI function, through deletion of beta 2-microblobulin, which causes lack of cell surface expression of MHCI. First, we confirmed that MHCI molecules are expressed in the NAc core in wild-type mice. Second, we performed electrophysiological recordings with NAc core slices from wild-type and beta 2-microglobulin knock-out mice lacking cell surface expression of MHCI. We found that low frequency stimulation induced long-term depression in wild-type but not knock-out mice, whereas high frequency stimulation induced long-term potentiation in both genotypes, with a larger magnitude in knock-out mice. Furthermore, we demonstrated that knock-out mice showed more persistent behavioral sensitization to cocaine, which is a NAc-related behavior. Using this model, we analyzed the density of total AMPA receptors and their subunits GluR1 and GluR2 in the NAc core, by SDS-digested freeze-fracture replica labeling. After repeated cocaine exposure, the density of GluR1 was increased, but there was no change in total AMPA receptors and GluR2 levels in wildtype mice. In contrast, following repeated cocaine exposure, increased densities of total AMPA receptors, GluR1 and GluR2 were observed in knock-out mice. These results indicate that functional deficiency of MHCI enhances synaptic potentiation, induced by electrical and pharmacological stimulation.	[Edamura, Mitsuhiro; Murakami, Gen; Meng, Hongrui; Nakahara, Daiichiro] Hamamatsu Univ Sch Med, Dept Integrated Human Sci, Div Psychol & Behav Neurosci, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Itakura, Makoto] Kitasato Univ, Sch Med, Dept Biochem, Sagamihara, Kanagawa 228, Japan; [Shigemoto, Ryuichi] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 444, Japan; [Shigemoto, Ryuichi] IST Austria, Klosterneuburg, Austria; [Fukuda, Atsuo] Hamamatsu Univ Sch Med, Dept Neurophysiol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Kitasato University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Institute of Science & Technology - Austria; Hamamatsu University School of Medicine	Edamura, M (corresponding author), Hamamatsu Univ Sch Med, Dept Integrated Human Sci, Div Psychol & Behav Neurosci, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan.	edamura@hama-med.ac.jp; nakahara@hama-med.ac.jp	Shigemoto, Ryuichi/E-3628-2013; Fukuda, Atsuo/ABA-6843-2020	Shigemoto, Ryuichi/0000-0001-8761-9444; Fukuda, Atsuo/0000-0001-7112-4834	Ministry of Education, Culture, Sports, Science and Technology of Japan [17330153]; Grants-in-Aid for Scientific Research [26110705] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) and (B) 17330153, from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal M, 2008, J NEUROSCI, V28, P9692, DOI 10.1523/JNEUROSCI.1551-08.2008; Bakker R, 2009, NEURAL NETWORKS, V22, P1159, DOI 10.1016/j.neunet.2009.07.014; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Dorfman JR, 1997, J IMMUNOL, V159, P5219; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Fourgeaud L, 2010, P NATL ACAD SCI USA, V107, P22278, DOI 10.1073/pnas.0914064107; FUJIMOTO K, 1995, J CELL SCI, V108, P3443; Glynn MW, 2011, NAT NEUROSCI, V14, P442, DOI 10.1038/nn.2764; Gonzalez-Sulser A, 2011, NEUROPHARMACOLOGY, V60, P1142, DOI 10.1016/j.neuropharm.2010.10.007; HARRIS KM, 1986, NEUROSCIENCE, V19, P857, DOI 10.1016/0306-4522(86)90304-0; Hoffman AF, 2003, J NEUROSCI, V23, P4815; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kawahara A, 2013, J PHYSIOL-LONDON, V591, P4777, DOI 10.1113/jphysiol.2013.252122; KOMBIAN SB, 1994, NATURE, V368, P242, DOI 10.1038/368242a0; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Lee H, 2014, NATURE; Luscher C, 2008, NAT NEUROSCI, V11, P737, DOI 10.1038/nn0708-737; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Mapelli J, 2007, J NEUROSCI, V27, P1285, DOI 10.1523/JNEUROSCI.4873-06.2007; Masugi-Tokita M, 2007, CURR OPIN NEUROBIOL, V17, P387, DOI 10.1016/j.conb.2007.04.012; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; McConnell MJ, 2009, P NATL ACAD SCI USA, V106, P6784, DOI 10.1073/pnas.0902018106; Narimatsu E, 2010, NEUROSCI RES, V68, P276, DOI 10.1016/j.neures.2010.08.008; Needleman LA, 2010, P NATL ACAD SCI USA, V107, P16999, DOI 10.1073/pnas.1006087107; Nelson PA, 2013, LEARN MEMORY, V20, P505, DOI 10.1101/lm.031351.113; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; PENNARTZ CMA, 1993, EUR J NEUROSCI, V5, P107, DOI 10.1111/j.1460-9568.1993.tb00475.x; Pereda A, 2003, J NEUROSCI, V23, P7489; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Schotanus SM, 2008, EUR J NEUROSCI, V27, P1957, DOI 10.1111/j.1460-9568.2008.06173.x; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Shinohara Y, 2013, P NATL ACAD SCI USA, V110, P10045; Staats KA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00249; Steidl EM, 2006, BRAIN RES, V1096, P70, DOI 10.1016/j.brainres.2006.04.034; Takabayashi S, 2012, EXP ANIM TOKYO, V61, P435, DOI 10.1538/expanim.61.435; Tanaka J, 2005, J NEUROSCI, V25, P799, DOI 10.1523/JNEUROSCI.4256-04.2005; Thams S, 2008, BRAIN RES REV, V57, P265, DOI 10.1016/j.brainresrev.2007.06.016; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	46	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107099	10.1371/journal.pone.0107099	http://dx.doi.org/10.1371/journal.pone.0107099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268136	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700028
J	Jameel, MN; Hu, QS; Zhang, JY				Jameel, Mohammad Nurulqadr; Hu, Qingsong; Zhang, Jianyi			Myocytes Oxygenation and High Energy Phosphate Levels during Hypoxia	PLOS ONE			English	Article							MYOCARDIAL-METABOLISM; MAGNETIC-RESONANCE; NMR-SPECTROSCOPY; IN-VIVO; DEOXYMYOGLOBIN; MYOGLOBIN; FLOW; TRANSPORT; PRESSURE; ISCHEMIA	Decrease of ambient oxygen level has been used in myocytes culture experiments in examining the responsiveness to stress secondary to hypoxia. However, none of these studies measure the myocytes oxygenation levels resulting in ambiguity as to whether there is insufficient oxygen delivery. This study examined the hypothesis that at a basal myocardial work state, adequate myocyte oxygenation would be maintained until extremely low arterial pO(2) levels were reached. Myocyte pO(2) values in normal dogs were calculated from the myocardial deoxymyoglobin (Mb-delta) levels using H-1-spectroscopy (MRS) and were normalized to Mb-delta obtained after complete LAD occlusion. During Protocol 1 (n = 6), Mb-delta was measured during sequential reductions of the oxygen fraction of inspired gas (FIO2) from 40, 21, 15, 10, and 5%, while in protocol 2 (n = 10) Mb-delta was measured at FIO2 of 3%. Protocol 3 (n = 9) evaluated time course of Mb-delta during prolonged exposure to FIO2 of 5%. Myocardial blood flow (MBF) was measured with microspheres and high energy phosphate (HEP) levels were determined with P-31-MRS. MVO2 progressively increased in response to the progressive reduction of FIO2 that is accompanied by increased LV pressure, heart rate, and MBF. Mb-delta was undetectable during FIO2 values of 21, 15, 10, and 5%. However, FIO2 of 3% or prolonged exposure to FIO2 of 5% caused progressive increases of Mb-d which were associated with decreases of PCr, ATP and the PCr/ATP ratio, as well as increases of inorganic phosphate. The intracellular PO2 values for 20% reductions of PCr and ATP were approximately 7.4 and 1.9 mmHg, respectively. These data demonstrate that in the in vivo system over a wide range of FIO2 and arterial pO(2) levels, the myocyte pO(2) values remain well above the Km value with respect to cytochrome oxidase, and oxygen availability does not limit mitochondrial oxidative phosphorylation at 5% FIO2.	[Zhang, Jianyi] Univ Minnesota, Dept Med, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; Univ Minnesota, Hlth Sci Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zhang, JY (corresponding author), Univ Minnesota, Dept Med, Ctr Magnet Resonance Res, Box 736 UMHC, Minneapolis, MN 55455 USA.	zhang047@umn.edu	Zhang, Jianyi/N-1949-2018	Zhang, Jianyi/0000-0002-3955-6554	NIH [RO1 HL 67828, RO1 HL 95077, RO1 HL 114120]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095077, R01HL114120, R01HL067828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH RO1s HL 67828, HL 95077, and HL 114120. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DG, 1985, J MOL CELL CARDIOL, V17, P821, DOI 10.1016/S0022-2828(85)80097-3; Ambrose LJA, 2014, J CARDIOVASC PHARM T, V19, P574, DOI 10.1177/1074248414524480; Chen W, 1997, MAGN RESON MED, V38, P193, DOI 10.1002/mrm.1910380206; CLARK A, 1987, AM J PHYSIOL, V252, pC583, DOI 10.1152/ajpcell.1987.252.6.C583; FEDELE FA, 1988, CIRCULATION, V78, P729, DOI 10.1161/01.CIR.78.3.729; GOFF H, 1977, J AM CHEM SOC, V99, P6599, DOI 10.1021/ja00462a022; GREGG DE, 1963, CIRC RES, V13, P497, DOI 10.1161/01.RES.13.6.497; GWIRTZ PA, 1986, J APPL PHYSIOL, V60, P720, DOI 10.1152/jappl.1986.60.2.720; HENDRICH K, 1991, J MAGN RESON, V92, P258, DOI 10.1016/0022-2364(91)90269-Y; HONIG CR, 1989, AM J PHYSIOL, V256, pH375, DOI 10.1152/ajpheart.1989.256.2.H375; ITO K, 1990, ADV EXP MED BIOL, V277, P449; KREUTZER U, 1991, AM J PHYSIOL, V261, pH2091, DOI 10.1152/ajpheart.1991.261.6.H2091; KREUTZER U, 1995, AM J PHYSIOL-HEART C, V268, pH1675, DOI 10.1152/ajpheart.1995.268.4.H1675; Lin PC, 2007, J PHYSIOL-LONDON, V578, P595, DOI 10.1113/jphysiol.2006.116061; MARBAN E, 1988, CIRC RES, V63, P673, DOI 10.1161/01.RES.63.3.673; MAZER CD, 1990, METABOLISM, V39, P913, DOI 10.1016/0026-0495(90)90300-2; OPIE LH, 1978, JPN CIRC J, V42, P1223, DOI 10.1253/jcj.42.1223; PANTELY GA, 1990, CIRC RES, V67, P1481, DOI 10.1161/01.RES.67.6.1481; PORTMAN MA, 1995, J CLIN INVEST, V95, P2134, DOI 10.1172/JCI117902; ROBITAILLE PM, 1990, MAGN RESON MED, V16, P91, DOI 10.1002/mrm.1910160110; ROBITAILLE PM, 1989, MAGNET RESON MED, V10, P14, DOI 10.1002/mrm.1910100103; Schenkman KA, 1997, J APPL PHYSIOL, V82, P86, DOI 10.1152/jappl.1997.82.1.86; SCHWARTZ S, 1981, AM J PHYSIOL, V241, pH864, DOI 10.1152/ajpheart.1981.241.6.H864; Takahashi E, 1998, AM J PHYSIOL-HEART C, V275, pH225, DOI 10.1152/ajpheart.1998.275.1.H225; VOGEL WM, 1982, CIRC RES, V51, P465, DOI 10.1161/01.RES.51.4.465; Zhang J, 2001, AM J PHYSIOL-HEART C, V280, pH1318; Zhang JY, 1999, AM J PHYSIOL-HEART C, V277, pH50, DOI 10.1152/ajpheart.1999.277.1.H50; Zhang X, 2014, CIRCULATION, V129, P1650, DOI 10.1161/CIRCULATIONAHA.113.005296	28	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e101317	10.1371/journal.pone.0101317	http://dx.doi.org/10.1371/journal.pone.0101317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268711	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700003
J	Liu, JJ; Huang, PW; He, YQ; Hong, WX; Ren, XH; Yang, XF; He, YX; Wang, WJ; Zhang, RL; Yang, H; Zhao, ZG; Huang, HY; Chen, L; Zhao, DJ; Xian, HX; Yang, F; Ma, DL; Yang, LQ; Yin, YD; Zhou, L; Chen, XZ; Cheng, JQ				Liu, Jianjun; Huang, Peiwu; He, Yaqing; Hong, Wen-Xu; Ren, Xiaohu; Yang, Xifei; He, Yanxia; Wang, Wenjian; Zhang, Renli; Yang, Hong; Zhao, Zhiguang; Huang, Haiyan; Chen, Long; Zhao, Dejian; Xian, Huixia; Yang, Fang; Ma, Dongli; Yang, Linqing; Yin, Yundong; Zhou, Li; Chen, Xiaozhen; Cheng, Jinquan			Serum Amyloid A and Clusterin as Potential Predictive Biomarkers for Severe Hand, Foot and Mouth Disease by 2D-DIGE Proteomics Analysis	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TUMOR-MARKERS; PROTEIN; EXPRESSION; ENTEROVIRUS-71; IDENTIFICATION; INFECTION; SAA	Hand, foot, and mouth disease (HFMD) affects more than one million children, is responsible for several hundred child deaths every year in China and is the cause of widespread concerns in society. Only a small fraction of HFMD cases will develop further into severe HFMD with neurologic complications. A timely and accurate diagnosis of severe HFMD is essential for assessing the risk of progression and planning the appropriate treatment. Human serum can reflect the physiological or pathological states, which is expected to be an excellent source of disease-specific biomarkers. In the present study, a comparative serological proteome analysis between severe HFMD patients and healthy controls was performed via a two-dimensional difference gel electrophoresis (2D-DIGE) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) strategy. Fifteen proteins were identified as differentially expressed in the sera of the severe HFMD patients compared with the controls. The identified proteins were classified into different groups according to their molecular functions, biological processes, protein classes and physiological pathways by bioinformatics analysis. The up-regulations of two identified proteins, serum amyloid A (SAA) and clusterin (CLU), were confirmed in the sera of the HFMD patients by ELISA assay. This study not only increases our background knowledge about and scientific insight into the mechanisms of HFMD, but also reveals novel potential biomarkers for the clinical diagnosis of severe HFMD.	[Liu, Jianjun; Huang, Peiwu; He, Yaqing; Hong, Wen-Xu; Ren, Xiaohu; Yang, Xifei; Zhang, Renli; Yang, Hong; Zhao, Zhiguang; Huang, Haiyan; Chen, Long; Zhao, Dejian; Xian, Huixia; Yang, Fang; Yang, Linqing; Zhou, Li; Cheng, Jinquan] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [He, Yanxia; Wang, Wenjian; Ma, Dongli; Yin, Yundong; Chen, Xiaozhen] Shenzhen Childrens Hosp, Shenzhen, Peoples R China	Shenzhen Center for Disease Control & Prevention (SZCDC)	Cheng, JQ (corresponding author), Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China.	bio-research@hotmail.com	Chen, Long/N-4705-2019	Chen, Long/0000-0003-1110-6495; Ma, Dongli/0000-0001-5299-6207	NSFC (the National Natural Science Foundation of China) [21102094]; Shenzhen Municipal Key Laboratory [JCYJ20130401102255980, CXB201111240109A]	NSFC (the National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Key Laboratory	This work was supported by NSFC (the National Natural Science Foundation of China) [21102094], and the Shenzhen Municipal Key Laboratory [JCYJ20130401102255980, CXB201111240109A]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDOBENSON MA, 1982, J IMMUNOL, V128, P2390; [Anonymous], 1997, JAMA-J AM MED ASSOC, V277, P925; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; BLASCHUK O, 1983, J BIOL CHEM, V258, P7714; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Chen SC, 2007, AM J TROP MED HYG, V77, P188, DOI 10.4269/ajtmh.2007.77.188; Cui AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061451; Deng L, 2012, CLIN MICROBIOL INFEC, V18, pE188, DOI 10.1111/j.1469-0691.2012.03836.x; Diamandis EP, 2004, CLIN CANCER RES, V10, P5293, DOI 10.1158/1078-0432.CCR-04-0377; Ebert MPA, 2004, J PROTEOME RES, V3, P1261, DOI 10.1021/pr049865s; Giannakopoulos P, 1998, ACTA NEUROPATHOL, V95, P387, DOI 10.1007/s004010050815; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Holtzman DM, 2001, NAT MED, V7, P977, DOI 10.1038/nm0901-977; Hortin GL, 2006, CLIN CHEM, V52, P1218, DOI 10.1373/clinchem.2006.067280; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Issaq HJ, 2007, CHEM REV, V107, P3601, DOI 10.1021/cr068287r; Jensen LE, 1998, BIOCHEM J, V334, P489, DOI 10.1042/bj3340489; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Kwan BCH, 2007, J AM SOC NEPHROL, V18, P1246, DOI 10.1681/ASN.2006091006; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; LINKE RP, 1991, BIOCHEM BIOPH RES CO, V176, P1100, DOI 10.1016/0006-291X(91)90397-P; Liu WT, 2007, CLIN CHIM ACTA, V377, P119, DOI 10.1016/j.cca.2006.09.005; Ma YL, 2009, ELECTROPHORESIS, V30, P2591, DOI 10.1002/elps.200900082; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; MCGEER PL, 1992, BRAIN RES, V579, P337, DOI 10.1016/0006-8993(92)90071-G; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; ROSENBERG ME, 1995, INT J BIOCHEM CELL B, V27, P633, DOI 10.1016/1357-2725(95)00027-M; Tapper H, 2000, BLOOD, V96, P2329; van Gorp ECM, 1999, J INFECT DIS, V180, P176, DOI 10.1086/314829; Wang SM, 2009, EXPERT REV ANTI-INFE, V7, P735, DOI 10.1586/ERI.09.45; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]; WEINSTEIN PS, 1984, SCAND J IMMUNOL, V19, P193; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738; Zhang H, 2007, MOL CELL PROTEOMICS, V6, P64, DOI 10.1074/mcp.M600160-MCP200	37	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108816	10.1371/journal.pone.0108816	http://dx.doi.org/10.1371/journal.pone.0108816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268271	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700169
J	Rodriguez-Viera, L; Perera, E; Casuso, A; Perdomo-Morales, R; Gutierrez, O; Scull, I; Carrillo, O; Martos-Sitcha, JA; Garcia-Galano, T; Mancera, JM				Rodriguez-Viera, Leandro; Perera, Erick; Casuso, Antonio; Perdomo-Morales, Rolando; Gutierrez, Odilia; Scull, Idania; Carrillo, Olimpia; Martos-Sitcha, Juan A.; Garcia-Galano, Tsai; Miguel Mancera, Juan			A Holistic View of Dietary Carbohydrate Utilization in Lobster: Digestion, Postprandial Nutrient Flux, and Metabolism	PLOS ONE			English	Article							PANULIRUS-ARGUS-LATREILLE; SOUTHERN ROCK LOBSTER; PENAEUS-SETIFERUS CRUSTACEA; SHRIMP LITOPENAEUS-VANNAMEI; JUVENILE SPINY LOBSTERS; SHORT-TERM STARVATION; JASUS-EDWARDSII; IN-VITRO; PYRUVATE-KINASE; STARCH GRANULES	Crustaceans exhibit a remarkable variation in their feeding habits and food type, but most knowledge on carbohydrate digestion and utilization in this group has come from research on few species. The aim of this study was to make an integrative analysis of dietary carbohydrate utilization in the spiny lobster Panulirus argus. We used complementary methodologies such as different assessments of digestibility, activity measurements of digestive and metabolic enzymes, and post-feeding flux of nutrients and metabolites. Several carbohydrates were well digested by the lobster, but maize starch was less digestible than all other starches studied, and its inclusion in diet affected protein digestibility. Most intense hydrolysis of carbohydrates in the gastric chamber of lobster occurred between 2-6 h after ingestion and afterwards free glucose increased in hemolymph. The inclusion of wheat in diet produced a slow clearance of glucose from the gastric fluid and a gradual increase in hemolymph glucose. More intense hydrolysis of protein in the gastric chamber occurred 6-12 h after ingestion and then amino acids tended to increase in hemolymph. Triglyceride concentration in hemolymph rose earlier in wheat-fed lobsters than in lobsters fed other carbohydrates, but it decreased the most 24 h later. Analyses of metabolite levels and activities of different metabolic enzymes revealed that intermolt lobsters had a low capacity to store and use glycogen, although it was slightly higher in wheat-fed lobsters. Lobsters fed maize and rice diets increased amino acid catabolism, while wheat-fed lobsters exhibited higher utilization of fatty acids. Multivariate analysis confirmed that the type of carbohydrate ingested had a profound effect on overall metabolism. Although we found no evidence of a protein-sparing effect of dietary carbohydrate, differences in the kinetics of their digestion and absorption impacted lobster metabolism determining the fate of other nutrients.	[Rodriguez-Viera, Leandro; Casuso, Antonio; Garcia-Galano, Tsai] Univ Havana, Ctr Marine Res, Havana, Cuba; [Perera, Erick; Martos-Sitcha, Juan A.] ICMAN CSIC, Inst Ciencias Marinas Andaluci, Cadiz, Spain; [Perdomo-Morales, Rolando] Ctr Pharmaceut Res & Dev, Dept Biochem, Havana, Cuba; [Gutierrez, Odilia; Scull, Idania] Inst Anim Sci, Mayabeque, Cuba; [Carrillo, Olimpia] Univ Havana, Fac Biol, Havana, Cuba; [Rodriguez-Viera, Leandro; Miguel Mancera, Juan] Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Campus Excelencia Int Mar CEI MAR, Cadiz, Spain	Universidad de la Habana; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); Instituto de Ciencia Animal; Universidad de la Habana; Universidad de Cadiz	Rodriguez-Viera, L (corresponding author), Univ Havana, Ctr Marine Res, Havana, Cuba.	leandro@cim.uh.cu	Martos-Sitcha, Juan Antonio/L-6140-2014; Perdomo-Morales, Rolando/AAC-8280-2020; Perera, Erick/E-9908-2018; Rodriguez-Viera, Leandro/AAD-3149-2020; Perera, Erick/F-2917-2012; Rodriguez-Viera, Leandro/AAA-8942-2020; Mancera Romero, Juan Miguel/A-8132-2014	Martos-Sitcha, Juan Antonio/0000-0002-0151-7250; Perdomo-Morales, Rolando/0000-0001-5598-6864; Perera, Erick/0000-0001-6108-1340; Rodriguez-Viera, Leandro/0000-0002-2392-0075; Perera, Erick/0000-0001-6108-1340; Rodriguez-Viera, Leandro/0000-0002-2392-0075; Mancera Romero, Juan Miguel/0000-0003-0751-5966; Carrillo Farnes, Olimpia Victoria/0000-0002-4650-9123	International Foundation for Science [A/4306-2]; Escuela Internacional de Doctorado en Agroalimentacion fellowship	International Foundation for Science(International Foundation for Science); Escuela Internacional de Doctorado en Agroalimentacion fellowship	This work was partially supported by International Foundation for Science (http://www.ifs.se/) through project no. A/4306-2 granted to EP, and Escuela Internacional de Doctorado en Agroalimentacion (http://www.ceia3.es/eida3) fellowship granted to LRV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 1990, OFF METH AN, P1108; Bednar GE, 2001, J NUTR, V131, P276, DOI 10.1093/jn/131.2.276; BERRY CS, 1986, J CEREAL SCI, V4, P301, DOI 10.1016/S0733-5210(86)80034-0; BIESIOT PM, 1990, COMP BIOCHEM PHYS A, V95, P47, DOI 10.1016/0300-9629(90)90008-G; Bordner C.E., 1983, Journal of the World Mariculture Society, V14, P11; BOULTON AP, 1970, COMP BIOCHEM PHYSIOL, V33, P491, DOI 10.1016/0010-406X(70)90366-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bridges CR, 2001, J EXP BIOL, V204, P1021; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Campanha RB, 2011, J THERM ANAL CALORIM, V106, P799, DOI 10.1007/s10973-011-1682-7; Capuzzo J.M., 1979, Proceedings of the Annual Meeting of the World Mariculture Society, V10, P689; Cousin M, 1996, AQUACULTURE, V140, P361, DOI 10.1016/0044-8486(95)01201-X; Crear BJ, 2002, AQUACULT ENG, V26, P239, DOI 10.1016/S0144-8609(02)00033-X; Crowe TC, 2000, J NUTR, V130, P2006, DOI 10.1093/jn/130.8.2006; CRUZRICQUE LE, 1989, AQUACULTURE, V76, P57, DOI 10.1016/0044-8486(89)90251-2; CRUZSUAREZ LE, 1994, AQUACULTURE, V123, P349, DOI 10.1016/0044-8486(94)90070-1; Cuzon G., 2000, AV NUTR AC 5 MEM 5 S; Dall W., 1983, P215; DAVIS DA, 1993, AQUACULTURE, V114, P285, DOI 10.1016/0044-8486(93)90303-G; ELLINGTON WR, 1983, J EXP ZOOL, V228, P431, DOI 10.1002/jez.1402280305; ENGLYST HN, 1985, AM J CLIN NUTR, V42, P778, DOI 10.1093/ajcn/42.5.778; Foruichi M, 1983, B JAPANESE SOC SCI F, V49, P1367; FRANCO CML, 1992, STARCH-STARKE, V44, P422, DOI 10.1002/star.19920441106; Fukuda N, 2013, J CLIN BIOCHEM NUTR, V53, P114, DOI 10.3164/jcbn.13-21; Gaxiola G, 2005, COMP BIOCHEM PHYS A, V140, P29, DOI 10.1016/j.cbpb.2004.10.018; GLASS HJ, 1995, J CRUSTACEAN BIOL, V15, P424, DOI 10.2307/1548764; Glencross B, 2001, AQUACULTURE, V199, P119, DOI 10.1016/S0044-8486(01)00520-8; Grillo LAM, 2007, INSECT BIOCHEM MOLEC, V37, P579, DOI 10.1016/j.ibmb.2007.03.002; HENRY RP, 1994, J EXP BIOL, V186, P215; Hernandez-Lopez J, 2003, FISH SHELLFISH IMMUN, V14, P105, DOI 10.1006/fsim.2002.0419; HERS HG, 1983, ANNU REV BIOCHEM, V52, P617, DOI 10.1146/annurev.bi.52.070183.003153; Hochachka PM, 1971, INT J BIOCHEM, V2, P25; Irvin SJ, 2007, AQUACULTURE, V269, P456, DOI 10.1016/j.aquaculture.2007.05.013; Irvin SJ, 2005, AQUACULTURE, V243, P269, DOI 10.1016/j.aquaculture.2004.10.001; Jane JL, 1997, CARBOHYD RES, V300, P219, DOI 10.1016/S0008-6215(97)00056-6; Jensen MA, 2013, COMP BIOCHEM PHYS A, V166, P191, DOI 10.1016/j.cbpa.2013.06.003; Ji H, 1996, J EXP ZOOL, V276, P375, DOI 10.1002/(SICI)1097-010X(19961215)276:6&lt;375::AID-JEZ1&gt;3.0.CO;2-K; Johnston DJ, 2003, MAR BIOL, V143, P1071, DOI 10.1007/s00227-003-1154-0; Johnston DJ, 2003, AQUACULTURE, V220, P667, DOI 10.1016/S0044-8486(02)00562-8; Keppler D., 1974, METHODS ENZYMATIC AN, P127; Kong BW, 2003, BIOTECHNOL PROGR, V19, P1162, DOI 10.1021/bp034005m; KOSHIO S, 1992, AQUACULTURE, V108, P285, DOI 10.1016/0044-8486(92)90113-Y; KRISTENSEN JH, 1972, MAR BIOL, V14, P130, DOI 10.1007/BF00373212; Laiz-Carrion R, 2003, J EXP ZOOL PART A, V298A, P105, DOI 10.1002/jez.a.10256; LALLIER FH, 1991, B MAR SCI, V48, P665; LEE RF, 1978, COMP BIOCHEM PHYS B, V59, P239, DOI 10.1016/0305-0491(78)90253-5; LESICKI A, 1977, COMP BIOCHEM PHYS B, V56, P15, DOI 10.1016/0305-0491(77)90215-2; LIPCIUS RN, 1982, MAR BIOL, V68, P241, DOI 10.1007/BF00409591; LOVETT DL, 1990, BIOL BULL, V178, P160, DOI 10.2307/1541974; LOVETT DL, 1990, BIOL BULL, V178, P144, DOI 10.2307/1541973; LYLE WG, 1983, J CRUSTACEAN BIOL, V3, P208, DOI 10.2307/1548257; Manelius R, 1996, J CEREAL SCI, V24, P139, DOI 10.1006/jcrs.1996.0047; Marqueze A, 2011, J EXP MAR BIOL ECOL, V404, P40, DOI 10.1016/j.jembe.2011.05.003; Martins TL, 2011, COMP BIOCHEM PHYS A, V158, P400, DOI 10.1016/j.cbpa.2010.11.023; MAYZAUD P, 1988, MAR ECOL PROG SER, V45, P289, DOI 10.3354/meps045289; MILLIGAN CL, 1988, J EXP BIOL, V135, P119; Morita T, 2007, J AOAC INT, V90, P1628; Munoz ME, 2003, COMP BIOCHEM PHYS B, V135, P197, DOI 10.1016/S1096-4959(03)00081-2; Omondi JG, 1996, AQUACULTURE, V139, P315, DOI 10.1016/0044-8486(95)01166-8; Panserat S, 2002, J NUTR, V132, P137, DOI 10.1093/jn/132.2.137; Parks EJ, 2001, J NUTR, V131, p2772S, DOI 10.1093/jn/131.10.2772S; Pavasovic M, 2004, AQUACULTURE, V242, P641, DOI 10.1016/j.aquaculture.2004.08.036; Perdomo-Morales R, 2007, FISH SHELLFISH IMMUN, V23, P1187, DOI 10.1016/j.fsi.2007.04.001; Perera E, 2005, AQUACULTURE, V244, P251, DOI 10.1016/j.aquaculture.2004.11.022; Perera E, 2008, COMP BIOCHEM PHYS B, V151, P250, DOI 10.1016/j.cbpb.2008.07.005; Perera E, 2008, COMP BIOCHEM PHYS B, V150, P247, DOI 10.1016/j.cbpb.2008.03.009; Perera E, 2007, AQUACULTURE, V265, P261, DOI 10.1016/j.aquaculture.2006.11.012; Perera E, 2012, BIOL BULL-US, V222, P158, DOI 10.1086/BBLv222n2p158; Perera E, 2012, J EXP BIOL, V215, P853, DOI 10.1242/jeb.063925; Perera E, 2010, AQUACULTURE, V310, P178, DOI 10.1016/j.aquaculture.2010.10.009; Radford CA, 2007, AQUACULTURE, V273, P151, DOI 10.1016/j.aquaculture.2007.09.021; Radford CA, 2005, COMP BIOCHEM PHYS A, V140, P241, DOI 10.1016/j.cbpb.2005.01.002; Regnault Michele, 1993, Marine Behaviour and Physiology, V22, P131; Robyt J.F., 1968, STARCH ITS DERIVATIV, P477; ROSAS C, 1995, BIOL BULL, V189, P168, DOI 10.2307/1542467; Rosas C, 2002, J EXP MAR BIOL ECOL, V268, P47, DOI 10.1016/S0022-0981(01)00370-7; Rosas C, 2001, J EXP MAR BIOL ECOL, V259, P1, DOI 10.1016/S0022-0981(01)00222-2; Rosas C, 2000, J EXP MAR BIOL ECOL, V249, P181, DOI 10.1016/S0022-0981(00)00184-2; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; Sanchez-Paz A, 2006, INSECT BIOCHEM MOLEC, V36, P241, DOI 10.1016/j.ibmb.2006.01.002; Sanchez-Paz A, 2008, J EXP MAR BIOL ECOL, V362, P79, DOI 10.1016/j.jembe.2008.06.002; Sanchez-Paz A, 2007, J EXP MAR BIOL ECOL, V340, P184, DOI 10.1016/j.jembe.2006.09.006; Sangiao-Alvarellos S, 2003, AM J PHYSIOL-REG I, V285, pR897, DOI 10.1152/ajpregu.00161.2003; Simon CJ, 2011, AQUACULT NUTR, V17, P613, DOI 10.1111/j.1365-2095.2011.00861.x; Simon CJ, 2008, AQUACULTURE, V280, P211, DOI 10.1016/j.aquaculture.2008.05.019; Simon CJ, 2013, AQUACULTURE, V384, P111, DOI 10.1016/j.aquaculture.2013.01.003; Simon CJ, 2009, AQUACULTURE, V296, P329, DOI 10.1016/j.aquaculture.2009.08.032; Simon CJ, 2009, AQUACULTURE, V294, P271, DOI 10.1016/j.aquaculture.2009.06.023; Simon CJ, 2009, AQUACULTURE, V290, P275, DOI 10.1016/j.aquaculture.2009.02.026; Simon CJ, 2009, NEW ZEAL J MAR FRESH, V43, P195, DOI 10.1080/00288330909509993; Smith DM, 2005, AQUACULT NUTR, V11, P209, DOI 10.1111/j.1365-2095.2005.00344.x; Smith DM, 2003, AQUACULT NUTR, V9, P231, DOI 10.1046/j.1365-2095.2003.00248.x; Song ZX, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-181; Speed SR, 2001, COMP BIOCHEM PHYS B, V128, P435, DOI 10.1016/S1096-4959(00)00340-7; Stone DAJ, 2003, REV FISH SCI, V11, P337, DOI 10.1080/10641260390260884; SUAREZ RK, 1987, CAN J ZOOL, V65, P1869, DOI 10.1139/z87-287; Svihus B, 2005, ANIM FEED SCI TECH, V122, P303, DOI 10.1016/j.anifeedsci.2005.02.025; TAYLOR EW, 1989, J EXP BIOL, V144, P417; Tester RF, 2006, ANIM FEED SCI TECH, V130, P39, DOI 10.1016/j.anifeedsci.2006.01.016; Tester RF, 2004, J CEREAL SCI, V39, P151, DOI 10.1016/j.jcs.2003.12.001; THABREW MI, 1971, COMP BIOCHEM PHYSIOL, V40, P531, DOI 10.1016/0305-0491(71)90238-0; TRAVIS DF, 1955, BIOL BULL, V108, P88, DOI 10.2307/1538400; Tufvesson F, 2001, LEBENSM-WISS TECHNOL, V34, P131, DOI 10.1006/fstl.2000.0727; Valentini G, 2002, J BIOL CHEM, V277, P23807, DOI 10.1074/jbc.M202107200; VANWORMHOUDT A, 1995, BIOCHEM SYST ECOL, V23, P139, DOI 10.1016/0305-1978(94)00090-4; Venou B, 2003, AQUACULTURE, V225, P207, DOI 10.1016/S0044-8486(03)00290-4; Verri T, 2001, COMP BIOCHEM PHYS A, V130, P585, DOI 10.1016/S1095-6433(01)00434-2; Voet D., 2011, BIOCHEMISTRY; Volpe MG, 2008, AQUACULTURE, V274, P339, DOI 10.1016/j.aquaculture.2007.11.026; WALSH PJ, 1990, MAR BIOL, V106, P343, DOI 10.1007/BF01344310; Ward L.R., 2003, NUTR JUVENILE ADULT, P40; Ward LR, 2009, AQUACULTURE, V296, P292, DOI 10.1016/j.aquaculture.2009.08.025; Ward LR, 2003, AQUACULTURE, V217, P483, DOI 10.1016/S0044-8486(02)00258-2; Wells RMG, 2001, COMP BIOCHEM PHYS B, V130, P339, DOI 10.1016/S1096-4959(01)00439-0; Weurding RE, 2001, J NUTR, V131, P2336, DOI 10.1093/jn/131.9.2336; Wigglesworth IM, 1994, MAR BIOL, V120, P571; Williams KC, 2007, AQUACULTURE, V263, P1, DOI 10.1016/j.aquaculture.2006.10.019; Xiao XC, 2014, AQUACULTURE, V426, P112, DOI 10.1016/j.aquaculture.2014.01.029; YEMM EW, 1955, ANALYST, V80, P209, DOI 10.1039/an9558000209	119	13	13	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108875	10.1371/journal.pone.0108875	http://dx.doi.org/10.1371/journal.pone.0108875			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268641	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700182
J	Dzyubachyk, O; Khmelinskii, A; Plenge, E; Kok, P; Snoeks, TJA; Poot, DHJ; Lowik, CWGM; Botha, CP; Niessen, WJ; van der Weerd, L; Meijering, E; Lelieveldt, BPF				Dzyubachyk, Oleh; Khmelinskii, Artem; Plenge, Esben; Kok, Peter; Snoeks, Thomas J. A.; Poot, Dirk H. J.; Lowik, Clemens W. G. M.; Botha, Charl P.; Niessen, Wiro J.; van der Weerd, Louise; Meijering, Erik; Lelieveldt, Boudewijn P. F.			Interactive Local Super-Resolution Reconstruction of Whole-Body MRI Mouse Data: A Pilot Study with Applications to Bone and Kidney Metastases	PLOS ONE			English	Article							FETAL-BRAIN MRI; IN-VIVO; PROPELLER; VOLUME	In small animal imaging studies, when the locations of the micro-structures of interest are unknown a priori, there is a simultaneous need for full-body coverage and high resolution. In MRI, additional requirements to image contrast and acquisition time will often make it impossible to acquire such images directly. Recently, a resolution enhancing post-processing technique called super-resolution reconstruction (SRR) has been demonstrated to improve visualization and localization of micro-structures in small animal MRI by combining multiple low-resolution acquisitions. However, when the field-of-view is large relative to the desired voxel size, solving the SRR problem becomes very expensive, in terms of both memory requirements and computation time. In this paper we introduce a novel local approach to SRR that aims to overcome the computational problems and allow researchers to efficiently explore both global and local characteristics in whole-body small animal MRI. The method integrates state-of-the-art image processing techniques from the areas of articulated atlas-based segmentation, planar reformation, and SRR. A proof-of-concept is provided with two case studies involving CT, BLI, and MRI data of bone and kidney tumors in a mouse model. We show that local SRR-MRI is a computationally efficient complementary imaging modality for the precise characterization of tumor metastases, and that the method provides a feasible high-resolution alternative to conventional MRI.	[Dzyubachyk, Oleh; Khmelinskii, Artem; Kok, Peter; Snoeks, Thomas J. A.; Lowik, Clemens W. G. M.; Botha, Charl P.; van der Weerd, Louise; Lelieveldt, Boudewijn P. F.] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Khmelinskii, Artem] Percuros BV, Enschede, Netherlands; [Plenge, Esben; Poot, Dirk H. J.; Niessen, Wiro J.; Meijering, Erik] Univ Med Ctr Rotterdam, Dept Radiol, Erasmus MC, Rotterdam, Netherlands; [Plenge, Esben; Poot, Dirk H. J.; Niessen, Wiro J.; Meijering, Erik] Univ Med Ctr Rotterdam, Dept Med Informat, Erasmus MC, Rotterdam, Netherlands; [Kok, Peter; Botha, Charl P.; Lelieveldt, Boudewijn P. F.] Delft Univ Technol, Dept Intelligent Syst, Delft, Netherlands; [Poot, Dirk H. J.; Niessen, Wiro J.] Delft Univ Technol, Quantitat Imaging Grp, Fac Sci Appl, Delft, Netherlands; [van der Weerd, Louise] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology; Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lelieveldt, BPF (corresponding author), Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands.	b.p.f.lelieveldt@lumc.nl	van der Weerd, Louise/B-5421-2014; Poot, Dirk/A-1182-2013; Dzyubachyk, Oleh/Y-3913-2018; Lelieveldt, Boudewijn/B-6501-2008; Meijering, Erik/AAL-8143-2020; Botha, Charl P./E-9506-2010; Khmelinskii, Artem/L-3714-2013	Poot, Dirk/0000-0003-0656-2963; Dzyubachyk, Oleh/0000-0003-1344-7189; Lelieveldt, Boudewijn/0000-0001-8269-7603; Khmelinskii, Artem/0000-0002-2665-7380; Niessen, Wiro/0000-0002-5822-1995; Snoeks, Thomas/0000-0003-3866-346X; van der Weerd, Louise/0000-0002-5997-2125	Medical Delta; European Union [612360]	Medical Delta; European Union(European Commission)	This work was funded by Medical Delta (http://www.medicaldelta.nl/research/large-research-programs-and-initiatives/molecular-image-processing). A. K. also acknowledges support from the FP7 European Union Marie Curie IAPP Program, BRAINPATH, under grant number 612360. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baiker M, 2012, MOL IMAGING BIOL, V14, P420, DOI 10.1007/s11307-011-0522-2; Baiker M, 2010, MED IMAGE ANAL, V14, P723, DOI 10.1016/j.media.2010.04.008; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bolin C, 2012, BIOL PROCED ONLINE, V14, DOI 10.1186/1480-9222-14-6; Gauvain KM, 2005, CLIN EXP METASTAS, V22, P403, DOI 10.1007/s10585-005-1264-9; Gholipour A, 2010, IEEE T MED IMAGING, V29, P1739, DOI 10.1109/TMI.2010.2051680; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hindorf C, 2010, EUR J NUCL MED MOL I, V37, pS274; Khmelinskii A, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1723, DOI 10.1109/ISBI.2012.6235912; Khmelinskii A, 2010, I S BIOMED IMAGING, P1197, DOI 10.1109/ISBI.2010.5490209; Khmelinskii A, 2011, MOL IMAGING BIOL, V13, P898, DOI 10.1007/s11307-010-0386-x; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Kok P, 2007, P SPIE MED IMAGING, V65091U, P1; Kok P, 2010, IEEE T VIS COMPUT GR, V16, P1396, DOI 10.1109/TVCG.2010.134; Pandit P, 2010, MAGN RESON MED, V64, P47, DOI 10.1002/mrm.22376; Plenge E, 2012, MAGN RESON MED, V68, P1983, DOI 10.1002/mrm.24187; Poole DS, 2014, NMR BIOMED, V27, P749, DOI 10.1002/nbm.3108; Poot DHJ, 2010, LECT NOTES COMPUT SC, V6361, P615; Rousseau F, 2010, LECT NOTES COMPUT SC, V6362, P355; Segars WP, 2004, MOL IMAGING BIOL, V6, P149, DOI 10.1016/j.mibio.2004.03.002; Shilling RZ, 2009, IEEE T MED IMAGING, V28, P633, DOI 10.1109/TMI.2008.2007348; Smal I, 2010, IEEE T MED IMAGING, V29, P282, DOI 10.1109/TMI.2009.2025127; Snoeks TJA, 2011, BONE, V48, P106, DOI 10.1016/j.bone.2010.07.027; Teh I, 2010, NMR BIOMED, V23, P1077, DOI 10.1002/nbm.1535	24	2	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108730	10.1371/journal.pone.0108730	http://dx.doi.org/10.1371/journal.pone.0108730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265510	Green Submitted, Green Published, gold			2022-12-27	WOS:000345745400114
J	Ji, YH; Zhang, JS; Wang, WW; Ji, JL				Ji, Yuhua; Zhang, Jinsheng; Wang, Wenwen; Ji, Juling			Functional Study of miR-27a in Human Hepatic Stellate Cells by Proteomic Analysis: Comprehensive View and a Role in Myogenic Tans-Differentiation	PLOS ONE			English	Article							PROTEIN; MICRORNAS; ADHESION; CANCER; TOOLS	We previous reported that miR-27a regulates lipid metabolism and cell proliferation during hepatic stellate cells (HSCs) activation. To further explore the biological function and underlying mechanisms of miR-27a in HSCs, global protein expression affected by overexpression of miR-27a in HSCs was analyzed by a cleavable isotope-coded affinity tags (cICAT) based comparative proteomic approach. In the present study, 1267 non-redundant proteins were identified with unique accession numbers (score >= 1.3, i.e. confidence >= 95%), among which 1171 were quantified and 149 proteins (12.72%) were differentially expressed with a differential expression ratio of 1.5. We found that up-regulated proteins by miR-27a mainly participate in cell proliferation and myogenesis, while down-regulated proteins were the key enzymes involved in de novo lipid synthesis. The expression of a group of six miR-27a regulated proteins was validated and the function of one miR-27a regulated protein was further validated. The results not only delineated the underlying mechanism of miR-27a in modulating fat metabolism and cell proliferation, but also revealed a novel role of miR-27a in promoting myogenic tansdifferentiation during HSCs activation. This study also exemplified proteomics strategy as a powerful tool for the functional study of miRNA.	[Ji, Yuhua] Nantong Univ, Key Lab Neuroregenerat, Nanton, Peoples R China; [Zhang, Jinsheng] Fudan Univ, Shanghai Med Coll, Dept Pathol, Shanghai 200433, Peoples R China; [Wang, Wenwen; Ji, Juling] Nantong Univ, Dept Pathol, Sch Med, Nantong, Peoples R China	Nantong University; Fudan University; Nantong University	Ji, JL (corresponding author), Nantong Univ, Dept Pathol, Sch Med, Nantong, Peoples R China.	jijuling@ntu.edu.cn	Ji, Juling/AAU-1464-2020; Ji, Juling/AAT-2550-2021; Ji, Yuhua/GZL-8978-2022; 张, 锦胜/GXF-8167-2022	Ji, Juling/0000-0001-6500-8052; Ji, Juling/0000-0001-6500-8052; Ji, Yuhua/0000-0002-6127-7287; 	Natural Science Foundation of China (NSFC) [81141048, 30900563, 81272027]; Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents from Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province [13KJA180005]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents from Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province	This research is supported by grants from the Natural Science Foundation of China (NSFC, http://www.nsfc.gov.cn/publish/portal1/), No. 81141048 and 30900563 to JJL, No. 81272027 to JYH, Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents from Jiangsu Provincial Department of Education (http://english.jsjyt.gov.cn/) to JJL, a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and Natural Science Foundation of the Higher Education Institutions of Jiangsu Province No. 13KJA180005 to JYH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo M, 2013, P NATL ACAD SCI USA, V110, P8573, DOI 10.1073/pnas.1302107110; AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; CARLSON CA, 1973, J BIOL CHEM, V248, P378; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Dong L, 2005, MOL CELL PROTEOMICS, V4, pS34; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Huang TC, 2013, PROTEOMICS, V13, P558, DOI 10.1002/pmic.201200339; Ji JL, 2012, HEPATOLOGY, V56, P332, DOI 10.1002/hep.25650; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Kwapiszewska G, 2008, CIRCULATION, V118, P1183, DOI 10.1161/CIRCULATIONAHA.107.761916; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li D, 2005, PROG BIOCHEM BIOPHYS, V32, P1026; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; MACKIE EJ, 1988, DEVELOPMENT, V102, P237; Nishi H, 2011, MOL CELL BIOL, V31, P744, DOI 10.1128/MCB.00581-10; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shields DJ, 2010, P NATL ACAD SCI USA, V107, P2189, DOI 10.1073/pnas.0911646107; Shiio Y, 2006, NAT PROTOC, V1, P139, DOI 10.1038/nprot.2006.22; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vickers KC, 2013, HEPATOLOGY, V57, P533, DOI 10.1002/hep.25846; Wang T, 2011, INT J MOL SCI, V12, P7950, DOI 10.3390/ijms12117950; Wei L, 1998, J BIOL CHEM, V273, P30287, DOI 10.1074/jbc.273.46.30287; Winder SJ, 1998, ACTA PHYSIOL SCAND, V164, P415, DOI 10.1111/j.1365-201X.1998.tb10697.x; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Xu WY, 2013, INT J ONCOL, V42, P757, DOI 10.3892/ijo.2012.1742	35	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108351	10.1371/journal.pone.0108351	http://dx.doi.org/10.1371/journal.pone.0108351			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265485	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400068
J	Marin, MA; Fonseca, EL; Andrade, BN; Cabral, AC; Vicente, ACP				Marin, Michel A.; Fonseca, Erica L.; Andrade, Bruno N.; Cabral, Adriana C.; Vicente, Ana Carolina P.			Worldwide Occurrence of Integrative Conjugative Element Encoding Multidrug Resistance Determinants in Epidemic Vibrio cholerae O1	PLOS ONE			English	Article							SXT; HAITI; AFRICA	In the last decades, there has been an increase of cholera epidemics caused by multidrug resistant strains. Particularly, the integrative and conjugative element (ICE) seems to play a major role in the emergence of multidrug resistant Vibrio cholerae. This study fully characterized, by whole genome sequencing, new ICEs carried by multidrug resistant V. cholerae O1 strains from Nigeria (2010) (ICEVchNig1) and Nepal (1994) (ICEVchNep1). The gene content and gene order of these two ICEs are the same, and identical to ICEVchInd5, ICEVchBan5 and ICEVchHai1 previously identified in multidrug resistant V. cholerae O1. This ICE is characterized by dfrA1, sul2, strAB and floR antimicrobial resistance genes, and by unique gene content in HS4 and HS5 ICE regions. Screening for ICEs, in publicly available V. cholerae genomes, revealed the occurrence and widespread distribution of this ICE among V. cholerae O1. Metagenomic analysis found segments of this ICE in marine environments far from the direct influence of the cholera epidemic. Therefore, this study revealed the epidemiology of a spatio-temporal prevalent ICE in V. cholerae O1. Its occurrence and dispersion in V. cholerae O1 strains from different continents throughout more than two decades can be indicative of its role in the fitness of the current pandemic lineage.	[Marin, Michel A.; Fonseca, Erica L.; Andrade, Bruno N.; Cabral, Adriana C.; Vicente, Ana Carolina P.] Oswaldo Cruz Fdn FIOCRUZ, Lab Mol Genet Microorganisms, Oswaldo Cruz Inst IOC, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Marin, MA (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Lab Mol Genet Microorganisms, Oswaldo Cruz Inst IOC, Rio De Janeiro, Brazil.	mfabanto@ioc.fiocruz.br	Andrade, Bruno Gabriel/K-8158-2016; Cabral, Adriana/AAX-3284-2021; Marin, Michel Abanto/AAH-3245-2019	Andrade, Bruno Gabriel/0000-0003-2481-401X; Marin, Michel Abanto/0000-0001-9136-0041	Instituto Oswaldo Cruz; FAPERJ; CAPES; CAPES-PNPD; CNPq; FIOCRUZ	Instituto Oswaldo Cruz; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES-PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FIOCRUZ	This work was supported by Instituto Oswaldo Cruz grant (PROEP), FAPERJ, CAPES, CAPES-PNPD, CNPq and FIOCRUZ fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amita, 2003, EMERG INFECT DIS, V9, P500; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Balado M, 2013, FEMS MICROBIOL ECOL, V83, P457, DOI 10.1111/1574-6941.12007; Bani S, 2007, FEMS MICROBIOL LETT, V266, P42, DOI 10.1111/j.1574-6968.2006.00518.x; Beaber JW, 2002, CELL MOL LIFE SCI, V59, P2065, DOI 10.1007/s000180200006; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Burrus V, 2006, PLASMID, V55, P173, DOI 10.1016/j.plasmid.2006.01.001; Ceccarelli D, 2011, LANCET INFECT DIS, V11, P262, DOI 10.1016/S1473-3099(11)70078-0; Ceccarelli D, 2011, INT J MED MICROBIOL, V301, P318, DOI 10.1016/j.ijmm.2010.11.005; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Kitaoka M, 2011, J MED MICROBIOL, V60, P397, DOI 10.1099/jmm.0.023051-0; Marin MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002049; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Opintan JA, 2008, J ANTIMICROB CHEMOTH, V62, P929, DOI 10.1093/jac/dkn334; Piarroux R, 2012, CLIN MICROBIOL INFEC, V18, P231, DOI 10.1111/j.1469-0691.2012.03763.x; Pugliese N, 2009, J ANTIMICROB CHEMOTH, V63, P438, DOI 10.1093/jac/dkn542; Reimer AR, 2011, EMERG INFECT DIS, V17, P2113, DOI 10.3201/eid1711.110794; Sjolund-Karlsson M, 2011, EMERG INFECT DIS, V17, P2151, DOI 10.3201/eid1711.110720; Talkington D, 2011, EMERG INFECT DIS, V17, P2122, DOI 10.3201/eid1711.110805; Valia R, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00354; Waldor MK, 1996, J BACTERIOL, V178, P4157, DOI 10.1128/jb.178.14.4157-4165.1996; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786	25	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108728	10.1371/journal.pone.0108728	http://dx.doi.org/10.1371/journal.pone.0108728			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25265418	Green Published, gold			2022-12-27	WOS:000345745400113
J	Rhoo, KH; Granger, M; Sur, J; Feng, CY; Gelbard, HA; Dewhurst, S; Polesskaya, O				Rhoo, Kun Hyoe; Granger, Megan; Sur, Joynita; Feng, Changyong; Gelbard, Harris A.; Dewhurst, Stephen; Polesskaya, Oksana			Pharmacologic Inhibition of MLK3 Kinase Activity Blocks the In Vitro Migratory Capacity of Breast Cancer Cells but Has No Effect on Breast Cancer Brain Metastasis in a Mouse Xenograft Model	PLOS ONE			English	Article							INVASION; OUTGROWTH	Brain metastasis of breast cancer is an important clinical problem, with few therapeutic options and a poor prognosis. Recent data have implicated mixed lineage kinase 3 (MLK3) in controlling the in vitro migratory capacity of breast cancer cells, as well as the metastasis of MDA-MB-231 breast cancer cells from the mammary fat pad to distant lymph nodes in a mouse xenograft model. We therefore set out to test whether MLK3 plays a role in brain metastasis of breast cancer cells. To address this question, we used a novel, brain penetrant, MLK3 inhibitor, URMC099. URMC099 efficiently inhibited the migration of breast cancer cells in an in vitro cell monolayer wounding assay, and an in vitro transwell migration assay, but had no effect on in vitro cell growth. We also tested the effect of URMC099 on tumor formation in a mouse xenograft model of breast cancer brain metastasis. This analysis showed that URMC099 had no effect on the either the frequency or size of breast cancer brain metastases. We conclude that pharmacologic inhibition of MLK3 by URMC099 can reduce the in vitro migratory capacity of breast cancer cells, but that it has no effect on either the frequency or size of breast cancer brain metastases, in a mouse xenograft model.	[Rhoo, Kun Hyoe; Granger, Megan; Sur, Joynita; Gelbard, Harris A.; Dewhurst, Stephen; Polesskaya, Oksana] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Gelbard, Harris A.] Univ Rochester, Med Ctr, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Gelbard, Harris A.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Gelbard, Harris A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Feng, Changyong] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Polesskaya, O (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	Oksana_Polesskaya@urmc.rochester.edu	Polesskaya, Oksana/AAX-9283-2021; Gelbard, Harris/M-9260-2019	Dewhurst, Stephen/0000-0001-7729-7920; Gelbard, Harris/0000-0001-5095-7976	University of Rochester Technology Development Fund award; NIH [P01 MH64570]; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH064570] Funding Source: NIH RePORTER	University of Rochester Technology Development Fund award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the University of Rochester Technology Development Fund award and by NIH grant P01 MH64570. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Chen J, 2010, ONCOGENE, V29, P4399, DOI 10.1038/onc.2010.198; Chen J, 2012, CANCER RES, V72, P4130, DOI 10.1158/0008-5472.CAN-12-0655; Cronan MR, 2012, ONCOGENE, V31, P3889, DOI 10.1038/onc.2011.544; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Goodfellow VS, 2013, J MED CHEM, V56, P8032, DOI 10.1021/jm401094t; Goodfellow VS, 2013, J MED CHEM; Gril B, 2008, JNCI-J NATL CANCER I, V100, P1092, DOI 10.1093/jnci/djn216; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Koh M, 2013, BIOORGAN MED CHEM, V21, P2305, DOI 10.1016/j.bmc.2013.02.015; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Lu WX, 2007, INT J CANCER, V120, P1023, DOI 10.1002/ijc.22388; Marker DF, 2013, J NEUROSCI, V33, P9998, DOI 10.1523/JNEUROSCI.0598-13.2013; Palmieri Diane, 2006, Breast Dis, V26, P139; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Polesskaya O, 2014, MOL IMMUNOL, V58, P214, DOI 10.1016/j.molimm.2013.11.016; Ramji K, 2013, MOL BIOL REP, V40, P6977, DOI 10.1007/s11033-013-2817-7; Rana A, 2013, GENES CANC; Schwartz MA, 2006, CELL, V125, P1223, DOI 10.1016/j.cell.2006.06.015; Shaffrey ME, 2004, CURR PROB SURG, V41, P665, DOI 10.1067/j.cpsurg.2004.06.001; SOULE HD, 1990, CANCER RES, V50, P6075; Weinberg RA, 2010, BIOL CANC; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Zhan Y, 2012, EXP CELL RES, V318, P1641, DOI 10.1016/j.yexcr.2012.05.002	29	6	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2014	9	9							e108487	10.1371/journal.pone.0108487	http://dx.doi.org/10.1371/journal.pone.0108487			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XR	25264786	Green Published, Green Submitted, gold			2022-12-27	WOS:000345745400080
J	Blarre, T; Bertrand, HO; Acher, FC; Kehoe, J				Blarre, Thomas; Bertrand, Hugues-Olivier; Acher, Francine C.; Kehoe, JacSue			Molecular Determinants of Agonist Selectivity in Glutamate-Gated Chloride Channels Which Likely Explain the Agonist Selectivity of the Vertebrate Glycine and GABA(A)-rho Receptors	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; ION-CHANNEL; DROSOPHILA-MELANOGASTER; LIGAND-BINDING; BETA-ALANINE; IDENTIFICATION; SUBUNITS; SENSITIVITY	Orthologous Cys-loop glutamate-gated chloride channels (GluClR's) have been cloned and described electrophysiologically and pharmacologically in arthropods and nematodes (both members of the invertebrate ecdysozoan superphylum). Recently, GluClR's from Aplysia californica (a mollusc from the lophotrochozoan superphylum) have been cloned and similarly studied. In spite of sharing a common function, the ecdysozoan and lophotrochozoan receptors have been shown by phylogenetic analyses to have evolved independently. The recent crystallization of the GluClR from C. elegans revealed the binding pocket of the nematode receptor. An alignment of the protein sequences of the nematode and molluscan GluClRs showed that the Aplysia receptor does not contain all of the residues defining the binding mode of the ecdysozoan receptor. That the two receptors have slightly different binding modes is not surprising since earlier electrophysiological and pharmacological experiments had suggested that they were differentially responsive to certain agonists. Knowledge of the structure of the C. elegans GluClR has permitted us to generate a homology model of the binding pocket of the Aplysia receptor. We have analyzed the differences between the two binding modes and evaluated the relative significance of their non-common residues. We have compared the GluClRs electrophysiologically and pharmacologically and we have used sitedirected mutagenesis on both receptor types to test predictions made from the model. Finally, we propose an explanation derived from the model for why the nematode receptors are gated only by glutamate, whereas the molluscan receptors can also be activated by beta-alanine, GABA and taurine. Like the Aplysia receptor, the vertebrate glycine and GABA(A)-rho receptors also respond to these other agonists. An alignment of the sequences of the molluscan and vertebrate receptors shows that the reasons we have given for the ability of the other agonists to activate the Aplysia receptor also explain the agonist profile seen in the glycine and GABA(A)-rho receptors.	[Blarre, Thomas; Acher, Francine C.] Univ Paris 05, Sorbonne Paris Cite, CNRS, Lab Chim & Biochim Pharmacol & Toxicol,UMR8601, Paris, France; [Blarre, Thomas; Bertrand, Hugues-Olivier] Accelrys, Orsay, France; [Kehoe, JacSue] Univ Paris 05, CNRS, Lab Physiol Cerebrale, UMR8118, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; BIOVIA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Acher, FC (corresponding author), Univ Paris 05, Sorbonne Paris Cite, CNRS, Lab Chim & Biochim Pharmacol & Toxicol,UMR8601, Paris, France.	francine.acher@parisdescartes.fr; jacsue.kehoe@parisdescartes.fr			Conventions Industrielles de Formation par la Recherche [1511/2010]; Association nationale de la recherche et de la technologie; Centre national de la recherche scientifique, France; Accelrys	Conventions Industrielles de Formation par la Recherche; Association nationale de la recherche et de la technologie(French National Research Agency (ANR)); Centre national de la recherche scientifique, France(Centre National de la Recherche Scientifique (CNRS)); Accelrys	TB was the beneficiary of a grant (1511/2010) funded by Conventions Industrielles de Formation par la Recherche and Association nationale de la recherche et de la technologie. http://www.anrt.asso.fr. JK and FA received funding from the Centre national de la recherche scientifique, France. Accelrys provided support in the form of salaries for authors TB and HOB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Beg AA, 2003, NAT NEUROSCI, V6, P1145, DOI 10.1038/nn1136; Beg AA, 2008, CELL, V132, P149, DOI 10.1016/j.cell.2007.10.058; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Changeux JP, 2012, J BIOL CHEM, V287, P40207, DOI 10.1074/jbc.R112.407668; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Cully DF, 1996, J BIOL CHEM, V271, P20187, DOI 10.1074/jbc.271.33.20187; Davies PA, 2003, J BIOL CHEM, V278, P712, DOI 10.1074/jbc.M208814200; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Dent JA, 2010, INSECT NICOTINE ACET; Dent JA, 2006, J MOL EVOL, V62, P523, DOI 10.1007/s00239-005-0018-2; Dutertre S, 2012, J BIOL CHEM, V287, P40216, DOI 10.1074/jbc.R112.408229; Etter A, 1996, J BIOL CHEM, V271, P16035, DOI 10.1074/jbc.271.27.16035; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Han NLR, 2001, J NEUROCHEM, V79, P636, DOI 10.1046/j.1471-4159.2001.00601.x; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Horikoshi T, BRAIN RES, V464, P97; Jullian N, 1999, J MED CHEM, V42, P1546, DOI 10.1021/jm980571q; Kehoe J, 2000, J NEUROSCI, V20, P8585; Kehoe J, 2009, J MOL EVOL, V69, P125, DOI 10.1007/s00239-009-9256-z; Kellenberger S, 2014, J MOL BIOL IN PRESS; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kozuska JL, 2012, CAN J PHYSIOL PHARM, V90, P771, DOI [10.1139/Y2012-018, 10.1139/y2012-018]; Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496; Lummis SCR, 2012, ACS CHEM NEUROSCI, V3, P186, DOI 10.1021/cn200103n; LUTHY R, 1991, PROTEINS, V10, P229, DOI 10.1002/prot.340100307; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Mori M, 2002, J PHYSIOL-LONDON, V539, P191, DOI 10.1113/jphysiol.2001.013147; Mounsey Kate E., 2007, Invertebrate Neuroscience, V7, P149, DOI 10.1007/s10158-007-0050-6; OYAMA Y, 1990, EUR J PHARMACOL, V185, P43, DOI 10.1016/0014-2999(90)90209-O; Putrenko I, 2005, J BIOL CHEM, V280, P6392, DOI 10.1074/jbc.M412644200; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Ringstad N, 2009, SCIENCE, V325, P96, DOI 10.1126/science.1169243; Saint Jan DD, 2001, J PHYSIOL-LONDON, V535, P741; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schnizler K, 2005, J BIOL CHEM, V280, P16254, DOI 10.1074/jbc.M411759200; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Smart TG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009662; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tiedje KE, 2010, NEUROCHEM INT, V57, P177, DOI 10.1016/j.neuint.2010.06.001; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; van Nierop P, 2005, J NEUROSCI, V25, P10617, DOI 10.1523/JNEUROSCI.2015-05.2005; Wolstenholme AJ, 2012, J BIOL CHEM, V287, P40232, DOI 10.1074/jbc.R112.406280; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Zheng YC, 2002, J BIOL CHEM, V277, P2000, DOI 10.1074/jbc.M107635200	49	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108458	10.1371/journal.pone.0108458	http://dx.doi.org/10.1371/journal.pone.0108458			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259865	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600075
J	Kidokoro, Y; Karasawa, K; Minowa, O; Sugitani, Y; Noda, T; Ikeda, K; Kamiya, K				Kidokoro, Yoshinobu; Karasawa, Keiko; Minowa, Osamu; Sugitani, Yoshinobu; Noda, Tetsuo; Ikeda, Katsuhisa; Kamiya, Kazusaku			Deficiency of Transcription Factor Brn4 Disrupts Cochlear Gap Junction Plaques in a Model of DFN3 Non-Syndromic Deafness	PLOS ONE			English	Article							MOUSE MODEL; CONNEXIN 26; GENE; MICE; FIBROCYTES	Brn4, which encodes a POU transcription factor, is the gene responsible for DFN3, an X chromosome-linked, non-syndromic type of hearing loss. Brn4-deficient mice have a low endocochlear potential (EP), hearing loss, and ultrastructural alterations in spiral ligament fibrocytes, however the molecular pathology through which Brn4 deficiency causes low EP is still unclear. Mutations in the Gjb2 and Gjb6 genes encoding the gap junction proteins connexin26 (Cx26) and connexin30 (Cx30) genes, respectively, which encode gap junction proteins and are expressed in cochlear fibrocytes and non-sensory epithelial cells (i.e., cochlear supporting cells) to maintain the proper EP, are responsible for hereditary sensorineural deafness. It has been hypothesized that the gap junction in the cochlea provides an intercellular passage by which K+ is transported to maintain the EP at the high level necessary for sensory hair cell excitation. Here we analyzed the formation of gap junction plaques in cochlear supporting cells of Brn4-deficient mice at different stages by confocal microscopy and three-dimensional graphic reconstructions. Gap junctions from control mice, which are composed mainly of Cx26 and Cx30, formed linear plaques along the cell-cell junction sites with adjacent cells. These plaques formed pentagonal or hexagonal outlines of the normal inner sulcus cells and border cells. Gap junction plaques in Brn4-deficient mice did not, however, show the normal linear structure but instead formed small spots around the cell-cell junction sites. Gap junction lengths were significantly shorter, and the level of Cx26 and Cx30 was significantly reduced in Brn4-deficient mice compared with littermate controls. Thus the Brn4 mutation affected the assembly and localization of gap junction proteins at the cell borders of cochlear supporting cells, suggesting that Brn4 substantially contributes to cochlear gap junction properties to maintain the proper EP in cochleae, similar to connexin-related deafness.	[Kidokoro, Yoshinobu; Karasawa, Keiko; Ikeda, Katsuhisa; Kamiya, Kazusaku] Juntendo Univ, Fac Med, Dept Otorhinolaryngol, Tokyo, Japan; [Minowa, Osamu; Noda, Tetsuo] Inst Phys & Chem Res RIKEN, BioResource Ctr, Tsukuba, Ibaraki, Japan; [Sugitani, Yoshinobu; Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 170, Japan	Juntendo University; RIKEN; Japanese Foundation for Cancer Research	Kamiya, K (corresponding author), Juntendo Univ, Fac Med, Dept Otorhinolaryngol, Tokyo, Japan.	kkamiya@juntendo.ac.jp	Kamiya, Kazusaku/Y-3376-2019; Minowa, Osamu/AAM-1238-2020; Noda, Tetsuo/B-1667-2016		Ministry of Education, Science and Culture; Ministry of Health, Labor and Welfare of Japan; Takeda Science Foundation; MEXT; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a research grant from the Ministry of Education, Science and Culture (to K. K.), Ministry of Health, Labor and Welfare of Japan (to K. K.), Takeda Science Foundation (to K. K.), MEXT-support program for the Strategic Research Foundation at Private Universities, 2011-2013 (to K. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2003, BIOCHEM BIOPH RES CO, V307, P362, DOI 10.1016/S0006-291X(03)01166-5; Bejarano E, 2014, NAT CELL BIOL, V16, P401, DOI 10.1038/ncb2934; Coate TM, 2012, NEURON, V73, P49, DOI 10.1016/j.neuron.2011.10.029; DEKOK YJM, 1995, HUM MOL GENET, V4, P2145; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; Delprat B, 2005, MOL CELL BIOL, V25, P847, DOI 10.1128/MCB.25.2.847-853.2005; Falk MM, 2014, FEBS LETT, V588, P1221, DOI 10.1016/j.febslet.2014.01.031; Gilleron J, 2008, J CELL SCI, V121, P4069, DOI 10.1242/jcs.033373; Kamiya K, 2014, J CLIN INVEST, V124, P1598, DOI 10.1172/JCI67621; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; Phippard D, 1998, HEARING RES, V120, P77, DOI 10.1016/S0378-5955(98)00059-8; Song MH, 2011, BIOCHEM BIOPH RES CO, V404, P528, DOI 10.1016/j.bbrc.2010.12.019; Trowe MO, 2008, DEVELOPMENT, V135, P1725, DOI 10.1242/dev.014043; Xia AP, 2002, HEARING RES, V166, P150, DOI 10.1016/S0378-5955(02)00309-X	15	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108216	10.1371/journal.pone.0108216	http://dx.doi.org/10.1371/journal.pone.0108216			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259580	Green Published, Green Submitted, gold			2022-12-27	WOS:000342685600054
J	Smith, SE; Figley, SA; Schreyer, DJ; Paterson, PG				Smith, Shari E.; Figley, Sarah A.; Schreyer, David J.; Paterson, Phyllis G.			Protein-Energy Malnutrition Developing after Global Brain Ischemia Induces an Atypical Acute-Phase Response and Hinders Expression of GAP-43	PLOS ONE			English	Article							TRANSIENT FOREBRAIN ISCHEMIA; STROKE PATIENTS; PERIPHERAL INFLAMMATION; HIPPOCAMPAL-FORMATION; NUTRITIONAL-STATUS; POOR OUTCOMES; MOSSY FIBERS; PLASTICITY; RATS; RECOVERY	Protein-energy malnutrition (PEM) is a common post-stroke problem. PEM can independently induce a systemic acute-phase response, and pre-existing malnutrition can exacerbate neuroinflammation induced by brain ischemia. In contrast, the effects of PEM developing in the post-ischemic period have not been studied. Since excessive inflammation can impede brain remodeling, we investigated the effects of post-ischemic malnutrition on neuroinflammation, the acute-phase reaction, and neuroplasticity-related proteins. Male, Sprague-Dawley rats were exposed to global forebrain ischemia using the 2-vessel occlusion model or sham surgery. The sham rats were assigned to control diet (18% protein) on day 3 after surgery, whereas the rats exposed to global ischemia were assigned to either control diet or a low protein (PEM, 2% protein) diet. Post-ischemic PEM decreased growth associated protein-43, synaptophysin and synaptosomal-associated protein-25 immunofluorescence within the hippocampal CA3 mossy fiber terminals on day 21, whereas the glial response in the hippocampal CA1 and CA3 subregions was unaltered by PEM. No systemic acute-phase reaction attributable to global ischemia was detected in control diet-fed rats, as reflected by serum concentrations of alpha-2-macroglobulin, alpha-1-acid glycoprotein, haptoglobin, and albumin. Acute exposure to the PEM regimen after global brain ischemia caused an atypical acute-phase response. PEM decreased the serum concentrations of albumin and haptoglobin on day 5, with the decreases sustained to day 21. Serum alpha-2-macroglobulin concentrations were significantly higher in malnourished rats on day 21. This provides the first direct evidence that PEM developing after brain ischemia exerts wide-ranging effects on mechanisms important to stroke recovery.	[Smith, Shari E.; Figley, Sarah A.; Paterson, Phyllis G.] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada; [Schreyer, David J.] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada; [Smith, Shari E.; Figley, Sarah A.; Schreyer, David J.; Paterson, Phyllis G.] Saskatoon City Hosp, Cameco MS Neurosci Res Ctr, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Paterson, PG (corresponding author), Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada.	phyllis.paterson@usask.ca			Heart and Stroke Foundation of Saskatchewan; Canadian Institutes of Health Research [111124]; University Graduate Scholarship from the University of Saskatchewan	Heart and Stroke Foundation of Saskatchewan; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University Graduate Scholarship from the University of Saskatchewan	P. Paterson gratefully acknowledges funding support from the Heart and Stroke Foundation of Saskatchewan and the Canadian Institutes of Health Research (Operating Grant 111124). S. Smith was supported by a University Graduate Scholarship from the University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLINGER FP, 1995, NEUROSCI LETT, V198, P95, DOI 10.1016/0304-3940(95)11976-4; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bobyn PJ, 2005, EXP NEUROL, V196, P308, DOI 10.1016/j.expneurol.2005.08.006; Brynningsen PK, 2007, J NUTR HEALTH AGING, V11, P75; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Cintra L, 1997, HIPPOCAMPUS, V7, P184, DOI 10.1002/(SICI)1098-1063(1997)7:2<184::AID-HIPO5>3.3.CO;2-K; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Cray C, 2009, COMPARATIVE MED, V59, P517; Davis JP, 2004, STROKE, V35, P1930, DOI 10.1161/01.STR.0000135227.10451.c9; Dennis M, 2003, STROKE, V34, P1450, DOI 10.1161/01.STR.0000074037.49197.8C; Di Filippo M, 2013, NEUROBIOL DIS, V52, P229, DOI 10.1016/j.nbd.2012.12.009; DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2; Dulger H, 2002, MEDIAT INFLAMM, V11, P363, DOI 10.1080/0962935021000051566; Dziedzic T, 2008, FRONT BIOSCI-LANDMRK, V13, P2922, DOI 10.2741/2897; FINESTONE HM, 1995, ARCH PHYS MED REHAB, V76, P310, DOI 10.1016/S0003-9993(95)80655-5; Foley N, 2013, NUTRITIONAL INTERVEN; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; Ha L, 2010, CLIN NUTR, V29, P567, DOI 10.1016/j.clnu.2010.01.011; Hebert-Lalancette M, 2007, J NEUROSCI, V27, P2596; Idicula TT, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-18; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Jablonka JA, 2012, EUR J NEUROSCI, V36, P2632, DOI 10.1111/j.1460-9568.2012.08174.x; JENNINGS G, 1992, J NUTR, V122, P1325, DOI 10.1093/jn/122.6.1325; Ji L, 2008, J NUTR BIOCHEM, V19, P770, DOI 10.1016/j.jnutbio.2007.09.011; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Kriz J, 2009, ACTA NEUROPATHOL, V117, P497, DOI 10.1007/s00401-009-0496-1; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Langdon KD, 2010, J CEREBR BLOOD F MET, V30, P1450, DOI 10.1038/jcbfm.2010.23; Langdon KD, 2008, EUR J NEUROSCI, V28, P2310, DOI 10.1111/j.1460-9568.2008.06513.x; Li S, 2002, NEUROSCIENCE, V115, P1221, DOI 10.1016/S0306-4522(02)00485-2; Ling PR, 2004, AM J PHYSIOL-REG I, V287, pR801, DOI 10.1152/ajpregu.00715.2003; Lowry S. F., 2014, Modern nutrition in health and disease, P1261; Maggio N, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00046; Marti E, 1998, ACTA NEUROPATHOL, V95, P254, DOI 10.1007/s004010050795; Martineau J, 2005, CLIN NUTR, V24, P1073, DOI 10.1016/j.clnu.2005.08.010; Morgane PJ, 2002, NEUROSCI BIOBEHAV R, V26, P471, DOI 10.1016/S0149-7634(02)00012-X; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Paterson PG, 1999, NEUROTOX RES, V1, P99, DOI 10.1007/BF03033274; Poels BJJ, 2006, DISABIL REHABIL, V28, P637, DOI 10.1080/09638280500276612; Prosser-Loose EJ, 2007, NUTR NEUROSCI, V10, P145, DOI 10.1080/10284150701523168; Prosser-Loose EJ, 2011, CURR NEUROVASC RES, V8, P170; Prosser-Loose EJ, 2010, CURR NEUROVASC RES, V7, P341; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Qu ZS, 1996, METABOLISM, V45, P1273, DOI 10.1016/S0026-0495(96)90247-4; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reid M, 2002, AM J CLIN NUTR, V76, P1409, DOI 10.1093/ajcn/76.6.1409; SchmidtKastner R, 1997, CELL TISSUE RES, V288, P225, DOI 10.1007/s004410050808; SCHREYER DJ, 1991, J NEUROSCI, V11, P3738; Silasi G, 2012, J CEREBR BLOOD F MET, V32, P1525, DOI 10.1038/jcbfm.2012.38; Smith CJ, 2006, J NEUROL SCI, V251, P77, DOI 10.1016/j.jns.2006.09.011; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; Smith SE, 2013, APPL PHYSIOL NUTR ME, V38, P844, DOI 10.1139/apnm-2012-0420; Smith SE, 2011, CURR NEUROVASC RES, V8, P64; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Yoo SH, 2008, ARCH NEUROL-CHICAGO, V65, P39, DOI 10.1001/archneurol.2007.12	56	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e107570	10.1371/journal.pone.0107570	http://dx.doi.org/10.1371/journal.pone.0107570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25259609	Green Submitted, Green Published, gold			2022-12-27	WOS:000342685600023
J	Yang, M; Chen, JC; Zhao, J; Meng, M				Yang, Mei; Chen, Jianchang; Zhao, Jing; Meng, Mei			Etanercept Attenuates Myocardial Ischemia/Reperfusion Injury by Decreasing Inflammation and Oxidative Stress	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ISCHEMIA-REPERFUSION INJURY; FACTOR-ALPHA; MONOCLONAL-ANTIBODY; DAMAGE; INFARCTION; INHIBITOR; APOPTOSIS; CHEMOKINE; ARTHRITIS	The protective role of etanercept in myocardial ischemia/reperfusion is not well understood. The aim of this study was to investigate whether etanercept modulates neutrophil accumulation, TNF-alpha induction and oxidative stress in an ischemia/reperfusion injured rat heart model. Rats were randomly exposed to sham operation, myocardial ischemia/reperfusion (MI/R) alone, MI/R+ etanercept. The results demonstrated that compared to MI/R, etanercept reduced myocardial infarction area, myocardial myeloperoxidase (MPO) levels, serum creatinine kinase (CK) and lactate dehydrogenase (LDH) levels, and both serum and myocardial TNF-alpha production. Etanercept also markedly enhanced the activities of antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GSH-PX), and reduced the level of malondialdehyde (MDA) in MI/R rats. In summary, our data suggested that etanercept has protective effects against MI/R injury in rats, which may be attributed to attenuating inflammation and oxidative stress.	[Yang, Mei] Third Hosp Jinan, Dept Crit Care Med, Jinan, Peoples R China; [Chen, Jianchang] Shandong Prov Hosp, Dept Emergency, Jinan, Peoples R China; [Zhao, Jing] Shandong Univ, Qilu Hosp, Dept Cardiol, Jinan 250100, Peoples R China; [Meng, Mei] Shandong Prov Hosp, Dept Crit Care Med, Jinan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Yang, M (corresponding author), Third Hosp Jinan, Dept Crit Care Med, Jinan, Peoples R China.	yangmei82014@163.com	zhao, jing/B-3868-2019					Batista ML, 2010, CYTOKINE, V49, P102, DOI 10.1016/j.cyto.2009.10.007; Berry MF, 2004, J HEART LUNG TRANSPL, V23, P1061, DOI 10.1016/j.healun.2004.06.021; Black SC, 1996, J PHARMACOL TOX MET, V35, P179, DOI 10.1016/1056-8719(96)00051-2; Candelario-Jalil E, 2001, NEUROSCI RES, V41, P233, DOI 10.1016/S0168-0102(01)00282-6; Cassano N, 2011, J BIOL REG HOMEOS AG, V25, P285; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Chandrasekar B, 2001, CIRCULATION, V103, P2296; ELLIOTT MJ, 1994, LANCET, V344, P1125, DOI 10.1016/S0140-6736(94)90632-7; Giannini EH, 2009, ARTHRITIS RHEUM, V60, P2794, DOI 10.1002/art.24777; Gurevitch J, 1997, J AM COLL CARDIOL, V30, P1554, DOI 10.1016/S0735-1097(97)00328-8; Jazwinski Alison B, 2011, Gastroenterol Hepatol (N Y), V7, P772; Khimenko PL, 1998, J APPL PHYSIOL, V85, P2005, DOI 10.1152/jappl.1998.85.6.2005; LEFER AM, 1993, AGENT ACTION SUPPL, V41, P127; Lin J, 2008, CLIN IMMUNOL, V126, P13, DOI 10.1016/j.clim.2007.08.012; Loh Kok Poh, 2006, Current Alzheimer Research, V3, P327; MA XL, 1992, CIRCULATION, V86, P937, DOI 10.1161/01.CIR.86.3.937; Manzanero S, 2013, NEUROCHEM INT, V62, P712, DOI 10.1016/j.neuint.2012.11.009; Meldrum DR, 1998, ANN THORAC SURG, V65, P439, DOI 10.1016/S0003-4975(97)01297-6; Naidu BV, 2004, J HEART LUNG TRANSPL, V23, P128, DOI 10.1016/S1053-2498(03)00102-5; Niizuma K, 2010, BBA-MOL BASIS DIS, V1802, P92, DOI 10.1016/j.bbadis.2009.09.002; Padfield GJ, 2013, HEART, V99, P1330, DOI 10.1136/heartjnl-2013-303648; Rodrigo R, 2013, DIS MARKERS, V2013, P773, DOI 10.1155/2013/974358; Speyer CL, 2011, J INVEST SURG, V24, P18, DOI 10.3109/08941939.2010.521232; Su H, 2007, AM J PHYSIOL-ENDOC M, V293, pE629, DOI 10.1152/ajpendo.00221.2007; Taylor JM, 2004, CLIN EXP PHARMACOL P, V31, P397, DOI 10.1111/j.1440-1681.2004.04017.x; Venegas-Pont M, 2010, HYPERTENSION, V56, P643, DOI 10.1161/HYPERTENSIONAHA.110.157685; Xiong J, 2010, CHINESE MED J-PEKING, V123, P2720, DOI 10.3760/cma.j.issn.0366-6999.2010.19.019; Zhu JX, 2006, CYTOKINE, V34, P96, DOI 10.1016/j.cyto.2006.04.010; Zou JX, 2002, CLIN EXP RHEUMATOL, V20, pS34	29	87	94	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2014	9	9							e108024	10.1371/journal.pone.0108024	http://dx.doi.org/10.1371/journal.pone.0108024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IP	25260027	Green Published, gold, Green Submitted			2022-12-27	WOS:000342685600044
J	Hua, HJ; Xing, FG; Selvaraj, JN; Wang, Y; Zhao, YJ; Zhou, L; Liu, X; Liu, Y				Hua, Huijuan; Xing, Fuguo; Selvaraj, Jonathan Nimal; Wang, Yan; Zhao, Yueju; Zhou, Lu; Liu, Xiao; Liu, Yang			Inhibitory Effect of Essential Oils on Aspergillus ochraceus Growth and Ochratoxin A Production	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; FUSARIUM-VERTICILLIOIDES; FUMONISIN PRODUCTION; ESCHERICHIA-COLI; EXTRACT; STORAGE; FUNGI; CINNAMALDEHYDE; CONTAMINATION; PROPICONAZOLE	Ochratoxin A (OTA) is a mycotoxin which is a common contaminant in grains during storage. Aspergillus ochraceus is the most common producer of OTA. Essential oils play a crucial role as a biocontrol in the reduction of fungal contamination. Essential oils namely natural cinnamaldehyde, cinnamon oil, synthetic cinnamaldehyde, Litsea citrate oil, citral, eugenol, peppermint, eucalyptus, anise and camphor oils, were tested for their efficacy against A. ochraceus growth and OTA production by fumigation and contact assays. Natural cinnamaldehyde proved to be the most effective against A. ochraceus when compared to other oils. Complete fungal growth inhibition was obtained at 150-250 mu L/L with fumigation and 250500 mu L/L with contact assays for cinnamon oil, natural and synthetic cinnamaldehyde, L. citrate oil and citral. Essential oils had an impact on the ergosterol biosynthesis and OTA production. Complete inhibition of ergosterol biosynthesis was observed at >= 100 mu g/mL of natural cinnamaldehyde and at 200 mu g/mL of citral, but total inhibition was not observed at 200 mu g/mL of eugenol. But, citral and eugenol could inhibit the OTA production at >= 75 mu g/mL and >= 150 mu g/mL respectively, while natural cinnamaldehyde couldn't fully inhibit OTA production at <= 200 mu g/mL. The inhibition of OTA by natural cinnamaldehyde is mainly due to the reduction in fungal biomass. However, citral and eugenol could significant inhibit the OTA biosynthetic pathway. Also, we observed that cinnamaldehyde was converted to cinnamic alcohol by A. ochraceus, suggesting that the antimicrobial activity of cinnamaldehyde was mainly attributed to its carbonyl aldehyde group. The study concludes that natural cinnamaldehyde, citral and eugenol could be potential biocontrol agents against OTA contamination in storage grains.	[Hua, Huijuan; Xing, Fuguo; Selvaraj, Jonathan Nimal; Wang, Yan; Zhao, Yueju; Zhou, Lu; Liu, Xiao; Liu, Yang] Chinese Acad Agr Sci, Key Lab Agroprod Proc, Minist Agr, Inst Agroprod Proc Sci & Technol, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Liu, Y (corresponding author), Chinese Acad Agr Sci, Key Lab Agroprod Proc, Minist Agr, Inst Agroprod Proc Sci & Technol, Beijing 100193, Peoples R China.	liuyang01@caas.cn	Xing, Fuguo/HGD-3209-2022		National Basic Research Program of China (973 program) [2013CB127805]; National Natural Science Foundation of China [31000776]; Ministry of Agriculture of China (Special Fund for Agro-Scientific Research in the Public Interest) [201203037]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China (Special Fund for Agro-Scientific Research in the Public Interest)	This work was supported by grants from National Basic Research Program of China (973 program) (2013CB127805), from the National Natural Science Foundation of China (31000776), from the Ministry of Agriculture of China (Special Fund for Agro-Scientific Research in the Public Interest, 201203037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Omair A, 2004, CHROMATOGRAPHIA, V59, P715, DOI 10.1365/s10337-004-0281-1; Avila-Sosa R, 2012, INT J FOOD MICROBIOL, V153, P66, DOI 10.1016/j.ijfoodmicro.2011.10.017; BAIRD RE, 1991, MYCOL RES, V95, P571, DOI 10.1016/S0953-7562(09)80071-3; Bayman P, 2006, MYCOPATHOLOGIA, V162, P215, DOI 10.1007/s11046-006-0055-4; Bendaha H, 2011, EUR J MED CHEM, V46, P4117, DOI 10.1016/j.ejmech.2011.06.012; Bluma RV, 2008, FOOD MICROBIOL, V25, P324, DOI 10.1016/j.fm.2007.10.004; Chen PJ, 2008, TOXICOL IN VITRO, V22, P1476, DOI 10.1016/j.tiv.2008.05.001; Chilvers MI, 2006, AUST J EXP AGR, V46, P1661, DOI 10.1071/EA05028; Cvek D, 2010, ARH HIG RADA TOKSIKO, V61, P191, DOI 10.2478/10004-1254-61-2010-2009; Dambolena JS, 2008, TOXICON, V51, P37, DOI 10.1016/j.toxicon.2007.07.005; Dambolena JS, 2010, INNOV FOOD SCI EMERG, V11, P410, DOI 10.1016/j.ifset.2009.08.005; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; Fandohan P, 2004, J AGR FOOD CHEM, V52, P6824, DOI 10.1021/jf040043p; Yamamoto-Ribeiro MMG, 2013, FOOD CHEM, V141, P3147, DOI 10.1016/j.foodchem.2013.05.144; Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145; Hocking AD, 2007, INT J FOOD MICROBIOL, V119, P84, DOI 10.1016/j.ijfoodmicro.2007.07.031; Huffman J, 2010, BIOPOLYMERS, V93, P764, DOI 10.1002/bip.21483; Isaac S., 1999, MYCOLOGIST, V13, P38; Jayashree T, 1999, LETT APPL MICROBIOL, V28, P179, DOI [10.1046/j.1365-2672.1999.00512.x, 10.1046/j.1365-2672.1999.00511.x]; Kocic-Tanackov S, 2012, LWT-FOOD SCI TECHNOL, V49, P14, DOI 10.1016/j.lwt.2012.04.013; Lucini EI, 2006, J PHYTOPATHOL, V154, P441, DOI 10.1111/j.1439-0434.2006.01126.x; Murthy PS, 2009, TURK J BIOL, V33, P211, DOI 10.3906/biy-0805-13; O'Brien E, 2005, CRIT REV TOXICOL, V35, P33, DOI 10.1080/10408440590905948; Pardo E, 2006, FOOD ADDIT CONTAM A, V23, P398, DOI 10.1080/02652030500376102; Passone MA, 2012, INT J FOOD MICROBIOL, V159, P198, DOI 10.1016/j.ijfoodmicro.2012.08.019; Patil JR, 2009, FOOD CHEM, V114, P1351, DOI 10.1016/j.foodchem.2008.11.033; Pereira MC, 2006, SCI RES ESSAYS, V1, P38; Pfohl-Leszkowicz A, 2007, MOL NUTR FOOD RES, V51, P61, DOI 10.1002/mnfr.200600137; Reddy KRN, 2010, TOXIN REV, V29, P3, DOI 10.3109/15569541003598553; Scudamore KA, 1998, FOOD ADDIT CONTAM A, V15, P401, DOI 10.1080/02652039809374659; Silva RR, 2010, WORLD J MICROB BIOT, V26, P841, DOI 10.1007/s11274-009-0241-x; Simko P, 2005, MOL NUTR FOOD RES, V49, P637, DOI 10.1002/mnfr.200400091; Sokolic-Mihalak D, 2012, ARH HIG RADA TOKSIKO, V63, P457, DOI 10.2478/10004-1254-63-2012-2309; THOMPSON DP, 1989, MYCOLOGIA, V81, P151, DOI 10.2307/3759462; Tian J, 2011, INT J FOOD MICROBIOL, V145, P464, DOI 10.1016/j.ijfoodmicro.2011.01.023; Tolouee M, 2010, INT J FOOD MICROBIOL, V139, P127, DOI 10.1016/j.ijfoodmicro.2010.03.032; Velluti A, 2004, J SCI FOOD AGR, V84, P1141, DOI 10.1002/jsfa.1769; Visvalingam J, 2013, APPL ENVIRON MICROB, V79, P942, DOI 10.1128/AEM.02767-12; Xing FG, 2014, FOOD CONTROL, V46, P343, DOI 10.1016/j.foodcont.2014.04.037	39	78	82	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108285	10.1371/journal.pone.0108285	http://dx.doi.org/10.1371/journal.pone.0108285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255251	gold, Green Published, Green Submitted			2022-12-27	WOS:000344862300069
J	Hinamoto, N; Maeshima, Y; Saito, D; Yamasaki, H; Tanabe, K; Nasu, T; Watatani, H; Ujike, H; Kinomura, M; Sugiyama, H; Sonoda, H; Sato, Y; Makino, H				Hinamoto, Norikazu; Maeshima, Yohei; Saito, Daisuke; Yamasaki, Hiroko; Tanabe, Katsuyuki; Nasu, Tatsuyo; Watatani, Hiroyuki; Ujike, Haruyo; Kinomura, Masaru; Sugiyama, Hitoshi; Sonoda, Hikaru; Sato, Yasufumi; Makino, Hirofumi			Urinary and Plasma Levels of Vasohibin-1 Can Predict Renal Functional Deterioration in Patients with Renal Disorders	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NEGATIVE FEEDBACK REGULATOR; BASEMENT-MEMBRANE GLOMERULONEPHRITIS; GLOMERULAR CAPILLARY REPAIR; TYPE-2 DIABETIC MICE; REMNANT KIDNEY MODEL; IMPAIRED ANGIOGENESIS; HEMODIALYSIS-PATIENTS; EXPRESSION; VEGF	Vasohibin-1 (VASH-1) is a negative feedback regulator of angiogenesis, and a small vasohibin-binding protein (SVBP) serves as its secretory chaperone and contributes to its antiangiogenic effects. In the present study, we aimed to define the clinical significance of VASH-1 and SVBP in patients with chronic kidney disease (CKD). We recruited 67 Japanese hospitalized patients with renal disorders with (n = 45) or without (n = 22) renal biopsy samples and 10 Japanese healthy controls. We evaluated the correlations between the plasma and urinary levels of VASH-1/VASH-1-SVBP complex/SVBP and the clinicopathological parameters. The plasma levels of VASH-1 were inversely correlated with age and systolic and diastolic blood pressure and positively correlated with crescent formation. Increased plasma and urinary levels of VASH-1 and VASH-1-SVBP complex were significantly correlated with worse renal outcomes. These results demonstrate an association between elevated urinary and plasma levels of VASH-1 and progressive decline of the renal function, thus suggesting a potential role for VASH-1 in predicting a worse renal prognosis in patients with renal disease, including CKD.	[Hinamoto, Norikazu; Maeshima, Yohei; Saito, Daisuke; Yamasaki, Hiroko; Tanabe, Katsuyuki; Nasu, Tatsuyo; Watatani, Hiroyuki; Ujike, Haruyo; Kinomura, Masaru; Sugiyama, Hitoshi; Makino, Hirofumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008530, Japan; [Maeshima, Yohei] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Chron Kidney Dis & Cardiovasc Dis, Okayama 7008530, Japan; [Sugiyama, Hitoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Ctr Chron Kidney Dis & Peritoneal Dialysis, Okayama 7008530, Japan; [Sonoda, Hikaru] Shionogi, Discovery Res Labs, Osaka, Japan; [Sato, Yasufumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Vasc Biol, Sendai, Miyagi 980, Japan	Okayama University; Okayama University; Okayama University; Shionogi & Company Limited; Tohoku University	Maeshima, Y (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008530, Japan.	ymaeshim@md.okayama-u.ac.jp	Sato, Yasufumi/AAF-3367-2019; Tanabe, Katsuyuki/J-1341-2019; Sugiyama, Hitoshi/B-2252-2011	Tanabe, Katsuyuki/0000-0003-4767-5892; Sugiyama, Hitoshi/0000-0002-4127-6471	JSPS KAKENHI [20590958, 23591193]; Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University	A portion of this study was supported by JSPS KAKENHI Grant Number (20590958, 23591193, YM) and the Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University (2010-2013, YM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Flyvbjerg A, 2002, DIABETES, V51, P3090, DOI 10.2337/diabetes.51.10.3090; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Futrakul N, 2008, CLIN HEMORHEOL MICRO, V38, P201; Guo QY, 2009, NEPHROL DIAL TRANSPL, V24, P3468, DOI 10.1093/ndt/gfp315; Hara A, 2006, KIDNEY INT, V69, P1986, DOI 10.1038/sj.ki.5000439; Heishi T, 2010, AM J PATHOL, V176, P1950, DOI 10.2353/ajpath.2010.090829; Hirokoshi K, 2007, NEPHRON CLIN PRACT, V106, pC43, DOI 10.1159/000101483; Hohenstein B, 2010, NEPHROL DIAL TRANSPL, V25, P3170, DOI 10.1093/ndt/gfq200; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Hosaka T, 2009, AM J PATHOL, V175, P430, DOI 10.2353/ajpath.2009.080788; Kang DH, 2001, AM J KIDNEY DIS, V37, P601, DOI 10.1053/ajkd.2001.22087; Kang DH, 2001, J AM SOC NEPHROL, V12, P1434, DOI 10.1681/ASN.V1271434; Kang DH, 2001, J AM SOC NEPHROL, V12, P1448, DOI 10.1681/ASN.V1271448; Kim W, 2006, NY TIMES BK REV, P1; Kim YG, 2000, KIDNEY INT, V58, P2390, DOI 10.1046/j.1523-1755.2000.00422.x; Kitamoto Y, 1997, J CLIN INVEST, V99, P2351, DOI 10.1172/JCI119416; Lemley KV, 2002, KIDNEY INT, V61, P1475, DOI 10.1046/j.1523-1755.2002.00269.x; Li DJ, 2010, CANCER SCI, V101, P448, DOI 10.1111/j.1349-7006.2009.01388.x; Long DA, 2001, J AM SOC NEPHROL, V12, P2721, DOI 10.1681/ASN.V12122721; Macconi D, 2006, AM J PATHOL, V168, P42, DOI 10.2353/ajpath.2006.050398; Mallamaci F, 2008, J HYPERTENS, V26, P1875, DOI 10.1097/HJH.0b013e328307c3d2; Masuda Y, 2001, AM J PATHOL, V159, P599, DOI 10.1016/S0002-9440(10)61731-2; Miyashita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046459; Miyazaki Y, 2012, CLIN CANCER RES, V18, P4145, DOI 10.1158/1078-0432.CCR-12-0073; Nasu T, 2012, AM J PHYSIOL-RENAL, V302, pF1616, DOI 10.1152/ajprenal.00538.2011; Nasu T, 2009, DIABETES, V58, P2365, DOI 10.2337/db08-1790; Ostendorf T, 1999, J CLIN INVEST, V104, P913, DOI 10.1172/JCI6740; Rizkalla B, 2005, J HYPERTENS, V23, P153, DOI 10.1097/00004872-200501000-00026; Saito D, 2011, AM J PHYSIOL-RENAL, V300, pF873, DOI 10.1152/ajprenal.00503.2010; Shen JK, 2006, FASEB J, V20, P723, DOI 10.1096/fj.05-5046fje; Shimizu A, 2004, J AM SOC NEPHROL, V15, P2655, DOI 10.1097/01.ASN.0000141038.28733.F2; Shulman K, 1996, J AM SOC NEPHROL, V7, P661; Sung SH, 2006, J AM SOC NEPHROL, V17, P3093, DOI 10.1681/ASN.2006010064; Suzuki Y, 2010, J CELL SCI, V123, P3094, DOI 10.1242/jcs.067538; Tamaki K, 2010, CANCER SCI, V101, P1051, DOI 10.1111/j.1349-7006.2009.01483.x; Tamaki K, 2009, CANCER SCI, V100, P88, DOI 10.1111/j.1349-7006.2008.01015.x; Thorner PS, 2008, J AM SOC NEPHROL, V19, P495, DOI 10.1681/ASN.2006101115; Tufro A, 1999, J AM SOC NEPHROL, V10, P2125; Wang G, 2009, AM J HYPERTENS, V22, P300, DOI 10.1038/ajh.2008.360; Wang QZ, 2012, MED ONCOL, V29, P2727, DOI 10.1007/s12032-011-0106-7; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Watanabe T, 2012, TRANSPL P, V44, P1155, DOI 10.1016/j.transproceed.2012.02.022; Woolf AS, 2001, PEDIATR NEPHROL, V16, P177, DOI 10.1007/s004670000509; Yamashita H, 2006, BIOCHEM BIOPH RES CO, V345, P919, DOI 10.1016/j.bbrc.2006.04.176; Yoshinaga K, 2008, CANCER SCI, V99, P914, DOI 10.1111/j.1349-7006.2008.00777.x; Yoshinaga K, 2011, CANCER SCI, V102, P446, DOI 10.1111/j.1349-7006.2010.01812.x; Yuan HT, 2002, KIDNEY INT, V61, P2078, DOI 10.1046/j.1523-1755.2002.00381.x	50	26	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e96932	10.1371/journal.pone.0096932	http://dx.doi.org/10.1371/journal.pone.0096932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	25255225	gold, Green Submitted, Green Published			2022-12-27	WOS:000340947700007
J	Hung, TM; Ho, CM; Liu, YC; Lee, JL; Liao, YR; Wu, YM; Ho, MC; Chen, CH; Lai, HS; Lee, PH				Hung, Tzu-Min; Ho, Cheng-Maw; Liu, Yen-Chun; Lee, Jia-Ling; Liao, Yow-Rong; Wu, Yao-Ming; Ho, Ming-Chih; Chen, Chien-Hung; Lai, Hong-Shiee; Lee, Po-Huang			Up-Regulation of MicroRNA-190b Plays a Role for Decreased IGF-1 That Induces Insulin Resistance in Human Hepatocellular Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR-I; SERUM-INSULIN; BINDING-PROTEINS; CANCER-RISK; LIVER; EXPRESSION; DISEASE; CELLS; GENE; RNA	Background & Aims: Insulin-like growth factor, (IGF)-1, is produced mainly by the liver and plays important roles in promoting growth and regulating metabolism. Previous study reported that development of hepatocellular carcinoma (HCC) was accompanied by a significant reduction in serum IGF-1 levels. Here, we hypothesized that dysregulation of microRNAs (miRNA) in HCC can modulate IGF-1 expression post-transcriptionally. Methods: The miRNAs expression profiles in a dataset of 29 HCC patients were examined using illumina BeadArray. Specific miRNA (miR)-190b, which was significantly up-regulated in HCC tumor tissues when compared with paired non-tumor tissues, was among those predicted to interact with 3'-untranslated region (UTR) of IGF-1. In order to explore the regulatory effects of miR-190b on IGF-1 expression, luciferase reporter assay, quantitative real-time PCR, western blotting and immunofluorecence analysis were performed in HCC cells. Results: Overexpression of miR-190b in Huh7 cells attenuated the expression of IGF-1, whereas inhibition of miR-190b resulted in up-regulation of IGF-1. Restoration of IGF-1 expression reversed miR-190b-mediated impaired insulin signaling in Huh7 cells, supporting that IGF-1 was a direct and functional target of miR-190b. Additionally, low serum IGF-1 level was associated with insulin resistance and poor overall survival in HCC patients. Conclusions: Increased expression of miR-190 may cause decreased IGF-1 in HCC development. Insulin resistance appears to be a part of the physiopathologic significance of decreased IGF-1 levels in HCC progression. This study provides a novel miRNA-mediated regulatory mechanism for controlling IGF-1 expression in HCC and elucidates the biological relevance of this interaction in HCC.	[Hung, Tzu-Min; Ho, Cheng-Maw; Liu, Yen-Chun; Lee, Jia-Ling; Liao, Yow-Rong; Wu, Yao-Ming; Ho, Ming-Chih; Lai, Hong-Shiee; Lee, Po-Huang] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Hung, Tzu-Min; Ho, Cheng-Maw; Liu, Yen-Chun; Lee, Jia-Ling; Liao, Yow-Rong; Wu, Yao-Ming; Ho, Ming-Chih; Lai, Hong-Shiee; Lee, Po-Huang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hung, Tzu-Min; Liu, Yen-Chun] E DA Hosp, Dept Med Res, Kaohsiung, Taiwan; [Ho, Cheng-Maw] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chen, Chien-Hung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lee, Po-Huang] E DA Hosp, Dept Surg, Kaohsiung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; E-Da Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; E-Da Hospital	Lee, PH (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	pohuang1115@ntu.edu.tw	Ho, Ming-Chih/AAR-9783-2021; Ho, Cheng-Maw/H-5366-2019; Dawson, Angela/A-6872-2011; Hung, Tommy/E-7450-2014	Ho, Ming-Chih/0000-0003-3660-1062; Ho, Cheng-Maw/0000-0003-1874-7615; LEE, Regina Lai Tong/0000-0003-1884-8360; Dawson, Angela/0000-0003-0926-2202; LEE, PO-HUANG/0000-0001-5831-035X; Chiang, Vico/0000-0002-6973-7241; Hung, Tommy/0000-0002-4031-7606; WU, YAO-MING/0000-0002-1720-7863; Lai, Hong-Shiee/0000-0002-7958-2183	National Science Council [NSC-99-2314-B-002-068-MY2, NSC-101-2314-B -650-005, NSC-102-2314-B-650-007-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in part by research grants NSC-99-2314-B-002-068-MY2, NSC-101-2314-B -650-005 and NSC-102-2314-B-650-007-MY3 from the National Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Afroze, 2008, Expert Rev Cardiovasc Ther, V6, P1135, DOI 10.1586/14779072.6.8.1135; Adeli K, 2011, AM J PHYSIOL-ENDOC M, V301, pE1051, DOI 10.1152/ajpendo.00399.2011; Bonefeld K, 2011, LIVER INT, V31, P911, DOI 10.1111/j.1478-3231.2010.02428.x; Boni V, 2010, MOL CANCER THER, V9, P2265, DOI 10.1158/1535-7163.MCT-10-0061; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Budhu A, 2006, J LEUKOCYTE BIOL, V80, P1197, DOI 10.1189/jlb.0506297; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; DeBenedetti F, 1997, J CLIN INVEST, V99, P643, DOI 10.1172/JCI119207; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; Hung CH, 2010, WORLD J GASTROENTERO, V16, P2265, DOI 10.3748/wjg.v16.i18.2265; Hung TM, 2011, CARCINOGENESIS, V32, P1815, DOI 10.1093/carcin/bgr219; Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC; Kaseb AO, 2011, J CLIN ONCOL, V29, P3892, DOI 10.1200/JCO.2011.36.0636; Kawaguchi T, 2011, WORLD J HEPATOL, V3, P99, DOI 10.4254/wjh.v3.i5.99; Kim SJ, 2011, J CONTROL RELEASE, V155, P427, DOI 10.1016/j.jconrel.2011.06.026; Kwiecinski M, 2012, LAB INVEST, V92, P978, DOI 10.1038/labinvest.2012.70; Lee EK, 2010, ENDOCRINOLOGY, V151, P1403, DOI 10.1210/en.2009-1123; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Loeper S, 2008, REV ENDOCR METAB DIS, V9, P41, DOI 10.1007/s11154-007-9063-z; Mazziotti G, 2002, CANCER, V95, P2539, DOI 10.1002/cncr.11002; Miuma S, 2009, ONCOL REP, V22, P1415, DOI 10.3892/or_00000583; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046045; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Raddatz D, 2007, Z GASTROENTEROL, V45, P51, DOI 10.1055/s-2006-927394; Rajpathak SN, 2009, DIABETES-METAB RES, V25, P3, DOI 10.1002/dmrr.919; Rehem RNAMA, 2011, HEPATO-GASTROENTEROL, V58, P949; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Sceusi EL, 2011, HPB, V13, P369, DOI 10.1111/j.1477-2574.2011.00303.x; Schober ME, 2012, J NEUROTRAUM, V29, P2075, DOI 10.1089/neu.2011.2276; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Shao YY, 2012, CLIN CANCER RES, V18, P3992, DOI 10.1158/1078-0432.CCR-11-2853; Stuver SO, 2000, INT J CANCER, V87, P118, DOI 10.1002/1097-0215(20000701)87:1<118::AID-IJC17>3.0.CO;2-W; SU TS, 1989, CANCER RES, V49, P1773; Su WW, 2010, J CLIN LAB ANAL, V24, P195, DOI 10.1002/jcla.20320; Sumie S, 2007, ONCOL REP, V18, P545; Svoboda M, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-195; Thissen JP, 1997, ENDOCRINOLOGY, V138, P1078, DOI 10.1210/en.138.3.1078; Tikhanovich I, 2013, J GASTROEN HEPATOL, V28, P125, DOI 10.1111/jgh.12021; Tsugane S, 2010, CANCER SCI, V101, P1073, DOI 10.1111/j.1349-7006.2010.01521.x; Wang XH, 2009, CLIN EXP PHARMACOL P, V36, P181, DOI 10.1111/j.1440-1681.2008.05057.x; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Yu R, 2003, MOL CELL ENDOCRINOL, V204, P31, DOI 10.1016/S0303-7207(03)00145-X; Yu XY, 2008, BIOCHEM BIOPH RES CO, V376, P548, DOI 10.1016/j.bbrc.2008.09.025	45	66	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89446	10.1371/journal.pone.0089446	http://dx.doi.org/10.1371/journal.pone.0089446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586785	gold, Green Submitted, Green Published			2022-12-27	WOS:000331714700120
J	Foley, KA; Ossenkopp, KP; Kavaliers, M; MacFabe, DF				Foley, Kelly A.; Ossenkopp, Klaus-Peter; Kavaliers, Martin; MacFabe, Derrick F.			Pre- and Neonatal Exposure to Lipopolysaccharide or the Enteric Metabolite, Propionic Acid, Alters Development and Behavior in Adolescent Rats in a Sexually Dimorphic Manner	PLOS ONE			English	Article							MATERNAL IMMUNE ACTIVATION; AUTISM SPECTRUM DISORDER; FETAL-BRAIN DEVELOPMENT; BODY-WEIGHT REGULATION; ANXIETY-LIKE BEHAVIOR; CHAIN FATTY-ACIDS; VALPROIC ACID; GENE-EXPRESSION; PRENATAL STRESS; BACTERIAL-ENDOTOXIN	Alterations in the composition of the gut microbiome and/or immune system function may have a role in the development of autism spectrum disorders (ASD). The current study examined the effects of prenatal and early life administration of lipopolysaccharide (LPS), a bacterial mimetic, and the short chain fatty acid, propionic acid (PPA), a metabolic fermentation product of enteric bacteria, on developmental milestones, locomotor activity, and anxiety-like behavior in adolescent male and female offspring. Pregnant Long-Evans rats were subcutaneously injected once a day with PPA (500 mg/kg) on gestation days G12-16, LPS (50 mu g/kg) on G15-16, or vehicle control on G12-16 or G15-16. Male and female offspring were injected with PPA (500 mg/kg) or vehicle twice a day, every second day from postnatal days (P) 10-18. Physical milestones and reflexes were monitored in early life with prenatal PPA and LPS inducing delays in eye opening. Locomotor activity and anxiety were assessed in adolescence (P40-42) in the elevated plus maze (EPM) and open-field. Prenatal and postnatal treatments altered behavior in a sex-specific manner. Prenatal PPA decreased time spent in the centre of the open-field in males and females while prenatal and postnatal PPA increased anxiety behavior on the EPM in female rats. Prenatal LPS did not significantly influence those behaviors. Evidence for the double hit hypothesis was seen as females receiving a double hit of PPA (prenatal and postnatal) displayed increased repetitive behavior in the open-field. These results provide evidence for the hypothesis that by-products of enteric bacteria metabolism such as PPA may contribute to ASD, altering development and behavior in adolescent rats similar to that observed in ASD and other neurodevelopmental disorders.	[Foley, Kelly A.; Ossenkopp, Klaus-Peter; Kavaliers, Martin] Univ Western Ontario, Grad Program Neurosci, London, ON, Canada; [Foley, Kelly A.; Ossenkopp, Klaus-Peter; Kavaliers, Martin; MacFabe, Derrick F.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Ossenkopp, Klaus-Peter; Kavaliers, Martin] Univ Western Ontario, Dept Psychol, Kilee Patchell Evans Autism Res Grp, London, ON, Canada; [MacFabe, Derrick F.] Univ Western Ontario, Dept Psychol, Div Dev Disabil, Kilee Patchell Evans Autism Res Grp, London, ON, Canada; [MacFabe, Derrick F.] Univ Western Ontario, Dept Psychiat, London, ON N6A 3K7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Foley, KA (corresponding author), Univ Western Ontario, Grad Program Neurosci, London, ON, Canada.	kfoley6@uwo.ca	Ossenkopp, Klaus-Peter/A-4810-2008; Foley, Kitty-Rose/C-8800-2018; Tonge, Bruce/T-8036-2018	Ossenkopp, Klaus-Peter/0000-0001-7391-3239; Foley, Kitty-Rose/0000-0002-1956-4995; Girdler, Sonya/0000-0001-7992-0800; Tonge, Bruce/0000-0002-4236-9688	GoodLife Children's Charities; Autism Research Institute (ARI); Natural Science and Engineering Research Council of Canada; Ontario Graduate Scholarship	GoodLife Children's Charities; Autism Research Institute (ARI); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This research was supported by contributions from GoodLife Children's Charities and Autism Research Institute (ARI) to Derrick MacFabe and by Natural Science and Engineering Research Council of Canada Grants to Klaus-Peter Ossenkopp and Martin Kavaliers. Kelly Foley was supported by the Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007; Al-Owain M, 2013, JIMD REP, V7, P63, DOI 10.1007/8904_2012_143; Baharnoori M, 2012, SCHIZOPHRENIA BULL, V38, P444, DOI 10.1093/schbul/sbq098; Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4; Bennet R, 2002, INFECTION, V30, P158, DOI 10.1007/s15010-002-2140-z; Bloise E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065728; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Brusque AM, 1999, PHARMACOL BIOCHEM BE, V64, P529, DOI 10.1016/S0091-3057(99)00127-6; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Challis J, 2013, PLACENTA, V34, P95, DOI 10.1016/j.placenta.2012.11.007; D'Souza A, 2009, BRAIN RES, V1247, P1, DOI 10.1016/j.brainres.2008.09.088; DAWSON DA, 1991, TERATOLOGY, V44, P531, DOI 10.1002/tera.1420440507; DeCastro M, 2005, MOL BRAIN RES, V142, P28, DOI 10.1016/j.molbrainres.2005.09.002; Dendrinos G, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00068; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Drude S, 2011, LAB ANIMAL, V40, P119, DOI 10.1038/laban0411-119; El-Ansary AK, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-142; Enayati M, 2012, BRAIN RES BULL, V87, P295, DOI 10.1016/j.brainresbull.2011.08.015; Fatemi SH, 2002, BIOL PSYCHIAT, V52, P805, DOI 10.1016/S0006-3223(02)01430-0; Feliz Brady, 2003, Arch Pathol Lab Med, V127, pe325; Finegold SM, 2012, ANAEROBE, V18, P260, DOI 10.1016/j.anaerobe.2011.12.018; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Fortier ME, 2004, J PSYCHIATR RES, V38, P335, DOI 10.1016/j.jpsychires.2003.10.001; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143; Garbett KA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.24; Goehler LE, 2008, BRAIN BEHAV IMMUN, V22, P354, DOI 10.1016/j.bbi.2007.08.009; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hanstock TL, 2004, PHYSIOL BEHAV, V82, P357, DOI 10.1016/j.physbeh.2004.04.002; Howland JG, 2012, NEUROSCIENCE, V201, P184, DOI 10.1016/j.neuroscience.2011.11.011; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Iwasa T, 2010, INT J DEV NEUROSCI, V28, P119, DOI 10.1016/j.ijdevneu.2009.08.015; Lin YL, 2012, BRAIN BEHAV IMMUN, V26, P459, DOI 10.1016/j.bbi.2011.12.003; Lynn DA, 2009, DEV PSYCHOBIOL, V51, P513, DOI 10.1002/dev.20386; Lyte M, 1998, PHYSIOL BEHAV, V65, P63, DOI 10.1016/S0031-9384(98)00145-0; MacFabe D., 2008, AM J BIOCH BIOTECHNO, V4, P146, DOI 10.3844/ajbbsp.2008.146.166; MacFabe DF, 2007, BEHAV BRAIN RES, V176, P149, DOI 10.1016/j.bbr.2006.07.025; MacFabe Derrick F., 2012, Microbial Ecology in Health and Disease, V23, P19260, DOI 10.3402/mehd.v23i0.19260; Mandy W, 2012, J AUTISM DEV DISORD, V42, P1304, DOI 10.1007/s10803-011-1356-0; Meyer U, 2014, BIOL PSYCHIAT, V75, P307, DOI 10.1016/j.biopsych.2013.07.011; Mitchell S, 2011, DEV DISABIL RES REV, V17, P130, DOI 10.1002/ddrr.1107; Muhammad A, 2011, BRAIN RES, V1400, P53, DOI 10.1016/j.brainres.2011.05.038; Nagai A, 2010, PLACENTA, V31, P126, DOI 10.1016/j.placenta.2009.11.013; Nouel D, 2012, EUR NEUROPSYCHOPHARM, V22, P300, DOI 10.1016/j.euroneuro.2011.08.001; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; Oblak AL, 2010, J NEUROCHEM, V114, P1414, DOI 10.1111/j.1471-4159.2010.06858.x; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Oskvig DB, 2012, BRAIN BEHAV IMMUN, V26, P623, DOI 10.1016/j.bbi.2012.01.015; Ossenkopp Klaus-Peter, 1996, P33; Ossenkopp KP, 2012, BEHAV BRAIN RES, V227, P134, DOI 10.1016/j.bbr.2011.10.045; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Reynolds S, 2012, DEV NEUROSCI-BASEL, V34, P258, DOI 10.1159/000336646; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Roullet FI, 2013, NEUROTOXICOL TERATOL, V36, P47, DOI 10.1016/j.ntt.2013.01.004; Ryabinin AE, 1999, PHARMACOL BIOCHEM BE, V63, P143, DOI 10.1016/S0091-3057(98)00239-1; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Schneider T, 2008, PSYCHONEUROENDOCRINO, V33, P728, DOI 10.1016/j.psyneuen.2008.02.011; Shi LM, 2005, INT J DEV NEUROSCI, V23, P299, DOI 10.1016/j.ijdevneu.2004.05.005; Skokauskas N, 2010, PSYCHOPATHOLOGY, V43, P8, DOI 10.1159/000255958; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Spencer SJ, 2007, AM J PHYSIOL-REG I, V293, pR581, DOI 10.1152/ajpregu.00262.2007; Stilling RM, 2014, GENES BRAIN BEHAV, V13, P69, DOI 10.1111/gbb.12109; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tenk CM, 2008, INT J DEV NEUROSCI, V26, P331, DOI 10.1016/j.ijdevneu.2008.01.001; Thomas RH, 2010, J NEUROCHEM, V113, P515, DOI 10.1111/j.1471-4159.2010.06614.x; Tjellstrom B, 2012, SCAND J GASTROENTERO, V47, P1454, DOI 10.3109/00365521.2012.703234; Ushigome F, 2001, EUR J PHARMACOL, V417, P169, DOI 10.1016/S0014-2999(01)00912-8; Wagner GC, 2006, J AUTISM DEV DISORD, V36, P779, DOI 10.1007/s10803-006-0117-y; Walker AK, 2009, PSYCHONEUROENDOCRINO, V34, P1515, DOI 10.1016/j.psyneuen.2009.05.010; Wang L, 2012, DIGEST DIS SCI, V57, P2096, DOI 10.1007/s10620-012-2167-7; Weinstock M, 2011, STRESS, V14, P604, DOI 10.3109/10253890.2011.588294; Williams BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024585; Wilson CA, 2013, BEHAV BRAIN RES, V238, P279, DOI 10.1016/j.bbr.2012.10.003; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhao JP, 2013, P NATL ACAD SCI USA, V110, P707, DOI 10.1073/pnas.1215854110	77	90	94	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87072	10.1371/journal.pone.0087072	http://dx.doi.org/10.1371/journal.pone.0087072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	25259577	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100249
J	Hou, X; Zhang, JF; Ahmad, H; Zhang, H; Xu, ZW; Wang, T				Hou, Xiang; Zhang, Jingfei; Ahmad, Hussain; Zhang, Hao; Xu, Ziwei; Wang, Tian			Evaluation of Antioxidant Activities of Ampelopsin and Its Protective Effect in Lipopolysaccharide-Induced Oxidative Stress Piglets	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; LIVER-INJURY; ENDOTOXIN; DAMAGE; ERYTHROCYTES; EXTRACT; CELL; HEMOLYSIS; TOXICITY; FRUITS	The aim of this study was to investigate the antioxidant potential of ampelopsin (APS) by using various methods in vitro, as well as to determine effects of APS on LPS-induced oxidative stress in piglets. The results showed that APS exhibited excellent free radical scavenging by DPPH, ABTS, O-2 center dot(-), H2O2 and ferric reducing antioxidant power. Ampelopsin also protected pig erythrocytes against AAPH-induced apoptosis and hemolysis, decreased total superoxide dismutase activity, and increased lipid peroxidation. Furthermore the results demonstrated that APS enhanced the total antioxidant capacity and decreased the malondialdehyde and protein carbonyl contents in LPS-treated piglets. The results of the present investigation suggest that APS possesses a strong antioxidant activity and alleviates LPS-induced oxidative stress, possibly due to its ability to prevent reactive oxygen species.	[Hou, Xiang; Zhang, Jingfei; Ahmad, Hussain; Zhang, Hao; Xu, Ziwei; Wang, Tian] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Xu, Ziwei] Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou, Zhejiang, Peoples R China	Nanjing Agricultural University; Zhejiang Academy of Agricultural Sciences	Xu, ZW (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	xzwfyz@sina.com	Ahmad, hussain/AAP-9386-2020; Zhang, Jing/HII-4294-2022	hou, xinguo/0000-0003-2045-1290	Science Technology Department of Zhejiang Province; Modern Agro-industry Technology Research Sytem of China [CARS-36]	Science Technology Department of Zhejiang Province; Modern Agro-industry Technology Research Sytem of China	This study was funded by the Science Technology Department of Zhejiang Province, and the Modern Agro-industry Technology Research Sytem of China (CARS-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalakova NI, 2011, TOXICOL IN VITRO, V25, P1609, DOI 10.1016/j.tiv.2011.06.006; Ahmad H, 2012, J AGR FOOD CHEM, V60, P7111, DOI 10.1021/jf3017207; Ak T, 2008, CHEM-BIOL INTERACT, V174, P27, DOI 10.1016/j.cbi.2008.05.003; Alvarez-Suarez JM, 2012, FOOD CHEM TOXICOL, V50, P1508, DOI 10.1016/j.fct.2012.01.042; Arora A, 2000, ARCH BIOCHEM BIOPHYS, V373, P102, DOI 10.1006/abbi.1999.1525; Bae SH, 2007, LWT-FOOD SCI TECHNOL, V40, P955, DOI 10.1016/j.lwt.2006.06.007; Bagchi D, 1995, TOXICOLOGY, V104, P129, DOI 10.1016/0300-483X(95)03156-A; Ben-Shaul V, 2001, TOXICOL LETT, V123, P1, DOI 10.1016/S0378-4274(01)00369-1; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Cadenas S, 1998, PHARMACOL TOXICOL, V82, P11, DOI 10.1111/j.1600-0773.1998.tb01391.x; Dai F, 2006, LIFE SCI, V78, P2488, DOI 10.1016/j.lfs.2005.10.009; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Diplock AT, 1998, BRIT J NUTR, V80, pS77, DOI 10.1079/BJN19980106; Dudonne S, 2009, J AGR FOOD CHEM, V57, P1768, DOI 10.1021/jf803011r; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Feng LJ, 2011, FOOD RES INT, V44, P404, DOI 10.1016/j.foodres.2010.09.035; GALANOS C, 1993, MEDIAT INFLAMM, V2, pS11, DOI 10.1155/S0962935193000687; Gunduz K, 2004, CLIN EXP DERMATOL, V29, P176, DOI 10.1111/j.1365-2230.2004.01488.x; Guo CJ, 2003, NUTR RES, V23, P1719, DOI 10.1016/j.nutres.2003.08.005; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; HEWETT JA, 1992, LAB INVEST, V66, P347; Kang KS, 2007, PHYTOMEDICINE, V14, P840, DOI 10.1016/j.phymed.2007.01.002; Kaur G, 2006, CLIN EXP IMMUNOL, V145, P313, DOI 10.1111/j.1365-2249.2006.03108.x; Kaur G, 2006, TOXICOLOGY, V226, P152, DOI 10.1016/j.tox.2006.06.018; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lopez-Revuelta A, 2006, CHEM-BIOL INTERACT, V161, P79, DOI 10.1016/j.cbi.2006.03.004; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Ma J, 2004, J AGR FOOD CHEM, V52, P5873, DOI 10.1021/jf049950k; Martinez V, 2012, J AGR FOOD CHEM, V60, P4090, DOI 10.1021/jf2051784; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miliauskas G, 2004, FOOD CHEM, V85, P231, DOI 10.1016/j.foodchem.2003.05.007; Minetti M, 2008, METHOD ENZYMOL, V440, P253, DOI [10.1016/S0076-6879(07)00816-6, 10.1016/S0076-6879(07)00876-6]; Murakami T, 2004, BIOFACTORS, V21, P175, DOI 10.1002/biof.552210136; Nemzek JA, 2008, COMPARATIVE MED, V58, P120; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Okoko T, 2009, TROP J PHARM RES, V8, P27; Persinger RL, 2002, MOL CELL BIOCHEM, V234, P71, DOI 10.1023/A:1015973530559; Pulido R, 2000, J AGR FOOD CHEM, V48, P3396, DOI 10.1021/jf9913458; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Roberts RA, 2007, TOXICOL SCI, V96, P2, DOI 10.1093/toxsci/kfl173; SATO Y, 1995, BIOCHEMISTRY-US, V34, P8940, DOI 10.1021/bi00028a002; Sautebin L, 2004, PLANTA MED, V70, P745, DOI 10.1055/s-2004-827206; SUGINO K, 1987, SURGERY, V101, P746; WALLING C, 1975, ACCOUNTS CHEM RES, V8, P125, DOI 10.1021/ar50088a003; Wang X, 2010, J ETHNOPHARMACOL, V127, P424, DOI 10.1016/j.jep.2009.10.022; Westphal M, 2003, INTENS CARE MED, V29, P301, DOI 10.1007/s00134-002-1546-5; Xu RH, 2011, EUR FOOD RES TECHNOL, V232, P231, DOI 10.1007/s00217-010-1382-8; YEAGLE PL, 1982, BIOPHYS J, V37, P227, DOI 10.1016/S0006-3495(82)84672-9; YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007; Yu R, 2000, MOL PHARMACOL, V58, P431, DOI 10.1124/mol.58.2.431	52	65	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108314	10.1371/journal.pone.0108314	http://dx.doi.org/10.1371/journal.pone.0108314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268121	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700078
J	Hou, XG; Wang, C; Zhang, XP; Zhao, XM; Wang, YL; Li, CQ; Li, M; Wang, SY; Yang, WF; Ma, ZQ; Ma, AX; Zheng, HZ; Wu, JH; Sun, Y; Song, J; Lin, P; Liang, K; Gong, L; Wang, MJ; Liu, FQ; Li, WJ; Xiao, J; Yan, F; Yang, JP; Wang, LS; Tian, M; Liu, JD; Zhao, RX; Chen, SH; Chen, L				Hou, Xinguo; Wang, Chuan; Zhang, Xiuping; Zhao, Xiangmin; Wang, Yulian; Li, Chengqiao; Li, Mei; Wang, Shaoyuan; Yang, Weifang; Ma, Zeqiang; Ma, Aixia; Zheng, Huizhen; Wu, Jiahui; Sun, Yu; Song, Jun; Lin, Peng; Liang, Kai; Gong, Lei; Wang, Meijian; Liu, Fuqiang; Li, Wenjuan; Xiao, Juan; Yan, Fei; Yang, Junpeng; Wang, Lingshu; Tian, Meng; Liu, Jidong; Zhao, Ruxing; Chen, Shihong; Chen, Li			Triglyceride Levels Are Closely Associated with Mild Declines in Estimated Glomerular Filtration Rates in Middle-Aged and Elderly Chinese with Normal Serum Lipid Levels	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RISK-FACTORS; DIABETIC INDIVIDUALS; POPULATION; PREVALENCE; MORTALITY; PREDICTION; CREATININE; CANCERS; CKD	Objective: To investigate the relationship between lipid profiles [including total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C)] and a mild decline in the estimated glomerular filtration rate (eGFR) in subjects with normal serum lipid levels. Design and Methods: In this study, we included 2647 participants who were >= 40 years old and had normal serum lipid levels. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation was used to estimate the GFR. A mildly reduced eGFR was defined as 60-90 mL/min/1.73 m(2). First, multiple linear regression analysis was used to estimate the association of lipid profiles with the eGFR. Then, the levels of each lipid component were divided into four groups, using the 25th, 50th and 75th percentiles as cut-off points. Finally, multiple logistic regression analysis was used to investigate the association of different lipid components with the risk of mildly reduced eGFR. Results: In the group with a mildly reduced eGFR, TG and LDL-C levels were significantly increased, but HDL-C levels were significantly decreased. After adjusting for age, gender, body mass index (BMI), systolic blood pressure (SBP), glycated hemoglobin (HbA(1c)), smoking and drinking, only TC and TG were independently related to the eGFR. Additionally, only TG showed a linear relationship with an increased risk of a mildly reduced eGFR, with the highest quartile group (TG: 108-150 mg/dl [1.22-1.70 mmol/L]) having a significantly increased risk after adjusting for the above factors. Conclusions: Triglyceride levels are closely associated with a mildly reduced eGFR in subjects with normal serum lipid levels. Dyslipidemia with lower TG levels could be used as new diagnostic criteria for subjects with mildly reduced renal function.	[Hou, Xinguo; Wang, Chuan; Ma, Aixia; Zheng, Huizhen; Wu, Jiahui; Sun, Yu; Song, Jun; Lin, Peng; Liang, Kai; Gong, Lei; Wang, Meijian; Liu, Fuqiang; Li, Wenjuan; Xiao, Juan; Yan, Fei; Yang, Junpeng; Wang, Lingshu; Tian, Meng; Liu, Jidong; Zhao, Ruxing] Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan, Shandong, Peoples R China; [Hou, Xinguo; Wang, Chuan; Ma, Aixia; Zheng, Huizhen; Wu, Jiahui; Sun, Yu; Song, Jun; Lin, Peng; Liang, Kai; Gong, Lei; Wang, Meijian; Liu, Fuqiang; Li, Wenjuan; Xiao, Juan; Yan, Fei; Yang, Junpeng; Wang, Lingshu; Tian, Meng; Liu, Jidong; Zhao, Ruxing; Chen, Li] Shandong Univ, Inst Endocrinol & Metab, Jinan, Shandong, Peoples R China; [Zhang, Xiuping; Zhao, Xiangmin] Shantui Community Hlth Ctr, Jining, Shandong, Peoples R China; [Wang, Yulian; Li, Chengqiao; Li, Mei] Second Peoples Hosp Jining, Dept Endocrinol, Jining, Shandong, Peoples R China; [Wang, Shaoyuan; Yang, Weifang] Lukang Hosp Jining, Jining, Shandong, Peoples R China; [Ma, Zeqiang] Corp Hosp, China Natl Heavy Duty Truck Grp, Jinan, Shandong, Peoples R China; [Chen, Shihong] Shandong Univ, Hosp 2, Dept Endocrinol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Chen, SH (corresponding author), Shandong Univ, Hosp 2, Dept Endocrinol, Jinan, Shandong, Peoples R China.	515751512@qq.com; wangchuansdu.edu@163.com	Ahmad, hussain/AAP-9386-2020; Zhang, Jing/HII-4294-2022	hou, xinguo/0000-0003-2045-1290	Chinese Society of Endocrinology; National Natural Science Foundation of China [81100617]; Medical and Health Science and Technology Development Projects of Shandong Province [2011HD005]; National Science and Technology Support Plan [2009BAI80B04]; Natural Science Foundation of Shandong Province [ZR2012HM014]; International Science and Technology Projects of Shandong Province [2012GGE27126]; Business Plan of Jinan Students Studying Abroad [20110407]; special scientific research fund of clinical medicine of Chinese Medical Association [12030420342]	Chinese Society of Endocrinology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical and Health Science and Technology Development Projects of Shandong Province; National Science and Technology Support Plan; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); International Science and Technology Projects of Shandong Province; Business Plan of Jinan Students Studying Abroad; special scientific research fund of clinical medicine of Chinese Medical Association	This study was supported by grants from the Chinese Society of Endocrinology, the National Natural Science Foundation of China (No. 81100617), the Medical and Health Science and Technology Development Projects of Shandong Province (2011HD005), the National Science and Technology Support Plan (2009BAI80B04), the Natural Science Foundation of Shandong Province (ZR2012HM014), the International Science and Technology Projects of Shandong Province (2012GGE27126), the Business Plan of Jinan Students Studying Abroad (20110407), and the special scientific research fund of clinical medicine of Chinese Medical Association (12030420342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Bi YF, 2014, J DIABETES, V6, P147, DOI 10.1111/1753-0407.12108; Campbell NG, 2012, HEART, V98, P42, DOI 10.1136/heartjnl-2011-300024; Chen W, 2009, NEPHROL DIAL TRANSPL, V24, P1205, DOI 10.1093/ndt/gfn604; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036332; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Delanaye P, 2013, NAT REV NEPHROL, V9, P513, DOI 10.1038/nrneph.2013.143; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Hermans MMH, 2007, J AM SOC NEPHROL, V18, P1942, DOI 10.1681/ASN.2006111217; Iseki Kunitoshi, 2014, Clin Exp Nephrol, V18, P185, DOI 10.1007/s10157-013-0891-8; Jessani S, 2014, AM J KIDNEY DIS, V63, P49, DOI 10.1053/j.ajkd.2013.07.023; Ji BL, 2013, CLIN BIOCHEM, V46, P750, DOI 10.1016/j.clinbiochem.2013.01.011; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Natali A, 2013, NUTR METAB CARDIOVAS; Ning G, 2012, J DIABETES, V4, P172, DOI 10.1111/j.1753-0407.2012.00182.x; Noborisaka Yuka, 2013, Nephrourol Mon, V5, P655, DOI 10.5812/numonthly.3527; Roy SK, 2011, VASC HEALTH RISK MAN, V7, P719, DOI 10.2147/VHRM.S24536; Shankar A, 2006, AM J EPIDEMIOL, V164, P263, DOI 10.1093/aje/kwj173; Tomonaga Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067848; Tonelli M, 2014, ANN INTERN MED, V160, P182, DOI 10.7326/M13-2453; Upadhyay A, 2012, ANN INTERN MED, V157, P251, DOI 10.7326/0003-4819-157-4-201208210-00005; Vaziri ND, 2011, BLOOD PURIFICAT, V31, P189, DOI 10.1159/000321845; Wang F, 2010, NEPHROL DIAL TRANSPL, V25, P3924, DOI 10.1093/ndt/gfq327; Wanner C, 2014, KIDNEY INT, V85, P1303, DOI 10.1038/ki.2014.31; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang X, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-19	33	65	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e106778	10.1371/journal.pone.0106778	http://dx.doi.org/10.1371/journal.pone.0106778			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25268121	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500005
J	Liu, WQ; Zhang, SW; Zhao, D; Zou, HW; Sun, NY; Liang, X; Dard, M; Lanske, B; Yuan, Q				Liu, Weiqing; Zhang, Shiwen; Zhao, Dan; Zou, Huawei; Sun, Ningyuan; Liang, Xing; Dard, Michel; Lanske, Beate; Yuan, Quan			Vitamin D Supplementation Enhances the Fixation of Titanium Implants in Chronic Kidney Disease Mice	PLOS ONE			English	Article							POSITION STATEMENT; RENAL-FAILURE; OSSEOINTEGRATION; PREVALENCE; BONE; DEFICIENCY; ASSOCIATION; ADOLESCENTS; CHILDREN; PATIENT	Vitamin D (Vit D) deficiency is a common condition in chronic kidney disease (CKD) patients that negatively affects bone regeneration and fracture healing. Previous study has shown that timely healing of titanium implants is impaired in CKD. This study aimed to investigate the effect of Vit D supplementation on implant osseointegration in CKD mice. Uremia was induced by 5/6 nephrectomy in C57BL mice. Eight weeks after the second renal surgery, animals were given 1,25(OH)(2)D-3 three times a week intraperitoneally for four weeks. Experimental titanium implants were inserted into the distal end of femurs two weeks later. Serum measurements confirmed decreased 1,25(OH)(2)D levels in CKD mice, which could be successfully corrected by Vit D injections. Moreover, the hyperparathyroidism observed in CKD mice was also corrected. Xray examination and histological sections showed successful osseointegration in these mice. Histomorphometrical analysis revealed that the bone-implant contact (BIC) ratio and bone volume (BV/TV) around the implant were significantly increased in the Vit D-supplementation group. In addition, resistance of the implant, as measured by a push-in method, was significantly improved compared to that in the vehicle group. These results demonstrate that Vit D supplementation is an effective approach to improve the fixation of titanium implants in CKD.	[Liu, Weiqing; Zhang, Shiwen; Zhao, Dan; Zou, Huawei; Sun, Ningyuan; Liang, Xing; Yuan, Quan] Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China; [Dard, Michel] NYU, Coll Dent, Dept Periodontol & Implant Dent, New York, NY USA; [Lanske, Beate] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Sichuan University; New York University; Harvard University; Harvard School of Dental Medicine	Yuan, Q (corresponding author), Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China.	yuanquan@scu.edu.cn	yuan, quan/GZM-5597-2022	Yuan, Quan/0000-0002-2836-1081; Lanske, Beate/0000-0003-4638-804X; zhao, dan/0000-0002-0037-1464	National Natural Science Foundation of China [NSFC 81371173]; New Century Excellent Talents in University [NCET-12-0379]; International Team of Implantology [ITI 717_2010]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01-073944]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); International Team of Implantology; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Natural Science Foundation of China (NSFC 81371173), New Century Excellent Talents in University (NCET-12-0379) and International Team of Implantology (ITI 717_2010) to Q.Y., and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, R01-073944) to B.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan Ali, 2012, Dent Res J (Isfahan), V9, P582; Alvim-Pereira F, 2008, CLIN ORAL IMPLAN RES, V19, P786, DOI 10.1111/j.1600-0501.2008.01532.x; Andress DL, 2008, KIDNEY INT, V73, P1345, DOI 10.1038/ki.2008.60; Andress DL, 2005, SEMIN DIALYSIS, V18, P315, DOI 10.1111/j.1525-139X.2005.18408.x; Bayraktar G, 2007, ORAL DIS, V13, P393, DOI 10.1111/j.1601-0825.2006.01297.x; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Brinker MR, 2007, J ORTHOP TRAUMA, V21, P557, DOI 10.1097/BOT.0b013e31814d4dc6; Chandra Prakash, 2008, Endocr Pract, V14, P10; Cho YJ, 2011, INT J ORAL MAX IMPL, V26, P1225; Choukroun J, 2013, J ORAL IMPLANTOL; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Craig RG, 2007, NEPHROL DIAL TRANSPL, V22, P312, DOI 10.1093/ndt/gfl604; Davidovich E, 2005, PEDIATR DENT, V27, P98; Davidovich E, 2005, J CLIN PERIODONTOL, V32, P1076, DOI 10.1111/j.1600-051X.2005.00812.x; DeRossi SS, 1996, J AM DENT ASSOC, V127, P211, DOI 10.14219/jada.archive.1996.0171; Dijakiewicz M, 2007, NEPHROL DIAL TRANSPL, V22, P2722, DOI 10.1093/ndt/gfm317; Dvorak G, 2012, CLIN ORAL IMPLAN RES, V23, P1308, DOI 10.1111/j.1600-0501.2011.02346.x; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Gonzalez EA, 2004, AM J NEPHROL, V24, P503, DOI 10.1159/000081023; Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Ishimura E, 1999, KIDNEY INT, V55, P1019, DOI 10.1046/j.1523-1755.1999.0550031019.x; Jingushi S, 1998, ENDOCRINOLOGY, V139, P1467, DOI 10.1210/en.139.4.1467; Cervero AJ, 2008, MED ORAL PATOL ORAL, V13, pE419; Kandula P, 2011, CLIN J AM SOC NEPHRO, V6, P50, DOI 10.2215/CJN.03940510; Kelly J, 2009, J PROSTHODONT, V18, P473, DOI 10.1111/j.1532-849X.2009.00446.x; Kimura Genjiro, 2007, Clin Exp Nephrol, V11, P188, DOI 10.1007/s10157-007-0474-7; LaClair RE, 2005, AM J KIDNEY DIS, V45, P1026, DOI 10.1053/j.ajkd.2005.02.029; Lee MM, 2010, J PERIODONTOL, V81, P300, DOI 10.1902/jop.2009.090379; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Mengatto CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015848; Messier MD, 2012, J PERIODONTOL, V83, P602, DOI 10.1902/jop.2011.110306; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Nickolas TL, 2010, J AM SOC NEPHROL, V21, P1371, DOI 10.1681/ASN.2009121208; Pillar R, 2013, HYPERTENS RES, V36, P428, DOI 10.1038/hr.2012.230; Rouached M, 2008, KIDNEY INT, V74, P389, DOI 10.1038/ki.2008.169; Ruospo M, 2013, NEPHROL DIAL TRANSPL; Saran R, 2010, ADV CHRONIC KIDNEY D, V17, P271, DOI 10.1053/j.ackd.2010.03.001; Stellingsma C, 2004, CRIT REV ORAL BIOL M, V15, P240, DOI 10.1177/154411130401500406; Wu YY, 2013, BONE, V52, P1, DOI 10.1016/j.bone.2012.09.005; Xu B, 2009, J DENT RES, V88, P1003, DOI 10.1177/0022034509346928; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhou CC, 2012, OR SURG OR MED OR PA, V114, pS174, DOI 10.1016/j.oooo.2011.09.030; Zou HW, 2013, BONE, V56, P410, DOI 10.1016/j.bone.2013.07.014	46	38	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95689	10.1371/journal.pone.0095689	http://dx.doi.org/10.1371/journal.pone.0095689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752599	Green Published, gold			2022-12-27	WOS:000335227400101
